PMID,NCTID,CombnID,Drug_Name,Dose_Level,Dose_Value,Dose_Unit,Frequency,Schedule,Comments
27853996,NCT01451632,4,seribantumab,-1,6,mg/kg,1,weekly,NA
27853996,NCT01451632,4,cetuximab,-1,NA,mg/m2,0,NA,NA
27853996,NCT01451632,4,cetuximab,-1,400,mg/m2,1,loading dose,NA
27853996,NCT01451632,4,cetuximab,-1,200,mg/m2,1,weekly,NA
27853996,NCT01451632,4,seribantumab,1,12,mg/kg,1,weekly,NA
27853996,NCT01451632,4,cetuximab,1,400,mg/m2,1,loading dose,NA
27853996,NCT01451632,4,cetuximab,1,200,mg/m2,1,weekly,NA
27853996,NCT01451632,4,seribantumab,2,20,mg/kg,1,weekly,dose level 2a
27853996,NCT01451632,4,cetuximab,2,400,mg/m2,1,loading dose,dose level 2a
27853996,NCT01451632,4,cetuximab,2,200,mg/m2,1,weekly,dose level 2a
27853996,NCT01451632,4,seribantumab,2.5,12,mg/kg,1,weekly,dose level 2b
27853996,NCT01451632,4,cetuximab,2.5,400,mg/m2,1,loading dose,dose level 2b
27853996,NCT01451632,4,cetuximab,2.5,250,mg/m2,1,weekly,dose level 2b
27853996,NCT01451632,4,seribantumab,3,40,mg/kg,1,loading dose,dose level 3a
27853996,NCT01451632,4,seribantumab,3,20,mg/kg,1,weekly,dose level 3a
27853996,NCT01451632,4,cetuximab,3,400,mg/m2,1,loading dose,dose level 3a
27853996,NCT01451632,4,cetuximab,3,200,mg/m2,1,weekly,dose level 3a
27853996,NCT01451632,4,seribantumab,3.5,20,mg/kg,1,weekly,dose level 3b
27853996,NCT01451632,4,cetuximab,3.5,400,mg/m2,1,loading dose,dose level 3b
27853996,NCT01451632,4,cetuximab,3.5,250,mg/m2,1,weekly,dose level 3b
27853996,NCT01451632,4,seribantumab,4,40,mg/kg,1,loading dose,NA
27853996,NCT01451632,4,seribantumab,4,20,mg/kg,1,weekly,NA
27853996,NCT01451632,4,cetuximab,4,400,mg/m2,1,loading dose,NA
27853996,NCT01451632,4,cetuximab,4,250,mg/m2,1,weekly,NA
27853996,NCT01451632,5,seribantumab,1,20,mg/kg,1,weekly,NA
27853996,NCT01451632,5,cetuximab,1,400,mg/m2,1,loading dose,NA
27853996,NCT01451632,5,cetuximab,1,250,mg/m2,1,weekly,NA
27853996,NCT01451632,5,irinotecan,1,180,mg/m2,1,once every 2 weeks,NA
27853996,NCT01451632,5,seribantumab,2,40,mg/kg,1,loading dose,NA
27853996,NCT01451632,5,seribantumab,2,20,mg/kg,1,weekly,NA
27853996,NCT01451632,5,cetuximab,2,400,mg/m2,1,loading dose,NA
27853996,NCT01451632,5,cetuximab,2,250,mg/m2,1,weekly,NA
27853996,NCT01451632,5,irinotecan,2,180,mg/m2,1,once every 2 weeks,NA
30278378,NCT02020577,7,afatinib,1,30,mg,1,Once per day,NA
30278378,NCT02020577,7,cetuximab,1,250,mg/m2,0,Once per week,NA
30278378,NCT02020577,7,afatinib,2,40,mg,1,Once per day,NA
30278378,NCT02020577,7,cetuximab,2,250,mg/m2,0,Once per week,NA
30278378,NCT02020577,7,afatinib,-1,30,mg,1,Once per day,NA
30278378,NCT02020577,7,cetuximab,-1,200,mg/m2,0,Once per week,NA
30278378,NCT02020577,7,afatinib,-0.5,40,mg,1,Once per day,NA
30278378,NCT02020577,7,cetuximab,-0.5,200,mg/m2,0,Once per week,NA
28280091,NCT00501410,25,cetuximab,NA,250,mg/m2,0,NA,"400 mg/m2 week 1
followed by weekly doses of 250 mg/m2"
28280091,NCT00501410,25,oxaliplatin,NA,85,mg/m2,0,q2 weeks,NA
28280091,NCT00501410,25,oxaliplatin,NA,85,mg/m2,0,q2 weeks,NA
28280091,NCT00501410,25,bolus 5-fu,NA,400,mg/m2,0,q2 weeks,NA
28280091,NCT00501410,25,leucovorin,NA,400,mg/m2,0,q2 weeks,"followed by a 46-hour infusion of 5-FU
(2,400 mg/m2 q2weeks)."
28280091,NCT00501410,25,dasatinib,1,100,mg,NA,NA,NA
28280091,NCT00501410,25,dasatinib,2,150,mg,NA,NA,NA
28280091,NCT00501410,25,dasatinib,3,200,mg,NA,NA,NA
32053229,NCT01962792,26,carfilzomib,NA,36,mg/m2,0,NA,"Carfilzomib was administered intravenously for
30 (+10) min on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle from cycle
1 through cycle 12 and thereafter on days 1, 2, 15, and 16. The
carfilzomib starting dose was 20 mg/m2 on days 1 and 2 of cycle 1, and
if tolerated, the dose was increased to 36 mg/m2 on day 8 of cycle
1 and stayed at that level for subsequent cycles."
32053229,NCT01962792,26,dexamethasone,NA,20,mg,0,NA,"Dexamethasone was
administered (orally or intravenously) at a dose of 20 mg on days 1, 2,
8, 9, 15, 16, 22, and 23 of each treatment cycle, with patients ≥75 years
of age receiving a reduced dose of 10 mg on these days."
32053229,NCT01962792,26,ibrutinib,NA,840,mg,1,NA,NA
28422758,NCT02095054,28,regorafenib,1,80,mg,0,NA,NA
28422758,NCT02095054,28,cetuximab,1,200,mg/m2,0,NA,"(cetuximab i.v. 200 mg/m2
 followed 
by 150 mg/m2
 weekly"
28422758,NCT02095054,28,regorafenib,2,120,mg,NA,NA,NA
28422758,NCT02095054,28,cetuximab,2,200,mg/m2,0,NA,"(cetuximab i.v. 200 mg/m2
 followed 
by 150 mg/m2
 weekly"
28422758,NCT02095054,28,regorafenib,3,120,mg,NA,NA,NA
28422758,NCT02095054,28,cetuximab,3,300,mg/m2,0,NA,"(cetuximab i.v. 300 mg/m2
 followed 
by 200 mg/m2
 weekly"
30327312,NCT02350712,30,patritumab,-1,9,mg/kg,0,NA,"15 mg/kg
loading dose; 9 mg/kg maintenance dose"
30327312,NCT02350712,30,patritumab,1,9,mg/kg,0,NA,"18 mg/kg
loading dose; 9 mg/kg maintenance dose"
30327312,NCT02350712,30,cetuximab,1,250,mg/m2,0,NA,"400 mg/m2 loading dose; 250 mg/m2 maintenance
dose"
30327312,NCT02350712,30,cisplatin or cisplatin,1,100,mg/m2,0,NA,carboplatin (AUC of 5) 
30941307,NCT02429089,31,cetuximab,NA,250,mg/m2,NA,NA,"400 mg/m2 was given intravenously on cycle 1 day 1, followed by 250 mg/m2 weekly, as per standard recommendations"
30941307,NCT02429089,31,ribociclib,1,400,mg,NA,NA,NA
30941307,NCT02429089,31,ribociclib,2,600,mg,NA,NA,NA
32545260,NCT02277197,38,ficlatuzumab,1,10,mg/kg,NA,NA,NA
32545260,NCT02277197,38,cetuximab,1,500,mg/m2,NA,NA,"every 2 week, on Days 1 and 15 of a 28 day cycle"
32545260,NCT02277197,38,ficlatuzumab,2,20,mg/kg,NA,NA,NA
32545260,NCT02277197,38,cetuximab,2,500,mg/m2,NA,NA,NA
27311401,NA,42,palbociclib,1,100,mg,NA,NA,"400 mg/m2 was given intravenously
on cycle 1 day 1"
27311401,NA,42,cetuximab,1,250,mg/m2,NA,NA,NA
27311401,NA,42,palbociclib,2,125,mg,NA,NA,"400 mg/m2 was given intravenously
on cycle 1 day 1"
27311401,NA,42,cetuximab,2,250,mg/m2,NA,NA,NA
27311401,NA,42,palbociclib,-1,75,mg,NA,NA,"400 mg/m2 was given intravenously
on cycle 1 day 1"
27311401,NA,42,cetuximab,-1,250,mg/m2,NA,NA,NA
28600476,NCT01482377,43,cetuximab,1,250,mg/m2,NA,NA,400 mg/m2 for the first infusion
28600476,NCT01482377,43,lumretuzumab,1,400,mg,NA,NA,NA
28600476,NCT01482377,43,cetuximab,2,250,mg/m2,NA,NA,NA
28600476,NCT01482377,43,lumretuzumab,2,800,mg,NA,NA,NA
28600476,NCT01482377,43,cetuximab,3,250,mg/m2,NA,NA,NA
28600476,NCT01482377,43,lumretuzumab,3,1200,mg,NA,NA,NA
28600476,NCT01482377,43,cetuximab,4,250,mg/m2,NA,NA,NA
28600476,NCT01482377,43,lumretuzumab,4,1600,mg,NA,NA,NA
28600476,NCT01482377,43,cetuximab,5,250,mg/m2,NA,NA,NA
28600476,NCT01482377,43,lumretuzumab,5,2000,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,1,150,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,1,150,mg,NA,NA,NA
28600476,NCT01482377,44,lumretuzumab,1,400,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,2,150,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,2,150,mg,NA,NA,NA
28600476,NCT01482377,44,lumretuzumab,2,800,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,3,150,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,3,150,mg,NA,NA,NA
28600476,NCT01482377,44,lumretuzumab,3,1600,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,4,150,mg,NA,NA,NA
28600476,NCT01482377,44,erlotinib,4,150,mg,NA,NA,NA
28600476,NCT01482377,44,lumretuzumab,4,2000,mg,NA,NA,NA
27729313,NCT01787500,45,vemurafenib,1,480,mg,2,NA,NA
27729313,NCT01787500,45,irinotecan,1,180,mg/m2,NA,NA,NA
27729313,NCT01787500,45,cetuximab,1,500,mg/m2,NA,NA,NA
27729313,NCT01787500,45,vemurafenib,2,720,mg,2,NA,NA
27729313,NCT01787500,45,irinotecan,2,180,mg/m2,NA,NA,NA
27729313,NCT01787500,45,cetuximab,2,500,mg/m2,NA,NA,NA
27729313,NCT01787500,45,vemurafenib,3,960,mg,2,NA,NA
27729313,NCT01787500,45,irinotecan,3,180,mg/m2,NA,NA,NA
27729313,NCT01787500,45,cetuximab,3,500,mg/m2,NA,NA,NA
34251048,NCT01755975,48,romidepsin,-1,8,mg/m2,0,NA,NA
34251048,NCT01755975,48,lenalidomide,-1,10,mg,0,NA,NA
34251048,NCT01755975,48,romidepsin,1,8,mg/m2,0,NA,NA
34251048,NCT01755975,48,lenalidomide,1,15,mg,0,NA,NA
34251048,NCT01755975,48,romidepsin,2,8,mg/m2,NA,NA,NA
34251048,NCT01755975,48,lenalidomide,2,25,mg,NA,NA,NA
34251048,NCT01755975,48,romidepsin,3,10,mg/m2,NA,NA,NA
34251048,NCT01755975,48,lenalidomide,3,25,mg,NA,NA,NA
34251048,NCT01755975,48,romidepsin,4,14,mg/m2,NA,NA,NA
34251048,NCT01755975,48,lenalidomide,4,25,mg,NA,NA,NA
31005227,NA,49,5-fu,1,800,mg/m2/d,NA,NA,NA
31005227,NA,49,cisplatin,1,100,mg/m2,NA,NA,NA
31005227,NA,49,cisplatin,1,100,mg/m2,NA,NA,NA
31005227,NA,49,cetuximab,1,250,mg/m2,NA,NA,NA
31005227,NA,49,5-fu,1,1000,mg/m2/d,NA,NA,NA
32335709,NA,50,carfilzomib,1,70,mg/m2,0,NA,"20 mg/m2 on Day 1 of Cycle 1, and 70 mg/m2 was given thereafter until progressive disease"
32335709,NA,50,dexamethasone,1,40,mg,0,NA,NA
28054329,NA,51,k-912/nc-6300,1,15,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,2,30,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,3,60,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,4,80,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,5,100,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,6,130,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,7,170,mg/m2,NA,NA,NA
28054329,NA,51,k-912/nc-6300,8,225,mg/m2,NA,NA,NA
32122924,NCT02889523,52,tazemetostat,1,400,mg,2,NA,NA
32122924,NCT02889523,52,rituximab,1,375,mg/m2,NA,NA,NA
32122924,NCT02889523,52,prednisolone,1,40,mg/m2,NA,NA,NA
32122924,NCT02889523,52,doxorubicine,1,50,mg/m2,NA,NA,NA
32122924,NCT02889523,52,cyclophosphamide,1,750,mg/m2,NA,NA,NA
32122924,NCT02889523,52,vincristine,1,1.4,mg/m2,NA,NA,NA
32122924,NCT02889523,52,tazemetostat,2,600,mg,2,NA,NA
32122924,NCT02889523,52,rituximab,2,375,mg/m2,NA,NA,NA
32122924,NCT02889523,52,prednisolone,2,40,mg/m2,NA,NA,NA
32122924,NCT02889523,52,doxorubicine,2,50,mg/m2,NA,NA,NA
32122924,NCT02889523,52,cyclophosphamide,2,750,mg/m2,NA,NA,NA
32122924,NCT02889523,52,vincristine,2,1.4,mg/m2,NA,NA,NA
32122924,NCT02889523,52,tazemetostat,3,800,mg,2,NA,NA
32122924,NCT02889523,52,rituximab,3,375,mg/m2,NA,NA,NA
32122924,NCT02889523,52,prednisolone,3,40,mg/m2,NA,NA,NA
32122924,NCT02889523,52,doxorubicine,3,50,mg/m2,NA,NA,NA
32122924,NCT02889523,52,cyclophosphamide,3,750,mg/m2,NA,NA,NA
32122924,NCT02889523,52,vincristine,3,1.4,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",1,125,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",2,150,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",3,170,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",4,185,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",5,200,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",6,215,mg/m2,NA,NA,NA
32381487, NCT03168061,53,"nc-6300
",7,230,mg/m2,NA,NA,NA
31675535,NCT00856037,54,doxorubicin,1,20,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,1,0.85,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,1,0.85,mg/m2,NA,NA,NA
31675535,NCT00856037,54,doxorubicin,2,20,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,2,1.05,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,2,1.05,mg/m2,NA,NA,NA
31675535,NCT00856037,54,doxorubicin,3,20,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,3,1.35,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,3,1.35,mg/m2,NA,NA,NA
31675535,NCT00856037,54,doxorubicin,4,20,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,4,1.65,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,4,1.65,mg/m2,NA,NA,NA
31675535,NCT00856037,54,doxorubicin,5,20,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,5,2.3,mg/m2,NA,NA,NA
31675535,NCT00856037,54,topotecan,5,2.3,mg/m2,NA,NA,NA
26903311,NCT00878904,55,panobinostat,1,20,mg,NA,NA,NA
26903311,NCT00878904,55,epirubicin,1,75,mg/m2,NA,NA,NA
26903311,NCT00878904,55,panobinostat,2,30,mg,NA,NA,NA
26903311,NCT00878904,55,epirubicin,2,75,mg/m2,NA,NA,NA
26903311,NCT00878904,55,panobinostat,3,40,mg,NA,NA,NA
26903311,NCT00878904,55,epirubicin,3,75,mg/m2,NA,NA,NA
26903311,NCT00878904,55,panobinostat,4,50,mg,NA,NA,NA
26903311,NCT00878904,55,epirubicin,4,75,mg/m2,NA,NA,NA
26903311,NCT00878904,55,panobinostat,5,60,mg,NA,NA,NA
26903311,NCT00878904,55,epirubicin,5,75,mg/m2,NA,NA,NA
33219014,NCT02779855,56,talimogene laherparepvec,1,NA,NA,NA,10^6 plaque-forming units (PFU) x 5 doses,NA
33219014,NCT02779855,56,paclitaxel,1,80,mg/m2,NA,NA,NA
33219014,NCT02779855,56,doxorubicin,1,60,mg/m2,NA,NA,NA
33219014,NCT02779855,56,cyclophosphamide,1,600,mg/m2,NA,NA,NA
33219014,NCT02779855,56,talimogene laherparepvec,2,NA,NA,NA,"10^6 PFUsfirst dose, then 10^8 PFUs x 4 doses",NA
33219014,NCT02779855,56,paclitaxel,2,80,mg/m2,NA,NA,NA
33219014,NCT02779855,56,doxorubicin,2,60,mg/m2,NA,NA,NA
33219014,NCT02779855,56,cyclophosphamide,2,600,mg/m2,NA,NA,NA
29856514,NA,57,metformin,1,666,mg/m2,2,NA,mg/m2/day
29856514,NA,57,metformin,2,1000,mg/m2,2,NA,mg/m2/day
29856514,NA,57,metformin,3,1333,mg/m2,2,NA,mg/m2/day
27403082,NCT00878800,58,belinostat,1,600,mg/m2,NA,NA,NA
27403082,NCT00878800,58,doxorubicin,1,50,mg/m2,NA,NA,NA
27403082,NCT00878800,58,belinostat,2,600,mg/m2,NA,NA,NA
27403082,NCT00878800,58,doxorubicin,2,75,mg/m2,NA,NA,NA
27403082,NCT00878800,58,belinostat,3,800,mg/m2,NA,NA,NA
27403082,NCT00878800,58,doxorubicin,3,75,mg/m2,NA,NA,NA
27403082,NCT00878800,58,belinostat,4,1000,mg/m2,NA,NA,NA
27403082,NCT00878800,58,doxorubicin,4,75,mg/m2,NA,NA,NA
33093947,EudraCT Number: 2015-003213-18; ISRCTN13626902 ,59,acp-196,1,100,mg,1,NA,"once daily taken orally, days 1–21"
33093947,EudraCT Number: 2015-003213-18; ISRCTN13626902 ,59,r-chop,1,NA,NA,NA,NA,NA
33093947,EudraCT Number: 2015-003213-18; ISRCTN13626902 ,59,acp-196,2,100,mg,2,NA,"twice daily, orally days 1–21"
33093947,EudraCT Number: 2015-003213-18; ISRCTN13626902 ,59,r-chop,2,NA,NA,NA,NA,NA
33602316,NCT01839097,60,belinostat,3,1000,mg/m2,NA,Days 1-3,NA
33602316,NCT01839097,60,belinostat,5,1000,mg/m2,NA,Days 1-5,NA
29055839,NA,61,dts-201,1,80,mg/m2,NA,NA,NA
29055839,NA,61,dts-201,2,160,mg/m2,NA,NA,NA
29055839,NA,61,dts-201,3,250,mg/m2,NA,NA,NA
29055839,NA,61,dts-201,4,400,mg/m2,NA,NA,NA
33474828,NCT02677116,62,olaratumab,A,15,mg/kg,NA,NA,NA
33474828,NCT02677116,62,olaratumab,B,20,mg/kg,NA,NA,NA
33474828,NCT02677116,62,olaratumab,C,20,mg/kg,NA,NA,NA
33474828,NCT02677116,62,doxorubicin,C,37.5,mg/m2,NA,NA,NA
33474828,NCT02677116,62,ifosfamide,C,2.8,g/m2,NA,NA,NA
33474828,NCT02677116,62,vincristine,C,1.5,mg/m2,NA,NA,NA
33474828,NCT02677116,62,irinotecan,C,50,mg/m2,NA,NA,NA
32055930,NCT01145430,63,veliparib,-2,30,mg,NA,on days 1–7 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,-2,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,-1,50,mg,NA,on days 1–7 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,-1,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,1,50,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,1,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,2,100,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,2,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,3,150,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,3,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,4,200,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,4,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,5,250,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,5,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,6,300,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,6,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,7,350,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,7,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
32055930,NCT01145430,63,veliparib,8,400,mg,NA,on days 1–14 twice daily (BID),NA
32055930,NCT01145430,63,pegylated liposomal doxorubicin,8,40,mg/m2,NA,on day 1 of a 28-day cycle,NA
27255289,NA,64,s-1,1,20,mg/m2,NA,NA,NA
27255289,NA,64,epirubicin,1,50,mg/m2,NA,NA,NA
27255289,NA,64,oxaliplatin,1,130,mg/m2,NA,NA,NA
27255289,NA,64,oxaliplatin,1,130,mg/m2,NA,NA,NA
27255289,NA,64,s-1,2,25,mg.m2,NA,NA,NA
27255289,NA,64,epirubicin,2,50,mg/m2,NA,NA,NA
27255289,NA,64,oxaliplatin,2,130,mg/m2,NA,NA,NA
27255289,NA,64,oxaliplatin,2,130,mg/m2,NA,NA,NA
29174203,NA,65,"pld (pegylated liposomal
doxorubicin)",1,30,mg/m2,NA,NA,NA
29174203,NA,65,cyclophosphamide,1,60,mg/m2,NA,NA,NA
29174203,NA,65,"pld (pegylated liposomal
doxorubicin)",2,35,mg/m2,NA,NA,NA
29174203,NA,65,cyclophosphamide,2,60,mg/m2,NA,NA,NA
27577069,NCT01176799,66,sunitinib,1,25,mg,NA,NA,NA
27577069,NCT01176799,66,sunitinib,-1,12.5,mg,NA,NA,NA
31772119,NCT01902225,67,romidepsin,1,8,mg/m2,NA,NA,"over 4 hours on days 1, 8, and 15,
following LD"
31772119,NCT01902225,67,liposomal doxorubicin,1,20,mg/m2,NA,NA,"over 1 hour on day 1 of
each 28-day cycle"
31772119,NCT01902225,67,romidepsin,2,10,mg/m2,NA,NA,"over 4 hours on days 1, 8, and 15,
following LD"
31772119,NCT01902225,67,liposomal doxorubicin,2,20,mg/m2,NA,NA,"over 1 hour on day 1 of
each 28-day cycle"
31772119,NCT01902225,67,romidepsin,3,12,mg/m2,NA,NA,"over 4 hours on days 1, 8, and 15,
following LD"
31772119,NCT01902225,67,liposomal doxorubicin,3,20,mg/m2,NA,NA,"over 1 hour on day 1 of
each 28-day cycle"
31772119,NCT01902225,67,romidepsin,4,14,mg/m2,NA,NA,"over 4 hours on days 1, 8, and 15,
following LD"
31772119,NCT01902225,67,liposomal doxorubicin,4,20,mg/m2,NA,NA,"over 1 hour on day 1 of
each 28-day cycle"
29104762,NCT01655693,68,dt,1,10,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,1,10,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,2,20,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,2,20,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,3,30,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,3,30,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,4,40,mg/m2,NA,NA,NA
29104762,NCT01655693,68,dt,4,40,mg/m2,NA,NA,NA
30361524,NCT01304797,72,mm-302,1,8,mg/m2,NA,NA,once every 4 weeks (q4w)
30361524,NCT01304797,72,mm-302,2,16,mg/m2,NA,NA,NA
30361524,NCT01304797,72,mm-302,3,30,mg/m2,NA,NA,NA
30361524,NCT01304797,72,mm-302,4,40,mg/m2,NA,NA,NA
30361524,NCT01304797,72,mm-302,5,50,mg/m2,NA,NA,NA
30361524,NCT01304797,73,mm-302,1,30,mg/m2,NA,NA,every 2 weeks (q2w).
30361524,NCT01304797,73,trastuzumab,1,4,mg/kg,NA,NA,with 6 mg/kg loading
30361524,NCT01304797,73,mm-302,2,40,mg/m2,NA,NA,NA
30361524,NCT01304797,73,trastuzumab,2,4,mg/kg,NA,NA,with 6 mg/kg loading
30361524,NCT01304797,73,mm-302,1,30,mg/m2,NA,NA,NA
30361524,NCT01304797,73,trastuzumab,1,6,mg/kg,NA,NA,with 8 mg/kg loading
30361524,NCT01304797,73,mm-302,2,30,mg/m2,NA,NA,NA
30361524,NCT01304797,73,trastuzumab,2,8,mg/kg,NA,NA,with 8 mg/kg loading
30361524,NCT01304797,74,mm-302,1,30,mg/m2,NA,NA,NA
30361524,NCT01304797,74,trastuzumab,1,6,mg/kg,NA,NA,with 8 mg/kg loading
30361524,NCT01304797,74,cyclophosphamid,1,450,mg/m2,NA,NA,q3w
33095287,NCT01606878,75,crizotinib,1,165,mg/m2,BID,D1-21,NA
33095287,NCT01606878,75,cyclophosphamide,1,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,crizotinib,2,215,mg/m2,BID,D1-21,NA
33095287,NCT01606878,75,cyclophosphamide,2,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,76,crizotinib,1,165,mg/m2,BID,D1-21,NA
33095287,NCT01606878,76,vincristine,1,1.5,mg/m2,NA,D1,NA
33095287,NCT01606878,76,doxorubicin,1,45,mg/m2,NA,D1,NA
33095287,NCT01606878,76,crizotinib,2,215,mg/m2,BID,D1-21,NA
33095287,NCT01606878,76,vincristine,2,1.5,mg/m2,NA,D1,NA
33095287,NCT01606878,76,doxorubicin,2,45,mg/m2,NA,D1,NA
33095287,NCT01606878,76,crizotinib,3,280,mg/m2,BID,D1-21,NA
33095287,NCT01606878,76,vincristine,3,1.5,mg/m2,NA,D1,NA
33095287,NCT01606878,76,doxorubicin,3,45,mg/m2,NA,D1,NA
33095287,NCT01606878,77,crizotinib,1,165,mg/m2,BID,D1-21,NA
33095287,NCT01606878,77,cyclophosphamide,1,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,crizotinib,2,215,mg/m2,BID,D1-21,NA
33095287,NCT01606878,77,cyclophosphamide,2,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,crizotinib,3,280,mg/m2,BID,D1-21,NA
33095287,NCT01606878,77,cyclophosphamide,3,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,3,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,77,topotecan,3,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,crizotinib,1,165,mg/m2,BID,D1-21,NA
33095287,NCT01606878,78,cyclophosphamide,1,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,topotecan,1,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,crizotinib,2,215,mg/m2,BID,D1-21,NA
33095287,NCT01606878,78,cyclophosphamide,2,250,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,78,topotecan,2,0.75,mg/m2,NA,D1-5,NA
33095287,NCT01606878,75,crizotinib,1,165,mg/m2,BID,D1-21,OS
33095287,NCT01606878,75,crizotinib,2,215,mg/m2,BID,D1-21,OS
33095287,NCT01606878,76,crizotinib,1,165,mg/m2,BID,D1-21,OS
33095287,NCT01606878,76,crizotinib,2,215,mg/m2,BID,D1-21,OS
33095287,NCT01606878,76,crizotinib,3,280,mg/m2,BID,D1-21,OS
33095287,NCT01606878,77,crizotinib,1,165,mg/m2,BID,D1-21,FC
33095287,NCT01606878,77,crizotinib,2,215,mg/m2,BID,D1-21,FC
33095287,NCT01606878,77,crizotinib,3,280,mg/m2,BID,D1-21,FC
33095287,NCT01606878,78,crizotinib,2,215,mg/m2,BID,D1-21,cMS
28718812,NCT02562378,79,trastuzumab emtansine,-1,3.6,mg/kg,NA,NA,NA
28718812,NCT02562378,79,non-pegylated liposomal doxorubicin,-1,15,mg/m2,NA,on day 1 of each cycle for up to 6 cycles,NA
28718812,NCT02562378,79,trastuzumab emtansine,1,3.6,mg/kg,NA,NA,NA
28718812,NCT02562378,79,non-pegylated liposomal doxorubicin,1,45,mg/m2,NA,on day 1 of each cycle for up to 6 cycles,NA
28718812,NCT02562378,79,trastuzumab emtansine,2,3.6,mg/kg,NA,NA,NA
28718812,NCT02562378,79,non-pegylated liposomal doxorubicin,2,50,mg/m2,NA,on day 1 of each cycle for up to 6 cycles,NA
28718812,NCT02562378,79,trastuzumab emtansine,3,3.6,mg/kg,NA,NA,NA
28718812,NCT02562378,79,non-pegylated liposomal doxorubicin,3,60,mg/m2,NA,on day 1 of each cycle for up to 6 cycles,NA
29903707,NCT01622439,80,sodium valproate,1,30,mg/kg,NA,NA,NA
29903707,NCT01622439,80,rituximab,1,375,mg/m2,NA,NA,NA
29903707,NCT01622439,80,cyclophosphamide,1,750,mg/m2,NA,NA,NA
29903707,NCT01622439,80,doxorubicin,1,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,vincristine,1,1.4,mg/m2,NA,NA,NA
29903707,NCT01622439,80,prednisone,1,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,sodium valproate,2,60,mg/kg,NA,NA,NA
29903707,NCT01622439,80,rituximab,2,375,mg/m2,NA,NA,NA
29903707,NCT01622439,80,cyclophosphamide,2,750,mg/m2,NA,NA,NA
29903707,NCT01622439,80,doxorubicin,2,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,vincristine,2,1.4,mg/m2,NA,NA,NA
29903707,NCT01622439,80,prednisone,2,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,sodium valproate,3,80,mg/kg,NA,NA,NA
29903707,NCT01622439,80,rituximab,3,375,mg/m2,NA,NA,NA
29903707,NCT01622439,80,cyclophosphamide,NA,750,mg/m2,NA,NA,NA
29903707,NCT01622439,80,doxorubicin,NA,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,vincristine,3,1.4,mg/m2,NA,NA,NA
29903707,NCT01622439,80,prednisone,3,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,sodium valproate,4,100,mg/kg,NA,NA,NA
29903707,NCT01622439,80,rituximab,4,375,mg/m2,NA,NA,NA
29903707,NCT01622439,80,cyclophosphamide,4,750,mg/m2,NA,NA,NA
29903707,NCT01622439,80,doxorubicin,4,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,vincristine,4,1.4,mg/m2,NA,NA,NA
29903707,NCT01622439,80,prednisone,4,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,sodium valproate,5,120,mg/kg,NA,NA,NA
29903707,NCT01622439,80,rituximab,5,375,mg/m2,NA,NA,NA
29903707,NCT01622439,80,cyclophosphamide,5,750,mg/m2,NA,NA,NA
29903707,NCT01622439,80,doxorubicin,5,50,mg/m2,NA,NA,NA
29903707,NCT01622439,80,vincristine,5,1.4,mg/m2,NA,NA,NA
29903707,NCT01622439,80,prednisone,5,50,mg/m2,NA,NA,NA
30850381,NCT02055820,81,venetoclax,1,200,mg/d,NA,for 8 cycles (21-day cycles),NA
30850381,NCT02055820,81,r-chop,1,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5; R (375 mg/m2 IV) on day 1 for 8 cycles"
30850381,NCT02055820,81,venetoclax,2,400,mg/d,NA,for 8 cycles (21-day cycles),NA
30850381,NCT02055820,81,r-chop,2,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5; R (375 mg/m2 IV) on day 1 for 8 cycles"
30850381,NCT02055820,81,venetoclax,3,600,mg/d,NA,for 8 cycles (21-day cycles),NA
30850381,NCT02055820,81,r-chop,3,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5; R (375 mg/m2 IV) on day 1 for 8 cycles"
30850381,NCT02055820,81,venetoclax,4,800,mg/d,NA,for 8 cycles (21-day cycles),NA
30850381,NCT02055820,81,r-chop,4,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5; R (375 mg/m2 IV) on day 1 for 8 cycles"
30850381,NCT02055820,82,venetoclax,1,200,mg/d,NA,NA,NA
30850381,NCT02055820,82,g-chop,1,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5. G (1000 mg IV) on days 1, 8, and 15 of cycle 1 and day 1 of cycles 2 to 8"
30850381,NCT02055820,82,venetoclax,2,400,mg/d,NA,NA,NA
30850381,NCT02055820,82,g-chop,2,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5. G (1000 mg IV) on days 1, 8, and 15 of cycle 1 and day 1 of cycles 2 to 8"
30850381,NCT02055820,82,venetoclax,3,600,mg/d,NA,NA,NA
30850381,NCT02055820,82,g-chop,3,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5. G (1000 mg IV) on days 1, 8, and 15 of cycle 1 and day 1 of cycles 2 to 8"
30850381,NCT02055820,82,venetoclax,4,800,mg/d,NA,NA,NA
30850381,NCT02055820,82,g-chop,4,NA,NA,NA,NA,"Standard CHOP chemotherapy consisted of IV cyclophosphamide 750 mg/m2, IV doxorubicin 50 mg/m2, and IV vincristine 1.4 mg/m2 (with a 2.0-mg cap) on day 1, and prednisone 100 mg/d orally on days 1 to 5. G (1000 mg IV) on days 1, 8, and 15 of cycle 1 and day 1 of cycles 2 to 8"
16870542,NA,83,cisplatin,1,100,mg/m2,NA,NA,NA
16870542,NA,83,cisplatin,1,100,mg/m2,NA,NA,NA
16870542,NA,83,vinorelbine,1,8,mg/m2/d,NA,NA,NA
16870542,NA,83,cisplatin,2,100,mg/m2,NA,NA,NA
16870542,NA,83,cisplatin,2,100,mg/m2,NA,NA,NA
16870542,NA,83,vinorelbine,2,9,mg/m2/d,NA,NA,NA
16870542,NA,83,cisplatin,3,100,mg/m2,NA,NA,NA
16870542,NA,83,cisplatin,3,100,mg/m2,NA,NA,NA
16870542,NA,83,vinorelbine,3,10,mg/m2/d,NA,NA,NA
16870542,NA,83,cisplatin,4,100,mg/m2,NA,NA,NA
16870542,NA,83,cisplatin,4,100,mg/m2,NA,NA,NA
16870542,NA,83,vinorelbine,4,11,mg/m2/d,NA,NA,NA
16179099,NA,84,vinorelbine,1,8,mg/m2/d,NA,NA,NA
16179099,NA,84,vinorelbine,2,9,mg/m2/d,NA,NA,NA
16179099,NA,84,vinorelbine,3,10,mg/m2/d,NA,NA,NA
16179099,NA,84,vinorelbine,4,11,mg/m2/d,NA,NA,NA
16179099,NA,84,vinorelbine,5,12,mg/m2/d,NA,NA,NA
12655441,NA,85,anhydrovinblastine,1,2.5,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,2,5,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,3,10,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,4,16.5,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,5,21,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,6,25,mg/m2,NA,NA,NA
12655441,NA,85,anhydrovinblastine,7,30,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,1,30,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,2,60,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,3,120,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,4,160,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,5,200,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,6,250,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,7,320,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,8,350,mg/m2,NA,NA,NA
12649112,NA,86,vinflunine,9,400,mg/m2,NA,NA,NA
15809877,NA,87,zosuquidar,1,100,mg/m2,NA,NA,every 8 h
15809877,NA,87,vinorelbine,1,30,mg/m2,NA,NA,NA
15809877,NA,87,zosuquidar,2,200,mg/m2,NA,NA,every 8 h
15809877,NA,87,vinorelbine,2,30,mg/m2,NA,NA,NA
15809877,NA,87,zosuquidar,3,200,mg/m2,NA,NA,every 12 h
15809877,NA,87,vinorelbine,3,22.5,mg/m2,NA,NA,NA
15809877,NA,87,zosuquidar,4,300,mg/m2,NA,NA,every 12 h
15809877,NA,87,vinorelbine,4,22.5,mg/m2,NA,NA,NA
16211365,NA,88,vinflunine,1,210,mg/m2,NA,NA,NA
16211365,NA,88,vinflunine,-1,190,mg/m2,NA,NA,NA
16211365,NA,88,vinflunine,-2,170,mg/m2,NA,NA,NA
16937306,NA,89,cisplatin,0,20,mg/m2,NA,NA,per week
16937306,NA,89,cisplatin,0,20,mg/m2,NA,NA,per week
16937306,NA,89,vinorelbine,0,10,mg/m2,NA,NA,per week
16937306,NA,89,cisplatin,1,20,mg/m2,NA,NA,per week
16937306,NA,89,cisplatin,1,20,mg/m2,NA,NA,per week
16937306,NA,89,vinorelbine,1,15,mg/m2,NA,NA,per week
16937306,NA,89,cisplatin,2,20,mg/m2,NA,NA,per week
16937306,NA,89,cisplatin,2,20,mg/m2,NA,NA,per week
16937306,NA,89,vinorelbine,2,20,mg/m2,NA,NA,per week
14984944,NA,90,vinorelbine,1,10,NA,NA,NA,NA
14984944,NA,90,vinorelbine,2,15,NA,NA,NA,NA
14984944,NA,90,vinorelbine,3,20,NA,NA,NA,NA
15122074,NA,91,vinorelbine,1,20,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,1,400,mg,NA,NA,NA
15122074,NA,91,vinorelbine,2,22.5,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,2,400,mg,NA,NA,NA
15122074,NA,91,vinorelbine,3,25,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,3,400,mg,NA,NA,NA
15122074,NA,91,vinorelbine,4,27.5,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,4,400,mg,NA,NA,NA
15122074,NA,91,vinorelbine,5,30,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,5,400,mg,NA,NA,NA
15122074,NA,91,vinorelbine,6,32.5,mg/m2,NA,NA,NA
15122074,NA,91,diphenylhydantoin,6,400,mg,NA,NA,NA
31959492,NA,1,paclitaxel,1,135,mg/m2,1,"Circle 1 -6, Day 1","over 3 h, fixed dose"
31959492,NA,1,bevacizumab,1,15,mg/kg,1,"From Circle 2, Day 1, followed paclitaxel",fixed dose
31959492,NA,1,cisplatin,1,75,mg/m2,1,"Circle 1-6, Day 2",fixed dose
31959492,NA,1,cisplatin,1,75,mg/m2,1,"Circle 1-6, Day 2",fixed dose
31959492,NA,1,olaparib,1,50,mg,2,"Circle 1-6, Day 2 - 8",NA
31959492,NA,1,olaparib,2,100,mg,2,"Circle 1-6, Day 2 - 8",NA
31959492,NA,1,olaparib,3,200,mg,2,"Circle 1-6, Day 2 - 8",NA
31959492,NA,1,paclitaxel,1,60,mg/m2,1,"Circle 1 -6, Day 8",NA
31959492,NA,1,bevacizumab,1,15,mg/kg,1,"circle 7 -22, Day 1",maintenance therapy phase
31959492,NA,1,olaparib,1,300,mg,2,"circle 7 -22, Day 1-21",maintenance therapy phase
7664282,NA,2,amifostine,1,750,mg/m2,1,NA,increased by 30% and round to 50
7664282,NA,2,amifostine,1,750,mg/m2,1,NA,increased by 30% and round to 50
7664282,NA,3,melphalan,1,35,mg/m2,1,NA,NA
7664282,NA,3,melphalan,2,45,mg/m2,1,NA,NA
7664282,NA,3,melphalan,3,60,mg/m2,1,NA,NA
29500276,NCT01696032,4,guadecitabine,1,45,mg/m2,1,Day 1-5,NA
29500276,NCT01696032,4,guadecitabine,2,60,mg/m2,1,Day 1-5,NA
29500276,NCT01696032,4,guadecitabine,-1,30,mg/m2,1,Day 1-5,NA
29500276,NCT01696032,4,carboplatin,1,0,NA,0,Day 8,AUC 4
29500276,NCT01696032,4,carboplatin,1,0,NA,0,Day 8,AUC 4
29348128,NCT01814826,5,azacitidine,1,75,mg/m2,1,"days 1 to 5, 8, and 9",fixed dose
29348128,NCT01814826,5,pevonedistat,1,20,mg/m2,1,"days 1, 3, and 5",NA
29348128,NCT01814826,5,pevonedistat,2,30,mg/m2,1,"days 1, 3, and 5",NA
28881739,NCT00748553,6,nab-paclitaxel,1,100,mg/m2,1,"Weekly * 3 weeks, Day 8",fixed dose
28881739,NCT00748553,6,azacitidine,-1,50,mg/m2,1,Days 1 - 5,NA
28881728,ACTRN12610001031055,7,azacitidine,1,75,mg/m2,1,days 1–5 and 8–9,fixed dose
28881728,ACTRN12610001031055,7,everolimus,1,2.5,mg,1,days 5–21 of each 28–day cycle,NA
28881728,ACTRN12610001031055,7,everolimus,1,2.5,mg,1,days 5–21 of each 28–day cycle,NA
28881728,ACTRN12610001031055,7,everolimus,2,5,mg,1,days 5–21 of each 28–day cycle,NA
28881728,ACTRN12610001031055,7,everolimus,2,5,mg,1,days 5–21 of each 28–day cycle,NA
28881728,ACTRN12610001031055,7,everolimus,3,10,mg,1,days 5–21 of each 28–day cycle,NA
28881728,ACTRN12610001031055,7,everolimus,3,10,mg,1,days 5–21 of each 28–day cycle,NA
28555084,NCT01729845,8,mitoxantrone,1,8,mg/m2,1,days 1-5 after 5 day break foe decitabine,fixed dose
28555084,NCT01729845,8,etoposide,1,100,mg/m2,1,days 1-5 after 5 day break foe decitabine,fixed dose
28555084,NCT01729845,8,cytarabine,1,1000,mg/m2,1,days 1-5 after 5 day break foe decitabine,fixed dose
28555084,NCT01729845,8,decitabine,1,20,mg/m2,1,5 days,NA
28555084,NCT01729845,8,decitabine,2,20,mg/m2,1,7 days,NA
28555084,NCT01729845,8,decitabine,3,20,mg/m2,1,10 days,NA
27542211,NCT01193517,10,azacitidine,1,75,mg/m2,1,days 1 -5,NA
27542211,NCT01193517,10,oxaliplatin,1,90,mg/m2,1,day 2,NA
27542211,NCT01193517,10,oxaliplatin,1,90,mg/m2,1,day 2,NA
27542211,NCT01193517,10,capecitabine,1,750,mg/m2,2,2 weeks every three weeks,NA
27542211,NCT01193517,10,capecitabine,1,750,mg/m2,2,2 weeks every three weeks,NA
27542211,NCT01193517,10,oxaliplatin,2,110,mg/m2,1,day 2,NA
27542211,NCT01193517,10,oxaliplatin,2,110,mg/m2,1,day 2,NA
26055299,NCT00986804,11,decitabine,1,5,mg/m2,1," 5 consecutive days every 6 weeks, for up to 8 cycles. ",NA
26055299,NCT00986804,11,decitabine,2,7.5,mg/m2,1," 5 consecutive days every 6 weeks, for up to 8 cycles. ",NA
26055299,NCT00986804,11,decitabine,3,10,mg/m2,1," 5 consecutive days every 6 weeks, for up to 8 cycles. ",NA
26055299,NCT00986804,11,decitabine,4,15,mg/m2,1," 5 consecutive days every 6 weeks, for up to 8 cycles. ",NA
25806091,NCT01039155,12,azacitidine,1,20,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,1,15,mg/m2,1, IV over 2 h on days 2 to 5 ,NA
25806091,NCT01039155,12,oxaliplatin,1,15,mg/m2,1, IV over 2 h on days 2 to 5 ,NA
25806091,NCT01039155,12,azacitidine,2,20,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,2,22.5,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,oxaliplatin,2,22.5,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,azacitidine,3,20,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,3,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,oxaliplatin,3,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,azacitidine,4,25,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,4,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,oxaliplatin,4,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,azacitidine,5,40,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,5,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,oxaliplatin,5,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,azacitidine,6,50,mg/m2,1,intravenously (IV) over 15 to 30 min on days 1 to 5,NA
25806091,NCT01039155,12,oxaliplatin,6,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25806091,NCT01039155,12,oxaliplatin,6,30,mg/m2,1,IV over 2 h on days 2 to 5,NA
25062770,NCT00925132,14,decitabine,1,0.1,mg/kg,1,three times weekly for 2 weeks,NA
25062770,NCT00925132,14,panobinostat,1,10,mg,NA,every 96 h,NA
25062770,NCT00925132,14,decitabine,2,0.1,mg/kg,1,three times weekly for 2 weeks,NA
25062770,NCT00925132,14,panobinostat,2,20,mg,NA,every 96 h,NA
25062770,NCT00925132,14,decitabine,3,0.2,mg/kg,1,three times weekly for 2 weeks,NA
25062770,NCT00925132,14,panobinostat,3,20,mg,NA,every 96 h,NA
25062770,NCT00925132,14,decitabine,4,0.2,mg/kg,1,three times weekly for 2 weeks,NA
25062770,NCT00925132,14,panobinostat,4,30,mg,NA,every 96 h,NA
25062770,NCT00925132,14,temozolomide,1,150,mg/m2,1,days 9 through 13,fixed dose
25062770,NCT00925132,14,temozolomide,1,150,mg/m2,1,days 9 through 13,fixed dose
25062770,NCT00925132,14,temozolomide,2,200,mg/m2,1,days 9 through 13,"fixed dose; In cytcle 2,  if neutropenia or thrombocytopenia had not occurred"
25062770,NCT00925132,14,temozolomide,2,200,mg/m2,1,days 9 through 13,"fixed dose; In cytcle 2,  if neutropenia or thrombocytopenia had not occurred"
24493831,NA,16,onartuzumab,1,1,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a, single agent"
24493831,NA,16,onartuzumab,2,4,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a, single agent"
24493831,NA,16,onartuzumab,3,10,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a, single agent"
24493831,NA,16,onartuzumab,4,20,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a, single agent"
24493831,NA,16,onartuzumab,5,30,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a, single agent"
24493831,NA,16,onartuzumab,6,15,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1a expansion, single agent at RP2D"
24493831,NA,16,onartuzumab,7,10,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1b, combined with bevacizumab"
24493831,NA,16,onartuzumab,8,15,mg/kg,1,"Q3W;Onartuzumab was administered over 90  10 minutes for the first two doses. Subsequent doses were administered over 30  10 minutes (for dose levels <10 mg/kg) or 60  10 minutes (for dose levels 10 mg/kg). In phase Ib, onartuzumab was given before bevacizumab.","phase 1b, combined with bevacizumab"
24493831,NA,16,bevacizumab,7,15,mg/kg,1,Q3W,"phase 1b, fixed dose"
24649202,NA,17,bevacizumab,1,5,mg/kg,1,"infused at fixed dose over 30‑90 min on Days 1, 15 and 29.",fixed dose
24649202,NA,17,l‑leucovorin,1,200,mg/m2,1,every 2 weeks during radiotherapy,fixed dose
24649202,NA,17,5‑fu civ,1,2000,mg/m2,1,every 2 weeks during radiotherapy,"initial loading dose of 2,000 mg/m2 over 46 h"
24649202,NA,17,5‑fu bolus,1,400,mg/m2,1,every 2 weeks during radiotherapy,"bolus dose, fixed dose"
24649202,NA,17,5‑fu civ,2,2400,mg/m2,1,every 2 weeks during radiotherapy,initial loading dose  over 46 h
24649202,NA,17,5‑fu civ,3,3000,mg/m2,1,every 2 weeks during radiotherapy,initial loading dose over 46 h
24649202,NA,17,5‑fu civ,-1,1600,mg/m2,1,every 2 weeks during radiotherapy,initial loading dose over 46 h
24770667,NCT00633529,18,erlotinib,1,150,mg,1,days 1–21,on an empty stomach;fixed dose
24770667,NCT00633529,18,erlotinib,1,150,mg,1,days 1–21,on an empty stomach;fixed dose
24770667,NCT00633529,18,bevacizumab,1,15,mg/kg,1,on day 1 of each 3-week cycle,fixes dose
24770667,NCT00633529,18,imo-2055,1,0.08,mg/kg,1,"on days 1, 8, and 15 of each 3-week treatment cycle",per week dose
24770667,NCT00633529,18,imo-2055,2,0.16,mg/kg,1,"on days 1, 8, and 15 of each 3-week treatment cycle",per week dose
24770667,NCT00633529,18,imo-2055,3,0.32,mg/kg,1,"on days 1, 8, and 15 of each 3-week treatment cycle",per week dose
24770667,NCT00633529,18,imo-2055,4,0.48,mg/kg,1,"on days 1, 8, and 15 of each 3-week treatment cycle",per week dose
24535315,NA,19,pm00104,1,2,mg/m2,1,Day 1 q3wk,fixed dose
24535315,NA,19,carboplatin,1,3,NA,1,Day 1 q3wk,"AUC, Heavily pretreated patients"
24535315,NA,19,carboplatin,1,3,NA,1,Day 1 q3wk,"AUC, Heavily pretreated patients"
24535315,NA,20,pm00104,1,2,mg/m2,1,Day 1 q3wk,fixed dose
24535315,NA,20,carboplatin,1,3,NA,1,Day 1 q3wk,AUC
24535315,NA,20,carboplatin,1,3,NA,1,Day 1 q3wk,AUC
24535315,NA,20,carboplatin,2,4,NA,1,Day 1 q3wk,AUC
24535315,NA,20,carboplatin,2,4,NA,1,Day 1 q3wk,AUC
24752867,NA,21,bevacizumab,1,3,mg/kg,1,on days 1 and 15 concurrent with cediranib,NA
24752867,NA,21,cediranib,1,20,mg,1,days 1 to 21 per cycle (each cycle was 28 days),NA
24752867,NA,21,bevacizumab,2,5,mg/kg,1,on days 1 and 15 concurrent with cediranib,NA
24752867,NA,21,cediranib,2,20,mg,1,days 1 to 21 per cycle (each cycle was 28 days),NA
24752867,NA,21,bevacizumab,3,5,mg/kg,1,on days 1 and 15 concurrent with cediranib,NA
24752867,NA,21,cediranib,3,30,mg,1,days 1 to 21 per cycle (each cycle was 28 days),NA
24752867,NA,21,bevacizumab,4,5,mg/kg,1,on days 1 and 15 concurrent with cediranib,NA
24752867,NA,21,cediranib,4,45,mg,1,days 1 to 21 per cycle (each cycle was 28 days),NA
24752867,NA,21,bevacizumab,5,10,mg/kg,1,on days 1 and 15 concurrent with cediranib,NA
24752867,NA,21,cediranib,5,45,mg,1,days 1 to 21 per cycle (each cycle was 28 days),NA
32847973,NCT00572078,22,paclitaxel,1,80,mg,1,"day 1, 8, 15 every 28 days",fixed dose
32847973,NCT00572078,22,bevacizumab,1,5,mg/kg,1,every 2 weeks,fixed dose
32847973,NCT00572078,22,sorafenib,1,200,mg,2,day 1 -5 in one week,NA
32847973,NCT00572078,22,sorafenib,2,200,mg,2,7 days a week,NA
32847973,NCT00572078,22,sorafenib,3,400,mg,2,day 1 -5 in one week,NA
32847973,NCT00572078,22,sorafenib,4,400,mg,2,7 days a week,NA
32847973,NCT00572078,22,sorafenib,-1,200,mg,1,7 days a week,NA
33159605,UMIN000006254,23,bevacizumab,1,15,mg/kg,1,every 3 weeks,NA
33159605,UMIN000006254,23,s-1,1,40,mg,2,day 1 - 15 of 21-day circle,BSA < 1.25 m2
33159605,UMIN000006254,23,s-1,1,50,mg,2,day 1 - 15 of 21-day circle,1.25 < BSA < 1.5 m2
33159605,UMIN000006254,23,s-1,1,60,mg,2,day 1 - 15 of 21-day circle,BSA > 1.5 m2
32522887,NCT02030561,24,trastuzumab,1,NA,NA,1,on day 1 of 21-day cycles up to 8 cycles,fixed dose
32522887,NCT02030561,24,nk-cell,1,1000000,NA,1,"day 2 of cycle 1, with subcutaneous IL2 support (1 million IU/m2) starting on day 1, followed by five additional doses given three times a week","Patients were eligible for a second NK-cell infusion at cycle 4 if they achieved complete response (CR) or partial response (PR) after cycle 2, or at cycle 6 if they achieved sustained stable disease (SD) or better after cycle 4; patients who achieved sustained SD or better after cycle 6 could receive a third NKcell infusion at cycle 8, up to a maximum of 3 NK-cell infusions over 8 treatment cycles."
32522887,NCT02030561,24,nk-cell,2,10000000,NA,1,"day 2 of cycle 1, with subcutaneous IL2 support (1 million IU/m2) starting on day 1, followed by five additional doses given three times a week","Patients were eligible for a second NK-cell infusion at cycle 4 if they achieved complete response (CR) or partial response (PR) after cycle 2, or at cycle 6 if they achieved sustained stable disease (SD) or better after cycle 4; patients who achieved sustained SD or better after cycle 6 could receive a third NKcell infusion at cycle 8, up to a maximum of 3 NK-cell infusions over 8 treatment cycles."
32522887,NCT02030561,24,nk-cell,3,50000000,NA,1,"day 2 of cycle 1, with subcutaneous IL2 support (1 million IU/m2) starting on day 1, followed by five additional doses given three times a week","Patients were eligible for a second NK-cell infusion at cycle 4 if they achieved complete response (CR) or partial response (PR) after cycle 2, or at cycle 6 if they achieved sustained stable disease (SD) or better after cycle 4; patients who achieved sustained SD or better after cycle 6 could receive a third NKcell infusion at cycle 8, up to a maximum of 3 NK-cell infusions over 8 treatment cycles."
32522887,NCT02030561,24,nk-cell,4,100000000,NA,1,"day 2 of cycle 1, with subcutaneous IL2 support (1 million IU/m2) starting on day 1, followed by five additional doses given three times a week","Patients were eligible for a second NK-cell infusion at cycle 4 if they achieved complete response (CR) or partial response (PR) after cycle 2, or at cycle 6 if they achieved sustained stable disease (SD) or better after cycle 4; patients who achieved sustained SD or better after cycle 6 could receive a third NKcell infusion at cycle 8, up to a maximum of 3 NK-cell infusions over 8 treatment cycles."
32490554,UMIN000016094,25,bevacizumab,0,5,mg/kg,1,every 2 weeks,NA
32490554,UMIN000016094,25,leucovorin,0,25,mg,2,"on Monday, Wednesday, and Friday",NA
32490554,UMIN000016094,25,s-1,0,40,mg/m2,2,"on Monday, Wednesday, and Friday",NA
32490554,UMIN000016094,25,bevacizumab,1,5,mg/kg,1,every 2 weeks,NA
32490554,UMIN000016094,25,leucovorin,1,25,mg,2,on evennumbered days,NA
32490554,UMIN000016094,25,s-1,1,40,mg/m2,2,on evennumbered days,NA
32490554,UMIN000016094,25,bevacizumab,2,5,mg/kg,1,every 2 weeks,NA
32490554,UMIN000016094,25,leucovorin,2,25,mg,2,"on Monday, Wednesday, and Friday",NA
32490554,UMIN000016094,25,s-1,2,40,mg/m2,2,"on Monday, Wednesday, and Friday",NA
31932108,NCT02055690,28,pazopanib,1,600,mg,1,every 28 days,≥1 h before or ≥ 2 h after a meal)
31932108,NCT02055690,28,fosbretabulin,1,54,mg/m2,1,"days 1, 8, 15, every 28 days;",NA
31932108,NCT02055690,28,pazopanib,2,800,mg,1,every 28 days,NA
31932108,NCT02055690,28,fosbretabulin,2,54,mg/m2,1,"days 1, 8, 15, every 28 days;",Whenpazopanib and fosbretabulin were administered together pazopanib was administered ≥1 h prior to fosbretabulin.
31932108,NCT02055690,28,pazopanib,3,800,mg,1,every 28 days,NA
31932108,NCT02055690,28,fosbretabulin,3,60,mg/m2,1,"days 1, 8, 15, every 28 days;",NA
31924737,NCT01916447,29,ftd/tpi,1,20,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,1,120,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31924737,NCT01916447,29,ftd/tpi,2,20,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,2,150,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31924737,NCT01916447,29,ftd/tpi,3,25,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,3,150,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31924737,NCT01916447,29,ftd/tpi,4,20,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,4,180,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31924737,NCT01916447,29,ftd/tpi,5,25,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,5,180,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31924737,NCT01916447,29,ftd/tpi,6,30,mg/m2,2,days 1–5 of a 14-day treatment cycle,NA
31924737,NCT01916447,29,irinotecan,6,180,mg/m2,1,on day 1 of every cycle at the same time as FTD/TPI,NA
31375879,NCT02354131,31,bevacizumab,1,15,mg/kg,1,on day 1 of each 21-day cycle,fixed dose; Bevacizumab was administered before niraparib in all patients.
31375879,NCT02354131,31,niraparib,1,100,mg,1,once daily,NA
31375879,NCT02354131,31,niraparib,2,200,mg,1,once daily,NA
31375879,NCT02354131,31,niraparib,3,300,mg,1,once daily,NA
31194228,NCT02657889,32,niraparib,1,200,mg,1,daily,NA
31194228,NCT02657889,32,pembrolizumab,1,200,mg,1,every 21 days,NA
31194228,NCT02657889,32,niraparib,2,300,mg,1,daily,NA
31194228,NCT02657889,32,pembrolizumab,2,200,mg,1,every 21 days,NA
30302599,NCT01047293,33,bevacizumab,1,5,mg/kg,1,day 1 and 15 of every cycle,fixed dose
30302599,NCT01047293,33,oxaliplatin,1,85,mg/m2,1,day 1 and 15 of every cycle,fixed dose
30302599,NCT01047293,33,oxaliplatin,1,85,mg/m2,1,day 1 and 15 of every cycle,fixed dose
30302599,NCT01047293,33,folinic acid,1,400,mg/m2,1,day 1 and 15 of every cycle,fixed dose
30302599,NCT01047293,33,folinic acid,1,400,mg/m2,NA,day 1 and 15 of every cycle,bolus; fixed dose
30302599,NCT01047293,33,5-fluorouracil,1,2600,mg/m2,NA,day 1 and 15 of every cycle,46-h infusion; fixed dose
30302599,NCT01047293,33,everolimus,1,5,mg,1,every other day,NA
30302599,NCT01047293,33,everolimus,1,5,mg,1,every other day,NA
30302599,NCT01047293,33,everolimus,2,5,mg,1,daily,NA
30302599,NCT01047293,33,everolimus,2,5,mg,1,daily,NA
30302599,NCT01047293,33,everolimus,3,10,mg,1,daily,NA
30302599,NCT01047293,33,everolimus,3,10,mg,1,daily,NA
30185228,NCT00960960,34,pictilisib,1,60,mg,1,daily on days 1–21 of each 28-day cycle (“21 + 7” schedule),"On study treatment days, pictilisib was administered prior to paclitaxel or bevacizumab."
30185228,NCT00960960,34,paclitaxel,1,90,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed dose
30185228,NCT00960960,34,bevacizumab,1,10,mg/kg,1,days 1 and 15 of each 28-day cycle.,fixed dose
30185228,NCT00960960,34,pictilisib,2,100,mg,1,daily on days 1–21 of each 28-day cycle (“21 + 7” schedule),"On study treatment days, pictilisib was administered prior to paclitaxel or bevacizumab."
30185228,NCT00960960,35,pictilisib,1,165,mg,NA,daily for 5 of 7 consecutive days [“5+2” schedule],NA
30185228,NCT00960960,35,paclitaxel,1,90,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",fixed dose; combined with pictilisib
30185228,NCT00960960,35,bevacizumab,1,10,mg/kg,1,days 1 and 15 of each 28-day cycle.,fixed dose; administrated when pictilisib + paclitacxel reached MTD
30185228,NCT00960960,35,pictilisib,2,250,mg,NA,daily for 5 of 7 consecutive days [“5+2” schedule],NA
30185228,NCT00960960,35,pictilisib,3,330,mg,NA,daily for 5 of 7 consecutive days [“5+2” schedule],NA
30185228,NCT00960960,36,pictilisib,1,180,mg,NA,daily for 5 of 7 consecutive days [“5+2” schedule],NA
30185228,NCT00960960,36,paclitaxel,1,90,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",fixed dose; combined with pictilisib
30185228,NCT00960960,36,trastuzumab,1,2,mg/kg,NA,"days 1, 8, 15, and 22 of each 28-day cycle.",fixed dose; administrated when pictilisib + paclitacxel reached MTD
30185228,NCT00960960,36,pictilisib,2,260,mg,1,daily for 5 of 7 consecutive days [“5+2” schedule],NA
30185228,NCT00960960,37,pictilisib,1,260,mg,1,daily,NA
30185228,NCT00960960,37,letrozole,1,2.5,mg,1,daily,NA
30603797,NCT02835833,38,nintedanib,1,150,mg,2,every day,NA
30603797,NCT02835833,38,bevacizumab,1,15,mg/kg,1,on day 1 of every 21-day cycle,fixed dose
30603797,NCT02835833,38,nintedanib,2,200,mg,2,every day,NA
30603797,NCT02835833,38,nintedanib,-1,100,mg,2,every day,NA
29695765,NCT01113476,40,gemcitabine,1,1000,mg/m2,NA,"days 1, 8, 15",fixed dose
29695765,NCT01113476,40,nab-paclitaxel,1,50,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,1,5,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,2,75,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,2,5,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,3,50,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,3,10,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,4,100,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,4,5,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,5,75,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,5,10,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,6,50,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,6,15,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,7,125,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,8,100,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,8,10,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,9,75,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,9,15,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,10,150,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,10,5,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,11,125,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,11,10,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,12,100,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,12,15,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,13,150,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,13,10,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,14,125,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,14,15,mg/kg,NA,"daya 1, 15",NA
29695765,NCT01113476,40,nab-paclitaxel,15,150,mg/m2,NA,"days 1, 8, 15",NA
29695765,NCT01113476,40,bevacizumab,15,15,mg/kg,NA,"daya 1, 15",NA
29290249,UMIN000015944,41,afatinib,0,40,mg,1,daily,NA
29290249,UMIN000015944,41,bevacizumab,0,15,mg/kg,1,every 3 weeks,fixed dose
29290249,UMIN000015944,41,afatinib,-1,30,mg,1,daily,NA
29290249,UMIN000015944,41,bevacizumab,-1,15,mg/kg,1,every 3 weeks,fixed dose
29264836,NA,42,bevacizumab,1,10,mg/kg,1,every other week starting on Day 1,fixed dose
29264836,NA,42,temozolomide,1,50,mg/m2,1,daily,fixed dose
29264836,NA,42,temozolomide,1,50,mg/m2,1,daily,fixed dose
29264836,NA,42,vorinostat,1,200,mg,1,"Days 1-7, 15-21 of 28 days circle",NA
29264836,NA,42,vorinostat,1,400,mg,1,"Days 1-7, 15-21 of 28 days circle",NA
29559563,NCT01248949,43,medi3617,1,5,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,2,10,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,3,20,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,4,100,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,5,300,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,6,1000,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,7,1500,mg,1,Day 1 Q3W,"infused over 60 minutes at doses less than 1,000 mg and over 90 minutes at doses of at least 1,000 mg."
29559563,NCT01248949,43,medi3617,NA,1000,mg,1,Day 1 Q3W,"expansion, ovarian cancer"
29559563,NCT01248949,43,medi3617,NA,1500,mg,1,Day 1 Q3W,"expansion, ovarian cancer"
29559563,NCT01248949,44,medi3617,1,100,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,44,bevacizumab,1,15,mg/kg,NA,Day 1 Q3W,fixed dose
29559563,NCT01248949,44,medi3617,2,300,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,44,medi3617,3,1000,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,44,medi3617,4,1500,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,45,medi3617,1,60,mg,NA,Day 1 Q2W,NA
29559563,NCT01248949,45,bevacizumab,1,10,mg/kg,NA,Day 1 Q2W,fixed dose
29559563,NCT01248949,45,medi3617,2,200,mg,NA,Day 1 Q2W,NA
29559563,NCT01248949,45,medi3617,3,600,mg,NA,Day 1 Q2W,NA
29559563,NCT01248949,45,medi3617,4,1000,mg,NA,Day 1 Q2W,NA
29559563,NCT01248949,46,medi3617,1,60,mg,NA,Days 1 and 15 Q2W,NA
29559563,NCT01248949,46,paclitaxel,1,80,mg/m2,NA,"Days 1, 8 and 15 QW",fixed dose
29559563,NCT01248949,46,medi3617,1,1000,mg,NA,Days 1 and 15 Q2W,NA
29559563,NCT01248949,47,medi3617,1,1000,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,47,paclitaxel,1,175,mg/m2,NA,Day 1 Q3W,fixed dose
29559563,NCT01248949,47,carboplatin,1,5,AUC,NA,day 1 Q3W,fixed dose
29559563,NCT01248949,47,carboplatin,1,5,AUC,NA,day 1 Q3W,fixed dose
29559563,NCT01248949,47,medi3617,2,1500,mg,NA,Day 1 Q3W,NA
29559563,NCT01248949,48,medi3617,1,1000,mg,NA,Days 1 and 15 Q2W,expansion cohort
29559563,NCT01248949,48,bevacizumab,1,10,mg/kg,NA,Days 1 and 15 Q2W,expansion cohort
28810837,NCT01202032,49,pazopanib,1,400,mg,1,once daily,NA
28810837,NCT01202032,49,bevacizumab,1,7.5,mg/kg,1,every 2 weeks,Bevacizumab injections started 2 weeks after pazopanib initiation.
28810837,NCT01202032,49,pazopanib,1.5,400,mg,1,once daily,Comfirmatory cohort
28810837,NCT01202032,49,bevacizumab,1.5,7.5,mg/kg,1,every 2 weeks,NA
28810837,NCT01202032,49,pazopanib,2,600,mg,1,once daily,NA
28810837,NCT01202032,49,bevacizumab,2,7.5,mg/kg,1,every 2 weeks,Bevacizumab injections started 2 weeks after pazopanib initiation.
29101518,UMIN000012536,50,pemetrexed,0,500,mg/m2,1,day 1 every 3 weeks,fixed dose
29101518,UMIN000012536,50,cisplatin,0,60,mg/m2,1,day 1 every 3 weeks,NA
29101518,UMIN000012536,50,cisplatin,0,60,mg/m2,1,day 1 every 3 weeks,NA
29101518,UMIN000012536,50,bevacizumab,0,15,mg/kg,1,day 1 every 3 weeks,fixed dose
29101518,UMIN000012536,50,erlotinib,0,150,mg,1,once daily,fixed dose
29101518,UMIN000012536,50,erlotinib,0,150,mg,1,once daily,fixed dose
29101518,UMIN000012536,50,pemetrexed,1,500,mg/m2,1,day 1 every 3 weeks,fixed dose
29101518,UMIN000012536,50,cisplatin,1,75,mg/m2,1,day 1 every 3 weeks,NA
29101518,UMIN000012536,50,cisplatin,1,75,mg/m2,1,day 1 every 3 weeks,NA
29101518,UMIN000012536,50,bevacizumab,1,15,mg/kg,1,day 1 every 3 weeks,fixed dose
29101518,UMIN000012536,50,erlotinib,1,150,mg,1,once daily,fixed dose
29101518,UMIN000012536,50,erlotinib,1,150,mg,1,once daily,fixed dose
28992562,NCT00974584,51,pictilisib,1,60,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,51,carboplatin,1,6,AUC,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,51,carboplatin,1,6,AUC,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,51,paclitaxel,1,200,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,51,pictilisib,2,100,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,51,pictilisib,3,165,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,51,pictilisib,4,250,mg,1,"Once a day, Days 1- 14",260 for capsules
28992562,NCT00974584,51,pictilisib,5,330,mg,1,"Once a day, Days 1- 14",340 for capsules
28992562,NCT00974584,52,pictilisib,1,100,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,52,carboplatin,1,6,AUC,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,52,carboplatin,1,6,AUC,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,52,paclitaxel,1,200,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,52,bevacizumab,1,15,mg/kg,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,52,pictilisib,2,165,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,52,pictilisib,3,250,mg,1,"Once a day, Days 1- 14",260 for capsules
28992562,NCT00974584,52,pictilisib,4,330,mg,1,"Once a day, Days 1- 14",340 for capsules
28992562,NCT00974584,52,pictilisib,5,330,mg,1,"Once a day, Days 1- 14",340 for capsules; expansion cohort
28992562,NCT00974584,53,pictilisib,1,260,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,53,cisplatin,1,75,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,53,cisplatin,1,75,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,53,pemetrexed,1,500,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,53,bevacizumab,1,15,mg/kg,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,53,pictilisib,2,340,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,53,pictilisib,3,250,mg,1,"Once a day, Days 1- 14",expansion cohort
28992562,NCT00974584,54,pictilisib,1,340,mg,1,"Once a day, Days 1- 14",NA
28992562,NCT00974584,54,cisplatin,1,75,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,54,cisplatin,1,75,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,54,pemetrexed,1,500,mg/m2,1,"every 3 weeks, Day 1",fixed dose
28992562,NCT00974584,54,pictilisib,1,340,mg,1,"Once a day, Days 1- 14",expansion cohort
28760399,NA,55,tas-102,1,35,mg/m2,2,"days 1-5, 8-12",NA
28760399,NA,55,bevacizumab,1,5,mg/kg,1,every 2 weeks,infusion for 30 min
28760399,NA,55,tas-102,-1,30,mg/m2,2,"days 1-5, 8-12",NA
28760399,NA,55,bevacizumab,-1,5,mg/kg,1,every 2 weeks,infusion for 30 min
28391576,NCT01660360,56,tanibirumab,1,1,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,2,2,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,3,4,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,4,8,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,5,12,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,6,16,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,7,20,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,8,24,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
28391576,NCT01660360,56,tanibirumab,9,28,mg/kg,NA,"Days 1, 8, 15, every four weeks",infusion 60 min
27943153,NCT00867321,57,sorafenib,0,400,mg,2,daily,NA
27943153,NCT00867321,57,bevacizumab,0,1.25,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,1,400,mg,2,daily,NA
27943153,NCT00867321,57,bevacizumab,1,2.5,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,2,400,mg,2,daily,NA
27943153,NCT00867321,57,bevacizumab,2,5,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-1,400,mg,2,day 1 -5 of 7 days,NA
27943153,NCT00867321,57,bevacizumab,-1,2.5,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-2,200,mg,2,day 1 -28,NA
27943153,NCT00867321,57,bevacizumab,-2,1.25,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-1.5,200,mg,2,day 1 -28,NA
27943153,NCT00867321,57,bevacizumab,-1.5,2.5,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-3,200,mg,2,day 1 -5 of 7 days,NA
27943153,NCT00867321,57,bevacizumab,-3,1.25,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-3a,200,mg,2,day 1 -5 of 7 days,NA
27943153,NCT00867321,57,bevacizumab,-3a,2.5,mg/kg,NA,every 2 weeks,NA
27943153,NCT00867321,57,sorafenib,-3b,200,mg,2,day 1 -5 of 7 days,NA
27943153,NCT00867321,57,bevacizumab,-3b,5,mg/kg,NA,every 2 weeks,NA
27765756,NA,58,nivolumab,1,10,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,"nivolumab 10 mg/kg on day 1 every 3 weeks until disease progression or unacceptable toxicity, as the first-line treatment for advanced NSCLC;"
27765756,NA,58,gemcitabine,1,1250,mg/m2,NA,day 1 and 8 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,58,cisplatin,1,80,mg/m2,NA,day 1 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,58,cisplatin,1,80,mg/m2,NA,day 1 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,58,nivolumab,-1,5,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,NA
27765756,NA,58,nivolumab,-2,2,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,NA
27765756,NA,59,nivolumab,1,10,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,"nivolumab 10 mg/kg on day 1 and pemetrexed 500 mg/m2 on day 1 every 3 weeks, as the first-line treatment for advanced non-squamous NSCLC"
27765756,NA,59,pemetrexed,1,500,mg/m2,NA,day 1 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,59,cisplatin,1,75,mg/m2,NA,day 1 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,59,cisplatin,1,75,mg/m2,NA,day 1 every 3 weeks foe up to 4 cycles,fixed dose
27765756,NA,59,nivolumab,-1,5,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,NA
27765756,NA,59,nivolumab,-2,2,mg/kg,NA,day 1 every 3 weeks foe up to 4 cycles,NA
27765756,NA,60,nivolumab,1,10,mg/kg,NA,day 1 every 3 weeks foe up to 6 cycles,NA
27765756,NA,60,paclitaxel,1,200,mg/m2,NA,day 1 every 3 weeks foe up to 6 cycles,fixed dose
27765756,NA,60,carboplatin,1,6,AUC,NA,day 1 every 3 weeks foe up to 6 cycles,fixed dose
27765756,NA,60,carboplatin,1,6,AUC,NA,day 1 every 3 weeks foe up to 6 cycles,fixed dose
27765756,NA,60,bevacizumab,NA,15,mg/kg,NA,day 1 every 3 weeks foe up to 6 cycles,fixed dose
27765756,NA,60,nivolumab,-1,5,mg/kg,NA,day 1 every 3 weeks foe up to 6 cycles,NA
27765756,NA,60,nivolumab,-2,2,mg/kg,NA,day 1 every 3 weeks foe up to 6 cycles,NA
27765756,NA,61,nivolumab,1,10,mg/kg,NA,"day 1 until disease progression or unacceptable toxicity, as the second- or thirdline treatment for advanced NSCLC",NA
27765756,NA,61,docetaxel,1,75,mg/m2,NA,"day 1 until disease progression or unacceptable toxicity, as the second- or thirdline treatment for advanced NSCLC",NA
27872953,NA,62,afatinib,1,40,mg,1,continuous once-daily dose beginning on Day 2 of Cycle 1,NA
27872953,NA,62,paclitaxel,1,80,mg/m2/week,NA,"Days 1, 8, and 15 of a 28-day cycle",NA
27872953,NA,62,bevacizumab,1,5,mg/kg,NA,"Days 1 and 15, after infusion of paclitaxel.",NA
27872953,NA,62,afatinib,2,30,mg,1,continuous once-daily dose beginning on Day 2 of Cycle 1,NA
27872953,NA,62,paclitaxel,2,80,mg/m2/week,NA,"Days 1, 8, and 15 of a 28-day cycle",NA
27872953,NA,62,bevacizumab,2,5,mg/kg,NA,"Days 1 and 15, after infusion of paclitaxel.",NA
27872953,NA,62,afatinib,3,20,mg,1,continuous once-daily dose beginning on Day 2 of Cycle 1,NA
27872953,NA,62,paclitaxel,3,80,mg/m2/week,NA,"Days 1, 8, and 15 of a 28-day cycle",NA
27872953,NA,62,bevacizumab,3,5,mg/kg,NA,"Days 1 and 15, after infusion of paclitaxel.",NA
27872953,NA,62,afatinib,4,20,mg,1,continuous once-daily dose beginning on Day 2 of Cycle 1,NA
27872953,NA,62,paclitaxel,4,80,mg/m2/week,NA,"Days 1, 8, and 15 of a 28-day cycle",NA
27872953,NA,62,bevacizumab,4,7.5,mg/kg,NA,"Days 1 and 15, after infusion of paclitaxel.",NA
27872953,NA,62,afatinib,5,20,mg,1,continuous once-daily dose beginning on Day 2 of Cycle 1,NA
27872953,NA,62,paclitaxel,5,80,mg/m2/week,NA,"Days 1, 8, and 15 of a 28-day cycle",NA
27872953,NA,62,bevacizumab,5,10,mg/kg,NA,"Days 1 and 15, after infusion of paclitaxel.",NA
27507617,NCT01183494,64,irinotecan,1,260,mg/m2,NA,days 1 and 15,over 90 mins infusion
27507617,NCT01183494,64,leucovorin,1,200,mg/m2,NA,NA,fixed dose
27507617,NCT01183494,64,5-fu,1,400,mg/m2,NA,days 1 and 15,"followed by 2,400 mg/m2 over a 46-hour continuous infusion;fixed dose"
27507617,NCT01183494,64,bevacizumab,1,5,mg/kg,NA,days 1 and 15,fixed dose
27507617,NCT01183494,64,irinotecan,2,310,mg/m2,NA,days 1 and 15,over 90 mins infusion
27507617,NCT01183494,64,irinotecan,3,370,mg/m2,NA,days 1 and 15,over 90 mins infusion
27507617,NCT01183494,65,irinotecan,1,260,mg/m2,NA,days 1 and 15,over 90 mins infusion
27507617,NCT01183494,65,leucovorin,1,200,mg/m2,NA,NA,fixed dose
27507617,NCT01183494,65,5-fu,1,400,mg/m2,NA,days 1 and 15,"followed by 2,400 mg/m2 over a 46-hour continuous infusion;fixed dose"
27507617,NCT01183494,65,bevacizumab,1,5,mg/kg,NA,days 1 and 15,fixed dose
27507617,NCT01183494,65,irinotecan,2,310,mg/m2,NA,days 1 and 15,over 90 mins infusion
27507617,NCT01183494,65,irinotecan,3,370,mg/m2,NA,days 1 and 15,over 90 mins infusion
27565810,NA,66,pictilisib,1,140,mg,1,once daily,NA
27565810,NA,66,pictilisib,2,260,mg,1,once daily,NA
27565810,NA,66,pictilisib,3,340,mg,1,once daily,NA
27565810,NA,67,pictilisib,1,260,mg,1,once daily,NA
27565810,NA,67,pictilisib,2,340,mg,1,once daily,NA
27565810,NA,67,carboplatin,1,6,AUC,NA,day 2,fixed dose
27565810,NA,67,carboplatin,1,6,AUC,NA,day 2,fixed dose
27565810,NA,67,paclitaxel,1,200,mg/m2,NA,day 2,fixed dose
27565810,NA,67,bevacizumab,1,15,mg/kg,NA,day 2,fixed dose
27457310,NA,68,crlx101,1,12,mg/m2,NA,every 2 weeks,NA
27457310,NA,68,bevacizumab,1,10,mg/kg,NA,every 2 weeks,fixed dose
27457310,NA,68,crlx101,1,15,mg/m2,NA,every 2 weeks,NA
27085994,NCT01183663,71,lenalidomide,1,10,mg,1,once daily for 21 days,NA
27085994,NCT01183663,71,bevacizumab,1,5,mg/kg,NA,every 2 weeks,NA
27085994,NCT01183663,71,lenalidomide,2,10,mg,1,once daily for 21 days,NA
27085994,NCT01183663,71,bevacizumab,2,7.5,mg/kg,NA,every 2 weeks,NA
27085994,NCT01183663,71,lenalidomide,3,20,mg,1,once daily for 21 days,NA
27085994,NCT01183663,71,bevacizumab,3,7.5,mg/kg,NA,every 2 weeks,NA
27085994,NCT01183663,71,lenalidomide,4,20,mg,1,once daily for 21 days,inclding expansion phase
27085994,NCT01183663,71,bevacizumab,4,10,mg/kg,NA,every 2 weeks,NA
27198170,NCT01283048,73,buparlisib,1,60,mg,1,once daily,NA
27198170,NCT01283048,73,bevacizumab,1,10,mg/kg,NA,every 2 weeks,fixed dose
27198170,NCT01283048,73,buparlisib,1,80,mg,1,once daily,NA
27198170,NCT01283048,73,buparlisib,1,100,mg,1,once daily,NA
26933802,NA,74,bevacizumab,1,5,mg/kg,NA,"Days 1, 15",NA
26933802,NA,74,temsirolimus,1,5,mg,NA,"Days 1, 8, 15,22",NA
26933802,NA,74,cetuximab,1,100,mg/m2,NA,"Days 1, 8, 15,22",fixed dose; 100/75
26933802,NA,74,bevacizumab,2,10,mg/kg,NA,"Days 1, 15",NA
26933802,NA,74,temsirolimus,2,5,mg,NA,"Days 1, 8, 15,22",NA
26933802,NA,74,bevacizumab,3,2.5,mg/kg,NA,"Days 1, 15",NA
26933802,NA,74,temsirolimus,3,12.5,mg,NA,"Days 1, 8, 15,22",NA
26616225,NA,76,pegylated liposomal doxorubicin,1,30,mg/m2,NA,one time,fixed dose
26616225,NA,76,carboplatin,1,5,AUC,NA,one time,fixed dose
26616225,NA,76,carboplatin,1,5,AUC,NA,one time,fixed dose
26616225,NA,76,veliparib,1,50,mg,2,days 1–7,NA
26616225,NA,76,bevacizumab,1,10,mg/kg,NA,days one and 15 after MTD of velliparib,fixed dose
26616225,NA,76,veliparib,2,80,mg,2,days 1–7,NA
26616225,NA,76,veliparib,3,120,mg,2,days 1–7,NA
26616225,NA,77,veliparib,1,50,mg,2,days 1–28,NA
26616225,NA,77,veliparib,2,80,mg,2,days 1–28,NA
26616225,NA,77,veliparib,3,120,mg,2,days 1–28,NA
26581401,NA,78,irinotecan,1,180,mg/m2,NA,day 1,fixed dose
26581401,NA,78,leucovorin,1,400,mg/m2,NA,day 1,fixed dose
26581401,NA,78,5-fluorouracil,1,400,mg/m2,NA,bolus day 1; 2400 mg/m2 over 46 hrs,fixed dose
26581401,NA,78,bevacizumab,1,5,mg/kg,NA,day 1,fixed dose
26581401,NA,78,sorafenib,1,200,mg,1,"Days 3 -7, 10-14",NA
26581401,NA,78,sorafenib,2,200,mg,2,"Days 3 -6, 10-13",NA
26581401,NA,78,sorafenib,3,200,mg,2,"Days 3 -7, 10-14",NA
26272806,NCT00904839,79,oxaliplatin,1,85,mg/m2,NA,NA,infused over 2h
26272806,NCT00904839,79,oxaliplatin,1,85,mg/m2,NA,NA,infused over 2h
26272806,NCT00904839,79,leucovorin,1,200,mg/m2,NA,NA,NA
26272806,NCT00904839,79,5-fluorouracil,1,400,mg/m2,NA,bolus; 2400 mg/m2 continuous,NA
26272806,NCT00904839,79,nintedanib,1,150,mg,2,daily,NA
26272806,NCT00904839,79,nintedanib,2,200,mg,2,daily,NA
25990659,NA,80,irinotecan,1,35,mg/m2,1,days 1 to 3,NA
25990659,NA,80,bevacizumab,1,10,mg/kg,NA,days 1 and 15,fixed dose
25990659,NA,80,irinotecan,2,45,mg/m2,1,days 1 to 3,NA
25990659,NA,80,irinotecan,3,60,mg/m2,1,days 1 to 3,NA
25990659,NA,80,irinotecan,4,75,mg/m2,1,days 1 to 3,expansion
25990659,NA,81,irinotecan,1,35,mg/m2,1,days 1 to 3,NA
25990659,NA,81,bevacizumab,1,10,mg/kg,NA,days 1 and 15,fixed dose
25990659,NA,81,oxaliplatin,1,60,mg/m2,NA,days 1 and 15,expansion cohort
25990659,NA,81,oxaliplatin,1,60,mg/m2,NA,days 1 and 15,expansion cohort
25990659,NA,81,irinotecan,2,45,mg/m2,1,days 1 to 3,NA
25990659,NA,81,oxaliplatin,2,60,mg/m2,NA,days 1 and 15,expansion cohort
25990659,NA,81,oxaliplatin,2,60,mg/m2,NA,days 1 and 15,expansion cohort
25990659,NA,81,irinotecan,3,45,mg/m2,1,days 1 to 3,NA
25990659,NA,81,oxaliplatin,3,80,mg/m2,NA,days 1 and 15,NA
25990659,NA,81,oxaliplatin,3,80,mg/m2,NA,days 1 and 15,NA
25990659,NA,82,irinotecan,1,35,mg/m2,1,days 1 to 3,NA
25990659,NA,82,bevacizumab,1,10,mg/kg,NA,days 1 and 15,fixed dose
25990659,NA,82,cetuximab,1,500,mg/kg,NA,days 1 and 15,fixed dose
25990659,NA,82,irinotecan,1,45,mg/m2,1,days 1 to 3,NA
25990659,NA,82,irinotecan,2,60,mg/m2,1,days 1 to 3,NA
25990659,NA,82,irinotecan,3,75,mg/m2,1,days 1 to 3,expansion cohort
25525888,NA,84,trebananib,1,3,mg/kg,NA,day 1 of second week,NA
25525888,NA,84,bevacizumab,1,15,mg/kg,NA,every 3 weeks,fixed dose
25525888,NA,84,trebananib,2,10,mg/kg,NA,every week,NA
25525888,NA,85,trebananib,1,3,mg/kg,NA,day 1 of second week,NA
25525888,NA,85,motesanib,1,75,mg,1,NA,NA
25525888,NA,85,trebananib,2,3,mg/kg,NA,day 1 of second week,NA
25525888,NA,85,motesanib,2,125,mg,1,NA,NA
25363205,NA,86,sorafenib,NA,NA,NA,NA,daily,No DL reported
25363205,NA,86,bevacizumab,NA,NA,NA,NA,every 2 weeks,No DL reported
25080061,UMIN000006937,87,s-1,1,80,mg/m2/day,2,"days 1-5, 8-12, 15-19, 22-26",total dose; fixed dose
25080061,UMIN000006937,87,oxaliplatin,1,40,mg/m2,NA,every week,NA
25080061,UMIN000006937,87,oxaliplatin,1,40,mg/m2,NA,every week,NA
25080061,UMIN000006937,87,radiotherapy,1,40,Gy,NA,5 days/week for 4 weeks,NA
25080061,UMIN000006937,87,bevacizumab,1,5,mg/kg,NA,day 1 and 15,a 90 min intravenous infusion
25080061,UMIN000006937,87,oxaliplatin,1,50,mg/m2,NA,every week,NA
25080061,UMIN000006937,87,oxaliplatin,1,50,mg/m2,NA,every week,NA
25080061,UMIN000006937,87,oxaliplatin,1,60,mg/m2,NA,every week,NA
25080061,UMIN000006937,87,oxaliplatin,1,60,mg/m2,NA,every week,NA
29764853,NCT01478685,88,cc-486,1,100,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,88,carboplatin,1,4,AUC,NA,Cycle 1: Day 8;Cycle 2+: Day 1,fixed dose
29764853,NCT01478685,88,carboplatin,1,4,AUC,NA,Cycle 1: Day 8;Cycle 2+: Day 1,fixed dose
29764853,NCT01478685,88,cc-486,1,200,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,88,carboplatin,1,300,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,88,carboplatin,1,300,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,89,cc-486,2,100,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,89,nab-paclitaxel,2,100,mg/m2,NA,Cycle 1: Days 8 and 15; Cycle 2+: Days 1 and 8,fixed dose
29764853,NCT01478685,89,cc-486,2,200,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,89,carboplatin,2,300,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,89,carboplatin,2,300,mg,NA,"Cycle 1: Days 1–7, 9–14, 22–28;Cycles 2+: Days 1–7 and 15–21",NA
29764853,NCT01478685,90,cc-486,3,100,mg,NA,Days 1-14,NA
29764853,NCT01478685,90,cc-486,3,200,mg,NA,Days 1-14,NA
29764853,NCT01478685,90,cc-486,3,300,mg,NA,Days 1-14,NA
28546581,NCT00946647,95,azacitidine,1,75,mg/m2,NA,D1-7,fixed dose
28546581,NCT00946647,95,panobinostat,1,20,mg,NA,"D3, 5, 8, 10, 12 & 15",NA
28546581,NCT00946647,95,panobinostat,2,30,mg,NA,"D3, 5, 8, 10, 12 & 15",NA
28546581,NCT00946647,95,panobinostat,3,40,mg,NA,"D3, 5, 8, 10, 12 & 15",NA
24875133,NA,99,decitabine,-1,5,mg/m2/d,NA,days 1-5 every 28 days,NA
24875133,NA,99,pegylated interferon alpha-2b,-1,1.5,ug/kg,NA,once weekly,NA
24875133,NA,99,decitabine,1,10,mg/m2/d,NA,days 1-5 every 28 days,NA
24875133,NA,99,pegylated interferon alpha-2b,1,3,ug/kg,NA,once weekly,NA
24875133,NA,99,decitabine,2,15,mg/m2/d,NA,days 1-5 every 28 days,NA
24875133,NA,99,pegylated interferon alpha-2b,2,3,ug/kg,NA,once weekly,NA
24875133,NA,99,decitabine,3,10,mg/m2/d,NA,days 1-5 every 28 days,NA
24875133,NA,99,pegylated interferon alpha-2b,3,4.5,ug/kg,NA,once weekly,NA
25483416,NA,101,azacitidine,1,75,mg/m2,NA,days 1-5,fixed dose
25483416,NA,101,belinostat,1,150,mg/m2,NA,days 1-5,NA
25483416,NA,101,belinostat,2,300,mg/m2,NA,days 1-5,NA
25483416,NA,101,belinostat,3,600,mg/m2,NA,days 1-5,NA
25483416,NA,101,belinostat,4,1000,mg/m2,NA,days 1-5,NA
24413064,ACTRN12610000924055,103,azacitidine,1,75,mg/m2,NA,days 1-5,fixed dose
24413064,ACTRN12610000924055,103,panobinostat,1,10,mg,NA,on Mon/Wed/Fri starting on day 5 for seven doses of each 28-day cycle,NA
24413064,ACTRN12610000924055,103,panobinostat,2,20,mg,NA,on Mon/Wed/Fri starting on day 5 for seven doses of each 28-day cycle,NA
24413064,ACTRN12610000924055,103,panobinostat,3,30,mg,NA,on Mon/Wed/Fri starting on day 5 for seven doses of each 28-day cycle,NA
24413064,ACTRN12610000924055,103,panobinostat,4,40,mg,NA,on Mon/Wed/Fri starting on day 5 for seven doses of each 28-day cycle,NA
24138944,NCT00861874,104,decitabine,1,20,mg/m2,NA,days 1-5,NA
24138944,NCT00861874,104,rapamycin,1,2,mg,NA,days 6-25,NA
24138944,NCT00861874,104,rapamycin,2,4,mg,NA,days 6-25,NA
24138944,NCT00861874,104,rapamycin,3,5,mg,NA,days 6-25,NA
23798029,NCT01130662,106,decitabine,1,20,mg/m2,NA,Days 1-5 over 1 hr,NA
23798029,NCT01130662,106,midostaurin,1,25,mg,2,days 8-21,NA
23798029,NCT01130662,106,midostaurin,2,50,mg,2,days 8-21,NA
23798029,NCT01130662,106,midostaurin,3,50,mg,2,days 1-28,NA
23789936,NA,107,rigosertib,1,70,mg,2,2 out 3 3 weeks,NA
23789936,NA,107,rigosertib,2,140,mg,2,2 out 3 3 weeks,NA
23789936,NA,107,rigosertib,3,280,mg,2,2 out 3 3 weeks,NA
23789936,NA,107,rigosertib,4,560,mg,2,2 out 3 3 weeks,NA
23789936,NA,107,rigosertib,5,700,mg,2,2 out 3 3 weeks,NA
21901396,NA,108,erlotinib,1,150,mg/d,NA,"Daily, 1 h before or  2h after a meal",fixed dose
21901396,NA,108,erlotinib,1,150,mg/d,NA,"Daily, 1 h before or  2h after a meal",fixed dose
21901396,NA,108,5-azacytidine,1,75,mg/m2/d,NA,Day 1 and 15,NA
21901396,NA,108,5-azacytidine,2,75,mg/m2/d,NA,"Days 1,2 15,16",NA
21901396,NA,108,5-azacytidine,3,75,mg/m2/d,NA,"Days 1- 3, 15-17",NA
21901396,NA,108,5-azacytidine,4,75,mg/m2/d,NA,"Days 1-4, 15- 18",NA
21901396,NA,108,5-azacytidine,5,100,mg/m2/d,NA,"Days 1-4, 15- 18",NA
21576646,NA,109,azacitidine,1,75,mg/m2/d,NA,SC for 7 days of a 28-day cycle during cycle 1,fixed dose
21576646,NA,109,azacitidine,1,120,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,2,180,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,3,240,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,4,300,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,5,360,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,6,480,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21576646,NA,109,azacitidine,7,600,mg,NA,Oral for the first 7 days of a 28-day cycle from cycle 2,NA
21278245,NA,110,decitabine,1,20,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,1,100,mg,2,Days 6 -21,NA
21278245,NA,110,decitabine,-1,15,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,-1,200,mg,2,Days 6 -21,NA
21278245,NA,110,decitabine,1a,20,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,1a,100,mg,2,Days 6 -12,NA
21278245,NA,110,decitabine,1b,15,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,1b,100,mg,2,Days 6 -12,NA
21278245,NA,110,decitabine,-1b,10,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,-1b,200,mg,2,Days 6 -12,NA
21278245,NA,110,decitabine,-2b,10,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,110,vorinostat,-2b,200,mg,3,Days 6 -12,NA
21278245,NA,111,decitabine,-2b,10,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,111,vorinostat,-2b,200,mg,2,Days 3 - 9,NA
21278245,NA,111,decitabine,-2c,10,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,111,vorinostat,-2c,200,mg,2,Days 3 - 16,NA
21278245,NA,111,decitabine,-3c,10,mg/m2/d,NA,days 1 to 5,NA
21278245,NA,111,vorinostat,-3c,200,mg,3,Days 3 - 16,NA
23172636,NCT00715793,112,decitabine,0,0.0375,mg/kg,NA,daily for 5 days a week for the first 2 weeks of a 6-week cycle,NA
23172636,NCT00715793,112,temozolomide,0,75,mg/m2,NA,daily for 4 weeks (weeks 2–5) of a 6week cycle,fixed dose
23172636,NCT00715793,112,temozolomide,0,75,mg/m2,NA,daily for 4 weeks (weeks 2–5) of a 6week cycle,fixed dose
23172636,NCT00715793,112,decitabine,1,0.075,mg/kg,NA,daily for 5 days a week for the first 2 weeks of a 6-week cycle,NA
23172636,NCT00715793,112,decitabine,2,0.15,mg/kg,NA,daily for 5 days a week for the first 2 weeks of a 6-week cycle,NA
22033493,NCT00890929,113,azacitidine,1,75,mg/m2/d,NA,"7 days of azacitidine 75 mg/m2/day intravenously or subcutaneously, followed by observation for 21 days (cycle 0). If tolerated, these patients then received azacitidine 75 mg/m2/day followed by 5 mg of lenalidomide orally for 21 days.",fixed dose
22033493,NCT00890929,113,lenalidomide,1,5,mg,NA,for 21 days,NA
22033493,NCT00890929,113,lenalidomide,2,10,mg,NA,for 21 days,NA
22033493,NCT00890929,113,lenalidomide,3,25,mg,NA,for 21 days,NA
22033493,NCT00890929,113,lenalidomide,4,50,mg,NA,for 21 days,NA
20456354,NA,114,decitabine,1,15,mg/m2,NA,days 1-10,NA
20456354,NA,114,decitabine,-1,10,mg/m2,NA,days 1-10,NA
20456354,NA,114,decitabine,1a,15,mg/m2,NA,days 1-10,NA
20456354,NA,115,decitabine,1,15,mg/m2,NA,days 1-10,NA
20456354,NA,115,decitabine,1a,15,mg/m2,NA,days 1-5,NA
14604977,NA,116,decitabine,1,5,mg/m2/d,NA,"5 days on, 2 days off, 5 days on",NA
14604977,NA,116,decitabine,2,10,mg/m2/d,NA,"5 days on, 2 days off, 5 days on",NA
14604977,NA,116,decitabine,3,15,mg/m2/d,NA,"5 days on, 2 days off, 5 days on",NA
14604977,NA,116,decitabine,4,20,mg/m2/d,NA,"5 days on, 2 days off, 5 days on",NA
14604977,NA,116,decitabine,5,15,mg/m2/d,NA,for 15 days,NA
14604977,NA,116,decitabine,6,15,mg/m2/d,NA,for 20 days,NA
14604977,NA,116,decitabine,7,15,mg/m2/d,NA,"5 days on, 2 days off, 5 days on",NA
10830142,NA,117,cisplatin,1,33,mg/m2,NA,"days 1–3, given as a 2-hr infusion",fixced dose
10830142,NA,117,cisplatin,1,33,mg/m2,NA,"days 1–3, given as a 2-hr infusion",fixced dose
10830142,NA,117,decytabine,1,45,mg/m2,NA,"days 1–3, given as a 2-hr infusion",NA
10830142,NA,117,decytabine,2,67,mg/m2,NA,"days 1–3, given as a 2-hr infusion",NA
10830142,NA,117,decytabine,3,90,mg/m2,NA,"days 1–3, given as a 2-hr infusion",NA
10830142,NA,117,decytabine,4,120,mg/m2,NA,"days 1–3, given as a 2-hr infusion",NA
10492074,NA,118,fazarabine,1,5-Feb,mg/m2/hr,NA,a continuousinfusion over 3 days every 3 to 4 weeks,Dose escalations in subsequent patients were in 50% increments untiI grade >1 toxicity was observed (except for nausea and vomiting) and then in 25% to 35% increments at each level until evidence of grade 3 toxicity based on the National Cancer Institute (NCI) toxicity grading system
10492074,NA,118,fazarabine,2,13-Jun,mg/m2/hr,NA,a continuousinfusion over 3 days every 3 to 4 weeks,Dose escalations in subsequent patients were in 50% increments untiI grade >1 toxicity was observed (except for nausea and vomiting) and then in 25% to 35% increments at each level until evidence of grade 3 toxicity based on the National Cancer Institute (NCI) toxicity grading system
10492074,NA,118,fazarabine,3,17-40,mg/m2/hr,NA,a continuousinfusion over 3 days every 3 to 4 weeks,Dose escalations in subsequent patients were in 50% increments untiI grade >1 toxicity was observed (except for nausea and vomiting) and then in 25% to 35% increments at each level until evidence of grade 3 toxicity based on the National Cancer Institute (NCI) toxicity grading system
10492074,NA,118,fazarabine,4,53-135,mg/m2/hr,NA,a continuousinfusion over 3 days every 3 to 4 weeks,Dose escalations in subsequent patients were in 50% increments untiI grade >1 toxicity was observed (except for nausea and vomiting) and then in 25% to 35% increments at each level until evidence of grade 3 toxicity based on the National Cancer Institute (NCI) toxicity grading system
10492074,NA,118,fazarabine,5,180-425,mg/m2/hr,NA,a continuousinfusion over 3 days every 3 to 4 weeks,Dose escalations in subsequent patients were in 50% increments untiI grade >1 toxicity was observed (except for nausea and vomiting) and then in 25% to 35% increments at each level until evidence of grade 3 toxicity based on the National Cancer Institute (NCI) toxicity grading system
20564122,NA,119,decitabine,1,10,mg/m2,NA,Days 1- 5,NA
20564122,NA,119,carboplatin,1,5,AUC,NA,Day 8,fixed dose
20564122,NA,119,carboplatin,1,5,AUC,NA,Day 8,fixed dose
20564122,NA,119,decitabine,2,20,mg/m2,NA,Days 1- 5,NA
17679729,NA,120,decitabine,1,15,mg/m2/d,NA,"days 1 through 10, every 28 days.",NA
17679729,NA,120,decitabine,2,20,mg/m2/d,NA,"days 1 through 10, every 28 days.",NA
17679729,NA,121,decitabine,1,20,mg/m2/d,NA,"days 1 through 10, every 28 days.",fixed dose
17679729,NA,121,valproic acid,1,15,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
17679729,NA,121,valproic acid,1,15,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
17679729,NA,121,valproic acid,2,20,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
17679729,NA,121,valproic acid,2,20,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
17679729,NA,121,valproic acid,3,25,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
17679729,NA,121,valproic acid,3,25,mg/kg/d,NA,"days 5 through 21, every 28 days",NA
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,bevacizumab,1,10,mg/kg,NA,every 2 weeks,fixed dose
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,irinotecan,1,125,mg/m2,NA,every 2 weeks,fixed dose
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,erlotinib,1,65,mg,1,NA,"Tablets were taken orally in the morning, at least one hour before or two hours after breakfast."
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,erlotinib,1,65,mg,1,NA,"Tablets were taken orally in the morning, at least one hour before or two hours after breakfast."
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,erlotinib,2,85,mg,1,NA,"Tablets were taken orally in the morning, at least one hour before or two hours after breakfast."
33963476,"EudraCT 2009-016080-11, Dutch Trial Register NTR2391",122,erlotinib,2,85,mg,1,NA,"Tablets were taken orally in the morning, at least one hour before or two hours after breakfast."
33777754,ChiCTR1900021555,123,cisplatin,1,70,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,1,70,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,2,75,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,2,75,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,3,80,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,3,80,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,4,85,mg/m2,NA,NA,NA
33777754,ChiCTR1900021555,123,cisplatin,4,85,mg/m2,NA,NA,NA
33616416,NCT01852409,124,bevacizumab,1,2.5,mg/kg,NA,NA,NA
33616416,NCT01852409,124,bevacizumab,2,5,mg/kg,NA,NA,NA
33616416,NCT01852409,124,bevacizumab,3,7.5,mg/kg,NA,NA,NA
34164713,NCT01749384,125,bevacizumab,1,10,mg/kg,NA,"on day -15 of cycle 1, then every 2 weeks",fixed dose
34164713,NCT01749384,125,tivantinib,-1,120,mg,1,on days 1–28 of each cycle,"Tivantinib was administered orally with meals, and missed or vomited doses were not replaced"
34164713,NCT01749384,125,tivantinib,1,120/120,mg,2,on days 1–28 of each cycle,NA
34164713,NCT01749384,125,tivantinib,2,240/120,mg,2,on days 1–28 of each cycle,NA
34164713,NCT01749384,125,tivantinib,3,240/240,mg,2,on days 1–28 of each cycle,NA
34164713,NCT01749384,125,tivantinib,4,360/240,mg,2,on days 1–28 of each cycle,NA
34164713,NCT01749384,125,tivantinib,5,360/360,mg,2,on days 1–28 of each cycle,NA
34164713,NCT01749384,125,tivantinib,3a,240/240,mg,2,on days 1–28 of each cycle,the second stage of the study
34164713,NCT01749384,125,tivantinib,2a,240/120,mg,2,on days 1–28 of each cycle,the second stage of the study
33215270,NA,128,pg-11047,1,100,mg,NA,"days 1, 15",NA
33215270,NA,128,gemcitabine,1,1000,mg/m2,NA,"Days 1, 8, 15",fixed dose
33215270,NA,128,pg-11047,-1,50,mg,NA,"days 1, 15",NA
33215270,NA,129,docetaxel,1,75,mg/m2,NA,day 1 (21-day cycle),fixed dose
33215270,NA,129,pg-11047,-1,50,mg,NA,day 1 (21-day cycle),NA
33215270,NA,129,pg-11047,1,100,mg,NA,day 1 (21-day cycle),NA
33215270,NA,130,bevacizumab,1,5,mg/kg,NA,"days 1, 15",fixed dose
33215270,NA,130,pg-11047,1,100,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,2,150,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,3,200,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,4,250,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,5,300,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,6,375,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,7,470,mg,NA,"days 1, 8, 15",NA
33215270,NA,130,pg-11047,8,590,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,erlotinib,1,150,mg,NA,Daily,fixed dose
33215270,NA,131,erlotinib,1,150,mg,NA,Daily,fixed dose
33215270,NA,131,pg-11047,1,100,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,2,150,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,3,200,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,4,250,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,5,300,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,6,375,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,7,470,mg,NA,"days 1, 8, 15",NA
33215270,NA,131,pg-11047,8,590,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,cisplatin,1,80,mg/m2,NA,day 1,fixed dose
33215270,NA,132,cisplatin,1,80,mg/m2,NA,day 1,fixed dose
33215270,NA,132,pg-11047,1,100,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,2,150,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,3,200,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,4,250,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,5,300,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,6,375,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,7,470,mg,NA,"days 1, 8, 15",NA
33215270,NA,132,pg-11047,8,590,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,leucovorin,1,500,mg/m2,NA,"days 1, 8, 15, 22, 29, 36 (56-day cycle)",fixed dose
33215270,NA,133,5fu,1,500,mg/m2,NA,"days 1, 8, 15, 22, 29, 36 (56-day cycle)",fixed dose
33215270,NA,133,pg-11047,1,100,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,2,150,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,3,200,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,4,250,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,5,300,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,6,375,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,7,470,mg,NA,"days 1, 8, 15",NA
33215270,NA,133,pg-11047,8,590,mg,NA,"days 1, 8, 15",NA
33215270,NA,134,sunitinib,1,50,mg,NA,daily for 28 days of 42-day cycle,fixed dose
33215270,NA,134,pg-11047,1,100,mg,NA,"days 1, 8 (21-day cycle)",NA
15205668,NA,135,amifostine,1,740,mg/m2,NA,"Two doses of amifostine were given 24 hours apart after preparation that included the discontinuance of antihypertensives,",fixed dose
15205668,NA,135,amifostine,1,740,mg/m2,NA,"Two doses of amifostine were given 24 hours apart after preparation that included the discontinuance of antihypertensives,",fixed dose
15205668,NA,135,melphalan,1,220,mg/m2,NA,NA,NA
15205668,NA,135,melphalan,2,240,mg/m2,NA,NA,NA
15205668,NA,135,melphalan,3,260,mg/m2,NA,NA,NA
15205668,NA,135,melphalan,4,280,mg/m2,NA,NA,NA
15205668,NA,135,melphalan,5,300,mg/m2,NA,NA,NA
8855989,NA,136,cyclophosphamide,1,1100,mg/m2,NA,day 1,NA
8855989,NA,136,doxorubicin,1,50,mg/m2,NA,day 1,NA
8855989,NA,136,etoposide,1,110,mg/m2,NA,day 1-3,NA
8855989,NA,136,cyclophosphamide,2,1200,mg/m2,NA,day 1,NA
8855989,NA,136,doxorubicin,2,55,mg/m2,NA,day 1,NA
8855989,NA,136,etoposide,2,120,mg/m2,NA,day 1-3,NA
8855989,NA,136,cyclophosphamide,3,1300,mg/m2,NA,day 1,NA
8855989,NA,136,doxorubicin,3,60,mg/m2,NA,day 1,NA
8855989,NA,136,etoposide,3,130,mg/m2,NA,day 1-3,NA
8855989,NA,136,filgastrim,1,5,ug/kg,NA,day 5 -11,fixed dose
8855989,NA,136,cyclophosphamide,2b,1200,mg/m2,NA,day 1,NA
8855989,NA,136,doxorubicin,2b,55,mg/m2,NA,day 1,NA
8855989,NA,136,etoposide,2b,120,mg/m2,NA,day 1-3,NA
8855989,NA,136,ciprofloxacin,2b,500,mg,2,day 5-11,NA
8855989,NA,136,ciprofloxacin,3,500,mg,2,day 5-11,NA
8855989,NA,136,cyclophosphamide,3b,1300,mg/m2,NA,day 1,NA
8855989,NA,136,doxorubicin,3b,60,mg/m2,NA,day 1,NA
8855989,NA,136,etoposide,3b,130,mg/m2,NA,day 1-3,NA
8855989,NA,136,ciprofloxacin,3b,500,mg,2,day 5-11,NA
8855989,NA,136,fluconazole,3b,100,mg,NA,day 5-11,NA
8855989,NA,136,fluconazole,3b,100,mg,NA,day 5-11,NA
8855989,NA,136,acyclovir,3b,800,mg,2,day 5-11,NA
8519675,NA,137,epirubicin,1,100,mg/m2,NA,day 1,30 min iv
8519675,NA,137,vinorelbine,1,20,mg/m2,NA,day 1 and 8,10  min iv
8519675,NA,137,epirubicin,2,120,mg/m2,NA,day 1,30 min iv
8519675,NA,137,vinorelbine,2,20,mg/m2,NA,day 1 and 8,10  min iv
8519675,NA,137,epirubicin,3,120,mg/m2,NA,day 1,30 min iv
8519675,NA,137,vinorelbine,3,25,mg/m2,NA,day 1 and 8,10  min iv
8519675,NA,137,epirubicin,4,135,mg/m2,NA,day 1,30 min iv
8519675,NA,137,vinorelbine,4,25,mg/m2,NA,day 1 and 8,10  min iv
8519675,NA,137,ondansetron chloride,NA,8,mg,2,day 1,Routine prophylaxis for nausea and vomiting
8519675,NA,137,ondansetron chloride,NA,8,mg,1,day 2,Routine prophylaxis for nausea and vomiting
8519675,NA,137,dexamethasone,NA,8,NA,NA,day 1,Routine prophylaxis for nausea and vomiting
8652277,NA,138,epirubicin,1,60,mg/m2,NA,Day 1,fixed dose
8652277,NA,138,vinorelbine,1,15,mg/m2,NA,Day 1,NA
8652277,NA,138,vinorelbine,2,20,mg/m2,NA,Day 1,NA
8652277,NA,138,vinorelbine,3,20,mg/m2,NA,Day 1 and 8,NA
8261569,NA,139,doxorubicin,1,20,mg/m2,NA,weekly for 3 weeks,NA
8261569,NA,139,doxorubicin,2,30,mg/m2,NA,weekly for 3 weeks,NA
8261569,NA,139,doxorubicin,3,37.5,mg/m2,NA,weekly for 3 weeks,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,1,2,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,2,4,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,3,6.7,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,4,10,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,5,14,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,6,19,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,7,26,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,8,52,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,9,70,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,10,80,mg/m2,NA,NA,NA
2313718,NA,140,4'-iodo-4'-deoxydoxorubicin,11,90,mg/m2,NA,NA,NA
7691117,NA,141,vinorelbine,1,25,mg/m2,NA,Day 1 and 8,fixed dose
7691117,NA,141,epirubicin,1,50,mg/m2,NA,day 1,NA
7691117,NA,141,epirubicin,2,60,mg/m2,NA,day 1,NA
7691117,NA,142,vinorelbine,1,25,mg/m2,NA,Day 1 and 8,fixed dose
7691117,NA,142,epirubicin,1,75,mg/m2,NA,day 1,NA
7691117,NA,142,epirubicin,2,90,mg/m2,NA,day 1,NA
7691117,NA,142,g-csf,1,5,ug/kg,NA,Day 4- 6 and 9-15,fixed dose
7691117,NA,142,g-csf,1,5,ug/kg,NA,Day 4- 6 and 9-15,fixed dose
8612318,NA,143,ifosfamide,1,3000,mg/m2,NA,NA,fixed dose
8612318,NA,143,epirubicin,1,75,mg/m2,NA,Day 1,NA
8612318,NA,143,epirubicin,2,90,mg/m2,NA,Day 1,NA
8612318,NA,143,epirubicin,3,105,mg/m2,NA,Day 1,NA
8612318,NA,143,epirubicin,4,120,mg/m2,NA,Day 1,NA
7529516,NA,144,cyclophosphamide,1,600,mg/m2,NA,day 1,fixed dose
7529516,NA,144,levofolinic acid,1,100,mg/m2,NA,day 1-3,fixed dose
7529516,NA,144,5-fluorouracil,1,375,mg/m2,NA,day 1 -3,fixed dose
7529516,NA,144,epidoxorubicin,1,20,mg/m2,NA,day 1 -3,NA
7529516,NA,144,g-csf,1,5,ug/kg,NA,for 10 days,fixed dose; rescue
7529516,NA,144,g-csf,1,5,ug/kg,NA,for 10 days,fixed dose; rescue
7529516,NA,144,epidoxorubicin,2,25,mg/m2,NA,day 1 -3,NA
7529516,NA,144,epidoxorubicin,3,30,mg/m2,NA,day 1 -3,NA
7529516,NA,144,epidoxorubicin,4,35,mg/m2,NA,day 1 -3,NA
7529516,NA,144,epidoxorubicin,5,40,mg/m2,NA,day 1 -3,NA
8392903,NA,145,cisplatin,1,60,mg/m2,NA,day 1,fixed dose
8392903,NA,145,cisplatin,1,60,mg/m2,NA,day 1,fixed dose
8392903,NA,145,etoposide,1,120,mg/m2,NA,days 1 -3,fixed dose
8392903,NA,145,epirubicin,1,45,mg/m2,NA,every 21 days,NA
8392903,NA,145,epirubicin,2,50,mg/m2,NA,every 21 days,NA
8392903,NA,145,epirubicin,3,55,mg/m2,NA,every 21 days,NA
8392903,NA,145,epirubicin,4,60,mg/m2,NA,every 21 days,NA
8392903,NA,146,cisplatin,1,60,mg/m2,NA,day 1,fixed dose
8392903,NA,146,cisplatin,1,60,mg/m2,NA,day 1,fixed dose
8392903,NA,146,etoposide,1,120,mg/m2,NA,days 1 -3,fixed dose
8392903,NA,146,gm-csf,1,10,ug/kg/day,NA,"for 11 consecutive days starting 24 hours after the last dose of chemotherapy (day 4 to day 14 of every cycle), with a 1-week interruption before the subsequent cycle of chemotherapy",fixed dose
8392903,NA,146,gm-csf,1,10,ug/kg/day,NA,"for 11 consecutive days starting 24 hours after the last dose of chemotherapy (day 4 to day 14 of every cycle), with a 1-week interruption before the subsequent cycle of chemotherapy",fixed dose
8392903,NA,146,epirubicin,1,60,mg/m2,NA,every 21 days,NA
8392903,NA,146,epirubicin,2,65,mg/m2,NA,every 21 days,NA
8392903,NA,146,epirubicin,3,70,mg/m2,NA,every 21 days,NA
7954234,NA,147,doxorubicin,1,50,mg/m2,NA,"during a period of 30 minutes, beginning 6 hours into the verapamil infusion.",fixed dose
7954234,NA,147,verapamil,1,0.3-0.6,mg/kg/h,NA,"In the absence of dose limiting toxicity, this was increased three times by 0.1-mg/ kg/hour increments at 30-minute intervals X 3, to a maximum of 0.6 mg/kg/hour.","At T = 0, patients received an intrahepatic bolus of verapamil 0.15 mg/kg,"
7954234,NA,147,verapamil,2,0.6-0.8,mg/kg/h,NA,Each subsequent dose leveI began at themaximum dose of the previous level and escalated twice at 30minute intervals by 0.1-mg/kg/hour increments;,NA
7954234,NA,147,verapamil,3,0.8-1.0,mg/kg/h,NA,Each subsequent dose leveI began at themaximum dose of the previous level and escalated twice at 30minute intervals by 0.1-mg/kg/hour increments;,NA
7954234,NA,147,verapamil,4,1.0-1.2,mg/kg/h,NA,Each subsequent dose leveI began at themaximum dose of the previous level and escalated twice at 30minute intervals by 0.1-mg/kg/hour increments;,NA
7954234,NA,147,verapamil,5,1.2-1.4,mg/kg/h,NA,Each subsequent dose leveI began at themaximum dose of the previous level and escalated twice at 30minute intervals by 0.1-mg/kg/hour increments;,NA
7954234,NA,147,verapamil,6,1.4-1.6,mg/kg/h,NA,Each subsequent dose leveI began at themaximum dose of the previous level and escalated twice at 30minute intervals by 0.1-mg/kg/hour increments;,NA
8070013,NA,148,cyclophosphamide,1,600,mg/m2,NA,Intravenous infusion of cyelophosphamide and 5-fluorouracil (600 rag/m2 each) was followed by escalating doses of epirubicin/ADR-529 for every 3 weeks,fixed dose
8070013,NA,148,5-fluorouracil,1,600,mg/m2,NA,Intravenous infusion of cyelophosphamide and 5-fluorouracil (600 rag/m2 each) was followed by escalating doses of epirubicin/ADR-529 for every 3 weeks,fixed dose
8070013,NA,148,tamoxifen,1,30,mg,NA,daily,fixed dose
8070013,NA,148,epirubicin,1,60,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,1,600,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,epirubicin,2,80,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,2,600,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,epirubicin,3,100,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,3,600,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,epirubicin,4,80,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,4,800,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,epirubicin,5,100,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,5,800,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,epirubicin,6,100,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8070013,NA,148,adr529,6,1000,mg/m2,NA,"every 3 weeks, ADR-529 was given intravenouslyover 15 min, followed by epirubicin given intravenously over 15 min.",NA
8453681,NA,149,doxorubicin,1,60,mg/m2,NA,"infusion for 15 mins, every 21 days",fixed dose
8453681,NA,149,prochlorperazine,1,15,mg/m2,NA,"infusion for 15 mins, every 21 days",NA
8453681,NA,149,prochlorperazine,2,30,mg/m2,NA,"infusion for 15 mins, every 21 days",NA
8453681,NA,149,prochlorperazine,3,50,mg/m2,NA,"infusion for 15 mins, every 21 days",NA
8453681,NA,149,prochlorperazine,4,75,mg/m2,NA,"infusion for 15 mins, every 21 days",NA
7987997,NA,150,5-fluorouracil,1,350,mg/m2,NA,"weekly, push at the 1-b point of the LV infusion",fixed dose
7987997,NA,150,leucovorin,1,500,mg/m2,NA,"weekly, i.v. over 2h",fixed dose
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,1,10,mg/m2,NA,"weekly, i.v. over 15 min",NA
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,2,15,mg/m2,NA,"weekly, i.v. over 15 min",NA
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,3,20,mg/m2,NA,"weekly, i.v. over 15 min",NA
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,4,25,mg/m2,NA,"weekly, i.v. over 15 min",NA
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,5,30,mg/m2,NA,"weekly, i.v. over 15 min",NA
7987997,NA,150,4'-o-tetrahydropyranyl-doxorubicin,6,35,mg/m2,NA,"weekly, i.v. over 15 min",NA
1768677,NA,151,doxorubicin,1A,40,mg/m2,NA,day 1,NA
1768677,NA,151,interleukin-2,1A,1,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
1768677,NA,151,interleukin-2,1A,1,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
1768677,NA,151,doxorubicin,1B,40,mg/m2,NA,day 1,NA
1768677,NA,151,interleukin-2,1B,3,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
1768677,NA,151,interleukin-2,1B,3,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
1768677,NA,151,doxorubicin,2A,60,mg/m2,NA,day 1,NA
1768677,NA,151,interleukin-2,2A,1,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
1768677,NA,151,interleukin-2,2A,1,U/m2/24h,NA,"days 2-5, 9-12, 16-19",NA
7636539,NA,152,etoposide,1,200,mg/m2,NA,"over 96 hrs, day 1-4",fixed dose
7636539,NA,152,vincristine,1,1.6,mg/m2,NA,"over 96 hrs, day 1-4",fixed dose
7636539,NA,152,doxorubicin,1,40,mg/m2,NA,"over 96 hrs, day 1-4",fixed dose
7636539,NA,152,cyclophosphamide,1,750,mg/m2,NA,day 6,fixed dose
7636539,NA,152,prednisone,1,60,mg/m2,NA,day 1-6,fixed dose
7636539,NA,152,dexverapamil,1,60,mg/m2,NA,every 6 h,NA
7636539,NA,152,dexverapamil,2,120,mg/m2,NA,every 6 h,NA
7636539,NA,152,dexverapamil,3,75,mg/m2,NA,every 4 h,NA
7636539,NA,152,dexverapamil,4,100,mg/m2,NA,every 4 h,NA
7636539,NA,152,dexverapamil,5,125,mg/m2,NA,every 4 h,NA
7636539,NA,152,dexverapamil,6,150,mg/m2,NA,every 4 h,NA
7636539,NA,152,dexverapamil,7,175,mg/m2,NA,every 4 h,NA
7636539,NA,152,dexverapamil,8,200,mg/m2,NA,every 4 h,NA
7913721,NA,153,paclitaxel,1,120,mg/m2,NA,administered over 96 hours,NA
7913721,NA,153,paclitaxel,2,140,mg/m2,NA,administered over 96 hours,NA
7913721,NA,153,paclitaxel,3,160,mg/m2,NA,administered over 96 hours,NA
8622073,NA,154,doxorubicin,1,40,mg/m2,NA,day 1 in every 2 weeks,fixed dose
8622073,NA,154,cyclophosphamide,1,1000,mg/m2,NA,day 1 in every 2 weeks,NA
8622073,NA,154,cyclophosphamide,2,1500,mg/m2,NA,day 1 in every 2 weeks,NA
8622073,NA,154,cyclophosphamide,3,2000,mg/m2,NA,day 1 in every 2 weeks,NA
8622073,NA,154,cyclophosphamide,4,2500,mg/m2,NA,day 1 in every 2 weeks,NA
8622080,NA,155,doxorubicin,1,40,mg/m2,NA,day 1,fixed dose
8622080,NA,155,granulocyte csf,1,5,ug/kg,NA,"from day 2 to 10 and until the absolute neutrophil count was greater than 10,000/uL",fixed dose
8622080,NA,155,cyclophosphamide,1,800,mg/m2,NA,day 1,NA
8622080,NA,155,cyclophosphamide,2,1200,mg/m2,NA,day 1,NA
8622080,NA,155,cyclophosphamide,3,1600,mg/m2,NA,day 1,NA
8622080,NA,155,cyclophosphamide,4,2000,mg/m2,NA,day 1,NA
8622080,NA,156,doxorubicin,1,40,mg/m2,NA,day 1,fixed dose
8622080,NA,156,granulocyte csf,1,5,ug/kg,NA,"from day 2 to 10 and until the absolute neutrophil count was greater than 10,000/uL",fixed dose
8622080,NA,156,pelvic radiotherapy,1,>30,Gy,NA,NA,fixed dose
8622080,NA,156,cyclophosphamide,1,800,mg/m2,NA,day 1,NA
8622080,NA,156,cyclophosphamide,2,1200,mg/m2,NA,day 1,NA
8622080,NA,156,cyclophosphamide,3,1600,mg/m2,NA,day 1,NA
8622080,NA,156,cyclophosphamide,4,2000,mg/m2,NA,day 1,NA
8523055,NA,157,cyclophosphamide,1,3000,mg/m2,NA,day 1 and 2 (1500 mg/m2/d),NA
8523055,NA,157,doxorubicin,1,50,mg/m2,NA,infusion over 48 h through day 1 and 2,NA
8523055,NA,157,vincristine,1,1.4,mg/m2,NA,day 1,NA
8523055,NA,157,prednisone,1,500,mg/m2,NA,day 1 - 5,NA
8523055,NA,157,granulocyte colony-stimulating factor,1,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,granulocyte colony-stimulating factor,1,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,cyclophosphamide,2,3000,mg/m2,NA,day 1 and 2 (1500 mg/m2/d),NA
8523055,NA,157,doxorubicin,2,70,mg/m2,NA,infusion over 48 h through day 1 and 2,NA
8523055,NA,157,vincristine,2,1.4,mg/m2,NA,day 1,NA
8523055,NA,157,prednisone,2,500,mg/m2,NA,day 1 - 5,NA
8523055,NA,157,granulocyte colony-stimulating factor,2,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,granulocyte colony-stimulating factor,2,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,cyclophosphamide,3,4000,mg/m2,NA,day 1 and 2 (2000 mg/m2/d),NA
8523055,NA,157,doxorubicin,3,70,mg/m2,NA,infusion over 48 h through day 1 and 2,NA
8523055,NA,157,vincristine,3,1.4,mg/m2,NA,day 1,NA
8523055,NA,157,prednisone,3,500,mg/m2,NA,day 1 - 5,NA
8523055,NA,157,granulocyte colony-stimulating factor,3,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,granulocyte colony-stimulating factor,3,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,cyclophosphamide,4,4000,mg/m2,NA,day 1 and 2 (2000 mg/m2/d),NA
8523055,NA,157,doxorubicin,4,90,mg/m2,NA,infusion over 48 h through day 1 and 2,NA
8523055,NA,157,vincristine,4,1.4,mg/m2,NA,day 1,NA
8523055,NA,157,prednisone,4,500,mg/m2,NA,day 1 - 5,NA
8523055,NA,157,granulocyte colony-stimulating factor,4,10,ug/kg/d,NA,day 4 -18,NA
8523055,NA,157,granulocyte colony-stimulating factor,4,10,ug/kg/d,NA,day 4 -18,NA
7680373,NA,158,methotrexate,1,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,1,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,1,3.4,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,1,34,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,1,70,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,1,70,mg/m2,NA,day 2,NA
7680373,NA,158,rhg-csf,1,5,ug/kg/per day,NA,day 4 -12; 15 -19,fixed dose
7680373,NA,158,methotrexate,2,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,2,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,2,3.4,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,2,45,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,2,70,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,2,70,mg/m2,NA,day 2,NA
7680373,NA,158,methotrexate,2A,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,2A,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,2A,3.4,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,2A,45,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,2A,100,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,2A,100,mg/m2,NA,day 2,NA
7680373,NA,158,methotrexate,3,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,3,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,3,5,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,3,45,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,3,70,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,3,70,mg/m2,NA,day 2,NA
7680373,NA,158,methotrexate,4,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,4,34,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,4,5,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,4,60,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,4,70,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,4,70,mg/m2,NA,day 2,NA
7680373,NA,158,methotrexate,5,40,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,methotrexate,5,40,mg/m2,NA,"day 1, 15 22",NA
7680373,NA,158,vinblostine,5,4,mg/m2,NA,"day 2, 15 ,22",NA
7680373,NA,158,adriamycin,5,30,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,5,70,mg/m2,NA,day 2,NA
7680373,NA,158,cisplatin,5,70,mg/m2,NA,day 2,NA
7689093,NA,159,piroxantrone,1,150,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,159,piroxantrone,2,185,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,piroxantrone,1,185,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,g-csf,1,10,ug/kg/per day,NA,"starting on day 2 of each cycle until the AGC was more than 4 ,000/uL for 2 consecutive days or until a single AGC was more than 10,000/uL.",fixed dose
7689093,NA,160,g-csf,1,10,ug/kg/per day,NA,"starting on day 2 of each cycle until the AGC was more than 4 ,000/uL for 2 consecutive days or until a single AGC was more than 10,000/uL.",fixed dose
7689093,NA,160,piroxantrone,2,230,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,piroxantrone,3,285,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,piroxantrone,4,355,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,piroxantrone,5,445,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
7689093,NA,160,piroxantrone,6,555,mg/m2,NA,given over 60 minutes via central venous line every 21 days,NA
8664188,NA,161,epirubicin,1,120,mg/m2,NA,"day 1, 22",NA
8664188,NA,161,cyclophosphamide,1,830,mg/m2,NA,"day 1, 22",NA
8664188,NA,161,filgrastim,1,4,ug/kg,NA,day 2 -20,NA
8664188,NA,161,filgrastim,1,4,ug/kg,NA,day 2 -20,NA
8664188,NA,161,epirubicin,2,120,mg/m2,NA,"day 1, 19",NA
8664188,NA,161,cyclophosphamide,2,830,mg/m2,NA,"day 1, 19",NA
8664188,NA,161,filgrastim,2,4,ug/kg,NA,day 2 -17,NA
8664188,NA,161,filgrastim,2,4,ug/kg,NA,day 2 -17,NA
8664188,NA,161,epirubicin,3,120,mg/m2,NA,"day 1, 16",NA
8664188,NA,161,cyclophosphamide,3,830,mg/m2,NA,"day 1, 16",NA
8664188,NA,161,filgrastim,3,4,ug/kg,NA,day 2 -14,NA
8664188,NA,161,filgrastim,3,4,ug/kg,NA,day 2 -14,NA
8664188,NA,161,epirubicin,4,120,mg/m2,NA,"day 1, 15",NA
8664188,NA,161,cyclophosphamide,4,830,mg/m2,NA,"day 1, 15",NA
8664188,NA,161,filgrastim,4,4,ug/kg,NA,day 2 -13,NA
8664188,NA,161,filgrastim,4,4,ug/kg,NA,day 2 -13,NA
8664188,NA,161,epirubicin,5,120,mg/m2,NA,"day 1, 13",NA
8664188,NA,161,cyclophosphamide,5,830,mg/m2,NA,"day 1, 13",NA
8664188,NA,161,filgrastim,5,4,ug/kg,NA,day 2 -11,NA
8664188,NA,161,filgrastim,5,4,ug/kg,NA,day 2 -11,NA
29850984,NA,162,alpelisib,1,300,mg,NA,daily,NA
29850984,NA,162,trastuzumab emtansine,1,3.6,mg/kg,NA,on day 1 of each cycle +/− 3 days (1 cycle =   21 day,fixed dose
29850984,NA,162,alpelisib,2,350,mg,NA,daily,NA
29850984,NA,162,alpelisib,3,400,mg,NA,daily,NA
29850984,NA,162,alpelisib,-1,250,mg,NA,daily,NA
29850984,NA,162,alpelisib,-2,200,mg,NA,daily,NA
29850984,NA,162,alpelisib,-3,150,mg,NA,daily,NA
1453205,NA,163,n-1-leucyldoxorubicin,1,50,mg/m2,NA,NA,NA
1453205,NA,163,n-1-leucyldoxorubicin,2,225,mg/m2,NA,NA,NA
1310105,NA,165,epirubicin,0,35,mg/m2,NA,3 consecutive days,NA
1310105,NA,165,epirubicin,1,40,mg/m2,NA,3 consecutive days,NA
1310105,NA,165,epirubicin,2,45,mg/m2,NA,3 consecutive days,NA
1310105,NA,165,epirubicin,3,50,mg/m2,NA,3 consecutive days,NA
1310105,NA,165,epirubicin,4,55,mg/m2,NA,3 consecutive days,NA
1310105,NA,165,epirubicin,5,60,mg/m2,NA,3 consecutive days,NA
8622023,NA,166,paclitaxel,1,160,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,1,45,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,g-csf,1,10,ug/kg,NA,daily starting approximately 24 hours following completion of the chemotherapy infusions,NA
8622023,NA,166,g-csf,1,10,ug/kg,NA,daily starting approximately 24 hours following completion of the chemotherapy infusions,NA
8622023,NA,166,paclitaxel,2,160,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,2,60,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,paclitaxel,3,160,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,3,75,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,paclitaxel,4,180,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,4,75,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,paclitaxel,5,180,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,5,60,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,paclitaxel,6,200,mg/m2,NA,72 hours continuous infusion,NA
8622023,NA,166,doxorubicin,6,60,mg/m2,NA,72 hours continuous infusion,NA
7595726,NA,167,paclitaxel,1,125,mg/m2,NA,"The two-drug combination was administered in the outpatient clinic every 21 days after premedication that consisted of oral prednisone (25 mg) given 12 hours before treatment; and intramuscular chlorpheniramine (10 mg), intravenous cimetidine (300 mg), and intravenous hydrocortisone (250 mg) given 30 minutes before paclitaxel administration.",NA
7595726,NA,167,doxorubicin,1,60,mg/m2,NA,"The two-drug combination was administered in the outpatient clinic every 21 days after premedication that consisted of oral prednisone (25 mg) given 12 hours before treatment; and intramuscular chlorpheniramine (10 mg), intravenous cimetidine (300 mg), and intravenous hydrocortisone (250 mg) given 30 minutes before paclitaxel administration.",fixed dose
7595726,NA,167,paclitaxel,2,150,mg/m2,NA,"The two-drug combination was administered in the outpatient clinic every 21 days after premedication that consisted of oral prednisone (25 mg) given 12 hours before treatment; and intramuscular chlorpheniramine (10 mg), intravenous cimetidine (300 mg), and intravenous hydrocortisone (250 mg) given 30 minutes before paclitaxel administration.",NA
7595726,NA,167,paclitaxel,3,175,mg/m2,NA,"The two-drug combination was administered in the outpatient clinic every 21 days after premedication that consisted of oral prednisone (25 mg) given 12 hours before treatment; and intramuscular chlorpheniramine (10 mg), intravenous cimetidine (300 mg), and intravenous hydrocortisone (250 mg) given 30 minutes before paclitaxel administration.",NA
7595726,NA,167,paclitaxel,4,200,mg/m2,NA,"The two-drug combination was administered in the outpatient clinic every 21 days after premedication that consisted of oral prednisone (25 mg) given 12 hours before treatment; and intramuscular chlorpheniramine (10 mg), intravenous cimetidine (300 mg), and intravenous hydrocortisone (250 mg) given 30 minutes before paclitaxel administration.",NA
8620409,NA,168,dexverapamil,1,250/300,mg,NA,every 6 hours for 3 consecutive days,"fixed dose;If no cardiovascular symptoms occurred during the first treatment cycle, the dose of DVPM was escalated during subsequent cycles to 300 mg every 6 hours for 3 consecutive day."
8620409,NA,168,epirubicin,1,90,mg/m2,NA,intravenous bolus injection on Day 2,NA
8620409,NA,168,gm-csf,1,400,ug/kg,NA,Days 5 through 14,"ug, fixed dose"
8620409,NA,168,gm-csf,1,400,ug/kg,NA,Days 5 through 14,"ug, fixed dose"
8620409,NA,168,epirubicin,2,105,mg/m2,NA,intravenous bolus injection on Day 2,NA
8620409,NA,168,epirubicin,3,120,mg/m2,NA,intravenous bolus injection on Day 2,NA
8620409,NA,168,epirubicin,4,135,mg/m2,NA,intravenous bolus injection on Day 2,NA
8246030,NA,169,recombinant human granulocytemacrophage colony-stimulating factor,1,125,ug/m2,NA,"once daily for 14 days, fromthe second and third cycles",NA
8246030,NA,169,cyclophosphamide,1,1000,mg/m2,NA,evety 3 weeks,fixed dose
8246030,NA,169,doxorubicin,1,50,mg/m2,NA,evety 3 weeks,fixed dose
8246030,NA,169,fluorouracil,1,500,mg/m2,NA,evety 3 weeks,fixed dose
8246030,NA,169,recombinant human granulocytemacrophage colony-stimulating factor,2,250,ug/m2,NA,"once daily for 14 days, fromthe second and third cycles",NA
8246030,NA,169,recombinant human granulocytemacrophage colony-stimulating factor,3,500,ug/m2,NA,"once daily for 14 days, fromthe second and third cycles",NA
1525387,NA,170,liposome-entrapped doxorubicin,1,15,mg/m2,NA,NA,3 mg/min
1525387,NA,170,liposome-entrapped doxorubicin,2,20,mg/m2,NA,NA,NA
1525387,NA,170,liposome-entrapped doxorubicin,3,22.5,mg/m2,NA,NA,NA
1525387,NA,170,liposome-entrapped doxorubicin,4,25,mg/m2,NA,NA,NA
1525387,NA,171,liposome-entrapped doxorubicin,1,60,mg/m2,NA,NA,NA
1525387,NA,171,liposome-entrapped doxorubicin,2,70,mg/m2,NA,NA,NA
1525387,NA,171,liposome-entrapped doxorubicin,3,80,mg/m2,NA,NA,NA
12056705,NA,172,gemcitabine,1,800,mg/m2,NA,day 1 nad 8,NA
12056705,NA,172,oxaliplatin,1,80,mg/m2,NA,dday 1,NA
12056705,NA,172,oxaliplatin,1,80,mg/m2,NA,dday 1,NA
12056705,NA,172,gemcitabine,2,1000,mg/m2,NA,day 1 nad 8,NA
12056705,NA,172,oxaliplatin,2,100,mg/m2,NA,dday 1,NA
12056705,NA,172,oxaliplatin,2,100,mg/m2,NA,dday 1,NA
12056705,NA,172,gemcitabine,3,1250,mg/m2,NA,day 1 nad 8,NA
12056705,NA,172,oxaliplatin,3,130,mg/m2,NA,dday 1,NA
12056705,NA,172,oxaliplatin,3,130,mg/m2,NA,dday 1,NA
15937714,NA,173,paclitaxel,1,135,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,1,1500,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,paclitaxel,2,135,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,2,2000,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,paclitaxel,3,150,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,3,2000,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,paclitaxel,4,150,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,4,2500,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,paclitaxel,5,175,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,5,2500,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,paclitaxel,6,175,mg/m2,NA,"on day 1 , every 2 weeks",NA
15937714,NA,173,gemcitabine,6,3000,mg/m2,NA,"on day 1 , every 2 weeks",NA
32147669,NCT02039336,174,dacomitinib,-1,15,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,-1,2,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,1,30,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,1,2,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,2,15,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,2,3,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,3,15,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,3,4,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,4,15,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,4,5,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,5,15,mg,NA,once daily continuously,NA
32147669,NCT02039336,174,mirdametinib,5,6,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,6,30,mg,NA,"once daily, 4 on 3 off",NA
32147669,NCT02039336,174,mirdametinib,6,6,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,7,30,mg,NA,"once daily, 5 on 2 off",NA
32147669,NCT02039336,174,mirdametinib,7,6,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
32147669,NCT02039336,174,dacomitinib,8,30,mg,NA,"once daily, 5 on 2 off",NA
32147669,NCT02039336,174,mirdametinib,8,5,mg,2,"twice daily, on first 21 days of each 28-day cycle",NA
29067643,NCT01347866,175,pf-04691502,1,4,mg,1,"once daily, continuous daily-dosing regimen",NA
29067643,NCT01347866,175,mirdametinib,1,8,mg,2,"twice daily, 3 wk on/ 1 wk off",NA
29067643,NCT01347866,175,pf-04691502,2,6,mg,1,"once daily, continuous daily-dosing regimen",NA
29067643,NCT01347866,175,mirdametinib,2,8,mg,2,"twice daily, 3 wk on/ 1 wk off",NA
29067643,NCT01347866,175,pf-04691502,4,4,mg,1,"once daily, continuous daily-dosing regimen",NA
29067643,NCT01347866,175,mirdametinib,4,5,mg,2,"twice daily, 3 wk on/ 1 wk off",NA
29067643,NCT01347866,176,pf-04691502,1,4,mg,NA, daily on days 2–12 and days 16–26 of each cycle,NA
29067643,NCT01347866,176,irinotecan,1,180,mg/m2,NA,day 1 and 15,fixed dose
29067643,NCT01347866,176,pf-04691502,2,6,mg,NA,daily on days 2–12 and days 16–26 of each cycle,NA
29067643,NCT01347866,176,irinotecan,2,180,mg/m2,NA,day 1 and 15,NA
29067643,NCT01347866,177,gedatolisib,1,95,mg,NA,"on days 2, 9, 16 and 23 of each 28-day cycle",NA
29067643,NCT01347866,177,irinotecan,1,180,mg/m2,NA,days 1 and 15 of each 28-day cycle,fixed dose
29067643,NCT01347866,177,gedatolisib,2,110,mg,NA,"on days 2, 9, 16 and 23 of each 28-day cycle",NA
29067643,NCT01347866,177,gedatolisib,3,130,mg,NA,"on days 2, 9, 16 and 23 of each 28-day cycle",NA
29067643,NCT01347866,178,gedatolisib,0,110,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,0,2,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,0A,130,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,0A,2,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,0B,154,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,0B,2,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,1,110,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,1,4,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,1A,130,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,1A,4,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,1B,154,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,1B,4,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,2,110,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,2,6,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
29067643,NCT01347866,178,gedatolisib,2A,130,mg,NA,"days −14 (during the PK lead-in portion of study), and on days 1, 8, 15 and 22 of each 28-day cycle",NA
29067643,NCT01347866,178,mirdametinib,2A,6,mg,NA,day −7 to day −1 (during the PK lead-in portion of the study) and on days 1–21 of each 28-day cycle,NA
20215549,NA,179,mirdametinib,1,1,mg,1,"QD intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,2,1,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,3,2,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,4,4,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,5,8,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,6,15,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,7,20,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,179,mirdametinib,8,30,mg,2,"BID intermittent, 3 wk on/1 wk off",NA
20215549,NA,180,mirdametinib,1,10,mg,2,BID continuous,NA
20215549,NA,180,mirdametinib,2,15,mg,2,BID continuous,NA
20215549,NA,180,mirdametinib,3,20,mg,2,BID continuous,NA
20215549,NA,181,mirdametinib,1,10,mg,2,"BID, 5 d on/2 d off",NA
11937310,NA,182,gemcitabine,1,800,mg/m2,NA,day 1 and 8 every 21 days,NA
11937310,NA,182,5-fu,1,200,mg/m2/d,NA,days 1-14 every 21 days,NA
11937310,NA,182,gemcitabine,2,1000,mg/m2,NA,day 1 and 8 every 21 days,NA
11937310,NA,182,5-fu,2,200,mg/m2/d,NA,days 1-14 every 21 days,NA
11937310,NA,182,gemcitabine,3,1000,mg/m2,NA,day 1 and 8 every 21 days,NA
11937310,NA,182,5-fu,3,250,mg/m2/d,NA,days 1-14 every 21 days,NA
11937310,NA,182,gemcitabine,4,1200,mg/m2,NA,day 1 and 8 every 21 days,NA
11937310,NA,182,5-fu,4,250,mg/m2/d,NA,days 1-14 every 21 days,NA
14739041,NA,183,gemcitabine,1,1250,mg/m2,NA,i.v. infusion in 250 ml of saline over 30 min on days 1 and 8,fixed dose
14739041,NA,183,oxaliplatin,1,70,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,1,70,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,2,90,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,2,90,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,3,110,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,3,110,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,4,130,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
14739041,NA,183,oxaliplatin,4,130,mg/m2,NA,every 3 weeks up to a maximum of six cycles,NA
11728688,NA,184,gemcitabine,1,20,mg/m2/week,NA,each Monday and Thursday,NA
11728688,NA,184,gemcitabine,2,40,mg/m2/week,NA,each Monday and Thursday,NA
11728688,NA,184,gemcitabine,3,70,mg/m2/week,NA,each Monday and Thursday,NA
11728688,NA,184,gemcitabine,4,100,mg/m2/week,NA,each Monday and Thursday,NA
11728688,NA,184,radiation treatment,1,60,Gy,NA,initiated on Day 1 of therapy concurrent with the first dose of twice-weekly gemcitabine,to a volume that included the primary tumor along with all involved hilar and mediastinal lymph nodes with a 1.5–2.0-cm margin.
11728688,NA,184,radiation treatment,1,39.6,Gy,NA,initiated on Day 1 of therapy concurrent with the first dose of twice-weekly gemcitabine,All uninvolved hilar or mediastinal lymph nodes were electively delivered in 22–180 cGy daily fractions with 1.5-cm margin.
14758140,NA,185,ifosfamide,1,3000,mg/m2,NA,"day 1, administered at a fixed dose of 3 g/m2 as a 24-hour perfusion concomitantly with mesna (3 g/m2 over 24 hours), followed by an oral dose of 1,000 mg/m2 2 and 6 hours after the end of the ifosfamide perfusion",fixed dose
14758140,NA,185,gemcitabine,1,1000,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,1,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,1,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,2,1250,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,2,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,2,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,3,1500,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,3,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,3,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,4,1750,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,4,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,4,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,5,2000,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,5,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,5,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,6,2250,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,6,80,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,6,80,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,3bis,1500,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,3bis,100,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,3bis,100,mg/m2,NA,day 15,NA
14758140,NA,185,gemcitabine,4bis,1750,mg/m2,NA,day 1 and 15,NA
14758140,NA,185,cisplatin,4bis,100,mg/m2,NA,day 15,NA
14758140,NA,185,cisplatin,4bis,100,mg/m2,NA,day 15,NA
12504047,NA,186,cisplatin,1,20,mg/m2/d,NA,"days 1-15, 29-33",fixed dose
12504047,NA,186,cisplatin,1,20,mg/m2/d,NA,"days 1-15, 29-33",fixed dose
12504047,NA,186,gemcitabine,1,600,mg/m2,NA,"days 2,5,12,19,26,33",NA
12504047,NA,186,concurrent radiotherapy,1,50.4,Gy,NA,5 days on/2 days off per week,1.8 Gy/d
12504047,NA,186,gemcitabine,-1,500,mg/m2,NA,"days 2,5,12,19,26,33",NA
12504047,NA,186,gemcitabine,-2,500,mg/m2,NA,"Days 2,5,26,33",NA
12504047,NA,186,gemcitabine,-3,400,mg/m2,NA,"Days 2,5,26,33",NA
12504047,NA,186,gemcitabine,-4,300,mg/m2,NA,"Days 2,5,26,33",NA
15484216,NA,187,gemcitabine,1,800,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
15484216,NA,187,dacarbazine,1,500,mg/m2,NA,every 2 weeks,NA
15484216,NA,187,gemcitabine,2,1000,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
15484216,NA,187,gemcitabine,3,1200,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
15484216,NA,187,gemcitabine,4,1500,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
15484216,NA,187,gemcitabine,5,1800,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
15484216,NA,187,gemcitabine,6,2160,mg/m2,NA,every 2 weeks,Gemcitabine was infused at a constant rate of 10 mg/m2/min
12702534,NA,188,vinorelbine,1,20,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,1,2000,mg/m2,NA,biweekly,NA
12702534,NA,188,vinorelbine,2,25,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,2,2500,mg/m2,NA,biweekly,NA
12702534,NA,188,vinorelbine,3,25,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,3,3000,mg/m2,NA,biweekly,NA
12702534,NA,188,vinorelbine,4,30,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,4,3000,mg/m2,NA,biweekly,NA
12702534,NA,188,vinorelbine,5,30,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,5,3500,mg/m2,NA,biweekly,NA
12702534,NA,188,vinorelbine,6,30,mg/m2,NA,biweekly,NA
12702534,NA,188,gemcitabine,6,2500,mg/m2,NA,biweekly,NA
12140144,NA,189,gemcitabine,1,100,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,concurrent radiotherapy,1,50.4(1.8),Gy,NA,NA,"The adopted radiotherapy technique was with angled fields, advanced 2D- and 3D-supported. The target volume was considered the primary tumor and the hilar-mediastinal involved lymph-nodes, plus the surrounding 1.5 cm area considered disease-free."
12140144,NA,189,gemcitabine,2,150,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,3,200,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,4,250,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,5,275,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,6,300,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,7,325,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,8,350,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
12140144,NA,189,gemcitabine,9,375,mg/m2,NA,5 consecutive weeks as a weekly 30-min intravenous infusion concurrent with radiotherapy.,NA
16150481,NA,190,gemcitabine,-1,800,mg/m2,NA,"day 1, 8","reducred to days 1, 8 from pt 5"
16150481,NA,190,topotecan,-1,0.5,mg/m2,NA,days  2-4,reduced to 1 -4 from pt 5
16150481,NA,190,topotecan,-1,0.5,mg/m2,NA,days  2-4,reduced to 1 -4 from pt 5
16150481,NA,190,gemcitabine,1,800,mg/m2,NA,"day 1, 8,15","reducred to days 1, 8 from pt 5"
16150481,NA,190,topotecan,1,0.5,mg/m2,NA,days  2-5,reduced to 1 -4 from pt 5
16150481,NA,190,topotecan,1,0.5,mg/m2,NA,days  2-5,reduced to 1 -4 from pt 5
16150481,NA,190,gemcitabine,2,800,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,2,0.75,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,2,0.75,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,3,800,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,3,1,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,3,1,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,4,800,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,4,1.25,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,4,1.25,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,5,800,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,5,1.5,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,5,1.5,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,6,900,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,6,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,6,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,7,1000,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,7,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,7,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,8,1100,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,8,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,8,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,gemcitabine,9,1200,mg/m2,NA,"day 1, 8",NA
16150481,NA,190,topotecan,9,MTD,mg/m2,NA,days  2-4,NA
16150481,NA,190,topotecan,9,MTD,mg/m2,NA,days  2-4,NA
12540024,NA,191,gemcitabine,1,350,mg/m2,NA,infused over 30 min once a week for 7 wk,infusion rate: 12 mg/m2/min
12540024,NA,191,dynamic intensity-modulated radiotherapy,1,33,Gy,NA,in  11 daily fractions of IMRT was initiated 24–48 h after the first gemcitabine dose.,NA
12540024,NA,191,gemcitabine,-1,250,mg/m2,NA,infused over 30 min once a week for 7 wk,NA
12540024,NA,191,dynamic intensity-modulated radiotherapy,-1,33,Gy,NA,in  11 daily fractions of IMRT was initiated 24–48 h after the first gemcitabine dose.,NA
14533441,NA,192,gemcitabine,1,1250,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,fixed dose
14533441,NA,192,topotecan,1,1,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,1,1,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,2,1.25,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,2,1.25,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,3,1.5,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,3,1.5,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,4,1.75,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,4,1.75,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,5,2,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,5,2,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,6,2.25,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
14533441,NA,192,topotecan,6,2.25,mg/m2,NA,30-minute intravenous infusion weekly times 3 out of 4 consecutive weeks constituting one cycle,NA
11157033,NA,193,radiation,1,2,Gy/fraction,NA,"once daily, 5 days a week","For macroscopic tumoe, The maximal dose to the spinal cord was restricted to 40 Gy; fixed dose"
11157033,NA,193,radiation,1,46-50,Gy,NA,NA,Lymph nodes
11157033,NA,193,gemcitabine,1,300,mg/m2,NA,once weekly,administered intravenously over 30 minutes; 4 hours before radiation
11157033,NA,193,gemcitabine,2,150,mg/m2,NA,once weekly,administered intravenously over 30 minutes; 4 hours before radiation
11157033,NA,193,gemcitabine,3,50,mg/m2,NA,once weekly,administered intravenously over 30 minutes; 4 hours before radiation
11157033,NA,193,gemcitabine,4,10,mg/m2,NA,once weekly,administered intravenously over 30 minutes; 4 hours before radiation
12003196,NA,194,gemcitabine,1,1000,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 30 minutes; after vinorelbine
12003196,NA,194,vinorelbine,1,25,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 10 minutes
12003196,NA,194,gemcitabine,2,1250,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 30 minutes; after vinorelbine
12003196,NA,194,vinorelbine,2,25,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 10 minutes
12003196,NA,194,gemcitabine,3,1250,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 30 minutes; after vinorelbine
12003196,NA,194,vinorelbine,3,30,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 10 minutes
12003196,NA,194,gemcitabine,4,1500,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 30 minutes; after vinorelbine
12003196,NA,194,vinorelbine,4,30,mg/m2,NA,days 1 and 8 of 21 cycle,administered over 10 minutes
12201494,NA,195,vinorelbine,1,25,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,gemcitabine,1,1000,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,cisplatin,1,50,mg/m2,NA,Day 2 and 9,fixed dose
12201494,NA,195,cisplatin,1,50,mg/m2,NA,Day 2 and 9,fixed dose
12201494,NA,195,vinorelbine,2,25,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,gemcitabine,2,1250,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,vinorelbine,3,25,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,gemcitabine,3,1500,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,vinorelbine,4,30,mg/m2,NA,Day 1 and 8,NA
12201494,NA,195,gemcitabine,4,1000,mg/m2,NA,Day 1 and 8,NA
12419757,NA,196,rubitecan,1,0.75,mg/m2,NA,days 1–5 and 8–12 every 21 days.,NA
12419757,NA,196,gemcitabine hydrochloride,1,1000,mg/m2,NA,10 mg/m2/min,10 mg/m2/min
12419757,NA,196,rubitecan,2,0.6,mg/m2,NA,days 1–5 and 8–12 every 21 days.,NA
12419757,NA,196,gemcitabine hydrochloride,2,750,mg/m2,NA,10 mg/m2/min,10 mg/m2/min
12419757,NA,196,rubitecan,3,0.75,mg/m2,NA,days 1–5 and 8–12 every 21 days.,NA
12419757,NA,196,gemcitabine hydrochloride,3,1000,mg/m2,NA,10 mg/m2/min,iv over 30 mins
12419757,NA,196,rubitecan,4,1,mg/m2,NA,days 1–5 and 8–12 every 21 days.,NA
12419757,NA,196,gemcitabine hydrochloride,4,1000,mg/m2,NA,10 mg/m2/min,iv over 30 mins
12419757,NA,196,rubitecan,5,1.25,mg/m2,NA,days 1–5 and 8–12 every 21 days.,NA
12419757,NA,196,gemcitabine hydrochloride,5,1000,mg/m2,NA,10 mg/m2/min,iv over 30 mins
11810040,NA,197,gemcitabine,0,1000,mg/m2,NA,on day 1 and 8 every 3 weeks,fixed dose
11810040,NA,197,leucovorin,0,100,mg/m2,NA,on day 1 and 8 every 3 weeks,fixed dose
11810040,NA,197,5-fu,0,425,mg/m2,NA,on day 1 and 8 every 3 weeks,fixed dose
11810040,NA,197,cyclophosphamide,0,1000,mg/m2,NA,on day 1 and 8 every 3 weeks,before gemcitabine
11810040,NA,197,cyclophosphamide,1,500,mg/m2,NA,on day 1 and 8 every 3 weeks,NA
11810040,NA,197,cyclophosphamide,2,600,mg/m2,NA,on day 1 and 8 every 3 weeks,NA
11810040,NA,197,cyclophosphamide,3,600,mg/m2,NA,on day 1 and 8 every 3 weeks,with G-CSF support
11810040,NA,197,cyclophosphamide,4,700,mg/m2,NA,on day 1 and 8 every 3 weeks,with G-CSF support
11810040,NA,197,cyclophosphamide,5,800,mg/m2,NA,on day 1 and 8 every 3 weeks,with G-CSF support
11810040,NA,197,cyclophosphamide,6,900,mg/m2,NA,on day 1 and 8 every 3 weeks,with G-CSF support
33052756,2018-000482-36,198,iadademstat,1,5,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,2,15,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,3,30,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,4,45,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,5,60,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,6,80,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,7,140,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
33052756,2018-000482-36,198,iadademstat,8,220,ug/m2/day,NA,5 days on/2 days off *4 weeks,NA
25977344,NCT01295827,199,pembrolizumab,1,1,mg/kg,NA,on days 1 and 28 and every 14 days thereafter until disease progression or intolerable toxicity occurred,NA
25977344,NCT01295827,199,pembrolizumab,2,3,mg/kg,NA,on days 1 and 28 and every 14 days thereafter until disease progression or intolerable toxicity occurred,NA
25977344,NCT01295827,199,pembrolizumab,3,10,mg/kg,NA,on days 1 and 28 and every 14 days thereafter until disease progression or intolerable toxicity occurred,NA
12562660,NA,200,gemcitabine,1,1000,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,1,60,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,1,60,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,2,1200,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,2,70,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,2,70,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,3,1200,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,3,80,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,3,80,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,4,1400,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,4,80,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,4,80,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,5,1400,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,5,90,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,5,90,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,6,1600,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,6,90,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,6,90,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,7,1600,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,7,100,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,7,100,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,8,1600,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,8,110,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,8,110,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,9,1600,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,9,120,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,9,120,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,10,1600,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,10,130,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,10,130,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,11,1800,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,11,130,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,11,130,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,gemcitabine,12,2000,mg/m2,NA,Days 1 and 8,NA
12562660,NA,200,oxaliplatin,12,130,mg/m2,NA,"Days 8, after gencitabine",NA
12562660,NA,200,oxaliplatin,12,130,mg/m2,NA,"Days 8, after gencitabine",NA
15125746,NA,201,gemcitabine,1,300,mg/m2/week,NA,once a week,infusion at a rate of 10 mg/m2/min
15125746,NA,201,radiotherapy,1,60-70,Gy,NA,2 Gy daily fraction,NA
15125746,NA,201,gemcitabine,2,450,mg/m2/week,NA,once a week,infusion at a rate of 10 mg/m2/min
14533444,NA,202,mitoguazone,1,500,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,1,1500,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,2,500,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,2,2000,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,3,600,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,3,2000,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,4,600,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,4,2500,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,5,700,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,5,2500,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,6,700,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,6,3000,mg/m2,NA,on day 2 of 14-day cycle,30 min
14533444,NA,202,mitoguazone,7,800,mg/m2,NA,on day 1 of 14-day cycle,30 min
14533444,NA,202,gemcitabine,7,3000,mg/m2,NA,on day 2 of 14-day cycle,30 min
15349753,NA,203,gemcitabine,1A,3600,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,203,cladribine,1A,8,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,203,gemcitabine,2A,4200,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,203,cladribine,2A,8,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,203,gemcitabine,3A,4200,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,203,cladribine,3A,10,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,203,gemcitabine,4A,4200,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,203,cladribine,4A,12.5,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,204,gemcitabine,1B,4200,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,204,cladribine,1B,8,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,204,gemcitabine,2B,5000,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,204,cladribine,2B,8,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,204,gemcitabine,3B,5000,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,204,cladribine,3B,10,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,204,gemcitabine,4B,5000,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,204,cladribine,4B,12.5,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
15349753,NA,204,gemcitabine,5B,5000,mg/m2,NA,day 1 of a 28-day cycle,NA
15349753,NA,204,cladribine,5B,16,mg/m2,NA,"day 1, 2, 3 of a 28-day cycle",NA
12881394,NA,205,cisplatin,1,40,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,fixed dose
12881394,NA,205,cisplatin,1,40,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,fixed dose
12881394,NA,205,gemcitabine,1,75,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,NA
12881394,NA,205,radiotherapy,1,50.4,Gy,NA,in 28 fractions followed 1 or 2 weeks later by intracavitary brachytherapy.,fixed dose
12881394,NA,205,gemcitabine,2,100,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,NA
12881394,NA,205,gemcitabine,3,125,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,NA
12881394,NA,205,gemcitabine,4,150,mg/m2,NA,on day 1 of radiotherapy and administrated 2 h before radiation weekly for 5 weeks.,NA
11458814,NA,206,topotecan,1,0.5,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,topotecan,1,0.5,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,gemcitabine,1,400,mg/m2,NA,Days 1 and 5,NA
11458814,NA,206,topotecan,2,0.75,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,topotecan,2,0.75,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,gemcitabine,2,400,mg/m2,NA,Days 1 and 5,NA
11458814,NA,206,topotecan,3,0.75,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,topotecan,3,0.75,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,gemcitabine,3,600,mg/m2,NA,Days 1 and 5,NA
11458814,NA,206,topotecan,4,1,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,topotecan,4,1,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,gemcitabine,4,600,mg/m2,NA,Days 1 and 5,NA
11458814,NA,206,topotecan,5,1,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,topotecan,5,1,mg/m2,NA,Days 1 -5,NA
11458814,NA,206,gemcitabine,5,800,mg/m2,NA,Days 1 and 5,NA
16327288,NA,207,radiotherapy,1,54,Gy,NA,30 daily fractions of 1.8 Gy over 6 weeks,NA
16327288,NA,207,gemcitabine,2,100,mg/m2,NA,weekly,NA
16327288,NA,207,gemcitabine,3,150,mg/m2,NA,weekly,NA
16327288,NA,207,gemcitabine,4,200,mg/m2,NA,weekly,NA
16327288,NA,207,gemcitabine,5,250,mg/m2,NA,weekly,NA
16327288,NA,207,gemcitabine,6,300,mg/m2,NA,weekly,NA
11172947,NA,208,radiotherapy,1,45,Gy,NA,1.8 Gy given 5 days a week,fixed dose
11172947,NA,208,gemcitabine,1,100,mg/m2,NA,"Days 1, 8,15",NA
11172947,NA,208,mitomycin c,1,8,mg/m2,NA,Day 1,fixed dose
11172947,NA,208,gemcitabine,2,130,mg/m2,NA,"Days 1, 8,15",NA
11172947,NA,208,gemcitabine,3,160,mg/m2,NA,"Days 1, 8,15",NA
15226322,NA,209,radiation therapy,1,60,Gy,NA,"2 Gy/d, for a total of 6 weeks.",NA
15226322,NA,209,gemcitabine,1,10,mg/m2,NA,on Monday and Thursday as a 30-minute infusion for 6 weeks,NA
15226322,NA,209,gemcitabine,2,20,mg/m2,NA,on Monday and Thursday as a 30-minute infusion for 6 weeks,NA
15226322,NA,209,gemcitabine,3,33,mg/m2,NA,on Monday and Thursday as a 30-minute infusion for 6 weeks,NA
15226322,NA,209,gemcitabine,4,27,mg/m2,NA,on Monday and Thursday as a 30-minute infusion for 6 weeks,NA
15226322,NA,209,gemcitabine,5,30,mg/m2,NA,on Monday and Thursday as a 30-minute infusion for 6 weeks,NA
12394252,NA,210,gemcitabine,1,500,mg/m2,NA,"days 1, 8 and 15",NA
12394252,NA,210,ifn-a2b,1,5,10^6 IU,NA,"days 1, 3, 5, 8, 10, 12, 15, 17 and 19",NA
12394252,NA,210,gemcitabine,2,1000,mg/m2,NA,"days 1, 8 and 15",NA
12394252,NA,210,ifn-a2b,2,5,10^6 IU,NA,"days 1, 3, 5, 8, 10, 12, 15, 17 and 19",NA
12394252,NA,210,gemcitabine,3,1000,mg/m2,NA,"days 1, 8 and 15",NA
12394252,NA,210,ifn-a2b,3,7,10^6 IU,NA,"days 1, 3, 5, 8, 10, 12, 15, 17 and 19",NA
12394252,NA,210,gemcitabine,4,1000,mg/m2,NA,"days 1, 8 and 15",NA
12394252,NA,210,ifn-a2b,4,10,10^6 IU,NA,"days 1, 3, 5, 8, 10, 12, 15, 17 and 19",NA
12394252,NA,210,gemcitabine,5,1200,mg/m2,NA,"days 1, 8 and 15",NA
12394252,NA,210,ifn-a2b,5,10,10^6 IU,NA,"days 1, 3, 5, 8, 10, 12, 15, 17 and 19",NA
16012794,NA,211,gemcitabine,1,1000,mg/m2,NA,"on days 1, 8 and 15",NA
16012794,NA,211,mitoxantrone,1,10,mg/m2,NA,on day 8 in 4-weeks cycles,NA
16012794,NA,211,gemcitabine,2,1000,mg/m2,NA,"on days 1, 8 and 15",NA
16012794,NA,211,mitoxantrone,2,12,mg/m2,NA,on day 8 in 4-weeks cycles,NA
16012794,NA,211,gemcitabine,3,1200,mg/m2,NA,"on days 1, 8 and 15",NA
16012794,NA,211,mitoxantrone,3,12,mg/m2,NA,on day 8 in 4-weeks cycles,NA
16012794,NA,211,gemcitabine,4,1200,mg/m2,NA,"on days 1, 8 and 15",NA
16012794,NA,211,mitoxantrone,4,14,mg/m2,NA,on day 8 in 4-weeks cycles,NA
16012794,NA,211,gemcitabine,5,1400,mg/m2,NA,"on days 1, 8 and 15",NA
16012794,NA,211,mitoxantrone,5,14,mg/m2,NA,on day 8 in 4-weeks cycles,NA
15714201,NA,212,conventional radiotherapy,1,30,Gy,NA,in 10 fractions for 12 days,fixed dose
15714201,NA,212,gemcitabine,1,25,mg/m2,NA,days 1 and 8,NA
15714201,NA,212,gemcitabine,2,25,mg/m2,NA,"1, 4, 8 and 11",NA
15714201,NA,212,gemcitabine,3,37.5,mg/m2,NA,"1, 4, 8 and 11",NA
15714201,NA,212,gemcitabine,4,50,mg/m2,NA,"1, 4, 8 and 11",NA
15714201,NA,212,gemcitabine,5,62.5,mg/m2,NA,"1, 4, 8 and 11",NA
15714201,NA,212,gemcitabine,6,75,mg/m2,NA,"1, 4, 8 and 11",NA
12182983,NA,213,diphenhydramine,1,25,mg,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",given 30 min before the initial infusion of paclitaxel; fixed dose
12182983,NA,213,dexamethasone,1,20,mg,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",given 30 min before the initial infusion of paclitaxel; foxed dose
12182983,NA,213,ranitidine,1,50,mg,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",given 30 min before the initial infusion of paclitaxel;fixed dose
12182983,NA,213,paclitaxel,1,40,mg/m2/week,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",fixed dose
12182983,NA,213,gemcitabine,1,75,mg/m2/week,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",NA
12182983,NA,213,gemcitabine,2,110,mg/m2/week,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",NA
12182983,NA,213,gemcitabine,3,150,mg/m2/week,NA,"for 6 weeks on Days 1, 8, 15, 22, 29, and 36.",NA
12182983,NA,213,radiation therapy,1,50.4,Gy,NA,in 28 fractions of 1.8 Gy per fraction,NA
16251868,NA,214,gemcitabine,1,750,mg/m2,NA,days 1 and 8,NA
16251868,NA,214,cisplatin,1,75,mg/m2,NA,day 1,NA
16251868,NA,214,cisplatin,1,75,mg/m2,NA,day 1,NA
16251868,NA,214,tipifarnib,1,100,mg,2,days 1-7,NA
16251868,NA,214,gemcitabine,2,750,mg/m2,NA,days 1 and 8,NA
16251868,NA,214,cisplatin,2,75,mg/m2,NA,day 1,NA
16251868,NA,214,cisplatin,2,75,mg/m2,NA,day 1,NA
16251868,NA,214,tipifarnib,2,200,mg,2,days 1-7,NA
16251868,NA,214,gemcitabine,3,1000,mg/m2,NA,days 1 and 8,NA
16251868,NA,214,cisplatin,3,75,mg/m2,NA,day 1,NA
16251868,NA,214,cisplatin,3,75,mg/m2,NA,day 1,NA
16251868,NA,214,tipifarnib,3,200,mg,2,days 1-7,NA
16251868,NA,214,gemcitabine,4,1000,mg/m2,NA,days 1 and 8,NA
16251868,NA,214,cisplatin,4,100,mg/m2,NA,day 1,NA
16251868,NA,214,cisplatin,4,100,mg/m2,NA,day 1,NA
16251868,NA,214,tipifarnib,4,200,mg,2,days 1-7,NA
16251868,NA,214,gemcitabine,5,1000,mg/m2,NA,days 1 and 8,NA
16251868,NA,214,cisplatin,5,100,mg/m2,NA,day 1,NA
16251868,NA,214,cisplatin,5,100,mg/m2,NA,day 1,NA
16251868,NA,214,tipifarnib,5,300,mg,2,days 1-7,NA
12481889,NA,215,gemcitabine,1,3600,mg/m2/week,NA,in normal saline at a concentration of 10 mg/ml and administered intravenously with an infusion pump at a rate of 10 mg/m2/min. for 3 consecutive weeks.,NA
12481889,NA,215,gemcitabine,2,4800,mg/m2/week,NA,in normal saline at a concentration of 10 mg/ml and administered intravenously with an infusion pump at a rate of 10 mg/m2/min. for 3 consecutive weeks.,NA
15165093,NA,216,gemcitabine,1,1000,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
15165093,NA,216,gemcitabine,2,1500,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
15165093,NA,216,gemcitabine,3,1750,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
15165093,NA,216,gemcitabine,4,2200,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
15165093,NA,216,gemcitabine,5,2800,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
15165093,NA,216,gemcitabine,6,3500,mg/m2,NA,over 30 min on a once-weekly basis for 3 consecutive weeks followed by 1 week of rest.,NA
12394268,NA,217,gemcitabine,0,1000,mg/m2,NA,"30 min, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",fixed dose
12394268,NA,217,folinic acid,0,200,mg/m2,NA,"30 min, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",fixed dose
12394268,NA,217,5-fu,0,750,mg/m2,NA,"24 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",fixed dose
12394268,NA,217,cisplatin,0,20,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
12394268,NA,217,cisplatin,0,20,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
12394268,NA,217,cisplatin,1,25,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
12394268,NA,217,cisplatin,1,25,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
12394268,NA,217,cisplatin,2,30,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
12394268,NA,217,cisplatin,2,30,mg/m2,NA,"1 hr, on days 1, 8, 15 and 22 followed by 2 weeks rest, days 23–42.",NA
14760128,NA,218,gemcitabine,1,1000,mg/m2,NA,"Days 1, 8, 15; a 30-min intravenous infusion 1 h after the administration of PKC412",fixed dose
14760128,NA,218,cisplatin,1,100,mg/m2,NA,"Day 2,  60 min intravenous infusion 1 h after the administration of PKC412",fixed dose
14760128,NA,218,cisplatin,1,100,mg/m2,NA,"Day 2,  60 min intravenous infusion 1 h after the administration of PKC412",fixed dose
14760128,NA,218,pkc412,1,25,mg,NA,daily,NA
14760128,NA,218,pkc412,2,25,mg,2,twice daily,NA
14760128,NA,218,pkc412,3,25,mg,3,t.i.d,NA
14760128,NA,218,pkc412,4,50,mg,2,b.i.d,NA
14760128,NA,218,pkc412,5,50,mg,3,t.i.d,NA
14760128,NA,218,pkc412,6,75,mg,3,t.i.d,NA
12499100,NA,219,gemcitabine,1,800,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,nedaplatin,1,60,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,gemcitabine,2,800,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,nedaplatin,2,70,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,gemcitabine,3,800,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,nedaplatin,3,80,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,gemcitabine,4,1000,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,nedaplatin,4,80,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,gemcitabine,5,1000,mg/m2,NA,every 3 weeks,NA
12499100,NA,219,nedaplatin,5,100,mg/m2,NA,every 3 weeks,NA
12643004,NA,220,gemcitabine,1,1000,mg/m2,NA,day 1 and 8 every 21 days,fixed dose
12643004,NA,220,paclitaxel,1,60,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,2,75,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,3,90,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,4,105,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,5,120,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,6,135,mg/m2,NA,day 1 and 8 every 21 days,NA
12643004,NA,220,paclitaxel,7,150,mg/m2,NA,day 1 and 8 every 21 days,NA
12393998,NA,221,gemcitabine,1,800,mg/m2,NA,day 1 and 8,NA
12393998,NA,221,paclitaxel,1,150,mg/m2,NA,day 1,NA
12393998,NA,221,gemcitabine,2,1000,mg/m2,NA,day 1 and 8,NA
12393998,NA,221,paclitaxel,2,150,mg/m2,NA,day 1,NA
12393998,NA,221,gemcitabine,3,1000,mg/m2,NA,day 1 and 8,NA
12393998,NA,221,paclitaxel,3,175,mg/m2,NA,day 1,NA
12393998,NA,221,gemcitabine,4,1000,mg/m2,NA,day 1 and 8,NA
12393998,NA,221,paclitaxel,4,200,mg/m2,NA,day 1,NA
12393998,NA,221,gemcitabine,5,1300,mg/m2,NA,day 1,NA
12393998,NA,221,paclitaxel,5,200,mg/m2,NA,day 1 and 8,NA
12393998,NA,221,gemcitabine,4A,1000,mg/m2,NA,day 1,"infused at a rate of 10 mg/m2/min and paclitaxel, administered during 1 hour"
12393998,NA,221,paclitaxel,4A,200,mg/m2,NA,day 1 and 8,"infused at a rate of 10 mg/m2/min and paclitaxel, administered during 1 hour"
12393998,NA,221,gemcitabine,5A,1300,mg/m2,NA,day 1,"infused at a rate of 10 mg/m2/min and paclitaxel, administered during 1 hour"
12393998,NA,221,paclitaxel,5A,200,mg/m2,NA,day 1 and 8,"infused at a rate of 10 mg/m2/min and paclitaxel, administered during 1 hour"
15493356,NA,222,topotecan,1,0.3,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,1,0.3,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,1,1000,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
15493356,NA,222,topotecan,2,0.6,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,2,0.6,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,2,1000,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
15493356,NA,222,topotecan,3,0.75,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,3,0.75,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,3,1000,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
15493356,NA,222,topotecan,4,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,4,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,4,1000,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
15493356,NA,222,topotecan,5,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,5,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,5,1250,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
15493356,NA,222,topotecan,6,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,topotecan,6,1,mg/m2,NA,30-minute IV infusion on days 1 – 5 of each cycle.,NA
15493356,NA,222,gemcitabine,6,1500,mg/m2,NA,administered by 30minute IV infusion on days 1 and 15 of each cycle.,NA
11821464,NA,223,concurrent radiotherapy,1,50.4,Gy,NA,1.8 Gy/d (5 weeks plus 3 days),fixed dose
11821464,NA,223,gemcitabine,1,100,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,2,150,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,3,200,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,4,250,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,5,275,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,6,300,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,7,325,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,8,350,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11821464,NA,223,gemcitabine,9,375,mg/m2,NA,weekly for 5 consecutive weeks as a 30-minute intravenous infusion at least 4 hours before radiation therapy,NA
11593051,NA,224,gemcitabine,1,300,mg/m2,NA,"on days 1, 8 and 15 of a 28-day cycle",NA
11593051,NA,224,gemcitabine,2,400,mg/m2,NA,"on days 1, 8 and 15 of a 28-day cycle",NA
11593051,NA,224,gemcitabine,3,450,mg/m2,NA,"on days 1, 8 and 15 of a 28-day cycle",NA
11593051,NA,224,gemcitabine,4,500,mg/m2,NA,"on days 1, 8 and 15 of a 28-day cycle",NA
16222156,NA,225,cisplatin,1,75,mg/m2,NA,on day 2 of a 3-weekly cycle,fixed dose
16222156,NA,225,cisplatin,1,75,mg/m2,NA,on day 2 of a 3-weekly cycle,fixed dose
16222156,NA,225,gemcitabine,1,130,mg/m2,NA,on day 1 and 8 of 3-weekly cycle,NA
16222156,NA,225,gemcitabine,2,170,mg/m2,NA,on day 1 and 8 of 3-weekly cycle,NA
16222156,NA,225,gemcitabine,3,210,mg/m2,NA,on day 1 and 8 of 3-weekly cycle,NA
16222156,NA,225,gemcitabine,4,250,mg/m2,NA,on day 1 and 8 of 3-weekly cycle,NA
15380578,NA,226,radiotherapy,1,50.4,Gy,NA,"in 28 fractions of 1.8 Gy per day, 5 days per week",fixed dose
15380578,NA,226,gemcitabine,1,20,mg/m2,NA,twice a week,NA
15380578,NA,226,gemcitabine,1,50,mg/m2,NA,twice a week,NA
15380578,NA,226,gemcitabine,1,100,mg/m2,NA,twice a week,NA
11804180,NA,227,gemcitabine,1,800,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,1,15,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,2,800,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,2,20,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,3,800,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,3,25,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,4,800,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,4,30,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,5,1000,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,5,30,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,6,1200,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,6,30,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,gemcitabine,7,1400,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11804180,NA,227,vinorelbine,7,30,mg/m2,NA,days 1 and 8 every 3 weeks,NA
11899362,NA,228,cyclophosphamide,1,600,mg/m2,NA,every 3 weeks,fixed dose
11899362,NA,228,gemcitabine,1,100,mg/m2,NA,every 3 weeks,NA
11899362,NA,228,gemcitabine,2,150,mg/m2,NA,every 3 weeks,NA
11899362,NA,228,gemcitabine,3,200,mg/m2,NA,every 3 weeks,NA
15245938,NA,229,rt,1,2,Gy/frac,NA,5 d/wk,fixed dose
15245938,NA,229,gemcitabine,1,10,mg/m2,NA,twice weekly,NA
15245938,NA,229,gemcitabine,2,20,mg/m2,NA,twice weekly,NA
15245938,NA,229,gemcitabine,3,27,mg/m2,NA,twice weekly,NA
15245938,NA,229,gemcitabine,4,30,mg/m2,NA,twice weekly,NA
15245938,NA,229,gemcitabine,5,33,mg/m2,NA,twice weekly,NA
11704320,NA,230,radiation therapy,1,45,Gy,NA,25 fractions of 1.8 Gy daily fractions,fixed dose
11704320,NA,230,amifostine,1,340,mg/m2,NA,twice a week,fixed dose
11704320,NA,230,amifostine,1,340,mg/m2,NA,twice a week,fixed dose
11704320,NA,230,gemcitabine,1,60,mg/m2,NA,twice a week,NA
11704320,NA,230,gemcitabine,2,90,mg/m2,NA,twice a week,NA
11704320,NA,230,gemcitabine,3,120,mg/m2,NA,twice a week,NA
27544076,NCT01451437,237,mk-8242,1,30,mg,NA,"QD, 7 day on/7 day off",NA
27544076,NCT01451437,237,mk-8242,2,60,mg,NA,"QD, 7 day on/7 day off",NA
27544076,NCT01451437,237,mk-8242,3,120,mg,NA,"QD, 7 day on/7 day off",NA
27544076,NCT01451437,237,mk-8242,4,250,mg,NA,"QD, 7 day on/7 day off",NA
27544076,NCT01451437,238,mk-8242,1,120,mg,NA,"BID, 7 day on/7 day off",NA
27544076,NCT01451437,238,mk-8242,2,170,mg,NA,"BID, 7 day on/7 day off",NA
27544076,NCT01451437,238,mk-8242,3,250,mg,NA,"BID, 7 day on/7 day off",NA
27544076,NCT01451437,239,mk-8242,1,210,mg,NA,"BID, 7 on/14 off in a 21-day cycle",NA
27544076,NCT01451437,239,mk-8242,2,300,mg,NA,"BID, 7 on/14 off in a 21-day cycle",NA
25854284,NCT00839982,241,cytarabine,1,20,mg or mg/m2/day,NA,20 mg subcutaneously twice daily for 10 d or at 20 mg/m2 subcutaneously once daily for 14 d,fixed dose
25854284,NCT00839982,241,clofarabine,1,5,mg,NA,daily for 5 d,NA
25854284,NCT00839982,241,clofarabine,2,10,mg,NA,daily for 5 d,NA
25854284,NCT00839982,241,clofarabine,3,15,mg,NA,daily for 5 d,NA
25854284,NCT00839982,241,clofarabine,4,20,mg,NA,daily for 5 d,NA
25854284,NCT00839982,241,clofarabine,5,25,mg,NA,daily for 5 d,NA
25854284,NCT00839982,241,clofarabine,6,30,mg,NA,daily for 5 d,NA
32009149,NCT01514201,242,radiation,1,5400,cGy,NA,30 fractions over 6 weeks to the planning target volume,fixed dose
32009149,NCT01514201,242,temozolomide,1,135,mg/m2/day,NA,for 5 days every 28 days in maintance phase,"fixed dose; intrapatientTMZ dose escalation was attempted for patients with predefined minimal toxicities in the preceding course, defined as grade ≤1 thrombocytopenia and grade ≤2 neutropenia and grade ≤2 non-hematologic toxicities. TMZ was escalated to 175  mg/m2/day and 200  mg/m2/day in subsequent courses, as tolerated."
32009149,NCT01514201,242,temozolomide,1,135,mg/m2/day,NA,for 5 days every 28 days in maintance phase,"fixed dose; intrapatientTMZ dose escalation was attempted for patients with predefined minimal toxicities in the preceding course, defined as grade ≤1 thrombocytopenia and grade ≤2 neutropenia and grade ≤2 non-hematologic toxicities. TMZ was escalated to 175  mg/m2/day and 200  mg/m2/day in subsequent courses, as tolerated."
32009149,NCT01514201,242,veliparib,1,50,mg/m2,NA,"b.i.d. Monday through Friday during radiation, morning dose was given 60–120 minutes prior to radiation",25  mg/m2/dose b.i.d. for maintance phase
32009149,NCT01514201,242,veliparib,2,65,mg/m2,NA,"b.i.d. Monday through Friday during radiation, morning dose was given 60–120 minutes prior to radiation",25  mg/m2/dose b.i.d. for maintance phase
32009149,NCT01514201,242,veliparib,3,85,mg/m2,NA,"b.i.d. Monday through Friday during radiation, morning dose was given 60–120 minutes prior to radiation",25  mg/m2/dose b.i.d. for maintance phase
32009149,NCT01514201,242,veliparib,-1,35,mg/m2,NA,"b.i.d. Monday through Friday during radiation, morning dose was given 60–120 minutes prior to radiation",25  mg/m2/dose b.i.d. for maintance phase
32002547,NCT01120639,243,temozolomide,1,75,mg/m2,NA,started the day prior to the first SRS treatment; 8 total days were prescribed.,fixed dose; ARM 1: PTV 0.1 to < 60 cm3
32002547,NCT01120639,243,temozolomide,1,75,mg/m2,NA,started the day prior to the first SRS treatment; 8 total days were prescribed.,fixed dose; ARM 1: PTV 0.1 to < 60 cm3
32002547,NCT01120639,243,hypofractionated stereotactic radiosurgery,1,25,Gy,NA,"in 5 consecutive days over 7 elapsed days, with extension over a weekend allowed.",ARM 1: PTV 0.1 to < 60 cm3
32002547,NCT01120639,243,hypofractionated stereotactic radiosurgery,2,30,Gy,NA,"in 5 consecutive days over 7 elapsed days, with extension over a weekend allowed.",ARM 1: PTV 0.1 to < 60 cm3
32002547,NCT01120639,243,hypofractionated stereotactic radiosurgery,3,35,Gy,NA,"in 5 consecutive days over 7 elapsed days, with extension over a weekend allowed.",ARM 1: PTV 0.1 to < 60 cm3
32002547,NCT01120639,243,hypofractionated stereotactic radiosurgery,4,40,Gy,NA,"in 5 consecutive days over 7 elapsed days, with extension over a weekend allowed.",ARM 1: PTV 0.1 to < 60 cm3
26333381,NCT00993239,246,birinapant,1,0.18,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,2,0.36,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,3,0.72,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,4,1.44,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,5,2.88,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,6,5.76,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,7,11.5,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,8,17.2,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,9,26,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,10,35,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,11,47,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
26333381,NCT00993239,246,birinapant,12,63,mg/m2,NA,once weekly for 3 weeks of each 4-week dosing cycle.,NA
28434648,NCT01658878,247,nivolumab,1,0.1,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,247,nivolumab,2,0.3,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,247,nivolumab,3,1,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,247,nivolumab,4,3,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,247,nivolumab,5,10,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,248,nivolumab,1,0.3,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,248,nivolumab,2,1,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,248,nivolumab,3,3,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,249,nivolumab,1,0.1,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,249,nivolumab,2,0.3,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,249,nivolumab,3,1,mg/kg,NA,every 2 weeks,NA
28434648,NCT01658878,249,nivolumab,4,3,mg/kg,NA,every 2 weeks,NA
22648179,NCT00932373,250,trastuzumab emtansine,1,1.2,mg/kg,NA,every week,NA
22648179,NCT00932373,250,trastuzumab emtansine,2,1.6,mg/kg,NA,every week,NA
22648179,NCT00932373,250,trastuzumab emtansine,3,2,mg/kg,NA,every week,NA
22648179,NCT00932373,250,trastuzumab emtansine,4,2.4,mg/kg,NA,every week,NA
22648179,NCT00932373,250,trastuzumab emtansine,5,2.9,mg/kg,NA,every week,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,1,0.05,mg/kg,NA,every 3 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,2,0.1,mg/kg,NA,every 3 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,3,0.2,mg/kg,NA,every 3 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,4,0.4,mg/kg,NA,every 3 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,5,0.8,mg/kg,NA,every 3 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,6,0.2,mg/kg,NA,every 6 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,7,0.3,mg/kg,NA,every 6 weeks,NA
27932068,NCT01901653,251,rovalpituzumab tesirine,8,0.4,mg/kg,NA,every 6 weeks,NA
20712886,NA,1,epirubicin,NA,150,mg/m2,NA,day 1 every 14 days,three cycles; fixed dose
20712886,NA,1,filgrastim,NA,5,ug/kg,NA,days 3-10,three cycles; fixed dose
20712886,NA,1,filgrastim,NA,5,ug/kg,NA,days 3-10,three cycles; fixed dose
20712886,NA,1,paclitaxel,NA,225,mg/m2,1,3-hour infusion on day 1 every 14 days,followed by another three cycles with filgrastim;fixed dose
20712886,NA,1,capecitabine,1,1000,mg/m2,2,days 1-14,Patients then received four cycles of capecitabine days 1-14 either alone (dose levels 1 and 3)
20712886,NA,1,capecitabine,1,1000,mg/m2,2,days 1-14,Patients then received four cycles of capecitabine days 1-14 either alone (dose levels 1 and 3)
20712886,NA,1,capecitabine,3,1250,mg/m2,2,days 1-14,Patients then received four cycles of capecitabine days 1-14 either alone (dose levels 1 and 3)
20712886,NA,1,capecitabine,3,1250,mg/m2,2,days 1-14,Patients then received four cycles of capecitabine days 1-14 either alone (dose levels 1 and 3)
20712886,NA,1,darbepoetin alfa,NA,NA,NA,NA,weekly,"All patients received darbepoetin alfa from day 1 of chemotherapy until the end of radiotherapy(starting dose of 300 μg weekly for 4 weeks, after this every 3 weeks)"
20712886,NA,1,tamoxifen,NA,20,mg,NA,20 mg/day for 5 years after completion of chemotherapy.,Patients with hormone receptor-positive disease
20712886,NA,2,epirubicin,NA,150,mg/m2,NA,day 1 every 14 days,three cycles;fixed dose
20712886,NA,2,filgrastim,NA,5,ug/kg,NA,days 3-10,three cycles;fixed dose
20712886,NA,2,filgrastim,NA,5,ug/kg,NA,days 3-10,three cycles;fixed dose
20712886,NA,2,paclitaxel,NA,225,mg/m2,1,3-hour infusion on day 1 every 14 days,followed by another three cycles with filgrastim;fixed dose
20712886,NA,2,capecitabine,2,1000,mg/m2,2,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,capecitabine,2,1000,mg/m2,2,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,capecitabine,4,1250,mg/m2,2,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,capecitabine,4,1250,mg/m2,2,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,vinorelbine,2,25,mg/m2,NA,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,vinorelbine,4,25,mg/m2,NA,days 1 and 8 of each 21-day cycle,Patients then received four cycles of in combination with vinorelbine at 25 mg/m² on days 1 and 8 of each 21-day cycle (dose levels 2 and 4).
20712886,NA,2,darbepoetin alfa,NA,NA,NA,NA,weekly,"All patients received darbepoetin alfa from day 1 of chemotherapy until the end of radiotherapy(starting dose of 300 μg weekly for 4 weeks, after this every 3 weeks)"
20712886,NA,2,tamoxifen,NA,20,mg,NA,20 mg/day for 5 years after completion of chemotherapy.,Patients with hormone receptor-positive disease
25924991,NCT01165216,1,ipilimumab,1,3,mg/kg,1,First treatment period: two cycles of PTX/CBDCA (q3wks) followed by four cycles of ipilimumab plus PTX/CBDCA q3wks. Second treatment period:patients without disease progression received ipilimumab alone(q12wks) as maintenance treatment.,"patients were required to meet core safety criteria and have adequate bone marrow function(ANC>1500/mm3 and platelet count>100,000/mm3)."
25924991,NCT01165216,1,ptx,1,175,mg/m2,NA,NA,fixed dose
25924991,NCT01165216,1,ptx,1,175,mg/m2,NA,NA,fixed dose
25924991,NCT01165216,1,cbdca,NA,NA,NA,NA,NA,AUC=6
25924991,NCT01165216,2,ipilimumab,2,10,mg/kg,NA,same as combination1,same as combination1
25924991,NCT01165216,2,ptx,2,175,mg/m2,NA,NA,fixed dose
25924991,NCT01165216,2,ptx,2,175,mg/m2,NA,NA,fixed dose
25924991,NCT01165216,2,cbdca,NA,NA,NA,NA,NA,AUC=6
25794535,NCT00969761,1,volasertib,1,100,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,1,volasertib,2,200,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,1,volasertib,3,300,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,1,volasertib,3.5,350,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,1,cisplatin,1,60,mg/m2,NA,day 1 each cycle,(AUC)4
25794535,NCT00969761,1,cisplatin,1,60,mg/m2,NA,day 1 each cycle,(AUC)4
25794535,NCT00969761,1,cisplatin,2,75,mg/m2,NA,day 1 each cycle,NA
25794535,NCT00969761,1,cisplatin,2,75,mg/m2,NA,day 1 each cycle,NA
25794535,NCT00969761,1,cisplatin,3,100,mg/m2,NA,day 1 each cycle,NA
25794535,NCT00969761,1,cisplatin,3,100,mg/m2,NA,day 1 each cycle,NA
25794535,NCT00969761,2,volasertib,1,100,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,2,volasertib,2,200,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,2,volasertib,3,300,mg,NA,day 1 each cycle,NA
25794535,NCT00969761,2,carboplatin,1,NA,NA,NA,day 1 each cycle,AUC4
25794535,NCT00969761,2,carboplatin,1,NA,NA,NA,day 1 each cycle,AUC4
25794535,NCT00969761,2,carboplatin,2,NA,NA,NA,day 1 each cycle,AUC5
25794535,NCT00969761,2,carboplatin,2,NA,NA,NA,day 1 each cycle,AUC5
25794535,NCT00969761,2,carboplatin,3,NA,NA,NA,day 1 each cycle,AUC6
25794535,NCT00969761,2,carboplatin,3,NA,NA,NA,day 1 each cycle,AUC6
21069335,NCT00684099,1,pemetrexed,1,65,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,1,400,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,2,65,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,2,450,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,3,70,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,3,450,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,4,70,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,4,500,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,5,75,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,5,500,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,6,80,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,6,500,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,7,80,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,7,550,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21069335,NCT00684099,1,pemetrexed,8,85,mg/m2,1,"on day 1, every 3 weeks",10-min intra- venous infusion
21069335,NCT00684099,1,docetaxel,8,500,mg/m2,1,"on day 1, every 3 weeks",1-h intravenous infusion
21481618,NA,1,docetaxel,-1,60,mg/m2,1,day 1 of  each 21-daycycle,G-CSF:No
21481618,NA,1,satraplatin,-1,40,mg/m2,NA,on days 1–5 of each 21-daycycle.,G-CSF:No
21481618,NA,1,docetaxel,1,60,mg/m2,NA,NA,G-CSF:No
21481618,NA,1,satraplatin,1,50,mg/m2,NA,NA,G-CSF:No
21481618,NA,1,docetaxel,2,60,mg/m2,NA,NA,G-CSF:Yes
21481618,NA,1,satraplatin,2,50,mg/m2,NA,NA,G-CSF:Yes
21481618,NA,1,docetaxel,3,70,mg/m2,NA,NA,G-CSF:Yes
21481618,NA,1,satraplatin,3,50,mg/m2,NA,NA,G-CSF:Yes
21481618,NA,1,docetaxel,4,60,mg/m2,NA,NA,"G-CSF:Yes: Phase 1b portion, included the use of prednisone 10 mg daily."
21481618,NA,1,satraplatin,4,50,mg/m2,NA,NA,"G-CSF:Yes: Phase 1b portion, included the use of prednisone 10 mg daily."
21481618,NA,1,docetaxel,5,75,mg/m2,NA,NA,"G-CSF:Yes: Phase 1b portion, included the use of prednisone 10 mg daily."
21481618,NA,1,satraplatin,5,50,mg/m2,NA,NA,"G-CSF:Yes: Phase 1b portion, included the use of prednisone 10 mg daily."
23942080,NA,1,px-866,1,4,mg,NA,"In cycle 1 only,docetaxel wasadministered on day 1 followed by initiation of treatment withdaily oral PX-866 on day 8.In all subsequent cycles, PX-866 wasadministered in a fasting state daily throughout the cycle.",Prophylactic and therapeutic use of filgrastim or pegfilgrastim
23942080,NA,1,px-866,2,6,mg,NA,NA,NA
23942080,NA,1,px-866,3,8,mg,NA,NA,NA
23942080,NA,1,docetaxel,1,75,mg/m2,1,once every 21 days,NA
23942080,NA,1,dexamethasone,1,8,mg,3,"receiveddexamethasone 8 mg PO at 12, 3, and 1 h before docetaxeladministration",Patients with CRPC 
23942080,NA,1,prednisone,1,5,mg,2,daily,Patients with CRPC
23942080,NA,1,dexamethasone,1,8,mg,2,all other patients received dexamethasone 8 mg PO BID for 3 days starting the day before,NA
22828917,NA,1,docetaxel,1,75,mg/m2,NA,run-in phase,fixed dose
22828917,NA,1,docetaxel,1,75,mg/m2,NA,combination treatment:q3w,fixed dose
22828917,NA,1,siltuximab,1,6000,ug/kg,NA,combination treatment:q2w,NA
22828917,NA,2,siltuximab,1,6000,ug/kg,NA,run-in phase,NA
22828917,NA,2,docetaxel,1,75,mg/m2,NA,combination treatment:q3w,fixed dose
22828917,NA,2,siltuximab,1,6000,ug/kg,NA,combination treatment:q2w,NA
22828917,NA,1,siltuximab,1,75,mg/m2,NA,combination treatment:q3w,fixed dose
22828917,NA,1,siltuximab,2,9000,ug/kg,NA,combination treatment:q3w,NA
22828917,NA,1,siltuximab,3,1200,ug/kg,NA,combination treatment:q3w,NA
21792569,NA,1,docetaxel,1,75,mg/m2,NA,on day 1 in a 21-day cycle,NA
21792569,NA,1,prednisolone,1,5,mg,2,NA,"Patients
received 8 mg dexamethasone on day 0 and day 1 as
premedication prior to docetaxel."
21792569,NA,1,re-hedp,1,1250,NA,NA,day 3, MBq/kg
21792569,NA,1,re-hedp,2,2500,NA,NA,after the third andsixth cycle of docetaxel,MBq/kg;
23553066,NCT00732745,1,docetaxel,1,35,mg/m2,NA,on days 1 and 8 over 1 h,Each cycle of treatment consisted of 21 days
23553066,NCT00732745,1,dexamethasone,1,8,mg,2,starting the day before chemotherapy administration and continuing until the day afterdocetaxel for a total of six doses.,NA
23553066,NCT00732745,1,oxaliplatin,1,100,mg/m2,NA,on day 1 over 2 h,NA
23553066,NCT00732745,1,oxaliplatin,1,100,mg/m2,NA,on day 1 over 2 h,NA
23553066,NCT00732745,2,dexamethasone,1,10,mg,NA,NA,"If the patient had not taken oral dexamethasone prior to chemotherapy administration,dexamethasone 10–20 mg intravenously or methylprednisolone 125 mg intravenously was administered prior to docetaxel."
23553066,NCT00732745,2,methylprednisolone,1,125,mg,NA,NA,"If the patient had not taken oral dexamethasone prior to chemotherapy administration,dexamethasone 10–20 mg intravenously or methylprednisolone 125 mg intravenously was administered prior to docetaxel."
23553066,NCT00732745,1,vandetanib,1,100,mg,1,on days 1–21,fixed dose
23553066,NCT00732745,1,docetaxel,-1,30,mg/m2,NA,ondays 1 and 8,NA
23553066,NCT00732745,1,oxaliplatin,-1,80,mg/m2,NA,on day 1.,NA
23553066,NCT00732745,1,oxaliplatin,-1,80,mg/m2,NA,on day 1.,NA
23553066,NCT00732745,1,vandetanib,-1,100,mg,1,on days 1–21,fixed dose
22124669,NCT00058253,1,docetaxel,1,55,mg/m2,NA,over 1 h followed immediately by 17-AAG,NA
22124669,NCT00058253,1,17-aag,1,80,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,2,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,2,80,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,3,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,3,110,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,4,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,4,160,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,5,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,5,220,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,6,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,6,300,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,7,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,7,375,mg/m2,NA,infuse over 1h,NA
22124669,NCT00058253,1,docetaxel,8,70,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,8,450,mg/m2,NA,infuse 2h,NA
22124669,NCT00058253,1,docetaxel,9,75,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,9,450,mg/m2,NA,infuse 2h,NA
22124669,NCT00058253,1,docetaxel,10,75,mg/m2,NA,NA,NA
22124669,NCT00058253,1,17-aag,10,540,mg/m2,NA,infuse 2h,NA
22124669,NCT00058253,1,docetaxel,NA,75,mg/m2,NA,NA,dose level 11
22124669,NCT00058253,1,17-aag,NA,650,mg/m2,NA,infuse 2h,dose level 11
22124669,NCT00058253,1,docetaxel,NA,70,mg/m2,NA,NA,dose level 12
22124669,NCT00058253,1,17-aag,NA,500,mg/m2,NA,infuse 2h,dose level 12
23712328,NA,1,oxaliplatin,1,130,mg/m2,NA,"2-h i.v. infusion on day 1,administered every 3 weeks.",fixed dose
23712328,NA,1,oxaliplatin,1,130,mg/m2,NA,"2-h i.v. infusion on day 1,administered every 3 weeks.",fixed dose
23712328,NA,1,docetaxel,1,60,mg/m2,NA,1-h i.v. infusion followed by oxaliplatin,NA
23712328,NA,1,docetaxel,2,75,mg/m2,NA,1-h i.v. infusion followed by oxaliplatin,NA
23712328,NA,1,docetaxel,3,90,mg/m2,NA,1-h i.v. infusion followed by oxaliplatin,NA
23712328,NA,1,docetaxel,4,100,mg/m2,NA,1-h i.v. infusion followed by oxaliplatin,NA
22042372,NA,1,gefitinib,1,250,mg,1,daily on days 2–14 of the 21-day cycle,NA
22042372,NA,1,trastuzumab,1,8000,ug/kg,NA,cycle 1,NA
22042372,NA,1,trastuzumab,-1,6000,ug/kg,NA,every 3 weeks (after an initial dose of 8 mg/kg with cycle 1),NA
22042372,NA,1,docetaxel,1,75,mg/m2,NA,cycle 1,NA
22042372,NA,1,docetaxel,-1,60,mg/m2,NA,every 3 weeks,NA
22999386,NA,1,lapatinib,1,1000,ug/kg/per day,1,orally and continuously from day 1–21,"once daily (morning) in fasted state (on
Cycle 1 within 1 h before starting docetaxel infusion"
22999386,NA,1,docetaxel,1,75,mg/m2,NA,over 1 h at the start of each cycle,NA
22999386,NA,1,lapatinib,2,1250,ug/kg/per day,1,same as dose level 1,NA
22999386,NA,1,docetaxel,2,75,mg/m2,NA,over 1 h at the start of each cycle,NA
22999386,NA,1,lapatinib,3,1000,ug/kg/per day,1,same as dose level 1,NA
22999386,NA,1,docetaxel,3,85,mg/m2,NA,over 1 h at the start of each cycle,NA
22999386,NA,1,lapatinib,4,1250,ug/kg/per day,1,same as dose level 1,NA
22999386,NA,1,docetaxel,4,85,mg/m2,NA,over 1 h at the start of each cycle,NA
22999386,NA,1,lapatinib,5,1000,ug/kg/per day,1,same as dose level 1,NA
22999386,NA,1,docetaxel,5,100,mg/m2,NA,over 1 h at the start of each cycle,NA
22999386,NA,1,lapatinib,6,1250,ug/kg/per day,1,same as dose level 1,NA
22999386,NA,1,docetaxel,6,100,mg/m2,NA,over 1 h at the start of each cycle,NA
20878160,NA,1,docetaxel,1,30,mg/m2,NA,days 1 and 15 of every 28-day cycle,NA
20878160,NA,1,docetaxel,2,35,mg/m2,NA,NA,NA
20878160,NA,1,docetaxel,3,40,mg/m2,NA,NA,NA
20878160,NA,1,cisplatin,1,40,mg/m2,NA,on days 1 and 15 of every 28-day cycle,fixed dose
20878160,NA,1,cisplatin,1,40,mg/m2,NA,on days 1 and 15 of every 28-day cycle,fixed dose
20878160,NA,1,cisplatin,2,40,mg/m2,NA,NA,NA
20878160,NA,1,cisplatin,2,40,mg/m2,NA,NA,NA
20878160,NA,1,cisplatin,3,40,mg/m2,NA,NA,NA
20878160,NA,1,cisplatin,3,40,mg/m2,NA,NA,NA
20878160,NA,1,5fu,1,400,mg/m2,NA,on days1–5 and 15–19 of every 28-day cycle.,fixed dose
20878160,NA,1,5fu,2,400,mg/m2,NA,NA,NA
20878160,NA,1,5fu,3,400,mg/m2,NA,NA,NA
20085867,NA,1,docetaxel,NA,20,mg/m2,NA,"days 1, 8, 15, 22, 29, and 36, with concurrent radiation therapy",NA
20085867,NA,1,cisplatin,NA,25,mg/m2,NA,"days 1, 8, 15, 22, 29, and 36, with concurrent radiation therapy",NA
20085867,NA,1,cisplatin,NA,25,mg/m2,NA,"days 1, 8, 15, 22, 29, and 36, with concurrent radiation therapy",NA
20085867,NA,1,concurrent radiation therapy,NA,2,Gy,NA,(5 daysper week; 2 Gy per day) starting on day 1 for a total dose of 66 Gy,NA
20085867,NA,1,dexamethasone,NA,8,mg,NA,NA,NA
20085867,NA,1,"5-ht3
antagonists",NA,NA,NA,NA,NA,as needed 30 minutes before the application of cisplatin
20085867,NA,2,docetaxel,1,60,mg/m2,NA,on days 71and 92 (3-week intervals),NA
20085867,NA,2,docetaxel,2,75,mg/m2,NA,"In the absence of DLTs in dose level 1,second treatment on day 92",NA
20085867,NA,2,dexamethasone,NA,8,mg,NA,(4 × 8 mg)in the evening and the morningbefore docetaxel infusion and in the evening of infusion and theday after infusion.,NA
20085867,NA,2,dexamethasone,NA,8,mg,NA,intravenously 30 minutes before infusion.,NA
20087171,NA,1,docetaxel,1,60,mg/m2,NA,1-h infusion on day 1,NA
20087171,NA,1,ifosfamide,1,1000,mg/m2,NA,continuousinfusion for 5 days,"Mesna would add to the same infusion bag and was continued for 12 h
after the end of ifosfamide.""Fixed dose"
20087171,NA,1,cisplatin,1,50,mg/m2,NA,"24-h infusion concomitantly with ifosfamide, but inseparate infusion bags, either on day 5 (schedule A) oron day 1 (schedule B)",NA
20087171,NA,1,cisplatin,1,50,mg/m2,NA,"24-h infusion concomitantly with ifosfamide, but inseparate infusion bags, either on day 5 (schedule A) oron day 1 (schedule B)",NA
20087171,NA,1,methylprednisolone,NA,NA,NA,NA,"orally 12 and 3 h before the docetaxel and every12 h thereafter on days 1 and 2, for a total of six doses.",NA
20087171,NA,1,methylprednisolone,NA,125,mg,NA,on day 1,NA
20087171,NA,1,ondansetron,NA,8,mg,NA,on days 1–5,NA
20087171,NA,1,docetaxel,2,75,mg/m2,NA,NA,NA
20087171,NA,1,ifosfamide,2,1000,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,2,50,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,2,50,mg/m2,NA,NA,NA
20087171,NA,1,docetaxel,3,75,mg/m2,NA,NA,NA
20087171,NA,1,ifosfamide,3,1000,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,3,75,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,3,75,mg/m2,NA,NA,NA
20087171,NA,1,docetaxel,2.5,60,mg/m2,NA,NA,NA
20087171,NA,1,ifosfamide,2.5,1000,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,2.5,75,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,2.5,75,mg/m2,NA,NA,NA
20087171,NA,1,docetaxel,4,85,mg/m2,NA,NA,NA
20087171,NA,1,ifosfamide,4,1000,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,4,75,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,4,75,mg/m2,NA,NA,NA
20087171,NA,1,docetaxel,5,85,mg/m2,NA,NA,NA
20087171,NA,1,ifosfamide,5,1000,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,5,100,mg/m2,NA,NA,NA
20087171,NA,1,cisplatin,5,100,mg/m2,NA,NA,NA
22989664,NA,1,lap（lapatinib）,1,500,mg,1,daily,NA
22989664,NA,1,lap（lapatinib）,2,750,mg,1,daily,NA
22989664,NA,1,lap（lapatinib）,3,1000,mg,1,daily,NA
22989664,NA,1,lap（lapatinib）,4,1250,mg,1,daily,NA
22989664,NA,1,lap（lapatinib）,5,1500,mg,1,daily,"During CRT, LAP was used at a fixed dose of 1500 mg daily."
22989664,NA,1,traditional pf regimen,NA,NA,NA,NA,NA,"docetaxel was planned to be introduced in cycle 2 at a dose of 60 mg/m2
. Docetaxel was to be increased up to
75 mg/m2 in cycle 3."
20530449,NA,1,docetaxel,1,40,mg/m2,NA,on day 1 intraperitoneally,NA
20530449,NA,1,docetaxel,2,50,mg/m2,NA,on day 1 intraperitoneally,NA
20530449,NA,1,docetaxel,3,60,mg/m2,NA,on day 1 intraperitoneally,NA
20530449,NA,1,s-1,1,40,mg/m2,2,ondays 1-14 every three weeks (one cycle),NA
21892109,NA,1,docetaxel,1,70,mg/m2,NA,day 1 of a 21-day,arm A
21892109,NA,1,docetaxel,2,70,mg/m2,NA,day 1 of a 21-day,arm A
21892109,NA,1,docetaxel,3,70,mg/m2,NA,day 1 of a 21-day,arm A
21892109,NA,1,docetaxel,4,75,mg/m2,NA,day 1 of a 21-day,arm A
21892109,NA,1,erlotinib,1,600,mg,NA,"days 2, 9, and 16,was taken orally in the morning with 200ml of water 1 hour before or 2 hours after meals.",arm A
21892109,NA,1,erlotinib,1,600,mg,NA,"days 2, 9, and 16,was taken orally in the morning with 200ml of water 1 hour before or 2 hours after meals.",arm A
21892109,NA,1,erlotinib,2,800,mg,NA,same as dose level 1,arm A
21892109,NA,1,erlotinib,2,800,mg,NA,same as dose level 1,arm A
21892109,NA,1,erlotinib,3,1000,mg,NA,same as dose level 1,arm A
21892109,NA,1,erlotinib,3,1000,mg,NA,same as dose level 1,arm A
21892109,NA,1,erlotinib,4,1000,mg,NA,same as dose level 1,arm A
21892109,NA,1,erlotinib,4,1000,mg,NA,same as dose level 1,arm A
21892109,NA,1,dexamethasone,1,4,mg,2,"orally twicedaily for 3 days, starting 12 to 24 hours before docetaxelinfusion",arm A
21892109,NA,1,dexamethasone,2,8,mg,NA,same as dose level 1,arm A
21892109,NA,1,docetaxel,1,70,mg/m2,NA,day 1 of a 21-day,arm B
21892109,NA,1,docetaxel,2,70,mg/m2,NA,day 1 of a 21-day,arm B
21892109,NA,1,docetaxel,3,75,mg/m2,NA,day 1 of a 21-day,arm B
21892109,NA,1,docetaxel,4,75,mg/m2,NA,day 1 of a 21-day,arm B
21892109,NA,1,docetaxel,5,75,mg/m2,NA,day 1 of a 21-day,arm B
21892109,NA,1,erlotinib,1,150,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,1,150,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,2,200,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,2,200,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,3,200,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,3,200,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,4,250,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,4,250,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,5,300,mg,NA,on days 2through 16,arm B
21892109,NA,1,erlotinib,5,300,mg,NA,on days 2through 16,arm B
21892109,NA,1,dexamethasone,1,4,mg,2,"orally twicedaily for 3 days, starting 12 to 24 hours before docetaxelinfusion",arm B
21892109,NA,1,dexamethasone,2,8,mg,NA,same as dose level 1,arm B
21075438,NA,1,docetaxel,1,20,mg/m2,NA,"on days 1, 8, 15, 22, 29, 36",NA
21075438,NA,1,docetaxel,2,25,mg/m2,NA,"on days 1, 8, 15, 22, 29, 36",NA
21075438,NA,1,docetaxel,3,30,mg/m2,NA,"on days 1, 8, 15, 22, 29, 36",NA
21075438,NA,1,dexamethason,NA,10,mg,NA,administered 0.5–1 h prior to each therapy,or anti-emetic
21075438,NA,1,"low-dose whole
abdominal radiation therapy",NA,60,cGy,NA,"was administered during orwithin 1 h after the completion of the docetaxel infusion for each ofthe 6 weeks of docetaxel therapy;twice daily for 2 days with a minimum of 4-h interfraction interval, starting on day 1 of eachchemotherapy cycle.",NA
20564143,NA,1,everolimus,1,5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,everolimus,1,5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,everolimus,2,5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,everolimus,2,5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,everolimus,3,7.5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,everolimus,3,7.5,mg,1,was given POon Days 1 to 19 of each 3-week treatment cycle,NA
20564143,NA,1,docetaxel,1,60,mg/m2,NA,a 60-minute intravenousinfusion on Day 1 of each cycle,NA
20564143,NA,1,docetaxel,2,75,mg/m2,NA,a 60-minute intravenousinfusion on Day 1 of each cycle,NA
20564143,NA,1,docetaxel,3,75,mg/m2,NA,a 60-minute intravenousinfusion on Day 1 of each cycle,NA
20564143,NA,1,dexamethasone,NA,8,mg,2,twice a day for 3 days beginning the day beforedocetaxel infusion.,NA
21327495,NA,1,docetaxel,NA,75,mg/m2,NA,"via IV infusion over 1 h, followed 2 h later (from the time the docetaxelinfusion began) by plinabulin",21-day cycles
21327495,NA,1,plinabulin,1,13.5,mg/m2,NA,was administered viaIV infusion over 30 min On day1,"On day 8, only plinabulin was
administered via IV infusion over 30 min."
21327495,NA,1,plinabulin,2,20,mg/m2,NA,was administered viaIV infusion over 30 min On day1,"On day 8, only plinabulin was
administered via IV infusion over 30 min."
21327495,NA,1,plinabulin,3,30,mg/m2,NA,was administered viaIV infusion over 30 min On day1,"On day 8, only plinabulin was
administered via IV infusion over 30 min."
21327495,NA,1,dexamethasone,NA,16,mg,NA,"given the day prior to, the day of and the day followingdocetaxel infusion (day 1).",NA
22872523,NA,1,motesanib,1,50,mg,1,"on days 1, 8, and15 every 28-day cycle",28-day cycle (Arm A)
22872523,NA,1,motesanib,2,125,mg,1,"on days 1, 8, and15 every 28-day cycle",28-day cycle (Arm A)
22872523,NA,1,paclitaxel,NA,90,mg/m2,NA,"on days 1, 8, and15 every 28-day cycle",28-day cycle (Arm A);fixed dose
22872523,NA,2,motesanib,1,50,mg,1,"""on day 1 every 21-daycycle""","21-day
cycle (Arm B),cohortB1"
22872523,NA,2,docetaxel,1,100,mg/m2,NA,"""on day 1 every 21-daycycle""","21-day
cycle (Arm B),cohortB1"
22872523,NA,2,motesanib,2,125,mg,1,"""on day 1 every 21-daycycle""","21-day
cycle (Arm B),cohortB2"
22872523,NA,2,docetaxel,2,100,mg/m2,NA,"""on day 1 every 21-daycycle""","21-day
cycle (Arm B),cohortB2"
22872523,NA,2,motesanib,3,125,mg,1,"""on day 1 every 21-daycycle""","21-day
cycle (Arm B)""Expanded cohortB3"
22872523,NA,2,docetaxel,3,75,mg/m2,NA,on day 1 every 21-daycycle,"21-day
cycle (Arm B)""Expanded cohortB3"
20142723,NA,1,liposomal doxorubicin,1,25,mg/m2,NA,Day 1 and repeated every 28 days,NA
20142723,NA,1,docetaxel,1,30,mg/m2,NA,"Day 1, 8, and 15",NA
20142723,NA,1,liposomal doxorubicin,2,33,mg/m2,NA,Day 1 and repeated every 28 days,NA
20142723,NA,1,docetaxel,2,30,mg/m2,NA,"Day 1, 8, and 15",NA
20142723,NA,1,liposomal doxorubicin,2.5,15,mg/m2,NA,"MTD reached, schedule of PLDwas changed and was administered on days 1 and 15",NA
20142723,NA,1,docetaxel,2.5,30,mg/m2,NA,"Day 1, 8, and 15",NA
20142723,NA,1,liposomal doxorubicin,3.5,20,mg/m2,NA,on days 1 and 15,NA
20142723,NA,1,docetaxel,3.5,30,mg/m2,NA,"Day 1, 8, and 15",NA
20142723,NA,1,liposomal doxorubicin,4.5,20,mg/m2,NA,on days 1 and 15,NA
20142723,NA,1,docetaxel,4.5,35,mg/m2,NA,"Day 1, 8, and 15",NA
20142723,NA,1,dexamethasone,NA,8,mg,NA,"on days 1, 8, and 15",NA
21439816,NA,1,su-014813,1,50,mg,NA,"every morning on an empty stomach with aglass of water, about 2 h from food intake in cycles of 3 weeksstarting from day 2 in cycle 1",NA
21439816,NA,1,docetaxel,1,60,mg/m2,NA,1 h intravenous infusionevery 21 days starting from day 1 in cycle 1,NA
21439816,NA,1,su-014813,2,50,mg,NA,NA,NA
21439816,NA,1,docetaxel,2,75,mg/m2,NA,NA,NA
21439816,NA,1,su-014813,3,100,mg,NA,NA,NA
21439816,NA,1,docetaxel,3,75,mg/m2,NA,NA,NA
23016517,NCT00225420,1,docetaxel,1,10,mg/m2,NA,"over 60 min weeklyfor 8 weeks, given during the course of RT.",NA
23016517,NCT00225420,1,docetaxel,2,15,mg/m2,NA,NA,NA
23016517,NCT00225420,1,docetaxel,3,20,mg/m2,NA,NA,NA
23016517,NCT00225420,1,dexamethasone,NA,4,mg,NA,"(4 mg × three doses) premedication,starting the night before each docetaxeladministration.",NA
23016517,NCT00225420,1,intensity-modulated rt,NA,NA,NA,NA,A total dose of 78 Gyin 39 fractions was delivered to theplanning target volume.,NA
22870147,NA,1,docetaxel,1,40,mg/m2,NA,1-h intravenousinfusion on day 1,NA
22870147,NA,1,s-1,1,65,mg/m2,NA,orally on days 1-14every 3 weeks.,NA
22870147,NA,1,docetaxel,2,50,mg/m2,NA,NA,NA
22870147,NA,1,s-1,2,65,mg/m2,NA,NA,NA
22870147,NA,1,docetaxel,3,60,mg/m2,NA,NA,NA
22870147,NA,1,s-1,3,65,mg/m2,NA,NA,NA
22870147,NA,1,docetaxel,4,60,mg/m2,NA,NA,NA
22870147,NA,1,s-1,4,80,mg/m2,NA,NA,NA
20407240,NA,1,docetaxel,1,5,mg/m2,NA,once a week,NA
20407240,NA,1,docetaxel,2,7.5,mg/m2,NA,once a week,NA
20407240,NA,1,docetaxel,3,10,mg/m2,NA,once a week,NA
20407240,NA,1,docetaxel,4,12.5,mg/m2,NA,once a week,NA
20407240,NA,1,docetaxel,5,15,mg/m2,NA,once a week,NA
20407240,NA,1,cisplatin,NA,20,mg/m2,NA,once a week,NA
20407240,NA,1,cisplatin,NA,20,mg/m2,NA,once a week,NA
20407240,NA,1,radiotherapy,NA,50.4,Gy,NA,1.8Gy/day,NA
24018362,NA,1,gemcitabine,1,600,mg/m2,NA,"on Days 3,10",Cycles were repeated every 21 days
24018362,NA,1,docetaxel,1,30,mg/m2,NA,onDay 10,NA
24018362,NA,1,imatinib mesylate,1,400,mg/m2,NA,"on Days 1–5,8–12 (included days 15–19)",NA
24018362,NA,1,gemcitabine,2,600,mg/m2,NA,NA,NA
24018362,NA,1,docetaxel,2,45,mg/m2,NA,NA,NA
24018362,NA,1,imatinib mesylate,2,400,mg/m2,NA,(included days 15–19),NA
24018362,NA,1,gemcitabine,2.5,600,mg/m2,NA,NA,Dose level is 2A
24018362,NA,1,docetaxel,2.5,45,mg/m2,NA,NA,Dose level is 2A
24018362,NA,1,imatinib mesylate,2.5,400,mg/m2,NA,"on Days 1–5,8–12",Dose level is 2A
24018362,NA,1,gemcitabine,3,600,mg/m2,NA,NA,Dose level is 2B
24018362,NA,1,docetaxel,3,30,mg/m2,NA,NA,Dose level is 2B
24018362,NA,1,imatinib mesylate,3,400,mg/m2,NA,"on Days 1–5,8–12",Dose level is 2B
24018362,NA,1,dexamethasone,NA,8,mg,2,twice dailyon the day prior to chemotherapy;on the day ofchemotherapy and on the day after chemotherapy.,NA
22752248,NA,1,docetaxel,1,75,mg/m2,NA,q3 weeks,NA
22752248,NA,1,prednisone,1,10,mg,1,daily,NA
22752248,NA,1,sorafenib,1,200,mg,NA,"BID,on days 2–19,with a3-day break between the docetaxel cycles.",NA
22752248,NA,1,sorafenib,2,200,mg,NA,continuously on days1–21,NA
22752248,NA,1,sorafenib,3,400,mg,NA,on days 2–19 with a 3-day break between the docetaxelcycles,NA
22752248,NA,1,sorafenib,4,400,mg,NA,BID continuously on days 1–21,NA
22752248,NA,1,sorafenib,NA,400,mg,NA,BID continuously on days 1–21,this dose level is also expanded cohort dose level
20686817,NA,1,docetaxel,-1,50,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,-1,100,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,0,60,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,0,100,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,1,200,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,1,60,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,2,200,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,2,75,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,3,300,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,3,75,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,4,400,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,4,75,mg,1,once daily for the first 14 days of each 21-daycycle,NA
20686817,NA,1,docetaxel,5,500,mg/m2,NA,on day 4 of each 21-day cycle,NA
20686817,NA,1,vorinostat,5,75,mg,1,once daily for the first 14 days of each 21-daycycle,NA
23482452,NA,1,dexamethasone,NA,7.5,mg,2,twice daily before chemotherapy,5–10 mg dexamethasone orally
23482452,NA,1,diphenhydramine hydrochloride,NA,20,mg,NA,NA,NA
23482452,NA,1,ranitidine,NA,20,mg,NA,NA,20–40 mg ranitidine intravenously
23482452,NA,1,docetaxel,1,56,mg/m2,NA,on day 1,NA
23482452,NA,1,docetaxel,2,60,mg/m2,NA,on day 1 and day 2,NA
23482452,NA,1,docetaxel,3,64,mg/m2,NA,on day 1,NA
23482452,NA,1,cisplatin,1,28,mg/m2,NA,on day 1 and day 2,NA
23482452,NA,1,cisplatin,1,28,mg/m2,NA,on day 1 and day 2,NA
23482452,NA,1,cisplatin,2,30,mg/m2,NA,on day 1,NA
23482452,NA,1,cisplatin,2,30,mg/m2,NA,on day 1,NA
23482452,NA,1,cisplatin,3,32,mg/m2,NA,on day 1 and day 2,NA
23482452,NA,1,cisplatin,3,32,mg/m2,NA,on day 1 and day 2,NA
23482452,NA,1,conformal or imrt radiotherapy,NA,2,Gy,NA,administered 5 days a week for 6-7weeks.,"was given using 10
MV or 6 MV photons at a dose of 60-70 Gy."
20530200,NA,1,docetaxel,1,50,mg/m2,NA,1-h infusion,"At dose levels 1–4,
treatment was repeated every 4 weeks"
20530200,NA,1,cisplatin,1,70,mg/m2,NA,2-h infusion on day 1,NA
20530200,NA,1,cisplatin,1,70,mg/m2,NA,2-h infusion on day 1,NA
20530200,NA,1,s-1,1,40,mg/m2,NA,twice daily on days 1–14,NA
20530200,NA,1,docetaxel,2,60,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,2,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,2,70,mg/m2,NA,NA,NA
20530200,NA,1,s-1,2,40,mg/m2,NA,NA,NA
20530200,NA,1,docetaxel,3,60,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,3,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,3,70,mg/m2,NA,NA,NA
20530200,NA,1,s-1,3,60,mg/m2,NA,NA,NA
20530200,NA,1,docetaxel,4,60,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,4,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,4,70,mg/m2,NA,NA,NA
20530200,NA,1,s-1,4,80,mg/m2,NA,NA,NA
20530200,NA,1,docetaxel,5,70,mg/m2,NA,NA,"At dose levels 5 and 6, the subject had to have locally
advanced HNC and to have received TPS every 3 weeks with a maximum of
three cycles allowed"
20530200,NA,1,cisplatin,5,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,5,70,mg/m2,NA,NA,NA
20530200,NA,1,s-1,5,80,mg/m2,NA,NA,NA
20530200,NA,1,docetaxel,6,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,6,70,mg/m2,NA,NA,NA
20530200,NA,1,cisplatin,6,70,mg/m2,NA,NA,NA
20530200,NA,1,s-1,6,60,mg/m2,NA,NA,NA
21157450,NA,1,external beam radiotherapy,NA,50,Gy,NA,"given to atotal dose of 50 Gy in 25 fractions, five fractions per week for5 weeks",NA
21157450,NA,1,docetaxel,0,10,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,0,10,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,0,10,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,1,15,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,1,15,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,1,15,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,2,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,2,15,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,2,15,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,3,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,3,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,3,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,4,25,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,4,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,4,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,5,30,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,5,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,5,20,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,docetaxel,6,30,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,6,30,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
21157450,NA,1,cisplatin,6,30,mg/m2,NA,"weekly(days 1, 8, 15, 22 and 29)",NA
20107799,NA,1,docetaxel,1,75,mg/m2,NA,intravenously over1 h on day 1 of each 3-week cycle.,NA
20107799,NA,1,docetaxel,2,56,mg/m2,NA,NA,NA
20107799,NA,1,suramin,NA,NA,NA,NA,"as a 30-min infusion, given 2.5 h prior tothe initiation of chemotherapy","The dose of suramin in milligram was calculated as the product of FACTOR x (BSA)2
,
where FACTOR is equal to 125 for day 1 of the Wrst cycle
and based on the nomogram for all subsequent doses,
including the day 8 gemcitabine dose."
20107799,NA,2,gemcitabine,1,1250,mg/m2,NA,over30 min on days 1 and 8 of each 3-week cycle.,NA
20107799,NA,2,suramin,NA,NA,NA,NA,NA,NA
21493186,NA,1,docetaxel,1,20,mg/m2,NA,weekly as a 30-min intravenous infusion.,NA
21493186,NA,1,docetaxel,-1,15,mg/m2,NA,weekly as a 30-min intravenous infusion.,NA
21493186,NA,1,dexamethasone,NA,8,mg,NA,"12 h and 1 h prior to the docetaxel infusion, and 12 h post-infusion",NA
21493186,NA,1,radiotherapy,NA,1.2,Gy,2,NA,"Patients received 1.2 Gy/
fraction b.d.with a 6–8 h interval 5 days a week with a
total dose of 74.4 Gy (62 sessions)"
23423490,NA,1,docetaxel,1,35,mg/m2,NA,for 2 hafter standard premedication on days 1 and 15. Each cyclewas performed every 4 weeks.,NA
23423490,NA,1,docetaxel,2,40,mg/m2,NA,for 2 hafter standard premedication on days 1 and 15. Each cyclewas performed every 4 weeks.,NA
23423490,NA,1,docetaxel,3,45,mg/m2,NA,for 2 hafter standard premedication on days 1 and 15. Each cyclewas performed every 4 weeks.,NA
23423490,NA,1,docetaxel,4,50,mg/m2,NA,for 2 hafter standard premedication on days 1 and 15. Each cyclewas performed every 4 weeks.,NA
23423490,NA,1,s-1,NA,40,mg/m2,2,twice daily on days 1–14 every 4 weeks,fixed dose
23033004,NA,1,s-1,NA,80,mg/m2,2,"orally twice daily after a meal for 7 consecutive days,followed by 7 days of rest",patients with a BSA of less than 1.25 m^2
23033004,NA,1,s-1,NA,100,mg/m2,2,"orally twice daily after a meal for 7 consecutive days,followed by 7 days of rest",those with a BSA of 1.25–1.5 m^2
23033004,NA,1,s-1,NA,120,mg/m2,2,"orally twice daily after a meal for 7 consecutive days,followed by 7 days of rest",those with a BSA greater than 1.5 m^2
23033004,NA,1,docetaxel,1,30,mg/m2,NA,infusion over 60 min on day 1,NA
23033004,NA,1,docetaxel,2,35,mg/m2,NA,infusion over 60 min on day 1,NA
23033004,NA,1,docetaxel,3,40,mg/m2,NA,infusion over 60 min on day 1,NA
23098625,NA,1,pr-104,1,275,mg/m2,NA,on days oneand eight of a 21 day,NA
23098625,NA,1,pr-104,2,140,mg/m2,NA,on days oneand eight of a 21 day,NA
23098625,NA,1,gemcitabine,NA,800,mg/m2,NA,on days oneand eight of a 21 day,NA
23098625,NA,2,pr-104,1,400,mg/m2,NA,on day one of a21 day treatment cycle,NA
23098625,NA,2,pr-104,2,200,mg/m2,NA,on day one of a21 day treatment cycle,NA
23098625,NA,2,docetaxe,NA,60,mg/m2,NA,on day one of a21 day treatment cycle,NA
23098625,NA,3,pr-104,1,200,mg/m2,NA,onday 2,NA
23098625,NA,3,pr-104,2,400,mg/m2,NA,onday 2,NA
23098625,NA,3,pr-104,3,550,mg/m2,NA,onday 2,NA
23098625,NA,3,pr-104,4,770,mg/m2,NA,onday 2,NA
23098625,NA,3,pr-104,5,1100,mg/m2,NA,onday 2,NA
23098625,NA,3,docetaxel + gcsf,1,60,mg/m2,NA,onday 2,NA
23098625,NA,4,pr-104,1,770,mg/m2,NA,onday 2,NA
23098625,NA,4,docetaxel + gcsf,NA,75,mg/m2,NA,onday 2,NA
23394629,NCT00374985,1,docetaxel,1,20,mg/m2,NA,"for 1 hour on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,1,40,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,1,40,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,docetaxel,2,20,mg/m2,NA,"for 1 hour on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,2,50,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,2,50,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,docetaxel,3,25,mg/m2,NA,"for 1 hour on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,3,50,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,oxaliplatin,3,50,mg/m2,NA,"for 2 hours on days 1, 8, 15, 22 and 29",NA
23394629,NCT00374985,1,radiotherapy,NA,1.8,Gy,NA,"on day 1 of the chemotherapyonce a day andfive times a week for five weeks on days 1–5, 8–12, 15–19,22–26 and 29–33 for a total dose of 45 Gy.The sixth weekof therapy included a boost of three extra radiotherapyfractions at 1.8 Gy (days 36–38) up to a maximum totaldose of 50.4 Gy.",NA
21821830,NCT00137436,1,sunitinib,NA,50,mg,NA,"for 4weeks, followed by 2 weeks off, before starting combination therapy.On day 1 of the lead-in period.",lead in
21821830,NCT00137436,2,docetaxel,1,60,mg/m2,NA,every 3 weeks,NA
21821830,NCT00137436,2,sunitinib,1,12.5,mg,NA,sunitinib was started 1 day afterdocetaxel,NA
21821830,NCT00137436,2,docetaxel,2,60,mg/m2,NA,every 3 weeks,NA
21821830,NCT00137436,2,sunitinib,2,37.5,mg,NA,sunitinib was started 1 day afterdocetaxel,NA
21821830,NCT00137436,2,docetaxel,3,60,mg/m2,NA,every 3 weeks,NA
21821830,NCT00137436,2,sunitinib,3,50,mg,NA,sunitinib was started 1 day afterdocetaxel,NA
21821830,NCT00137436,2,docetaxel,4,75,mg/m2,NA,every 3 weeks,NA
21821830,NCT00137436,2,sunitinib,4,37.5,mg,NA,sunitinib was started 1 day afterdocetaxel,NA
21821830,NCT00137436,2,prednisone,NA,5,mg,2,NA,NA
21821830,NCT00137436,2,dexamethasone,NA,NA,NA,NA,beforedocetaxel infusions.,NA
20628389,NA,1,docetaxel,1,75,mg/m2,NA,on day 1 every 21 days,NA
20628389,NA,1,figitumumab,1,100,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,2,400,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,3,800,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,4,1500,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,5,3000,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,6,6000,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,7,10000,ug/kg,NA,on day 2,NA
20628389,NA,1,figitumumab,8,20000,ug/kg,NA,on day 2,NA
20628389,NA,1,dexamethasone,NA,8,mg,2,for 3 days starting at day –1,NA
34070561,2604784,1,cisplatin,1,15,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,1,15,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,1,3,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,2,30,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,2,30,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,2,6,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,3,50,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,3,50,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,3,10,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,4,67,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,4,67,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,4,13,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,5,88,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,5,88,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,5,18,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,6,93,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,6,93,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,6,23,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,7,100,mg/m2,NA,NA,NA
34070561,2604784,1,cisplatin,7,100,mg/m2,NA,NA,NA
34070561,2604784,1,doxorubicin,7,30,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,1,100,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,1,100,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,2,135,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,2,135,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,3,155,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,3,155,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,4,180,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,4,180,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,5,200,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,5,200,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,6,235,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,6,235,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,7,270,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,7,270,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,8,300,mg/m2,NA,NA,NA
34070561,2604784,2,oxaliplatin,8,300,mg/m2,NA,NA,NA
33755379,2987244,1,cyclophosphamide,NA,750,mg/m2,NA,day1,repeated every 21 days
33755379,2987244,1,doxorubicin,NA,50,mg/m2,NA,day1,repeated every 21 days
33755379,2987244,1,vincristine,NA,1.4,mg/m2,NA,day1,repeated every 21 days
33755379,2987244,1,etoposide,NA,100,mg,NA,on days 1–3,repeated every 21 days
33755379,2987244,1,oral prednisone,NA,60,mg/m2,NA,on days 1–5,repeated every 21 days
33755379,2987244,1,chidamide,1,15,mg,NA,twice a week,repeated every 21 days
33755379,2987244,1,chidamide,2,20,mg,NA,twice a week,repeated every 21 days
33755379,2987244,1,chidamide,3,25,mg,NA,twice a week,repeated every 21 days
11051260,NA,1,docetaxel,1,50,mg/m2,NA,NA,NA
11051260,NA,1,doxorubicin,1,40,mg/m2,NA,NA,NA
11051260,NA,1,docetaxel,2,60,mg/m2,NA,NA,NA
11051260,NA,1,doxorubicin,2,40,mg/m2,NA,NA,NA
11051260,NA,1,docetaxel,3,60,mg/m2,NA,NA,NA
11051260,NA,1,doxorubicin,3,50,mg/m2,NA,NA,NA
11051260,NA,1,docetaxel,4,50,mg/m2,NA,NA,NA
11051260,NA,1,doxorubicin,4,70,mg/m2,NA,NA,NA
11408509,NA,1,doxil,1,30,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupA;G-CSF:No
11408509,NA,1,docetaxel,1,75,mg/m2,NA,IV infusion over 1 hour,GroupA;G-CSF:No
11408509,NA,1,doxil,2,30,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupB-1;G-CSF:Yes
11408509,NA,1,docetaxel,2,75,mg/m2,NA,IV infusionover 1 hour,GroupB-1;G-CSF:Yes
11408509,NA,1,doxil,3,40,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupB-2;G-CSF:Yes
11408509,NA,1,docetaxel,3,75,mg/m2,NA,IV infusionover 1 hour,GroupB-2;G-CSF:Yes
11408509,NA,1,doxil,4,45,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupB-3;G-CSF:Yes
11408509,NA,1,docetaxel,4,75,mg/m2,NA,IV infusionover 1 hour,GroupB-3;G-CSF:Yes
11408509,NA,1,doxil,5,40,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupC;G-CSF:Yes
11408509,NA,1,docetaxel,5,75,mg/m2,NA,IV infusionover 1 hour,GroupC;G-CSF:Yes
11408509,NA,1,doxil,6,30,mg/m2,NA,"intravenous (IV) infusion over 60 minutes duringthe first cycle, then 30 minutes for subsequent cycles",GroupD;G-CSF:No
11408509,NA,1,docetaxel,6,60,mg/m2,NA,IV infusionover 1 hour,GroupD;G-CSF:No
11408509,NA,1,dexamethasone,NA,8,mg,2,orally bid was given for 3 days beginning 1 day before each treatment cycle,NA
11408509,NA,1,diphenhydramine,NA,25,mg,NA,given IV before the Doxil,NA
9053501,NA,1,docetaxel,1,50,mg/m2,NA,infused over 1hour,"At all
levels, cycles were repeated every 3 weeks."
9053501,NA,1,cisplatin,1,75,mg/m2,NA,infused over 1 hour immediately on completion of the docetaxelinfusion,NA
9053501,NA,1,cisplatin,1,75,mg/m2,NA,infused over 1 hour immediately on completion of the docetaxelinfusion,NA
9053501,NA,1,docetaxel,2,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,2,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,2,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,docetaxel,3,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,3,100,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,3,100,mg/m2,NA,same as dose level1,NA
9053501,NA,1,docetaxel,4,100,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,4,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,4,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,docetaxel,2.5,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,2.5,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,cisplatin,2.5,75,mg/m2,NA,same as dose level1,NA
9053501,NA,1,ondansetron,NA,8,mg,NA,before and 4 hours after the cisplatin infusion,NA
9053501,NA,1,ondansetron,NA,8,mg,NA,oral or intravenous ondansetron 8 mg twicedaily for a further 48 hours.,NA
9053501,NA,1,dexamethasone,NA,8,mg,2,for a further 48 hours.,NA
9053501,NA,1,dexamethasone,NA,8,mg,2,starting 24 hours before thedocetaxel infusion and continuing until 48 hours after the docetaxelinfusion,NA
9440738,NA,1,docetaxel,1,40,mg/m2,NA,"a 1-hour intravenous infusion before the firstweekly radiotherapy dose; schedule A, once every 3weeks: on day 1",NA
9440738,NA,1,docetaxel,2,60,mg/m2,NA,"schedule A, once every 3",NA
9440738,NA,1,dexamethasone,NA,8,mg,2,twice daily for 3 days twice daily for 3 daysbeginning 24 hours before docetaxel.,fixed dose
9440738,NA,1,radiation therapy.,NA,200,cGy,1,21 -day cycle times two for treatment duration of 6 weeksand total radiation dose of 60 Gy,NA
9440738,NA,2,docetaxel,1,20,mg/m2,NA,"schedule B, 2 of 3 weeks: on day 1 and day8",NA
9440738,NA,2,docetaxel,2,30,mg/m2,NA,"schedule B, 2 of 3 weeks: on day 1 and day8",NA
9440738,NA,2,dexamethasone,NA,8,mg,2,twice daily for 3 days twice daily for 3 daysbeginning 24 hours before docetaxel.,fixed dose
9440738,NA,2,radiation therapy.,NA,200,cGy,1,21 -day cycle times two for treatment duration of 6 weeksand total radiation dose of 60 Gy,NA
9440738,NA,3,docetaxel,1,20,mg/m2,NA,"schedule C, weekly:on day 1, day 8, and day15",NA
9440738,NA,3,docetaxel,2,25,mg/m2,NA,"schedule C, weekly:on day 1, day 8, and day15",NA
9440738,NA,3,dexamethasone,NA,8,mg,2,twice daily for 3 days twice daily for 3 daysbeginning 24 hours before docetaxel.,fixed dose
9440738,NA,3,radiation therapy.,NA,200,cGy,1,21 -day cycle times two for treatment duration of 6 weeksand total radiation dose of 60 Gy,NA
9459161,NA,1,docetaxel,1,60,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,1,2500,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,2,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,2,2500,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,3,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,3,3000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,4,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,4,4000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,5,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,5,5000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,6,85,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,6,5000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,1,docetaxel,7,100,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule A
9459161,NA,1,fosfamide,7,5000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule A
9459161,NA,2,docetaxel,1,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule B
9459161,NA,2,fosfamide,1,3000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule B
9459161,NA,2,docetaxel,2,75,mg/m2,NA,1-h i.v. infusion every 3 weeks.,schedule B
9459161,NA,2,fosfamide,2,4000,mg/m2,NA,24-h i.v. continuous infusion every 3 weeks.,schedule B
9459161,NA,1,methylprednisolone,NA,32,mg,NA,"orally 12 and 3 h before docetaxel infusion andthen 12 and 24 h after the end of docetaxel infusion, followed byeither 32 mg or 8 mg twice daily for an additional 3 days",methylprednisolone or  dexamethasone
9459161,NA,1,dexamethasone,NA,8,mg,NA,"orally 12 and 3 h before docetaxel infusion andthen 12 and 24 h after the end of docetaxel infusion, followed byeither 32 mg or 8 mg twice daily for an additional 3 days",methylprednisolone or  dexamethasone
9459161,NA,2,methylprednisolone,NA,32,mg,NA,"orally 12 and 3 h before docetaxel infusion andthen 12 and 24 h after the end of docetaxel infusion, followed byeither 32 mg or 8 mg twice daily for an additional 3 days",methylprednisolone or  dexamethasone
9459161,NA,2,dexamethasone,NA,8,mg,NA,"orally 12 and 3 h before docetaxel infusion andthen 12 and 24 h after the end of docetaxel infusion, followed byeither 32 mg or 8 mg twice daily for an additional 3 days",methylprednisolone or  dexamethasone
9193350,NA,1,docetaxel,1,55,mg/m2,NA,1-hour intravenous infusion every 21 days,NA
9193350,NA,1,docetaxel,2,75,mg/m2,NA,1-hour intravenous infusion every 21 days,NA
9193350,NA,1,docetaxel,3,65,mg/m2,NA,1-hour intravenous infusion every 21 days,NA
9193350,NA,1,diphenhydramine,NA,1000,ug/kg,4,24 hoursbefore drug administration,fixed dose;premedication
9193350,NA,1,dexamethasone,NA,3,mg/m2,2,24 hoursbefore drug administration,fixed dose;premedication
9850032,NA,1,gemcitabine,NA,800,mg/m2,NA,"a 30-minute intravenous infusiondays 1, 8, and 15 of a 28-day cycle. D",fixed dose
9850032,NA,1,docetaxel,1,45,mg/m2,NA,1-hour infusion after gemcitabine day I,NA
9850032,NA,1,docetaxel,2,60,mg/m2,NA,1-hour infusion after gemcitabine day I,NA
9850032,NA,1,docetaxel,3,75,mg/m2,NA,1-hour infusion after gemcitabine day I,NA
9850032,NA,1,docetaxel,4,100,mg/m2,NA,1-hour infusion after gemcitabine day I,NA
9850032,NA,1,dexamethasone,NA,8,mg,NA,every 12 hours for five doses that started 24 hours before docetaxel.,NA
9850032,NA,1,ciprofloxacin,NA,NA,NA,NA,NA,"""when grades 3 to 4
neutropenia occurred."""
9850032,NA,2,gemcitabine,NA,800,mg/m2,NA,"""a 30-minute intravenous infusiondays 1, 8, and 15 of a 28-day cycle. D""",fixed dose
9850032,NA,2,docetaxel,1,45,mg/m2,NA,1-hour infusion after gemcitabine day 15,NA
9850032,NA,2,docetaxel,2,60,mg/m2,NA,1-hour infusion after gemcitabine day 15,NA
9850032,NA,2,docetaxel,3,75,mg/m2,NA,1-hour infusion after gemcitabine day 15,NA
9850032,NA,2,docetaxel,4,100,mg/m2,NA,1-hour infusion after gemcitabine day 15,NA
9850032,NA,2,dexamethasone,NA,8,mg,NA,every 12 hours for five doses that started 24 hours before docetaxel.,NA
9850032,NA,2,ciprofloxacin,NA,NA,NA,NA,NA,"""when grades 3 to 4
neutropenia occurred."""
11138457,NA,1,taxotere,1,10,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
11138457,NA,1,taxotere,2,20,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
11138457,NA,1,taxotere,3,40,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
11138457,NA,1,taxotere,4,50,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
11138457,NA,1,taxotere,5,55,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
11138457,NA,1,taxotere,6,65,mg/m2/d,NA,1-hourIV infusion  on days I and 8  every 3 weeks,NA
10678557,NA,1,docetaxel,NA,60,mg/m2,NA,every 3-4 weeks,fixed dose
10678557,NA,1,cisplatin,NA,80,mg/m2,NA,every 3-4 weeks,fixed dose
10678557,NA,1,cisplatin,NA,80,mg/m2,NA,every 3-4 weeks,fixed dose
10678557,NA,1,mitomycin c,1,4,mg/m2,NA,every 3-4 weeks,NA
10678557,NA,1,mitomycin c,2,6,mg/m2,NA,every 3-4 weeks,NA
10678557,NA,1,granisetron hydrochloride,NA,3,mg,NA,NA,fixed dose
10678557,NA,1,dexamethasone,NA,16,mg,NA,NA,fixed dose
10811508,NA,1,docetaxel,1,30,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,1,docetaxel,2,35,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,1,docetaxel,3,40,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,1,docetaxel,4,45,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,1,gemcitabin,NA,1000,mg/m2,NA,over 30 minutes,NA
10811508,NA,1,gemcitabin,NA,1000,mg/m2,NA,over 30 minutes,NA
10811508,NA,1,dexamethasone,NA,NA,NA,NA,oral dexamethasone 12 hours and 4 hours,NA
10811508,NA,2,docetaxel,1,30,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,2,docetaxel,2,35,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,2,docetaxel,3,40,mg/m2,NA,one-hour infusionon days 1 and,NA
10811508,NA,2,vinorelbine,NA,25,mg/m2,NA,on days 1 and,NA
10811508,NA,2,dexamethasone,NA,NA,NA,NA,oral dexamethasone 12 hours and 4 hours,NA
11051260,NA,1,docetaxel,1,50,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,1,doxorubicin,1,40,mg/m2,NA,5-minbolus i.v. injection just after the administration ofdocetaxel,NA
11051260,NA,1,docetaxel,2,60,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,1,doxorubicin,2,40,mg/m2,NA,5-minbolus i.v. injection just after the administration ofdocetaxel,NA
11051260,NA,2,docetaxel,1,50,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,2,doxorubicin,1,40,mg/m2,NA,"""5-minbolus i.v. injection just before the administration ofdocetaxel""",NA
11051260,NA,2,docetaxel,2,60,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,2,doxorubicin,2,40,mg/m2,NA,"""5-minbolus i.v. injection just before the administration ofdocetaxel""",NA
11051260,NA,2,docetaxel,3,60,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,2,doxorubicin,3,50,mg/m2,NA,"""5-minbolus i.v. injection just before the administration ofdocetaxel""",NA
11051260,NA,2,docetaxel,4,70,mg/m2,NA,i.v. dripinfusion over 1 h,NA
11051260,NA,2,doxorubicin,4,50,mg/m2,NA,"""5-minbolus i.v. injection just before the administration ofdocetaxel""",NA
11147602,NA,2,docetaxel,1,30,mg/m2,NA,NA,NA
11147602,NA,2,paclitaxel,1,50,mg/m2,NA,NA,NA
11147602,NA,2,paclitaxel,2,65,mg/m2,NA,NA,NA
11147602,NA,2,paclitaxel,3,80,mg/m2,NA,NA,NA
10944133,NA,1,docetaxel,1,30,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,1,40,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
10944133,NA,1,docetaxel,2,40,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,2,40,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
10944133,NA,1,docetaxel,3,40,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,3,50,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
10944133,NA,1,docetaxel,4,50,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,4,50,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
10944133,NA,1,docetaxel,5A,50,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,5A,60,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
10944133,NA,1,docetaxel,5b,60,mg/m2,NA,a 60-minute intravenous infusion onday 2,The regimen was repeated every 28 days.
10944133,NA,1,cpt-11,5b,50,mg/m2,NA,"90-minute intravenous infusion on days1, 8, and 15.",The regimen was repeated every 28 days.
9060547,NA,1,docetaxel,1,55,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,1,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,1,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,2,70,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,2,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,2,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,3,85,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,3,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,3,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,4,100,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,4,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,4,50,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,5,55,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,5,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,5,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,6,70,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,6,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,6,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,7,85,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,7,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,7,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,8,100,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,8,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,8,75,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,9,75,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,9,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,9,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,10,85,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,10,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,10,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,docetaxel,11,100,mg/m2,NA,a 1-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,11,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,cisplatin,11,100,mg/m2,NA,3-hour infusion,"docetaxel preceding
cisplatin (schedule A)"
9060547,NA,1,dexamethasone,NA,10,mg,NA,"24 and 6 hours before and 24 hours afterdocetaxel administration,",(schedule A)
9060547,NA,1,antihistamine clemastine fumarate,NA,2,mg,NA,30 minutes before docetaxeladministration,(schedule A)
9060547,NA,2,cisplatin,6,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,cisplatin,6,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,docetaxel,6,70,mg/m2,NA,a 1-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,cisplatin,7,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,cisplatin,7,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,docetaxel,7,85,mg/m2,NA,a 1-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,cisplatin,8,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,cisplatin,8,75,mg/m2,NA,3-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,docetaxel,8,100,mg/m2,NA,a 1-hour infusion,cisplatin preceding docetaxel (schedule B).
9060547,NA,2,dexamethasone,NA,10,mg,NA,"24 and 6 hours before and 24 hours afterdocetaxel administration,",(schedule B)
9060547,NA,2,antihistamine clemastine fumarate,NA,2,mg,NA,30 minutes before docetaxeladministration,(schedule B)
11032597,NA,1,docetaxel,1,40,mg/m2,NA,"Docetaxel was administered as a1-hour IV infusion after premedication with corticosteroids followed immediately by irinotecan as a 90-minute IV infusion, every 3 weeks.",NA
11032597,NA,1,irinotecan,1,140,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,2,50,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,2,175,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,3,60,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,3,210,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,4,60,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,4,250,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,4.1,60,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,4.1,275,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,4.2,60,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,4.2,300,mg/m2,NA,NA,NA
11032597,NA,1,docetaxel,5,70,mg/m2,NA,NA,NA
11032597,NA,1,irinotecan,5,250,mg/m2,NA,NA,NA
11032597,NA,1,methylprednisolone,NA,64,mg,NA,"the daybefore infusion, 3 hours before infusion, and 24 hours after infusion",NA
11032597,NA,1,metoclopramide,NA,100,mg,NA,NA,NA
11032597,NA,1,loperamide,NA,100,mg,NA,NA,NA
10963645,NA,1,rpr 109881a,1,15,mg/m2,NA,administered in 250 mL of dextrose or 0.9% saline as a1-hour IV infusion,Therapy was repeated every 21 days
10963645,NA,1,rpr 109881a,2,30,mg/m2,NA,NA,NA
10963645,NA,1,rpr 109881a,3,45,mg/m2,NA,NA,NA
10963645,NA,1,rpr 109881a,4,60,mg/m2,NA,NA,NA
10963645,NA,1,rpr 109881a,5,75,mg/m2,NA,NA,NA
33856277,NCT02142049,1,ibrutinib,NA,560,mg,NA,days 1–7 ofa 21-day cycle for up to six cycles,fixed dose
33856277,NCT02142049,1,lenalidomide,1,0,mg,NA,days 1–7 ofa 21-day cycle for up to six cycles,NA
33856277,NCT02142049,1,lenalidomide,2,15,mg,NA,days 1–7 ofa 21-day cycle for up to six cycles,NA
33856277,NCT02142049,1,lenalidomide,3,20,mg,NA,days 1–7 ofa 21-day cycle for up to six cycles,NA
33856277,NCT02142049,1,lenalidomide,4,25,mg,NA,days 1–7 ofa 21-day cycle for up to six cycles,NA
33856277,NCT02142049,1,da-epoch-r,NA,standard doses,NA,NA,Days 1–5 of each 21-day cycle ,NA
34474927,NCT03639246,1,avb-500,1,10,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,1,avb-500,2,15,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,1,avb-500,3,20,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,1,paclitaxel,NA,80,mg/m2,NA,"Days 1, 8, and 15 ofa 28-day cycle",NA
34474927,NCT03639246,2,avb-500,1,10,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,2,avb-500,2,15,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,2,avb-500,3,20,mg/kg,NA,q2wk ofa 28-day cycle,NA
34474927,NCT03639246,2,pegylated liposomal doxorubicin,NA,40,mg/m2,NA,Day 1 ofa 28-day cycle,NA
11181674,NA,1,dexamethasone,NA,8,mg,2,beginning the night before therapy for a totalof six doses,premedicine;Treatments were repeated every 3 weeks.
11181674,NA,1,ciprofloxacin,NA,500,mg,2,10 daysbeginning on day 5 of treatment,premedicine;Treatments were repeated every 3 weeks.
11181674,NA,1,5-ht3 antagonist,NA,NA,NA,NA,Immediately before treatment,premedicine;Treatments were repeated every 3 weeks.
11181674,NA,1,docetaxel,NA,75,mg/m2,NA,1-hourinfusion on day 1,premedicine;Treatments were repeated every 3 weeks. fixed dose
11181674,NA,1,cisplatin,1,75,mg/m2,NA,on day 1,Treatments were repeated every 3 weeks.
11181674,NA,1,cisplatin,1,75,mg/m2,NA,on day 1,Treatments were repeated every 3 weeks.
11181674,NA,1,cisplatin,2,100,mg/m2,NA,on day 1,Treatments were repeated every 3 weeks.
11181674,NA,1,cisplatin,2,100,mg/m2,NA,on day 1,Treatments were repeated every 3 weeks.
11181674,NA,1,5-fu,NA,NA,NA,NA,"immediately after completion ofthe cisplatin infusion at 1,000 mg/m2/d for 4 days","was completed on day
5.Treatments were repeated every 3 weeks."
9552034,NA,1,docetaxe,1,25,mg/m2,NA,"1-hour intravenous infusion onday 1 of each cycle, beginning 3 hours before cisplatin and leucovorin","each cycle was repeated every 28 days for a
maximum of three cycles."
9552034,NA,1,docetaxe,2,45,mg/m2,NA,NA,NA
9552034,NA,1,docetaxe,3.1,60,mg/m2,NA,NA,no G-CSF
9552034,NA,1,docetaxe,3.2,60,mg/m2,NA,NA,G-CSF
9552034,NA,1,cisplatin,NA,25,mg/m2/d,NA,"on days 1 through 5 (total-dose, 125 mg/m2)","each cycle was repeated every 28 days for a
maximum of three cycles."
9552034,NA,1,cisplatin,NA,25,mg/m2/d,NA,"on days 1 through 5 (total-dose, 125 mg/m2)","each cycle was repeated every 28 days for a
maximum of three cycles."
9552034,NA,1,5-fu,NA,700,mg/m2/d,NA,"on days 2 through 5 (total-dose, 2,800 mg/m2)","each cycle was repeated every 28 days for a
maximum of three cycles."
9552034,NA,1,leucovorin,NA,500,mg/m2/d,NA,"on days 1 through 5 (total-dose, 2,500 mg/m2)","each cycle was repeated every 28 days for a
maximum of three cycles."
10416004,NA,1,epirubicin,1,60,mg/m2,NA,on day 1 (di),NA
10416004,NA,1,docetaxe,1,70,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,NA
10416004,NA,1,epirubicin,2,60,mg/m2,NA,on day 1 (di),NA
10416004,NA,1,docetaxe,2,80,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,NA
10416004,NA,1,epirubicin,3,70,mg/m2,NA,on day 1 (di),NA
10416004,NA,1,docetaxe,3,80,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,NA
10416004,NA,1,epirubicin,3a,70,mg/m2,NA,on day 1 (di),The dose level was repeated with prophylactic G-CSF support
10416004,NA,1,docetaxe,3a,80,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,The dose level was repeated with prophylactic G-CSF support
10416004,NA,1,epirubicin,4,60,mg/m2,NA,on day 1 (di),NA
10416004,NA,1,docetaxe,4,90,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,NA
10416004,NA,1,epirubicin,4a,60,mg/m2,NA,on day 1 (di),The dose level was repeated with prophylactic G-CSF support
10416004,NA,1,docetaxe,4a,90,mg/m2,NA,one-hour infusionafter appropriate premedication on day 1,The dose level was repeated with prophylactic G-CSF support
10416004,NA,1,epirubicin,3b,70,mg/m2,NA,on day 1,NA
10416004,NA,1,docetaxe,3b,80,mg/m2,NA,on day 2,NA
10416004,NA,1,epirubicin,4b,70,mg/m2,NA,on day 1,NA
10416004,NA,1,docetaxe,4b,90,mg/m2,NA, on day 2,NA
10416004,NA,1,epirubicin,5b,80,mg/m2,NA,on day 1,NA
10416004,NA,1,docetaxe,5b,90,mg/m2,NA, on day 2,NA
10416003,NA,1,dexamethasone,NA,8,mg,2,on days 1 and 2,every three weeks
10416003,NA,1,cimetidine,NA,300,mg,1,daily,every three weeks
10416003,NA,1,docetaxel,1,75,mg/m2,NA,one-hour infusion on day 1,every three weeks
10416003,NA,1,epirubicin,1,75,mg/m2,NA,a 15-minute infusion followedafter one-hour interval by D,every three weeks
10416003,NA,1,docetaxel,2,75,mg/m2,NA,one-hour infusion on day 1,NA
10416003,NA,1,epirubicin,2,90,mg/m2,NA,a 15-minute infusion followedafter one-hour interval by D,NA
10416003,NA,1,docetaxel,3a,75,mg/m2,NA,one-hour infusion on day 1,G-CSF support from cycle 1
10416003,NA,1,epirubicin,3a,120,mg/m2,NA,a 15-minute infusion followedafter one-hour interval by D,G-CSF support from cycle 1
10416003,NA,1,docetaxel,4a,85,mg/m2,NA,one-hour infusion on day 1,G-CSF support from cycle 1
10416003,NA,1,epirubicin,4a,120,mg/m2,NA,a 15-minute infusion followedafter one-hour interval by D,G-CSF support from cycle 1
10416005,NA,1,docetaxel,1,50,mg/m2,NA,one-hour i.v. infusion,every three weeks
10416005,NA,1,doxorubicin,1,40,mg/m2,NA,Doxorubicin was administered as a 15 min intravenous (i.v.) bolusfollowed by docetaxel. There was an interval of one hour between theend of doxorubicin treatment and the start of docetaxel infusion.,every three weeks
10416005,NA,1,docetaxel,2,60,mg/m2,NA,NA,NA
10416005,NA,1,doxorubicin,2,40,mg/m2,NA,NA,NA
10416005,NA,1,docetaxel,3,60,mg/m2,NA,NA,NA
10416005,NA,1,doxorubicin,3,50,mg/m2,NA,NA,NA
10416005,NA,1,docetaxel,4,75,mg/m2,NA,NA,NA
10416005,NA,1,doxorubicin,4,50,mg/m2,NA,NA,NA
10416005,NA,1,docetaxel,5,85,mg/m2,NA,NA,NA
10416005,NA,1,doxorubicin,5,50,mg/m2,NA,NA,NA
10416005,NA,1,docetaxel,6,60,mg/m2,NA,NA,NA
10416005,NA,1,doxorubicin,6,60,mg/m2,NA,NA,NA
10416005,NA,1,dexamethasone,NA,8,mg,NA,"13, 7 and 1 hour before docetaxel and 6, 12, 18, 24, 30, 36 and 42hours post-infusion.",NA
10416005,NA,1,cetirizine,NA,10,mg,NA,seven and onehours before docetaxel,NA
10416005,NA,1,ranitidine,NA,300,mg,NA,"oncedaily for three days, commencing the day prior to docetaxel administration.",NA
11137204,NA,1,irinotecan,NA,100,mg/m2,NA,60-min i.v. infusion at a fixed dose on day1,Treatment was repeated every 3 weeks.
11137204,NA,2,irinotecan,1,100,mg/m2,NA,escalating doses on day 8,NA
11137204,NA,2,irinotecan,2,110,mg/m2,NA,escalating doses on day 8,NA
11137204,NA,2,irinotecan,3,120,mg/m2,NA,escalating doses on day 8,NA
11137204,NA,2,irinotecan,4,120,mg/m2,NA,escalating doses on day 8,with G-CSF
11137204,NA,2,cisplatin,NA,80,mg/m2,NA,"fixed dose on day 8, 2 h afterCPT-11 administration;",NA
11137204,NA,2,cisplatin,NA,80,mg/m2,NA,"fixed dose on day 8, 2 h afterCPT-11 administration;",NA
9989521,NA,1,radiotherapy,NA,1.4*2fractions,Gy,1,a total dose of 74 Gy,Brain tumors;Radiotherapy
9989521,NA,1,methylprednisolone,NA,32-48,mg,1,during the first 2 weeks of radiotherapy,Brain tumors;Radiotherapy
9989521,NA,1,methylprednisolone,NA,32-48,mg,NA,NA,Brain tumors;Radiotherapy
9989521,NA,1,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,Neutrophil grade 2 toxicity
9989521,NA,1,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,Neutrophil grade 2 toxicity
9989521,NA,1,ranitidine,NA,300,mg,1,throughout the 6-week treatment period,Brain tumors;Docetaxel administration
9989521,NA,1,tropisetron,NA,5,mg,NA,twice a2week (d1 and d4),Brain tumors;Docetaxel administration
9989521,NA,1,methylprednisolone,NA,32-48,mg,NA,1,brain tumors
9989521,NA,1,docetaxel,1,15,mg/m2,NA,twice a2week (d1 and d4),Brain tumors;Docetaxel administration
9989521,NA,1,docetaxel,2,19,mg/m2,NA,twice a2week (d1 and d4),Brain tumors;Docetaxel administration
9989521,NA,1,docetaxel,3,23,mg/m2,NA,twice a2week (d1 and d4),Brain tumors;Docetaxel administration
9989521,NA,2,radiotherapy,NA,2,Gy,1,a total dose of 44 Gy,"Chest tumor;The field dimensions ranged from 140 –178
22
cm (mean 143 cm ; blocked area excluded). Lateral or
oblique portals were used to boost the residual tumor to a total dose of 60 Gy.Patients whose whole hemithorax was irradiated received 18 Gy with 1.4 Gy per fraction, and conventionally fractionated radiotherapy followed as previously described."
9989521,NA,2,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,Neutrophil grade 2 toxicity
9989521,NA,2,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,Neutrophil grade 2 toxicity
9989521,NA,2,docetaxel,1,15,mg/m2,NA,NA,NA
9989521,NA,2,docetaxel,2,19,mg/m2,NA,NA,NA
9989521,NA,2,methylprednisolone,NA,32,mg,NA,orally (p.o.),NA
9989521,NA,2,methylprednisolone,NA,125,mg,NA,intrave- nous (IV) bolus,NA
9989521,NA,2,ranitidine,NA,300,mg,1,throughout the 6-week treatment period,NA
9989521,NA,2,tropisetron,NA,5,mg,NA,NA,NA
9989521,NA,2,methylprednisolone,NA,32,mg,NA,whenever allergic reaction was observed;patients were given methylprednisolone 12 hours after chemotherapy,NA
9989521,NA,3,radiotherapy,NA,2,Gy,NA,anteroposterior fields (diamond shaped) to a total dose of 46 Gy (2 Gy/day) and lateral/oblique fields were used to boost the tumor area to a total dose of 64 Gy.,pelvic tumorsComplete or partial response of cervical or endometrial cancer was followed by one intracavitary radiotherapy ap- plication of 18 Gy to point A.
9989521,NA,3,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,pelvic tumors;Neutrophil grade 2 toxicity
9989521,NA,3,g-csf,NA,300,ug/m2,NA,subcutaneously on Saturday and Sunday every week) starting immediately after diagnosis and con- tinuing throughout the radiotherapy period.,pelvic tumors;Neutrophil grade 2 toxicity
9989521,NA,3,docetaxel,1,15,mg/m2,NA,NA,pelvic tumors
9989521,NA,3,docetaxel,2,19,mg/m2,NA,NA,pelvic tumors
9989521,NA,3,methylprednisolone,NA,32,mg,NA,orally (p.o.),pelvic tumors
9989521,NA,3,methylprednisolone,NA,125,mg,NA,intrave- nous (IV) bolus,pelvic tumors
9989521,NA,3,ranitidine,NA,300,mg,1,throughout the 6-week treatment period,pelvic tumors
9989521,NA,3,tropisetron,NA,5,mg,NA,NA,pelvic tumors
9989521,NA,2,methylprednisolone,NA,32,mg,NA,whenever allergic reaction was observed;patients were given methylprednisolone 12 hours after chemotherapy,pelvic tumors
34189636,NA,1,dexamethasone,NA,NA,NA,NA,NA,premedication
34189636,NA,1,5-ht3,NA,NA,NA,NA,NA,premedication
34189636,NA,1,pegylated lipo- somal doxorubicin,NA,30,mg/m2,NA,30 min after premedicine;infused over 90 min,NA
34189636,NA,1,trabectedin,1,0.9,mg/m2,NA,"administered via a central venous line over 3 h, and follow-up continued for 20 days",NA
34189636,NA,1,trabectedin,2,1.1,mg/m2,NA,NA,NA
34189636,NA,1,trabectedin,-1,0.75,mg/m2,NA,NA,NA
11429197,NA,1,dexamethasone,NA,12,mg,NA,2–3 hbefore each TXT,4-weeks cycle；Anti-allergic prophylaxis
11429197,NA,1,granisetron,NA,3,mg,NA,30 min before TXT,4-weeks cycle；antiemetic
11429197,NA,1,docetaxel,1,20,mg/m2,NA,"on days 1,8 and 15,",4-weeks cycle
11429197,NA,1,docetaxel,2,25,mg/m2,NA,"on days 1,8 and 15,",4-weeks cycle
11429197,NA,1,docetaxel,3,30,mg/m2,NA,"on days 1,8 and 15,",4-weeks cycle
11429197,NA,1,docetaxel,4,35,mg/m2,NA,"on days 1,8 and 15,",4-weeks cycle
11429197,NA,1,cisplatin,NA,80,mg/m2,NA,2000 ml of fluids via a 30 min i.v. infusion afterTXT infusion on day 1,4-weeks cycle;fixed dose
11429197,NA,1,cisplatin,NA,80,mg/m2,NA,2000 ml of fluids via a 30 min i.v. infusion afterTXT infusion on day 1,4-weeks cycle;fixed dose
34669023,NA,1,veliparib,1,10,mg,NA,every 12 h(h) given Days 1–4,Group1
34669023,NA,1,veliparib,2,20,mg,NA,NA,NA
34669023,NA,1,veliparib,3,50,mg,NA,NA,NA
34669023,NA,1,veliparib,4,50,mg,NA,NA,NA
34669023,NA,1,veliparib,5,50,mg,NA,NA,NA
34669023,NA,1,veliparib,6,100,mg,NA,NA,NA
34669023,NA,1,veliparib,7,150,mg,NA,NA,NA
34669023,NA,1,veliparib,8,200,mg,NA,NA,NA
34669023,NA,1,cyclophosphamide,1,450,mg/m2,NA,IV over60 min on day 3 on a 21-day cycle,NA
34669023,NA,1,cyclophosphamide,2,450,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,3,450,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,4,600,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,5,750,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,6,750,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,7,750,mg/m2,NA,NA,NA
34669023,NA,1,cyclophosphamide,8,750,mg/m2,NA,NA,NA
34669023,NA,2,veliparib,1a,50,mg,NA,every 12 h(h) given Days 1–4,Group2
34669023,NA,2,veliparib,2a,100,mg,NA,NA,NA
34669023,NA,2,veliparib,3a,150,mg,NA,NA,NA
34669023,NA,2,cyclophosphamide,1a,600,mg/m2,NA,IV over60 min on Day 3,NA
34669023,NA,2,cyclophosphamide,2a,600,mg/m2,NA,NA,NA
34669023,NA,2,cyclophosphamide,3a,600,mg/m2,NA,NA,NA
34669023,NA,2,doxorubicin,1a,60,mg/m2,NA,IVP over15 min on Day 3,NA
34669023,NA,2,doxorubicin,2a,60,mg/m2,NA,NA,NA
34669023,NA,2,doxorubicin,3a,60,mg/m2,NA,NA,NA
34669023,NA,3,veliparib,1b,100,mg,NA,every 12 h(h) given on Days 1–7,Group3
34669023,NA,3,cyclophosphamide,1b,600,mg/m2,NA,"""IV over60 min on Day 1",NA
34669023,NA,3,doxorubicin,1b,60,mg/m2,NA,IVP over15 min on Day 1,NA
34669023,NA,4,veliparib,1b,100,mg,NA,every 12 h(h) given on Days 1-14,Group4
34669023,NA,4,cyclophosphamide,1b,600,mg/m2,NA,"""IV over60 min on Day 1",NA
34669023,NA,4,doxorubicin,1b,60,mg/m2,NA,IVP over15 min on Day 1,NA
12954580,NA,1,liposomal doxorubicin,1,25,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,1,20,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,2,30,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,2,20,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,3,35,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,3,20,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,4,20,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,4,25,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,5,25,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,5,25,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,6,30,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,6,25,mg/m2,NA,on days 1 and 8 every 21 days,NA
12954580,NA,1,liposomal doxorubicin,7,35,mg/m2,NA,on day 1 every 21 days,NA
12954580,NA,1,vinorelbine,7,25,mg/m2,NA,on days 1 and 8 every 21 days,NA
15292922,NA,1,gemcitabine,1,1000,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,1,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,1,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,gemcitabine,2,1100,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,2,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,2,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,gemcitabine,3,1200,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,3,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,3,35,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,gemcitabine,4,1200,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,4,45,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
15292922,NA,1,cisplatin,4,45,mg/m2,NA,on days 1 and 8 of a 21-day cycle,NA
11925133,NA,1,etoposide,1,50,mg/m2/d,NA,Day 2 ( (days 2–9), Cycles were repeated every 28 days
11925133,NA,1,liposomal doxorubicin,1,20,mg/m2,NA,Day 1 iv over1 h,NA
11925133,NA,1,etoposide,2,50,mg/m2/d,NA,Day 2  (days 2–11),NA
11925133,NA,1,liposomal doxorubicin,2,20,mg/m2,NA,Day 1 iv over1 h,NA
11925133,NA,1,etoposide,3,50,mg/m2/d,NA,Day 2   (days 2–13),NA
11925133,NA,1,liposomal doxorubicin,3,20,mg/m2,NA,Day 1 iv over1 h,NA
11925133,NA,1,etoposide,4,50,mg/m2/d,NA,Day 2    (days 2–15),NA
11925133,NA,1,liposomal doxorubicin,4,20,mg/m2,NA,Day 1 iv over1 h,NA
11557123,NA,1,topotecan,1,0.5,mg/m2,NA,30-min intravenous infusion from day 1 to day 5,Treatment was repeated every 28 days.
11557123,NA,1,topotecan,1,0.5,mg/m2,NA,30-min intravenous infusion from day 1 to day 5,Treatment was repeated every 28 days.
11557123,NA,1,epirubicin,1,40,mg/m2,NA,on day 8 as a 10-min intravenous infusion,NA
11557123,NA,1,topotecan,2,0.5,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,2,0.5,mg/m2,NA,NA,NA
11557123,NA,1,epirubicin,2,50,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,3,0.75,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,3,0.75,mg/m2,NA,NA,NA
11557123,NA,1,epirubicin,3,40,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,4,0.9,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,4,0.9,mg/m2,NA,NA,NA
11557123,NA,1,epirubicin,4,40,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,5,1,mg/m2,NA,NA,NA
11557123,NA,1,topotecan,5,1,mg/m2,NA,NA,NA
11557123,NA,1,epirubicin,5,40,mg/m2,NA,NA,NA
12452452,NA,1,doxorubicin,NA,80,mg/m2,NA,"""first threecycles""",NA
12452452,NA,1,paclitaxel,NA,140,mg/m2,NA,96 hcontinuous infusion,NA
12452452,NA,1,g-csf,NA,5,ug/kg,NA,"""on day 2 through 14 of each of the firstsix treatment cycles""",NA
12452452,NA,1,g-csf,NA,5,ug/kg,NA,"""on day 2 through 14 of each of the firstsix treatment cycles""",NA
12452452,NA,1,5-fluorouracil,1,1655,mg/m2,NA,"""72 h continuous intravenous infusion every 21 daysas a single agent""",single agent
12452452,NA,1,5-fluorouracil,-1,1470,mg/m2,NA,72 h continuous intravenous infusion every 21 daysas a single agent,NA
12452452,NA,1,5-fluorouracil,-2,1285,mg/m2,NA,72 h continuous intravenous infusion every 21 daysas a single agent,NA
12452452,NA,1,5-fluorouracil,2,1840,mg/m2,NA,"""72 h continuous intravenous infusion every 21 daysas a single agent""",NA
12452452,NA,1,5-fluorouracil,3,2300,mg/m2,NA,72 h continuous intravenous infusion every 21 daysas a single agent,NA
12452452,NA,1,5-fluorouracil,4,2875,mg/m2,NA,"""72 h continuous intravenous infusion every 21 daysas a single agent""",NA
11350887,NA,2,dexamethasone,NA,20,mg,NA,NA,premedication
11350887,NA,2,famotidine,NA,20,mg,NA,NA,premedication
11350887,NA,2,diphenhydramine,NA,25,mg,NA,NA,premedication
11350887,NA,2,ondansetron,NA,10,mg,NA,NA,premedication
11350887,NA,2,doxorubicin,1,40,mg/m2,NA,i.v. 15-min infusion,for the first cycle
11350887,NA,2,paclitaxel,1,175,mg/m2,NA,followed by paclitaxel 1 h i.v. infusion,for the first cycle
11350887,NA,2,doxorubicin,-1,35,mg/m2,NA,NA,for the first cycle
11350887,NA,2,paclitaxel,-1,150,mg/m2,NA,NA,for the first cycle
11350887,NA,3,p-glycoprotein inhibitor valspodar,1,5,mg/kg,4,four times daily for a total of 12 doses using the liquid formulation,"Three
weeks later from the combination2;every 3 to 4 weeks"
11350887,NA,3,doxorubicin,1,10,mg/m2,NA,NA,every 3 to 4 weeks
11350887,NA,3,paclitaxel,1,70,mg/m2,NA,NA,every 3 to 4 weeks
11350887,NA,3,p-glycoprotein inhibitor valspodar,2,NA,NA,NA,NA,"Three
weeks later from the combination2;every 3 to 4 weeks"
11350887,NA,3,doxorubicin,2,12.5,mg/m2,NA,NA,every 3 to 4 weeks
11350887,NA,3,paclitaxel,2,70,mg/m2,NA,NA,every 3 to 4 weeks
11350887,NA,3,p-glycoprotein inhibitor valspodar,3,NA,mg/m2,NA,NA,"Three
weeks later from the combination2;"
11350887,NA,3,doxorubicin,3,15,mg/m2,NA,NA,NA
11350887,NA,3,paclitaxel,3,80,mg/m2,NA,NA,NA
11350887,NA,3,p-glycoprotein inhibitor valspodar,4,NA,NA,NA,NA,#NAME?
11350887,NA,3,doxorubicin,4,20,mg/m2,NA,NA,#NAME?
11350887,NA,3,paclitaxel,4,80,mg/m2,NA,NA,#NAME?
11350887,NA,3,p-glycoprotein inhibitor valspodar,5,NA,NA,NA,NA,#NAME?
11350887,NA,3,doxorubicin,5,20,mg/m2,NA,NA,#NAME?
11350887,NA,3,paclitaxel,5,90,mg/m2,NA,NA,#NAME?
11466671,NA,1,doxorubicin,NA,50,mg/m2,NA,Day1,standard doses
11466671,NA,1,vincristine,NA,1.4,mg/m2,NA,Day1, standard doses
11466671,NA,1,prednisone,NA,100,mg,1,Days 1–5, standard doses
11466671,NA,1,cytoxan,1,750,mg/m2,NA,Day 1,Cycles were repeated every 21 days
11466671,NA,1,etoposide,1,80,mg/m2,NA,Days 1–3,NA
11466671,NA,1,cytoxan,2,1000,mg/m2,NA,Day 1,NA
11466671,NA,1,etoposide,2,80,mg/m2,NA,Days 1–3,NA
11466671,NA,1,cytoxan,3,1000,mg/m2,NA,Day 1,NA
11466671,NA,1,etoposide,3,100,mg/m2,NA,Days 1–3,NA
11466671,NA,1,cytoxan,4,1500,mg/m2,NA,Day 1,NA
11466671,NA,1,etoposide,4,100,mg/m2,NA,Days 1–3,NA
11466671,NA,1,g-csf,4,200,ug/m2,NA,Days 2–19,NA
11466671,NA,1,g-csf,4,200,ug/m2,NA,Days 2–19,NA
11466671,NA,1,cytoxan,5,1500,mg/m2,NA,Day 1,NA
11466671,NA,1,etoposide,5,160,mg/m2,NA,Days 1–3,NA
11466671,NA,2,doxorubicin,NA,50,mg/m2,NA,Day1,standard doses
11466671,NA,2,vincristine,NA,1.4,mg/m2,NA,Day1,standard doses
11466671,NA,2,prednisone,NA,100,mg,1,Days 1–5,standard doses
11466671,NA,2,cytoxan,1,1000,mg/m2,NA,Day1,Cycles were repeated every 21 days
11466671,NA,2,etoposide,1,100,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,1,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,1,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,cytoxan,2,1500,mg/m2,NA,Day1,NA
11466671,NA,2,etoposide,2,100,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,2,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,2,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,cytoxan,3A,1500,mg/m2,NA,Day1,NA
11466671,NA,2,etoposide,3A,160,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,3A,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,3A,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,cytoxan,3B,1500,mg/m2,NA,Day1,NA
11466671,NA,2,etoposide,3B,160,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,3B,400,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,3B,400,ug/m2,NA,Days 5–19,NA
11466671,NA,2,cytoxan,4,1500,mg/m2,NA,Day1,NA
11466671,NA,2,etoposide,4,160,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,4,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,4,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,cytoxan,5,2000,mg/m2,NA,Day1,NA
11466671,NA,2,etoposide,5,160,mg/m2,NA,Days 1–3,NA
11466671,NA,2,g-csf,5,200,ug/m2,NA,Days 5–19,NA
11466671,NA,2,g-csf,5,200,ug/m2,NA,Days 5–19,NA
12782942,NA,1,tropisetron,NA,5,mg,NA,NA,standardized dose
12782942,NA,1,cisplatin,1,80,mg/m2,NA,1-h infusion on day 2,cycle:every 4 weeks
12782942,NA,1,cisplatin,1,80,mg/m2,NA,1-h infusion on day 2,cycle:every 4 weeks
12782942,NA,1,epirubicin,1,80,mg/m2,NA,i.v. bolus onday 2,NA
12782942,NA,1,paclitaxel,1,80,mg/m2,NA,on day 1 over 3 h employing a polyethyl infusion set,NA
12782942,NA,1,cisplatin,2,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,2,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,2,80,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,2,100,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,3,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,3,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,3,80,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,3,120,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,4,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,4,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,4,100,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,4,120,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,5,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,5,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,5,100,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,5,140,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,6,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,6,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,6,80,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,6,140,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,7,80,mg/m2,NA,NA,NA
12782942,NA,1,cisplatin,7,80,mg/m2,NA,NA,NA
12782942,NA,1,epirubicin,7,80,mg/m2,NA,NA,NA
12782942,NA,1,paclitaxel,7,160,mg/m2,NA,NA,NA
12419750,NA,1,ondansetron,NA,8,mg,NA,before chemotherapy administration,NA
12419750,NA,1,gemcitabine,1,1000,mg/m2,NA,infused over 30 min on days 1 and 8 every 3 week,NA
12419750,NA,1,doxorubicin,1,30,mg/m2,NA,on day 1 every 3 week,NA
12419750,NA,1,gemcitabine,2,1250,mg/m2,NA,infused over 30 min on days 1 and 8 every 3 week,NA
12419750,NA,1,doxorubicin,2,30,mg/m2,NA,on day 1 every 3 week,NA
12419750,NA,1,gemcitabine,3,1250,mg/m2,NA,infused over 30 min on days 1 and 8 every 3 week,NA
12419750,NA,1,doxorubicin,3,45,mg/m2,NA,on day 1 every 3 week,NA
12419750,NA,1,gemcitabine,4,1250,mg/m2,NA,infused over 30 min on days 1 and 8 every 3 week,NA
12419750,NA,1,doxorubicin,4,60,mg/m2,NA,on day 1 every 3 week,NA
12621462,NA,1,gemcitabine,NA,1000,mg/m2,NA,days 1 and 4,every 3 weeks for six courses
12621462,NA,1,epirubicin,NA,90,mg/m2,NA,day 1,every 3 weeks for six courses
12621462,NA,1,paclitaxel,NA,175,mg/m2,NA,over 3 h,every 3 weeks for six courses
12621462,NA,1,rhg-csf,NA,5,ug/kg/per day,NA,starting fromday 5 after the third course,NA
12621462,NA,1,idarubicin,1,40,mg/m2,NA, infused over 48 h,NA
12621462,NA,1,idarubicin,2,50,mg/m2,NA, infused over 48 h,NA
12621462,NA,1,idarubicin,3,60,mg/m2,NA, infused over 48 h,NA
12621462,NA,1,idarubicin,4,70,mg/m2,NA, infused over 48 h,NA
12621462,NA,1,dexamethasone,NA,20,mg,1,NA,NA
12621462,NA,1,ondasentron,NA,48,mg,1,NA,NA
12621462,NA,1,peripheral blood progenitor cell,NA,NA,NA,NA,"216 h (9 days) after the end ofthe infusion in the first four patients and then, on the basisof the idarubicin and idarubicinol plasma levels, after 144 h(6 days) in the other 10 patients.",at least 3*10^6 CD34+ cells/kg were reinfused.
12621462,NA,1,rhg-csf,NA,5,ug/kg/per day,NA,Following PBPC infusion;until WBC 41000/ml for threeconsecutive days.,NA
12621462,NA,1,acyclovir,NA,500,NA,NA, every 12 h,NA
12621462,NA,2,thiotepa,NA,600,NA,"divided in three equal doses as a 1 h infusion
1 h apart each",(day 3),HDC
12621462,NA,2,melphalan,NA,160,NA,"48 h after
thiotepa divided in three equal doses as an i.v. bolus 2 h
apart each",(day 1),HDC
12621462,NA,2,autologous pbpc,NA,NA,NA,NA,NA,HDC
15218308,NA,1,prednisolone,NA,130,mg,NA,12 and 6 h before paclitaxel,"Courses
were repeated every 21 days"
15218308,NA,1,dexchlorpheniramine,NA,5,mg,NA,30 min before paclitaxel,NA
15218308,NA,1,cimetidine,NA,300,mg,NA,30 min before paclitaxel,NA
15218308,NA,1,paclitaxel,1,150,mg/m2,NA,over 3 h after premedication,NA
15218308,NA,1,paclitaxel,2,175,mg/m2,NA,NA,NA
15218308,NA,1,paclitaxel,3,200,mg/m2,NA,NA,NA
15218308,NA,1,paclitaxel,4,225,mg/m2,NA,NA,NA
15218308,NA,1,paclitaxel,5,200,mg/m2,NA,NA,NA
15218308,NA,1,paclitaxel,6,200,mg/m2,NA,NA,NA
15218308,NA,1,paclitaxel,7,200,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,1,50,mg/m2,NA,intravenous bolus over 5–15 min,NA
15218308,NA,1,epirubicin,2,50,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,3,50,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,4,50,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,5,60,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,6,75,mg/m2,NA,NA,NA
15218308,NA,1,epirubicin,7,90,mg/m2,NA,NA,NA
15218308,NA,1,cyclophosphamide,NA,500,mg/m2,NA,intravenous infusion over 30 min,fixed dose
12196358,NA,1,doxorubicin,NA,75,mg/m2,NA,NA,fixed dose
12196358,NA,1,cyclophosphamide,1,1750,mg/m2,NA,NA,"""every
21 days"""
12196358,NA,1,cyclophosphamide,2,2000,mg/m2,NA,NA,NA
12196358,NA,1,cyclophosphamide,3,2250,mg/m2,NA,NA,NA
12196358,NA,1,granulocyte colony-stimulating factor,NA,300,ug/day,NA,on days 7–12 of each cycle.,NA
12196358,NA,1,granulocyte colony-stimulating factor,NA,300,ug/day,NA,on days 7–12 of each cycle.,NA
12196358,NA,1,involved-field radiotherapy,NA,25–30,Gy,NA,five to six cycles followed by radiotherapy (25–30 Gy) on bulky site(s) of disease at diagnosis,NA
11870176,NA,1,antiserotonin agent plus dexamethasone,NA,NA,NA,NA,15-minute infusion before chemotherapy,NA
11870176,NA,1,epirubicin,1,140,mg/m2,NA,NA,every 3 weeks
11870176,NA,1,epirubicin,2,160,mg/m2,NA,NA,NA
11870176,NA,1,epirubicin,3,180,mg/m2,NA,NA,NA
11900234,NA,1,doxorubicin,1,5,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,1,20,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,1,20,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,2,6.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,2,20,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,2,20,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,3,6.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,3,25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,3,25,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,4,7.81,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,4,25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,4,25,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,5,7.81,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,5,31.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,5,31.25,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,6,9.76,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,6,31.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,6,31.25,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,7,12.2,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,7,39.1,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,7,39.1,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,8,15.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,8,39.1,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,8,39.1,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,9,15.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,9,43,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,9,43,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,10,19,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,10,43,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,10,43,mg/L,NA,NA,NA
11900234,NA,1,doxorubicin,11,15.25,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,11,43,mg/L,NA,NA,NA
11900234,NA,1,cisplatin,11,43,mg/L,NA,NA,NA
15166622,NA,1,dexamethasone,NA,20,mg,NA,12and 6 h before paclitaxel infusion,The combination was administered every 28 days
15166622,NA,1,diphenhydramine,NA,50,mg,NA,1 h before paclitaxel,NA
15166622,NA,1,cimetidine,NA,300,mg,NA,1 h before paclitaxel infusion,NA
15166622,NA,1,g-csf,NA,5,ug/kg/per day,NA,NA,"if absolute neutrophil count (ANC) was
< 500/ml or in the case of febrile neutropenia."
15166622,NA,1,g-csf,NA,5,ug/kg/per day,NA,NA,"if absolute neutrophil count (ANC) was
< 500/ml or in the case of febrile neutropenia."
15166622,NA,1,pegylated liposomal doxorubicin hydrochloride,1,35,mg/m2,NA,over60 min on day 1,NA
15166622,NA,1,paclitaxel,1,175,mg/m2,NA,over 3 h on day 1.,fixed dose
15166622,NA,1,pegylated liposomal doxorubicin hydrochloride,2,40,mg/m2,NA,over60 min on day 1,NA
15166622,NA,1,paclitaxel,2,175,mg/m2,NA,over 3 h on day 1.,fixed dose
15166622,NA,1,pegylated liposomal doxorubicin hydrochloride,3,45,mg/m2,NA,over60 min on day 1,NA
15166622,NA,1,paclitaxel,3,175,mg/m2,NA,over 3 h on day 1.,fixed dose
15138468,NA,1,mitomycin c,NA,7,mg/m2,NA,ondays 8 and 36,NA
15138468,NA,1,dexamethasone,NA,8,mg,NA,toMMC to prevent pulmonary toxicity,NA
15138468,NA,1,clemastine,NA,0.5,mg,NA,Dexamethasone 8 mg andclemastine 0.5 mg were added routinely to Caelyx after theobservation of allergic reactions in two patients during the firstCaelyx administration.,NA
15138468,NA,1,pegylated doxorubicin,1,15,mg/m2,NA,1-hinfusion on days 1 and 29,NA
15138468,NA,1,pegylated doxorubicin,1a,20,mg/m2,NA,1-hinfusion on days 1 and 29,NA
15138468,NA,1,pegylated doxorubicin,2,25,mg/m2,NA,1-hinfusion on days 1 and 29,NA
11335910,NA,1,cimetidine,NA,200,mg,NA,NA,NA
11335910,NA,1,hydrocortisone,NA,100,mg,NA,NA,NA
11335910,NA,1,hydrocortisone,NA,100,mg,NA,NA,NA
11335910,NA,1,diphenhydramine,NA,30,mg,NA,NA,NA
11335910,NA,1,polyethylene-glycolated liposomal doxorubicin,1,30,mg/m2/3 weeks,NA,NA,NA
11335910,NA,1,polyethylene-glycolated liposomal doxorubicin,2,40,mg/m2/3 weeks,NA,NA,NA
11335910,NA,1,polyethylene-glycolated liposomal doxorubicin,3,50,mg/m2/3 weeks,NA,NA,NA
11335910,NA,1,polyethylene-glycolated liposomal doxorubicin,4,45,mg/m2/3 weeks,NA,NA,NA
14998859,NA,1,mcc-465),1,6.5,mg/m2,NA,"was infused intravenously for 60 min, or120 min once every 3 weeks",NA
14998859,NA,1,mcc-465,2,13,mg/m2,NA,NA,NA
14998859,NA,1,mcc-465,3,21,mg/m2,NA,NA,NA
14998859,NA,1,mcc-465,4,32.5,mg/m2,NA,NA,NA
14998859,NA,1,mcc-465,5,45.5,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,1,20,mg/m2,NA,over 30 to 60 minutes IVonce every 3 weeks,NA
11387367,NA,1,nsc 655649,2,40,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,3,100,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,4,140,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,5,186,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,6,247,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,7,375,mg/m2,NA,NA,NA
11387367,NA,1,nsc 655649,8,440,mg/m2,NA,NA,heavily pretreated (HP)
11387367,NA,1,nsc 655649,9,500,mg/m2,NA,NA,heavily pretreated (HP)
11387367,NA,1,nsc 655649,10,572,mg/m2,NA,NA,minimally pretreated (MP) and heavily pretreated (HP)
11387367,NA,1,nsc 655649,11,744,mg/m2,NA,NA,minimally pretreated (MP)
11408511,NA,1,vx-710,1,20,mg/m2/h,NA,96-hour continuousintravenous infusion;During week 1 of the first treatment cycle；,every 21 to 28 days
11408511,NA,1,vx-710,2,40,mg/m2/h,NA,NA,NA
11408511,NA,1,vx-710,3,80,mg/m2/h,NA,NA,NA
11408511,NA,1,vx-710,4,120,mg/m2/h,NA,NA,NA
11408511,NA,1,vx-710,5,160,mg/m2/h,NA,NA,NA
15150584,NA,1,sp1049c,1,5,mg/m2,NA,once every 3 weeks,NA
15150584,NA,1,sp1049c,2,10,mg/m2,NA,NA,NA
15150584,NA,1,sp1049c,3,20,mg/m2,NA,NA,NA
15150584,NA,1,sp1049c,4,35,mg/m2,NA,NA,NA
15150584,NA,1,sp1049c,5,50,mg/m2,NA,NA,NA
15150584,NA,1,sp1049c,6,70,mg/m2,NA,NA,NA
15150584,NA,1,sp1049c,7,90,mg/m2,NA,NA,NA
11432625,NA,1,bbr 2778,1,5,mg/m2/w,NA,"one hour weekly on days 1, 8 and 15",NA
11432625,NA,1,bbr 2778,2,10,mg/m2/w,NA,NA,NA
11432625,NA,1,bbr 2778,3,16.5,mg/m2/w,NA,NA,NA
11432625,NA,1,bbr 2778,4,25,mg/m2/w,NA,NA,NA
11432625,NA,1,bbr 2778,5,34,mg/m2/w,NA,NA,NA
11432625,NA,1,bbr 2778,6,56,mg/m2/w,NA,NA,NA
11432625,NA,1,bbr 2778,7,84,mg/m2/w,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,1,20,mg/m2,NA,60-minintravenous infusion on day 1,cycles were repeated every 21 days.
11914595,NA,1,gemcitabine,1,600,mg/m2,NA,days 1 and 8 by 30-min intravenous infusion,NA
11914595,NA,1,combined liposomal doxorubicin,2,20,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,2,800,mg/m2,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,3,20,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,3,1000,mg/m2,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,4,30,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,4,800,mg/m2,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,5,30,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,5,1000,mg/m2,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,6,35,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,6,800,mg/m2,NA,NA,NA
11914595,NA,1,combined liposomal doxorubicin,7,35,mg/m2,NA,NA,NA
11914595,NA,1,gemcitabine,7,1000,mg/m2,NA,NA,NA
14501385,NA,1,dexamethasone,NA,20,mg,NA,15-min i.v,NA
14501385,NA,1,5-ht3 antagonist,NA,100,mg,NA,NA,NA
14501385,NA,1,"pegylated liposomal
doxorubicin",NA,40,mg/m2,NA,"fixed dose; i.v. 1 h in 1 day, every 3 weeks",NA
14501385,NA,1,oxaliplatin,1,80,mg/m2,NA,"i.v. after PLD in3 h in 1 day, every 3 weeks",NA
14501385,NA,1,oxaliplatin,1,80,mg/m2,NA,"i.v. after PLD in3 h in 1 day, every 3 weeks",NA
14501385,NA,1,oxaliplatin,2,90,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,2,90,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,3,100,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,3,100,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,4,110,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,4,110,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,5,120,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,5,120,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,6,130,mg/m2,NA,NA,NA
14501385,NA,1,oxaliplatin,6,130,mg/m2,NA,NA,NA
11996468,NA,1,men-10755,1,15,mg/m2,NA,short intravenousinfusion weekly for 3 weeks and cycles were repeated every 28 days,was given weekly for 3 weeks followed by 1 week rest
11996468,NA,1,men-10755,2,30,mg/m2,NA,NA,NA
11996468,NA,1,men-10755,3,45,mg/m2,NA,NA,NA
11996468,NA,1,men-10755,4,40,mg/m2,NA,NA,including pretreated and not pretreated two groups.
12065868,NA,1,dexamethasone,NA,20,mg,NA,orally 14 and 7 hbefore treatment and,NA
12065868,NA,1,cimetidine,NA,300,mg,NA,i.v.30 min before treatment,NA
12065868,NA,1,diphenhydramine,NA,50,mg,NA,i.v.30 min before treatment,NA
12065868,NA,1,ondansentron,NA,16,mg,NA, intravenously 30 min before chemotherapy,NA
12065868,NA,1,dexamethasone,NA,8,mg,NA, intravenously 30 min before chemotherapy,NA
12065868,NA,1,pegylated liposomal doxorubicin,1,12.5,mg/m2,NA,30-min intravenous infusion on day 1,NA
12065868,NA,1,paclitaxel,1,90,mg/m2,NA,3-hour intravenous infusionon day 2 every 2 weeks without growth factor support,NA
12065868,NA,1,pegylated liposomal doxorubicin,2,12.5,mg/m2,NA,NA,NA
12065868,NA,1,paclitaxel,2,100,mg/m2,NA,NA,NA
12065868,NA,1,pegylated liposomal doxorubicin,3,15,mg/m2,NA,NA,NA
12065868,NA,1,paclitaxel,3,100,mg/m2,NA,NA,NA
12065868,NA,1,pegylated liposomal doxorubicin,4,15,mg/m2,NA,NA,NA
12065868,NA,1,paclitaxel,4,115,mg/m2,NA,NA,NA
12065868,NA,1,pegylated liposomal doxorubicin,5,17.5,mg/m2,NA,NA,NA
12065868,NA,1,paclitaxel,5,115,mg/m2,NA,NA,NA
22918789,NA,1,erlotinib,-1,150,mg,NA,in the morning with up to200 ml of water 1 h before and 2 h after food;started on Cycle one day 1 of the study.,NA
22918789,NA,1,erlotinib,-1,150,mg,NA,in the morning with up to200 ml of water 1 h before and 2 h after food;started on Cycle one day 1 of the study.,NA
22918789,NA,1,sirolimus,-1,"9/3(loading/
maintenance)",mg,1,"In order toestablish pharmacokinetic data and toxicities related toerlotinib alone, sirolimus was not started until day 8 of cycleone with a loading dose, usually three times the daily maintenance dose. Starting day 9, sirolimus was given at a oncedaily maintenance dosage.",NA
22918789,NA,1,sirolimus,-1,"9/3(loading/
maintenance)",mg,1,"In order toestablish pharmacokinetic data and toxicities related toerlotinib alone, sirolimus was not started until day 8 of cycleone with a loading dose, usually three times the daily maintenance dose. Starting day 9, sirolimus was given at a oncedaily maintenance dosage.",NA
22918789,NA,1,erlotinib,1,150,mg,NA,NA,NA
22918789,NA,1,erlotinib,1,150,mg,NA,NA,NA
22918789,NA,1,sirolimus,1,"15/5(loading/
maintenance)",mg,NA,NA,NA
22918789,NA,1,sirolimus,1,"15/5(loading/
maintenance)",mg,NA,NA,NA
22918789,NA,1,erlotinib,2,200,mg,NA,NA,NA
22918789,NA,1,erlotinib,2,200,mg,NA,NA,NA
22918789,NA,1,sirolimus,2,"15/5(loading/
maintenance)",mg,NA,NA,NA
22918789,NA,1,sirolimus,2,"15/5(loading/
maintenance)",mg,NA,NA,NA
22918789,NA,1,erlotinib,2b,150,mg,NA,NA,NA
22918789,NA,1,erlotinib,2b,150,mg,NA,NA,NA
22918789,NA,1,sirolimus,2b,"30/10(loading/
maintenance)",mg,NA,NA,NA
22918789,NA,1,sirolimus,2b,"30/10(loading/
maintenance)",mg,NA,NA,NA
11251001,NA,1,gemcitabine,1,1000,mg/m2,NA,"Days 1 and 8, 15 to 28 days",NA
11251001,NA,1,liposomal doxorubicin,1,20,mg/m2,NA,"Days 1 and 8, 15 to 28 days",NA
11251001,NA,1,gemcitabine,2,800,mg/m2,NA,"Days 1 and 8, 15 to 28 days",NA
11251001,NA,1,liposomal doxorubicin,2,20,mg/m2,NA,"Days 1 and 8, 15 to 28 days",NA
11251001,NA,1,gemcitabine,3,800,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,liposomal doxorubicin,3,20,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,gemcitabine,4,800,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,liposomal doxorubicin,4,24,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,gemcitabine,5,800,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,liposomal doxorubicin,5,29,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,gemcitabine,6,800,mg/m2,NA,"Day 1, 8 to 21 days",NA
11251001,NA,1,liposomal doxorubicin,6,29,mg/m2,NA,"Day 1, 8 to 21 days",NA
12376203,NA,1,"pegylated liposomal
doxorubicin",1,6,mg/m2,NA,1-h infusion followed by afixed (80 mg/m2/week) dose of paclitaxe on the samedays in cycles of 6 weeks,NA
12376203,NA,1,paclitaxel,1,80,mg/m2,NA, 1-h infusion in cycles of 6 weeks,NA
12376203,NA,1,"pegylated liposomal
doxorubicin",2,8,mg/m2,NA,NA,NA
12376203,NA,1,paclitaxel,2,80,mg/m2,NA,NA,NA
12376203,NA,1,"pegylated liposomal
doxorubicin",3,10,mg/m2,NA,NA,NA
12376203,NA,1,paclitaxel,3,80,mg/m2,NA,NA,NA
12376203,NA,1,"pegylated liposomal
doxorubicin",4,12,mg/m2,NA,NA,NA
12376203,NA,1,paclitaxel,4,80,mg/m2,NA,NA,NA
15196868,NA,1,pegylated liposomal doxorubicin,NA,30,mg/m2,NA,Day 1 intravenously in 250-ml D5W over 60 min,fixed dose
15196868,NA,1,topotecan,1,0.5,mg/m2,NA,immediately followedby topotecan over 72-h intravenous infusion using a CADDambulatory pump perallocated dose level on a 21-day schedule,NA
15196868,NA,1,topotecan,1,0.5,mg/m2,NA,immediately followedby topotecan over 72-h intravenous infusion using a CADDambulatory pump perallocated dose level on a 21-day schedule,NA
15196868,NA,1,topotecan,2,0.7,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,2,0.7,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,3,0.9,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,3,0.9,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,4,1.1,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,4,1.1,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,5,1.3,mg/m2,NA,NA,NA
15196868,NA,1,topotecan,5,1.3,mg/m2,NA,NA,NA
11458813,NA,1,vinorelbine,NA,8,mg,NA,They received 8 mg of vinorelbine by i.v. bolus over 10 min followed by a continuous infusion of vinorelbine over 96 hr,"i.v. bolus,""3-
week intervals"""
11458813,NA,1,vinorelbine,-2,5,mg/m2/day,NA,NA,"3-
week intervals"
11458813,NA,1,vinorelbine,NA,8,mg,NA,NA,i.v. bolus
11458813,NA,1,vinorelbine,-1,6,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,0,7,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,1,8,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,2,9,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,3,10,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,4,11,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,5,12,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,6,13,mg/m2/day,NA,NA,NA
11458813,NA,1,vinorelbine,7,14,mg/m2/day,NA,NA,NA
11408493,NA,1,valspodar ld,A1,1.5,mg/kg,NA,2-hour intravenous (IV) infusion on day 1,NA
11408493,NA,1,valspodar civi,A1,2,mg/kg/d,NA,days 1 to 4,NA
11408493,NA,1,doxorubicin,A1,50,mg/m2/d,NA,15- to 20-minute IV infusion on day 1 at end of valspodar infusion for MTD-finding cohorts and on day 3at 45 to 48 hours after the day 1 valspodar dose,NA
11408493,NA,1,cisplatin,A1,50,mg/m2/d,NA, 15- to 20-minute infusion on day 3,NA
11408493,NA,1,cisplatin,A1,50,mg/m2/d,NA, 15- to 20-minute infusion on day 3,NA
11408493,NA,1,valspodar ld,B2,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,B2,4,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,B2,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,B2,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,B2,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,B3,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,B3,4,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,B3,20,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,B3,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,B3,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,C4,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,C4,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,C4,20,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C4,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C4,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,C5,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,C5,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,C5,25,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C5,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C5,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,C6,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,C6,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,C6,30,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C6,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C6,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,C7,1.5,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,C7,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,C7,30,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C7,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,C7,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,D8,2,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,D8,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,D8,35,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D8,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D8,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,D9,2,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,D9,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,D9,35,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D9,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D9,50,mg/m2/d,NA,NA,NA
11408493,NA,1,valspodar ld,D10,2,mg/kg,NA,NA,NA
11408493,NA,1,valspodar civi,D10,10,mg/kg/d,NA,NA,NA
11408493,NA,1,doxorubicin,D10,40,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D10,50,mg/m2/d,NA,NA,NA
11408493,NA,1,cisplatin,D10,50,mg/m2/d,NA,NA,NA
14962724,NA,1,paclitaxel analogue bms-184476,1,40,mg/m2,NA,3-weekly,NA
14962724,NA,1,doxorubicin,1,50,mg/m2,NA,3-weekly,fixed dose
14962724,NA,1,paclitaxel analogue bms-184476,2,30,mg/m2,NA,3-weekly,NA
14962724,NA,1,doxorubicin,2,50,mg/m2,NA,3-weekly,fixed dose
14962724,NA,2,paclitaxel analogue bms-184476,1,30+30,mg/m2,NA,on day 1 and day 8 every 3 weeks,NA
14962724,NA,2,doxorubicin,1,50,mg/m2,NA,on day 1 only,fixed dose
14962724,NA,2,paclitaxel analogue bms-184476,2,35+35,mg/m2,NA,on day 1 and day 8 every 3 weeks,NA
14962724,NA,2,doxorubicin,2,50,mg/m2,NA,on day 1 only,fixed dose
23099006,NA,1,osi-930 dose,1,200,mg,NA,BID on day 1 of 28-d,"Cycle 1 consisted of 7 d of single-agent OSI-930
followed by 21 d of OSI-930 co-administered with
erlotinib. Subsequent treatment cycles comprised 28 d
of both drugs administered in combination."
23099006,NA,1,erlotinib dose,1,100,mg,NA,QD on day 8 of 28-d,NA
23099006,NA,1,osi-930 dose,2,200,mg,NA,NA,NA
23099006,NA,1,erlotinib dose,2,150,mg,NA,NA,NA
23099006,NA,1,osi-930 dose,3,300,mg,NA,NA,NA
23099006,NA,1,erlotinib dose,3,150,mg,NA,NA,NA
26886016,NCT01010945,1,gemcitabine,1,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",28-day cycles
26886016,NCT01010945,1,nab-paclitaxel,1,125,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,1,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,1,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,gemcitabine,2,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,nab-paclitaxel,2,125,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,2,150,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,2,150,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,gemcitabine,-1,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,nab-paclitaxel,-1,100,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,-1,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,-1,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,gemcitabine,-2a,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,nab-paclitaxel,-2a,100,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,-2a,75,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,-2a,75,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,gemcitabine,-2b,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,nab-paclitaxel,-2b,75,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,-2b,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,-2b,100,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,gemcitabine,-3,1000,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,nab-paclitaxel,-3,75,mg/m2,NA,"intravenously (IV) over 30 min over 30 minon days 1, 8, and 15",NA
26886016,NCT01010945,1,erlotinib,-3,75,mg,1,oncedaily continuously from days 1 to 28,NA
26886016,NCT01010945,1,erlotinib,-3,75,mg,1,oncedaily continuously from days 1 to 28,NA
29801474,NA,1,erlotinib,NA,1000,mg/m2/weekly,NA,"for 3 weeks, followed bya 1-week rest",4 weeks a cycle
29801474,NA,1,erlotinib,NA,1000,mg/m2/weekly,NA,"for 3 weeks, followed bya 1-week rest",4 weeks a cycle
29801474,NA,1,gemcitabine,NA,100,mg,1,NA,NA
29801474,NA,1,hf10,1,1000000,pfu/day,NA,started at day 1 of cycle 2;four timesin total (once every 2 weeks),NA
29801474,NA,1,hf10,2,3000000,pfu/day,NA,NA,NA
29801474,NA,1,hf10,3,10000000,pfu/day,NA,NA,NA
28424891,NCT00600496,1,selumetinib,1a,50,mg,1,QD,NA
28424891,NCT00600496,1,erlotinib,1a,100,mg,1,QD,NA
28424891,NCT00600496,1,erlotinib,1a,100,mg,1,QD,NA
28424891,NCT00600496,1,selumetinib,2a,75,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,2a,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,2a,100,mg,NA,NA,NA
28424891,NCT00600496,1,selumetinib,1b,50,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,1b,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,1b,100,mg,NA,NA,NA
28424891,NCT00600496,1,selumetinib,2b,50,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,2b,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,2b,100,mg,NA,NA,NA
28424891,NCT00600496,1,selumetinib,3b,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,3b,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,3b,100,mg,NA,NA,NA
28424891,NCT00600496,1,selumetinib,4b,150,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,4b,100,mg,NA,NA,NA
28424891,NCT00600496,1,erlotinib,4b,100,mg,NA,NA,NA
28424891,NCT00600496,2,selumetinib,1a,50,mg,NA,twicedaily (BID),NA
28424891,NCT00600496,2,temsirolimus,1a,25,mg,NA,"once weekly on days 1，8, and 15 of each 21-day cycle",NA
28424891,NCT00600496,2,selumetinib,2a,75,mg,NA,NA,NA
28424891,NCT00600496,2,temsirolimus,2a,25,mg,NA,NA,NA
28424891,NCT00600496,2,selumetinib,1b,50,mg,NA,NA,NA
28424891,NCT00600496,2,temsirolimus,1b,20,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,1,60,mg,NA,dailyon days 1–21 of a 28-day cycle (21/28), pictilisib capsules 
28798270,NCT00975182,1,erlotinib,1,150,mg,NA,daily from day 2,NA
28798270,NCT00975182,1,erlotinib,1,150,mg,NA,daily from day 2,NA
28798270,NCT00975182,1,pictilisib,2,30,mg,NA,"5 days on, 2 days off", pictilisib capsules 
28798270,NCT00975182,1,erlotinib,2,150,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,2,150,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,3,60,mg,NA,"5 days on, 2 days off", pictilisib capsules 
28798270,NCT00975182,1,erlotinib,3,150,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,3,150,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,4,60,mg,NA,"5 days on, 2 days off", pictilisib capsules 
28798270,NCT00975182,1,erlotinib,4,100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,4,100,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,5,100,mg,NA,"5 days on, 2 days off", pictilisib capsules 
28798270,NCT00975182,1,erlotinib,5,100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,5,100,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,6,165,mg,NA,"5 days on, 2 days off", pictilisib capsules 
28798270,NCT00975182,1,erlotinib,6,100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,6,100,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,7,250,mg,NA,"5 days on, 2 days of",pictilisib tablets
28798270,NCT00975182,1,erlotinib,7,100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,7,100,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,8,340,mg,NA,"5 days on, 2 days of",pictilisib tablets
28798270,NCT00975182,1,erlotinib,8,100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,8,100,mg,NA,NA,NA
28798270,NCT00975182,1,pictilisib,"Dose-expansion
cohort",340,mg,NA,"5 days on, 2 days of",pictilisib tablets
28798270,NCT00975182,1,erlotinib,"Dose-expansion
cohort",100,mg,NA,NA,NA
28798270,NCT00975182,1,erlotinib,"Dose-expansion
cohort",100,mg,NA,NA,NA
29050231,NA,1,erlotinib,1,100,mg,NA,alone daily for 14 days during cycle 1,4 weeks a cycle
29050231,NA,1,erlotinib,1,100,mg,NA,alone daily for 14 days during cycle 1,4 weeks a cycle
29050231,NA,1,foretinib,1,30,mg,NA,"initiated on day 15, cycle 1 if erlotinib was well tolerated",NA
29050231,NA,1,erlotinib,2,150,mg,NA,NA,NA
29050231,NA,1,erlotinib,2,150,mg,NA,NA,NA
29050231,NA,1,foretinib,2,30,mg,NA,NA,NA
29050231,NA,1,erlotinib,3,150,mg,NA,NA,NA
29050231,NA,1,erlotinib,3,150,mg,NA,NA,NA
29050231,NA,1,foretinib,3,45,mg,NA,NA,NA
29050231,NA,1,erlotinib,3expansion,150,mg,NA,NA,NA
29050231,NA,1,erlotinib,3expansion,150,mg,NA,NA,NA
29050231,NA,1,foretinib,3expansion,45,mg,NA,NA,NA
29050231,NA,1,erlotinib,2expansion,150,mg,NA,NA,NA
29050231,NA,1,erlotinib,2expansion,150,mg,NA,NA,NA
29050231,NA,1,foretinib,2expansion,30,mg,NA,NA,NA
29050231,NA,1,erlotinib,1expansion,150,mg,NA,NA,NA
29050231,NA,1,erlotinib,1expansion,150,mg,NA,NA,NA
29050231,NA,1,foretinib,1expansion,30,mg,NA,NA,NA
27036206,NCT00966472,1,erlotinib,NA,150,mg,1,daily,fixed dose
27036206,NCT00966472,1,erlotinib,NA,150,mg,1,daily,fixed dose
27036206,NCT00966472,1,rosuvastatin,1,1,mg/kg/day,NA,"1 week off, thendaily for 2  weeks, then 1  week of in cycle 1","For all subsequent
cycles, rosuvastatin was given daily for the first 3 weeks
of each 28-day cycle"
27036206,NCT00966472,1,rosuvastatin,2,2,mg/kg/day,NA,NA,NA
27036206,NCT00966472,1,ubiquinone,NA,60,mg,4,if patientdeveloped grade 3 or 4 muscle toxicity and continueduntil recovery to baseline.,NA
27036206,NCT00966472,1,ubiquinone,NA,60,mg,4,if patientdeveloped grade 3 or 4 muscle toxicity and continueduntil recovery to baseline.,NA
27036206,NCT00966472,2,erlotinib,NA,150,mg,NA,alternating weekly schedule of rosuvastatin,fixed dose
27036206,NCT00966472,2,erlotinib,NA,150,mg,NA,alternating weekly schedule of rosuvastatin,fixed dose
27036206,NCT00966472,2,rosuvastatin,1,1,mg/kg/day,NA,alternating weekly schedule of rosuvastatin,NA
27036206,NCT00966472,2,ubiquinone,NA,NA,NA,NA,if patientdeveloped grade 3 or 4 muscle toxicity and continueduntil recovery to baseline.,NA
27036206,NCT00966472,2,ubiquinone,NA,NA,NA,NA,if patientdeveloped grade 3 or 4 muscle toxicity and continueduntil recovery to baseline.,NA
27853997,NCT00987766,1,erlotinib,0,50,mg,1,orally once daily for 5 days on days 3–8,Course 1 (two 14-day cycles)
27853997,NCT00987766,1,erlotinib,0,50,mg,1,orally once daily for 5 days on days 3–8,Course 1 (two 14-day cycles)
27853997,NCT00987766,1,gemcitabline,0,800,mg/m2,NA,10 mg/m2/min infusion on day 1,NA
27853997,NCT00987766,1,oxaliplatin,0,85,mg/m2,NA,2 h infusion on day 2 every two weeks,NA
27853997,NCT00987766,1,oxaliplatin,0,85,mg/m2,NA,2 h infusion on day 2 every two weeks,NA
27853997,NCT00987766,1,erlotinib,1,75,mg,NA,NA,NA
27853997,NCT00987766,1,erlotinib,1,75,mg,NA,NA,NA
27853997,NCT00987766,1,gemcitabline,1,800,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,1,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,1,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,erlotinib,2,100,mg,NA,NA,NA
27853997,NCT00987766,1,erlotinib,2,100,mg,NA,NA,NA
27853997,NCT00987766,1,gemcitabline,2,800,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,2,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,2,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,erlotinib,3,150,mg,NA,NA,NA
27853997,NCT00987766,1,erlotinib,3,150,mg,NA,NA,NA
27853997,NCT00987766,1,gemcitabline,3,800,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,3,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,3,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,erlotinib,4,150,mg,NA,NA,NA
27853997,NCT00987766,1,erlotinib,4,150,mg,NA,NA,NA
27853997,NCT00987766,1,gemcitabline,4,1000,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,4,85,mg/m2,NA,NA,NA
27853997,NCT00987766,1,oxaliplatin,4,85,mg/m2,NA,NA,NA
22271880,NA,1,erlotinib,1,50,mg,1,"""dailystarting as a 14-day run-in and continued until RT wascompleted""",NA
22271880,NA,1,erlotinib,1,50,mg,1,"""dailystarting as a 14-day run-in and continued until RT wascompleted""",NA
22271880,NA,1,erlotinib,2,100,mg,NA,NA,NA
22271880,NA,1,erlotinib,2,100,mg,NA,NA,NA
22271880,NA,1,erlotinib,3,150,mg,NA,NA,NA
22271880,NA,1,erlotinib,3,150,mg,NA,NA,NA
22271880,NA,1,odansetron,NA,8,mg/m2,NA,was administeredbefore cisplatin,NA
22271880,NA,1,cisplatin,1,6,mg/m2,NA,"over 20minutes, 3 hours before RT;wasstarted together with radiotherapy on day 15 and given for 5doses each week (Monday–Friday) for a total of 35 doses(thus cumulative cisplatin dose was 210 mgs/m2)",fixed dose
22271880,NA,1,cisplatin,1,6,mg/m2,NA,"over 20minutes, 3 hours before RT;wasstarted together with radiotherapy on day 15 and given for 5doses each week (Monday–Friday) for a total of 35 doses(thus cumulative cisplatin dose was 210 mgs/m2)",fixed dose
22271880,NA,1,cisplatin,2,6,mg/m2,NA,NA,NA
22271880,NA,1,cisplatin,2,6,mg/m2,NA,NA,NA
22271880,NA,1,cisplatin,3,6,mg/m2,NA,NA,NA
22271880,NA,1,cisplatin,3,6,mg/m2,NA,NA,NA
22271880,NA,1,carboplatin,NA,25,mg/m2,NA,wassubstituted for cisplatin in the event of persistent elevationof creatinine to more than 1.5 mg/dL despite prehydrationor for grade 2 or more electrolyte wasting,NA
22271880,NA,1,carboplatin,NA,25,mg/m2,NA,wassubstituted for cisplatin in the event of persistent elevationof creatinine to more than 1.5 mg/dL despite prehydrationor for grade 2 or more electrolyte wasting,NA
22271880,NA,1,radiotherapy,1,70,Gy,NA,daily for 5 daysper week starting on day 15 to a total dose of 66 to 70 Gy in 2Gy daily fractions over 7 weeks.,NA
22271880,NA,1,radiotherapy,1,70,Gy,NA,NA,NA
33159216,NCT00770263,1,erlotinib,1A,100,mg,1,orally daily,NA
33159216,NCT00770263,1,erlotinib,1A,100,mg,1,orally daily,NA
33159216,NCT00770263,1,temsirolimus,1A,10,mg,NA,weekly,NA
33159216,NCT00770263,1,"prophylactic
minocycline",NA,50,mg,2,was started on cycle1 day 1 for erlotinib-induced rash,NA
33159216,NCT00770263,1,erlotinib,1,100,mg,1,orally daily,NA
33159216,NCT00770263,1,erlotinib,1,100,mg,1,orally daily,NA
33159216,NCT00770263,1,temsirolimus,1,15,mg,NA,weekly,NA
33159216,NCT00770263,1,erlotinib,2,100,mg,1,orally daily,NA
33159216,NCT00770263,1,erlotinib,2,100,mg,1,orally daily,NA
33159216,NCT00770263,1,temsirolimus,2,20,mg,NA,weekly,NA
33159216,NCT00770263,1,erlotinib,3,100,mg,1,orally daily,NA
33159216,NCT00770263,1,erlotinib,3,100,mg,1,orally daily,NA
33159216,NCT00770263,1,temsirolimus,3,25,mg,NA,weekly,NA
33159216,NCT00770263,1,erlotinib,Dose expansion phase,100,mg,1,orally daily,NA
33159216,NCT00770263,1,erlotinib,Dose expansion phase,100,mg,1,orally daily,NA
33159216,NCT00770263,1,temsirolimus,Dose expansion phase,25,mg,NA,weekly,NA
24429877,NCT00738751,1,panobinostat,1,20,mg,NA,per ostwice weekly for 2 out of 3 weeks,Each cycle was defined as a 21-day period
24429877,NCT00738751,1,erlotinib,1,100,mg,NA,per osdaily,NA
24429877,NCT00738751,1,erlotinib,1,100,mg,NA,per osdaily,NA
24429877,NCT00738751,1,panobinostat,2,30,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,2,100,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,2,100,mg,NA,NA,NA
24429877,NCT00738751,1,panobinostat,3,30,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,3,150,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,3,150,mg,NA,NA,NA
24429877,NCT00738751,1,panobinostat,4,40,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,4,150,mg,NA,NA,NA
24429877,NCT00738751,1,erlotinib,4,150,mg,NA,NA,NA
22237261,NA,1,erlotinib,NA,150,mg,1,daily in 28-day cycles,NA
22237261,NA,1,erlotinib,NA,150,mg,1,daily in 28-day cycles,NA
22237261,NA,1,cixutumumab,1,6,mg/kg,1,daily in 28-day cycles,NA
22237261,NA,1,cixutumumab,2,5,mg/kg,NA,"on days 1, 8, 15, and 22 in 28-day cycles",NA
22237261,NA,1,cixutumumab,3,15,mg/kg,NA,21-day cycles,NA
22547007,NCT00266097,1,oxaliplatin,-1,30,mg/m2/wk,NA,once weekly for a maximum of 6 weeks,NA
22547007,NCT00266097,1,oxaliplatin,-1,30,mg/m2/wk,NA,once weekly for a maximum of 6 weeks,NA
22547007,NCT00266097,1,gemcitabine,-1,60,mg/m2/wk,NA,once weekly for a maximum of 6 weeks,NA
22547007,NCT00266097,1,"standard
radiotherapy",NA,54,Gy,1,daily,all patients received RT to 50.4 Gy
22547007,NCT00266097,1,oxaliplatin,1,30,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,1,30,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,gemcitabine,1,100,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,2,30,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,2,30,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,gemcitabine,2,200,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,3,45,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,3,45,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,gemcitabine,3,200,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,4,50,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,oxaliplatin,4,50,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,1,gemcitabine,4,200,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,2,oxaliplatin,-1,30,mg/m2/wk,NA,wasadministered over 2 hours weekly,NA
22547007,NCT00266097,2,oxaliplatin,-1,30,mg/m2/wk,NA,wasadministered over 2 hours weekly,NA
22547007,NCT00266097,2,gemcitabine,-1,60,mg/m2,NA,administered over 30 minutes weekly,NA
22547007,NCT00266097,2,erlotinib,-1,50,mg,1,daily beginning on day1,NA
22547007,NCT00266097,2,erlotinib,-1,50,mg,1,daily beginning on day1,NA
22547007,NCT00266097,2,"standard
radiotherapy",NA,54,Gy,1,daily,all patients received RT to 50.4 Gy
22547007,NCT00266097,2,oxaliplatin,1,45,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,2,oxaliplatin,1,45,mg/m2/wk,NA,NA,NA
22547007,NCT00266097,2,gemcitabine,1,100,mg/m2,NA,NA,NA
22547007,NCT00266097,2,erlotinib,1,50,mg,NA,NA,NA
22547007,NCT00266097,2,erlotinib,1,50,mg,NA,NA,NA
21791058,NCT01235416,1,gemcitabine,1,1000,mg/m2,NA,"7 weeks (cycle 1) or 3 weeks (cycles 2-11), followed by 1week of rest",NA
21791058,NCT01235416,1,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,1,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,2,gemcitabine,1,1000,mg/m2,NA,"7 weeks (cycle 1) or 3 weeks (cycles 2-11), followed by 1week of rest",NA
21791058,NCT01235416,2,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,2,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,2,motesanib,1,50,mg,1,QD;on day 2 of week 2 of thefirst cycle and continued throughout the study,NA
21791058,NCT01235416,2,gemcitabine,2,1000,mg/m2,1,QD,NA
21791058,NCT01235416,2,erlotinib,2,100,mg,1,QD,NA
21791058,NCT01235416,2,erlotinib,2,100,mg,1,QD,NA
21791058,NCT01235416,2,motesanib,2,75,mg,2,BID,NA
21791058,NCT01235416,2,gemcitabine,3,1000,mg/m2,1,QD,NA
21791058,NCT01235416,2,erlotinib,3,100,mg,1,QD,NA
21791058,NCT01235416,2,erlotinib,3,100,mg,1,QD,NA
21791058,NCT01235416,2,motesanib,3,125,mg,1,QD,NA
21791058,NCT01235416,2,gemcitabine,4,1000,mg/m2,1,QD,NA
21791058,NCT01235416,2,erlotinib,4,100,mg,1,QD,NA
21791058,NCT01235416,2,erlotinib,4,100,mg,1,QD,NA
21791058,NCT01235416,2,motesanib,4,100,mg,1,QD,NA
21791058,NCT01235416,3,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,3,erlotinib,1,100,mg,1,QD,NA
21791058,NCT01235416,3,motesanib,1,100,mg,1,QD,NA
21791058,NCT01235416,3,erlotinib,2,150,mg,1,QD,NA
21791058,NCT01235416,3,erlotinib,2,150,mg,1,QD,NA
21791058,NCT01235416,3,motesanib,2,125,mg,1, QD,NA
25521398,NA,1,dacomitinib,1,30,mg,1,"During phase I, a single lead-in dose of dacomitinibwas administered between completion of screening and day−9. Assigned treatment was then initiated on day 1.",NA
25521398,NA,1,dacomitinib,2,45,mg,1,NA,NA
28761738,NA,1,metformin,1,2000,mg,NA,"starting with a dose of 500 mg twice a day, orally withmeals (day 0). At day 4, a metformin dose increase wasplanned at 500 mg three times a day. At day 8, metforminwas increased to 1000 mg twice a day.",NA
28761738,NA,1,erlotinib,1,150,mg,1,At day 12,NA
28761738,NA,1,erlotinib,1,150,mg,1,At day 12,NA
28761738,NA,1,metformin,2,1500,mg,NA,NA,NA
28761738,NA,1,erlotinib,2,150,mg,NA,NA,NA
28761738,NA,1,erlotinib,2,150,mg,NA,NA,NA
29843755,NCT00769483,1,gemcitabine,1,1000,mg/m2,NA,"Day1,8,15",NA
29843755,NCT00769483,1,mk-0646,1,5,mg/kg,NA,"Day1,8,15,22",NA
29843755,NCT00769483,1,gemcitabine,2,1000,mg/m2,NA,"Day1,8,15",NA
29843755,NCT00769483,1,mk-0646,2,10,mg/kg,NA,"Day1,8,15,22",NA
29843755,NCT00769483,2,gemcitabine,1,1000,mg/m2,NA,"Day1,8,15",NA
29843755,NCT00769483,2,mk-0646,1,5,mg/kg,NA,"Day1,8,15,22",NA
29843755,NCT00769483,2,erlotinib,1,100,mg,NA,Day1-28,NA
29843755,NCT00769483,2,erlotinib,1,100,mg,NA,Day1-28,NA
29843755,NCT00769483,2,gemcitabine,2,1000,mg/m2,NA,"Day1,8,15",NA
29843755,NCT00769483,2,mk-0646,2,10,mg/kg,NA,"Day1,8,15,22",NA
29843755,NCT00769483,2,erlotinib,2,10,mg,NA,Day1-28,NA
29843755,NCT00769483,2,erlotinib,2,10,mg,NA,Day1-28,NA
23135778,NCT00619424,1,pazopanib,0,400,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,0,100,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,0,100,mg,1,QD,NA
23135778,NCT00619424,1,pazopanib,1,400,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,1,150,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,1,150,mg,1,QD,NA
23135778,NCT00619424,1,pazopanib,2,600,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,2,150,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,2,150,mg,1,QD,NA
23135778,NCT00619424,1,pazopanib,3,800,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,3,150,mg,1,QD,NA
23135778,NCT00619424,1,erlotinib,3,150,mg,1,QD,NA
32943457,NA,1,green tea ppe,NA,200,mg,NA,three times a day,fixed dose
32943457,NA,1,erlotinib,1,50,mg,1,daily,NA
32943457,NA,1,erlotinib,1,50,mg,1,daily,NA
32943457,NA,1,erlotinib,2,75,mg,1, daily,NA
32943457,NA,1,erlotinib,2,75,mg,1, daily,NA
32943457,NA,1,erlotinib,3,100,mg,1, daily,NA
32943457,NA,1,erlotinib,3,100,mg,1, daily,NA
28971268,NCT01839955,1,erlotinib,-1,150,mg,1,daily,"For Cycle1,
patients received 7 days of erlotinib (150 mg daily) alone
before starting combination of quinacrine and erlotinib.. Erlotinib was administered at
fixed continuous daily dose of 150 mg orally for 28 days, after
this initial phase in cycle 1."
28971268,NCT01839955,1,erlotinib,-1,150,mg,1,daily,"For Cycle1,
patients received 7 days of erlotinib (150 mg daily) alone
before starting combination of quinacrine and erlotinib.. Erlotinib was administered at
fixed continuous daily dose of 150 mg orally for 28 days, after
this initial phase in cycle 1."
28971268,NCT01839955,1,quinacrine,-1,50,mg,3,LoadingDose:TID for 7 days;,NA
28971268,NCT01839955,1,quinacrine,-1,50,mg,NA,Maintenace dose::every other day for three weeks (day 8 to 28),NA
28971268,NCT01839955,1,erlotinib,1,150,mg,1,daily,NA
28971268,NCT01839955,1,erlotinib,1,150,mg,1,daily,NA
28971268,NCT01839955,1,quinacrine,1,50,mg,3,LoadingDose:TID for 7 days;,NA
28971268,NCT01839955,1,quinacrine,1,50,mg,NA,Maintenace dose::every other day for three weeks (day 8 to 28),NA
28971268,NCT01839955,1,erlotinib,2,150,mg,1,daily,NA
28971268,NCT01839955,1,erlotinib,2,150,mg,1,daily,NA
28971268,NCT01839955,1,quinacrine,2,100,mg,3,LoadingDose:TID for 7 days;,NA
28971268,NCT01839955,1,quinacrine,2,100,mg,NA,Maintenace dose::every other day for three weeks (day 8 to 28),NA
28971268,NCT01839955,1,erlotinib,3,150,mg,1,daily,NA
28971268,NCT01839955,1,erlotinib,3,150,mg,1,daily,NA
28971268,NCT01839955,1,quinacrine,3,150,mg,3,LoadingDose:TID for 7 days;,NA
28971268,NCT01839955,1,quinacrine,3,200,mg,NA,Maintenace dose::every other day for three weeks (day 8 to 28),NA
28971268,NCT01839955,1,erlotinib,4,150,mg,1,daily,NA
28971268,NCT01839955,1,erlotinib,4,150,mg,1,daily,NA
28971268,NCT01839955,1,quinacrine,4,200,mg,3,LoadingDose:TID for 7 days;,NA
28971268,NCT01839955,1,quinacrine,4,400,mg,NA,Maintenace dose::every other day for three weeks (day 8 to 28),NA
24496004,NCT00777699,1,sar245409,1,30,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,1,100,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,1,100,mg,1,QD,NA
24496004,NCT00777699,1,sar245409,2,50,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,2,100,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,2,100,mg,1,QD,NA
24496004,NCT00777699,1,sar245409,3,70,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,3,100,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,3,100,mg,1,QD,NA
24496004,NCT00777699,1,sar245409,4,90,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,4,100,mg,1,QD,NA
24496004,NCT00777699,1,erlotinib,4,100,mg,1,QD,NA
24496004,NCT00777699,2,sar245409,1,20,mg,2,BID,NA
24496004,NCT00777699,2,erlotinib,1,100,mg,1,QD,NA
24496004,NCT00777699,2,erlotinib,1,100,mg,1,QD,NA
24496004,NCT00777699,2,sar245409,2,30,mg,2,BID,NA
24496004,NCT00777699,2,erlotinib,2,100,mg,1,QD,NA
24496004,NCT00777699,2,erlotinib,2,100,mg,1,QD,NA
27697581,NCT00965731,1,erlotinib,-1,100,mg,1,starting between day -14 and -7,NA
27697581,NCT00965731,1,erlotinib,-1,100,mg,1,starting between day -14 and -7,NA
27697581,NCT00965731,1,crizotinib,-1,150,mg,2,continuously beginning on day 1 of treatmentcycle 1,NA
27697581,NCT00965731,1,erlotinib,1,100,mg,1,starting between day -14 and -7,NA
27697581,NCT00965731,1,erlotinib,1,100,mg,1,starting between day -14 and -7,NA
27697581,NCT00965731,1,crizotinib,1,200,mg,2,continuously beginning on day 1 of treatmentcycle 1,NA
24901237,NCT00725634,1,ficlatuzumab,1,2,mg/kg,NA,over 60 min once per 14-day cycle,NA
24901237,NCT00725634,1,ficlatuzumab,2,5,mg/kg,NA,over 60 min once per 14-day cycle,NA
24901237,NCT00725634,1,ficlatuzumab,3,10,mg/kg,NA,over 60 min once per 14-day cycle,NA
24901237,NCT00725634,1,ficlatuzumab,4,20,mg/kg,NA,over 60 min once per 14-day cycle,NA
21778302,NA,1,erlotinib,1,100,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,erlotinib,1,100,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,cisplatin,1,30,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,cisplatin,1,30,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,radiotherapy,1,63,Gy,NA,Radiation therapy was administered in conventional 1.8Gy/day fractions 5 days/week to a total dose of 63 Gy to the surgical bedand regional lymph node areas.,NA
21778302,NA,1,erlotinib,2,150,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,erlotinib,2,150,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,cisplatin,2,30,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,cisplatin,2,30,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,radiotherapy,2,63,Gy,NA,Radiation therapy was administered in conventional 1.8Gy/day fractions 5 days/week to a total dose of 63 Gy to the surgical bedand regional lymph node areas.,NA
21778302,NA,1,erlotinib,3,150,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,erlotinib,3,150,mg/day,1,once a day for seven consecutive weeks,NA
21778302,NA,1,cisplatin,3,40,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,cisplatin,3,40,mg/m2/week,NA,"at day 1of each week, for seven consecutive weeks.",NA
21778302,NA,1,radiotherapy,3,63,Gy,NA,Radiation therapy was administered in conventional 1.8Gy/day fractions 5 days/week to a total dose of 63 Gy to the surgical bedand regional lymph node areas.,NA
25441058,NCT00761345,1,radiotherapy,1,40,cGy,2,"twicedaily at least 4 h apart on days 1, 2, 8, and 9 of each 21 day cycle.",NA
25441058,NCT00761345,1,gemcitabine,1,1000,mg/m2,NA,over 30 min on days 1 and 8 of each 21 day cycle.,NA
25441058,NCT00761345,1,erlotinib,1,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,erlotinib,1,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,radiotherapy,2,50,cGy,2,"twicedaily at least 4 h apart on days 1, 2, 8, and 9 of each 21 day cycle.",NA
25441058,NCT00761345,1,gemcitabine,2,1000,mg/m2,NA,over 30 min on days 1 and 8 of each 21 day cycle.,NA
25441058,NCT00761345,1,erlotinib,2,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,erlotinib,2,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,radiotherapy,3,60,cGy,2,"twicedaily at least 4 h apart on days 1, 2, 8, and 9 of each 21 day cycle.",NA
25441058,NCT00761345,1,gemcitabine,3,1000,mg/m2,NA,over 30 min on days 1 and 8 of each 21 day cycle.,NA
25441058,NCT00761345,1,erlotinib,3,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,erlotinib,3,100,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,radiotherapy,4,60,cGy,2,"twicedaily at least 4 h apart on days 1, 2, 8, and 9 of each 21 day cycle.",NA
25441058,NCT00761345,1,gemcitabine,4,1000,mg/m2,NA,over 30 min on days 1 and 8 of each 21 day cycle.,NA
25441058,NCT00761345,1,erlotinib,4,150,mg/day,NA,once daily continuously duringtreatment.,NA
25441058,NCT00761345,1,erlotinib,4,150,mg/day,NA,once daily continuously duringtreatment.,NA
31570268,NCT01650506,1,metformin,-1,500,mg,NA,daily wk 1; twicedaily thereafter (1000 mg),NA
31570268,NCT01650506,1,erlotinib,-1,150,mg,1,daily,NA
31570268,NCT01650506,1,erlotinib,-1,150,mg,1,daily,NA
31570268,NCT01650506,1,metformin,0,850,mg,NA,"daily wk 1;""daily wk 1; twicedaily thereafter (1700 mg)""",NA
31570268,NCT01650506,1,erlotinib,0,150,mg,1,daily,NA
31570268,NCT01650506,1,erlotinib,0,150,mg,1,daily,NA
31570268,NCT01650506,1,metformin,1,850,mg,NA,daily wk 1;twicedaily wk 2;3 times dailythereafter (2550 mg),NA
31570268,NCT01650506,1,erlotinib,1,150,mg,1,daily,NA
31570268,NCT01650506,1,erlotinib,1,150,mg,1,daily,NA
21220471,NCT00225121,1,pf299804,1,0.5,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,2,1,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,3,2,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,4,4,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,5,8,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,6,16,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,7,30,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,8,45,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,1,pf299804,9,45,mg/d,NA,a loading dose ofPF299804 at the schedule A MTD administered twicedaily for 3 days followed by QD dosing at the scheduleA MTD for the rest of cycle 1 and subsequent cycles,NA
21220471,NCT00225121,1,pf299804,10,60,mg/d,1,once daily continuously (schedule A) ,NA
21220471,NCT00225121,2,pf299804,1,60,mg/d,NA,intermittently (schedule B),NA
19786667,NCT00153933,1,lenalidomide,1,5,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
19786667,NCT00153933,1,lenalidomide,2,5,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
19786667,NCT00153933,1,lenalidomide,3,10,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
19786667,NCT00153933,1,lenalidomide,4,10,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
19786667,NCT00153933,1,lenalidomide,5,15,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,5,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
19786667,NCT00153933,1,lenalidomide,6,15,mg,1,on days 1 through 14 of a 21-day cycle,NA
19786667,NCT00153933,1,bortezomib,6,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
20150632,NA,2,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,1,750,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20150632,NA,2,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20150632,NA,2,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,3,1250,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20150632,NA,2,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20150632,NA,2,bortezomib,5,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,5,1250,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20150632,NA,2,bortezomib,6,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
20150632,NA,2,gemcitabine,6,1500,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20378507,NA,3,bortezomib,1,0.7,mg/m2,1,"on days 1, 4, 8, and 11 every 21 days for 2 cycles",NA
20378507,NA,3,5-fu,1,225,mg/m2,1,continuously begun on day 2,NA
20378507,NA,3,radiation,1,180,cGy,1,on days 1-5 every 21 days,NA
20378507,NA,3,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8, and 11 every 21 days for 2 cycles",NA
20378507,NA,3,5-fu,2,225,mg/m2,1,continuously begun on day 2,NA
20378507,NA,3,radiation,2,180,cGy,1,on days 1-5 every 21 days,NA
19774377,NA,4,bortezomib,-1,0.6,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,-1,80,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,1,0.6,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,1,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,1.5,0.8,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,1.5,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,2,0.8,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,2,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,3,1.2,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,3,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,4,1.6,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,4,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,5,1.8,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,5,100,mg/m2,1,on day 8 of a 21 day cycle,NA
19774377,NA,4,bortezomib,6,2,mg/m2,1,on days 2 and 9 of a 21 day cycle,NA
19774377,NA,4,paclitaxel,6,100,mg/m2,1,on day 8 of a 21 day cycle,NA
21447728,NA,5,alvocidib,1,40,mg/m2,1,on days 1 and 8 of a3-week cyle,NA
21447728,NA,5,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 3-week cycle",NA
21447728,NA,5,alvocidib,2,60,mg/m2,1,on days 1 and 8 of a3-week cyle,NA
21447728,NA,5,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 3-week cycle",NA
21447728,NA,5,alvocidib,3,80,mg/m2,1,on days 1 and 8 of a3-week cyle,NA
21447728,NA,5,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 3-week cycle",NA
21596852,NCT00724568,6,lenalidomide,1,15,mg,1,on days1-14 of each 21-day cycle,NA
21596852,NCT00724568,6,bortezomib,1,1.3,mg/m2,1,"ondays 1, 4, 8, and 11 of  each 21-day cycle",NA
21596852,NCT00724568,6,dexamethasone,1,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
21596852,NCT00724568,6,pegylated liposomal doxorubicin,1,20,mg/m2,1,on day 4 of each 21-day cycle,NA
21596852,NCT00724568,6,lenalidomide,2,20,mg,1,on days1-14 of each 21-day cycle,NA
21596852,NCT00724568,6,bortezomib,2,1.3,mg/m2,1,"ondays 1, 4, 8, and 11 of  each 21-day cycle",NA
21596852,NCT00724568,6,dexamethasone,2,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
21596852,NCT00724568,6,pegylated liposomal doxorubicin,2,20,mg/m2,1,on day 4 of each 21-day cycle,NA
21596852,NCT00724568,6,lenalidomide,3,25,mg,1,on days1-14 of each 21-day cycle,NA
21596852,NCT00724568,6,bortezomib,3,1.3,mg/m2,1,"ondays 1, 4, 8, and 11 of  each 21-day cycle",NA
21596852,NCT00724568,6,dexamethasone,3,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
21596852,NCT00724568,6,pegylated liposomal doxorubicin,3,20,mg/m2,1,on day 4 of each 21-day cycle,NA
21596852,NCT00724568,6,lenalidomide,4,25,mg,1,on days1-14 of each 21-day cycle,NA
21596852,NCT00724568,6,bortezomib,4,1.3,mg/m2,1,"ondays 1, 4, 8, and 11 of  each 21-day cycle",NA
21596852,NCT00724568,6,dexamethasone,4,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
21596852,NCT00724568,6,pegylated liposomal doxorubicin,4,30,mg/m2,1,on day 4 of each 21-day cycle,NA
21680752,NA,7,bortezomib,1,0.7,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,paclitaxel,1,40,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,bortezomib,2,0.75,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,paclitaxel,2,45,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,bortezomib,3,0.86,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,paclitaxel,3,51,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,bortezomib,4,1,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,paclitaxel,4,60,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,bortezomib,5,1,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21680752,NA,7,paclitaxel,5,60,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
21911830, NCT00431990,8,romidepsin,1,8,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,bortezomib,1,1.3,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,dexamethasone,1,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,romidepsin,2,10,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,bortezomib,2,1.3,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,dexamethasone,2,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,romidepsin,3,12,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,bortezomib,3,1.3,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,dexamethasone,3,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,romidepsin,4,14,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,bortezomib,4,1.3,mg/m2,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21911830, NCT00431990,8,dexamethasone,4,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and12 every 28 days",NA
21812533,NA,9,ibritumomab tiuxetan,1,5,mCi,1,on day 1,NA
21812533,NA,9,bortezomib,1,1,mg/m2,1,"on days 4, 8, 11 and 15",NA
21812533,NA,9,ibritumomab tiuxetan,2,5,mCi,1,on day 1,NA
21812533,NA,9,bortezomib,2,1.3,mg/m2,1,"on days 4, 8, 11 and 15",NA
21812533,NA,9,ibritumomab tiuxetan,3,5,mCi,1,on day 1,NA
21812533,NA,9,bortezomib,3,1.5,mg/m2,1,"on days 4, 8, 11 and 15",NA
22479278,NCT00379574,10,bortezomib,1,1,mg/m2,1,on day 1 and 4 every 14 days,NA
22479278,NCT00379574,10,cyclophosphamide,1,750,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,doxorubicin,1,50,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,vincristine,1,1.4,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,prednisolone,1,100,mg,1,on day 1 through 5 every 14 days,NA
22479278,NCT00379574,10,lenograstim,1,5,ug/kg,1,on day 4-13 every 14 days,NA
22479278,NCT00379574,10,lenograstim,1,5,ug/kg,1,on day 4-13 every 14 days,NA
22479278,NCT00379574,10,bortezomib,2,1.3,mg/m2,1,on day 1 and 4 every 14 days,NA
22479278,NCT00379574,10,cyclophosphamide,2,750,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,doxorubicin,2,50,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,vincristine,2,1.4,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,prednisolone,2,100,mg,1,on day 1 through 5 every 14 days,NA
22479278,NCT00379574,10,lenograstim,2,5,ug/kg,1,on day 4-13 every 14 days,NA
22479278,NCT00379574,10,lenograstim,2,5,ug/kg,1,on day 4-13 every 14 days,NA
22479278,NCT00379574,10,bortezomib,3,1.6,mg/m2,1,on day 1 and 4 every 14 days,NA
22479278,NCT00379574,10,cyclophosphamide,3,750,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,doxorubicin,3,50,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,vincristine,3,1.4,mg/m2,1,on day 1 every 14 days,NA
22479278,NCT00379574,10,prednisolone,3,100,mg,1,on day 1 through 5 every 14 days,NA
22479278,NCT00379574,10,lenograstim,3,5,ug/kg,1,on day 4-13 every 14 days,NA
22479278,NCT00379574,10,lenograstim,3,5,ug/kg,1,on day 4-13 every 14 days,NA
22534815,NA,11,bortezomib,1,1.3,mg/m2,1,on day 1 and day 8 every 3 weeks,NA
22534815,NA,11,bevacizumab,1,15,mg/kg,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,1,6,AUC,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,1,6,AUC,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,bortezomib,2,1.6,mg/m2,1,on day 1 and day 8 every 3 weeks,NA
22534815,NA,11,bevacizumab,2,15,mg/kg,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,2,6,AUC,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,2,6,AUC,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,bortezomib,3,1.8,mg/m2,1,on day 1 and day 8 every 3 weeks,NA
22534815,NA,11,bevacizumab,3,16,mg/kg,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,3,6,AUC,1,on day 1 of every 21-day cycle,NA
22534815,NA,11,carboplatin,3,6,AUC,1,on day 1 of every 21-day cycle,NA
22291084,NCT00726869,12,elotuzumab,1,2.5,mg/kg,1,on days 1 and 11 of a 21-day cycle,NA
22291084,NCT00726869,12,bortezomib,1,1.3,mg/m2,1,"on days1,4, 8, and 11 of a 21-day cycle",NA
22291084,NCT00726869,12,elotuzumab,2,5,mg/kg,1,on days 1 and 11 of a 21-day cycle,NA
22291084,NCT00726869,12,bortezomib,2,1.3,mg/m2,1,"on days1,4, 8, and 11 of a 21-day cycle",NA
22291084,NCT00726869,12,elotuzumab,3,10,mg/kg,1,on days 1 and 11 of a 21-day cycle,NA
22291084,NCT00726869,12,bortezomib,3,1.3,mg/m2,1,"on days1,4, 8, and 11 of a 21-day cycle",NA
22291084,NCT00726869,12,elotuzumab,4,20,mg/kg,1,on days 1 and 11 of a 21-day cycle,NA
22291084,NCT00726869,12,bortezomib,4,1.3,mg/m2,1,"on days1,4, 8, and 11 of a 21-day cycle",NA
22677155, NCT00294632,13,lenalidomide,1,10,mg,1,on days 1–21 of each 28-day cycle,NA
22677155, NCT00294632,13,rituximab,1,375,mg/m2,1,"once per week for 4 weeks only during cycle 1, beginning on day 1",NA
22677155, NCT00294632,13,lenalidomide,2,15,mg,1,on days 1–21 of each 28-day cycle,NA
22677155, NCT00294632,13,rituximab,2,375,mg/m2,1,"once per week for 4 weeks only during cycle 1, beginning on day 1",NA
22677155, NCT00294632,13,lenalidomide,3,20,mg,1,on days 1–21 of each 28-day cycle,NA
22677155, NCT00294632,13,rituximab,3,375,mg/m2,1,"once per week for 4 weeks only during cycle 1, beginning on day 1",NA
22677155, NCT00294632,13,lenalidomide,4,25,mg,1,on days 1–21 of each 28-day cycle,NA
22677155, NCT00294632,13,rituximab,4,375,mg/m2,1,"once per week for 4 weeks only during cycle 1, beginning on day 1",NA
22535574,NA,14,bortezomib,0,1,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,rituximab,0,375,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,doxorubicin,0,50,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,cyclophosphamide,0,750,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,vincristine,0,1.5,mg,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,prednisone,0,100,mg,1,on days 1-5 every 21 days,NA
22535574,NA,14,bortezomib,1,1.3,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,rituximab,1,375,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,doxorubicin,1,50,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,cyclophosphamide,1,750,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,vincristine,1,1.5,mg,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,prednisone,1,100,mg,1,on days 1-5 every 21 days,NA
22535574,NA,14,bortezomib,2,1.6,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,rituximab,2,375,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,doxorubicin,2,50,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,cyclophosphamide,2,750,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,vincristine,2,1.5,mg,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,prednisone,2,100,mg,1,on days 1-5 every 21 days,NA
22535574,NA,14,bortezomib,3,1.6,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,rituximab,3,375,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,doxorubicin,3,50,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,cyclophosphamide,3,750,mg/m2,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,vincristine,3,2,mg,1,on days 1 and 8 every 21 days,NA
22535574,NA,14,prednisone,3,100,mg,1,on days 1-5 every 21 days,NA
23150919,NA,15,bendamustine,1,50,mg/m2,1,on days 1 and 4 of each 28-d treatment cycle,NA
23150919,NA,15,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 28-d treatment cycle",NA
23150919,NA,15,bendamustine,2,70,mg/m2,1,on days 1 and 4 of each 28-d treatment cycle,NA
23150919,NA,15,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 28-d treatment cycle",NA
23150919,NA,15,bendamustine,3,90,mg/m2,1,on days 1 and 4 of each 28-d treatment cycle,NA
23150919,NA,15,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 28-d treatment cycle",NA
22906230,NA,16,"y-90-ibritumomab 
tiuxetan",1,0.4,mCi.kg,1,on day 15,NA
22906230,NA,16,bortezomib,1,1,mg/m2,1,"on days 1, 8, 15 and 22",NA
22906230,NA,16,rituximab,1,250,mg,1,on days 8 and 15,NA
22906230,NA,16,"y-90-ibritumomab 
tiuxetan",2,0.4,mCi/kg,1,on day 15,NA
22906230,NA,16,bortezomib,2,1.3,mg/m2,1,"on days 1, 8, 15 and 22",NA
22906230,NA,16,rituximab,2,250,mg,1,on days 8 and 15,NA
22906230,NA,16,"y-90-ibritumomab 
tiuxetan",3,0.4,mCi.kg,1,on day 15,NA
22906230,NA,16,bortezomib,3,1.6,mg/m2,1,"on days 1, 8, 15 and 22",NA
22906230,NA,16,rituximab,3,250,mg,1,on days 8 and 15,NA
23322195,NCT00720148,17,bortezomib,1,1,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,1,25,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,2,1,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,2,37.5,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,3,1,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,3,50,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,4,1.3,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,4,50,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,5,1.3,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,5,37.5,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,6,1.6,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,6,37.5,mg,1,daily for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,bortezomib,7,1.9,mg/m2,1,weekly for 4 weeks every 6 weeks,NA
23322195,NCT00720148,17,sunitinib,7,37.5,mg,1,daily for 4 weeks every 6 weeks,NA
23243282,NCT00833833,18,pomalidomide,1,2,mg,1,on days 1 to 21 of each 28-day cycle,NA
23243282,NCT00833833,18,pomalidomide,2,3,mg,1,on days 1 to 21 of each 28-day cycle,NA
23243282,NCT00833833,18,pomalidomide,3,4,mg,1,on days 1 to 21 of each 28-day cycle,NA
23243282,NCT00833833,18,pomalidomide,4,5,mg,1,on days 1 to 21 of each 28-day cycle,NA
23256542, NCT00103272,19,17-allyamino-17-demethoxygeldanamycin,1,150,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
23256542, NCT00103272,19,bortezomib,1,0.7,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
23256542, NCT00103272,19,17-allyamino-17-demethoxygeldanamycin,2,200,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
23256542, NCT00103272,19,bortezomib,2,0.7,mg/m2,1,"on days 1, 4, 8 and 11 of each 21-day cycle",NA
23887852,NCT00303797,20,sorafenib,-1,200,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,-1,0.5,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,0,200,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,0,0.75,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,1,200,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,1,1,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,2,200,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,2,1.3,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,3,400,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,3,1.3,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,4,400,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,4,1.5,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23887852,NCT00303797,20,sorafenib,5,400,mg,2,daily,NA
23887852,NCT00303797,20,bortezomib,5,1.7,mg/m2,1,"y on days 1, 4, 8, 11of a 3-week cycle",NA
23543109,NA,21,tanespimycin,1,100,mg/m2,1,"on days 1, 4, 8, and 11 every 21 days",NA
23543109,NA,21,bortezomib,1,0.7,mg/m2,1,"on days 4, 8, and 11 every 21 days",NA
23543109,NA,21,tanespimycin,2,250,mg/m2,1,"on days 1, 4, 8, and 11 every 21 days",NA
23543109,NA,21,bortezomib,2,1,mg/m2,1,"on days 4, 8, and 11 every 21 days",NA
23543109,NA,21,tanespimycin,3,250,mg/m2,1,"on days 1, 4, 8, and 11 every 21 days",NA
23543109,NA,21,bortezomib,3,1.3,mg/m2,1,"on days 4, 8, and 11 every 21 days",NA
24019544,NCT00532389,22,panobinostat,1,10,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,1,1,mg/m2,1,twice weekly for 2 weeks,NA
24019544,NCT00532389,22,panobinostat,2,20,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,2,1,mg/m2,1,twice weekly for 2 weeks,NA
24019544,NCT00532389,22,panobinostat,3,20,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,3,1.3,mg/m2,1,twice weekly for 2 weeks,NA
24019544,NCT00532389,22,panobinostat,4,30,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,4,1.3,mg/m2,1,twice weekly for 2 weeks,NA
24019544,NCT00532389,22,panobinostat,5,25,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,5,1.3,mg/m2,1,twice weekly for 2 weeks,NA
24019544,NCT00532389,22,panobinostat,6,20,mg,1,three timesper week every week,NA
24019544,NCT00532389,22,bortezomib,6,1.3,mg/m2,1,twice weekly for 2 weeks,NA
24075534,NCT00382954,23,idarubicin,1,10,mg/m2,1,"on days 1, 8, 15, and 22",NA
24075534,NCT00382954,23,bortezomib,1,0.8,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25",NA
24075534,NCT00382954,23,idarubicin,1.5,8,mg/m2,1,"on days 1, 8, 15, and 22",NA
24075534,NCT00382954,23,bortezomib,1.5,0.8,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25",NA
24075534,NCT00382954,23,idarubicin,2,8,mg/m2,1,"on days 1, 8, 15, and 22",NA
24075534,NCT00382954,23,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25",NA
24075534,NCT00382954,23,idarubicin,3,8,mg/m2,1,"on days 1, 8, 15, and 22",NA
24075534,NCT00382954,23,bortezomib,3,1.2,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25",NA
24114121,NA,24,vorinostat,1,400,mg,1,on days 1–14 every 21 days,NA
24114121,NA,24,bortezomib,1,0.7,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
24114121,NA,24,vorinostat,2,400,mg,1,on days 1–14 every 21 days,NA
24114121,NA,24,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
24114121,NA,24,vorinostat,3,400,mg,1,on days 1–14 every 21 days,NA
24114121,NA,24,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
24114121,NA,24,vorinostat,4,400,mg,1,on days 1–14 every 21 days,NA
24114121,NA,24,bortezomib,4,1.5,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
24114123,NA,25,vorinostat,-1,100,mg,2,on days 1–14 every 21 days,NA
24114123,NA,25,bortezomib,-1,0.7,mg/m2,1,"on day 1, 4, 8 and 11 every 21 days",NA
24114123,NA,25,vorinostat,1,200,mg,2,on days 1–14 every 21 days,NA
24114123,NA,25,bortezomib,1,1,mg/m2,1,"on day 1, 4, 8 and 11 every 21 days",NA
24114123,NA,25,vorinostat,1.5,200,mg,2,on days 1–4 and 8–11 every 21 days,NA
24114123,NA,25,bortezomib,1.5,1,mg/m2,1,"on day 1, 4, 8 and 11 every 21 days",NA
24114123,NA,25,vorinostat,2,200,mg,2,on days 1–4 and 8–11 every 21 days,NA
24114123,NA,25,bortezomib,2,1.3,mg/m2,1,"on day 1, 4, 8 and 11 every 21 days",NA
24114123,NA,25,vorinostat,3,300,mg,2,on days 1–4 and 8–11 every 21 days,NA
24114123,NA,25,bortezomib,3,1.3,mg/m2,1,"on day 1, 4, 8 and 11 every 21 days",NA
23665866,NA,26,bortezomib,1,0.7,mg/m2,1,ondays 1 and 8 every 21 days from cycle 2,NA
23665866,NA,26,epirubicin,1,50,mg/m2,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,capecitabine,1,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,capecitabine,1,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,bortezomib,2,1,mg/m2,1,ondays 1 and 8 every 21 days from cycle 2,NA
23665866,NA,26,epirubicin,2,50,mg/m2,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,capecitabine,2,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,capecitabine,2,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,bortezomib,3,1.3,mg/m2,1,ondays 1 and 8 every 21 days from cycle 2,NA
23665866,NA,26,epirubicin,3,50,mg/m2,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,capecitabine,3,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,capecitabine,3,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,bortezomib,4,1.6,mg/m2,1,ondays 1 and 8 every 21 days from cycle 2,NA
23665866,NA,26,epirubicin,4,50,mg/m2,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
23665866,NA,26,capecitabine,4,625,mg/m2,1,days 1–21every 21 days,NA
23665866,NA,26,capecitabine,4,625,mg/m2,1,days 1–21every 21 days,NA
24434781,NA,27,bortezomib,1,0.8,mg/m2,1,"on days -11,-8, -5, and -2",NA
24434781,NA,27,carmustine,1,300,mg/m2,1,on day -5,NA
24434781,NA,27,etoposide,1,100,mg/m2,2,"on days -5, -4, -3, and -2",NA
24434781,NA,27,cyatabine,1,100,mg/m2,2,"on days -5, -4, -3, and -2",NA
24434781,NA,27,melphalan,1,140,mg/m2,1,on day -1,NA
24434781,NA,27,bortezomib,2,1,mg/m2,1,"on days -11,-8, -5, and -2",NA
24434781,NA,27,bortezomib,2,300,mg/m2,1,on day -5,NA
24434781,NA,27,bortezomib,2,100,mg/m2,2,"on days -5, -4, -3, and -2",NA
24434781,NA,27,bortezomib,2,140,mg/m2,1,on day -1,NA
24434781,NA,27,bortezomib,3,1.3,mg/m2,1,"on days -11,-8, -5, and -2",NA
24434781,NA,27,bortezomib,3,300,mg/m2,1,on day -5,NA
24434781,NA,27,bortezomib,3,100,mg/m2,2,"on days -5, -4, -3, and -2",NA
24434781,NA,27,bortezomib,3,140,mg/m2,1,on day -1,NA
24434781,NA,27,bortezomib,4,1.5,mg/m2,1,"on days -11,-8, -5, and -2",NA
24434781,NA,27,bortezomib,4,300,mg/m2,1,on day -5,NA
24434781,NA,27,bortezomib,4,100,mg/m2,2,"on days -5, -4, -3, and -2",NA
24434781,NA,27,bortezomib,4,140,mg/m2,1,on day -1,NA
24429497,NCT01365559,28,carfilzomib,1,20,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
24429497,NCT01365559,28,carfilzomib,2,27,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
24429497,NCT01365559,28,carfilzomib,3,36,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
24429497,NCT01365559,28,carfilzomib,4,45,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,1,0.24,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,2,0.48,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,3,0.8,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,4,1.2,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,5,1.68,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,6,2.23,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,7,2.97,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
24904120,NCT00963820,29,ixazomib,8,3.95,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
25248382,NCT00082784,30,bortezomib,1,1,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,1,15,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,2,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,2,15,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,3,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,3,22,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,4,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,4,30,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,5,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,5,40,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,6,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,6,50,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,7,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,7,60,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,8,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,8,75,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,bortezomib,9,1.3,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25248382,NCT00082784,30,alvocidib,9,90,mg/m2,1,"On days 1, 4, 8, and 11 of a 3-week cycle",NA
25373733,NA,31,bevacizumab,1,2.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,1,0.7,mg/m2,1,"on days 1, and 8 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,2,2.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,2,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,3,5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,3,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,4,5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,4,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,5,7.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,5,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,6,7.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,6,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,7,10,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,7,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,8,12.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,8,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25373733,NA,31,bevacizumab,9,15,mg/kg,1,on day 1 of each 21-day cycle,NA
25373733,NA,31,bortezomib,9,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,bortezomib,-1,0.5,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,-1,120,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,-1,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,-1,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,-1,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,0,0.5,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,0,135,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,0,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,0,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,0,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,1,0.5,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,1,150,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,1,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,1,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,1,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,2,0.8,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,2,150,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,2,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,2,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,2,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,3,150,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,3,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,3,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,3,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,4,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,4,175,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,4,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,4,5,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,4,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,5,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,5,175,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,5,6,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,5,6,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,5,60,Gy,1,5 days per week,NA
25247339,NA,32,bortezomib,6,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25247339,NA,32,paclitaxel,6,175,mg/m2,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,6,6,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,carboplatin,6,6,AUC,1,on day 2 of each 21-day cycle,NA
25247339,NA,32,thoracic radiation,6,60,Gy,1,5 days per week,NA
24730538,NCT00777114,33,bortezomib,1,0.3,mg/m2,1,"on days 6, 10, 13, 16 and 20",NA
24730538,NCT00777114,33,131 i-tositumomab,1,50,cGy,1,on day 8,NA
24730538,NCT00777114,33,bortezomib,2,0.3,mg/m2,1,"on days 6, 10, 13, 16 and 20",NA
24730538,NCT00777114,33,131 i-tositumomab,2,75,cGy,1,on day 8,NA
24730538,NCT00777114,33,bortezomib,3,0.6,mg/m2,1,"on days 6, 10, 13, 16 and 20",NA
24730538,NCT00777114,33,131 i-tositumomab,3,75,cGy,1,on day 8,NA
24730538,NCT00777114,33,bortezomib,4,0.9,mg/m2,1,"on days 6, 10, 13, 16 and 20",NA
24730538,NCT00777114,33,131 i-tositumomab,4,75,cGy,1,on day 8,NA
24730538,NCT00777114,33,bortezomib,5,1.2,mg/m2,1,"on days 6, 10, 13, 16 and 20",NA
24730538,NCT00777114,33,131 i-tositumomab,5,75,cGy,1,on day 8,NA
25655379,NCT01309412,34,siltuximab,1,5.5,mg/kg,1,on day 1 of each 21-day cycle,NA
25655379,NCT01309412,34,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25655379,NCT01309412,34,dexamethasone,1,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
25655379,NCT01309412,34,siltuximab,2,11,mg/kg,1,on day 1 of each 21-day cycle,NA
25655379,NCT01309412,34,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
25655379,NCT01309412,34,dexamethasone,2,20,mg,1,"days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle",NA
25986244,NCT01078961,35,bortezomib,-1,1,mg/m2,1,"on days 1, 8 and 15 of each 28 day cycle",NA
25986244,NCT01078961,35,sorafenib,-1,200,mg,2,"on days 1, 8 and 15 of each 28 day cycle",NA
25986244,NCT01078961,35,bortezomib,1,1,mg/m2,1,"on days 1, 8 and 15 of each 28 day cycle",NA
25986244,NCT01078961,35,sorafenib,1,400,mg,2,"on days 1, 8 and 15 of each 28 day cycle",NA
25986244,NCT01078961,35,bortezomib,2,1.3,mg/m2,1,"on days 1, 8 and 15 of each 28 day cycle",NA
25986244,NCT01078961,35,sorafenib,2,400,mg,2,"on days 1, 8 and 15 of each 28 day cycle",NA
25749662,NCT01371227,36,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8 and 11 each 21-day cycle",NA
25749662,NCT01371227,36,doxorubicin,1,30,mg/m2,1,on day 4 each 21-day cycle,NA
25809731,NCT00708292,37,nvp-auy922,1,8,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,2,16,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,3,30,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,4,45,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,5,60,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,6,70,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase I
25809731,NCT00708292,37,nvp-auy922,7,50,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase IB
25809731,NCT00708292,37,bortezomib,7,1.3,mg/m2,1,"on days 1, 8, and15 of a 21-day treatment cycle",Phase IB
26298823,UMIN000001347,38,cyclophosphamide,1,300,mg/m2,1,on days 1 and 8 of each 3-week cycle,NA
26298823,UMIN000001347,38,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
26298823,UMIN000001347,38,dexamethasone,1,20,mg/m2,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 3-week cycle",NA
26298823,UMIN000001347,38,cyclophosphamide,2,400,mg/m2,1,on days 1 and 8 of each 3-week cycle,NA
26298823,UMIN000001347,38,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
26298823,UMIN000001347,38,dexamethasone,2,20,mg/m2,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 3-week cycle",NA
26298823,UMIN000001347,38,cyclophosphamide,3,500,mg/m2,1,on days 1 and 8 of each 3-week cycle,NA
26298823,UMIN000001347,38,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
26298823,UMIN000001347,38,dexamethasone,3,20,mg/m2,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 of each 3-week cycle",NA
26331432,NCT01049945,39,bendamustine,1,50,mg/m2,1,on days 1 of the 28-day cycle,NA
26331432,NCT01049945,39,lenalidomide,1,15,mg,1,days 1–21 of the 28-day cycle,NA
26331432,NCT01049945,39,dexamethasone,1,40,mg,1,"days 1, 8, 15 and 22 of the 28-day cycle",NA
26331432,NCT01049945,39,bendamustine,2,50,mg/m2,1,on days 1 and 2 of the 28-day cycle,NA
26331432,NCT01049945,39,lenalidomide,2,15,mg,1,days 1–21 of the 28-day cycle,NA
26331432,NCT01049945,39,dexamethasone,2,40,mg,1,"on days 1, 8, 15, and 22 of the 28-day cycle",NA
26331432,NCT01049945,39,bendamustine,3,75,mg/m2,1,on days 1 and 2 of the 28-day cycle,NA
26331432,NCT01049945,39,lenalidomide,3,15,mg,1,days 1–21 of the 28-day cycle,NA
26331432,NCT01049945,39,dexamethasone,3,40,mg,1,"on days 1, 8, 15, and 22 of the 28-day cycle",NA
26331432,NCT01049945,39,bendamustine,4,75,mg/m2,1,on days 1 and 2 of the 28-day cycle,NA
26331432,NCT01049945,39,lenalidomide,4,25,mg,1,days 1–21 of the 28-day cycle,NA
26331432,NCT01049945,39,dexamethasone,4,40,mg,1,"on days 1, 8, 15, and 22 of the 28-day cycle",NA
26331432,NCT01049945,39,bendamustine,5,100,mg/m2,1,on days 1 and 2 of the 28-day cycle,NA
26331432,NCT01049945,39,lenalidomide,5,25,mg,1,days 1–21 of the 28-day cycle,NA
26331432,NCT01049945,39,dexamethasone,5,40,mg,1,days 1–21 of the 28-day cycle,NA
26619834,NCT00858234,41,bortezomib,1,1.3,mg/m2,1,"on Days 1, 4, 8, and 11 every 21-day cycle",NA
26619834,NCT00858234,41,vorinostat,1,400,mg,1,from Day 1 through Day 14 every 21-day cycle,NA
26619834,NCT00858234,41,bortezomib,1,1,mg/m2,1,"on Days 1, 4, 8, and 11 every 21-day cycle",NA
26619834,NCT00858234,41,vorinostat,1,300,mg,1,from Day 1 through Day 14 every 21-day cycle,NA
26588925,UMIN000006604,42,bortezomib,1,1,mg/m2,1,"days 1, 4, 8, and 11 of 28-day treatment cycles",NA
26588925,UMIN000006604,42,melphalan,1,8,mg/m2,1,on days 1–4 every 28 days,NA
26588925,UMIN000006604,42,dexamethasone,1,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 every 28 days",NA
26588925,UMIN000006604,42,bortezomib,2,1.3,mg/m2,1,"days 1, 4, 8, and 11 of 28-day treatment cycles",NA
26588925,UMIN000006604,42,melphalan,2,8,mg/m2,1,on days 1–4 every 28 days,NA
26588925,UMIN000006604,42,dexamethasone,2,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11, and 12 every 28 days",NA
26494130,NCT01023308,43,panobinostat,1,10,mg,1,NA,NA
26494130,NCT01023308,43,bortezomib,1,1,mg/m2,1,NA,NA
26494130,NCT01023308,43,panobinostat,2,20,mg,1,NA,NA
26494130,NCT01023308,43,bortezomib,2,1,mg/m2,1,NA,NA
26494130,NCT01023308,43,panobinostat,3,20,mg,1,NA,NA
26494130,NCT01023308,43,bortezomib,3,1.3,mg/m2,1,NA,NA
26494130,NCT01023308,43,panobinostat,4,30,mg,1,NA,NA
26494130,NCT01023308,43,bortezomib,4,1.3,mg/m2,1,NA,NA
26494130,NCT01023308,43,panobinostat,3.5,25,mg,1,NA,NA
26494130,NCT01023308,43,bortezomib,3.5,1.3,mg/m2,1,NA,NA
26871714, NCT01531998,44,lenalidomide,1,25,mg,1,on days 1–14 every 21 days,NA
26871714, NCT01531998,44,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
26871714, NCT01531998,44,dexamethasone,1,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11 and 12 every 21 days",NA
26871714, NCT01531998,44,siltuximab,1,11,mg/kg,1,on day 1 every 21 days,NA
26871714, NCT01531998,44,lenalidomide,-1,25,mg,1,on days 1–14 every 21 days,NA
26871714, NCT01531998,44,bortezomib,-1,1.3,mg/m2,1,"on days 1, 4, 8 and 11 every 21 days",NA
26871714, NCT01531998,44,dexamethasone,-1,20,mg,1,"on days 1, 2, 4, 5, 8, 9, 11 and 12 every 21 days",NA
26871714, NCT01531998,44,siltuximab,-1,8.3,mg/kg,1,on day 1 every 21 days,NA
27009059,NCT00461045,45,marizomib,-3,0.025,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,-2,0.05,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,-1,0.075,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,1,0.15,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,2,0.3,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,3,0.6,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,4,0.7,mg/m2,1,"on days 1, 8, and 15 in4-week cycles",Schedule A
27009059,NCT00461045,45,marizomib,1,0.15,mg/m2,1,"on days 1, 4, 8, and11 in 3-week cycles",Schedule B
27009059,NCT00461045,45,marizomib,2,0.4,mg/m2,1,"on days 1, 4, 8, and11 in 3-week cycles",Schedule B
27009059,NCT00461045,45,marizomib,3,0.5,mg/m2,1,"on days 1, 4, 8, and11 in 3-week cycles",Schedule B
27009059,NCT00461045,45,marizomib,4,0.6,mg/m2,1,"on days 1, 4, 8, and11 in 3-week cycles",Schedule B
27207788,NCT01677858,46,carfilzomib,1,45,mg/m2,1,"on days 1, 8, and 15of 28-day cycles",NA
27207788,NCT01677858,46,dexamethasone,1,40,mg,1,"y on days 1, 8, 15, and 22 of 28-day cycles",NA
27207788,NCT01677858,46,carfilzomib,2,56,mg/m2,1,"on days 1, 8, and 15of 28-day cycles",NA
27207788,NCT01677858,46,dexamethasone,2,40,mg,1,"y on days 1, 8, 15, and 22 of 28-day cycles",NA
27207788,NCT01677858,46,carfilzomib,3,70,mg/m2,1,"on days 1, 8, and 15of 28-day cycles",NA
27207788,NCT01677858,46,dexamethasone,3,40,mg,1,"y on days 1, 8, 15, and 22 of 28-day cycles",NA
27207788,NCT01677858,46,carfilzomib,4,88,mg/m2,1,"on days 1, 8, and 15of 28-day cycles",NA
27207788,NCT01677858,46,dexamethasone,4,40,mg,1,"y on days 1, 8, 15, and 22 of 28-day cycles",NA
26758913,NA,47,quisinostat,1,6,mg,1,"on days 1, 3, and 5 of each 21-d cycle",NA
26758913,NA,47,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-dcycle (cycles 1–8; except the first cycle when it was givenon days 2, 5, 8, and 11) and on days 1, 8, 15, and 22 ofeach 35-d cycle (cycles 9–11)",NA
26758913,NA,47,dexamethasone,1,20,mg,1,on the day of and the day afterbortezomib dosing,NA
26758913,NA,47,quisinostat,2,8,mg,1,"on days 1, 3, and 5 of each 21-d cycle",NA
26758913,NA,47,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-dcycle (cycles 1–8; except the first cycle when it was givenon days 2, 5, 8, and 11) and on days 1, 8, 15, and 22 ofeach 35-d cycle (cycles 9–11)",NA
26758913,NA,47,dexamethasone,2,20,mg,1,on the day of and the day afterbortezomib dosing,NA
26758913,NA,47,quisinostat,3,10,mg,1,"on days 1, 3, and 5 of each 21-d cycle",NA
26758913,NA,47,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-dcycle (cycles 1–8; except the first cycle when it was givenon days 2, 5, 8, and 11) and on days 1, 8, 15, and 22 ofeach 35-d cycle (cycles 9–11)",NA
26758913,NA,47,dexamethasone,3,20,mg,1,on the day of and the day afterbortezomib dosing,NA
26758913,NA,47,quisinostat,4,12,mg,1,"on days 1, 3, and 5 of each 21-d cycle",NA
26758913,NA,47,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-dcycle (cycles 1–8; except the first cycle when it was givenon days 2, 5, 8, and 11) and on days 1, 8, 15, and 22 ofeach 35-d cycle (cycles 9–11)",NA
26758913,NA,47,dexamethasone,4,20,mg,1,on the day of and the day afterbortezomib dosing,NA
27502784,NA,48,bortezomib,1,1.3,mg/m2,1,on day 1 of weeks 1–4 of each 42-day cycle,NA
27502784,NA,48,bevacizumab,1,10,mg/kg,1,"on day 1 of weeks 1, 3, and 5 of each 42-day cycle",NA
27502784,NA,48,temozolomide,1,25,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27502784,NA,48,temozolomide,1,25,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27502784,NA,48,bortezomib,2,1.3,mg/m2,1,on day 1 of weeks 1–4 of each 42-day cycle,NA
27502784,NA,48,bevacizumab,2,10,mg/kg,1,"on day 1 of weeks 1, 3, and 5 of each 42-day cycle",NA
27502784,NA,48,temozolomide,2,50,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27502784,NA,48,temozolomide,2,50,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27502784,NA,48,bortezomib,3,1.3,mg/m2,1,on day 1 of weeks 1–4 of each 42-day cycle,NA
27502784,NA,48,bevacizumab,3,10,mg/kg,1,"on day 1 of weeks 1, 3, and 5 of each 42-day cycle",NA
27502784,NA,48,temozolomide,3,75,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27502784,NA,48,temozolomide,3,75,mg/m2,1,on days 1–28 of each 42-day cycle,NA
27647864,NCT01352338,49,lenalidomide,1,10,mg,1,on days 1 to 21 of a 28-day cycle,NA
27647864,NCT01352338,49,cyclophosphamide,1,100,mg,1,daily continuous,NA
27647864,NCT01352338,49,prednisone,1,20,mg,1,daily continuous,NA
27647864,NCT01352338,49,lenalidomide,2,15,mg,1,on days 1 to 21 of a 28-day cycle,NA
27647864,NCT01352338,49,cyclophosphamide,2,50,mg,1,daily continuous,NA
27647864,NCT01352338,49,prednisone,2,20,mg,1,daily continuous,NA
27647864,NCT01352338,49,lenalidomide,3,15,mg,1,on days 1 to 21 of a 28-day cycle,NA
27647864,NCT01352338,49,cyclophosphamide,3,100,mg,1,daily continuous,NA
27647864,NCT01352338,49,prednisone,3,20,mg,1,daily continuous,NA
27647864,NCT01352338,49,lenalidomide,4,25,mg,1,on days 1 to 21 of a 28-day cycle,NA
27647864,NCT01352338,49,cyclophosphamide,4,50,mg,1,daily continuous,NA
27647864,NCT01352338,49,prednisone,4,20,mg,1,daily continuous,NA
27647864,NCT01352338,49,lenalidomide,5,25,mg,1,on days 1 to 21 of a 28-day cycle,NA
27647864,NCT01352338,49,cyclophosphamide,5,100,mg,1,daily continuous,NA
27647864,NCT01352338,49,prednisone,5,20,mg,1,daily continuous,NA
28341300,NCT01074411,50,bortezomib,1.5,0.5,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,1.5,5,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,1.5,5,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,1,0.5,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,1,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,1,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,2,0.9,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,2,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,2,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,3,1.3,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,3,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,3,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,4,1.7,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,4,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,4,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,5,2.1,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,5,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,5,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,bortezomib,6,2.5,mg/m2,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,6,4,AUC,1,on Day 1 of a 21-day cycle,NA
28341300,NCT01074411,50,carboplatin,6,4,AUC,1,on Day 1 of a 21-day cycle,NA
28103725,NCT00963274,51,romidepsin,-1,6,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,-1,1,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,romidepsin,1,8,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,1,1.3,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,romidepsin,2,10,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,2,1.3,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,romidepsin,2.5,8,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,2.5,1.6,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,romidepsin,3,10,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,3,1.6,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,romidepsin,4,12,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28103725,NCT00963274,51,bortezomib,4,1.6,mg/m2,1,"On days 1, 8, and 15 of a 28-day cycle",NA
28550039,NCT01659658,52,ixazomib,1,4,mg,1,"on days 1, 8, and 15 of a 28-day cycle",NA
28550039,NCT01659658,52,ixazomib,2,5.5,mg,1,"on days 1, 8, and 15 of a 28-day cycle",NA
28873084,NCT01063907,53,kw-2478,1,130,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,kw-2478,2,130,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,kw-2478,3,175,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,kw-2478,4,175,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28873084,NCT01063907,53,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
28436582,NA,54,irinotecan,1,35,mg/m2,1,on days1–5 of each 21-day cycle,NA
28436582,NA,54,bortezomib,1,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
28436582,NA,54,irinotecan,2,40,mg/m2,1,on days1–5 of each 21-day cycle,NA
28436582,NA,54,bortezomib,2,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
28436582,NA,54,irinotecan,3,45,mg/m2,1,on days1–5 of each 21-day cycle,NA
28436582,NA,54,bortezomib,3,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 21-day cycle",NA
28642620,NCT01497093,55,pomalidomide,1,1,mg,1,on days 1–14 of a 21-day cycle,NA
28642620,NCT01497093,55,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
28642620,NCT01497093,55,dexamethasone,1,20,mg,1,"on days 1-2, 4-5, 8-9 and 11-12 of a 21-day cycle",NA
28642620,NCT01497093,55,pomalidomide,2,2,mg,1,on days 1–14 of a 21-day cycle,NA
28642620,NCT01497093,55,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
28642620,NCT01497093,55,dexamethasone,2,20,mg,1,"on days 1-2, 4-5, 8-9 and 11-12 of a 21-day cycle",NA
28642620,NCT01497093,55,pomalidomide,3,3,mg,1,on days 1–14 of a 21-day cycle,NA
28642620,NCT01497093,55,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
28642620,NCT01497093,55,dexamethasone,3,20,mg,1,"on days 1-2, 4-5, 8-9 and 11-12 of a 21-day cycle",NA
28642620,NCT01497093,55,pomalidomide,4,4,mg,1,on days 1–14 of a 21-day cycle,NA
28642620,NCT01497093,55,bortezomib,4,1,mg/m2,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
28642620,NCT01497093,55,dexamethasone,4,20,mg,1,"on days 1-2, 4-5, 8-9 and 11-12 of a 21-day cycle",NA
28642620,NCT01497093,55,pomalidomide,5,4,mg,1,on days 1–14 of a 21-day cycle,NA
28642620,NCT01497093,55,bortezomib,5,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
28642620,NCT01497093,55,dexamethasone,5,20,mg,1,"on days 1-2, 4-5, 8-9 and 11-12 of a 21-day cycle",NA
29076150,NA,56,marizomib,1,0.3,mg/m2,1,"on days 1, 4, 8 and 11 of a 28-day cycle",NA
29076150,NA,56,pomalidomide,1,3,mg,1,on days 1–21 of a 28-day cycle,NA
29076150,NA,56,dexamethasone,1,10,mg,1,"on days 1,2, 4, 5, 8, 9, 11, 12, 15, 16, 22 and 23 of a 28-day cycle",10 mg(<=75 years) or 5 mg(>75 years)
29076150,NA,56,marizomib,2,0.4,mg/m2,1,"on days 1, 4, 8 and 11 of a 28-day cycle",NA
29076150,NA,56,pomalidomide,2,3,mg,1,on days 1–21 of a 28-day cycle,NA
29076150,NA,56,dexamethasone,2,10,mg,1,"on days 1,2, 4, 5, 8, 9, 11, 12, 15, 16, 22 and 23 of a 28-day cycle",10 mg(<=75 years) or 5 mg(>75 years)
29076150,NA,56,marizomib,3,0.4,mg/m2,1,"on days 1, 4, 8 and 11 of a 28-day cycle",NA
29076150,NA,56,pomalidomide,3,4,mg,1,on days 1–21 of a 28-day cycle,NA
29076150,NA,56,dexamethasone,3,10,mg,1,"on days 1,2, 4, 5, 8, 9, 11, 12, 15, 16, 22 and 23 of a 28-day cycle",10 mg(<=75 years) or 5 mg(>75 years)
29076150,NA,56,marizomib,4,0.5,mg/m2,1,"on days 1, 4, 8 and 11 of a 28-day cycle",NA
29076150,NA,56,pomalidomide,4,4,mg,1,on days 1–21 of a 28-day cycle,NA
29076150,NA,56,dexamethasone,4,10,mg,1,"on days 1,2, 4, 5, 8, 9, 11, 12, 15, 16, 22 and 23 of a 28-day cycle",10 mg(<=75 years) or 5 mg(>75 years)
28696812, NCT00671112,57,everolimus,1,5,mg,1,every other day,NA
28696812, NCT00671112,57,everolimus,1,5,mg,1,every other day,NA
28696812, NCT00671112,57,bortezomib,1,0.7,mg/m2,1,"on days 1, 4,8, and 11 every 21 days",NA
28696812, NCT00671112,57,everolimus,2,5,mg,1,every other day,NA
28696812, NCT00671112,57,everolimus,2,5,mg,1,every other day,NA
28696812, NCT00671112,57,bortezomib,2,1,mg/m2,1,"on days 1, 4,8, and 11 every 21 days",NA
28696812, NCT00671112,57,everolimus,3,5,mg,1,daily,NA
28696812, NCT00671112,57,everolimus,3,5,mg,1,daily,NA
28696812, NCT00671112,57,bortezomib,3,1,mg/m2,1,"on days 1, 4,8, and 11 every 21 days",NA
28696812, NCT00671112,57,everolimus,4,5,mg,1,daily,NA
28696812, NCT00671112,57,everolimus,4,5,mg,1,daily,NA
28696812, NCT00671112,57,bortezomib,4,1.3,mg/m2,1,"on days 1, 4,8, and 11 every 21 days",NA
28696812, NCT00671112,57,everolimus,5,10,mg,1,daily,NA
28696812, NCT00671112,57,everolimus,5,10,mg,1,daily,NA
28696812, NCT00671112,57,bortezomib,5,1.3,mg/m2,1,"on days 1, 4,8, and 11 every 21 days",NA
30061664, NCT01864018.,58,ixazomib,1,4,mg,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30061664, NCT01864018.,58,dexamethasone,1,40,mg,1,"on days 1,8, 15, and 22 of the 28-day cycle",NA
30061664, NCT01864018.,58,cyclophosphamide,1,300,mg/m2,1,"on days 1, 8, 15 and 22) during the 28-daycycle",NA
30061664, NCT01864018.,58,ixazomib,2,4,mg,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30061664, NCT01864018.,58,dexamethasone,2,40,mg,1,"on days 1,8, 15, and 22 of the 28-day cycle",NA
30061664, NCT01864018.,58,cyclophosphamide,2,400,mg/m2,1,"on days 1, 8, 15 and 22) during the 28-daycycle",NA
30058108,JapicCTI‐122020,59,carfilzomib,1,20,mg/m2,1,"on Days 1, 8 and 15 in the 28‐day cycle",NA
30058108,JapicCTI‐122020,59,carfilzomib,1,70,mg/m2,1,on Days 8 and 15 in the 28‐day cycle,NA
30058108,JapicCTI‐122020,59,dexamethasone,1,40,mg,1,"on Days 1, 8, 15 and 22 in Cycles 1 to 9 and on Days 1, 8and 15 thereafter",NA
30400780,NCT02993094,60,ixazomib,1,3,mg,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,1,1.5,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,1,1.5,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,ixazomib,2,3,mg,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,2,2,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,2,2,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,ixazomib,3,4,mg,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,3,2,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,3,2,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,ixazomib,4,4,mg,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,4,2.5,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30400780,NCT02993094,60,carboplatin,4,2.5,AUC,1,"on days 1, 8, and 15 of a 4-week cycle",NA
30352784,NCT02343042,61,selinexor,1,80,mg,1,"Days 1, 8, 15, 22, 29 of every 35 days",NA
30352784,NCT02343042,61,dexamethasone,1,40,mg,1,"Days 1, 8, 15, 22, 29 of every 35 days",NA
30352784,NCT02343042,61,bortezomib,1,1.3,mg/m2,1,"Days 1, 8, 15, 22 of every 35 days",NA
30352784,NCT02343042,61,selinexor,2,100,mg,1,"Days 1, 8, 15, 22, 29 of every 35 days",NA
30352784,NCT02343042,61,dexamethasone,2,40,mg,1,"Days 1, 8, 15, 22, 29 of every 35 days",NA
30352784,NCT02343042,61,bortezomib,2,1.3,mg/m2,1,"Days 1, 8, 15, 22 of every 35 days",NA
30352784,NCT02343042,61,selinexor,3,80,mg,1,"Days 1, 8, 15 of every 21 days",NA
30352784,NCT02343042,61,dexamethasone,3,40,mg,1,"Days 1, 8, 15 of every 21 days",NA
30352784,NCT02343042,61,bortezomib,3,1.3,mg/m2,1,"Days 1, 4, 8, 11 of every 21 days",NA
30352784,NCT02343042,61,selinexor,4,60,mg,1,"Days 1, 3, 8, 10, 15, 17, 22, 24 of every 35 days",NA
30352784,NCT02343042,61,dexamethasone,4,20,mg,1,"Days 1, 3, 8, 10, 15, 17, 22, 24, 29, 31 of every 35 days",NA
30352784,NCT02343042,61,bortezomib,4,1.3,mg/m2,1,"Days 1, 8, 15, 22 of every 35 days",NA
30352784,NCT02343042,61,selinexor,5,80,mg,1,"Days 1, 3, 8, 10, 15, 17, 22, 24 of every 35 days",NA
30352784,NCT02343042,61,dexamethasone,5,20,mg,1,"Days 1, 3, 8, 10, 15, 17, 22, 24, 29, 31 of every 35 days",NA
30352784,NCT02343042,61,bortezomib,5,1.3,mg/m2,1,"Days 1, 8, 15, 22 of every 35 days",NA
30297385,NCT00923247,62,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
30297385,NCT00923247,62,vandetanib,1,100,mg,1,daily,NA
30297385,NCT00923247,62,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
30297385,NCT00923247,62,vandetanib,2,100,mg,1,daily,NA
30297385,NCT00923247,62,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
30297385,NCT00923247,62,vandetanib,3,200,mg,1,daily,NA
30297385,NCT00923247,62,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
30297385,NCT00923247,62,vandetanib,4,300,mg,1,daily,NA
30610196, NCT01549431,63,carfilzomib,1,27,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30610196, NCT01549431,63,panobinostat,1,15,mg,1,"TIW, 3 weeks on/1 week off, every 28 days",NA
30610196, NCT01549431,63,carfilzomib,2,27,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30610196, NCT01549431,63,panobinostat,2,20,mg,1,"TIW, 3 weeks on/1 week off, every 28 days",NA
30610196, NCT01549431,63,carfilzomib,3,36,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30610196, NCT01549431,63,panobinostat,3,20,mg,1,"TIW, 3 weeks on/1 week off, every 28 days",NA
30610196, NCT01549431,63,carfilzomib,4,45,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30610196, NCT01549431,63,panobinostat,4,20,mg,1,"TIW, 3 weeks on/1 week off, every 28 days",NA
30279233,NCT01522872,64,evofosfamide,1,240,mg/m2,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,dexamethasone,1,40,mg,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,evofosfamide,2,340,mg/m2,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,dexamethasone,2,40,mg,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,evofosfamide,3,480,mg/m2,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,dexamethasone,3,40,mg,1,"on days 1, 4, 8, and 11of a 21-day cycle",Arm A
30279233,NCT01522872,64,evofosfamide,4,240,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,dexamethasone,4,40,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,bortezomib,4,1.3,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,evofosfamide,5,340,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,dexamethasone,5,40,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,bortezomib,5,1.3,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",Arm B
30279233,NCT01522872,64,evofosfamide,6,480,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
30279233,NCT01522872,64,dexamethasone,6,40,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
30279233,NCT01522872,64,bortezomib,6,1.3,NA,1,"on days 1, 4, 8, and 11 of a 21-day cycle",NA
30952640,NCT01246063,65,carfilzomib,1,27,mg/m2,1,"days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30952640,NCT01246063,65,doxorubicin,1,30,mg/m2,1,on day 8 of 28-day cycle,NA
30952640,NCT01246063,65,carfilzomib,2,36,mg/m2,1,"days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30952640,NCT01246063,65,doxorubicin,2,30,mg/m2,1,on day 8 of 28-day cycle,NA
30952640,NCT01246063,65,carfilzomib,3,45,mg/m2,1,"days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30952640,NCT01246063,65,doxorubicin,3,30,mg/m2,1,on day 8 of 28-day cycle,NA
30952640,NCT01246063,65,carfilzomib,4,56,mg/m2,1,"days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30952640,NCT01246063,65,doxorubicin,4,30,mg/m2,1,on day 8 of 28-day cycle,NA
30952640,NCT01246063,65,carfilzomib,5,56,mg/m2,1,"days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
30952640,NCT01246063,65,doxorubicin,5,30,mg/m2,1,on day 8 of 28-day cycle,NA
30952640,NCT01246063,65,dexamethasone,5,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of 28-day cycle",NA
31053600,NCT02302495,66,melphalan,1,0.25,mg/kg,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,prednisone,1,60,mg/m2,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,carfilzomib,1,36,mg/m2,1,"on days 1, 8, 15, and 22 of a 35-day cycle",NA
31053600,NCT02302495,66,melphalan,2,0.25,mg/kg,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,prednisone,2,60,mg/m2,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,carfilzomib,2,45,mg/m2,1,"on days 1, 8, 15, and 22 of a 35-day cycle",NA
31053600,NCT02302495,66,melphalan,3,0.25,mg/kg,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,prednisone,3,60,mg/m2,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,carfilzomib,3,56,mg/m2,1,"on days 1, 8, 15, and 22 of a 35-day cycle",NA
31053600,NCT02302495,66,melphalan,4,0.25,mg/kg,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,prednisone,4,60,mg/m2,1,on days 1 to 4 of a 35-day cycle,NA
31053600,NCT02302495,66,carfilzomib,4,70,mg/m2,1,"on days 1, 8, 15, and 22 of a 35-day cycle",NA
31124580,NCT02199665,67,selinexor,-2,20,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,-2,20,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,-2,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,-1,20,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,-1,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,-1,27,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,-1,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,1,30,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,1,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,1,27,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,1,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,2,40,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,2,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,2,36,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,2,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,2.5,60,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,2.5,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,2.5,27,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,2.5,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,3,60,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,3,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,3,36,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,3,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,4,60,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,4,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,4,45,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,4,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,selinexor,5,60,mg,1,"on days 1, 3, 8, 10, 15, and 17 of each 28-day cycle",NA
31124580,NCT02199665,67,carfilzomib,5,20,mg/m2,1,on Days 1–2 of Cycle 1,NA
31124580,NCT02199665,67,carfilzomib,5,56,mg/m2,1,"on Days 8, 9, 15, and 16 of each 28-day cycle",NA
31124580,NCT02199665,67,dexamethasone,5,20,mg,1,"on days 1, 2, 8, 9, 15, and 16 of each 28-day cycle",NA
31120355,NCT01111188,68,palbociclib,1,75,mg,1,on days 1–12 of each 21-day cycle,NA
31120355,NCT01111188,68,bortezomib,1,1,mg/m2,1,"on days 8, 11, 15, and 18 of each 21-day cycle",NA
31120355,NCT01111188,68,palbociclib,2,100,mg,1,on days 1–12 of each 21-day cycle,NA
31120355,NCT01111188,68,bortezomib,2,1,mg/m2,1,"on days 8, 11, 15, and 18 of each 21-day cycle",NA
31120355,NCT01111188,68,palbociclib,3,125,mg,1,on days 1–12 of each 21-day cycle,NA
31120355,NCT01111188,68,bortezomib,3,1,mg/m2,1,"on days 8, 11, 15, and 18 of each 21-day cycle",NA
31120355,NCT01111188,68,palbociclib,4,125,mg,1,on days 1–12 of each 21-day cycle,NA
31120355,NCT01111188,68,bortezomib,4,1.3,mg/m2,1,"on days 8, 11, 15, and 18 of each 21-day cycle",NA
10531568,NA,69,etoposide,1,800,mg/m2,1,days −5 to −3,NA
10531568,NA,69,thiotepa,1,150,mg/m2,1,day −2,NA
10531568,NA,69,busulfan,1,480,mg/m2,4,days −9 to −6,NA
10531568,NA,69,etoposide,2,800,mg/m2,1,days −5 to −3,NA
10531568,NA,69,thiotepa,2,300,mg/m2,1,day −2,NA
10531568,NA,69,busulfan,2,480,mg/m2,4,days −9 to −6,NA
10531568,NA,69,etoposide,3,800,mg/m2,1,days −5 to −3,NA
10531568,NA,69,thiotepa,3,450,mg/m2,1,day −2,NA
10531568,NA,69,busulfan,3,480,mg/m2,4,days −9 to −6,NA
10531568,NA,69,etoposide,4,800,mg/m2,1,days −5 to −3,NA
10531568,NA,69,thiotepa,4,600,mg/m2,1,day −2,NA
10531568,NA,69,busulfan,4,480,mg/m2,4,days −9 to −6,NA
10531568,NA,69,etoposide,5,800,mg/m2,1,days −5 to −3,NA
10531568,NA,69,thiotepa,5,750,mg/m2,1,day −2,NA
10531568,NA,69,busulfan,5,480,mg/m2,4,days −9 to −6,NA
11025470,NA,70,busulfan,1,40,mg/m2,4,on days 8 through 5,NA
11025470,NA,70,etoposide,1,40,mg/kg,1,on day 4,NA
11025470,NA,70,cyclophosphamide,1,60,mg/kg,1,"on days 3, and 2",NA
11025470,NA,70,busulfan,2,40,mg/m2,4,on days 8 through 5,NA
11025470,NA,70,etoposide,2,50,mg/kg,1,on day 4,NA
11025470,NA,70,cyclophosphamide,2,60,mg/kg,1,"on days 3, and 2",NA
11025470,NA,70,busulfan,3,40,mg/m2,4,on days 8 through 5,NA
11025470,NA,70,etoposide,3,60,mg/kg,1,on day 4,NA
11025470,NA,70,cyclophosphamide,3,60,mg/kg,1,"on days 3, and 2",NA
11025470,NA,70,busulfan,4,40,mg/m2,4,on days 8 through 5,NA
11025470,NA,70,etoposide,4,60,mg/kg,1,on day 4,NA
11025470,NA,70,cyclophosphamide,4,75,mg/kg,1,"on days 3, and 2",NA
11025470,NA,70,busulfan,5,40,mg/m2,4,on days 8 through 5,NA
11025470,NA,70,etoposide,5,60,mg/kg,1,on day 4,NA
11025470,NA,70,cyclophosphamide,5,90,mg/kg,1,"on days 3, and 2",NA
12420202,NA,71,etoposide,1,50,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,1,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,1,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,2,100,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,2,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,2,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,3,150,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,3,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,3,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,4,200,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,4,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,4,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,5,250,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,5,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,5,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,6,300,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,6,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,6,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,7,350,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,7,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,7,60,mg/kg,1,on day -3and day -2,in autograft recipients
12420202,NA,71,etoposide,8,400,mg/kg,1,5 consecutive days from day -8 to day -3,in autograft recipients
12420202,NA,71,busulphan,8,1,mg/kg,1,on day -7 to day -4,in autograft recipients
12420202,NA,71,cyclophosphamide,8,60,mg/kg,1,on day -3and day -2,in autograft recipients
12431963,NA,72,bortezomib,1,0.4,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25 of each 6-week cycle",NA
12431963,NA,72,bortezomib,2,1.04,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25 of each 6-week cycle",NA
12431963,NA,72,bortezomib,3,1.2,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25 of each 6-week cycle",NA
12431963,NA,72,bortezomib,4,1.38,mg/m2,1,"on days 1, 4, 8, 11, 15, 18, 22, and 25 of each 6-week cycle",NA
15286694,NA,73,treosulfan,0,30000,mg/m2,1,on day -3,first high-dose therapy
15286694,NA,73,melphalan,0,140,mg/m2,1,on day -4,first high-dose therapy
15286694,NA,73,treosulfan,1,30000,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15286694,NA,73,thiotepa,1,250,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15286694,NA,73,treosulfan,2,39000,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15286694,NA,73,thiotepa,2,250,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15286694,NA,73,treosulfan,3,48000,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15286694,NA,73,thiotepa,3,250,mg/m2,1,"given on days -5, -4, and -3",Second high-dose therapy 8-12 weeks after the first one
15570082,NA,75,bortezomib,1,1.2,mg/m2,1,"days 1, 4, 8, and 11 every 21 days",NA
15570082,NA,75,bortezomib,2,1.6,mg/m2,1,"days 1, 4, 8, and 11 every 21 days",NA
15626743,NA,76,bortezomib,1,0.9,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,1,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
15626743,NA,76,bortezomib,2,1.05,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,2,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
15626743,NA,76,bortezomib,3,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,3,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
15626743,NA,76,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,4,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
15626743,NA,76,bortezomib,5,1.4,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,5,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
15626743,NA,76,bortezomib,6,1.5,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 days",NA
15626743,NA,76,doxorubicin,6,30,mg/m2,1,2 on day 4 of each 21-day cycle,NA
16135477,NA,77,bortezomib,1,0.25,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,2,0.5,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,3,0.8,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,4,1,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,5,1.2,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,6,1.45,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,7,1.75,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
16135477,NA,77,bortezomib,8,1.9,mg/m2,1,on days 1 and 4 of a 14-day cycle,NA
17409841,NA,78,bortezomib,1,1,mg/m2,1,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
17409841,NA,78,bortezomib,2,1,mg/m2,1,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,2,65,mg/m2,1,on day 1 every 3 weeks,NA
17409841,NA,78,bortezomib,3,1,mg/m2,1,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,3,70,mg/m2,1,on day 1 every 3 weeks,NA
17409841,NA,78,bortezomib,4,1,mg/m2,1,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,4,75,mg/m2,1,on day 1 every 3 weeks,NA
17409841,NA,78,bortezomib,5,1.3,mg/m2,1,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,5,75,mg/m2,0,on day 1 every 3 weeks,NA
17409841,NA,78,bortezomib,6,1.5,mg/m2,0,"days 1, 4, 8, and 11 every 3 weeks",NA
17409841,NA,78,docetaxel,6,75,mg/m2,0,on day 1 every 3 weeks,NA
16489083,NA,79,docetaxel,1,0,mg/m2,1,"on days 1 and 8, ofa 21-day cycle",NA
16489083,NA,79,bortezomib,1,0,mg/m2,1,"on days 2, 5, 9, and 12 of a 21-day cycle",NA
16418495,NA,80,bortezomib,1,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,1,0.025,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,2,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,2,0.05,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,3,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,3,0.1,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,4,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,4,0.15,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,5,0.7,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,5,0.25,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,6,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,6,0.025,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,7,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,7,0.1,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16418495,NA,80,bortezomib,8,1,mg/m2,1,"on days 1, 4, 8, and 11 of a 28-day cycle",NA
16418495,NA,80,melphalan,8,0.25,mg/kg,1,on days 1 to 4 of the 28-day cycle,NA
16533779,PBTC-004,81,spartaject busulfan,1,5,mg,1,"two treatmentsa week, at least 3 days apart for 2 weeks",NA
16533779,PBTC-004,81,spartaject busulfan,2,7.5,mg,1,"two treatmentsa week, at least 3 days apart for 2 weeks",NA
16533779,PBTC-004,81,spartaject busulfan,3,10,mg,1,"two treatmentsa week, at least 3 days apart for 2 weeks",NA
16533779,PBTC-004,81,spartaject busulfan,4,13,mg,1,"two treatmentsa week, at least 3 days apart for 2 weeks",NA
16533779,PBTC-004,81,spartaject busulfan,5,17,mg,1,"two treatmentsa week, at least 3 days apart for 2 weeks",NA
17036355,NA,82,bortezomib,1,1,mg/m2,1,"on Days 1, 4, 8, and 11 of each 21-day treatment cycle",NA
17036355,NA,82,gemcitabine,1,500,mg/m2,1,on Day 8 of each 21-day treatment cycle,NA
17036355,NA,82,bortezomib,2,1,mg/m2,1,"on Days 1, 4, 8, and 11 of each 21-day treatment cycle",NA
17036355,NA,82,gemcitabine,2,800,mg/m2,1,on Day 8 of each 21-day treatment cycle,NA
17036355,NA,82,bortezomib,3,1,mg/m2,1,"on Days 1, 4, 8, and 11 of each 21-day treatment cycle",NA
17036355,NA,82,gemcitabine,3,1000,mg/m2,1,on Day 8 of each 21-day treatment cycle,NA
17036355,NA,82,bortezomib,4,1.3,mg/m2,1,"on Days 1, 4, 8, and 11 of each 21-day treatment cycle",NA
17036355,NA,82,gemcitabine,4,800,mg/m2,1,on Day 8 of each 21-day treatment cycle,NA
16763792,NA,83,bortezomib,1,0.7,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,1,135,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,2,0.9,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,2,135,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,3,1.2,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,3,135,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,3,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,3,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,4,1.2,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,4,150,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,5,1.2,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,5,175,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,5,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,5,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,6,1.5,mg/m2,1,"on days 2, 5, and 8 of a 21-day cycle",Schedule A
16763792,NA,83,paclitaxel,6,175,mg/m2,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,6,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,carboplatin,6,6,AUC,1,on day 1 of a 21-day cycle,Schedule A
16763792,NA,83,bortezomib,1,0.7,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,1,135,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,1,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,1,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,bortezomib,2,0.9,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,2,135,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,2,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,2,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,bortezomib,3,1.2,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,3,135,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,3,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,3,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,bortezomib,4,1.2,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,4,150,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,4,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,4,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,bortezomib,5,1.2,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,5,175,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,5,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,5,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,bortezomib,6,1.5,mg/m2,1,"on days 1, 4 and 8 of a 21-day cycle",Schedule B
16763792,NA,83,paclitaxel,6,175,mg/m2,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,6,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
16763792,NA,83,carboplatin,6,6,AUC,1,on day 2 of a 21-day cycle,Schedule B
17575229,NA,84,bortezomib,1,0.7,mg/m2,1,"on days 1, 4, 8, and11 every 21 days",Twice-Weekly schedule
17575229,NA,84,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,1,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,1,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8, and11 every 21 days",Twice-Weekly schedule
17575229,NA,84,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,2,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,2,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and11 every 21 days",Twice-Weekly schedule
17575229,NA,84,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,3,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,cisplatin,3,70,mg/m2,1,on day 1 every 21 days,Twice-Weekly schedule
17575229,NA,84,bortezomib,4,1,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,4,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,4,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17575229,NA,84,bortezomib,5,1.3,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,5,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,5,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17575229,NA,84,bortezomib,6,1.6,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,gemcitabine,6,1000,mg/m2,1,on days 1 and 8 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,6,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17575229,NA,84,cisplatin,6,70,mg/m2,1,on day 1 every 21 days,Weekly schedule
17905421,NA,85,bortezomib,1,0.8,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
17905421,NA,85,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
17905421,NA,85,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
17905421,NA,85,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,bortezomib,4,1.5,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
17905421,NA,85,carboplatin,4,5,AUC,1,on day 1 every 28 days,NA
17905421,NA,85,carboplatin,4,5,AUC,1,on day 1 every 28 days,NA
18432260,NA,86,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8 and 11 on a 21 day cycle",NA
18432260,NA,86,thalidomide,1,50,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,1,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,2,100,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,2,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,3,1,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,3,150,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,3,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,4,1,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,4,200,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,4,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,5,1.3,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,5,50,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,5,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,6,1.3,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,6,100,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,6,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,7,1.3,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,7,150,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,7,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18432260,NA,86,bortezomib,8,1.3,mg/m2,1,"on days 1, 4, 8 and 11 on a 21day cycle",NA
18432260,NA,86,thalidomide,8,200,mg,1,starting with the second cycle,NA
18432260,NA,86,dexamethasone,8,20,mg,1,starting from the fourth cycle on the days of and after bortezomib administration,NA
18640031,NA,87,bortezomib,1,0.7,mg/m2,1,"day 1, 4, 8, 11 evrey 3 weeks",NA
18640031,NA,87,paclitaxel,1,80,mg/m2,1,"day 1, 8 every 3 weeks",NA
18640031,NA,87,bortezomib,2,1,mg/m2,1,"day 1, 4, 8, 11 evrey 3 weeks",NA
18640031,NA,87,paclitaxel,2,80,mg/m2,1,"day 1, 8 every 3 weeks",NA
18640031,NA,87,bortezomib,3,1.3,mg/m2,1,"day 1, 4, 8, 11 evrey 3 weeks",NA
18640031,NA,87,paclitaxel,3,80,mg/m2,1,"day 1, 8 every 3 weeks",NA
18640031,NA,87,bortezomib,4,1.3,mg/m2,1,"day 1, 4, 8, 11 evrey 3 weeks",NA
18640031,NA,87,paclitaxel,4,100,mg/m2,1,"day 1, 8 every 3 weeks",NA
18645194,NA,88,prednisone,1,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,1,150,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,1,0.7,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
18645194,NA,88,prednisone,2,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,2,300,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,2,0.7,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
18645194,NA,88,prednisone,3,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,3,300,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,3,1,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
18645194,NA,88,prednisone,4,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,4,300,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,4,1,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
18645194,NA,88,prednisone,5,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,5,300,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,5,1.3,mg/m2,1,"on days 1, 4, 8, and 11 every 28 days",NA
18645194,NA,88,prednisone,6,100,mg,1,every 2 days,NA
18645194,NA,88,cyclophosphamide,6,300,mg/m2,1,"on days 1, 8, 15, and 22 every 28 days",NA
18645194,NA,88,bortezomib,6,1.5,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
18689866,NA,89,cyclophosphamide,1,750,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,doxorubicin,1,50,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,vincristine,1,1.4,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,prednisolone,1,100,mg,1,on days 1 to 5 every 21 days,NA
18689866,NA,89,bortezomib,1,1,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18689866,NA,89,cyclophosphamide,2,750,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,doxorubicin,2,50,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,vincristine,2,1.4,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,prednisolone,2,100,mg,1,on days 1 to 5 every 21 days,NA
18689866,NA,89,bortezomib,2,1.3,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18689866,NA,89,cyclophosphamide,3,750,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,doxorubicin,3,50,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,vincristine,3,1.4,mg/m2,1,on day 1 every 21 days,NA
18689866,NA,89,prednisolone,3,100,mg,1,on days 1 to 5 every 21 days,NA
18689866,NA,89,bortezomib,3,1.6,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18327587,NA,90,bortezomib,1,0.9,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18327587,NA,90,bortezomib,2,1.05,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18327587,NA,90,bortezomib,3,1.2,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18327587,NA,90,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,4,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18327587,NA,90,bortezomib,5,1.4,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,5,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18327587,NA,90,bortezomib,6,1.5,mg/m2,1,"on days 1, 4, 8, and 11 of each 3-week cycle",NA
18327587,NA,90,pegylated liposomal doxorubicin,6,30,mg/m2,1,on day 4 of each 3-week cycle,NA
18322686,NA,91,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8 and 11of a 21 day cycle",NA
18322686,NA,91,doxorubicin,1,15,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
18322686,NA,91,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8 and 11of a 21 day cycle",NA
18322686,NA,91,doxorubicin,2,15,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
18322686,NA,91,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8 and 11of a 21 day cycle",NA
18322686,NA,91,doxorubicin,3,20,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
18322686,NA,91,bortezomib,3.5,1.5,mg/m2,1,"on days 1, 4, 8 and 11of a 21 day cycle",NA
18322686,NA,91,doxorubicin,3.5,15,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
18322686,NA,91,bortezomib,4,1.5,mg/m2,1,"on days 1, 4, 8 and 11of a 21 day cycle",NA
18322686,NA,91,doxorubicin,4,20,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
18809314,NA,92,bortezomib,1,1.3,mg/m2,1,"on days 1, 8 and 15 of each 4 weeks",NA
18809314,NA,92,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,leucovorin,1,200,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,5-fluorouracil,1,400,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,bortezomib,2,1.6,mg/m2,1,"on days 1, 8 and 15 of each 4 weeks",NA
18809314,NA,92,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,leucovorin,2,200,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,5-fluorouracil,2,400,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,bortezomib,3,1.8,mg/m2,1,"on days 1, 8 and 15 of each 4 weeks",NA
18809314,NA,92,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,leucovorin,3,200,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,5-fluorouracil,3,400,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,bortezomib,4,2,mg/m2,1,"on days 1, 8 and 15 of each 4 weeks",NA
18809314,NA,92,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 of each 4 weeks,NA
18809314,NA,92,leucovorin,4,200,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,5-fluorouracil,4,400,mg/m2,1,"on days 1, 2, 15 and 16 of each 4 weeks",NA
18809314,NA,92,bortezomib,5,NA,NA,NA,NA,NA
18809314,NA,92,oxaliplatin,5,NA,NA,NA,NA,NA
18809314,NA,92,oxaliplatin,5,NA,NA,NA,NA,NA
18809314,NA,92,leucovorin,5,NA,NA,NA,NA,NA
18809314,NA,92,5-fluorouracil,5,NA,NA,NA,NA,NA
19183191,NA,93,bortezomib,1.5,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 28-day cycle",NA
19183191,NA,93,melphalan,1.5,10,mg/m2,1,on day 2 of each 28-d cycle,NA
19183191,NA,93,dexamethasone,1.5,20,mg,1,on the day of and theday after each bortezomib injection,"administered to
patients with progressive disease or stable disease/response
plateau after 2 or 4 cycles, respectively"
19183191,NA,93,bortezomib,1,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 28-day cycle",NA
19183191,NA,93,melphalan,1,1.5,mg/m2,1,on day 2 of each 28-d cycle,NA
19183191,NA,93,dexamethasone,1,20,mg,1,on the day of and theday after each bortezomib injection,"administered to
patients with progressive disease or stable disease/response
plateau after 2 or 4 cycles, respectively"
19183191,NA,93,bortezomib,2,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 28-day cycle",NA
19183191,NA,93,melphalan,2,5,mg/m2,1,on day 2 of each 28-d cycle,NA
19183191,NA,93,dexamethasone,2,20,mg,1,on the day of and theday after each bortezomib injection,"administered to
patients with progressive disease or stable disease/response
plateau after 2 or 4 cycles, respectively"
19183191,NA,93,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8 and 11 of each 28-day cycle",NA
19183191,NA,93,melphalan,3,7.5,mg/m2,1,on day 2 of each 28-d cycle,NA
19183191,NA,93,dexamethasone,3,20,mg,1,on the day of and theday after each bortezomib injection,"administered to
patients with progressive disease or stable disease/response
plateau after 2 or 4 cycles, respectively"
19401697, NCT00622674,94,bortezomib,1,1.3,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,1,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,2,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,2,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,3,1.5,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,3,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,4,1.6,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,4,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,5,1.7,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,5,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,6,1.8,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,6,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,7,1.9,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,7,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
19401697, NCT00622674,94,bortezomib,8,2,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19401697, NCT00622674,94,cetuximab,8,250,mg/m2,1,"on days 1, 8 and 15 of a 21-day cycle",NA
21252987, NCT00477542,95,busulfan,1,0.8,mg/kg,4,on day -7 to -4,NA
21252987, NCT00477542,95,clofarabine,1,30,mg/kg,1,on days -6 to -2,NA
21252987, NCT00477542,95,busulfan,2,0.8,mg/kg,4,on day -7 to -4,NA
21252987, NCT00477542,95,clofarabine,2,40,mg/kg,1,on days -6 to -2,NA
21252987, NCT00477542,95,busulfan,3,0.8,mg/kg,4,on day -7 to -4,NA
21252987, NCT00477542,95,clofarabine,3,50,mg/kg,1,on days -6 to -2,NA
21252987, NCT00477542,95,busulfan,4,0.8,mg/kg,4,on day -7 to -4,NA
21252987, NCT00477542,95,clofarabine,4,60,mg/kg,1,on days -6 to -2,NA
22080439,NA,96,brentuximab vedotin,1,0.4,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22080439,NA,96,brentuximab vedotin,2,0.6,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22080439,NA,96,brentuximab vedotin,3,0.8,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22080439,NA,96,brentuximab vedotin,4,1,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22080439,NA,96,brentuximab vedotin,5,1.2,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22080439,NA,96,brentuximab vedotin,6,1.4,mg/kg,1,"on Days 1, 8, and 15 of each 28-day cycle",NA
22179664,NCT00195260,97,bosutinib,1,50,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,2,100,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,3,200,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,4,300,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,5,400,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,6,500,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22179664,NCT00195260,97,bosutinib,7,600,mg,1,on Day 1 and Days 3 through 21 for a total cycle length of 21 days,NA
22198540,NA,98,busulfan,1,170,mg/m2,1,"on days 6, 5, 4, and 3",NA
22198540,NA,98,fludarabine,1,40,mg/m2,1,"on days 6, 5, 4, and 3",NA
22198540,NA,98,busulfan,2,180,mg/m2,1,"on days 6, 5, 4, and 3",NA
22198540,NA,98,fludarabine,2,40,mg/m2,1,"on days 6, 5, 4, and 3",NA
22198540,NA,98,busulfan,3,220,mg/m2,1,"on days 6, 5, 4, and 3",NA
22198540,NA,98,fludarabine,3,40,mg/m2,1,"on days 6, 5, 4, and 3",NA
24239220,NCT01060904,99,brentuximab vedotin,1,0.6,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,doxorubicin,1,25,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,bleomycin,1,10,unit/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,vinblastine,1,6,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,dacarbazine,1,375,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,brentuximab vedotin,2,0.9,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,doxorubicin,2,25,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,bleomycin,2,10,unit/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,vinblastine,2,6,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,dacarbazine,2,375,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,brentuximab vedotin,3,1.2,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,doxorubicin,3,25,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,bleomycin,3,10,unit/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,vinblastine,3,6,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,dacarbazine,3,375,mg/m2,1,on days 1 and 15 of each 28-day cycle,ABVD
24239220,NCT01060904,99,brentuximab vedotin,4,1.2,mg/m2,1,on days 1 and 15 of each 28-day cycle,AVD
24239220,NCT01060904,99,doxorubicin,4,25,mg/m2,1,on days 1 and 15 of each 28-day cycle,AVD
24239220,NCT01060904,99,vinblastine,4,6,mg/m2,1,on days 1 and 15 of each 28-day cycle,AVD
24239220,NCT01060904,99,dacarbazine,4,375,mg/m2,1,on days 1 and 15 of each 28-day cycle,AVD
25776193,NA,101,busulfan,1,14.4,mg/kg,1,on day -11 or -10of autologous HSCT,NA
25776193,NA,101,etoposide,1,60,mg/kg,1,24 hours after the last busulfan dose and 3 days before stem cell infusion,NA
25776193,NA,101,busulfan,2,16,mg/kg,1,on day -11 or -10of autologous HSCT,NA
25776193,NA,101,etoposide,2,60,mg/kg,1,24 hours after the last busulfan dose and 3 days before stem cell infusion,NA
26210442,NCT00448357,102,busulfan,1,4800,AUC,1,on Days -7 to -4,NA
26210442,NCT00448357,102,fludarabine phosphate,1,30,mg/m2,1,on Days -7 through -3,NA
26210442,NCT00448357,102,tacrolimus,1,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,tacrolimus,1,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,methotrexate,1,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,methotrexate,1,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,busulfan,2,5760,AUC,1,on Days -7 to -4,NA
26210442,NCT00448357,102,fludarabine phosphate,2,30,mg/m2,1,on Days -7 through -3,NA
26210442,NCT00448357,102,tacrolimus,2,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,tacrolimus,2,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,methotrexate,2,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,methotrexate,2,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,busulfan,3,6912,AUC,1,on Days -7 to -4,NA
26210442,NCT00448357,102,fludarabine phosphate,3,30,mg/m2,1,on Days -7 through -3,NA
26210442,NCT00448357,102,tacrolimus,3,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,tacrolimus,3,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,methotrexate,3,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,methotrexate,3,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,busulfan,4,7603,AUC,1,on Days -7 to -4,NA
26210442,NCT00448357,102,fludarabine phosphate,4,30,mg/m2,1,on Days -7 through -3,NA
26210442,NCT00448357,102,tacrolimus,4,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,tacrolimus,4,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,methotrexate,4,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,methotrexate,4,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,busulfan,5,8363,AUC,1,on Days -7 to -4,NA
26210442,NCT00448357,102,fludarabine phosphate,5,30,mg/m2,1,on Days -7 through -3,NA
26210442,NCT00448357,102,tacrolimus,5,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,tacrolimus,5,0.03,mg/kg,2,starting on day -1,NA
26210442,NCT00448357,102,methotrexate,5,5,mg/m2,1,"on days +1, +3 and +6",NA
26210442,NCT00448357,102,methotrexate,5,5,mg/m2,1,"on days +1, +3 and +6",NA
28473406,NCT01940796,103,brentuximab vedotin,1,0.6,mg/kg,1,every week for 3 doses,NA
28473406,NCT01940796,103,brentuximab vedotin,2,0.9,mg/kg,1,every week for 3 doses,NA
28473406,NCT01940796,103,brentuximab vedotin,3,0.6,mg/kg,1,every two weeks for 4 doses,NA
28473406,NCT01940796,103,brentuximab vedotin,4,0.8,mg/kg,1,every two weeks for 4 doses,NA
31619057,NA,104,busulfan,1,3.2,mg/kg,1,for 3 days,NA
31619057,NA,104,busulfan,2,3.2,mg/kg,1,for 4 days,NA
31619057,NA,104,busulfan,3,4.3,mg/kg,1,for 3 days,NA
31619057,NA,104,busulfan,4,5.6,mg/kg,1,on Day -1 and Day -3,NA
31619057,NA,104,busulfan,5,5.6,mg/kg,1,on Day -1 and Day -2,NA
33991360,NCT02311998,105,bosutinib,1,300,mg,1,daily starting onCycle one Day one continuously,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,1,0.5,mg/m2,1,on days 8 and 15 of each 28-day cycle,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,1,0.8,mg/m2,1,on day 1 of each 28-day cycle,NA
33991360,NCT02311998,105,bosutinib,2,400,mg,1,daily starting onCycle one Day one continuously,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,2,0.5,mg/m2,1,on days 8 and 15 of each 28-day cycle,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,2,0.8,mg/m2,1,on day 1 of each 28-day cycle,NA
33991360,NCT02311998,105,bosutinib,3,500,mg,1,daily starting onCycle one Day one continuously,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,3,0.5,mg/m2,1,on days 8 and 15 of each 28-day cycle,NA
33991360,NCT02311998,105,inotuzumab ozogamicin,3,0.8,mg/m2,1,on day 1 of each 28-day cycle,NA
34614506,NCT03613532,106,venetoclax,1,200,mg,1,on days -8 through -3,NA
34614506,NCT03613532,106,fludarabine,1,30,mg/m2,1,on days -5 through -2,NA
34614506,NCT03613532,106,busulfan,1,0.8,mg/kg,2,on days -5 through -2,NA
34614506,NCT03613532,106,venetoclax,2,200,mg,1,on days -8 through -2,NA
34614506,NCT03613532,106,fludarabine,2,30,mg/m2,1,on days -5 through -2,NA
34614506,NCT03613532,106,busulfan,2,0.8,mg/kg,2,on days -5 through -2,NA
34614506,NCT03613532,106,venetoclax,3,400,mg,1,on days -8 through -2,NA
34614506,NCT03613532,106,fludarabine,3,30,mg/m2,1,on days -5 through -2,NA
34614506,NCT03613532,106,busulfan,3,0.8,mg/kg,2,on days -5 through -2,NA
9537208,NA,107,gallium nitrate,1,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,1,90,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,2,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,2,110,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,3,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,3,135,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,1.5,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,1.5,135,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,1.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,1.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,2.5,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,2.5,155,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,2.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,2.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,3.5,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,3.5,175,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,3.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,3.5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,4,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,4,200,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,4,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,4,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,5,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,5,225,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,5,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,gallium nitrate,6,300,mg/m2,1,on days 1 through 5 of each 21-day cycle,NA
9537208,NA,107,paclitaxel,6,250,mg/m2,1,on day 5 of each 21-day cycle,NA
9537208,NA,107,filgrastim,6,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
9537208,NA,107,filgrastim,6,5,ug/kg/per day,1,on days 7 through 16 of each 21-day cycle,NA
17317832,NA,108,calcitriol,1,10,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,1,10,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,1,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,2,15,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,2,15,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,2,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,3,20,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,3,20,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,3,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,4,26,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,4,26,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,4,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,5,34,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,5,34,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,5,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,6,44,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,6,44,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,6,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,7,57,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,7,57,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,7,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,8,74,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,8,74,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,8,250,mg,1,started on day 8 continuously,NA
17317832,NA,108,calcitriol,9,96,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,calcitriol,9,96,ug,1,on days 1 and 15 and weekly thereafter,NA
17317832,NA,108,gefitinib,9,250,mg,1,started on day 8 continuously,NA
17066293,NA,109,dn-101,1,15,ug,1,weekly,NA
17066293,NA,109,dn-101,2,30,ug,1,weekly,NA
17066293,NA,109,dn-101,4,60,ug,1,weekly,NA
17066293,NA,109,dn-101,5,75,ug,1,weekly,NA
17066293,NA,109,dn-101,3,45,ug,1,weekly,NA
19396601,NA,110,calcitriol,1,57,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,calcitriol,1,57,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,dexamethasone,1,4,mg,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,gefitinib,1,250,mg,1,starting on day 8 and daily thereafter,NA
19396601,NA,110,calcitriol,2,74,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,calcitriol,2,74,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,dexamethasone,2,4,mg,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,gefitinib,2,250,mg,1,starting on day 8 and daily thereafter,NA
19396601,NA,110,calcitriol,3,96,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,calcitriol,3,96,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,dexamethasone,3,4,mg,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,gefitinib,3,250,mg,1,starting on day 8 and daily thereafter,NA
19396601,NA,110,calcitriol,4,125,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,calcitriol,4,125,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,dexamethasone,4,4,mg,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,gefitinib,4,250,mg,1,starting on day 8 and daily thereafter,NA
19396601,NA,110,calcitriol,5,163,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,calcitriol,5,163,ug,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,dexamethasone,5,4,mg,1,on days 1 and 15 and weekly thereafter,NA
19396601,NA,110,gefitinib,5,250,mg,1,starting on day 8 and daily thereafter,NA
21606412,NCT00215605,112,cabozantinib,1,0.08,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,2,0.16,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,3,0.32,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,4,0.64,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,5,1.28,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,6,2.56,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,7,5.12,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,8,7.68,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,9,11.52,mg,1,once daily for 5 days followed by 9 days rest,suspension formulation
21606412,NCT00215605,112,cabozantinib,10,175,mg,1,daily continuously,suspension formulation
21606412,NCT00215605,112,cabozantinib,11,265,mg,1,daily continuously,suspension formulation
21606412,NCT00215605,112,cabozantinib,12,175,mg,1,daily continuously,capsule formulation
21606412,NCT00215605,112,cabozantinib,13,265,mg,1,daily continuously,capsule formulation
22975213,NA,113,cabazitaxel,1,10,mg/m2,1,every 3 weeks,NA
22975213,NA,113,cabazitaxel,2,20,mg/m2,1,every 3 weeks,NA
22975213,NA,113,cabazitaxel,3,25,mg/m2,1,every 3 weeks,NA
22975213,NA,113,cabazitaxel,4,30,mg/m2,1,every 3 weeks,NA
23435876,NA,114,calcitriol,1,30,ug/m2,1,once every 21 days,NA
23435876,NA,114,calcitriol,1,30,ug/m2,1,once every 21 days,NA
23435876,NA,114,cisplatin,1,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,cisplatin,1,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,docetaxel,1,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,calcitriol,2,45,ug/m2,1,once every 21 days,NA
23435876,NA,114,calcitriol,2,45,ug/m2,1,once every 21 days,NA
23435876,NA,114,cisplatin,2,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,cisplatin,2,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,docetaxel,2,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,calcitriol,3,60,ug/m2,1,once every 21 days,NA
23435876,NA,114,calcitriol,3,60,ug/m2,1,once every 21 days,NA
23435876,NA,114,cisplatin,3,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,cisplatin,3,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,docetaxel,3,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,calcitriol,4,80,ug/m2,1,once every 21 days,NA
23435876,NA,114,calcitriol,4,80,ug/m2,1,once every 21 days,NA
23435876,NA,114,cisplatin,4,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,cisplatin,4,75,mg/m2,1,every 3 weeks,NA
23435876,NA,114,docetaxel,4,75,mg/m2,1,every 3 weeks,NA
24099585, NCT01755390,115,cabazitaxel,1,1.5,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24099585, NCT01755390,115,cabazitaxel,2,3,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24099585, NCT01755390,115,cabazitaxel,3,6,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24099585, NCT01755390,115,cabazitaxel,4,8.4,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24099585, NCT01755390,115,cabazitaxel,5,10,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24099585, NCT01755390,115,cabazitaxel,6,12,mg/m2,1,"on Days 1, 8, 15 and 22 of each 5-week cycle",NA
24488323,NA,116,cabazitaxel,1,20,mg/m2,1,every 3 weeks,NA
24488323,NA,116,cabazitaxel,2,25,mg/m2,1,every 3 weeks,NA
25013124,NA,117,inecalcitol,1,40,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,1,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,1,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,2,80,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,2,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,2,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,3,160,ug,1,every other day up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,3,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,3,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,4,160,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,4,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,4,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,5,300,ug,1,every other day up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,5,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,5,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,6,300,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,6,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,6,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,7,600,ug,1,every other day up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,7,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,7,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,8,600,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,8,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,8,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,9,1000,ug,1,every other day up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,9,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,9,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,10,1000,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,10,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,10,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,11,2000,ug,1,daily up tosix 21-day treatment cycles,NA
25013124,NA,117,docetaxel,11,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,11,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,inecalcitol,12,4000,ug,1,daily or twice a day up to six 21-day treatment cycles,NA
25013124,NA,117,docetaxel,12,75,mg/m2,1,once every 3 weeks,NA
25013124,NA,117,prednisone,12,5,mg,2,twice a day up to six 21-day treatment cycles,NA
25117475,NCT00925743,118,cabazitaxel,-1,15,mg/m2,1,On Day 1 of each 3-week cycle,NA
25117475,NCT00925743,118,cisplatin,-1,75,mg/m2,1,On Day 1 of each 3-week cycle,NA
25117475,NCT00925743,118,cisplatin,-1,75,mg/m2,1,On Day 1 of each 3-week cycle,NA
25117475,NCT00925743,118,cabazitaxel,0,20,mg/m2,1,On Day 1 of each 3-week cycle,NA
25117475,NCT00925743,118,cisplatin,0,75,mg/m2,1,On Day 1 of each 3-week cycle,NA
25117475,NCT00925743,118,cisplatin,0,75,mg/m2,1,On Day 1 of each 3-week cycle,NA
25486878,NCT01497964,119,cabazitaxel,1,20,mg/m2,1,on Day 1 of each 3-week cycle,NA
25486878,NCT01497964,119,cabazitaxel,2,25,mg/m2,1,on Day 1 of each 3-week cycle,NA
25486878,NCT01497964,119,cabazitaxel,-1,15,mg/m2,1,on Day 1 of each 3-week cycle,NA
26020806,NCT01001221,120,cabazitaxel,0,20,mg/m2,1,on Day 1 of each 3-week cycle,NA
26020806,NCT01001221,120,gemcitabine,0,1000,mg/m2,1,on Days 1 and 8 of each 3-week cycle,NA
26020806,NCT01001221,120,cabazitaxel,-1,15,mg/m2,1,on Day 1 of each 3-week cycle,NA
26020806,NCT01001221,120,gemcitabine,-1,900,mg/m2,1,on Days 1 and 8 of each 3-week cycle,NA
26020806,NCT01001221,120,cabazitaxel,-2,15,mg/m2,1,on Day 1 of each 3-week cycle,NA
26020806,NCT01001221,120,gemcitabine,-2,700,mg/m2,1,on Days 1 and 8 of each 3-week cycle,NA
27439894,NCT01663272,121,cabozantinib,-1,20,mg,1,daily beginning on day −7,NA
27439894,NCT01663272,121,gemcitabine,-1,800,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
27439894,NCT01663272,121,cabozantinib,1,20,mg,1,daily beginning on day −7,NA
27439894,NCT01663272,121,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
27439894,NCT01663272,121,cabozantinib,2,40,mg,1,daily beginning on day −7,NA
27439894,NCT01663272,121,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
27439894,NCT01663272,121,cabozantinib,3,60,mg,1,daily beginning on day −7,NA
27439894,NCT01663272,121,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
27439894,NCT01663272,121,cabozantinib,4,80,mg,1,daily beginning on day −7,NA
27439894,NCT01663272,121,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
28039155,NCT01511536,122,cabazitaxel,1,20,mg/m2,1,n on day 1 of each 3-weekly cycle,NA
28039155,NCT01511536,122,abiraterone,1,1000,mg,1,daily,NA
28039155,NCT01511536,122,prednisone,1,5,mg,2,daily,NA
28058445,NCT01140607,123,cabazitaxel,1,25,mg/m2,1,on Day 1 of each 3-week cycle,"normal hepatic 
function"
28058445,NCT01140607,123,cabazitaxel,2,20,mg/m2,1,on Day 1 of each 3-week cycle,mild hepatic impairment
28058445,NCT01140607,123,cabazitaxel,3,25,mg/m2,1,on Day 1 of each 3-week cycle,mild hepatic impairment
28058445,NCT01140607,123,cabazitaxel,4,10,mg/m2,1,on Day 1 of each 3-week cycle,moderate hepatic impairment
28058445,NCT01140607,123,cabazitaxel,5,15,mg/m2,1,on Day 1 of each 3-week cycle,moderate hepatic impairment
28058445,NCT01140607,123,cabazitaxel,6,20,mg/m2,1,on Day 1 of each 3-week cycle,moderate hepatic impairment
28058445,NCT01140607,123,cabazitaxel,7,10,mg/m2,1,on Day 1 of each 3-week cycle,severe hepatic impairment
28058445,NCT01140607,123,cabazitaxel,8,15,mg/m2,1,on Day 1 of each 3-week cycle,severe hepatic impairment
28058445,NCT01140607,123,cabazitaxel,9,20,mg/m2,1,on Day 1 of each 3-week cycle,severe hepatic impairment
27862097,NCT01513733,124,cabazitaxel,1,0.25,mg,1,daily,NA
27862097,NCT01513733,124,tasquinimod,1,25,mg/m2,1,once every 3 weeks,NA
27862097,NCT01513733,124,cabazitaxel,2,0.5,mg,1,daily,NA
27862097,NCT01513733,124,tasquinimod,2,25,mg/m2,1,once every 3 weeks,NA
27862097,NCT01513733,124,cabazitaxel,3,1,mg,1,daily,NA
27862097,NCT01513733,124,tasquinimod,3,25,mg/m2,1,once every 3 weeks,NA
28352985,NCT00596648,125,erlotinib,1,150,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,erlotinib,1,150,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,cabozantinib,1,60,mg,1,daily,NA
28352985,NCT00596648,125,erlotinib,2,100,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,erlotinib,2,100,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,cabozantinib,2,60,mg,1,daily,NA
28352985,NCT00596648,125,erlotinib,2.5,150,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,erlotinib,2.5,150,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,cabozantinib,2.5,40,mg,1,daily,NA
28352985,NCT00596648,125,erlotinib,3,100,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,erlotinib,3,100,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,cabozantinib,3,100,mg,1,daily,NA
28352985,NCT00596648,125,erlotinib,4,50,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,erlotinib,4,50,mg,1,"from days -14 to -1, and daily in 28-day cycles",NA
28352985,NCT00596648,125,cabozantinib,4,100,mg,1,daily,NA
28263212,NA,126,188re-hedp,-1,1.1,mCi/kg,1,administered after the second and after thefourth cycle of cabazitaxel,NA
28263212,NA,126,cabazitaxel,-1,20,mg/m2,1,Six cycles of 3-weekly,NA
28263212,NA,126,188re-hedp,1,1,mCi/kg,1,administered after the second and after thefourth cycle of cabazitaxel,NA
28263212,NA,126,cabazitaxel,1,25,mg/m2,1,Six cycles of 3-weekly,NA
28263212,NA,126,cabazitaxel,1,20,mg/m2,1,once in cycles 7 and 8,NA
28263212,NA,126,188re-hedp,2,1.1,mCi/kg,1,administered after the second and after thefourth cycle of cabazitaxel,NA
28263212,NA,126,cabazitaxel,2,25,mg/m2,1,Six of 3-weekly cycles,NA
28688700,NA,127,cabazitaxel,1,10,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,1,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,1,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,1,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,2,12.5,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,2,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,2,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,2,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,3,15,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,3,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,3,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,3,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,4,17.5,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,4,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,4,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,4,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,5,20,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,5,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,5,100,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,5,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,-1,17.5,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-1,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-1,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,-1,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,-2,20,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-2,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-2,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,-2,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28688700,NA,127,cabazitaxel,-3,22.5,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-3,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,cisplatin,-3,75,mg/m2,1,"at Days 1, 22, 43",NA
28688700,NA,127,5-fu,-3,800,mg/m2,1,"on Days 1-4, 22-25, 43-46",NA
28960265,NCT01961765,128,cabozantinib,1,40,mg,1,daily every 28 days,NA
28960265,NCT01961765,128,cabozantinib,2,60,mg,1,daily every 28 days,NA
28960265,NCT01961765,128,cabozantinib,3,80,mg,1,daily every 28 days,NA
29750396,NCT01751308,131,cabazitaxel,1,20,mg/m2,1,on day 1 of every 21-day cycle,NA
29750396,NCT01751308,131,cabazitaxel,2,25,mg/m2,1,on day 1 of every 21-day cycle,NA
29750396,NCT01751308,131,cabazitaxel,3,30,mg/m2,1,on day 1 of every 21-day cycle,NA
29750396,NCT01751308,131,cabazitaxel,4,35,mg/m2,1,on day 1 of every 21-day cycle,NA
31765988,NA,133,capecitabine,1,1250,mg/m2,2,on days 4-21 of every 21-day cycle,Schedule 1
31765988,NA,133,capecitabine,1,1250,mg/m2,2,on days 4-21 of every 21-day cycle,Schedule 1
31765988,NA,133,oxaliplatin,1,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 1
31765988,NA,133,oxaliplatin,1,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 1
31765988,NA,133,azd8931,1,20,mg,2,on days 1-14 of every 21-day cycle,Schedule 1
31765988,NA,133,capecitabine,2,1250,mg/m2,2,on days 4-21 of every 21-day cycle,continuously
31765988,NA,133,capecitabine,2,1250,mg/m2,2,on days 4-21 of every 21-day cycle,continuously
31765988,NA,133,oxaliplatin,2,130,mg/m2,1,on day 4 one of every 21-day cycle,continuously
31765988,NA,133,oxaliplatin,2,130,mg/m2,1,on day 4 one of every 21-day cycle,continuously
31765988,NA,133,azd8931,2,20,mg,2,daily continuously,continuously
31765988,NA,133,capecitabine,3,1250,mg/m2,2,on days 4-21 one of every 21-day cycle,Schedule 2
31765988,NA,133,capecitabine,3,1250,mg/m2,2,on days 4-21 one of every 21-day cycle,Schedule 2
31765988,NA,133,oxaliplatin,3,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 2
31765988,NA,133,oxaliplatin,3,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 2
31765988,NA,133,azd8931,3,20,mg,2,"on days 1-4, 8-11, 15-18 of every 21-day cycle",Schedule 2
31765988,NA,133,capecitabine,4,1250,mg/m2,2,on days 4-21 of every 21-day cycle,Schedule 2
31765988,NA,133,capecitabine,4,1250,mg/m2,2,on days 4-21 of every 21-day cycle,Schedule 2
31765988,NA,133,oxaliplatin,4,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 2
31765988,NA,133,oxaliplatin,4,130,mg/m2,1,on day 4 of every 21-day cycle,Schedule 2
31765988,NA,133,azd8931,4,40,mg,2,"on days 1-4, 8-11, 15-18 of every 21-day cycle",Schedule 2
32175106,NA,134,tosedostat,0,120,mg,2,on days 1–21 of each 21-day cycle,NA
32175106,NA,134,capecitabine,0,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
32175106,NA,134,capecitabine,0,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
32175106,NA,134,tosedostat,1,60,mg,2,on days 1–21 of each 21-day cycle,NA
32175106,NA,134,capecitabine,1,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
32175106,NA,134,capecitabine,1,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
33206291,NCT01588522,135,bpm31543,1,5,ug/ml,2,daily for 2 weeks,NA
33206291,NCT01588522,135,bpm31543,2,10,ug/ml,2,daily for 2 weeks,NA
33206291,NCT01588522,135,bpm31543,3,20,ug/ml,2,daily for 2 weeks,NA
33206291,NCT01588522,135,bpm31543,4,40,ug/ml,2,daily for 2 weeks,NA
33206291,NCT01588522,135,bpm31543,5,60,ug/ml,2,daily for 2 weeks,NA
33206291,NCT01588522,135,bpm31543,6,80,ug/ml,2,daily for 2 weeks,NA
33469991,NCT02008383,136,panitumumab,1,6,mg/kg,1,daily,NA
33469991,NCT02008383,136,cabozantinib,1,60,mg,1,every 2 weeks,NA
32969563,NCT01683994,137,docetaxel,1,75,mg/m2,1,daily,NA
32969563,NCT01683994,137,prednisone,1,10,mg,2,daily,NA
32969563,NCT01683994,137,cabozantinib,1,20,mg,1,on day 1 of each 21-day cycle,NA
32969563,NCT01683994,137,docetaxel,2,75,mg/m2,1,daily,NA
32969563,NCT01683994,137,prednisone,2,10,mg,2,daily,NA
32969563,NCT01683994,137,cabozantinib,2,40,mg,1,on day 1 of each 21-day cycle,NA
32969563,NCT01683994,137,docetaxel,3,75,mg/m2,1,daily,NA
32969563,NCT01683994,137,prednisone,3,10,mg,2,daily,NA
32969563,NCT01683994,137,cabozantinib,3,60,mg,1,on day 1 of each 21-day cycle,NA
34019214, NCT04097444,138,bevacizumab,1,7.5,mg/kg,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,irinotecan hydrochloride,1,200,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,1,130,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,1,130,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,1,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,1,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,bevacizumab,0,7.5,mg/kg,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,irinotecan hydrochloride,0,200,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,0,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,0,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,0,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,0,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,bevacizumab,-0.5,7.5,mg/kg,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,irinotecan hydrochloride,-0.5,180,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,-0.5,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,-0.5,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,-0.5,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,-0.5,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,bevacizumab,-1,7.5,mg/kg,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,irinotecan hydrochloride,-1,150,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,-1,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,oxaliplatin,-1,100,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,-1,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
34019214, NCT04097444,138,capecitabine,-1,1600,mg/m2,1,on days 1–14 days every 3 weeks,NA
32584367,NCT01702558,139,capecitabine,1,750,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,1,750,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,trastuzumab emtansine,1,3.6,mg/kg,1,on Day 1 [on Day 2 for Cycle 1] of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,-1,700,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,-1,700,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,trastuzumab emtansine,-1,3.6,mg/kg,1,on Day 1 [on Day 2 for Cycle 1] of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,-2,650,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,-2,650,mg/m2,2,on Days 1-14 of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,trastuzumab emtansine,-2,3.6,mg/kg,1,on Day 1 [on Day 2 for Cycle 1] of each 21-day cycle,mBC cohort
32584367,NCT01702558,139,capecitabine,-1,700,mg/m2,NA,"on Days 1-14 followed by a 7-day rest period, in each 21-day cycle",LA/mGC Cohort
32584367,NCT01702558,139,capecitabine,-1,700,mg/m2,NA,"on Days 1-14 followed by a 7-day rest period, in each 21-day cycle",LA/mGC Cohort
32584367,NCT01702558,139,trastuzumab emtansine,-1,2.4,mg/kg,NA,on Day 1 (on Day 2 of first week) of every week,LA/mGC Cohort
32253554,NA,140,trifluridine/tipiracil,1,35,mg/m2,2,on days 1–5 and 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,1,100,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,1,100,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32253554,NA,140,trifluridine/tipiracil,2,35,mg/m2,2,on days 1–5 and 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,2,150,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,2,150,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32253554,NA,140,trifluridine/tipiracil,3,35,mg/m2,2,on days 1–5 and 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,3,200,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32253554,NA,140,temozolomide,3,200,mg/m2,1,on days 8–12 of each 28-day cycle,NA
32382808,NTR4639,141,capecitabine,1,1000,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,1,1000,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,2,1275,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,2,1275,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,3,1600,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,3,1600,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,4,2000,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,4,2000,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,5,2550,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32382808,NTR4639,141,capecitabine,5,2550,mg/m2,1,on day 1–21 of a 21-day cycle,NA
32915679,NCT02496208,143,cabozantinib,1,40,mg,1,daily,Part 1
32915679,NCT02496208,143,nivolumab,1,1,mg/kg,1,every 2 weeks of each 28-day cycle,Part 1
32915679,NCT02496208,143,cabozantinib,2,40,mg,1,daily,Part 1
32915679,NCT02496208,143,nivolumab,2,3,mg/kg,1,every 2 weeks of each 28-day cycle,Part 1
32915679,NCT02496208,143,cabozantinib,3,60,mg,1,daily,Part 1
32915679,NCT02496208,143,nivolumab,3,1,mg/kg,1,every 2 weeks of each 28-day cycle,Part 1
32915679,NCT02496208,143,cabozantinib,4,60,mg,1,daily,Part 1
32915679,NCT02496208,143,nivolumab,4,3,mg/kg,1,every 2 weeks of each 28-day cycle,Part 1
32915679,NCT02496208,143,cabozantinib,5,40,mg,1,daily,Part 2
32915679,NCT02496208,143,nivolumab,5,1,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
32915679,NCT02496208,143,ipilimumab,5,1,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
32915679,NCT02496208,143,cabozantinib,6,40,mg,1,daily,Part 2
32915679,NCT02496208,143,nivolumab,6,3,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
32915679,NCT02496208,143,ipilimumab,6,1,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
32915679,NCT02496208,143,cabozantinib,7,60,mg,1,daily,Part 2
32915679,NCT02496208,143,nivolumab,7,3,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
32915679,NCT02496208,143,ipilimumab,7,1,mg/kg,1,"every 3 weeks of each 21-day cycle for first 4 cycles, then 28 days",Part 2
33452614,NA,144,taletrectinib,1,50,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,2,100,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,3,200,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,4,400,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,5,800,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,6,1200,mg,1,daily in 21-day cycles,NA
33452614,NA,144,taletrectinib,7,400,mg,2,daily in 21-day cycles,NA
29882250,NA,145,cabozantinib,1,20,mg,1,daily,NA
29882250,NA,145,abiraterone acetate,1,1000,mg,1,daily,NA
29882250,NA,145,prednisone,1,5,mg,2,daily,NA
29882250,NA,145,cabozantinib,2,40,mg,1,daily,NA
29882250,NA,145,abiraterone acetate,2,1000,mg,1,daily,NA
29882250,NA,145,prednisone,2,5,mg,2,daily,NA
29882250,NA,145,cabozantinib,3,60,mg,1,daily,NA
29882250,NA,145,abiraterone acetate,3,1000,mg,1,daily,NA
29882250,NA,145,prednisone,3,5,mg,2,daily,NA
29693796, NCT01709435,147,cabozantinib,1,30,mg/m2,1,daily,NA
29693796, NCT01709435,147,cabozantinib,2,40,mg/m2,1,daily,NA
29693796, NCT01709435,147,cabozantinib,3,55,mg/m2,1,daily,NA
25577134, UMIN000005440,148,oxaliplatin,1,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,oxaliplatin,1,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,1,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,1,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,irinotecan,1,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,bevacizumab,1,7.5,mg/kg,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,2,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,2,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,irinotecan,2,120,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,bevacizumab,2,7.5,mg/kg,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,oxaliplatin,3,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,oxaliplatin,3,100,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,3,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,capecitabine,3,1700,mg/m2,1,from day 2 to 15 every 3 weeks,NA
25577134, UMIN000005440,148,irinotecan,3,150,mg/m2,1,on day 1 every 3 weeks,NA
25577134, UMIN000005440,148,bevacizumab,3,7.5,mg/kg,1,on day 1 every 3 weeks,NA
25318436,NA,149,capecitabine,1,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,1,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,1,20,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
25318436,NA,149,capecitabine,2,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,2,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,2,30,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
25318436,NA,149,capecitabine,3,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,3,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,3,45,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
25318436,NA,149,capecitabine,4,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,4,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,4,68,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
25318436,NA,149,capecitabine,5,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,5,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,5,100,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
25318436,NA,149,capecitabine,6,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,capecitabine,6,1000,mg/m2,2,days 1-14  of a 21 day cycle,NA
25318436,NA,149,ro4929097,6,150,mg,1,"days 1–3, 8–10 and 15–17 of each 21 day cycle",NA
29725881,NA,150,irinotecan,1,160,mg/m2,1,on day 1 of each 21-day cycle,NA
29725881,NA,150,capecitabine,1,1900,mg/m2,1,Day 2–15 of each 21-day cycle,NA
29725881,NA,150,capecitabine,1,1900,mg/m2,1,Day 2–15 of each 21-day cycle,NA
29725881,NA,150,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
29725881,NA,150,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
29725881,NA,150,irinotecan,-1,120,mg/m2,1,on day 1 of each 21-day cycle,NA
29725881,NA,150,capecitabine,-1,1425,mg/m2,1,Day 2–15 of each 21-day cycle,NA
29725881,NA,150,capecitabine,-1,1425,mg/m2,1,Day 2–15 of each 21-day cycle,NA
29725881,NA,150,oxaliplatin,-1,85,mg/m2,1,on day 1 of each 21-day cycle,NA
29725881,NA,150,oxaliplatin,-1,85,mg/m2,1,on day 1 of each 21-day cycle,NA
28973403,NCT01791374,151,rilotumumab,1,10,mg/kg,1,on Days 1 and 15 of each 28-day cycle,NA
28973403,NCT01791374,151,rilotumumab,2,20,mg/kg,1,on Days 1 and 15 of each 28-day cycle,NA
28973403,NCT01791374,151,rilotumumab,3,15,mg/kg,NA,on Day 1 of every 21-day cycle,NA
28973403,NCT01791374,151,cisplatin,3,80,mg/m2,1,on Day 1 of every 21-day cycle,NA
28973403,NCT01791374,151,cisplatin,3,80,mg/m2,1,on Day 1 of every 21-day cycle,NA
28973403,NCT01791374,151,capecitabine,3,1000,mg/m2,2,on Days 1–14 of every 21-day cycle,NA
28973403,NCT01791374,151,capecitabine,3,1000,mg/m2,2,on Days 1–14 of every 21-day cycle,NA
26706729,NA,152,capecitabine,-1,500,mg/m2,2,14/21 days,NA
26706729,NA,152,capecitabine,-1,500,mg/m2,2,14/21 days,NA
26706729,NA,152,erlotinib,-1,50,mg,1,daily,NA
26706729,NA,152,erlotinib,-1,50,mg,1,daily,NA
26706729,NA,152,capecitabine,1,500,mg/m2,2,14/21 days,NA
26706729,NA,152,capecitabine,1,500,mg/m2,2,14/21 days,NA
26706729,NA,152,erlotinib,1,100,mg,1,daily,NA
26706729,NA,152,erlotinib,1,100,mg,1,daily,NA
26706729,NA,152,capecitabine,2,750,mg/m2,2,14/21 days,NA
26706729,NA,152,capecitabine,2,750,mg/m2,2,14/21 days,NA
26706729,NA,152,erlotinib,2,100,mg,1,daily,NA
26706729,NA,152,erlotinib,2,100,mg,1,daily,NA
26706729,NA,152,capecitabine,3,1000,mg/m2,2,14/21 days,NA
26706729,NA,152,capecitabine,3,1000,mg/m2,2,14/21 days,NA
26706729,NA,152,erlotinib,3,100,mg,1,daily,NA
26706729,NA,152,erlotinib,3,100,mg,1,daily,NA
30783204, NCT01323530,153,eribulin mesilate,1,1.2,mg/m2,1,on day 1 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,1,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,1,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,eribulin mesilate,2,1.6,mg/m2,1,on day 1 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,2,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,2,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,eribulin mesilate,3,2,mg/m2,1,on day 1 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,3,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,capecitabine,3,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 1
30783204, NCT01323530,153,eribulin mesilate,4,0.7,mg/m2,1,on days 1and 8 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,4,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,4,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,eribulin mesilate,5,1.1,mg/m2,1,on days 1and 8 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,5,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,5,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,eribulin mesilate,6,1.4,mg/m2,1,on days 1and 8 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,6,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
30783204, NCT01323530,153,capecitabine,6,1000,mg/m2,2,on days 1–14 of a 21-day cycle,schedule 2
24820348,NA,154,irinotecan,1,80,mg/m2,1,on days 1 and 15 of each 28 days,NA
24820348,NA,154,capecitabine,1,1657,mg/m2,1,on days 1-21 of each 28 days,NA
24820348,NA,154,capecitabine,1,1657,mg/m2,1,on days 1-21 of each 28 days,NA
24820348,NA,154,irinotecan,2,90,mg/m2,1,on days 1 and 15 of each 28 days,NA
24820348,NA,154,capecitabine,2,1657,mg/m2,1,on days 1-21 of each 28 days,NA
24820348,NA,154,capecitabine,2,1657,mg/m2,1,on days 1-21 of each 28 days,NA
24820348,NA,154,irinotecan,3,100,mg/m2,1,on days 1 and 15 of each 28 days,NA
24820348,NA,154,capecitabine,3,1657,mg/m2,1,on days 1-21 of each 28 days,NA
24820348,NA,154,capecitabine,3,1657,mg/m2,1,on days 1-21 of each 28 days,NA
29330005,NA,155,irinotecan,1,180,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,1,850,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,1,850,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,1,85,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,1,85,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,2,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,2,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,2,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,2,75,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,2,75,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,3,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,3,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,3,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,3,85,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,3,85,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,4,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,4,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,4,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,4,95,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,4,95,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,5,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,5,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,5,750,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,5,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,5,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,6,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,6,850,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,6,850,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,6,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,6,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,7,160,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,7,950,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,7,950,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,7,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,7,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,irinotecan,8,175,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,capecitabine,8,950,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,capecitabine,8,950,mg/m2,2,on days 2 to 15 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,8,100,mg/m2,1,on day 1 of a 3-week cycle,NA
29330005,NA,155,oxaliplatin,8,100,mg/m2,1,on day 1 of a 3-week cycle,NA
31266024,NA,156,capecitabine,1,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,capecitabine,1,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,1,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,1,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,irinotecan,1,150,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,capecitabine,0,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,capecitabine,0,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,0,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,0,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,irinotecan,0,120,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,capecitabine,-1,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,capecitabine,-1,1000,mg/m2,2,on days 1–7 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,-1,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,oxaliplatin,-1,85,mg/m2,1,on day 1 of a biweekly schedule,NA
31266024,NA,156,irinotecan,-1,100,mg/m2,1,on day 1 of a biweekly schedule,NA
26460795,NCT01226732,157,auy922,1,22,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,1,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,1,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,auy922,2,28,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,2,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,2,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,auy922,3,40,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,3,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,3,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,auy922,4,55,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,4,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,4,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,auy922,5,70,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,5,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,5,1000,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,auy922,6,70,mg/m2,1,"on days 1, 8, 15 of cycle 1 (21 days)",NA
26460795,NCT01226732,157,capecitabine,6,1250,mg/m2,2,daily for the first14 days of each cycle,NA
26460795,NCT01226732,157,capecitabine,6,1250,mg/m2,2,daily for the first14 days of each cycle,NA
29153866,NCT01300962,158,buparlisib,1,50,mg,1,daily for 3weeks,NA
29153866,NCT01300962,158,capecitabine,1,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,capecitabine,1,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,buparlisib,2,80,mg,1,daily for 3weeks,NA
29153866,NCT01300962,158,capecitabine,2,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,capecitabine,2,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,buparlisib,3,100,mg,1,daily for 3weeks,NA
29153866,NCT01300962,158,capecitabine,3,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,capecitabine,3,1000,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,buparlisib,4,100,mg,1,daily for 3weeks,NA
29153866,NCT01300962,158,capecitabine,4,1250,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
29153866,NCT01300962,158,capecitabine,4,1250,mg/m2,2,daily for 2 weeks followed by a 1-week break,NA
31675952,NCT01661972,159,capecitabine,1,850,mg/m2,2,Days 1–14 every 3 weeks,NA
31675952,NCT01661972,159,capecitabine,1,850,mg/m2,2,Days 1–14 every 3 weeks,NA
31675952,NCT01661972,159,ziv-aflibercept,1,6,mg/kg,1,Day 1 every 3 weeks,NA
31675952,NCT01661972,159,capecitabine,2,1000,mg/m2,2,Days 1–14 every 3 weeks,NA
31675952,NCT01661972,159,capecitabine,2,1000,mg/m2,2,Days 1–14 every 3 weeks,NA
31675952,NCT01661972,159,ziv-aflibercept,2,6,mg/kg,1,Day 1 every 3 weeks,NA
30418178,NA,160,capecitabine,0,200,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,capecitabine,0,200,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,capecitabine,0,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,0,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,0,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,capecitabine,0,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,capecitabine,1,300,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,capecitabine,1,300,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,capecitabine,1,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,1,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,1,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,capecitabine,1,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,dovitinib,2,400,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,2,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,capecitabine,2,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,dovitinib,3,500,mg,1,"days 1 to 5, 8 to 12 and 15 to 19 of every 21-day cycle",NA
30418178,NA,160,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
30418178,NA,160,capecitabine,3,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
30418178,NA,160,capecitabine,3,1300,mg/m2,1,from day 1 to 14 of every 21-day cycle,NA
27390847,NCT00845884,161,docetaxel,0,30,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,cisplatin,0,30,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,cisplatin,0,30,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,bevacizumab,0,7.5,mg/kg,1,on D1 n 3-week cycles,NA
27390847,NCT00845884,161,capecitabine,0,800,mg/m2,2,on D1-14 in 3-week cycles,NA
27390847,NCT00845884,161,capecitabine,0,800,mg/m2,2,on D1-14 in 3-week cycles,NA
27390847,NCT00845884,161,docetaxel,-1,30,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,cisplatin,-1,25,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,cisplatin,-1,25,mg/m2,1,"on D1,8 in 3-week cycles",NA
27390847,NCT00845884,161,bevacizumab,-1,7.5,mg/kg,1,on D1 n 3-week cycles,NA
27390847,NCT00845884,161,capecitabine,-1,800,mg/m2,2,on D1-14 in 3-week cycles,NA
27390847,NCT00845884,161,capecitabine,-1,800,mg/m2,2,on D1-14 in 3-week cycles,NA
29573846,NA,162,docetaxel,-3,45,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,-3,625,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,-3,625,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,-3,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,-3,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,docetaxel,-2,45,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,-2,800,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,-2,800,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,-2,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,-2,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,docetaxel,-1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,-1,800,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,-1,800,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,-1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,-1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,docetaxel,0,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,0,1000,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,0,1000,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,0,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,0,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,docetaxel,1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,1,1250,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,1,1250,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,1,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,docetaxel,2,75,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,capecitabine,2,1250,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,capecitabine,2,1250,mg/m2,1,continuously days 1-21,in 2 divided doses
29573846,NA,162,cisplatinum,2,60,mg/m2,1,on day 1 in 21 day cycles,NA
29573846,NA,162,cisplatinum,2,60,mg/m2,1,on day 1 in 21 day cycles,NA
29038850,UMIN 000009144,163,cetuximab,1,400,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,irinotecan,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,1,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,1,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
29038850,UMIN 000009144,163,cetuximab,2,400,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,irinotecan,2,120,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,2,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,2,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
29038850,UMIN 000009144,163,cetuximab,3,400,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,irinotecan,3,150,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,oxaliplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,3,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
29038850,UMIN 000009144,163,capecitabine,3,1700,mg/m2,1,from day 2 to 15 of each 3-week cycle,NA
30949758,NCT03295084,164,irinotecan,1,17.5,mg/m2,1,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
30949758,NCT03295084,164,capecitabine,1,800,mg/m2,2,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
30949758,NCT03295084,164,capecitabine,1,800,mg/m2,2,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
30949758,NCT03295084,164,irinotecan,2,21,mg/m2,1,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
30949758,NCT03295084,164,capecitabine,2,800,mg/m2,2,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
30949758,NCT03295084,164,capecitabine,2,800,mg/m2,2,"14 consecutive days , followed by 1 week of medication in a 3-week treatment cycle",NA
25290090,NCT00959946,165,bosutinib,3,200,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,2,200,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,2,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,2,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,1,200,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,1,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,1,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,4,300,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,4,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,4,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,5,300,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,5,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,5,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,6,300,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,6,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,6,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,7,400,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,7,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,7,625,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,8,400,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,8,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,8,750,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,bosutinib,9,400,mg,1,daily continuously,NA
25290090,NCT00959946,165,capecitabine,9,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
25290090,NCT00959946,165,capecitabine,9,1000,mg/m2,2,on days 1 to 14 of each 21-day treatment cycle,NA
29707156,NA,166,capecitabine,1,825,mg/m2,2,5 days/week,NA
29707156,NA,166,capecitabine,1,825,mg/m2,2,5 days/week,NA
29707156,NA,166,oxaliplatin,1,35,mg/m2,1,once per week,NA
29707156,NA,166,oxaliplatin,1,35,mg/m2,1,once per week,NA
29707156,NA,166,radiotherapy,1,45,Gy,2,5 days a week,NA
29707156,NA,166,capecitabine,2,825,mg/m2,2,5 days/week,NA
29707156,NA,166,capecitabine,2,825,mg/m2,2,5 days/week,NA
29707156,NA,166,oxaliplatin,2,40,mg/m2,1,once per week,NA
29707156,NA,166,oxaliplatin,2,40,mg/m2,1,once per week,NA
29707156,NA,166,radiotherapy,2,45,mg/m2,2,5 days a week,NA
28894576,NA,167,capecitabine,1,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
28894576,NA,167,capecitabine,1,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
28894576,NA,167,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,NA
28894576,NA,167,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,NA
28894576,NA,167,capecitabine,0,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
28894576,NA,167,capecitabine,0,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
28894576,NA,167,oxaliplatin,0,100,mg/m2,1,on day 1 every 3 weeks,NA
28894576,NA,167,oxaliplatin,0,100,mg/m2,1,on day 1 every 3 weeks,NA
29273261,NCT01474187,168,capecitabine,1,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,capecitabine,1,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,irinotecan,1,50,mg/m2,1,on d1 every week,NA
29273261,NCT01474187,168,radiotherapy,1,2,Gy,1,d1-5 every weeks,NA
29273261,NCT01474187,168,capecitabine,2,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,capecitabine,2,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,irinotecan,2,65,mg/m2,1,on d1 every week,NA
29273261,NCT01474187,168,radiotherapy,2,2,Gy,1,d1-5 every weeks,NA
29273261,NCT01474187,168,capecitabine,3,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,capecitabine,3,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,irinotecan,3,80,mg/m2,1,on d1 every week,NA
29273261,NCT01474187,168,radiotherapy,3,2,Gy,1,d1-5 every weeks,NA
29273261,NCT01474187,168,capecitabine,4,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,capecitabine,4,625,mg/m2,2,d1-5 every week,NA
29273261,NCT01474187,168,irinotecan,4,95,mg/m2,1,on d1 every week,NA
29273261,NCT01474187,168,radiotherapy,4,2,Gy,1,d1-5 every weeks,NA
26632033,NA,169,abt-751,1,150,mg,1,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,1,800,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,1,800,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,irinotecan,1,200,mg/m2,1,day 1  of each 21-day cycle,NA
26632033,NA,169,abt-751,2,150,mg,1,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,2,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,2,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,irinotecan,2,250,mg/m2,1,day 1  of each 21-day cycle,NA
26632033,NA,169,abt-751,2.5,150,mg,1,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,2.5,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,2.5,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,irinotecan,2.5,200,mg/m2,1,day 1  of each 21-day cycle,NA
26632033,NA,169,bevacizumab,2.5,7.5,mg/kg,1,day 1  of each 21-day cycle,NA
26632033,NA,169,abt-751,1.5,150,mg,1,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,1.5,800,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,1.5,800,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,irinotecan,1.5,200,mg/m2,1,day 1  of each 21-day cycle,NA
26632033,NA,169,bevacizumab,1.5,7.5,mg/kg,1,day 1  of each 21-day cycle,NA
26632033,NA,169,abt-751,3,125,mg,1,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,3,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,capecitabine,3,1000,mg/m2,2,days 1 to 14 of each 21-day cycle,NA
26632033,NA,169,irinotecan,3,250,mg/m2,1,day 1  of each 21-day cycle,NA
26632033,NA,169,bevacizumab,3,7.5,mg/kg,1,day 1  of each 21-day cycle,NA
27473815,NCT01781403,170,temozolomide,1,45,mg/m2,1,daily,NA
27473815,NCT01781403,170,temozolomide,1,45,mg/m2,1,daily,NA
27473815,NCT01781403,170,capecitabine,1,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,capecitabine,1,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,radiation therapy,1,50.4,Gy,NA,every week,NA
27473815,NCT01781403,170,temozolomide,2,60,mg/m2,1,daily,NA
27473815,NCT01781403,170,temozolomide,2,60,mg/m2,1,daily,NA
27473815,NCT01781403,170,capecitabine,2,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,capecitabine,2,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,radiation therapy,2,50.4,Gy,NA,every week,NA
27473815,NCT01781403,170,temozolomide,3,75,mg/m2,1,daily,NA
27473815,NCT01781403,170,temozolomide,3,75,mg/m2,1,daily,NA
27473815,NCT01781403,170,capecitabine,3,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,capecitabine,3,825,mg/m2,2,daily,NA
27473815,NCT01781403,170,radiation therapy,3,50.4,Gy,NA,every week,NA
26499900,NA,171,docetaxel,1,50,mg/m2,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,1,650,mg/m2,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,1,650,mg/m2,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,docetaxel,2,50,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,2,100,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,2,100,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,2,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,2,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,docetaxel,3,50,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,3,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,3,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,3,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,3,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,docetaxel,4,65,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,4,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,4,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,4,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,4,850,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,docetaxel,5,65,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,5,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,5,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,5,1000,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,5,1000,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,docetaxel,6,75,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,6,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,oxaliplatin,6,130,NA,1,on day 1 of each 3-week cycle,NA
26499900,NA,171,capecitabine,6,1000,NA,2,on days 1–14 of each 3-week cycle,NA
26499900,NA,171,capecitabine,6,1000,NA,2,on days 1–14 of each 3-week cycle,NA
27404453,NCT01730222,172,nab-paclitaxel,1,100,mg/m2,1,on days 1 and 15 of each 28-day cycles,NA
27404453,NCT01730222,172,gemcitabine,1,800,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,1,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,1,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,1,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,1,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,nab-paclitaxel,2,125,mg/m2,1,on days 1 and 15 of each 28-day cycles,NA
27404453,NCT01730222,172,gemcitabine,2,800,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,2,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,2,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,2,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,2,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,nab-paclitaxel,3,150,mg/m2,1,on days 1 and 15 of each 28-day cycles,NA
27404453,NCT01730222,172,gemcitabine,3,800,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,3,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,capecitabine,3,1250,mg/m2,1,on days 1 through 28 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,3,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
27404453,NCT01730222,172,cisplatin,3,30,mg/m2,1,on days 1 and 15 of each 28-day cycles,fixed
31207904,NCT02273713,173,nab-paclitaxel,1,60,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,1,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,1,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,1,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,1,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,nab-paclitaxel,2,80,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,2,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,2,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,2,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,2,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,nab-paclitaxel,3,100,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,3,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,3,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,3,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,3,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,nab-paclitaxel,4,120,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,4,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,capecitabine,4,65,mg/m2,2,on days 1-14 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,4,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
31207904,NCT02273713,173,oxaliplatin,4,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,NA
25687867,NCT00842244,174,axitinib,1,5,mg,2,on days 1 to 21 of each 21-day cycle,NA
25687867,NCT00842244,174,cisplatin,1,80,mg/m2,1,on day 1 of each 21-day cycle,NA
25687867,NCT00842244,174,cisplatin,1,80,mg/m2,1,on day 1 of each 21-day cycle,NA
25687867,NCT00842244,174,capecitabine,1,1000,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
25687867,NCT00842244,174,capecitabine,1,1000,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
25687867,NCT00842244,174,axitinib,-1,3,mg,2,on days 1 to 21 of each 21-day cycle,NA
25687867,NCT00842244,174,cisplatin,-1,80,mg/m2,1,on day 1 of each 21-day cycle,NA
25687867,NCT00842244,174,cisplatin,-1,80,mg/m2,1,on day 1 of each 21-day cycle,NA
25687867,NCT00842244,174,capecitabine,-1,1000,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
25687867,NCT00842244,174,capecitabine,-1,1000,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
24983373,NCT00604409,175,capecitabine,1,375,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,capecitabine,1,375,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,sirt,1,NA,NA,NA,on day 2 with two cycles of capecitabine,NA
24983373,NCT00604409,175,capecitabine,2,600,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,capecitabine,2,600,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,sirt,2,NA,NA,NA,on day 2 with two cycles of capecitabine,NA
24983373,NCT00604409,175,capecitabine,3,750,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,capecitabine,3,750,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,sirt,3,NA,NA,NA,on day 2 with two cycles of capecitabine,NA
24983373,NCT00604409,175,capecitabine,4,900,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,capecitabine,4,900,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,sirt,4,NA,NA,NA,on day 2 with two cycles of capecitabine,NA
24983373,NCT00604409,175,capecitabine,5,1000,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,capecitabine,5,1000,mg/m2,2,14 days every 21 days,NA
24983373,NCT00604409,175,sirt,5,NA,NA,NA,on day 2 with two cycles of capecitabine,NA
24711126,NCT00849550,176,capecitabine,1,850,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,capecitabine,1,850,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,1,130,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,1,130,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,bevacizumab,1,7.5,mg/kg,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,everolimus,1,5,mg,1,3 times weekly,NA
24711126,NCT00849550,176,everolimus,1,5,mg,1,3 times weekly,NA
24711126,NCT00849550,176,capecitabine,-1.5,680,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,capecitabine,-1.5,680,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,-1.5,100,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,-1.5,100,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,bevacizumab,-1.5,7.5,mg/kg,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,everolimus,-1.5,5,mg,1,days 1–21 of each 21-day,NA
24711126,NCT00849550,176,everolimus,-1.5,5,mg,1,days 1–21 of each 21-day,NA
24711126,NCT00849550,176,capecitabine,-1,680,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,capecitabine,-1,680,mg/m2,2,days 1–14 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,-1,100,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,oxaliplatin,-1,100,mg/m2,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,bevacizumab,-1,7.5,mg/kg,1,day 1 of each 21-day cycle,NA
24711126,NCT00849550,176,everolimus,-1,5,mg,1,3 times weekly,NA
24711126,NCT00849550,176,everolimus,-1,5,mg,1,3 times weekly,NA
25750312,NCT00478634,177,everolimus,1,30,mg,1,NA,once weekly
25750312,NCT00478634,177,everolimus,1,30,mg,1,NA,once weekly
25750312,NCT00478634,177,cetuximab,1,400,mg/m2,1,NA,once weekly
25750312,NCT00478634,177,irinotecan,1,350,mg/m2,1,NA,once every 3 weeks
25750312,NCT00478634,177,everolimus,2,50,mg,1,NA,once weekly
25750312,NCT00478634,177,everolimus,2,50,mg,1,NA,once weekly
25750312,NCT00478634,177,cetuximab,2,400,mg/m2,1,NA,once weekly
25750312,NCT00478634,177,irinotecan,2,350,mg/m2,1,NA,once every 3 weeks
25750312,NCT00478634,177,everolimus,-1,20,mg,1,NA,once weekly
25750312,NCT00478634,177,everolimus,-1,20,mg,1,NA,once weekly
25750312,NCT00478634,177,cetuximab,-1,400,mg/m2,1,NA,once weekly
25750312,NCT00478634,177,irinotecan,-1,250,mg/m2,1,NA,once every 3 weeks
30988080,NCT02650752,178,lapatinib,-2,500,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,-2,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,-2,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,lapatinib,-1,750,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,-1,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,-1,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,lapatinib,1,1000,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,1,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,1,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,lapatinib,2,1500,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,2,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,2,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,lapatinib,3,2000,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,3,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,3,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,lapatinib,4,2500,mg,2,on day 1–3 and day 15–17 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,4,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
30988080,NCT02650752,178,capecitabine,4,1500,mg,2,on day 8–14 and day 22–28 on an every 28-day cycle,NA
25142843,EudraCT: 2007-001021-10,179,sunitinib,1,37.5,mg,1,daily,NA
25142843,EudraCT: 2007-001021-10,179,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 for six 21-day cycles,NA
25142843,EudraCT: 2007-001021-10,179,capecitabine,1,850,mg/m2,2,on days 1–14 for six 21-day cycles,NA
25142843,EudraCT: 2007-001021-10,179,capecitabine,1,850,mg/m2,2,on days 1–14 for six 21-day cycles,NA
25142843,EudraCT: 2007-001021-10,179,sunitinib,0,37.5,mg,1,daily,NA
25142843,EudraCT: 2007-001021-10,179,gemcitabine,0,1000,mg/m2,1,on days 1 and 8 for six 21-day cycles,NA
25142843,EudraCT: 2007-001021-10,179,capecitabine,0,650,mg/m2,2,on days 1–14 for six 21-day cycles,NA
25142843,EudraCT: 2007-001021-10,179,capecitabine,0,650,mg/m2,2,on days 1–14 for six 21-day cycles,NA
27336466,NA,180,bevacizumab,1,5,mg/kg,1,every 2 weeks,Weeks 1 through 6
27336466,NA,180,capecitabine,1,400,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,capecitabine,1,400,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,erlotinib,1,100,mg,1,daily,Weeks 1 through 6
27336466,NA,180,erlotinib,1,100,mg,1,daily,Weeks 1 through 6
27336466,NA,180,radiation therapy,1,50.4,Gy,NA,NA,in 28 fraction
27336466,NA,180,bevacizumab,2,5,mg/kg,1,every 2 weeks,Weeks 1 through 6
27336466,NA,180,capecitabine,2,650,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,capecitabine,2,650,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,erlotinib,2,100,mg,1,daily,Weeks 1 through 6
27336466,NA,180,erlotinib,2,100,mg,1,daily,Weeks 1 through 6
27336466,NA,180,radiation therapy,2,50.4,Gy,NA,NA,in 28 fraction
27336466,NA,180,bevacizumab,3,5,mg/kg,1,every 2 weeks,Weeks 1 through 6
27336466,NA,180,capecitabine,3,650,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,capecitabine,3,650,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,erlotinib,3,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,erlotinib,3,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,radiation therapy,3,50.4,Gy,NA,NA,in 28 fraction
27336466,NA,180,bevacizumab,4,5,mg/kg,1,every 2 weeks,Weeks 1 through 6
27336466,NA,180,capecitabine,4,825,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,capecitabine,4,825,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,erlotinib,4,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,erlotinib,4,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,radiation therapy,4,50.4,Gy,NA,NA,in 28 fraction
27336466,NA,180,bevacizumab,5,10,mg/kg,1,every 2 weeks,Weeks 1 through 6
27336466,NA,180,capecitabine,5,825,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,capecitabine,5,825,mg/m2,2,on days of radiation,Weeks 1 through 6
27336466,NA,180,erlotinib,5,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,erlotinib,5,150,mg,1,daily,Weeks 1 through 6
27336466,NA,180,radiation therapy,5,50.4,Gy,NA,NA,in 28 fraction
26715573,NCT00551096,181,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, 15 of each 28 day cycle",NA
26715573,NCT00551096,181,capecitabine,1,850,mg/m2,2,on days 1–21 of each 28 day cycle,NA
26715573,NCT00551096,181,capecitabine,1,850,mg/m2,2,on days 1–21 of each 28 day cycle,NA
26715573,NCT00551096,181,vandetanib,1,200,mg,1,daily,NA
26715573,NCT00551096,181,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, 15 of each 28 day cycle",NA
26715573,NCT00551096,181,capecitabine,2,850,mg/m2,2,on days 1–21 of each 28 day cycle,NA
26715573,NCT00551096,181,capecitabine,2,850,mg/m2,2,on days 1–21 of each 28 day cycle,NA
26715573,NCT00551096,181,vandetanib,2,300,mg,1,daily,NA
27106554,NA,182,vorinostat,1,100,mg,1,daily on the days of radiation and then daily M–F for two weeks after completion of radiation,NA
27106554,NA,182,capecitabine,1,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,capecitabine,1,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,radiation,1,30,Gy,NA,two weeks,in 10 fractions
27106554,NA,182,vorinostat,2,200,mg,1,daily on the days of radiation and then daily M–F for two weeks after completion of radiation,NA
27106554,NA,182,capecitabine,2,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,capecitabine,2,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,radiation,2,30,Gy,NA,two weeks,in 10 fractions
27106554,NA,182,vorinostat,3,300,mg,1,daily on the days of radiation and then daily M–F for two weeks after completion of radiation,NA
27106554,NA,182,capecitabine,3,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,capecitabine,3,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,radiation,3,30,Gy,NA,two weeks,in 10 fractions
27106554,NA,182,vorinostat,4,400,mg,1,daily on the days of radiation and then daily M–F for two weeks after completion of radiation,NA
27106554,NA,182,capecitabine,4,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,capecitabine,4,1000,mg,2,from days 1-14 of each 21 day cycle,NA
27106554,NA,182,radiation,4,30,Gy,NA,two weeks,in 10 fractions
27542211,NCT01193517,183,azacitidine,1,75,mg/m2,1,days 1=5 every 3 weeks,NA
27542211,NCT01193517,183,oxaliplatin,1,90,mg/m2,1,day 2 every 3 weeks,NA
27542211,NCT01193517,183,oxaliplatin,1,90,mg/m2,1,day 2 every 3 weeks,NA
27542211,NCT01193517,183,capecitabine,1,750,mg/m2,2,daily for 2 weeks every three weeks,NA
27542211,NCT01193517,183,capecitabine,1,750,mg/m2,2,daily for 2 weeks every three weeks,NA
27542211,NCT01193517,183,azacitidine,2,75,mg/m2,1,days 1=5 every 3 weeks,NA
27542211,NCT01193517,183,oxaliplatin,2,110,mg/m2,1,day 2 every 3 weeks,NA
27542211,NCT01193517,183,oxaliplatin,2,110,mg/m2,1,day 2 every 3 weeks,NA
27542211,NCT01193517,183,capecitabine,2,750,mg/m2,2,daily for 2 weeks every three weeks,NA
27542211,NCT01193517,183,capecitabine,2,750,mg/m2,2,daily for 2 weeks every three weeks,NA
25267761,NA,184,glembatumumab vedotin,1,1.34,mg/kg,1,day 1 of repeated 21 day cycles,NA
25267761,NA,184,glembatumumab vedotin,0,1,mg/kg,1,day 1 of repeated 21 day cycles,NA
25267761,NA,184,glembatumumab vedotin,2,1.88,mg/kg,1,day 1 of repeated 21 day cycles,NA
30858085,NCT02010567,185,radiation therapy,1,1.8,Gy,1,on Day1 of neoadjuvant chemotherapy and continues for 28 (if <T4) or 30 (T4 disease) consecutive weekdays,NA
30858085,NCT02010567,185,capecitabine,1,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,capecitabine,1,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,crlx101,1,12,NA,1,"once on weeks 1, 3, 5",NA
30858085,NCT02010567,185,radiation therapy,2,1.8,Gy,1,on Day1 of neoadjuvant chemotherapy and continues for 28 (if <T4) or 30 (T4 disease) consecutive weekdays,NA
30858085,NCT02010567,185,capecitabine,2,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,capecitabine,2,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,crlx101,2,15,NA,1,"once on weeks 1, 3, 5",NA
30858085,NCT02010567,185,radiation therapy,3,1.8,Gy,1,on Day1 of neoadjuvant chemotherapy and continues for 28 (if <T4) or 30 (T4 disease) consecutive weekdays,NA
30858085,NCT02010567,185,capecitabine,3,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,capecitabine,3,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,crlx101,3,12,NA,1,weekly,NA
30858085,NCT02010567,185,radiation therapy,4,1.8,Gy,1,on Day1 of neoadjuvant chemotherapy and continues for 28 (if <T4) or 30 (T4 disease) consecutive weekdays,NA
30858085,NCT02010567,185,capecitabine,4,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,capecitabine,4,825,mg/m2,2,daily Monday through Fridayfor the duration of RT,NA
30858085,NCT02010567,185,crlx101,4,15,NA,1,weekly,NA
29998365,NCT 00925769,186,capecitabine,1,500,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,1,500,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,1,100,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,1,100,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,1,5,mg/kg,1,once every 2 weeks,NA
29998365,NCT 00925769,186,capecitabine,2,650,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,2,650,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,2,100,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,2,100,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,2,5,mg/kg,1,once every 2 weeks,NA
29998365,NCT 00925769,186,capecitabine,3,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,3,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,3,100,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,3,100,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,3,5,mg/kg,1,once every 2 weeks,NA
29998365,NCT 00925769,186,capecitabine,4,900,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,4,900,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,4,100,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,4,100,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,4,5,mg/kg,1,once every 2 weeks,NA
29998365,NCT 00925769,186,capecitabine,5,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,5,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,5,150,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,5,150,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,5,5,mg/kg,1,once every 2 weeks,NA
29998365,NCT 00925769,186,capecitabine,6,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,capecitabine,6,800,mg/m2,2,daily continuously,NA
29998365,NCT 00925769,186,erlotinib,6,150,mg,1,daily,NA
29998365,NCT 00925769,186,erlotinib,6,150,mg,1,daily,NA
29998365,NCT 00925769,186,bevacizumab,6,10,mg/kg,1,once every 2 weeks,NA
25287822,NCT00741260,187,capecitabine,1,750,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,capecitabine,1,750,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,neratinib,1,160,mg,1,daily continuously,NA
25287822,NCT00741260,187,capecitabine,4,750,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,capecitabine,4,750,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,neratinib,4,240,mg,1,daily continuously,NA
25287822,NCT00741260,187,capecitabine,5,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,capecitabine,5,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,neratinib,5,240,mg,1,daily continuously,NA
25287822,NCT00741260,187,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,neratinib,3,200,mg,1,daily continuously,NA
25287822,NCT00741260,187,capecitabine,2,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,capecitabine,2,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
25287822,NCT00741260,187,neratinib,2,160,mg,1,daily continuously,NA
31138588,NCT02361112,188,pyrotinib,1,160,mg,1,daily continuously,NA
31138588,NCT02361112,188,capecitabine,1,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,capecitabine,1,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,pyrotinib,2,240,mg,1,daily continuously,NA
31138588,NCT02361112,188,capecitabine,2,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,capecitabine,2,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,pyrotinib,3,320,mg,1,daily continuously,NA
31138588,NCT02361112,188,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,capecitabine,3,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,pyrotinib,4,400,mg,1,daily continuously,NA
31138588,NCT02361112,188,capecitabine,4,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
31138588,NCT02361112,188,capecitabine,4,1000,mg/m2,2,on days 1 to 14 of a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,1,750,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,1,750,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,docetaxel,1,75,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,1,100,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,1,100,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,2,1000,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,2,1000,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,docetaxel,2,75,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,2,100,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,2,100,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,3,1250,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,3,1250,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,docetaxel,3,75,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,3,1000,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,3,1000,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,4,1500,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,capecitabine,4,1500,mg/m2,2,on d1-7 within a 21-day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,docetaxel,4,75,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,4,100,mg/m2,1,on d1 within a 21‑day cycle,NA
28413680,"ChiCTR‑ONRC‑13,004,023",189,oxaliplatin,4,100,mg/m2,1,on d1 within a 21‑day cycle,NA
30893699,UMIN000018383,190,trastuzumab emtansine,0,3.6,mg/kg,1,on day 1 every 3 weeks,NA
30893699,UMIN000018383,190,s-1,0,65,mg/m2,1,14 days in a 3-week cycle,NA
30893699,UMIN000018383,190,trastuzumab emtansine,1,3.6,mg/kg,1,on day 1 every 3 weeks,NA
30893699,UMIN000018383,190,s-1,1,40,mg/m2,2,14 days in a 3-week cycle,NA
19319526,NA,191,188re-hedp,1,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,1,400,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,1,400,mg,2,daily doses for 14 days,NA
19319526,NA,191,188re-hedp,2,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,2,500,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,2,500,mg,2,daily doses for 14 days,NA
19319526,NA,191,188re-hedp,3,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,3,900,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,3,900,mg,2,daily doses for 14 days,NA
19319526,NA,191,188re-hedp,4,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,4,1150,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,4,1150,mg,2,daily doses for 14 days,NA
19319526,NA,191,188re-hedp,5,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,5,1250,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,5,1250,mg,2,daily doses for 14 days,NA
19319526,NA,191,188re-hedp,6,37,MBq/kg,1,NA,NA
19319526,NA,191,capecitabine,6,1400,mg,2,daily doses for 14 days,NA
19319526,NA,191,capecitabine,6,1400,mg,2,daily doses for 14 days,NA
19839918,NA,192,docetaxel,1,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,1,1000,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,1,1000,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,1,70,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,1,70,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,docetaxel,2,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,2,1125,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,2,1125,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,2,70,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,2,70,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,docetaxel,3,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,3,1125,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,3,1125,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,3,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,3,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,docetaxel,4,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,4,1250,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,4,1250,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,4,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,4,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,docetaxel,5,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,5,1375,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,5,1375,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,5,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,5,75,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,docetaxel,6,50,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,capecitabine,6,1375,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,capecitabine,6,1375,mg/m2,2,on days 1 to 7 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,6,80,mg/m2,1,on day 1 of each 2-week cycle,NA
19839918,NA,192,oxaliplatin,6,80,mg/m2,1,on day 1 of each 2-week cycle,NA
21339064,NA,193,capecitabine,-1,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,-1,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,-1,15,mg/m2,1,on day 1 of each 3-week cycle,NA
21339064,NA,193,capecitabine,1,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,1,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,1,20,mg/m2,1,on day 1 of each 3-week cycle,NA
21339064,NA,193,capecitabine,2,1000,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,2,1000,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,2,20,mg/m2,1,on day 1 of each 3-week cycle,NA
21339064,NA,193,capecitabine,-3,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,-3,825,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,-3,25,mg/m2,1,on day 1 of each 3-week cycle,NA
21339064,NA,193,capecitabine,3,1000,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,3,1000,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,3,25,mg/m2,1,on day 1 of each 3-week cycle,NA
21339064,NA,193,capecitabine,4,1250,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,capecitabine,4,1250,mg/m2,2,from day 1to day 14 of each 3-week cycle,NA
21339064,NA,193,cabazitaxel,4,25,mg/m2,1,on day 1 of each 3-week cycle,NA
19657639,NA,194,capecitabine,1,1000,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,capecitabine,1,1000,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,mitomycin c,1,6,mg/m2,1,on day 1 of each 28-day cycle,NA
19657639,NA,194,capecitabine,2,1250,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,capecitabine,2,1250,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,mitomycin c,2,6,mg/m2,1,on day 1 of each 28-day cycle,NA
19657639,NA,194,capecitabine,3,1500,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,capecitabine,3,1500,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,mitomycin c,3,6,mg/m2,1,on day 1 of each 28-day cycle,NA
19657639,NA,194,capecitabine,4,2000,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,capecitabine,4,2000,mg/m2,2,on days 8–21 of each 28-day cycle,NA
19657639,NA,194,mitomycin c,4,6,mg/m2,1,on day 1 of each 28-day cycle,NA
20839949,NA,195,docetaxe,0,25,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,0,45,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,0,45,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,0,550,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,0,550,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,docetaxe,1,30,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,1,50,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,1,50,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,1,675,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,1,675,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,docetaxe,2,30,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,2,750,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,2,750,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,docetaxe,3,30,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,3,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,3,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,3,750,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,3,750,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,docetaxe,4,30,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,4,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,4,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,4,850,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,4,850,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,docetaxe,5,35,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,5,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,oxaliplatin,5,55,mg/m2,1,on days 1 and 8 of every 21-day cycle,NA
20839949,NA,195,capecitabine,5,850,mg/m2,2,on days 1-14 of every 21-day cycle,NA
20839949,NA,195,capecitabine,5,850,mg/m2,2,on days 1-14 of every 21-day cycle,NA
23263993,NA,196,capecitabine,1,2250,mg/m2,3,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,capecitabine,1,2250,mg/m2,3,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,oxaliplatin,1,85,mg/m2,1,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,oxaliplatin,1,85,mg/m2,1,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,sorafenib,1,200,mg,2,daily takencontinuously,NA
23263993,NA,196,capecitabine,2,2250,mg/m2,3,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,capecitabine,2,2250,mg/m2,3,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,oxaliplatin,2,85,mg/m2,1,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,oxaliplatin,2,85,mg/m2,1,on days1 and 15 of each 28-day cycle,NA
23263993,NA,196,sorafenib,2,400,mg,2,daily takencontinuously,NA
20837944,NCT 00618124,197,sunitinib,-1,25,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,-1,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,-1,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,1,37.5,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,1,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,1,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,2,50,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,2,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,2,825,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,2.5,37.5,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,2.5,1000,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,2.5,1000,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,3,50,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,3,1000,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,3,1000,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,4,37.5,mg,1,2 weeks on treatment followed by 1 week off treatment (3-week cycles) or 4 weeks on treatment followed by 2 weeks off treatment (6-week cycles),schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,4,1250,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,capecitabine,4,1250,mg/m2,2,days 1 to 14 of all schedules as well as days 22 to 35 of Schedule 4/2,schedule 2/1 and 4/2
20837944,NCT 00618124,197,sunitinib,5,25,mg,1,continuous daily dosing (3-week cycles),continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,5,825,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,5,825,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,sunitinib,6,37.5,mg,1,continuous daily dosing (3-week cycles),continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,6,825,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,6,825,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,sunitinib,7,25,mg,1,continuous daily dosing (3-week cycles),continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,7,1000,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,7,1000,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,sunitinib,8,37.5,mg,1,continuous daily dosing (3-week cycles),continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,8,1000,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,8,1000,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,sunitinib,9,25,mg,1,continuous daily dosing (3-week cycles),continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,9,1250,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20837944,NCT 00618124,197,capecitabine,9,1250,mg/m2,2,days 1 to 14 of each 3-week cyle,continuous daily dosing (3-week cycles)
20461379,NCT00320749,198,docetaxel,1,30,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,1,500,mg/m2,2,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,1,500,mg/m2,2,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,gemcitabine,1,750,mg/m2,1,on days 8and 15 of each 21-day cycle,NA
20461379,NCT00320749,198,docetaxel,2,30,mg/m2,2,on days 1 and 8 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,2,625,mg/m2,1,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,2,625,mg/m2,1,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,gemcitabine,2,750,mg/m2,2,on days 8and 15 of each 21-day cycle,NA
20461379,NCT00320749,198,docetaxel,3,36,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,3,625,mg/m2,2,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,capecitabine,3,625,mg/m2,2,on days 8–21 of each 21-day cycle,NA
20461379,NCT00320749,198,gemcitabine,3,750,mg/m2,1,on days 8and 15 of each 21-day cycle,NA
21184645,NA,199,satraplatin,1,60,mg/m2,1,from d1 to d5 of every four week cycle,NA
21184645,NA,199,capecitabine,1,825,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,capecitabine,1,825,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,satraplatin,2,80,mg/m2,1,from d1 to d5 of every four week cycle,NA
21184645,NA,199,capecitabine,2,825,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,capecitabine,2,825,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,satraplatin,3,50,mg/m2,1,from d1 to d5 of every four week cycle,NA
21184645,NA,199,capecitabine,3,1000,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,capecitabine,3,1000,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,satraplatin,4,70,mg/m2,1,from d1 to d5 of every four week cycle,NA
21184645,NA,199,capecitabine,4,1000,mg/m2,2,from d8 to d21 of every four week cycle,NA
21184645,NA,199,capecitabine,4,1000,mg/m2,2,from d8 to d21 of every four week cycle,NA
22045498,NA,200,vinflunine,1,280,mg/m2,1,once every3 weeks,NA
22045498,NA,200,capecitabine,1,825,mg/m2,2,from days 1 to 14 every3 weeks,NA
22045498,NA,200,capecitabine,1,825,mg/m2,2,from days 1 to 14 every3 weeks,NA
22045498,NA,200,vinflunine,2,320,mg/m2,1,once every3 weeks,NA
22045498,NA,200,capecitabine,2,825,mg/m2,2,from days 1 to 14 every3 weeks,NA
22045498,NA,200,capecitabine,2,825,mg/m2,2,from days 1 to 14 every3 weeks,NA
22045498,NA,200,vinflunine,3,280,mg/m2,1,once every3 weeks,NA
22045498,NA,200,capecitabine,3,1000,mg/m2,2,from days 1 to 14 every3 weeks,NA
22045498,NA,200,capecitabine,3,1000,mg/m2,2,from days 1 to 14 every3 weeks,NA
23053263,NA,201,capecitabine,0,750,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,capecitabine,0,750,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,gemcitabine,0,750,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,nab-paclitaxel,0,100,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,capecitabine,1,750,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,capecitabine,1,750,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,gemcitabine,1,1000,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,nab-paclitaxel,1,100,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,capecitabine,2,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,capecitabine,2,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,gemcitabine,2,1000,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,nab-paclitaxel,2,100,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,capecitabine,3,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,capecitabine,3,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,gemcitabine,3,1000,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,nab-paclitaxel,3,125,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,capecitabine,4,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,capecitabine,4,1000,mg/m2,2,on days 1-7 of a 14-day cycle,NA
23053263,NA,201,gemcitabine,4,1000,mg/m2,1,on day 4 of a 14-day cycle,NA
23053263,NA,201,nab-paclitaxel,4,150,mg/m2,1,on day 4 of a 14-day cycle,NA
21590447,NCT00705375,202,capecitabine,1,800,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,1,800,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,1,30,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,2,950,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,2,950,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,2,30,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,3,950,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,3,950,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,3,40,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,4,1100,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,4,1100,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,4,40,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,5,1100,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,5,1100,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,5,50,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,6,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,6,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,6,50,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,7,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,7,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,7,60,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
21590447,NCT00705375,202,capecitabine,8,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,capecitabine,8,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
21590447,NCT00705375,202,vinorelbine,8,70,mg,1,"thrice aweek on Mondays, Wednesdays, and Fridays continuously",NA
20881475,NCT00121251,203,sorafenib,1,200,mg,2,continuously,NA
20881475,NCT00121251,203,capecitabine,1,622,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,capecitabine,1,622,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,gemcitabine,1,750,mg/m2,1,on days 1 and 8 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,sorafenib,2,200,mg,2,continuously,NA
20881475,NCT00121251,203,capecitabine,2,415,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,capecitabine,2,415,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,gemcitabine,2,750,mg/m2,1,on days 1 and 8 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,sorafenib,3,400,mg,2,continuously,NA
20881475,NCT00121251,203,capecitabine,3,415,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,capecitabine,3,415,mg/m2,2,on days 1 to 14 withcycles repeated every 21 days,NA
20881475,NCT00121251,203,gemcitabine,3,750,mg/m2,1,on days 1 and 8 withcycles repeated every 21 days,NA
21404105,NA,204,capecitabine,1,1000,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,capecitabine,1,1000,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,1,130,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,1,130,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,vandetanib,1,100,mg,1,daily continuously,NA
21404105,NA,204,capecitabine,2,1000,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,capecitabine,2,1000,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,2,130,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,2,130,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,vandetanib,2,300,mg,1,daily continuously,NA
21404105,NA,204,capecitabine,3,130,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,capecitabine,3,130,mg/m2,2,on days 1–14 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,3,1000,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,oxaliplatin,3,1000,mg/m2,1,on day 1 of a 3 weekcycle,NA
21404105,NA,204,vandetanib,3,300,mg,1,daily continuously,NA
21404105,NA,204,bevacizumab,3,7.5,mg/kg,1,on day 1 every 3 weeks,NA
20670085,NCT00350961,205,gemcitabin,1,800,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,1,800,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,1,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,1,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,1,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,1,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,2,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,2,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,2,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,2,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,2,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,2,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,3,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,3,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,3,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,3,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,3,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,3,60,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,4,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,4,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,4,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,4,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,4,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,4,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,5,1200,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,5,1200,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,5,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,5,1250,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,5,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,5,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,3.5,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,gemcitabin,3.5,1000,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,3.5,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,capecitabine,3.5,1000,mg/m2,2,days 1–7 and 14–21 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,3.5,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
20670085,NCT00350961,205,oxaliplatin,3.5,85,mg/m2,1,days 1 and 14 of each 28-day cycle,NA
22367239,NCT01077986,206,everolimus,-1,5,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,everolimus,-1,5,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,capecitabine,-1,400,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,capecitabine,-1,400,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,cetuximab,-1,250,mg,1,"weekly, starting at day 8",NA
22367239,NCT01077986,206,everolimus,1,5,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,everolimus,1,5,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,capecitabine,1,600,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,capecitabine,1,600,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,cetuximab,1,250,mg,1,"weekly, starting at day 8",NA
22367239,NCT01077986,206,everolimus,2,10,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,everolimus,2,10,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,capecitabine,2,600,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,capecitabine,2,600,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,cetuximab,2,250,mg,1,"weekly, starting at day 8",NA
22367239,NCT01077986,206,everolimus,3,10,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,everolimus,3,10,mg,1,"daily continuously, starting on day 1",NA
22367239,NCT01077986,206,capecitabine,3,800,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,capecitabine,3,800,mg/m2,2,"14 days in a 3 weekly cycle, starting on day 8",NA
22367239,NCT01077986,206,cetuximab,3,250,mg,1,"weekly, starting at day 8",NA
19693503,NA,207,liposomal doxorubicin,0,60,mg/m2,1,on day 1 every 21 days,NA
19693503,NA,207,capecitabine,0,825,mg/m2,2,on days 1–14 every 21 days,NA
19693503,NA,207,capecitabine,0,825,mg/m2,2,on days 1–14 every 21 days,NA
19693503,NA,207,liposomal doxorubicin,1,60,mg/m2,1,on day 1 every 21 days,NA
19693503,NA,207,capecitabine,1,1000,mg/m2,2,on days 1–14 every 21 days,NA
19693503,NA,207,capecitabine,1,1000,mg/m2,2,on days 1–14 every 21 days,NA
22977524,EudraCT 2005005548-21,208,erlotinib,1,100,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,erlotinib,1,100,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,folfox4,1,NA,NA,1,on day 1 every 14 days,MO17974
22977524,EudraCT 2005005548-21,208,erlotinib,2,125,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,erlotinib,2,125,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,folfox4,2,NA,NA,1,on day 1 every 14 days,MO17974
22977524,EudraCT 2005005548-21,208,erlotinib,3,150,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,erlotinib,3,150,mg,1,from day 3 to day 10 of each 14-day cycle,MO17974
22977524,EudraCT 2005005548-21,208,folfox4,3,NA,NA,1,on day 1 every 14 days,MO17974
22977524,EudraCT 2005005548-21,209,erlotinib,1,100,mg,1,on days 2-18 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,erlotinib,1,100,mg,1,on days 2-18 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,capecitabine,1,825,mg/m2,2,on days 1-14 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,capecitabine,1,825,mg/m2,2,on days 1-14 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,bevacizumab,1,7.5,mg/kg,1,on day 1 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,erlotinib,2,150,mg,1,on days 2-18 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,erlotinib,2,150,mg,1,on days 2-18 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,capecitabine,2,825,mg/m2,2,on days 1-14 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,capecitabine,2,825,mg/m2,2,on days 1-14 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,oxaliplatin,2,130,mg/m2,1,on day 1 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,oxaliplatin,2,130,mg/m2,1,on day 1 every 21 days,ML18511
22977524,EudraCT 2005005548-21,209,bevacizumab,2,7.5,mg/kg,1,on day 1 every 21 days,ML18511
20397772,NA,210,capecitabine,1,800,mg/m2,2,daily for five weeks,NA
20397772,NA,210,capecitabine,1,800,mg/m2,2,daily for five weeks,NA
20397772,NA,210,radiation,1,50,Gy,NA,totally for five weeks,2.0 Gy per fraction
20397772,NA,210,capecitabine,2,800,mg/m2,2,daily for five weeks,NA
20397772,NA,210,capecitabine,2,800,mg/m2,2,daily for five weeks,NA
20397772,NA,210,radiation,2,55,Gy,NA,totally for five weeks,2.2 Gy per fraction
24661655,NCT00858429,211,90y radioembolization,1,110,Gy,NA,during Cycle #2 on days 1-7,total dose
24661655,NCT00858429,211,capecitabin,1,1000,mg/m2,2,days 1 to 14 of a 21-day cycle,NA
24661655,NCT00858429,211,90y radioembolization,2,130,NA,NA,during Cycle #2 on days 1-7,total dose
24661655,NCT00858429,211,capecitabin,2,1000,mg,2,days 1 to 14 of a 21-day cycle,NA
24661655,NCT00858429,211,90y radioembolization,3,150,NA,NA,during Cycle #2 on days 1-7,total dose
24661655,NCT00858429,211,capecitabin,3,1000,NA,2,days 1 to 14 of a 21-day cycle,NA
24661655,NCT00858429,211,90y radioembolization,4,170,NA,NA,during Cycle #2 on days 1-7,total dose
24661655,NCT00858429,211,capecitabin,4,1000,NA,2,days 1 to 14 of a 21-day cycle,NA
22681700,NA,1,capecitabine,1,825,mg/m2,2,d 1–14; 22–35,NA
22681700,NA,1,capecitabine,1,825,mg/m2,2,d 1–14; 22–35,NA
22681700,NA,1,oxaliplatin,1,50,mg/m2,1,"d 1, 8, 22, 29",NA
22681700,NA,1,oxaliplatin,1,50,mg/m2,1,"d 1, 8, 22, 29",NA
22681700,NA,1,3d-crt,1,2,Gy,1,Monday through Friday,36 Gy total
22681700,NA,1,capecitabine,2,825,mg/m2,2,d 1–14; 22–35,NA
22681700,NA,1,capecitabine,2,825,mg/m2,2,d 1–14; 22–35,NA
22681700,NA,1,oxaliplatin,2,50,mg/m2,1,"d 1, 8, 22, 29",NA
22681700,NA,1,oxaliplatin,2,50,mg/m2,1,"d 1, 8, 22, 29",NA
22681700,NA,1,3d-crt,2,2,Gy,1,Monday through Friday,44 Gy total
23403636,NCT00452673,2,dasatinib,1,50,mg,2,continuously,NA
23403636,NCT00452673,2,capecitabine,1,825,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,capecitabine,1,825,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,dasatinib,2,70,mg,2,continuously,NA
23403636,NCT00452673,2,capecitabine,2,825,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,capecitabine,2,825,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,dasatinib,3,70,mg,2,continuously,NA
23403636,NCT00452673,2,capecitabine,3,1000,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,capecitabine,3,1000,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,dasatinib,3.5,100,mg,1,continuously,NA
23403636,NCT00452673,2,capecitabine,3.5,1000,mg/m2,2,on days 1 to 14of 21-day cycles,NA
23403636,NCT00452673,2,capecitabine,3.5,1000,mg/m2,2,on days 1 to 14of 21-day cycles,NA
19858399,NA,3,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
19858399,NA,3,capecitabine,1,455,mg/m2,2,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,capecitabine,1,455,mg/m2,2,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,bevacizumab,1,5,mg/kg,1,on days 1 and 15 of a 28-day cycle,NA
19858399,NA,3,erlotinib,1,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,erlotinib,1,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
19858399,NA,3,capecitabine,2,580,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,capecitabine,2,580,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,bevacizumab,2,5,mg/kg,1,on days 1 and 15 of a 28-day cycle,NA
19858399,NA,3,erlotinib,2,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,erlotinib,2,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
19858399,NA,3,capecitabine,3,700,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,capecitabine,3,700,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,bevacizumab,3,5,mg/kg,1,on days 1 and 15 of a 28-day cycle,NA
19858399,NA,3,erlotinib,3,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,erlotinib,3,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
19858399,NA,3,capecitabine,4,830,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,capecitabine,4,830,mg/m2,1,days 1 to 21 of a 28-day cycle,NA
19858399,NA,3,bevacizumab,4,5,mg/kg,1,on days 1 and 15 of a 28-day cycle,NA
19858399,NA,3,erlotinib,4,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
19858399,NA,3,erlotinib,4,100,mg,1,on days 1 through 28 of a 28-day cycle,NA
24551455,NA,4,vinorelbine,1,20,mg,1,days 1–3–5 for 3 consecutive weeks,NA
24551455,NA,4,capecitabine,1,500,mg,3,continuously,NA
24551455,NA,4,capecitabine,1,500,mg,3,continuously,NA
24551455,NA,4,vinorelbine,2,30,mg,1,days 1–3–5 for 3 consecutive weeks,NA
24551455,NA,4,capecitabine,2,500,mg,3,continuously,NA
24551455,NA,4,capecitabine,2,500,mg,3,continuously,NA
24551455,NA,4,vinorelbine,3,40,mg,1,days 1–3–5 for 3 consecutive weeks,NA
24551455,NA,4,capecitabine,3,500,mg,3,continuously,NA
24551455,NA,4,capecitabine,3,500,mg,3,continuously,NA
22037922,NCT 00544063,5,irinotecan,1,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRI
22037922,NCT 00544063,5,capecitabine,1,1000,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,capecitabine,1,1000,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,irinotecan,2,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRI
22037922,NCT 00544063,5,capecitabine,2,1250,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,capecitabine,2,1250,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,irinotecan,3,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRI
22037922,NCT 00544063,5,capecitabine,3,1500,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,capecitabine,3,1500,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,irinotecan,4,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRI
22037922,NCT 00544063,5,capecitabine,4,1750,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,capecitabine,4,1750,mg/m2,2,from D1 to D7 every 2 weeks,XELIRI
22037922,NCT 00544063,5,oxaliplatin,5,85,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,oxaliplatin,5,85,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,irinotecan,5,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,capecitabine,5,1250,mg/m2,2,from D1 to D7 every 2 weeks,XELIRINOX
22037922,NCT 00544063,5,capecitabine,5,1250,mg/m2,2,from D1 to D7 every 2 weeks,XELIRINOX
22037922,NCT 00544063,5,oxaliplatin,6,85,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,oxaliplatin,6,85,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,irinotecan,6,180,mg/m2,1,on day 1 of each 2-week cycle,XELIRINOX
22037922,NCT 00544063,5,capecitabine,6,1500,mg/m2,2,from D1 to D7 every 2 weeks,XELIRINOX
22037922,NCT 00544063,5,capecitabine,6,1500,mg/m2,2,from D1 to D7 every 2 weeks,XELIRINOX
20215798,NA,7,gefitinib,1,250,mg,1,continuously daily,NA
20215798,NA,7,capecitabine,1,1000,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,capecitabine,1,1000,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,gefitinib,2,250,mg,1,continuously daily,NA
20215798,NA,7,capecitabine,2,1250,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,capecitabine,2,1250,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,gefitinib,3,500,mg,1,continuously daily,NA
20215798,NA,7,capecitabine,3,1000,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,capecitabine,3,1000,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,gefitinib,4,500,mg,1,continuously daily,NA
20215798,NA,7,capecitabine,4,1250,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
20215798,NA,7,capecitabine,4,1250,mg/m2,2,from day 1 to day 14 of each 3-week cycle,NA
19443364,NA,8,capecitabine,1,650,mg/m2,2,on days 2-15 every 28 days,NA
19443364,NA,8,capecitabine,1,650,mg/m2,2,on days 2-15 every 28 days,NA
19443364,NA,8,gemcitabine,1,1000,mg/m2,1,on day 2 of each 28 cycle,NA
19443364,NA,8,epirubicin,1,35,mg/m2,1,every 28 days,NA
19443364,NA,8,cisplatin,1,42,mg/m2,1,every 28 days,NA
19443364,NA,8,cisplatin,1,42,mg/m2,1,every 28 days,NA
19443364,NA,8,capecitabine,2,650,mg/m2,2,on days 2-15 every 28 days,NA
19443364,NA,8,capecitabine,2,650,mg/m2,2,on days 2-15 every 28 days,NA
19443364,NA,8,gemcitabine,2,1300,mg/m2,1,on day 2 of each 28 cycle,NA
19443364,NA,8,epirubicin,2,35,mg/m2,1,every 28 days,NA
19443364,NA,8,cisplatin,2,42,mg/m2,1,every 28 days,NA
19443364,NA,8,cisplatin,2,42,mg/m2,1,every 28 days,NA
21552099,NA,9,gemcitabine,-1,1000,mg/m2,1,on day 1 of a 14-day cycle,NA
21552099,NA,9,capecitabine,-1,800,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,capecitabine,-1,800,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,gemcitabine,0,1000,mg/m2,1,on day 1 of a 14-day cycle,NA
21552099,NA,9,capecitabine,0,1000,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,capecitabine,0,1000,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,gemcitabine,1,1000,mg/m2,1,on day 1 of a 14-day cycle,NA
21552099,NA,9,capecitabine,1,1250,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,capecitabine,1,1250,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,gemcitabine,2,1000,mg/m2,1,on day 1 of a 14-day cycle,NA
21552099,NA,9,capecitabine,2,1500,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
21552099,NA,9,capecitabine,2,1500,mg/m2,2,on days 1 to 7 of a 14-day cycle,NA
20216541,NA,10,oxaliplatin,1,85,mg/m2,1,on day 1 every two weeks,NA
20216541,NA,10,oxaliplatin,1,85,mg/m2,1,on day 1 every two weeks,NA
20216541,NA,10,irinotecan,1,150,mg/m2,1,on day 1 every two weeks,NA
20216541,NA,10,capecitabine,1,0,mg/m2,2,day 1 to day 7 every two weeks,NA
20216541,NA,10,capecitabine,1,0,mg/m2,2,day 1 to day 7 every two weeks,NA
21931969,NA,11,trabectedin,1,0.4,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,1,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,1,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,2,0.6,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,2,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,2,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,3,0.75,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,3,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,3,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,4,0.9,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,4,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,4,1000,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,2.5,0.6,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,2.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,2.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,3.5,0.75,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,3.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,3.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,4.5,0.9,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,4.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,4.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,5.5,1.1,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,5.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,5.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,trabectedin,6.5,1.3,mg/m2,1,day 1 in3-week cycles,NA
21931969,NA,11,capecitabine,6.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
21931969,NA,11,capecitabine,6.5,800,mg/m2,2,days 2-15  in 3-week cycles,NA
20839031,NA,12,sorafenib,1,400,mg,1,daily,NA
20839031,NA,12,capecitabine,1,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,capecitabine,1,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,cisplatin,1,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,cisplatin,1,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,sorafenib,2,800,mg,1,daily,NA
20839031,NA,12,capecitabine,2,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,capecitabine,2,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,cisplatin,2,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,cisplatin,2,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,sorafenib,3,800,mg,1,daily,NA
20839031,NA,12,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,cisplatin,3,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,cisplatin,3,80,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,sorafenib,1.5,800,mg,1,daily,NA
20839031,NA,12,capecitabine,1.5,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,capecitabine,1.5,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
20839031,NA,12,cisplatin,1.5,60,mg/m2,1,on day 1 of each 3-week cycle,NA
20839031,NA,12,cisplatin,1.5,60,mg/m2,1,on day 1 of each 3-week cycle,NA
22648745,NA,13,oxaliplatin,1,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,1,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,1,2500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,1,2500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,oxaliplatin,2,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,2,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,2,3000,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,2,3000,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,oxaliplatin,3,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,3,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,3,3500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,3,3500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,oxaliplatin,4,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,4,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,4,4000,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,4,4000,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,oxaliplatin,5,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,5,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,5,4500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,5,4500,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,oxaliplatin,6,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,oxaliplatin,6,100,mg/m2,1,on day 1 every 14 days,NA
22648745,NA,13,capecitabine,6,5000,mg,1,on days 1–5 every 14 days,NA
22648745,NA,13,capecitabine,6,5000,mg,1,on days 1–5 every 14 days,NA
19936751,NA,14,docetaxel,1,45,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,capecitabine,1,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,capecitabine,1,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,docetaxel,2,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,capecitabine,2,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,capecitabine,2,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,docetaxel,3,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,docetaxel,4,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,4,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,4,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,capecitabine,4,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,capecitabine,4,800,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,docetaxel,5,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,oxaliplatin,5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19936751,NA,14,capecitabine,5,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19936751,NA,14,capecitabine,5,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
21853311,NCT00960349,16,cediranib,1,20,mg,1,daily starting on day 2 of each 5-week cycle,NA
21853311,NCT00960349,16,cisplatin,1,60,mg/m2,1,on day 1 of each 5-week cycle,NA
21853311,NCT00960349,16,cisplatin,1,60,mg/m2,1,on day 1 of each 5-week cycle,NA
21853311,NCT00960349,16,s-1,1,40,mg,2,days 1–21 of each 5-week cycle,40-60 mg
21853311,NCT00960349,16,cediranib,2,20,mg,1,daily starting on day 2 of each 3-week cycle,NA
21853311,NCT00960349,16,cisplatin,2,40,mg,0,on day 1 of each 3-week cycle,40-60 mg
21853311,NCT00960349,16,cisplatin,2,40,mg,0,on day 1 of each 3-week cycle,40-60 mg
21853311,NCT00960349,16,capecitabine,2,1000,mg/m2,2,days 1–14 of each 3-week cycle,Arm B
21853311,NCT00960349,16,capecitabine,2,1000,mg/m2,2,days 1–14 of each 3-week cycle,Arm B
24173967,NCT00920868,17,dasatinib,1,50,mg,2,daily,NA
24173967,NCT00920868,17,capecitabine,1,850,mg/m2,2,days 1–14 every 3 weeks,NA
24173967,NCT00920868,17,capecitabine,1,850,mg/m2,2,days 1–14 every 3 weeks,NA
24173967,NCT00920868,17,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,NA
24173967,NCT00920868,17,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,NA
24173967,NCT00920868,17,bevacizumab,1,7.5,mg/kg,1,on day 1 every 3 weeks,NA
24173967,NCT00920868,17,dasatinib,-1,70,mg,1,daily,NA
24173967,NCT00920868,17,capecitabine,-1,850,mg/m2,2,days 1–14 every 3 weeks,NA
24173967,NCT00920868,17,capecitabine,-1,850,mg/m2,2,days 1–14 every 3 weeks,NA
24173967,NCT00920868,17,oxaliplatin,-1,130,mg/m2,1,on day 1 every 3 weeks,NA
24173967,NCT00920868,17,oxaliplatin,-1,130,mg/m2,1,on day 1 every 3 weeks,NA
24173967,NCT00920868,17,bevacizumab,-1,7.5,mg/kg,1,on day 1 every 3 weeks,NA
20429725,NA,18,docetaxel,1,60,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,1,85,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,1,85,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,capecitabine,1,500,mg/m2,2,continuously,NA
20429725,NA,18,capecitabine,1,500,mg/m2,2,continuously,NA
20429725,NA,18,docetaxel,2,60,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,2,100,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,2,100,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,capecitabine,2,625,mg/m2,2,continuously,NA
20429725,NA,18,capecitabine,2,625,mg/m2,2,continuously,NA
20429725,NA,18,docetaxel,3,60,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,3,115,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,3,115,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,capecitabine,3,625,mg/m2,2,continuously,NA
20429725,NA,18,capecitabine,3,625,mg/m2,2,continuously,NA
20429725,NA,18,docetaxel,4,75,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,4,115,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,4,115,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,capecitabine,4,625,mg/m2,2,continuously,NA
20429725,NA,18,capecitabine,4,625,mg/m2,2,continuously,NA
20429725,NA,18,docetaxel,5,75,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,5,130,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,oxaliplatin,5,130,mg/m2,1,day 1 every 3 weeks,NA
20429725,NA,18,capecitabine,5,625,mg/m2,2,continuously,NA
20429725,NA,18,capecitabine,5,625,mg/m2,2,continuously,NA
20857171,NA,19,irinotecan,1,50,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,irinotecan,2,60,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,irinotecan,3,70,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,irinotecan,4,40,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,capecitabine,4,800,mg/m2,2,on days 6–14 of each 21 day cycle,NA
20857171,NA,19,capecitabine,4,800,mg/m2,2,on days 6–14 of each 21 day cycle,NA
20857171,NA,19,irinotecan,5,50,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,capecitabine,5,800,mg/m2,2,on days 6–14 of each 21 day cycle,NA
20857171,NA,19,capecitabine,5,800,mg/m2,2,on days 6–14 of each 21 day cycle,NA
20857171,NA,19,irinotecan,6,50,mg/m2,1,on days 1–5 of each 21 day cycle,NA
20857171,NA,19,capecitabine,6,1000,mg/m2,2,on days 6–14 of each 21 day cycle,NA
20857171,NA,19,capecitabine,6,1000,mg/m2,2,on days 6–14 of each 21 day cycle,NA
24574780,NA,20,capecitabine,1,625,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,1,625,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,intensity modulated radiotherapy,1,1.8,Gy,1,5 d a week over 5 wk,NA
24574780,NA,20,capecitabine,2,700,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,2,700,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,intensity modulated radiotherapy,2,1.8,Gy,1,5 d a week over 5 wk,NA
24574780,NA,20,capecitabine,NA,800,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,NA,800,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,intensity modulated radiotherapy,NA,1.8,Gy,1,5 d a week over 5 wk,NA
24574780,NA,20,capecitabine,NA,900,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,NA,900,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,NA,1000,mg/m2,2,from the beginning to the end of theduration of RT,NA
24574780,NA,20,capecitabine,NA,1000,mg/m2,2,from the beginning to the end of theduration of RT,NA
20421151,NA,21,radiation therapy,1,3,Gy,1,"Week 1, Monday–Friday; Week 2, Monday–Friday",NA
20421151,NA,21,capecitabine,1,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,capecitabine,1,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,radiation therapy,2,5,Gy,1,"Week 1, Monday, Wednesday, and Friday; Week 2, Tuesdayand Thursday",NA
20421151,NA,21,capecitabine,2,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,capecitabine,2,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,radiation therapy,3,5,Gy,1,"Week 1, Monday, Tuesday, Thursday, and Friday; Week 2, Monday",NA
20421151,NA,21,capecitabine,3,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,capecitabine,3,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,radiation therapy,4,5,Gy,1,"Week 1, Monday through Friday",NA
20421151,NA,21,capecitabine,4,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
20421151,NA,21,capecitabine,4,825,mg/m2,2,"Week 1 and 2, Monday through Friday",NA
24091982,NCT00555620,22,sunitinib,1,37.5,mg,1,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,1,800,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,1,800,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,1,60,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,1,60,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,sunitinib,2,37.5,mg,1,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,2,1000,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,2,1000,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,2,60,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,2,60,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,sunitinib,3,25,mg,1,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,3,80,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,cisplatin,3,80,mg/m2,1,on day 1 of each 3-week cycle,XP
24091982,NCT00555620,22,sunitinib,4,37.5,mg,1,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,4,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,4,800,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,oxaliplatin,4,110,mg/m2,1,on day 1 of each 3-week cycle,XELOX
24091982,NCT00555620,22,oxaliplatin,4,110,mg/m2,1,on day 1 of each 3-week cycle,XELOX
24091982,NCT00555620,22,sunitinib,5,37.5,mg,1,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,5,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,5,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,oxaliplatin,5,110,mg/m2,1,on day 1 of each 3-week cycle,NA
24091982,NCT00555620,22,oxaliplatin,5,110,mg/m2,1,on day 1 of each 3-week cycle,NA
24091982,NCT00555620,22,sunitinib,6,25,mg,1,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,6,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,capecitabine,6,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
24091982,NCT00555620,22,oxaliplatin,6,110,mg/m2,1,on day 1 of each 3-week cycle,NA
24091982,NCT00555620,22,oxaliplatin,6,110,mg/m2,1,on day 1 of each 3-week cycle,NA
20092990,NA,23,capecitabine,1,1000,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,capecitabine,1,1000,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,phy906,1,800,mg,2,days 1-4 of a 14-day cycle,NA
20092990,NA,23,capecitabine,2,1250,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,capecitabine,2,1250,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,phy906,2,800,mg,2,days 1-4 of a 14-day cycle,NA
20092990,NA,23,capecitabine,3,1500,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,capecitabine,3,1500,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,phy906,3,800,mg,2,days 1-4 of a 14-day cycle,NA
20092990,NA,23,capecitabine,4,1750,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,capecitabine,4,1750,mg/m2,2,daily for 7 days of a 14-day cycle,NA
20092990,NA,23,phy906,4,8000,mg,2,days 1-4 of a 14-day cycle,NA
22669361,NA,24,docetaxel,1,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,1,60,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,1,60,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,capecitabine,1,700,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,capecitabine,1,700,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,docetaxel,2,30,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,2,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,2,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,capecitabine,2,800,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,capecitabine,2,800,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,docetaxel,2.5,30,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,2.5,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,2.5,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,capecitabine,2.5,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,capecitabine,2.5,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,docetaxel,3,35,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,3,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,oxaliplatin,3,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
22669361,NA,24,capecitabine,3,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
22669361,NA,24,capecitabine,3,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
23235319,NA,25,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
23235319,NA,25,capecitabine,1,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,capecitabine,1,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,erlotinib,1,50,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,erlotinib,1,50,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
23235319,NA,25,capecitabine,2,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,capecitabine,2,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,erlotinib,2,75,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,erlotinib,2,75,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
23235319,NA,25,capecitabine,3,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,capecitabine,3,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,erlotinib,3,100,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,erlotinib,3,100,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,gemcitabine,4,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
23235319,NA,25,capecitabine,4,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,capecitabine,4,830,mg/m2,2,on days 1-21 of a 28-day cycle,NA
23235319,NA,25,erlotinib,4,125,mg,1,on days 1-28 of a 28-day cycle,NA
23235319,NA,25,erlotinib,4,125,mg,1,on days 1-28 of a 28-day cycle,NA
23647753,NA,26,radiotherapy,1,50.4,Gy,NA,NA,NA
23647753,NA,26,nelfinavir,1,750,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,nelfinavir,1,750,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,1,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,1,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,radiotherapy,2,50.4,Gy,NA,NA,NA
23647753,NA,26,nelfinavir,2,1250,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,nelfinavir,2,1250,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,2,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,2,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,radiotherapy,3,50.4,Gy,NA,NA,NA
23647753,NA,26,nelfinavir,3,1000,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,nelfinavir,3,1000,mg,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,3,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
23647753,NA,26,capecitabine,3,825,mg/m2,2,1 or 2 cycles could be administered in the interval between thecompletion of CRT and resection,NA
24315563,NA,27,capecitabine,1,650,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,capecitabine,1,650,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,bevacizumab,1,5,mg/kg,1,every 2 weeks,NA
24315563,NA,27,erlotinib,1,50,mg,2,daily in the first 3 weeks of radiation,NA
24315563,NA,27,erlotinib,1,50,mg,2,daily in the first 3 weeks of radiation,NA
24315563,NA,27,radiation,1,50.4,Gy,NA,in 28 fractions,NA
24315563,NA,27,capecitabine,2,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,capecitabine,2,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,bevacizumab,2,5,mg/kg,1,every 2 weeks,NA
24315563,NA,27,erlotinib,2,50,mg,2,daily in the first 3 weeks of radiation,NA
24315563,NA,27,erlotinib,2,50,mg,2,daily in the first 3 weeks of radiation,NA
24315563,NA,27,radiation,2,50.4,Gy,NA,in 28 fractions,NA
24315563,NA,27,capecitabine,3,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,capecitabine,3,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,bevacizumab,3,5,mg/kg,1,every 2 weeks,NA
24315563,NA,27,erlotinib,3,50,mg,2,daily in the  weeks 1-6,NA
24315563,NA,27,erlotinib,3,50,mg,2,daily in the  weeks 1-6,NA
24315563,NA,27,radiation,3,50.4,Gy,NA,in 28 fractions,NA
24315563,NA,27,capecitabine,4,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,capecitabine,4,825,mg/m2,2,daily on the days of radiation,NA
24315563,NA,27,bevacizumab,4,5,mg/kg,1,every 2 weeks,NA
24315563,NA,27,erlotinib,4,100,mg,2,daily in the  weeks 1-6,NA
24315563,NA,27,erlotinib,4,100,mg,2,daily in the  weeks 1-6,NA
24315563,NA,27,radiation,4,50.4,NA,NA,in 28 fractions,NA
23517808,NA,28,sib-imrt,1,1.8,Gy,1,33 daily fractions,NA
23517808,NA,28,capecitabine,1,500,mg/m2,2,on irradiation days,NA
23517808,NA,28,capecitabine,1,500,mg/m2,2,on irradiation days,NA
23517808,NA,28,mitomycin c,1,10,mg/m2,1,on day 1,NA
23517808,NA,28,sib-imrt,2,1.8,Gy,1,33 daily fractions,NA
23517808,NA,28,capecitabine,2,650,mg/m2,2,on irradiation days,NA
23517808,NA,28,capecitabine,2,650,mg/m2,2,on irradiation days,NA
23517808,NA,28,mitomycin c,2,10,mg/m2,1,on day 1,NA
23517808,NA,28,sib-imrt,3,1.8,Gy,1,33 daily fractions,NA
23517808,NA,28,capecitabine,3,825,mg/m2,2,on irradiation days,NA
23517808,NA,28,capecitabine,3,825,mg/m2,2,on irradiation days,NA
23517808,NA,28,mitomycin c,3,10,mg/m2,1,on day 1,NA
21547572,NA,29,tesetaxel,1,18,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,1,1250,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,1,1250,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,tesetaxel,2,27,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,2,1250,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,2,1250,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,tesetaxel,3,27,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,3,1900,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,3,1900,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,tesetaxel,4,35,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,4,1900,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,4,1900,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,tesetaxel,5,27,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,5,2500,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,5,2500,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,tesetaxel,6,35,mg/m2,1,on Day 1 of each 21-day cycle,NA
21547572,NA,29,capecitabine,6,2500,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
21547572,NA,29,capecitabine,6,2500,mg/m2,2,on Days 1through 14 of each 21-day cycle,NA
19294501,NA,30,capecitabine,1,750,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,capecitabine,1,750,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,gefitinib,1,250,mg,1,daily continuously,NA
19294501,NA,30,capecitabine,2,875,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,capecitabine,2,875,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,gefitinib,2,250,mg,1,daily continuously,NA
19294501,NA,30,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 21-day cycle,NA
19294501,NA,30,gefitinib,3,250,mg,1,daily continuously,NA
24114122,NCT00433550,31,irinotecan,-2,75,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,-2,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,-2,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,-2,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,-2,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,-1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,-1,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,-1,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,-1,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,-1,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,1,150,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,1,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,1,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,1,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,1,400,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,2,150,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,2,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,2,85,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,2,800,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,2,800,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,3,150,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,3,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,3,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,3,800,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,3,800,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,4,150,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,4,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,4,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,4,1600,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,4,1600,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,irinotecan,5,175,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,5,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,oxaliplatin,5,120,mg/m2,1,on day 1 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,5,1600,mg/m2,2,on days 2–15 of each 3-week cycle,NA
24114122,NCT00433550,31,capecitabine,5,1600,mg/m2,2,on days 2–15 of each 3-week cycle,NA
17998790,NA,32,paclitaxel,1,100,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,1,40,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,1,40,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,capecitabine,1,800,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,capecitabine,1,800,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,paclitaxel,2,100,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,2,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,2,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,capecitabine,2,800,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,capecitabine,2,800,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,paclitaxel,3,100,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,3,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,3,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,capecitabine,3,1000,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,capecitabine,3,1000,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,paclitaxel,4,110,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,4,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,oxaliplatin,4,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
17998790,NA,32,capecitabine,4,1000,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17998790,NA,32,capecitabine,4,1000,mg/m2,2,on days 1–7 and days 15–21 every 4 weeks,NA
17628744,NA,33,irofulven,1,0.3,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,1,850,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,1,850,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,irofulven,2,0.4,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,2,850,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,2,850,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,irofulven,3,0.4,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,3,1000,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,3,1000,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,irofulven,4,0.5,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,4,1000,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17628744,NA,33,capecitabine,4,1000,mg/m2,2,on days 1-15 of each 28-day cycle,NA
17426973,NA,34,capecitabine,1,750,mg/m2,2,on days 2–15 and 23–36,NA
17426973,NA,34,capecitabine,1,750,mg/m2,2,on days 2–15 and 23–36,NA
17426973,NA,34,irinotecan,1,80,mg/m2,1,"on days 1, 8, 22, and 29",NA
17426973,NA,34,capecitabine,2,1000,mg/m2,2,on days 2–15 and 23–36,NA
17426973,NA,34,capecitabine,2,1000,mg/m2,2,on days 2–15 and 23–36,NA
17426973,NA,34,irinotecan,2,80,mg/m2,1,"on days 1, 8, 22, and 29",NA
18765554,NA,36,ekb-569,1,25,mg,1,daily for 21 days,NA
18765554,NA,36,capecitabine,1,750,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,capecitabine,1,750,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,ekb-569,2,50,mg,1,daily for 21 days,NA
18765554,NA,36,capecitabine,2,750,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,capecitabine,2,750,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,ekb-569,3,50,mg,1,daily for 21 days,NA
18765554,NA,36,capecitabine,3,1000,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,capecitabine,3,1000,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,ekb-569,4,75,mg,1,daily for 21 days,NA
18765554,NA,36,capecitabine,4,1000,mg/m2,2,daily for 14 days of a 21-day cycle,NA
18765554,NA,36,capecitabine,4,1000,mg/m2,2,daily for 14 days of a 21-day cycle,NA
19074845,NA,37,gefitinib,-1,250,mg,1,days 1-21 every 28 days,NA
19074845,NA,37,capecitabine,-1,1000,mg/m2,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,-1,1000,mg/m2,1,days 1-14 every 28 days,NA
19074845,NA,37,celecoxib,-1,400,mg,2,days 1-21 every 28 days,NA
19074845,NA,37,gefitinib,1,250,mg,1,days 1-21 every 28 days,NA
19074845,NA,37,capecitabine,1,1500,mg/m2,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,1,1500,mg/m2,1,days 1-14 every 28 days,NA
19074845,NA,37,celecoxib,1,400,mg,2,days 1-21 every 28 days,NA
19074845,NA,37,gefitinib,2,250,mg,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,2,1000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,capecitabine,2,1000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,celecoxib,2,400,mg,2,days 1-28 every 28 days,NA
19074845,NA,37,gefitinib,3,250,mg,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,3,1500,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,capecitabine,3,1500,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,celecoxib,3,400,mg,2,days 1-28 every 28 days,NA
19074845,NA,37,gefitinib,4,250,mg,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,4,2000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,capecitabine,4,2000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,celecoxib,4,400,mg,2,days 1-28 every 28 days,NA
19074845,NA,37,gefitinib,5,500,mg,1,days 1-14 every 28 days,NA
19074845,NA,37,capecitabine,5,2000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,capecitabine,5,2000,mg/m2,1,days 8-21 every 28 days,NA
19074845,NA,37,celecoxib,5,400,mg,2,days 1-28 every 28 days,NA
17582215,NA,38,thalidomide,1,100,mg,1,daily,NA
17582215,NA,38,capecitabine,1,1000,mg,1,daily,NA
17582215,NA,38,capecitabine,1,1000,mg,1,daily,NA
17582215,NA,38,temozolomide,1,50,mg,1,daily,NA
17582215,NA,38,temozolomide,1,50,mg,1,daily,NA
17582215,NA,38,thalidomide,2,100,mg,1,daily,NA
17582215,NA,38,capecitabine,2,1000,mg,1,daily,NA
17582215,NA,38,capecitabine,2,1000,mg,1,daily,NA
17582215,NA,38,temozolomide,2,100,mg,1,daily,NA
17582215,NA,38,temozolomide,2,100,mg,1,daily,NA
17582215,NA,38,thalidomide,3,100,mg,1,daily,NA
17582215,NA,38,capecitabine,3,2000,mg,1,daily,NA
17582215,NA,38,capecitabine,3,2000,mg,1,daily,NA
17582215,NA,38,temozolomide,3,100,mg,1,daily,NA
17582215,NA,38,temozolomide,3,100,mg,1,daily,NA
17582215,NA,38,thalidomide,4,100,mg,1,daily,NA
17582215,NA,38,capecitabine,4,2000,mg,1,daily,NA
17582215,NA,38,capecitabine,4,2000,mg,1,daily,NA
17582215,NA,38,temozolomide,4,150,mg,1,daily,NA
17582215,NA,38,temozolomide,4,150,mg,1,daily,NA
17582215,NA,38,thalidomide,5,100,mg,1,daily,NA
17582215,NA,38,capecitabine,5,3000,mg,1,daily,NA
17582215,NA,38,capecitabine,5,3000,mg,1,daily,NA
17582215,NA,38,temozolomide,5,150,mg,1,daily,NA
17582215,NA,38,temozolomide,5,150,mg,1,daily,NA
17582215,NA,38,thalidomide,3.5,100,mg,1,daily,NA
17582215,NA,38,capecitabine,3.5,2000,mg,1,days 8-28 of each 28-day cycle,NA
17582215,NA,38,capecitabine,3.5,2000,mg,1,days 8-28 of each 28-day cycle,NA
17582215,NA,38,temozolomide,3.5,100,mg,1,days 8-28 of each 28-day cycle,NA
17582215,NA,38,temozolomide,3.5,100,mg,1,days 8-28 of each 28-day cycle,NA
16750332,NA,39,oxaliplatin,-1,50,mg,1,weekly for 5 weeks,NA
16750332,NA,39,oxaliplatin,-1,50,mg,1,weekly for 5 weeks,NA
16750332,NA,39,capecitabine,-1,725,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,capecitabine,-1,725,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,radiotherapy,-1,1.8,Gy,1,daily for 28 days,NA
16750332,NA,39,oxaliplatin,1,50,mg,1,weekly for 5 weeks,NA
16750332,NA,39,oxaliplatin,1,50,mg,1,weekly for 5 weeks,NA
16750332,NA,39,capecitabine,1,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,capecitabine,1,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,radiotherapy,1,1.8,Gy,1,daily for 28 days,NA
16750332,NA,39,oxaliplatin,2,60,mg,1,weekly for 5 weeks,NA
16750332,NA,39,oxaliplatin,2,60,mg,1,weekly for 5 weeks,NA
16750332,NA,39,capecitabine,2,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,capecitabine,2,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,radiotherapy,2,1.8,Gy,1,daily for 28 days,NA
16750332,NA,39,oxaliplatin,3,70,mg,1,weekly for 5 weeks,NA
16750332,NA,39,oxaliplatin,3,70,mg,1,weekly for 5 weeks,NA
16750332,NA,39,capecitabine,3,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,capecitabine,3,825,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,radiotherapy,3,1.8,Gy,1,daily for 28 days,NA
16750332,NA,39,oxaliplatin,4,70,mg,1,weekly for 5 weeks,NA
16750332,NA,39,oxaliplatin,4,70,mg,1,weekly for 5 weeks,NA
16750332,NA,39,capecitabine,4,900,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,capecitabine,4,900,mg/m2,2,daily Monday through Friday concurrently withRT,NA
16750332,NA,39,radiotherapy,4,1.8,Gy,1,daily for 28 days,NA
17158771,NA,40,gemcitabine,1,600,mg/m2,1,on days 1 and 8 every 21 days,NA
17158771,NA,40,capecitabine,1,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
17158771,NA,40,capecitabine,1,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
17158771,NA,40,gemcitabine,2,700,mg/m2,1,on days 1 and 8 every 21 days,NA
17158771,NA,40,capecitabine,2,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
17158771,NA,40,capecitabine,2,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
17158771,NA,40,gemcitabine,3,800,mg/m2,1,on days 1 and 8 every 21 days,NA
17158771,NA,40,capecitabine,3,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
17158771,NA,40,capecitabine,3,650,mg/m2,2,on days 1–14 of a 21-day cycle,NA
18209010,NA,41,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8 and 11 in 3-week cycles",NA
18209010,NA,41,capecitabine,1,750,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,capecitabine,1,750,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,bortezomib,2,1,mg/m2,1,"on days 1, 4, 8 and 11 in 3-week cycles",NA
18209010,NA,41,capecitabine,2,1000,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,capecitabine,2,1000,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,bortezomib,3,1.3,mg/m2,1,"on days 1, 4, 8 and 11 in 3-week cycles",NA
18209010,NA,41,capecitabine,3,1000,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,capecitabine,3,1000,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,bortezomib,4,1.3,mg/m2,1,"on days 1, 4, 8 and 11 in 3-week cycles",NA
18209010,NA,41,capecitabine,4,1250,mg/m2,2,on days 1–14 in 3-week cycles,NA
18209010,NA,41,capecitabine,4,1250,mg/m2,2,on days 1–14 in 3-week cycles,NA
17641893,NA,42,capecitabine,-1,628,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,capecitabine,-1,628,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,paclitaxe,-1,70,mg/m2,1,"on days 1, 8, and 15 of each 4-week cycle",NA
17641893,NA,42,capecitabine,1,628,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,capecitabine,1,628,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,paclitaxe,1,80,mg/m2,1,"on days 1, 8, and 15 of each 4-week cycle",NA
17641893,NA,42,capecitabine,2,829,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,capecitabine,2,829,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,paclitaxe,2,80,mg/m2,1,"on days 1, 8, and 15 of each 4-week cycle",NA
17641893,NA,42,capecitabine,3,829,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,capecitabine,3,829,mg/m2,2,on days 1-21 of each 4-week cycle,NA
17641893,NA,42,paclitaxe,3,90,mg/m2,1,"on days 1, 8, and 15 of each 4-week cycle",NA
18000507,NA,43,capecitabine,1,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,capecitabine,1,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,docetaxel,1,40,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,mitomycin c,1,4,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,capecitabine,2,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,capecitabine,2,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,docetaxel,2,40,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,mitomycin c,2,6,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,capecitabine,3,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,docetaxel,3,50,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,mitomycin c,3,1000,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,capecitabine,4,6,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,capecitabine,4,6,mg/m2,2,on days 1-14 of each 3-week cycle,NA
18000507,NA,43,docetaxel,4,60,mg/m2,1,on day 1 of each 3-week cycle,NA
18000507,NA,43,mitomycin c,4,6,mg/m2,1,on day 1 of each 3-week cycle,NA
17465235,NA,44,capecitabine,1,628,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,capecitabine,1,628,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,cyclophosphamide,1,33,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,capecitabine,2,829,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,capecitabine,2,829,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,cyclophosphamide,2,33,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,capecitabine,3,829,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,capecitabine,3,829,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
17465235,NA,44,cyclophosphamide,3,50,mg/m2,2,on days 1 to 14 of each 21-day cycle,NA
18936940,NA,45,irinotecan,1,50,mg,1,on day 1 of each 21-day cycle,NA
18936940,NA,45,capecitabine,1,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,capecitabine,1,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,erlotinib,1,180,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,erlotinib,1,180,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,irinotecan,2,100,mg,1,on day 1 of each 21-day cycle,NA
18936940,NA,45,capecitabine,2,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,capecitabine,2,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,erlotinib,2,180,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,erlotinib,2,180,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,irinotecan,3,100,mg,1,on day 1 of each 21-day cycle,NA
18936940,NA,45,capecitabine,3,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,capecitabine,3,750,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,erlotinib,3,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,erlotinib,3,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,irinotecan,4,100,mg,1,on day 1 of each 21-day cycle,NA
18936940,NA,45,capecitabine,4,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,capecitabine,4,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,erlotinib,4,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,erlotinib,4,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,irinotecan,5,150,mg,1,on day 1 of each 21-day cycle,NA
18936940,NA,45,capecitabine,5,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,capecitabine,5,1000,mg/m2,2,on days 2-15 of each 21-day cycle,NA
18936940,NA,45,erlotinib,5,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18936940,NA,45,erlotinib,5,240,mg/m2,1,daily starting on day 1 throughout the 21-day cycle,NA
18841362,NA,46,capecitabine,1,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,capecitabine,1,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,gemcitabine,1,400,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
18841362,NA,46,capecitabine,2,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,capecitabine,2,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,gemcitabine,2,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
18841362,NA,46,capecitabine,3,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,capecitabine,3,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,gemcitabine,3,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
18841362,NA,46,capecitabine,4,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,capecitabine,4,500,mg/m2,2,on days 1 through 14 of each 21-day cycle,NA
18841362,NA,46,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
18187954,NA,47,cyclophosphamide,0,600,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,epirubicin,0,75,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,capecitabine,0,628,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,capecitabine,0,628,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,cyclophosphamide,1,600,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,epirubicin,1,75,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,capecitabine,1,829,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,capecitabine,1,829,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,cyclophosphamide,2,600,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,epirubicin,2,90,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,capecitabine,2,829,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,capecitabine,2,829,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,cyclophosphamide,3,600,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,epirubicin,3,90,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,capecitabine,3,900,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,capecitabine,3,900,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,cyclophosphamide,4,600,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,epirubicin,4,100,mg/m2,1,on day 1 of each 3-week cycle,NA
18187954,NA,47,capecitabine,4,900,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
18187954,NA,47,capecitabine,4,900,mg/m2,2,on days 1–14 of eaoch 3-week cycle,NA
16778105,NA,48,irinotecan,1,25,mg/m2,1,from days 1 to 14 every 3 weeks,part 1
16778105,NA,48,irinotecan,2,30,mg/m2,1,from days 1 to 14 every 3 weeks,part 1
16778105,NA,48,irinotecan,3,35,mg/m2,1,from days 1 to 14 every 3 weeks,part 1
16778105,NA,48,irinotecan,4,20,mg/m2,1,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,4,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,4,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,irinotecan,5,25,mg/m2,1,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,5,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,5,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,irinotecan,6,30,mg/m2,1,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,6,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,6,800,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,irinotecan,7,30,mg/m2,1,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,7,1000,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
16778105,NA,48,capecitabine,7,1000,mg/m2,2,from days 1 to 14 every 3 weeks,part 2
17600871,NA,49,capecitabine,1,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,capecitabine,1,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,paclitaxel,1,60,mg/m2,1,"on days 1, 8, and 15 of each 21-day cycle",NA
17600871,NA,49,capecitabine,2,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,capecitabine,2,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,paclitaxel,2,75,mg/m2,1,"on days 1, 8, and 15 of each 21-day cycle",NA
17600871,NA,49,capecitabine,3,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,capecitabine,3,1000,mg/m2,2,days 1-14 of each 21-day cycle,NA
17600871,NA,49,paclitaxel,3,90,mg/m2,1,"on days 1, 8, and 15 of each 21-day cycle",NA
16821609,NA,50,docetaxel,1,40,mg/m2,1,on day 1 every 4 weeks,NA
16821609,NA,50,ifosfamide,1,1200,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,1,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,1,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,capecitabine,1,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,capecitabine,1,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,radiotherapy,1,240,cGy,1,on days 1-5 per week over 38 days,NA
16821609,NA,50,docetaxel,2,50,mg/m2,1,on day 1 every 4 weeks,NA
16821609,NA,50,ifosfamide,2,1200,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,2,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,2,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,capecitabine,2,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,capecitabine,2,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,radiotherapy,2,240,cGy,1,on days 1-5 per week over 38 days,NA
16821609,NA,50,docetaxel,3,60,mg/m2,1,on day 1 every 4 weeks,NA
16821609,NA,50,ifosfamide,3,1200,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,3,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,3,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,capecitabine,3,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,capecitabine,3,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,radiotherapy,3,240,cGy,1,on days 1-5 per week over 38 days,NA
16821609,NA,50,docetaxel,4,70,mg/m2,1,on day 1 every 4 weeks,NA
16821609,NA,50,ifosfamide,4,1200,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,4,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,cisplatin,4,20,mg/m2,1,on days 1 to 4 every 4 weeks,NA
16821609,NA,50,capecitabine,4,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,capecitabine,4,500,mg/m2,2,on days 1-5 per week over 38 days,NA
16821609,NA,50,radiotherapy,4,250,cGy,1,on days 1-5 per week over 38 days,NA
18249110,NA,51,erlotinib,1,100,mg,1,continuously,NA
18249110,NA,51,erlotinib,1,100,mg,1,continuously,NA
18249110,NA,51,capecitabine,1,825,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,1,825,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,1,60,mg/m2,1,on the first day of each 3-week cycle,NA
18249110,NA,51,erlotinib,2,100,mg,1,continuously,NA
18249110,NA,51,erlotinib,2,100,mg,1,continuously,NA
18249110,NA,51,capecitabine,2,825,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,2,825,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,2,75,mg/m2,1,on the first day of each 3-week cycle,NA
18249110,NA,51,erlotinib,3,100,mg,1,continuously,NA
18249110,NA,51,erlotinib,3,100,mg,1,continuously,NA
18249110,NA,51,capecitabine,3,1000,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,3,1000,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,3,75,mg/m2,1,on the first day of each 3-week cycle,NA
18249110,NA,51,erlotinib,4,150,mg,1,continuously,NA
18249110,NA,51,erlotinib,4,150,mg,1,continuously,NA
18249110,NA,51,capecitabine,4,1000,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,4,1000,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,4,75,mg/m2,1,on the first day of each 3-week cycle,NA
18249110,NA,51,erlotinib,5,100,mg,1,continuously,NA
18249110,NA,51,erlotinib,5,100,mg,1,continuously,NA
18249110,NA,51,capecitabine,5,1250,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,5,1250,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,5,75,mg/m2,1,on the first day of each 3-week cycle,NA
18249110,NA,51,erlotinib,6,150,mg,1,continuously,NA
18249110,NA,51,erlotinib,6,150,mg,1,continuously,NA
18249110,NA,51,capecitabine,6,1250,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,capecitabine,6,1250,mg/m2,2,on days 1 to 14 every 3 weeks,NA
18249110,NA,51,docetaxel,6,75,mg/m2,1,on the first day of each 3-week cycle,NA
18539404,NA,52,capecitabine,1,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,capecitabine,1,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,radiotherapy,1,1.8,Gy,1,25 fractions of 1.8 Gy to a total dose of 45 Gy in 5 weeks,NA
18539404,NA,52,capecitabine,2,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,capecitabine,2,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,oxaliplatin,2,40,mg/m2,1,"Days 1, 8, 15, 22, and 29",NA
18539404,NA,52,oxaliplatin,2,40,mg/m2,1,"Days 1, 8, 15, 22, and 29",NA
18539404,NA,52,radiotherapy,2,1.8,Gy,1,25 fractions of 1.8 Gy to a total dose of 45 Gy in 5 weeks,NA
18539404,NA,52,capecitabine,3,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,capecitabine,3,825,mg/m2,2,Days 1–33,NA
18539404,NA,52,oxaliplatin,3,50,mg/m2,1,"Days 1, 8, 15, 22, and 29",NA
18539404,NA,52,oxaliplatin,3,50,mg/m2,1,"Days 1, 8, 15, 22, and 29",NA
18539404,NA,52,radiotherapy,3,1.8,Gy,1,25 fractions of 1.8 Gy to a total dose of 45 Gy in 5 weeks,NA
17195945,NA,53,irinotecan,1,75,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,1,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,1,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,irinotecan,2,85,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,2,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,2,750,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,irinotecan,3,85,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,3,875,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,3,875,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,irinotecan,4,100,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,4,875,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,4,875,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,irinotecan,5,100,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,5,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,5,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,irinotecan,6,115,mg/m2,1,"on days 1 and 8, every 21 days",NA
17195945,NA,53,capecitabine,6,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
17195945,NA,53,capecitabine,6,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
18414865,NA,54,oxaliplatin,1.5,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,1.5,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,irinotecan,1.5,40,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,1.5,1000,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,1.5,1000,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,1,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,1,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,irinotecan,1,40,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,1,300,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,1,300,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,2,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,2,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,irinotecan,2,40,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,2,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,2,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,3,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,3,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,irinotecan,3,50,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,3,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,3,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,4,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,oxaliplatin,4,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,irinotecan,4,60,mg/m2,1,"weekly, for 4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,4,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18414865,NA,54,capecitabine,4,450,mg,2,"Monday through Friday for4 weeks, followed by a 2-week rest",NA
18525298,NA,55,irinotecan,-1,250,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,-1,40,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,-1,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,-1,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,irinotecan,0,180,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,0,30,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,0,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,0,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,irinotecan,1,180,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,1,30,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,1,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,1,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,irinotecan,2,180,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,2,40,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,2,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,2,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,irinotecan,3,180,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,3,50,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,3,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,3,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,irinotecan,4,180,mg/m2,1,on day 1 every 21 days,NA
18525298,NA,55,epirubicin,4,60,mg/m2,1,on day 2 every 21 days,NA
18525298,NA,55,capecitabine,4,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18525298,NA,55,capecitabine,4,750,mg/m2,2,on days 2 to 14 every 21 days,NA
18398145,NA,56,capecitabine,-2,1000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-2,1000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-2,1000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-2,1000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-1,1000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-1,1000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-1,1500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,-1,1500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,0,1500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,0,1500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,0,1500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,0,1500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,1,1500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,1,1500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,1,2000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,1,2000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,2,2000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,2,2000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,2,2000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,2,2000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,3,2000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,3,2000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,3,2500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,3,2500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,4,2500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,4,2500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,4,2500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,4,2500,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,5,2500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,5,2500,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,5,3000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,5,3000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,6,3000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,6,3000,mg,1,"AM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,6,3000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18398145,NA,56,capecitabine,6,3000,mg,1,"PM dose; on days 1-7, and 15-21 every 28 days",NA
18534963,NA,57,oxaliplatin,-1,85,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,-1,85,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,gemcitabine,-1,600,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,capecitabine,-1,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,capecitabine,-1,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,gemcitabine,1,800,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,capecitabine,1,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,capecitabine,1,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,gemcitabine,2,800,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,capecitabine,2,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,capecitabine,2,600,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,3,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,3,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,gemcitabine,3,800,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,capecitabine,3,800,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,capecitabine,3,800,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,4,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,oxaliplatin,4,100,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,gemcitabine,4,1000,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
18534963,NA,57,capecitabine,4,800,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18534963,NA,57,capecitabine,4,800,mg/m2,2,on days 1–7 and days15–21 of each 28-day cycle,NA
18773144,NA,58,cisplatin,1,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,cisplatin,1,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,irinotecan,1,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,capecitabine,1,500,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,capecitabine,1,500,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,cisplatin,2,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,cisplatin,2,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,irinotecan,2,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,capecitabine,2,750,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,capecitabine,2,750,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,cisplatin,3,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,cisplatin,3,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,irinotecan,3,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,capecitabine,3,1000,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,capecitabine,3,1000,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,cisplatin,4,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,cisplatin,4,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,irinotecan,4,50,mg/m2,1,"on days 11, 18, and 25 of each 38-day cycle",NA
18773144,NA,58,capecitabine,4,1250,mg/m2,2,on days 1-10 of each 38-day cycle,NA
18773144,NA,58,capecitabine,4,1250,mg/m2,2,on days 1-10 of each 38-day cycle,NA
16909414,NA,59,capecitabine,-1,800,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,-1,800,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,-1,50,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,-1,50,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,0,900,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,0,900,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,0,75,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,0,75,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,1,900,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,1,900,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,1,100,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,1,100,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,2,1000,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,2,1000,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,2,100,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,2,100,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,3,1000,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,capecitabine,3,1000,mg/m2,2,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,3,150,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
16909414,NA,59,temozolomide,3,150,mg/m2,1,on Days 1–5 and Days 8–12 every 21 days,NA
19238629,NA,60,matuzumab,1,400,mg,1,weekly,NA
19238629,NA,60,epirubicin,1,50,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,1,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,1,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,capecitabine,1,500,mg/m2,2,continuously,NA
19238629,NA,60,capecitabine,1,500,mg/m2,2,continuously,NA
19238629,NA,60,matuzumab,2,800,mg,1,weekly,NA
19238629,NA,60,epirubicin,2,50,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,2,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,2,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,capecitabine,2,500,mg/m2,2,continuously,NA
19238629,NA,60,capecitabine,2,500,mg/m2,2,continuously,NA
19238629,NA,60,matuzumab,3,1200,mg,1,every 3 weeks,NA
19238629,NA,60,epirubicin,3,50,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,3,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,3,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,capecitabine,3,500,mg/m2,2,continuously,NA
19238629,NA,60,capecitabine,3,500,mg/m2,2,continuously,NA
19238629,NA,60,matuzumab,4,1600,mg,1,every 3 weeks,NA
19238629,NA,60,epirubicin,4,50,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,4,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,cisplatin,4,60,mg/m2,1,on day 1 of each 3-week cycle,NA
19238629,NA,60,capecitabine,4,500,mg/m2,2,continuously,NA
19238629,NA,60,capecitabine,4,500,mg/m2,2,continuously,NA
18455328,NA,61,oxaliplatin,1,40,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,oxaliplatin,1,40,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,capecitabine,1,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,capecitabine,1,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,radiotherapy,1,2,Gy,1,Monday through Friday for 5 weeks,NA
18455328,NA,61,oxaliplatin,2,50,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,oxaliplatin,2,50,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,capecitabine,2,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,capecitabine,2,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,radiotherapy,2,2,Gy,1,Monday through Friday for 5 weeks,NA
18455328,NA,61,oxaliplatin,3,60,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,oxaliplatin,3,60,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,capecitabine,3,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,capecitabine,3,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,radiotherapy,3,2,Gy,1,Monday through Friday for 5 weeks,NA
18455328,NA,61,oxaliplatin,4,70,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,oxaliplatin,4,70,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,capecitabine,4,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,capecitabine,4,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,radiotherapy,4,2,Gy,1,Monday through Friday for 5 weeks,NA
18455328,NA,61,oxaliplatin,5,80,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,oxaliplatin,5,80,mg/m2,1,"on Days 1, 8, 22, and 29",NA
18455328,NA,61,capecitabine,5,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,capecitabine,5,650,mg/m2,2,on Days 1–14 and 22–35 of RT,NA
18455328,NA,61,radiotherapy,5,2,Gy,1,Monday through Friday for 5 weeks,NA
17450468,NA,62,oxaliplatin,1,85,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,1,85,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,capecitabine,1,500,mg/m2,2,continuously,NA
17450468,NA,62,capecitabine,1,500,mg/m2,2,continuously,NA
17450468,NA,62,epirubicin,1,50,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,capecitabine,2,500,mg/m2,2,continuously,NA
17450468,NA,62,capecitabine,2,500,mg/m2,2,continuously,NA
17450468,NA,62,epirubicin,2,50,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,3,115,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,3,115,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,capecitabine,3,500,mg/m2,2,continuously,NA
17450468,NA,62,capecitabine,3,500,mg/m2,2,continuously,NA
17450468,NA,62,epirubicin,3,50,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,4,130,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,4,130,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,capecitabine,4,500,mg/m2,2,continuously,NA
17450468,NA,62,capecitabine,4,500,mg/m2,2,continuously,NA
17450468,NA,62,epirubicin,4,50,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,5,130,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,oxaliplatin,5,130,mg/m2,1,on day 1 every 3 weeks,NA
17450468,NA,62,capecitabine,5,625,mg/m2,2,continuously,NA
17450468,NA,62,capecitabine,5,625,mg/m2,2,continuously,NA
17450468,NA,62,epirubicin,5,50,mg/m2,1,on day 1 every 3 weeks,NA
19219674,NA,63,cisplatin,1,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,1,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,5-fluorouracil,1,425,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,irinotecan,1,40,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,2,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,2,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,5-fluorouracil,2,425,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,irinotecan,2,50,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,3,425,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,3,425,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,5-fluorouracil,3,NA,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,irinotecan,3,65,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,4,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,cisplatin,4,25,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,5-fluorouracil,4,500,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
19219674,NA,63,irinotecan,4,65,mg/m2,1,"repeated6-week cycles that consisted of weekly treatment for 4 weeks, followed by a 2-week rest period",NA
18208793,NA,64,gefitinib,1,250,mg,1,continuously every 21 days,NA
18208793,NA,64,capecitabine,1,1000,mg/m2,2,continuously every 21 days,NA
18208793,NA,64,capecitabine,1,1000,mg/m2,2,continuously every 21 days,NA
18208793,NA,64,gefitinib,2,250,mg,1,continuously every 21 days,NA
18208793,NA,64,capecitabine,2,1250,mg/m2,2,continuously every 21 days,NA
18208793,NA,64,capecitabine,2,1250,mg/m2,2,continuously every 21 days,NA
18650153,NA,65,ixabepilone,1,40,mg/m2,1,on day 1 every 3 weeks,Schedule A
18650153,NA,65,capecitabine,1,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule A
18650153,NA,65,capecitabine,1,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule A
18650153,NA,65,ixabepilone,2,40,mg/m2,1,on day 1 every 3 weeks,Schedule A
18650153,NA,65,capecitabine,2,1000,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule A
18650153,NA,65,capecitabine,2,1000,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule A
18650153,NA,65,ixabepilone,3,8,mg/m2,1,on day 1-3 every 3 weeks,Schedule B
18650153,NA,65,capecitabine,3,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule B
18650153,NA,65,capecitabine,3,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule B
18650153,NA,65,ixabepilone,4,10,mg/m2,1,on day 1-3 every 3 weeks,Schedule B
18650153,NA,65,capecitabine,4,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule B
18650153,NA,65,capecitabine,4,825,mg/m2,2,on days 1-14 of a 21-day cycle,Schedule B
17848909,NA,66,capecitabine,1,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,1,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,1,250,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,1,250,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,1,3,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,1,3,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,1,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,2,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,2,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,2,250,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,2,250,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,2,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,2,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,2,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,3,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,3,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,3,350,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,3,350,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,3,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,3,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,3,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,4,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,4,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,4,500,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,4,500,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,4,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,4,4,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,4,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,5,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,5,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,5,575,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,5,575,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,5,5,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,5,5,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,5,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,6,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,6,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,6,650,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,6,650,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,6,5,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,6,5,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,6,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17848909,NA,66,capecitabine,7,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,7,1000,mg/m2,2,on days 1 –14,NA
17848909,NA,66,capecitabine,7,650,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,capecitabine,7,650,mg/m2,2,"starting on day 22, daily before radiotherapy",NA
17848909,NA,66,cisplatin,7,6,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,cisplatin,7,6,mg/m2,1,daily 1 h before radiotherapy,NA
17848909,NA,66,radiotherapy,7,1.8,Gy,1,"starting on day 22, 5 fractions per week for 5 weeks",NA
17653805,NA,67,capecitabine,1,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,capecitabine,1,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,oxaliplatin,1,85,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,oxaliplatin,1,85,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,radiotherapy,1,1.8,Gy,1,5 days per week for 5 weeks with a boost to the tumor in 3 fractions of 1.8 Gy to a total of 50.4 Gy,NA
17653805,NA,67,capecitabine,2,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,capecitabine,2,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,oxaliplatin,2,100,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,oxaliplatin,2,100,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,radiotherapy,2,1.8,Gy,1,5 days per week for 5 weeks with a boost to the tumor in 3 fractions of 1.8 Gy to a total of 50.4 Gy,NA
17653805,NA,67,capecitabine,3,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,capecitabine,3,1000,mg/m2,2,on days 1–14 and 25–38,NA
17653805,NA,67,oxaliplatin,3,135,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,oxaliplatin,3,135,mg/m2,1,on days 1 and 29,NA
17653805,NA,67,radiotherapy,3,1.8,Gy,1,5 days per week for 5 weeks with a boost to the tumor in 3 fractions of 1.8 Gy to a total of 50.4 Gy,NA
17415843,NA,68,capecitabine,1,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,capecitabine,1,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,oxaliplatin,1,100,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,oxaliplatin,1,100,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,pelvic rt,1,1.8,Gy,1,on days 1-5 of each week for 27 days,NA
17415843,NA,68,capecitabine,2,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,capecitabine,2,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,oxaliplatin,2,110,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,oxaliplatin,2,110,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,pelvic rt,2,1.8,Gy,1,on days 1-5 of each week for 27 days,NA
17415843,NA,68,capecitabine,3,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,capecitabine,3,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,oxaliplatin,3,120,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,oxaliplatin,3,120,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,pelvic rt,3,1.8,Gy,1,on days 1-5 of each week for 27 days,NA
17415843,NA,68,capecitabine,4,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,capecitabine,4,825,mg/m2,2,on days 1-14 and 22-35 of RT,NA
17415843,NA,68,oxaliplatin,4,130,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,oxaliplatin,4,130,mg/m2,1,on days 1 and 22,NA
17415843,NA,68,pelvic rt,4,1.8,Gy,1,on days 1-5 of each week for 27 days,NA
17333194,NA,69,capecitabine,1,665.5,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,1,665.5,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,2,832.5,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,2,832.5,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,3,1000,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,3,1000,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,4,1125,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,4,1125,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,5,1255,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,5,1255,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,6,1375,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
17333194,NA,69,capecitabine,6,1375,mg/m2,2,"5 consecutive days each week, followed by a weekend break",NA
16374040,NA,70,pegylated liposomal doxorubicin,1,35,mg/m2,1,on day 1 every 3 weeks,NA
16374040,NA,70,capecitabine,1,800,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,capecitabine,1,800,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,pegylated liposomal doxorubicin,2,35,mg/m2,1,on day 1 every 3 weeks,NA
16374040,NA,70,capecitabine,2,850,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,capecitabine,2,850,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,pegylated liposomal doxorubicin,3,40,mg/m2,1,on day 1 every 3 weeks,NA
16374040,NA,70,capecitabine,3,850,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,capecitabine,3,850,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,pegylated liposomal doxorubicin,4,40,mg/m2,1,on day 1 every 3 weeks,NA
16374040,NA,70,capecitabine,4,900,mg/m2,2,on days 1–14 every 3 weeks,NA
16374040,NA,70,capecitabine,4,900,mg/m2,2,on days 1–14 every 3 weeks,NA
15729602,NA,71,capecitabine,1,251,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,1,251,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,2,502,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,2,502,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,3,828,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,3,828,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,4,1255,mg/m2,2,daily for at least 6weeks,NA
15729602,NA,71,capecitabine,4,1255,mg/m2,2,daily for at least 6weeks,NA
14739668,NA,72,cisplatin,1,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,cisplatin,1,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,irinotecan,1,40,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,capecitabine,1,500,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,capecitabine,1,500,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,cisplatin,2,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,cisplatin,2,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,irinotecan,2,60,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,capecitabine,2,500,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,capecitabine,2,500,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,cisplatin,3,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,cisplatin,3,30,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,irinotecan,3,60,mg/m2,1,on days 1 and 8 every 3 weeks,step A
14739668,NA,72,capecitabine,3,650,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,capecitabine,3,650,mg,2,on days 1-14 every 3 weeks,step A
14739668,NA,72,cisplatin,4,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,cisplatin,4,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,irinotecan,4,60,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,capecitabine,4,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,capecitabine,4,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,cisplatin,5,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,cisplatin,5,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,irinotecan,5,70,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,capecitabine,5,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,capecitabine,5,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,cisplatin,6,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,cisplatin,6,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,irinotecan,6,80,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,capecitabine,6,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,capecitabine,6,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,cisplatin,7,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,cisplatin,7,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,irinotecan,7,90,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,capecitabine,7,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,capecitabine,7,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,cisplatin,8,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,cisplatin,8,20,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,irinotecan,8,100,mg/m2,1,on days 1 and 8 every 3 weeks,step B
14739668,NA,72,capecitabine,8,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,capecitabine,8,1000,mg,2,on days 1-14 every 3 weeks,step B
14739668,NA,72,cisplatin,9,20,mg/m2,1,on days 1 and 8 every 3 weeks,step C
14739668,NA,72,cisplatin,9,20,mg/m2,1,on days 1 and 8 every 3 weeks,step C
14739668,NA,72,irinotecan,9,60,mg/m2,1,on days 1 and 8 every 3 weeks,step C
14739668,NA,72,capecitabine,9,650,mg,2,on days 1-14 every 3 weeks,step C
14739668,NA,72,capecitabine,9,650,mg,2,on days 1-14 every 3 weeks,step C
16622464,NA,73,irinotecan,1,150,mg/m2,1,on day 1 every 14 days,NA
16622464,NA,73,capecitabine,1,850,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,capecitabine,1,850,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,irinotecan,2,150,mg/m2,1,on day 1 every 14 days,NA
16622464,NA,73,capecitabine,2,1000,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,capecitabine,2,1000,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,irinotecan,3,180,mg/m2,1,on day 1 every 14 days,NA
16622464,NA,73,capecitabine,3,1000,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,capecitabine,3,1000,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,irinotecan,4,180,mg/m2,1,on day 1 every 14 days,NA
16622464,NA,73,capecitabine,4,1250,mg/m2,2,on days 1– 9 every 14 days,NA
16622464,NA,73,capecitabine,4,1250,mg/m2,2,on days 1– 9 every 14 days,NA
12196374,NA,74,cisplatin,1,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,cisplatin,1,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,epirubicin,1,50,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,capecitabine,1,500,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,capecitabine,1,500,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,cisplatin,2,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,cisplatin,2,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,epirubicin,2,50,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,capecitabine,2,835,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,capecitabine,2,835,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,cisplatin,3,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,cisplatin,3,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,epirubicin,3,50,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,capecitabine,3,1000,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,capecitabine,3,1000,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,cisplatin,4,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,cisplatin,4,60,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,epirubicin,4,50,mg/m2,1,on day 1 every 21 days,NA
12196374,NA,74,capecitabine,4,1250,mg/m2,2,on days 1-14 every 21 days,NA
12196374,NA,74,capecitabine,4,1250,mg/m2,2,on days 1-14 every 21 days,NA
10883663,NA,75,capecitabine,1,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,1,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,1,75,mg/m2,1,on day 1 of each 21-day cycle,NA
10883663,NA,75,capecitabine,2,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,2,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,2,85,mg/m2,1,on day 1 of each 21-day cycle,NA
10883663,NA,75,capecitabine,3,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,3,825,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
10883663,NA,75,capecitabine,4,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,4,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,4,100,mg/m2,1,on day 1 of each 21-day cycle,NA
10883663,NA,75,capecitabine,5,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,5,1000,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,5,75,mg/m2,1,on day 1 of each 21-day cycle,NA
10883663,NA,75,capecitabine,6,1250,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,capecitabine,6,1250,mg/m2,2,on days 1–14 of each 21-day cycle,NA
10883663,NA,75,docetaxel,6,75,mg/m2,1,on day 1 of each 21-day cycle,NA
11432617,NA,76,paclitaxel,1,175,mg/m2,1,on day 1 every 3 weeks,NA
11432617,NA,76,capecitabine,1,825,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,capecitabine,1,825,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,paclitaxel,2,175,mg/m2,1,on day 1 every 3 weeks,NA
11432617,NA,76,capecitabine,2,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,capecitabine,2,1000,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,paclitaxel,3,175,mg/m2,1,on day 1 every 3 weeks,NA
11432617,NA,76,capecitabine,3,750,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,capecitabine,3,750,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,paclitaxel,4,175,mg/m2,1,on day 1 every 3 weeks,NA
11432617,NA,76,capecitabine,4,500,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,capecitabine,4,500,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,paclitaxel,5,135,mg/m2,1,on day 1 every 3 weeks,NA
11432617,NA,76,capecitabine,5,750,mg/m2,2,on days 1-14 every 3 weeks,NA
11432617,NA,76,capecitabine,5,750,mg/m2,2,on days 1-14 every 3 weeks,NA
16284060,NA,77,capecitabine,1,500,mg/m2,2,daily,NA
16284060,NA,77,capecitabine,1,500,mg/m2,2,daily,NA
16284060,NA,77,oxaliplatin,1,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,oxaliplatin,1,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,pre-operative pelvic radiotherapy,1,1.8,Gy,1,Monday–Friday for 5 weeks,NA
16284060,NA,77,capecitabine,2,650,mg/m2,2,daily,NA
16284060,NA,77,capecitabine,2,650,mg/m2,2,daily,NA
16284060,NA,77,oxaliplatin,2,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,oxaliplatin,2,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,pre-operative pelvic radiotherapy,2,1.8,Gy,1,Monday–Friday for 5 weeks,NA
16284060,NA,77,capecitabine,3,825,mg/m2,2,daily,NA
16284060,NA,77,capecitabine,3,825,mg/m2,2,daily,NA
16284060,NA,77,oxaliplatin,3,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,oxaliplatin,3,130,mg/m2,1,on days 1 and 29,NA
16284060,NA,77,pre-operative pelvic radiotherapy,3,1.8,Gy,1,Monday–Friday for 5 weeks,NA
12491516,NA,78,9-nitrocamptothecin,1,0.5,mg/m2,1,"on days 1-5, and 8-12 every 21 days",NA
12491516,NA,78,capecitabine,1,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,capecitabine,1,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,9-nitrocamptothecin,2,0.75,mg/m2,1,"on days 1-5, and 8-12 every 21 days",NA
12491516,NA,78,capecitabine,2,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,capecitabine,2,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,9-nitrocamptothecin,3,1,mg/m2,1,"on days 1-5, and 8-12 every 21 days",NA
12491516,NA,78,capecitabine,3,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,capecitabine,3,650,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,9-nitrocamptothecin,4,1.25,mg/m2,1,"on days 1-5, and 8-12 every 21 days",NA
12491516,NA,78,capecitabine,4,620,mg/m2,2,on days 1-14 every 21 days,NA
12491516,NA,78,capecitabine,4,620,mg/m2,2,on days 1-14 every 21 days,NA
12864942,NA,79,vinorelbine,1,25,mg/m2,1,on days 1 and 8 of a 3-week schedule,NA
12864942,NA,79,capecitabine,1,700,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,capecitabine,1,700,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,vinorelbine,2,25,mg/m2,1,on days 1 and 8 of a 3-week schedule,NA
12864942,NA,79,capecitabine,2,750,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,capecitabine,2,750,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,vinorelbine,3,25,mg/m2,1,on days 1 and 8 of a 3-week schedule,NA
12864942,NA,79,capecitabine,3,875,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,capecitabine,3,875,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,vinorelbine,4,25,mg/m2,1,on days 1 and 8 of a 3-week schedule,NA
12864942,NA,79,capecitabine,4,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,capecitabine,4,1000,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,vinorelbine,5,25,mg/m2,1,on days 1 and 8 of a 3-week schedule,NA
12864942,NA,79,capecitabine,5,1125,mg/m2,2,on days 1-14 of each 3-week cycle,NA
12864942,NA,79,capecitabine,5,1125,mg/m2,2,on days 1-14 of each 3-week cycle,NA
16242260,NA,80,capecitabine,1,500,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,1,500,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,postoperative pelvic rt,1,2,Gy,1,"Monday through Friday, over a period of approximately 5 weeks",NA
16242260,NA,80,capecitabine,2,600,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,2,600,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,postoperative pelvic rt,2,2,Gy,1,"Monday through Friday, over a period of approximately 5 weeks",NA
16242260,NA,80,capecitabine,NA,700,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,700,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,postoperative pelvic rt,NA,2,Gy,1,"Monday through Friday, over a period of approximately 5 weeks",NA
16242260,NA,80,capecitabine,NA,750,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,750,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,800,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,800,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,850,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
16242260,NA,80,capecitabine,NA,850,mg/m2,2,continuously for 14 days and followed by a7-day rest. Another 14-day cycle followed the rest period,NA
15827767,NA,81,doxifluridine,1,600,mg/m2,1,on days 1–14 every 3 weeks,NA
15827767,NA,81,paclitaxel,1,60,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15827767,NA,81,doxifluridine,2,600,mg/m2,1,on days 1–14 every 3 weeks,NA
15827767,NA,81,paclitaxel,2,70,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15827767,NA,81,doxifluridine,3,600,mg/m2,1,on days 1–14 every 3 weeks,NA
15827767,NA,81,paclitaxel,3,80,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15827767,NA,81,doxifluridine,4,800,mg/m2,1,on days 1–14 every 3 weeks,NA
15827767,NA,81,paclitaxel,4,80,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15827767,NA,81,doxifluridine,5,800,mg/m2,1,on days 1–14 every 3 weeks,NA
15827767,NA,81,paclitaxel,5,90,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15520075,NA,82,ci-994,1,4,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,1,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,1,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,ci-994,2,6,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,2,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,2,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,ci-994,3,8,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,3,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,3,825,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,ci-994,4,10,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule A
15520075,NA,82,capecitabine,4,825,mg/m2,2,daily for 2 weeks of a 3-weekcycle,schedule A
15520075,NA,82,capecitabine,4,825,mg/m2,2,daily for 2 weeks of a 3-weekcycle,schedule A
15520075,NA,82,ci-994,5,6,mg/m2,1,daily for 5 of 6 weeks,schedule B
15520075,NA,82,capecitabine,5,825,mg/m2,2,daily for 5 of 6 weeks,schedule B
15520075,NA,82,capecitabine,5,825,mg/m2,2,daily for 5 of 6 weeks,schedule B
15520075,NA,82,ci-994,6,4,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,6,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,6,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,ci-994,7,6,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,7,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,7,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,ci-994,8,8,mg/m2,1,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,8,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15520075,NA,82,capecitabine,8,1000,mg/m2,2,daily for 2 weeks of a 3-week cycle,schedule C
15612026,NA,83,gemcitabine,1,600,mg/m2,1,"on Days 1, 8, and 15 of a 28-day cycle",NA
15612026,NA,83,capecitabine,1,830,mg/m2,2,on Days 1–21 of a 28-day cycle,NA
15612026,NA,83,capecitabine,1,830,mg/m2,2,on Days 1–21 of a 28-day cycle,NA
15612026,NA,83,gemcitabine,0,600,mg/m2,1,"on Days 1, 8, and 15 of a 28-day cycle",NA
15612026,NA,83,capecitabine,0,415,mg/m2,2,on Days 1–21 of a 28-day cycle,NA
15612026,NA,83,capecitabine,0,415,mg/m2,2,on Days 1–21 of a 28-day cycle,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,1,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,1,425,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,1,425,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,2,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,2,500,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,2,500,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,3,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,3,625,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,3,625,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,4,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,4,825,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,4,825,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,5,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,5,900,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,5,900,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,6,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,6,1000,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,6,1000,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,standard preoperative pelvic radiotherapy,7,50.4,Gy,NA,in 28 fractions in 5 weeks and 3 days,NA
15305186,NA,84,capecitabine,7,1250,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15305186,NA,84,capecitabine,7,1250,mg/m2,2,from Monday to Friday throughout the course of radiotherapy,NA
15939714,NA,85,capecitabine,4,1000,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,capecitabine,4,1000,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,irinotecan,4,300,mg/m2,1,on day 1repeated every 21 days,NA
15939714,NA,85,capecitabine,5,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,capecitabine,5,1250,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,irinotecan,5,300,mg/m2,1,on day 1repeated every 21 days,NA
15939714,NA,85,capecitabine,1,750,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,capecitabine,1,750,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,irinotecan,1,200,mg/m2,1,on day 1repeated every 21 days,NA
15939714,NA,85,capecitabine,2,750,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,capecitabine,2,750,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,irinotecan,2,250,mg/m2,1,on day 1repeated every 21 days,NA
15939714,NA,85,capecitabine,3,1000,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,capecitabine,3,1000,mg/m2,2,on days 1–14 every 3 weeks,NA
15939714,NA,85,irinotecan,3,250,mg/m2,1,on day 1repeated every 21 days,NA
16601432,NA,86,gemcitabine,1,900,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16601432,NA,86,vinorelbine,1,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16601432,NA,86,capecitabine,1,1000,mg/m2,2,on days 1 to 5 and 8 to 12 every 3 weeks,NA
16601432,NA,86,capecitabine,1,1000,mg/m2,2,on days 1 to 5 and 8 to 12 every 3 weeks,NA
16601432,NA,86,gemcitabine,2,900,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16601432,NA,86,vinorelbine,2,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16601432,NA,86,capecitabine,2,1000,mg/m2,2,on days 1 to 6 and 8to 13 every 3 weeks,NA
16601432,NA,86,capecitabine,2,1000,mg/m2,2,on days 1 to 6 and 8to 13 every 3 weeks,NA
12763217,NA,87,capecitabine,1,750,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,capecitabine,1,750,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,cyclophosphamide,1,600,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,epirubicin,1,100,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,capecitabine,2,900,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,capecitabine,2,900,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,cyclophosphamide,2,600,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,epirubicin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,capecitabine,3,1050,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,capecitabine,3,1050,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,cyclophosphamide,3,600,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,epirubicin,3,100,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,capecitabine,4,1250,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,capecitabine,4,1250,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
12763217,NA,87,cyclophosphamide,4,600,mg/m2,1,on day 1 every 3 weeks,NA
12763217,NA,87,epirubicin,4,100,mg/m2,1,on day 1 every 3 weeks,NA
11768362,NA,88,epirubicin,1,30,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,cyclophosphamide,1,400,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,5-fluorouracil,1,200,mg/m2,1,from day 1 to 28,NA
11768362,NA,88,epirubicin,2,45,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,cyclophosphamide,2,400,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,5-fluorouracil,2,200,mg/m2,1,from day 1 to 28,NA
11768362,NA,88,epirubicin,3,60,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,cyclophosphamide,3,400,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,5-fluorouracil,3,200,mg/m2,1,from day 1 to 28,NA
11768362,NA,88,epirubicin,3.5,60,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,cyclophosphamide,3.5,400,mg/m2,1,on days 1 & 8 every 4 weeks,NA
11768362,NA,88,5-fluorouracil,3.5,200,mg/m2,1,from day 1 to 21,NA
12954586,NA,89,irinotecan,1,70,mg/m2,1,once a week for 6 weeks,NA
12954586,NA,89,capecitabine,1,1000,mg/m2,2,on days 1–14 and 22–36,NA
12954586,NA,89,capecitabine,1,1000,mg/m2,2,on days 1–14 and 22–36,NA
12954586,NA,89,irinotecan,2,70,mg/m2,1,once a week for 6 weeks,NA
12954586,NA,89,capecitabine,2,1250,mg/m2,2,on days 1–14 and 22–36,NA
12954586,NA,89,capecitabine,2,1250,mg/m2,2,on days 1–14 and 22–36,NA
12954586,NA,89,irinotecan,3,80,mg/m2,1,once a week for 6 weeks,NA
12954586,NA,89,capecitabine,3,1250,mg/m2,2,on days 1–14 and 22–36,NA
12954586,NA,89,capecitabine,3,1250,mg/m2,2,on days 1–14 and 22–36,NA
11843252,NA,90,capecitabine,1,825,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,1,825,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,2,1000,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,2,1000,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,3,1000,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,3,1000,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,3,110,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,3,110,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,4,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,4,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,4,110,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,4,110,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,5,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,5,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,5,120,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,5,120,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,6,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,capecitabine,6,1250,mg/m2,2,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,6,130,mg/m2,1,on day 1 of each 21-day cycle,NA
11843252,NA,90,oxaliplatin,6,130,mg/m2,1,on day 1 of each 21-day cycle,NA
15550580,NA,91,vinorelbine,0,20,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,0,400,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,0,400,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,1,500,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,1,500,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,2,625,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,2,625,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,vinorelbine,3,25,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,3,625,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,3,625,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,4,750,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,4,750,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,vinorelbine,5,30,mg/m2,1,on days 1 and 8 every 21 days,NA
15550580,NA,91,capecitabine,5,750,mg/m2,2,on days 1–14 every 21 days,NA
15550580,NA,91,capecitabine,5,750,mg/m2,2,on days 1–14 every 21 days,NA
15238990,NA,92,capecitabine,1,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,capecitabine,1,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,mitomycin c,1,4,mg/m2,1,on day 1 of each 21-day cycle,NA
15238990,NA,92,capecitabine,2,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,capecitabine,2,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,mitomycin c,2,6,mg/m2,1,on day 1 of each 21-day cycle,NA
15238990,NA,92,capecitabine,3,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,capecitabine,3,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,mitomycin c,3,8,mg/m2,1,on day 1 of each 21-day cycle,NA
15238990,NA,92,capecitabine,4,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,capecitabine,4,1000,mg/m2,2,"on days 1–14, every 3 weeks",NA
15238990,NA,92,mitomycin c,4,10,mg/m2,1,on day 1 of each 21-day cycle,NA
16462509,NA,93,capecitabine,1,825,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,capecitabine,1,825,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,oxaliplatin,1,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,oxaliplatin,1,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,capecitabine,2,1000,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,capecitabine,2,1000,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,oxaliplatin,2,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,oxaliplatin,2,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,capecitabine,3,1000,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,capecitabine,3,1000,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,oxaliplatin,3,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,oxaliplatin,3,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,capecitabine,4,1250,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,capecitabine,4,1250,mg/m2,2,"from day 1 to day 14, every 3 weeks",NA
16462509,NA,93,oxaliplatin,4,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16462509,NA,93,oxaliplatin,4,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
15539915,NA,94,capecitabine,-1,400,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,capecitabine,-1,400,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,paclitaxel,-1,80,mg/m2,1,"on days 1, 8 and 15 every 21 days",NA
15539915,NA,94,capecitabine,0,500,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,capecitabine,0,500,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,paclitaxel,0,80,mg/m2,1,"on days 1, 8 and 15 every 21 days",NA
15539915,NA,94,capecitabine,1,750,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,capecitabine,1,750,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,paclitaxel,1,80,mg/m2,1,"on days 1, 8 and 15 every 21 days",NA
15539915,NA,94,capecitabine,2,1000,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,capecitabine,2,1000,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,paclitaxel,2,80,mg/m2,1,"on days 1, 8 and 15 every 21 days",NA
15539915,NA,94,capecitabine,3,1250,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,capecitabine,3,1250,mg/m2,2,on days 1–14 every 21 days,NA
15539915,NA,94,paclitaxel,3,80,mg/m2,1,"on days 1, 8 and 15 every 21 days",NA
34301752,NCT02264678,95,ceralasertib,1,20,mg,2,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 3–19 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,1,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,1,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,2,20,mg,2,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 4–12 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,2,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,2,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,3,40,mg,2,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 4–12 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,3,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,3,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,4,40,mg,2,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 4–10 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,4,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,4,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,5,60,mg,1,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 4–10 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,5,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,5,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,6,60,mg,1,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 1-3 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,6,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,6,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,ceralasertib,7,40,mg,1,"a single dose (cycle 0 day 1), then twice daily dosing for up to 5 days before beginning cycle 1, then on days 1-2 in 21-daycycles",NA
34301752,NCT02264678,95,carboplatin,7,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
34301752,NCT02264678,95,carboplatin,7,5,AUC,1,"on day 1 in 21-day cycle, starting on cycle 1",NA
16283312,NA,96,capecitabine,1,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,capecitabine,1,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,vinorelbine,1,20,mg,1,on days 1 and 8 in a 21-day cycle,NA
16283312,NA,96,capecitabine,2,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,capecitabine,2,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,vinorelbine,2,30,mg,1,on days 1 and 8 in a 21-day cycle,NA
16283312,NA,96,capecitabine,3,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,capecitabine,3,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,vinorelbine,3,40,mg,1,on days 1 and 8 in a 21-day cycle,NA
16283312,NA,96,capecitabine,4,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,capecitabine,4,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,vinorelbine,4,45,mg,1,on days 1 and 8 in a 21-day cycle,NA
16283312,NA,96,capecitabine,5,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,capecitabine,5,1500,mg,2,on days 1–14 in a 21-day cycle,NA
16283312,NA,96,vinorelbine,5,50,mg,1,on days 1 and 8 in a 21-day cycle,NA
12506172,NA,97,capecitabine,1,0,mg/m2,2,on days 1-14 of a 21-day cycle,NA
12506172,NA,97,capecitabine,1,0,mg/m2,2,on days 1-14 of a 21-day cycle,NA
12506172,NA,97,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15218291,NA,98,capecitabine,1,600,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,1,600,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,1,50,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,1,50,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,2,700,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,2,700,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,3,700,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,3,700,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,3,60,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,3,60,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,4,800,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,4,800,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,4,60,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,4,60,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,5,800,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,5,800,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,5,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,5,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,6,900,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,6,900,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,6,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,6,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,7,1000,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,7,1000,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,7,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,7,65,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,8,1000,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,8,1000,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,8,70,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,8,70,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,capecitabine,9,1050,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,capecitabine,9,1050,mg/m2,2,on days 1-14 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,9,70,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
15218291,NA,98,oxaliplatin,9,70,mg/m2,1,on days 1 and 8 of a 3-week cycle,NA
11786589,NA,99,gemcitabine,1,400,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11786589,NA,99,capecitabine,1,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,capecitabine,1,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,gemcitabine,2,600,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11786589,NA,99,capecitabine,2,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,capecitabine,2,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,gemcitabine,3,800,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11786589,NA,99,capecitabine,3,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,capecitabine,3,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11786589,NA,99,capecitabine,4,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,capecitabine,4,840,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,gemcitabine,5,800,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11786589,NA,99,capecitabine,5,2000,mg/m2,2,on days 1-21 every 4 weeks,NA
11786589,NA,99,capecitabine,5,2000,mg/m2,2,on days 1-21 every 4 weeks,NA
16446337,NA,100,radiation therapy,1,50.4,Gy,NA,"1.8 Gy per fraction given daily, Monday through Friday, followed by a 5.4 Gy boost",NA
16446337,NA,100,gefitinib,1,250,mg/m2,1,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
16446337,NA,100,capecitabine,1,650,mg/m2,2,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
16446337,NA,100,capecitabine,1,650,mg/m2,2,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
16446337,NA,100,radiation therapy,2,50.4,Gy,NA,"1.8 Gy per fraction given daily, Monday through Friday, followed by a 5.4 Gy boost",NA
16446337,NA,100,gefitinib,2,250,mg/m2,1,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
16446337,NA,100,capecitabine,2,825,mg/m2,2,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
16446337,NA,100,capecitabine,2,825,mg/m2,2,"daily throughout the course of radiation, beginning on day 1, seven days per week",NA
12377646,NA,101,oxaliplatin,0,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,oxaliplatin,0,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,capecitabine,0,1250,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,capecitabine,0,1250,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,capecitabine,1,1500,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,capecitabine,1,1500,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,capecitabine,2,1750,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,capecitabine,2,1750,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
12377646,NA,101,capecitabine,3,2000,mg/m2,2,from days 1 to 7 every 2 weeks,NA
12377646,NA,101,capecitabine,3,2000,mg/m2,2,from days 1 to 7 every 2 weeks,NA
10561233,NA,102,paclitaxel,1,135,mg/m2,1,on day 1 and repeated every 3 weeks,NA
10561233,NA,102,capecitabine,1,502,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,capecitabine,1,502,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,paclitaxel,2,135,mg/m2,1,on day 1 and repeated every 3 weeks,NA
10561233,NA,102,capecitabine,2,666,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,capecitabine,2,666,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,paclitaxel,3,135,mg/m2,1,on day 1 and repeated every 3 weeks,NA
10561233,NA,102,capecitabine,3,829,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,capecitabine,3,829,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,paclitaxel,4,175,mg/m2,1,on day 1 and repeated every 3 weeks,NA
10561233,NA,102,capecitabine,4,829,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,capecitabine,4,829,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,paclitaxel,5,175,mg/m2,1,on day 1 and repeated every 3 weeks,NA
10561233,NA,102,capecitabine,5,666,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
10561233,NA,102,capecitabine,5,666,mg/m2,2,on day 3 after the first paclitaxel treatment and continued for the duration of the study,NA
12393999,NA,103,irinotecan,1,200,mg/m2,1,on day 1 and repeated every 3 weeks,NA
12393999,NA,103,capecitabine,1,1500,mg/m2,2,on day2-15 and repeated every 3 weeks,NA
12393999,NA,103,capecitabine,1,1500,mg/m2,2,on day2-15 and repeated every 3 weeks,NA
15312392,NA,104,radiotherapy,1,2,Gy,1,Monday through Friday every week,68 - 72 Gy/34 - 36 fractions was delivered to the nasopharynx and 64 - 70 Gy/32 - 35 fractions to the node-positive area
15312392,NA,104,capecitabine,1,500,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,capecitabine,1,500,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,radiotherapy,2,2,Gy,1,Monday through Friday every week,68 - 72 Gy/34 - 36 fractions was delivered to the nasopharynx and 64 - 70 Gy/32 - 35 fractions to the node-positive area
15312392,NA,104,capecitabine,2,750,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,capecitabine,2,750,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,radiotherapy,3,2,Gy,1,Monday through Friday every week,68 - 72 Gy/34 - 36 fractions was delivered to the nasopharynx and 64 - 70 Gy/32 - 35 fractions to the node-positive area
15312392,NA,104,capecitabine,3,1000,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,capecitabine,3,1000,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,radiotherapy,4,2,Gy,1,Monday through Friday every week,68 - 72 Gy/34 - 36 fractions was delivered to the nasopharynx and 64 - 70 Gy/32 - 35 fractions to the node-positive area
15312392,NA,104,capecitabine,4,1250,mg/m2,2,Monday through Friday every week,Monday through Friday every week
15312392,NA,104,capecitabine,4,1250,mg/m2,2,Monday through Friday every week,Monday through Friday every week
16062072,NA,105,carboplatin,1,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,carboplatin,1,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,docetaxel,1,35,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,capecitabine,1,250,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,capecitabine,1,250,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,carboplatin,2,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,carboplatin,2,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,docetaxel,2,40,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,capecitabine,2,250,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,capecitabine,2,250,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,carboplatin,3,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,carboplatin,3,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,docetaxel,3,40,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,capecitabine,3,500,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,capecitabine,3,500,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,carboplatin,4,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,carboplatin,4,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,docetaxel,4,40,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,capecitabine,4,750,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,capecitabine,4,750,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,carboplatin,5,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,carboplatin,5,2,AUC,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,docetaxel,5,40,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
16062072,NA,105,capecitabine,5,1000,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16062072,NA,105,capecitabine,5,1000,mg/m2,2,on days 1 to 10 in a 21-day cycle,NA
16504126,NA,106,capecitabine,1,1500,mg,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,1,1500,mg,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,2,1750,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,2,1750,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,3,2000,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,3,2000,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,4,2250,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,4,2250,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,5,2500,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,5,2500,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,6,2750,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
16504126,NA,106,capecitabine,6,2750,NA,3,Days 1–14 of a 21-day cycle,1/4 of dose at 8:00 a.m.; 1/4 of dose at 6:00 p.m. and 1/2 of dose at 11:00 p.m
12351595,NA,107,capecitabine,1,250,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,1,250,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,1,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,2,375,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,2,375,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,2,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,3,500,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,3,500,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,3,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,4,650,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,4,650,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,4,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,5,825,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,5,825,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,5,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,6,1000,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,6,1000,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,6,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
12351595,NA,107,capecitabine,7,1250,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,capecitabine,7,1250,mg/m2,2,continuously for the duration of radiotherapy,NA
12351595,NA,107,irradiation,7,1.8,Gy,1,Monday through Friday over a period ofapproximately 6 weeks,NA
15894361,NA,109,cisplatin,1,40,mg/m2,1,on Monday per week during the radiotherapy,NA
15894361,NA,109,cisplatin,1,40,mg/m2,1,on Monday per week during the radiotherapy,NA
15894361,NA,109,capecitabine,1,300,mg/m2,2,on the day of radiotherapy and continuing for 6 weeks,NA
15894361,NA,109,capecitabine,1,300,mg/m2,2,on the day of radiotherapy and continuing for 6 weeks,NA
15894361,NA,109,radical radiotherapy,1,45,Gy,NA,given in 25 fractions over 5 weeks in 1.8-Gy fractions,NA
15894361,NA,109,cisplatin,2,40,mg/m2,1,on Monday per week during the radiotherapy,NA
15894361,NA,109,cisplatin,2,40,mg/m2,1,on Monday per week during the radiotherapy,NA
15894361,NA,109,capecitabine,2,450,mg/m2,2,on the day of radiotherapy and continuing for 6 weeks,NA
15894361,NA,109,capecitabine,2,450,mg/m2,2,on the day of radiotherapy and continuing for 6 weeks,NA
15894361,NA,109,radical radiotherapy,2,45,Gy,NA,given in 25 fractions over 5 weeks in 1.8-Gy fractions,NA
34562230,NCT02419495,111,selinexor,1,60,mg,1,"on days 1, 3, 8, and 10 of each 21-day cycle",NA
34562230,NCT02419495,111,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,paclitaxel,1,175,mg/m2,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,selinexor,2,60,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
34562230,NCT02419495,111,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,paclitaxel,2,175,mg/m2,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,selinexor,3,40,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
34562230,NCT02419495,111,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,paclitaxel,3,175,mg/m2,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,selinexor,4,40,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
34562230,NCT02419495,111,carboplatin,4,4,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,carboplatin,4,4,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,paclitaxel,4,175,mg/m2,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,selinexor,5,60,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
34562230,NCT02419495,111,carboplatin,5,4,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,carboplatin,5,4,AUC,1,on day 1 every 3 weeks,NA
34562230,NCT02419495,111,paclitaxel,5,175,mg/m2,1,on day 1 every 3 weeks,NA
34607210,NCT02944396,112,veliparib,1,120,mg,2,on Day –2 (2 days prior to start of CT) through Day 5 of each 21-day cycle for six cycles,C/PAC
34607210,NCT02944396,112,nivolumab,1,360,mg,1,"on Day 1 every 3 weeks of Cycles 1–6, then every 3 weeks until disease progression",C/PAC
34607210,NCT02944396,112,carboplatin,1,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PAC
34607210,NCT02944396,112,carboplatin,1,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PAC
34607210,NCT02944396,112,paclitaxel,1,200,mg/m2,1,on Day 1 every 3 weeks for six cycles,C/PAC
34607210,NCT02944396,112,veliparib,2,80,mg,2,on Day –2 (2 days prior to start of CT) through Day 5 of each 21-day cycle for six cycles,C/PEM
34607210,NCT02944396,112,nivolumab,2,360,mg,1,"on Day 1 every 3 weeks of Cycles 1–6, then every 3 weeks until disease progression",C/PEM
34607210,NCT02944396,112,carboplatin,2,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,carboplatin,2,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,pemetrexed,2,500,mg/m2,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,veliparib,3,120,mg,2,on Day –2 (2 days prior to start of CT) through Day 5 of each 21-day cycle for six cycles,C/PEM
34607210,NCT02944396,112,nivolumab,3,360,mg,1,"on Day 1 every 3 weeks of Cycles 1–6, then every 3 weeks until disease progression",C/PEM
34607210,NCT02944396,112,carboplatin,3,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,carboplatin,3,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,pemetrexed,3,500,mg/m2,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,veliparib,4,200,mg,2,on Day –2 (2 days prior to start of CT) through Day 5 of each 21-day cycle for six cycles,C/PEM
34607210,NCT02944396,112,nivolumab,4,360,mg,1,"on Day 1 every 3 weeks of Cycles 1–6, then every 3 weeks until disease progression",C/PEM
34607210,NCT02944396,112,carboplatin,4,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,carboplatin,4,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,pemetrexed,4,500,mg/m2,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,veliparib,5,240,mg,2,on Day –2 (2 days prior to start of CT) through Day 5 of each 21-day cycle for six cycles,C/PEM
34607210,NCT02944396,112,nivolumab,5,360,mg,1,"on Day 1 every 3 weeks of Cycles 1–6, then every 3 weeks until disease progression",C/PEM
34607210,NCT02944396,112,carboplatin,5,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,carboplatin,5,6,AUC,1,on Day 1 every 3 weeks for six cycles,C/PEM
34607210,NCT02944396,112,pemetrexed,5,500,mg/m2,1,on Day 1 every 3 weeks for six cycles,C/PEM
34311345,NCT02412371,113,veliparib,1,60,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,1,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,1,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,1,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,1,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,1,120,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,1,6,AUC,1,Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,carboplatin,1,6,AUC,1,Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,paclitaxel,1,200,mg/m2,1,Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,veliparib,2,80,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,2,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,2,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,2,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,2,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,2,120,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,paclitaxel,2,200,mg/m2,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,veliparib,3,120,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,3,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,3,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,3,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,3,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,3,120,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,3,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,carboplatin,3,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,paclitaxel,3,200,mg/m2,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,veliparib,4,200,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,4,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,4,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,4,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,4,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,4,120,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,paclitaxel,4,200,mg/m2,1,on Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,veliparib,5,240,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,5,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,5,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,5,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,5,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,5,120,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,5,6,AUC,1,on Day 1 of each 21-day cycl,consolidation
34311345,NCT02412371,113,carboplatin,5,6,AUC,1,on Day 1 of each 21-day cycl,consolidation
34311345,NCT02412371,113,paclitaxel,5,200,mg/m2,1,on Day 1 of each 21-day cycl,consolidation
34311345,NCT02412371,113,veliparib,6,240,mg,2,on Day –3 throughout chemoradiotherapy until 1 day after RT completion,Concurrent CRT
34311345,NCT02412371,113,carboplatin,6,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,carboplatin,6,2,AUC,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,paclitaxel,6,45,mg/m2,1,on Day 1 of each week during RT,Concurrent CRT
34311345,NCT02412371,113,rt,6,60,Gy,NA,"in 30 daily fractions, 5 days of every 7",Concurrent CRT
34311345,NCT02412371,113,veliparib,6,240,mg,2,"Day –2 through Day 5, i.e., for 7 days, of each 21-day cycle",consolidation
34311345,NCT02412371,113,carboplatin,6,6,AUC,1,Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,carboplatin,6,6,AUC,1,Day 1 of each 21-day cycle,consolidation
34311345,NCT02412371,113,paclitaxel,6,200,mg/m2,1,Day 1 of each 21-day cycle,consolidation
16284056,NA,114,paclitaxel,1,70,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,1,1650,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,1,1650,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,paclitaxel,2,70,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,2,2000,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,2,2000,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,3,2000,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,3,2000,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,paclitaxel,4,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,4,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,4,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,paclitaxel,5,90,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,5,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,5,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,paclitaxel,6,100,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
16284056,NA,114,capecitabine,6,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
16284056,NA,114,capecitabine,6,2500,mg/m2/d,2,daily from day 1 through day 14 every 21 days,NA
31174889,NCT02092363,115,ipafricept,1,5,mg/kg,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,paclitaxel,1,175,mg/m2,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,1,5,AUC,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,1,5,AUC,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,ipafricept,2,10,mg/kg,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,paclitaxel,2,5,mg/m2,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,2,175,AUC,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,2,175,AUC,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,ipafricept,3,2,mg/kg,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,paclitaxel,3,5,mg/m2,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,3,175,AUC,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,3,175,AUC,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,ipafricept,4,4,mg/kg,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,paclitaxel,4,5,mg/m2,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,4,175,AUC,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,4,175,AUC,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,ipafricept,5,6,mg/kg,1,on Day 1 of each 21-day cycle,NA
31174889,NCT02092363,115,paclitaxel,5,5,mg/m2,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,5,175,AUC,1,on Day 3 of each 21-day cycle,NA
31174889,NCT02092363,115,carboplatin,5,175,AUC,1,on Day 3 of each 21-day cycle,NA
31190276,NCT00268905,116,eribulin,1,0.7,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,1,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,1,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,2,0.9,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,2,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,2,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,3,1.1,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,3,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,3,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,4,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,4,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,4,5,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,5,0.7,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,5,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,5,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,6,0.9,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,6,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,6,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,7,1.1,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,7,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,7,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,eribulin,8,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,8,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
31190276,NCT00268905,116,carboplatin,8,6,AUC,1,on day 1 of the21-day cycle,eribulin 1 h before (Schedule A) or 1 h after (Schedule B)
29500276,NCT01696032,117,guadecitabine,1,45,mg/m2,1,on days 1 to 5 of 28-day cycles,NA
29500276,NCT01696032,117,carboplatin,1,5,AUC,1,on day 8 of 28-day cycles,NA
29500276,NCT01696032,117,carboplatin,1,5,AUC,1,on day 8 of 28-day cycles,NA
29500276,NCT01696032,117,guadecitabine,0,30,mg/m2,1,on days 1 to 5 of 28-day cycles,NA
29500276,NCT01696032,117,carboplatin,0,4,AUC,1,on day 8 of 28-day cycles,NA
29500276,NCT01696032,117,carboplatin,0,4,AUC,1,on day 8 of 28-day cycles,NA
33539540,NCT02418624,118,carboplatin,-1,3,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,carboplatin,-1,3,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,olaparib,-1,25,mg,2,from Day 0 continuously for a21-days cycle,NA
33539540,NCT02418624,118,carboplatin,1,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,carboplatin,1,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,olaparib,1,25,mg,2,from Day 0 continuously for a21-days cycle,NA
33539540,NCT02418624,118,carboplatin,2,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,carboplatin,2,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,olaparib,2,50,mg,2,from Day 0 continuously for a21-days cycle,NA
33539540,NCT02418624,118,carboplatin,3,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,carboplatin,3,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,olaparib,3,75,mg,2,from Day 0 continuously for a21-days cycle,NA
33539540,NCT02418624,118,carboplatin,4,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,carboplatin,4,4,AUC,1,on Day 1 of the first two cycles,NA
33539540,NCT02418624,118,olaparib,4,100,mg,2,from Day 0 continuously for a21-days cycle,NA
30327308,NCT02289690,119,veliparib,1,80,mg,2,"on days - 2 to 5 (7-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,1,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,1,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,1,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,2,120,mg,2,"on days - 2 to 5 (7-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,2,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,2,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,2,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,3,160,mg,2,"on days - 2 to 5 (7-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,3,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,3,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,3,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,4,200,mg,2,"on days - 2 to 5 (7-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,4,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,4,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,4,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,5,240,mg,2,"on days - 2 to 5 (7-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,5,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,5,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,5,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,6,240,mg,2,"on days - 2 to 12 (14-day schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,6,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,6,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,6,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
30327308,NCT02289690,119,veliparib,7,240,mg,2,"on days - 2 to 19 (continuous schedule) during cycles 1, 3,and 4",NA
30327308,NCT02289690,119,carboplatin,7,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,carboplatin,7,5,AUC,1,on day 1  during 21-day cycles,NA
30327308,NCT02289690,119,etoposide,7,100,mg/m2,1,on days 1 to 3 during 21-day cycles,NA
31231786,NCT03201146,120,apatinib,3,750,mg,1,daily continuously,NA
31231786,NCT03201146,120,pemetrexed,3,500,mg/m2,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,apatinib,2,500,mg,1,daily continuously,NA
31231786,NCT03201146,120,pemetrexed,2,500,mg/m2,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,apatinib,1,500,mg,1,daily continuously 2 weeks on 1 week of,NA
31231786,NCT03201146,120,pemetrexed,1,500,mg/m2,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
31231786,NCT03201146,120,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
30174176,NA,121,paclitaxel,1,135,mg/m2,1,every 3 weeks,NA
30174176,NA,121,carboplatin,1,4,AUC,1,every 3 weeks,NA
30174176,NA,121,carboplatin,1,4,AUC,1,every 3 weeks,NA
30174176,NA,121,cisplatin,1,40,mg/m2,1,weekly for 6 weeks during the radiation therapy,NA
30174176,NA,121,cisplatin,1,40,mg/m2,1,weekly for 6 weeks during the radiation therapy,NA
30174176,NA,121,radiation,1,4500,cGy,NA,"in 30 fractions,  five consecutive day for 5 consecutive weeks",NA
30174176,NA,121,paclitaxel,2,135,mg/m2,1,every 3 weeks,NA
30174176,NA,121,carboplatin,2,5,AUC,1,every 3 weeks,NA
30174176,NA,121,carboplatin,2,5,AUC,1,every 3 weeks,NA
30174176,NA,121,cisplatin,2,40,mg/m2,NA,weekly for 6 weeks during the radiation therapy,NA
30174176,NA,121,cisplatin,2,40,mg/m2,NA,weekly for 6 weeks during the radiation therapy,NA
30174176,NA,121,radiation,2,4500,cGy,NA,"in 30 fractions,  five consecutive day for 5 consecutive weeks",NA
33634324,NCT01304303,122,picn,1,175,mg/m2,1,on Day 1 of every 3-week cycle,Part A
33634324,NCT01304303,122,picn,2,260,mg/m2,1,on Day 1 of every 3-week cycle,Part A
33634324,NCT01304303,122,picn,3,295,mg/m2,1,on Day 1 of every 3-week cycle,Part A
33634324,NCT01304303,122,picn,4,325,mg/m2,1,on Day 1 of every 3-week cycle,Part A
33634324,NCT01304303,122,picn,5,220,mg/m2,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,5,6,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,5,6,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,picn,6,260,mg/m2,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,6,6,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,6,6,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,picn,7,260,mg/m2,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,7,5,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,7,5,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,picn,8,295,mg/m2,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,8,5,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,8,5,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,picn,9,325,mg/m2,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,9,5,AUC,1,on Day 1 of every 3-week cycle,Part B
33634324,NCT01304303,122,carboplatin,9,5,AUC,1,on Day 1 of every 3-week cycle,Part B
31953695,NA,123,ro4929097,1,10,mg,1,"on days 1–3, 8–10 and 15–17 for six 21-day cycles",NA
31953695,NA,123,paclitaxel,1,80,mg/m2,1,weekly,NA
31953695,NA,123,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,ro4929097,-1,10,mg,1,"on days 1–3, 8–10 and 15–17 for six 21-day cycles",NA
31953695,NA,123,paclitaxel,-1,80,mg/m2,1,weekly,NA
31953695,NA,123,carboplatin,-1,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,carboplatin,-1,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,ro4929097,2,20,mg,1,"on days 1–3, 8–10 and 15–17 for six 21-day cycles",NA
31953695,NA,123,paclitaxel,2,80,mg/m2,1,weekly,NA
31953695,NA,123,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,ro4929097,3,30,mg,1,"on days 1–3, 8–10 and 15–17 for six 21-day cycles",NA
31953695,NA,123,paclitaxel,3,80,mg/m2,1,weekly,NA
31953695,NA,123,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,ro4929097,4,40,mg,1,"on days 1–3, 8–10 and 15–17 for six 21-day cycles",NA
31953695,NA,123,paclitaxel,4,80,mg/m2,1,weekly,NA
31953695,NA,123,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
31953695,NA,123,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
31388792,NCT00891072,124,at-101,1,40,mg,2,"on days 1, 2 and 3of each 21-day cycle",NA
31388792,NCT00891072,124,paclitaxel,1,150,mg/m2,1,on day 1 of each 21-day cycle,NA
31388792,NCT00891072,124,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
31388792,NCT00891072,124,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
31388792,NCT00891072,124,at-101,2,40,mg,2,"on days 1, 2 and 3of each 21-day cycle",NA
31388792,NCT00891072,124,paclitaxel,2,175,mg/m2,1,on day 1 of each 21-day cycle,NA
31388792,NCT00891072,124,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
31388792,NCT00891072,124,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
34052705,NCT02185690,125,binimetinib,1,30,mg,2,on days 1–14 of a 21-day cycle,NA
34052705,NCT02185690,125,carboplatin,1,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,carboplatin,1,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,pemetrexed,1,500,mg/m2,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,binimetinib,2,45,mg,2,on days 1–14 of a 21-day cycle,NA
34052705,NCT02185690,125,carboplatin,2,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,carboplatin,2,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,pemetrexed,2,500,mg/m2,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,binimetinib,-1,30,mg,2,on days 1–14 of a 21-day cycle,NA
34052705,NCT02185690,125,carboplatin,-1,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,carboplatin,-1,5,AUC,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
34052705,NCT02185690,125,pemetrexed,-1,500,mg/m2,1,"on day 8 of  the first 21-day cyccle, on day 1 of each subsequent cycle",NA
31708167,NCT00989651,126,veliparib,1,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,1,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,1,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,1,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,2,50,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,2,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,2,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,2,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,2,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,3,80,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,3,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,3,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,3,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,3,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,4,100,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,4,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,4,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,4,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,4,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,5,150,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,5,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,5,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,5,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,5,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,6,200,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,6,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,6,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,6,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,6,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,7,250,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,7,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,7,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,7,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,7,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,8,300,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,8,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,8,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,8,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,8,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,9,350,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,9,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,9,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,9,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,9,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,10,400,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 1
31708167,NCT00989651,126,paclitaxel,10,175,mg/m2,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,10,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,carboplatin,10,6,AUC,1,day 1 every 21 days,regimen 1
31708167,NCT00989651,126,bevacizumab,10,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 1
31708167,NCT00989651,126,veliparib,1,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,1,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,1,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,1,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,2,50,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,2,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,2,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,2,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,3,80,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,3,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,3,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,3,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,4,100,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,4,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,4,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,4,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,4,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,5,150,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,5,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,5,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,5,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,5,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,6,200,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,6,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,6,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,6,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,6,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,7,250,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,7,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,7,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,7,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,7,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,8,300,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,8,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,8,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,8,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,8,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,9,350,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,9,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,9,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,9,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,9,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,10,400,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 2
31708167,NCT00989651,126,paclitaxel,10,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",regimen 2
31708167,NCT00989651,126,carboplatin,10,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,carboplatin,10,6,AUC,1,day 1 every 21 days,regimen 2
31708167,NCT00989651,126,bevacizumab,10,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 2
31708167,NCT00989651,126,veliparib,1,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,1,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,1,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,1,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,1,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,2,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,2,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,2,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,2,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,2,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,3,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,3,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,3,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,3,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,3,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,4,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,4,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,4,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,4,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,4,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,5,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,5,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,5,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,5,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,5,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,6,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,6,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,6,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,6,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,6,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,7,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,7,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,7,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,7,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,7,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,8,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,8,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,8,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,8,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,8,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,9,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,9,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,9,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,9,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,9,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
31708167,NCT00989651,126,veliparib,10,30,mg,2,continuous (c) ) days 1-21 or intermittent (i)  days -2 to 5 every 21 days,regimen 3
31708167,NCT00989651,126,paclitaxel,10,135,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,10,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,cisplatin,10,75,mg/m2,1,day 1 every 21 days,regimen 3
31708167,NCT00989651,126,bevacizumab,10,15,mg/kg,1,day 1 (starting cycle 2) every 21 days,regimen 3
30088048,NCT00809133,127,afatinib,1,20,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,1,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,1,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,afatinib,2,40,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,afatinib,3,20,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,3,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,3,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,paclitaxel,3,175,mg/m2,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,afatinib,4,20,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,paclitaxel,4,175,mg/m2,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,afatinib,5,30,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,5,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,5,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,paclitaxel,5,175,mg/m2,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,afatinib,6,40,mg,1,"daily, beginning on Day 2 of Cycle 1 in 21-day cycles",NA
30088048,NCT00809133,127,carboplatin,6,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,carboplatin,6,5,AUC,1,on Day 1 of each 21-day cycle,NA
30088048,NCT00809133,127,paclitaxel,6,175,mg/m2,1,on Day 1 of each 21-day cycle,NA
33513474,NCT01711541,128,veliparib,1,200,mg,2,days 1–7 every 21 days,NA
33513474,NCT01711541,128,paclitaxel,1,100,mg/m2,1,"days 1, 8, and 15 every 21 days",NA
33513474,NCT01711541,128,carboplatin,1,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,carboplatin,1,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,veliparib,2,250,mg,2,days 1–7 every 21 days,NA
33513474,NCT01711541,128,paclitaxel,2,100,mg/m2,1,"days 1, 8, and 15 every 21 days",NA
33513474,NCT01711541,128,carboplatin,2,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,carboplatin,2,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,veliparib,3,300,mg,2,days 1–7 every 21 days,NA
33513474,NCT01711541,128,paclitaxel,3,100,mg/m2,1,"days 1, 8, and 15 every 21 days",NA
33513474,NCT01711541,128,carboplatin,3,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,carboplatin,3,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,veliparib,4,350,mg,2,days 1–7 every 21 days,NA
33513474,NCT01711541,128,paclitaxel,4,100,mg/m2,1,"days 1, 8, and 15 every 21 days",NA
33513474,NCT01711541,128,carboplatin,4,6,AUC,1,day 1 every 21 days,NA
33513474,NCT01711541,128,carboplatin,4,6,AUC,1,day 1 every 21 days,NA
31791552,NCT01663857,130,ralimetinib,1,200,mg,2,on Days 1-10 of a 21-day cycle,NA
31791552,NCT01663857,130,gemcitabine,1,1000,mg/m2,1,on Days 3and 10 of a 21-day cycle,NA
31791552,NCT01663857,130,carboplatin,1,4,AUC,1,on Day 3 of a 21-day cycle,NA
31791552,NCT01663857,130,carboplatin,1,4,AUC,1,on Day 3 of a 21-day cycle,NA
31791552,NCT01663857,130,ralimetinib,2,300,mg,2,on Days 1-10 of a 21-day cycle,NA
31791552,NCT01663857,130,gemcitabine,2,1000,mg/m2,1,on Days 3and 10 of a 21-day cycle,NA
31791552,NCT01663857,130,carboplatin,2,4,AUC,1,on Day 3 of a 21-day cycle,NA
31791552,NCT01663857,130,carboplatin,2,4,AUC,1,on Day 3 of a 21-day cycle,NA
31446228,NCT01868022,131,gsk3052230,1,10,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm A
31446228,NCT01868022,131,paclitaxel,1,200,mg/m2,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,1,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,1,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,gsk3052230,2,10,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm A
31446228,NCT01868022,131,paclitaxel,2,200,mg/m2,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,2,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,2,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,gsk3052230,3,20,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm A
31446228,NCT01868022,131,paclitaxel,3,200,mg/m2,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,3,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,3,6,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,gsk3052230,-1,5,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm A
31446228,NCT01868022,131,paclitaxel,-1,175,mg/m2,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,-1,5,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,-1,5,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,gsk3052230,-2,5,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm A
31446228,NCT01868022,131,paclitaxel,-2,135,mg/m2,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,-2,4,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,carboplatin,-2,4,AUC,1,on day 1 every 21 days,Arm A
31446228,NCT01868022,131,gsk3052230,1,5,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm B
31446228,NCT01868022,131,paclitaxel,1,200,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,1,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,1,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,docetaxel,1,75,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,gsk3052230,2,10,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm B
31446228,NCT01868022,131,paclitaxel,2,200,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,2,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,2,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,docetaxel,2,75,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,gsk3052230,3,20,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm B
31446228,NCT01868022,131,paclitaxel,3,200,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,3,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,3,6,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,docetaxel,3,75,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,gsk3052230,-1,5,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm B
31446228,NCT01868022,131,paclitaxel,-1,175,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,-1,5,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,-1,5,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,docetaxel,-1,55,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,gsk3052230,-2,5,mg/kg,1,"on days 1, 8, and 15 every 21 days",Arm B
31446228,NCT01868022,131,paclitaxel,-2,135,mg/m2,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,-2,4,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,carboplatin,-2,4,AUC,1,on day 1 every 21 days,Arm B
31446228,NCT01868022,131,docetaxel,-2,40,mg/m2,1,on day 1 every 21 days,Arm B
30596402,NCT01165112,132,bendamustine,1,60,mg/m2,1,on days 1 and 2 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,etoposide,1,100,mg/m2,1,on days 1–3 of each 21-day cycle,NA
30596402,NCT01165112,132,bendamustine,2,80,mg/m2,1,on days 1 and 2 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,etoposide,2,100,mg/m2,1,on days 1–3 of each 21-day cycle,NA
30596402,NCT01165112,132,bendamustine,3,100,mg/m2,1,on days 1 and 2 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,etoposide,3,100,mg/m2,1,on days 1–3 of each 21-day cycle,NA
30596402,NCT01165112,132,bendamustine,4,120,mg/m2,1,on days 1 and 2 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,4,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,carboplatin,4,5,AUC,1,on day 1 of each 21-day cycle,NA
30596402,NCT01165112,132,etoposide,4,100,mg/m2,1,on days 1–3 of each 21-day cycle,NA
32665311,NCT01934361,133,buparlisib,1,80,mg,1,continuous daily,NA
32665311,NCT01934361,133,carboplatin,1,5,AUC,1,every 3 weeks,NA
32665311,NCT01934361,133,carboplatin,1,5,AUC,1,every 3 weeks,NA
32665311,NCT01934361,133,buparlisib,2,100,mg,1,continuous daily,NA
32665311,NCT01934361,133,carboplatin,2,5,AUC,1,every 3 weeks,NA
32665311,NCT01934361,133,carboplatin,2,5,AUC,1,every 3 weeks,NA
32665311,NCT01934361,133,buparlisib,3,60,mg,1,continuous daily,NA
32665311,NCT01934361,133,lomustine,3,100,mg/m2,1,every 6 weeks in a 42 day cycles,NA
30842183,NA,134,carboplatin,0,5,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,carboplatin,0,5,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,nab-paclitaxel,0,100,mg/m2,1,on days 1 and 8 every 21 days,NA
30842183,NA,134,carboplatin,-1,5,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,carboplatin,-1,5,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,nab-paclitaxel,-1,75,mg/m2,1,on days 1 and 8 every 21 days,NA
30842183,NA,134,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
30842183,NA,134,nab-paclitaxel,1,100,mg/m2,1,on days 1 and 8 every 21 days,NA
28790114,NCT02358200,135,talazoparib,1,0.75,mg,1,daily,NA
28790114,NCT02358200,135,carboplatin,1,1.5,AUC,1,"weekly, 2 weeks out of a 3-week cycle",NA
28790114,NCT02358200,135,carboplatin,1,1.5,AUC,1,"weekly, 2 weeks out of a 3-week cycle",NA
28790114,NCT02358200,135,talazoparib,2,1,mg,1,daily,NA
28790114,NCT02358200,135,carboplatin,2,1.5,AUC,1,"weekly, 2 weeks out of a 3-week cycle",NA
28790114,NCT02358200,135,carboplatin,2,1.5,AUC,1,"weekly, 2 weeks out of a 3-week cycle",NA
28790114,NCT02358200,135,talazoparib,3,1,mg,1,daily,NA
28790114,NCT02358200,135,carboplatin,3,1.5,AUC,1,weekly of a 3-week cycle,NA
28790114,NCT02358200,135,carboplatin,3,1.5,AUC,1,weekly of a 3-week cycle,NA
28790114,NCT02358200,135,talazoparib,3.5,1,mg,1,"daily, 2 weeks out of a 3-week cycle",NA
28790114,NCT02358200,135,carboplatin,3.5,1.5,AUC,1,weekly of a 3-week cycle,NA
28790114,NCT02358200,135,carboplatin,3.5,1.5,AUC,1,weekly of a 3-week cycle,NA
28356425,NCT01149083,136,veliparib,1,50,mg,2,daily continuously,NA
28356425,NCT01149083,136,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,veliparib,2,50,mg,2,daily continuously,NA
28356425,NCT01149083,136,carboplatin,2,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,carboplatin,2,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,veliparib,3,100,mg,2,daily continuously,NA
28356425,NCT01149083,136,carboplatin,3,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,carboplatin,3,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,veliparib,4,150,mg,2,daily continuously,NA
28356425,NCT01149083,136,carboplatin,4,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,carboplatin,4,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,veliparib,5,200,mg,2,daily continuously,NA
28356425,NCT01149083,136,carboplatin,5,5,AUC,1,on day 1 of a 21-day cycle,NA
28356425,NCT01149083,136,carboplatin,5,5,AUC,1,on day 1 of a 21-day cycle,NA
32669375,NCT01590160,137,cisplatin,1,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,cisplatin,1,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,pemetrexed,1,500,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,ganetespib,1,100,mg/m2,1,on day 1 and day 15 of each 21-day cycle,cisplatin cohort
32669375,NCT01590160,137,cisplatin,2,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,cisplatin,2,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,pemetrexed,2,500,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,ganetespib,2,150,mg/m2,1,on day 1 and day 15 of each 21-day cycle,cisplatin cohort
32669375,NCT01590160,137,cisplatin,3,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,cisplatin,3,75,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,pemetrexed,3,500,mg/m2,1,Day 1 every 21 days,cisplatin cohort
32669375,NCT01590160,137,ganetespib,3,200,mg/m2,1,on day 1 and day 15 of each 21-day cycle,cisplatin cohort
32669375,NCT01590160,137,carboplatin,1,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,carboplatin,1,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,pemetrexed,1,500,mg/m2,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,ganetespib,1,100,mg/m2,1,on day 1 and day 15 of each 21-day cycle,carboplatin cohort
32669375,NCT01590160,137,carboplatin,2,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,carboplatin,2,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,pemetrexed,2,500,mg/m2,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,ganetespib,2,150,mg/m2,1,on day 1 and day 15 of each 21-day cycle,carboplatin cohort
32669375,NCT01590160,137,carboplatin,3,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,carboplatin,3,5,AUC,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,pemetrexed,3,500,mg/m2,1,Day 1 every 21 days,carboplatin cohort
32669375,NCT01590160,137,ganetespib,3,200,mg/m2,1,on day 1 and day 15 of each 21-day cycle,carboplatin cohort
30383888,NCT01636622,138,vemurafenib,1,480,mg,2,daily for 21 days,NA
30383888,NCT01636622,138,paclitaxel,1,100,mg/m2,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,1,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,1,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,vemurafenib,2,720,mg,2,daily for 21 days,NA
30383888,NCT01636622,138,paclitaxel,2,100,mg/m2,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,2,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,2,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,vemurafenib,3,720,mg,2,daily for 21 days,NA
30383888,NCT01636622,138,paclitaxel,3,135,mg/m2,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,3,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,3,5,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,vemurafenib,4,720,mg,2,daily for 21 days,NA
30383888,NCT01636622,138,paclitaxel,4,135,mg/m2,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,4,6,AUC,1,on day 1 of the 21-day cycle,NA
30383888,NCT01636622,138,carboplatin,4,6,AUC,1,on day 1 of the 21-day cycle,NA
31549216,NCT00535119,1,veliparib,1,10,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,1,150,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,1,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,1,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,2,20,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,2,150,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,2,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,2,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,3,20,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,3,175,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,3,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,3,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,4,40,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,4,175,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,4,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,4,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,5,40,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,5,200,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,5,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,5,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,6,50,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,6,200,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,6,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,6,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,7,80,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,7,200,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,7,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,7,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,7.5,100,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,7.5,200,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,7.5,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,7.5,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,veliparib,8,120,mg,2,on days 1–7 of each 21-day cycle except for cycle 1,NA
31549216,NCT00535119,1,paclitaxel,8,200,mg/m2,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,8,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
31549216,NCT00535119,1,carboplatin,8,6,AUC,1,on day 1 of cycle 1 and on day 3 of cycle 2 onward,NA
32534811,NA,2,lifastuzumab vedotin,1,1.2,mg/kg,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,1,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,1,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,lifastuzumab vedotin,2,1.8,mg/kg,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,2,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,2,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,lifastuzumab vedotin,3,2.4,mg/kg,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,3,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,3,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,lifastuzumab vedotin,4,2.4,mg/kg,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,4,6,AUC,1,on the first day of 21-day cycles,NA
32534811,NA,2,carboplatin,4,6,AUC,1,on the first day of 21-day cycles,NA
29352572,NCT01063816,3,veliparib,1,30,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,1,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,1,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,1,1000,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,2,30,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,2,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,2,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,2,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,3,60,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,3,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,3,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,3,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,4,80,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,4,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,4,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,4,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,5,140,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,5,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,5,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,5,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,6,210,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,6,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,6,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,6,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,7,310,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,7,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,7,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,7,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
29352572,NCT01063816,3,veliparib,8,250,mg,2,continuously beginning in C2,NA
29352572,NCT01063816,3,carboplatin,8,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,carboplatin,8,4,AUC,1,on D1 of each 21-day cycle,NA
29352572,NCT01063816,3,gemcitabine,8,800,mg/m2,1,on D1 and D8 of each 21-day cycle,NA
32146550,NCT02312661,7,carboplatin,-1,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,carboplatin,-1,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,paclitaxel,-1,175,mg/m2,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,metformin,-1,500,mg,2,on day3 of cycle 1 and continued until 3 weeks after the last chemotherapy administration,NA
32146550,NCT02312661,7,carboplatin,1,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,carboplatin,1,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,paclitaxel,1,175,mg/m2,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,metformin,1,500,mg,3,on day3 of cycle 1 and continued until 3 weeks after the last chemotherapy administration,NA
32146550,NCT02312661,7,carboplatin,2,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,carboplatin,2,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,paclitaxel,2,175,mg/m2,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,metformin,2,850,mg,3,on day3 of cycle 1 and continued until 3 weeks after the last chemotherapy administration,NA
32146550,NCT02312661,7,carboplatin,3,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,carboplatin,3,6,AUC,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,paclitaxel,3,175,mg/m2,1,on day 1 of every 3-week cycle,NA
32146550,NCT02312661,7,metformin,3,1000,mg,3,on day3 of cycle 1 and continued until 3 weeks after the last chemotherapy administration,NA
28413662,UMIN000007600,8,nab-paclitaxel,1,220,mg/m2,1,every 3 weeks,NA
28413662,UMIN000007600,8,carboplatin,1,6,AUC,1,every 3 weeks,NA
28413662,UMIN000007600,8,carboplatin,1,6,AUC,1,every 3 weeks,NA
28413662,UMIN000007600,8,trastuzumab,1,8,mg/kg,1,every 3 weeks,NA
28413662,UMIN000007600,8,nab-paclitaxel,2,260,mg/m2,1,every 3 weeks,NA
28413662,UMIN000007600,8,carboplatin,2,6,AUC,1,every 3 weeks,NA
28413662,UMIN000007600,8,carboplatin,2,6,AUC,1,every 3 weeks,NA
28413662,UMIN000007600,8,trastuzumab,2,6,mg/kg,1,every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,1,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,1,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,paclitaxel,1,175,mg/m2,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,ridaforolimus,1,10,mg,1,"on days 2–5, days 8–12, and days 15–19 during the first cycle of therapy and then 5 days a week (days 1–5, days 8–12, and days 15– 19) throughout the remainder of therapy beginning with the second cycle of therapy",NA
28595616,NCT01256268,9,carboplatin,1.5,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,1.5,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,paclitaxel,1.5,175,mg/m2,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,ridaforolimus,1.5,10,mg,1,"on days 2–5, and days 8–12 during the first cycle of therapy and then 5 days a week (days 1–5, days 8–12, and days 15– 19) throughout the remainder of therapy beginning with the second cycle of therapy",NA
28595616,NCT01256268,9,carboplatin,2,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,2,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,paclitaxel,2,175,mg/m2,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,ridaforolimus,2,20,mg,1,"on days 2–5, and days 8–12 during the first cycle of therapy and then 5 days a week (days 1–5, days 8–12, and days 15– 19) throughout the remainder of therapy beginning with the second cycle of therapy",NA
28595616,NCT01256268,9,carboplatin,3,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,3,5,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,paclitaxel,3,175,mg/m2,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,ridaforolimus,3,30,mg,1,"on days 2–5, and days 8–12 during the first cycle of therapy and then 5 days a week (days 1–5, days 8–12, and days 15– 19) throughout the remainder of therapy beginning with the second cycle of therapy",NA
28595616,NCT01256268,9,carboplatin,4,6,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,carboplatin,4,6,AUC,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,paclitaxel,4,175,mg/m2,1,day 1 every 3 weeks,NA
28595616,NCT01256268,9,ridaforolimus,4,30,mg,1,"on days 2–5, and days 8–12 during the first cycle of therapy and then 5 days a week (days 1–5, days 8–12, and days 15– 19) throughout the remainder of therapy beginning with the second cycle of therapy",NA
33147935,NCT03212937,10,selinexor,1,40,mg,1,"on days 3, 5 and 7 in a 21-day cycle",NA
33147935,NCT03212937,10,dexamethasone,1,20,mg,1,on days 3-7 in a21-day cycle,NA
33147935,NCT03212937,10,ifosfamide,1,5000,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,1,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,1,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,etoposide,1,100,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,selinexor,2,60,mg,1,"on days 3, 5 and 7 in a 21-day cycle",NA
33147935,NCT03212937,10,dexamethasone,2,20,mg,1,on days 3-7 in a21-day cycle,NA
33147935,NCT03212937,10,ifosfamide,2,5000,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,2,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,2,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,etoposide,2,100,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,selinexor,3,80,mg,1,"on days 3, 5 and 7 in a 21-day cycle",NA
33147935,NCT03212937,10,dexamethasone,3,20,mg,1,on days 3-7 in a21-day cycle,NA
33147935,NCT03212937,10,ifosfamide,3,5000,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,3,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,3,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,etoposide,3,100,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,selinexor,-1,20,mg,1,"on days 3, 5 and 7 in a 21-day cycle",NA
33147935,NCT03212937,10,dexamethasone,-1,20,mg,1,on days 3-7 in a21-day cycle,NA
33147935,NCT03212937,10,ifosfamide,-1,5000,mg/m2,1,on days 1-3 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,-1,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,carboplatin,-1,5,AUC,1,on day 1 in a 21-day cycle,NA
33147935,NCT03212937,10,etoposide,-1,100,mg/m2,1,on days 1-3 in a 21-day cycle,NA
32452601,NCT01251874,11,veliparib,1,50,mg,2,1–7 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,1,6,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,1,6,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,1.5,50,mg,2,1–7 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,1.5,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,1.5,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,2,50,mg,2,1–4 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,2,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,2,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,3,100,mg,2,1–4 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,3,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,3,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,4,150,mg,2,1–4 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,4,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,4,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,5,200,mg,2,1–4 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,5,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,5,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,6,200,mg,2,1–21 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,6,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,6,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,veliparib,7,250,mg,2,1–21 days of 21-day cycles,NA
32452601,NCT01251874,11,carboplatin,7,5,AUC,1,every 3 weeks,NA
32452601,NCT01251874,11,carboplatin,7,5,AUC,1,every 3 weeks,NA
32568634,NCT02157792,12,m6620,1,60,mg/m2,1,once weekly in 21-day cycles,Part A
32568634,NCT02157792,12,m6620,2,120,mg/m2,1,once weekly in 21-day cycles,Part A
32568634,NCT02157792,12,m6620,3,240,mg/m2,1,once weekly in 21-day cycles,Part A
32568634,NCT02157792,12,m6620,4,480,mg/m2,1,once weekly in 21-day cycles,Part A
32568634,NCT02157792,12,m6620,5,240,mg/m2,1,"on days 1 and 4, 8 and 11, and 15 and 18 of a 21-day cycle",Part A
32568634,NCT02157792,12,m6620,1,240,mg/m2,1,on days 2 and 9 weekly in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,1,5,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,1,5,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,m6620,2,120,mg/m2,1,on days 2 and 9 weekly in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,2,5,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,2,5,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,m6620,3,120,mg/m2,1,on days 2 and 9 weekly in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,3,4,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,3,4,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,m6620,4,90,mg/m2,1,on days 2 and 9 weekly in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,4,5,AUC,1,on day 1 in 21-day cycles,Part B
32568634,NCT02157792,12,carboplatin,4,5,AUC,1,on day 1 in 21-day cycles,Part B
33373402,NCT01644955,13,carboplatin,1,1,ug,1,every 28 days,NA
33373402,NCT01644955,13,carboplatin,1,1,ug,1,every 28 days,NA
33373402,NCT01644955,13,carboplatin,2,2,ug,1,every 28 days,NA
33373402,NCT01644955,13,carboplatin,2,2,ug,1,every 28 days,NA
33373402,NCT01644955,13,carboplatin,3,4,ug,1,every 28 days,NA
33373402,NCT01644955,13,carboplatin,3,4,ug,1,every 28 days,NA
31080557,NCT01445418,14,olaparib,1,400,mg,1,on days 1–7 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,1,3,AUC,1,on day 1 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,1,3,AUC,1,on day 1 of each 21-day cycle,NA
31080557,NCT01445418,14,olaparib,2,400,mg,1,on days 1–7 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,2,4,AUC,1,on day 1 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,2,4,AUC,1,on day 1 of each 21-day cycle,NA
31080557,NCT01445418,14,olaparib,3,400,mg,1,on days 1–7 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
31080557,NCT01445418,14,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
32559454,UMIN000011216,15,carboplatin,1,5,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,carboplatin,1,5,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
32559454,UMIN000011216,15,carboplatin,0,4,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,carboplatin,0,4,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,nab-paclitaxel,0,100,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
32559454,UMIN000011216,15,carboplatin,2,6,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,carboplatin,2,6,AUC,1,on day 1 every 4 weeks,NA
32559454,UMIN000011216,15,nab-paclitaxel,2,100,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
30563934,NCT01653912,16,afuresertib,1,50,mg,1,daily,NA
30563934,NCT01653912,16,carboplatin,1,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,carboplatin,1,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,paclitaxel,1,175,mg/m2,1,every 3 weeks,NA
30563934,NCT01653912,16,afuresertib,1.5,75,mg,1,daily,NA
30563934,NCT01653912,16,carboplatin,1.5,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,carboplatin,1.5,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,paclitaxel,1.5,175,mg/m2,1,every 3 weeks,NA
30563934,NCT01653912,16,afuresertib,2,100,mg,1,daily,NA
30563934,NCT01653912,16,carboplatin,2,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,carboplatin,2,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,paclitaxel,2,175,mg/m2,1,every 3 weeks,NA
30563934,NCT01653912,16,afuresertib,3,125,mg,1,daily,NA
30563934,NCT01653912,16,carboplatin,3,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,carboplatin,3,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,paclitaxel,3,175,mg/m2,1,every 3 weeks,NA
30563934,NCT01653912,16,afuresertib,4,150,mg,1,daily,NA
30563934,NCT01653912,16,carboplatin,4,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,carboplatin,4,5,AUC,1,every 3 weeks,NA
30563934,NCT01653912,16,paclitaxel,4,175,mg/m2,1,every 3 weeks,NA
29781056,NCT01862328,17,pevonedistat,1,15,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 1
29781056,NCT01862328,17,docetaxel,1,75,mg/m2,1,on day 1 of 21-day cycles,Arm 1
29781056,NCT01862328,17,pevonedistat,2,25,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 1
29781056,NCT01862328,17,docetaxel,2,75,mg/m2,1,on day 1 of 21-day cycles,Arm 1
29781056,NCT01862328,17,pevonedistat,1,15,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 2a
29781056,NCT01862328,17,carboplatin,1,6,AUC,1,on day 1 of 21-day cycles,Arm 2a
29781056,NCT01862328,17,carboplatin,1,6,AUC,1,on day 1 of 21-day cycles,Arm 2a
29781056,NCT01862328,17,pevonedistat,1,15,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 2
29781056,NCT01862328,17,carboplatin,1,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,carboplatin,1,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,paclitaxel,1,175,mg/m2,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,pevonedistat,2,25,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 2
29781056,NCT01862328,17,carboplatin,2,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,carboplatin,2,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,paclitaxel,2,175,mg/m2,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,pevonedistat,3,20,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 2
29781056,NCT01862328,17,carboplatin,3,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,carboplatin,3,5,AUC,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,paclitaxel,3,175,mg/m2,1,on day 1 of 21-day cycles,Arm 2
29781056,NCT01862328,17,pevonedistat,1,25,mg/m2,1,"on days 1, 3, and 5 of 21-day cycles",Arm 3
29781056,NCT01862328,17,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of 28-day cycles",Arm 3
30089585,NCT01573338,18,roniciclib,1,2.5,mg,2,"on days 1-3, 8-10, and 15-17 of each 21-day cycle",CIS-ETOP
30089585,NCT01573338,18,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,etoposide,1,100,mg/m2,1,on days 1–3 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,roniciclib,2,5,mg,2,"on days 1-3, 8-10, and 15-17 of each 21-day cycle",CIS-ETOP
30089585,NCT01573338,18,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,etoposide,2,100,mg/m2,1,on days 1–3 of each 21-day cycle,CIS-ETOP
30089585,NCT01573338,18,roniciclib,1,2.5,mg,2,"on days 1-3, 8-10, and 15-17 of each 21-day cycle",CARBO-ETOP
30089585,NCT01573338,18,carboplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,CARBO-ETOP
30089585,NCT01573338,18,carboplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,CARBO-ETOP
30089585,NCT01573338,18,etoposide,1,100,mg/m2,1,on days 1–3 of each 21-day cycle,CARBO-ETOP
30089585,NCT01573338,18,roniciclib,2,5,mg,2,"on days 1-3, 8-10, and 15-17 of each 21-day cycle",CARBO-ETOP
30089585,NCT01573338,18,carboplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,CARBO-ETOP
30089585,NCT01573338,18,carboplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,CARBO-ETOP
30089585,NCT01573338,18,etoposide,2,100,mg/m2,1,on days 1–3 of each 21-day cycle,CARBO-ETOP
28792260,NCT01169636,19,panobinostat,0,20,mg,1,"Starting Day -6 of Cycle 1 on Monday, Wednesday, and Friday during Cycles 1 and (Days -6, -4, and -2 of Cycle 1 and Days 1, 3, 5, 8, 10, and 12 of Cycles 1 and 2)",NA
28792260,NCT01169636,19,ifosfamide,0,5,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,mesna,0,2,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,0,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,0,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,etoposide,0,100,mg/m2,1,"Days 1,3 of Cycles 1-3",NA
28792260,NCT01169636,19,panobinostat,1,30,mg,1,"Starting Day -6 of Cycle 1 on Monday, Wednesday, and Friday during Cycles 1 and (Days -6, -4, and -2 of Cycle 1 and Days 1, 3, 5, 8, 10, and 12 of Cycles 1 and 2)",NA
28792260,NCT01169636,19,ifosfamide,1,5,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,mesna,1,2,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,1,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,1,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,etoposide,1,100,mg/m2,1,"Days 1,3 of Cycles 1-3",NA
28792260,NCT01169636,19,panobinostat,-1,10,mg,1,"Starting Day -6 of Cycle 1 on Monday, Wednesday, and Friday during Cycles 1 and (Days -6, -4, and -2 of Cycle 1 and Days 1, 3, 5, 8, 10, and 12 of Cycles 1 and 2)",NA
28792260,NCT01169636,19,ifosfamide,-1,5,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,mesna,-1,2,mg/m2,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,-1,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,carboplatin,-1,5,AUC,1,Day 1 of Cycles 1-3,NA
28792260,NCT01169636,19,etoposide,-1,100,mg/m2,1,"Days 1,3 of Cycles 1-3",NA
30552156,NCT01844947,20,vinflunine,1,320,mg/m2,1,on day 1 every 3 weeks,NA
30552156,NCT01844947,20,sorafenib,1,200,mg,2,on days 2–21 every 3 weeks,NA
30552156,NCT01844947,20,vinflunine,-1,280,mg/m2,1,on day 1 every 3 weeks,NA
30552156,NCT01844947,20,sorafenib,-1,200,mg,2,on days 2–21 every 3 weeks,NA
30552156,NCT01844947,20,vinflunine,2,280,mg/m2,1,on day 1 every 3 weeks,NA
30552156,NCT01844947,20,sorafenib,2,300,mg,2,on days 2–21 every 3 weeks,NA
30552156,NCT01844947,20,vinflunine,3,280,mg/m2,1,on day 1 every 3 weeks,NA
30552156,NCT01844947,20,sorafenib,3,400,mg,2,on days 2–21 every 3 weeks,NA
26403509,NCT01287520,21,ly2090314,1,10,mg,1,"on Day 1 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,1,500,mg/m2,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,1,5,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,1,5,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,2,10,mg,1,"on Day 1 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,2,500,mg/m2,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,2,6,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,2,6,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,3,20,mg,1,"on Day 1 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,3,500,mg/m2,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,3,6,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,3,6,AUC,1,"on Days 1 and 8 of the first 28-day cycle, and subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,4,40,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,4,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,4,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,4,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,5,80,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,5,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,5,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,5,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,6,120,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,6,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,6,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,6,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,7,80,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,7,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,7,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,7,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ranitidine premedication,7,50,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,8,60,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,8,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,8,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,8,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ranitidine premedication,8,50,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,ly2090314,9,40,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
26403509,NCT01287520,21,pemetrexed,9,500,mg/m2,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,9,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,carboplatin,9,6,AUC,1,"on Day 8 of the first 28-day cycle, and day 1 of the subsequent 21-day cycles",NA
26403509,NCT01287520,21,ranitidine premedication,9,50,mg,1,"on Days 1 and 8 of the first 28-day cycle, and on C3D1 and beyond 21-day cycles",NA
22988282,NA,22,radiation,1,2,Gy,1,"five daily per week for 6 weeks, and one day in week 7",NA
22988282,NA,22,vinorelbine,1,25,mg/m2,1,"on d1, d8 repeated every 28 d",NA
22988282,NA,22,carboplatin,1,5,AUC,1,"on d8, repeated every 28 d",NA
22988282,NA,22,carboplatin,1,5,AUC,1,"on d8, repeated every 28 d",NA
22988282,NA,22,radiation,2,2,Gy,1,"five daily per week for 6 weeks, and 3 days in week 7",NA
22988282,NA,22,vinorelbine,2,25,mg/m2,1,"on d1, d8 repeated every 28 d",NA
22988282,NA,22,carboplatin,2,5,AUC,1,"on d8, repeated every 28 d",NA
22988282,NA,22,carboplatin,2,5,AUC,1,"on d8, repeated every 28 d",NA
22988282,NA,22,radiation,3,2,Gy,1,"five daily per week for 6 weeks, and five days in week 7",NA
22988282,NA,22,vinorelbine,3,25,mg/m2,1,"on d1, d8 repeated every 28 d",NA
22988282,NA,22,carboplatin,3,5,AUC,1,"on d8, repeated every 28 d",NA
22988282,NA,22,carboplatin,3,5,AUC,1,"on d8, repeated every 28 d",NA
27323902, NCT02418624,23,carboplatin,1,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,carboplatin,1,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,NA,25,mg,2,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,1,300,mg,2,on day 1 every 3 weeks after cycle 2,NA
27323902, NCT02418624,23,carboplatin,2,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,carboplatin,2,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,2,50,mg,2,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,2,300,mg,2,on day 1 every 3 weeks after cycle 2,NA
27323902, NCT02418624,23,carboplatin,3,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,carboplatin,3,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,3,75,mg,2,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,3,300,mg,2,on day 1 every 3 weeks after cycle 2,NA
27323902, NCT02418624,23,carboplatin,4,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,carboplatin,4,4,AUC,1,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,4,100,mg,2,on day 1 of cycles 1 and 2 (every 3 weeks),NA
27323902, NCT02418624,23,olaparib,4,300,mg,2,on day 1 every 3 weeks after cycle 2,NA
26705063,NCT01732640,24,afatinib,1,20,mg,1,continuous daily for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,1,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,1,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,paclitaxel,1,175,mg/m2,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,afatinib,2,30,mg,1,continuous daily for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,2,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,2,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,paclitaxel,2,175,mg/m2,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,afatinib,3,40,mg,1,continuous daily for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,3,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,carboplatin,3,6,AUC,0,Day 1 every 21 days for 2 cycles,NA
26705063,NCT01732640,24,paclitaxel,3,175,mg/m2,0,Day 1 every 21 days for 2 cycles,NA
23835505,NA,25,intensity-modulated pelvic radiotherapy,1,50.4,Gy,NA,NA,NA
23835505,NA,25,carboplatin,1,2,AUC,1,weekly,NA
23835505,NA,25,carboplatin,1,2,AUC,1,weekly,NA
23835505,NA,25,paclitaxel,1,35,mg/m2,1,weekly,NA
23835505,NA,25,intensity-modulated pelvic radiotherapy,2,50.4,Gy,NA,NA,NA
23835505,NA,25,carboplatin,2,2,AUC,1,weekly,NA
23835505,NA,25,carboplatin,2,2,AUC,1,weekly,NA
23835505,NA,25,paclitaxel,2,40,mg/m2,1,weekly,NA
23835505,NA,25,intensity-modulated pelvic radiotherapy,3,50.4,Gy,NA,NA,NA
23835505,NA,25,carboplatin,3,2,AUC,1,weekly,NA
23835505,NA,25,carboplatin,3,2,AUC,1,weekly,NA
23835505,NA,25,paclitaxel,3,45,mg/m2,1,weekly,NA
23835505,NA,25,intensity-modulated pelvic radiotherapy,4,50.4,Gy,NA,NA,NA
23835505,NA,25,carboplatin,4,2,AUC,1,weekly,NA
23835505,NA,25,carboplatin,4,2,AUC,1,weekly,NA
23835505,NA,25,paclitaxel,4,50,mg/m2,1,weekly,NA
22644799,NCT01016769,26,temsirolimus,1,15,mg,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,1,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,1,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,paclitaxel,1,80,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,temsirolimus,2,20,mg,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,2,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,2,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,paclitaxel,2,80,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,temsirolimus,3,25,mg,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,3,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,carboplatin,3,1.5,AUC,1,on days 1 and 8 of a 21-day cycle,NA
22644799,NCT01016769,26,paclitaxel,3,80,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
27551000,NA,27,veliparib,1,10,mg,2,on days 1–8 of each 21-day cycle,NA
27551000,NA,27,topotecan,1,1,mg/m2,1,on days 3–7 of each 21-day cycle,NA
27551000,NA,27,topotecan,1,1,mg/m2,1,on days 3–7 of each 21-day cycle,NA
27551000,NA,27,veliparib,2,10,mg,2,on days 1–8 of each 21-day cycle,NA
27551000,NA,27,topotecan,2,1.3,mg/m2,1,on days 3–7 of each 21-day cycle,NA
27551000,NA,27,topotecan,2,1.3,mg/m2,1,on days 3–7 of each 21-day cycle,NA
22943879,NA,29,docetaxel,1,55,mg/m2,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,1,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,1,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,paclitaxel,1,60,mg/m2,1,On day 8 every 3 weeks,NA
22943879,NA,29,docetaxel,2,65,mg/m2,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,2,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,2,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,paclitaxel,2,60,mg/m2,1,On day 8 every 3 weeks,NA
22943879,NA,29,docetaxel,3,75,mg/m2,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,3,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,3,5,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,paclitaxel,3,60,mg/m2,1,On day 8 every 3 weeks,NA
22943879,NA,29,docetaxel,4,75,mg/m2,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,4,6,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,carboplatin,4,6,AUC,1,On day 1 every 3 weeks,NA
22943879,NA,29,paclitaxel,4,60,mg/m2,1,On day 8 every 3 weeks,NA
23147218,NCT00735878,30,abt-751,1,100,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,1,4.5,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,1,4.5,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,abt-751,2,125,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,2,4.5,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,2,4.5,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,abt-751,3,125,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,3,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,3,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,abt-751,4,150,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,4,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,4,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,abt-751,5,175,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,5,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,5,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,abt-751,6,200,mg,2,on days 1-7 every 21 days,NA
23147218,NCT00735878,30,carboplatin,6,6,AUC,1,on Day 1 every 21 days,NA
23147218,NCT00735878,30,carboplatin,6,6,AUC,1,on Day 1 every 21 days,NA
22837181,NCT00672295,31,dasatinib,1,100,NA,1,continuously on days 2 to 21 in the first cycle of therapy and continuously (days 1 to 21) throughout the remainder of therapy,NA
22837181,NCT00672295,31,paclitaxel,1,175,mg/m2,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,1,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,1,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,dasatinib,2,120,NA,1,continuously on days 2 to 21 in the first cycle of therapy and continuously (days 1 to 21) throughout the remainder of therapy,NA
22837181,NCT00672295,31,paclitaxel,2,175,mg/m2,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,2,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,2,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,dasatinib,3,150,NA,1,continuously on days 2 to 21 in the first cycle of therapy and continuously (days 1 to 21) throughout the remainder of therapy,NA
22837181,NCT00672295,31,paclitaxel,3,175,mg/m2,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,3,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,3,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,dasatinib,4,200,NA,1,continuously on days 2 to 21 in the first cycle of therapy and continuously (days 1 to 21) throughout the remainder of therapy,NA
22837181,NCT00672295,31,paclitaxel,4,175,mg/m2,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,4,6,AUC,1,on day 1 of each 3-week cycle,NA
22837181,NCT00672295,31,carboplatin,4,6,AUC,1,on day 1 of each 3-week cycle,NA
26616225,26616225,32,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,1,50,mg,2,on days 1–7 every 28 days,NA
26616225,26616225,32,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,2,50,mg,2,on days 1–28 every 28 days,NA
26616225,26616225,32,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,3,80,mg,2,on days 1–7 every 28 days,NA
26616225,26616225,32,pegylated liposomal doxorubicin,4,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,4,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,4,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,4,80,mg,2,on days 1–28 every 28 days,NA
26616225,26616225,32,pegylated liposomal doxorubicin,5,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,5,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,5,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,5,120,mg,2,on days 1–7 every 28 days,NA
26616225,26616225,32,pegylated liposomal doxorubicin,6,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,6,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,carboplatin,6,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,32,veliparib,6,120,mg,2,on days 1–28 every 28 days,NA
26616225,26616225,33,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,33,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,33,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,33,veliparib,1,80,mg,2,on days 1–7 every 28 days,NA
26616225,26616225,33,bevacizumab,1,10,mg/kg,1,on days 1 and 5 every 28 days,NA
26616225,26616225,33,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 every 28 days,NA
26616225,26616225,33,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,33,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
26616225,26616225,33,veliparib,2,80,mg,2,on days 1–28 every 28 days,NA
26616225,26616225,33,bevacizumab,2,10,mg/kg,1,on days 1 and 5 every 28 days,NA
23468081,NCT00420186,34,bms-690514,1,100,mg,1,on Days 4–19 every 3 weeks,NA
23468081,NCT00420186,34,paclitaxel,1,200,mg/m2,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,1,6,AUC,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,1,6,AUC,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,bms-690514,2,150,mg,1,on Days 4–19 every 3 weeks,NA
23468081,NCT00420186,34,paclitaxel,2,200,mg/m2,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,2,6,AUC,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,2,6,AUC,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,bms-690514,3,200,mg,1,on Days 4–19 every 3 weeks,NA
23468081,NCT00420186,34,paclitaxel,3,200,mg/m2,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,3,6,AUC,1,on Day 1 of every 3-week cycle,NA
23468081,NCT00420186,34,carboplatin,3,6,AUC,1,on Day 1 of every 3-week cycle,NA
28028994,NA,35,genexol-pm,1,220,mg/m2,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,1,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,1,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,genexol-pm,2,260,mg/m2,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,2,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,2,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,genexol-pm,3,300,mg/m2,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,3,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
28028994,NA,35,carboplatin,3,5,AUC,1,on the first day of every cycle (one cycle consisted of 3 weeks),NA
22610355,NA,36,nedaplatin,1,8,AUC,1,on day 1 every 21 days,NA
22610355,NA,36,irinotecan,1,60,mg/m2,1,on days 1 and 8 every 21 days,NA
22610355,NA,36,nedaplatin,2,10,AUC,1,on day 1 every 21 days,NA
22610355,NA,36,irinotecan,2,60,mg/m2,1,on days 1 and 8 every 21 days,NA
22610355,NA,36,nedaplatin,3,12,AUC,1,on day 1 every 21 days,NA
22610355,NA,36,irinotecan,3,60,mg/m2,1,on days 1 and 8 every 21 days,NA
23957889,NA,37,vinorelbine,1,25,mg/m2,1,on days 1 and 8 every 28 days,NA
23957889,NA,37,carboplatin,1,5,AUC,1,on day 8 every 28 days,NA
23957889,NA,37,carboplatin,1,5,AUC,1,on day 8 every 28 days,NA
23957889,NA,37,accelerated hypofractionated three-dimensional conformal radiotherapy,1,66,Gy,NA,"Weeks 1–5: 3 Gy/f, 1 f/d, 5 f/w",NA
23957889,NA,37,carboplatin,NA,5,AUC,1,on day 8 every 28 days,NA
23957889,NA,37,carboplatin,NA,5,AUC,1,on day 8 every 28 days,NA
23957889,NA,37,accelerated hypofractionated three-dimensional conformal radiotherapy,NA,69,Gy,NA,"Weeks 1–5: 3 Gy/f, 1 f/d, 5 f/w",NA
23957889,NA,37,vinorelbine,NA,25,mg/m2,1,on days 1 and 8 every 28 days,NA
23957889,NA,37,accelerated hypofractionated three-dimensional conformal radiotherapy,NA,72,Gy,NA,"Weeks 1–5: 3 Gy/f, 1 f/d, 5 f/w",NA
23907406,NCT00529022,38,azacitidine,1,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,1,40,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,1,40,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,1,2,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,1,2,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,azacitidine,2,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,2,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,2,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,2,2,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,2,2,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,azacitidine,3,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,3,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,3,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,3,2.5,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,3,2.5,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,azacitidine,4,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,4,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,4,50,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,4,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,4,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,azacitidine,4.5,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,4.5,30,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,4.5,30,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,4.5,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,4.5,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,azacitidine,3.5,75,mg/m2,1,days 1to 5 every 28 days,NA
23907406,NCT00529022,38,valproic acid,3.5,20,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,valproic acid,3.5,20,mg/kg,1,from days 5 to 11 every 28 days,NA
23907406,NCT00529022,38,carboplatin,3.5,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
23907406,NCT00529022,38,carboplatin,3.5,3,AUC,1,starting in the second cycle on days 3 and 10 every 28 days,NA
22665539,NA,39,carboplatin,3,30,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,3,30,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,3,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,3,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,4,35,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,4,35,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,4,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,4,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,5,35,mg/m2,1,20 doses in 4 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,5,35,mg/m2,1,20 doses in 4 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,5,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,5,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,6,35,mg/m2,1,25 doses in 5 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,6,35,mg/m2,1,25 doses in 5 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,6,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,6,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,7,35,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,7,35,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,7,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,7,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,8,40,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,8,40,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,8,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,8,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,9,45,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,9,45,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,9,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,9,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,10,50,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,10,50,mg/m2,1,30 doses in 6 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,10,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,10,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,1,20,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,1,20,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,1,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,1,1.5,mg/m2,1,weekly X 6 during RT,NA
22665539,NA,39,carboplatin,2,25,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,carboplatin,2,25,mg/m2,1,15 doses in 3 weeks. 1 to 4 hours before eachfraction of radiation,NA
22665539,NA,39,craniospinal and boost radiotherapy,2,36,Gy,NA,Monday through Friday for 6 weeks,with boosts to sites of disease
22665539,NA,39,vincristine,2,1.5,mg/m2,1,weekly X 6 during RT,NA
27421044,NA,40,pralatrexate,1,30,mg/m2,1,on days 1 and 5  every 28 days),NA
27421044,NA,40,carboplatin,1,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,carboplatin,1,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,pralatrexate,2,45,mg/m2,1,on days 1 and 5  every 28 days),NA
27421044,NA,40,carboplatin,2,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,carboplatin,2,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,pralatrexate,3,60,mg/m2,1,on days 1 and 5  every 28 days),NA
27421044,NA,40,carboplatin,3,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,carboplatin,3,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,pralatrexate,4,75,mg/m2,1,on days 1 and 5  every 28 days),NA
27421044,NA,40,carboplatin,4,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,carboplatin,4,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,pralatrexate,5,90,mg/m2,1,on days 1 and 5  every 28 days),NA
27421044,NA,40,carboplatin,5,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,carboplatin,5,5,AUC,1,on day 1 every 28 days),fixed
27421044,NA,40,pralatrexate,5,105,mg/m2,1,on days 1 and 5  every 28 days),NA
25103371,NA,41,everolimus,-1,2.5,mg,1,every other day,NA
25103371,NA,41,everolimus,-1,2.5,mg,1,every other day,NA
25103371,NA,41,cetuximab,-1,250,mg/m2,1,"on days 8, 15, and 22 of each 28-day cycle",at a loading dose of 400 mg/m2 on day 1
25103371,NA,41,carboplatin,-1,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,carboplatin,-1,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,everolimus,1,2.5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,everolimus,1,2.5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,cetuximab,1,250,mg/m2,1,"on days 8, 15, and 22 of each 28-day cycle",at a loading dose of 400 mg/m2 on day 1
25103371,NA,41,carboplatin,1,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,carboplatin,1,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,everolimus,2,5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,everolimus,2,5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,cetuximab,2,250,mg/m2,1,"on days 8, 15, and 22 of each 28-day cycle",at a loading dose of 400 mg/m2 on day 1
25103371,NA,41,carboplatin,2,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,carboplatin,2,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,everolimus,3,7.5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,everolimus,3,7.5,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,cetuximab,3,250,mg/m2,1,"on days 8, 15, and 22 of each 28-day cycle",at a loading dose of 400 mg/m2 on day 1
25103371,NA,41,carboplatin,3,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,carboplatin,3,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,everolimus,4,10,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,everolimus,4,10,mg,1,daily started on day 1 of each 28-day cycle,NA
25103371,NA,41,cetuximab,4,250,mg/m2,1,"on days 8, 15, and 22 of each 28-day cycle",at a loading dose of 400 mg/m2 on day 1
25103371,NA,41,carboplatin,4,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
25103371,NA,41,carboplatin,4,2,AUC,1,"on days 1, 8, and 15 of each 28-day cycle for a total of 4 cycles",NA
23860537, NCT00832819,42,lenvatinib,1,6,mg,2,continuous,NA
23860537, NCT00832819,42,carboplatin,1,6,AUC,1,on day 1 every 3 weeks,NA
23860537, NCT00832819,42,carboplatin,1,6,AUC,1,on day 1 every 3 weeks,NA
23860537, NCT00832819,42,paclitaxel,1,200,mg/m2,1,on day 1 every 3 weeks,NA
23860537, NCT00832819,42,lenvatinib,-1,4,mg,2,continuous,NA
23860537, NCT00832819,42,carboplatin,-1,6,AUC,1,on day 1 every 3 weeks,NA
23860537, NCT00832819,42,carboplatin,-1,6,AUC,1,on day 1 every 3 weeks,NA
23860537, NCT00832819,42,paclitaxel,-1,200,mg/m2,1,on day 1 every 3 weeks,NA
24387695,NCT00848718,43,mk-2206,1,45,NA,1,"on days 1, 3, 5, and 7 (days 1-7) of a 21-daycycle",NA
24387695,NCT00848718,43,carboplatin,1,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,carboplatin,1,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,paclitaxel,1,200,mg/m2,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,mk-2206,2,60,mg,1,"on days 1, 3, 5, and 7 (days 1-7) of a 21-daycycle",NA
24387695,NCT00848718,43,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,carboplatin,2,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,paclitaxel,2,200,mg/m2,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,mk-2206,3,90,mg,1,on day 1 of a 21-daycycle,NA
24387695,NCT00848718,43,carboplatin,3,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,carboplatin,3,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,paclitaxel,3,200,mg/m2,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,mk-2206,4,135,mg,1,on day 1 of a 21-daycycle,NA
24387695,NCT00848718,43,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,carboplatin,4,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,paclitaxel,4,200,mg/m2,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,mk-2206,5,200,mg,1,on day 1 of a 21-daycycle,NA
24387695,NCT00848718,43,carboplatin,5,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,carboplatin,5,6,AUC,1,on Day 1 of each 21-day cycle,NA
24387695,NCT00848718,43,paclitaxel,5,200,mg/m2,1,on Day 1 of each 21-day cycle,NA
24849582,NCT00881166,46,amuvatinib,1,100,mg,1,daily,NA
24849582,NCT00881166,46,paclitaxel,1,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,1,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,1,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,2,200,mg,1,daily,NA
24849582,NCT00881166,46,paclitaxel,2,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,2,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,2,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,3,330,mg,1,daily,NA
24849582,NCT00881166,46,paclitaxel,3,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,3,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,3,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,4,500,mg,1,daily,NA
24849582,NCT00881166,46,paclitaxel,4,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,4,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,4,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,5,700,mg,1,daily,NA
24849582,NCT00881166,46,paclitaxel,5,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,5,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,5,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,6,300,mg,2,daily,NA
24849582,NCT00881166,46,paclitaxel,6,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,6,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,6,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,amuvatinib,7,400,mg,2,daily,NA
24849582,NCT00881166,46,paclitaxel,7,200,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,7,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,46,carboplatin,7,6,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,1,100,mg,1,daily,NA
24849582,NCT00881166,47,carboplatin,1,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,1,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,1,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,2,200,mg,1,daily,NA
24849582,NCT00881166,47,carboplatin,2,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,2,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,2,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,3,330,mg,1,daily,NA
24849582,NCT00881166,47,carboplatin,3,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,3,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,3,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,4,500,mg,1,daily,NA
24849582,NCT00881166,47,carboplatin,4,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,4,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,4,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,5,700,mg,1,daily,NA
24849582,NCT00881166,47,carboplatin,5,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,5,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,5,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,6,300,mg,2,daily,NA
24849582,NCT00881166,47,carboplatin,6,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,6,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,6,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,47,amuvatinib,7,400,mg,2,daily,NA
24849582,NCT00881166,47,carboplatin,7,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,carboplatin,7,5,AUC,1,on Day 1 every 21 days,NA
24849582,NCT00881166,47,etoposide,7,100,mg/m2,1,on Days 1–3 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,1,100,mg,1,daily,NA
24849582,NCT00881166,48,topotecan,1,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,1,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,2,200,mg,1,daily,NA
24849582,NCT00881166,48,topotecan,2,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,2,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,3,330,mg,1,daily,NA
24849582,NCT00881166,48,topotecan,3,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,3,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,4,500,mg,1,daily,NA
24849582,NCT00881166,48,topotecan,4,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,4,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,5,700,mg,1,daily,NA
24849582,NCT00881166,48,topotecan,5,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,5,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,6,300,mg,2,daily,NA
24849582,NCT00881166,48,topotecan,6,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,6,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,amuvatinib,7,400,mg,2,daily,NA
24849582,NCT00881166,48,topotecan,7,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,48,topotecan,7,1.5,mg/m2,1,on Days 1–5 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,1,100,mg,1,daily,NA
24849582,NCT00881166,49,docetaxel,1,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,2,200,mg,1,daily,NA
24849582,NCT00881166,49,docetaxel,2,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,3,330,mg,1,daily,NA
24849582,NCT00881166,49,docetaxel,3,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,4,500,mg,1,daily,NA
24849582,NCT00881166,49,docetaxel,4,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,5,700,mg,1,daily,NA
24849582,NCT00881166,49,docetaxel,5,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,6,300,mg,2,daily,NA
24849582,NCT00881166,49,docetaxel,6,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,49,amuvatinib,7,400,mg,2,daily,NA
24849582,NCT00881166,49,docetaxel,7,75,mg/m2,1,on Day 1 every 21 days,NA
24849582,NCT00881166,50,amuvatinib,1,100,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,1,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,1,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,2,200,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,2,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,2,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,3,330,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,3,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,3,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,4,500,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,4,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,4,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,5,700,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,5,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,5,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,6,300,mg,2,daily,NA
24849582,NCT00881166,50,erlotinib,6,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,6,150,mg,1,daily,NA
24849582,NCT00881166,50,amuvatinib,7,400,mg,2,daily,NA
24849582,NCT00881166,50,erlotinib,7,150,mg,1,daily,NA
24849582,NCT00881166,50,erlotinib,7,150,mg,1,daily,NA
23267154,UMIN 000005263,51,paclitaxel,1,100,mg/m2,1,consecutively on days 1 and 15 every 28 days,NA
23267154,UMIN 000005263,51,carboplatin,1,3,AUC,1,consecutively on days 1 and 15 every 28 days,fixed dose
23267154,UMIN 000005263,51,carboplatin,1,3,AUC,1,consecutively on days 1 and 15 every 28 days,fixed dose
24942022,NCT00101205,52,ifosfamide,1,1500,mg/m2,1,on days 1-3 every 21 days,NA
24942022,NCT00101205,52,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,NA
24942022,NCT00101205,52,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,NA
24942022,NCT00101205,52,etoposide,1,75,mg/m2,1,on days 1-3 every 21 days,NA
24942022,NCT00101205,52,ifosfamide,0,1200,mg/m2,1,on days 1-3 every 21 days,NA
24942022,NCT00101205,52,oxaliplatin,0,130,mg/m2,1,on day 1 every 21 days,NA
24942022,NCT00101205,52,oxaliplatin,0,130,mg/m2,1,on day 1 every 21 days,NA
24942022,NCT00101205,52,etoposide,0,75,mg/m2,1,on days 1-3 every 21 days,NA
23609829,NA,54,tas-106,1,2,mg/m2,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,1,4,AUC,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,1,4,AUC,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,tas-106,2,3,mg/m2,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,2,4,AUC,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,2,4,AUC,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,tas-106,3,4,mg/m2,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
23609829,NA,54,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
28275119,NCT00756847,55,pilaralisib,1,100,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,1,150,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,1,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,1,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,2,150,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,2,150,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,2,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,2,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,3,200,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,3,150,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,3,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,3,5,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,4,200,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,4,175,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,4,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,4,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,5,400,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,5,175,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,5,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,5,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,6,600,mg,1,once daily starting on day 1,capsule
28275119,NCT00756847,55,paclitaxel,6,175,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,6,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,6,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,7,200,mg,1,once daily starting on day 1,tablet
28275119,NCT00756847,55,paclitaxel,7,175,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,7,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,7,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,pilaralisib,8,300,mg,1,once daily starting on day 1,tablet
28275119,NCT00756847,55,paclitaxel,8,175,mg/m2,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,8,6,AUC,1,on day 1 of 21-day cycles,NA
28275119,NCT00756847,55,carboplatin,8,6,AUC,1,on day 1 of 21-day cycles,NA
26119093,NA,57,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,vorinostat,1,200,mg,1,on days 1-14 every 21 days,NA
26119093,NA,57,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 every 21 days,NA
26119093,NA,57,carboplatin,2,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,carboplatin,2,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,vorinostat,2,300,mg,1,on days 1-14 every 21 days,NA
26119093,NA,57,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 21 days,NA
26119093,NA,57,carboplatin,3,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,carboplatin,3,4,AUC,1,on day 1 every 21 days,NA
26119093,NA,57,vorinostat,3,200,mg,2,"on days 1-3, and 8-10 every 21 days",NA
26119093,NA,57,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 21 days,NA
26119093,NA,57,carboplatin,4,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,carboplatin,4,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,vorinostat,4,200,mg,2,"on days 1, 2, 8, and 9 every 21 days",NA
26119093,NA,57,gemcitabine,4,1000,mg/m2,1,on days 2 and 9 every 21 days,NA
26119093,NA,57,carboplatin,5,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,carboplatin,5,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,vorinostat,5,300,mg,1,on days 1 and 2 every 21 days,NA
26119093,NA,57,gemcitabine,5,1000,mg/m2,1,on days 2 and 9 every 21 days,NA
26119093,NA,57,carboplatin,6,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,carboplatin,6,4,AUC,1,on day 2 every 21 days,NA
26119093,NA,57,vorinostat,6,400,mg,1,on days 1 and 2 every 21 days,NA
26119093,NA,57,gemcitabine,6,1000,mg/m2,1,on days 2 and 9 every 21 days,NA
27995307,"UMIN 000,020,359",59,nab‑paclitaxel,0,30,mg/m2,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,0,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,0,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,thoracic radiotherapy,0,2,Gy,1,5 times per week for 6 weeks,NA
27995307,"UMIN 000,020,359",59,nab‑paclitaxel,1,40,mg/m2,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,1,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,1,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,thoracic radiotherapy,1,2,Gy,1,5 times per week for 6 weeks,NA
27995307,"UMIN 000,020,359",59,nab‑paclitaxel,2,60,mg/m2,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,2,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,2,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,thoracic radiotherapy,2,2,Gy,1,5 times per week for 6 weeks,NA
27995307,"UMIN 000,020,359",59,nab‑paclitaxel,3,80,mg/m2,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,3,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,carboplatin,3,2,AUC,1,on day 1 weekly for 6 weeks,NA
27995307,"UMIN 000,020,359",59,thoracic radiotherapy,3,2,Gy,1,5 times per week for 6 weeks,NA
23483678,NCT00607048,60,"cp-870,893",1,0.1,mg/kg,1,on DAY 3 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,1,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,paclitaxel,1,175,mg/m2,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,"cp-870,893",2,0.2,mg/kg,1,on DAY 3 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,paclitaxel,2,175,mg/m2,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,"cp-870,893",3,0.1,mg/kg,1,on DAY 8 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,3,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,3,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,paclitaxel,3,175,mg/m2,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,"cp-870,893",4,0.2,mg/kg,1,on DAY 8 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,NA
23483678,NCT00607048,60,paclitaxel,4,175,mg/m2,1,on day 1 of a 21-day cycle,NA
27016411,NA,61,cidofovir,1,1,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,cidofovir,1,1,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,radiotherapy,1,45,Gy,NA,NA,NA
27016411,NA,61,carboplatin,1,2.5,AUC,1,weekly,NA
27016411,NA,61,carboplatin,1,2.5,AUC,1,weekly,NA
27016411,NA,61,cidofovir,2,2.5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,cidofovir,2,2.5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,radiotherapy,2,45,Gy,NA,NA,NA
27016411,NA,61,carboplatin,2,2.5,AUC,1,weekly,NA
27016411,NA,61,carboplatin,2,2.5,AUC,1,weekly,NA
27016411,NA,61,cidofovir,3,5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,cidofovir,3,5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,radiotherapy,3,45,Gy,NA,NA,NA
27016411,NA,61,carboplatin,3,2.5,AUC,1,weekly,NA
27016411,NA,61,carboplatin,3,2.5,AUC,1,weekly,NA
27016411,NA,61,cidofovir,4,6.5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,cidofovir,4,6.5,mg/kg,1,"weekly, over two consecutive weeks and then every two weeks from the start of CRT up to a total of 6 injectionsin 10 weeks",NA
27016411,NA,61,radiotherapy,4,45,Gy,NA,NA,NA
27016411,NA,61,carboplatin,4,2.5,AUC,1,weekly,NA
27016411,NA,61,carboplatin,4,2.5,AUC,1,weekly,NA
26072101,NA,64,ifosfamide,1,2000,mg/m2,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,paclitaxel,1,200,mg/m2,1,on day 1 every 21 to 28 days,NA
26072101,NA,64,carboplatin,1,7,AUC,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,carboplatin,1,7,AUC,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,ifosfamide,2,2670,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,paclitaxel,2,200,NA,1,on day 1 every 21 to 28 days,NA
26072101,NA,64,carboplatin,2,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,carboplatin,2,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,ifosfamide,3,3333,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,paclitaxel,3,200,NA,1,on day 1 every 21 to 28 days,NA
26072101,NA,64,carboplatin,3,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,carboplatin,3,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,ifosfamide,4,3333,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,paclitaxel,4,250,NA,1,on day 1 every 21 to 28 days,NA
26072101,NA,64,carboplatin,4,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,carboplatin,4,7,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,ifosfamide,5,3333,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,paclitaxel,5,250,NA,1,on day 1 every 21 to 28 days,NA
26072101,NA,64,carboplatin,5,8,NA,1,on days 1-3 every 21 to 28 days,NA
26072101,NA,64,carboplatin,5,8,NA,1,on days 1-3 every 21 to 28 days,NA
26395450,NA,65,bendamustine,1,80,mg/m2,1,on days 1 and 2 every 21 days for a total of three cycles,NA
26395450,NA,65,irinotecan,1,150,mg/m2,1,on day 1 every 21 days for a total of three cycles,NA
26395450,NA,65,etoposide,1,100,mg/m2,1,"on days 1,-3 from Cycles 3 to 6 every 21 days",NA
26395450,NA,65,carboplatin,1,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
26395450,NA,65,carboplatin,1,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
26395450,NA,65,bendamustine,2,100,mg/m2,1,on days 1 and 2 every 21 days for a total of three cycles,NA
26395450,NA,65,irinotecan,2,150,mg/m2,1,on day 1 every 21 days for a total of three cycles,NA
26395450,NA,65,etoposide,2,100,mg/m2,1,"on days 1,-3 from Cycles 3 to 6 every 21 days",NA
26395450,NA,65,carboplatin,2,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
26395450,NA,65,carboplatin,2,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
26395450,NA,65,bendamustine,3,120,mg/m2,1,on days 1 and 2 every 21 days for a total of three cycles,NA
26395450,NA,65,irinotecan,3,150,mg/m2,1,on day 1 every 21 days for a total of three cycles,NA
26395450,NA,65,etoposide,3,100,mg/m2,1,"on days 1,-3 from Cycles 3 to 6 every 21 days",NA
26395450,NA,65,carboplatin,3,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
26395450,NA,65,carboplatin,3,6,AUC,1,on day 1 from Cycles 3 to 6 every 21 days,NA
27565810,JapicCTI-132162,66,pictilisib,1,140,mg,1,"single dose during days -4 to -8, and daily every 28-day cycle",NA
27565810,JapicCTI-132162,66,pictilisib,2,260,mg,1,"single dose during days -4 to -8, and daily every 28-day cycle",NA
27565810,JapicCTI-132162,66,pictilisib,3,340,mg,1,"single dose during days -4 to -8, and daily every 28-day cycle",NA
27565810,JapicCTI-132162,67,pictilisib,1,260,mg,1,on days 1-15 every 21 days,NA
27565810,JapicCTI-132162,67,carboplatin,1,6,AUC,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,carboplatin,1,6,AUC,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,paclitaxel,1,200,mg/m2,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,bevacizumab,1,15,mg/kg,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,pictilisib,2,340,mg,1,on days 1-15 every 21 days,NA
27565810,JapicCTI-132162,67,carboplatin,2,6,AUC,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,carboplatin,2,6,AUC,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,paclitaxel,2,200,mg/m2,1,on day 2 every 21 days,fixed
27565810,JapicCTI-132162,67,bevacizumab,2,15,mg/kg,1,on day 2 every 21 days,fixed
27246305,NCT02217956,68,cisplatin,1,50,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,cisplatin,1,50,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,carboplatin,1,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,carboplatin,1,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,paclitaxel,1,175,mg/m2,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,bevacizumab,1,15,mg/kg,1,"every 3 weeks × 22 cycles, started 10 to 14 weeks after CCRS + HIPEC",fixed
27246305,NCT02217956,68,cisplatin,2,60,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,cisplatin,2,60,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,carboplatin,2,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,carboplatin,2,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,paclitaxel,2,175,mg/m2,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,bevacizumab,2,15,mg/kg,1,"every 3 weeks × 22 cycles, started 10 to 14 weeks after CCRS + HIPEC",fixed
27246305,NCT02217956,68,cisplatin,3,70,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,cisplatin,3,70,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,carboplatin,3,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,carboplatin,3,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,paclitaxel,3,175,mg/m2,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,bevacizumab,3,15,mg/kg,1,"every 3 weeks × 22 cycles, started 10 to 14 weeks after CCRS + HIPEC",fixed
27246305,NCT02217956,68,cisplatin,4,80,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,cisplatin,4,80,mg/m2,1,HIPEC performed within 10 weeks after the last  carboplatin,Hyperthermic intraperitoneal chemotherapy using cisplatin heated for one hour at 42 °C+/−1 °C
27246305,NCT02217956,68,carboplatin,4,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,carboplatin,4,5,AUC,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,paclitaxel,4,175,mg/m2,1,every three weeks x 6 cycles,fixed
27246305,NCT02217956,68,bevacizumab,4,15,mg/kg,1,"every 3 weeks × 22 cycles, started 10 to 14 weeks after CCRS + HIPEC",fixed
27663600,NCT01237067,69,olaparib,1,100,mg,2,on days 1-7 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,1,3,AUC,1,on day 1 or 2 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,1,3,AUC,1,on day 1 or 2 every 3 weeks,NA
27663600,NCT01237067,69,olaparib,2,200,mg,2,on days 1-7 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,2,4,AUC,1,on day 1 or 2 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,2,4,AUC,1,on day 1 or 2 every 3 weeks,NA
27663600,NCT01237067,69,olaparib,3,200,mg,2,on days 1-7 every 3 weeks,expansion cohort
27663600,NCT01237067,69,carboplatin,3,4,AUC,1,on day 1 or 2 every 3 weeks,expansion cohort
27663600,NCT01237067,69,carboplatin,3,4,AUC,1,on day 1 or 2 every 3 weeks,expansion cohort
27663600,NCT01237067,69,olaparib,4,200,mg,2,on days 1-7 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,4,5,AUC,1,on day 1 or 2 every 3 weeks,NA
27663600,NCT01237067,69,carboplatin,4,5,AUC,1,on day 1 or 2 every 3 weeks,NA
23963796,NCT00528619,70,sunitinib,1,37.5,mg,1,continuous daily dosing,CDD schedule
23963796,NCT00528619,70,pemetrexed,1,400,mg/m2,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,1,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,1,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,sunitinib,2,37.5,mg,1,"2 weeks on treatment, 1 week off treatment",CDD schedule
23963796,NCT00528619,70,pemetrexed,2,500,mg/m2,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,2,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,2,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,sunitinib,3,50,mg,1,"2 weeks on treatment, 1 week off treatment",CDD schedule
23963796,NCT00528619,70,pemetrexed,3,500,mg/m2,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,3,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,carboplatin,3,5,AUC,1,once every 3 weeks,CDD schedule
23963796,NCT00528619,70,sunitinib,4,37.5,mg,1,"2 weeks on treatment, 1 week off treatment",schedule 2/1
23963796,NCT00528619,70,pemetrexed,4,400,mg/m2,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,4,5,AUC,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,4,5,AUC,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,sunitinib,5,37.5,mg,1,"2 weeks on treatment, 1 week off treatment",schedule 2/1
23963796,NCT00528619,70,pemetrexed,5,500,mg/m2,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,5,5,AUC,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,5,5,AUC,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,sunitinib,6,50,mg,1,"2 weeks on treatment, 1 week off treatment",schedule 2/1
23963796,NCT00528619,70,pemetrexed,6,500,mg/m2,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,6,5,AUC,1,once every 3 weeks,schedule 2/1
23963796,NCT00528619,70,carboplatin,6,5,AUC,1,once every 3 weeks,schedule 2/1
22843927,NCT00930475,71,everolimus,1,2.5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,everolimus,1,2.5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,carboplatin,1,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,carboplatin,1,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,everolimus,2,5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,everolimus,2,5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,carboplatin,2,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,carboplatin,2,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,everolimus,3,7.5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,everolimus,3,7.5,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,carboplatin,3,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,carboplatin,3,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,everolimus,4,10,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,everolimus,4,10,mg,1,on days 1-21 in 3-week cycles,NA
22843927,NCT00930475,71,carboplatin,4,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
22843927,NCT00930475,71,carboplatin,4,2,AUC,1,"on days 1, 8 and 15 in 3-week cycles",NA
26100175,NA,72,irinotecan,0,40,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
26100175,NA,72,carboplatin,0,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,carboplatin,0,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,irinotecan,1,50,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
26100175,NA,72,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,carboplatin,1,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,irinotecan,2,60,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
26100175,NA,72,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,carboplatin,2,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,irinotecan,3,70,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
26100175,NA,72,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,carboplatin,3,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,irinotecan,4,80,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
26100175,NA,72,carboplatin,4,5,AUC,1,on day 1 of each 21-day cycle,NA
26100175,NA,72,carboplatin,4,5,AUC,1,on day 1 of each 21-day cycle,NA
21826439,NA,73,kos-862,1,50,mg/m2,1,on Days 1 and 8 of 3-week cycles,NA
21826439,NA,73,carboplatin,1,5,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,carboplatin,1,5,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,kos-862,2,75,mg/m2,1,on Days 1 and 8 of 3-week cycles,NA
21826439,NA,73,carboplatin,2,5,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,carboplatin,2,5,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,kos-862,3,75,mg/m2,1,on Days 1 and 8 of 3-week cycles,NA
21826439,NA,73,carboplatin,3,6,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,carboplatin,3,6,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,kos-862,4,100,mg/m2,1,on Days 1 and 8 of 3-week cycles,NA
21826439,NA,73,carboplatin,4,6,AUC,1,"on day 1, of 3-week cycles",NA
21826439,NA,73,carboplatin,4,6,AUC,1,"on day 1, of 3-week cycles",NA
19088046,NA,74,ixabepilone,1,30,mg/m2,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,1,5,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,1,5,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,ixabepilone,2,30,mg/m2,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,2,6,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,ixabepilone,3,40,mg/m2,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,3,5,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,3,5,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,ixabepilone,4,40,mg/m2,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,carboplatin,4,6,AUC,1,on day 1 of a 21-day cycle,schedule A
19088046,NA,74,ixabepilone,5,20,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,5,5,AUC,1,on day 1 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,5,5,AUC,1,on day 1 of a 21-day cycle,Schedule B
19088046,NA,74,ixabepilone,6,20,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,6,6,AUC,1,on day 1 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,6,6,AUC,1,on day 1 of a 21-day cycle,Schedule B
19088046,NA,74,ixabepilone,7,25,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,7,6,AUC,1,on day 1 of a 21-day cycle,Schedule B
19088046,NA,74,carboplatin,7,6,AUC,1,on day 1 of a 21-day cycle,Schedule B
19889612,NA,75,paclitaxel,1,175,mg/m2,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,1,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,1,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,bibf 1120,1,100,mg,2,On days 2–21 of each 28-day treatment phase,NA
19889612,NA,75,paclitaxel,2,175,mg/m2,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,2,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,2,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,bibf 1120,2,150,mg,2,On days 2–21 of each 28-day treatment phase,NA
19889612,NA,75,paclitaxel,3,175,mg/m2,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,3,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,3,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,bibf 1120,3,200,mg,2,On days 2–21 of each 28-day treatment phase,NA
19889612,NA,75,paclitaxel,4,175,mg/m2,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,4,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,carboplatin,4,5,AUC,1,On day 1 of each 28-day treatment period,NA
19889612,NA,75,bibf 1120,4,250,mg,2,On days 2–21 of each 28-day treatment phase,NA
19404211,NA,76,amrubicin,1,30,mg/m2,1,on day 1 every 3 weeks,NA
19404211,NA,76,carboplatin,1,5,AUC,1,on days 1 to 3 every 3 weeks,NA
19404211,NA,76,carboplatin,1,5,AUC,1,on days 1 to 3 every 3 weeks,NA
19404211,NA,76,amrubicin,2,35,mg/m2,1,on day 1 every 3 weeks,NA
19404211,NA,76,carboplatin,2,5,AUC,1,on days 1 to 3 every 3 weeks,NA
19404211,NA,76,carboplatin,2,5,AUC,1,on days 1 to 3 every 3 weeks,NA
19404211,NA,76,amrubicin,3,40,mg/m2,1,on day 1 every 3 weeks,NA
19404211,NA,76,carboplatin,3,5,AUC,1,on days 1 to 3 every 3 weeks,NA
19404211,NA,76,carboplatin,3,5,AUC,1,on days 1 to 3 every 3 weeks,NA
18618082,NA,77,bortezomib,-1,0.75,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 day cycle",NA
18618082,NA,77,carboplatin,-1,4,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,carboplatin,-1,4,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,etoposide,-1,75,mg/m2,1,on days 1-3 of each 21 day cycle,NA
18618082,NA,77,bortezomib,1,1,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 day cycle",NA
18618082,NA,77,carboplatin,1,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,carboplatin,1,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,etoposide,1,100,mg/m2,1,on days 1-3 of each 21 day cycle,NA
18618082,NA,77,bortezomib,-0.5,0.75,mg/m2,1,"on days 1, 4, 8, and 11 of each 21 day cycle",NA
18618082,NA,77,carboplatin,-0.5,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,carboplatin,-0.5,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,etoposide,-0.5,75,mg/m2,1,on days 1-3 of each 21 day cycle,NA
18618082,NA,77,bortezomib,1.5,1,mg/m2,1,on days 1 and 8 of each 21 day cycle,NA
18618082,NA,77,carboplatin,1.5,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,carboplatin,1.5,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,etoposide,1.5,75,mg/m2,1,on days 1-3 of each 21 day cycle,NA
18618082,NA,77,bortezomib,2,1,mg/m2,1,on days 1 and 8 of each 21 day cycle,NA
18618082,NA,77,carboplatin,2,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,carboplatin,2,5,AUC,1,on day 1 of each 21 day cycle,NA
18618082,NA,77,etoposide,2,100,mg/m2,1,on days 1-3 of each 21 day cycle,NA
19520688,NA,78,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of a 21-day course,NA
19520688,NA,78,carboplatin,1,4,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,carboplatin,1,4,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day course,NA
19520688,NA,78,carboplatin,2,4,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,carboplatin,2,4,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day course,NA
19520688,NA,78,carboplatin,3,4.5,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,carboplatin,3,4.5,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day course,NA
19520688,NA,78,carboplatin,4,5,AUC,1,on day 1 of a 21-day course,NA
19520688,NA,78,carboplatin,4,5,AUC,1,on day 1 of a 21-day course,NA
18692224,NA,79,lapatinib,1,750,mg,1,daily,NA
18692224,NA,79,carboplatin,1,6,AUC,1,every 21 days,NA
18692224,NA,79,carboplatin,1,6,AUC,1,every 21 days,NA
18692224,NA,79,lapatinib,2,1000,mg,1,daily,NA
18692224,NA,79,carboplatin,2,6,AUC,1,every 21 days,NA
18692224,NA,79,carboplatin,2,6,AUC,1,every 21 days,NA
19479255,NA,80,larotaxel,1,45,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,1,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,1,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,larotaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,2,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,2,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,larotaxel,3,75,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,larotaxel,3.5,75,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,3.5,5,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,3.5,5,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,larotaxel,4,90,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,4,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,4,6,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,larotaxel,4.5,90,mg/m2,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,4.5,5,AUC,1,on day 1 every 3 weeks,NA
19479255,NA,80,carboplatin,4.5,5,AUC,1,on day 1 every 3 weeks,NA
19843663,NA,81,sirolimus,1,3,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,1,3,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,1,1,mg,1,on days 2 to 7,NA
19843663,NA,81,sirolimus,1,1,mg,1,on days 2 to 7,NA
19843663,NA,81,mitoxantrone,1,8,mg/m2,1,on days 1-5,NA
19843663,NA,81,etoposide,1,100,mg/m2,1,on days 1-5,NA
19843663,NA,81,cytarabine,1,1000,mg/m2,1,on days 1-5,NA
19843663,NA,81,sirolimus,2,6,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,2,6,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,2,2,mg,1,on days 2 to 7,NA
19843663,NA,81,sirolimus,2,2,mg,1,on days 2 to 7,NA
19843663,NA,81,mitoxantrone,2,8,mg/m2,1,on days 1-5,NA
19843663,NA,81,etoposide,2,100,mg/m2,1,on days 1-5,NA
19843663,NA,81,cytarabine,2,1000,mg/m2,1,on days 1-5,NA
19843663,NA,81,sirolimus,3,9,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,3,9,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,3,3,mg,1,on days 2 to 7,NA
19843663,NA,81,sirolimus,3,3,mg,1,on days 2 to 7,NA
19843663,NA,81,mitoxantrone,3,8,mg/m2,1,on days 1-5,NA
19843663,NA,81,etoposide,3,100,mg/m2,1,on days 1-5,NA
19843663,NA,81,cytarabine,3,1000,mg/m2,1,on days 1-5,NA
19843663,NA,81,sirolimus,4,12,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,4,12,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,4,3,mg,1,on days 2 to 7,NA
19843663,NA,81,sirolimus,4,3,mg,1,on days 2 to 7,NA
19843663,NA,81,mitoxantrone,4,8,mg/m2,1,on days 1-5,NA
19843663,NA,81,etoposide,4,100,mg/m2,1,on days 1-5,NA
19843663,NA,81,cytarabine,4,1000,mg/m2,1,on days 1-5,NA
19843663,NA,81,sirolimus,5,15,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,5,15,mg,1,loading dose no day 1,NA
19843663,NA,81,sirolimus,5,5,mg,1,on days 2 to 7,NA
19843663,NA,81,sirolimus,5,5,mg,1,on days 2 to 7,NA
19843663,NA,81,mitoxantrone,5,8,mg/m2,1,on days 1-5,NA
19843663,NA,81,etoposide,5,100,mg/m2,1,on days 1-5,NA
19843663,NA,81,cytarabine,5,1000,mg/m2,1,on days 1-5,NA
20588278,NA,82,belinostat,1,600,mg/m2,1,on days 1 –5 q21,NA
20588278,NA,82,carboplatin,1,5,AUC,1,on day 3 q21 days,NA
20588278,NA,82,carboplatin,1,5,AUC,1,on day 3 q21 days,NA
20588278,NA,83,belinostat,1,600,mg/m2,1,on days 1 –5 q21,NA
20588278,NA,83,paclitaxel,1,175,mg/m2,1,on day 3 q21 days,NA
19297278,NA,85,ts-1,0,65,mg/m2,2,"14 consecutive days, followed by a 14-day rest period",NA
19297278,NA,85,carboplatin,0,4,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,carboplatin,0,4,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,ts-1,1,80,mg/m2,2,"14 consecutive days, followed by a 14-day rest period",NA
19297278,NA,85,carboplatin,1,4,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,carboplatin,1,4,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,ts-1,2,80,mg/m2,2,"14 consecutive days, followed by a 14-day rest period",NA
19297278,NA,85,carboplatin,2,5,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,carboplatin,2,5,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,ts-1,3,80,mg/m2,2,"14 consecutive days, followed by a 14-day rest period",NA
19297278,NA,85,carboplatin,3,6,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
19297278,NA,85,carboplatin,3,6,AUC,1,on day 8 of the 14-day Ts-1 administration,NA
21277623,NA,4,paclitaxel,1,175,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
21277623,NA,4,carboplatin,1,5,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,carboplatin,1,5,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,paclitaxel,2,175,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
21277623,NA,4,carboplatin,2,6,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,carboplatin,2,6,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,paclitaxel,3,175,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
21277623,NA,4,carboplatin,3,7,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,carboplatin,3,7,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,paclitaxel,4,175,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
21277623,NA,4,carboplatin,4,8,AUC,1,On day 1 of each 21-day treatment cycle,NA
21277623,NA,4,carboplatin,4,8,AUC,1,On day 1 of each 21-day treatment cycle,NA
22155262,NA,5,paclitaxel,-1,135,mg/m2,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,-1,60,mg/m2,1,on day 8 every 21 days,NA
22155262,NA,5,carboplatin,-1,6,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,carboplatin,-1,6,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,1,175,mg/m2,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,1,60,mg/m2,1,on day 8 every 21 days,NA
22155262,NA,5,carboplatin,1,5,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,carboplatin,1,5,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,2,175,mg/m2,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,2,60,mg/m2,1,on day 8 every 21 days,NA
22155262,NA,5,carboplatin,2,6,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,carboplatin,2,6,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,3,175,mg/m2,1,On day 1 every 21 days,NA
22155262,NA,5,paclitaxel,3,60,mg/m2,1,on day 8 every 21 days,NA
22155262,NA,5,carboplatin,3,7,AUC,1,On day 1 every 21 days,NA
22155262,NA,5,carboplatin,3,7,AUC,1,On day 1 every 21 days,NA
20580118,NCT00573690,6,sorafenib,0,200,mg,2,on days 1-21 every 21 days,NA
20580118,NCT00573690,6,cisplatin,0,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,cisplatin,0,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,etoposide,0,120,mg/m2,1,on days 1-3 every 21 days,NA
20580118,NCT00573690,6,sorafenib,-1,200,mg,1,on days 1-21 every 21 days,NA
20580118,NCT00573690,6,cisplatin,-1,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,cisplatin,-1,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,etoposide,-1,120,mg/m2,1,on days 1-3 every 21 days,NA
20580118,NCT00573690,6,sorafenib,1,400,mg,2,on days 1-21 every 21 days,NA
20580118,NCT00573690,6,cisplatin,1,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,cisplatin,1,60,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,6,etoposide,1,120,mg/m2,1,on days 1-3 every 21 days,NA
20580118,NCT00573690,7,sorafenib,-1,200,mg/m2,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,-1,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,-1,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,-1,500,mg/m2,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,sorafenib,0,200,NA,2,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,0,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,0,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,0,500,mg/m2,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,sorafenib,1,400,NA,2,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,1,6,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,1,500,mg/m2,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,sorafenib,2,200,NA,1,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,2,500,mg/m2,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,sorafenib,3,200,NA,2,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,3,500,mg/m2,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,sorafenib,4,400,NA,2,on day 2 of courses 1 and 2 (every 21 days)  and on day 1 of all subsequent courses,NA
20580118,NCT00573690,7,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
20580118,NCT00573690,7,pemetrexed,4,500,mg/m2,1,on day 1 every 21 days,NA
22345119,NA,8,bibf 1120,1,100,mg,2,on days 2–21 of each 21-day treatment cycle,NA
22345119,NA,8,paclitaxel,1,200,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,1,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,1,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,bibf 1120,2,200,NA,2,on days 2–21 of each 21-day treatment cycle,NA
22345119,NA,8,paclitaxel,2,200,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,2,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,2,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,bibf 1120,3,250,NA,2,on days 2–21 of each 21-day treatment cycle,NA
22345119,NA,8,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,3,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22345119,NA,8,carboplatin,3,6,AUC,1,on day 1 of each 21-day treatment cycle,NA
22306126,NA,9,carboplatin,1,4,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,carboplatin,1,4,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,gemcitabine,1,800,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22306126,NA,9,carboplatin,2,4,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,carboplatin,2,4,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22306126,NA,9,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22306126,NA,9,carboplatin,2.5,5,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,carboplatin,2.5,5,AUC,1,on day 1 every 3 weeks,NA
22306126,NA,9,gemcitabine,2.5,800,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18506181,NA,10,erlotinib,1,50,mg,1,continuously,NA
18506181,NA,10,erlotinib,1,50,mg,1,continuously,NA
18506181,NA,10,docetaxel,1,75,mg/m2,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,1,5,AUC,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,1,5,AUC,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,erlotinib,2,75,mg,1,continuously,NA
18506181,NA,10,erlotinib,2,75,mg,1,continuously,NA
18506181,NA,10,docetaxel,2,75,mg/m2,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,2,5,AUC,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,2,5,AUC,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,erlotinib,2.5,100,mg,1,continuously,NA
18506181,NA,10,erlotinib,2.5,100,mg,1,continuously,NA
18506181,NA,10,docetaxel,2.5,75,mg/m2,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,2.5,5,AUC,1,On day 1 of a 3-week cycle,NA
18506181,NA,10,carboplatin,2.5,5,AUC,1,On day 1 of a 3-week cycle,NA
20054549,NA,11,pemetrexed,-1,400,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,-1,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,-1,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,1,500,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,1,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,1,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,2,600,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,2,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,2,5,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,3,600,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,3,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,3,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,4,700,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,4,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,4,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,5,800,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,5,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,5,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,pemetrexed,6,900,mg/m2,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,6,6,AUC,1,every 21 days for 6 cycles,NA
20054549,NA,11,carboplatin,6,6,AUC,1,every 21 days for 6 cycles,NA
19404408,NA,12,irinotecan,1,100,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,2,100,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,3,150,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,4,200,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,5,250,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,5,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,5,5,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,6,250,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,7,300,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,7,6,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,7,6,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,irinotecan,8,350,mg/m2,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,8,6,AUC,1,on day 1 every 21 days,NA
19404408,NA,12,carboplatin,8,6,AUC,1,on day 1 every 21 days,NA
19520687,NA,13,paclitaxel,1,50,mg/m2,1,on day 1 every week,NA
19520687,NA,13,carboplatin,1,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,carboplatin,1,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,paclitaxel,2,60,mg/m2,1,on day 1 every week,NA
19520687,NA,13,carboplatin,2,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,carboplatin,2,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,paclitaxel,3,70,mg/m2,1,on day 1 every week,NA
19520687,NA,13,carboplatin,3,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,carboplatin,3,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,paclitaxel,4,80,mg/m2,1,on day 1 every week,NA
19520687,NA,13,carboplatin,4,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,carboplatin,4,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,paclitaxel,5,90,mg/m2,1,on day 1 every week,NA
19520687,NA,13,carboplatin,5,2,AUC,1,on day 1 every week,fixed
19520687,NA,13,carboplatin,5,2,AUC,1,on day 1 every week,fixed
19800673,NA,14,fdr gemcitabine,1,800,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,1,4,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,1,4,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,2,1000,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,2,4,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,2,4,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,3,1000,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,3,5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,3,5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,4,1200,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,4,5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,4,5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,5,1200,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,5,6,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,5,6,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,5.5,1200,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,5.5,5.5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,5.5,5.5,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,fdr gemcitabine,6,1400,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,6,6,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,14,carboplatin,6,6,AUC,1,on day 1 for 21-day cycles,Arm 1
19800673,NA,15,fdr gemcitabine,1,800,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,1,2,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,1,2,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,fdr gemcitabine,2,1000,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,2,2,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,2,2,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,fdr gemcitabine,3,1000,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,3,2.5,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,3,2.5,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,fdr gemcitabine,4,1200,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,4,2.5,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,4,2.5,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,fdr gemcitabine,5,1200,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,5,3,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,5,3,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,fdr gemcitabine,6,1400,mg/m2,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,6,3,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,15,carboplatin,6,3,AUC,1,on days 1 and 8 for 21-day cycles,Arm 2
19800673,NA,16,fdr gemcitabine,1,1000,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,1,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,1,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,2,1250,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,2,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,2,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,3,1500,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,3,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,3,2.5,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,4,1500,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,4,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,4,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,5,2000,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,5,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,5,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,6,2500,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,6,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,6,3,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,fdr gemcitabine,7,2500,mg/m2,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,7,4,AUC,1,on day 1 for 14-day cycles,Arm 3
19800673,NA,16,carboplatin,7,4,AUC,1,on day 1 for 14-day cycles,Arm 3
19652058,NA,17,paclitaxel,1,200,mg/m2,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,mapatumumab,1,3,mg/kg,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,paclitaxel,2,200,mg/m2,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,mapatumumab,2,10,mg/kg,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,NA
19652058,NA,17,mapatumumab,3,20,mg/kg,1,on day 1 of each 21-day cycle,NA
20049927,NA,19,cyclophosphamide,0,2000,mg/m2,1,on days 1 and 2 every 21 days,fixed
20049927,NA,19,etoposide,0,200,mg/m2,1,on days 1–3 every 21 days,fixed
20049927,NA,19,carboplatin,0,800,mg/m2,1,on days 1 and 2 every 21 days,NA
20049927,NA,19,carboplatin,0,800,mg/m2,1,on days 1 and 2 every 21 days,NA
20049927,NA,19,cyclophosphamide,1,2000,mg/m2,1,on days 1 and 2 every 21 days,fixed
20049927,NA,19,etoposide,1,200,mg/m2,1,on days 1–3 every 21 days,fixed
20049927,NA,19,carboplatin,1,1000,mg/m2,1,on days 1 and 2 every 21 days,NA
20049927,NA,19,carboplatin,1,1000,mg/m2,1,on days 1 and 2 every 21 days,NA
19090012,NA,20,carboplatin,-2.5,5,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,-2.5,5,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,-2.5,12,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,-2,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,-2,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,-2,12,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,-1,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,-1,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,-1,15,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,1,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,1,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,1,18,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,2,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,2,4,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,2,20,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,3,5,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,3,5,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,3,20,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,4,6,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,4,6,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,4,20,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
19090012,NA,20,carboplatin,5,7,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,carboplatin,5,7,AUC,1,Day 1 every 21 days,NA
19090012,NA,20,irinotecan,5,20,mg/m2,1,"days 1-5, and 8-12 every 21 days",NA
20159815,NA,21,dulanermin,1,4,mg/kg,1,for 5 consecutive days of each 21-day cycle,NA
20159815,NA,21,paclitaxel,1,200,mg/m2,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,bevacizumab,1,15,mg/kg,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,dulanermin,2,8,mg/kg,1,for 5 consecutive days of each 21-day cycle,NA
20159815,NA,21,paclitaxel,2,200,mg/m2,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,bevacizumab,2,15,mg/kg,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,dulanermin,3,15,mg/kg,1,for 2 consecutive days of each 21-day cycle,NA
20159815,NA,21,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,bevacizumab,3,15,mg/kg,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,dulanermin,4,20,mg/kg,1,for 2 consecutive days of each 21-day cycle,NA
20159815,NA,21,paclitaxel,4,200,mg/m2,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,4,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,carboplatin,4,6,AUC,1,on day 1 of each 21-day cycle,fixed
20159815,NA,21,bevacizumab,4,15,mg/kg,1,on day 1 of each 21-day cycle,fixed
20028752,NCT00094835,22,motesanib,1,50,mg,1,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,22,paclitaxel,1,200,mg/m2,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,1,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,1,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,motesanib,2,125,mg,1,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,22,paclitaxel,2,200,mg/m2,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,2,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,2,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,motesanib,3,75,mg,2,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,22,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,3,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,22,carboplatin,3,6,AUC,1,on day 1 of each 21-d cycle for up to six cycles,NA
20028752,NCT00094835,23,motesanib,1,50,mg,1,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,23,panitumumab,1,9,mg/kg,1,on day 1 of each 21-d cycle,NA
20028752,NCT00094835,23,motesanib,2,125,mg,1,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,23,panitumumab,2,9,mg/kg,1,on day 1 of each 21-d cycle,NA
20028752,NCT00094835,23,motesanib,3,75,mg,2,on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter.,NA
20028752,NCT00094835,23,panitumumab,3,9,mg/kg,1,on day 1 of each 21-d cycle,NA
20927639,NA,25,trabectedin,1,0.8,mg/m2,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,carboplatin,1,4,AUC,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,carboplatin,1,4,AUC,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,trabectedin,2,1,mg/m2,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,carboplatin,2,4,AUC,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,carboplatin,2,4,AUC,1,q3wk,carboplatin-pretreated patients
20927639,NA,25,trabectedin,3,0.5,mg/m2,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,3,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,3,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,trabectedin,4,0.65,mg/m2,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,4,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,4,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,trabectedin,5,0.8,mg/m2,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,5,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,5,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,trabectedin,6,1,mg/m2,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,6,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,6,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,trabectedin,7,1.2,mg/m2,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,7,5,AUC,1,q3wk,carboplatin-naïve patients
20927639,NA,25,carboplatin,7,5,AUC,1,q3wk,carboplatin-naïve patients
21035955,NCT00721292,26,vandetanib,1,100,mg,1,"7 days a week, starting at least 7 days before SRS",NA
21035955,NCT00721292,26,fractionated stereotactic radiotherapy,1,12,Gy,1,3 consecutive days totally,NA
21035955,NCT00721292,26,vandetanib,2,200,mg,1,"7 days a week, starting at least 7 days before SRS",NA
21035955,NCT00721292,26,fractionated stereotactic radiotherapy,2,12,Gy,1,3 consecutive days totally,NA
21035955,NCT00721292,26,vandetanib,3,300,mg,1,"7 days a week, starting at least 7 days before SRS",NA
21035955,NCT00721292,26,fractionated stereotactic radiotherapy,3,12,Gy,1,3 consecutive days totally,NA
19531625,NA,27,carboplatin,1,4,AUC,1,on day 1 every 28 d,C->T schedule
19531625,NA,27,carboplatin,1,4,AUC,1,on day 1 every 28 d,C->T schedule
19531625,NA,27,topotecan,1,0.5,mg/m2,1,on days 1-3 every 28 d,C->T schedule
19531625,NA,27,topotecan,1,0.5,mg/m2,1,on days 1-3 every 28 d,C->T schedule
19531625,NA,27,carboplatin,2,5,AUC,1,on day 1 every 28 d,C->T schedule
19531625,NA,27,carboplatin,2,5,AUC,1,on day 1 every 28 d,C->T schedule
19531625,NA,27,topotecan,2,0.5,mg/m2,1,on days 1-3 every 28 d,C->T schedule
19531625,NA,27,topotecan,2,0.5,mg/m2,1,on days 1-3 every 28 d,C->T schedule
19531625,NA,27,topotecan,3,0.5,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,3,0.5,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,3,4,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,3,4,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,4,0.5,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,4,0.5,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,4,5,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,4,5,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,5,0.6,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,5,0.6,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,5,5,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,5,5,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,6,0.7,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,6,0.7,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,6,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,6,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,7,0.8,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,7,0.8,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,7,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,7,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,8,0.9,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,8,0.9,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,8,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,8,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,topotecan,9,1.1,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,topotecan,9,1.1,mg/m2,1,on days 1-3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,9,6,AUC,1,on day 3 every 28 d,T->C schedule
19531625,NA,27,carboplatin,9,6,AUC,1,on day 3 every 28 d,T->C schedule
19390943,NA,28,amrubicin,1,35,mg/m2,1,on days 1–3 every 3 weeks,NA
19390943,NA,28,vinorelbine,1,15,mg/m2,1,on days 1 and 8 every 3 weeks,NA
19390943,NA,28,amrubicin,2,35,mg/m2,1,on days 1–3 every 3 weeks,NA
19390943,NA,28,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
19390943,NA,28,amrubicin,3,40,mg/m2,1,on days 1–3 every 3 weeks,NA
19390943,NA,28,vinorelbine,3,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
19390943,NA,28,amrubicin,4,45,mg/m2,1,on days 1–3 every 3 weeks,NA
19390943,NA,28,vinorelbine,4,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
19390943,NA,28,amrubicin,5,45,mg/m2,1,on days 1–3 every 3 weeks,NA
19390943,NA,28,vinorelbine,5,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
19596976,NA,29,capecitabine,0,1000,mg/m2,1,on days 1-14 and 22-35,NA
19596976,NA,29,capecitabine,0,1000,mg/m2,1,on days 1-14 and 22-35,NA
19596976,NA,29,carboplatin,0,2,AUC,1,six weekly doses,NA
19596976,NA,29,carboplatin,0,2,AUC,1,six weekly doses,NA
19596976,NA,29,imrt,0,70,Gy,NA,in 35 fractions over 7 weeks,NA
19596976,NA,29,capecitabine,-1,850,mg/m2,1,on days 1-14 and 22-35,NA
19596976,NA,29,capecitabine,-1,850,mg/m2,1,on days 1-14 and 22-35,NA
19596976,NA,29,carboplatin,-1,2,AUC,1,six weekly doses,NA
19596976,NA,29,carboplatin,-1,2,AUC,1,six weekly doses,NA
19596976,NA,29,imrt,-1,70,Gy,NA,in 35 fractions over 7 weeks,NA
21397973,NA,30,paclitaxel,1,40,mg/m2,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,carboplatin,1,2,AUC,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,carboplatin,1,2,AUC,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,rtrt,1,66,Gy,NA,concurrently on day1 with chemotherapy for all patients for 7 weeks,NA
21397973,NA,30,paclitaxel,2,45,mg/m2,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,carboplatin,2,2,AUC,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,carboplatin,2,2,AUC,1,"on days 1, 8, 15, 22, 29, 36, and 43",NA
21397973,NA,30,rtrt,2,66,Gy,NA,"concurrently on day1 with chemotherapy for all patients for 7 weeks, at 2 Gy/fraction, 5 days/week",NA
18621626,NA,31,paclitaxel,1,175,mg/m2,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,flavopiridol,1,30,mg/m2,1,21-26 hours after the start of paclitaxel every 3 weeks,NA
18621626,NA,31,paclitaxel,2,175,mg/m2,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,flavopiridol,2,50,mg/m2,1,21-26 hours after the start of paclitaxel every 3 weeks,NA
18621626,NA,31,paclitaxel,3,175,mg/m2,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,flavopiridol,3,70,mg/m2,1,21-26 hours after the start of paclitaxel every 3 weeks,NA
18621626,NA,31,paclitaxel,4,175,mg/m2,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
18621626,NA,31,flavopiridol,4,85,mg/m2,1,21-26 hours after the start of paclitaxel every 3 weeks,NA
18166842,NA,32,irinotecan,0,100,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,0,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,0,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,paclitaxel,0,175,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,irinotecan,0,30,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,carboplatin,0,2,AUC,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,carboplatin,0,2,AUC,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,paclitaxel,0,45,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,chest radiotherapy,0,2,Gy,1,daily from day 43 to 85,NA
18166842,NA,32,irinotecan,-1,100,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-1,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-1,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,paclitaxel,-1,175,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,irinotecan,-1,30,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,paclitaxel,-1,45,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,chest radiotherapy,-1,2,Gy,1,daily from day 43 to 85,NA
18166842,NA,32,irinotecan,-2,100,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-2,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-2,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,paclitaxel,-2,175,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,irinotecan,-2,30,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,paclitaxel,-2,40,mg/m2,1,"on days 43, 50, 57, 64, 71, and 78",NA
18166842,NA,32,chest radiotherapy,-2,2,Gy,1,daily from day 43 to 85,NA
18166842,NA,32,irinotecan,-3,100,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-3,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,carboplatin,-3,5,AUC,1,on days 1 and 22,NA
18166842,NA,32,paclitaxel,-3,175,mg/m2,1,on days 1 and 22,NA
18166842,NA,32,irinotecan,-3,30,mg/m2,1,"on days 50, 57, 71, and 78",NA
18166842,NA,32,paclitaxel,-3,40,mg/m2,1,"on days 50, 57, 71, and 78",NA
18166842,NA,32,chest radiotherapy,-3,2,Gy,1,daily from day 43 to 85,NA
18802151,NA,33,oxaliplatin,1,40,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,1,40,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,2,50,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,2,50,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,3,60,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,3,60,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,4,75,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,4,75,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,5,90,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,5,90,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,6,110,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18802151,NA,33,oxaliplatin,6,110,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
20623160,NA,34,plitidepsin,-1,1.8,mg/m2,1,"on Days 1, 8 and 15 q4wk",NA
20623160,NA,34,carboplatin,-1,4,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,carboplatin,-1,4,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,plitidepsin,1,1.8,mg/m2,1,"on Days 1, 8 and 15 q4wk",NA
20623160,NA,34,carboplatin,1,5,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,carboplatin,1,5,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,plitidepsin,2,2.4,mg/m2,1,"on Days 1, 8 and 15 q4wk",NA
20623160,NA,34,carboplatin,2,5,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,carboplatin,2,5,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,plitidepsin,3,3,mg/m2,1,"on Days 1, 8 and 15 q4wk",NA
20623160,NA,34,carboplatin,3,5,AUC,1,on Day 1 q4wk,NA
20623160,NA,34,carboplatin,3,5,AUC,1,on Day 1 q4wk,NA
20647930,ACTRN12609000790246,35,carboplatin,1,5,AUC,1,on day 1,NA
20647930,ACTRN12609000790246,35,carboplatin,1,5,AUC,1,on day 1,NA
20647930,ACTRN12609000790246,35,irinotecan,1,50,mg/m2,1,on days 1 and 8,NA
20647930,ACTRN12609000790246,35,paclitaxel,1,50,mg/m2,1,on days 1 and 8,NA
20647930,ACTRN12609000790246,35,carboplatin,-1,5,AUC,1,on day 1,NA
20647930,ACTRN12609000790246,35,carboplatin,-1,5,AUC,1,on day 1,NA
20647930,ACTRN12609000790246,35,irinotecan,-1,40,mg/m2,1,on days 1 and 8,NA
20647930,ACTRN12609000790246,35,paclitaxel,-1,40,mg/m2,1,on days 1 and 8,NA
20107803,NA,36,tamoxifen,1,100,mg,2,on day 1 every 4 weeks,NA
20107803,NA,36,topotecan,1,0.25,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,topotecan,1,0.25,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,carboplatin,1,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,carboplatin,1,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,tamoxifen,2,100,mg,2,on day 1 every 4 weeks,NA
20107803,NA,36,topotecan,2,0.5,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,topotecan,2,0.5,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,carboplatin,2,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,carboplatin,2,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,tamoxifen,3,100,mg,2,on day 1 every 4 weeks,NA
20107803,NA,36,topotecan,3,0.75,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,topotecan,3,0.75,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,carboplatin,3,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,carboplatin,3,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,tamoxifen,4,100,mg,2,on day 1 every 4 weeks,NA
20107803,NA,36,topotecan,4,1,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,topotecan,4,1,mg/m2,1,on days 1-3 every 4 weeks,NA
20107803,NA,36,carboplatin,4,3,AUC,1,on day 3 every 4 weeks,NA
20107803,NA,36,carboplatin,4,3,AUC,1,on day 3 every 4 weeks,NA
19096311,NA,37,gemcitabine,1,300,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,1,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,37,gemcitabine,2,300,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,2,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,2,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,2,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,37,gemcitabine,3,450,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,3,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,3,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,3,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,37,gemcitabine,4,600,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,4,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,4,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,4,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,37,gemcitabine,5,750,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,5,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,5,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,5,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,37,gemcitabine,6,900,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,6,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,carboplatin,6,2,AUC,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,37,thoracic radiation therapy,6,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,1,300,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,1,30,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,1,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,2,450,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,2,30,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,2,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,3,450,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,3,40,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,3,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,4,600,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,4,40,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,4,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,5,600,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,5,50,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,5,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,6,750,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,6,50,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,6,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
19096311,NA,38,gemcitabine,7,900,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,paclitaxel,7,50,mg/m2,1,"on days 1, 8, 22, 29, and 43 of the plannedradiation therapy course",NA
19096311,NA,38,thoracic radiation therapy,7,1.8,Gy,1,5 days per week to a dose of 45 Gy to the primary and mediastinum plus a boost of 18 Gy in 9 2.0 Gy fractions to the primary andinvolved nodes,NA
21140147,NA,39,sunitinib,1,25,mg,1,on days 1-14 of each 21-day cycle,schedule 2/1
21140147,NA,39,paclitaxel,1,175,mg/m2,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,sunitinib,2,37.5,mg,1,on days 1-14 of each 21-day cycle,schedule 2/1
21140147,NA,39,paclitaxel,2,175,mg/m2,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,sunitinib,3,37.5,mg,1,on days 1-14 of each 21-day cycle,schedule 2/1
21140147,NA,39,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,schedule 2/1
21140147,NA,39,sunitinib,4,25,mg,1,daily,CDD schedule
21140147,NA,39,paclitaxel,4,175,mg/m2,1,daily,CDD schedule
21140147,NA,39,carboplatin,4,6,AUC,1,daily,CDD schedule
21140147,NA,39,carboplatin,4,6,AUC,1,daily,CDD schedule
21140147,NA,39,sunitinib,5,37.5,mg,1,daily,CDD schedule
21140147,NA,39,paclitaxel,5,175,mg/m2,1,daily,CDD schedule
21140147,NA,39,carboplatin,5,6,AUC,1,daily,CDD schedule
21140147,NA,39,carboplatin,5,6,AUC,1,daily,CDD schedule
21140147,NA,39,sunitinib,6,50,mg,1,daily,CDD schedule
21140147,NA,39,paclitaxel,6,175,mg/m2,1,daily,CDD schedule
21140147,NA,39,carboplatin,6,6,AUC,1,daily,CDD schedule
21140147,NA,39,carboplatin,6,6,AUC,1,daily,CDD schedule
21140147,NA,39,sunitinib,7,25,mg,1,daily,CDD schedule
21140147,NA,39,paclitaxel,7,200,mg/m2,1,daily,CDD schedule
21140147,NA,39,carboplatin,7,6,AUC,1,daily,CDD schedule
21140147,NA,39,carboplatin,7,6,AUC,1,daily,CDD schedule
21447615,NA,40,temsirolimus,1,25,mg,1,on days 8 and 15 every 21 days,NA
21447615,NA,40,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,1,135,mg/m2,1,on day 1 every 21 days,NA
21447615,NA,40,temsirolimus,2,25,mg,1,on days 8 and 15 every 21 days,NA
21447615,NA,40,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,2,175,mg/m2,1,on day 1 every 21 days,NA
21447615,NA,40,temsirolimus,3,15,mg,1,on days 1 and 8 every 21 days,NA
21447615,NA,40,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,3,175,mg/m2,1,on day 1 every 21 days,NA
21447615,NA,40,temsirolimus,4,20,mg,1,on days 1 and 8 every 21 days,NA
21447615,NA,40,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,4,175,mg/m2,1,on day 1 every 21 days,NA
21447615,NA,40,temsirolimus,5,25,mg,1,on days 1 and 8 every 21 days,NA
21447615,NA,40,carboplatin,5,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,5,5,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,5,175,mg/m2,1,on day 1 every 21 days,NA
21447615,NA,40,temsirolimus,6,25,mg,1,on days 1 and 8 every 21 days,NA
21447615,NA,40,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
21447615,NA,40,paclitaxel,6,175,mg/m2,1,on day 1 every 21 days,NA
17278895,NA,43,carboplatin,1,4,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,carboplatin,1,4,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,docetaxel,1,20,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17278895,NA,43,carboplatin,2,4,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,carboplatin,2,4,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,docetaxel,2,25,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17278895,NA,43,carboplatin,3,5,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,carboplatin,3,5,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,docetaxel,3,25,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17278895,NA,43,carboplatin,4,5,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,carboplatin,4,5,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,docetaxel,4,30,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17278895,NA,43,carboplatin,5,6,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,carboplatin,5,6,AUC,1,on day 1 every 4 weeks,NA
17278895,NA,43,docetaxel,5,30,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,irinotecan,1,50,mg/m2,1,"Days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,carboplatin,1,4,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,carboplatin,1,4,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,irinotecan,2,60,mg/m2,1,"Days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,carboplatin,2,4,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,carboplatin,2,4,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,irinotecan,3,50,mg/m2,1,"Days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,carboplatin,3,5,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,carboplatin,3,5,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,irinotecan,4,60,mg/m2,1,"Days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,carboplatin,4,5,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,carboplatin,4,5,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,irinotecan,5,50,mg/m2,1,"Days 1, 8, and 15 every 4 weeks",NA
16047343,NA,44,carboplatin,5,6,AUC,1,on Day 1 every 4 weeks,NA
16047343,NA,44,carboplatin,5,6,AUC,1,on Day 1 every 4 weeks,NA
17409916,NA,45,amrubicin,0,35,mg/m2,1,"on days 1, 2, and 3 of each 21-day treatment cycle",NA
17409916,NA,45,carboplatin,0,4,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,carboplatin,0,4,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,amrubicin,1,40,mg/m2,1,"on days 1, 2, and 3 of each 21-day treatment cycle",NA
17409916,NA,45,carboplatin,1,4,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,carboplatin,1,4,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,amrubicin,2,40,mg/m2,1,"on days 1, 2, and 3 of each 21-day treatment cycle",NA
17409916,NA,45,carboplatin,2,5,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,carboplatin,2,5,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,amrubicin,3,45,mg/m2,1,"on days 1, 2, and 3 of each 21-day treatment cycle",NA
17409916,NA,45,carboplatin,3,5,AUC,1,on day 1 of each 21-day treatment cycle,NA
17409916,NA,45,carboplatin,3,5,AUC,1,on day 1 of each 21-day treatment cycle,NA
17197129,NA,46,capecitabine,1,825,mg/m2,2,daily beginning on Day 1 and finishing on the evening of the last day of RT,NA
17197129,NA,46,capecitabine,1,825,mg/m2,2,daily beginning on Day 1 and finishing on the evening of the last day of RT,NA
17197129,NA,46,carboplatin,1,2,AUC,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,carboplatin,1,2,AUC,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,paclitaxel,1,60,mg/m2,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,rt,1,1.8,Gy,1,total 50.4 Gy,NA
17197129,NA,46,capecitabine,-1,600,mg/m2,2,daily beginning on Day 1 and finishing on the evening of the last day of RT,NA
17197129,NA,46,capecitabine,-1,600,mg/m2,2,daily beginning on Day 1 and finishing on the evening of the last day of RT,NA
17197129,NA,46,carboplatin,-1,1.5,AUC,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,carboplatin,-1,1.5,AUC,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,paclitaxel,-1,45,mg/m2,1,"on Days 2, 9, 16, 23, and 30",NA
17197129,NA,46,rt,-1,1.8,Gy,1,total 50.4 Gy,NA
15737558,NA,47,topotecan,1,10,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,1,10,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,1,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,1,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,paclitaxel,1,175,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,2,15,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,2,15,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,2,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,2,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,paclitaxel,2,175,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,3,20,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,3,20,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,3,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,3,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,paclitaxel,3,175,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,4,25,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,topotecan,4,25,mg/m2,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,4,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,carboplatin,4,6,AUC,1,On day 1 every 21 days,NA
15737558,NA,47,paclitaxel,4,175,mg/m2,1,On day 1 every 21 days,NA
17881149,NA,48,uft,1,200,mg,2,"daily Monday–Friday, finishing on the evening of the last day of RT",NA
17881149,NA,48,uft,1,200,mg,2,"daily Monday–Friday, finishing on the evening of the last day of RT",NA
17881149,NA,48,leucovorin,1,30,mg,2,daily beginning  on Day 1 and finishing on the evening of the last day of RT,NA
17881149,NA,48,carboplatin,1,5,NA,1,"d 2, 23",NA
17881149,NA,48,carboplatin,1,5,NA,1,"d 2, 23",NA
17881149,NA,48,paclitaxel,1,175,NA,1,"d 2, 23",NA
17881149,NA,48,rt,1,1.8,Gy,1,Monday–Friday for 25 days,NA
17881149,NA,48,uft,2,300,mg,2,"daily Monday–Friday, finishing on the evening of the last day of RT",NA
17881149,NA,48,uft,2,300,mg,2,"daily Monday–Friday, finishing on the evening of the last day of RT",NA
17881149,NA,48,leucovorin,2,30,mg,2,daily beginning  on Day 1 and finishing on the evening of the last day of RT,NA
17881149,NA,48,carboplatin,2,5,NA,1,"d 2, 23",NA
17881149,NA,48,carboplatin,2,5,NA,1,"d 2, 23",NA
17881149,NA,48,paclitaxel,2,175,NA,1,"d 2, 23",NA
17881149,NA,48,rt,2,1.8,Gy,1,Monday–Friday for 25 days,NA
16203659,NA,49,topotecan,1,7,AUC,1,on Days 1–5 every 21 days,AUC 7-23
16203659,NA,49,topotecan,1,7,AUC,1,on Days 1–5 every 21 days,AUC 7-23
16203659,NA,49,etoposide,1,50,mg/m2,2,Days 6–8 every 21 days,NA
16203659,NA,49,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
16203659,NA,49,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
16203659,NA,49,topotecan,2,7,AUC,1,on Days 1–5 every 21 days,AUC 7-23
16203659,NA,49,topotecan,2,7,AUC,1,on Days 1–5 every 21 days,AUC 7-23
16203659,NA,49,etoposide,2,50,mg/m2,2,Days 6–8 every 21 days,NA
16203659,NA,49,carboplatin,2,5,AUC,1,on day 5 every 21 days,NA
16203659,NA,49,carboplatin,2,5,AUC,1,on day 5 every 21 days,NA
16203659,NA,49,topotecan,3,24,AUC,1,on Days 1–5 every 21 days,AUC 24-36
16203659,NA,49,topotecan,3,24,AUC,1,on Days 1–5 every 21 days,AUC 24-36
16203659,NA,49,etoposide,3,50,mg/m2,2,Days 6–8 every 21 days,NA
16203659,NA,49,carboplatin,3,5,AUC,1,on day 5 every 21 days,NA
16203659,NA,49,carboplatin,3,5,AUC,1,on day 5 every 21 days,NA
16203659,NA,49,topotecan,4,7,AUC,1,on Days 1–3 every 21 days,AUC 7-23
16203659,NA,49,topotecan,4,7,AUC,1,on Days 1–3 every 21 days,AUC 7-23
16203659,NA,49,etoposide,4,50,mg/m2,2,Days 4–6 every 21 days,NA
16203659,NA,49,carboplatin,4,5,AUC,1,on day 3 every 21 days,NA
16203659,NA,49,carboplatin,4,5,AUC,1,on day 3 every 21 days,NA
16203659,NA,49,topotecan,5,24,AUC,1,on Days 1–3 every 21 days,AUC 24-36
16203659,NA,49,topotecan,5,24,AUC,1,on Days 1–3 every 21 days,AUC 24-36
16203659,NA,49,etoposide,5,50,mg/m2,2,Days 4–6 every 21 days,NA
16203659,NA,49,carboplatin,5,5,AUC,1,on day 3 every 21 days,NA
16203659,NA,49,carboplatin,5,5,AUC,1,on day 3 every 21 days,NA
16203659,NA,49,topotecan,6,37,AUC,1,on Days 1–3 every 21 days,AUC 37-53
16203659,NA,49,topotecan,6,37,AUC,1,on Days 1–3 every 21 days,AUC 37-53
16203659,NA,49,etoposide,6,50,mg/m2,2,Days 4–6 every 21 days,NA
16203659,NA,49,carboplatin,6,5,AUC,NA,on day 3 every 21 days,NA
16203659,NA,49,carboplatin,6,5,AUC,NA,on day 3 every 21 days,NA
16203659,NA,49,topotecan,7,54,AUC,1,on Days 1–3 every 21 days,AUC 54-66
16203659,NA,49,topotecan,7,54,AUC,1,on Days 1–3 every 21 days,AUC 54-66
16203659,NA,49,etoposide,7,50,mg/m2,2,Days 4–6 every 21 days,NA
16203659,NA,49,carboplatin,7,5,AUC,1,on day 3 every 21 days,NA
16203659,NA,49,carboplatin,7,5,AUC,1,on day 3 every 21 days,NA
16463061,NA,50,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,1,80,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
16463061,NA,50,carboplatin,2,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,2,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,2,80,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
16463061,NA,50,carboplatin,3,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,3,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,3,90,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
16463061,NA,50,carboplatin,4,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,4,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,4,100,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
16463061,NA,50,carboplatin,5,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,5,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,5,110,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
16463061,NA,50,carboplatin,6,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,carboplatin,6,4,AUC,1,on day 1 every 28 days,NA
16463061,NA,50,etoposide,6,120,mg/m2,1,"on days 1, 2 and 3 every 28 days",NA
17882655,NCT00117572,51,carboplatin,1,6,AUC,1,on Day 1 for two 4-week cycles,induction chemotherapy
17882655,NCT00117572,51,carboplatin,1,6,AUC,1,on Day 1 for two 4-week cycles,induction chemotherapy
17882655,NCT00117572,51,docetaxel,1,30,mg/m2,1,"on Days 1, 8, 15 for two 4-week cycles",induction chemotherapy
17882655,NCT00117572,51,docetaxel,1,20,NA,1,on Day 1 for 5 2-week cycle,concomitant chemoradiation 1-2 weeks after induction chemotherapy
17882655,NCT00117572,51,hydroxyurea,1,500,mg,2,"days 0, 1-5  for 5 2-week cycle",concomitant chemoradiation 1-2 weeks after induction chemotherapy
17882655,NCT00117572,51,5-fu,1,600,mg/m2,1,"days 0, 1-4 for 5 2-week cycle",concomitant chemoradiation 1-2 weeks after induction chemotherapy
17882655,NCT00117572,51,carboplatin,2,6,AUC,1,on Day 1 for two 4-week cycles,induction chemotherapy
17882655,NCT00117572,51,carboplatin,2,6,AUC,1,on Day 1 for two 4-week cycles,induction chemotherapy
17882655,NCT00117572,51,docetaxel,2,35,mg/m2,1,"on Days 1, 8, 15 for two 4-week cycles",induction chemotherapy
17882655,NCT00117572,51,docetaxel,2,25,NA,1,on Day 1 for 5 2-week cycle,concomitant chemoradiation 1-2 weeks after induction chemotherapy
17882655,NCT00117572,51,hydroxyurea,2,500,mg,2,"days 0, 1-5  for 5 2-week cycle",concomitant chemoradiation 1-2 weeks after induction chemotherapy
17882655,NCT00117572,51,5-fu,2,600,mg/m2,1,"days 0, 1-4 for 5 2-week cycle",concomitant chemoradiation 1-2 weeks after induction chemotherapy
16622691,NA,52,gemcitabine,1,1200,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,irinotecan,1,150,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,gemcitabine,2,1500,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,irinotecan,2,150,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,gemcitabine,3,1500,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,irinotecan,3,180,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,gemcitabine,4,1800,mg/m2,1,days 1 and 15 every 4 days,NA
16622691,NA,52,irinotecan,4,180,mg/m2,1,days 1 and 15 every 4 days,NA
16193241,NA,53,docetaxel,1,50,mg/m2,1,day 1 every 21 days,NA
16193241,NA,53,etoposide,1,80,mg/m2,1,on days 2 and 3 every 21 days,i.v.
16193241,NA,53,carboplatin,1,6,AUC,1,day 1 every 21 days,NA
16193241,NA,53,carboplatin,1,6,AUC,1,day 1 every 21 days,NA
16193241,NA,53,etoposide,1,160,mg/m2,1,day 1 every 21 days,orally
16193241,NA,53,docetaxel,-1,50,mg/m2,1,day 1 every 21 days,NA
16193241,NA,53,etoposide,-1,50,mg/m2,1,on days 2 and 3 every 21 days,i.v.
16193241,NA,53,carboplatin,-1,5,AUC,1,day 1 every 21 days,NA
16193241,NA,53,carboplatin,-1,5,AUC,1,day 1 every 21 days,NA
16193241,NA,53,etoposide,-1,100,mg/m2,1,day 1 every 21 days,orally
15246197,NA,54,carboplatin,1,5,AUC,1,on day1 of two 21-day cycle,NA
15246197,NA,54,carboplatin,1,5,AUC,1,on day1 of two 21-day cycle,NA
15246197,NA,54,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of two 21-day cycle,NA
15246197,NA,54,paclitaxel,1,50,mg/m2,1,"began on day43 began on day43, weekly for 4 weeks",NA
15246197,NA,54,vinorelbine,1,10,mg/m2,1,"began on day43 began on day43, weekly for 4 weeks",NA
15246197,NA,54,radiation,NA,200,cGy,1,"began on day 43, 5 days per week, (Monday to Friday) for a planned total of approximately 30 fractions or six treatment weeks (total radiotherapycourse of 60 cGy)",NA
15246197,NA,54,carboplatin,2,5,AUC,1,on day1 of two 21-day cycle,NA
15246197,NA,54,carboplatin,2,5,AUC,1,on day1 of two 21-day cycle,NA
15246197,NA,54,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of two 21-day cycle,NA
15246197,NA,54,paclitaxel,2,50,mg/m2,1,"began on day43, weekly for 4 weeks",NA
15246197,NA,54,vinorelbine,2,15,mg/m2,1,"began on day43, weekly for 4 weeks",NA
15246197,NA,54,radiation,2,200,cGy,1,"began on day 43, 5 days per week, (Monday to Friday) for a planned total of approximately 30 fractions or six treatment weeks (total radiotherapycourse of 60 cGy)",NA
17634546,NA,55,patupilone,1,3.6,mg/m2,1,once every3 weeks,NA
17634546,NA,55,carboplatin,1,5,AUC,1,once every3 weeks,NA
17634546,NA,55,carboplatin,1,5,AUC,1,once every3 weeks,NA
17634546,NA,55,patupilone,2,4.8,mg/m2,1,once every3 weeks,NA
17634546,NA,55,carboplatin,2,5,AUC,1,once every3 weeks,NA
17634546,NA,55,carboplatin,2,5,AUC,1,once every3 weeks,NA
17634546,NA,55,patupilone,3,4.8,mg/m2,1,once every3 weeks,NA
17634546,NA,55,carboplatin,3,6,AUC,1,once every3 weeks,NA
17634546,NA,55,carboplatin,3,6,AUC,1,once every3 weeks,NA
17634546,NA,55,patupilone,4,6,mg/m2,1,once every3 weeks,NA
17634546,NA,55,carboplatin,4,6,AUC,1,once every3 weeks,NA
17634546,NA,55,carboplatin,4,6,AUC,1,once every3 weeks,NA
15690136,NA,56,cyclophosphamide,1,3500,mg/m2,1,on days 1 and 2,NA
15690136,NA,56,carboplatin,1,400,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,1,400,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,cyclophosphamide,2,3500,mg/m2,1,on days 1 and 2,NA
15690136,NA,56,carboplatin,2,475,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,2,475,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,cyclophosphamide,3,3500,mg/m2,1,on days 1 and 2,NA
15690136,NA,56,carboplatin,3,550,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,3,550,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,cyclophosphamide,4,3500,mg/m2,1,on days 1 and 2,NA
15690136,NA,56,carboplatin,4,625,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,4,625,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,cyclophosphamide,5,3500,mg/m2,1,on days 1 and 2,NA
15690136,NA,56,carboplatin,5,700,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,5,700,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,5,775,mg/m2,1,starting at day 17 for 3 days,NA
15690136,NA,56,carboplatin,5,775,mg/m2,1,starting at day 17 for 3 days,NA
17523723,NA,57,bendamustine,1,80,mg/m2,1,on days 1 and 2 every 3 weeks,NA
17523723,NA,57,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,bendamustine,2,100,mg/m2,1,on days 1 and 2 every 3 weeks,NA
17523723,NA,57,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,bendamustine,3,100,mg/m2,1,on days 1 and 2 every 3 weeks,NA
17523723,NA,57,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,bendamustine,4,120,mg/m2,1,on days 1 and 2 every 3 weeks,NA
17523723,NA,57,carboplatin,4,6,AUC,1,on day 1 every 3 weeks,NA
17523723,NA,57,carboplatin,4,6,AUC,1,on day 1 every 3 weeks,NA
15150564,NA,58,nedaplatin,1,60,mg/m2,1,on day 1 every 3 weeks,NA
15150564,NA,58,gemcitabine,1,800,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
15150564,NA,58,nedaplatin,2,80,mg/m2,1,on day 1 every 3 weeks,NA
15150564,NA,58,gemcitabine,2,800,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
15150564,NA,58,nedaplatin,3,80,mg/m2,1,on day 1 every 3 weeks,NA
15150564,NA,58,gemcitabine,3,1000,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
15150564,NA,58,nedaplatin,4,100,mg/m2,1,on day 1 every 3 weeks,NA
15150564,NA,58,gemcitabine,4,1000,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
15007250,NA,59,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of each 21-day course,NA
15007250,NA,59,topotecan,1,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,topotecan,1,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,gemcitabine,0.5,600,mg/m2,1,on days 1 and 8 of each 21-day course,NA
15007250,NA,59,topotecan,0.5,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,topotecan,0.5,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,gemcitabine,1.5,800,mg/m2,1,on day 1 of each 21-day course,NA
15007250,NA,59,gemcitabine,1.5,600,mg/m2,1,on day 8 of each 21-day course,NA
15007250,NA,59,topotecan,1.5,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,topotecan,1.5,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,gemcitabine,2,800,mg/m2,1,on day 1 of each 21-day course,NA
15007250,NA,59,gemcitabine,2,600,mg/m2,1,on day 8 of each 21-day course,NA
15007250,NA,59,topotecan,2,0.75,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,topotecan,2,0.75,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,gemcitabine,3,800,mg/m2,1,on day 1 of each 21-day course,NA
15007250,NA,59,gemcitabine,3,600,mg/m2,1,on day 8 of each 21-day course,NA
15007250,NA,59,topotecan,3,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15007250,NA,59,topotecan,3,0.5,mg/m2,1,on days 1–5 of each 21-day course,NA
15054448,NA,60,carboplatin,1,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,1,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,paclitaxel,1,175,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,2,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,2,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,paclitaxel,2,175,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,gemcitabine,2,800,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,3,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,3,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,paclitaxel,3,175,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,gemcitabine,3,1000,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,4,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,carboplatin,4,6,AUC,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,paclitaxel,4,175,mg/m2,1,"of a 10-day cycle, for six cycles",NA
15054448,NA,60,gemcitabine,4,1200,mg/m2,1,"of a 10-day cycle, for six cycles",NA
17498782,NA,61,carboplatin,1,400,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,1,400,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,2,600,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,2,600,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,3,800,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,3,800,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,4,1000,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,4,1000,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,5,1200,mg/m2,1,NA,NA
17498782,NA,61,carboplatin,5,1200,mg/m2,1,NA,NA
16959305,NA,62,paclitaxel,1,175,mg/m2,1,every 28 days,NA
16959305,NA,62,carboplatin,1,5,AUC,1,every 28 days,NA
16959305,NA,62,carboplatin,1,5,AUC,1,every 28 days,NA
16959305,NA,62,liposomal doxorubicin,1,20,mg/m2,1,every 28 days,NA
16959305,NA,62,paclitaxel,2,175,mg/m2,1,every 28 days,NA
16959305,NA,62,carboplatin,2,5,AUC,1,every 28 days,NA
16959305,NA,62,carboplatin,2,5,AUC,1,every 28 days,NA
16959305,NA,62,liposomal doxorubicin,2,30,mg/m2,1,every 28 days,NA
16959305,NA,62,paclitaxel,3,175,mg/m2,1,every 28 days,NA
16959305,NA,62,carboplatin,3,5,AUC,1,every 28 days,NA
16959305,NA,62,carboplatin,3,5,AUC,1,every 28 days,NA
16959305,NA,62,liposomal doxorubicin,3,40,mg/m2,1,every 28 days,NA
16959305,NA,62,paclitaxel,4,175,mg/m2,1,every 21 days,NA
16959305,NA,62,carboplatin,4,5,AUC,1,every 21 days,NA
16959305,NA,62,carboplatin,4,5,AUC,1,every 21 days,NA
16959305,NA,62,liposomal doxorubicin,4,40,mg/m2,1,every 42 days,NA
16959305,NA,62,paclitaxel,5,175,mg/m2,1,every 7 days,NA
16959305,NA,62,carboplatin,5,5,AUC,1,every 21 days,NA
16959305,NA,62,carboplatin,5,5,AUC,1,every 21 days,NA
16959305,NA,62,liposomal doxorubicin,5,40,mg/m2,1,every 42 days,NA
16282248,NA,63,pegylated liposomal doxorubicin,1,20,mg/m2,1,every 28 days,NA
16282248,NA,63,carboplatin,1,6,AUC,1,every 28 days,NA
16282248,NA,63,carboplatin,1,6,AUC,1,every 28 days,NA
16282248,NA,63,pegylated liposomal doxorubicin,2,30,mg/m2,1,every 28 days,NA
16282248,NA,63,carboplatin,2,6,AUC,1,every 28 days,NA
16282248,NA,63,carboplatin,2,6,AUC,1,every 28 days,NA
16282248,NA,63,pegylated liposomal doxorubicin,3,40,mg/m2,1,every 28 days,NA
16282248,NA,63,carboplatin,3,6,AUC,1,every 28 days,NA
16282248,NA,63,carboplatin,3,6,AUC,1,every 28 days,NA
16282248,NA,63,pegylated liposomal doxorubicin,4,50,mg/m2,1,every 28 days,NA
16282248,NA,63,carboplatin,4,6,AUC,1,every 28 days,NA
16282248,NA,63,carboplatin,4,6,AUC,1,every 28 days,NA
16115936,NA,64,flavopiridol,1,50,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,1,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,1,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,flavopiridol,2,75,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,2,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,2,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,flavopiridol,3,100,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,3,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,3,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,flavopiridol,4,135,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,4,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,4,30,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,flavopiridol,5,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,5,30,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,5,30,mg/m2,1,every 3 weeks,NA
16115936,NA,64,flavopiridol,6,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,6,45,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,6,45,mg/m2,1,every 3 weeks,NA
16115936,NA,64,flavopiridol,7,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,7,60,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,7,60,mg/m2,1,every 3 weeks,NA
16115936,NA,64,flavopiridol,8,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,64,cisplatin,8,75,mg/m2,1,every 3 weeks,NA
16115936,NA,64,cisplatin,8,75,mg/m2,1,every 3 weeks,NA
16115936,NA,65,flavopiridol,1,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,65,carboplatin,1,2,AUC,1,every 3 weeks,NA
16115936,NA,65,carboplatin,1,2,AUC,1,every 3 weeks,NA
16115936,NA,65,flavopiridol,2,100,mg/m2,1,every 3 weeks,fixed
16115936,NA,65,carboplatin,2,3,AUC,1,every 3 weeks,NA
16115936,NA,65,carboplatin,2,3,AUC,1,every 3 weeks,NA
15812395,NA,66,docetaxel,1,150,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,NA,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,1,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,1,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,2,250,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,2,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,2,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,2,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,3,350,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,3,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,3,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,3,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,4,450,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,4,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,4,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,4,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,5,550,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,5,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,5,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,5,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,6,500,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,6,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,6,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,6,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,7,450,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,7,165,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,7,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,7,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,8,450,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,8,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,8,1300,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,8,1300,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,docetaxel,9,400,mg/m2,1,on day -6 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,melphalan,9,150,mg/m2,1,from day -5 to day -3 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,9,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
15812395,NA,66,carboplatin,9,1000,mg/m2,1,on day -5 of Autologous Hematopoietic Progenitor Cell Support,NA
17950919,NA,67,gemcitabine,1,10,mg/m2/min,1,9 hr from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,1,300,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,1,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,1,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,1,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,2,10,mg/m2/min,1,12h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,2,300,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,2,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,2,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,2,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,3,10,mg/m2/min,1,15h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,3,300,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,3,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,3,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,3,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,4,10,mg/m2/min,1,15h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,4,350,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,4,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,4,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,4,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,5,10,mg/m2/min,1,18h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,5,350,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,5,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,5,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,5,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,6,10,mg/m2/min,1,20h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,6,350,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,6,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,6,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,6,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,gemcitabine,7,10,mg/m2/min,1,20h from day -6 until day -5 of autologous stem cell transplantation,NA
17950919,NA,67,docetaxel,7,350,mg/m2,1,on day -5 of autologous stem cell transplantation,NA
17950919,NA,67,melphalan,7,50,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,7,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17950919,NA,67,carboplatin,7,333,mg/m2,1,"on days -4, -3, and -2 of autologous stem cell transplantation",NA
17285317,NA,68,abi-007,1,220,mg/m2,1,on day 1 every 21 days,Group A
17285317,NA,68,carboplatin,1,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,1,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,abi-007,2,260,mg/m2,1,on day 1 every 21 days,Group A
17285317,NA,68,carboplatin,2,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,2,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,abi-007,3,300,mg/m2,1,on day 1 every 21 days,Group A
17285317,NA,68,carboplatin,3,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,3,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,abi-007,4,340,mg/m2,1,on day 1 every 21 days,Group A
17285317,NA,68,carboplatin,4,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,4,6,AUC,1,on day 1 every 21 days,fixed
17285317,NA,68,abi-007,5,100,mg/m2,1,"on days 1, 8, and 15 every 28 days",Group B
17285317,NA,68,carboplatin,5,6,AUC,1,on day 1 every 28 days,fixed
17285317,NA,68,carboplatin,5,6,AUC,1,on day 1 every 28 days,fixed
17285317,NA,68,abi-007,6,125,mg/m2,1,"on days 1, 8, and 15 every 28 days",Group B
17285317,NA,68,carboplatin,6,6,AUC,1,on day 1 every 28 days,fixed
17285317,NA,68,carboplatin,6,6,AUC,1,on day 1 every 28 days,fixed
17285317,NA,68,abi-007,7,125,mg/m2,NA,on days 1 and 8 every 21 days,Group C
17285317,NA,68,carboplatin,7,6,AUC,NA,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,7,6,AUC,NA,on day 1 every 21 days,fixed
17285317,NA,68,abi-007,8,150,mg/m2,NA,on days 1 and 8 every 21 days,Group C
17285317,NA,68,carboplatin,8,6,AUC,NA,on day 1 every 21 days,fixed
17285317,NA,68,carboplatin,8,6,AUC,NA,on day 1 every 21 days,fixed
17049403,NA,69,carboplatin,1,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,carboplatin,1,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,etoposide,1,150,mg,1,on days 6-10 every 21 days,NA
17049403,NA,69,topotecan,1,2,mg,1,on days 1-5 every 21 days,NA
17049403,NA,69,topotecan,1,2,mg,1,on days 1-5 every 21 days,NA
17049403,NA,69,carboplatin,2,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,carboplatin,2,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,etoposide,2,150,mg,1,on days 6-10 every 21 days,NA
17049403,NA,69,topotecan,2,3,mg,1,on days 1-5 every 21 days,NA
17049403,NA,69,topotecan,2,3,mg,1,on days 1-5 every 21 days,NA
17049403,NA,69,carboplatin,3,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,carboplatin,3,5,AUC,1,on day 6 every 21 days,NA
17049403,NA,69,etoposide,3,200,mg,1,on days 6-10 every 21 days,NA
17049403,NA,69,topotecan,3,3,mg,1,on days 1-5 every 21 days,NA
17049403,NA,69,topotecan,3,3,mg,1,on days 1-5 every 21 days,NA
15589596,NA,70,paclitaxel,1,50,mg/m2,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,1,1.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,1,1.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,external beam therapy,1,180,cGy,1,daily in five fractions per week for a total of 25 fractions,NA
15589596,NA,70,paclitaxel,2,50,mg/m2,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,2,2,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,2,2,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,external beam therapy,2,180,cGy,1,daily in five fractions per week for a total of 25 fractions,NA
15589596,NA,70,paclitaxel,3,50,mg/m2,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,3,2.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,3,2.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,external beam therapy,3,180,cGy,1,daily in five fractions per week for a total of 25 fractions,NA
15589596,NA,70,paclitaxel,4,50,mg/m2,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,4,3,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,4,3,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,external beam therapy,4,180,cGy,1,daily in five fractions per week for a total of 25 fractions,NA
15589596,NA,70,paclitaxel,5,50,mg/m2,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,5,3.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,carboplatin,5,3.5,AUC,1,weekly prior to external beam radiation,NA
15589596,NA,70,external beam therapy,5,180,cGy,1,daily in five fractions per week for a total of 25 fractions,NA
16421427,NA,71,131i-mibg,1,12,mCi/kg,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,1,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,1,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,etoposide,1,1200,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,melphalan,1,210,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,131i-mibg,2,15,mCi/kg,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,2,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,2,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,etoposide,2,1200,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,melphalan,2,210,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,131i-mibg,3,18,mCi/kg,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,3,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,3,1500,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,etoposide,3,1200,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,melphalan,3,210,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,131i-mibg,4,18,mCi/kg,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,4,1700,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,carboplatin,4,1700,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,etoposide,4,1200,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,melphalan,4,210,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Normal GFR >= 100 mL/min/1.73 m2
16421427,NA,71,131i-mibg,1.5,12,mg/m2,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,carboplatin,1.5,3.3,AUC,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,carboplatin,1.5,3.3,AUC,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,etoposide,1.5,640,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,melphalan,1.5,180,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,131i-mibg,2.5,15,mg/m2,1,on day-21 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,carboplatin,2.5,3.3,AUC,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,carboplatin,2.5,3.3,AUC,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,etoposide,2.5,640,mg/m2,1,on days -7 to -3 before autologous stem-celltransplantation (ASCT),Patients With Low GFR 60-99 mL/min/1.73 m2
16421427,NA,71,melphalan,2.5,180,mg/m2,1,"days -7, -6, and -5 autologous stem-celltransplantation (ASCT)",Patients With Low GFR 60-99 mL/min/1.73 m2
15249718,NA,72,irinotecan,1,50,mg/m2,1,"on day 1, 8, and 15 every 28 days",NA
15249718,NA,72,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
15249718,NA,72,carboplatin,1,5,AUC,1,on day 1 every 28 days,NA
15249718,NA,72,irinotecan,2,50,mg/m2,1,"on day 1, 8, and 15 every 28 days",NA
15249718,NA,72,carboplatin,2,6,AUC,1,on day 1 every 28 days,NA
15249718,NA,72,carboplatin,2,6,AUC,1,on day 1 every 28 days,NA
17921708,NA,73,paclitaxel,1,100,mg/m2,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,1,3,AUC,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,1,3,AUC,1,on day 1 every 2 weeks,NA
17921708,NA,73,paclitaxel,2,120,mg/m2,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,2,3,AUC,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,2,3,AUC,1,on day 1 every 2 weeks,NA
17921708,NA,73,paclitaxel,3,140,mg/m2,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,3,3,AUC,1,on day 1 every 2 weeks,NA
17921708,NA,73,carboplatin,3,3,AUC,1,on day 1 every 2 weeks,NA
17326096,NA,74,gemcitabine,1,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,irinotecan,1,80,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,carboplatin,1,4,AUC,1,on Day 1 every 3 weeks,NA
17326096,NA,74,carboplatin,1,4,AUC,1,on Day 1 every 3 weeks,NA
17326096,NA,74,gemcitabine,2,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,irinotecan,2,80,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,carboplatin,2,5,AUC,1,on Day 1 every 3 weeks,NA
17326096,NA,74,carboplatin,2,5,AUC,1,on Day 1 every 3 weeks,NA
17326096,NA,74,gemcitabine,3,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,irinotecan,3,60,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,carboplatin,3,2,AUC,1,on Days 1 and 8 every 3 weeks,NA
17326096,NA,74,carboplatin,3,2,AUC,1,on Days 1 and 8 every 3 weeks,NA
16377585,NA,75,ct-2103,1,175,mg/m2,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,1,5,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,1,5,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,ct-2103,2,210,mg/m2,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,2,5,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,2,5,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,ct-2103,3,210,mg/m2,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,3,6,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,3,6,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,ct-2103,4,225,mg/m2,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,4,6,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,4,6,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,ct-2103,5,250,mg/m2,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,5,6,AUC,1,on Day 1 of a 21-day cycle,NA
16377585,NA,75,carboplatin,5,6,AUC,1,on Day 1 of a 21-day cycle,NA
17917089,NA,77,paclitaxel,1,150,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,1,4,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,1,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,1,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,paclitaxel,2,180,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,2,4,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,2,4,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,2,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,2,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,paclitaxel,3,180,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,3,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,3,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,paclitaxel,4,180,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,4,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,4,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,4,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,4,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,paclitaxel,5,200,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,5,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,5,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,5,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,5,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,paclitaxel,6,225,mg/m2,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,carboplatin,6,6,AUC,1,on day 1 every 21 days,NA
17917089,NA,77,uft,6,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17917089,NA,77,uft,6,400,mg/m2,1,on days 1–5 and 8–12 every 21 days,NA
17103043,NA,79,docetaxel,-1,60,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,-1,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,-1,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,-1,5,mg,1,on days 1-14 of each 21-day cycle,NA
17103043,NA,79,docetaxel,1,60,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,1,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,1,10,mg,1,on days 1-14 of each 21-day cycle,NA
17103043,NA,79,docetaxel,2,75,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,2,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,2,10,mg,1,on days 1-14 of each 21-day cycle,NA
17103043,NA,79,docetaxel,3,75,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,3,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,3,15,mg,1,on days 1-14 of each 21-day cycle,NA
17103043,NA,79,docetaxel,4,75,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,4,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,4,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,4,20,mg,1,on days 1-14 of each 21-day cycle,NA
17103043,NA,79,docetaxel,5,75,mg/m2,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,5,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,carboplatin,5,6,AUC,1,on day 1 of each 21-day cycle,NA
17103043,NA,79,lenalidomide,5,25,mg,1,on days 1-14 of each 21-day cycle,NA
15494716,NA,80,dha – paclitaxel,1,660,mg/m2,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
15494716,NA,80,dha – paclitaxel,2,880,mg/m2,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
15494716,NA,80,dha – paclitaxel,3,1100,mg/m2,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
15494716,NA,80,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
16445611,NA,81,carboplatin,1,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,carboplatin,1,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,paclitaxel,1,250,mg/m2,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,topotecan,1,5,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,topotecan,1,5,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,etoposide,1,600,mg/m2,1,on day -3 in cycle 2 of HDC,NA
16445611,NA,81,thiotepa,1,500,mg/m2,1,on day -3 in cycle 3 of HDC,NA
16445611,NA,81,carboplatin,2,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,carboplatin,2,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,paclitaxel,2,250,mg/m2,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,topotecan,2,7,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,topotecan,2,7,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,etoposide,2,600,mg/m2,1,on day -3 in cycle 2 of HDC,NA
16445611,NA,81,thiotepa,2,500,mg/m2,1,on day -3 in cycle 3 of HDC,NA
16445611,NA,81,carboplatin,3,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,carboplatin,3,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,paclitaxel,3,250,mg/m2,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,topotecan,3,9,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,topotecan,3,9,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,etoposide,3,600,mg/m2,1,on day -3 in cycle 2 of HDC,NA
16445611,NA,81,thiotepa,3,500,mg/m2,1,on day -3 in cycle 3 of HDC,NA
16445611,NA,81,carboplatin,4,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,carboplatin,4,20,AUC,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,paclitaxel,4,250,mg/m2,1,in cycle 1 of HDC over 2 days (starting onday -5),NA
16445611,NA,81,topotecan,4,11,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,topotecan,4,11,mg/m2,1,on day -8 in cycle 2 of HDC,NA
16445611,NA,81,etoposide,4,600,mg/m2,1,on day -3 in cycle 2 of HDC,NA
16445611,NA,81,thiotepa,4,500,mg/m2,1,on day -3 in cycle 3 of HDC,NA
15856233,NA,82,docetaxel,1,50,mg/m2,1,on day 1  (schedule A) or after (schedule B) carboplatin every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,1,5,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,1,5,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,docetaxel,2,60,mg/m2,1,on day 1  (schedule A) or after (schedule B) carboplatin every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,2,5,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,2,5,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,docetaxel,3,60,mg/m2,1,on day 1  (schedule A) or after (schedule B) carboplatin every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,3,6,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,3,6,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,docetaxel,4,60,mg/m2,1,on day 1  (schedule A) or after (schedule B) carboplatin every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,4,7,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,4,7,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,docetaxel,5,70,mg/m2,1,on day 1  (schedule A) or after (schedule B) carboplatin every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,5,6,AUC,1,on day 1 every 3 or 4 weeks,NA
15856233,NA,82,carboplatin,5,6,AUC,1,on day 1 every 3 or 4 weeks,NA
17922272,NA,83,topotecan,0,1,mg/m2,1,on days 1 to 3 every 21 days,NA
17922272,NA,83,topotecan,0,1,mg/m2,1,on days 1 to 3 every 21 days,NA
17922272,NA,83,carboplatin,0,5,AUC,1,on day 3 every 21 days,NA
17922272,NA,83,carboplatin,0,5,AUC,1,on day 3 every 21 days,NA
17922272,NA,83,topotecan,-1,0.75,mg/m2,1,on days 1 to 3 every 21 days,NA
17922272,NA,83,topotecan,-1,0.75,mg/m2,1,on days 1 to 3 every 21 days,NA
17922272,NA,83,carboplatin,-1,5,AUC,1,on day 3 every 21 days,NA
17922272,NA,83,carboplatin,-1,5,AUC,1,on day 3 every 21 days,NA
12120886,NA,84,carboplatin,1,4,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,carboplatin,1,4,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
12120886,NA,84,carboplatin,2,5,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,carboplatin,2,5,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
12120886,NA,84,carboplatin,3,6,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,carboplatin,3,6,AUC,1,on day 1 in a 21-day cycle,NA
12120886,NA,84,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 in a 21-day cycle,NA
14612900,NA,85,carboplatin,1,3,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,1,3,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,1,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,1,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,2,4,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,2,4,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,2,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,2,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,3,5,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,3,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,3,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,4,6,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,4,6,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,4,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,4,150,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,5,3,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,5,3,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,5,200,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,5,200,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,6,4,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,6,4,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,6,200,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,6,200,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,carboplatin,7,5,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,carboplatin,7,5,AUC,1,on day 1 every 28 days,NA
14612900,NA,85,temozolomide,7,200,mg/m2,1,on days 1-5 every 28 days,NA
14612900,NA,85,temozolomide,7,200,mg/m2,1,on days 1-5 every 28 days,NA
12201492,NA,86,pyrazoloacridine,1,200,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,1,3,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,1,3,AUC,1,every 4 weeks,NA
12201492,NA,86,pyrazoloacridine,2,400,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,2,3,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,2,3,AUC,1,every 4 weeks,NA
12201492,NA,86,pyrazoloacridine,3,400,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,3,4,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,3,4,AUC,1,every 4 weeks,NA
12201492,NA,86,pyrazoloacridine,4,400,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,4,5,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,4,5,AUC,1,every 4 weeks,NA
12201492,NA,86,pyrazoloacridine,5,500,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,5,5,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,5,5,AUC,1,every 4 weeks,NA
12201492,NA,86,pyrazoloacridine,6,600,mg/m2,1,every 4 weeks,NA
12201492,NA,86,carboplatin,6,5,AUC,1,every 4 weeks,NA
12201492,NA,86,carboplatin,6,5,AUC,1,every 4 weeks,NA
12404295,NA,87,paclitaxel,1,135,mg/m2,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,1,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,1,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,paclitaxel,2,150,mg/m2,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,2,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,2,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,paclitaxel,3,175,mg/m2,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,3,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
12404295,NA,87,carboplatin,3,2,AUC,1,weekly for 6 consecutive weeks of each 8-week cycle,NA
11127946,NA,88,carboplatin,1,4,AUC,1,on day 1 every 28 days,NA
11127946,NA,88,carboplatin,1,4,AUC,1,on day 1 every 28 days,NA
11127946,NA,88,doxorubicin,1,15,mg/m2,1,on days 1-4 every 28 days,NA
11127946,NA,88,ifosfamide,1,1250,mg/m2,1,on days 1-4 every 28 days,NA
11127946,NA,88,mesna,1,1000,mg/m2,1,on days 1-4 every 28 days,NA
14733637,NA,89,irinotecan,1,30,mg/m2,1,weekly for 6 weeks,NA
14733637,NA,89,thoracic radiotherapy,1,2,Gy,1,for a total dose of 60 Gy over 6 weeks,NA
14733637,NA,89,irinotecan,1,40,mg/m2,1,weekly for 6 weeks,NA
14733637,NA,89,irinotecan,1,50,mg/m2,1,weekly for 6 weeks,NA
11733958,NA,90,topotecan,1,0.5,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,topotecan,1,0.5,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,carboplatin,1,5,AUC,1,on day 3,fixed
11733958,NA,90,carboplatin,1,5,AUC,1,on day 3,fixed
11733958,NA,90,topotecan,2,0.75,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,topotecan,2,0.75,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,carboplatin,2,5,AUC,1,on day 3,fixed
11733958,NA,90,carboplatin,2,5,AUC,1,on day 3,fixed
11733958,NA,90,topotecan,3,1,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,topotecan,3,1,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,carboplatin,3,5,AUC,1,on day 3,fixed
11733958,NA,90,carboplatin,3,5,AUC,1,on day 3,fixed
11733958,NA,90,topotecan,4,1.25,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,topotecan,4,1.25,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,carboplatin,4,5,AUC,1,on day 3,fixed
11733958,NA,90,carboplatin,4,5,AUC,1,on day 3,fixed
11733958,NA,90,topotecan,5,1.5,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,topotecan,5,1.5,mg/m2,1,on days 1-3 every 3 weeks,NA
11733958,NA,90,carboplatin,5,5,AUC,1,on day 3,fixed
11733958,NA,90,carboplatin,5,5,AUC,1,on day 3,fixed
11768362,NA,91,epirubicin,1,30,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,cyclophosphamide,1,400,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,5-fluorouracil,1,200,mg/m2,1,"from day 1 to 28, q 4 weeks",NA
11768362,NA,91,epirubicin,2,45,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,cyclophosphamide,2,400,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,5-fluorouracil,2,200,mg/m2,1,"from day 1 to 28, q 4 weeks",NA
11768362,NA,91,epirubicin,3,60,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,cyclophosphamide,3,400,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,5-fluorouracil,3,200,mg/m2,1,"from day 1 to 28, q 4 weeks",NA
11768362,NA,91,epirubicin,3.5,60,mg/m2,1,"on days 1 & 8,q4W",modified dose level 3
11768362,NA,91,cyclophosphamide,3.5,400,mg/m2,1,"on days 1 & 8,q4W",NA
11768362,NA,91,5-fluorouracil,3.5,200,mg/m2,1,"from day 1 to 21, q 4 weeks",NA
11506300,NA,92,carboplatin,1,4,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,carboplatin,1,4,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,etoposide,1,90,mg/m2,1,on days 1-3 every 4 weeks,NA
11506300,NA,92,carboplatin,2,4,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,carboplatin,2,4,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,etoposide,2,100,mg/m2,1,on days 1-3 every 4 weeks,NA
11506300,NA,92,carboplatin,3,4.5,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,carboplatin,3,4.5,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,etoposide,3,100,mg/m2,1,on days 1-3 every 4 weeks,NA
11506300,NA,92,carboplatin,4,5,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,carboplatin,4,5,AUC,1,on day 1 every 4 weeks,NA
11506300,NA,92,etoposide,4,100,mg/m2,1,on days 1-3 every 4 weeks,NA
14984965,NA,93,carboplatin,1,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,carboplatin,1,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,docetaxel,1,60,mg,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,carboplatin,2,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,carboplatin,2,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,docetaxel,2,75,mg,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,carboplatin,3,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,carboplatin,3,5,AUC,1,on day 1 of each 3-weekly cycle,NA
14984965,NA,93,docetaxel,3,90,mg,1,on day 1 of each 3-weekly cycle,NA
11398884,NA,94,cyclophosphamide,5,3000,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,5,800,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,5,800,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,cyclophosphamide,1,1200,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,1,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,1,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,cyclophosphamide,2,1800,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,2,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,2,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,cyclophosphamide,3,2400,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,3,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,3,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,cyclophosphamide,4,3000,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,4,600,mg/m2,1,every 28 days for 3 cycles,NA
11398884,NA,94,carboplatin,4,600,mg/m2,1,every 28 days for 3 cycles,NA
11828945,NA,95,paclitaxel,1,175,mg/m2,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,1,4,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,1,4,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,paclitaxel,2,175,mg/m2,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,2,5,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,2,5,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,paclitaxel,3,175,mg/m2,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,3,6,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,3,6,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,paclitaxel,4,175,mg/m2,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,4,7,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,4,7,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,paclitaxel,5,175,mg/m2,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,5,8,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,carboplatin,5,8,AUC,1,On day 1 of 3-week cycle,Group A
11828945,NA,95,paclitaxel,6,115,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,6,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,6,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,paclitaxel,7,130,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,7,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,7,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,paclitaxel,8,145,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,8,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,8,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,paclitaxel,9,160,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,9,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,9,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,paclitaxel,10,175,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,10,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,10,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,paclitaxel,11,190,mg/m2,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,11,6,AUC,1,On day 1 of 3-week cycle,Group B
11828945,NA,95,carboplatin,11,6,AUC,1,On day 1 of 3-week cycle,Group B
11142482,NA,96,paclitaxel,1,175,NA,1,on day 1 every three weeks,NA
11142482,NA,96,gemcitabine,1,800,NA,1,on days 1 and 8 every three weeks,NA
11142482,NA,96,carboplatin,1,6,AUC,1,on day 1 every three weeks,NA
11142482,NA,96,carboplatin,1,6,AUC,1,on day 1 every three weeks,NA
11142482,NA,96,paclitaxel,2,175,NA,1,on day 1 every three weeks,NA
11142482,NA,96,gemcitabine,2,1000,NA,1,on days 1 and 8 every three weeks,NA
11142482,NA,96,carboplatin,2,6,AUC,1,on day 1 every three weeks,NA
11142482,NA,96,carboplatin,2,6,AUC,1,on day 1 every three weeks,NA
11142482,NA,96,paclitaxel,3,200,NA,1,on day 1 every three weeks,NA
11142482,NA,96,gemcitabine,3,1000,NA,1,on days 1 and 8 every three weeks,NA
11142482,NA,96,carboplatin,3,6,AUC,1,on day 1 every three weeks,NA
11142482,NA,96,carboplatin,3,6,AUC,1,on day 1 every three weeks,NA
11134194,NA,97,paclitaxel,1,60,mg/m2,1,weekly,NA
11134194,NA,97,estramustine,1,3.3,mg/kg,3,day -2 through day +2 every 4 weeks,NA
11134194,NA,97,paclitaxel,2,60,mg/m2,1,weekly,NA
11134194,NA,97,carboplatin,2,6,AUC,1,every 4 weeks,NA
11134194,NA,97,carboplatin,2,6,AUC,1,every 4 weeks,NA
11134194,NA,97,estramustine,2,3.3,mg/kg,3,day -2 through day +2 every 4 weeks,NA
11134194,NA,97,paclitaxel,3,80,mg/m2,1,weekly,NA
11134194,NA,97,carboplatin,3,6,AUC,1,every 4 weeks,NA
11134194,NA,97,carboplatin,3,6,AUC,1,every 4 weeks,NA
11134194,NA,97,estramustine,3,3.3,mg/kg,1,day -2 through day +2 every 4 weeks,NA
11134194,NA,97,paclitaxel,4,100,mg/m2,1,weekly,NA
11134194,NA,97,carboplatin,4,6,AUC,1,every 4 weeks,NA
11134194,NA,97,carboplatin,4,6,AUC,1,every 4 weeks,NA
11134194,NA,97,estramustine,4,3.3,mg/kg,1,day -2 through day +2 every 4 weeks,NA
14613998,NA,98,bms-188797,1,35,mg/m2,1,"on day 1, 8, and 15 of each 21-day cycle",NA
14613998,NA,98,bms-188797,2,50,mg/m2,1,"on day 1, 8, and 15 of each 21-day cycle",NA
14613998,NA,98,bms-188797,3,65,mg/m2,1,"on day 1, 8, and 15 of each 21-day cycle",NA
12743738,NA,99,paclitaxel,1,100,mg/m2,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,1,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,1,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,paclitaxel,2,120,mg/m2,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,2,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,2,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,paclitaxel,3,140,mg/m2,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,3,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,3,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,paclitaxel,4,160,mg/m2,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,4,3,AUC,1,on day 1 every 2 weeks,NA
12743738,NA,99,carboplatin,4,3,AUC,1,on day 1 every 2 weeks,NA
12177114,NA,100,pemetrexed disodium,1,400,mg/m2,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,1,3,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,1,3,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,pemetrexed disodium,2,400,mg/m2,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,2,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,pemetrexed disodium,3,500,mg/m2,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,3,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,pemetrexed disodium,4,600,mg/m2,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,4,5,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,pemetrexed disodium,5,500,mg/m2,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,5,6,AUC,1,on day 1 every 21 days,NA
12177114,NA,100,carboplatin,5,6,AUC,1,on day 1 every 21 days,NA
11398891,NA,101,paclitaxel,1,175,mg/m2,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,1,6,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,1,6,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,topotecan,1,0.5,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,topotecan,1,0.5,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,paclitaxel,2,175,mg/m2,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,2,6,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,2,6,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,topotecan,2,0.75,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,topotecan,2,0.75,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,paclitaxel,3,175,mg/m2,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,3,5,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,3,5,AUC,1,on day 1 (early sequence) or 5 (late sequence every 21 days,NA
11398891,NA,101,topotecan,3,0.75,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,topotecan,3,0.75,mg/m2,1,on days 1-5 every 21 days,NA
11398891,NA,101,paclitaxel,4,175,mg/m2,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,4,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,4,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,topotecan,4,0.75,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,101,topotecan,4,0.75,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,paclitaxel,1,175,mg/m2,1,on day 1 every 21 days,NA
11398891,NA,102,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
11398891,NA,102,carboplatin,1,5,AUC,1,on day 1 every 21 days,NA
11398891,NA,102,topotecan,1,0.75,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,topotecan,1,0.75,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,granulocyte colony-stimulating factor,1,5,ug/kg,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11398891,NA,102,granulocyte colony-stimulating factor,1,5,ug/kg,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11398891,NA,101,paclitaxel,5,175,mg/m2,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,5,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,carboplatin,5,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,101,topotecan,5,1,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,101,topotecan,5,1,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,paclitaxel,2,175,mg/m2,1,on day 5 (late sequence)  every 21 days,NA
11398891,NA,102,carboplatin,2,5,AUC,1,on day 5 (late sequence)  every 21 days,NA
11398891,NA,102,carboplatin,2,5,AUC,1,on day 5 (late sequence)  every 21 days,NA
11398891,NA,102,topotecan,2,1,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,topotecan,2,1,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,granulocyte colony-stimulating factor,2,5,ug/kg,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11398891,NA,102,granulocyte colony-stimulating factor,2,5,ug/kg,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11398891,NA,102,paclitaxel,3,175,mg/m2,1,on day 5 (late sequence every 21 days,NA
11398891,NA,102,carboplatin,3,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,102,carboplatin,3,5,AUC,1,on day 5 (late sequence every 21 days,NA
11398891,NA,102,topotecan,3,1.25,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,topotecan,3,1.25,mg/m2,1,on days 1-4 every 21 days,NA
11398891,NA,102,granulocyte colony-stimulating factor,3,5,ug/kg/per day,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11398891,NA,102,granulocyte colony-stimulating factor,3,5,ug/kg/per day,1,"starting day 6 (24 hours after lasttopotecan dose) through day 19 or until the neutrophil count wasabove 10,000/ul",NA
11925132,NA,103,carboplatin,0,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,0,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,0,0.75,mg/m2,1,on Days 1-5 every 21 days,NA
11925132,NA,103,topotecan,0,0.75,mg/m2,1,on Days 1-5 every 21 days,NA
11925132,NA,103,carboplatin,1,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,1,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,1,0.6,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,topotecan,1,0.6,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,carboplatin,2,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,2,5,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,2,0.75,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,topotecan,2,0.75,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,carboplatin,3,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,3,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,3,0.75,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,topotecan,3,0.75,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,carboplatin,4,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,4,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,4,0.9,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,topotecan,4,0.9,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,carboplatin,5,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,carboplatin,5,4,AUC,1,on Day 1 every 21 days,NA
11925132,NA,103,topotecan,5,1,mg/m2,1,on Days 1-3 every 21 days,NA
11925132,NA,103,topotecan,5,1,mg/m2,1,on Days 1-3 every 21 days,NA
11142689,NA,104,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,irinotecan,1,40,mg/m2,1,on day 1 every 3 weeks,NA
11142689,NA,104,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,irinotecan,2,50,mg/m2,1,on day 1 every 3 weeks,NA
11142689,NA,104,docetaxel,3,60,mg/m2,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
11142689,NA,104,irinotecan,3,60,mg/m2,1,on day 1 every 3 weeks,NA
12649113,NA,105,doxorubicin,1,50,mg/m2,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,1,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,1,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,paclitaxel,1,60,mg/m2,1,"days 1, 8, 15, 21, 28-day cycle",NA
12649113,NA,105,doxorubicin,2,50,mg/m2,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,2,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,2,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,paclitaxel,2,75,mg/m2,1,"days 1, 8, 15, 21, 28-day cycle",NA
12649113,NA,105,doxorubicin,3,50,mg/m2,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,3,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,carboplatin,3,6,AUC,1,"day 1, 28-day cycle",NA
12649113,NA,105,paclitaxel,3,90,mg/m2,1,"days 1, 8, 15, 21, 28-day cycle",NA
12045462,NA,106,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,irinotecan,1,40,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,docetaxel,1,30,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,irinotecan,2,50,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,docetaxel,2,30,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,irinotecan,3,60,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,docetaxel,3,30,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
12045462,NA,106,irinotecan,4,60,mg/m2,1,on days 1 and  8 every 3 weeks,NA
12045462,NA,106,docetaxel,4,35,mg/m2,1,on days 1 and  8 every 3 weeks,NA
11325490,NA,107,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
11325490,NA,107,carboplatin,1,4,AUC,1,on day 1 of a 21-day cycle,NA
11325490,NA,107,carboplatin,1,4,AUC,1,on day 1 of a 21-day cycle,NA
11325490,NA,107,gemcitabine,0.5,800,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
11325490,NA,107,carboplatin,0.5,4,AUC,1,on day 1 of a 21-day cycle,NA
11325490,NA,107,carboplatin,0.5,4,AUC,1,on day 1 of a 21-day cycle,NA
11325490,NA,107,gemcitabine,1.5,800,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
11325490,NA,107,carboplatin,1.5,5,AUC,1,on day 1 of a 21-day cycle,NA
11325490,NA,107,carboplatin,1.5,5,AUC,1,on day 1 of a 21-day cycle,NA
11800024,NA,108,docetaxel,1,40,mg/m2,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,1,5,AUC,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,1,5,AUC,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,docetaxel,2,50,mg/m2,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,2,5,AUC,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,2,5,AUC,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,docetaxel,3,60,mg/m2,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,3,5,AUC,1,on day 1 every 3-4 weeks,NA
11800024,NA,108,carboplatin,3,5,AUC,1,on day 1 every 3-4 weeks,NA
11914594,NA,109,vinorelbine,1,25,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,1,4,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,1,4,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,vinorelbine,2,25,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,2,5,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,vinorelbine,3,25,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,3,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,3,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,vinorelbine,4,30,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,4,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,4,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,vinorelbine,5,35,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,5,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,5,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,vinorelbine,6,35,mg/m2,1,on days 1 and 8 every 28 days,NA
11914594,NA,109,carboplatin,6,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,carboplatin,6,6,AUC,1,on day 1 every 28 days,NA
11914594,NA,109,g-csf,6,NA,NA,1,on days 10–15 every 28 days,NA
11914594,NA,109,g-csf,6,NA,NA,1,on days 10–15 every 28 days,NA
11550166,NA,110,amifostine,1,740,mg,2,on Days 1-3,NA
11550166,NA,110,amifostine,1,740,mg,2,on Days 1-3,NA
11550166,NA,110,ifosfamide,1,3000,mg/m2,1,on Days 1 and 2,NA
11550166,NA,110,carboplatin,1,635,mg/m2,1,on Day 3,NA
11550166,NA,110,carboplatin,1,635,mg/m2,1,on Day 3,NA
11550166,NA,110,etoposide,1,150,mg/m2,1,on Days 1 and 2,NA
11550166,NA,110,amifostine,-1,600,mg,2,on Days 1-3,NA
11550166,NA,110,amifostine,-1,600,mg,2,on Days 1-3,NA
11550166,NA,110,ifosfamide,-1,3000,mg/m2,1,on Days 1 and 2,NA
11550166,NA,110,carboplatin,-1,635,mg/m2,1,on Day 3,NA
11550166,NA,110,carboplatin,-1,635,mg/m2,1,on Day 3,NA
11550166,NA,110,etoposide,-1,150,mg/m2,1,on Days 1 and 2,NA
11925132,NA,111,topotecan,0,0.75,mg/m2,1,"on Days 1-5 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,0,0.75,mg/m2,1,"on Days 1-5 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,0,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,0,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,0,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
11925132,NA,111,topotecan,1,0.6,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,1,0.6,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,1,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,1,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,1,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
11925132,NA,111,topotecan,2,0.75,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,2,0.75,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,2,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,2,5,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,2,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
11925132,NA,111,topotecan,3,0.75,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,3,0.75,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,3,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,3,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,3,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
11925132,NA,111,topotecan,4,0.9,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,4,0.9,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,4,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,4,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,4,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
11925132,NA,111,topotecan,5,1,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,topotecan,5,1,mg/m2,1,"on Days 1-3 in cycles (21-day) 1, 3, 5, and 7",NA
11925132,NA,111,carboplatin,5,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,carboplatin,5,4,AUC,1,on Day 1 in all 21-day cycles,NA
11925132,NA,111,paclitaxel,5,175,mg/m2,1,"on Day 1 in cycles (21-day) 2, 4, 6 and 8",NA
12750842,NA,112,gemcitabine,1,10,mg/m2/min,1,60 min on days 1 and 8 every 21-day cycle,NA
12750842,NA,112,carboplatin,1,5,AUC,1,on day 1 every 21-day cycle,NA
12750842,NA,112,carboplatin,1,5,AUC,1,on day 1 every 21-day cycle,NA
12750842,NA,112,gemcitabine,2,10,mg/m2/min,1,90 min on days 1 and 8 every 21-day cycle,NA
12750842,NA,112,carboplatin,2,5,AUC,1,on day 1 every 21-day cycle,NA
12750842,NA,112,carboplatin,2,5,AUC,1,on day 1 every 21-day cycle,NA
12750842,NA,112,gemcitabine,1.5,10,mg/m2/min,1,75 min on days 1 and 8 every 21-day cycle,NA
12750842,NA,112,carboplatin,1.5,5,AUC,1,on day 1 every 21-day cycle,NA
12750842,NA,112,carboplatin,1.5,5,AUC,1,on day 1 every 21-day cycle,NA
11955654,NA,113,gemcitabine,1,750,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,1,4,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,1,4,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,2,875,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,2,4,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,2,4,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,3,875,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,3,5,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,3,5,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,4,1000,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,4,5,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,4,5,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,5,1000,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,5,6,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,5,6,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,6,1250,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,6,6,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,6,6,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,gemcitabine,7,1500,mg/m2,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,7,6,AUC,1,on day 1 of every 21 days cycle,NA
11955654,NA,113,carboplatin,7,6,AUC,1,on day 1 of every 21 days cycle,NA
11710627,NA,114,lobradimil,1,100,ng/kg IBW,1,"on days 1-3 of the first cycle, and days 1 and 2 of each subsequent cycle",NA
11710627,NA,114,carboplatin,1,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,carboplatin,1,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,lobradimil,2,300,ng/kg IBW,1,"on days 1-3 of the first cycle, and days 1 and 2 of each subsequent cycle",NA
11710627,NA,114,carboplatin,2,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,carboplatin,2,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,lobradimil,3,450,ng/kg IBW,1,"on days 1-3 of the first cycle, and days 1 and 2 of each subsequent cycle",NA
11710627,NA,114,carboplatin,3,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,carboplatin,3,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,lobradimil,4,600,ng/kg IBW ,1,"on days 1-3 of the first cycle, and days 1 and 2 of each subsequent cycle",NA
11710627,NA,114,carboplatin,4,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11710627,NA,114,carboplatin,4,2.5,AUC,1,on days 2 and 3 every 28 days,NA
11714542,NA,115,docetaxel,1,20,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,115,thoracic radiation therapy,1,200,cGy,1,5 days each week for 6 weeks,NA
11714542,NA,115,docetaxel,2,30,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,115,thoracic radiation therapy,2,200,cGy,1,5 days each week for 6 weeks,NA
11714542,NA,115,docetaxel,3,40,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,115,thoracic radiation therapy,3,200,cGy,1,5 days each week for 6 weeks,NA
11714542,NA,116,docetaxel,1,20,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,carboplatin,1,2,AUC,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,carboplatin,1,2,AUC,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,thoracic radiation therapy,1,200,cGy,1,5 days each week for 6 weeks,NA
11714542,NA,116,docetaxel,2,20,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,carboplatin,2,2,AUC,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,carboplatin,2,2,AUC,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
11714542,NA,116,thoracic radiation therapy,2,200,cGy,1,5 days each week for 6 weeks,NA
11800029,NA,117,irinotecan,1,40,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11800029,NA,117,carboplatin,1,300,mg/m2,1,on day 1 every 4 weeks,NA
11800029,NA,117,carboplatin,1,300,mg/m2,1,on day 1 every 4 weeks,NA
11800029,NA,117,irinotecan,2,50,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11800029,NA,117,carboplatin,2,300,mg/m2,1,on day 1 every 4 weeks,NA
11800029,NA,117,carboplatin,2,300,mg/m2,1,on day 1 every 4 weeks,NA
11800029,NA,117,irinotecan,3,60,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
11800029,NA,117,carboplatin,3,300,mg/m2,1,on day 1 every 4 weeks,NA
11800029,NA,117,carboplatin,3,300,mg/m2,1,on day 1 every 4 weeks,NA
12702526,NA,118,ifosfamide,1,2000,mg/m2,1,on days 1 and 2 every 21 days,NA
12702526,NA,118,paclitaxel,1,200,mg/m2,1,on day 1 every 21 days,NA
12702526,NA,118,carboplatin,1,6,AUC,1,on day 2 every 21 days,NA
12702526,NA,118,carboplatin,1,6,AUC,1,on day 2 every 21 days,NA
12702526,NA,118,ifosfamide,2,1500,mg/m2,1,on days 1 and 2 every 21 days,NA
12702526,NA,118,paclitaxel,2,200,mg/m2,1,on day 1 every 21 days,NA
12702526,NA,118,carboplatin,2,5,AUC,1,on day 2 every 21 days,NA
12702526,NA,118,carboplatin,2,5,AUC,1,on day 2 every 21 days,NA
12702526,NA,118,ifosfamide,3,2000,mg/m2,1,on days 1 and 2 every 21 days,NA
12702526,NA,118,paclitaxel,3,1500,mg/m2,1,on day 1 every 21 days,NA
12702526,NA,118,carboplatin,3,5,AUC,1,on day 2 every 21 days,NA
12702526,NA,118,carboplatin,3,5,AUC,1,on day 2 every 21 days,NA
12942108,NA,119,carboplatin,1,20,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,carboplatin,1,20,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,5-fluorouracil,1,200,mg/m2,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,radiation therapy,1,2,Gy,1,five days per week over 6 weeks,NA
12942108,NA,119,carboplatin,2,25,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,carboplatin,2,25,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,5-fluorouracil,2,200,mg/m2,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,radiation therapy,2,2,Gy,1,five days per week over 6 weeks,NA
12942108,NA,119,carboplatin,3,30,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,carboplatin,3,30,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,5-fluorouracil,3,200,mg/m2,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,radiation therapy,3,2,Gy,1,five days per week over 6 weeks,NA
12942108,NA,119,carboplatin,4,35,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,carboplatin,4,35,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,5-fluorouracil,4,200,mg/m2,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,radiation therapy,4,2,Gy,1,five days per week over 6 weeks,NA
12942108,NA,119,carboplatin,5,40,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,carboplatin,5,40,mg/m2/d,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,5-fluorouracil,5,200,mg/m2,1,concurrently with radiotherapy on days 1 –33,NA
12942108,NA,119,radiation therapy,5,2,Gy,1,five days per week over 6 weeks,NA
11330952,NA,120,paclitaxel,1,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,1,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,carboplatin,1,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,pbpc,1,NA,NA,NA,on day 0 every 28 days,NA
11330952,NA,120,paclitaxel,2,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,2,12,AUC,1,on day (-6) every 28 days,NA
11330952,NA,120,carboplatin,2,12,AUC,1,on day (-6) every 28 days,NA
11330952,NA,120,topotecan,2,1.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,topotecan,2,1.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,pbpc,2,NA,NA,NA,on day 0 every 28 days,NA
11330952,NA,120,paclitaxel,3,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,3,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,carboplatin,3,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,topotecan,3,2.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,topotecan,3,2.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,pbpc,3,NA,NA,NA,on day 0 every 28 days,NA
11330952,NA,120,paclitaxel,4,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,4,12,AUC,1,on day (-6) every 28 days,NA
11330952,NA,120,carboplatin,4,12,AUC,1,on day (-6) every 28 days,NA
11330952,NA,120,topotecan,4,3.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,topotecan,4,3.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,pbpc,4,NA,NA,NA,on day 0 every 28 days,NA
11330952,NA,120,paclitaxel,5,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,5,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,carboplatin,5,12,AUC,1,on day (-3) every 28 days,NA
11330952,NA,120,topotecan,5,4.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,topotecan,5,4.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,pbpc,5,NA,NA,NA,on day 0 every 28 days,NA
11330952,NA,120,paclitaxel,6,250,mg/m2,1,on day (-4) every 28 days,NA
11330952,NA,120,carboplatin,6,16,AUC,1,on either day (-3) or day(-6) every 28 days,NA
11330952,NA,120,carboplatin,6,16,AUC,1,on either day (-3) or day(-6) every 28 days,NA
11330952,NA,120,topotecan,6,2.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,topotecan,6,2.5,mg/m2,1,from days (-6) to (-2) every 28 days,NA
11330952,NA,120,pbpc,6,NA,NA,NA,on day 0 every 28 days,NA
11583193,NA,121,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
11583193,NA,121,carboplatin,1,5,AUC,1,on day I of a 21 day cycle,NA
11583193,NA,121,carboplatin,1,5,AUC,1,on day I of a 21 day cycle,NA
11583193,NA,121,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
11583193,NA,121,carboplatin,2,5,AUC,1,on day I of a 21 day cycle,NA
11583193,NA,121,carboplatin,2,5,AUC,1,on day I of a 21 day cycle,NA
11583193,NA,121,gemcitabine,1.5,1000,mg/m2,1,on days 1 and 8 of a 21 day cycle,NA
11583193,NA,121,carboplatin,1.5,4,AUC,1,on day I of a 21 day cycle,NA
11583193,NA,121,carboplatin,1.5,4,AUC,1,on day I of a 21 day cycle,NA
11325487,NA,122,paclitaxel,1,40,mg/m2,1,once weekly for 6 weeks,NA
11325487,NA,122,3d-conformal radiotherapy,1,60,Gy,NA,per week for 6 weeks,NA
11325487,NA,122,paclitaxel,2,50,mg/m2,1,once weekly for 6 weeks,NA
11325487,NA,122,3d-conformal radiotherapy,2,60,Gy,NA,per week for 6 weeks,NA
11325487,NA,122,paclitaxel,3,60,mg/m2,1,once weekly for 6 weeks,NA
11325487,NA,122,3d-conformal radiotherapy,3,60,Gy,NA,per week for 6 weeks,NA
11325487,NA,122,paclitaxel,4,79,mg/m2,1,once weekly for 6 weeks,NA
11325487,NA,122,3d-conformal radiotherapy,4,60,Gy,NA,per week for 6 weeks,NA
12468349,NA,123,docetaxel,1,25,mg/m2,1,every week,NA
12468349,NA,123,carboplatin,1,2,AUC,1,every week,NA
12468349,NA,123,carboplatin,1,2,AUC,1,every week,NA
12468349,NA,123,docetaxel,2,30,mg/m2,1,every week,NA
12468349,NA,123,carboplatin,2,2,AUC,1,every week,NA
12468349,NA,123,carboplatin,2,2,AUC,1,every week,NA
12468349,NA,123,docetaxel,3,35,mg/m2,1,every week,NA
12468349,NA,123,carboplatin,3,2,AUC,1,every week,NA
12468349,NA,123,carboplatin,3,2,AUC,1,every week,NA
12468349,NA,123,docetaxel,4,35,mg/m2,1,every week,NA
12468349,NA,123,carboplatin,4,2.5,AUC,1,every week,NA
12468349,NA,123,carboplatin,4,2.5,AUC,1,every week,NA
15341977,NA,125,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,treosulfan,1,2500,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,treosulfan,2,3000,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,treosulfan,3,3500,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 every 28 days,NA
15341977,NA,125,treosulfan,4,4000,mg/m2,1,on days 1 and 8 every 28 days,NA
11066051,NA,126,carboplatin,1,10,mg/m2,1,"daily, received a total dose of 360 mg/m2",NA
11066051,NA,126,carboplatin,1,10,mg/m2,1,"daily, received a total dose of 360 mg/m2",NA
11066051,NA,126,radiation,1,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
11066051,NA,126,carboplatin,2,10,mg/m2,1,"daily, received a total dose of 400 mg/m2",NA
11066051,NA,126,carboplatin,2,10,mg/m2,1,"daily, received a total dose of 400 mg/m2",NA
11066051,NA,126,radiation,2,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
11066051,NA,126,carboplatin,3,15,mg/m2,1,"daily, received a total dose of 405 mg/m2",NA
11066051,NA,126,carboplatin,3,15,mg/m2,1,"daily, received a total dose of 405 mg/m2",NA
11066051,NA,126,radiation,3,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
11066051,NA,126,carboplatin,4,15,mg/m2,1,"daily, received a total dose of 450 mg/m2",NA
11066051,NA,126,carboplatin,4,15,mg/m2,1,"daily, received a total dose of 450 mg/m2",NA
11066051,NA,126,radiation,4,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
11066051,NA,126,carboplatin,5,20,mg/m2,1,"daily, received a total dose of 460 mg/m2",NA
11066051,NA,126,carboplatin,5,20,mg/m2,1,"daily, received a total dose of 460 mg/m2",NA
11066051,NA,126,radiation,5,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
11066051,NA,126,carboplatin,6,20,mg/m2,1,"daily, received a total dose of 500 mg/m2",NA
11066051,NA,126,carboplatin,6,20,mg/m2,1,"daily, received a total dose of 500 mg/m2",NA
11066051,NA,126,radiation,6,2,Gy,1,"5 times a week, totaling 50 – 60 Gy (56 Gy onaverage",NA
10997810,NA,127,topotecan,1,0.75,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,topotecan,1,0.75,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,1,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,1,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,vincristine,1,1.3,mg/m2,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,1,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,1,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,1,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,1,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,teniposide,1,50,mg/m2,1,on days 1-5 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,topotecan,2,1,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,topotecan,2,1,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,2,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,2,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,vincristine,2,1.3,mg/m2,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,2,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,2,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,2,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,2,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,teniposide,2,50,mg/m2,1,on days 1-5 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,topotecan,3,1.25,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,topotecan,3,1.25,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,3,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,3,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,vincristine,3,1.3,mg/m2,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,3,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,cisplatin,3,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,3,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,3,4,AUC,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,teniposide,3,50,mg/m2,1,on days 1-5 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,topotecan,4,1.5,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,topotecan,4,1.5,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,4,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,cisplatin,4,50,mg/m2,1,"on day 5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,vincristine,4,1.25,mg/m2,1,"on day 1-5 every 21 days in cycles 1, 3, and 5",cycle A
10997810,NA,127,carboplatin,4,1.3,mg/m2,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,carboplatin,4,1.3,mg/m2,1,on day 1 every 28 days in cycles 2. 4 and 6,cycle B
10997810,NA,127,teniposide,4,35,mg/m2,1,on days 2 and 3 every 28 days in cycles 2. 4 and 6,cycle B
9610696,NA,128,carboplatin,1,5,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,carboplatin,1,5,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,irinotecan,1,60,mg/m2,1,"on Days 1, 8, and 15 every 4 weeks",NA
9610696,NA,128,recombinant human granulocyte-colony stimulating factor,1,2,ug/kg,1,"daily, except on Days 1, 8, and 15, until the leukocyte count exceeded 20,000/mm3 (10,000/mm3 after Day 16)",NA
9610696,NA,128,carboplatin,2,5,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,carboplatin,2,5,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,irinotecan,2,70,mg/m2,1,"on Days 1, 8, and 15 every 4 weeks",NA
9610696,NA,128,recombinant human granulocyte-colony stimulating factor,2,2,ug/kg,1,"daily, except on Days 1, 8, and 15, until the leukocyte count exceeded 20,000/mm3 (10,000/mm3 after Day 16)",NA
9610696,NA,128,carboplatin,3,6,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,carboplatin,3,6,AUC,1,on Day 1 every 4 weeks,NA
9610696,NA,128,irinotecan,3,60,mg/m2,1,"on Days 1, 8, and 15 every 4 weeks",NA
9610696,NA,128,recombinant human granulocyte-colony stimulating factor,3,2,ug/kg,1,"daily, except on Days 1, 8, and 15, until the leukocyte count exceeded 20,000/mm3 (10,000/mm3 after Day 16)",NA
10654007,NA,129,ifosfamide,1,3000,mg/m2,1,on day 1 every week,NA
10654007,NA,129,etoposide,1,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,129,carboplatin,1,300,mg/m2,1,on day 1 every week,NA
10654007,NA,129,carboplatin,1,300,mg/m2,1,on day 1 every week,NA
10654007,NA,129,ifosfamide,2,5000,mg/m2,1,on day 1 every week,NA
10654007,NA,129,etoposide,2,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,129,carboplatin,2,400,mg/m2,1,on day 1 every week,NA
10654007,NA,129,carboplatin,2,400,mg/m2,1,on day 1 every week,NA
10654007,NA,129,ifosfamide,3,7000,mg/m2,1,on day 1 every week,NA
10654007,NA,129,etoposide,3,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,129,carboplatin,3,400,mg/m2,1,on day 1 every week,NA
10654007,NA,129,carboplatin,3,400,mg/m2,1,on day 1 every week,NA
10654007,NA,129,ifosfamide,4,9000,mg/m2,1,on day 1 every week,NA
10654007,NA,129,etoposide,4,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,129,carboplatin,4,400,mg/m2,1,on day 1 every week,NA
10654007,NA,129,carboplatin,4,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,ifosfamide,1,3000,mg/m2,1,on day 1 every week,NA
10654007,NA,130,etoposide,1,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,130,carboplatin,1,300,mg/m2,1,on day 1 every week,NA
10654007,NA,130,carboplatin,1,300,mg/m2,1,on day 1 every week,NA
10654007,NA,130,ifosfamide,2,5000,mg/m2,1,on day 1 every week,NA
10654007,NA,130,etoposide,2,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,130,carboplatin,2,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,carboplatin,2,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,ifosfamide,3,7000,mg/m2,1,on day 1 every week,NA
10654007,NA,130,etoposide,3,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,130,carboplatin,3,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,carboplatin,3,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,ifosfamide,4,9000,mg/m2,1,on day 1 every week,NA
10654007,NA,130,etoposide,4,100,mg/m2,1,"on days 1, 2 and 3 every week",NA
10654007,NA,130,carboplatin,4,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,carboplatin,4,400,mg/m2,1,on day 1 every week,NA
10654007,NA,130,radiation,1,1.5,Gy,2,daily for the initial 3 weeks to a total dose of 45 Gy,NA
10654007,NA,130,radiation,2,1.5,Gy,2,daily for the initial 3 weeks to a total dose of 45 Gy,NA
10654007,NA,130,radiation,3,1.5,Gy,2,daily for the initial 3 weeks to a total dose of 45 Gy,NA
10654007,NA,130,radiation,4,1.5,Gy,2,daily for the initial 3 weeks to a total dose of 45 Gy,NA
11127945,NA,131,dipyridamole,1,1,mg/kg,4,every 21 days,NA
11127945,NA,131,carboplatin,1,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,1,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,1,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,2,1,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,2,18,mg,1,every 21 days,NA
11127945,NA,131,carboplatin,2,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,2,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,2,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,3,1,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,3,18,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,3,7.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,3,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,3,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,3,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,4,2,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,4,18,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,4,7.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,4,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,4,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,4,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,5,2,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,5,21,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,5,7.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,5,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,5,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,5,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,6,2,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,6,21,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,6,8.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,6,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,6,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,6,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,7,3.3,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,7,21,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,7,8.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,7,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,7,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,7,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,8,3.3,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,8,24,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,8,8.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,8,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,8,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,8,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,9,3.3,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,9,23,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,9,9.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,9,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,9,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,9,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,10,5,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,10,24,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,10,9.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,10,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,10,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,10,200,mg/m2,1,every 21 days,NA
11127945,NA,131,dipyridamole,11,5,mg/kg,4,every 21 days,NA
11127945,NA,131,prochlorperazine,11,27,mg,1,every 21 days,NA
11127945,NA,131,cyclosporine a,11,9.5,mg/kg,1,every 21 days,NA
11127945,NA,131,carboplatin,11,300,mg/m2,1,every 21 days,NA
11127945,NA,131,carboplatin,11,300,mg/m2,1,every 21 days,NA
11127945,NA,131,etoposide,11,200,mg/m2,1,every 21 days,NA
9486605,NA,132,carboplatin,1,25,mg/m2,1,Monday-Friday for 4 weeks,NA
9486605,NA,132,carboplatin,1,25,mg/m2,1,Monday-Friday for 4 weeks,NA
9486605,NA,132,carboplatin,1,350,mg/m2,1,day 1 every 21 days after 4-week rest period chemoradiotherapy,NA
9486605,NA,132,carboplatin,1,350,mg/m2,1,day 1 every 21 days after 4-week rest period chemoradiotherapy,NA
9486605,NA,132,ahf-xrt,1,1.5,Gy,2,a total dose of 60.0 Gy given in 48 fractions over 4 weeks.,NA
9486605,NA,132,carboplatin,2,30,mg/m2,1,Monday-Friday for 4 weeks,NA
9486605,NA,132,carboplatin,2,30,mg/m2,1,Monday-Friday for 4 weeks,NA
9486605,NA,132,carboplatin,2,350,mg/m2,1,day 1 every 21 days after 4-week rest period chemoradiotherapy,NA
9486605,NA,132,carboplatin,2,350,mg/m2,1,day 1 every 21 days after 4-week rest period chemoradiotherapy,NA
9486605,NA,132,ahf-xrt,2,1.5,Gy,2,a total dose of 60.0 Gy given in 48 fractions over 4 weeks.,NA
9404925,NA,133,melphalan,1,160,mg/m2,1,on day −4,NA
9404925,NA,133,mitoxantrone,1,25,mg/m2,1,on days −4 and −3,NA
9404925,NA,133,carboplatin,1,1000,mg/m2,1,on day −3,NA
9404925,NA,133,carboplatin,1,1000,mg/m2,1,on day −3,NA
9404925,NA,133,melphalan,2,160,mg/m2,1,on day −4,NA
9404925,NA,133,mitoxantrone,2,25,mg/m2,1,on days −4 and −3,NA
9404925,NA,133,carboplatin,2,1200,mg/m2,1,on day −3,NA
9404925,NA,133,carboplatin,2,1200,mg/m2,1,on day −3,NA
9404925,NA,133,melphalan,3,160,mg/m2,1,on day −4,NA
9404925,NA,133,mitoxantrone,3,25,mg/m2,1,on days −4 and −3,NA
9404925,NA,133,carboplatin,3,1400,mg/m2,1,on day −3,NA
9404925,NA,133,carboplatin,3,1400,mg/m2,1,on day −3,NA
9404925,NA,133,melphalan,4,160,mg/m2,1,on day −4,NA
9404925,NA,133,mitoxantrone,4,25,mg/m2,1,on days −4 and −3,NA
9404925,NA,133,carboplatin,4,1600,mg/m2,1,on day −3,NA
9404925,NA,133,carboplatin,4,1600,mg/m2,1,on day −3,NA
10491535,NA,134,carboplatin,1,20,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,1,20,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,1,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,2,35,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,2,35,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,2,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,3,50,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,3,50,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,3,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,4,65,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,4,65,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,4,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,5,80,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,5,80,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,5,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,6,95,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,6,95,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,6,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,7,110,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,7,110,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,7,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,8,125,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,8,125,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,8,100,cGy,2,"5 days a week, for 7 weeks",NA
10491535,NA,134,carboplatin,9,140,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,carboplatin,9,140,mg/m2,1,on Monday and Wendesday of each week,NA
10491535,NA,134,hyperfractionated radiotherapy,9,100,cGy,2,"5 days a week, for 7 weeks",NA
9000605,NA,135,5-fu,1,350,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,leucovorin,1,20,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,carboplatin,1,5,AUC,1,on day 3 every 4 weeks,NA
9000605,NA,135,carboplatin,1,5,AUC,1,on day 3 every 4 weeks,NA
9000605,NA,135,5-fu,2,370,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,leucovorin,2,20,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,carboplatin,2,5,AUC,1,on day 3 every 4 weeks,NA
9000605,NA,135,carboplatin,2,5,AUC,1,on day 3 every 4 weeks,NA
9000605,NA,135,5-fu,3,400,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,leucovorin,3,20,mg/m2,1,on days 1-5 every 4 weeks,NA
9000605,NA,135,carboplatin,3,5,AUC,1,on day 3 every 4 weeks,NA
9000605,NA,135,carboplatin,3,5,AUC,1,on day 3 every 4 weeks,NA
8656258,NA,136,carboplatin,1,5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,carboplatin,1,5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,paclitaxel,1,135,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,136,carboplatin,2,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,carboplatin,2,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,paclitaxel,2,135,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,136,carboplatin,3,10,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,carboplatin,3,10,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,136,paclitaxel,3,135,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,137,carboplatin,4,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,carboplatin,4,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,paclitaxel,4,135,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,137,g-csf,4,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,g-csf,4,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,carboplatin,5,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,carboplatin,5,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,paclitaxel,5,175,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,137,g-csf,5,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,g-csf,5,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,carboplatin,6,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,carboplatin,6,7.5,AUC,1,after paclitaxel every 21 days,NA
8656258,NA,137,paclitaxel,6,225,mg/m2,1,"over 24h infusion, every 21 days",NA
8656258,NA,137,g-csf,6,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,g-csf,6,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,136,carboplatin,7,7.5,AUC,1,every 21 days,NA
8656258,NA,136,carboplatin,7,7.5,AUC,1,every 21 days,NA
8656258,NA,136,paclitaxel,7,175,mg/m2,1,"over 3h infusion, every 21 days",NA
8656258,NA,136,carboplatin,8,7.5,AUC,1,every 21 days,NA
8656258,NA,136,carboplatin,8,7.5,AUC,1,every 21 days,NA
8656258,NA,136,paclitaxel,8,225,mg/m2,1,"over 3h infusion, every 21 days",NA
8656258,NA,137,carboplatin,9,7.5,AUC,1,every 21 days,NA
8656258,NA,137,carboplatin,9,7.5,AUC,1,every 21 days,NA
8656258,NA,137,paclitaxel,9,225,mg/m2,1,"over 3h infusion, every 21 days",NA
8656258,NA,137,g-csf,9,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,g-csf,9,5,ug/kg/per day,1,"daily, 24 hours after completion of chemotherapy and continuing through the nadir and hematologic recovery",NA
8656258,NA,137,carboplatin,10,7.5,AUC,1,on day 5 every 21 days,NA
8656258,NA,137,carboplatin,10,7.5,AUC,1,on day 5 every 21 days,NA
8656258,NA,137,paclitaxel,10,120,mg/m2,1,"over 96h infusion, every 21 days",NA
9001351,NA,138,irinotecan hydrochloride,1,20,mg/m2,1,on days 1 through 3 and 8 through 10 every 28 days,NA
9001351,NA,138,carboplatin,1,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,carboplatin,1,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,irinotecan hydrochloride,2,25,mg/m2,1,on days 1 through 3 and 8 through 10 every 28 days,NA
9001351,NA,138,carboplatin,2,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,carboplatin,2,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,irinotecan hydrochloride,3,30,mg/m2,1,on days 1 through 3 and 8 through 10 every 28 days,NA
9001351,NA,138,carboplatin,3,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,carboplatin,3,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,irinotecan hydrochloride,4,35,mg/m2,1,on days 1 through 3 and 8 through 10 every 28 days,NA
9001351,NA,138,carboplatin,4,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,carboplatin,4,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,irinotecan hydrochloride,5,40,mg/m2,1,on days 1 through 3 and 8 through 10 every 28 days,NA
9001351,NA,138,carboplatin,5,300,mg/m2,1,On day 1 every 28 days,fixed
9001351,NA,138,carboplatin,5,300,mg/m2,1,On day 1 every 28 days,fixed
9514802,NA,139,carboplatin,1,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,carboplatin,1,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,ifosfamide,1,4,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,cisplatin,1,40,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,cisplatin,1,40,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,carboplatin,2,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,carboplatin,2,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,ifosfamide,2,4,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,cisplatin,2,50,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,cisplatin,2,50,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,carboplatin,3,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,carboplatin,3,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,ifosfamide,3,4,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,cisplatin,3,60,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,cisplatin,3,60,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,carboplatin,4,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,carboplatin,4,300,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,ifosfamide,4,4,mg/m2,1,on day 1 of a 28-day cycle,NA
9514802,NA,139,cisplatin,4,70,mg/m2,1,on day 8 of a 28-day cycle,NA
9514802,NA,139,cisplatin,4,70,mg/m2,1,on day 8 of a 28-day cycle,NA
10762746,NA,140,docetaxel,1,70,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,docetaxel,2,70,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,2,6,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,2,6,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,docetaxel,3,80,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,3,6,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,docetaxel,4,80,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,4,7,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,4,7,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,docetaxel,5,90,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,5,7,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,5,7,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,docetaxel,6,100,mg/m2,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,6,6,AUC,1,on day 1 every 3 weeks,NA
10762746,NA,140,carboplatin,6,6,AUC,1,on day 1 every 3 weeks,NA
11036956,NA,141,paclitaxel,1,100,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,1,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,1,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,2,125,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,2,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,2,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,3,150,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,3,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,3,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,4,175,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,4,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,4,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,5,200,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,5,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,5,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,6,225,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,6,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,6,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,7,250,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,7,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,7,325,mg/m2,1,every 3 weeks,NA
11036956,NA,141,paclitaxel,8,250,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,8,350,mg/m2,1,every 3 weeks,NA
11036956,NA,141,carboplatin,8,350,mg/m2,1,every 3 weeks,NA
9508176,NA,142,melphalan,1,50,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,1,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,1,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,etoposide,1,200,mg/m2,1,day -7 through -4,NA
9508176,NA,142,cyclophosphamide,1,750,mg/m2,1,day -7 through -4,NA
9508176,NA,142,melphalan,2,50,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,2,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,2,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,etoposide,2,200,mg/m2,1,day -7 through -4,NA
9508176,NA,142,cyclophosphamide,2,1000,mg/m2,1,day -7 through -4,NA
9508176,NA,142,melphalan,3,50,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,3,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,3,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,etoposide,3,200,mg/m2,1,day -7 through -4,NA
9508176,NA,142,cyclophosphamide,3,1250,mg/m2,1,day -7 through -4,NA
9508176,NA,142,melphalan,4,50,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,4,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,carboplatin,4,300,mg/m2,1,day -7 through -4,NA
9508176,NA,142,etoposide,4,200,mg/m2,1,day -7 through -4,NA
9508176,NA,142,cyclophosphamide,4,1500,mg/m2,1,day -7 through -4,NA
8151314,NA,143,il-l a,1,0.1,ug/m2,1,"on days 1-4 of the 3-week prechemo cycle, and days 2-5 of the 4-week cycle 2",NA
8151314,NA,143,carboplatin,1,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,carboplatin,1,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,il-l a,2,0.3,ug/m2,1,"on days 1-4 of the 3-week prechemo cycle, and days 2-5 of the 4-week cycle 2",NA
8151314,NA,143,carboplatin,2,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,carboplatin,2,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,il-l a,3,1,ug/m2,1,"on days 1-4 of the 3-week prechemo cycle, and days 2-5 of the 4-week cycle 2",NA
8151314,NA,143,carboplatin,3,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,carboplatin,3,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,il-l a,4,3,ug/m2,1,"on days 1-4 of the 3-week prechemo cycle, and days 2-5 of the 4-week cycle 2",NA
8151314,NA,143,carboplatin,4,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,carboplatin,4,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,il-l a,5,10,ug/m2,1,"on days 1-4 of the 3-week prechemo cycle, and days 2-5 of the 4-week cycle 2",NA
8151314,NA,143,carboplatin,5,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8151314,NA,143,carboplatin,5,400,mg/m2,1,on day 1 of 4-week's cycle 1 and 2,NA
8201386,NA,144,ifosfamide,1,5000,mg/m2,1,continuous infusion over 48 hours on days 1-2 every 21 days,NA
8201386,NA,144,carboplatin,1,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,carboplatin,1,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,mesna,1,6000,mg/m2,1,continuous infusion over 60 hours on days 1-3 every 21 days,NA
8201386,NA,144,etoposide,1,150,mg/m2,1,on days 1-2 every 21 days,NA
8201386,NA,144,granulocyte-macrophage colony-stimulating factor,1,5,ug/kg,1,from day 4 until neutrophil recovery,NA
8201386,NA,144,ifosfamide,2,5000,mg/m2,1,continuous infusion over 48 hours on days 1-2 every 21 days,NA
8201386,NA,144,carboplatin,2,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,carboplatin,2,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,mesna,2,6000,mg/m2,1,continuous infusion over 60 hours on days 1-3 every 21 days,NA
8201386,NA,144,etoposide,2,300,mg/m2,1,on days 1-2 every 21 days,NA
8201386,NA,144,granulocyte-macrophage colony-stimulating factor,2,5,ug/kg,1,from day 4 until neutrophil recovery,NA
8201386,NA,144,ifosfamide,3,5000,mg/m2,1,continuous infusion over 48 hours on days 1-2 every 21 days,NA
8201386,NA,144,carboplatin,3,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,carboplatin,3,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,mesna,3,6000,mg/m2,1,continuous infusion over 60 hours on days 1-3 every 21 days,NA
8201386,NA,144,etoposide,3,450,mg/m2,1,on days 1-2 every 21 days,NA
8201386,NA,144,granulocyte-macrophage colony-stimulating factor,3,5,ug/kg,1,from day 4 until neutrophil recovery,NA
8201386,NA,144,ifosfamide,4,5000,mg/m2,1,continuous infusion over 48 hours on days 1-2 every 21 days,NA
8201386,NA,144,carboplatin,4,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,carboplatin,4,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,mesna,4,6000,mg/m2,1,continuous infusion over 60 hours on days 1-3 every 21 days,NA
8201386,NA,144,etoposide,4,600,mg/m2,1,on days 1-2 every 21 days,NA
8201386,NA,144,granulocyte-macrophage colony-stimulating factor,4,5,ug/kg,1,from day 4 until neutrophil recovery,NA
8201386,NA,144,ifosfamide,5,5000,mg/m2,1,continuous infusion over 48 hours on days 1-2 every 21 days,NA
8201386,NA,144,carboplatin,5,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,carboplatin,5,400,mg/m2,1,on day 1 every 21 days,NA
8201386,NA,144,mesna,5,6000,mg/m2,1,continuous infusion over 60 hours on days 1-3 every 21 days,NA
8201386,NA,144,etoposide,5,600,mg/m2,1,on days 1-2 every 21 days,NA
8201386,NA,144,granulocyte-macrophage colony-stimulating factor,5,10,ug/kg,1,from day 4 until neutrophil recovery,NA
7620926,NA,145,ifosfamide,1,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,1,300,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,1,300,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,1,100,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,ifosfamide,2,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,2,375,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,2,375,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,2,100,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,ifosfamide,3,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,3,460,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,3,460,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,3,100,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,ifosfamide,4,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,4,575,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,4,575,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,4,100,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,ifosfamide,5,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,5,635,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,5,635,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,5,100,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,ifosfamide,6,1500,mg/m2,3,daily every 3-4 weeks,NA
7620926,NA,145,carboplatin,6,700,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,carboplatin,6,700,mg/m2,1,on day 3 every 3-4 weeks,NA
7620926,NA,145,etoposide,6,100,mg/m2,3,daily every 3-4 weeks,NA
7844593,NA,146,ifosfamide,1,6000,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,1,1200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,1,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,2,7200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,2,1200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,2,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,3,8700,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,3,1200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,3,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,4,10200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,4,1200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,4,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,5,10200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,5,1500,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,5,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,6,10200,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,6,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,6,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,7,12000,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,7,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,7,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,8,14400,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,8,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,8,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,9,14400,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,9,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,9,2100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,10,14400,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,10,2100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,10,2100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,11,17100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,11,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,11,2100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,12,17100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,12,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,12,2400,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,13,20100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,13,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,13,2400,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,14,20100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,14,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,14,2700,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,15,24000,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,15,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,15,2700,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,ifosfamide,16,20100,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,corboplatin,16,1800,mg/m2,1,from day -8 through day -3.,NA
7844593,NA,146,etoposide,16,3000,mg/m2,1,from day -8 through day -3.,NA
9440750,NA,147,paclitaxel,1,150,mg/m2,1,every 3 weeks.,NA
9440750,NA,147,carboplatin,1,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,carboplatin,1,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,paclitaxel,2,175,mg/m2,1,every 3 weeks.,NA
9440750,NA,147,carboplatin,2,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,carboplatin,2,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,paclitaxel,3,200,mg/m2,1,every 3 weeks.,NA
9440750,NA,147,carboplatin,3,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,carboplatin,3,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,paclitaxel,4,225,mg/m2,1,every 3 weeks.,NA
9440750,NA,147,carboplatin,4,6,AUC,1,every 3 weeks.,fixed
9440750,NA,147,carboplatin,4,6,AUC,1,every 3 weeks.,fixed
11095134,NA,148,jm216,1,50,mg/m2,1,five consecutive days every 26 days,NA
11095134,NA,148,jm216,2,75,mg/m2,1,five consecutive days every 26 days,NA
11095134,NA,148,jm216,3,100,mg/m2,1,five consecutive days every 26 days,NA
11095134,NA,148,jm216,4,120,mg/m2,1,five consecutive days every 26 days,NA
11054441,NA,149,paclitaxel,1,54,mg/m2,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,6,AUC,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,6,AUC,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,valspodar,1,5,mg/kg,4,from day 0 through day 3 of each 3-week cycle,NA
11054441,NA,149,paclitaxel,1,67.5,mg/m2,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,paclitaxel,1,81,mg/m2,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,paclitaxel,1,94.5,mg/m2,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,7.5,AUC,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,7.5,AUC,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,9,AUC,1,on day 1 of each 3-week cycle,NA
11054441,NA,149,carboplatin,1,9,AUC,1,on day 1 of each 3-week cycle,NA
7790322,NA,150,etoposide,1,40,mg/m2,1,daily,NA
7790322,NA,150,carboplatin,1,300,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,carboplatin,1,300,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,etoposide,2,40,mg/m2,1,daily,NA
7790322,NA,150,carboplatin,2,350,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,carboplatin,2,350,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,etoposide,3,40,mg/m2,1,daily,NA
7790322,NA,150,carboplatin,3,400,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,carboplatin,3,400,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,etoposide,4,50,mg/m2,1,daily,NA
7790322,NA,150,carboplatin,4,400,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,carboplatin,4,400,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,etoposide,5,60,mg/m2,1,daily,NA
7790322,NA,150,carboplatin,5,400,mg/m2,1,on day 1 every 21 days,NA
7790322,NA,150,carboplatin,5,400,mg/m2,1,on day 1 every 21 days,NA
8931678,NA,151,carboplatin,1,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,carboplatin,1,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,epirubicin,1,75,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,vp-16,1,100,mg/m2,1,on days 1-3 every 3 weeks,NA
8931678,NA,151,g-csf,1,5,ug/kg,1,on days 6-15 every 3 weeks,NA
8931678,NA,151,g-csf,1,5,ug/kg,1,on days 6-15 every 3 weeks,NA
8931678,NA,151,carboplatin,2,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,carboplatin,2,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,epirubicin,2,75,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,vp-16,2,120,mg/m2,1,on days 1-3 every 3 weeks,NA
8931678,NA,151,g-csf,2,5,ug/kg,1,on days 6-15 every 3 weeks,NA
8931678,NA,151,g-csf,2,5,ug/kg,1,on days 6-15 every 3 weeks,NA
8931678,NA,151,carboplatin,3,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,carboplatin,3,300,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,epirubicin,3,75,mg/m2,1,on day 1 every 3 weeks,NA
8931678,NA,151,vp-16,3,140,mg/m2,1,on days 1-3 every 3 weeks,NA
8931678,NA,151,g-csf,3,5,ug/kg,1,on days 6-15 every 3 weeks,NA
8931678,NA,151,g-csf,3,5,ug/kg,1,on days 6-15 every 3 weeks,NA
9220292,NA,152,paclitaxel,1,175,mg/m2,1,every 3 weeks,NA
9220292,NA,152,carboplatin,1,7,AUC,1,every 3 weeks,NA
9220292,NA,152,carboplatin,1,7,AUC,1,every 3 weeks,NA
9220292,NA,152,paclitaxel,2,175,mg/m2,1,every 3 weeks,NA
9220292,NA,152,carboplatin,2,9,AUC,1,every 3 weeks,NA
9220292,NA,152,carboplatin,2,9,AUC,1,every 3 weeks,NA
9220292,NA,152,paclitaxel,3,200,mg/m2,1,every 3 weeks,NA
9220292,NA,152,carboplatin,3,9,AUC,1,every 3 weeks,NA
9220292,NA,152,carboplatin,3,9,AUC,1,every 3 weeks,NA
9220292,NA,152,paclitaxel,4,225,mg/m2,1,every 3 weeks,NA
9220292,NA,152,carboplatin,4,9,AUC,1,every 3 weeks,NA
9220292,NA,152,carboplatin,4,9,AUC,1,every 3 weeks,NA
9220292,NA,152,paclitaxel,5,225,mg/m2,1,every 3 weeks,NA
9220292,NA,152,carboplatin,5,7,AUC,1,every 3 weeks,NA
9220292,NA,152,carboplatin,5,7,AUC,1,every 3 weeks,NA
10944128,NA,153,paclitaxel,1,175,mg/m2,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,1,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,etoposide,1,50,mg/m2,1,beginning on day 2 for 4 days every 3 weeks,"the number of days of
etoposide therapy was escalated on the basis of toxicity"
10944128,NA,153,paclitaxel,2,175,mg/m2,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,2,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,etoposide,2,50,mg/m2,1,beginning on day 2 for 6 days every 3 weeks,"the number of days of
etoposide therapy was escalated on the basis of toxicity"
10944128,NA,153,paclitaxel,3,175,mg/m2,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,3,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,etoposide,3,50,mg/m2,1,beginning on day 2 for 8 days every 3 weeks,"the number of days of
etoposide therapy was escalated on the basis of toxicity"
10944128,NA,153,paclitaxel,4,175,mg/m2,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,4,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,etoposide,4,50,mg/m2,1,beginning on day 2 for 10 days every 3 weeks,"the number of days of
etoposide therapy was escalated on the basis of toxicity"
10944128,NA,153,paclitaxel,5,175,mg/m2,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,5,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,carboplatin,5,5,AUC,1,on day 1 every 3 weeks,NA
10944128,NA,153,etoposide,5,50,mg/m2,1,beginning on day 2 for 12 days every 3 weeks,"the number of days of
etoposide therapy was escalated on the basis of toxicity"
7666081,NA,154,cyclosporine,1,5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,cyclosporine,1,5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,carboplatin,1,300,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,1,300,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,2,7.5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,cyclosporine,2,7.5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,carboplatin,2,300,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,2,300,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,3,8.8,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,cyclosporine,3,8.8,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,carboplatin,3,300,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,3,300,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,4,8.8,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,cyclosporine,4,8.8,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,carboplatin,4,250,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,4,250,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,5,9.5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,cyclosporine,5,9.5,mg/kg,1,36-hour continuous infusion,NA
7666081,NA,154,carboplatin,5,250,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,5,250,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,6,8.8,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,cyclosporine,6,8.8,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,carboplatin,6,250,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,6,250,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,7,9.5,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,cyclosporine,7,9.5,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,carboplatin,7,250,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,7,250,mg/m2,1,NA,NA
7666081,NA,154,cyclosporine,8,10,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,cyclosporine,8,10,mg/kg,1,36-hour continuous infusion staring from cycle 2,NA
7666081,NA,154,carboplatin,8,250,mg/m2,1,NA,NA
7666081,NA,154,carboplatin,8,250,mg/m2,1,NA,NA
10785477,NA,155,paclitaxel,1,175,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,1,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,1,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,etoposide,1,50,mg,3,days 1-3 every 3 weeks,NA
10785477,NA,155,cyclophosphamide,1,600,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,g-csf,1,NA,NA,1,begun from day 4,NA
10785477,NA,155,g-csf,1,NA,NA,1,begun from day 4,NA
10785477,NA,155,paclitaxel,2,175,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,2,7,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,2,7,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,etoposide,2,50,mg,3,days 1-3 every 3 weeks,NA
10785477,NA,155,cyclophosphamide,2,600,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,g-csf,2,NA,NA,1,begun from day 4,NA
10785477,NA,155,g-csf,2,NA,NA,1,begun from day 4,NA
10785477,NA,155,paclitaxel,3,175,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,3,7,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,3,7,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,etoposide,3,50,mg,3,days 1-3 every 3 weeks,NA
10785477,NA,155,cyclophosphamide,3,750,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,g-csf,3,NA,NA,1,begun from day 4,NA
10785477,NA,155,g-csf,3,NA,NA,1,begun from day 4,NA
10785477,NA,155,paclitaxel,3.5,175,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,3.5,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,3.5,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,etoposide,3.5,50,mg,3,days 1-3 every 3 weeks,NA
10785477,NA,155,cyclophosphamide,3.5,750,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,g-csf,3.5,NA,NA,1,begun from day 4,NA
10785477,NA,155,g-csf,3.5,NA,NA,1,begun from day 4,NA
10785477,NA,155,paclitaxel,4,175,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,4,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,carboplatin,4,5,AUC,1,Day 1 every 3 weeks,NA
10785477,NA,155,etoposide,4,50,mg,4,days 1-3 every 3 weeks,NA
10785477,NA,155,cyclophosphamide,4,750,mg/m2,1,Day 1 every 3 weeks,NA
10785477,NA,155,g-csf,4,NA,NA,1,begun from day 4,NA
10785477,NA,155,g-csf,4,NA,NA,1,begun from day 4,NA
9740546,NA,156,edatrexate,1,60,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,1,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,1,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,2,70,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,2,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,2,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,3,80,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,3,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,3,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,4,90,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,4,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,4,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,4.5,90,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,leucovorin,4.5,15,mg,4,beginning at 24 hours following administration of edatrexate,NA
9740546,NA,156,carboplatin,4.5,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,4.5,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,5,100,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,5,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,5,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,6,110,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,6,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,6,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,edatrexate,7,120,mg/m2,1,"on day 8 weekly for 5 weeks , and then every other week",NA
9740546,NA,156,carboplatin,7,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9740546,NA,156,carboplatin,7,350,mg/m2,1,on day 1 and repeated every 28 days,NA
9020283,NA,157,etoposide,1,200,mg/m2,1,on days 1-3 every 28 days,NA
9020283,NA,157,carboplatin,1,125,mg/m2,1,on days 1-3 every 28 days,NA
9020283,NA,157,carboplatin,1,125,mg/m2,1,on days 1-3 every 28 days,NA
9020283,NA,157,gm-csf,1,10,ug/kg,1,on days 4-18 every 28 days,NA
9020283,NA,157,gm-csf,1,10,ug/kg,1,on days 4-18 every 28 days,NA
9020283,NA,157,etoposide,2,200,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,2,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,2,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,2,10,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,2,10,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,3,200,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,3,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,3,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,3,20,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,3,20,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,4,250,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,4,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,4,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,4,20,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,4,20,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,5,250,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,5,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,5,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,5,5,ug/kg,2,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,5,5,ug/kg,2,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,6,300,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,6,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,6,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,6,5,ug/kg,2,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,6,5,ug/kg,2,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,7,250,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,7,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,7,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,7,5,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,7,5,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,8,300,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,8,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,8,125,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,8,5,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,8,5,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,etoposide,9,300,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,9,150,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,carboplatin,9,150,mg/m2,1,on days 1-3 every 21 days,NA
9020283,NA,157,gm-csf,9,5,ug/kg,1,on days 4-18 every 21 days,NA
9020283,NA,157,gm-csf,9,5,ug/kg,1,on days 4-18 every 21 days,NA
9143391,NA,158,rhuil-1a,1,0,NA,0,NA,NA
9143391,NA,158,carboplatin,1,8,AUC,1,on day 1,NA
9143391,NA,158,carboplatin,1,8,AUC,1,on day 1,NA
9143391,NA,158,ifosfamide,1,2000,mg/m2,1,"on days 2, 3, and 4",NA
9143391,NA,158,etoposide,1,100,mg/m2,1,"on days 2, 3, and 4",NA
10071285,NA,159,gemcitabine,1,800,mg/m2,1,on day 1 of the 28-day cycle,NA
10071285,NA,159,carboplatin,1,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,carboplatin,1,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,gemcitabine,2,900,mg/m2,1,on day 1 of the 28-day cycle,NA
10071285,NA,159,carboplatin,2,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,carboplatin,2,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,gemcitabine,3,1000,mg/m2,1,on day 1 of the 28-day cycle,NA
10071285,NA,159,carboplatin,3,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,carboplatin,3,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,gemcitabine,4,1100,mg/m2,1,on day 1 of the 28-day cycle,NA
10071285,NA,159,carboplatin,4,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,carboplatin,4,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,gemcitabine,5,1200,mg/m2,1,on day 1 of the 28-day cycle,NA
10071285,NA,159,carboplatin,5,5,AUC,1,on day 8 of the 28-day cycle,fixed
10071285,NA,159,carboplatin,5,5,AUC,1,on day 8 of the 28-day cycle,fixed
10466861,NA,160,paclitaxel,1,130,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,1,230,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,1,230,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,2,130,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,2,260,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,2,260,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,3,140,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,3,260,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,3,260,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,4,140,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,4,280,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,4,280,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,5,150,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,5,280,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,5,280,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,6,175,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,6,300,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,6,300,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,7,175,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,7,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,7,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,8,185,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,8,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,8,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,9,195,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,9,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,9,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,10,205,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,10,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,10,350,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,11,205,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,11,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,11,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,12,215,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,12,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,12,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,13,225,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,13,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,13,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,paclitaxel,14,235,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,14,375,mg/m2,1,every 4 weeks,NA
10466861,NA,160,carboplatin,14,375,mg/m2,1,every 4 weeks,NA
8882989,NA,161,cisplatin,1,50,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,cisplatin,1,50,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,1,200,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,1,200,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,etoposide,1,100,mg/m2,1,"on days 1, 3, and 5 repeated at 3- or 4- intervals",fixed
8882989,NA,161,cisplatin,2,60,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,cisplatin,2,60,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,2,200,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,2,200,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,etoposide,2,100,mg/m2,1,"on days 1, 3, and 5 repeated at 3- or 4- intervals",fixed
8882989,NA,161,cisplatin,3,60,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,cisplatin,3,60,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,3,250,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,3,250,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,etoposide,3,100,mg/m2,1,"on days 1, 3, and 5 repeated at 3- or 4- intervals",fixed
8882989,NA,161,cisplatin,4,70,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,cisplatin,4,70,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,4,250,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,carboplatin,4,250,mg/m2,1,on day 1 repeated at 3- or 4- intervals,NA
8882989,NA,161,etoposide,4,100,mg/m2,1,"on days 1, 3, and 5 repeated at 3- or 4- intervals",fixed
9209665,NA,162,carboplatin,1,5,AUC,1,on day 1 every 21 days for a maximum of six courses,fixed
9209665,NA,162,carboplatin,1,5,AUC,1,on day 1 every 21 days for a maximum of six courses,fixed
9209665,NA,162,paclitaxel,1,135,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,2,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,2,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,2,160,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,3,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,3,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,3,185,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,4,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,4,5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,4,210,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,5,6,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,5,6,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,5,185,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,6,7.5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,6,7.5,AUC,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,6,185,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,7,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,7,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,7,135,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,8,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,8,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,8,165,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,9,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,9,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,9,185,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,10,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,carboplatin,10,5,AUC,1,on day 2 every 21 days for a maximum of six courses,NA
9209665,NA,162,paclitaxel,10,210,mg/m2,1,on day 1 every 21 days for a maximum of six courses,NA
10231137,NA,163,carboplatin,1,1600,mg/m2,NA,"continuous infusion for 72 h start day -5 in cycle 2, cycle 3, and cycle 4 (3-4 week intervals)",NA
10231137,NA,163,carboplatin,1,1600,mg/m2,NA,"continuous infusion for 72 h start day -5 in cycle 2, cycle 3, and cycle 4 (3-4 week intervals)",NA
10231137,NA,163,cyclophosphamide,1,6000,mg/m2,NA,divided over 4 days from day -5 in cycle 1 (3-4 week intervals),NA
10231137,NA,163,etoposide,1,200,mg/m2,2,days -5 to -2 in cyle 4,NA
10231137,NA,163,melphalan,1,140,mg/m2,1,day -1 in cycle 4,NA
10231137,NA,163,carboplatin,2,1800,mg/m2,NA,continuous infusion for 72 h start day -5 in cycle 2 and cycle 3 (3-4 week intervals),NA
10231137,NA,163,carboplatin,2,1800,mg/m2,NA,continuous infusion for 72 h start day -5 in cycle 2 and cycle 3 (3-4 week intervals),NA
10231137,NA,163,carboplatin,2,1600,mg/m2,NA,"continuous infusion for 72 h start day -5 in cycle 2, cycle 3, and cycle 4 (3-4 week intervals)",NA
10231137,NA,163,carboplatin,2,1600,mg/m2,NA,"continuous infusion for 72 h start day -5 in cycle 2, cycle 3, and cycle 4 (3-4 week intervals)",NA
10231137,NA,163,cyclophosphamide,2,6000,mg/m2,NA,divided over 4 days from day -5 in cycle 1 (3-4 week intervals),NA
10231137,NA,163,etoposide,2,200,mg/m2,2,days -5 to -2 in cyle 4,NA
10231137,NA,163,melphalan,2,140,mg/m2,1,day -1 in cycle 4,NA
8398708,NA,164,carboplatin,1,100,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,1,100,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,1,50,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,2,200,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,2,200,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,2,50,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,3,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,3,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,3,50,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,4,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,4,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,4,100,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,5,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,5,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,5,150,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,6,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,6,300,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,etoposide,6,200,mg/m2,1,every 4 weeks,high risk patients
8398708,NA,164,carboplatin,7,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,7,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,7,50,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,8,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,8,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,8,75,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,9,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,9,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,9,100,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,10,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,10,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,10,150,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-1,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-1,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,-1,200,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-2,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-2,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,-2,250,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-3,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-3,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,-3,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-4,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-4,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,-4,350,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-5,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,carboplatin,-5,300,mg/m2,1,every 4 weeks,low risk patients
8398708,NA,164,etoposide,-5,400,mg/m2,1,every 4 weeks,low risk patients
2651580,NA,165,carboplatin,1,375,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,1,375,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,2,500,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,2,500,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,3,900,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,3,900,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,4,1200,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,4,1200,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,5,1600,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,5,1600,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,6,2000,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,6,2000,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,7,2400,mg/m2,NA,four-day continuous infusion,NA
2651580,NA,165,carboplatin,7,2400,mg/m2,NA,four-day continuous infusion,NA
32590047,NCT02442531,166,cpc634,1,15,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,2,30,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,3,60,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,4,70,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,5,80,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,6,100,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,166,cpc634,7,45,mg/m2,1,every two weeks (Q2W),NA
32590047,NCT02442531,167,cpc634,1,60,mg/m2,1,every three weeks (Q3W),NA
32590047,NCT02442531,167,dexamethasone,1,NA,NA,NA,NA,premedication
25762000,NCT00566410,168,dichloroacetate,1,6.25,mg/kg,2,every 28 days,NA
25762000,NCT00566410,168,dichloroacetate,2,12.6,mg/kg,2,every 28 days,NA
1846407,NA,169,ifosfamide,1,3000,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,1,100,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,1,100,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,mesna,1,3000,mg/m2,1,day 1-5,NA
1846407,NA,169,ifosfamide,2,3000,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,2,200,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,2,200,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,mesna,2,3000,mg/m2,1,day 1-5,NA
1846407,NA,169,ifosfamide,3,3000,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,3,300,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,3,300,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,mesna,3,3000,mg/m2,1,day 1-5,NA
1846407,NA,169,ifosfamide,4,3000,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,4,400,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,carboplatin,4,400,mg/m2,1,"4-day continuous infusion, day 1-4",NA
1846407,NA,169,mesna,4,3000,mg/m2,1,day 1-5,NA
23335436,CCI-06-00092,170,oxaliplatin,1,105,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,oxaliplatin,1,105,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,doxorubicin,1,20,mg/m2,1,"on days 1, 2, and 3 of a 21 day course",NA
23335436,CCI-06-00092,170,oxaliplatin,2,130,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,oxaliplatin,2,130,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,doxorubicin,2,20,mg/m2,1,"on days 1, 2, and 3 of a 21 day course",NA
23335436,CCI-06-00092,170,oxaliplatin,3,130,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,oxaliplatin,3,130,mg/m2,1,on day 1 of a 21 day course,NA
23335436,CCI-06-00092,170,doxorubicin,3,25,mg/m2,1,"on days 1, 2, and 3 of a 21 day course",NA
1698110,NA,171,carboplatin,1,150,mg/m2,1,every 28 days,NA
1698110,NA,171,carboplatin,1,150,mg/m2,1,every 28 days,NA
1698110,NA,171,vindesine,1,3,mg/m2,1,"weekly for 5 doses, then every 2 weeks thereafter",NA
1698110,NA,171,bleomycin,1,10,unit/m2,1,days 3-7 and 31-35,NA
1698110,NA,171,carboplatin,2,200,mg/m2,1,every 28 days,NA
1698110,NA,171,carboplatin,2,200,mg/m2,1,every 28 days,NA
1698110,NA,171,vindesine,2,3,mg/m2,1,"weekly for 5 doses, then every 2 weeks thereafter",NA
1698110,NA,171,bleomycin,2,10,unit/m2,1,days 3-7 and 31-35,NA
1698110,NA,171,carboplatin,3,250,mg/m2,1,every 28 days,NA
1698110,NA,171,carboplatin,3,250,mg/m2,1,every 28 days,NA
1698110,NA,171,vindesine,3,3,mg/m2,1,"weekly for 5 doses, then every 2 weeks thereafter",NA
1698110,NA,171,bleomycin,3,10,unit/m2,1,days 3-7 and 31-35,NA
1698110,NA,172,carboplatin,1,250,mg/m2,1,every 28 days,prior therapy
1698110,NA,172,carboplatin,1,250,mg/m2,1,every 28 days,prior therapy
1698110,NA,172,vindesine,1,3,mg/m2,1,"weekly for 5 doses, then every 2 weeks thereafter",prior therapy
1698110,NA,172,carboplatin,2,250,mg/m2,1,every 28 days,no prior therapy
1698110,NA,172,carboplatin,2,250,mg/m2,1,every 28 days,no prior therapy
1698110,NA,172,vindesine,2,3,mg/m2,1,"weekly for 5 doses, then every 2 weeks thereafter",no prior therapy
1698110,NA,173,carboplatin,1,250,mg/m2,1,every 28 days,NA
1698110,NA,173,carboplatin,1,250,mg/m2,1,every 28 days,NA
1698110,NA,173,vinblastine,1,5,mg/m2,1,every other weeks,NA
1698110,NA,173,carboplatin,2,300,mg/m2,1,every 28 days,NA
1698110,NA,173,carboplatin,2,300,mg/m2,1,every 28 days,NA
1698110,NA,173,vinblastine,2,5,mg/m2,1,every other weeks,NA
1698110,NA,173,carboplatin,3,350,mg/m2,1,every 28 days,NA
1698110,NA,173,carboplatin,3,350,mg/m2,1,every 28 days,NA
1698110,NA,173,vinblastine,3,5,mg/m2,1,every other weeks,NA
1698110,NA,173,carboplatin,4,400,mg/m2,1,every 28 days,NA
1698110,NA,173,carboplatin,4,400,mg/m2,1,every 28 days,NA
1698110,NA,173,vinblastine,4,5,mg/m2,1,every other weeks,NA
1698110,NA,173,carboplatin,5,500,mg/m2,1,every 28 days,NA
1698110,NA,173,carboplatin,5,500,mg/m2,1,every 28 days,NA
1698110,NA,173,vinblastine,5,5,mg/m2,1,every other weeks,NA
2162912,NA,174,cyclophosphamide,1,1500,mg/m2,1,for 4 days,NA
2162912,NA,174,thiotepa,1,180,mg/m2,1,for 4 days,NA
2162912,NA,174,carboplatin,1,400,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,carboplatin,1,400,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,cyclophosphamide,2,1500,mg/m2,1,for 4 days,NA
2162912,NA,174,thiotepa,2,180,mg/m2,1,for 4 days,NA
2162912,NA,174,carboplatin,2,800,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,carboplatin,2,800,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,cyclophosphamide,3,1500,mg/m2,1,for 4 days,NA
2162912,NA,174,thiotepa,3,125,mg/m2,1,for 4 days,NA
2162912,NA,174,carboplatin,3,800,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,carboplatin,3,800,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,cyclophosphamide,4,1500,mg/m2,1,for 4 days,NA
2162912,NA,174,thiotepa,4,125,mg/m2,1,for 4 days,NA
2162912,NA,174,carboplatin,4,1000,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2162912,NA,174,carboplatin,4,1000,mg/m2,NA,"continuous intravenous infusions, over 96 hours, on days -7 to -3",NA
2072142,NA,175,carboplatin,1,250,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,1,250,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,1,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,2,300,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,2,300,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,2,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,3,330,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,3,330,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,3,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,4,350,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,4,350,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,4,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,5,375,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,5,375,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,5,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,6,400,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,6,400,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,6,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,7,420,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,7,420,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,7,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
2072142,NA,175,carboplatin,8,450,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,carboplatin,8,450,mg/m2,1,on day 1 every 4 weeks,NA
2072142,NA,175,fluorouracil,8,1000,mg/m2,1,continuous infusion over 96 hours day 1 to day 4 every 4 weeks,NA
33144248,NA,178,docetaxel,1,5,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,nedaplatin,1,5,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,radiotherapy,1,2,Gy,1,64 Gy in 32 fractions,NA
33144248,NA,178,docetaxel,2,10,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,nedaplatin,2,10,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,radiotherapy,2,2,Gy,1,64 Gy in 32 fractions,NA
33144248,NA,178,docetaxel,3,15,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,nedaplatin,3,15,mg/m2,1,"on day 1, 4 each week concurrently for 4–6 weeks with radiotherapy",NA
33144248,NA,178,radiotherapy,3,2,Gy,1,64 Gy in 32 fractions,NA
33870151,NCT02223247,179,tvb-2640,1,60,mg/m2,1,every 21 days,BSA-based dose
33870151,NCT02223247,179,tvb-2640,2,120,mg/m2,1,every 21 days,BSA-based dose
33870151,NCT02223247,179,tvb-2640,3,240,mg/m2,1,every 21 days,BSA-based dose
33870151,NCT02223247,179,tvb-2640,4,80,mg/m2,1,every 21 days,BSA-based dose
33870151,NCT02223247,179,tvb-2640,5,200,mg,1,every 21 days,flat doses
33870151,NCT02223247,179,tvb-2640,6,250,mg,1,every 21 days,flat doses
33870151,NCT02223247,180,tvb-2640,1,60,mg/m2,1,every 28 days,BSA-based dose
33870151,NCT02223247,180,paclitaxel,1,NA,IU/m2/d,NA,NA,NA
33870151,NCT02223247,180,tvb-2640,2,200,mg,NA,every 28 days,flat doses
33870151,NCT02223247,180,paclitaxel,2,NA,NA,NA,NA,NA
33870151,NCT02223247,181,tvb-2640,1,60,mg/m2,NA,every 28 days,BSA-based dose
33870151,NCT02223247,181,docetaxel,1,NA,NA,NA,NA,NA
8281628,NA,182,doxorubicin,1,60,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,1,200,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,1,200,mg/m2,1,every 28 days.,NA
8281628,NA,182,doxorubicin,2,60,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,2,250,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,2,250,mg/m2,1,every 28 days.,NA
8281628,NA,182,doxorubicin,3,60,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,3,325,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,3,325,mg/m2,1,every 28 days.,NA
8281628,NA,182,doxorubicin,4,60,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,4,400,mg/m2,1,every 28 days.,NA
8281628,NA,182,carboplatin,4,400,mg/m2,1,every 28 days.,NA
8281628,NA,183,doxorubicin,1,60,mg/m2,1,every 28 days.,NA
8281628,NA,183,carboplatin,1,400,mg/m2,1,every 28 days.,NA
8281628,NA,183,carboplatin,1,400,mg/m2,1,every 28 days.,NA
8281628,NA,183,gm-csf,1,10,ug/kg,1,days 1-21 in a 28-day cycle,NA
8281628,NA,183,gm-csf,1,10,ug/kg,1,days 1-21 in a 28-day cycle,NA
1403054,NA,184,etoposide,1,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,1,10000,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,1,900,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,1,900,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,2,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,2,12500,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,2,900,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,2,900,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,3,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,3,12500,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,3,1125,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,3,1125,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,4,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,4,15624,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,4,1125,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,4,1125,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,5,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,5,15624,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,5,1407,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,5,1407,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,6,600,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,6,15624,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,6,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,6,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,7,1050,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,7,15624,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,7,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,7,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,8,1428,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,8,15624,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,8,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,8,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,9,1500,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,9,16000,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,9,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,9,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,10,1500,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,10,18000,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,10,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,10,1800,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,etoposide,11,1500,mg/m2,2,on days -6 to -4.,NA
1403054,NA,184,ifosfamide,11,16000,mg/m2,1,on days -6 to -3.,NA
1403054,NA,184,carboplatin,11,1980,mg/m2,1,on days -6 to -4.,NA
1403054,NA,184,carboplatin,11,1980,mg/m2,1,on days -6 to -4.,NA
8270975,NA,185,carboplatin,1,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,carboplatin,1,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,cyclophosphamide,1,90,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,mitoxantrone,1,30,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,carboplatin,2,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,carboplatin,2,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,cyclophosphamide,2,120,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,mitoxantrone,2,45,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,carboplatin,3,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,carboplatin,3,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,cyclophosphamide,3,120,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,mitoxantrone,3,60,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,carboplatin,4,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,carboplatin,4,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,cyclophosphamide,4,120,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,mitoxantrone,4,75,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,carboplatin,5,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,carboplatin,5,1500,mg/m2,1,24-hour continuous infusion on day -8 to day -3 before marrow infusion,NA
8270975,NA,185,cyclophosphamide,5,150,mg/m2,1,"on days -8, -6, and -4.",NA
8270975,NA,185,mitoxantrone,5,75,mg/m2,1,"on days -8, -6, and -4.",NA
8422699,NA,186,ci-973,1,70,mg/m2,1,every 28 days,NA
8422699,NA,186,ci-973,2,150,mg/m2,1,every 28 days,NA
8422699,NA,186,ci-973,3,177,mg/m2,1,every 28 days,NA
8422699,NA,186,ci-973,4,188,mg/m2,1,every 28 days,NA
8422699,NA,186,ci-973,5,230,mg/m2,1,every 28 days,NA
8422699,NA,186,ci-973,6,290,mg/m2,1,every 28 days,NA
21152384,NA,187,decitabine,1,20,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,1,100,mg,2,on days 6 to 21 every 28 days,sequential schedule
21152384,NA,187,decitabine,-1,15,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,-1,200,mg,2,on days 6 to 21 every 28 days,sequential schedule
21152384,NA,187,decitabine,1.5,20,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,1.5,100,mg,2,on days 6 to 12 every 28 days,sequential schedule
21152384,NA,187,decitabine,2,15,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,2,200,mg,2,on days 6 to 12 every 28 days,sequential schedule
21152384,NA,187,decitabine,-1.5,10,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,-1.5,200,mg,2,on days 6 to 12 every 28 days,sequential schedule
21152384,NA,187,decitabine,-2,10,mg/m2,1,on days 1 to 5 every 28 days,sequential schedule
21152384,NA,187,vorinostat,-2,200,mg,3,on days 6 to 12 every 28 days,cocurrent schedule
21152384,NA,187,decitabine,-2.5,10,mg/m2,1,on days 1 to 5 every 28 days,cocurrent schedule
21152384,NA,187,vorinostat,-2.5,200,mg,2,on days 3 to 9 every 28 days,cocurrent schedule
21152384,NA,187,decitabine,-3,10,mg/m2,1,on days 1 to 5 every 28 days,cocurrent schedule
21152384,NA,187,vorinostat,-3,200,mg,2,on days 3 to 16 every 28 days,cocurrent schedule
21152384,NA,187,decitabine,-3.5,10,mg/m2,1,on days 1 to 5 every 28 days,cocurrent schedule
21152384,NA,187,vorinostat,-3.5,200,mg,3,on days 3 to 9 every 28 days,cocurrent schedule
34310349,NA,188,docetaxel,1,60,mg/m2,1,on day 1 of each 21-day cycle,NA
34310349,NA,188,temsirolimus,1,15,mg/m2,1,"days 1, 8, 15 of each 21-day cycle",NA
34310349,NA,188,docetaxel,2,60,mg/m2,1,on day 1 of each 21-day cycle,NA
34310349,NA,188,temsirolimus,2,25,mg/m2,1,"days 1, 8, 15 of each 21-day cycle",NA
34310349,NA,188,docetaxel,-1,50,mg/m2,1,on day 1 of each 21-day cycle,NA
34310349,NA,188,temsirolimus,-1,15,mg/m2,1,"days 1, 8, 15 of each 21-day cycle",NA
34310349,NA,188,docetaxel,-2,50,mg/m2,1,on day 1 of each 21-day cycle,NA
34310349,NA,188,temsirolimus,-2,10,mg/m2,1,"days 1, 8, 15 of each 21-day cycle",NA
2258073,NA,189,carboplatin,1,300,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,1,300,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,2,400,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,2,400,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,3,500,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,3,500,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,4,550,mg/m2,1,every 28 days,NA
2258073,NA,189,carboplatin,4,550,mg/m2,1,every 28 days,NA
9427692,NA,190,dab389il-2,1,3,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,2,6,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,3,9,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,4,12,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,5,15,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,6,19,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,7,23,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,8,27,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
9427692,NA,190,dab389il-2,9,31,ug/kg,1,daily for 5 days every 3 or 4 weeks,NA
34263358,NA,191,docetaxel,0,40,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,0,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,0,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,5‑fuorouracil,0,700,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,radiotherapy,0,66,Gy,NA,"fve times per week, 2 Gy per fraction",NA
34263358,NA,191,docetaxel,1,50,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,1,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,1,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,5‑fuorouracil,1,700,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,radiotherapy,1,66,Gy,NA,"fve times per week, 2 Gy per fraction",NA
34263358,NA,191,docetaxel,2,60,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,2,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,cisplatin,2,70,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,5‑fuorouracil,2,700,mg/m2,1,on days 1 and 29,NA
34263358,NA,191,radiotherapy,2,66,Gy,NA,"fve times per week, 2 Gy per fraction",NA
32600929,NCT00916123,192,docetaxel,1,75,mg/m2,1,"every 21 days for 3 cycles, Cycle 4 was administered a minimum of 6 weeks following cycle 3, up to a maximum of 9 weeks later without being deemed dose limiting",NA
32600929,NCT00916123,192,177lu-j591,1,1.48,MBq/kg,NA,half of 177Lu-J591 dose 2 to 3 days prior to docetaxel in cycle 3 and the other half 2 weeks later,NA
32600929,NCT00916123,192,docetaxel,2,75,mg/m2,1,"every 21 days for 3 cycles, Cycle 4 was administered a minimum of 6 weeks following cycle 3, up to a maximum of 9 weeks later without being deemed dose limiting",NA
32600929,NCT00916123,192,177lu-j591,2,1.85,MBq/kg,NA,half of 177Lu-J591 dose 2 to 3 days prior to docetaxel in cycle 3 and the other half 2 weeks later,NA
32600929,NCT00916123,192,docetaxel,3,75,mg/m2,1,"every 21 days for 3 cycles, Cycle 4 was administered a minimum of 6 weeks following cycle 3, up to a maximum of 9 weeks later without being deemed dose limiting",NA
32600929,NCT00916123,192,177lu-j591,3,2.22,MBq/kg,NA,half of 177Lu-J591 dose 2 to 3 days prior to docetaxel in cycle 3 and the other half 2 weeks later,NA
32600929,NCT00916123,192,docetaxel,4,75,mg/m2,1,"every 21 days for 3 cycles, Cycle 4 was administered a minimum of 6 weeks following cycle 3, up to a maximum of 9 weeks later without being deemed dose limiting",NA
32600929,NCT00916123,192,177lu-j591,4,2.59,MBq/kg,NA,half of 177Lu-J591 dose 2 to 3 days prior to docetaxel in cycle 3 and the other half 2 weeks later,NA
32600929,NCT00916123,192,docetaxel,5,75,mg/m2,1,"every 21 days for 3 cycles, Cycle 4 was administered a minimum of 6 weeks following cycle 3, up to a maximum of 9 weeks later without being deemed dose limiting",NA
32600929,NCT00916123,192,177lu-j591,5,2.96,MBq/kg,NA,half of 177Lu-J591 dose 2 to 3 days prior to docetaxel in cycle 3 and the other half 2 weeks later,NA
10071279,NA,193,dexrazoxane,1,600,mg/m2,1,NA,NA
10071279,NA,193,doxorubicin,1,60,mg/m2,1,NA,NA
10071279,NA,193,paclitaxel,1,150,mg/m2,1,NA,NA
10071279,NA,194,dexrazoxane,1,600,mg/m2,1,NA,NA
10071279,NA,194,doxorubicin,1,60,mg/m2,1,NA,NA
10071279,NA,194,paclitaxel,1,150,mg/m2,1,NA,NA
10071279,NA,194,g-csf,1,10,ug/kg,1,NA,NA
10071279,NA,194,g-csf,1,10,ug/kg,1,NA,NA
10071279,NA,194,dexrazoxane,2,600,mg/m2,1,NA,NA
10071279,NA,194,doxorubicin,2,60,mg/m2,1,NA,NA
10071279,NA,194,paclitaxel,2,175,mg/m2,1,NA,NA
10071279,NA,194,g-csf,2,10,ug/kg,1,NA,NA
10071279,NA,194,g-csf,2,10,ug/kg,1,NA,NA
17442993,NA,195,g3139,1,3,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,1,30,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,1,500,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,g3139,2,3,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,2,22.5,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,2,400,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,g3139,3,5,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,3,22.5,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,3,400,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,g3139,4,7,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,4,22.5,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,4,400,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,g3139,5,7,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,5,30,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,5,500,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,g3139,6,7,mg/kg,1,continuous infusion from days 1 to 7 every 21 days,NA
17442993,NA,195,doxorubicin,6,37.5,mg/m2,1,on days 5 and 6 every 21 days,NA
17442993,NA,195,cyclophosphamide,6,600,mg/m2,1,on days 5 and 6 every 21 days,NA
8383914,NA,196,etoposide,1,200,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,1,50,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,1,50,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,etoposide,2,200,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,2,100,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,2,100,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,etoposide,3,200,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,3,125,mg/m2,1,on 3 consecutive days every 4 weeks,NA
8383914,NA,196,carboplatin,3,125,mg/m2,1,on 3 consecutive days every 4 weeks,NA
29463550,NCT01546038,197,glasdegib,1,100,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,197,cytarabine,1,20,mg,2,on days 1 to 10 of each 28-day cycle,NA
29463550,NCT01546038,197,glasdegib,2,200,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,197,cytarabine,2,20,mg,2,on days 1 to 10 of each 28-day cycle,NA
29463550,NCT01546038,198,glasdegib,1,100,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,198,decitabine,1,20,mg/m2,1,the first 5 days of each 28-day cycle,NA
29463550,NCT01546038,198,glasdegib,2,200,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,198,decitabine,2,20,mg/m2,1,the first 5 days of each 28-day cycle,NA
29463550,NCT01546038,199,glasdegib,1,100,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,199,cytarabine,1,100,mg/m2,1,on days 1–7 in 28-day cycle,NA
29463550,NCT01546038,199,daunorubicin,1,60,mg/m2,1,on days 1–3 in 28-day cycle,NA
29463550,NCT01546038,199,glasdegib,2,200,mg,1,once daily in 28-day cycles,NA
29463550,NCT01546038,199,cytarabine,2,100,mg/m2,1,on days 1–7 in 28-day cycle,NA
29463550,NCT01546038,199,daunorubicin,2,60,mg/m2,1,on days 1–3 in 28-day cycle,NA
15113758,NA,200,denileukin diftitox,1,9,ug/kg,1,on days 1 and 15 every 4 weeks,NA
15113758,NA,200,denileukin diftitox,2,9,ug/kg,1,"on days 1, 3, 5, 15, 17, and 19 every 4 weeks",NA
15113758,NA,200,denileukin diftitox,3,9,ug/kg,1,on days 1 to 5 and 15 to 19 every 4 weeks,NA
18719348,NA,201,s-1,0,40,mg/m2,2,daily on days 1-14 of each 28-day cycle,NA
18719348,NA,201,docetaxel,0,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,0,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,0,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,s-1,1,40,mg/m2,2,daily on days 1-14 of each 28-day cycle,NA
18719348,NA,201,docetaxel,1,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,1,60,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,1,60,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,s-1,2,40,mg/m2,2,daily on days 1-14 of each 28-day cycle,NA
18719348,NA,201,docetaxel,2,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,2,70,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,2,70,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,s-1,3,40,mg/m2,2,daily on days 1-14 of each 28-day cycle,NA
18719348,NA,201,docetaxel,3,40,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,3,80,mg/m2,1,on day 1  every 28 days,NA
18719348,NA,201,cisplatin,3,80,mg/m2,1,on day 1  every 28 days,NA
17519066,NA,202,tipifarnib,1,200,mg,2,daily continuously,NA
17519066,NA,202,docetaxel,1,75,mg/m2,1,on day 1 of multiple 21-day cycles,NA
17519066,NA,202,tipifarnib,2,200,mg,2,on days 1-7 every 21 days,NA
17519066,NA,202,docetaxel,2,75,mg/m2,1,on day 1 of multiple 21-day cycles,NA
17519066,NA,202,tipifarnib,3,300,mg,2,on days 1-7 every 21 days,NA
17519066,NA,202,docetaxel,3,75,mg/m2,1,on day 1 of multiple 21-day cycles,NA
17519066,NA,202,tipifarnib,4,200,mg,2,on days 1-14 every 21 days,NA
17519066,NA,202,docetaxel,4,75,mg/m2,1,on day 1 of multiple 21-day cycles,NA
17519066,NA,202,tipifarnib,5,200,mg,2,on days 1-14 every 21 days,NA
17519066,NA,202,docetaxel,5,85,mg/m2,1,on day 1 of multiple 21-day cycles,NA
17519066,NA,202,tipifarnib,6,300,mg,2,on days 1-14 every 21 days,NA
17519066,NA,202,docetaxel,6,60,mg/m2,1,on day 1 of multiple 21-day cycles,NA
19251309,NA,203,docetaxel,1,20,mg/m2,1,weekly by standard infusion for 4–6 cycles given during radiotherapy,NA
19251309,NA,203,radiotherapy,1,85,Gy,NA,total dose,NA
19251309,NA,203,docetaxel,2,30,mg/m2,1,weekly by standard infusion for 4–6 cycles given during radiotherapy,NA
19251309,NA,203,radiotherapy,2,85,Gy,NA,total dose,NA
19251309,NA,203,docetaxel,3,40,mg/m2,1,weekly by standard infusion for 4–6 cycles given during radiotherapy,NA
19251309,NA,203,radiotherapy,3,85,Gy,NA,total dose,NA
17909805,NA,204,ketoconazole,1,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,1,10,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,2,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,2,20,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,3,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,3,25,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,4,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,4,30,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,5,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,5,50,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,6,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,6,60,mg/m2,1,once in every 3 week,NA
17909805,NA,204,ketoconazole,7,200,mg,2,3 days starting 2 days before the administration of docetaxel,NA
17909805,NA,204,docetaxel,7,70,mg/m2,1,once in every 3 week,NA
18405987,NA,205,docetaxel,1,20,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,1,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,1,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,5-fluorouracil,1,400,mg/m2,1,"on days 1–5, 15–19, 29–33, and 43–47",NA
18405987,NA,205,radiotherapy,1,1.8,Gy,1,"a dose of 61.2 Gy was administered in 34 fractions of 1.8 Gy per day, 5 times per week, starting on day 1",NA
18405987,NA,205,docetaxel,2,30,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,2,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,2,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,5-fluorouracil,2,400,mg/m2,1,"on days 1–5, 15–19, 29–33, and 43–47",NA
18405987,NA,205,radiotherapy,2,1.8,Gy,1,"a dose of 61.2 Gy was administered in 34 fractions of 1.8 Gy per day, 5 times per week, starting on day 1",NA
18405987,NA,205,docetaxel,3,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,3,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,3,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,5-fluorouracil,3,400,mg/m2,1,"on days 1–5, 15–19, 29–33, and 43–47",NA
18405987,NA,205,radiotherapy,3,1.8,Gy,1,"a dose of 61.2 Gy was administered in 34 fractions of 1.8 Gy per day, 5 times per week, starting on day 1",NA
18405987,NA,205,docetaxel,2.5,35,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,2.5,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,cisplatin,2.5,40,mg/m2,1,"on days 1, 15, 29, and 43",NA
18405987,NA,205,5-fluorouracil,2.5,400,mg/m2,1,"on days 1–5, 15–19, 29–33, and 43–47",NA
18405987,NA,205,radiotherapy,2.5,1.8,Gy,1,"a dose of 61.2 Gy was administered in 34 fractions of 1.8 Gy per day, 5 times per week, starting on day 1",NA
18172649,NA,206,patupilone,1,1.5,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,patupilone,1.5,1.5,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,gemcitabine,1.5,750,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,patupilone,2,2,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,gemcitabine,2,750,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,patupilone,3,2.5,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,gemcitabine,3,750,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,patupilone,4,3,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18172649,NA,206,gemcitabine,4,750,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
19499186,NA,207,imexon,1,390,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,1,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,2,550,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,2,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,3,750,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,3,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,4,1000,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,4,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,5,1300,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,5,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,6,1700,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,6,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
19499186,NA,207,imexon,7,1500,mg/m2,1,on days 1–5 of a 21 day cycle,NA
19499186,NA,207,docetaxel,7,75,mg/m2,1,on day 1 (30 min after imexon) of each 21 day treatment cycle,NA
18319713,NA,208,ispinesib,-2,6,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,-2,50,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,-1,6,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,-1,60,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,0,8,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,0,60,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,0.5,10,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,0.5,60,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,1,8,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,1,75,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,1.5,10,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,1.5,75,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,2,12,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,2,75,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,3,15,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,3,75,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,ispinesib,4,18,mg/m2,1,On day 1 every 21 days,NA
18319713,NA,208,docetaxel,4,75,mg/m2,1,On day 1 every 21 days,NA
17896192,NA,209,docetaxel,1,25,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17896192,NA,209,topotecan,1,4,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17896192,NA,209,topotecan,1,4,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17896192,NA,209,docetaxel,-1,25,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17896192,NA,209,topotecan,-1,3,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17896192,NA,209,topotecan,-1,3,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
17940076,NA,210,docetaxel,1,30,mg/m2,1,"on days 1, 15 and 29",NA
17940076,NA,210,radiation,1,2,Gy,1,"30 fractions,  five fractions per week",NA
17940076,NA,210,docetaxel,2,35,mg/m2,1,"on days 1, 15 and 29",NA
17940076,NA,210,radiation,2,2,Gy,1,"30 fractions,  five fractions per week",NA
17940076,NA,210,docetaxel,3,40,mg/m2,1,"on days 1, 15 and 29",NA
17940076,NA,210,radiation,3,2,Gy,1,"30 fractions,  five fractions per week",NA
17940076,NA,210,docetaxel,0,25,mg/m2,1,"on days 1, 15 and 29",NA
17940076,NA,210,radiation,0,2,Gy,1,"30 fractions,  five fractions per week",NA
19704337,NA,211,gti-2040,1,3,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,gti-2040,1,3,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,docetaxel,1,60,mg/m2,1,on day 3 of 21 days,NA
19704337,NA,211,gti-2040,2,5,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,gti-2040,2,5,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,docetaxel,2,60,mg/m2,1,on day 3 of 21 days,NA
19704337,NA,211,gti-2040,3,5,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,gti-2040,3,5,mg/kg,1,"administered as a continuous intravenous infusion (CVI) for 14 days starting on day 1 of each cycle, followed by a 7-day break",NA
19704337,NA,211,docetaxel,3,75,mg/m2,1,on day 3 of 21 days,NA
19066894,NA,212,oxaliplatin,1,100,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,oxaliplatin,1,100,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,oxaliplatin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,docetaxel,2,75,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,oxaliplatin,3,130,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,oxaliplatin,3,130,mg/m2,1,on day 1 every 3 weeks,NA
19066894,NA,212,docetaxel,3,75,mg/m2,1,on day 1 every 3 weeks,NA
18000498,NA,213,pertuzumab,1,1050,mg,1,every 3 weeks,NA
18000498,NA,213,docetaxel,1,60,mg/m2,1,every 3 weeks,NA
18000498,NA,213,pertuzumab,2,1050,mg,1,every 3 weeks,NA
18000498,NA,213,docetaxel,2,75,mg/m2,1,every 3 weeks,NA
18000498,NA,213,pertuzumab,3,1050,mg,1,every 3 weeks,NA
18000498,NA,213,docetaxel,3,1000,mg/m2,1,every 3 weeks,NA
18000498,NA,213,pertuzumab,1.5,840,mg,1,loading dose,NA
18000498,NA,213,pertuzumab,1.5,420,mg,1,every 3 weeks from cycle 2,NA
18000498,NA,213,docetaxel,1.5,60,mg/m2,1,every 3 weeks,NA
18000498,NA,213,pertuzumab,2.5,840,mg,1,loading dose,NA
18000498,NA,213,pertuzumab,2.5,420,mg,1,every 3 weeks from cycle 2,NA
18000498,NA,213,docetaxel,2.5,75,mg/m2,1,every 3 weeks,NA
18000498,NA,213,pertuzumab,3.5,840,mg,1,loading dose,NA
18000498,NA,213,pertuzumab,3.5,420,mg,1,every 3 weeks from cycle 2,NA
18000498,NA,213,docetaxel,3.5,1000,mg/m2,1,every 3 weeks,NA
17826308,NA,214,nedaplatin,1,60,mg/m2,1,on day 1,NA
17826308,NA,214,docetaxel,1,60,mg/m2,1,on day 1,NA
17826308,NA,214,nedaplatin,2,70,mg/m2,1,on day 1,NA
17826308,NA,214,docetaxel,2,60,mg/m2,1,on day 1,NA
17826308,NA,214,nedaplatin,3,80,mg/m2,1,on day 1,NA
17826308,NA,214,docetaxel,3,60,mg/m2,1,on day 1,NA
17826308,NA,214,nedaplatin,4,90,mg/m2,1,on day 1,NA
17826308,NA,214,docetaxel,4,60,mg/m2,1,on day 1,NA
18493840,NA,215,docetaxel,0,40,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,0,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,0,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,1,45,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,1,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,1,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,2,50,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,2,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,2,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,3,55,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,3,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,3,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,4,60,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,4,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,4,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,5,65,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,5,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,5,600,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,docetaxel,6,70,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,epirubicin,6,80,mg/m2,1,every 21 days for four cycles,NA
18493840,NA,215,cyclophosphamide,6,600,mg/m2,1,every 21 days for four cycles,NA
17594929,NA,216,docetaxel,1,70,mg/m2,1,on day 1 every 21 days,NA
17594929,NA,216,ifosfamide,1,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17594929,NA,216,docetaxel,2,85,mg/m2,1,on day 1 every 21 days,NA
17594929,NA,216,ifosfamide,2,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17594929,NA,216,docetaxel,3,85,mg/m2,1,on day 1 every 21 days,NA
17594929,NA,216,ifosfamide,3,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17594929,NA,216,g-csf,3,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
17594929,NA,216,g-csf,3,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
17594929,NA,216,docetaxel,4,100,mg/m2,1,on day 1 every 21 days,NA
17594929,NA,216,ifosfamide,4,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17594929,NA,216,g-csf,4,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
17594929,NA,216,g-csf,4,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
17594929,NA,216,docetaxel,5,100,mg/m2,1,on day 1 every 21 days,NA
17594929,NA,216,ifosfamide,5,6000,mg/m2,1,on days 1 and 2 every 21 days,NA
17594929,NA,216,g-csf,5,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
17594929,NA,216,g-csf,5,150,ug/m2,1,"from day 4 until day 10 or until WBC≥10,000/µl, whichever came first",NA
18758179,NA,217,epirubicin,1,50,mg/m2,1,on day 1 every 3 weeks,NA
18758179,NA,217,docetaxel,1,50,mg/m2,1,on day 1 every 3 weeks,NA
18758179,NA,217,epirubicin,2,50,mg/m2,1,on day 1 every 3 weeks,NA
18758179,NA,217,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
18758179,NA,217,epirubicin,3,60,mg/m2,1,on day 1 every 3 weeks,NA
18758179,NA,217,docetaxel,3,60,mg/m2,1,on day 1 every 3 weeks,NA
19190908,NA,218,docetaxel,0,52.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0,80,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0,80,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,0,60,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0.5,52.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0.5,52.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,0.5,80,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,0.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,1,52.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,1,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,1,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,1,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,1.5,52.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,1.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,1.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,1.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,2,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,2,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,2,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,2,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,2.5,60,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,2.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,2.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,2.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,3,67.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,3,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,3,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,3,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,3.5,67.5,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,3.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,3.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,3.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,4,75,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,4,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,4,105,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,4,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
19190908,NA,218,docetaxel,4.5,75,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,4.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,oxaliplatin,4.5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
19190908,NA,218,s-1,4.5,80,mg/m2,1,daily from day 1 to day 14 of each 21-day cycle,NA
18425392,NA,219,docetaxel,1,25,mg/m2,1,every 3 weeks,NA
18425392,NA,219,docetaxel,2,35,mg/m2,1,every 3 weeks,NA
18425392,NA,219,docetaxel,3,45,mg/m2,1,every 3 weeks,NA
18425392,NA,219,docetaxel,4,60,mg/m2,1,every 3 weeks,NA
19543076,NA,220,docetaxel,0,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,0,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,0,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,s-1,0,40,mg/m2,2,on days 1–14 every 4 weeks,NA
19543076,NA,220,docetaxel,1,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,1,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,1,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,s-1,1,40,mg/m2,2,on days 1–14 every 4 weeks,NA
19543076,NA,220,docetaxel,2,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,2,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,2,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,s-1,2,40,mg/m2,2,on days 1–14 every 4 weeks,NA
19543076,NA,220,docetaxel,3,40,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,3,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,cisplatin,3,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
19543076,NA,220,s-1,3,40,mg/m2,2,on days 1–14 every 4 weeks,NA
18477581,NA,221,oblimersen,1,3,mg/kg,1,24-h infusion on days 1–7 for cycle 1,NA
18477581,NA,221,docetaxel,1,75,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,adriamycin,1,50,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,cyclophosphamide,1,500,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,oblimersen,2,5,mg/kg,1,24-h infusion on days 1–7 for cycle 1,NA
18477581,NA,221,docetaxel,2,75,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,adriamycin,2,50,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,cyclophosphamide,2,500,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,oblimersen,3,7,mg/kg,1,24-h infusion on days 1–7 for cycle 1,NA
18477581,NA,221,docetaxel,3,75,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,adriamycin,3,50,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
18477581,NA,221,cyclophosphamide,3,500,mg/m2,1,on day 5 every 3 weeks for 5 cycles,NA
19415031,NA,222,docetaxel,1,20,mg/m2,1,weekly for 6 weeks,NA
19415031,NA,222,radiation therapy,1,60,Gy,NA,in 30 fractions over six weeks,NA
19415031,NA,222,docetaxel,0,15,mg/m2,1,weekly for 6 weeks,NA
19415031,NA,222,radiation therapy,0,60,Gy,NA,in 30 fractions over six weeks,NA
18824702,NA,223,ym155,1,1.8,mg/m2,1,every 21 days,NA
18824702,NA,223,ym155,2,3.6,mg/m2,1,every 21 days,NA
18824702,NA,223,ym155,3,4.8,mg/m2,1,every 21 days,NA
18824702,NA,223,ym155,4,6,mg/m2,1,every 21 days,NA
19074216,NA,224,liposomal-encapsulated doxorubicin,0,60,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,0,75,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,0,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,1,70,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,1,70,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,1,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,2,70,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,2,75,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,2,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,3,75,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,3,75,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,3,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,-1,55,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,-1,75,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,-1,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,-2,50,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,-2,70,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,-2,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,-3,50,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,-3,65,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,-3,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
19074216,NA,224,liposomal-encapsulated doxorubicin,-4,50,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,docetaxel,-4,60,mg/m2,1,on day 1 every 21 days,NA
19074216,NA,224,trastuzumab,-4,4,mg/kg,1,"loading dose on day 1, followed by 2 mg/kg weekly",NA
18493761,NA,225,docetaxel,1,40,mg/m2,1,on day 1 of each 3-week cycle,NA
18493761,NA,225,s-1,1,40,mg/m2,2,on days 1–14 of each 3-week cycle,NA
18493761,NA,225,docetaxel,2,50,mg/m2,1,on day 1 of each 3-week cycle,NA
18493761,NA,225,s-1,2,40,mg/m2,2,on days 1–14 of each 3-week cycle,NA
18493761,NA,225,docetaxel,3,60,mg/m2,1,on day 1 of each 3-week cycle,NA
18493761,NA,225,s-1,3,40,mg/m2,2,on days 1–14 of each 3-week cycle,NA
18493761,NA,225,docetaxel,4,70,mg/m2,1,on day 1 of each 3-week cycle,NA
18493761,NA,225,s-1,4,40,mg/m2,2,on days 1–14 of each 3-week cycle,NA
19636016,NA,226,abr-217620,1,0.5,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,2,0.7,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,3,0.9,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,4,1.2,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,5,1.6,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,6,2.1,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,7,2.8,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,8,3.7,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,9,4.9,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,10,6.6,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,11,8.8,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,12,11.6,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,13,12.8,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,14,15.5,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,15,15.6,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,16,17,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,17,17.3,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,18,19.7,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,19,20.2,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,20,20.6,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,21,21,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,22,22.2,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,23,23.2,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,24,23.4,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,25,24.7,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,26,25.7,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,27,26.4,ug/kg,1,days 1 through 5,NA
19636016,NA,226,abr-217620,28,27.4,ug/kg,1,days 1 through 5,NA
19636016,NA,227,abr-217620,1,10.3,ug/kg,1,on days 1 through 4 and days 22 through 25 comprising cycles 1 and 2 (in 21-day cycles),NA
19636016,NA,227,docetaxel,1,75,mg/m2,1,"on days 5, 26, and 47 comprising cycles 1 and2 (in 21-day cycles)",NA
19636016,NA,227,abr-217620,2,16.5,ug/kg,1,on days 1 through 4 and days 22 through 25 comprising cycles 1 and 2 (in 21-day cycles),NA
19636016,NA,227,docetaxel,2,75,mg/m2,1,"on days 5, 26, and 47 comprising cycles 1 and2 (in 21-day cycles)",NA
19636016,NA,227,abr-217620,3,22,ug/kg,1,on days 1 through 4 and days 22 through 25 comprising cycles 1 and 2 (in 21-day cycles),NA
19636016,NA,227,docetaxel,3,75,mg/m2,1,"on days 5, 26, and 47 comprising cycles 1 and2 (in 21-day cycles)",NA
18343924,NA,228,docetaxel,1,33.3,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,1,30,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,1,30,mg/m2,1,weekly,NA
18343924,NA,228,5-fu,1,1000,mg/m2,1,"24-h continuous infusion on days 1, 8 and 15 every 4 weeks",NA
18343924,NA,228,docetaxel,2,33.3,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,2,30,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,2,30,mg/m2,1,weekly,NA
18343924,NA,228,5-fu,2,1250,mg/m2,1,"24-h continuous infusion on days 1, 8 and 15 every 4 weeks",NA
18343924,NA,228,docetaxel,3,33.3,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,3,30,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,3,30,mg/m2,1,weekly,NA
18343924,NA,228,5-fu,3,1500,mg/m2,1,"24-h continuous infusion on days 1, 8 and 15 every 4 weeks",NA
18343924,NA,228,docetaxel,4,33.3,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,4,30,mg/m2,1,weekly,NA
18343924,NA,228,cisplatin,4,30,mg/m2,1,weekly,NA
18343924,NA,228,5-fu,4,1750,mg/m2,1,"24-h continuous infusion on days 1, 8 and 15 every 4 weeks",NA
18751437,NA,229,s-1,0,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,0,15,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,1,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,1,20,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,2,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,2,25,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,3,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,3,30,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,4,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,4,35,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,5,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,5,40,mg/m2,1,on days 1 and 15 every month,NA
18751437,NA,229,s-1,6,80,mg/m2,2,on days 1-7 and 15-21 every month,NA
18751437,NA,229,docetaxel,6,45,mg/m2,1,on days 1 and 15 every month,NA
19704061,NA,230,cisplatin,1,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,cisplatin,1,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,docetaxel,1,75,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,fluorouracil,1,700,mg/m2,1,for 4 days every 21 days,NA
19704061,NA,230,cetuximab,1,250,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,cisplatin,2,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,cisplatin,2,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,docetaxel,2,75,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,fluorouracil,2,850,mg/m2,1,for 4 days every 21 days,NA
19704061,NA,230,cetuximab,2,250,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,cisplatin,3,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,cisplatin,3,100,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,docetaxel,3,75,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
19704061,NA,230,fluorouracil,3,1000,mg/m2,1,for 4 days every 21 days,NA
19704061,NA,230,cetuximab,3,250,mg/m2,1,"every 21 days starting on days 1, 22, and 43",NA
17695429,NA,231,docetaxel,1,15,mg/m2,1,"on day 1, 8 and 15 every 5 weeks",NA
17695429,NA,231,s-1,1,80,mg/m2,1,"on days 1-21, every 5 weeks",NA
17695429,NA,231,docetaxel,2,20,mg/m2,1,"on day 1, 8 and 15 every 5 weeks",NA
17695429,NA,231,s-1,2,80,mg/m2,1,"on days 1-21, every 5 weeks",NA
17695429,NA,231,docetaxel,3,25,mg/m2,1,"on day 1, 8 and 15 every 5 weeks",NA
17695429,NA,231,s-1,3,80,mg/m2,1,"on days 1-21, every 5 weeks",NA
19768460,NA,232,cyclophosphamide,0,500,mg/m2,1,on day 1 of each 3-week cycle,NA
19768460,NA,232,paclitaxel,0,80,mg/m2,1,"on days 1, 8, and 15 of each 3-week cycle",NA
19768460,NA,232,cyclophosphamide,1,600,mg/m2,1,on day 1 of each 3-week cycle,NA
19768460,NA,232,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 of each 3-week cycle",NA
19768460,NA,232,cyclophosphamide,2,600,mg/m2,1,on day 1 of each 3-week cycle,NA
19768460,NA,232,paclitaxel,2,100,mg/m2,1,"on days 1, 8, and 15 of each 3-week cycle",NA
17695421,NA,233,docetaxel,1,7.5,mg/m2,1,"on days 1, 8, 22 and 29",NA
17695421,NA,233,5-fluorouracil,1,250,mg/m2,1,"continuous infusion for 24 h on days 1-5, 8-12,15-19, 22-26, 29-33, 36-40 and 43-45",NA
17695421,NA,233,radiotherapy,1,2,Gy,1,"on days 1-5, 8-12, 15-19, 22-26, 29-33, 36-40 and 43-45",NA
17695421,NA,233,docetaxel,2,10,mg/m2,1,"on days 1, 8, 22 and 29",NA
17695421,NA,233,5-fluorouracil,2,250,mg/m2,1,"continuous infusion for 24 h on days 1-5, 8-12,15-19, 22-26, 29-33, 36-40 and 43-45",NA
17695421,NA,233,radiotherapy,2,2,Gy,1,"on days 1-5, 8-12, 15-19, 22-26, 29-33, 36-40 and 43-45",NA
19437020,NA,234,larotaxel,-1,45,mg/m2,1,every 3 weeks,NA
19437020,NA,234,larotaxel,1,60,mg/m2,1,every 3 weeks,NA
19437020,NA,234,larotaxel,2,75,mg/m2,1,every 3 weeks,NA
19437020,NA,234,larotaxel,3,90,mg/m2,1,every 3 weeks,NA
19437020,NA,234,larotaxel,4,105,mg/m2,1,every 3 weeks,NA
19437020,NA,234,larotaxel,5,120,mg/m2,1,every 3 weeks,NA
17848958,NA,235,s-1,1,40,mg/m2,2,on days 1 – 14 every 3 weeks,NA
17848958,NA,235,docetaxel,1,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,1,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,1,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,s-1,2,40,mg/m2,2,on days 1 – 14 every 3 weeks,NA
17848958,NA,235,docetaxel,2,70,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,2,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,2,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,s-1,3,40,mg/m2,2,on days 1 – 14 every 3 weeks,NA
17848958,NA,235,docetaxel,3,80,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,3,60,mg/m2,1,on day 8 every 3 weeks,NA
17848958,NA,235,cisplatin,3,60,mg/m2,1,on day 8 every 3 weeks,NA
19002462,NA,236,docetaxel,-1,15,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19002462,NA,236,temozolomide,-1,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,temozolomide,-1,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,cisplatin,-1,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,cisplatin,-1,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,docetaxel,0,20,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19002462,NA,236,temozolomide,0,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,temozolomide,0,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,cisplatin,0,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,cisplatin,0,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,docetaxel,1,25,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19002462,NA,236,temozolomide,1,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,temozolomide,1,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,cisplatin,1,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,cisplatin,1,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,docetaxel,2,30,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19002462,NA,236,temozolomide,2,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,temozolomide,2,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,cisplatin,2,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,cisplatin,2,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,docetaxel,3,35,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19002462,NA,236,temozolomide,3,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,temozolomide,3,150,mg/m2,1,on days 1–5 every 4 weeks,NA
19002462,NA,236,cisplatin,3,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19002462,NA,236,cisplatin,3,20,mg/m2,1,on days 1–4 every 4 weeks,NA
19237630,NA,237,aeg35156,1,48,mg/m2,1,7-Day Infusion of a 21-day treatment cycle,NA
19237630,NA,237,aeg35156,2,96,mg/m2,1,7-Day Infusion of a 21-day treatment cycle,NA
19237630,NA,237,aeg35156,3,125,mg/m2,1,7-Day Infusion of a 21-day treatment cycle,NA
19237630,NA,237,aeg35156,4,160,mg/m2,1,7-Day Infusion of a 21-day treatment cycle,NA
19237630,NA,237,aeg35156,5,160,mg/m2,1,3-Day Infusion of a 21-day treatment cycle,NA
19237630,NA,237,aeg35156,6,213,mg/m2,1,3-Day Infusion of a 21-day treatment cycle,NA
18470481,NA,238,thalidomide,1,100,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,1,10,mg/m2,1,weekly of each 12-week cycle,NA
18470481,NA,238,thalidomide,2,100,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,2,20,mg/m2,1,weekly of each 12-week cycle,NA
18470481,NA,238,thalidomide,3,100,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,3,25,mg/m2,1,weekly of each 12-week cycle,NA
18470481,NA,238,thalidomide,4,100,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,4,30,mg/m2,1,weekly of each 12-week cycle,NA
18470481,NA,238,thalidomide,5,150,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,5,20,mg/m2,1,weekly of each 12-week cycle,NA
18470481,NA,238,thalidomide,6,150,mg,2,daily of each 12-week cycle,NA
18470481,NA,238,docetaxel,6,25,mg/m2,1,weekly of each 12-week cycle,NA
19011760,NA,239,docetaxel,1,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,1,5,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,docetaxel,2,50,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,2,5,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,docetaxel,3,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,3,5,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,g-csf,3,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,g-csf,3,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,docetaxel,4,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,4,10,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,g-csf,4,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,g-csf,4,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,docetaxel,5,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,5,15,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,g-csf,5,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,g-csf,5,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,docetaxel,6,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,6,20,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,g-csf,6,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,g-csf,6,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,docetaxel,7,75,mg/m2,1,on day 1 of a 21-day cycle,NA
19011760,NA,239,lenalidomide,7,25,mg,1,on days 1-14 of a 21-day cycle,NA
19011760,NA,239,g-csf,7,6,mg,1,on day 2 of a 21-day cycle,NA
19011760,NA,239,g-csf,7,6,mg,1,on day 2 of a 21-day cycle,NA
18626572,NA,240,docetaxel,1,25,mg/m2,1,"on days 1, 8, and 15 in 4 week cycles",NA
18626572,NA,240,temozolomide,1,75,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,temozolomide,1,75,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,docetaxel,2,25,mg/m2,1,"on days 1, 8, and 15 in 4 week cycles",NA
18626572,NA,240,temozolomide,2,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,temozolomide,2,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,docetaxel,3,30,mg/m2,1,"on days 1, 8, and 15 in 4 week cycles",NA
18626572,NA,240,temozolomide,3,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,temozolomide,3,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,docetaxel,4,35,mg/m2,1,"on days 1, 8, and 15 in 4 week cycles",NA
18626572,NA,240,temozolomide,4,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,temozolomide,4,90,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,docetaxel,5,35,mg/m2,1,"on days 1, 8, and 15 in 4 week cycles",NA
18626572,NA,240,temozolomide,5,100,mg/m2,1,days 1–21 in 4 week cycles,NA
18626572,NA,240,temozolomide,5,100,mg/m2,1,days 1–21 in 4 week cycles,NA
19434371,NA,241,docetaxel,1,15,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,doxorubicin,1,15,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,cyclophosphamide,1,60,mg/m2,1,daily in 6-week cycles,NA
19434371,NA,241,g-csf,1,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,g-csf,1,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,docetaxel,2,20,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,doxorubicin,2,20,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,cyclophosphamide,2,60,mg/m2,1,daily in 6-week cycles,NA
19434371,NA,241,g-csf,2,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,g-csf,2,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,docetaxel,3,25,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,doxorubicin,3,25,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,cyclophosphamide,3,60,mg/m2,1,daily in 6-week cycles,NA
19434371,NA,241,g-csf,3,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,g-csf,3,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,docetaxel,4,30,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,doxorubicin,4,30,mg/m2,1,on day 1 weekly,NA
19434371,NA,241,cyclophosphamide,4,60,mg/m2,1,daily in 6-week cycles,NA
19434371,NA,241,g-csf,4,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19434371,NA,241,g-csf,4,5,ug/kg,1,Daily except on days doxorubicin and Taxotere are given,NA
19740565,C000000281,242,docetaxel,0,40,mg/m2,1,on day 1 every 3 weeks,NA
19740565,C000000281,242,s-1,0,40,mg/m2,2,on days 1–14 and repeated every 3 weeks,fixed
19740565,C000000281,242,docetaxel,1,50,mg/m2,1,on day 1 every 3 weeks,NA
19740565,C000000281,242,s-1,1,40,mg/m2,2,on days 1–14 and repeated every 3 weeks,fixed
19740565,C000000281,242,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
19740565,C000000281,242,s-1,2,40,mg/m2,2,on days 1–14 and repeated every 3 weeks,fixed
18362939,NA,243,s-1,1,30,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,1,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,2,35,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,2,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,3,35,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,3,30,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,4,40,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,4,30,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,5,40,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,5,35,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,6,45,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,6,35,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18362939,NA,243,s-1,7,45,mg/m2,2,on days 1 – 14 every 3 weeks,NA
18362939,NA,243,docetaxel,7,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18481067,NA,244,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
18481067,NA,244,s-1,1,30,mg/m2,2,"on days 1-14, every 3 weeks",NA
18481067,NA,244,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
18481067,NA,244,s-1,2,40,mg/m2,2,"on days 1-14, every 3 weeks",NA
18481067,NA,244,docetaxel,2.5,75,mg/m2,1,on day 1 every 3 weeks,NA
18481067,NA,244,s-1,2.5,30,mg/m2,2,"on days 1-14, every 3 weeks",NA
18481067,NA,244,docetaxel,3,75,mg/m2,1,on day 1 every 3 weeks,NA
18481067,NA,244,s-1,3,40,mg/m2,2,"on days 1-14, every 3 weeks",NA
20043166,NA,245,sunitinib,0,25,mg,1,daily for 4 consecutive weeks of once-daily treatment followed by 2 weeks off treatment (Schedule 4/2) in three repeated 6-week cycles,Schedule 4/2
20043166,NA,245,docetaxel,0,60,mg/m2,1,q21d,Schedule 4/2
20043166,NA,245,sunitinib,1,37.5,mg,1,daily for 4 consecutive weeks of once-daily treatment followed by 2 weeks off treatment (Schedule 4/2) in three repeated 6-week cycles,Schedule 4/2
20043166,NA,245,docetaxel,1,60,mg/m2,1,q21d,Schedule 4/2
20043166,NA,245,sunitinib,0.5,25,mg,1,daily for 2 consecutive weeks of once-daily treatment followed by 1-week off treatment (Schedule 2/1) in six repeated 3-week cycles,Schedule 2/1
20043166,NA,245,docetaxel,0.5,60,mg/m2,1,q21d,Schedule 2/1
20043166,NA,245,sunitinib,1.5,37.5,mg,1,daily for 2 consecutive weeks of once-daily treatment followed by 1-week off treatment (Schedule 2/1) in six repeated 3-week cycles,Schedule 2/1
20043166,NA,245,docetaxel,1.5,60,mg/m2,1,q21d,Schedule 2/1
20043166,NA,245,sunitinib,2.5,50,mg,1,daily for 2 consecutive weeks of once-daily treatment followed by 1-week off treatment (Schedule 2/1) in six repeated 3-week cycles,Schedule 2/1
20043166,NA,245,docetaxel,2.5,60,mg/m2,1,q21d,Schedule 2/1
20043166,NA,245,sunitinib,3,50,mg,1,daily for 2 consecutive weeks of once-daily treatment followed by 1-week off treatment (Schedule 2/1) in six repeated 3-week cycles,Schedule 2/1
20043166,NA,245,docetaxel,3,75,mg/m2,1,q21d,Schedule 2/1
20043166,NA,245,sunitinib,3.5,37.5,mg,1,daily for 2 consecutive weeks of once-daily treatment followed by 1-week off treatment (Schedule 2/1) in six repeated 3-week cycles,Schedule 2/1
20043166,NA,245,docetaxel,3.5,75,mg/m2,1,q21d,Schedule 2/1
17569044,NA,246,vinorelbine,1,25,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,1,60,mg/m2,1,on day 8 every 3 weeks,NA
17569044,NA,246,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,1.5,25,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,1.5,60,mg/m2,1,on day 15 every 3 weeks,NA
17569044,NA,246,docetaxel,1.5,60,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,2,25,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,2,60,mg/m2,1,on day 8 every 3 weeks,NA
17569044,NA,246,docetaxel,2,70,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,3,20,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,3,60,mg/m2,1,on day 15 every 3 weeks,NA
17569044,NA,246,docetaxel,3,60,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,4,22.5,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,4,60,mg/m2,1,on day 15 every 3 weeks,NA
17569044,NA,246,docetaxel,4,60,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,5,20,mg/m2,1,on day 1 every 3 weeks,NA
17569044,NA,246,vinorelbine,5,60,mg/m2,1,on day 15 every 3 weeks,NA
17569044,NA,246,docetaxel,5,70,mg/m2,1,on day 1 every 3 weeks,NA
16683205,NA,247,gem231,1,220,mg/m2,1,"on days 4, 8, 11, 15, and 18 every 3 weeks",schedule A
16683205,NA,247,docetaxel,1,50,mg/m2,1,on day 1 every 21 days,schedule A
16683205,NA,247,gem231,2,220,mg/m2,1,on days 15 and 18 every 3 weeks,schedule B
16683205,NA,247,docetaxel,2,50,mg/m2,1,on day 1 every 21 days,schedule B
16683205,NA,247,gem231,3,220,mg/m2,1,on days 15 and 18 every 3 weeks,schedule B
16683205,NA,247,docetaxel,3,60,mg/m2,1,on day 1 every 21 days,schedule B
16683205,NA,247,gem231,4,220,mg/m2,1,on days 15 and 18 every 3 weeks,schedule B
16683205,NA,247,docetaxel,4,75,mg/m2,1,on day 1 every 21 days,schedule B
16619558,NA,248,s-1,1,80,mg/m2,2,"within 30 minutes of the morning and evening meals for 4 weeks, followed by a drug-free interval of 2 weeks (1 cycle)",NA
16619558,NA,248,docetaxel,1,25,mg/m2,1,"days 1, 15 and 29 for 6 weeks",NA
16619558,NA,248,s-1,2,80,mg/m2,2,"within 30 minutes of the morning and evening meals for 4 weeks, followed by a drug-free interval of 2 weeks (1 cycle)",NA
16619558,NA,248,docetaxel,2,30,mg/m2,1,"days 1, 15 and 29 for 6 weeks",NA
16619558,NA,248,s-1,3,80,mg/m2,2,"within 30 minutes of the morning and evening meals for 4 weeks, followed by a drug-free interval of 2 weeks (1 cycle)",NA
16619558,NA,248,docetaxel,3,35,mg/m2,1,"days 1, 15 and 29 for 6 weeks",NA
16683073,NA,249,flavopiridol,-2,50,mg/m2,1,over 24 h on day 2 every 3 weeks,NA
16683073,NA,249,docetaxel,-2,50,mg/m2,1,on day 1 every 3 weeks,NA
16683073,NA,249,flavopiridol,-1,60,mg/m2,1,over 24 h on day 2 every 3 weeks,NA
16683073,NA,249,docetaxel,-1,50,mg/m2,1,on day 1 every 3 weeks,NA
16683073,NA,249,flavopiridol,1,60,mg/m2,1,over 24 h on day 2 every 3 weeks,NA
16683073,NA,249,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
16683073,NA,249,flavopiridol,2,75,mg/m2,1,over 24 h on day 2 every 3 weeks,NA
16683073,NA,249,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
15277270,NA,250,g3139,1,1,mg/kg,1,continuous infusion for 21 days (days 1–22) every 28 days,Part I
15277270,NA,250,docetaxel,1,35,mg/m2,1,"on days 8, 15 and 22 every 28 days",Part I
15277270,NA,250,g3139,2,2,mg/kg,1,continuous infusion for 21 days (days 1–22) every 28 days,Part I
15277270,NA,250,docetaxel,2,35,mg/m2,1,"on days 8, 15 and 22 every 28 days",Part I
15277270,NA,250,g3139,3,3,mg/kg,1,continuous infusion for 21 days (days 1–22) every 28 days,Part I
15277270,NA,250,docetaxel,3,35,mg/m2,1,"on days 8, 15 and 22 every 28 days",Part I
15277270,NA,250,g3139,4,4,mg/kg,1,continuous infusion for 21 days (days 1–22) every 28 days,Part I
15277270,NA,250,docetaxel,4,35,mg/m2,1,"on days 8, 15 and 22 every 28 days",Part I
15277270,NA,250,g3139,5,5,mg/kg,1,"continuous infusion on days 1-5, 12, 13, 19, and 20 every 28 days",Part II
15277270,NA,250,docetaxel,5,35,mg/m2,1,"on days 6, 12, 14, 19, 21 and 28 every 28 days",Part II
15277270,NA,250,g3139,6,7,mg/kg,1,"continuous infusion on days 1-5, 12, 13, 19, and 20 every 28 days",Part II
15277270,NA,250,docetaxel,6,35,mg/m2,1,"on days 6, 12, 14, 19, 21 and 28 every 28 days",Part II
15277270,NA,250,g3139,7,9,mg/kg,1,"continuous infusion on days 1-5, 12, 13, 19, and 20 every 28 days",Part II
15277270,NA,250,docetaxel,7,35,mg/m2,1,"on days 6, 12, 14, 19, 21 and 28 every 28 days",Part II
17009034,NA,251,cisplatin,1,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,cisplatin,1,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,docetaxel,1,30,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,gemcitabine,1,400,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,cisplatin,2,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,cisplatin,2,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,docetaxel,2,30,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,gemcitabine,2,600,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,cisplatin,3,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,cisplatin,3,40,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,docetaxel,3,30,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17009034,NA,251,gemcitabine,3,800,mg/m2,1,on days 1 and 8 every 4 weeks,NA
15494635,NA,252,irinotecan,1,30,mg/m2,1,on day 1 every 2 weeks,NA
15494635,NA,252,docetaxel,1,30,mg/m2,1,on day 2 every 2 weeks,NA
15494635,NA,252,irinotecan,2,60,mg/m2,1,on day 1 every 2 weeks,NA
15494635,NA,252,docetaxel,2,30,mg/m2,1,on day 2 every 2 weeks,NA
15494635,NA,252,irinotecan,3,90,mg/m2,1,on day 1 every 2 weeks,NA
15494635,NA,252,docetaxel,3,30,mg/m2,1,on day 2 every 2 weeks,NA
15494635,NA,252,irinotecan,4,120,mg/m2,1,on day 1 every 2 weeks,NA
15494635,NA,252,docetaxel,4,30,mg/m2,1,on day 2 every 2 weeks,NA
15494635,NA,252,irinotecan,5,105,mg/m2,1,on day 1 every 2 weeks,NA
15494635,NA,252,docetaxel,5,30,mg/m2,1,on day 2 every 2 weeks,NA
17357187,NA,253,docetaxel,1,70,mg/m2,1,on day 1 every 21 days,NA
17357187,NA,253,ifosfamide,1,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17357187,NA,253,docetaxel,2,85,mg/m2,1,on day 1 every 21 days,NA
17357187,NA,253,ifosfamide,2,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17357187,NA,253,docetaxel,3,85,mg/m2,1,on day 1 every 21 days,NA
17357187,NA,253,ifosfamide,3,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17357187,NA,253,g-csf,3,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17357187,NA,253,g-csf,3,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17357187,NA,253,docetaxel,4,100,mg/m2,1,on day 1 every 21 days,NA
17357187,NA,253,ifosfamide,4,5000,mg/m2,1,on days 1 and 2 every 21 days,NA
17357187,NA,253,g-csf,4,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17357187,NA,253,g-csf,4,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17357187,NA,253,docetaxel,5,100,mg/m2,1,on day 1 every 21 days,NA
17357187,NA,253,ifosfamide,5,6000,mg/m2,1,on days 1 and 2 every 21 days,NA
17357187,NA,253,g-csf,5,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17357187,NA,253,g-csf,5,150,ug/m2,1,"from day 4 until day 10 or until white blood cells (WBC) ≥ 10.000/µl, whatever came first",NA
17180514,NA,254,docetaxel,0,30,mg/m2,1,"on days 1 and 15, every 4 weeks",NA
17180514,NA,254,nedaplatin,0,70,mg/m2,1,on day 1 every 4 weeks,NA
17180514,NA,254,docetaxel,1,30,mg/m2,1,"on days 1 and 15, every 4 weeks",NA
17180514,NA,254,nedaplatin,1,80,mg/m2,1,on day 1 every 4 weeks,NA
17180514,NA,254,docetaxel,2,35,mg/m2,1,"on days 1 and 15, every 4 weeks",NA
17180514,NA,254,nedaplatin,2,80,mg/m2,1,on day 1 every 4 weeks,NA
17180514,NA,254,docetaxel,3,35,mg/m2,1,"on days 1 and 15, every 4 weeks",NA
17180514,NA,254,nedaplatin,3,90,mg/m2,1,on day 1 every 4 weeks,NA
17180514,NA,254,docetaxel,4,40,mg/m2,1,"on days 1 and 15, every 4 weeks",NA
17180514,NA,254,nedaplatin,4,90,mg/m2,1,on day 1 every 4 weeks,NA
16162980,NA,255,gemcitabine,1,1250,mg/m2,1,on day 1 every 2 weeks for 5 cycles,NA
16162980,NA,255,epirubicin,1,90,mg/m2,1,on day 1 every 2 weeks for 5 cycles,NA
16162980,NA,255,docetaxel,1,100,mg/m2,1,on day 1 every 2 weeks for 4 cycles starting from cycle 6,NA
16162980,NA,255,gemcitabine,2,1250,mg/m2,1,on day 1 every 2 weeks for 5 cycles,NA
16162980,NA,255,epirubicin,2,100,mg/m2,1,on day 1 every 2 weeks for 5 cycles,NA
16162980,NA,255,docetaxel,2,80,mg/m2,1,on day 1 every 2 weeks for 4 cycles starting from cycle 6,NA
15519516,NA,256,epirubicin,1,60,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,docetaxel,1,60,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,gemcitabine,1,800,mg/m2,1,on days 1 and 8 every 21 days for up to 6 cycles,NA
15519516,NA,256,epirubicin,2,60,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,docetaxel,2,75,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,gemcitabine,2,800,mg/m2,NA,on days 1 and 8 every 21 days for up to 6 cycles,NA
15519516,NA,256,epirubicin,3,75,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,docetaxel,3,75,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,gemcitabine,3,800,mg/m2,NA,on days 1 and 8 every 21 days for up to 6 cycles,NA
15519516,NA,256,epirubicin,4,90,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,docetaxel,4,75,mg/m2,1,on day 1 every 21 days for up to 6 cycles,NA
15519516,NA,256,gemcitabine,4,800,mg/m2,NA,on days 1 and 8 every 21 days for up to 6 cycles,NA
15140550,NA,257,docetaxel,1,30,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,1,700,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,docetaxel,2,35,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,2,700,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,docetaxel,3,35,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,3,800,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,docetaxel,4,40,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,4,800,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,docetaxel,5,40,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,5,900,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,docetaxel,6,40,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15140550,NA,257,gemcitabine,6,1000,mg/m2,1,on a weekly basis for three consecutive weeks in cycles of 4 weeks,NA
15509491,NA,258,docetaxel,1,60,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,nedaplatin,1,70,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,docetaxel,2,60,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,nedaplatin,2,80,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,docetaxel,3,60,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,nedaplatin,3,90,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,docetaxel,4,60,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,nedaplatin,4,100,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,docetaxel,5,70,mg/m2,1,on day 1 every 28 days,NA
15509491,NA,258,nedaplatin,5,100,mg/m2,1,on day 1 every 28 days,NA
15809878,NA,259,irinotecan,1,50,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,1,30,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,irinotecan,2,50,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,2,35,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,irinotecan,3,66,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,3,35,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,irinotecan,4,57,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,4,30,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,irinotecan,5,65,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,5,30,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,irinotecan,6,80,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
15809878,NA,259,docetaxel,6,30,mg/m2,1,weekly for four consecutive weeks followed by 2 weeks off treatment (each 6-week interval represented one cycle),NA
16379039,NA,260,docetaxel,1,30,mg/m2,1,weekly for 6 weeks followed by a two-week rest period,NA
16379039,NA,260,exisulind,1,200,mg,2,daily,NA
16379039,NA,260,docetaxel,2,35,mg/m2,1,weekly for 6 weeks followed by a two-week rest period,NA
16379039,NA,260,exisulind,2,200,mg,2,daily,NA
16379039,NA,260,docetaxel,3,35,mg/m2,1,weekly for 6 weeks followed by a two-week rest period,NA
16379039,NA,260,exisulind,3,250,mg,2,daily,NA
16379039,NA,260,docetaxel,4,40,mg/m2,1,weekly for 6 weeks followed by a two-week rest period,NA
16379039,NA,260,exisulind,4,250,mg,2,daily,NA
16042786,NA,261,docetaxel,1,75,mg/m2,1,On day 1 every 3 weeks,NA
16042786,NA,261,5-fluorouracil,1,250,mg/m2,1,continuous infusion from day 1 to day 5 every 3 weeks,NA
16042786,NA,261,docetaxel,2,75,mg/m2,1,On day 1 every 3 weeks,NA
16042786,NA,261,5-fluorouracil,2,500,mg/m2,1,continuous infusion from day 1 to day 5 every 3 weeks,NA
16042786,NA,261,docetaxel,3,75,mg/m2,1,On day 1 every 3 weeks,NA
16042786,NA,261,5-fluorouracil,3,750,mg/m2,1,continuous infusion from day 1 to day 5 every 3 weeks,NA
16969706,NA,262,2-methoxyestradiol,1,200,mg,1,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,2,400,mg,1,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,3,600,mg,1,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,4,800,mg,1,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,5,1000,mg,1,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,6,200,mg,2,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,7,400,mg,2,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,8,600,mg,2,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,262,2-methoxyestradiol,9,800,mg,2,"daily for 28 days followed by a 14-day observation period in cycle 1. After cycle one, 2ME2 was given continuously until progression; 28 days defined each subsequent cycle.",NA
16969706,NA,263,2-methoxyestradiol,1,200,mg,1,daily on Days 2–29 followed by a 13-day observation period in cycle one; continuously thereafter,NA
16969706,NA,263,docetaxel,1,35,mg/m2,1,weekly for four of six weeks,NA
16969706,NA,263,2-methoxyestradiol,2,400,mg,1,daily on Days 2–29 followed by a 13-day observation period in cycle one; continuously thereafter,NA
16969706,NA,263,docetaxel,2,35,mg/m2,1,weekly for four of six weeks,NA
16969706,NA,263,2-methoxyestradiol,3,600,mg,1,daily on Days 2–29 followed by a 13-day observation period in cycle one; continuously thereafter,NA
16969706,NA,263,docetaxel,3,35,mg/m2,1,weekly for four of six weeks,NA
16969706,NA,263,2-methoxyestradiol,4,800,mg,1,daily on Days 2–29 followed by a 13-day observation period in cycle one; continuously thereafter,NA
16969706,NA,263,docetaxel,4,35,mg/m2,1,weekly for four of six weeks,NA
16969706,NA,263,2-methoxyestradiol,5,1000,mg,1,daily on Days 2–29 followed by a 13-day observation period in cycle one; continuously thereafter,NA
16969706,NA,263,docetaxel,5,35,mg/m2,1,weekly for four of six weeks,NA
15274365,NA,264,s-1,1,40,mg/m2,2,daily for two weeks every three weeks,NA
15274365,NA,264,docetaxel,1,40,mg/m2,1,Day 1 every 3 weeks,NA
15274365,NA,264,s-1,2,40,mg/m2,2,daily for two weeks every three weeks,NA
15274365,NA,264,docetaxel,2,50,mg/m2,1,Day 1 every 3 weeks,NA
15274365,NA,264,s-1,3,40,mg/m2,2,daily for two weeks every three weeks,NA
15274365,NA,264,docetaxel,3,60,mg/m2,1,Day 1 every 3 weeks,NA
15274365,NA,264,s-1,4,40,mg/m2,2,daily for two weeks every three weeks,NA
15274365,NA,264,docetaxel,4,70,mg/m2,1,Day 1 every 3 weeks,NA
16525670,NA,265,s-1,1,40,mg,2,on days 1-14 every 28 days,NA
16525670,NA,265,docetaxel,1,40,mg/m2,1,on days 1 and 15 every 28 days,NA
16525670,NA,265,s-1,0,40,mg,2,on days 1-14 every 28 days,NA
16525670,NA,265,docetaxel,0,35,mg/m2,1,on days 1 and 15 every 28 days,NA
16525670,NA,265,s-1,-1,40,mg,2,on days 1-14 every 28 days,NA
16525670,NA,265,docetaxel,-1,30,mg/m2,1,on days 1 and 15 every 28 days,NA
16127289,NA,267,docetaxel,1,20,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,1,6,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,2,20,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,2,8,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,3,25,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,3,9,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,4,27.5,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,4,8,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,5,27.5,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,5,10,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,6,30,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,6,10,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,7,32.5,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,7,10,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,8,32.5,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,8,12,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,9,35,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,9,12,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,10,35,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,10,14,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,docetaxel,11,35,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
16127289,NA,267,pegylated liposomal doxorubicin,11,16,mg/m2,1,on a weekly basis for 3 consecutive weeks in cycles of 4 weeks,NA
15221599,NA,268,docetaxel,0,60,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,0,60,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,0,60,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,0,600,mg/m2,1,days 1–5  every 4 weeks,NA
15221599,NA,268,docetaxel,-1,50,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,-1,60,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,-1,60,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,-1,600,mg/m2,1,days 1–5  every 4 weeks,NA
15221599,NA,268,docetaxel,1,60,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,1,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,1,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,1,600,mg/m2,1,days 1–5  every 4 weeks,NA
15221599,NA,268,docetaxel,2,70,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,2,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,2,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,2,600,mg/m2,1,days 1–5  every 4 weeks,NA
15221599,NA,268,docetaxel,3,60,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,3,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,3,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,3,750,mg/m2,1,days 1–5  every 4 weeks,NA
15221599,NA,268,docetaxel,4,70,mg/m2,1,day 1  every 4 weeks,NA
15221599,NA,268,cisplatin,4,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,cisplatin,4,70,mg/m2,1,day 4  every 4 weeks,NA
15221599,NA,268,5-fluorouracil,4,750,mg/m2,1,days 1–5  every 4 weeks,NA
16809732,NA,269,docetaxel,0,5,mg/m2,1,six weekly instillations,NA
16809732,NA,269,docetaxel,1,10,mg/m2,1,six weekly instillations,NA
16809732,NA,269,docetaxel,2,20,mg/m2,1,six weekly instillations,NA
16809732,NA,269,docetaxel,3,40,mg/m2,1,six weekly instillations,NA
16809732,NA,269,docetaxel,4,60,mg/m2,1,six weekly instillations,NA
16809732,NA,269,docetaxel,5,75,mg/m2,1,six weekly instillations,NA
15849219,NA,270,d-99,1,60,mg/m2,1,on day 1 every 21 days,NA
15849219,NA,270,docetaxel,1,35,mg/m2,1,on days 1 and 8 every 21 days,NA
15849219,NA,270,d-99,2,50,mg/m2,1,on day 1 every 21 days,NA
15849219,NA,270,docetaxel,2,25,mg/m2,1,on days 1 and 8 every 21 days,NA
15849219,NA,270,d-99,3,50,mg/m2,1,on day 1 every 21 days,NA
15849219,NA,270,docetaxel,3,30,mg/m2,1,on days 1 and 8 every 21 days,NA
15849219,NA,270,d-99,4,50,mg/m2,1,on day 1 every 21 days,NA
15849219,NA,270,docetaxel,4,35,mg/m2,1,on days 1 and 8 every 21 days,NA
15143084,NA,271,docetaxel,1,5,mg/m2,1,once a week for 8 to 9 weeks,NA
15143084,NA,271,external beam 3-d crt,1,1.8,Gy,1,to a total dose of 70.2 Gy,NA
15143084,NA,271,docetaxel,2,8,mg/m2,1,once a week for 8 to 9 weeks,NA
15143084,NA,271,external beam 3-d crt,2,1.8,Gy,1,to a total dose of 70.2 Gy,NA
15143084,NA,271,docetaxel,3,12,mg/m2,1,once a week for 8 to 9 weeks,NA
15143084,NA,271,external beam 3-d crt,3,1.8,Gy,1,to a total dose of 70.2 Gy,NA
15143084,NA,271,docetaxel,4,16,mg/m2,1,once a week for 8 to 9 weeks,NA
15143084,NA,271,external beam 3-d crt,4,1.8,Gy,1,to a total dose of 70.2 Gy,NA
15143084,NA,271,docetaxel,5,20,mg/m2,1,once a week for 8 to 9 weeks,NA
15143084,NA,271,external beam 3-d crt,5,1.8,Gy,1,to a total dose of 70.2 Gy,NA
15143084,NA,271,docetaxel,5,25,mg/m2,1,once a week for 8 to 9 weeks,NA
16773074,NA,272,docetaxel,0,40,mg/m2,1,on day 1 every 4 weeks,NA
16773074,NA,272,s-1,0,40,mg/m2,2,on days 1 –14 every 4 weeks,NA
16773074,NA,272,docetaxel,1,50,mg/m2,1,on day 1 every 4 weeks,NA
16773074,NA,272,s-1,1,40,mg/m2,2,on days 1 –14 every 4 weeks,NA
16773074,NA,272,docetaxel,2,60,mg/m2,1,on day 1 every 4 weeks,NA
16773074,NA,272,s-1,2,40,mg/m2,2,on days 1 –14 every 4 weeks,NA
16773074,NA,272,docetaxel,3,70,mg/m2,1,on day 1 every 4 weeks,NA
16773074,NA,272,s-1,3,40,mg/m2,2,on days 1 –14 every 4 weeks,NA
16943532,NA,273,docetaxel,1,0,NA,0,NA,NA
16943532,NA,273,cisplatin,1,0,NA,0,NA,NA
16943532,NA,273,cisplatin,1,0,NA,0,NA,NA
16943532,NA,273,boost radiation,1,0,NA,0,NA,NA
16791410,NA,274,docetaxel,1,40,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,doxorubicin,1,40,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,ifosfamide,1,2000,mg/m2,1,on days one and two,NA
16791410,NA,274,mesna,1,670,mg/m2,1,on days one and two,NA
16791410,NA,274,g-csf,1,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,g-csf,1,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,docetaxel,2,50,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,doxorubicin,2,50,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,ifosfamide,2,2500,mg/m2,1,on days one and two,NA
16791410,NA,274,mesna,2,830,mg/m2,1,on days one and two,NA
16791410,NA,274,g-csf,2,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,g-csf,2,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,docetaxel,3,60,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,doxorubicin,3,60,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,ifosfamide,3,3000,mg/m2,1,on days one and two,NA
16791410,NA,274,mesna,3,1000,mg/m2,1,on days one and two,NA
16791410,NA,274,g-csf,3,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,g-csf,3,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,docetaxel,4,75,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,doxorubicin,4,75,mg/m2,1,on day one every 21 days,NA
16791410,NA,274,ifosfamide,4,3750,mg/m2,1,on days one and two,NA
16791410,NA,274,mesna,4,1250,mg/m2,1,on days one and two,NA
16791410,NA,274,g-csf,4,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16791410,NA,274,g-csf,4,5,ug/kg,1,on days 3–12 or until absolute neutrophil count >1000/µL,NA
16416334,NA,275,docetaxel,1,20,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,cisplatin,1,25,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,cisplatin,1,25,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,thoracic radiotherapy,1,2,Gy,1,30 doses from day 1 to 43,split schedule (SS)
16416334,NA,275,docetaxel,2,25,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,cisplatin,2,25,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,cisplatin,2,25,mg/m2,1,"day 1, 8, 15, 29, 36, and 43 every 4 weeks",split schedule (SS)
16416334,NA,275,thoracic radiotherapy,2,2,Gy,1,30 doses from day 1 to 43,split schedule (SS)
16416334,NA,275,docetaxel,3,20,mg/m2,1,"on days 1, 8, 15, 22, 29, 36",continuous schedule (CS)
16416334,NA,275,cisplatin,3,25,mg/m2,1,"on days 1, 8, 15, 22, 29, 36",continuous schedule (CS)
16416334,NA,275,cisplatin,3,25,mg/m2,1,"on days 1, 8, 15, 22, 29, 36",continuous schedule (CS)
16416334,NA,275,thoracic radiotherapy,3,2,Gy,1,30 doses from day 1 to 43,continuous schedule (CS)
16565832,NA,276,docetaxel,1,30,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,thoracic radiation,1,2,Gy,1,5 days/week for 6 weeks,NA
16565832,NA,276,docetaxel,2,35,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,2,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,2,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,thoracic radiation,2,2,Gy,1,5 days/week for 6 weeks,NA
16565832,NA,276,docetaxel,3,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,3,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,3,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,thoracic radiation,3,2,Gy,1,5 days/week for 6 weeks,NA
16565832,NA,276,docetaxel,4,45,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,4,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,cisplatin,4,40,mg/m2,1,on day 1 every 2 weeks for 6 to 8 cycles,NA
16565832,NA,276,thoracic radiation,4,2,Gy,1,5 days/week for 6 weeks,NA
15838660,NA,277,docetaxel,1,50,mg/m2,1,administered as a 1-h infusionevery 21 days,schedule A
15838660,NA,277,topotecan,1,0.68,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,topotecan,1,0.68,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,docetaxel,1.5,50,mg/m2,1,"followed topotecan, administered as a 1-h infusionevery 21 days",schedule B
15838660,NA,277,topotecan,1.5,0.68,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,topotecan,1.5,0.68,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,docetaxel,2,50,mg/m2,1,administered as a 1-h infusionevery 21 days,schedule A
15838660,NA,277,topotecan,2,0.85,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,topotecan,2,0.85,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,docetaxel,2.5,50,mg/m2,1,"followed topotecan, administered as a 1-h infusionevery 21 days",schedule B
15838660,NA,277,topotecan,2.5,0.85,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,topotecan,2.5,0.85,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,docetaxel,3,60,mg/m2,1,administered as a 1-h infusionevery 21 days,schedule A
15838660,NA,277,topotecan,3,0.85,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,topotecan,3,0.85,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,docetaxel,3.5,60,mg/m2,1,"followed topotecan, administered as a 1-h infusionevery 21 days",schedule B
15838660,NA,277,topotecan,3.5,0.85,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,topotecan,3.5,0.85,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,docetaxel,4,60,mg/m2,1,administered as a 1-h infusionevery 21 days,schedule A
15838660,NA,277,topotecan,4,1.05,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,topotecan,4,1.05,mg/m2,1,"followed docetaxel, administered as a 72-h infusionevery 21 days",schedule A
15838660,NA,277,docetaxel,4.5,60,mg/m2,1,"followed topotecan, administered as a 1-h infusionevery 21 days",schedule B
15838660,NA,277,topotecan,4.5,1.05,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15838660,NA,277,topotecan,4.5,1.05,mg/m2,1,administered as a 72-h infusion every 21 days,schedule B
15310776,NA,278,docetaxel,1,20,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,1,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,1,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,docetaxel,2,25,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,2,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,2,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,docetaxel,3,30,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,3,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,3,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,docetaxel,4,35,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,4,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,4,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,docetaxel,5,40,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,5,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,5,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,docetaxel,6,45,mg/m2,1,"days 1, 8, 15, and 22 every 6 weeks",NA
15310776,NA,278,imatinib,6,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15310776,NA,278,imatinib,6,600,mg,1,"daily lead-in for 30 days, then daily in combination with docetaxel",NA
15567941,NA,279,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 1 every 21 days,NA
15567941,NA,279,docetaxel,1,35,mg/m2,1,on days 2 and 9 every 21 days,fixed
15567941,NA,279,pegylated liposomal doxorubicin,2,35,mg/m2,1,on day 1 every 21 days,NA
15567941,NA,279,docetaxel,2,35,mg/m2,1,on days 2 and 9 every 21 days,fixed
15567941,NA,279,pegylated liposomal doxorubicin,3,40,mg/m2,1,on day 1 every 21 days,NA
15567941,NA,279,docetaxel,3,35,mg/m2,1,on days 2 and 9 every 21 days,fixed
15581049,NA,280,mitomycin-c,1,6,mg/m2,1,day 1 every 28 days,NA
15581049,NA,280,docetaxel,1,30,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,irinotecan,1,70,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,mitomycin-c,2,6,mg/m2,1,day 1 every 28 days,NA
15581049,NA,280,docetaxel,2,30,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,irinotecan,2,100,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,mitomycin-c,3,6,mg/m2,1,day 1 every 28 days,NA
15581049,NA,280,docetaxel,3,30,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,irinotecan,3,85,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,mitomycin-c,4,6,mg/m2,1,day 1 every 28 days,NA
15581049,NA,280,docetaxel,4,35,mg/m2,1,days 2 and 8 every 28 days,NA
15581049,NA,280,irinotecan,4,85,mg/m2,1,days 2 and 8 every 28 days,NA
17327701,NA,281,thalidomide,1,100,mg,1,daily for 4 consecutive weeks,NA
17327701,NA,281,cyclophosphamide,1,50,mg,1,daily for 4 consecutive weeks,NA
17327701,NA,281,thalidomide,2,200,mg,1,daily for 4 consecutive weeks,NA
17327701,NA,281,cyclophosphamide,2,50,mg,1,daily for 4 consecutive weeks,NA
16020963,NA,282,docetaxel,1,30,mg/m2,1,weekly for a maximum of 24 weeks,NA
16020963,NA,282,docetaxel,2,35,mg/m2,1,weekly for a maximum of 24 weeks,NA
16020963,NA,282,docetaxel,3,40,mg/m2,1,weekly for a maximum of 24 weeks,NA
15111343,NA,283,cisplatin,1,60,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,1,60,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,1,70,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,1,200,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,2,60,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,2,60,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,2,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,2,200,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,3,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,3,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,3,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,3,200,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,4,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,4,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,4,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,4,225,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,5,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,5,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,5,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,5,250,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,6,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,6,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,6,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,6,275,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,7,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,7,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,7,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,7,300,mg/m2,1,from day 1 to day 14 every 21 days,NA
15111343,NA,283,cisplatin,8,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,cisplatin,8,75,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,docetaxel,8,85,mg/m2,1,on day 1 every 21 days,NA
15111343,NA,283,5-fu,8,350,mg/m2,1,from day 1 to day 14 every 21 days,NA
15075667,NA,284,docetaxel,1,40,mg/m2,1,every 3 weeks,NA
15075667,NA,284,pegylated liposomal doxorubicin,1,30,mg/m2,1,every 3 weeks,NA
15075667,NA,284,docetaxel,2,60,mg/m2,1,every 3 weeks,NA
15075667,NA,284,pegylated liposomal doxorubicin,2,30,mg/m2,1,every 3 weeks,NA
15075667,NA,284,docetaxel,3,80,mg/m2,1,every 3 weeks,NA
15075667,NA,284,pegylated liposomal doxorubicin,3,30,mg/m2,1,every 3 weeks,NA
15075667,NA,284,docetaxel,4,80,mg/m2,1,every 3 weeks,NA
15075667,NA,284,pegylated liposomal doxorubicin,4,30,mg/m2,1,every 3 weeks,NA
15075667,NA,284,granulocyte colony stimulating factor,4,NA,NA,NA,NA,NA
15075667,NA,284,granulocyte colony stimulating factor,4,NA,NA,NA,NA,NA
15075667,NA,284,docetaxel,5,100,mg/m2,1,every 3 weeks,NA
15075667,NA,284,pegylated liposomal doxorubicin,5,30,mg/m2,1,every 3 weeks,NA
15075667,NA,284,granulocyte colony stimulating factor,5,NA,NA,NA,NA,NA
15075667,NA,284,granulocyte colony stimulating factor,5,NA,NA,NA,NA,NA
12702535,NA,285,docetaxel,1,110,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,1,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,1,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,2,120,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,2,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,2,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,3,130,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,3,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,3,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,4,140,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,4,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,4,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,5,150,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,5,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,5,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,6,160,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,6,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,6,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,docetaxel,7,170,mg/m2,1,every 3 weeks,NA
12702535,NA,285,g-csf,7,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12702535,NA,285,g-csf,7,5,ug/kg,1,commencing the day after chemotherapy and continuing until neutrophils were ≥1.0 × 109/l,NA
12901280,NA,286,docetaxel,1,50,mg/m2,1,on day 1 every 28 days,NA
12901280,NA,286,gemcitabine,1,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12901280,NA,286,docetaxel,2,60,mg/m2,1,on day 1 every 28 days,NA
12901280,NA,286,gemcitabine,2,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12901280,NA,286,docetaxel,3,70,mg/m2,1,on day 1 every 28 days,NA
12901280,NA,286,gemcitabine,3,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12901280,NA,286,docetaxel,4,80,mg/m2,1,on day 1 every 28 days,NA
12901280,NA,286,gemcitabine,4,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12901280,NA,286,docetaxel,5,70,mg/m2,1,on day 1 every 28 days,de-escalation dose level
12901280,NA,286,gemcitabine,5,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",de-escalation dose level
12381903,NA,287,docetaxel,1,30,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,1,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,1,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,1,1600,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,1,300,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,docetaxel,2,40,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,2,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,2,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,2,1600,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,2,300,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,docetaxel,3,50,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,3,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,3,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,3,1600,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,3,300,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,docetaxel,4,40,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,4,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,4,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,4,2000,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,4,300,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,docetaxel,4.5,40,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,4.5,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,4.5,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,4.5,2000,mg/m2,1,3-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,4.5,300,mg/m2,1,3-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,docetaxel,5,40,mg/m2,1,1-hour infusions weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,5,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,cisplatin,5,30,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,5-fu,5,2400,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12381903,NA,287,leucovorin,5,300,mg/m2,1,24-hour infusion weekly for 2 consecutive weeks every 3 weeks,NA
12138236,NA,288,gemcitabine,1,600,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,docetaxel,1,25,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,gemcitabine,2,600,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,docetaxel,2,35,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,gemcitabine,3,750,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,docetaxel,3,35,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,gemcitabine,4,900,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
12138236,NA,288,docetaxel,4,35,mg/m2,1,"on days 1, 8, and 15 on a 28-day cycle for a maximum of 6 cycles",NA
14725740,NA,289,docetaxel,1,20,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
14725740,NA,289,thoracic radiation therapy,1,2,Gy,1,on day 1 for 5 days each week for 6 weeks,NA
14725740,NA,289,docetaxel,2,30,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
14725740,NA,289,thoracic radiation therapy,2,2,Gy,1,on day 1 for 5 days each week for 6 weeks,NA
14725740,NA,289,docetaxel,3,40,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36 of the planned radiation therapy course",NA
14725740,NA,289,thoracic radiation therapy,3,2,Gy,1,on day 1 for 5 days each week for 6 weeks,NA
11857398,NA,290,docetaxel,1,80,mg/m2,1,on day 1 every 21 days,NA
11857398,NA,290,ifosfamide,1,2,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,1,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,1,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,docetaxel,2,80,mg/m2,1,on day 1 every 21 days,NA
11857398,NA,290,ifosfamide,2,2.5,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,2,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,2,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,docetaxel,3,100,mg/m2,1,on day 1 every 21 days,NA
11857398,NA,290,ifosfamide,3,2.5,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,3,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,3,40,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,docetaxel,4,100,mg/m2,1,on day 1 every 21 days,NA
11857398,NA,290,ifosfamide,4,2.5,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,4,50,mg/m2,2,"days 1, 2 every 21 days",NA
11857398,NA,290,cisplatin,4,50,mg/m2,2,"days 1, 2 every 21 days",NA
11551421,NA,291,cisplatin,1,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,1,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,1,700,mg/m2,1,on days 2–4 every 3 weeks,NA
11551421,NA,291,cisplatin,2,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,2,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,2,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,2,1000,mg/m2,1,on days 2–4 every 3 weeks,NA
11551421,NA,291,cisplatin,3,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,3,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,3,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,3,1300,mg/m2,1,on days 2–4 every 3 weeks,NA
11551421,NA,291,cisplatin,4,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,4,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,4,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,4,1500,mg/m2,1,on days 2–4 every 3 weeks,NA
11551421,NA,291,cisplatin,5,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,5,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,5,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,5,1700,mg/m2,1,on days 2–4 every 3 weeks,NA
11551421,NA,291,cisplatin,6,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,cisplatin,6,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,docetaxel,6,60,mg/m2,1,on day 1 every 3 weeks,NA
11551421,NA,291,ifosfamide,6,2000,mg/m2,1,on days 2–4 every 3 weeks,NA
12237916,NA,292,docetaxel,1,20,mg/m2,1,"weekly on Monday, Tuesday, or before radiation on Wednesday",NA
12237916,NA,292,radiation,1,2,Gy,1,daily to a total dose of 68–72 Gy,NA
12237916,NA,292,docetaxel,2,25,mg/m2,1,"weekly on Monday, Tuesday, or before radiation on Wednesday",NA
12237916,NA,292,radiation,2,2,Gy,1,daily to a total dose of 68–72 Gy,NA
12237916,NA,292,docetaxel,3,30,mg/m2,1,"weekly on Monday, Tuesday, or before radiation on Wednesday",NA
12237916,NA,292,radiation,3,2,Gy,1,daily to a total dose of 68–72 Gy,NA
14520528,NA,293,docetaxel,1,30,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,irinotecan,1,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,docetaxel,2,35,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,irinotecan,2,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,docetaxel,3,40,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,irinotecan,3,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,docetaxel,4,40,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,irinotecan,4,60,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,docetaxel,5,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
14520528,NA,293,irinotecan,5,60,mg/m2,1,on days 1 and 15 every 4 weeks,NA
12581570,NA,294,docetaxel,1,15,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,1,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,1,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,radiation therapy,1,2,Gy,1,5 times weekly for 6 weeks,NA
12581570,NA,294,docetaxel,2,20,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,2,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,2,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,radiation therapy,2,2,Gy,1,5 times weekly for 6 weeks,NA
12581570,NA,294,docetaxel,3,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,3,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,3,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,radiation therapy,3,2,Gy,1,5 times weekly for 6 weeks,NA
12581570,NA,294,docetaxel,4,30,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,4,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,cisplatin,4,25,mg/m2,1,"weekly, on the first day of the first week in which XRT began",NA
12581570,NA,294,radiation therapy,4,2,Gy,1,5 times weekly for 6 weeks,NA
14584067,NA,295,docetaxel,1,55,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,1,0,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14584067,NA,295,docetaxel,2,55,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,2,100,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14584067,NA,295,docetaxel,3,55,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,3,200,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14584067,NA,295,docetaxel,4,55,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,4,400,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14584067,NA,295,docetaxel,5,55,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,5,600,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14584067,NA,295,docetaxel,6,65,mg/m2,1,on Day 1 every 21 days,NA
14584067,NA,295,ketoconazole,6,400,mg,2,daily starting on Day 8 after their first docetaxel dose,NA
14508124,NA,296,docetaxel,1,20,mg/m2,1,every week for 4 weeks,NA
14508124,NA,296,radiotherapy,1,40,Gy,NA,"in 20 fractions of 2 Gy per fractions, 5 days/week, over 4 weeks",NA
14508124,NA,296,docetaxel,2,25,mg/m2,1,every week for 4 weeks,NA
14508124,NA,296,radiotherapy,2,40,Gy,NA,"in 20 fractions of 2 Gy per fractions, 5 days/week, over 4 weeks",NA
14508124,NA,296,docetaxel,3,30,mg/m2,1,every week for 4 weeks,NA
14508124,NA,296,radiotherapy,3,40,Gy,NA,"in 20 fractions of 2 Gy per fractions, 5 days/week, over 4 weeks",NA
14508124,NA,296,docetaxel,4,35,mg/m2,1,every week for 4 weeks,NA
14508124,NA,296,radiotherapy,4,40,Gy,NA,"in 20 fractions of 2 Gy per fractions, 5 days/week, over 4 weeks",NA
11583191,NA,297,docetaxel,1,60,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,epirubicin,1,90,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,docetaxel,2,70,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,epirubicin,2,90,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,docetaxel,3,80,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,epirubicin,3,90,mg/m2,1,on day 1 every 3 weeks,Step 1
11583191,NA,297,docetaxel,3.5,80,mg/m2,1,on day 1 every 3 weeks,Step 2
11583191,NA,297,epirubicin,3.5,75,mg/m2,1,on day 1 every 3 weeks,Step 2
11583191,NA,297,docetaxel,4.5,90,mg/m2,1,on day 1 every 3 weeks,Step 2
11583191,NA,297,epirubicin,4.5,75,mg/m2,1,on day 1 every 3 weeks,Step 2
11583191,NA,297,docetaxel,5,70,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,epirubicin,5,90,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,g-csf,5,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,g-csf,5,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,docetaxel,6,80,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,epirubicin,6,90,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,g-csf,6,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,g-csf,6,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,docetaxel,7,90,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,epirubicin,7,90,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,g-csf,7,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,g-csf,7,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,docetaxel,8,100,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,epirubicin,8,90,mg/m2,1,on day 1 every 3 weeks,Step 3
11583191,NA,297,g-csf,8,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11583191,NA,297,g-csf,8,5,ug/kg,1,"starting 48 hours after completion of chemotherapy, until there was evidence of hematological recovery, i.e., ANC> 2000/ul after the nadir.",Step 3
11598413,NA,298,topotecan,1,0.5,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,1,0.5,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,1,20,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,topotecan,2,0.5,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,2,0.5,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,2,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,topotecan,3,0.75,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,3,0.75,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,3,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,topotecan,4,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,4,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,4,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,topotecan,5,0.75,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,5,0.75,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,5,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,g-csf,5,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,g-csf,5,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,topotecan,6,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,6,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,6,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,g-csf,6,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,g-csf,6,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,topotecan,7,1,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,7,1,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,7,25,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,g-csf,7,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,g-csf,7,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,topotecan,8,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,topotecan,8,0.85,mg/m2,1,days 1–5 in 21-day cycles,NA
11598413,NA,298,vinorelbine,8,30,mg/m2,1,on days 1 and 5 in 21-day cycles,NA
11598413,NA,298,g-csf,8,5,ug/kg,1,days 8–12 in 21-day cycles,NA
11598413,NA,298,g-csf,8,5,ug/kg,1,days 8–12 in 21-day cycles,NA
12665678,NA,299,docetaxel,1,100,mg/m2,1,on d 1 of each 21-d cycle,NA
12665678,NA,299,g-csf,1,5,ug/kg,1,on d 3–10 every 21 days,NA
12665678,NA,299,g-csf,1,5,ug/kg,1,on d 3–10 every 21 days,NA
12665678,NA,299,docetaxel,2,120,mg/m2,1,on d 1 of each 21-d cycle,NA
12665678,NA,299,g-csf,2,5,ug/kg,1,on d 3–10 every 21 days,NA
12665678,NA,299,g-csf,2,5,ug/kg,1,on d 3–10 every 21 days,NA
12665678,NA,299,docetaxel,3,145,mg/m2,1,on d 1 of each 21-d cycle,NA
12665678,NA,299,g-csf,3,5,ug/kg,1,on d 3–10 every 21 days,NA
12665678,NA,299,g-csf,3,5,ug/kg,1,on d 3–10 every 21 days,NA
12419756,NA,300,epirubicin,1,60,mg/m2,1,every 21 days,NA
12419756,NA,300,cyclophosphamide,1,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,1,60,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,1.5,60,mg/m2,1,every 21 days,with ciprofloxacin
12419756,NA,300,cyclophosphamide,1.5,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,1.5,60,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,0.5,60,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,0.5,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,0.5,75,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,2,60,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,2,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,2,75,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,3,75,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,3,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,3,75,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,4,90,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,4,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,4,75,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,5,90,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,5,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,5,85,mg/m2,1,every 21 days,NA
12419756,NA,300,epirubicin,6,105,mg/m2,1,every 21 days,with G-CSF
12419756,NA,300,cyclophosphamide,6,600,mg/m2,1,every 21 days,fixed
12419756,NA,300,docetaxel,6,85,mg/m2,1,every 21 days,NA
11561784,NA,301,docetaxel,1,30,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,docetaxel,2,40,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,gemcitabine,2,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,docetaxel,3,40,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,docetaxel,4,40,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
11561784,NA,301,gemcitabine,4,1250,mg/m2,1,on days 1 and 8 of each 21-day cycle,gemcitabin->docetaxel or docetaxel->gemcitabin
12879480,NA,302,pegylated liposomal doxorubicin,1,15,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,1,30,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,2,15,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,2,35,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,3,20,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,3,35,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,4,20,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,4,40,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,5,25,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,5,40,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,6,25,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,docetaxel,6,45,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm A, the PEG-LD
infusion preceded docetaxel on both days"
12879480,NA,302,pegylated liposomal doxorubicin,1.5,15,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,1.5,30,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,pegylated liposomal doxorubicin,2.5,15,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,2.5,35,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,pegylated liposomal doxorubicin,3.5,20,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,3.5,35,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,pegylated liposomal doxorubicin,4.5,20,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,4.5,40,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,pegylated liposomal doxorubicin,5.5,25,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,5.5,40,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,pegylated liposomal doxorubicin,6.5,25,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
12879480,NA,302,docetaxel,6.5,45,mg/m2,1,on Days 1 and 15 of the 28-day cycle,"Arm B, the docetaxel infusion preceded PEG-LD on both days"
11521794,NA,303,docetaxel,1,60,mg/m2,1,on day 1 every 21 days,NA
11521794,NA,303,vinorelbine,1,20,mg/m2,1,on days 1 and 5 every 21 days,NA
11521794,NA,303,docetaxel,2,75,mg/m2,1,on day 1 every 21 days,NA
11521794,NA,303,vinorelbine,2,20,mg/m2,1,on days 1 and 5 every 21 days,NA
11521794,NA,303,docetaxel,3,75,mg/m2,1,on day 1 every 21 days,NA
11521794,NA,303,vinorelbine,3,22.5,mg/m2,1,on days 1 and 5 every 21 days,NA
11521794,NA,303,docetaxel,4,85,mg/m2,1,on day 1 every 21 days,NA
11521794,NA,303,vinorelbine,4,20,mg/m2,1,on days 1 and 5 every 21 days,NA
11521794,NA,303,docetaxel,5,100,mg/m2,1,on day 1 every 21 days,NA
11521794,NA,303,vinorelbine,5,20,mg/m2,1,on days 1 and 5 every 21 days,NA
11521794,NA,303,docetaxel,5.5,100,mg/m2,1,on day 1 every 21 days,G-CSF permitted
11521794,NA,303,vinorelbine,5.5,20,mg/m2,1,on days 1 and 5 every 21 days,G-CSF permitted
15139070,NA,304,docetaxel,0,60,mg/m2,1,on Day 1 of each 21-day cycle,NA
15139070,NA,304,topotecan,0,1.2,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
15139070,NA,304,topotecan,0,1.2,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
15139070,NA,304,docetaxel,1,75,mg/m2,1,on Day 1 of each 21-day cycle,NA
15139070,NA,304,topotecan,1,1.4,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
15139070,NA,304,topotecan,1,1.4,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
15139070,NA,304,docetaxel,2,90,mg/m2,1,on Day 1 of each 21-day cycle,NA
15139070,NA,304,topotecan,2,1.6,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
15139070,NA,304,topotecan,2,1.6,mg/m2,1,on Days 1–3 of each 21-day cycle,NA
12736567,NA,305,docetaxel,1,40,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,1,200,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,docetaxel,2,40,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,2,400,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,docetaxel,3,50,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,3,400,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,docetaxel,4,60,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,4,400,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,docetaxel,5,60,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,5,500,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,docetaxel,6,60,mg/m2,1,every 3-4 weeks,NA
12736567,NA,305,cyclophosphamide,6,600,mg/m2,1,every 3-4 weeks,NA
12373597,NA,306,docetaxel,1,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,1,1500,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,without G-CSF
12373597,NA,306,docetaxel,1.5,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,1.5,1500,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
12373597,NA,306,docetaxel,2,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,2,1750,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
12373597,NA,306,docetaxel,3,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,3,2000,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
12373597,NA,306,docetaxel,4,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,4,2250,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
12373597,NA,306,docetaxel,5,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,5,2500,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
12373597,NA,306,docetaxel,6,75,mg/m2,1,on day 1 every 3 weeks,fixed
12373597,NA,306,ifosfamide,6,2750,mg/m2,1,a 24-h continuous infusion on days 1-3 every 3 weeks,with G-CSF
11852999,NA,307,vinorelbine,0,20,mg/m2,1,on days 1 and 5 every three weeks,NA
11852999,NA,307,docetaxel,0,85,mg/m2,1,on day 1 every three weeks,NA
11852999,NA,307,g-csf,0,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,g-csf,0,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,vinorelbine,-1,20,mg/m2,1,on days 1 and 5 every three weeks,NA
11852999,NA,307,docetaxel,-1,75,mg/m2,1,on day 1 every three weeks,NA
11852999,NA,307,g-csf,-1,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,g-csf,-1,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,vinorelbine,-2,20,mg/m2,1,on days 1 and 5 every three weeks,NA
11852999,NA,307,docetaxel,-2,60,mg/m2,1,on day 1 every three weeks,NA
11852999,NA,307,g-csf,-2,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,g-csf,-2,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,vinorelbine,-3,16,mg/m2,1,on days 1 and 5 every three weeks,NA
11852999,NA,307,docetaxel,-3,48,mg/m2,1,on day 1 every three weeks,NA
11852999,NA,307,g-csf,-3,5,mg/kg,1,on days 3–10 every three weeks,NA
11852999,NA,307,g-csf,-3,5,mg/kg,1,on days 3–10 every three weeks,NA
12140145,NA,308,irinotecan,1,60,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,docetaxel,1,20,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,irinotecan,2,60,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,docetaxel,2,25,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,irinotecan,3,70,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,docetaxel,3,25,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,irinotecan,4,70,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12140145,NA,308,docetaxel,4,30,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
11777624,NA,309,cisplatin,1,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,cisplatin,1,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,docetaxel,1,0,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,thoracic rt,1,1.8,Gy,1,the total dose 63 Gy during 6 weeks,NA
11777624,NA,309,cisplatin,2,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,cisplatin,2,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,docetaxel,2,10,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,thoracic rt,2,1.8,Gy,1,the total dose 63 Gy during 6 weeks,NA
11777624,NA,309,cisplatin,3,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,cisplatin,3,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,docetaxel,3,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,thoracic rt,3,1.8,Gy,1,the total dose 63 Gy during 6 weeks,NA
11777624,NA,309,cisplatin,4,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,cisplatin,4,20,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,docetaxel,4,30,mg/m2,1,"Days 1, 8, 15, 22, 29, 36",NA
11777624,NA,309,thoracic rt,4,1.8,Gy,1,the total dose 63 Gy during 6 weeks,NA
12913084,NA,310,docetaxel,1,10,mg/m2,1,"On days 1, 8, 15, 22, 29 and 36",NA
12913084,NA,310,radiotherapy,1,2,Gy,1,5 fractions/week to a total dose of 60–70 Gy,NA
12913084,NA,310,docetaxel,2,15,mg/m2,1,"On days 1, 8, 15, 22, 29 and 36",NA
12913084,NA,310,radiotherapy,2,2,Gy,1,5 fractions/week to a total dose of 60–70 Gy,NA
12913084,NA,310,docetaxel,3,20,mg/m2,1,"On days 1, 8, 15, 22, 29 and 36",NA
12913084,NA,310,radiotherapy,3,2,Gy,1,5 fractions/week to a total dose of 60–70 Gy,NA
14977829,NA,311,docetaxel,1,35,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,mitoxantrone,1,2,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,docetaxel,2,35,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,mitoxantrone,2,3,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,docetaxel,3,35,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,mitoxantrone,3,4,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,docetaxel,4,35,mg/m2,1,weekly for 3 of every 4 weeks,NA
14977829,NA,311,mitoxantrone,4,5,mg/m2,1,weekly for 3 of every 4 weeks,NA
14735175,NA,312,docetaxel,2,70,mg/m2,1,on day 1 every 4 weeks,NA
14735175,NA,312,cisplatin,2,70,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,cisplatin,2,70,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,5-fu,2,600,mg/m2,1,on days 1-5 as 120 h continuous infusion every 4 weeks,NA
14735175,NA,312,radiation,2,1.8,Gy,1,"begin on the first day of chemotherapy, day 1, 5 days per week, totally between 63.0 and 74.0 Gy",NA
14735175,NA,312,docetaxel,1,60,mg/m2,1,on day 1 every 4 weeks,NA
14735175,NA,312,cisplatin,1,70,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,cisplatin,1,70,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,5-fu,1,600,mg/m2,1,on days 1-5 as 120 h continuous infusion every 4 weeks,NA
14735175,NA,312,radiation,1,1.8,Gy,1,"begin on the first day of chemotherapy, day 1, 5 days per week, totally between 63.0 and 74.0 Gy",NA
14735175,NA,312,docetaxel,0,60,mg/m2,1,on day 1 every 4 weeks,NA
14735175,NA,312,cisplatin,0,60,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,cisplatin,0,60,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,5-fu,0,600,mg/m2,1,on days 1-5 as 120 h continuous infusion every 4 weeks,NA
14735175,NA,312,radiation,0,1.8,Gy,1,"begin on the first day of chemotherapy, day 1, 5 days per week, totally between 63.0 and 74.0 Gy",NA
14735175,NA,312,docetaxel,-1,50,mg/m2,1,on day 1 every 4 weeks,NA
14735175,NA,312,cisplatin,-1,60,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,cisplatin,-1,60,mg/m2,1,on day 4 every 4 weeks,NA
14735175,NA,312,5-fu,-1,600,mg/m2,1,on days 1-5 as 120 h continuous infusion every 4 weeks,NA
14735175,NA,312,radiation,-1,1.8,Gy,1,"begin on the first day of chemotherapy, day 1, 5 days per week, totally between 63.0 and 74.0 Gy",NA
14676112,NA,313,docetaxel,1,40,mg/m2,1,every 3 weeks,NA
14676112,NA,313,docetaxel,2,80,mg/m2,1,every 3 weeks,NA
14676112,NA,313,docetaxel,3,100,mg/m2,1,every 3 weeks,NA
14676112,NA,313,docetaxel,4,125,mg/m2,1,every 3 weeks,NA
14676112,NA,313,docetaxel,5,156,mg/m2,1,every 3 weeks,NA
12491518,NA,314,docetaxel,1,20,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,gemcitabine,1,400,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,docetaxel,2,30,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,gemcitabine,2,400,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,docetaxel,3,30,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,gemcitabine,3,600,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,docetaxel,4,36,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,gemcitabine,4,600,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,docetaxel,5,36,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
12491518,NA,314,gemcitabine,5,800,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
11557122,NA,315,cisplatin,1,70,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,cisplatin,1,70,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,docetaxel,1,15,mg/m2,1,"days 1, 8, 15 every 28 days",NA
11557122,NA,315,cisplatin,2,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,cisplatin,2,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,docetaxel,2,15,mg/m2,1,"days 1, 8, 15 every 28 days",NA
11557122,NA,315,cisplatin,3,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,cisplatin,3,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,docetaxel,3,20,mg/m2,1,"days 1, 8, 15 every 28 days",NA
11557122,NA,315,cisplatin,4,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,cisplatin,4,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,docetaxel,4,25,mg/m2,1,"days 1, 8, 15 every 28 days",NA
11557122,NA,315,cisplatin,5,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,cisplatin,5,80,mg/m2,1,day 1 every 28 days,NA
11557122,NA,315,docetaxel,5,30,mg/m2,1,"days 1, 8, 15 every 28 days",NA
12602908,NA,316,docetaxel,1,40,mg/m2,1,every 15 days,NA
12602908,NA,316,docetaxel,2,50,mg/m2,1,every 15 days,NA
12602908,NA,316,docetaxel,3,60,mg/m2,1,every 15 days,NA
12602908,NA,316,docetaxel,4,70,mg/m2,1,every 15 days,NA
12698179,NA,317,docetaxel,1,70,mg/m2,1,on day 1 every 21 days,NA
12698179,NA,317,ifosfamide,1,2.5,mg/m2,1,over days 1 and 2 every 21 days,NA
12698179,NA,317,docetaxel,2,85,mg/m2,1,on day 1 every 21 days,NA
12698179,NA,317,ifosfamide,2,2.5,mg/m2,1,over days 1 and 2 every 21 days,NA
12698179,NA,317,docetaxel,3,85,mg/m2,1,on day 1 every 21 days,with G-CSF
12698179,NA,317,ifosfamide,3,2.5,mg/m2,1,over days 1 and 2 every 21 days,with G-CSF
12698179,NA,317,docetaxel,4,100,mg/m2,1,on day 1 every 21 days,with G-CSF
12698179,NA,317,ifosfamide,4,2.5,mg/m2,1,over days 1 and 2 every 21 days,with G-CSF
12698179,NA,317,docetaxel,5,100,mg/m2,1,on day 1 every 21 days,with G-CSF
12698179,NA,317,ifosfamide,5,3,mg/m2,1,over days 1 and 2 every 21 days,with G-CSF
12942107,NA,318,docetaxel,1,20,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,1,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,1,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,1,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,2,25,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,2,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,2,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,2,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,3,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,3,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,3,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,3,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,4,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,4,35,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,4,35,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,4,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,5,30,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,5,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,5,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,5,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,6,35,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,6,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,6,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,6,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,7,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,7,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,7,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,7,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
12942107,NA,318,docetaxel,8,45,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,8,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,cisplatin,8,40,mg/m2,1,"on days 1, 8, 29, and 36",NA
12942107,NA,318,thoracic radiotherapy,8,2,Gy,1,starting on day 1 for five consecutive days each week for 6 weeks to a total dose of 60 Gy,NA
15122076,NA,319,docetaxel,1,60,mg/m2,1,on d1 every 21 days,NA
15122076,NA,319,gemcitabine,1,600,mg/m2,1,on d1 & 8 every 21 days,NA
11943893,NA,320,leucovorin,1,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,1,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,1,60,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,1,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,1,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,2,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,2,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,2,70,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,2,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,3,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,3,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,3,75,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,3,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,4,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,4,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,4,80,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,4,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,4,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,4,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,5,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,5,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,5,85,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,5,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,5,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,5,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,6,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,6,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,6,90,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,6,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,6,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,6,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,leucovorin,7,100,mg,2,6 and 12 hours before docetaxel,NA
11943893,NA,320,leucovorin,7,500,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
11943893,NA,320,docetaxel,7,95,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,7,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,cisplatin,7,100,mg/m2,1,on day 1 of each 21-day cycle,NA
11943893,NA,320,5-fu,7,700,mg/m2,1,continuous infusion d1–4 of each 21-day cycle,NA
15108042,NA,321,docetaxel,1,10,mg/m2,1,weekly for 6 weeks,NA
15108042,NA,321,radiation,1,2,Gy,1,daily fractions X 5 days per 1 week for 6 weeks to a total dose of 60Gy,NA
15108042,NA,321,docetaxel,2,15,mg/m2,1,weekly for 6 weeks,NA
15108042,NA,321,radiation,2,2,Gy,1,daily fractions X 5 days per 1 week for 6 weeks to a total dose of 60Gy,NA
15108042,NA,321,docetaxel,3,20,mg/m2,1,weekly for 6 weeks,NA
15108042,NA,321,radiation,3,2,Gy,1,daily fractions X 5 days per 1 week for 6 weeks to a total dose of 60Gy,NA
12172503,NA,322,docetaxel,1,85,mg/m2,1,on day 15 every 4 weeks,NA
12172503,NA,322,gemcitabine,1,800,mg/m2,1,"on days 1, 8, and 15 every 4 weeks starting1 h after the end of the docetaxel infusion",NA
12172503,NA,322,docetaxel,2,100,mg/m2,1,on day 15 every 4 weeks,NA
12172503,NA,322,gemcitabine,2,800,mg/m2,1,"on days 1, 8, and 15 every 4 weeks starting1 h after the end of the docetaxel infusion",NA
12172503,NA,322,docetaxel,3,85,mg/m2,1,on day 8 every 3 weeks,NA
12172503,NA,322,gemcitabine,3,800,mg/m2,1,"on days 1, and 8 every 4 weeks, starting1 h after the end of the docetaxel infusion",NA
12172503,NA,322,docetaxel,3.5,85,mg/m2,1,"on day 8 every 3 weeks, starting 1 h after the end of gemcitabine infusion",NA
12172503,NA,322,gemcitabine,3.5,800,mg/m2,1,"on days 1, and 8 every 4 weeks",NA
12172503,NA,322,docetaxel,4,85,mg/m2,1,on day 8 every 3 weeks,NA
12172503,NA,322,gemcitabine,4,1000,mg/m2,1,"on days 1, and 8 every 4 weeks, starting 1 h after the end of the docetaxel infusion",NA
11810041,NA,323,gemcitabine,1,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
11810041,NA,323,docetaxel,1,30,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
11810041,NA,323,gemcitabine,2,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
11810041,NA,323,docetaxel,2,35,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
11810041,NA,323,gemcitabine,3,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
11810041,NA,323,docetaxel,3,40,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
14663635,NA,324,docetaxel,1,30,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
14663635,NA,324,docetaxel,2,35,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
14663635,NA,324,docetaxel,3,40,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
14663635,NA,324,docetaxel,4,45,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
25947565,NCT01624441,325,dinaciclib,1,20,mg/m2,1,on day 1 of a 21 day cycle,NA
25947565,NCT01624441,325,epirubicin,1,75,mg/m2,1,on day 2 of a 21 day cycle,NA
25947565,NCT01624441,325,dinaciclib,2,30,mg/m2,1,on day 1 of a 21 day cycle,NA
25947565,NCT01624441,325,epirubicin,2,75,mg/m2,1,on day 2 of a 21 day cycle,NA
25947565,NCT01624441,325,dinaciclib,3,40,mg/m2,1,on day 1 of a 21 day cycle,NA
25947565,NCT01624441,325,epirubicin,3,75,mg/m2,1,on day 2 of a 21 day cycle,NA
25947565,NCT01624441,325,dinaciclib,4,50,mg/m2,1,on day 1 of a 21 day cycle,NA
25947565,NCT01624441,325,epirubicin,4,75,mg/m2,1,on day 2 of a 21 day cycle,NA
25947565,NCT01624441,325,dinaciclib,-1,20,mg/m2,1,on day 1 of a 21 day cycle,NA
25947565,NCT01624441,325,epirubicin,-1,50,mg/m2,1,on day 2 of a 21 day cycle,NA
25312684, NCT01337505,326,aldoxorubicin,1,230,mg/m2,1,on day 1 of every 21-day cycle for a maximum of 6 consecutive cycles,NA
25312684, NCT01337505,326,aldoxorubicin,2,350,mg/m2,1,on day 1 of every 21-day cycle for a maximum of 6 consecutive cycles,NA
25312684, NCT01337505,326,aldoxorubicin,3,450,mg/m2,1,on day 1 of every 21-day cycle for a maximum of 6 consecutive cycles,NA
24807889,NA,1,vtx-2337,1,0.1,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,2,0.2,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,3,0.4,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,4,0.8,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,5,1.3,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,6,2,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,7,2.8,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24807889,NA,1,vtx-2337,8,3.9,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
24585045,NA,2,irinotecan,0,40,mg/m2,1,on days 1 and 15 every 28 days,NA
24585045,NA,2,pegylated liposomal doxorubicin,0,30,mg/m2,1,on day 3 every 28 days,fixed
24585045,NA,2,irinotecan,1,50,mg/m2,1,on days 1 and 15 every 28 days,NA
24585045,NA,2,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 3 every 28 days,fixed
24585045,NA,2,irinotecan,2,60,mg/m2,1,on days 1 and 15 every 28 days,NA
24585045,NA,2,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 3 every 28 days,fixed
24585045,NA,2,irinotecan,3,70,mg/m2,1,on days 1 and 15 every 28 days,NA
24585045,NA,2,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 3 every 28 days,fixed
24585045,NA,2,irinotecan,4,80,mg/m2,1,on days 1 and 15 every 28 days,NA
24585045,NA,2,pegylated liposomal doxorubicin,4,30,mg/m2,1,on day 3 every 28 days,fixed
25958319,NA,3,doxorubicin,-1,30,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,-1,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,cisplatin,-1,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,paclitaxel,-1,50,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,doxorubicin,1,45,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,1,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,cisplatin,1,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,paclitaxel,1,60,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,doxorubicin,2,45,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,2,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,cisplatin,2,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,paclitaxel,2,75,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,doxorubicin,3,45,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,3,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,cisplatin,3,50,mg/m2,1,"q 21 day 1, during cycles 3-6",IV
25958319,NA,3,paclitaxel,3,90,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,doxorubicin,4,45,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,4,75,mg/m2,1,"q 21 day 1, during cycles 3-6",IP
25958319,NA,3,cisplatin,4,75,mg/m2,1,"q 21 day 1, during cycles 3-6",IP
25958319,NA,3,paclitaxel,4,75,mg/m2,1,"q 21 day 8, during cycles 3-6",NA
25958319,NA,3,doxorubicin,5,45,mg/m2,1,"q 21 day 1, during cycles 3-6",NA
25958319,NA,3,cisplatin,5,75,mg/m2,1,"q 21 day 1, during cycles 3-6",IP
25958319,NA,3,cisplatin,5,75,mg/m2,1,"q 21 day 1, during cycles 3-6",IP
25958319,NA,3,paclitaxel,5,?,mg/m2,1,"q 21 day 8, during cycles 3-6",NA
21625179,NA,4,doxorubicin,1,75,mg/m2,1,on day 1 every 21 days,fixed
21625179,NA,4,th-302,1,240,mg/m2,1,on days 1 and 8 every 21 days,NA
21625179,NA,4,doxorubicin,2,75,mg/m2,1,on day 1 every 21 days,fixed
21625179,NA,4,th-302,2,240,mg/m2,1,on days 1 and 8 every 21 days,with G-CSF
21625179,NA,4,doxorubicin,3,75,mg/m2,1,on day 1 every 21 days,fixed
21625179,NA,4,th-302,3,300,mg/m2,1,on days 1 and 8 every 21 days,with G-CSF
21625179,NA,4,doxorubicin,4,75,mg/m2,1,on day 1 every 21 days,fixed
21625179,NA,4,th-302,4,340,mg/m2,1,on days 1 and 8 every 21 days,with G-CSF
25189481,NCT01100944,5,belinostat,1,250,mg/m2,1,4 consecutive 12-hour continuous intravenous infusions for 48 hours starting on day 1 every 21 days,NA
25189481,NCT01100944,5,cisplatin,1,50,mg/m2,1,on day 2 every 21 days,NA
25189481,NCT01100944,5,cisplatin,1,50,mg/m2,1,on day 2 every 21 days,NA
25189481,NCT01100944,5,doxorubicin,1,25,mg/m2,1,on days 2 and 3 every 21 days,NA
25189481,NCT01100944,5,cyclophosphamide,1,500,mg/m2,1,on day 3 every 21 days,NA
25189481,NCT01100944,5,belinostat,2,500,mg/m2,1,4 consecutive 12-hour continuous intravenous infusions for 48 hours starting on day 1 every 21 days,NA
25189481,NCT01100944,5,cisplatin,2,50,mg/m2,1,on day 2 every 21 days,NA
25189481,NCT01100944,5,cisplatin,2,50,mg/m2,1,on day 2 every 21 days,NA
25189481,NCT01100944,5,doxorubicin,2,25,mg/m2,1,on days 2 and 3 every 21 days,NA
25858498,NCT00789633,6,doxorubicin,1,75,mg/m2,1,continuous infusion over 48 h on day 1 of a 21 day cycle,NA
25858498,NCT00789633,6,cixutumumab,1,1,mg/kg,1,on days 1/8/15 of a 21 day cycle,NA
25858498,NCT00789633,6,doxorubicin,2,75,mg/m2,1,continuous infusion over 48 h on day 1 of a 21 day cycle,NA
25858498,NCT00789633,6,cixutumumab,2,3,mg/kg,1,on days 1/8/15 of a 21 day cycle,NA
25858498,NCT00789633,6,doxorubicin,3,75,mg/m2,1,continuous infusion over 48 h on day 1 of a 21 day cycle,NA
25858498,NCT00789633,6,cixutumumab,3,6,mg/kg,1,on days 1/8/15 of a 21 day cycle,NA
25615852,NA,7,pazopanib,-1,400,mg,1,daily,NA
25615852,NA,7,liposomal doxorubicin,-1,30,mg/m2,1,day 1 every 28 days,NA
25615852,NA,7,pazopanib,1,400,mg,1,daily,NA
25615852,NA,7,liposomal doxorubicin,1,40,mg/m2,1,day 1 every 28 days,NA
25615852,NA,7,pazopanib,1.5,400,mg,1,Days 3–26 every 28 days,NA
25615852,NA,7,liposomal doxorubicin,1.5,30,mg/m2,1,day 1 every 28 days,NA
25615852,NA,7,pazopanib,2,400,mg,1,Days 3–26 every 28 days,NA
25615852,NA,7,liposomal doxorubicin,2,40,mg/m2,1,day 1 every 28 days,NA
25615852,NA,7,pazopanib,3,800,mg,1,Days 3–26 every 28 days,NA
25615852,NA,7,liposomal doxorubicin,3,40,mg/m2,1,day 1 every 28 days,NA
24141374,NA,8,pegylated liposomal doxorubicin,0,35,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,0,500,mg/m2,1,every 4 weeks,NA
24141374,NA,8,pegylated liposomal doxorubicin,1,35,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,1,600,mg/m2,1,every 4 weeks,NA
24141374,NA,8,pegylated liposomal doxorubicin,2,40,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,2,500,mg/m2,1,every 4 weeks,NA
24141374,NA,8,pegylated liposomal doxorubicin,3,40,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,3,600,mg/m2,1,every 4 weeks,NA
24141374,NA,8,pegylated liposomal doxorubicin,4,45,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,4,500,mg/m2,1,every 4 weeks,NA
24141374,NA,8,pegylated liposomal doxorubicin,5,45,mg/m2,1,every 4 weeks,NA
24141374,NA,8,cyclophosphamide,5,600,mg/m2,1,every 4 weeks,NA
25536954,NCT01027910,9,abexinostat,1,30,mg/m2,2,on days 1 through 5 of every 21-day cycle,Arm B
25536954,NCT01027910,9,doxorubicin,1,75,mg/m2,1,on day 4 of every 21-day cycle,Arm B
25536954,NCT01027910,9,g-csf,1,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,g-csf,1,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,abexinostat,2,45,mg/m2,2,on days 1 through 5 of every 21-day cycle,Arm B
25536954,NCT01027910,9,doxorubicin,2,75,mg/m2,1,on day 4 of every 21-day cycle,Arm B
25536954,NCT01027910,9,g-csf,2,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,g-csf,2,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,abexinostat,3,60,mg/m2,2,on days 1 through 5 of every 21-day cycle,Arm B
25536954,NCT01027910,9,doxorubicin,3,75,mg/m2,1,on day 4 of every 21-day cycle,Arm B
25536954,NCT01027910,9,g-csf,3,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,g-csf,3,NA,NA,1,on Day 5 of each 3 weeks cycle,Arm B
25536954,NCT01027910,9,abexinostat,0,15,mg/m2,2,on days 1 through 5 of every 21-day cycle,Arm A
25536954,NCT01027910,9,doxorubicin,0,75,mg/m2,1,on day 4 of every 21-day cycle,Arm A
25536954,NCT01027910,9,abexinostat,1.5,30,mg/m2,2,on days 1 through 5 of every 21-day cycle,Arm A
25536954,NCT01027910,9,doxorubicin,1.5,75,mg/m2,1,on day 4 of every 21-day cycle,Arm A
20629034,NA,10,ptk787/zk222584,1,750,mg,1,every 3 weeks for a maximum of 6 cycles,NA
20629034,NA,10,doxorubicin,1,60,mg/m2,1,every 3 weeks for a maximum of 6 cycles,NA
20629034,NA,10,ptk787/zk222584,2,1000,mg,1,every 3 weeks for a maximum of 6 cycles,NA
20629034,NA,10,doxorubicin,2,60,mg/m2,1,every 3 weeks for a maximum of 6 cycles,NA
20629034,NA,10,ptk787/zk222584,3,1250,mg,1,every 3 weeks for a maximum of 6 cycles,NA
20629034,NA,10,doxorubicin,3,60,mg/m2,1,every 3 weeks for a maximum of 6 cycles,NA
25698442,NCT00710125,11,gpx-150,1,14,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,2,28,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,3,56,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,4,84,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,5,112,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,6,150,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,7,200,mg/m2,1,every 21 days for up to 8 cycles,NA
25698442,NCT00710125,11,gpx-150,8,265,mg/m2,1,every 21 days for up to 8 cycles,NA
25058346,NA,12,nintedanib,1,150,mg,2,daily during the 12 courses of weekly paclitaxel,NA
25058346,NA,12,paclitaxel,1,80,mg/m2,1,weekly for 12 weeks,fixed
25058346,NA,12,adriamycin,1,60,mg/m2,1,on day 99 every 21 days for 4 cycles,fixed
25058346,NA,12,cyclophosphamide,1,600,mg/m2,1,on day 99 every 21 days for 4 cycles,fixed
25058346,NA,12,nintedanib,2,200,mg,2,daily during the 12 courses of weekly paclitaxel,NA
25058346,NA,12,paclitaxel,2,80,mg/m2,1,weekly for 12 weeks,fixed
25058346,NA,12,adriamycin,2,60,mg/m2,1,on day 99 every 21 days for 4 cycles,fixed
25058346,NA,12,cyclophosphamide,2,600,mg/m2,1,on day 99 every 21 days for 4 cycles,fixed
22752217,NA,13,epirubicin,1,50,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,1,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,s-1,1,35,mg/m2,2,on days 1–14 every 21 days,NA
22752217,NA,13,epirubicin,2,50,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,2,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,2,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,s-1,2,40,mg/m2,2,on days 1–14 every 21 days,NA
22752217,NA,13,epirubicin,3,50,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,3,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,3,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,s-1,3,45,mg/m2,2,on days 1–14 every 21 days,NA
22752217,NA,13,epirubicin,4,50,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,4,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,oxaliplatin,4,130,mg/m2,1,on day 1 every 21 days,fixed
22752217,NA,13,s-1,4,50,mg/m2,2,on days 1–14 every 21 days,NA
22178041,NA,14,heat-deployed liposomal doxorubicin,1,20,mg/m2,1,Not defined,NA
22178041,NA,14,heat-deployed liposomal doxorubicin,2,30,mg/m2,1,Not defined,NA
22178041,NA,14,heat-deployed liposomal doxorubicin,3,40,mg/m2,1,Not defined,NA
22178041,NA,14,heat-deployed liposomal doxorubicin,4,50,mg/m2,1,Not defined,NA
22178041,NA,14,heat-deployed liposomal doxorubicin,5,60,mg/m2,1,Not defined,NA
26115930,NA,15,myocet®,1,60,mg/m2,1,on day 1 of a 21-day cycle,NA
26115930,NA,15,myocet®,2,75,mg/m2,1,on day 1 of a 21-day cycle,NA
20352294,NA,16,pemetrexed,1,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20352294,NA,16,pegylated liposomal doxorubicin,1,30,mg/m2,1,"day 1 only, of each 28-day cycle",NA
20352294,NA,16,pemetrexed,2,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20352294,NA,16,pegylated liposomal doxorubicin,2,35,mg/m2,1,"day 1 only, of each 28-day cycle",NA
20352294,NA,16,pemetrexed,3,500,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20352294,NA,16,pegylated liposomal doxorubicin,3,35,mg/m2,1,"day 1 only, of each 28-day cycle",NA
20352294,NA,16,pemetrexed,4,500,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20352294,NA,16,pegylated liposomal doxorubicin,4,40,mg/m2,1,"day 1 only, of each 28-day cycle",NA
20352294,NA,16,pemetrexed,5,500,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20352294,NA,16,pegylated liposomal doxorubicin,5,45,mg/m2,1,"day 1 only, of each 28-day cycle",NA
20405155,NA,17,liposomal doxorubicin,-1,25,mg/m2,1,every 4 weeks,NA
20405155,NA,17,zd1839,-1,250,mg,1,every day,fixed
20405155,NA,17,liposomal doxorubicin,1,30,mg/m2,1,every 4 weeks,NA
20405155,NA,17,zd1839,1,250,mg,1,every day,fixed
20405155,NA,17,liposomal doxorubicin,2,35,mg/m2,1,every 4 weeks,NA
20405155,NA,17,zd1839,2,250,mg,1,every day,fixed
20405155,NA,17,liposomal doxorubicin,3,40,mg/m2,1,every 4 weeks,NA
20405155,NA,17,zd1839,3,250,mg,1,every day,fixed
25278449,NCT01240629,18,aezs-108,1,160,mg/m2,1,every 21 days for up to 6 cycles,NA
25278449,NCT01240629,18,aezs-108,2,210,mg/m2,1,every 21 days for up to 6 cycles,NA
25278449,NCT01240629,18,aezs-108,3,267,mg/m2,1,every 21 days for up to 6 cycles,NA
23763920,NCT00271063,19,annamycin,-1,150,mg/m2,1,3 consecutive days followed by 18 days without study drug (treatment cycle equaled 21 days),NA
23763920,NCT00271063,19,annamycin,1,190,mg/m2,1,3 consecutive days followed by 18 days without study drug (treatment cycle equaled 21 days),NA
23763920,NCT00271063,19,annamycin,2,230,mg/m2,1,3 consecutive days followed by 18 days without study drug (treatment cycle equaled 21 days),NA
23763920,NCT00271063,19,annamycin,3,280,mg/m2,1,3 consecutive days followed by 18 days without study drug (treatment cycle equaled 21 days),NA
23763920,NCT00271063,19,annamycin,4,310,mg/m2,1,3 consecutive days followed by 18 days without study drug (treatment cycle equaled 21 days),NA
24455463,NA,20,idarubicin,1,11,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,1,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,1,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,1,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,1,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,1,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,1,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,2,12,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,2,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,2,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,2,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,2,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,2,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,2,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,3,13,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,3,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,3,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,3,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,3,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,3,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,3,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,4,14,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,4,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,4,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,4,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,4,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,4,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,4,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,5,15,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,5,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,5,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,5,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,5,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,5,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,5,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,6,16,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,6,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,6,100,mg/m2,1,bolus infusion on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,6,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,6,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,6,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,6,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,idarubicin,6.5,16,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,NA
24455463,NA,20,cyclophosphamide,6.5,750,mg/m2,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,etoposide,6.5,100,mg/m2,1,24 h civ on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,vincristine,6.5,2,mg,1,on day 1 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,prednisolone,6.5,100,mg,1,d1 – 5 of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,6.5,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
24455463,NA,20,g-csf,6.5,300/480,ug,1,d5 - 13 of each of each 14-day cycle for 6 cycles,fixed
20495918,NA,21,5-fu,1,200,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,1,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,1,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,1,10,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,1,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,2,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,2,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,2,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,2,10,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,2,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,3,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,3,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,3,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,3,15,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,3,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,4,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,4,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,4,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,4,15,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,4,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,5,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,5,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,5,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,5,15,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,5,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,6,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,6,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,6,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,6,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,6,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,21,5-fu,7,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,21,cisplatin,7,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,cisplatin,7,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,epirubicin,7,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,21,radiation therapy,7,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,1,200,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,1,30,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,1,10,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,1,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,2,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,2,30,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,2,10,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,2,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,3,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,3,30,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,3,15,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,3,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,4,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,4,30,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,4,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,4,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,5,225,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,5,40,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,5,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,5,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,6,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,6,40,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,6,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,6,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,7,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,7,50,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,7,20,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,7,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
20495918,NA,22,5-fu,8,250,mg/m2,1,continuous infusion on days 1-28 during radiation treatment,NA
20495918,NA,22,irinotecan,8,50,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,epirubicin,8,25,mg/m2,1,"days 1, 8, 15, 22, and 29 of the treatment plan",NA
20495918,NA,22,radiation therapy,8,54,Gy,NA,"5 1/2 weeks with a dose of 45 Gy in 25 fractions of 1.8 Gy, with an additional comedown of 5.4 Gy",NA
17551496,NA,23,pegylated liposomal doxorubicin,1,10,mg/m2,1,on day 1 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,paclitaxel,1,100,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,gemcitabine,1,800,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,pegylated liposomal doxorubicin,2,12,mg/m2,1,on day 1 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,paclitaxel,2,100,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,gemcitabine,2,800,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,pegylated liposomal doxorubicin,3,12,mg/m2,1,on day 1 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,paclitaxel,3,100,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,gemcitabine,3,1000,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,pegylated liposomal doxorubicin,4,12,mg/m2,1,on day 1 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,paclitaxel,4,110,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17551496,NA,23,gemcitabine,4,1000,mg/m2,1,on day 2 every 2 weeks in cycles of 4 weeks,NA
17960381,NA,24,pegylated liposomal doxorubicin,1,10,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,1,100,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,1,50,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,1,50,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,2,12,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,2,100,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,2,50,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,2,50,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,3,12,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,3,100,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,3,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,3,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,4,12,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,4,110,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,4,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,4,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,5,14,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,5,110,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,5,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,5,60,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,6,14,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,6,110,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,6,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,6,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,7,14,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,7,120,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,7,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,7,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,pegylated liposomal doxorubicin,8,16,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,paclitaxel,8,120,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,8,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17960381,NA,24,oxaliplatin,8,70,mg/m2,1,on days 1 and 15 of a 4-week cycle,NA
17641537,NA,25,pegylated liposomal doxorubicin,1,25,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,1,80,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,1,80,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,2,80,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,2,80,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,3,90,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,3,90,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,4,35,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,4,90,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,4,90,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,5,35,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,5,100,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,5,100,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,6,40,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,6,100,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,6,100,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,7,40,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,7,110,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,7,110,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,8,45,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,8,110,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,8,110,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,9,45,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,9,120,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,9,120,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,10,45,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,10,130,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,10,130,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,pegylated liposomal doxorubicin,11,50,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,11,130,mg/m2,1,on day 1 every 3 weeks,NA
17641537,NA,25,oxaliplatin,11,130,mg/m2,1,on day 1 every 3 weeks,NA
16880787,NA,26,liposomal daunorubicin,1,80,mg/m2,1,on day 1 of a 21 day cycle,Arm A – patients who relapsed after conventional therapy.
16880787,NA,26,liposomal daunorubicin,2,100,mg/m2,1,on day 1 of a 21 day cycle,Arm A – patients who relapsed after conventional therapy.
16880787,NA,26,liposomal daunorubicin,3,125,mg/m2,1,on day 1 of a 21 day cycle,Arm A – patients who relapsed after conventional therapy.
16880787,NA,26,liposomal daunorubicin,4,155,mg/m2,1,on day 1 of a 21 day cycle,Arm A – patients who relapsed after conventional therapy.
16880787,NA,26,liposomal daunorubicin,5,190,mg/m2,1,on day 1 of a 21 day cycle,Arm A – patients who relapsed after conventional therapy.
16880787,NA,26,liposomal daunorubicin,1,80,mg/m2,1,on day 1 of a 21 day cycle,Arm B – patients previously treated with craniospinal radiotherapy and/or high dose therapy
16880787,NA,26,liposomal daunorubicin,2,100,mg/m2,1,on day 1 of a 21 day cycle,Arm B – patients previously treated with craniospinal radiotherapy and/or high dose therapy
16880787,NA,26,liposomal daunorubicin,3,125,mg/m2,1,on day 1 of a 21 day cycle,Arm B – patients previously treated with craniospinal radiotherapy and/or high dose therapy
16880787,NA,26,liposomal daunorubicin,5,155,mg/m2,1,on day 1 of a 21 day cycle,Arm B + G-CSF – patients previously treated with craniospinal radiotherapy and/or high dose therapy
16880787,NA,26,liposomal daunorubicin,6,190,mg/m2,1,on day 1 of a 21 day cycle,Arm B + G-CSF – patients previously treated with craniospinal radiotherapy and/or high dose therapy
16880787,NA,26,liposomal daunorubicin,4,125,mg/m2,1,on day 1 of a 21 day cycle,Arm B + G-CSF – patients previously treated with craniospinal radiotherapy and/or high dose therapy
18497430,NA,27,trabectedin,1,0.4,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,1,30,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,trabectedin,2,0.6,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,2,30,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,trabectedin,3,0.75,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,3,30,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,trabectedin,4,0.9,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,4,30,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,trabectedin,5,1.1,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,5,30,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,trabectedin,6,1.3,mg/m2,1,On day 1 of each 3-week cycle,NA
18497430,NA,27,pegylated liposomal doxorubicin,6,30,mg/m2,1,On day 1 of each 3-week cycle,NA
19082825,NA,28,triapine®,1,25,mg/m2,1,on days 1-4 every 21 days,NA
19082825,NA,28,doxorubicin,1,60,mg/m2,1,on day 1 every 21 days,NA
19082825,NA,28,triapine®,0.5,25,mg/m2,1,on days 1-4 every 21 days,NA
19082825,NA,28,doxorubicin,0.5,45,mg/m2,1,on day 1 every 21 days,NA
19082825,NA,28,triapine®,2,45,mg/m2,1,on days 1-4 every 21 days,NA
19082825,NA,28,doxorubicin,2,60,mg/m2,1,on day 1 every 21 days,NA
19082825,NA,28,triapine®,1.5,45,mg/m2,1,on days 1-4 every 21 days,NA
19082825,NA,28,doxorubicin,1.5,45,mg/m2,1,on day 1 every 21 days,NA
16126736,NA,29,paclitaxel,1,135,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,doxorubicin,1,30,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,paclitaxel,2,150,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,doxorubicin,2,30,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,paclitaxel,3,150,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,doxorubicin,3,35,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,29,paclitaxel,4,150,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,30,doxorubicin,4,40,mg/m2,1,on day 1 of each 4-week cycle,NA
16126736,NA,30,doxorubicin,1,30,mg/m2,1,on day 1 of the first 4-week cycle,NA
16126736,NA,30,paclitaxel,1,135,mg/m2,1,on day 1 of the first 4-week cycle,NA
16126736,NA,30,doxorubicin,1,15,mg/m2,1,on day 2 of the second 4-week cycle,NA
16126736,NA,30,paclitaxel,1,70,mg/m2,1,on day 2 of the second 4-week cycle,NA
16126736,NA,30,valspodar,1,5,mg/kg,4,on day 1 of the second 4-week cycle,NA
16126736,NA,30,doxorubicin,2,30,mg/m2,1,on day 1 of the first 4-week cycle,NA
16126736,NA,30,paclitaxel,2,150,mg/m2,1,on day 1 of the first 4-week cycle,NA
16126736,NA,30,doxorubicin,2,15,mg/m2,1,on day 2 of the second 4-week cycle,NA
16126736,NA,30,paclitaxel,2,60,mg/m2,1,on day 2 of the second 4-week cycle,NA
16126736,NA,30,valspodar,2,5,mg/kg,4,on day 1 of the second 4-week cycle,NA
17609947,NA,31,pegylated liposomal doxorubicin,1,30,mg/m2,1,every 21 days,NA
17609947,NA,31,paclitaxel,1,150,mg/m2,1,every 21 days,NA
17609947,NA,31,pegylated liposomal doxorubicin,2,35,mg/m2,1,every 21 days,NA
17609947,NA,31,paclitaxel,2,150,mg/m2,1,every 21 days,NA
17609947,NA,31,pegylated liposomal doxorubicin,3,40,mg/m2,1,every 21 days,NA
17609947,NA,31,paclitaxel,3,150,mg/m2,1,every 21 days,NA
17609947,NA,31,pegylated liposomal doxorubicin,4,35,mg/m2,1,every 21 days,NA
17609947,NA,31,paclitaxel,4,160,mg/m2,1,every 21 days,NA
17609947,NA,31,pegylated liposomal doxorubicin,5,35,mg/m2,1,every 21 days,NA
17609947,NA,31,paclitaxel,5,170,mg/m2,1,every 21 days,NA
15466828,NA,32,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,paclitaxel,1,110,mg/m2,1,continuous i.v. infusion on day 1 following DOX administration every 21 days,fixed
15466828,NA,32,doxorubicin,1,20,mg/m2,1,on day 1 every 21 days,NA
15466828,NA,32,cisplatin,2,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,cisplatin,2,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,paclitaxel,2,110,mg/m2,1,continuous i.v. infusion on day 1 following DOX administration every 21 days,fixed
15466828,NA,32,doxorubicin,2,30,mg/m2,1,on day 1 every 21 days,NA
15466828,NA,32,cisplatin,3,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,cisplatin,3,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,paclitaxel,3,110,mg/m2,1,continuous i.v. infusion on day 1 following DOX administration every 21 days,fixed
15466828,NA,32,doxorubicin,3,40,mg/m2,1,on day 1 every 21 days,NA
15466828,NA,32,cisplatin,4,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,cisplatin,4,75,mg/m2,1,on day 2 every 21 days,fixed
15466828,NA,32,paclitaxel,4,110,mg/m2,1,continuous i.v. infusion on day 1 following DOX administration every 21 days,fixed
15466828,NA,32,doxorubicin,4,50,mg/m2,1,on day 1 every 21 days,NA
17852117,NA,33,5-fluorouracil,1,200,mg/m2,1,28 days every 4 weeks,fixed
17852117,NA,33,epirubicin,1,30,mg/m2,1,on Day 1 and 14 every 4 weeks,fixed
17852117,NA,33,cisplatin,1,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,cisplatin,1,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,gemcitabine,1,600,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,5-fluorouracil,2,200,mg/m2,1,28 days every 4 weeks,fixed
17852117,NA,33,epirubicin,2,30,mg/m2,1,on Day 1 and 14 every 4 weeks,fixed
17852117,NA,33,cisplatin,2,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,cisplatin,2,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,gemcitabine,2,700,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,5-fluorouracil,3,200,mg/m2,1,28 days every 4 weeks,fixed
17852117,NA,33,epirubicin,3,30,mg/m2,1,on Day 1 and 14 every 4 weeks,fixed
17852117,NA,33,cisplatin,3,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,cisplatin,3,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,gemcitabine,3,800,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,5-fluorouracil,4,200,mg/m2,1,28 days every 4 weeks,fixed
17852117,NA,33,epirubicin,4,30,mg/m2,1,on Day 1 and 14 every 4 weeks,fixed
17852117,NA,33,cisplatin,4,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,cisplatin,4,30,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,gemcitabine,4,900,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,5-fluorouracil,5,200,mg/m2,1,28 days every 4 weeks,fixed
17852117,NA,33,epirubicin,5,30,mg/m2,1,on Day 1 and 14 every 4 weeks,fixed
17852117,NA,33,cisplatin,5,40,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,cisplatin,5,40,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
17852117,NA,33,gemcitabine,5,800,mg/m2,1,on Day 1 and 14 every 4 weeks,NA
16107496,NA,34,gefitinib,1,250,mg,1,daily,NA
16107496,NA,34,epirubicin,1,20,mg/m2,1,weekly  for six consecutive weeks followed by a 2-week rest period. Treatment was recycled every 8 weeks,NA
16107496,NA,34,gefitinib,2,250,mg,1,daily,NA
16107496,NA,34,epirubicin,2,25,mg/m2,1,weekly  for six consecutive weeks followed by a 2-week rest period. Treatment was recycled every 8 weeks,NA
16107496,NA,34,gefitinib,3,250,mg,1,daily,NA
16107496,NA,34,epirubicin,3,30,mg/m2,1,weekly  for six consecutive weeks followed by a 2-week rest period. Treatment was recycled every 8 weeks,NA
16107496,NA,34,gefitinib,4,250,mg,1,daily,NA
16107496,NA,34,epirubicin,4,35,mg/m2,1,weekly  for six consecutive weeks followed by a 2-week rest period. Treatment was recycled every 8 weeks,NA
17045160,NA,35,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,1,50,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,2,50,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,3,1200,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,3,50,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,4,1200,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,4,60,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,5,1200,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,5,75,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,6,1300,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,6,75,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,7,1400,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,7,75,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,8,1500,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,8,75,mg/m2,1,on day 1 of 21-day cycles,NA
17045160,NA,35,gemcitabine,9,1500,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
17045160,NA,35,epirubicin,9,90,mg/m2,1,on day 1 of 21-day cycles,NA
16980599,NA,36,lenalidomide,1,5,mg,1,on days 1–21 in 28-day cycles,NA
16980599,NA,36,pegylated liposomal doxorubicin,1,40,mg/m2,1,on day 1 in 28-day cycles,NA
16980599,NA,36,vincristine,1,2,mg,1,on day 1 in 28-day cycles,NA
16980599,NA,36,dexamethasone,1,40,mg,1,on days 1–4 in 28-day cycles,NA
16980599,NA,36,lenalidomide,2,10,mg,1,on days 1–21 in 28-day cycles,NA
16980599,NA,36,pegylated liposomal doxorubicin,2,40,mg/m2,1,on day 1 in 28-day cycles,NA
16980599,NA,36,vincristine,2,2,mg,1,on day 1 in 28-day cycles,NA
16980599,NA,36,dexamethasone,2,40,mg,1,on days 1–4 in 28-day cycles,NA
16980599,NA,36,lenalidomide,3,15,mg,1,on days 1–21 in 28-day cycles,NA
16980599,NA,36,pegylated liposomal doxorubicin,3,40,mg/m2,1,on day 1 in 28-day cycles,NA
16980599,NA,36,vincristine,3,2,mg,1,on day 1 in 28-day cycles,NA
16980599,NA,36,dexamethasone,3,40,mg,1,on days 1–4 in 28-day cycles,NA
19182205,NCT00306813,37,lenalidomide,1,10,mg,1,on days 1 through 21 of the 28-day cycle,NA
19182205,NCT00306813,37,adriamycin,1,4,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,NA
19182205,NCT00306813,37,dexamethasone,1,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,NA
19182205,NCT00306813,37,lenalidomide,2,10,mg,1,on days 1 through 21 of the 28-day cycle,NA
19182205,NCT00306813,37,adriamycin,2,6,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,NA
19182205,NCT00306813,37,dexamethasone,2,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,NA
19182205,NCT00306813,37,lenalidomide,3,10,mg,1,on days 1 through 21 of the 28-day cycle,NA
19182205,NCT00306813,37,adriamycin,3,9,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,NA
19182205,NCT00306813,37,dexamethasone,3,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,NA
19182205,NCT00306813,37,lenalidomide,4,15,mg,1,on days 1 through 21 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,adriamycin,4,9,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,dexamethasone,4,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,lenalidomide,4.5,15,mg,1,on days 1 through 21 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,adriamycin,4.5,9,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,dexamethasone,4.5,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,lenalidomide,5,25,mg,1,on days 1 through 21 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,adriamycin,5,9,mg/m2,1,continuous infusion on day 1 of the 28-day cycle,with G-CSF
19182205,NCT00306813,37,dexamethasone,5,40,mg,1,on days 1 through 4 and 17 through 20 of the 28-day cycle,with G-CSF
15675483,NA,38,caelix,1,10,mg/L,1,during hyperthermic perfusion at a temperature of 41.5°C,NA
15675483,NA,38,caelix,2,12,mg/L,1,during hyperthermic perfusion at a temperature of 41.5°C,NA
15675483,NA,38,caelix,3,14,mg/L,1,during hyperthermic perfusion at a temperature of 41.5°C,NA
15675483,NA,38,caelix,4,16,mg/L,1,during hyperthermic perfusion at a temperature of 41.5°C,NA
15675483,NA,38,caelix,5,18,mg/L,1,during hyperthermic perfusion at a temperature of 41.5°C,NA
17095524,NA,39,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 1 of each 28-day cycle,NA
17095524,NA,39,pegylated liposomal doxorubicin,2,40,mg/m2,1,on day 1 of each 28-day cycle,NA
17095524,NA,39,pegylated liposomal doxorubicin,3,50,mg/m2,1,on day 1 of each 28-day cycle,NA
16891112,NA,40,liposomal doxorubicin,1,30,mg/m2,1,d 1 q 3 weeks,NA
16891112,NA,40,ifosfamide,1,1700,mg,1,d 1–3 q 3 weeks,NA
16891112,NA,40,liposomal doxorubicin,2,30,mg/m2,1,d 1 q 3 weeks,NA
16891112,NA,40,ifosfamide,2,2000,mg,1,d 1–3 q 3 weeks,NA
16891112,NA,40,liposomal doxorubicin,3,30,mg/m2,1,d 1 q 3 weeks,NA
16891112,NA,40,ifosfamide,3,2500,mg,1,d 1–3 q 3 weeks,NA
16891112,NA,40,liposomal doxorubicin,4,30,mg/m2,1,d 1 q 3 weeks,NA
16891112,NA,40,ifosfamide,4,3000,mg,1,d 1–3 q 3 weeks,NA
16891112,NA,40,liposomal doxorubicin,5,40,mg/m2,1,d 1 q 3 weeks,NA
16891112,NA,40,ifosfamide,5,3000,mg,1,d 1–3 q 3 weeks,NA
15477860,NA,41,nk911,1,6,mg/m2,1,every 3 weeks,NA
15477860,NA,41,nk911,2,12,mg/m2,1,every 3 weeks,NA
15477860,NA,41,nk911,3,24,mg/m2,1,every 3 weeks,NA
15477860,NA,41,nk911,4,36,mg/m2,1,every 3 weeks,NA
15477860,NA,41,nk911,5,50,mg/m2,1,every 3 weeks,NA
15477860,NA,41,nk911,6,67,mg/m2,1,every 3 weeks,NA
20204368,NA,42,cisplatin,1,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,1,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,liposomal doxorubicin,1,20,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,2,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,2,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,liposomal doxorubicin,2,25,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,3,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,3,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,liposomal doxorubicin,3,30,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,4,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,4,100,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,liposomal doxorubicin,4,35,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,5,125,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,cisplatin,5,125,mg/m2,1,day 1 every 28 days,NA
20204368,NA,42,liposomal doxorubicin,5,35,mg/m2,1,day 1 every 28 days,NA
16377584,NA,43,topotecan,1,0.75,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,topotecan,1,0.75,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,pegylated liposomal doxorubicin,1,40,mg/m2,1,on Day 4 of a 28-day cycle,NA
16377584,NA,43,topotecan,2,1,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,topotecan,2,1,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,pegylated liposomal doxorubicin,2,40,mg/m2,1,on Day 4 of a 28-day cycle,NA
16377584,NA,43,topotecan,3,1.25,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,topotecan,3,1.25,mg/m2,1,on days 1–3 of a 28-day cycle,NA
16377584,NA,43,pegylated liposomal doxorubicin,3,40,mg/m2,1,on Day 4 of a 28-day cycle,NA
16377584,NA,43,topotecan,4,1,mg/m2,1,on days 1–3 of a 21-day cycle,NA
16377584,NA,43,topotecan,4,1,mg/m2,1,on days 1–3 of a 21-day cycle,NA
16377584,NA,43,pegylated liposomal doxorubicin,4,25,mg/m2,1,on Day 4 of a 21-day cycle,NA
16377584,NA,43,topotecan,5,1,mg/m2,1,on days 1–3 of a 21-day cycle,NA
16377584,NA,43,topotecan,5,1,mg/m2,1,on days 1–3 of a 21-day cycle,NA
16377584,NA,43,pegylated liposomal doxorubicin,5,30,mg/m2,1,on Day 4 of a 21-day cycle,NA
18927308,NA,44,trabectedin,-1,0.9,mg/m2,1,on day 1 of a 3-week cycle,without G-CSF
18927308,NA,44,doxorubicin,-1,50,mg/m2,1,on day 1 of a 3-week cycle,without G-CSF
18927308,NA,44,trabectedin,1,0.9,mg/m2,1,on day 1 of a 3-week cycle,without G-CSF
18927308,NA,44,doxorubicin,1,60,mg/m2,1,on day 1 of a 3-week cycle,without G-CSF
18927308,NA,44,trabectedin,1.5,0.9,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,doxorubicin,1.5,60,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,trabectedin,2,1.1,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,doxorubicin,2,60,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,trabectedin,3,1.3,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,doxorubicin,3,60,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,trabectedin,4,1.3,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
18927308,NA,44,doxorubicin,4,75,mg/m2,1,on day 1 of a 3-week cycle,with G-CSF
17317836,NA,46,doxorubicin,1,0.4,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,2,0.6,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,3,0.8,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,4,1.2,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,5,1.5,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,6,1.9,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,7,2.4,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,8,3,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,9,3.8,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,10,4.8,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,11,6,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,12,7.5,mg/m2,1,every 3 weeks,NA
17317836,NA,46,doxorubicin,13,9.4,mg/m2,1,every 3 weeks,NA
19582371,NA,47,myocet,1,40,mg/m2,1,on day 1 every 3 weeks,NA
19582371,NA,47,ifosfamide,1,3000,mg/m2,1,on days 1– 3 every 3 weeks,NA
19582371,NA,47,myocet,2,50,mg/m2,1,on day 1 every 3 weeks,NA
19582371,NA,47,ifosfamide,2,3000,mg/m2,1,on days 1– 3 every 3 weeks,NA
19582371,NA,47,myocet,3,60,mg/m2,1,on day 1 every 3 weeks,NA
19582371,NA,47,ifosfamide,3,3000,mg/m2,1,on days 1– 3 every 3 weeks,NA
19582371,NA,47,myocet,4,70,mg/m2,1,on day 1 every 3 weeks,NA
19582371,NA,47,ifosfamide,4,3000,mg/m2,1,on days 1– 3 every 3 weeks,NA
19582371,NA,47,myocet,5,80,mg/m2,1,on day 1 every 3 weeks,NA
19582371,NA,47,ifosfamide,5,3000,mg/m2,1,on days 1– 3 every 3 weeks,NA
15942626,NA,48,pegylated liposomal doxorubicin,1,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,1,8,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,1,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,2,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,2,10,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,2,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,3,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,3,12,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,3,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,4,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,4,14,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,4,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,5,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,5,16,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,5,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,6,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,6,18,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,6,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,7,20,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,7,20,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,7,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,8,22,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,8,22,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,8,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
15942626,NA,48,pegylated liposomal doxorubicin,9,25,mg/m2,1,on day 1 of the first 14-day cycle,NA
15942626,NA,48,pegylated liposomal doxorubicin,9,24,mg/m2,1,on day 1 of the subsequent cycles,NA
15942626,NA,48,valspodar,9,1.42 mg kg-1 h-1 infusion over 2 h and then reduced to 0.42 mg kg h-1 (10 mg kg d-1 ) for an additional 70 h,mg/kg,1,72 h continuous intravenous infusion with PEG-LD in subsequent 14-day cycles,NA
16891870,NA,49,pegylated liposomal doxorubicin,1,25,mg/m2,1,on day 1 every 28 days,NA
16891870,NA,49,ifosfamide,1,1700,mg/m2,1,on days 1-3 every 28 days,fixed
16891870,NA,49,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 every 28 days,NA
16891870,NA,49,ifosfamide,2,1700,mg/m2,1,on days 1-3 every 28 days,fixed
16891870,NA,49,pegylated liposomal doxorubicin,3,35,mg/m2,1,on day 1 every 28 days,NA
16891870,NA,49,ifosfamide,3,1700,mg/m2,1,on days 1-3 every 28 days,fixed
16891870,NA,49,pegylated liposomal doxorubicin,4,40,mg/m2,1,on day 1 every 28 days,NA
16891870,NA,49,ifosfamide,4,1700,mg/m2,1,on days 1-3 every 28 days,fixed
16891870,NA,49,pegylated liposomal doxorubicin,5,45,mg/m2,1,on day 1 every 28 days,NA
16891870,NA,49,ifosfamide,5,1700,mg/m2,1,on days 1-3 every 28 days,fixed
15528980,NA,50,tomudex,1,2.5,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,1,30,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,tomudex,2,2.5,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,2,40,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,tomudex,3,2.5,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,3,50,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,tomudex,4,2.5,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,4,60,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,tomudex,5,3,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,5,60,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,tomudex,6,3.5,mg/m2,1,day 1 every 3 weeks,NA
15528980,NA,50,doxorubicin,6,60,mg/m2,1,day 1 every 3 weeks,NA
19997959,NA,51,motexafin gadolinium,1,1,mg/kg,1,"on days 8, 9, and 10 every 28 days (cycle 1) and then on days 1-3 every 21 days (subsequent cycles)",NA
19997959,NA,51,doxorubicin,1,30,mg/m2,1,on day 8 every 28 days (cycle 1) and then on day 1 every 21 days (subsequent cycles),fixed
19997959,NA,51,motexafin gadolinium,2,2,mg/kg,1,"on days 8, 9, and 10 every 28 days (cycle 1) and then on days 1-3 every 21 days (subsequent cycles)",NA
19997959,NA,51,doxorubicin,2,30,mg/m2,1,on day 8 every 28 days (cycle 1) and then on day 1 every 21 days (subsequent cycles),fixed
19997959,NA,51,motexafin gadolinium,3,3.3,mg/kg,1,"on days 8, 9, and 10 every 28 days (cycle 1) and then on days 1-3 every 21 days (subsequent cycles)",NA
19997959,NA,51,doxorubicin,3,30,mg/m2,1,on day 8 every 28 days (cycle 1) and then on day 1 every 21 days (subsequent cycles),fixed
16755180,NA,52,pegylated liposomal doxorubicin,1,30,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule A
16755180,NA,52,paclitaxel,1,80,mg/m2,1,"in a 60 minute IV infusion on days 1, 8, and 15 of each 28 day cycle",Schedule A
16755180,NA,52,pegylated liposomal doxorubicin,2,35,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule A
16755180,NA,52,paclitaxel,2,80,mg/m2,1,"in a 60 minute IV infusion on days 1, 8, and 15 of each 28 day cycle",Schedule A
16755180,NA,52,pegylated liposomal doxorubicin,3,40,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule A
16755180,NA,52,paclitaxel,3,80,mg/m2,1,"in a 60 minute IV infusion on days 1, 8, and 15 of each 28 day cycle",Schedule A
16755180,NA,52,pegylated liposomal doxorubicin,4,40,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule A
16755180,NA,52,paclitaxel,4,90,mg/m2,1,"in a 60 minute IV infusion on days 1, 8, and 15 of each 28 day cycle",Schedule A
16755180,NA,52,pegylated liposomal doxorubicin,5,40,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule A
16755180,NA,52,paclitaxel,5,100,mg/m2,1,"in a 60 minute IV infusion on days 1, 8, and 15 of each 28 day cycle",Schedule A
16755180,NA,52,pegylated liposomal doxorubicin,1,35,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule B
16755180,NA,52,paclitaxel,1,"70 on day 1, 90 on days 8 and 15",mg/m2,1,"in a 24 hour IV infusion on day1 on day 1, ,and in a 60 min IV infusion on days 8 and 15 of each 28 day cycle",Schedule B
16755180,NA,52,pegylated liposomal doxorubicin,2,35,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule B
16755180,NA,52,paclitaxel,2,"80 on day 1, 90 on days 8 and 15",mg/m2,1,"in a 24 hour IV infusion on day1 on day 1, ,and in a 60 min IV infusion on days 8 and 15 of each 28 day cycle",Schedule B
16755180,NA,52,pegylated liposomal doxorubicin,3,40,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule B
16755180,NA,52,paclitaxel,3,"80 on day 1, 90 on days 8 and 15",mg/m2,1,"in a 24 hour IV infusion on day1 on day 1, ,and in a 60 min IV infusion on days 8 and 15 of each 28 day cycle",Schedule B
16755180,NA,52,pegylated liposomal doxorubicin,4,40,mg/m2,1,in a 60 minute IV infusion on day 1 of each 28 day cycle,Schedule B
16755180,NA,52,paclitaxel,4,90,mg/m2,1,"in a 24 hour IV infusion on day1 on day 1, ,and in a 60 min IV infusion on days 8 and 15 of each 28 day cycle",Schedule B
18502128,NA,53,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18502128,NA,53,pegylated liposomal doxorubicin,1,25,mg/m2,1,on day 1 of a 21-day cycle,NA
18502128,NA,53,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18502128,NA,53,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 of a 21-day cycle,NA
18502128,NA,53,gemcitabine,3,1200,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18502128,NA,53,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 1 of a 21-day cycle,NA
18502128,NA,53,gemcitabine,4,1200,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
18502128,NA,53,pegylated liposomal doxorubicin,4,35,mg/m2,1,on day 1 of a 21-day cycle,NA
16520906,NA,54,caelyx,1,7,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,caelyx,1,7,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,cisplatin,1,20-25,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,cisplatin,1,20-25,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,external pelvic rt,1,NA,NA,NA,NA,NA
16520906,NA,54,caelyx,2,NA,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,caelyx,2,NA,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,cisplatin,2,NA,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,cisplatin,2,NA,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,external pelvic rt,2,NA,NA,NA,NA,NA
16520906,NA,54,caelyx,3,NA,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,caelyx,3,NA,NA,NA,"D1, D8, D15, D22, D29, D36, D43 at the beginning of the week",NA
16520906,NA,54,cisplatin,3,NA,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,cisplatin,3,NA,NA,NA,"on days D4, D11, D18, D25, D32, D39, D46",NA
16520906,NA,54,external pelvic rt,3,NA,NA,NA,NA,NA
18525299,NA,55,irinotecan,-3,100,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,-3,25,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,-2,100,mg/m2,1,on day 1  for 21-day cycles,"for previously
chemotherapy-treated patients"
18525299,NA,55,epirubicin,-2,50,mg/m2,1,on day 1  for 21-day cycles,"for previously
chemotherapy-treated patients"
18525299,NA,55,irinotecan,-1,150,mg/m2,1,on day 1  for 21-day cycles,for chemonaive patients
18525299,NA,55,epirubicin,-1,50,mg/m2,1,on day 1  for 21-day cycles,for chemonaive patients
18525299,NA,55,irinotecan,1,200,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,1,50,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,2,200,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,2,75,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,3,250,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,3,75,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,4,300,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,4,75,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,5,300,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,5,100,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,irinotecan,6,350,mg/m2,1,on day 1  for 21-day cycles,NA
18525299,NA,55,epirubicin,6,100,mg/m2,1,on day 1  for 21-day cycles,NA
16503137,NA,56,gemcitabine,-1,700,mg/m2,1,days 1 and 8/ every 21 days,NA
16503137,NA,56,imatinib,-1,300,mg,1,everyday,NA
16503137,NA,56,imatinib,-1,300,mg,1,everyday,NA
16503137,NA,56,gemcitabine,0,700,mg/m2,1,"days 1, 8 and 15/ every 28 days",NA
16503137,NA,56,imatinib,0,400,mg,1,everyday,NA
16503137,NA,56,imatinib,0,400,mg,1,everyday,NA
16503137,NA,56,gemcitabine,1,800,mg/m2,1,"days 1, 8 and 15/ every 28 days",NA
16503137,NA,56,imatinib,1,400,mg,1,everyday,NA
16503137,NA,56,imatinib,1,400,mg,1,everyday,NA
16503137,NA,57,doxorubicin,-1,50,mg/m2,1,day 1/every 21 days,NA
16503137,NA,57,imatinib,-1,300,mg,1,everyday,NA
16503137,NA,57,imatinib,-1,300,mg,1,everyday,NA
16503137,NA,57,doxorubicin,0,50,mg/m2,1,day 1/every 21 days,NA
16503137,NA,57,imatinib,0,400,mg,1,everyday,NA
16503137,NA,57,imatinib,0,400,mg,1,everyday,NA
16503137,NA,57,doxorubicin,1,60,mg/m2,1,day 1/every 21 days,NA
16503137,NA,57,imatinib,1,400,mg,1,everyday,NA
16503137,NA,57,imatinib,1,400,mg,1,everyday,NA
15367419,NA,59,paclitaxel,1,50,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,1,30,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,2,60,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,2,30,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,3,70,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,3,30,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,4,80,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,4,30,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,5,90,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,5,30,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,6,50,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,6,35,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,7,60,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,7,35,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,8,70,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,8,35,mg/m2,1,on day 1 every 28 days,NA
15367419,NA,59,paclitaxel,9,80,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
15367419,NA,59,pegylated liposomal doxorubicin,9,35,mg/m2,1,on day 1 every 28 days,NA
10942057,NA,60,cyclophosphamide,1,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,1,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,1,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,1,50,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,cyclophosphamide,2,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,2,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,2,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,2,60,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,cyclophosphamide,3,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,3,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,3,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,3,70,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,cyclophosphamide,4,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,4,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,4,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,4,80,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,cyclophosphamide,5,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,5,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,5,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,5,90,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,cyclophosphamide,6,750,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,vincristine,6,1.4,mg/m2,1,on day 1 every 21 days,NA
10942057,NA,60,prednisone,6,100,mg,1,on days 1-5 every 21 days,NA
10942057,NA,60,liposomal daunorubicin,6,100,mg/m2,1,on day 1 every 21 days,NA
10850343,NA,61,cbt-1,1,100,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,1,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10850343,NA,61,cbt-1,2,200,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,2,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10850343,NA,61,cbt-1,3,300,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,3,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10850343,NA,61,cbt-1,4,400,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,4,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10850343,NA,61,cbt-1,5,500,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,5,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10850343,NA,61,cbt-1,6,600,mg/m2,1,on days 1-7 of each 21-day cycle,NA
10850343,NA,61,doxorubicin,6,60,mg/m2,1,on day 6 of each 21-day cycle,NA
10870069,NA,62,cisplatin,1,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,cisplatin,1,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,doxorubicin,1,10,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,etoposide,1,640,mg/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each 28-day course,NA
10870069,NA,62,ifosfamide,1,10,g/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each  28-day course,NA
10870069,NA,62,gm-csf,1,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10870069,NA,62,gm-csf,1,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10870069,NA,62,cisplatin,2,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,cisplatin,2,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,doxorubicin,2,10,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,etoposide,2,800,mg/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each 28-day course,NA
10870069,NA,62,ifosfamide,2,10,g/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each  28-day course,NA
10870069,NA,62,gm-csf,2,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10870069,NA,62,gm-csf,2,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10870069,NA,62,cisplatin,3,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,cisplatin,3,40,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,doxorubicin,3,10,mg/m2,1,continuous infusion over 24 hours on Days 0 –3 of each 28-day course,NA
10870069,NA,62,etoposide,3,640,mg/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each 28-day course,NA
10870069,NA,62,ifosfamide,3,12.4,g/m2/96 hrs,NA,continuous infusion on Days 0 –3 of each  28-day course,NA
10870069,NA,62,gm-csf,3,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10870069,NA,62,gm-csf,3,5,ug/kg/per day,1,"beginning on Day 5 of each 28-day course,  daily for at least 14 days and until the absolute neutrophil count (ANC) was > 1500/uL for 2 consecutive days. GM-CSF was discontinued before Day 14 if the ANC was >= 10,000/uL.",NA
10389912,NA,63,doxorubicin,1,7.5,mg/m2,1,on days 1-4 every 21 days,NA
10389912,NA,63,paclitaxel,1,25,mg/m2,1,on days 1-4 every 21 days,fixed
10389912,NA,63,granulocyte colony-stimulating factor,1,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,granulocyte colony-stimulating factor,1,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,doxorubicin,2,10,mg/m2,1,on days 1-4 every 21 days,NA
10389912,NA,63,paclitaxel,2,25,mg/m2,1,on days 1-4 every 21 days,fixed
10389912,NA,63,granulocyte colony-stimulating factor,2,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,granulocyte colony-stimulating factor,2,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,doxorubicin,3,12.5,mg/m2,1,on days 1-4 every 21 days,NA
10389912,NA,63,paclitaxel,3,25,mg/m2,1,on days 1-4 every 21 days,fixed
10389912,NA,63,granulocyte colony-stimulating factor,3,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,granulocyte colony-stimulating factor,3,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,doxorubicin,4,15,mg/m2,1,on days 1-4 every 21 days,NA
10389912,NA,63,paclitaxel,4,25,mg/m2,1,on days 1-4 every 21 days,fixed
10389912,NA,63,granulocyte colony-stimulating factor,4,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10389912,NA,63,granulocyte colony-stimulating factor,4,5,ug/kg,1,"daily beginning on day 6 and continuing untilthe absolute neutrophil count exceeded 10,000/ul",NA
10907958,NA,64,epirubicin,1,60,mg/m2,1,at day 1 every 3 weeks,NA
10907958,NA,64,gemcitabine,1,800,mg/m2,1,at days 1 and 8 every 3 weeks,NA
10907958,NA,64,epirubicin,2,60,mg/m2,1,at day 1 every 3 weeks,NA
10907958,NA,64,gemcitabine,2,1000,mg/m2,1,at days 1 and 8 every 3 weeks,NA
10907958,NA,64,epirubicin,3,75,mg/m2,1,at day 1 every 3 weeks,NA
10907958,NA,64,gemcitabine,3,1000,mg/m2,1,at days 1 and 8 every 3 weeks,NA
10907958,NA,64,epirubicin,4,75,mg/m2,1,at day 1 every 3 weeks,NA
10907958,NA,64,gemcitabine,4,1000,mg/m2,1,at days 1 and 8 every 3 weeks,NA
10343189,NA,65,epirubicin,1,90,mg/m2,1,at day 1 every 4 weeks,NA
10343189,NA,65,paclitaxel,1,150,mg/m2,1,at day 1 every 4 weeks,fixed
10343189,NA,65,epirubicin,2,90,mg/m2,1,at day 1 every 4 weeks,NA
10343189,NA,65,paclitaxel,2,150,mg/m2,1,at day 1 every 4 weeks,fixed
10343189,NA,65,prophylactic filgrastim,2,5,ug/kg/per day,1,"given in case of grade 4 leukopenia(levels without support) or from day 4 up to leukocyte count 110,000/mm3 after nadir (levels with support)",NA
10343189,NA,65,epirubicin,3,90,mg/m2,1,at day 1 every 4 weeks,NA
10343189,NA,65,paclitaxel,3,150,mg/m2,1,at day 1 every 4 weeks,fixed
10343189,NA,65,prophylactic filgrastim,3,5,ug/kg/per day,1,"given in case of grade 4 leukopenia(levels without support) or from day 4 up to leukocyte count 110,000/mm3 after nadir (levels with support)",NA
10343189,NA,65,epirubicin,4,90,mg/m2,1,at day 1 every 4 weeks,NA
10343189,NA,65,paclitaxel,4,150,mg/m2,1,at day 1 every 4 weeks,fixed
10343189,NA,65,prophylactic filgrastim,4,5,ug/kg/per day,1,"given in case of grade 4 leukopenia(levels without support) or from day 4 up to leukocyte count 110,000/mm3 after nadir (levels with support)",NA
9887248,NA,66,paclitaxel,1,135,mg/m2,1,over 24 h on day 1 every 21 days,NA
9887248,NA,66,doxorubicin,1,30,mg/m2,1,on day 1 every 21 days,NA
9887248,NA,66,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,NA
9887248,NA,66,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,NA
9887248,NA,66,paclitaxel,2,135,mg/m2,1,over 24 h on day 1 every 21 days,NA
9887248,NA,66,doxorubicin,2,40,mg/m2,1,on day 1 every 21 days,NA
9887248,NA,66,cisplatin,2,75,mg/m2,1,on day 2 every 21 days,NA
9887248,NA,66,cisplatin,2,75,mg/m2,1,on day 2 every 21 days,NA
9815746,NA,67,topotecan,-1,1.05,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,67,topotecan,-1,1.05,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,67,doxorubicin,-1,45,mg/m2,1,on day 5 every 21-28 days,NA
9815746,NA,67,topotecan,1,1.5,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,67,topotecan,1,1.5,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,67,doxorubicin,1,45,mg/m2,1,on day 5 every 21-28 days,NA
9815746,NA,68,topotecan,1,1.5,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,topotecan,1,1.5,mg/m2,NA,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,doxorubicin,1,45,mg/m2,1,on day 5 every 21-28 days,NA
9815746,NA,68,g-csf,1,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
9815746,NA,68,g-csf,1,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
9815746,NA,68,topotecan,2,2.25,mg/m2,1,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,topotecan,2,2.25,mg/m2,1,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,doxorubicin,2,45,mg/m2,1,on day 5 every 21-28 days,NA
9815746,NA,68,g-csf,2,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
9815746,NA,68,g-csf,2,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
9815746,NA,68,topotecan,3,3,mg/m2,1,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,topotecan,3,3,mg/m2,1,"72-h continuous infusion on days 1, 2, and 3 every 21-28 days",NA
9815746,NA,68,doxorubicin,3,45,mg/m2,1,on day 5 every 21-28 days,NA
9815746,NA,68,g-csf,3,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
9815746,NA,68,g-csf,3,5,mg/kg,1,"after the doxorubicin was administered and continued until the WBC count was >=10,000/ul on two successive determinations after the expected nadir",NA
8909321,NA,69,5-fluorouracil,1,1000,mg/m2,1,"Days 2, 16 every 15 days",NA
8909321,NA,69,uridine,1,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,69,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,69,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,69,doxorubicin,1,30,mg/m2,1,Day 2 in cycle 2 (every other 15 day cycle),NA
8909321,NA,69,leucovorin,1,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,69,5-fluorouracil,2,1200,mg/m2,1,"Days 2, 16 every 15 days",NA
8909321,NA,69,uridine,2,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,69,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,69,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,69,doxorubicin,2,30,mg/m2,1,Day 2 in cycle 2 (every other 15 day cycle),NA
8909321,NA,69,leucovorin,2,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,70,5-fluorouracil,1,1000,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,70,uridine,1,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,70,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,leucovorin,1,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,70,5-fluorouracil,2,1200,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,70,uridine,2,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,70,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,leucovorin,2,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,70,5-fluorouracil,3,1400,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,70,uridine,3,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,70,methotrexate,3,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,methotrexate,3,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,leucovorin,3,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,70,5-fluorouracil,4,1600,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,70,uridine,4,8000,mg/m2,4,"Days 3-5, every 15 days",NA
8909321,NA,70,methotrexate,4,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,methotrexate,4,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,70,leucovorin,4,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,71,5-fluorouracil,1,800,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,71,doxorubicin,1,30,mg/m2,4,Day 2 in cycle 2 (every other 15 day cycle),NA
8909321,NA,71,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,71,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,71,leucovorin,1,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,71,5-fluorouracil,2,900,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,71,doxorubicin,2,30,mg/m2,4,Day 2 in cycle 2 (every other 15 day cycle),NA
8909321,NA,71,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,71,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,71,leucovorin,2,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,72,5-fluorouracil,1,800,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,72,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,methotrexate,1,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,leucovorin,1,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,72,5-fluorouracil,2,900,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,72,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,methotrexate,2,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,leucovorin,2,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,72,5-fluorouracil,3,1000,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,72,methotrexate,3,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,methotrexate,3,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,leucovorin,3,15,mg/m2,4,Days 2-4 every 15 days,NA
8909321,NA,72,5-fluorouracil,4,1100,mg/m2,1,"Day 2, 16 every 15 days",NA
8909321,NA,72,methotrexate,4,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,methotrexate,4,1.5,mg/m2,1,"on Days 1, 15 every 15 days",NA
8909321,NA,72,leucovorin,4,15,mg/m2,4,Days 2-4 every 15 days,NA
10321510,NA,73,vinorelbine,1,20,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,doxorubicin,1,40,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,1,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,1,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,leucovorin,1,10,mg/m2,4,for six doses beginning on day 2 every 21 days,NA
10321510,NA,73,vinorelbine,2,25,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,doxorubicin,2,40,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,2,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,2,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,leucovorin,2,10,mg/m2,4,for six doses beginning on day 2 every 21 days,NA
10321510,NA,73,vinorelbine,3,30,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,doxorubicin,3,40,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,3,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,3,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,leucovorin,3,10,mg/m2,4,for six doses beginning on day 2 every 21 days,NA
10321510,NA,73,vinorelbine,4,25,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,doxorubicin,4,50,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,4,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,4,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,leucovorin,4,10,mg/m2,4,for six doses beginning on day 2 every 21 days,NA
10321510,NA,73,vinorelbine,5,25,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,doxorubicin,5,60,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,5,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,methotrexate,5,100,mg/m2,1,on day 1 every 21 days,NA
10321510,NA,73,leucovorin,5,10,mg/m2,4,for six doses beginning on day 2 every 21 days,NA
10573115,NA,74,cisplatin,0,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,0,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,0,55,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,0,20,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,1,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,1,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,1,55,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,1,30,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,2,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,2,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,2,65,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,2,30,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,3,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,3,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,3,65,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,3,40,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,4,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,4,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,4,75,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,4,40,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,5,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,5,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,5,85,mg/m2,1,weekly,NA
10573115,NA,74,epirubicin,5,40,mg/m2,1,weekly,NA
10573115,NA,74,cisplatin,5.5,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,5.5,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,5.5,85,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,epirubicin,5.5,40,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,cisplatin,6,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,6,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,6,100,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,epirubicin,6,40,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,cisplatin,7,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,7,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,7,120,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,epirubicin,7,40,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,cisplatin,8,30,mg/m2,1,weekly,fixed
10573115,NA,74,cisplatin,8,30,mg/m2,1,weekly,fixed
10573115,NA,74,paclitaxel,8,120,mg/m2,1,weekly,with concomitant G-CSF
10573115,NA,74,epirubicin,8,50,mg/m2,1,weekly,with concomitant G-CSF
11106111,NA,75,cyclophosphamide,1,750,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,doxorubicin,1,50,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,vincristine,1,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,75,prednisolone,1,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,75,cyclophosphamide,2,1000,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,doxorubicin,2,50,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,vincristine,2,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,75,prednisolone,2,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,75,cyclophosphamide,3,1000,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,doxorubicin,3,60,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,vincristine,3,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,75,prednisolone,3,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,75,cyclophosphamide,4,1250,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,doxorubicin,4,60,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,vincristine,4,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,75,prednisolone,4,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,75,cyclophosphamide,5,1250,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,doxorubicin,5,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,75,vincristine,5,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,75,prednisolone,5,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,cyclophosphamide,6,1250,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,doxorubicin,6,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,vincristine,6,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,76,prednisolone,6,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,prophylactic rhug-csf,6,2,ug/kg,1,from day 3 until day 15 every 3 weeks,fixed
11106111,NA,76,cyclophosphamide,7,1500,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,doxorubicin,7,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,vincristine,7,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,76,prednisolone,7,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,prophylactic rhug-csf,7,2,ug/kg,1,from day 3 until day 15 every 3 weeks,fixed
11106111,NA,76,cyclophosphamide,8,1750,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,doxorubicin,8,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,vincristine,8,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,76,prednisolone,8,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,prophylactic rhug-csf,8,2,ug/kg,1,from day 3 until day 15 every 3 weeks,fixed
11106111,NA,76,cyclophosphamide,9,2000,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,doxorubicin,9,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,vincristine,9,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,76,prednisolone,9,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,prophylactic rhug-csf,9,2,ug/kg,1,from day 3 until day 15 every 3 weeks,fixed
11106111,NA,76,cyclophosphamide,10,2250,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,doxorubicin,10,70,mg/m2,1,day 1 every 3 weeks,NA
11106111,NA,76,vincristine,10,1.4,mg/m2,1,day 1 every 3 weeks,fixed
11106111,NA,76,prednisolone,10,100,mg,1,days 1-5 every 3 weeks,fixed
11106111,NA,76,prophylactic rhug-csf,10,2,ug/kg,1,from day 3 until day 15 every 3 weeks,fixed
9215819,NA,77,paclitaxel,1,135,mg/m2,1,every 3 weeks,NA
9215819,NA,77,epirubicin,1,90,mg/m2,1,every 3 weeks,fixed
9215819,NA,77,paclitaxel,2,155,mg/m2,1,every 3 weeks,NA
9215819,NA,77,epirubicin,2,90,mg/m2,1,every 3 weeks,fixed
9215819,NA,77,paclitaxel,3,175,mg/m2,1,every 3 weeks,NA
9215819,NA,77,epirubicin,3,90,mg/m2,1,every 3 weeks,fixed
9215819,NA,77,paclitaxel,4,200,mg/m2,1,every 3 weeks,NA
9215819,NA,77,epirubicin,4,90,mg/m2,1,every 3 weeks,fixed
9215819,NA,77,paclitaxel,5,225,mg/m2,1,every 3 weeks,NA
9215819,NA,77,epirubicin,5,90,mg/m2,1,every 3 weeks,fixed
9848577,NA,78,epirubicin,1,10,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",NA
9848577,NA,78,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",fixed
9848577,NA,78,epirubicin,2,15,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",NA
9848577,NA,78,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",fixed
9848577,NA,78,epirubicin,3,20,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",NA
9848577,NA,78,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, 15 of a 28 day cycle",fixed
10949988,NA,79,doxorubicin,1,50,mg/m2,1,on day 1 every 3 weeks in six cycles,fixed
10949988,NA,79,paclitaxel,1,130,mg/m2,1,on day 2 every 3 weeks in six cycles,NA
10949988,NA,79,doxorubicin,2,50,mg/m2,1,on day 1 every 3 weeks in six cycles,fixed
10949988,NA,79,paclitaxel,2,160,mg/m2,1,on day 2 every 3 weeks in six cycles,NA
10949988,NA,79,doxorubicin,3,50,mg/m2,1,on day 1 every 3 weeks in six cycles,fixed
10949988,NA,79,paclitaxel,3,190,mg/m2,1,on day 2 every 3 weeks in six cycles,NA
10949988,NA,79,doxorubicin,4,50,mg/m2,1,on day 1 every 3 weeks in six cycles,fixed
10949988,NA,79,paclitaxel,4,220,mg/m2,1,on day 2 every 3 weeks in six cycles,NA
10949988,NA,79,doxorubicin,5,50,mg/m2,1,on day 1 every 3 weeks in six cycles,fixed
10949988,NA,79,paclitaxel,5,250,mg/m2,1,on day 2 every 3 weeks in six cycles,NA
9193334,NA,80,4'-epidoxorubicin,1,50,mg/m2,NA,on days 1 and 2 every 3 weeks,NA
9193334,NA,80,ifosfamide,1,1800,mg/m2/d,1,from days 1 to 5 every 3 weeks,fixed
9193334,NA,80,gm-csf,1,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9193334,NA,80,gm-csf,1,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9193334,NA,80,4'-epidoxorubicin,2,60,mg/m2,NA,on days 1 and 2 every 3 weeks,NA
9193334,NA,80,ifosfamide,2,1800,mg/m2/d,1,from days 1 to 5 every 3 weeks,fixed
9193334,NA,80,gm-csf,2,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9193334,NA,80,gm-csf,2,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9193334,NA,80,4'-epidoxorubicin,3,70,mg/m2,NA,on days 1 and 2 every 3 weeks,NA
9193334,NA,80,ifosfamide,3,1800,mg/m2/d,1,from days 1 to 5 every 3 weeks,fixed
9193334,NA,80,gm-csf,3,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9193334,NA,80,gm-csf,3,5,ug/kg,1,from days +6 to + 19 every 3 weeks,NA
9150898,NA,81,mitoxantrone,1,8,mg/m2,1,days 1 and 2 every 21 days,NA
9150898,NA,81,5-fluorouracil,1,350,mg/m2,1,on days 1–3 every 21 days,fixed
9150898,NA,81,leucovorin,1,300,mg,1,on days 1–3 every 21 days,fixed
9150898,NA,81,filgrastim,1,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,filgrastim,1,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,mitoxantrone,2,10,mg/m2,1,days 1 and 2 every 21 days,NA
9150898,NA,81,5-fluorouracil,2,350,mg/m2,1,on days 1–3 every 21 days,fixed
9150898,NA,81,leucovorin,2,300,mg,1,on days 1–3 every 21 days,fixed
9150898,NA,81,filgrastim,2,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,filgrastim,2,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,mitoxantrone,3,12,mg/m2,1,days 1 and 2 every 21 days,NA
9150898,NA,81,5-fluorouracil,3,350,mg/m2,1,on days 1–3 every 21 days,fixed
9150898,NA,81,leucovorin,3,300,mg,1,on days 1–3 every 21 days,fixed
9150898,NA,81,filgrastim,3,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,filgrastim,3,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,mitoxantrone,4,16,mg/m2,1,days 1 and 2 every 21 days,NA
9150898,NA,81,5-fluorouracil,4,350,mg/m2,1,on days 1–3 every 21 days,fixed
9150898,NA,81,leucovorin,4,300,mg,1,on days 1–3 every 21 days,fixed
9150898,NA,81,filgrastim,4,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,filgrastim,4,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,mitoxantrone,5,8,mg/m2,1,days 1 and 2 every 21 days,NA
9150898,NA,81,5-fluorouracil,5,350,mg/m2,1,on days 1–3 every 21 days,fixed
9150898,NA,81,leucovorin,5,300,mg,1,on days 1–3 every 21 days,fixed
9150898,NA,81,filgrastim,5,5,ug/kg,1,on days 4–13 every 21 days,fixed
9150898,NA,81,filgrastim,5,5,ug/kg,1,on days 4–13 every 21 days,fixed
9402167,NA,82,doxorubicin,1,90,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,cyclophosphamide,1,1000,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,g-csf,1,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,g-csf,1,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,doxorubicin,2,100,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,cyclophosphamide,2,2000,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,g-csf,2,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,g-csf,2,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,doxorubicin,3,110,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,cyclophosphamide,3,3000,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,g-csf,3,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,g-csf,3,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,doxorubicin,4,120,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,cyclophosphamide,4,4000,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,g-csf,4,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,g-csf,4,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,doxorubicin,5,110,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,cyclophosphamide,5,6000,mg/m2,1,on day 1 every 3 weeks,NA
9402167,NA,82,g-csf,5,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
9402167,NA,82,g-csf,5,15,ug/kg,1,"on days 3, 4 or 6 every 3 weeks",NA
10370782,NA,83,paclitaxel,3,210,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,3,60,mg/m2,1,over 48 hours followed by paclitaxel every 3 weeks,NA
10370782,NA,83,paclitaxel,2,180,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,2,60,mg/m2,1,over 48 hours followed by paclitaxel every 3 weeks,NA
10370782,NA,83,paclitaxel,1,150,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,1,60,mg/m2,1,over 48 hours followed by paclitaxel every 3 weeks,NA
10370782,NA,83,paclitaxel,0,125,mg/m2,1,over 24 hours followed by doxorubicin every 3 weeks,NA
10370782,NA,83,doxorubicin,0,60,mg/m2,1,over 48 hours every 3 weeks,NA
10370782,NA,83,paclitaxel,-1,125,mg/m2,1,over 24 hours followed by doxorubicin every 3 weeks,NA
10370782,NA,83,doxorubicin,-1,48,mg/m2,1,over 48 hours every 3 weeks,NA
10370782,NA,83,paclitaxel,-2,100,mg/m2,1,over 24 hours followed by doxorubicin every 3 weeks,NA
10370782,NA,83,doxorubicin,-2,48,mg/m2,1,over 48 hours every 3 weeks,NA
10370782,NA,83,paclitaxel,-3,100,mg/m2,1,over 24 hours followed by doxorubicin every 3 weeks,NA
10370782,NA,83,doxorubicin,-3,40,mg/m2,1,over 48 hours every 3 weeks,NA
10370782,NA,83,paclitaxel,-4,90,mg/m2,1,over 24 hours followed by doxorubicin every 3 weeks,NA
10370782,NA,83,doxorubicin,-4,36,mg/m2,1,over 48 hours every 3 weeks,NA
10370782,NA,83,paclitaxel,8,200,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,8,60,mg/m2,1,bolus dose before paclitaxel during the first two 21-day cycles,NA
10370782,NA,83,paclitaxel,7,175,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,7,60,mg/m2,1,bolus dose before paclitaxel during the first two 21-day cycles,NA
10370782,NA,83,paclitaxel,6,160,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,6,60,mg/m2,1,bolus dose before paclitaxel during the first two 21-day cycles,NA
10370782,NA,83,paclitaxel,5,160,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,5,50,mg/m2,1,bolus dose before paclitaxel during the first two 21-day cycles,NA
10370782,NA,83,paclitaxel,4,135,mg/m2,1,over 24 hours every 3 weeks,NA
10370782,NA,83,doxorubicin,4,50,mg/m2,1,bolus dose before paclitaxel during the first two 21-day cycles,NA
11244325,NA,84,paclitaxel,1,100,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,84,ifosfamide,1,1500,mg/m2,1,on days 4 and 5 every 3 weeks,NA
11244325,NA,84,paclitaxel,2,100,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,84,ifosfamide,2,2000,mg/m2,1,on days 4 and 5 every 3 weeks,NA
11244325,NA,84,paclitaxel,3,135,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,84,ifosfamide,3,2000,mg/m2,1,on days 4 and 5 every 3 weeks,NA
11244325,NA,84,paclitaxel,4,135,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,84,ifosfamide,4,2500,mg/m2,1,on days 4 and 5 every 3 weeks,NA
11244325,NA,85,paclitaxel,1,100,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,85,epirubicin,1,40,mg/m2,1,on day 4 every 3 weeks,NA
11244325,NA,85,paclitaxel,2,100,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,85,epirubicin,2,50,mg/m2,1,on day 4 every 3 weeks,NA
11244325,NA,85,paclitaxel,3,135,mg/m2,1,72-hour continuous infusion every 3 weeks,NA
11244325,NA,85,epirubicin,3,50,mg/m2,1,on day 4 every 3 weeks,NA
10509151,NA,86,cyclophosphamide,1,900,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,1,90,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,cyclophosphamide,2,1200,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,2,120,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,cyclophosphamide,3,1500,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,3,150,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,cyclophosphamide,4,1800,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,4,180,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,cyclophosphamide,5,1800,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,5,150,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,cyclophosphamide,6,2100,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,86,epirubicin,6,150,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,87,filgrastim,1,5,ug/kg,1,days 2-12 up to six cycles,NA
10509151,NA,87,filgrastim,1,5,ug/kg,1,days 2-12 up to six cycles,NA
10509151,NA,87,cyclophosphamide,1,1500,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,87,epirubicin,1,150,mg/m2,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,87,vincristine,1,2,mg,1,on day 1 every 21 days up to six cycles,NA
10509151,NA,87,prednisolone,1,100,mg,1,five days commencing on day 1 every 21 days up to six cycles,NA
9488597,NA,88,s9788,1,8,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,1,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,2,16,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,2,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,3,26,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,3,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,4,40,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,4,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,5,48,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,5,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,6,56,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,6,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,7,72,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,7,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,8,80,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,8,50,mg/m2,1,at days 8 every 3 weeks,NA
9488597,NA,88,s9788,9,96,mg/m2,1,at days 1  and 8 every 3 weeks,NA
9488597,NA,88,doxorubicin,9,50,mg/m2,1,at days 8 every 3 weeks,NA
10501914,NA,89,pnu 152243,1,59,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,2,118,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,3,235,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,4,470,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,5,700,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,6,820,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,7,940,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10501914,NA,89,pnu 152243,8,470,ug/m2,1,on day 1 to be repeated every 4 weeks,NA
10673526,NA,90,doxorubicin,1,30,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,gemcitabine,1,1000,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,ifosfamide,1,1500,mg/m2,1,days 1-3 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,paclitaxel,1,200,mg/m2,1,day 1 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,1,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,1,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,doxorubicin,2,30,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,gemcitabine,2,1500,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,ifosfamide,2,1500,mg/m2,1,days 1-3 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,paclitaxel,2,200,mg/m2,1,day 1 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,2,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,2,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,doxorubicin,3,30,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,gemcitabine,3,2000,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,ifosfamide,3,1500,mg/m2,1,days 1-3 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,paclitaxel,3,200,mg/m2,1,day 1 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,3,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,3,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,doxorubicin,4,40,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,gemcitabine,4,2000,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,ifosfamide,4,1500,mg/m2,1,days 1-3 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,paclitaxel,4,200,mg/m2,1,day 1 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,4,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,4,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,doxorubicin,5,50,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,gemcitabine,5,2000,mg/m2,1,On day 1 of each 2-week cycle for 6 cycles,AG chemotherapy
10673526,NA,90,ifosfamide,5,1500,mg/m2,1,days 1-3 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,paclitaxel,5,200,mg/m2,1,day 1 every 3 weeks for four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,5,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
10673526,NA,90,cisplatin,5,70,mg/m2,1,day 1 every 3 weeksfor four cycles,ITP chemotherapy after AG chemotherapy
9789611,NA,91,ifosfamide,1,12000,mg/m2,1,a continuous infusion over five days every 3 weeks,NA
9789611,NA,91,doxorubicin,1,25,mg/m2,1,on two days every 3 weeks,NA
9789611,NA,91,ifosfamide,2,12000,mg/m2,1,a continuous infusion over five days every 3 weeks,NA
9789611,NA,91,doxorubicin,2,30,mg/m2,1,on three days every 3 weeks,NA
9789611,NA,91,ifosfamide,3,12000,mg/m2,1,a continuous infusion over five days every 3 weeks,NA
9789611,NA,91,doxorubicin,3,30,mg/m2,1,on three days every 3 weeks,NA
9789611,NA,91,ifosfamide,4,10000,mg/m2,1,a continuous infusion over five days every 3 weeks,NA
9789611,NA,91,doxorubicin,4,25,mg/m2,1,on three days every 3 weeks,NA
9789611,NA,91,ifosfamide,5,10000,mg/m2,1,a continuous infusion over five days every 3 weeks,NA
9789611,NA,91,doxorubicin,5,30,mg/m2,1,on three days every 3 weeks,NA
9443614,NA,92,fluorouracil,1,500,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,doxorubicin,1,50,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,vinorelbine,1,15,mg/m2,1,"on days 1, 8 and 15 every 3 weeks",NA
9443614,NA,92,fluorouracil,2,500,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,doxorubicin,2,50,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,vinorelbine,2,15,mg/m2,1,"on days 1, 8 every 3 weeks",NA
9443614,NA,92,fluorouracil,3,500,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,doxorubicin,3,50,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,vinorelbine,3,20,mg/m2,1,"on days 1, 8 every 3 weeks",NA
9443614,NA,92,fluorouracil,4,500,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,doxorubicin,4,50,mg/m2,1,on day 1 every 3 weeks,NA
9443614,NA,92,vinorelbine,4,25,mg/m2,1,"on days 1, 8 every 3 weeks",NA
9443614,NA,93,fluorouracil,1,340,mg/m2,1,"on days 1, 2, 3, 4 and 5 every 4 weeks",NA
9443614,NA,93,doxorubicin,1,40,mg/m2,1,on day 1 every 4 weeks,NA
9443614,NA,93,vinorelbine,1,15,mg/m2,1,on days 1 and 5 every 4 weeks,NA
9443614,NA,93,folinic acid,1,200,mg/m2,1,"on days 1, 2, 3, 4 and 5 every 4 weeks",NA
9443614,NA,93,fluorouracil,2,340,mg/m2,1,"on days 1, 2, 3, 4 and 5 every 4 weeks",NA
9443614,NA,93,doxorubicin,2,40,mg/m2,1,on day 1 every 4 weeks,NA
9443614,NA,93,vinorelbine,2,20,mg/m2,1,on days 1 and 5 every 4 weeks,NA
9443614,NA,93,folinic acid,2,200,mg/m2,1,"on days 1, 2, 3, 4 and 5 every 4 weeks",NA
10811502,NA,94,caelyx,1,30,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,1,30,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,2,35,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,2,35,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,3,40,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,3,40,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,4,45,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,4,45,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,5,50,mg/m2,1,every 21 days,NA
10811502,NA,94,caelyx,5,50,mg/m2,1,every 21 days,NA
11187897,NA,95,cinchonine,1,15,mg/kg/d,1,"a continuous i.v. infusion from day 1 to day 3, over a 48-h period every 28 days",NA
11187897,NA,95,cyclophosphamide,1,600,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,doxorubicin,1,25,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,vinblastine,1,6,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,methylprednisolone,1,1,mg/kg/d,1,on days 2 and 3 and further given per os from days 4 to 6 every 28 days,NA
11187897,NA,95,cinchonine,2,20,mg/kg/d,1,"a continuous i.v. infusion from day 1 to day 3, over a 48-h period every 28 days",NA
11187897,NA,95,cyclophosphamide,2,600,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,doxorubicin,2,25,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,vinblastine,2,6,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,methylprednisolone,2,1,mg/kg/d,1,on days 2 and 3 and further given per os from days 4 to 6 every 28 days,NA
11187897,NA,95,cinchonine,3,25,mg/kg/d,1,"a continuous i.v. infusion from day 1 to day 3, over a 48-h period every 28 days",NA
11187897,NA,95,cyclophosphamide,3,600,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,doxorubicin,3,25,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,vinblastine,3,6,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,methylprednisolone,3,1,mg/kg/d,1,on days 2 and 3 and further given per os from days 4 to 6 every 28 days,NA
11187897,NA,95,cinchonine,4,30,mg/kg/d,1,"a continuous i.v. infusion from day 1 to day 3, over a 48-h period every 28 days",NA
11187897,NA,95,cyclophosphamide,4,600,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,doxorubicin,4,25,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,vinblastine,4,6,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,methylprednisolone,4,1,mg/kg/d,1,on days 2 and 3 and further given per os from days 4 to 6 every 28 days,NA
11187897,NA,95,cinchonine,5,35,mg/kg/d,1,"a continuous i.v. infusion from day 1 to day 3, over a 48-h period every 28 days",NA
11187897,NA,95,cyclophosphamide,5,600,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,doxorubicin,5,25,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,vinblastine,5,6,mg/m2,1,on day 2 every 28 days,NA
11187897,NA,95,methylprednisolone,5,1,mg/kg/d,1,on days 2 and 3 and further given per os from days 4 to 6 every 28 days,NA
10037175,NA,96,edatrexate,1,180,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,1,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,2,210,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,2,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,3,240,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,3,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,4,270,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,4,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,5,300,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,5,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,6,350,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,6,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10037175,NA,96,edatrexate,7,400,mg/m2,1,on day 1 every 21 days,NA
10037175,NA,96,paclitaxel,7,175,mg/m2,1,24 h after edatrexate every 21 days,fixed
10394119,NA,97,epirubicin,1,120,mg/m2,1,every 3 weeks,NA
10394119,NA,97,epirubicin,2,135,mg/m2,1,every 3 weeks,NA
10394119,NA,97,epirubicin,3,150,mg/m2,1,every 3 weeks,NA
10394119,NA,97,epirubicin,4,180,mg/m2,1,every 3 weeks,NA
10394119,NA,97,epirubicin,5,200,mg/m2,1,every 3 weeks,NA
11127949,NA,98,annamycin,1,150,mg/m2,1,every 3 weeks,NA
11127949,NA,98,annamycin,2,180,mg/m2,1,every 3 weeks,NA
11127949,NA,98,annamycin,3,210,mg/m2,1,every 3 weeks,NA
11127949,NA,98,annamycin,4,240,mg/m2,1,every 3 weeks,NA
9164225,NA,99,liposome-encapsulated doxorubicin,1,75,mg/m2,1,every 2 weeks,NA
9164225,NA,99,g-csf,1,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,g-csf,1,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,liposome-encapsulated doxorubicin,2,90,mg/m2,1,every 2 weeks,NA
9164225,NA,99,g-csf,2,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,g-csf,2,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,liposome-encapsulated doxorubicin,3,105,mg/m2,1,every 2 weeks,NA
9164225,NA,99,g-csf,3,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,g-csf,3,0,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,liposome-encapsulated doxorubicin,4,105,mg/m2,1,every 2 weeks,NA
9164225,NA,99,g-csf,4,5,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,g-csf,4,5,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,liposome-encapsulated doxorubicin,5,120,mg/m2,1,every 2 weeks,NA
9164225,NA,99,g-csf,5,5,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9164225,NA,99,g-csf,5,5,ug/kg,1,"started on day 5 of each 2-week cycle and administered until the recovering absolute neutrophil count (ANC) was greater than 1,500/uL",NA
9037361,NA,100,cyclophosphamide,1,500,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,epirubicin,1,37.5,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,vincristine,1,2,mg,1,Day 1-5 every 3 weeks,fixed
9037361,NA,100,prednisolone,1,75,mg/m2,1,on days 1-5 every 3 weeks,fixed
9037361,NA,100,filgrastim,1,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,1,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,1,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
9037361,NA,100,filgrastim,1,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
9037361,NA,100,cyclophosphamide,2,750,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,epirubicin,2,50,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,vincristine,2,2,mg,1,Day 1-5 every 3 weeks,fixed
9037361,NA,100,prednisolone,2,75,mg/m2,1,on days 1-5 every 3 weeks,fixed
9037361,NA,100,filgrastim,2,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,2,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,2,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
9037361,NA,100,filgrastim,2,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
9037361,NA,100,cyclophosphamide,3,1000,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,epirubicin,3,62.5,mg/m2,1,on day 1 every 3 weeks,NA
9037361,NA,100,vincristine,3,2,mg,1,Day 1-5 every 3 weeks,fixed
9037361,NA,100,prednisolone,3,75,mg/m2,1,on days 1-5 every 3 weeks,fixed
9037361,NA,100,filgrastim,3,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,3,1,ug/kg,1,"prior to the first cycle of chemotherapy, daily for 3-7 days to assess neutrophil response,",fixed
9037361,NA,100,filgrastim,3,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
9037361,NA,100,filgrastim,3,10,ug/kg,1,"followed by CEOP  daily, day 2-14, continued if the absolute neutrophil count (ANC) <1.2x 109/l",fixed
10445421,NA,101,mitoxantrone,1,13,mg/m2,1,every 28 days,NA
10445421,NA,101,mitoxantrone,2,15,mg/m2,1,every 28 days,NA
10445421,NA,101,mitoxantrone,3,19,mg/m2,1,every 28 days,NA
10445421,NA,101,mitoxantrone,4,25,mg/m2,1,every 28 days,NA
10445421,NA,101,mitoxantrone,5,31,mg/m2,1,every 28 days,NA
10445421,NA,101,mitoxantrone,6,39,mg/m2,1,every 28 days,NA
29719113,NCT02171260,102,eribulin,1,1.1,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
29719113,NCT02171260,102,eribulin,2,1.4,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
29719113,NCT02171260,102,eribulin,3,1.8,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
34773474,NCT02206763,103,momelotinib,1,100,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,1,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,1,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,momelotinib,2,200,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,2,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,2,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,momelotinib,2.5,100,mg,2,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,2.5,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,2.5,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,momelotinib,3,150,mg,2,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,3,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,3,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,momelotinib,4,200,mg,2,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,4,NA,mg,1,daily every 28 days,NA
34773474,NCT02206763,103,erlotinib,4,NA,mg,1,daily every 28 days,NA
6957420,NA,104,aclacinomycina,1,10,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,2,15,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,3,16,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,4,20,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,5,22,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,6,25,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
6957420,NA,104,aclacinomycina,7,30,mg/m2,1,Five-Consecutive-Day every 4 weeks,NA
26554651,NCT00410553,105,eribulin mesylate,1,0.7,mg/m2,1,"on day 1, 8, and 15 for the 28-day schedule",NA
26554651,NCT00410553,105,gemcitabine,1,800,mg/m2,1,"on day 1, 8, and 15 for the 28-day schedule",NA
26554651,NCT00410553,105,eribulin mesylate,1.5,0.7,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,gemcitabine,1.5,800,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,eribulin mesylate,2,0.7,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,gemcitabine,2,1000,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,eribulin mesylate,3,1,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,gemcitabine,3,1000,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,eribulin mesylate,4,1.4,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
26554651,NCT00410553,105,gemcitabine,4,1000,mg/m2,1,on day 1 and 8 for the 21-day schedule,NA
25654665,"UMIN-CTR, UMIN 000009716",106,eribulin,1,1.1,mg/m2,1,on days 1 and 8 every 3 weeks,NA
25654665,"UMIN-CTR, UMIN 000009716",106,s-1,1,65,mg/m2,2,on days 1–14 every 3 weeks,NA
25654665,"UMIN-CTR, UMIN 000009716",106,eribulin,2,1.4,mg/m2,1,on days 1 and 8 every 3 weeks,NA
25654665,"UMIN-CTR, UMIN 000009716",106,s-1,2,65,mg/m2,2,on days 1–14 every 3 weeks,NA
25654665,"UMIN-CTR, UMIN 000009716",106,eribulin,3,1.4,mg/m2,1,on days 1 and 8 every 3 weeks,NA
25654665,"UMIN-CTR, UMIN 000009716",106,s-1,3,80,mg/m2,2,on days 1–14 every 3 weeks,NA
19509177,NA,107,eribulin mesylate,1,0.25,mg/m2,1,"on days1, 8, and 15 of a 28-day cycle",NA
19509177,NA,107,eribulin mesylate,2,0.5,mg/m2,1,"on days1, 8, and 15 of a 28-day cycle",NA
19509177,NA,107,eribulin mesylate,3,0.7,mg/m2,1,"on days1, 8, and 15 of a 28-day cycle",NA
19509177,NA,107,eribulin mesylate,4,1,mg/m2,1,"on days1, 8, and 15 of a 28-day cycle",NA
19509177,NA,107,eribulin mesylate,5,1.4,mg/m2,1,"on days1, 8, and 15 of a 28-day cycle",NA
34468905,NCT02942095,108,ixazomib,1,3,mg,1,"on Days 1, 8, and 15 of a 28-day cycle",NA
34468905,NCT02942095,108,erlotinib,1,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
34468905,NCT02942095,108,erlotinib,1,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
34468905,NCT02942095,108,ixazomib,2,4,mg,1,"on Days 1, 8, and 15 of a 28-day cycle",NA
34468905,NCT02942095,108,erlotinib,2,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
34468905,NCT02942095,108,erlotinib,2,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
34468905,NCT02942095,108,ixazomib,3,5.3,mg,1,"on Days 1, 8, and 15 of a 28-day cycle",NA
34468905,NCT02942095,108,erlotinib,3,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
34468905,NCT02942095,108,erlotinib,3,150,mg,1,on Days 1 - 28 of a 29 day cycle,NA
12477447,NA,109,topotecan,1,2,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,1,2,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,1,60,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,2,2.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,2,2.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,2,85,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,3,3,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,3,3,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,3,80,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,4,3.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,4,3.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,4,90,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,5,4,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,5,4,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,5,100,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,6,4.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,topotecan,6,4.5,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
12477447,NA,109,paclitaxel,6,110,mg/m2,1,"on Days 0, 7, and 14 every 3 weeks",NA
30703739,UMIN00009498,110,olaparib,1,25,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,1,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,2,50,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,2,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,3,75,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,3,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,4,100,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,4,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,5,150,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,5,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,6,200,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,6,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
30703739,UMIN00009498,110,olaparib,7,300,mg,2,daily,NA
30703739,UMIN00009498,110,eribulin,7,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
26943987,EudraCT number: 2014-000135-17,111,eribulin mesylate,1,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,1,2.5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,1,2.5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,eribulin mesylate,2,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,2,5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,2,5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,eribulin mesylate,3,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,3,7.5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,3,7.5,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,eribulin mesylate,4,1.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,4,10,mg,1,daily,NA
26943987,EudraCT number: 2014-000135-17,111,everolimus,4,10,mg,1,daily,NA
3367191,NA,113,doxorubicin,1,60,mg/m2,1,96-hour continuous infusion on days 2 through 5 every 21 to 28 days,NA
3367191,NA,113,trifluoperazine,1,5,mg,4,on days 1 through 6 every 21 to 28 days,NA
3367191,NA,113,doxorubicin,2,60,mg/m2,1,96-hour continuous infusion on days 2 through 5 every 21 to 28 days,NA
3367191,NA,113,trifluoperazine,2,10,mg,4,on days 1 through 6 every 21 to 28 days,NA
3367191,NA,113,doxorubicin,3,60,mg/m2,1,96-hour continuous infusion on days 2 through 5 every 21 to 28 days,NA
3367191,NA,113,trifluoperazine,3,15,mg,4,on days 1 through 6 every 21 to 28 days,NA
3367191,NA,113,doxorubicin,4,60,mg/m2,1,96-hour continuous infusion on days 2 through 5 every 21 to 28 days,NA
3367191,NA,113,trifluoperazine,4,20,mg,4,on days 1 through 6 every 21 to 28 days,NA
3367191,NA,113,doxorubicin,5,60,mg/m2,1,96-hour continuous infusion on days 2 through 5 every 21 to 28 days,NA
3367191,NA,113,trifluoperazine,5,25,mg,4,on days 1 through 6 every 21 to 28 days,NA
32943461,NCT02207504,114,crizotinib,1,250,mg,1,daily-28 day cycle,NA
32943461,NCT02207504,114,enzalutamide,1,160,mg,1,daily-28 day cycle,fixed
32943461,NCT02207504,114,crizotinib,2,200,mg,2,daily-28 day cycle,NA
32943461,NCT02207504,114,enzalutamide,2,160,mg,1,daily-28 day cycle,fixed
32943461,NCT02207504,114,crizotinib,3,250,mg,2,daily-28 day cycle,NA
32943461,NCT02207504,114,enzalutamide,3,160,mg,1,daily-28 day cycle,fixed
21887501,NCT00326950,115,eribulin,1,0.7,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
21887501,NCT00326950,115,eribulin,2,1,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
21887501,NCT00326950,115,eribulin,3,1.4,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
21887501,NCT00326950,115,eribulin,4,2,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
33926914,NCT03386942,116,morab-202,1,0.3,mg/kg,1,every 3 weeks (on day1),NA
33926914,NCT03386942,116,morab-202,2,0.45,mg/kg,1,every 3 weeks (on day1),NA
33926914,NCT03386942,116,morab-202,3,0.68,mg/kg,1,every 3 weeks (on day1),NA
33926914,NCT03386942,116,morab-202,4,0.9,mg/kg,1,every 3 weeks (on day1),NA
33926914,NCT03386942,116,morab-202,5,1.2,mg/kg,1,every 3 weeks (on day1),NA
26362045,NA,117,e7389,1,0.125,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,2,0.18,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,3,0.25,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,4,0.35,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,5,0.5,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,6,0.7,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,7,1,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,8,1.4,mg/m2,1,weekly for 3 weeks out of four,NA
26362045,NA,117,e7389,9,2,mg/m2,1,weekly for 3 weeks out of four,NA
9402745,NA,118,idarubicin,1,2,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,2,3,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,3,4,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,4,5,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,5,6,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,6,7,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,7,8,mg,2,daily for 21 days every two weeks,NA
9402745,NA,118,idarubicin,8,9,mg,2,daily for 21 days every two weeks,NA
25242374,NCT01432886,119,eribulin mesylate,1,1.4,mg/m2,1,on days 1 and 8 of every 3 week cycle,NA
25242374,NCT01432886,119,trastuzumab,1,4 mg/kg loading dose followed by 2 mg/kg,mg/kg,1,weekly,NA
25242374,NCT01432886,119,eribulin mesylate,2,NA,mg/m2,1,on days 1 and 8 of every 3 week cycle,NA
25242374,NCT01432886,119,trastuzumab,2,8 mg/kg loading dose followed by 6 mg/kg,mg/kg,1,tri-weekly,NA
30679780,NA,120,eribulin-lf,1,1,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,2,1.5,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,3,2,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,4,2.5,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,5,3,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,6,3.5,mg/m2,1,on day 1 every 21 days,schedule 1
30679780,NA,120,eribulin-lf,1.5,1,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
30679780,NA,120,eribulin-lf,2.5,1.5,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
30679780,NA,120,eribulin-lf,3.5,2,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
30679780,NA,120,eribulin-lf,4.5,2.5,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
30679780,NA,120,eribulin-lf,5.5,3,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
30679780,NA,120,eribulin-lf,6.5,3.5,mg/m2,1,on days 1 and 15 every 28 days,schedule 2
29468456,NCT01585870,121,eribulin mesylate,1,1.4,mg/m2,1,on days 1 and 8 of each 21-day cycle,fixed
29468456,NCT01585870,121,sorafenib,1,200,mg,2,daily initiated  on day 11 of the first 21-day cycle,NA
29468456,NCT01585870,121,eribulin mesylate,2,1.4,mg/m2,1,on days 1 and 8 of each 21-day cycle,fixed
29468456,NCT01585870,121,sorafenib,2,600 (200 mg am/400 mg pm),mg,2,daily initiated  on day 11 of the first 21-day cycle,NA
29468456,NCT01585870,121,eribulin mesylate,3,1.4,mg/m2,1,on days 1 and 8 of each 21-day cycle,fixed
29468456,NCT01585870,121,sorafenib,3,400,mg,2,daily initiated  on day 11 of the first 21-day cycle,NA
31703728,NCT02120469.,122,everolimus,1,5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,122,everolimus,1,5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,122,eribulin,1,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
31703728,NCT02120469.,122,everolimus,2,7.5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,122,everolimus,2,7.5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,122,eribulin,2,1.4,mg/m2,1,on days 1 and 8 every 21 days,NA
31703728,NCT02120469.,123,everolimus,1,5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,123,everolimus,1,5,mg,1,on days 1-21 every 21 days,NA
31703728,NCT02120469.,123,eribulin,1,1.1,mg/m2,1,on days 1 and 8 every 21 days,NA
31703728,NCT02120469.,123,dexamethasone,1,0.5,mg,4,on days 1-21 every 21 days,NA
6590530,NA,124,4-demethoxydaunorubicin,1,1.5,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,2,3,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,3,5,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,4,7.5,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,5,10.5,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,6,13.5,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,7,15,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,8,18,mg/m2,1,every 3 weeks,Intravenous route
6590530,NA,124,4-demethoxydaunorubicin,1.5,6,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,2.5,10,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,3.5,15,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,4.5,21,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,5.5,27,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,6.5,36,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,7.5,48,mg/m2,1,every 3 weeks,Oral route
6590530,NA,124,4-demethoxydaunorubicin,8.5,60,mg/m2,1,every 3 weeks,Oral route
19509146,NA,125,eribulin mesylate,1,0.25,mg/m2,1,every 21days,NA
19509146,NA,125,eribulin mesylate,2,0.5,mg/m2,1,every 21days,NA
19509146,NA,125,eribulin mesylate,3,1,mg/m2,1,every 21days,NA
19509146,NA,125,eribulin mesylate,4,2,mg/m2,1,every 21days,NA
19509146,NA,125,eribulin mesylate,5,2.8,mg/m2,1,every 21days,NA
19509146,NA,125,eribulin mesylate,6,4,mg/m2,1,every 21days,NA
25349975,NA,126,eribulin mesylate,1,0.7,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
25349975,NA,126,cisplatin,1,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,cisplatin,1,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,eribulin mesylate,2,1,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
25349975,NA,126,cisplatin,2,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,cisplatin,2,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,eribulin mesylate,3,1.2,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
25349975,NA,126,cisplatin,3,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,cisplatin,3,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,eribulin mesylate,4,1.4,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
25349975,NA,126,cisplatin,4,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,cisplatin,4,60,mg/m2,1,day 1 every 28-day cycle,NA
25349975,NA,126,eribulin mesylate,5,1.4,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
25349975,NA,126,cisplatin,5,60,mg/m2,1,day 1 every 21-day cycle,NA
25349975,NA,126,cisplatin,5,60,mg/m2,1,day 1 every 21-day cycle,NA
25349975,NA,126,eribulin mesylate,6,1.4,mg/m2,1,"on days 1, 8, and 15 every 21 days",NA
25349975,NA,126,cisplatin,6,75,mg/m2,1,day 1 every 21-day cycle,NA
25349975,NA,126,cisplatin,6,75,mg/m2,1,day 1 every 21-day cycle,NA
1963273,NA,127,pirarubicin,1,40,mg/m2,1,on day 1 every 3 weeks,NA
1963273,NA,127,etoposide,1,100,mg/m2,1,days 1-3 every 3 weeks,NA
1963273,NA,127,vincristine,1,2,mg,1,on day 1 every 3 weeks,NA
1963273,NA,127,pirarubicin,2,50,mg/m2,1,on day 1 every 3 weeks,NA
1963273,NA,127,etoposide,2,100,mg/m2,1,days 1-3 every 3 weeks,NA
1963273,NA,127,vincristine,2,2,mg,1,on day 1 every 3 weeks,NA
1963273,NA,127,pirarubicin,3,55,mg/m2,1,on day 1 every 3 weeks,NA
1963273,NA,127,etoposide,3,100,mg/m2,1,days 1-3 every 3 weeks,NA
1963273,NA,127,vincristine,3,2,mg,1,on day 1 every 3 weeks,NA
1963273,NA,127,pirarubicin,4,60,mg/m2,1,on day 1 every 3 weeks,NA
1963273,NA,127,etoposide,4,100,mg/m2,1,days 1-3 every 3 weeks,NA
1963273,NA,127,vincristine,4,2,mg,1,on day 1 every 3 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,1,5,mg/m2,1,weekly for 3-4 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,2,10,mg/m2,1,weekly for 3-4 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,3,12.5,mg/m2,1,weekly for 3-4 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,4,15,mg/m2,1,weekly for 3-4 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,5,17.5,mg/m2,1,weekly for 3-4 weeks,NA
6511241,NA,128,4' -deoxydoxorubicin,6,20,mg/m2,1,weekly for 3-4 weeks,NA
15886476,NA,129,cisplatin,1,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,1,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,1,0.75,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,1,0.75,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,2,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,2,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,2,0.9,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,2,0.9,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,3,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,3,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,3,1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,3,1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,4,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,4,25,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,4,1.15,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,topotecan,4,1.15,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule A
15886476,NA,129,cisplatin,-1,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,cisplatin,-1,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-1,1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-1,1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
15886476,NA,129,cisplatin,-2,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,cisplatin,-2,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-2,1.1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-2,1.1,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
15886476,NA,129,cisplatin,-3,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,cisplatin,-3,20,mg/m2,1,3 consecutive days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-3,1.2,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
15886476,NA,129,topotecan,-3,1.2,mg/m2,1,at the end of cisplatin infusion daily for 3 days every 3 or 4 weeks,Schedule B
24132922,NA,130,sorafenib,1,200,mg,1,initiated 14 days before the first cycle of chemotherapy; discontinued 1 week before surgery and resumed 1 week after surgery and then continued until the completion of postoperative chemotherapy,NA
24132922,NA,130,epirubicin,1,30,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,ifosfamide,1,2500,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,external beam hypofractionated radiotherapy,1,3.5,Gy,1,administered over 8 daily fractions during cycle 2,NA
24132922,NA,130,sorafenib,2,400,mg,1,initiated 14 days before the first cycle of chemotherapy; discontinued 1 week before surgery and resumed 1 week after surgery and then continued until the completion of postoperative chemotherapy,NA
24132922,NA,130,epirubicin,2,30,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,ifosfamide,2,2500,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,external beam hypofractionated radiotherapy,2,3.5,Gy,1,administered over 8 daily fractions during cycle 2,NA
24132922,NA,130,sorafenib,3,400,mg,2,initiated 14 days before the first cycle of chemotherapy; discontinued 1 week before surgery and resumed 1 week after surgery and then continued until the completion of postoperative chemotherapy,NA
24132922,NA,130,epirubicin,3,30,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,ifosfamide,3,2500,mg/m2,1,days 1–3 every 21 days for 3 preoperative and 3 postoperative cycles,NA
24132922,NA,130,external beam hypofractionated radiotherapy,3,3.5,Gy,1,administered over 8 daily fractions during cycle 2,NA
34036220,NCT01911507,131,capmatinib,1,100,mg,2,daily of a 28-day cycle,capsule
34036220,NCT01911507,131,erlotinib,1,100,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,1,100,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,2,100,mg,2,daily of a 28-day cycle,capsule
34036220,NCT01911507,131,erlotinib,2,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,2,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,3,200,mg,2,daily of a 28-day cycle,capsule
34036220,NCT01911507,131,erlotinib,3,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,3,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,4,400,mg,2,daily of a 28-day cycle,capsule
34036220,NCT01911507,131,erlotinib,4,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,4,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,5,600,mg,2,daily of a 28-day cycle,capsule
34036220,NCT01911507,131,erlotinib,5,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,5,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,6,400,mg,2,daily of a 28-day cycle,tablet
34036220,NCT01911507,131,erlotinib,6,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,6,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,capmatinib,6.5,200,mg,2,daily of a 28-day cycle,tablet
34036220,NCT01911507,131,erlotinib,6.5,150,mg,1,daily of a 28-day cycle,NA
34036220,NCT01911507,131,erlotinib,6.5,150,mg,1,daily of a 28-day cycle,NA
33235994,NA,132,sorafenib,-2,200,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,-2,75,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,-2,75,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,sorafenib,-1,200,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,-1,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,-1,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,sorafenib,0,200,mg,2,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,0,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,0,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,sorafenib,1,400,mg,2,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,1,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,1,100,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,sorafenib,2,400,mg,2,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,2,150,mg,1,daily every 4 weeks (28 days),NA
33235994,NA,132,erlotinib,2,150,mg,1,daily every 4 weeks (28 days),NA
32548867,NCT02642913,133,enzalutamide,1,160,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,enzalutamide,-1,120,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,sorafenib,-1,400,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,enzalutamide,1,160,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,sorafenib,1,400,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,enzalutamide,2,160,mg,1,Daily for 28-day cycles,NA
32548867,NCT02642913,134,sorafenib,2,400,mg,2,Daily for 28-day cycles,NA
31822498,NCT02457910,135,taselisib,1,2,mg,1,on days 1-28 every 28 days,NA
31822498,NCT02457910,135,enzalutamide,1,160,mg,1,on days 9-28 of course 1 and days 1-28 of subsequent courses every 28 days,NA
31822498,NCT02457910,135,taselisib,2,4,mg,1,on days 1-28 every 28 days,NA
31822498,NCT02457910,135,enzalutamide,2,160,mg,1,on days 9-28 of course 1 and days 1-28 of subsequent courses every 28 days,NA
31822498,NCT02457910,135,taselisib,3,6,mg,1,on days 1-28 every 28 days,NA
31822498,NCT02457910,135,enzalutamide,3,160,mg,1,on days 9-28 of course 1 and days 1-28 of subsequent courses every 28 days,NA
31822498,NCT02457910,135,taselisib,4,8,mg,1,on days 1-28 every 28 days,NA
31822498,NCT02457910,135,enzalutamide,4,160,mg,1,on days 9-28 of course 1 and days 1-28 of subsequent courses every 28 days,NA
18465342,NA,136,vinorelbine,1,25,mg/m2,1,on days 1 and 8 in a three weekly schedule,NA
18465342,NA,136,vinorelbine,2,30,mg/m2,1,on days 1 and 8 in a three weekly schedule,NA
18465342,NA,136,vinorelbine,3,35,mg/m2,1,on days 1 and 8 in a three weekly schedule,NA
18465342,NA,136,vinorelbine,4,40,mg/m2,1,on days 1 and 8 in a three weekly schedule,NA
25985977,NCT01642251,138,veliparib,1,60,mg,2,on days 1–7 of the cycle every 21 days,NA
25985977,NCT01642251,138,cisplatin,1,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,cisplatin,1,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,etoposide,1,100,mg/m2,1,on days 1–3 every 21 days,fixed
25985977,NCT01642251,138,veliparib,2,100,mg,2,on days 1–7 of the cycle every 21 days,NA
25985977,NCT01642251,138,cisplatin,2,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,cisplatin,2,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,etoposide,2,100,mg/m2,1,on days 1–3 every 21 days,fixed
25985977,NCT01642251,138,veliparib,-1,40,mg,2,on days 1–7 of the cycle every 21 days,NA
25985977,NCT01642251,138,cisplatin,-1,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,cisplatin,-1,75,mg/m2,1,on day 1 every 21 days,fixed
25985977,NCT01642251,138,etoposide,-1,100,mg/m2,1,on days 1–3 every 21 days,fixed
29980894,NCT00858377,139,amg 900,1,1,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,2,2,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,3,4,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,4,8,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,5,16,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,6,24,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,6.5,25,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,7,30,mg,1,4 days on/10 days off,NA
29980894,NCT00858377,139,amg 900,8,30,mg,1,4 days on/10 days off,with G-CSF support
29980894,NCT00858377,139,amg 900,9,35,mg,1,4 days on/10 days off,with G-CSF support
29980894,NCT00858377,139,amg 900,10,40,mg,1,4 days on/10 days off,with G-CSF support
29980894,NCT00858377,139,amg 900,11,50,mg,1,4 days on/10 days off,with G-CSF support
19956953,NA,140,erlotinib,1,25,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,1,25,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,2,50,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,2,50,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,3,75,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,3,75,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,4,100,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
19956953,NA,140,erlotinib,4,100,"mg,  mg/m2",1,iv infusion on day 1 and oral tablets on day 8,NA
23860642,NA,141,at-101,-1,20,mg,2,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,cisplatin,-1,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,cisplatin,-1,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,etoposide,-1,100,mg/m2,1,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,at-101,1,30,mg,2,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,cisplatin,1,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,cisplatin,1,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,etoposide,1,100,mg/m2,1,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,at-101,1.5,30,mg,2,on days 1-3 of a 21 day cycle,"with filgastrim 6 mg subcutaneously on
day 5 of cycle 1 and on day 4 of all subsequent cycles"
23860642,NA,141,cisplatin,1.5,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,cisplatin,1.5,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,etoposide,1.5,100,mg/m2,1,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,at-101,2,30,mg,2,on days 1-3 of a 21 day cycle,"with filgastrim 6 mg subcutaneously on
day 5 of cycle 1 and on day 4 of all subsequent cycles"
23860642,NA,141,cisplatin,2,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,cisplatin,2,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,etoposide,2,120,mg/m2,1,on days 1-3 of a 21 day cycle,NA
23860642,NA,141,at-101,3,40,mg,2,on days 1-3 of a 21 day cycle,"with filgastrim 6 mg subcutaneously on
day 5 of cycle 1 and on day 4 of all subsequent cycles"
23860642,NA,141,cisplatin,3,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,cisplatin,3,60,mg/m2,1,on day 1 of a 21 day cycle,NA
23860642,NA,141,etoposide,3,120,mg/m2,1,on days 1-3 of a 21 day cycle,NA
26376115,NCT01279096,142,clofarabine,1,20,mg/m2,1,on days 1-5 every 14 days,NA
26376115,NCT01279096,142,mitoxantrone,1,8,mg/m2,1,on days 3-4 every 14 days,fixed
26376115,NCT01279096,142,etoposide,1,150,mg/m2,1,on days 3-5 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,1,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,1,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,dexamethasone,1,20,mg/m2,1,on days 1-5 every 14 days,fixed
26376115,NCT01279096,142,clofarabine,2,26,mg/m2,1,on days 1-5 every 14 days,NA
26376115,NCT01279096,142,mitoxantrone,2,8,mg/m2,1,on days 3-4 every 14 days,fixed
26376115,NCT01279096,142,etoposide,2,150,mg/m2,1,on days 3-5 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,2,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,2,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,dexamethasone,2,20,mg/m2,1,on days 1-5 every 14 days,fixed
26376115,NCT01279096,142,clofarabine,3,32,mg/m2,1,on days 1-5 every 14 days,NA
26376115,NCT01279096,142,mitoxantrone,3,8,mg/m2,1,on days 3-4 every 14 days,fixed
26376115,NCT01279096,142,etoposide,3,150,mg/m2,1,on days 3-5 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,3,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,3,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,dexamethasone,3,20,mg/m2,1,on days 1-5 every 14 days,fixed
26376115,NCT01279096,142,dexamethasone,4,20,mg/m2,1,on days 1-5 every 14 days,fixed
26376115,NCT01279096,142,clofarabine,4,40,mg/m2,1,on days 1-5 every 14 days,NA
26376115,NCT01279096,142,mitoxantrone,4,8,mg/m2,1,on days 3-4 every 14 days,fixed
26376115,NCT01279096,142,etoposide,4,150,mg/m2,1,on days 3-5 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,4,10000,IU/m2/d,1,on day 7 every 14 days,fixed
26376115,NCT01279096,142,asparaginase,4,10000,IU/m2/d,1,on day 7 every 14 days,fixed
17878176,NA,143,erlotinib,1,100,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,erlotinib,1,100,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,gemcitabine,1,40,mg/m2,1,on a twice weekly eigher Monday/Thursday or Tuesday/Friday schedule beginning on day 1 or day 2,NA
17878176,NA,143,radiation,1,180,cGy,1,"beginning on day 1, in 28 fractions over 5.5 weeks for a total of 5040 cGy",NA
17878176,NA,143,erlotinib,2,125,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,erlotinib,2,125,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,gemcitabine,2,40,mg/m2,1,on a twice weekly eigher Monday/Thursday or Tuesday/Friday schedule beginning on day 1 or day 2,NA
17878176,NA,143,radiation,2,180,cGy,1,"beginning on day 1, in 28 fractions over 5.5 weeks for a total of 5040 cGy",NA
17878176,NA,143,erlotinib,3,150,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,erlotinib,3,150,mg,1,"daily continuously throughout the radiation period, beginning on day 1",NA
17878176,NA,143,gemcitabine,3,40,mg/m2,1,on a twice weekly eigher Monday/Thursday or Tuesday/Friday schedule beginning on day 1 or day 2,NA
17878176,NA,143,radiation,3,180,cGy,1,"beginning on day 1, in 28 fractions over 5.5 weeks for a total of 5040 cGy",NA
29119643,NCT01681537,144,lenalidomide,1.5,10,mg,1,daily on days 1–10 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,1.5,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,1.5,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,1.5,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,lenalidomide,-1.5,5,mg,1,daily on days 1–10 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,-1.5,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,-1.5,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,-1.5,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,lenalidomide,1,10,mg,1,daily on days 1–14 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,1,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,1,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,1,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,lenalidomide,-1,5,mg,1,daily on days 1–14 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,-1,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,-1,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,-1,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,lenalidomide,2,25,mg,1,daily on days 1–10 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,2,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,2,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,2,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,lenalidomide,3,50,mg,1,daily on days 1–10 of 14-day treatment,NA
29119643,NCT01681537,144,mitoxantrone,3,8,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,etoposide,3,100,mg/m2,1,on days 4-8 of 14-day treament,NA
29119643,NCT01681537,144,cytarabine,3,1000,mg/m2,1,on days 4-8 of 14-day treament,NA
12544260,NA,145,paclitaxel,1,40,mg/m2,1,on days 3 and 8 every 3 weeks,NA
12544260,NA,145,estramustine phosphate,1,300,mg/m2,3,on days 1–3 and 8–10 every 3 weeks,fixed
12544260,NA,145,vinorelbine,1,20,mg/m2,1,on days 3 and 10 every 3 weeks,NA
12544260,NA,145,paclitaxel,2,50,mg/m2,1,on days 3 and 8 every 3 weeks,NA
12544260,NA,145,estramustine phosphate,2,300,mg/m2,3,on days 1–3 and 8–10 every 3 weeks,fixed
12544260,NA,145,vinorelbine,2,20,mg/m2,1,on days 3 and 10 every 3 weeks,NA
12544260,NA,145,paclitaxel,3,50,mg/m2,1,on days 3 and 8 every 3 weeks,NA
12544260,NA,145,estramustine phosphate,3,300,mg/m2,3,on days 1–3 and 8–10 every 3 weeks,fixed
12544260,NA,145,vinorelbine,3,25,mg/m2,1,on days 3 and 10 every 3 weeks,NA
12544260,NA,145,paclitaxel,4,60,mg/m2,1,on days 3 and 8 every 3 weeks,NA
12544260,NA,145,estramustine phosphate,4,300,mg/m2,3,on days 1–3 and 8–10 every 3 weeks,fixed
12544260,NA,145,vinorelbine,4,25,mg/m2,1,on days 3 and 10 every 3 weeks,NA
23370364,NCT00537511,146,pomalidomide,1,1,mg,1,on days 1 to 14 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,1,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,1,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,etoposide,1,100,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,pomalidomide,2,3,mg,1,on days 1 to 14 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,2,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,2,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,etoposide,2,100,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,pomalidomide,3,4,mg,1,on days 1 to 14 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,3,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,3,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,etoposide,3,100,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,pomalidomide,4,5,mg,1,on days 1 to 14 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,4,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,cisplatin,4,25,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
23370364,NCT00537511,146,etoposide,4,100,mg/m2,1,on days 1 to 3 of each 21-day cycle,NA
26920889,NCT01411267,147,quizartinib,1,25,mg/m2,1,daily on days 7–28 every 28 days,NA
26920889,NCT01411267,147,cytarabine,1,1000,mg/m2,2,on days 1–5 every 28 days,NA
26920889,NCT01411267,147,etoposide,1,150,mg/m2,1,on days 1–5 every 28 days,NA
26920889,NCT01411267,147,quizartinib,2,40,mg/m2,1,daily on days 7–28 every 28 days,NA
26920889,NCT01411267,147,cytarabine,2,1000,mg/m2,2,on days 1–5 every 28 days,NA
26920889,NCT01411267,147,etoposide,2,150,mg/m2,1,on days 1–5 every 28 days,NA
26920889,NCT01411267,147,quizartinib,3,60,mg/m2,1,daily on days 7–28 every 28 days,NA
26920889,NCT01411267,147,cytarabine,3,1000,mg/m2,2,on days 1–5 every 28 days,NA
26920889,NCT01411267,147,etoposide,3,150,mg/m2,1,on days 1–5 every 28 days,NA
31876107,NCT01331135,148,sirolimus,1,1,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,sirolimus,1,1,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,celecoxib,1,100,mg,2,daily in 6-week cycle,NA
31876107,NCT01331135,148,etoposide,1,50,mg/m2,1,alternating every 21 days cyclophosphamideevery in 42-day cycles,NA
31876107,NCT01331135,148,cyclophosphamide,1,2.5,mg/kg,1,every 21 days in 42-day cycles,NA
31876107,NCT01331135,148,sirolimus,2,1.5,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,sirolimus,2,1.5,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,celecoxib,2,100,mg,2,daily in 6-week cycle,NA
31876107,NCT01331135,148,etoposide,2,50,mg/m2,1,alternating every 21 days cyclophosphamideevery in 42-day cycles,NA
31876107,NCT01331135,148,cyclophosphamide,2,2.5,mg/kg,1,every 21 days in 42-day cycles,NA
31876107,NCT01331135,148,sirolimus,3,2,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,sirolimus,3,2,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,celecoxib,3,100,mg,2,daily in 6-week cycle,NA
31876107,NCT01331135,148,etoposide,3,50,mg/m2,1,alternating every 21 days cyclophosphamideevery in 42-day cycles,NA
31876107,NCT01331135,148,cyclophosphamide,3,2.5,mg/kg,1,every 21 days in 42-day cycles,NA
31876107,NCT01331135,148,sirolimus,4,2.5,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,sirolimus,4,2.5,mg/m2,1,daily in 6-week cycle,NA
31876107,NCT01331135,148,celecoxib,4,100,mg,2,daily in 6-week cycle,NA
31876107,NCT01331135,148,etoposide,4,50,mg/m2,1,alternating every 21 days cyclophosphamideevery in 42-day cycles,NA
31876107,NCT01331135,148,cyclophosphamide,4,2.5,mg/kg,1,every 21 days in 42-day cycles,NA
20150371,NA,149,erlotinib,1,150,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,1,150,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,2,200,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,2,200,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,3,275,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,3,275,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,4,400,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,4,400,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,5,525,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,5,525,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,6,650,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,6,650,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,7,775,mg,1,daily in 28-day cycles,NA
20150371,NA,149,erlotinib,7,775,mg,1,daily in 28-day cycles,NA
20965266,NA,150,etoposide,1,60,mg/kg,1,on day -8,fixed
20965266,NA,150,cyclophosphamide,1,100,mg/kg,1,on day -6,fixed
20965266,NA,150,clofarabine,1,30,mg/kg,1,on days -6 to -2,NA
20965266,NA,150,etoposide,2,60,mg/kg,1,on day -8,fixed
20965266,NA,150,cyclophosphamide,2,100,mg/kg,1,on day -6,fixed
20965266,NA,150,clofarabine,2,40,mg/kg,1,on days -6 to -2,NA
20965266,NA,150,etoposide,3,60,mg/kg,1,on day -8,fixed
20965266,NA,150,cyclophosphamide,3,100,mg/kg,1,on day -6,fixed
20965266,NA,150,clofarabine,3,50,mg/kg,1,on days -6 to -2,NA
20965266,NA,150,etoposide,4,60,mg/kg,1,on day -8,fixed
20965266,NA,150,cyclophosphamide,4,100,mg/kg,1,on day -6,fixed
20965266,NA,150,clofarabine,4,60,mg/kg,1,on days -6 to -2,NA
20965266,NA,150,etoposide,5,60,mg/kg,1,on day -8,fixed
20965266,NA,150,cyclophosphamide,5,100,mg/kg,1,on day -6,fixed
20965266,NA,150,clofarabine,5,70,mg/kg,1,on days -6 to -2,NA
27565909,NCT01579929,151,sonidegib,1,400,mg,1,daily from day 1 in 21-day cycles,NA
27565909,NCT01579929,151,etoposide,1,120,mg/m2,1,on days 1-3 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,1,60,mg/m2,1,on day 1 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,1,60,mg/m2,1,on day 1 in 21-day cycles,NA
27565909,NCT01579929,151,sonidegib,2,800,mg,1,daily from day 1 in 21-day cycles,NA
27565909,NCT01579929,151,etoposide,2,120,mg/m2,1,on days 1-3 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,2,60,mg/m2,1,on day 1 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,2,60,mg/m2,1,on day 1 in 21-day cycles,NA
27565909,NCT01579929,151,sonidegib,-1,200,mg,1,daily from day 1 in 21-day cycles,NA
27565909,NCT01579929,151,etoposide,-1,120,mg/m2,1,on days 1-3 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,-1,60,mg/m2,1,on day 1 in 21-day cycles,NA
27565909,NCT01579929,151,cisplatin,-1,60,mg/m2,1,on day 1 in 21-day cycles,NA
11391583,NA,152,paclitaxel,1,40,mg/m2,1,weekly for a minimum of 12 consecutive weeks of therapy with a break on Week 7,NA
11391583,NA,152,estramustine,1,600,mg/m2,1,"Two days preceding the paclitaxel infusion, patients began a 3-day course of oral estramustine given in three divided doses 1 hour before or 2 hours after meals.",NA
11391583,NA,152,paclitaxel,2,60,mg/m2,1,weekly for a minimum of 12 consecutive weeks of therapy with a break on Week 7,NA
11391583,NA,152,estramustine,2,900,mg/m2,1,"Two days preceding the paclitaxel infusion, patients began a 3-day course of oral estramustine given in three divided doses 1 hour before or 2 hours after meals.",NA
11391583,NA,152,paclitaxel,3,75,mg/m2,1,weekly for a minimum of 12 consecutive weeks of therapy with a break on Week 7,NA
11391583,NA,152,estramustine,3,900,mg/m2,1,"Two days preceding the paclitaxel infusion, patients began a 3-day course of oral estramustine given in three divided doses 1 hour before or 2 hours after meals.",NA
11391583,NA,152,paclitaxel,4,90,mg/m2,1,weekly for a minimum of 12 consecutive weeks of therapy with a break on Week 7,NA
11391583,NA,152,estramustine,4,900,mg/m2,1,"Two days preceding the paclitaxel infusion, patients began a 3-day course of oral estramustine given in three divided doses 1 hour before or 2 hours after meals.",NA
24368401,NCT00466466,153,everolimus,1,2.5,mg,1,daily starting on day 2 of cycle 1,NA
24368401,NCT00466466,153,everolimus,1,2.5,mg,1,daily starting on day 2 of cycle 1,NA
24368401,NCT00466466,153,cisplatin,1,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,cisplatin,1,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,etoposide,1,100,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,everolimus,2,5,mg,1,daily starting on day 2 of cycle 1,NA
24368401,NCT00466466,153,everolimus,2,5,mg,1,daily starting on day 2 of cycle 1,NA
24368401,NCT00466466,153,cisplatin,2,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,cisplatin,2,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,etoposide,2,100,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,everolimus,1.5,2.5,mg,1,daily starting on day 2 of cycle 1,with G-CSF
24368401,NCT00466466,153,everolimus,1.5,2.5,mg,1,daily starting on day 2 of cycle 1,with G-CSF
24368401,NCT00466466,153,cisplatin,1.5,75,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,cisplatin,1.5,75,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,etoposide,1.5,100,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,everolimus,2.5,5,mg,1,daily starting on day 2 of cycle 1,with G-CSF
24368401,NCT00466466,153,everolimus,2.5,5,mg,1,daily starting on day 2 of cycle 1,with G-CSF
24368401,NCT00466466,153,cisplatin,2.5,75,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,cisplatin,2.5,75,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,etoposide,2.5,100,mg/m2,1,on days 1 and 1–3 every 21 days,with G-CSF
24368401,NCT00466466,153,everolimus,3,20,mg,1,"on days 2, 8, and 15 of cycle 1 and days 1, 8, and 15 of every cycle thereafter",NA
24368401,NCT00466466,153,everolimus,3,20,mg,1,"on days 2, 8, and 15 of cycle 1 and days 1, 8, and 15 of every cycle thereafter",NA
24368401,NCT00466466,153,cisplatin,3,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,cisplatin,3,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,etoposide,3,100,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,everolimus,4,30,mg,1,"on days 2, 8, and 15 of cycle 1 and days 1, 8, and 15 of every cycle thereafter",NA
24368401,NCT00466466,153,everolimus,4,30,mg,1,"on days 2, 8, and 15 of cycle 1 and days 1, 8, and 15 of every cycle thereafter",NA
24368401,NCT00466466,153,cisplatin,4,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,cisplatin,4,75,mg/m2,1,on days 1 and 1–3 every 21 days,NA
24368401,NCT00466466,153,etoposide,4,100,mg/m2,1,on days 1 and 1–3 every 21 days,NA
20922800,NCT00569114,154,apricoxib,1,100,mg,1,daily,NA
20922800,NCT00569114,154,erlotinib,1,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
20922800,NCT00569114,154,erlotinib,1,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
20922800,NCT00569114,154,apricoxib,2,200,mg,1,daily,NA
20922800,NCT00569114,154,erlotinib,2,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
20922800,NCT00569114,154,erlotinib,2,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
20922800,NCT00569114,154,apricoxib,3,400,mg,1,daily,NA
20922800,NCT00569114,154,erlotinib,3,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
20922800,NCT00569114,154,erlotinib,3,150,mg,1,on day 8 of cycle 1. Each cycle was 28 days.,fixed
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,-1,20,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,-1,50,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,-1,200,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,0,20,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,0,50,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,0,340,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,1,20,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,1,75,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,1,340,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,2,20,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,2,75,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,2,440,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,3,30,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,3,75,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,3,440,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,clofarabine,4,30,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,etoposide,4,100,mg/m2,1,5 consecutive days,NA
33230647,"UMIN-CTR (ID, 000015373)",155,cyclophosphamide,4,440,mg/m2,1,5 consecutive days,NA
17440682,NA,156,vinorelbine,1,25,mg/m2,1,on day 1 and 8 on a 21 day treatment cycle,NA
17440682,NA,156,erlotinib,1,100,mg,1,daily,NA
17440682,NA,156,erlotinib,1,100,mg,1,daily,NA
17440682,NA,156,vinorelbine,2,25,mg/m2,1,on day 1 and 8 on a 21 day treatment cycle,NA
17440682,NA,156,erlotinib,2,150,mg,1,daily,NA
17440682,NA,156,erlotinib,2,150,mg,1,daily,NA
17440682,NA,156,vinorelbine,3,30,mg/m2,1,on day 1 and 8 on a 21 day treatment cycle,NA
17440682,NA,156,erlotinib,3,150,mg,1,daily,NA
17440682,NA,156,erlotinib,3,150,mg,1,daily,NA
28531881,NCT02094560,157,cap7.1,1,45,mg/m2,1,on days 1-5 every 21 days,NA
28531881,NCT02094560,157,cap7.1,2,90,mg/m2,1,on days 1-5 every 21 days,NA
28531881,NCT02094560,157,cap7.1,3,150,mg/m2,1,on days 1-5 every 21 days,NA
28531881,NCT02094560,157,cap7.1,4,200,mg/m2,1,on days 1-5 every 21 days,NA
29427728,NCT02028949,158,idarubicin,1,10,mg,1,on days 1 (session 1) and 21 (session 2),NA
29427728,NCT02028949,158,idarubicin,2,15,mg,1,on days 1 (session 1) and 21 (session 2),NA
29427728,NCT02028949,158,idarubicin,3,20,mg,1,on days 1 (session 1) and 21 (session 2),NA
29427728,NCT02028949,158,idarubicin,4,25,mg,1,on days 1 (session 1) and 21 (session 2),NA
19164205,NA,160,erlotinib,1,200,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,1,200,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,2,250,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,2,250,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,3,300,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,3,300,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,4,350,mg,1,daily for 14 days,NA
19164205,NA,160,erlotinib,4,350,mg,1,daily for 14 days,NA
18794549,NA,161,erlotinib,1,35,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,erlotinib,1,35,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,temozolomide,1,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,1,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,erlotinib,2,50,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,erlotinib,2,50,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,temozolomide,2,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,2,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,erlotinib,3,65,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,erlotinib,3,65,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,temozolomide,3,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,3,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,erlotinib,4,85,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,erlotinib,4,85,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,temozolomide,4,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,4,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,erlotinib,5,110,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,erlotinib,5,110,mg/m2,1,daily of each 28-day course,oral solution
18794549,NA,161,temozolomide,5,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,5,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,erlotinib,6,85,mg/m2,1,daily of each 28-day course,oral tablet
18794549,NA,161,erlotinib,6,85,mg/m2,1,daily of each 28-day course,oral tablet
18794549,NA,161,temozolomide,6,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
18794549,NA,161,temozolomide,6,180,mg/m2,1,"starting from course 2, on days 1 through 5 of each 28-day erlotinib course",NA
19117350,NA,162,oxaliplatin,1,130,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,oxaliplatin,1,130,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,etoposide,1,75,mg/m2,1,on Days 1 to 3 of each 21-day course,NA
19117350,NA,162,oxaliplatin,2,130,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,oxaliplatin,2,130,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,etoposide,2,100,mg/m2,1,on Days 1 to 3 of each 21-day course,NA
19117350,NA,162,oxaliplatin,3,145,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,oxaliplatin,3,145,mg/m2,1,on Day 1 of each 21-day course,NA
19117350,NA,162,etoposide,3,100,mg/m2,1,on Days 1 to 3 of each 21-day course,NA
34543383,NCT02306291,163,mitoxantrone,1,10,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,etoposide,1,100,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,cytarabine,1,1000,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,uproleselan,1,5,mg/kg,2,daily for 8 days for 1 induction cycle,NA
34543383,NCT02306291,163,mitoxantrone,2,10,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,etoposide,2,100,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,cytarabine,2,1000,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,uproleselan,2,10,mg/kg,2,daily for 8 days for 1 induction cycle,NA
34543383,NCT02306291,163,mitoxantrone,3,10,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,etoposide,3,100,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,cytarabine,3,1000,mg/m2,1,5 days for 1 induction cycle,NA
34543383,NCT02306291,163,uproleselan,3,20,mg/kg,2,daily for 8 days for 1 induction cycle,NA
17255274,NA,164,oxaliplatin,1,65,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,oxaliplatin,1,65,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,leucovorin,1,200,mg/m2,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,5-fu,1,400,mg/m2,1,15 min i.v. bolus followed by continuous infusion over 22h on days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,1,100,mg,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,1,100,mg,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,oxaliplatin,2,85,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,oxaliplatin,2,85,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,leucovorin,2,200,mg/m2,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,5-fu,2,400,mg/m2,1,15 min i.v. bolus followed by 600 mg/m2 continuous infusion over 22h on days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,2,100,mg,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,2,100,mg,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,oxaliplatin,3,85,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,oxaliplatin,3,85,mg/m2,1,day 1 every 2 weeks,NA
17255274,NA,164,leucovorin,3,200,mg/m2,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,5-fu,3,400,mg/m2,1,15 min i.v. bolus followed by 600 mg/m2 continuous infusion over 22h on days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,3,150,mg,1,days 1 and 2 every 2 weeks,NA
17255274,NA,164,erlotinib,3,150,mg,1,days 1 and 2 every 2 weeks,NA
19147777,NA,165,erlotinib,1,70,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,erlotinib,1,70,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,local radiotherapy,1,54-59.4,Gy,1,1.8 Gy per day,NA
19147777,NA,165,erlotinib,2,90,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,erlotinib,2,90,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,local radiotherapy,2,54-59.4,Gy,1,1.8 Gy per day,NA
19147777,NA,165,erlotinib,3,120,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,erlotinib,3,120,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,local radiotherapy,3,54-59.4,Gy,1,1.8 Gy per day,NA
19147777,NA,165,erlotinib,4,160,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,erlotinib,4,160,mg/m2,1,"started on the same day of radiotherapy, daily for a maximum of 3 years",NA
19147777,NA,165,local radiotherapy,4,54-59.4,Gy,1,1.8 Gy per day,NA
17634483,NA,166,erlotinib,-1,25,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,-1,25,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,0,50,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,0,50,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,1,75,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,1,75,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,2,100,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,2,100,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,3,150,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,3,150,mg,1,daily,"Administered to cohorts 1, 1a, and 2"
17634483,NA,166,erlotinib,-1,50,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,-1,50,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,0,75,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,0,75,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,1,100,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,1,100,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,2,150,mg,1,daily,Administered to Cohorts 3 and 3a
17634483,NA,166,erlotinib,2,150,mg,1,daily,Administered to Cohorts 3 and 3a
22156765,NA,167,etoposide,1,50,mg,1,"D6–D10, Q3W",NA
22156765,NA,167,belotecan,1,0.5,mg/m2,1,"D1–D5, Q3W",fixed
22156765,NA,167,etoposide,2,75,mg,1,"D6–D10, Q3W",NA
22156765,NA,167,belotecan,2,0.5,mg/m2,1,"D1–D5, Q3W",fixed
23666235,NA,168,temozolomide,1,120,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,temozolomide,1,120,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,etoposide,1,50,mg/m2,1,on days 1–8 every 28 days,NA
23666235,NA,168,temozolomide,2,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,temozolomide,2,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,etoposide,2,50,mg/m2,1,on days 1–8 every 28 days,NA
23666235,NA,168,temozolomide,3,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,temozolomide,3,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,etoposide,3,50,mg/m2,1,on days 1–10 every 28 days,NA
23666235,NA,168,temozolomide,4,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,temozolomide,4,150,mg/m2,1,on days 1–5 every 28 days,NA
23666235,NA,168,etoposide,4,50,mg/m2,1,on days 1–12 every 28 days,NA
20538454,NA,169,temozolomide,1,120,mg/m2,1,on days 1–5 every 28 days,NA
20538454,NA,169,temozolomide,1,120,mg/m2,1,on days 1–5 every 28 days,NA
20538454,NA,169,etoposide,1,50,mg/m2,1,on days 1–8 every 28 days,NA
20538454,NA,169,temozolomide,2,150,mg/m2,1,on days 1–5 every 28 days,NA
20538454,NA,169,temozolomide,2,150,mg/m2,1,on days 1–5 every 28 days,NA
20538454,NA,169,etoposide,2,50,mg/m2,1,on days 1–8 every 28 days,NA
20538454,NA,169,etoposide,2,50,mg/m2,1,on days 1–10 every 28 days,NA
20538454,NA,169,etoposide,2,50,mg/m2,1,on days 1–12 every 28 days,NA
22028494,NA,170,ifosfamide,1,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,1,10,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,1,10,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,1,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,2,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,2,15,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,2,15,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,2,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,3,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,3,20,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,3,20,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,3,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,4,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,4,27,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,4,27,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,4,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,5,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,5,36,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,5,36,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,5,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,6,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,6,48,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,6,48,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,6,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,7,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,7,64,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,7,64,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,7,500,mg/m2,1,days -5 through -3,NA
22028494,NA,170,ifosfamide,8,3333,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,8,85,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,topotecan,8,85,mg/m2,1,on days -8 through -6,NA
22028494,NA,170,etoposide,8,500,mg/m2,1,days -5 through -3,NA
20209646,NA,171,valspodar,1,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,1,8,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,1,10,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,1,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,valspodar,2,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,2,10,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,2,10,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,2,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,valspodar,3,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,3,8,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,3,12.5,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,3,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,valspodar,4,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,4,15,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,4,10,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,4,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,valspodar,5,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,5,17.5,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,5,10,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,5,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,valspodar,6,2,mg/kg/hr,1,IV over 2 hr between hours 22 and 24 of the first day of therapy,NA
20209646,NA,171,valspodar,6,20,mg/kg/hr,NA,continuous infusion over 122 hr initiated at the same time that the loading dose was administered,NA
20209646,NA,171,mitoxantrone,6,10,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
20209646,NA,171,etoposide,6,100,mg/m2,1,"on day 1 every 5 days, then on days 2–5 at 50% of the day 1 dose",NA
16626884,NA,172,erlotinib,1,100,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,erlotinib,1,100,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,radiation therapy,1,200,cGy,1,"once a day, 5 times a week, to 60 Gy total",NA
16626884,NA,172,erlotinib,2,150,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,erlotinib,2,150,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,radiation therapy,2,200,cGy,1,"once a day, 5 times a week, to 60 Gy total",NA
16626884,NA,172,erlotinib,3,200,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,erlotinib,3,200,mg,1,"once-daily concurrently with radiation therapy, followed by maintenance erlotinib until progression",NA
16626884,NA,172,radiation therapy,3,200,cGy,1,"once a day, 5 times a week, to 60 Gy total",NA
23445779,NA,173,etoposide,1,25,mg,1,"on five consecutive days/week, in conjunction with continuous conventional radiotherapy",NA
23445779,NA,173,radiotherapy,1,2,Gy,1,"5 fractions per week, up to 70 Gy in 35 fractions and seven weeks",NA
23445779,NA,173,etoposide,2,50,mg,1,"on five consecutive days/week, in conjunction with continuous conventional radiotherapy",NA
23445779,NA,173,radiotherapy,2,2,Gy,1,"5 fractions per week, up to 70 Gy in 35 fractions and seven weeks",NA
19495755,NA,174,ddp-h,1,25,mg/m2,1,NA,NA
19495755,NA,174,ddp-h,2,30,mg/m2,1,NA,NA
19495755,NA,174,ddp-h,3,35,mg/m2,1,NA,NA
19495755,NA,174,ddp-h,4,40,mg/m2,1,NA,NA
25316653,NCT00667615,175,vorinostat,1,300,mg,1,days 1–10 every 28 days,NA
25316653,NCT00667615,175,rituximab,1,375,mg/m2,1,day 1 every 28 days,NA
25316653,NCT00667615,175,cyclophosphamide,1,600,mg/m2,1,days 1 and 8 every 28 days,NA
25316653,NCT00667615,175,etoposide,1,70,mg/m2,1,day 1 every 28 days,i.v.
25316653,NCT00667615,175,etoposide,1,140,mg/m2,1,days 2 and 3 every 28 days,PO
25316653,NCT00667615,175,prednisone,1,60,mg/m2,1,days 1-10 every 28 days,NA
25316653,NCT00667615,175,vorinostat,2,400,mg,1,days 1–10 every 28 days,NA
25316653,NCT00667615,175,rituximab,2,375,mg/m2,1,day 1 every 28 days,NA
25316653,NCT00667615,175,cyclophosphamide,2,600,mg/m2,1,days 1 and 8 every 28 days,NA
25316653,NCT00667615,175,etoposide,2,70,mg/m2,1,day 1 every 28 days,i.v.
25316653,NCT00667615,175,etoposide,2,140,mg/m2,1,days 2 and 3 every 28 days,PO
25316653,NCT00667615,175,prednisone,2,60,mg/m2,1,days 1-10 every 28 days,NA
23403629,NCT00357305,176,vorinostat,1,200,mg,2,on days 1 to 7 every 6-7 weeks,NA
23403629,NCT00357305,176,etoposide,1,100,mg/m2,1,on days 11 to 14 every 6-7 weeks,NA
23403629,NCT00357305,176,cytarabine,1,1000 or 2000,mg/m2,2,on days 11 to 14 every 6-7 weeks,NA
23403629,NCT00357305,176,vorinostat,2,200,mg,3,on days 1 to 7 every 6-7 weeks,NA
23403629,NCT00357305,176,etoposide,2,100,mg/m2,1,on days 11 to 14 every 6-7 weeks,NA
23403629,NCT00357305,176,cytarabine,2,1000 or 2000,mg/m2,2,on days 11 to 14 every 6-7 weeks,NA
12506184,NA,177,pegylated camptothecin,1,600,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,2,1200,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,3,2400,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,4,4800,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,5,5600,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,6,7000,mg/m2,1,every 3 weeks,NA
12506184,NA,177,pegylated camptothecin,7,8750,mg/m2,1,every 3 weeks,NA
15661261,NA,178,idarubicin,1,6,mg/m2,1,continuous infusion on Day 1–Day 5,NA
15661261,NA,178,etoposide,1,60,mg/m2,1,continuous infusion for 3 consecutive days,NA
15661261,NA,178,cytarabine,1,100,mg/m2,1,continuous infusion for 7 days starting on Day 1,NA
15661261,NA,178,psc-833,1,2 and 10,mg/kg,1,a loading dose of 2 mg/kg infused over 2 h started simultaneously with a 50 h continuous infusion at a dose of 10 mg/kg for 24 h beginning 2 h before the second dose of idarubicin,NA
15661261,NA,178,idarubicin,2,8,mg/m2,1,continuous infusion on Day 1–Day 5,NA
15661261,NA,178,etoposide,2,60,mg/m2,1,continuous infusion for 3 consecutive days,NA
15661261,NA,178,cytarabine,2,100,mg/m2,1,continuous infusion for 7 days starting on Day 1,NA
15661261,NA,178,psc-833,2,2 and 10,mg/kg,1,a loading dose of 2 mg/kg infused over 2 h started simultaneously with a 50 h continuous infusion at a dose of 10 mg/kg for 24 h beginning 2 h before the second dose of idarubicin,NA
15661261,NA,178,idarubicin,3,10,mg/m2,1,continuous infusion on Day 1–Day 5,NA
15661261,NA,178,etoposide,3,60,mg/m2,1,continuous infusion for 3 consecutive days,NA
15661261,NA,178,cytarabine,3,100,mg/m2,1,continuous infusion for 7 days starting on Day 1,NA
15661261,NA,178,psc-833,3,2 and 10,mg/kg,1,a loading dose of 2 mg/kg infused over 2 h started simultaneously with a 50 h continuous infusion at a dose of 10 mg/kg for 24 h beginning 2 h before the second dose of idarubicin,NA
15661261,NA,178,idarubicin,4,12,mg/m2,1,continuous infusion on Day 1–Day 5,NA
15661261,NA,178,etoposide,4,60,mg/m2,1,continuous infusion for 3 consecutive days,NA
15661261,NA,178,cytarabine,4,100,mg/m2,1,continuous infusion for 7 days starting on Day 1,NA
15661261,NA,178,psc-833,4,2 and 10,mg/kg,1,a loading dose of 2 mg/kg infused over 2 h started simultaneously with a 50 h continuous infusion at a dose of 10 mg/kg for 24 h beginning 2 h before the second dose of idarubicin,NA
15661261,NA,178,idarubicin,5,14,mg/m2,1,continuous infusion on Day 1–Day 5,NA
15661261,NA,178,etoposide,5,60,mg/m2,1,continuous infusion for 3 consecutive days,NA
15661261,NA,178,cytarabine,5,100,mg/m2,1,continuous infusion for 7 days starting on Day 1,NA
15661261,NA,178,psc-833,5,2 and 10,mg/kg,1,a loading dose of 2 mg/kg infused over 2 h started simultaneously with a 50 h continuous infusion at a dose of 10 mg/kg for 24 h beginning 2 h before the second dose of idarubicin,NA
10867130,NA,179,psc 833,0,2 and 10,mg/kg,1,a loading dose of 2 mg/kg followed by continuous intravenous infusion of 10 mg/kg per day over 120 h,NA
10867130,NA,179,mitoxantrone,0,4,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,etoposide,0,40,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,psc 833,1,2 and 10,mg/kg,1,a loading dose of 2 mg/kg followed by continuous intravenous infusion of 10 mg/kg per day over 120 h,NA
10867130,NA,179,mitoxantrone,1,5,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,etoposide,1,50,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,psc 833,2,2 and 10,mg/kg,1,a loading dose of 2 mg/kg followed by continuous intravenous infusion of 10 mg/kg per day over 120 h,NA
10867130,NA,179,mitoxantrone,2,6,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,etoposide,2,60,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,psc 833,3,2 and 10,mg/kg,1,a loading dose of 2 mg/kg followed by continuous intravenous infusion of 10 mg/kg per day over 120 h,NA
10867130,NA,179,mitoxantrone,3,7,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
10867130,NA,179,etoposide,3,70,mg/m2,1,"for 5 days, started 2 h after PSC 833 was initiated",NA
9493138,NA,180,paclitaxel,1,150,mg/m2,1,on day 1 of a 21-day cycle,NA
9493138,NA,180,etoposide,1,100,mg/m2,1,on days 2–4 of a 21-day cycle,NA
9493138,NA,180,paclitaxel,2,175,mg/m2,1,on day 1 of a 21-day cycle,NA
9493138,NA,180,etoposide,2,100,mg/m2,1,on days 2–4 of a 21-day cycle,NA
9493138,NA,180,paclitaxel,3,175,mg/m2,1,on day 1 of a 21-day cycle,NA
9493138,NA,180,etoposide,3,120,mg/m2,1,on days 2–4 of a 21-day cycle,NA
9493138,NA,180,paclitaxel,4,200,mg/m2,1,on day 1 of a 21-day cycle,NA
9493138,NA,180,etoposide,4,100,mg/m2,1,on days 2–4 of a 21-day cycle,NA
9493138,NA,180,paclitaxel,5,225,mg/m2,1,on day 1 of a 21-day cycle,NA
9493138,NA,180,etoposide,5,100,mg/m2,1,on days 2–4 of a 21-day cycle,NA
11822756,NA,182,topotecan,1,75,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,1,75,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,etoposide,1,75,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,1.5,75,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,1.5,75,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,etoposide,1.5,75,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,2,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,2,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,etoposide,2,75,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,2.5,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,2.5,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,etoposide,2.5,75,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,3,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,3,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,etoposide,3,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,3.5,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,3.5,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,etoposide,3.5,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,4,125,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,4,125,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,etoposide,4,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,4.5,125,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,4.5,125,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,etoposide,4.5,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,5,150,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,5,150,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,etoposide,5,100,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","ET schedule in first course, TE schedule in second course"
11822756,NA,182,topotecan,5.5,150,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,topotecan,5.5,150,mg/m2,1,"on days 1-3 of the 1st course, on days 4-6 of the 2nd course","TE schedule in first course, ET schedule in second course"
11822756,NA,182,etoposide,5.5,100,mg/m2,1,"on days 4-6 of the 1st course, on days 1-3 of the 2nd course","TE schedule in first course, ET schedule in second course"
8882988,NA,184,etoposide,1,200,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,1,20,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,1,20,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,etoposide,2,200,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,2,30,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,2,30,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,etoposide,3,200,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,3,35,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
8882988,NA,184,cisplatin,3,35,mg/m2,1,on days 1 through 3 every 4 weeks.,NA
10561292,NA,186,paclitaxel,-2,85,mg/m2,1,on day 1 every 21 days,NA
10561292,NA,186,cisplatin,-2,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,cisplatin,-2,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,etoposide,-2,80,mg/m2,1,on days 2-4 every 21 days,NA
10561292,NA,186,paclitaxel,-1,105,mg/m2,1,on day 1 every 21 days,NA
10561292,NA,186,cisplatin,-1,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,cisplatin,-1,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,etoposide,-1,80,mg/m2,1,on days 2-4 every 21 days,NA
10561292,NA,186,paclitaxel,0,130,mg/m2,1,on day 1 every 21 days,NA
10561292,NA,186,cisplatin,0,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,cisplatin,0,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,etoposide,0,80,mg/m2,1,on days 2-4 every 21 days,NA
10561292,NA,186,paclitaxel,1,160,mg/m2,1,on day 1 every 21 days,NA
10561292,NA,186,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,cisplatin,1,75,mg/m2,1,on day 2 every 21 days,NA
10561292,NA,186,etoposide,1,80,mg/m2,1,on days 2-4 every 21 days,NA
9445186,NA,187,cisplatin,-2,14,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,cisplatin,-2,14,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,ifosfamide,-2,1000,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,etoposide,-2,30,mg/m2,1,on Days 4-17 every 4 weeks,NA
9445186,NA,187,cisplatin,-1,17,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,cisplatin,-1,17,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,ifosfamide,-1,1200,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,etoposide,-1,40,mg/m2,1,on Days 4-17 every 4 weeks,NA
9445186,NA,187,cisplatin,0,20,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,cisplatin,0,20,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,ifosfamide,0,1500,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,etoposide,0,50,mg/m2,1,on Days 4-17 every 4 weeks,NA
9445186,NA,187,cisplatin,1,25,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,cisplatin,1,25,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,ifosfamide,1,1800,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,etoposide,1,60,mg/m2,1,on Days 4-17 every 4 weeks,NA
9445186,NA,187,cisplatin,2,30,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,cisplatin,2,30,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,ifosfamide,2,2100,mg/m2,1,on Days 1-3 every 4 weeks,NA
9445186,NA,187,etoposide,2,70,mg/m2,1,on Days 4-17 every 4 weeks,NA
11233806,NA,188,etoposide,1,150,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,1,130,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,2,150,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,2,160,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,3,150,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,3,190,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,4,150,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,4,220,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,5,300,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,5,220,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,6,150,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,6,250,mg/m2,1,on day 1,NA
11233806,NA,188,etoposide,7,300,mg/m2,1,on days 1 to 3,NA
11233806,NA,188,paclitaxel,7,250,mg/m2,1,on day 1,NA
8683232,NA,189,etoposide,1,80,mg/m2,1,5 days every 3 weeks after week 1 (course 2),NA
8683232,NA,189,etoposide phosphate,1,50,mg/m2,1,5 days in week 1 (course 1) every 3 weeks,NA
8683232,NA,189,etoposide,2,80,mg/m2,1,5 days every 3 weeks after week 1 (course 2),NA
8683232,NA,189,etoposide phosphate,2,100,mg/m2,1,5 days in week 1 (course 1),NA
8683232,NA,189,etoposide,3,80,mg/m2,1,5 days every 3 weeks after week 1 (course 2),NA
8683232,NA,189,etoposide phosphate,3,125,mg/m2,1,5 days in week 1 (course 1),NA
8683232,NA,189,etoposide,4,80,mg/m2,1,5 days every 3 weeks after week 1 (course 2),NA
8683232,NA,189,etoposide phosphate,4,150,mg/m2,1,5 days in week 1 (course 1),NA
9457817,NA,190,cisplatin,-2,17,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,cisplatin,-2,17,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,ifosfamide,-2,1000,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,etoposide,-2,30,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,thoracic radiation,-2,1.5,Gy,2,30 fractions days l-19 cycle 1,NA
9457817,NA,190,filgrastim,-2,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,filgrastim,-2,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,cisplatin,-1,20,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,cisplatin,-1,20,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,ifosfamide,-1,1200,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,etoposide,-1,40,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,thoracic radiation,-1,1.5,Gy,2,30 fractions days l-19 cycle 1,NA
9457817,NA,190,filgrastim,-1,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,filgrastim,-1,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,cisplatin,-1.5,20,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,cisplatin,-1.5,20,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,ifosfamide,-1.5,1200,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,etoposide,-1.5,40,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,thoracic radiation,-1.5,1.5,Gy,2,30 fractions days l-19 cycle 1,NA
9457817,NA,190,filgrastim,-1.5,0,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,filgrastim,-1.5,0,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,cisplatin,0,20,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,cisplatin,0,20,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,ifosfamide,0,1500,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,etoposide,0,50,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,thoracic radiation,0,1.5,Gy,2,30 fractions days l-19 cycle 1,NA
9457817,NA,190,filgrastim,0,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,filgrastim,0,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,cisplatin,1,25,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,cisplatin,1,25,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,ifosfamide,1,1800,mg/m2,1,days 1-3 every 28 days,NA
9457817,NA,190,etoposide,1,60,mg/m2,1,days 1-14 every 28 days,NA
9457817,NA,190,thoracic radiation,1,1.5,Gy,2,30 fractions days l-19 cycle 1,NA
9457817,NA,190,filgrastim,1,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
9457817,NA,190,filgrastim,1,5,ug/kg,1,on days 29-25 of cyde 1 after completion ofradiation and following completion of oral etoposide in subsequent cycles,NA
10694563,NA,191,paclitaxel,1,100,mg/m2,1,on day 1 every 21 days in cycles 1 and 2,NA
10694563,NA,191,paclitaxel,1,170,mg/m2,1,on day 1 every 21 days in cycles 3 and 4,fixed
10694563,NA,191,cisplatin,1,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,cisplatin,1,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,etoposide,1,60,mg/m2,1,"On days 1, 2, and 3 for cycles 1 and 2",fixed
10694563,NA,191,etoposide,NA,80,mg/m2,1,"On days 1, 2, and 3 for cycles 3 and 4",fixed
10694563,NA,191,chest radiation,1,9,Gy/wk,1,in five fractions for 5 weeks beginning on day 1 of cycle 1,fixed
10694563,NA,191,paclitaxel,2,135,mg/m2,1,on day 1 every 21 days in cycles 1 and 2,NA
10694563,NA,191,paclitaxel,2,170,mg/m2,1,on day 1 every 21 days in cycles 3 and 4,fixed
10694563,NA,191,cisplatin,2,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,cisplatin,2,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,etoposide,2,60,mg/m2,1,"On days 1, 2, and 3 for cycles 1 and 2",fixed
10694563,NA,191,etoposide,2,80,mg/m2,1,"On days 1, 2, and 3 for cycles 3 and 4",fixed
10694563,NA,191,chest radiation,2,9,Gy/wk,1,in five fractions for 5 weeks beginning on day 1 of cycle 1,fixed
10694563,NA,191,paclitaxel,3,170,mg/m2,1,on day 1 every 21 days in cycles 1 and 2,NA
10694563,NA,191,paclitaxel,3,170,mg/m2,1,on day 1 every 21 days in cycles 3 and 4,fixed
10694563,NA,191,cisplatin,3,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,cisplatin,3,60,mg/m2,1,on day 2 every 21 days for all cycles,fixed
10694563,NA,191,etoposide,3,60,mg/m2,1,"On days 1, 2, and 3 for cycles 1 and 2",fixed
10694563,NA,191,etoposide,3,80,mg/m2,1,"On days 1, 2, and 3 for cycles 3 and 4",fixed
10694563,NA,191,chest radiation,3,9,Gy/wk,1,in five fractions for 5 weeks beginning on day 1 of cycle 1,fixed
8652278,NA,192,etoposide phosphate,1,25,mg/m2,1,for 5 days every 3 weeks,NA
8652278,NA,192,etoposide phosphate,2,50,mg/m2,1,for 5 days every 3 weeks,NA
8652278,NA,192,etoposide phosphate,3,75,mg/m2,1,for 5 days every 3 weeks,NA
8652278,NA,192,etoposide phosphate,4,90,mg/m2,1,for 5 days every 3 weeks,NA
8652278,NA,192,etoposide phosphate,5,110,mg/m2,1,for 5 days every 3 weeks,NA
9053503,NA,193,etoposide phosphate,1,10,mg/m2,1,for 6 weeks followed by a 2-weekrest,NA
9053503,NA,193,etoposide phosphate,2,20,mg/m2,1,for 6 weeks followed by a 2-weekrest,NA
9053503,NA,193,etoposide phosphate,3,25,mg/m2,1,for 6 weeks followed by a 2-weekrest,NA
9053503,NA,193,etoposide phosphate,4,30,mg/m2,1,for 6 weeks followed by a 2-weekrest,NA
10378670,NA,194,cisplatin,1,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,cisplatin,1,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,etoposide,1,100,mg/m2,1,on days 2-4 every 3 weeks,fixed
10378670,NA,194,ro 40-8757,1,84,mg/m2,1,day 1-21 every 3 weeks,NA
10378670,NA,194,cisplatin,2,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,cisplatin,2,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,etoposide,2,100,mg/m2,1,on days 2-4 every 3 weeks,fixed
10378670,NA,194,ro 40-8757,2,28,mg/m2,3,day 1-21 every 3 weeks,NA
10378670,NA,194,cisplatin,3,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,cisplatin,3,100,mg/m2,1,on day 2 every 3 weeks,fixed
10378670,NA,194,etoposide,3,100,mg/m2,1,on days 2-4 every 3 weeks,fixed
10378670,NA,194,ro 40-8757,3,42,mg/m2,3,day 1-21 every 3 weeks,NA
9400949,NA,195,topotecan,1,0.5,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,topotecan,1,0.5,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,etoposide,1,20,mg,2,on days 6-12 every 4 weeks,NA
9400949,NA,195,topotecan,2,1,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,topotecan,2,1,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,etoposide,2,20,mg,2,on days 6-12 every 4 weeks,NA
9400949,NA,195,topotecan,3,1,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,topotecan,3,1,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,etoposide,3,40,mg,2,on days 6-12 every 4 weeks,NA
9400949,NA,195,topotecan,4,1.25,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,topotecan,4,1.25,mg/m2,1,on days 1-5 every 4 weeks,NA
9400949,NA,195,etoposide,4,40,mg,2,on days 6-12 every 4 weeks,NA
9400949,NA,195,topotecan,3.5,1,mg/m2,1,on days 1-5 every 3 weeks,NA
9400949,NA,195,topotecan,3.5,1,mg/m2,1,on days 1-5 every 3 weeks,NA
9400949,NA,195,etoposide,3.5,40,mg,2,on days 6-16 every 3 weeks,NA
9400949,NA,195,topotecan,2.5,1,mg/m2,1,on days 1-5 every 3 weeks,NA
9400949,NA,195,topotecan,2.5,1,mg/m2,1,on days 1-5 every 3 weeks,NA
9400949,NA,195,etoposide,2.5,20,mg,2,on days 6-16 every 3 weeks,NA
7799021,NA,196,etoposide phosphate,1,50,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
7799021,NA,196,etoposide phosphate,2,100,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
7799021,NA,196,etoposide phosphate,3,125,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
7799021,NA,196,etoposide phosphate,4,175,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
7799021,NA,196,etoposide phosphate,5,220,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
12448655,NA,197,gemcitabine,1,400,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,1,50,NA,NA,days 1 through 10 every 28 days,NA
12448655,NA,197,gemcitabine,2,550,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,2,50,NA,NA,days 1 through 10 every 28 days,NA
12448655,NA,197,gemcitabine,3,700,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,3,50,NA,NA,days 1 through 10 every 28 days,NA
12448655,NA,197,gemcitabine,4,700,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,4,50,NA,NA,days 1 through 14 every 28 days,NA
12448655,NA,197,gemcitabine,5,700,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,5,50,NA,NA,days 1 through 17 every 28 days,NA
12448655,NA,197,gemcitabine,6,700,NA,NA,on days 1 and 8 every 28 days,NA
12448655,NA,197,etoposide,6,50,NA,NA,days 1 through 21 every 28 days,NA
8083713,NA,198,etoposide phosphate,1,50,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
8083713,NA,198,etoposide phosphate,2,75,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
8083713,NA,198,etoposide phosphate,3,100,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
8083713,NA,198,etoposide phosphate,4,125,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
8083713,NA,198,etoposide phosphate,5,150,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
8083713,NA,198,etoposide phosphate,6,175,mg/m2,1,"days 1, 3, and 5 repeated every 21 days",NA
11155918,NA,199,etoposide,1,25,mg/m2,1,continuous infusion for 14 days,fixed
11155918,NA,199,irinotecan,1,40,mg/m2,1,"on days 1, 8 and 15",NA
11155918,NA,199,etoposide,2,25,mg/m2,1,continuous infusion for 14 days,fixed
11155918,NA,199,irinotecan,2,60,mg/m2,1,"on days 1, 8 and 15",NA
8636778,NA,200,etoposide,1,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over 5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,1,1,mg/kg,1,loading dose was delivered as a 2-hour IV infusion on day 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,1,1,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,2,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,2,1,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,2,2,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,3,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,3,1,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,3,4,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,4,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,4,1,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,4,6.6,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,5,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,5,1,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,5,9,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,6,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,6,2,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,6,10,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,7,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,7,2,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,7,12,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,8,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,8,2,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,8,13.5,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,9,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,9,2,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,9,15,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
8636778,NA,200,etoposide,5.5,75 to 100,mg/m2,1,from day 1 as a 2-hour infusion over5 consecutive days at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,5.5,2,mg/kg,1,loading dose wasdelivered as a 2-hour IV infusion onday 2 at 3 to 4-week intervals,NA
8636778,NA,200,psc 833,5.5,9,mg/kg,1,a 5-day continuous infusion from day 2 at 3 to 4-week intervals,NA
15959778,NA,201,irinotecan,1,60,mg/m2,1,on day 1 every 21 or 28 days,NA
15959778,NA,201,etoposide,1,75,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,1,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,1,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,granisetron,1,3,mg,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,irinotecan,2,100,mg/m2,1,on day 1 every 21 or 28 days,NA
15959778,NA,201,etoposide,2,75,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,2,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,2,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,granisetron,2,3,mg,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,irinotecan,3,120,mg/m2,1,on day 1 every 21 or 28 days,NA
15959778,NA,201,etoposide,3,75,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,3,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,3,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,granisetron,3,3,mg,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,irinotecan,3.5,120,mg/m2,1,on day 3 every 21 or 28 days,NA
15959778,NA,201,etoposide,3.5,75,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,3.5,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,3.5,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,granisetron,3.5,3,mg,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,irinotecan,4,140,mg/m2,1,on day 1 every 21 or 28 days,NA
15959778,NA,201,etoposide,4,75,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,4,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,cisplatin,4,20,mg/m2,1,"on day 1, 2, 3 every 21 or 28 days",NA
15959778,NA,201,granisetron,4,3,mg,1,"on day 1, 2, 3 every 21 or 28 days",NA
8021737,NA,202,etoposide,1,50,mg/m2,3,daily for 21 days,NA
8021737,NA,202,etoposide,2,60,mg/m2,3,daily for 21 days,NA
8021737,NA,202,etoposide,3,75,mg/m2,3,daily for 21 days,NA
9537196,NA,203,etoposide,1,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,1,80,NA,1,on day 4 every 21 days,NA
9537196,NA,203,etoposide,2,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,2,120,NA,1,on day 4 every 21 days,NA
9537196,NA,203,etoposide,3,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,3,150,NA,1,on day 4 every 21 days,NA
9537196,NA,203,etoposide,4,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,4,170,NA,1,on day 4 every 21 days,NA
9537196,NA,203,etoposide,5,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,5,170,NA,1,on day 4 every 21 days,with filgrastim
9537196,NA,203,etoposide,6,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,6,200,NA,1,on day 4 every 21 days,with filgrastim
9537196,NA,203,etoposide,7,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,7,225,NA,1,on day 4 every 21 days,with filgrastim
9537196,NA,203,etoposide,8,100,mg/m2,1,"on days 1, 2, and 3 every 21 days",fixed
9537196,NA,203,paclitaxel,8,250,NA,1,on day 4 every 21 days,with filgrastim
12673724,NA,204,temozolomide,1,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,temozolomide,1,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,etoposide,1,50,mg/m2,1,Days 1–5 every 28 days,NA
12673724,NA,204,temozolomide,2,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,temozolomide,2,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,etoposide,2,50,mg/m2,1,Days 1–8 every 28 days,NA
12673724,NA,204,temozolomide,3,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,temozolomide,3,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,etoposide,3,50,mg/m2,1,Days 1–12 every 28 days,NA
12673724,NA,204,temozolomide,4,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,temozolomide,4,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,etoposide,5,50,mg/m2,1,Days 1–16 every 28 days,NA
12673724,NA,204,temozolomide,6,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,temozolomide,6,150,mg/m2,1,Days 1–5 every 28 days,fixed
12673724,NA,204,etoposide,6,50,mg/m2,1,Days 1–20 every 28 days,NA
14596703,NA,205,cisplatin,1,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,cisplatin,1,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,irinotecan,1,80,mg/m2,NA,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,g-csf,1,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,g-csf,1,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,etoposide,1,60,mg/m2,1,"on days 1-3 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,1,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,1,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,radiation therapy to the chest,1,1.5,Gy,2,daily in 30 fractions of 1.5 Gy each over 15 days on days 1-5 of weeks 4-6,NA
14596703,NA,205,etoposide,1,120,mg/m2,1,on days 1-3 of week 4,NA
14596703,NA,205,cisplatin,1,60,mg/m2,1,on day 1  of week 4,NA
14596703,NA,205,cisplatin,1,60,mg/m2,1,on day 1  of week 4,NA
14596703,NA,205,cisplatin,2,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,cisplatin,2,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,irinotecan,2,90,mg/m2,NA,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,g-csf,2,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,g-csf,2,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,etoposide,2,60,mg/m2,1,"on days 1-3 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,2,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,2,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,radiation therapy to the chest,2,1.5,Gy,2,daily in 30 fractions of 1.5 Gy each over 15 days on days 1-5 of weeks 4-6,NA
14596703,NA,205,etoposide,2,120,mg/m2,1,on days 1-3 of week 4,NA
14596703,NA,205,cisplatin,2,60,mg/m2,1,on day 1  of week 4,NA
14596703,NA,205,cisplatin,2,60,mg/m2,1,on day 1  of week 4,NA
14596703,NA,205,cisplatin,3,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,cisplatin,3,20,mg/m2,1,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,irinotecan,3,100,mg/m2,NA,"on day 1 of weeks 1, 3, 7, 9, and 11",IP regimen
14596703,NA,205,g-csf,3,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,g-csf,3,5,mg/kg,1,"on days 2-5 of weeks 1, 3, 7, 9, and 11, on days 4-7 of weeks 2, 8, 10, and 12",IP regimen
14596703,NA,205,etoposide,3,60,mg/m2,1,"on days 1-3 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,3,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,cisplatin,3,20,mg/m2,1,"on day 1 of weeks 2, 8, 10, and 12",EP regimen
14596703,NA,205,radiation therapy to the chest,3,1.5,Gy,2,daily in 30 fractions of 1.5 Gy each over 15 days on days 1-5 of weeks 4-6,NA
14596703,NA,205,etoposide,3,120,mg/m2,1,on days 1-3 of week 4,NA
14596703,NA,205,cisplatin,3,60,mg/m2,1,on day 1  of week 4,NA
14596703,NA,205,cisplatin,3,60,mg/m2,1,on day 1  of week 4,NA
10512128,NA,206,etoposide,1,12,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,1,4,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,1,4,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,thoracic radiation,1,180–200,cGy,1,5 days per week for 5 weeks,NA
10512128,NA,206,cisplatin,1,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,cisplatin,1,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,etoposide,1,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on days 1, 2 and 3 every 28 days for 3 cycles",NA
10512128,NA,206,etoposide,2,18,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,2,6,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,2,6,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,thoracic radiation,2,180–200,cGy,1,5 days per week for 5 weeks,NA
10512128,NA,206,cisplatin,2,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,cisplatin,2,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,etoposide,2,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on days 1, 2 and 3 every 28 days for 3 cycles",NA
10512128,NA,206,etoposide,3,18,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,3,5,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,cisplatin,3,5,mg/m2,1,begun on the first day of radiation therapy and ran for 5 days per week for 5 consecutive weeks,NA
10512128,NA,206,thoracic radiation,3,180–200,cGy,1,5 days per week for 5 weeks,NA
10512128,NA,206,cisplatin,3,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,cisplatin,3,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on day 1 every 28 days for 3 cycles",NA
10512128,NA,206,etoposide,3,80,mg/m2,1,"21 days after the completion of combined chemoradiotherapy, on days 1, 2 and 3 every 28 days for 3 cycles",NA
7916039,NA,207,dacarbazine,1,3000,mg/m2,1,Three days before transplantation,NA
7916039,NA,207,cyclophosphamide,1,1800,mg/m2,1,daily for 4 days beginning 7 days beforetransplantation,NA
7916039,NA,207,carmustine,1,300,mg/m2,2,in two separate doses administered 12 hours apart 4 days before transplantation,NA
7916039,NA,207,etoposide,1,400,mg/m2,2,for six total doses beginning 7 days before transplantation,NA
7916039,NA,207,dacarbazine,2,3900,mg/m2,1,Three days before transplantation,NA
7916039,NA,207,cyclophosphamide,2,1800,mg/m2,1,daily for 4 days beginning 7 days beforetransplantation,NA
7916039,NA,207,carmustine,2,300,mg/m2,2,in two separate doses administered 12 hours apart 4 days before transplantation,NA
7916039,NA,207,etoposide,2,400,mg/m2,2,for six total doses beginning 7 days before transplantation,NA
7916039,NA,207,dacarbazine,3,5070,mg/m2,1,Three days before transplantation,NA
7916039,NA,207,cyclophosphamide,3,1800,mg/m2,1,daily for 4 days beginning 7 days beforetransplantation,NA
7916039,NA,207,carmustine,3,300,mg/m2,2,in two separate doses administered 12 hours apart 4 days before transplantation,NA
7916039,NA,207,etoposide,3,400,mg/m2,2,for six total doses beginning 7 days before transplantation,NA
7916039,NA,207,dacarbazine,4,6591,mg/m2,1,Three days before transplantation,NA
7916039,NA,207,cyclophosphamide,4,1800,mg/m2,1,daily for 4 days beginning 7 days beforetransplantation,NA
7916039,NA,207,carmustine,4,300,mg/m2,2,in two separate doses administered 12 hours apart 4 days before transplantation,NA
7916039,NA,207,etoposide,4,400,mg/m2,2,for six total doses beginning 7 days before transplantation,NA
10086724,NA,208,topotecan,1,1.5,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,1,1.5,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,1,100,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
10086724,NA,208,topotecan,2,1.75,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,2,1.75,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,2,100,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
10086724,NA,208,topotecan,3,2,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,3,2,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,3,100,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
10086724,NA,208,topotecan,4,1.5,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,4,1.5,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,4,150,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
10086724,NA,208,topotecan,5,1.75,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,5,1.75,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,5,150,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
10086724,NA,208,topotecan,6,2,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,topotecan,6,2,mg/m2,1,continuous infusion on days 1–5 (120 h infusion total) every 28 days,NA
10086724,NA,208,etoposide,6,150,mg/m2,1,"on days 6, 7 and 8 every 28 days",NA
8270989,NA,209,etoposide,1,10,mg/m2,1,"On day 1. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,etoposide,1,20,mg/m2,1,"infused continuously for 14 days (336 hours). Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,1,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,1,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,etoposide,2,10,mg/m2,1,"On day 1. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,etoposide,2,25,mg/m2,1,"infused continuously for 14 days (336 hours). Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,2,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,2,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,etoposide,3,10,mg/m2,1,"On day 1. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,etoposide,3,30,mg/m2,1,"infused continuously for 14 days (336 hours). Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,3,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
8270989,NA,209,cisplatin,3,30,mg/m2,1,"on chemotherapy days 1, 2, and 3. Treatment was repeated after WBCs, platelets, and serum creatinine recovered to the level of the eligibility criteria described earlier.",NA
16649219,NA,210,gemcitabine,1,600,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
16649219,NA,210,etoposide,1,60,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,1,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,1,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,gemcitabine,2,800,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
16649219,NA,210,etoposide,2,60,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,2,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,2,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,gemcitabine,3,1000,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
16649219,NA,210,etoposide,3,60,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,3,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,3,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,gemcitabine,4,1200,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
16649219,NA,210,etoposide,4,60,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,4,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,4,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,gemcitabine,5,1400,mg/m2,1,"on Days 1, 8, and 15 every 28 days",NA
16649219,NA,210,etoposide,5,60,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,5,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
16649219,NA,210,cisplatin,5,20,mg/m2,1,on Days 1 through 3 every 28 days,fixed
15756278,NA,211,etoposide,1,37.5,mg/m2,2,on days 1 –10 of each 3-week treatment cycle,NA
15756278,NA,211,gm-csf,1,0,ug,1,days 12 –19 of each 3-week treatment cycle,NA
15756278,NA,211,gm-csf,1,0,ug,1,days 12 –19 of each 3-week treatment cycle,NA
15756278,NA,211,etoposide,1,50,mg/m2,2,on days 1 –10 of each 3-week treatment cycle,NA
15756278,NA,211,gm-csf,1,400,ug,1,days 12 –19 of each 3-week treatment cycle,NA
15756278,NA,211,gm-csf,1,400,ug,1,days 12 –19 of each 3-week treatment cycle,NA
15756278,NA,211,etoposide,1,62.5,mg/m2,2,on days 1 –10 of each 3-week treatment cycle,NA
12609572,NA,212,etoposide,1,50,mg/m2,1,"on days 3, 4, and 5 every 3 weeks",fixed
12609572,NA,212,cisplatin,1,70,mg/m2,1,on day 2 every 3 weeks,fixed
12609572,NA,212,cisplatin,1,70,mg/m2,1,on day 2 every 3 weeks,fixed
12609572,NA,212,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12609572,NA,212,etoposide,2,75,mg/m2,1,"on days 3, 4, and 5 every 3 weeks",fixed
12609572,NA,212,cisplatin,2,70,mg/m2,1,on day 2 every 3 weeks,fixed
12609572,NA,212,cisplatin,2,70,mg/m2,1,on day 2 every 3 weeks,fixed
12609572,NA,212,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12394265,NA,213,cisplatin,1,5,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,cisplatin,1,5,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,etoposide,1,50,mg/m2,1,14 days every 14 days,NA
12394265,NA,213,cisplatin,2,6.5,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,cisplatin,2,6.5,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,etoposide,2,50,mg/m2,1,14 days every 14 days,NA
12394265,NA,213,cisplatin,3,8,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,cisplatin,3,8,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,etoposide,3,50,mg/m2,1,14 days every 14 days,NA
12394265,NA,213,cisplatin,4,9,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,cisplatin,4,9,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,etoposide,4,50,mg/m2,1,14 days every 14 days,NA
12394265,NA,213,cisplatin,5,10,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,cisplatin,5,10,mg/m2,1,continuously via an infuser for 14 days every 14 days,NA
12394265,NA,213,etoposide,5,50,mg/m2,1,14 days every 14 days,NA
8194024,NA,214,etoposide,1,25,mg/m2,1,"continuous infusion was administered for at least 21 days or until either the leukocyte count dropped to less than 2,000/mm3, platelets dropped to less than 75,000/mm3, or tumor progression occurred",NA
8194024,NA,214,etoposide,0,20,mg/m2,1,"continuous infusion was administered for at least 21 days or until either the leukocyte count dropped to less than 2,000/mm3, platelets dropped to less than 75,000/mm3, or tumor progression occurred",NA
8194024,NA,214,etoposide,-1,18,mg/m2,1,"continuous infusion was administered for at least 21 days or until either the leukocyte count dropped to less than 2,000/mm3, platelets dropped to less than 75,000/mm3, or tumor progression occurred",NA
8194024,NA,214,etoposide,-2,15,mg/m2,1,"continuous infusion was administered for at least 21 days or until either the leukocyte count dropped to less than 2,000/mm3, platelets dropped to less than 75,000/mm3, or tumor progression occurred",NA
8194024,NA,214,etoposide,-3,12-Sep,mg/m2,1,"continuous infusion was administered for at least 21 days or until either the leukocyte count dropped to less than 2,000/mm3, platelets dropped to less than 75,000/mm3, or tumor progression occurred",NA
16412499,NA,215,topotecan,1,0.8,mg/m2,1,days 1 – 5 every 28 days,NA
16412499,NA,215,topotecan,1,0.8,mg/m2,1,days 1 – 5 every 28 days,NA
16412499,NA,215,etoposide,1,50,mg/m2,1,days 8 – 12 every 28 days,NA
16412499,NA,215,topotecan,2,0.8,mg/m2,1,days 1 – 5 every 28 days,NA
16412499,NA,215,topotecan,2,0.8,mg/m2,1,days 1 – 5 every 28 days,NA
16412499,NA,215,etoposide,2,50,mg/m2,1,days 8 – 12 every 28 days,NA
16412499,NA,215,topotecan,3,0.8,mg/m2,1,days 1 – 5 and 15-17 every 28 days,NA
16412499,NA,215,topotecan,3,0.8,mg/m2,1,days 1 – 5 and 15-17 every 28 days,NA
16412499,NA,215,etoposide,3,50,mg/m2,1,days 8 – 12 every 28 days,NA
16412499,NA,215,topotecan,4,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,topotecan,4,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,etoposide,4,50,mg/m2,1,days 8 – 12 every 28 days,NA
16412499,NA,215,topotecan,5,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,topotecan,5,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,etoposide,5,50,mg/m2,1,days 8 – 12 and 22-24 every 28 days,NA
16412499,NA,215,topotecan,6,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,topotecan,6,0.8,mg/m2,1,days 1 – 5 and 15-19 every 28 days,NA
16412499,NA,215,etoposide,6,50,mg/m2,1,days 8 – 12 and 22-26 every 28 days,NA
15719439,NA,216,topotecan,1,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,1,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,1,50,mg/m2,1,Days 6–12 in a 28-day schedule,NA
15719439,NA,216,topotecan,2,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,2,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,2,50,mg/m2,1,Days 6–19 in a 28-day schedule,NA
15719439,NA,216,topotecan,3,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,3,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,3,75,mg/m2,1,Days 6–12 in a 28-day schedule,NA
15719439,NA,216,topotecan,4,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,4,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,4,75,mg/m2,1,Days 6–19 in a 28-day schedule,NA
15719439,NA,216,topotecan,5,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,5,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,5,100,mg/m2,1,Days 6–12 in a 28-day schedule,NA
15719439,NA,216,topotecan,6,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,topotecan,6,1,mg/m2,1,Days 1–5 in a 28-day schedule,NA
15719439,NA,216,etoposide,6,100,mg/m2,1,Days 6–19 in a 28-day schedule,NA
16757061,NA,217,radiotherapy,1,1.8-45 + 9 (RP),Gy,1,A total dose of 54 Gy during the two 28-day cycles,NA
16757061,NA,217,irinotecan,1,40,mg/m2,1,"Day 1/8/15, 29/36/43 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,1,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,1,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
16757061,NA,217,radiotherapy,2,1.8-45 + 9 (RP),Gy,1,A total dose of 54 Gy during the two 28-day cycles,NA
16757061,NA,217,irinotecan,2,50,mg/m2,1,"Day 1/8/15, 29/36/43 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,2,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,2,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
16757061,NA,217,radiotherapy,3,1.8-45 + 9 (RP),Gy,1,A total dose of 54 Gy during the two 28-day cycles,NA
16757061,NA,217,irinotecan,3,60,mg/m2,1,"Day 1/8/15, 29/36/43 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,3,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
16757061,NA,217,cisplatin,3,20,mg/m2,1,"Days 1—3, 29—31 (two 28-day cycles)",NA
9137533,NA,218,etoposide,1,100,mg/m2,1,"on days 1, 2, and 3 evvery 3-4 weeks",fixed
9137533,NA,218,thiotepa,1,40,mg/m2,1,on day 2 every 3-4 weeks,NA
9137533,NA,218,etoposide,2,100,mg/m2,1,"on days 1, 2, and 3 evvery 3-4 weeks",fixed
9137533,NA,218,thiotepa,2,50,mg/m2,1,on day 2 every 3-4 weeks,NA
9137533,NA,218,etoposide,3,100,mg/m2,1,"on days 1, 2, and 3 evvery 3-4 weeks",fixed
9137533,NA,218,thiotepa,3,60,mg/m2,1,on day 2 every 3-4 weeks,NA
9137533,NA,218,etoposide,4,100,mg/m2,1,"on days 1, 2, and 3 evvery 3-4 weeks",fixed
9137533,NA,218,thiotepa,4,70,mg/m2,1,on day 2 every 3-4 weeks,NA
21387258,NA,219,everolimus,1,2.5,mg,1,daily in 4-week cycles,NA
21387258,NA,219,everolimus,1,2.5,mg,1,daily in 4-week cycles,NA
21387258,NA,219,sorafenib,1,400,mg,2,daily in 4-week cycles,NA
21387258,NA,219,everolimus,2,5,mg,1,daily in 4-week cycles,NA
21387258,NA,219,everolimus,2,5,mg,1,daily in 4-week cycles,NA
21387258,NA,219,sorafenib,2,400,mg,2,daily in 4-week cycles,NA
21387258,NA,219,everolimus,3,10,mg,1,daily in 4-week cycles,NA
21387258,NA,219,everolimus,3,10,mg,1,daily in 4-week cycles,NA
21387258,NA,219,sorafenib,3,200,mg,2,daily in 4-week cycles,NA
24190702,NCT01136733,220,lenvatinib,1,12,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,1,5,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,1,5,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,lenvatinib,2,18,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,2,5,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,2,5,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,lenvatinib,3,24,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,3,5,mg,1,daily in 28-day treatment cycles,NA
24190702,NCT01136733,220,everolimus,3,5,mg,1,daily in 28-day treatment cycles,NA
33547201,NCT03387020,221,ribociclib,1,120,mg/m2,1,daily for 21 days followed by a 7-day break,NA
33547201,NCT03387020,221,everolimus,1,1.2,mg/m2,1,daily for a 28-day cycle,NA
33547201,NCT03387020,221,everolimus,1,1.2,mg/m2,1,daily for a 28-day cycle,NA
33547201,NCT03387020,221,ribociclib,2,170,mg/m2,1,daily for 21 days followed by a 7-day break,NA
33547201,NCT03387020,221,everolimus,2,1.2,mg/m2,1,daily for a 28-day cycle,NA
33547201,NCT03387020,221,everolimus,2,1.2,mg/m2,1,daily for a 28-day cycle,NA
33547201,NCT03387020,221,ribociclib,3,120,mg/m2,1,daily for 21 days followed by a 7-day break,expansion cohort
33547201,NCT03387020,221,everolimus,3,1.2,mg/m2,1,daily for a 28-day cycle,expansion cohort
33547201,NCT03387020,221,everolimus,3,1.2,mg/m2,1,daily for a 28-day cycle,expansion cohort
27206639,NCT01217177,222,everolimus,1,2.5,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,everolimus,1,2.5,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,cisplatin,1,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,cisplatin,1,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,radiotherapy,1,4.5,Gy,1,"from day 0, 25 daily fractions, 5 days a week, followed by brachytherapy",NA
27206639,NCT01217177,222,everolimus,2,5,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,everolimus,2,5,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,cisplatin,2,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,cisplatin,2,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,radiotherapy,2,4.5,Gy,1,"from day 0, 25 daily fractions, 5 days a week, followed by brachytherapy",NA
27206639,NCT01217177,222,everolimus,3,10,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,everolimus,3,10,mg,1,day −7 until last day of brachytherapy,NA
27206639,NCT01217177,222,cisplatin,3,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,cisplatin,3,40,mg/m2,1,"days 0, 7, 14, 21 and 28",NA
27206639,NCT01217177,222,radiotherapy,3,4.5,Gy,1,"from day 0, 25 daily fractions, 5 days a week, followed by brachytherapy",NA
32005746,NCT01470209,223,everolimus,1,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,1,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,1,20,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,2,10,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,2,10,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,2,20,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,3,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,3,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,3,40,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,4,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,4,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,4,60,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,5,10,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,5,10,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,5,60,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,6,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,everolimus,6,5,mg,1,daily every 4 weeks,NA
32005746,NCT01470209,223,buparlisib,6,80,mg,1,daily every 4 weeks,NA
24819684,NCT00610948,224,everolimus,1,15,mg,1,weekly in each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,1,15,mg,1,weekly in each 28-day cycle,NA
24819684,NCT00610948,224,5-fluorouracil,1,400/1800 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,1,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,2,30,mg,1,weekly in each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,2,30,mg,1,weekly in each 28-day cycle,NA
24819684,NCT00610948,224,5-fluorouracil,2,400/1800 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,2,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,3,2.5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,3,2.5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,5-fluorouracil,3,400/1800 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,3,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,4,5,mg,1,once daily on days 1-28,NA
24819684,NCT00610948,224,everolimus,4,5,mg,1,once daily on days 1-28,NA
24819684,NCT00610948,224,5-fluorouracil,4,400/1800 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,4,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,5,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,5,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,5-fluorouracil,5,400/2400 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,5,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,6,10,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,everolimus,6,10,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,224,5-fluorouracil,6,400/1800 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,224,leucovorin,6,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,1,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,1,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,5-fluorouracil,1,400/2400 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,225,leucovorin,1,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,1,85,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,1,85,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,panitumumab,1,0,mg/kg,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,-1,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,-1,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,5-fluorouracil,-1,400/2400 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,225,leucovorin,-1,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,-1,65,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,-1,65,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,panitumumab,-1,0,mg/kg,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,-2,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,everolimus,-2,5,mg,1,daily in each 28-day cycle,NA
24819684,NCT00610948,225,5-fluorouracil,-2,400/2400 (B/I),mg/m2,1,on Days 1 and 15 of each 28-day cycle,B/I Bolus/Infusion dose (infusion occurs over 46 h)
24819684,NCT00610948,225,leucovorin,-2,400,mg/m2,1,on Days 1 and 15 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,-2,65,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,oxaliplatin,-2,65,mg/m2,1,on day 1 of each 28-day cycle,NA
24819684,NCT00610948,225,panitumumab,-2,3.6,mg/kg,1,on day 1 of each 28-day cycle,NA
25788492,NA,226,bnc105p,1,4.2,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
25788492,NA,226,everolimus,1,10,mg,1,daily with a 7-day lead in before the first administration of BNC105P,NA
25788492,NA,226,everolimus,1,10,mg,1,daily with a 7-day lead in before the first administration of BNC105P,NA
25788492,NA,226,bnc105p,2,8.4,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
25788492,NA,226,everolimus,2,10,mg,1,daily with a 7-day lead in before the first administration of BNC105P,NA
25788492,NA,226,everolimus,2,10,mg,1,daily with a 7-day lead in before the first administration of BNC105P,NA
25788492,NA,226,bnc105p,1,12.6,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
25788492,NA,226,bnc105p,1,16,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
34903452,NCT01149356,227,gsi ro4929097,1,20,mg,1,"on days 1-3, 8-10, and 15-17 every 21 days",NA
34903452,NCT01149356,227,exemestane,1,25,mg,1,daily on days 1-21 every 21 days,NA
34903452,NCT01149356,227,gsi ro4929097,2,30,mg,1,"on days 1-3, 8-10, and 15-17 every 21 days",NA
34903452,NCT01149356,227,exemestane,2,25,mg,1,daily on days 1-21 every 21 days,NA
34903452,NCT01149356,227,gsi ro4929097,3,45,mg,1,"on days 1-3, 8-10, and 15-17 every 21 days",NA
34903452,NCT01149356,227,exemestane,3,25,mg,1,daily on days 1-21 every 21 days,NA
34903452,NCT01149356,227,gsi ro4929097,4,90,mg,1,"on days 1-3, 8-10, and 15-17 every 21 days",NA
34903452,NCT01149356,227,exemestane,4,25,mg,1,daily on days 1-21 every 21 days,NA
34903452,NCT01149356,227,gsi ro4929097,5,140,mg,1,"on days 1-3, 8-10, and 15-17 every 21 days",NA
34903452,NCT01149356,227,exemestane,5,25,mg,1,daily on days 1-21 every 21 days,NA
24908540,NCT01714765,228,dovitinib,0,200,mg,1,day 1–5/7,NA
24908540,NCT01714765,228,everolimus,0,5,mg,1,daily,NA
24908540,NCT01714765,228,everolimus,0,5,mg,1,daily,NA
24908540,NCT01714765,228,dovitinib,1,300,mg,1,day 1–5/7,NA
24908540,NCT01714765,228,everolimus,1,5,mg,1,daily,NA
24908540,NCT01714765,228,everolimus,1,5,mg,1,daily,NA
24908540,NCT01714765,228,dovitinib,2,300,mg,1,day 1–5/7,NA
24908540,NCT01714765,228,everolimus,2,10,mg,1,daily,NA
24908540,NCT01714765,228,everolimus,2,10,mg,1,daily,NA
24908540,NCT01714765,228,dovitinib,3,500,mg,1,day 1–5/7,NA
24908540,NCT01714765,228,everolimus,3,10,mg,1,daily,NA
24908540,NCT01714765,228,everolimus,3,10,mg,1,daily,NA
24908540,NCT01714765,228,dovitinib,-1,100,mg,1,day 1–5/7,NA
24908540,NCT01714765,228,everolimus,-1,5,mg,1,daily,NA
24908540,NCT01714765,228,everolimus,-1,5,mg,1,daily,NA
24685058,NA,229,vatalanib,1,1000,mg,1,daily begun on day 1 of the 28-day cycle,NA
24685058,NA,229,everolimus,1,5,mg,1,daily begun on day 15 of the 28-day cycle,NA
24685058,NA,229,everolimus,1,5,mg,1,daily begun on day 15 of the 28-day cycle,NA
24685058,NA,229,vatalanib,2.5,1000,mg,1,daily begun on day 1 of the 28-day cycle,NA
24685058,NA,229,everolimus,2.5,10,mg,1,daily begun on day 15 of the 28-day cycle,NA
24685058,NA,229,everolimus,2.5,10,mg,1,daily begun on day 15 of the 28-day cycle,NA
24685058,NA,229,vatalanib,2,1250,mg,1,daily begun on day 1 of the 28-day cycle,NA
24685058,NA,229,everolimus,2,5,mg,1,daily begun on day 15 of the 28-day cycle,NA
24685058,NA,229,everolimus,2,5,mg,1,daily begun on day 15 of the 28-day cycle,NA
28616837,NA,230,everolimus,-1,5,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,-1,5,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,-1,500,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,1,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,1,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,1,500,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,2,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,2,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,2,850,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,3,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,3,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,3,1000,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,4,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,4,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,4,1350,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,5,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,5,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,5,1500,mg,2,daily started on day 8,NA
28616837,NA,230,everolimus,6,10,mg,1,daily started on day 1,NA
28616837,NA,230,everolimus,6,10,mg,1,daily started on day 1,NA
28616837,NA,230,metformin,6,1850,mg,2,daily started on day 8,NA
25335932,NCT01154335,231,linsitinib,1,50,mg,2,daily,NA
25335932,NCT01154335,231,everolimus,1,5,mg,1,daily,NA
25335932,NCT01154335,231,everolimus,1,5,mg,1,daily,NA
25335932,NCT01154335,231,linsitinib,2,100,mg,2,daily,NA
25335932,NCT01154335,231,everolimus,2,10,mg,1,daily,NA
25335932,NCT01154335,231,everolimus,2,10,mg,1,daily,NA
25335932,NCT01154335,231,linsitinib,1.5,100,mg,2,daily,NA
25335932,NCT01154335,231,everolimus,1.5,5,mg,1,daily,NA
25335932,NCT01154335,231,everolimus,1.5,5,mg,1,daily,NA
33451345,NCT02123823,232,xentuzumab,1,750,mg,1,weekly in 28-day cycles,NA
33451345,NCT02123823,232,exemestane,1,25,mg,1,daily,NA
33451345,NCT02123823,232,everolimus,1,10,mg,1,daily,NA
33451345,NCT02123823,232,everolimus,1,10,mg,1,daily,NA
33451345,NCT02123823,232,xentuzumab,2,1000,mg,1,weekly in 28-day cycles,NA
33451345,NCT02123823,232,exemestane,2,25,mg,1,daily,NA
23963141,NCT01079481,233,everolimus,1,2.5,mg,1,daily,NA
23963141,NCT01079481,233,everolimus,1,2.5,mg,1,daily,NA
23963141,NCT01079481,233,paclitaxel,1,175,mg/m2,1,once every 3 weeks,NA
23963141,NCT01079481,233,everolimus,2,5,mg,1,daily,NA
23963141,NCT01079481,233,everolimus,2,5,mg,1,daily,NA
23963141,NCT01079481,233,paclitaxel,2,175,mg/m2,1,once every 3 weeks,NA
23963141,NCT01079481,233,everolimus,3,10,mg,1,daily,NA
23963141,NCT01079481,233,everolimus,3,10,mg,1,daily,NA
23963141,NCT01079481,233,paclitaxel,3,175,mg/m2,1,once every 3 weeks,NA
33964572,NCT02077933,234,alpelisib,1,300,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,1,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,1,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,alpelisib,2,250,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,2,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,2,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,alpelisib,3,200,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,3,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,234,everolimus,3,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,235,alpelisib,1,200,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,235,everolimus,1,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,235,everolimus,1,2.5,mg,1,"Daily, continuous (28-day cycles)",NA
33964572,NCT02077933,235,exemestane,1,25,mg,1,"Daily, continuous (28-day cycles)",NA
30635337,NA,236,everolimus,1,10,mg,1,daily begining from day 1 in first cycle (35 days) and subsequent cycles (28 days),NA
30635337,NA,236,everolimus,1,10,mg,1,daily begining from day 1 in first cycle (35 days) and subsequent cycles (28 days),NA
30635337,NA,236,hydroxychloroquine,1,400,NA,2,daily beginning 1 week later in the first cycle (35 days) and daily from day 1 in subsequent cycles (28 days),NA
30635337,NA,236,hydroxychloroquine,1,400,NA,2,daily beginning 1 week later in the first cycle (35 days) and daily from day 1 in subsequent cycles (28 days),NA
30635337,NA,236,everolimus,2,10,mg,1,daily begining from day 1 in first cycle (35 days) and subsequent cycles (28 days),NA
30635337,NA,236,everolimus,2,10,mg,1,daily begining from day 1 in first cycle (35 days) and subsequent cycles (28 days),NA
30635337,NA,236,hydroxychloroquine,2,600,NA,2,daily beginning 1 week later in the first cycle (35 days) and daily from day 1 in subsequent cycles (28 days),NA
30635337,NA,236,hydroxychloroquine,2,600,NA,2,daily beginning 1 week later in the first cycle (35 days) and daily from day 1 in subsequent cycles (28 days),NA
21177764,NCT00927966,237,everolimus,1,10,mg,1,daily,NA
21177764,NCT00927966,237,everolimus,1,10,mg,1,daily,NA
21177764,NCT00927966,237,figitumumab,1,20,mg/kg,1,on Day 1 every 21 days,NA
25029236,NCT00560963,238,everolimus,1,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,everolimus,1,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,gemcitabine,1,400,mg/m2,1,weekly in 28-day cycles,NA
25029236,NCT00560963,238,everolimus,2,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,everolimus,2,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,gemcitabine,2,500,mg/m2,1,weekly in 28-day cycles,NA
25029236,NCT00560963,238,everolimus,3,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,everolimus,3,5,mg,1,every second day in 28-days cycles,NA
25029236,NCT00560963,238,gemcitabine,3,600,mg/m2,1,weekly in 28-day cycles,NA
25029236,NCT00560963,238,everolimus,4,5,mg,1,daily in 28-days cycles,NA
25029236,NCT00560963,238,everolimus,4,5,mg,1,daily in 28-days cycles,NA
25029236,NCT00560963,238,gemcitabine,4,400,mg/m2,1,weekly in 28-day cycles,NA
25029236,NCT00560963,238,everolimus,5,5,mg,1,daily in 28-days cycles,NA
25029236,NCT00560963,238,everolimus,5,5,mg,1,daily in 28-days cycles,NA
25029236,NCT00560963,238,gemcitabine,5,500,mg/m2,1,weekly in 28-day cycles,NA
18332469,NA,239,everolimus,1,5,mg,1,daily,NA
18332469,NA,239,everolimus,1,5,mg,1,daily,NA
18332469,NA,239,everolimus,2,10,mg,1,daily,NA
18332469,NA,239,everolimus,2,10,mg,1,daily,NA
18332469,NA,239,everolimus,3,20,mg,1,weekly,NA
18332469,NA,239,everolimus,3,20,mg,1,weekly,NA
18332469,NA,239,everolimus,4,50,mg,1,weekly,NA
18332469,NA,239,everolimus,4,50,mg,1,weekly,NA
18332469,NA,239,everolimus,5,70,mg,1,weekly,NA
18332469,NA,239,everolimus,5,70,mg,1,weekly,NA
21984222,NA,240,aee788,2,200,mg,1,once daily (qd) in 28-day cycles,NA
21984222,NA,240,rad001,2,5,mg,1,once daily (qd) in 28-day cycles,NA
21984222,NA,240,aee788,1,150,mg,1,once daily (qd) in 28-day cycles,NA
21984222,NA,240,rad001,1,5,mg,1,once every other day in 28-day cycles,NA
32704173,NCT01218555,241,lenalidomide,1,10,mg,1,daily in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,1,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,1,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,lenalidomide,2,15,mg,1,daily in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,2,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,2,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,lenalidomide,3,20,mg,1,daily in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,3,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,3,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,lenalidomide,4,25,mg,1,daily in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,4,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,4,5,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,lenalidomide,5,25,mg,1,daily in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,5,10,mg,1,daily  in a 28-day cycle,NA
32704173,NCT01218555,241,everolimus,5,10,mg,1,daily  in a 28-day cycle,NA
34819039,NCT02623751,242,entinostat,1,3,mg,1,once weekly  for 7 days (cycle 0) and 28 days (cycle 1),NA
34819039,NCT02623751,242,exemestane,1,25,mg,1,daily started from cycle 1,NA
34819039,NCT02623751,242,entinostat,2,5,mg,1,once weekly  for 7 days (cycle 0) and 28 days (cycle 1),NA
34819039,NCT02623751,242,exemestane,2,25,mg,1,daily started from cycle 1,NA
34819039,NCT02623751,242,entinostat,3,10,mg,1,single dose in cycle 0,NA
34819039,NCT02623751,242,entinostat,3,5,mg,1,weekly started 2 weeks after the singleadministration of ENT 10 mg,NA
34819039,NCT02623751,242,exemestane,3,25,mg,1,daily initiated 1 week after the first ENT administration,NA
34819039,NCT02623751,243,entinostat,4,5,mg,1,once weekly  for 7 days (cycle 0) and 28 days (cycle 1),NA
34819039,NCT02623751,243,exemestane,4,25,mg,1,daily started from cycle 1,NA
21898375,NA,244,everolimus,1,2.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,1,2.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,sunitinib,1,37.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,2,5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,2,5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,sunitinib,2,37.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,3,20,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,everolimus,3,20,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,sunitinib,3,37.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,4,30,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,everolimus,4,30,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,sunitinib,4,37.5,mg,1,on days 1 to 28 of a 42-day cycle,NA
21898375,NA,244,everolimus,5,30,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,everolimus,5,30,mg,1,"on days 7, 14, 21, and 28 of a 42-day cycle",NA
21898375,NA,244,sunitinib,5,50,mg,1,on days 1 to 28 of a 42-day cycle,NA
32335374,NCT02577458,245,vorolanib,1,100,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,1,5,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,1,5,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,vorolanib,2,150,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,2,5,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,2,5,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,vorolanib,3,200,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,3,5,mg,1,once a day on 28-day cycles,NA
32335374,NCT02577458,245,everolimus,3,5,mg,1,once a day on 28-day cycles,NA
8336196,NA,246,etoposide,1,300,mg/m2,1,continuous infusion over 14 days,NA
8336196,NA,246,etoposide,2,400,mg/m2,1,continuous infusion over 14 days,NA
8336196,NA,246,etoposide,3,500,mg/m2,1,continuous infusion over 14 days,NA
8336196,NA,246,etoposide,4,600,mg/m2,1,continuous infusion over 14 days,NA
8336196,NA,246,etoposide,5,700,mg/m2,1,continuous infusion over 14 days,NA
25902899,NA,247,everolimus,5,10,mg,1,"on D1 through D5, and then every odd cycle (28 days)-day",other DLs not described
25902899,NA,247,everolimus,5,10,mg,1,"on D1 through D5, and then every odd cycle (28 days)-day",other DLs not described
25902899,NA,247,pazopanib,5,600,mg,1,"on D1 through D6, and then every even cycle (28 days)-day",other DLs not described
24057042,NCT00352443,248,everolimus,1,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,1,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,1,750,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,2,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,2,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,2,1000,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,3,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,3,2.5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,3,1250,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,4,5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,4,5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,4,1250,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,5,5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,5,5,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,5,1500,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,5.5,10,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,5.5,10,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,5.5,1250,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,6,10,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,everolimus,6,10,mg,1,days 1-28 daily,NA
24057042,NCT00352443,248,lapatinib,6,1500,mg,1,days 1-28 daily,NA
23928403,NCT00828594,249,sorafenib,1,400,mg,2,daily,fixed
23928403,NCT00828594,249,everolimus,1,2.5,mg,1,daily,NA
23928403,NCT00828594,249,everolimus,1,2.5,mg,1,daily,NA
23928403,NCT00828594,249,sorafenib,2,400,mg,2,daily,fixed
23928403,NCT00828594,249,everolimus,2,5,mg,1,daily,NA
23928403,NCT00828594,249,everolimus,2,5,mg,1,daily,NA
7692002,NA,250,cpt-11,1,40,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,etoposide,1,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,1,0,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,1,0,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,cpt-11,1.5,40,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,etoposide,1.5,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,1.5,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,1.5,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,cpt-11,2,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,etoposide,2,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,2,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,2,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,cpt-11,3,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,etoposide,3,80,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,3,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,3,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,cpt-11,3.5,80,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,etoposide,3.5,60,mg/m2,1,on days I through 3 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,3.5,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
7692002,NA,250,g-csf,3.5,50,ug/m2,1,on days 4 through 17 every 3 to 4 weeks,NA
23930209,NCT01042782,251,mitomycin c,1,5,mg/m2,1,every 3 weeks,NA
23930209,NCT01042782,251,everolimus,1,5,mg,1,daily starting 3 days prior to MMC,NA
23930209,NCT01042782,251,everolimus,1,5,mg,1,daily starting 3 days prior to MMC,NA
23930209,NCT01042782,251,mitomycin c,2,7.5,mg/m2,1,every 3 weeks,NA
23930209,NCT01042782,251,everolimus,2,5,mg,1,daily starting 3 days prior to MMC,NA
23930209,NCT01042782,251,everolimus,2,5,mg,1,daily starting 3 days prior to MMC,NA
23930209,NCT01042782,251,mitomycin c,3,10,mg/m2,1,every 3 weeks,NA
23930209,NCT01042782,251,everolimus,3,5,mg,1,daily starting 3 days prior to MMC,NA
23930209,NCT01042782,251,everolimus,3,5,mg,1,daily starting 3 days prior to MMC,NA
17947729,NA,252,everolimus,1,2.1,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,1,2.1,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,2,3,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,2,3,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,3,5,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,3,5,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,4,6.5,mg/m2,1,daily (one course = 28 days),NA
17947729,NA,252,everolimus,4,6.5,mg/m2,1,daily (one course = 28 days),NA
20975068,NA,253,everolimus,1,5,mg,1,daily,NA
20975068,NA,253,everolimus,1,5,mg,1,daily,NA
20975068,NA,253,paclitaxel,1,80,mg/m2,1,"days 1, 8, and 15, q28 days",NA
20975068,NA,253,trastuzumab,1,2,mg/kg,1,"days 1, 8, and 15, q28 days",NA
20975068,NA,253,everolimus,2,10,mg,1,daily,NA
20975068,NA,253,everolimus,2,10,mg,1,daily,NA
20975068,NA,253,paclitaxel,2,80,mg/m2,1,"days 1, 8, and 15, q28 days",NA
20975068,NA,253,trastuzumab,2,2,mg/kg,1,"days 1, 8, and 15, q28 days",NA
20975068,NA,253,everolimus,3,30,mg,1,weekly,NA
20975068,NA,253,everolimus,3,30,mg,1,weekly,NA
20975068,NA,253,paclitaxel,3,80,mg/m2,1,"days 1, 8, and 15, q28 days",NA
20975068,NA,253,trastuzumab,3,2,mg/kg,1,"days 1, 8, and 15, q28 days",NA
33115815,NCT02152943,254,everolimus,-1,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,-1,2.5,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,-1,LD: 4; MD: 2,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 4 mg/kg on day 1 of cycle 1 and a maintenance dose of 4mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,-1,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,1,5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,1,5,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,1,LD: 4; MD: 2,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 4 mg/kg on day 1 of cycle 1 and a maintenance dose of 2 mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,1,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,2,5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,2,5,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,2,LD: 6; MD: 4,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 6 mg/kg on day 1 of cycle 1 and a maintenance dose of 4 mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,2,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,3,7.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,3,7.5,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,3,LD: 6; MD: 4,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 6 mg/kg on day 1 of cycle 1 and a maintenance dose of 4mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,3,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,4,7.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,4,7.5,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,4,LD: 8; MD: 6,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 8 mg/kg on day 1 of cycle 1 and a maintenance dose of 6 mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,4,2.5,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,5,10,mg,1,daily,NA
33115815,NCT02152943,254,everolimus,5,10,mg,1,daily,NA
33115815,NCT02152943,254,trastuzumab,5,LD:8; MD: 6,mg/kg,1,on day 1 of a 21-day cycle,loading dose of 8 mg/kg on day 1 of cycle 1 and a maintenance dose of 6 mg/kg on day 1 of each subsequent 21-day cycle
33115815,NCT02152943,254,letrozole,5,2.5,mg,1,daily,NA
23475104,NCT00942682,255,sorafenib,1,200,mg,2,daily,NA
23475104,NCT00942682,255,everolimus,1,10,mg,1,daily,NA
23475104,NCT00942682,255,everolimus,1,10,mg,1,daily,NA
23475104,NCT00942682,255,sorafenib,2,"200 in the morning, 400 in the evening",mg,2,daily,NA
23475104,NCT00942682,255,everolimus,2,10,mg,1,daily,NA
23475104,NCT00942682,255,everolimus,2,10,mg,1,daily,NA
25900182,NCT01204476,256,cixutumumab,1,10,mg/kg,1,on day 1 every 21 days for a 21-day cycle,NA
25900182,NCT01204476,256,everolimus,1,10,mg,1,daily,Fixed
25900182,NCT01204476,256,everolimus,1,10,mg,1,daily,Fixed
25900182,NCT01204476,256,octreotide,1,20,mg,1,on day 1 every 21 days for a 21-day cycle,Fixed
25900182,NCT01204476,256,cixutumumab,2,15,mg/kg,1,on day 1 every 21 days for a 21-day cycle,NA
25900182,NCT01204476,256,everolimus,2,10,mg,1,daily,Fixed
25900182,NCT01204476,256,everolimus,2,10,mg,1,daily,Fixed
25900182,NCT01204476,256,octreotide,2,20,mg,1,on day 1 every 21 days for a 21-day cycle,Fixed
31654285,NCT01582009,257,panobinostat,2,20,mg,1,"3 times weekly on Monday, Wednesday, Friday (MWF) during weeks 1 and 2 (days 1, 3, 5, 8, 10, 12)",NA
31654285,NCT01582009,257,everolimus,2,10,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,everolimus,2,10,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,panobinostat,1.5,10,mg,1,"3 times weekly on Monday, Wednesday, Friday (MWF) during weeks 1 and 2 (days 1, 3, 5, 8, 10, 12)",NA
31654285,NCT01582009,257,everolimus,1.5,10,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,everolimus,1.5,10,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,panobinostat,1,10,mg,1,"3 times weekly on Monday, Wednesday, Friday (MWF) during weeks 1 and 2 (days 1, 3, 5, 8, 10, 12)",NA
31654285,NCT01582009,257,everolimus,1,5,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,everolimus,1,5,mg,1,daily for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,panobinostat,-1,5,mg,1,"3 times weekly on Monday, Wednesday, Friday (MWF) during weeks 1 and 2 (days 1, 3, 5, 8, 10, 12)",NA
31654285,NCT01582009,257,everolimus,-1,5,mg,1,every other day for the duration of the 21-day cycle,NA
31654285,NCT01582009,257,everolimus,-1,5,mg,1,every other day for the duration of the 21-day cycle,NA
1403040,NA,258,etoposide,1,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,1,LD: 2; CI: 5,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,1,LD: 2; CI: 5,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,2,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,2,LD: 2.5; CI: 6.25,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,2,LD: 2.5; CI: 6.25,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,3,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,3,LD: 3; CI: 7.8,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,3,LD: 3; CI: 7.8,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,4,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,4,LD: 3.5; CI: 9.8,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,4,LD: 3.5; CI: 9.8,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,5,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,5,LD: 4; CI: 12.2,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,5,LD: 4; CI: 12.2,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,6,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,6,LD: 4.5; CI: 14.6,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,6,LD: 4.5; CI: 14.6,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,6.5,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,6.5,LD: 5; CI: 15,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,6.5,LD: 5; CI: 15,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,7,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,7,LD: 5; CI: 17.6,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,7,LD: 5; CI: 17.6,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,7.5,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,7.5,LD: 6; CI: 18.0,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,7.5,LD: 6; CI: 18.0,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,etoposide,8,150 to 200,mg/m2,1,daily for 3 days every 3 to 4 weeks,fixed
1403040,NA,258,cyclosporine,8,LD: 7; CI: 21,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
1403040,NA,258,cyclosporine,8,LD: 7; CI: 21,mg/kg,1,"an IV loading dose (LD) during a 2-hour period, followed by a continuous infusion (CI) for 3 days (72 hours) every 3 to 4 weeks",NA
25701455,NA,259,everolimus,1,10,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,1,10,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,1,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
25701455,NA,259,everolimus,2,20,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,2,20,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,2,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
25701455,NA,259,everolimus,3,50,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,3,50,mg,1,"weekly for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,3,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
25701455,NA,259,everolimus,1.5,2.5,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,1.5,2.5,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,1.5,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
25701455,NA,259,everolimus,2.5,5,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,2.5,5,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,2.5,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
25701455,NA,259,everolimus,3.5,10,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,everolimus,3.5,10,mg,1,"daily for 11 weeks: 1 week before, and during radiotherapy until 3.5 weeks after the end of radiotherapy",NA
25701455,NA,259,thoracic radiotherapy,3.5,2,Gy,1,"66 Gy in 6.5 weeks, 5 fractions/week",NA
22169794,NA,260,everolimus,1,2.5,mg,1,daily,NA
22169794,NA,260,everolimus,1,2.5,mg,1,daily,NA
22169794,NA,260,sorafenib,1,400,mg,2,daily,NA
22169794,NA,260,everolimus,2,5,mg,1,daily,NA
22169794,NA,260,everolimus,2,5,mg,1,daily,NA
22169794,NA,260,sorafenib,2,400,mg,2,daily,NA
22169794,NA,260,everolimus,3,10,mg,1,daily,NA
22169794,NA,260,everolimus,3,10,mg,1,daily,NA
22169794,NA,260,sorafenib,3,400,mg,2,daily,NA
24740268,NA,261,gemcitabine,-2,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,-2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,everolimus,-2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,gemcitabine,-1,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,-1,5,mg,1,daily,NA
24740268,NA,261,everolimus,-1,5,mg,1,daily,NA
24740268,NA,261,gemcitabine,0,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,0,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,everolimus,0,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,1,5,mg,1,daily,NA
24740268,NA,261,everolimus,1,5,mg,1,daily,NA
24740268,NA,261,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,everolimus,2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,261,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,3,5,mg,1,daily,NA
24740268,NA,261,everolimus,3,5,mg,1,daily,NA
24740268,NA,261,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,261,everolimus,4,10,mg,1,daily,NA
24740268,NA,261,everolimus,4,10,mg,1,daily,NA
24740268,NA,262,gemcitabine,-2,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,-2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,everolimus,-2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,cisplatin,-2,12.5,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,-2,12.5,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,-1,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,-1,5,mg,1,daily,NA
24740268,NA,262,everolimus,-1,5,mg,1,daily,NA
24740268,NA,262,cisplatin,-1,12.5,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,-1,12.5,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,0,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,0,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,everolimus,0,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,cisplatin,0,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,0,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,1,5,mg,1,daily,NA
24740268,NA,262,everolimus,1,5,mg,1,daily,NA
24740268,NA,262,cisplatin,1,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,1,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,everolimus,2,5,mg,1,on MWF weekly of each 21-day cycle,NA
24740268,NA,262,cisplatin,2,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,2,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,3,5,mg,1,daily,NA
24740268,NA,262,everolimus,3,5,mg,1,daily,NA
24740268,NA,262,cisplatin,3,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,3,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,everolimus,4,10,mg,1,daily,NA
24740268,NA,262,everolimus,4,10,mg,1,daily,NA
24740268,NA,262,cisplatin,4,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24740268,NA,262,cisplatin,4,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
21107682,NCT00426530,263,everolimus,1,5,mg,1,daily,NA
21107682,NCT00426530,263,everolimus,1,5,mg,1,daily,NA
21107682,NCT00426530,263,trastuzumab,1,2,mg/kg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,vinorelbine,1,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
21107682,NCT00426530,263,everolimus,2,10,mg,1,daily,NA
21107682,NCT00426530,263,everolimus,2,10,mg,1,daily,NA
21107682,NCT00426530,263,trastuzumab,2,2,mg/kg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,vinorelbine,2,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
21107682,NCT00426530,263,everolimus,-1,2.5,mg,1,daily,NA
21107682,NCT00426530,263,everolimus,-1,2.5,mg,1,daily,NA
21107682,NCT00426530,263,trastuzumab,-1,2,mg/kg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,vinorelbine,-1,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
21107682,NCT00426530,263,everolimus,3,20,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,everolimus,3,20,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,trastuzumab,3,2,mg/kg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,vinorelbine,3,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
21107682,NCT00426530,263,everolimus,4,30,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,everolimus,4,30,mg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,trastuzumab,4,2,mg/kg,1,"on days 1, 8, and 15 of each 21-day cycle",NA
21107682,NCT00426530,263,vinorelbine,4,25,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
34562750,NCT02432274,264,lenvatinib,-1,9,mg/m2,1,daily on days 1 to 28 of each 28-day cycle,NA
34562750,NCT02432274,264,lenvatinib,1,11,mg/m2,1,daily on days 1 to 28 of each 28-day cycle,NA
34562750,NCT02432274,264,lenvatinib,2,14,mg/m2,1,daily on days 1 to 28 of each 28-day cycle,NA
34562750,NCT02432274,264,lenvatinib,3,17,mg/m2,1,daily on days 1 to 28 of each 28-day cycle,NA
32998962,NCT01857193,265,ribociclib,1,200,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fed cohort
32998962,NCT01857193,265,exemestane,1,25,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,1,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,1,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,ribociclib,2,250,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fed cohort
32998962,NCT01857193,265,exemestane,2,25,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,2,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,2,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,ribociclib,3,300,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fed cohort
32998962,NCT01857193,265,exemestane,3,25,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,3,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,3,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,ribociclib,4,350,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fed cohort
32998962,NCT01857193,265,exemestane,4,25,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,4,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,4,2.5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,ribociclib,5,200,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fed cohort
32998962,NCT01857193,265,exemestane,5,25,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,5,5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,everolimus,5,5,mg,1,daily in 28-day cycles,fed cohort
32998962,NCT01857193,265,ribociclib,1.5,200,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fasting cohort
32998962,NCT01857193,265,exemestane,1.5,25,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,1.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,1.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,ribociclib,2.5,250,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fasting cohort
32998962,NCT01857193,265,exemestane,2.5,25,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,2.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,2.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,ribociclib,3.5,300,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fasting cohort
32998962,NCT01857193,265,exemestane,3.5,25,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,3.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,3.5,2.5,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,ribociclib,4.5,350,mg,1,daily for 21 consecutive days followed by 7 days off treatment,fasting cohort
32998962,NCT01857193,265,exemestane,4.5,25,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,4.5,1,mg,1,daily in 28-day cycles,fasting cohort
32998962,NCT01857193,265,everolimus,4.5,1,mg,1,daily in 28-day cycles,fasting cohort
27093189,NA,266,5-fluorouracil,1,400,mg/m2,1,slow push on day 1 every 28 days,NA
27093189,NA,266,5-fluorouracil,1,2400,mg/m2,NA,continuous infusion days 1–2 every 28 days,NA
27093189,NA,266,leucovorin,1,400,mg/m2,1,every 2 weeks,NA
27093189,NA,266,oxaliplatin,1,85,mg/m2,1,every 2 weeks,NA
27093189,NA,266,oxaliplatin,1,85,mg/m2,1,every 2 weeks,NA
27093189,NA,266,everolimus,1,1.5,mg,1,daily,NA
27093189,NA,266,everolimus,1,1.5,mg,1,daily,NA
29739790,NA,267,panitumumab,-1,4.8,mg/kg,1,every 14 days,NA
29739790,NA,267,irinotecan,-1,150,mg/m2,1,every 14 days,NA
29739790,NA,267,everolimus,-1,5,mg,1,daily,NA
29739790,NA,267,everolimus,-1,5,mg,1,daily,NA
29739790,NA,267,panitumumab,1,6,mg/kg,1,every 14 days,NA
29739790,NA,267,irinotecan,1,200,mg/m2,1,every 14 days,NA
29739790,NA,267,everolimus,1,5,mg,1,daily,NA
29739790,NA,267,everolimus,1,5,mg,1,daily,NA
29739790,NA,267,panitumumab,2,6,mg/kg,1,every 14 days,NA
29739790,NA,267,irinotecan,2,200,mg/m2,1,every 14 days,NA
29739790,NA,267,everolimus,2,5,mg,1,daily,NA
29739790,NA,267,everolimus,2,5,mg,1,daily,NA
29739790,NA,267,panitumumab,3,5,mg/kg,1,every 14 days,NA
29739790,NA,267,irinotecan,3,200,mg/m2,1,every 14 days,NA
29739790,NA,267,everolimus,3,10,mg,1,daily,NA
29739790,NA,267,everolimus,3,10,mg,1,daily,NA
23725999,NA,268,everolimus,1,2.5,mg,1,daily with concurrent radiation,NA
23725999,NA,268,everolimus,1,2.5,mg,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,1,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,1,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,radiation therapy,1,60,Gy,NA,in 30 fractions of 2 Gy,NA
23725999,NA,268,everolimus,2,5,mg,1,daily with concurrent radiation,NA
23725999,NA,268,everolimus,2,5,mg,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,2,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,2,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,radiation therapy,2,60,Gy,NA,in 30 fractions of 2 Gy,NA
23725999,NA,268,everolimus,3,10,mg,1,daily with concurrent radiation,NA
23725999,NA,268,everolimus,3,10,mg,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,3,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,temozolomide,3,75,mg/m2,1,daily with concurrent radiation,NA
23725999,NA,268,radiation therapy,3,60,Gy,NA,in 30 fractions of 2 Gy,NA
33721621,NCT01582191,269,vandetanib,0,100,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,0,2.5,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,0,2.5,NA,1,daily,NA
33721621,NCT01582191,269,vandetanib,1,200,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,1,2.5,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,1,2.5,NA,1,daily,NA
33721621,NCT01582191,269,vandetanib,2,200,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,2,5,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,2,5,NA,1,daily,NA
33721621,NCT01582191,269,vandetanib,3,300,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,3,5,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,3,5,NA,1,daily,NA
33721621,NCT01582191,269,vandetanib,4,300,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,4,10,NA,1,daily,NA
33721621,NCT01582191,269,everolimus,4,10,NA,1,daily,NA
18039566,NA,270,everolimus,1,5,mg,1,daily,NA
18039566,NA,270,everolimus,1,5,mg,1,daily,NA
18039566,NA,270,letrozole,1,2.5,mg,1,daily,fixed
18039566,NA,270,everolimus,2,10,mg,1,daily,NA
18039566,NA,270,everolimus,2,10,mg,1,daily,NA
18039566,NA,270,letrozole,2,2.5,mg,1,daily,fixed
26699397,NCT00935792,271,everolimus,1,2.5,mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 1  for 9 weeks",NA
26699397,NCT00935792,271,everolimus,1,2.5,mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 1  for 9 weeks",NA
26699397,NCT00935792,271,alemtuzumab,1,"3 mg–10 mg–30 mg during the first week if tolerated
after which 30 mg was given M-W-F",mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 8  for 8 weeks",NA
26699397,NCT00935792,271,everolimus,2,5,mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 1  for 9 weeks",NA
26699397,NCT00935792,271,everolimus,2,5,mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 1  for 9 weeks",NA
26699397,NCT00935792,271,alemtuzumab,2,"3 mg–10 mg–30 mg during the first week if tolerated
after which 30 mg was given M-W-F",mg,1,"on Monday, Wednesday, and Friday (M-W-F) from day 8  for 8 weeks",NA
33738668,NCT01784861,272,vorolanib,1,100,mg,1,daily on a 28-day cycle,NA
33738668,NCT01784861,272,everolimus,1,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,everolimus,1,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,vorolanib,2,150,mg,1,daily on a 28-day cycle,NA
33738668,NCT01784861,272,everolimus,2,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,everolimus,2,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,vorolanib,3,200,mg,1,daily on a 28-day cycle,NA
33738668,NCT01784861,272,everolimus,3,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,everolimus,3,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,vorolanib,4,300,mg,1,daily on a 28-day cycle,NA
33738668,NCT01784861,272,everolimus,4,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,everolimus,4,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,vorolanib,5,400,mg,1,daily on a 28-day cycle,NA
33738668,NCT01784861,272,everolimus,5,10,mg,1,daily on a 28-day cycle,fixed
33738668,NCT01784861,272,everolimus,5,10,mg,1,daily on a 28-day cycle,fixed
20953860,NA,273,flavopiridol,1,40,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,1,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,1,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,1,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,1,1800,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,2,50,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,2,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,2,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,2,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,2,1800,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,3,50,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,3,125,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,3,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,3,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,3,1800,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,4,50,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,4,125,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,4,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,4,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,4,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,5,50,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,5,150,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,5,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,5,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,5,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,6,60,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,6,150,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,6,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,6,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,6,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,7,60,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,7,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,7,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,7,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,7,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,8,70,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,8,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,8,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,8,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,8,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,9,80,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,9,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,9,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,9,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,9,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,10,90,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,irinotecan,10,180,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,leucovorin,10,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,10,400,mg/m2,1,weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,fluorouracil,10,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,bolus schedule
20953860,NA,273,flavopiridol,11,35,mg/m2,2,30-min bolus followed by a 4-h infusion weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,irinotecan,11,180,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,leucovorin,11,400,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,fluorouracil,11,400,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,fluorouracil,11,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,flavopiridol,12,40,mg/m2,2,30-min bolus followed by a 4-h infusion weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,irinotecan,12,180,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,leucovorin,12,400,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,fluorouracil,12,400,mg/m2,1,weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20953860,NA,273,fluorouracil,12,2400,mg/m2,1,48-h infusion(after bolus fluorouracil) weekly for 4 of every 6 weeks,split-dose Xavopiridol cohort
20461440,NA,274,vorinostat,1,400,mg,1,on days 1–3 and 8–10 of each 21-day cycle,NA
20461440,NA,274,flavopiridol,1,60,mg/m2,1,on day 2 and 9 of each 21-day cycle,fixed
20461440,NA,274,vorinostat,2,600,mg,1,on days 1–3 and 8–10 of each 21-day cycle,NA
20461440,NA,274,flavopiridol,2,60,mg/m2,1,on day 2 and 9 of each 21-day cycle,fixed
20461440,NA,274,vorinostat,3,800,mg,1,on days 1–3 and 8–10 of each 21-day cycle,NA
20461440,NA,274,flavopiridol,3,60,mg/m2,1,on day 2 and 9 of each 21-day cycle,fixed
20461440,NA,274,vorinostat,4,600,NA,1,on days 1–3 and 8–10 of each 21-day cycle,NA
20461440,NA,274,flavopiridol,4,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 9 of each 21-day cycle,fixed
20461440,NA,274,vorinostat,5,400,mg,1,on days 1–3 and 8–10 of each 21-day cycle,NA
20461440,NA,274,flavopiridol,5,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 9 of each 21-day cycle,fixed
20461440,NA,274,vorinostat,6,400,mg,1,on days 1–3 and 15–17 of each 28-day cycle,NA
20461440,NA,274,flavopiridol,6,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 16 of each 28-day cycle,fixed
20461440,NA,274,vorinostat,7,600,mg,1,on days 1–3 and 15–17 of each 28-day cycle,NA
20461440,NA,274,flavopiridol,7,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 16 of each 28-day cycle,fixed
20461440,NA,274,vorinostat,8,800,mg,1,on days 1–3 and 15–17 of each 28-day cycle,NA
20461440,NA,274,flavopiridol,8,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 16 of each 28-day cycle,fixed
20461440,NA,274,vorinostat,9,1000,mg,1,on days 1–3 and 15–17 of each 28-day cycle,NA
20461440,NA,274,flavopiridol,9,30,mg/m2,2,a split-dose schedule of flavopiridol 30 mg/m2 over 30 min followed by 30 mg/m2 over 4 h on day 2 and 16 of each 28-day cycle,fixed
9790795,NA,275,vinorelbine,1,20,mg/m2,1,daily for 3 consecutive days every 21 days,NA
9790795,NA,275,vinorelbine,2,25,mg/m2,1,daily for 3 consecutive days every 21 days,NA
9790795,NA,275,vinorelbine,3,20,mg/m2,1,daily for 3 consecutive days every 21 days,with filgrastim support
9790795,NA,275,vinorelbine,4,25,mg/m2,1,daily for 3 consecutive days every 21 days,with filgrastim support
9790795,NA,275,vinorelbine,5,30,mg/m2,1,daily for 3 consecutive days every 21 days,with filgrastim support
33423090,NCT00387504,277,fenretinide,1,1280,mg/m2,1,a continuous intravenous (CIV) infusion for fve consecutive days (D1 through D5) in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,0,724,mg/m2,1,a continuous intravenous (CIV) infusion for fve consecutive days (D1 through D5) in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,1.5,905,mg/m2,1,a continuous intravenous (CIV) infusion for fve consecutive days (D1 through D5) in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,2,1131,mg/m2,1,a continuous intravenous (CIV) infusion for fve consecutive days (D1 through D5) in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,2.5,600,mg/m2,1,on day 1 in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,2.5,1131,mg/m2,1,a continuous intravenous (CIV) infusion for four consecutive days (D2 through D5) in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,3,600,mg/m2,1,on day 1 in 21-day cycles,NA
33423090,NCT00387504,277,fenretinide,3,1414,mg/m2,1,a continuous intravenous (CIV) infusion for four consecutive days (D2 through D5) in 21-day cycles,NA
23515411,NA,278,alvocidib,1,10,mg/m2,1,on days 1 to 5 of a 21-day cycle,NA
23515411,NA,278,vorinostat,1,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,2,20,mg/m2,1,on days 1 to 5 of a 21-day cycle,NA
23515411,NA,278,vorinostat,2,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,3,30,mg/m2,1,on days 1 to 5 of a 21-day cycle,NA
23515411,NA,278,vorinostat,3,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,4,40,mg/m2,1,on days 1 to 5 of a 21-day cycle,NA
23515411,NA,278,vorinostat,4,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,5,LD: 20; MD: 20,mg/m2,1,"on days 1, 8 of a 21-day cycle",NA
23515411,NA,278,vorinostat,5,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,6,LD: 30; MD: 20,mg/m2,1,"on days 1, 8 of a 21-day cycle",NA
23515411,NA,278,vorinostat,6,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
23515411,NA,278,alvocidib,6.5,LD: 30; MD: 30,mg/m2,1,"on days 1, 8 of a 21-day cycle",NA
23515411,NA,278,vorinostat,6.5,200,mg,3,on days 1 to 14 of a 21-day cycle,NA
9681085,NA,279,paclitaxel,1,100,mg/m2,1,on day 2 every 21 day,NA
9681085,NA,279,ifosfamide,1,1600,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,vinorelbine,1,25,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,filgrastim,1,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,filgrastim,1,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,paclitaxel,2,100,mg/m2,1,on day 2 every 21 day,NA
9681085,NA,279,ifosfamide,2,1200,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,vinorelbine,2,20,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,filgrastim,2,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,filgrastim,2,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,paclitaxel,3,135,mg/m2,1,on day 2 every 21 day,NA
9681085,NA,279,ifosfamide,3,1200,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,vinorelbine,3,20,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,filgrastim,3,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,filgrastim,3,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,paclitaxel,4,150,mg/m2,1,on day 2 every 21 day,NA
9681085,NA,279,ifosfamide,4,1200,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,vinorelbine,4,20,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,filgrastim,4,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,filgrastim,4,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,paclitaxel,5,175,mg/m2,1,on day 2 every 21 day,NA
9681085,NA,279,ifosfamide,5,1200,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,vinorelbine,5,20,mg/m2,1,on days 1-3 every 21 day,NA
9681085,NA,279,filgrastim,5,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
9681085,NA,279,filgrastim,5,5,mg/kg,1,"starting on day 5 and continuing until the post-nadir absolute neutrophil count was >= 10,000/mcl",NA
29392425,NCT01435343,280,fludarabine,1,30,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,idarubicin,1,10,mg/m2,1,on days 1 to 3,fixed
29392425,NCT01435343,280,cytarabine,1,1000,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,plerixafor,1,120,ug/kg/per 12h,2,on days 1 to 4,NA
29392425,NCT01435343,280,g-csf,1,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,g-csf,1,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,fludarabine,2,30,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,idarubicin,2,10,mg/m2,1,on days 1 to 3,fixed
29392425,NCT01435343,280,cytarabine,2,1000,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,plerixafor,2,160,ug/kg/per 12h,2,on days 1 to 4,NA
29392425,NCT01435343,280,g-csf,2,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,g-csf,2,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,fludarabine,3,30,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,idarubicin,3,10,mg/m2,1,on days 1 to 3,fixed
29392425,NCT01435343,280,cytarabine,3,1000,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,plerixafor,3,200,ug/kg/per 12h,2,on days 1 to 4,NA
29392425,NCT01435343,280,g-csf,3,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,g-csf,3,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,fludarabine,4,30,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,idarubicin,4,10,mg/m2,1,on days 1 to 3,fixed
29392425,NCT01435343,280,cytarabine,4,1000,mg/m2,1,on days 1 to 4,fixed
29392425,NCT01435343,280,plerixafor,4,240,ug/kg/per 12h,2,on days 1 to 4,NA
29392425,NCT01435343,280,g-csf,4,5,ug/kg,1,on days 1 to 4,fixed
29392425,NCT01435343,280,g-csf,4,5,ug/kg,1,on days 1 to 4,fixed
27655665,NCT01096992,281,bendamustine,1,20,mg/m2,1,"on Days 1,2,3 every 4 weeks",NA
27655665,NCT01096992,281,fludarabine,1,20,mg/m2,1,"days 2-4 during course 1, and days 1-3 during courses 2-6",fixed
27655665,NCT01096992,281,rituximab,1,375,mg/m2,1,Day 4 during course 1,fixed
27655665,NCT01096992,281,rituximab,1,500,mg/m2,1,Day 1 during courses 2-6,fixed
27655665,NCT01096992,281,bendamustine,2,30,mg/m2,1,"on Days 1,2,3 every 4 weeks",NA
27655665,NCT01096992,281,fludarabine,2,20,mg/m2,1,"days 2-4 during course 1, and days 1-3 during courses 2-6",fixed
27655665,NCT01096992,281,rituximab,2,375,mg/m2,1,Day 4 during course 1,fixed
27655665,NCT01096992,281,rituximab,2,500,mg/m2,1,Day 1 during courses 2-6,fixed
27655665,NCT01096992,281,bendamustine,3,40,mg/m2,1,"on Days 1,2,3 every 4 weeks",NA
27655665,NCT01096992,281,fludarabine,3,20,mg/m2,1,"days 2-4 during course 1, and days 1-3 during courses 2-6",fixed
27655665,NCT01096992,281,rituximab,3,375,mg/m2,1,Day 4 during course 1,fixed
27655665,NCT01096992,281,rituximab,3,500,mg/m2,1,Day 1 during courses 2-6,fixed
27655665,NCT01096992,281,bendamustine,4,50,mg/m2,1,"on Days 1,2,3 every 4 weeks",NA
27655665,NCT01096992,281,fludarabine,4,20,mg/m2,1,"days 2-4 during course 1, and days 1-3 during courses 2-6",fixed
27655665,NCT01096992,281,rituximab,4,375,mg/m2,1,Day 4 during course 1,fixed
27655665,NCT01096992,281,rituximab,4,500,mg/m2,1,Day 1 during courses 2-6,fixed
9256828,NA,282,idarubicin,1,6,mg/m2,1,"on days 0, 1, and 2",NA
9256828,NA,282,fludarabine,1,10.5,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,fludarabine,1,1.27,mg/m2/hour,NA,continuous infusion of 48 h,fixed
9256828,NA,282,cytarabine,1,390,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,cytarabine,1,101,mg/m2/hour,NA,continuous infusion of 72 h,fixed
9256828,NA,282,idarubicin,2,9,mg/m2,1,"on days 0, 1, and 2",NA
9256828,NA,282,fludarabine,2,10.5,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,fludarabine,2,1.27,mg/m2/hour,NA,continuous infusion of 48 h,fixed
9256828,NA,282,cytarabine,2,390,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,cytarabine,2,101,mg/m2/hour,NA,continuous infusion of 72 h,fixed
9256828,NA,282,idarubicin,3,12,mg/m2,1,"on days 0, 1, and 2",NA
9256828,NA,282,fludarabine,3,10.5,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,fludarabine,3,1.27,mg/m2/hour,NA,continuous infusion of 48 h,fixed
9256828,NA,282,cytarabine,3,390,mg/m2,1,loading dose over 15 min,fixed
9256828,NA,282,cytarabine,3,101,mg/m2/hour,NA,continuous infusion of 72 h,fixed
23228986,NCT00559624,283,acadesine,1,50,mg/kg,1,on Day 1 every 21 days,NA
23228986,NCT00559624,283,acadesine,2,83.5,mg/kg,1,on Day 1 every 21 days,NA
23228986,NCT00559624,283,acadesine,3,139.5,mg/kg,1,on Day 1 every 21 days,NA
23228986,NCT00559624,283,acadesine,4,210,mg/kg,1,on Day 1 every 21 days,NA
23228986,NCT00559624,283,acadesine,5,315,mg/kg,1,on Day 1 every 21 days,NA
27862308,NA,284,alemtuzumab,1,10,mg,1,once weekly for up to 8 wk with treatment start no earlier than 90 d and no later than 150 d after the last dose of induction therapy,NA
27862308,NA,284,alemtuzumab,2,20,mg,1,once weekly for up to 8 wk with treatment start no earlier than 90 d and no later than 150 d after the last dose of induction therapy,NA
27862308,NA,284,alemtuzumab,1.5,10,mg,1,once weekly for up to 8 wk with treatment start no earlier than 90 d and no later than 150 d after the last dose of induction therapy,NA
25684345,NCT00462358,286,filanesib,1,2.5,mg/m2,1,on Day 1 of each 3- week cycle,NA
25684345,NCT00462358,286,filanesib,2,3.3,mg/m2,1,on Day 1 of each 3- week cycle,NA
25684345,NCT00462358,286,filanesib,1.5,1.25,mg/m2,1,on Day 1 and Day 2 of each 2-week treatment cycle,NA
25684345,NCT00462358,286,filanesib,2.5,1.6,mg/m2,1,on Day 1 and Day 2 of each 2-week treatment cycle,NA
25684345,NCT00462358,286,filanesib,3,1.6,mg/m2,1,on Day 1 and Day 2 of each 2-week treatment cycle,with filgrastim
25684345,NCT00462358,286,filanesib,4,2,mg/m2,1,on Day 1 and Day 2 of each 2-week treatment cycle,with filgrastim
23959599,NA,287,flavopiridol,1,30 mg/m2 bolus + 30 mg/m2 continuous infusion,mg/m2,1,4 consecutive weeks every 6 weeks,NA
23959599,NA,287,flavopiridol,2,30 mg/m2 bolus + 50 mg/m2 continuous infusion,mg/m2,1,4 consecutive weeks every 6 weeks,NA
23959599,NA,287,flavopiridol,3,50 mg/m2 bolus + 50 mg/m2 continuous infusion,mg/m2,1,4 consecutive weeks every 6 weeks,NA
22402597,NA,288,fludarabine,1,10,mg/m2,1,"3–4 h before radiotherapy, day 1–5, week 5–6",NA
22402597,NA,288,radiotherapy,1,2,Gy,1,5 days/week for 6 weeks to 60 Gy,NA
22402597,NA,288,fludarabine,2,13,mg/m2,1,"3–4 h before radiotherapy, day 1–5, week 5–6",NA
22402597,NA,288,radiotherapy,2,2,Gy,1,5 days/week for 6 weeks to 60 Gy,NA
22402597,NA,288,fludarabine,3,16,mg/m2,1,"3–4 h before radiotherapy, day 1–5, week 5–6",NA
22402597,NA,288,radiotherapy,3,2,Gy,1,5 days/week for 6 weeks to 60 Gy,NA
9923543,NA,289,vinorelbine,1,15,mg/m2,1,"on days 1, 2, and 3 on an every 21-day schedule",NA
9923543,NA,289,filgrastim,1,0,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,filgrastim,1,0,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,vinorelbine,2,20,mg/m2,1,"on days 1, 2, and 3 on an every 21-day schedule",NA
9923543,NA,289,filgrastim,2,0,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,filgrastim,2,0,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,vinorelbine,3,15,mg/m2,1,"on days 1, 2, and 3 on an every 21-day schedule",NA
9923543,NA,289,filgrastim,3,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,filgrastim,3,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,vinorelbine,4,20,mg/m2,1,"on days 1, 2, and 3 on an every 21-day schedule",NA
9923543,NA,289,filgrastim,4,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,filgrastim,4,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,vinorelbine,5,25,mg/m2,1,"on days 1, 2, and 3 on an every 21-day schedule",NA
9923543,NA,289,filgrastim,5,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9923543,NA,289,filgrastim,5,5,ug/kg,1,started on day 4 of the 21-day cycle and continued daily until the total neutrophil count exceeded 10 000 cells/mm3,NA
9626219,NA,290,krn8602,1,10,mg/m2,1,every 21 days,NA
9626219,NA,290,krn8602,2,20,mg/m2,1,every 21 days,NA
9626219,NA,290,krn8602,3,30,mg/m2,1,every 21 days,NA
9626219,NA,290,krn8602,4,40,mg/m2,1,every 21 days,NA
9626219,NA,290,krn8602,5,50,mg/m2,1,every 21 days,NA
9626219,NA,290,krn8602,5.5,50,mg/m2,1,every 21 days,with filgrastim
9626219,NA,290,krn8602,6,60,mg/m2,1,every 21 days,with filgrastim
9626219,NA,290,krn8602,7,70,mg/m2,1,every 21 days,with filgrastim
9626219,NA,290,krn8602,8,80,mg/m2,1,every 21 days,with filgrastim
16463060,NA,291,nv06,-2,1,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,-1,2.5,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,0,5,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,1,10,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,2,15,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,3,20,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,4,25,mg/kg,1,weekly every 4 weeks,NA
16463060,NA,291,nv06,5,30,mg/kg,1,weekly every 4 weeks,NA
8622024,NA,292,paclitaxel,1,135,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,1,750,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,1,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,1,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,2,170,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,2,750,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,2,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,2,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,3,200,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,3,750,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,3,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,3,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,4,200,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,4,1000,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,4,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,4,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,5,250,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,5,1000,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,5,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,5,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,6,250,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,6,1250,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,6,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,6,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,7,200,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,7,1250,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,7,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,7,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,8,200,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,8,1600,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,8,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,8,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,paclitaxel,9,200,mg/m2,1,every 21 days,NA
8622024,NA,292,cyclophosphamide,9,2000,mg/m2,1,every 21 days,NA
8622024,NA,292,filgrastim,9,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
8622024,NA,292,filgrastim,9,5,ug/kg,1,beginning no sooner than 24 hours after the end of chemotherapy,NA
12073049,NA,293,topotecan,1,0.75,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,topotecan,1,0.75,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,ifosfamide,1,750,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,mesna,1,300,mg/m2,3,on days 1–5 every 21 days,NA
12073049,NA,293,topotecan,2,1,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,topotecan,2,1,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,ifosfamide,2,750,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,mesna,2,300,mg/m2,3,on days 1–5 every 21 days,NA
12073049,NA,293,topotecan,3,1.25,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,topotecan,3,1.25,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,ifosfamide,3,750,mg/m2,1,on days 1–5 every 21 days,NA
12073049,NA,293,mesna,3,300,mg/m2,3,on days 1–5 every 21 days,NA
12351605,NA,294,flavopiridol,1,12,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,2,17,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,3,24,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,4,30,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,5,37.5,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,6,52.5,mg/m2,1,daily for 5 days every 3 weeks,NA
12351605,NA,294,flavopiridol,7,50,mg/m2,1,daily for 3 days every 3 weeks,NA
12351605,NA,294,flavopiridol,8,62.5,mg/m2,1,daily for 3 days every 3 weeks,NA
12351605,NA,294,flavopiridol,9,62.5,mg/m2,1,once every 3 weeks,NA
12351605,NA,294,flavopiridol,10,78,mg/m2,1,once every 3 weeks,NA
12451473,NA,295,flavopiridol,1,8,mg/m2,1,72-h continuous infusion every 2 weeks,NA
12451473,NA,295,flavopiridol,2,16,mg/m2,1,72-h continuous infusion every 2 weeks,NA
12451473,NA,295,flavopiridol,3,26.6,mg/m2,1,72-h continuous infusion every 2 weeks,NA
12451473,NA,295,flavopiridol,4,40,mg/m2,1,72-h continuous infusion every 2 weeks,NA
12451473,NA,295,flavopiridol,5,56,mg/m2,1,72-h continuous infusion every 2 weeks,NA
12451473,NA,295,flavopiridol,6,50,mg/m2,1,72-h continuous infusion every 2 weeks,NA
9164208,NA,296,paclitaxel,1,150,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,paclitaxel,2,175,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,paclitaxel,3,200,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,3,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,3,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,paclitaxel,4,225,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,4,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,4,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,paclitaxel,5,250,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,5,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,5,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,paclitaxel,6,275,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,6,75,mg/m2,1,on day 1 of each 21-day cycle,NA
9164208,NA,296,cisplatin,6,75,mg/m2,1,on day 1 of each 21-day cycle,NA
11822765,NA,297,irinotecan,1,125,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,2,150,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,3,175,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,4,200,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,5,225,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,6,250,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,7,275,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,297,irinotecan,8,300,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,298,irinotecan,1,300,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,298,g-csf,1,300,ug,1,"starting on day 2 of each cycle and continuing until the post-nadir absolute neutrophil count (ANC) was >= 10,000/mm3",NA
11822765,NA,298,g-csf,1,300,ug,1,"starting on day 2 of each cycle and continuing until the post-nadir absolute neutrophil count (ANC) was >= 10,000/mm3",NA
11822765,NA,298,irinotecan,2,325,mg/m2,1,on day 1 every two weeks,NA
11822765,NA,298,g-csf,2,300,ug,1,"starting on day 2 of each cycle and continuing until the post-nadir absolute neutrophil count (ANC) was >= 10,000/mm3",NA
11822765,NA,298,g-csf,2,300,ug,1,"starting on day 2 of each cycle and continuing until the post-nadir absolute neutrophil count (ANC) was >= 10,000/mm3",NA
18766965,NA,299,gemcitabine,1,10,mg/m2/min,1,3h on day 1,NA
18766965,NA,299,fludarabine,1,25,mg/m2,1,days 1–5,NA
18766965,NA,299,mitoxantrone,1,10,mg/m2,1,days 1–3,NA
18766965,NA,299,gemcitabine,2,10,mg/m2/min,1,6h on day 1,NA
18766965,NA,299,fludarabine,2,25,mg/m2,1,days 1–5,NA
18766965,NA,299,mitoxantrone,2,10,mg/m2,1,days 1–3,NA
18766965,NA,299,gemcitabine,3,10,mg/m2/min,1,9h on day 1,NA
18766965,NA,299,fludarabine,3,25,mg/m2,1,days 1–5,NA
18766965,NA,299,mitoxantrone,3,10,mg/m2,1,days 1–3,NA
18766965,NA,299,gemcitabine,4,10,mg/m2/min,1,12h on day 1,NA
18766965,NA,299,fludarabine,4,25,mg/m2,1,days 1–5,NA
18766965,NA,299,mitoxantrone,4,10,mg/m2,1,days 1–3,NA
18766965,NA,299,gemcitabine,5,10,mg/m2/min,1,15h on day 1,NA
18766965,NA,299,fludarabine,5,25,mg/m2,1,days 1–5,NA
18766965,NA,299,mitoxantrone,5,10,mg/m2,1,days 1–3,NA
32998965,NCT03298984,302,alvocidib,1,20 i.v. bolus followed by 30 i.v. infusion over 4 hours,mg/m2,1,on days 1–3,NA
32998965,NCT03298984,302,cytarabine,1,100,mg/m2,1,on days 5–11,fixed
32998965,NCT03298984,302,daunorubicin,1,60,mg/m2,1,on days 5–7,fixed
32998965,NCT03298984,302,alvocidib,2,30 i.v. bolus followed by 40 i.v. infusion over 4 hours,mg/m2,1,on days 1–3,NA
32998965,NCT03298984,302,cytarabine,2,100,mg/m2,1,on days 5–11,fixed
32998965,NCT03298984,302,daunorubicin,2,60,mg/m2,1,on days 5–7,fixed
32998965,NCT03298984,302,alvocidib,3,30 i.v. bolus followed by 50 i.v. infusion over 4 hours,mg/m2,1,on days 1–3,NA
32998965,NCT03298984,302,cytarabine,3,100,mg/m2,1,on days 5–11,fixed
32998965,NCT03298984,302,daunorubicin,3,60,mg/m2,1,on days 5–7,fixed
32998965,NCT03298984,302,alvocidib,4,30 i.v. bolus followed by 60 i.v. infusion over 4 hours,mg/m2,1,on days 1–3,NA
32998965,NCT03298984,302,cytarabine,4,100,mg/m2,1,on days 5–11,fixed
32998965,NCT03298984,302,daunorubicin,4,60,mg/m2,1,on days 5–7,fixed
9250790,NA,303,fludarabine,1,12,mg/m2,1,IV bolus for 5 days,NA
9250790,NA,303,paclitaxel,1,25,mg/m2,1,continuous infusion over 4 days,NA
9250790,NA,303,fludarabine,2,15,mg/m2,1,IV bolus for 5 days,NA
9250790,NA,303,paclitaxel,2,25,mg/m2,1,continuous infusion over 4 days,NA
9250790,NA,303,fludarabine,3,20,mg/m2,1,IV bolus for 5 days,NA
9250790,NA,303,paclitaxel,3,25,mg/m2,1,continuous infusion over 4 days,NA
9250790,NA,303,fludarabine,4,20,mg/m2,1,IV bolus for 5 days,NA
9250790,NA,303,paclitaxel,4,30,mg/m2,1,continuous infusion over 4 days,NA
9250790,NA,303,fludarabine,5,20,mg/m2,1,IV bolus for 5 days,NA
9250790,NA,303,paclitaxel,5,60,mg/m2,1,continuous infusion over 72 hours,NA
7545219,NA,304,topotecan,1,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,1,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,1,50,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,1,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,1,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,2,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,2,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,2,80,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,2,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,2,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,3,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,3,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,3,110,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,3,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,3,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,4,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,4,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,4,110,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,4,5,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,4,5,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,5,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,5,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,5,135,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,5,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,5,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,6,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,6,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,6,160,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,6,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,6,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,7,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,7,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,7,190,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,7,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,7,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,topotecan,8,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,topotecan,8,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7545219,NA,304,paclitaxel,8,230,mg/m2,1,on day 1 every 21 days,NA
7545219,NA,304,filgrastim,8,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7545219,NA,304,filgrastim,8,0,ug/kg,1,"on days 6 through 14, or until the absolute neutrophil count (ANC) was greater than 10,000/uL after the nadir",NA
7527456,NA,305,cisplatin,1,25,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,cisplatin,1,25,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,topotecan,1,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,topotecan,1,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,cisplatin,2,50,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,cisplatin,2,50,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,topotecan,2,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,topotecan,2,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,cisplatin,3,75,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,cisplatin,3,75,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,topotecan,3,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,topotecan,3,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,cisplatin,4,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,cisplatin,4,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,topotecan,4,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,topotecan,4,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,cisplatin,5,50,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,cisplatin,5,50,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,305,topotecan,5,1.25,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,305,topotecan,5,1.25,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,cisplatin,6,75,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,cisplatin,6,75,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,topotecan,6,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,topotecan,6,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,filgrastim,6,5,ug/kg,1,"days 6 to 11 and then until the neutrophilcount was greater than 10,000/uL",NA
7527456,NA,306,filgrastim,6,5,ug/kg,1,"days 6 to 11 and then until the neutrophilcount was greater than 10,000/uL",NA
7527456,NA,306,cisplatin,7,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,cisplatin,7,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,topotecan,7,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,topotecan,7,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,filgrastim,7,5,ug/kg,1,"days 6 to 11 and then until the neutrophilcount was greater than 10,000/uL",NA
7527456,NA,306,filgrastim,7,5,ug/kg,1,"days 6 to 11 and then until the neutrophilcount was greater than 10,000/uL",NA
7527456,NA,306,cisplatin,8,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,cisplatin,8,100,mg/m2,1,on day 1 every 21 days,NA
7527456,NA,306,topotecan,8,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,topotecan,8,1,mg/m2,1,on days 1 through 5 every 21 days,fixed
7527456,NA,306,filgrastim,8,5,ug/kg,1,on days -6 to -2 before the first treatment course,NA
7527456,NA,306,filgrastim,8,5,ug/kg,1,on days -6 to -2 before the first treatment course,NA
9508177,NA,307,topotecan,1,0.6,mg/m2,1,on days 1 through 5 of the 21-day cycle,NA
9508177,NA,307,topotecan,1,0.6,mg/m2,1,on days 1 through 5 of the 21-day cycle,NA
9508177,NA,307,cyclophosphamide,1,250,mg/m2,1,on days 1 through 5 of the 21-day cycle,fixed
9508177,NA,307,topotecan,2,0.6,mg/m2,1,on days 1 through 5 of the 21-day cycle,with G-CSF
9508177,NA,307,topotecan,2,0.6,mg/m2,1,on days 1 through 5 of the 21-day cycle,with G-CSF
9508177,NA,307,cyclophosphamide,2,250,mg/m2,1,on days 1 through 5 of the 21-day cycle,fixed
9508177,NA,307,topotecan,3,0.75,mg/m2,1,on days 1 through 5 of the 21-day cycle,NA
9508177,NA,307,topotecan,3,0.75,mg/m2,1,on days 1 through 5 of the 21-day cycle,NA
9508177,NA,307,cyclophosphamide,3,250,mg/m2,1,on days 1 through 5 of the 21-day cycle,fixed
9508177,NA,307,topotecan,4,0.75,mg/m2,1,on days 1 through 5 of the 21-day cycle,with G-CSF
9508177,NA,307,topotecan,4,0.75,mg/m2,1,on days 1 through 5 of the 21-day cycle,with G-CSF
9508177,NA,307,cyclophosphamide,4,250,mg/m2,1,on days 1 through 5 of the 21-day cycle,fixed
16186597,NA,308,oblimersen,1,3,mg/kg,1,"5 days in cycle 1 and for 7 days in all subsequent cycles, followed by a minimum 2 week observation period after each cycle every 3 weeks",NA
16186597,NA,308,oblimersen,2,4,mg/kg,1,"5 days in cycle 1 and for 7 days in all subsequent cycles, followed by a minimum 2 week observation period after each cycle every 3 weeks",NA
16186597,NA,308,oblimersen,3,5,mg/kg,1,"5 days in cycle 1 and for 7 days in all subsequent cycles, followed by a minimum 2 week observation period after each cycle every 3 weeks",NA
16186597,NA,308,oblimersen,4,6,mg/kg,1,"5 days in cycle 1 and for 7 days in all subsequent cycles, followed by a minimum 2 week observation period after each cycle every 3 weeks",NA
16186597,NA,308,oblimersen,5,7,mg/kg,1,"5 days in cycle 1 and for 7 days in all subsequent cycles, followed by a minimum 2 week observation period after each cycle every 3 weeks",NA
21745173,NA,309,7-hydroxystaurosporine,1,135,mg/m2,1,continuous intravenous (CIV) infusion over 72 h on the first cycle,finished
21745173,NA,309,7-hydroxystaurosporine,1,67.5,mg/m2,1,CIVX36 h (days 1–2) on cycles 2–6,finished
21745173,NA,309,fludararbine monophosphate,1,NA,mg/m2,1,on day 1 in cycles 2–6,NA
21745173,NA,309,7-hydroxystaurosporine,2,135,mg/m2,1,continuous intravenous (CIV) infusion over 72 h on the first cycle,finished
21745173,NA,309,7-hydroxystaurosporine,2,67.5,mg/m2,1,CIVX36 h (days 1–2) on cycles 2–6,finished
21745173,NA,309,fludararbine monophosphate,2,NA,mg/m2,1,on days 1-2 in cycles 2–6,NA
21745173,NA,309,7-hydroxystaurosporine,3,135,mg/m2,1,continuous intravenous (CIV) infusion over 72 h on the first cycle,finished
21745173,NA,309,7-hydroxystaurosporine,3,67.5,mg/m2,1,CIVX36 h (days 1–2) on cycles 2–6,finished
21745173,NA,309,fludararbine monophosphate,3,NA,mg/m2,1,on days 1-3 in cycles 2–6,NA
21745173,NA,309,7-hydroxystaurosporine,4,135,mg/m2,1,continuous intravenous (CIV) infusion over 72 h on the first cycle,finished
21745173,NA,309,7-hydroxystaurosporine,4,67.5,mg/m2,1,CIVX36 h (days 1–2) on cycles 2–6,finished
21745173,NA,309,fludararbine monophosphate,4,NA,mg/m2,1,on days 1-4 in cycles 2–6,NA
21745173,NA,309,7-hydroxystaurosporine,5,135,mg/m2,1,continuous intravenous (CIV) infusion over 72 h on the first cycle,finished
21745173,NA,309,7-hydroxystaurosporine,5,67.5,mg/m2,1,CIVX36 h (days 1–2) on cycles 2–6,finished
21745173,NA,309,fludararbine monophosphate,5,NA,mg/m2,1,on days 1-5 in cycles 2–6,NA
9773805,NA,310,paclitaxel,1,140,mg/m2,1,96 h continuous infusion,NA
9773805,NA,310,filgrastim,1,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,filgrastim,1,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,paclitaxel,2,160,mg/m2,1,96 h continuous infusion,NA
9773805,NA,310,filgrastim,2,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,filgrastim,2,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,paclitaxel,3,180,mg/m2,1,96 h continuous infusion,NA
9773805,NA,310,filgrastim,3,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,filgrastim,3,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,paclitaxel,4,200,mg/m2,1,96 h continuous infusion,NA
9773805,NA,310,filgrastim,4,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9773805,NA,310,filgrastim,4,5,ug/kg,1,24 h after completion of the paclitaxel infusion and continued until WBC>=10000/mm3,NA
9738567,NA,311,flavopiridol,1,4,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,4,16,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,5,16,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,6,21,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,7,28,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,8,35,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,9,39,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,10,50,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,11,62.5,mg/m2,1,a 72-hour infusion every 2 weeks,in the absence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,12,78,mg/m2,1,a 72-hour infusion every 2 weeks,in the presence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,13,98,mg/m2,1,a 72-hour infusion every 2 weeks,in the presence of antidiarrheal prophylaxis
9738567,NA,311,flavopiridol,14,122.5,mg/m2,1,a 72-hour infusion every 2 weeks,in the presence of antidiarrheal prophylaxis
23813912,NCT00295919,312,4-hpr/lxs,1,352,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,2,458,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,3,595,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,4,774,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,5,1006,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,6,1308,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,7,1700,mg/day,2,"for 7 consecutive days, every three weeks",NA
23813912,NCT00295919,312,4-hpr/lxs,8,2210,mg/day,2,"for 7 consecutive days, every three weeks",NA
8823338,NA,313,cyclophosphamide,1,1200,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,1,16,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,1,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,1,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,2,1200,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,2,24,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,2,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,2,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,3,1200,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,3,28,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,3,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,3,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,4,2400,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,4,16,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,4,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,4,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,5,600,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,5,24,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,5,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,5,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,6,600,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,6,28,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,6,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,6,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,cyclophosphamide,7,600,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,mitoxantrone,7,32,mg/m2,1,on day one every 3 weeks,NA
8823338,NA,313,filgrastim,7,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
8823338,NA,313,filgrastim,7,5,ug/kg,1,"daily beginning day 2 and continuing until the postnadir absolute neutrophil count (ANC) was >= 10,000/uL on two consecutive evaluations",NA
16849757,NA,314,fenretinide,1,350,mg/m2/d,2,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,2,450,mg/m2/d,2,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,3,600,mg/m2/d,2,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,4,800,mg/m2/d,2,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,5,1050,mg/m2/d,3,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,6,1395,mg/m2/d,3,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,7,1860,mg/m2/d,3,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,8,2475,mg/m2/d,3,7 days of 4-HPR every 3 weeks,NA
16849757,NA,314,fenretinide,9,3300,mg/m2/d,3,7 days of 4-HPR every 3 weeks,NA
12151959,NA,315,topotecan,1,1.5,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,topotecan,1,1.5,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,vinorelbine,1,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12151959,NA,315,topotecan,2,1.75,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,topotecan,2,1.75,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,vinorelbine,2,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12151959,NA,315,topotecan,3,1.75,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,topotecan,3,1.75,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,vinorelbine,3,30,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12151959,NA,315,topotecan,4,2,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,topotecan,4,2,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,vinorelbine,4,30,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12151959,NA,315,topotecan,5,2,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,topotecan,5,2,mg/m2,1,days 1–3 every 3 weeks,NA
12151959,NA,315,vinorelbine,5,35,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18182662,NA,316,oxaliplatin,1,17.5,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,oxaliplatin,1,17.5,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,fludarabine,1,30,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,cytarabine,1,1000,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,rituximab,1,375,mg/m2,1,on day 3 of course 1 and on day 1 of subsequent courses in a 4- to 6-hour infusion,fixed
18182662,NA,316,pegfilgrastim,1,6,mg,1,on day 6 every 4 weeks,fixed
18182662,NA,316,oxaliplatin,2,20,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,oxaliplatin,2,20,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,fludarabine,2,30,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,cytarabine,2,1000,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,rituximab,2,375,mg/m2,1,on day 3 of course 1 and on day 1 of subsequent courses in a 4- to 6-hour infusion,fixed
18182662,NA,316,pegfilgrastim,2,6,mg,1,on day 6 every 4 weeks,fixed
18182662,NA,316,oxaliplatin,3,25,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,oxaliplatin,3,25,mg/m2,1,on days 1 through 4 every 4 weeks,NA
18182662,NA,316,fludarabine,3,30,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,cytarabine,3,1000,mg/m2,1,On days 2 through 3 every 4 weeks,fixed
18182662,NA,316,rituximab,3,375,mg/m2,1,on day 3 of course 1 and on day 1 of subsequent courses in a 4- to 6-hour infusion,fixed
18182662,NA,316,pegfilgrastim,3,6,mg,1,on day 6 every 4 weeks,fixed
32401633,NCT02642965,317,liposome-encapsulated daunorubicin-cytarabine,1,135,mg/m2,1,"on days 1, 3, and 5 in course 1",NA
32401633,NCT02642965,317,fludarabine,1,30,mg/m2,1,on days 1-5 in course 2,fixed
32401633,NCT02642965,317,cytarabine,1,2000,mg/m2,1,on days 1-5 in course 2,fixed
32401633,NCT02642965,317,granulocyte-colony stimulating factor,1,5,ug/kg,1,days 1-5 and day 15 through absolute neutrophil count > 500/uL]) in course 2,fixed
32401633,NCT02642965,317,liposome-encapsulated daunorubicin-cytarabine,0,100,mg/m2,1,"on days 1, 3, and 5 in course 1",NA
32401633,NCT02642965,317,fludarabine,0,30,mg/m2,1,on days 1-5 in course 2,fixed
32401633,NCT02642965,317,cytarabine,0,2000,mg/m2,1,on days 1-5 in course 2,fixed
32401633,NCT02642965,317,granulocyte-colony stimulating factor,0,5,ug/kg,1,days 1-5 and day 15 through absolute neutrophil count > 500/uL]) in course 2,fixed
9256119,NA,318,fludarabine,1,LD: 10.5; CI 30.5,mg/m2,NA,10.5 mg/m2 over 15 minutes on day 0 followed by a CI of 30.5 mg/m2 /24 hours for a total of 48 hours,NA
9256119,NA,318,cytarabine,1,LD: 390; CI 101,mg/m2,NA,390 mglm2 over 15 minutes and a CI over 72 hours of 101 mg/m2/h,NA
9256119,NA,318,idarubicin,1,6,mg/m2,1,"on days 0, 1, and 2",NA
9256119,NA,318,fludarabine,2,LD: 10.5; CI 30.5,mg/m2,NA,10.5 mg/m2 over 15 minutes on day 0 followed by a CI of 30.5 mg/m2 /24 hours for a total of 48 hours,NA
9256119,NA,318,cytarabine,2,LD: 390; CI 101,mg/m2,NA,390 mglm2 over 15 minutes and a CI over 72 hours of 101 mg/m2/h,NA
9256119,NA,318,idarubicin,2,9,mg/m2,1,"on days 0, 1, and 2",NA
9256119,NA,318,fludarabine,3,LD: 10.5; CI 30.5,mg/m2,NA,10.5 mg/m2 over 15 minutes on day 0 followed by a CI of 30.5 mg/m2 /24 hours for a total of 48 hours,NA
9256119,NA,318,cytarabine,3,LD: 390; CI 101,mg/m2,NA,390 mglm2 over 15 minutes and a CI over 72 hours of 101 mg/m2/h,NA
9256119,NA,318,idarubicin,3,12,mg/m2,1,"on days 0, 1, and 2",NA
16292542,NA,319,bendamustine,-2,60,mg/m2,1,on days 1 and 2 every 3 weeks,NA
16292542,NA,319,bendamustine,-1,75,mg/m2,1,on days 1 and 2 every 3 weeks,NA
16292542,NA,319,bendamustine,0,100,mg/m2,1,on days 1 and 2 every 3 weeks,NA
16292542,NA,319,bendamustine,1,110,mg/m2,1,on days 1 and 2 every 3 weeks,NA
16292542,NA,319,bendamustine,2,120,mg/m2,1,on days 1 and 2 every 3 weeks,NA
20479064,NA,320,tremelimumab,1,3,mg/kg,1,on day 1 of Q28D,NA
20479064,NA,320,exemestane,1,25,mg,1,daily,fixed
20479064,NA,320,tremelimumab,2,6,mg/kg,1,on day 1 of Q28D,NA
20479064,NA,320,exemestane,2,25,mg,1,daily,fixed
20479064,NA,320,tremelimumab,3,6,mg/kg,1,on day 1 of Q90D,NA
20479064,NA,320,exemestane,3,25,mg,1,daily,fixed
20479064,NA,320,tremelimumab,4,10,mg/kg,1,on day 1 of Q90D,NA
20479064,NA,320,exemestane,4,25,mg,1,daily,fixed
23104721,NA,321,tnferade™ biologic,1,4 × 109,PU,1,on day 1 of each 14-day cycle,NA
23104721,NA,321,tnferade™ biologic,2,4 × 1010,PU,1,on day 1 of each 14-day cycle,NA
23104721,NA,321,tnferade™ biologic,3,4 × 1011,PU,1,on day 1 of each 14-day cycle,NA
25612635,NCT01227239,322,s-1,1,80,mg/m2,2,"for 5 days a week at 1st week, 2nd week, 4th week and 5th week",fixed
25612635,NCT01227239,322,oxaliplatin,1,40,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,oxaliplatin,1,40,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,radiation,1,1.8,Gy,1,28 fractions over approximately 6 weeks,fixed
25612635,NCT01227239,322,s-1,2,80,mg/m2,2,"for 5 days a week at 1st week, 2nd week, 4th week and 5th week",fixed
25612635,NCT01227239,322,oxaliplatin,2,50,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,oxaliplatin,2,50,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,radiation,2,1.8,Gy,1,28 fractions over approximately 6 weeks,fixed
25612635,NCT01227239,322,s-1,3,80,mg/m2,2,"for 5 days a week at 1st week, 2nd week, 4th week and 5th week",fixed
25612635,NCT01227239,322,oxaliplatin,3,60,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,oxaliplatin,3,60,mg/m2,1,"on day 1, 8, 22 and 29",NA
25612635,NCT01227239,322,radiation,3,1.8,Gy,1,28 fractions over approximately 6 weeks,fixed
21567184,NA,323,tsu-68,1,200,mg,2,daily,NA
21567184,NA,323,s-1,1,35,mg,2,on Days 1–14 every 3 weeks,fixed
21567184,NA,323,oxaliplatin,1,130,mg/m2,1,on Day 1 repeatedly every 3 weeks,fixed
21567184,NA,323,oxaliplatin,1,130,mg/m2,1,on Day 1 repeatedly every 3 weeks,fixed
21567184,NA,323,tsu-68,2,400,mg,2,daily,NA
21567184,NA,323,s-1,2,35,mg,2,on Days 1–14 every 3 weeks,fixed
21567184,NA,323,oxaliplatin,2,130,mg/m2,1,on Day 1 repeatedly every 3 weeks,fixed
21567184,NA,323,oxaliplatin,2,130,mg/m2,1,on Day 1 repeatedly every 3 weeks,fixed
21290246,NA,324,s-1,1,70,mg/m2,2,for 14 consecutive days followed by a 7-day rest period,NA
21290246,NA,324,irinotecan,1,175,mg/m2,1,on day 1 every 3 weeks,NA
21290246,NA,324,s-1,2,75,mg/m2,2,for 14 consecutive days followed by a 7-day rest period,NA
21290246,NA,324,irinotecan,2,200,mg/m2,1,on day 1 every 3 weeks,NA
21290246,NA,324,s-1,3,225,mg/m2,2,for 14 consecutive days followed by a 7-day rest period,NA
21290246,NA,324,irinotecan,3,70,mg/m2,1,on day 1 every 3 weeks,NA
21290246,NA,324,s-1,4,225,mg/m2,2,for 14 consecutive days followed by a 7-day rest period,NA
21290246,NA,324,irinotecan,4,80,mg/m2,1,on day 1 every 3 weeks,NA
21290246,NA,324,s-1,5,250,mg/m2,2,for 14 consecutive days followed by a 7-day rest period,NA
21290246,NA,324,irinotecan,5,80,mg/m2,1,on day 1 every 3 weeks,NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,1,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,1,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,1,30,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,1,30,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,1,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,1,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,1,150,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,1,150,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,cetuximab,1,400,mg/m2,1,before radiotherapy on day 15,fixed
22993353,Eudract 2005-002658-23,325,cetuximab,1,250,mg/m2,1,weekly for the duration of the radiotherapy treatment,fixed
22993353,Eudract 2005-002658-23,325,radiotherapy,1,1.8,Gy,1,"on days 22-66, five fractions per week, total 33 fractions to 59.4 Gy",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,2,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,2,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,2,30,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,2,30,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,2,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,2,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,2,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,2,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,cetuximab,2,400,mg/m2,1,before radiotherapy on day 15,fixed
22993353,Eudract 2005-002658-23,325,cetuximab,2,250,mg/m2,1,weekly for the duration of the radiotherapy treatment,fixed
22993353,Eudract 2005-002658-23,325,radiotherapy,2,1.8,Gy,1,"on days 22-66, five fractions per week, total 33 fractions to 59.4 Gy",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,3,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,3,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,3,60,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,3,60,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,3,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,3,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,3,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,3,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,cetuximab,3,400,mg/m2,1,before radiotherapy on day 15,fixed
22993353,Eudract 2005-002658-23,325,cetuximab,3,250,mg/m2,1,weekly for the duration of the radiotherapy treatment,fixed
22993353,Eudract 2005-002658-23,325,radiotherapy,3,1.8,Gy,1,"on days 22-66, five fractions per week, total 33 fractions to 59.4 Gy",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,4,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,4,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,4,85,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,4,85,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,4,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,4,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,4,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,4,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,cetuximab,4,400,mg/m2,1,before radiotherapy on day 15,fixed
22993353,Eudract 2005-002658-23,325,cetuximab,4,250,mg/m2,1,weekly for the duration of the radiotherapy treatment,fixed
22993353,Eudract 2005-002658-23,325,radiotherapy,4,1.8,Gy,1,"on days 22-66, five fractions per week, total 33 fractions to 59.4 Gy",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,5,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,5,130,mg/m2,1,"on days 1, 78 and 99",fixed
22993353,Eudract 2005-002658-23,325,oxaliplatin,5,110,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,oxaliplatin,5,110,mg/m2,1,every 2 weeks during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,5,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,5,150,mg/m2,2,"on days 1-14, 78-91 and 99-112",fixed
22993353,Eudract 2005-002658-23,325,tegafur/uracil,5,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,tegafur/uracil,5,300,mg/m2,2,Monday to Friday during radiotherapy (days 15-66),NA
22993353,Eudract 2005-002658-23,325,cetuximab,5,400,mg/m2,1,before radiotherapy on day 15,fixed
22993353,Eudract 2005-002658-23,325,cetuximab,5,250,mg/m2,1,weekly for the duration of the radiotherapy treatment,fixed
22993353,Eudract 2005-002658-23,325,radiotherapy,5,1.8,Gy,1,"on days 22-66, five fractions per week, total 33 fractions to 59.4 Gy",fixed
22508373,UMIN000000883,326,irinotecan,1,165,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,5-fu,1,3200,mg/m2,NA,a continuous infusion over the course of 46 h on days 1-3 every 2 weeks,NA
22508373,UMIN000000883,326,leucovorin,1,200,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,irinotecan,2,180,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,5-fu,2,3200,mg/m2,NA,a continuous infusion over the course of 46 h on days 1-3 every 2 weeks,NA
22508373,UMIN000000883,326,leucovorin,2,200,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,irinotecan,0,165,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,0,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,0,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,5-fu,0,2400,mg/m2,NA,a continuous infusion over the course of 46 h on days 1-3 every 2 weeks,NA
22508373,UMIN000000883,326,leucovorin,0,200,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,irinotecan,-1,150,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,-1,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,-1,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,5-fu,-1,2400,mg/m2,NA,a continuous infusion over the course of 46 h on days 1-3 every 2 weeks,NA
22508373,UMIN000000883,326,leucovorin,-1,200,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,irinotecan,-2,120,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,-2,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,oxaliplatin,-2,85,mg/m2,1,on day 1 every 2 weeks,NA
22508373,UMIN000000883,326,5-fu,-2,2400,mg/m2,NA,a continuous infusion over the course of 46 h on days 1-3 every 2 weeks,NA
22508373,UMIN000000883,326,leucovorin,-2,200,mg/m2,1,on day 1 every 2 weeks,NA
21152917,NA,327,s-1,1,80,mg/m2,2,from day 1 to day 14 every 21-day cycle,fixed
21152917,NA,327,irinotecan,1,60,mg/m2,1,on days 1 and 8 every 21-day cycle,NA
21152917,NA,327,s-1,2,80,mg/m2,2,from day 1 to day 14 every 21-day cycle,fixed
21152917,NA,327,irinotecan,2,80,mg/m2,1,on days 1 and 8 every 21-day cycle,NA
21152917,NA,327,s-1,3,80,mg/m2,2,from day 1 to day 14 every 21-day cycle,fixed
21152917,NA,327,irinotecan,3,100,mg/m2,1,on days 1 and 8 every 21-day cycle,NA
22623210,NA,328,sunitinib,1,25,mg,1,"daily on schdule 2/2 (2 weeks on treatment, followed by 2 weeks off) treatment",NA
22623210,NA,328,oxaliplatin,1,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,1,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,1,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,1,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,2,37.5,mg,1,"daily on schdule 2/2 (2 weeks on treatment, followed by 2 weeks off) treatment",NA
22623210,NA,328,oxaliplatin,2,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,2,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,2,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,2,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,3,50,mg,1,"daily on schdule 2/2 (2 weeks on treatment, followed by 2 weeks off) treatment",NA
22623210,NA,328,oxaliplatin,3,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,3,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,3,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,3,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,4,37.5,mg,1,"daily on Schedule 4/2 (4 weeks on treatment, followed by 2 weeks off treatment)",NA
22623210,NA,328,oxaliplatin,4,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,4,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,4,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,4,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,5,50,mg,1,"on Schedule 4/2 (4 weeks on treatment, followed by 2 weeks off treatment)",NA
22623210,NA,328,oxaliplatin,5,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,5,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,5,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,5,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,6,25,mg,1,on the continuous daily dosing (CDD) schedule,NA
22623210,NA,328,oxaliplatin,6,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,6,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,6,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,6,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
22623210,NA,328,sunitinib,7,37.5,mg,1,on the continuous daily dosing (CDD) schedule,NA
22623210,NA,328,oxaliplatin,7,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,oxaliplatin,7,85,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,leucovorin,7,400,mg/m2,1,on days 1–2 of every 2-week cycle,fixed
22623210,NA,328,5-fu,7,400/2400,mg/m2,1,"an intravenous bolus of 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2 on days 1–2 of every 2-week cycle",fixed
21447616,NA,329,sunitinib,1,37.5,mg,1,4 weeks on treatment followed by 2 weeks off (Schedule 4/2) in 6-week cycles,NA
21447616,NA,329,irinotecan,1,180,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,leucovorin,1,200,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,5-fu,1,400/2400,mg/m2,1,"on day 1 every 2 weeks, 400 mg/m2 bolus and then 2400 mg/m2 infused over 46 h",fixed
21447616,NA,329,sunitinib,2,50,mg,1,4 weeks on treatment followed by 2 weeks off (Schedule 4/2) in 6-week cycles,NA
21447616,NA,329,irinotecan,2,180,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,leucovorin,2,200,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,5-fu,2,400/2400,mg/m2,1,"on day 1 every 2 weeks, 400 mg/m2 bolus and then 2400 mg/m2 infused over 46 h",fixed
21447616,NA,329,sunitinib,3,25,mg,1,continuous daily dosing (CDD) schedule,NA
21447616,NA,329,irinotecan,3,180,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,leucovorin,3,200,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,5-fu,3,400/2400,mg/m2,1,"on day 1 every 2 weeks, 400 mg/m2 bolus and then 2400 mg/m2 infused over 46 h",fixed
21447616,NA,329,sunitinib,4,37.5,mg,1,continuous daily dosing (CDD) schedule,NA
21447616,NA,329,irinotecan,4,180,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,leucovorin,4,200,mg/m2,1,on day 1 every 2 weeks,fixed
21447616,NA,329,5-fu,4,400/2400,mg/m2,1,"on day 1 every 2 weeks, 400 mg/m2 bolus and then 2400 mg/m2 infused over 46 h",fixed
21968516,NA,330,vinorelbine,1,40,mg/m2,1,weekly on Mondays continuously,NA
21968516,NA,330,tegafur-uracil,1,250,mg/m2/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,folinic acid,1,90,mg/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,vinorelbine,2,40,mg/m2,1,weekly on Mondays continuously,NA
21968516,NA,330,tegafur-uracil,2,90,mg/m2/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,folinic acid,2,300,mg/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,vinorelbine,3,40,mg/m2,1,weekly on Mondays continuously,NA
21968516,NA,330,tegafur-uracil,3,90,mg/m2/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,folinic acid,3,350,mg/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,vinorelbine,4,60,mg/m2,1,weekly on Mondays continuously,NA
21968516,NA,330,tegafur-uracil,4,90,mg/m2/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,folinic acid,4,350,mg/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,vinorelbine,5,80,mg/m2,1,weekly on Mondays continuously,NA
21968516,NA,330,tegafur-uracil,5,90,mg/m2/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
21968516,NA,330,folinic acid,5,350,mg/d,3,"from day 1 to day 28, followed by a 1-week rest period",NA
25427841,NCT01183494,331,irinotecan,1,240,mg/m2,1,on day 3 every 2 weeks,"the 0 DA group (wild-type homozygotes: * 1/ * 1 ), and the 1 DA
group (heterozygotes that contained only one of the DAs: * 1/ * 28 or * 1/ * 6"
25427841,NCT01183494,331,leucovorin,1,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,1,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25427841,NCT01183494,331,irinotecan,2,270,mg/m2,1,on day 3 every 2 weeks,"the 0 DA group (wild-type homozygotes: * 1/ * 1 ), and the 1 DA
group (heterozygotes that contained only one of the DAs: * 1/ * 28 or * 1/ * 6"
25427841,NCT01183494,331,leucovorin,2,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,2,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25427841,NCT01183494,331,irinotecan,3,300,mg/m2,1,on day 3 every 2 weeks,"the 0 DA group (wild-type homozygotes: * 1/ * 1 ), and the 1 DA
group (heterozygotes that contained only one of the DAs: * 1/ * 28 or * 1/ * 6"
25427841,NCT01183494,331,leucovorin,3,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,3,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25427841,NCT01183494,331,irinotecan,4,330,mg/m2,1,on day 3 every 2 weeks,the 0 DA group (wild-type homozygotes: * 1/ * 1 )
25427841,NCT01183494,331,leucovorin,4,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,4,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25427841,NCT01183494,331,irinotecan,-1,150,mg/m2,1,on day 3 every 2 weeks,"the 2 DA group (DA homozygotes or double heterozygotes for both DAs: * 28/ * 28 , * 6/ * 6 , or * 1/ * 28 and * 1/ * 6 )."
25427841,NCT01183494,331,leucovorin,-1,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,-1,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25427841,NCT01183494,331,irinotecan,0,180,mg/m2,1,on day 3 every 2 weeks,"the 2 DA group (DA homozygotes or double heterozygotes for both DAs: * 28/ * 28 , * 6/ * 6 , or * 1/ * 28 and * 1/ * 6 )."
25427841,NCT01183494,331,leucovorin,0,200,mg/m2,1,on day 1 every 2 weeks,fixed
25427841,NCT01183494,331,5-fluorouracil,0,400/2400,mg/m2,NA,"bolus 400 mg/m 2 on day 1, continuous infusion of 5-fluorouracil 2,400 mg/m 2 for 46 h every 2 weeks",fixed
25143299,UMIN000007556,332,s-1,1,40,mg/m2,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,leucovorin,1,25,mg,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,gemcitabine,1,600,mg/m2,1,on day 1 every 2 weeks,NA
25143299,UMIN000007556,332,s-1,2,40,mg/m2,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,leucovorin,2,25,mg,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,gemcitabine,2,800,mg/m2,1,on day 1 every 2 weeks,NA
25143299,UMIN000007556,332,s-1,3,40,mg/m2,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,leucovorin,3,25,mg,2,from days 1–7 every 2 weeks,fixed
25143299,UMIN000007556,332,gemcitabine,3,1000,mg/m2,1,on day 1 every 2 weeks,NA
23575907,NCT00557557,333,5-fu,1,200,mg/m2,1,NA,NA
23575907,NCT00557557,333,oxaliplatin,1,40,mg/m2,1,NA,fixed
23575907,NCT00557557,333,oxaliplatin,1,40,mg/m2,1,NA,fixed
23575907,NCT00557557,333,5-fu,2,300,mg/m2,1,NA,NA
23575907,NCT00557557,333,oxaliplatin,2,40,mg/m2,1,NA,fixed
23575907,NCT00557557,333,oxaliplatin,2,40,mg/m2,1,NA,fixed
24839048,UMIN_CTR00002845,334,s-1,1,40,mg/m2,2,"on days 1–5, 8–12, 15–19, 22–26 and 29–33",fixed
24839048,UMIN_CTR00002845,334,oxaliplatin,1,50,mg/m2,1,"on days 1, 8, 15, 22 and 29",NA
24839048,UMIN_CTR00002845,334,oxaliplatin,1,50,mg/m2,1,"on days 1, 8, 15, 22 and 29",NA
24839048,UMIN_CTR00002845,334,pelvic radiation,1,50.4,Gy,NA,"in 28 fractions on days 1–5, 8–12, 15–19, 22–26 and 29–33",fixed
24839048,UMIN_CTR00002845,334,s-1,2,40,mg/m2,2,"on days 1–5, 8–12, 15–19, 22–26 and 29–33",fixed
24839048,UMIN_CTR00002845,334,oxaliplatin,2,60,mg/m2,1,"on days 1, 8, 15, 22 and 29",NA
24839048,UMIN_CTR00002845,334,oxaliplatin,2,60,mg/m2,1,"on days 1, 8, 15, 22 and 29",NA
24839048,UMIN_CTR00002845,334,pelvic radiation,2,50.4,Gy,NA,"in 28 fractions on days 1–5, 8–12, 15–19, 22–26 and 29–33",fixed
22318782,NA,335,s-1,1,60,mg/m2,2,on days 1–14 and 22–35 during radiotherapy,NA
22318782,NA,335,radiotherapy,1,2,Gy,1,"total 60 Gy in 30 fractions, 5 days/week (Monday to Friday)",NA
22318782,NA,335,s-1,2,70,mg/m2,2,on days 1–14 and 22–35 during radiotherapy,NA
22318782,NA,335,radiotherapy,2,2,Gy,1,"total 60 Gy in 30 fractions, 5 days/week (Monday to Friday)",NA
22318782,NA,335,s-1,3,80,mg/m2,2,on days 1–14 and 22–35 during radiotherapy,NA
22318782,NA,335,radiotherapy,3,2,Gy,1,"total 60 Gy in 30 fractions, 5 days/week (Monday to Friday)",NA
22615059,NA,336,sunitinib,1,25,mg,2,"for 2 weeks of each 3-week cycle (Schedule 2/1) in the morning, starting on day 1",NA
22615059,NA,336,cisplatin,1,80,mg/m2,1,on day 1 of each 3-week (21-day) cycle,NA
22615059,NA,336,cisplatin,1,80,mg/m2,1,on day 1 of each 3-week (21-day) cycle,NA
22615059,NA,336,5-fu,1,4000,mg/m2,NA,"split over 6 consecutive days, on day 1 of each cycle",NA
22615059,NA,336,sunitinib,2,37.5,mg,2,"for 2 weeks of each 3-week cycle (Schedule 2/1) in the morning, starting on day 1",NA
22615059,NA,336,cisplatin,2,80,mg/m2,1,on day 1 of each 3-week (21-day) cycle,NA
22615059,NA,336,cisplatin,2,80,mg/m2,1,on day 1 of each 3-week (21-day) cycle,NA
22615059,NA,336,5-fu,2,4000,mg/m2,NA,"split over 6 consecutive days, on day 1 of each cycle",NA
20463088,NA,337,vorinostat,1,600,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,1,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,1,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,2,800,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,2,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,2,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,3,1000,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,3,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,3,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,4,1200,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,4,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,4,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,5,1400,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,5,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,5,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,6,1700,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,6,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,6,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,7,2000,mg,1,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,7,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,7,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,8,500,mg,2,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,8,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,8,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,9,600,mg,2,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,9,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,9,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
20463088,NA,337,vorinostat,10,800,mg,2,consecutive days every 14 days,NA
20463088,NA,337,5-fluorouracil,10,400/2400,mg/m2,NA,"at 400 mg/m2 over 2 hours, followed by FU 400 mg/m2 over 5 minutes as an i.v. bolus and 2,400 mg/m2 over 46 hours on days 2 and 3 every 14 days",fixed
20463088,NA,337,leucovorin,10,400,mg/m2,1,on days 2 and 3 every 14 days,fixed
24599799,UMIN000002590,338,s-1,1,48,mg/m2,1,days 1–14 every 21 days,NA
24599799,UMIN000002590,338,sorafenib,1,400,mg/m2,1,every day,NA
24599799,UMIN000002590,338,s-1,2,48,mg/m2,1,days 1–14 every 21 days,NA
24599799,UMIN000002590,338,sorafenib,2,800,mg/m2,1,every day,NA
24599799,UMIN000002590,338,s-1,2.5,64,mg/m2,1,days 1–14 every 21 days,NA
24599799,UMIN000002590,338,sorafenib,2.5,400,mg/m2,1,every day,NA
24599799,UMIN000002590,338,s-1,3,64,mg/m2,1,days 1–14 every 21 days,NA
24599799,UMIN000002590,338,sorafenib,3,800,mg/m2,1,every day,NA
24599799,UMIN000002590,338,s-1,4,80,mg/m2,1,days 1–14 every 21 days,NA
24599799,UMIN000002590,338,sorafenib,4,800,mg/m2,1,every day,NA
20062993,NA,339,vorinostat,1,400,mg,1,"on days -6 to -1, and days 1-14 of each 28-day cycle",NA
20062993,NA,339,5-fluorouracil,1,300/1800,mg/m2,1,"300 mg/m2, followed by 5-FU continuous i.v. infusion at 1,800 mg/m2 over 46 h on days 1 and 15 of each 28-day cycle",NA
20062993,NA,339,leucovorin,1,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20062993,NA,339,vorinostat,2,400,mg,1,"on days -6 to -1, and days 1-14 of each 28-day cycle",NA
20062993,NA,339,5-fluorouracil,2,400/2400,mg/m2,1,"300 mg/m2, followed by 5-FU continuous i.v. infusion at 1,800 mg/m2 over 46 h on days 1 and 15 of each 28-day cycle",NA
20062993,NA,339,leucovorin,2,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20062993,NA,339,vorinostat,-1,400,mg,1,"on days -6 to -1, and from day 1 for 7 days every 2 weeks",NA
20062993,NA,339,5-fluorouracil,-1,300/1800,mg/m2,1,"300 mg/m2, followed by 5-FU continuous i.v. infusion at 1,800 mg/m2 over 46 h on days 1 and 15 of each 28-day cycle",NA
20062993,NA,339,leucovorin,-1,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
20062993,NA,339,vorinostat,-2,400,mg,1,"on days -6 to -1, and from day 1 for 5 days every 2 weeks",NA
20062993,NA,339,5-fluorouracil,-2,225/1350,mg/m2,1,"300 mg/m2, followed by 5-FU continuous i.v. infusion at 1,800 mg/m2 over 46 h on days 1 and 15 of each 28-day cycle",NA
20062993,NA,339,leucovorin,-2,400,mg/m2,1,on days 1 and 15 of each 28-day cycle,NA
25591799,NCT00660153,340,tivozanib,1,0.5,mg,1,daily from day 1 to 21 every 28 days,NA
25591799,NCT00660153,340,leucovorin,1,400,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,5-fluorouracil,1,400/2400,mg/m2,1,a bolus of 400 mg/m2 I.V. over 10 minutes and a 46-hour continuous infusion of 2400 mg/m2 on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,tivozanib,2,1,mg,1,daily from day 1 to 21 every 28 days,NA
25591799,NCT00660153,340,leucovorin,2,400,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,5-fluorouracil,2,400/2400,mg/m2,1,a bolus of 400 mg/m2 I.V. over 10 minutes and a 46-hour continuous infusion of 2400 mg/m2 on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,tivozanib,3,1.5,mg,1,daily from day 1 to 21 every 28 days,NA
25591799,NCT00660153,340,leucovorin,3,400,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,5-fluorouracil,3,400/2400,mg/m2,1,a bolus of 400 mg/m2 I.V. over 10 minutes and a 46-hour continuous infusion of 2400 mg/m2 on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
25591799,NCT00660153,340,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
20103995,NA,341,s-1,1,60,mg/m2,2,"on days 3 to 7, 10 to 14, and 17 to 21 of a 28-day cycle",NA
20103995,NA,341,irinotecan,1,40,mg/m2,1,"on day 1, 8, and 15 of a 28-day cycle",NA
20103995,NA,341,s-1,2,80,mg/m2,2,"on days 3 to 7, 10 to 14, and 17 to 21 of a 28-day cycle",NA
20103995,NA,341,irinotecan,2,40,mg/m2,1,"on day 1, 8, and 15 of a 28-day cycle",NA
20103995,NA,341,s-1,3,80,mg/m2,2,"on days 3 to 7, 10 to 14, and 17 to 21 of a 28-day cycle",NA
20103995,NA,341,irinotecan,3,50,mg/m2,1,"on day 1, 8, and 15 of a 28-day cycle",NA
20103995,NA,341,s-1,4,80,mg/m2,2,"on days 3 to 7, 10 to 14, and 17 to 21 of a 28-day cycle",NA
20103995,NA,341,irinotecan,4,60,mg/m2,1,"on day 1, 8, and 15 of a 28-day cycle",NA
25572362,NCT01310478 ,342,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,1,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,1,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,1,7.5,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,2,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,2,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,2,15,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,3,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,3,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,3,30,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,4,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,4,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,4,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,4,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,4,45,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,5,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,5,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,5,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,5,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,5,60,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,6,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,oxaliplatin,6,85,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,folinic acid,6,400,mg/m2,1,on day 1 every 2 weeks,NA
25572362,NCT01310478 ,342,5-fu,6,400/2400,mg/m2,NA,"intravenous bolus of 5-FU 400 mg/m2 and a 46-h CIV 5-FU 2,400 mg/m2 on day 1 every 2 weeks",NA
25572362,NCT01310478 ,342,endostar,6,75,mg/m2,1,on day 4 to day 14 every 2 weeks,NA
21344302,NA,343,eniluracil,1,5,mg,1,"on Days 1, 8, and 15 in 28-day cycle",NA
21344302,NA,343,5-fluorouracil,1,20,mg,1,"on Days 2, 9, and 16 in 28-day cycles",NA
21344302,NA,343,eniluracil,2,5,mg,1,"on Days 1, 8, and 15 in 28-day cycle",NA
21344302,NA,343,5-fluorouracil,2,30,mg,1,"on Days 2, 9, and 16 in 28-day cycles",NA
21344302,NA,343,eniluracil,3,5,mg,1,"on Days 1, 8, and 15 in 28-day cycle",NA
21344302,NA,343,5-fluorouracil,3,80,mg,1,"on Days 2, 9, and 16 in 28-day cycles",NA
21372498,NA,344,s-1,1,80,mg,1,daily from day 1 t0 14 every four weeks,fixed
21372498,NA,344,paclitaxel,1,40,mg/m2,1,on days 1 and 14 every four weeks,NA
21372498,NA,344,s-1,2,80,mg,1,daily from day 1 t0 14 every four weeks,fixed
21372498,NA,344,paclitaxel,2,60,mg/m2,1,on days 1 and 14 every four weeks,NA
21372498,NA,344,s-1,3,80,mg,1,daily from day 1 t0 14 every four weeks,fixed
21372498,NA,344,paclitaxel,3,80,mg/m2,1,on days 1 and 14 every four weeks,NA
21372498,NA,344,s-1,4,80,mg,1,daily from day 1 t0 14 every four weeks,fixed
21372498,NA,344,paclitaxel,4,90,mg/m2,1,on days 1 and 14 every four weeks,NA
21372498,NA,344,s-1,5,80,mg,1,daily from day 1 t0 14 every four weeks,fixed
21372498,NA,344,paclitaxel,5,100,mg/m2,1,on days 1 and 14 every four weeks,NA
24097815,NA,345,cisplatin,1,170,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,1,170,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,5-fluorouracil,1,1000,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,2,180,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,2,180,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,5-fluorouracil,2,1000,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,3,190,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,3,190,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,5-fluorouracil,3,1000,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,4,200,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,cisplatin,4,200,mg/m2,1,twice over a 4-week interval,NA
24097815,NA,345,5-fluorouracil,4,1000,mg/m2,1,twice over a 4-week interval,NA
23674135,NA,346,cetuximab,-1,"400 mg/m2 initial dose, then 250 mg/m2",mg/m2,1,"on days 1, 8, 15, 29, 36, 43, and 50",fixed
23674135,NA,346,5-fluorouracil,-1,600,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,-1,50,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,-1,50,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,radiotherapy,-1,1.8-2.0,Gy,1,"starting on day 1, total dose of 55-59 Gyin 30-32 fractions over 6.0-6.5 weeks",fixed
23674135,NA,346,cetuximab,0,"400 mg/m2 initial dose, then 250 mg/m2",mg/m2,1,"on days 1, 8, 15, 29, 36, 43, and 50",fixed
23674135,NA,346,5-fluorouracil,0,800,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,0,60,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,0,60,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,radiotherapy,0,1.8-2.0,Gy,1,"starting on day 1, total dose of 55-59 Gyin 30-32 fractions over 6.0-6.5 weeks",fixed
23674135,NA,346,cetuximab,1,"400 mg/m2 initial dose, then 250 mg/m2",mg/m2,1,"on days 1, 8, 15, 29, 36, 43, and 50",fixed
23674135,NA,346,5-fluorouracil,1,800,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,1,80,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,1,80,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,radiotherapy,1,1.8-2.0,Gy,1,"starting on day 1, total dose of 55-59 Gyin 30-32 fractions over 6.0-6.5 weeks",fixed
23674135,NA,346,cetuximab,2,"400 mg/m2 initial dose, then 250 mg/m2",mg/m2,1,"on days 1, 8, 15, 29, 36, 43, and 50",fixed
23674135,NA,346,5-fluorouracil,2,1000,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,2,80,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,cisplatin,2,80,mg/m2,1,on days 1 and 29,NA
23674135,NA,346,radiotherapy,2,1.8-2.0,Gy,1,"starting on day 1, total dose of 55-59 Gyin 30-32 fractions over 6.0-6.5 weeks",fixed
23982118,NA,347,s-1,1,30,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,1,120,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,1,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,1,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,s-1,2,30,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,2,130,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,2,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,2,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,s-1,3,35,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,3,130,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,3,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,3,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,s-1,4,35,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,4,140,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,4,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,4,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,s-1,5,40,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,5,140,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,5,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,5,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,s-1,6,40,mg/m2,2,daily on days 1-14,NA
23982118,NA,347,irinotecan,6,150,mg/m2,1,on day 1 every 3 weeks,NA
23982118,NA,347,oxaliplatin,6,85,mg/m2,1,on day 1 every 3 weeks,fixed
23982118,NA,347,oxaliplatin,6,85,mg/m2,1,on day 1 every 3 weeks,fixed
21611734,NA,348,cediranib,1,20,mg,1,daily starting on day 1 in 14-day cycles,NA
21611734,NA,348,oxaliplatin,1,85,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,oxaliplatin,1,85,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,leucovorin,1,200,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,5-fu,1,400/2400,mg/m2,1,"400 mg/m2 iv bolus immediately after the completion of oxaliplatin/leucovorin, followed immediately by 2,400 mg/m2 of 5-FU by continuous iv infusion over 46 h",fixed
21611734,NA,348,cediranib,2,30,mg,1,daily starting on day 1 in 14-day cycles,NA
21611734,NA,348,oxaliplatin,2,85,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,oxaliplatin,2,85,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,leucovorin,2,200,mg/m2,1,on day 1 in 14-day cycles,fixed
21611734,NA,348,5-fu,2,400/2400,mg/m2,1,"400 mg/m2 iv bolus immediately after the completion of oxaliplatin/leucovorin, followed immediately by 2,400 mg/m2 of 5-FU by continuous iv infusion over 46 h",fixed
25074036,NCT01291615,349,gemcitabine,0,1000,mg/m2,1,Day 1 every 3 weeks,NA
25074036,NCT01291615,349,gemcitabine,1,800,mg/m2,1,"Days 1, 15 every 4 weeks",NA
25074036,NCT01291615,349,gemcitabine,2,1000,mg/m2,1,"Days 1, 15 every 4 weeks",NA
25074036,NCT01291615,349,gemcitabine,3,800,mg/m2,1,"Days 1, 8 every 3 weeks",NA
25074036,NCT01291615,349,gemcitabine,4,1000,mg/m2,1,"Days 1, 8 every 3 weeks",NA
25074036,NCT01291615,349,gemcitabine,5,800,mg/m2,1,"Days 1, 8, 15 every 4 weeks",NA
25074036,NCT01291615,349,gemcitabine,6,1000,mg/m2,1,"Days 1, 8, 15 every 4 weeks",NA
25074036,NCT01291615,350,s-1,0,50,mg,1,day 1-14 every 3 weeks,NA
25074036,NCT01291615,350,s-1,1,60,mg,1,day 1-14 every 3 weeks,NA
25074036,NCT01291615,350,s-1,2,80,mg,1,day 1-14 every 3 weeks,NA
25074036,NCT01291615,350,s-1,3,100,mg,1,day 1-14 every 3 weeks,NA
25074036,NCT01291615,350,s-1,4,100,mg,1,day 1-28 every 6 weeks,NA
25877225,UMIN000006123,351,gemcitabine,1,1000,mg/m2,1,on day 1 every 2 weeks,NA
25877225,UMIN000006123,351,cisplatin,1,30,mg/m2,1,on day 1 every 2 weeks,fixed
25877225,UMIN000006123,351,cisplatin,1,30,mg/m2,1,on day 1 every 2 weeks,fixed
25877225,UMIN000006123,351,s-1,1,40,mg,2,on days 1–7 every 2 weeks,fixed
25877225,UMIN000006123,351,gemcitabine,2,1200,mg/m2,1,on day 1 every 2 weeks,NA
25877225,UMIN000006123,351,cisplatin,2,30,mg/m2,1,on day 1 every 2 weeks,fixed
25877225,UMIN000006123,351,cisplatin,2,30,mg/m2,1,on day 1 every 2 weeks,fixed
25877225,UMIN000006123,351,s-1,2,40,mg,2,on days 1–7 every 2 weeks,fixed
21786211,NA,352,irinotecan,1,50,mg/m2,1,24-h intravenous infusion on day 1 every 2 weeks,NA
21786211,NA,352,5-fluorouracil,1,800,mg/m2,1,24-h intravenous infusion on day 2 every 2 weeks,NA
21786211,NA,352,irinotecan,2,75,mg/m2,1,24-h intravenous infusion on day 1 every 2 weeks,NA
21786211,NA,352,5-fluorouracil,2,800,mg/m2,1,24-h intravenous infusion on day 2 every 2 weeks,NA
21786211,NA,352,irinotecan,3,100,mg/m2,1,24-h intravenous infusion on day 1 every 2 weeks,NA
21786211,NA,352,5-fluorouracil,3,800,mg/m2,1,24-h intravenous infusion on day 2 every 2 weeks,NA
21786211,NA,352,irinotecan,4,125,mg/m2,1,24-h intravenous infusion on day 1 every 2 weeks,NA
21786211,NA,352,5-fluorouracil,4,800,mg/m2,1,24-h intravenous infusion on day 2 every 2 weeks,NA
21786211,NA,352,irinotecan,5,150,mg/m2,1,24-h intravenous infusion on day 1 every 2 weeks,NA
21786211,NA,352,5-fluorouracil,5,800,mg/m2,1,24-h intravenous infusion on day 2 every 2 weeks,NA
22763610,NA,353,matuzumab,1,400,mg,1,"weekly on days 1, 8, 15, 22, 29, 36 and 43 of a 7-week cycle",NA
22763610,NA,353,5-fluorouracil,1,NA,mg/m2,1,"days 1, 8, 15, 22, 29 and 36 of a 7-week cycle",fixed
22763610,NA,353,leucovorin,1,500,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
22763610,NA,353,cisplatin,1,50,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
22763610,NA,353,cisplatin,1,50,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
22763610,NA,353,matuzumab,2,800,mg,1,"weekly on days 1, 8, 15, 22, 29, 36 and 43 of a 7-week cycle",NA
22763610,NA,353,5-fluorouracil,2,NA,mg/m2,1,"days 1, 8, 15, 22, 29 and 36 of a 7-week cycle",fixed
22763610,NA,353,leucovorin,2,500,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
22763610,NA,353,cisplatin,2,50,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
22763610,NA,353,cisplatin,2,50,mg/m2,1,"days 1, 15 and 29 of a 7-week cycle",fixed
24480865,NA,354,s-1,1,80,mg/m2,2,days 1-14 every 28 days,NA
24480865,NA,354,nedaplatin,1,70,mg/m2,1,on day 8 every 28 days,NA
24480865,NA,354,s-1,2,80,mg/m2,2,days 1-14 every 28 days,NA
24480865,NA,354,nedaplatin,2,80,mg/m2,1,on day 8 every 28 days,NA
24480865,NA,354,s-1,3,80,mg/m2,2,days 1-14 every 28 days,NA
24480865,NA,354,nedaplatin,3,90,mg/m2,1,on day 8 every 28 days,NA
24480865,NA,354,s-1,4,80,mg/m2,2,days 1-14 every 28 days,NA
24480865,NA,354,nedaplatin,4,100,mg/m2,1,on day 8 every 28 days,NA
23292146,NA,356,s-1,1,40,mg/m2,2,on the day with the radiation therapy,NA
23292146,NA,356,radiotherapy,1,2,Gy,1,a total dose of 64–70 Gy in 32–35 fractions over 6–7 weeks,NA
23292146,NA,356,s-1,2,60,mg/m2,2,on the day with the radiation therapy,NA
23292146,NA,356,radiotherapy,2,2,Gy,1,a total dose of 64–70 Gy in 32–35 fractions over 6–7 weeks,NA
23292146,NA,356,s-1,3,80,mg/m2,2,on the day with the radiation therapy,NA
23292146,NA,356,radiotherapy,3,2,Gy,1,a total dose of 64–70 Gy in 32–35 fractions over 6–7 weeks,NA
23208490,NCT00220649,357,gemcitabine,1,500,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,irinotecan,1,120,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,5-fluorouracil,1,400/1500,mg/m2,1,bolus/24h infusion on day 1 every 14 days,fixed
23208490,NCT00220649,357,leucovorin,1,300,mg,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,oxaliplatin,1,50,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,oxaliplatin,1,50,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,gemcitabine,2,500,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,irinotecan,2,120,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,5-fluorouracil,2,400/1500,mg/m2,1,bolus/24h infusion on day 1 every 14 days,fixed
23208490,NCT00220649,357,leucovorin,2,300,mg,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,oxaliplatin,2,60,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,oxaliplatin,2,60,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,gemcitabine,3,500,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,irinotecan,3,120,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,5-fluorouracil,3,400/1500,mg/m2,1,bolus/24h infusion on day 1 every 14 days,fixed
23208490,NCT00220649,357,leucovorin,3,300,mg,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,oxaliplatin,3,70,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,oxaliplatin,3,70,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,gemcitabine,4,500,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,irinotecan,4,120,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,5-fluorouracil,4,400/1500,mg/m2,1,bolus/24h infusion on day 1 every 14 days,fixed
23208490,NCT00220649,357,leucovorin,4,300,mg,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,oxaliplatin,4,80,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,oxaliplatin,4,80,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,gemcitabine,5,500,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,irinotecan,5,120,mg/m2,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,5-fluorouracil,5,400/1500,mg/m2,1,bolus/24h infusion on day 1 every 14 days,fixed
23208490,NCT00220649,357,leucovorin,5,300,mg,1,on day 1 every 14 days,fixed
23208490,NCT00220649,357,oxaliplatin,5,85,mg/m2,1,on day 2 every 14 days,NA
23208490,NCT00220649,357,oxaliplatin,5,85,mg/m2,1,on day 2 every 14 days,NA
20934959,NA,358,paclitaxel,-1,80,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,-1,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,-1,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,5-fluorouracil,-1,200,mg/m2,1,on days 1 – 5 and 8 – 12 every 28 days,NA
20934959,NA,358,paclitaxel,1,80,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,1,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,1,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,5-fluorouracil,1,300,mg/m2,1,on days 1 – 5 and 8 – 12 every 28 days,NA
20934959,NA,358,paclitaxel,2,80,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,2,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,2,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,5-fluorouracil,2,400,mg/m2,1,on days 1 – 5 and 8 – 12 every 28 days,NA
20934959,NA,358,paclitaxel,3,80,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,3,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,cisplatin,3,50,mg/m2,1,on days 1 and 8 every 28 days,NA
20934959,NA,358,5-fluorouracil,3,500,mg/m2,1,on days 1 – 5 and 8 – 12 every 28 days,NA
21868555,NA,359,s-1,1,80,mg/m2,2,daily from day 1 to day 28 every 42 days,NA
21868555,NA,359,trastuzumab,1,"4 mg/kg, and then of 2 mg/kg over 90 min",mg/kg,1,every week,fixed
21868555,NA,359,s-1,-1,65,mg/m2,2,daily from day 1 to day 28 every 42 days,NA
21868555,NA,359,trastuzumab,-1,"4 mg/kg, and then of 2 mg/kg over 90 min",mg/kg,1,every week,fixed
21868555,NA,359,s-1,-2,50,mg/m2,2,daily from day 1 to day 28 every 42 days,NA
21868555,NA,359,trastuzumab,-2,"4 mg/kg, and then of 2 mg/kg over 90 min",mg/kg,1,every week,fixed
23665950,NCT00553696,360,sunitinib,1,25,mg,1,continuous daily,CDD schedule
23665950,NCT00553696,360,s-1,1,40,mg/m2,2,daily from day 1 to day 21 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,1,60,mg/m2,1,on day 1 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,1,60,mg/m2,1,on day 1 every 28 days,fixed
23665950,NCT00553696,360,sunitinib,2,25,mg,1,daily from day 1 to day 14 in4-weekcycles,2/2 schedule
23665950,NCT00553696,360,s-1,2,40,mg/m2,2,daily from day 1 to day 21 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,2,60,mg/m2,1,on day 1 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,2,60,mg/m2,1,on day 1 every 28 days,fixed
23665950,NCT00553696,360,sunitinib,3,37.5,mg,1,daily from day 1 to day 14 in4-weekcycles,2/2 schedule
23665950,NCT00553696,360,s-1,3,40,mg/m2,2,daily from day 1 to day 21 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,3,60,mg/m2,1,on day 1 every 28 days,fixed
23665950,NCT00553696,360,cisplatin,3,60,mg/m2,1,on day 1 every 28 days,fixed
24829073,NA,361,tsu-68,0.5,200,mg,2,continuously for 28 days followed by a 14-day rest period,fixed
24829073,NA,361,s-1,0.5,25,mg,2,continuously for 28 days followed by a 14-day rest period,NA
24829073,NA,361,tsu-68,1.5,200,mg,2,continuously for 28 days followed by a 14-day rest period,fixed
24829073,NA,361,s-1,1.5,40,mg,2,continuously for 28 days followed by a 14-day rest period,NA
24829073,NA,361,tsu-68,2.5,200,mg,2,continuously for 28 days followed by a 14-day rest period,fixed
24829073,NA,361,s-1,2.5,50,mg,2,continuously for 28 days followed by a 14-day rest period,NA
24829073,NA,361,tsu-68,0,200,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,fixed
24829073,NA,361,s-1,0,25,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,NA
24829073,NA,361,tsu-68,1,200,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,fixed
24829073,NA,361,s-1,1,40,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,NA
24829073,NA,361,tsu-68,2,200,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,fixed
24829073,NA,361,s-1,2,50,mg,2,continuous administration of the drug for 14 days followed by a 7-day rest period,NA
21134076,NA,362,radiotherapy,1,2,Gy,1,35 fractions on Monday-Friday for 7 weeks,NA
21134076,NA,362,s-1,1,20,mg/m2,2,"on days 1–14, days 36–49",NA
21134076,NA,362,cisplatin,1,20,mg/m2,1,"on days 8–11, days 43–46",NA
21134076,NA,362,cisplatin,1,20,mg/m2,1,"on days 8–11, days 43–46",NA
21134076,NA,362,radiotherapy,2,2,Gy,1,35 fractions on Monday-Friday for 7 weeks,NA
21134076,NA,362,s-1,2,30,mg/m2,2,"on days 1–14, days 36–49",NA
21134076,NA,362,cisplatin,2,20,mg/m2,1,"on days 8–11, days 43–46",NA
21134076,NA,362,cisplatin,2,20,mg/m2,1,"on days 8–11, days 43–46",NA
21134076,NA,362,radiotherapy,3,2,Gy,1,35 fractions on Monday-Friday for 7 weeks,NA
21134076,NA,362,s-1,3,40,mg/m2,2,"on days 1–14, days 36–49",NA
21134076,NA,362,cisplatin,3,20,mg/m2,1,"on days 8–11, days 43–46",NA
21134076,NA,362,cisplatin,3,20,mg/m2,1,"on days 8–11, days 43–46",NA
25217393,NA,363,floxuridine,1,0.1,mg/kg/day,1,14-day on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,5‑fluorouracil,1,400,mg/m2,1,continuous infusion for 46 h on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,leucovorin,1,2400,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,floxuridine,2,0.12,mg/kg/day,1,14-day on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,5‑fluorouracil,2,400,mg/m2,1,continuous infusion for 46 h on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,leucovorin,2,2400,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,floxuridine,3,0.15,mg/kg/day,1,14-day on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,5‑fluorouracil,3,400,mg/m2,1,continuous infusion for 46 h on days 1 and 15 on a 4-week cycle,NA
25217393,NA,363,leucovorin,3,2400,mg/m2,1,on days 1 and 15 on a 4-week cycle,NA
22237958,NCT01284413,364,gemcitabine,0,800,mg/m2,1,on day 1 every 2 weeks,NA
22237958,NCT01284413,364,s-1,0,60/50,mg,2,days 1-7 every 2 weeks,NA
22237958,NCT01284413,364,cisplatin,0,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,cisplatin,0,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,gemcitabine,1,1000,mg/m2,1,on day 1 every 2 weeks,NA
22237958,NCT01284413,364,s-1,1,80/60,mg,2,days 1-7 every 2 weeks,NA
22237958,NCT01284413,364,cisplatin,1,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,cisplatin,1,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,gemcitabine,2,1000,mg/m2,1,on day 1 every 2 weeks,NA
22237958,NCT01284413,364,s-1,2,100/80,mg,2,days 1-7 every 2 weeks,NA
22237958,NCT01284413,364,cisplatin,2,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,cisplatin,2,25,mg/m2,1,on day 1 every 2 weeks,fixed
22237958,NCT01284413,364,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22237958,NCT01284413,364,s-1,3,120/100,mg,2,days 1-14 every 3 weeks,NA
22237958,NCT01284413,364,cisplatin,3,25,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
22237958,NCT01284413,364,cisplatin,3,25,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
25687990,UMIN000003803,365,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25687990,UMIN000003803,365,s-1,1,30,mg/m2,2,"14 consecutive days, followed by a 7-day rest",NA
25687990,UMIN000003803,365,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25687990,UMIN000003803,365,s-1,2,35,mg/m2,2,"14 consecutive days, followed by a 7-day rest",NA
25687990,UMIN000003803,365,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25687990,UMIN000003803,365,s-1,3,40,mg/m2,2,"14 consecutive days, followed by a 7-day rest",NA
25422155,UMIN000008415,366,s-1,0,40,mg,1,on alternate days on 21-day cycles,NA
25422155,UMIN000008415,366,cisplatin,0,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,cisplatin,0,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,gemcitabine,0,1000,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,s-1,1,50,mg,1,on alternate days on 21-day cycles,NA
25422155,UMIN000008415,366,cisplatin,1,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,cisplatin,1,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,s-1,2,60,mg,1,on alternate days on 21-day cycles,NA
25422155,UMIN000008415,366,cisplatin,2,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,cisplatin,2,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,s-1,3,80,mg,1,on alternate days on 21-day cycles,NA
25422155,UMIN000008415,366,cisplatin,3,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,cisplatin,3,25,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
25422155,UMIN000008415,366,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 on 21-day cycles,fixed
21077997,NA,367,irinotecan,1,80,mg/m2,1,on days 1 and 8 every 21 days,NA
21077997,NA,367,s-1,1,40,mg/m2,2,14 consecutive days followed by a 7-day rest period,NA
21077997,NA,367,irinotecan,2,100,mg/m2,1,on days 1 and 8 every 21 days,NA
21077997,NA,367,s-1,2,40,mg/m2,2,14 consecutive days followed by a 7-day rest period,NA
21077997,NA,367,irinotecan,3,120,mg/m2,1,on days 1 and 8 every 21 days,NA
21077997,NA,367,s-1,3,40,mg/m2,2,14 consecutive days followed by a 7-day rest period,NA
21540865,NCT00705016,368,cilengitide,1,500,mg,1,twice a week,NA
21540865,NCT00705016,368,cetuximab,1,"initial dose of 400, followed by 250",mg/m2,1,weekly,fixed
21540865,NCT00705016,368,cisplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,cisplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,5-fu,1,1000,mg/m2,1,continuous infusion from day 1 to 4 of each 3-week cycle,fixed
21540865,NCT00705016,368,cilengitide,2,1000,mg,1,twice a week,NA
21540865,NCT00705016,368,cetuximab,2,"initial dose of 400, followed by 250",mg/m2,1,weekly,fixed
21540865,NCT00705016,368,cisplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,cisplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,5-fu,2,1000,mg/m2,1,continuous infusion from day 1 to 4 of each 3-week cycle,fixed
21540865,NCT00705016,368,cilengitide,3,2000,mg,1,twice a week,NA
21540865,NCT00705016,368,cetuximab,3,"initial dose of 400, followed by 250",mg/m2,1,weekly,fixed
21540865,NCT00705016,368,cisplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,cisplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,fixed
21540865,NCT00705016,368,5-fu,3,1000,mg/m2,1,continuous infusion from day 1 to 4 of each 3-week cycle,fixed
23397499,NA,369,imo-2055,1,0.16,mg/kg/day,1,"on Days 1, 8, and 15 of each 3-week treatment cycle",NA
23397499,NA,369,5-fluorouracil,1,1000,mg/m2,1,continuous i.v. infusion from Day 1 to Day 4 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,1,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,1,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cetuximab,1,"The first cetuximab dose (400 mg/m2/day, with subsequent doses (250 mg/m2/day)",mg/m2,1,"Days 1, 8, and 15 of each 3-week treatment cycle",fixed
23397499,NA,369,imo-2055,2,0.32,mg/kg/day,1,"on Days 1, 8, and 15 of each 3-week treatment cycle",NA
23397499,NA,369,5-fluorouracil,2,1000,mg/m2,1,continuous i.v. infusion from Day 1 to Day 4 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,2,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,2,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cetuximab,2,"The first cetuximab dose (400 mg/m2/day, with subsequent doses (250 mg/m2/day)",mg/m2,1,"Days 1, 8, and 15 of each 3-week treatment cycle",fixed
23397499,NA,369,imo-2055,3,0.48,mg/kg/day,1,"on Days 1, 8, and 15 of each 3-week treatment cycle",NA
23397499,NA,369,5-fluorouracil,3,1000,mg/m2,1,continuous i.v. infusion from Day 1 to Day 4 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,3,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cisplatin,3,100,mg/m2,1,on Day 1 of each 3-week treatment cycle,fixed
23397499,NA,369,cetuximab,3,"The first cetuximab dose (400 mg/m2/day, with subsequent doses (250 mg/m2/day)",mg/m2,1,"Days 1, 8, and 15 of each 3-week treatment cycle",fixed
16203658,NA,370,oxaliplatin,1,50,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,1,50,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,1,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,1,1800,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,2,60,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,2,60,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,2,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,2,1800,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,3,60,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,3,60,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,3,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,3,2000,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,4,54,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,4,54,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,4,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,4,2000,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,5,65,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,5,65,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,5,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,5,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,6,70,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,6,70,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,6,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,6,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,7,75,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,7,75,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,7,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,7,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,8,80,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,8,80,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,8,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,8,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,9,85,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,9,85,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,9,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,9,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,10,90,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,10,90,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,10,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,10,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,11,95,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,11,95,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,11,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,11,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
16203658,NA,370,oxaliplatin,12,100,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,oxaliplatin,12,100,mg/m2,1,on Days 1 and 15 in cycles of 6 weeks,NA
16203658,NA,370,leucovorin,12,500,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",fixed
16203658,NA,370,5-fluorouracil,12,2200,mg/m2,1,"on Days 1, 8, 15, 21 every 6 weeks",NA
22510347,NA,372,ganciclovir,1,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ganciclovir,1,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ad5.sstr/tk.rgd,1,1 x 109,vp/dose,1,daily for 3 consecutive days,NA
22510347,NA,372,ganciclovir,2,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ganciclovir,2,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ad5.sstr/tk.rgd,2,5 x 109,vp/dose,1,daily for 3 consecutive days,NA
22510347,NA,372,ganciclovir,3,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ganciclovir,3,5,mg/kg,2,from days 5 to 18,fixed
22510347,NA,372,ad5.sstr/tk.rgd,3,1 x 1012,vp/dose,1,daily for 3 consecutive days,NA
16163539,NA,373,s-1,1,80,mg/m2/d,2,from day 1 to day 14 and then with 2 weeks rest,fixed
16163539,NA,373,paclitaxel,1,100,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16163539,NA,373,s-1,2,80,mg/m2/d,2,from day 1 to day 14 and then with 2 weeks rest,fixed
16163539,NA,373,paclitaxel,2,110,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16163539,NA,373,s-1,3,80,mg/m2/d,2,from day 1 to day 14 and then with 2 weeks rest,fixed
16163539,NA,373,paclitaxel,3,120,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16163539,NA,373,s-1,4,80,mg/m2/d,2,from day 1 to day 14 and then with 2 weeks rest,fixed
16163539,NA,373,paclitaxel,4,130,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16319514,NA,374,s-1,1,60,mg/m2/d,2,from day 1 to day 14 followed by a 1-week rest,NA
16319514,NA,374,gemcitabine,1,800,mg/m2,1,weekly for 2 weeks followed by a 1-week rest,NA
16319514,NA,374,s-1,2,60,mg/m2/d,2,from day 1 to day 14 followed by a 1-week rest,NA
16319514,NA,374,gemcitabine,2,1000,mg/m2,1,weekly for 2 weeks followed by a 1-week rest,NA
16319514,NA,374,s-1,3,70,mg/m2/d,2,from day 1 to day 14 followed by a 1-week rest,NA
16319514,NA,374,gemcitabine,3,1000,mg/m2,1,weekly for 2 weeks followed by a 1-week rest,NA
16319514,NA,374,s-1,4,80,mg/m2/d,2,from day 1 to day 14 followed by a 1-week rest,NA
16319514,NA,374,gemcitabine,4,1000,mg/m2,1,weekly for 2 weeks followed by a 1-week rest,NA
16466986,NA,375,eniluracil,-1,5,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,5-fu,-1,0.5,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,radiation,-1,180,cGy,1,"5 days/week over 5.5 weeks, a total dose of 5040 cGy",NA
16466986,NA,375,eniluracil,1,6,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,5-fu,1,0.6,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,radiation,1,180,cGy,1,"5 days/week over 5.5 weeks, a total dose of 5040 cGy",NA
16466986,NA,375,eniluracil,2,8,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,5-fu,2,0.8,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,radiation,2,180,cGy,1,"5 days/week over 5.5 weeks, a total dose of 5040 cGy",NA
16466986,NA,375,eniluracil,3,10,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,5-fu,3,1,mg/m2,2,starting on the morning of the first day of radiation and finishing in the evening on the last day of radiation,NA
16466986,NA,375,radiation,3,180,cGy,1,"5 days/week over 5.5 weeks, a total dose of 5040 cGy",NA
15473585,NA,376,uft,1,200,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,uft,1,200,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,leucovorin,1,15,mg/d,2,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,fixed
15473585,NA,376,radiotherapy,1,1.8,Gy,1,"5 times per week for 5 weeks, 45 Gy total",NA
15473585,NA,376,uft,2,240,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,uft,2,240,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,leucovorin,2,15,mg/d,2,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,fixed
15473585,NA,376,radiotherapy,2,1.8,Gy,1,"5 times per week for 5 weeks, 45 Gy total",NA
15473585,NA,376,uft,3,270,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,uft,3,270,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,leucovorin,3,15,mg/d,2,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,fixed
15473585,NA,376,radiotherapy,3,1.8,Gy,1,"5 times per week for 5 weeks, 45 Gy total",NA
15473585,NA,376,uft,4,300,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,uft,4,300,mg/m2/d,3,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,NA
15473585,NA,376,leucovorin,4,15,mg/d,2,28 continuous days concomitant with the initial 4 weeks of the 5 weeks radiotherapy course,fixed
15473585,NA,376,radiotherapy,4,1.8,Gy,1,"5 times per week for 5 weeks, 45 Gy total",NA
26783290,NCT01344031,377,anastrozole,1,1,mg,1,on days 1-28 on 28-day cycles,fixed
26783290,NCT01344031,377,mk-2206,1,150,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
26783290,NCT01344031,377,anastrozole,1.5,1,mg,1,on days 1-28 on 28-day cycles,fixed
26783290,NCT01344031,377,mk-2206,1.5,150,mg,1,"on days 1, 8, 15, and 22 every 28 days","with prophylactic
prednisone"
26783290,NCT01344031,377,anastrozole,-1,1,mg,1,on days 1-28 on 28-day cycles,fixed
26783290,NCT01344031,377,mk-2206,-1,100,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
26783290,NCT01344031,377,anastrozole,2,1,mg,1,on days 1-28 on 28-day cycles,fixed
26783290,NCT01344031,377,mk-2206,2,200,mg,1,"on days 1, 8, 15, and 22 every 28 days","with prophylactic
prednisone"
14605864,NA,378,bbr 3464,1,0.6,mg/m2,1,on day 1 of the 21-day cycle,NA
14605864,NA,378,5-fluorouracil,1,200,mg/m2/d,1,for all 21 days of the 21-day cycle,NA
14605864,NA,378,bbr 3464,2,0.75,mg/m2,1,on day 1 of the 21-day cycle,NA
14605864,NA,378,5-fluorouracil,2,200,mg/m2/d,1,for all 21 days of the 21-day cycle,NA
14605864,NA,378,bbr 3464,3,0.75,mg/m2,1,on day 1 of the 21-day cycle,NA
14605864,NA,378,5-fluorouracil,3,250,mg/m2/d,1,for all 21 days of the 21-day cycle,NA
14605864,NA,378,bbr 3464,4,0.9,mg/m2,1,on day 1 of the 21-day cycle,NA
14605864,NA,378,5-fluorouracil,4,250,mg/m2/d,1,for all 21 days of the 21-day cycle,NA
14605864,NA,378,bbr 3464,5,0.9,mg/m2,1,on day 1 of the 21-day cycle,NA
14605864,NA,378,5-fluorouracil,5,300,mg/m2/d,1,for all 21 days of the 21-day cycle,NA
14739662,NA,379,pkc412,1,25,mg,1,daily throughout the entire monthly cycle,NA
14739662,NA,379,5-fu,1,200,mg/m2,1,continuous i.v. infusion for the initial 21 days of each 28-day cycle of therapy,fixed
14739662,NA,379,pkc412,2,25,mg,3,daily throughout the entire monthly cycle,NA
14739662,NA,379,5-fu,2,200,mg/m2,1,continuous i.v. infusion for the initial 21 days of each 28-day cycle of therapy,fixed
14739662,NA,379,pkc412,3,50,mg,2,daily throughout the entire monthly cycle,NA
14739662,NA,379,5-fu,3,200,mg/m2,1,continuous i.v. infusion for the initial 21 days of each 28-day cycle of therapy,fixed
14739662,NA,379,pkc412,4,50,mg,3,daily throughout the entire monthly cycle,NA
14739662,NA,379,5-fu,4,200,mg/m2,1,continuous i.v. infusion for the initial 21 days of each 28-day cycle of therapy,fixed
14739662,NA,379,pkc412,5,75,mg,3,daily throughout the entire monthly cycle,NA
14739662,NA,379,5-fu,5,200,mg/m2,1,continuous i.v. infusion for the initial 21 days of each 28-day cycle of therapy,fixed
15818508,NA,380,irinotecan,1,150,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,1,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,2,175,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,2,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,3,200,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,3,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,4,250,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,4,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,5,300,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,5,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,6,350,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,6,250,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
15818508,NA,380,irinotecan,7,350,mg/m2,1,on day 1 every 21 days,NA
15818508,NA,380,5-fu,7,300,mg/m2,1,CI over 14 days followed by a 7-day rest period,fixed
16199307,NA,381,cisplatin,0,10,mg/m2,1,"on days 35, and 42 of the radiation therapy course",NA
16199307,NA,381,cisplatin,0,10,mg/m2,1,"on days 35, and 42 of the radiation therapy course",NA
16199307,NA,381,5-fluorouracil,0,320,mg/m2,1,Days 35–39 and Days 42– 46 of the radiation therapy course,NA
16199307,NA,381,radiation,0,2,Gy,1,5 days per week for 7 weeks,NA
16249791,NA,382,oxaliplatin,1,85,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,oxaliplatin,1,85,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,leucovorin,1,20,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,5-fluorouracil,NA,350,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,radiotherapy,1,1.8,Gy,1,45 Gy in 25 daily fractions,fixed
16249791,NA,382,oxaliplatin,2,130,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,oxaliplatin,2,130,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,leucovorin,2,20,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,5-fluorouracil,2,350,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,radiotherapy,2,1.8,Gy,1,45 Gy in 25 daily fractions,fixed
16249791,NA,382,oxaliplatin,3,150,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,oxaliplatin,3,150,mg/m2,1,on days 2 and 30,NA
16249791,NA,382,leucovorin,3,20,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,5-fluorouracil,3,350,mg/m2,1,on days 1-5 and 29-33,fixed
16249791,NA,382,radiotherapy,3,1.8,Gy,1,45 Gy in 25 daily fractions,fixed
15729600,NA,383,s-1,1,40,mg/m2,2,"for 14 days, followed by a 14-day period with no treatment",NA
15729600,NA,383,cisplatin,1,60,mg/m2,1,on day 8 of the 28-day course,NA
15729600,NA,383,cisplatin,1,60,mg/m2,1,on day 8 of the 28-day course,NA
15729600,NA,383,s-1,2,40,mg/m2,2,"for 14 days, followed by a 14-day period with no treatment",NA
15729600,NA,383,cisplatin,2,70,mg/m2,1,on day 8 of the 28-day course,NA
15729600,NA,383,cisplatin,2,70,mg/m2,1,on day 8 of the 28-day course,NA
15729600,NA,383,s-1,3,40,mg/m2,2,"for 14 days, followed by a 14-day period with no treatment",NA
15729600,NA,383,cisplatin,3,80,mg/m2,1,on day 8 of the 28-day course,NA
15729600,NA,383,cisplatin,3,80,mg/m2,1,on day 8 of the 28-day course,NA
30684019,NCT02109016,384,fulvestrant,1,500,mg,1,at C1D1 and then every 28 days (every cycle),NA
30684019,NCT02109016,384,lucitanib,1,7.5,mg,1,daily from C1D15,NA
30684019,NCT02109016,384,fulvestrant,2,500,mg,1,at C1D1 and then every 28 days (every cycle),NA
30684019,NCT02109016,384,lucitanib,2,10,mg,1,daily from C1D15,NA
30684019,NCT02109016,384,fulvestrant,3,500,mg,1,at C1D1 and then every 28 days (every cycle),NA
30684019,NCT02109016,384,lucitanib,3,12.5,mg,1,daily from C1D15,NA
30684019,NCT02109016,384,fulvestrant,4,500,mg,1,at C1D1 and then every 28 days (every cycle),NA
30684019,NCT02109016,384,lucitanib,4,15,mg,1,daily from C1D15,NA
30543347,NCT01219699,385,alpelisib,1,300,mg,1,daily continuously in 28-day cycles,NA
30543347,NCT01219699,385,fulvestrant,1,500,mg,1,on days 1 and 15 of cycle 1 and day 1 ofeach subsequent cycle,fixed
30543347,NCT01219699,385,alpelisib,2,350,mg,1,daily continuously in 28-day cycles,NA
30543347,NCT01219699,385,fulvestrant,2,500,mg,1,on days 1 and 15 of cycle 1 and day 1 ofeach subsequent cycle,fixed
30543347,NCT01219699,385,alpelisib,3,400,mg,1,daily continuously in 28-day cycles,NA
30543347,NCT01219699,385,fulvestrant,3,500,mg,1,on days 1 and 15 of cycle 1 and day 1 ofeach subsequent cycle,fixed
16297614,NA,386,5-fluorouracil,1,150,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,1,30,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,1,30,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,1,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,2,175,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,2,30,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,2,30,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,2,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,3,175,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,3,40,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,3,40,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,3,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,4,200,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,4,50,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,4,50,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,4,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,5,225,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,5,50,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,5,50,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,5,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,6,225,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,6,60,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,6,60,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,6,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,7,225,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,7,70,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,7,70,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,7,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
16297614,NA,386,5-fluorouracil,8,225,mg/m2,1,continuous infusion (7 days/week) for 5 weeks,NA
16297614,NA,386,oxaliplatin,8,80,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,oxaliplatin,8,80,mg/m2,1,per week for duration of 5 weeks,NA
16297614,NA,386,radiotherapy,8,1.8,Gy,1,5 days per week to a total of 45 Gy,NA
15205598,NA,387,topotecan,1,0.2,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,1,0.2,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,1,62,mg/m2,1,weekly,NA
15205598,NA,387,topotecan,2,0.25,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,2,0.25,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,2,62,mg/m2,1,weekly,NA
15205598,NA,387,topotecan,3,0.3,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,3,0.3,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,3,62,mg/m2,1,weekly,NA
15205598,NA,387,topotecan,4,0.35,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,4,0.35,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,4,75,mg/m2,1,weekly,NA
15205598,NA,387,topotecan,5,0.4,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,5,0.4,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,5,100,mg/m2,1,weekly,NA
15205598,NA,387,topotecan,6,0.45,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,topotecan,6,0.45,mg/m2/d,1,continuous infusion for 2 weeks every 28 days,NA
15205598,NA,387,irinotecan,6,125,mg/m2,1,weekly,NA
28854070,NA,388,endoxifen,1,20,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,2,40,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,3,60,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,4,80,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,5,100,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,6,120,mg,1,daily on 28-day cycles,NA
28854070,NA,388,endoxifen,7,160,mg,1,daily on 28-day cycles,NA
15274409,NA,389,gemcitabine,1,800,mg/m2,1,"on days 1, 8 and 15 of each 28-day cycle",NA
15274409,NA,389,fluorouracil,1,200,mg/m2/d,1,protracted infusion for six months,NA
15274409,NA,389,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of each 28-day cycle",NA
15274409,NA,389,fluorouracil,2,200,mg/m2/d,1,protracted infusion for six months,NA
15274409,NA,389,gemcitabine,3,1100,mg/m2,1,"on days 1, 8 and 15 of each 28-day cycle",NA
15274409,NA,389,fluorouracil,3,200,mg/m2/d,1,protracted infusion for six months,NA
16596209,NA,390,5-fluorouracil,1,600,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,1,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,2,700,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,2,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,3,800,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,3,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,4,900,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,4,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,5,1000,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,5,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,6,1100,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,6,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
16596209,NA,390,5-fluorouracil,7,1200,mg/m2/d,2,"on days 1-4 and 15-18, every 4 weeks",NA
16596209,NA,390,irinotecan,7,180,mg/m2,1,"on days 1 and 15, every 4 weeks",fixed
15596912,NA,391,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,1,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,1,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,2,50,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,2,50,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,2,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,2,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,3,60,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,3,60,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,3,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,3,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,4,70,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,4,70,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,4,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,4,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,5,80,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,5,80,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,5,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,5,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,6,90,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,6,90,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,6,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,6,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,cisplatin,7,100,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,cisplatin,7,100,mg/m2,1,on day 1 every 2 weeks,NA
15596912,NA,391,5-fluorouracil,7,400/1200,mg/m2,1,bolus/continuous over 44 hs on days 1 and 2 every 2 weeks,fixed
15596912,NA,391,leucovorin,7,200,mg/m2,1,on days 1 and 2 every 2 weeks,fixed
16319513,NA,392,s-1,1,80,mg/d,2,"14 consecutive days followed by a 7-day rest, repeated every 3 weeks",NA
16319513,NA,392,paclitaxel,1,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16319513,NA,392,s-1,2,80,mg/d,2,"14 consecutive days followed by a 7-day rest, repeated every 3 weeks",NA
16319513,NA,392,paclitaxel,2,60,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16319513,NA,392,s-1,3,80,mg/d,2,"14 consecutive days followed by a 7-day rest, repeated every 3 weeks",NA
16319513,NA,392,paclitaxel,3,70,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16319513,NA,392,s-1,4,80,mg/d,2,"14 consecutive days followed by a 7-day rest, repeated every 3 weeks",NA
16319513,NA,392,paclitaxel,4,80,mg/m2,1,on days 1 and 8 every 3 weeks,NA
14581279,NA,393,oxaliplatin,1,85,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,oxaliplatin,1,85,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,gemcitabine,1,450,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
14581279,NA,393,5-fu,1,200,mg/m2/d,1,for two consecutive weeks (14 days)followed by a 1 week rest period,fixed
14581279,NA,393,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,oxaliplatin,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,gemcitabine,2,450,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
14581279,NA,393,5-fu,2,200,mg/m2/d,1,for two consecutive weeks (14 days)followed by a 1 week rest period,fixed
14581279,NA,393,oxaliplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,oxaliplatin,3,100,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,gemcitabine,3,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
14581279,NA,393,5-fu,3,200,mg/m2/d,1,for two consecutive weeks (14 days)followed by a 1 week rest period,fixed
14581279,NA,393,oxaliplatin,4,130,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,oxaliplatin,4,130,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,gemcitabine,4,600,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
14581279,NA,393,5-fu,4,200,mg/m2/d,1,for two consecutive weeks (14 days)followed by a 1 week rest period,fixed
14581279,NA,393,oxaliplatin,5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,oxaliplatin,5,130,mg/m2,1,on day 1 of each 21-day cycle,NA
14581279,NA,393,gemcitabine,5,650,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
14581279,NA,393,5-fu,5,200,mg/m2/d,1,for two consecutive weeks (14 days)followed by a 1 week rest period,fixed
23260601,NA,394,valacyclovir,1,15,mg/kg,3,daily for 40 days (day -2 to 38),NA
23260601,NA,394,cyclophosphamide,1,40,mg/kg,1,on day 8,fixed
23260601,NA,394,cyclophosphamide,1,60,mg/kg,1,"on days 18, and 28",fixed
23260601,NA,394,valacyclovir,2,30,mg/kg,3,daily for 40 days (day -2 to 38),NA
23260601,NA,394,cyclophosphamide,2,40,mg/kg,1,on day 8,fixed
23260601,NA,394,cyclophosphamide,2,60,mg/kg,1,"on days 18, and 28",fixed
15613903,NA,395,oxaliplatin,1,55,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,oxaliplatin,1,55,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,tegafur–uracil,1,300,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,leucovorin,1,60,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,oxaliplatin,2,70,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,oxaliplatin,2,70,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,tegafur–uracil,2,300,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,leucovorin,2,60,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,oxaliplatin,3,85,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,oxaliplatin,3,85,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,tegafur–uracil,3,300,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,leucovorin,3,60,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,oxaliplatin,4,100,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,oxaliplatin,4,100,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,tegafur–uracil,4,300,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,leucovorin,4,60,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,oxaliplatin,5,115,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,oxaliplatin,5,115,mg/m2,1,on day 1 and day 15 every 28 days,NA
15613903,NA,395,tegafur–uracil,5,300,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15613903,NA,395,leucovorin,5,60,mg/m2/d,3,"day 1 to day 21, followed by a 7-day break",fixed
15014353,NA,396,irinotecan,0,80,mg/m2,1,on day 1 every 14 days,NA
15014353,NA,396,5-fluorouracil,0,400/1500,mg/m2,1,"bolus on day 1, followed by a 24-h infusion every 14 days",fixed
15014353,NA,396,leucovorin,0,300,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,gemcitabine,0,500,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,cisplatin,0,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,cisplatin,0,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,irinotecan,1,100,mg/m2,1,on day 1 every 14 days,NA
15014353,NA,396,5-fluorouracil,1,400/1500,mg/m2,1,"bolus on day 1, followed by a 24-h infusion every 14 days",fixed
15014353,NA,396,leucovorin,1,300,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,gemcitabine,1,500,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,cisplatin,1,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,cisplatin,1,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,irinotecan,2,120,mg/m2,1,on day 1 every 14 days,NA
15014353,NA,396,5-fluorouracil,2,400/1500,mg/m2,1,"bolus on day 1, followed by a 24-h infusion every 14 days",fixed
15014353,NA,396,leucovorin,2,300,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,gemcitabine,2,500,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,cisplatin,2,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,cisplatin,2,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,irinotecan,3,140,mg/m2,1,on day 1 every 14 days,NA
15014353,NA,396,5-fluorouracil,3,400/1500,mg/m2,1,"bolus on day 1, followed by a 24-h infusion every 14 days",fixed
15014353,NA,396,leucovorin,3,300,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,gemcitabine,3,500,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,cisplatin,3,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,cisplatin,3,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,irinotecan,4,160,mg/m2,1,on day 1 every 14 days,NA
15014353,NA,396,5-fluorouracil,4,400/1500,mg/m2,1,"bolus on day 1, followed by a 24-h infusion every 14 days",fixed
15014353,NA,396,leucovorin,4,300,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,gemcitabine,4,500,mg/m2,1,on day 1 every 14 days,fixed
15014353,NA,396,cisplatin,4,35,mg/m2,1,on day 2 every 14 days,fixed
15014353,NA,396,cisplatin,4,35,mg/m2,1,on day 2 every 14 days,fixed
15961435,NA,397,paclitaxel,1,60,mg/m2,1,"on days 8, 15 and 22 every 4 weeks",NA
15961435,NA,397,5-fluorouracil,1,600,mg/m2/d,1,continuous infusion for 5 days on days 1–5 every 4 weeks,NA
15961435,NA,397,paclitaxel,2,70,mg/m2,1,"on days 8, 15 and 22 every 4 weeks",NA
15961435,NA,397,5-fluorouracil,2,600,mg/m2/d,1,continuous infusion for 5 days on days 1–5 every 4 weeks,NA
15961435,NA,397,paclitaxel,3,80,mg/m2,1,"on days 8, 15 and 22 every 4 weeks",NA
15961435,NA,397,5-fluorouracil,3,600,mg/m2/d,1,continuous infusion for 5 days on days 1–5 every 4 weeks,NA
15961435,NA,397,paclitaxel,4,90,mg/m2,1,"on days 8, 15 and 22 every 4 weeks",NA
15961435,NA,397,5-fluorouracil,4,600,mg/m2/d,1,continuous infusion for 5 days on days 1–5 every 4 weeks,NA
16145066,NA,398,s-1,1,25,mg/m2,2,on days 1 to 21 every 28 days,NA
16145066,NA,398,cisplatin,1,75,mg/m2,1,on day 1 every 28 days,NA
16145066,NA,398,cisplatin,1,75,mg/m2,1,on day 1 every 28 days,NA
16145066,NA,398,s-1,1.5,30,mg/m2,2,on days 1 to 21 every 28 days,NA
16145066,NA,398,cisplatin,1.5,60,mg/m2,1,on day 1 every 28 days,NA
16145066,NA,398,cisplatin,1.5,60,mg/m2,1,on day 1 every 28 days,NA
16145066,NA,398,s-1,2,30,mg/m2,2,on days 1 to 21 every 28 days,NA
16145066,NA,398,cisplatin,2,75,mg/m2,1,on day 1 every 28 days,NA
16145066,NA,398,cisplatin,2,75,mg/m2,1,on day 1 every 28 days,NA
15719490,NA,399,raltitrexed,1,1.5,mg/m2,1,on days 1 and 22 of the treatment,NA
15719490,NA,399,radiotherapy,1,70,Gy,NA,given over 7 weeks in five fractions of 2 Gy per week,NA
15719490,NA,399,raltitrexed,2,2,mg/m2,1,on days 1 and 22 of the treatment,NA
15719490,NA,399,radiotherapy,2,70,Gy,NA,given over 7 weeks in five fractions of 2 Gy per week,NA
15719490,NA,399,raltitrexed,3,2.5,mg/m2,1,on days 1 and 22 of the treatment,NA
15719490,NA,399,radiotherapy,3,70,Gy,NA,given over 7 weeks in five fractions of 2 Gy per week,NA
15719490,NA,399,raltitrexed,4,3,mg/m2,1,on days 1 and 22 of the treatment,NA
15719490,NA,399,radiotherapy,4,70,Gy,NA,given over 7 weeks in five fractions of 2 Gy per week,NA
15297392,NA,400,paclitaxel,1,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,1,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,1,50,mg/m2,1,on day 1 during all five cycles(C1–5),NA
15297392,NA,400,5-fluorouracil,1,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,2,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,2,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,2,100,mg/m2,1,on day 1 during all five cycles(C1–5),NA
15297392,NA,400,5-fluorouracil,2,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,3,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,3,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,3,150,mg/m2,1,on day 1 during all five cycles(C1–5),NA
15297392,NA,400,5-fluorouracil,3,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,4,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,4,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,4,150,mg/m2,1,on day 1 during cyclesC3–5,NA
15297392,NA,400,5-fluorouracil,4,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,5,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,5,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,5,200,mg/m2,1,on day 1 during cycles C3–5,NA
15297392,NA,400,5-fluorouracil,5,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,6,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,6,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,6,250,mg/m2,1,on day 1 during cycles C3–5,NA
15297392,NA,400,5-fluorouracil,6,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,7,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,7,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,7,300,mg/m2,1,on day 1 during cycles C3–5,NA
15297392,NA,400,5-fluorouracil,7,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15297392,NA,400,paclitaxel,8,100,mg/m2,1,on day 1 every 2 weeks,fixed
15297392,NA,400,radiation therapy,8,1.5 or 2,Gy,2,"Each cycle of chemoradiotherapy comprised 5 consecutive days of radiation therapy, followed by a 9-day break",fixed
15297392,NA,400,gemcitabine,8,150,mg/m2,1,on day 1 during cycles C4–5,NA
15297392,NA,400,5-fluorouracil,8,600,mg/m2,1,120 h of continuous infusion starting on day 0 every 2 weeks,fixed
15108040,NA,401,irinotecan,1,80,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,5-fluorouracil,1,400,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,leucovorin,1,25,mg/body,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,irinotecan,2,100,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,5-fluorouracil,2,400,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,leucovorin,2,25,mg/body,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,irinotecan,3,100,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,5-fluorouracil,3,500,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,leucovorin,3,25,mg/body,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,irinotecan,4,120,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,5-fluorouracil,4,500,mg/m2,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
15108040,NA,401,leucovorin,4,25,mg/body,1,"on days 1, 8, and 15, and cycles were repeated every 28 days",NA
16141295,NA,402,s-1,1,40,mg/m2,2,for 21 consecutive days followed by a 2 week rest,NA
16141295,NA,402,irinotecan,1,40,mg/m2,1,on days 1 and 15 of each 28-day course,NA
16141295,NA,402,s-1,2,40,mg/m2,2,for 21 consecutive days followed by a 2 week rest,NA
16141295,NA,402,irinotecan,2,60,mg/m2,1,on days 1 and 15 of each 28-day course,NA
16141295,NA,402,s-1,3,40,mg/m2,2,for 21 consecutive days followed by a 2 week rest,NA
16141295,NA,402,irinotecan,3,80,mg/m2,1,on days 1 and 15 of each 28-day course,NA
16141295,NA,402,s-1,4,40,mg/m2,2,for 21 consecutive days followed by a 2 week rest,NA
16141295,NA,402,irinotecan,4,100,mg/m2,1,on days 1 and 15 of each 28-day course,NA
15028404,NA,403,radiation,0,50,Gy,NA,"daily fractions of 2 Gy, 5 times/week",NA
15028404,NA,403,uft,0,300,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,uft,0,300,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,leucovorin,0,90,mg/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,radiation,1,50,Gy,NA,"daily fractions of 2 Gy, 5 times/week",NA
15028404,NA,403,uft,1,350,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,uft,1,350,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,leucovorin,1,90,mg/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,radiation,2,50,Gy,NA,"daily fractions of 2 Gy, 5 times/week",NA
15028404,NA,403,uft,2,400,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,uft,2,400,mg/m2/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15028404,NA,403,leucovorin,2,90,mg/d,3,5 days per week concurrently withradiation to 50 Gy,NA
15122078,NA,404,irinotecan,1,150,mg/m2,1,on day 1 of each course every 3 weeks,NA
15122078,NA,404,oxaliplatin,1,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15122078,NA,404,oxaliplatin,1,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15122078,NA,404,irinotecan,2,175,mg/m2,1,on day 1 of each course every 3 weeks,NA
15122078,NA,404,oxaliplatin,2,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15122078,NA,404,oxaliplatin,2,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15122078,NA,404,irinotecan,3,200,mg/m2,1,on day 1 of each course every 3 weeks,NA
15122078,NA,404,oxaliplatin,3,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15122078,NA,404,oxaliplatin,3,130,mg/m2,1,on day 1 of each course every 3 weeks,fixed
15942632,NA,405,s-1,1,60,mg/m2/d,2,"for 14 consecutive days (from the evening of day 1 to the morning of day 15), followed by a 1-week break",NA
15942632,NA,405,gemcitabine,1,800,mg/m2,1,on days 8 and 15 of each 21-day cycle,NA
15942632,NA,405,s-1,2,80,mg/m2/d,2,"for 14 consecutive days (from the evening of day 1 to the morning of day 15), followed by a 1-week break",NA
15942632,NA,405,gemcitabine,2,800,mg/m2,1,on days 8 and 15 of each 21-day cycle,NA
15942632,NA,405,s-1,2.5,60,mg/m2/d,2,"for 14 consecutive days (from the evening of day 1 to the morning of day 15), followed by a 1-week break",NA
15942632,NA,405,gemcitabine,2.5,1000,mg/m2,1,on days 8 and 15 of each 21-day cycle,NA
15014354,NA,406,raltitrexed,1,0.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,1,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,2,1,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,2,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,3,1.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,3,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,4,2,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,4,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,5,2.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,5,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,6,3,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,6,900,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,7,3,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,7,1050,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,8,3,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,8,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,9,3,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,9,1350,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,10,3.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,10,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,11,4,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,11,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,12,4.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,12,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,13,5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,13,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,14,5.5,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,14,1200,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,raltitrexed,15,6,mg/m2,1,once every 3 weeks,NA
15014354,NA,406,5-fu,15,1200,mg/m2,1,once every 3 weeks,NA
16009951,NA,407,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,1,150,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,1,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,407,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,2,150,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,2,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,407,oxaliplatin,3,130,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,3,130,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,3,150,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,3,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,407,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,4,200,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,4,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,407,oxaliplatin,5,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,5,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,5,200,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,5,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,407,oxaliplatin,6,130,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,oxaliplatin,6,130,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,irinotecan,6,200,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,407,floxuridine,6,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,408,oxaliplatin,1,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,oxaliplatin,1,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,fluorouracil,1,1000,mg/m2,1,48-hour infusion on days 1 and 15 every 2 weeks,NA
16009951,NA,408,leucovorin,1,400,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,floxuridine,1,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,408,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,oxaliplatin,2,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,fluorouracil,2,1200,mg/m2,1,48-hour infusion on days 1 and 15 every 2 weeks,NA
16009951,NA,408,leucovorin,2,400,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,floxuridine,2,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,408,oxaliplatin,3,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,oxaliplatin,3,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,fluorouracil,3,1400,mg/m2,1,48-hour infusion on days 1 and 15 every 2 weeks,NA
16009951,NA,408,leucovorin,3,400,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,floxuridine,3,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
16009951,NA,408,oxaliplatin,4,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,oxaliplatin,4,100,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,fluorouracil,4,1600,mg/m2,1,48-hour infusion on days 1 and 15 every 2 weeks,NA
16009951,NA,408,leucovorin,4,400,mg/m2,1,on days 1 and 15 every 2 weeks,NA
16009951,NA,408,floxuridine,4,0.12,mg/kg,1,over 14 days starting on day 1 of each 28-day cycle,fixed
14962716,NA,409,uft,1,200,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,uft,1,200,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,leucovorin,1,60,mg/d,2,on days 2–15 of each 21-day treatment cycle,fixed
14962716,NA,409,irinotecan,1,200,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
14962716,NA,409,uft,2,200,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,uft,2,200,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,leucovorin,2,60,mg/d,2,on days 2–15 of each 21-day treatment cycle,fixed
14962716,NA,409,irinotecan,2,250,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
14962716,NA,409,uft,3,250,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,uft,3,250,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,leucovorin,3,60,mg/d,2,on days 2–15 of each 21-day treatment cycle,fixed
14962716,NA,409,irinotecan,3,250,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
14962716,NA,409,uft,4,250,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,uft,4,250,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,leucovorin,4,60,mg/d,2,on days 2–15 of each 21-day treatment cycle,fixed
14962716,NA,409,irinotecan,4,310,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
14962716,NA,409,uft,5,300,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,uft,5,300,mg/m2,2,on days 2–15 of each 21-day treatment cycle,NA
14962716,NA,409,leucovorin,5,60,mg/d,2,on days 2–15 of each 21-day treatment cycle,fixed
14962716,NA,409,irinotecan,5,310,mg/m2,1,on day 1 of each 21-day treatment cycle,NA
29289986,NA,410,alisertib,1,40,mg,2,"on days 1–3, 8–10, and 15–17 of each 28-day cycle",NA
29289986,NA,410,fulvestrant,1,500,mg,1,on days 1 & 15 of cycle 1 and day 1 of all subsequent cycles,fixed
29289986,NA,410,alisertib,2,50,mg,2,"on days 1–3, 8–10, and 15–17 of each 28-day cycle",NA
29289986,NA,410,fulvestrant,2,500,mg,1,on days 1 & 15 of cycle 1 and day 1 of all subsequent cycles,fixed
15549585,NA,411,irinotecan,1,100,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
15549585,NA,411,5-fluorouracil,1,400,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15549585,NA,411,l-leucovorin,1,10,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
15549585,NA,411,irinotecan,2,100,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
15549585,NA,411,5-fluorouracil,2,500,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15549585,NA,411,l-leucovorin,2,10,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
14676796,NA,412,s-1,1,40,mg/m2,2,for 21 consecutive days following a 2-week rest,NA
14676796,NA,412,cisplatin,1,60,mg/m2,1,on day 8  every 5 weeks,NA
14676796,NA,412,cisplatin,1,60,mg/m2,1,on day 8  every 5 weeks,NA
14676796,NA,412,s-1,2,40,mg/m2,2,for 21 consecutive days following a 2-week rest,NA
14676796,NA,412,cisplatin,2,70,mg/m2,1,on day 8  every 5 weeks,NA
14676796,NA,412,cisplatin,2,70,mg/m2,1,on day 8  every 5 weeks,NA
16570038,NA,413,s-1,1,80,mg/m2/d,2,for 14 consecutive days every 4weeks,NA
16570038,NA,413,irinotecan,1,70,mg/m2,1,on days 1 and 8 every 4weeks,NA
16570038,NA,413,s-1,2,80,mg/m2/d,2,for 14 consecutive days every 4weeks,NA
16570038,NA,413,irinotecan,2,80,mg/m2,1,on days 1 and 8 every 4weeks,NA
16570038,NA,413,s-1,3,80,mg/m2/d,2,for 14 consecutive days every 4weeks,NA
16570038,NA,413,irinotecan,3,90,mg/m2,1,on days 1 and 8 every 4weeks,NA
16570038,NA,413,s-1,4,80,mg/m2/d,2,for 14 consecutive days every 4weeks,NA
16570038,NA,413,irinotecan,4,100,mg/m2,1,on days 1 and 8 every 4weeks,NA
15033659,NA,414,irinotecan,1,60,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,1,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
15033659,NA,414,irinotecan,2,70,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,2,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
15033659,NA,414,irinotecan,3,80,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,3,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
15033659,NA,414,irinotecan,4,90,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,4,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
15033659,NA,414,irinotecan,5,100,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,5,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
15033659,NA,414,irinotecan,6,110,mg/m2,1,"days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",NA
15033659,NA,414,5-fu,6,3000,mg/m2,1,"48-h i.v. infusion on days 1–2, 8–9, 15–16, 22–23, 29–30 and 36–37 every 6 weeks",fixed
16601426,NA,415,semaxinib,1,85,mg/m2,1,twice weekly throughout a 6-week period,NA
16601426,NA,415,irinotecan,1,125,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
16601426,NA,415,5-fu,1,500,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
16601426,NA,415,leucovorin,1,20,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
16601426,NA,415,semaxinib,2,145,mg/m2,1,twice weekly throughout a 6-week period,NA
16601426,NA,415,irinotecan,2,125,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
16601426,NA,415,5-fu,2,500,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
16601426,NA,415,leucovorin,2,20,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",fixed
33641211,NCT02384746,416,ixazomib,1,2.3,mg,1,"Days 1, 4, 8, and 11 of a 21‐day cycle",NA
33641211,NCT02384746,416,fulvestrant,1,500,mg,1,Day 1 of a 28‐day cycle,fixed
33641211,NCT02384746,416,ixazomib,2,3,mg,1,"Days 1, 4, 8, and 11 of a 21‐day cycle",NA
33641211,NCT02384746,416,fulvestrant,2,500,mg,1,Day 1 of a 28‐day cycle,fixed
33641211,NCT02384746,416,ixazomib,3,4,mg,1,"Days 1, 4, 8, and 11 of a 21‐day cycle",NA
33641211,NCT02384746,416,fulvestrant,3,500,mg,1,Day 1 of a 28‐day cycle,fixed
14647137,NA,417,5-fu,1,2600,mg/m2,1,a 24-h continuous infusion weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,folinic acid,1,500,mg/m2,1,weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,mitomycin c,1,6,mg/m2,1,on days 1 and 22 of 7-weekly courses,NA
14647137,NA,417,5-fu,2,2600,mg/m2,1,a 24-h continuous infusion weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,folinic acid,2,500,mg/m2,1,weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,mitomycin c,2,8,mg/m2,1,on days 1 and 22 of 7-weekly courses,NA
14647137,NA,417,5-fu,3,2600,mg/m2,1,a 24-h continuous infusion weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,folinic acid,3,500,mg/m2,1,weekly for 6 weeks followed by 1 week rest,NA
14647137,NA,417,mitomycin c,3,10,mg/m2,1,on days 1 and 22 of 7-weekly courses,NA
15947933,NA,418,irinotecan,1,20,mg/m2,1,"on days 1, and 8 every 3 weeks",NA
15947933,NA,418,gemcitabine,1,1000,mg/m2,1,on days 2 and 9 every 3 weeks,fixed
15947933,NA,418,irinotecan,2,40,mg/m2,1,"on days 1, and 8 every 3 weeks",NA
15947933,NA,418,gemcitabine,2,1000,mg/m2,1,on days 2 and 9 every 3 weeks,fixed
15947933,NA,418,irinotecan,3,60,mg/m2,1,"on days 1, and 8 every 3 weeks",NA
15947933,NA,418,gemcitabine,3,1000,mg/m2,1,on days 2 and 9 every 3 weeks,fixed
15947933,NA,418,irinotecan,4,80,mg/m2,1,"on days 1, and 8 every 3 weeks",NA
15947933,NA,418,gemcitabine,4,1000,mg/m2,1,on days 2 and 9 every 3 weeks,fixed
15947933,NA,418,irinotecan,5,100,mg/m2,1,"on days 1, and 8 every 3 weeks",NA
15947933,NA,418,gemcitabine,5,1000,mg/m2,1,on days 2 and 9 every 3 weeks,fixed
16549999,NA,419,oxaliplatin,-1,70,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,-1,70,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,uft,-1,250,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,uft,-1,250,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,1,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,uft,1,250,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,uft,1,250,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,2,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,uft,2,300,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,uft,2,300,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,3,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,uft,3,350,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,uft,3,350,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,oxaliplatin,4,85,mg/m2,1,on days 1 and 15 of a 28-day cycle,NA
16549999,NA,419,uft,4,400,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
16549999,NA,419,uft,4,400,mg/m2/d,3,on days 1–21 followed of 1 week rest of a 28-day cycle,NA
34417914,NA,420,rx-3117,1,500,mg/d,1,5 times per week (5 consecutive days followed by 2 days of) for 3 consecutive weeks followed by 1 week off,NA
34417914,NA,420,nab‑paclitaxel,1,125,mg/m2,1,"once per week for 3 weeks (Days 1,8, and 15) followed by 1 week off",fixed
34417914,NA,420,rx-3117,2,600,mg/d,1,5 times per week (5 consecutive days followed by 2 days of) for 3 consecutive weeks followed by 1 week off,NA
34417914,NA,420,nab‑paclitaxel,2,125,mg/m2,1,"once per week for 3 weeks (Days 1,8, and 15) followed by 1 week off",fixed
34417914,NA,420,rx-3117,3,700,mg/d,1,5 times per week (5 consecutive days followed by 2 days of) for 3 consecutive weeks followed by 1 week off,NA
34417914,NA,420,nab‑paclitaxel,3,125,mg/m2,1,"once per week for 3 weeks (Days 1,8, and 15) followed by 1 week off",fixed
30635165,NCT01908478,421,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,1,20,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,1,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
30635165,NCT01908478,421,gemcitabine,2,750,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,2,20,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,2,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
30635165,NCT01908478,421,gemcitabine,3,500,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,3,20,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,3,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
30635165,NCT01908478,421,gemcitabine,4,400,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,4,20,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,4,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
30635165,NCT01908478,421,gemcitabine,5,400,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,5,40,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,5,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
30635165,NCT01908478,421,gemcitabine,6,400,mg/m2,1,"on days 1, 8, 15 of the 3-week cycle",NA
30635165,NCT01908478,421,veliparib,6,60,mg,2,daily in 3-week cycles,NA
30635165,NCT01908478,421,intensity modulated radiation therapy,6,2.4,Gy,1,"36 Gy in 15 fractions (2.4 Gy per fraction, one fraction per day, 5 fractions per week, Monday through Friday) beginning on day 1",fixed
17119113,NA,422,ganciclovir,1,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,ganciclovir,1,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,arginine butyrate,1,500,mg/kg/d,1,continuous infusion on day 0 for 2 days every 28 days,NA
17119113,NA,422,ganciclovir,2,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,ganciclovir,2,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,arginine butyrate,2,1000,mg/kg/d,1,continuous infusion on day 0 for 2 days every 28 days,NA
17119113,NA,422,ganciclovir,3,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,ganciclovir,3,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,arginine butyrate,3,1500,mg/kg/d,1,continuous infusion on day 0 for 2 days every 28 days,NA
17119113,NA,422,ganciclovir,4,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,ganciclovir,4,5,mg/kg,2,On days −1 or day 0 continued throughout the 28-day cycle,fixed
17119113,NA,422,arginine butyrate,4,2000,mg/kg/d,1,continuous infusion on day 0 until day 21 every 28 days,NA
31338636,NA,423,vantictumab,1,3.5,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
31338636,NA,423,nab-paclitaxel,1,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,vantictumab,2,7,mg/kg,1,on days 1 and 15 of each 28-day cycle,NA
31338636,NA,423,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,vantictumab,3,3,mg/kg,1,on day 1 of each 28-day cycle,NA
31338636,NA,423,nab-paclitaxel,3,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,vantictumab,4,5,mg/kg,1,on day 1 of each 28-day cycle,NA
31338636,NA,423,nab-paclitaxel,4,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31338636,NA,423,vantictumab,5,5,mg/kg,1,on day 1 of each 28-day cycle,NA
31338636,NA,423,nab-paclitaxel,5,125,mg/m2,1,"on days 3, 10, and 17 of each 28-day cycle",fixed
31338636,NA,423,gemcitabine,5,1000,mg/m2,1,"on days 3, 10, and 17 of each 28-day cycle",fixed
20708924,NA,424,gefitinib,1,100,mg,1,daily in 4-week cycles,BSG (brain stem gliomas) Stratum
20708924,NA,424,radiation therapy,1,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,BSG (brain stem gliomas) Stratum
20708924,NA,424,gefitinib,2,250,mg,1,daily in 4-week cycles,BSG (brain stem gliomas) Stratum
20708924,NA,424,radiation therapy,2,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,BSG (brain stem gliomas) Stratum
20708924,NA,424,gefitinib,3,375,mg,1,daily in 4-week cycles,BSG (brain stem gliomas) Stratum
20708924,NA,424,radiation therapy,3,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,BSG (brain stem gliomas) Stratum
20708924,NA,424,gefitinib,1,100,mg,1,daily in 4-week cycles,STMG (supertentorial malignant gliomas)
20708924,NA,424,radiation therapy,1,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,STMG (supertentorial malignant gliomas)
20708924,NA,424,gefitinib,2,250,mg,1,daily in 4-week cycles,STMG (supertentorial malignant gliomas)
20708924,NA,424,radiation therapy,2,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,STMG (supertentorial malignant gliomas)
20708924,NA,424,gefitinib,3,375,mg,1,daily in 4-week cycles,STMG (supertentorial malignant gliomas)
20708924,NA,424,radiation therapy,3,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,STMG (supertentorial malignant gliomas)
20708924,NA,424,gefitinib,1,100,mg,1,daily in 4-week cycles,STMG + EIACD (nzyme-inducing anticonvulsant drug)
20708924,NA,424,radiation therapy,1,1.8,Gy,1,A total dose of 55.8 Gy was given in 180 cGy daily fractions,STMG + EIACD (nzyme-inducing anticonvulsant drug)
30895346,NA,425,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30895346,NA,425,dasatinib,1,40,mg,2,daily continuously,NA
30895346,NA,425,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30895346,NA,425,dasatinib,2,50,mg,2,daily continuously,NA
30895346,NA,425,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30895346,NA,425,dasatinib,3,70,mg,2,daily continuously,NA
32772340,jRCTs 031180095,426,paclitaxel,0,20,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,gemcitabine,0,600,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,nab-paclitaxel,0,75,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,paclitaxel,1,20,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,gemcitabine,1,800,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,paclitaxel,2,20,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,paclitaxel,3,30,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
32772340,jRCTs 031180095,426,nab-paclitaxel,3,125,mg/m2,1,"on days 1, 8 and 15 in 4-week cycles",NA
15744591,NA,427,zd1839,1,150,mg,1,daily in 28-day cycles,NA
15744591,NA,427,zd1839,2,225,mg,1,daily in 28-day cycles,NA
15744591,NA,427,zd1839,3,300,mg,1,daily in 28-day cycles,NA
15744591,NA,427,zd1839,4,400,mg,1,daily in 28-day cycles,NA
15744591,NA,427,zd1839,5,600,mg,1,daily in 28-day cycles,NA
15744591,NA,427,zd1839,6,800,mg,1,daily in 28-day cycles,NA
34319586,NCT02227940,428,ceritinib,1,450,mg/m2,1,daily,NA
34319586,NCT02227940,428,gemcitabine,1,1000,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,428,ceritinib,2,600,mg/m2,1,daily,NA
34319586,NCT02227940,428,gemcitabine,2,1000,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,429,ceritinib,1,450,mg/m2,1,daily,NA
34319586,NCT02227940,429,gemcitabine,1,1000,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,429,nab-paclitaxel,1,125,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,429,ceritinib,2,600,mg/m2,1,daily,NA
34319586,NCT02227940,429,gemcitabine,2,1000,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,429,nab-paclitaxel,2,125,mg/m2,1,1/8/15 (28-day cycle),fixed
34319586,NCT02227940,430,ceritinib,1,450,mg/m2,1,daily,NA
34319586,NCT02227940,430,gemcitabine,1,1000,mg/m2,1,on Days 1/8,fixed
34319586,NCT02227940,430,cisplatin,1,60,mg/m2,1,on Day1 (21-day cycle),fixed
34319586,NCT02227940,430,cisplatin,1,60,mg/m2,1,on Day1 (21-day cycle),fixed
34319586,NCT02227940,430,ceritinib,2,600,mg/m2,1,daily,NA
34319586,NCT02227940,430,gemcitabine,2,1000,mg/m2,1,on Days 1/8,fixed
34319586,NCT02227940,430,cisplatin,2,60,mg/m2,1,on Day1 (21-day cycle),fixed
34319586,NCT02227940,430,cisplatin,2,60,mg/m2,1,on Day1 (21-day cycle),fixed
23261229,NA,431,nimotuzumab,1,100,mg,1,weekly in 28-day cycles,NA
23261229,NA,431,gefitinib,1,250,mg,1,daily until disease progression or unacceptable toxicity,fixed
23261229,NA,431,nimotuzumab,2,200,mg,1,weekly in 28-day cycles,NA
23261229,NA,431,gefitinib,2,250,mg,1,daily until disease progression or unacceptable toxicity,fixed
25784657,NCT00372515,432,gefitinib,1,750,mg,1,On days 1-14 every 28 days,NA
25784657,NCT00372515,432,gefitinib,1,500,mg,1,on days 15-28 of each 28-day cycle,NA
25784657,NCT00372515,432,gefitinib,2,1000,mg,1,On days 1-14 every 28 days,NA
25784657,NCT00372515,432,gefitinib,2,500,mg,1,on days 15-28 of each 28-day cycle,NA
25784657,NCT00372515,432,gefitinib,3,1250,mg,1,On days 1-14 every 28 days,NA
25784657,NCT00372515,432,gefitinib,3,500,mg,1,on days 15-28 of each 28-day cycle,NA
33523334,NCT02624492,433,bi 836826,1,25,mg,1,on day 8 of each 14-day cycle,NA
33523334,NCT02624492,433,gemcitabine,1,1000,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,1,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,1,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,bi 836826,2,50,mg,1,on day 8 of each 14-day cycle,NA
33523334,NCT02624492,433,gemcitabine,2,1000,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,2,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,2,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,bi 836826,3,100,mg,1,on day 8 of each 14-day cycle,NA
33523334,NCT02624492,433,gemcitabine,3,1000,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,3,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
33523334,NCT02624492,433,oxaliplatin,3,100,mg/m2,1,on day 1 of each 14-day cycle,fixed
34066784,NCT02109341,434,nab-paclitaxel,1,90,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,1,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,1,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,1,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,nab-paclitaxel,2,100,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,2,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,2,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,2,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,nab-paclitaxel,3,110,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,3,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,3,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,3,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,nab-paclitaxel,4,120,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,4,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,4,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,4,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,nab-paclitaxel,5,130,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,5,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,5,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,5,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,nab-paclitaxel,6,140,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,l-folinic acid,6,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,434,5-fu,6,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,434,irinotecan,6,180,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,1,90,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,1,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,1,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,1,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,2,100,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,2,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,2,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,2,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,3,110,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,3,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,3,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,3,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,4,120,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,4,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,4,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,4,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,4,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,5,130,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,5,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,5,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,5,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,5,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,6,140,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,6,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,6,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,6,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,6,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,7,150,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,7,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,7,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,7,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,7,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,8,160,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,8,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,8,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,8,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,8,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,nab-paclitaxel,9,170,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,l-folinic acid,9,200,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,5-fu,9,400/2400,mg/m2,1,bolus 400 mg/m2 iv and 48 h continuous infusion (ci) 2400 mg/m2 at days 1 and 2 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,9,85,mg/m2,1,on day 1 every 2 weeks,NA
34066784,NCT02109341,435,oxaliplatin,9,85,mg/m2,1,on day 1 every 2 weeks,NA
30068505,NCT01582776,436,lenalidomide,1,10,mg,1,on days 1-21 of the first 28-day cycle and on days 2-22 of 28-day cycles 2-6,NA
30068505,NCT01582776,436,obinutuzumab,1,1000,mg,1,"on days 8, 15, and 22 of the first cycle and on day 1 of cycles 2-6",fixed
30068505,NCT01582776,436,lenalidomide,2,15,mg,1,on days 1-21 of the first 28-day cycle and on days 2-22 of 28-day cycles 2-6,NA
30068505,NCT01582776,436,obinutuzumab,2,1000,mg,1,"on days 8, 15, and 22 of the first cycle and on day 1 of cycles 2-6",fixed
30068505,NCT01582776,436,lenalidomide,3,20,mg,1,on days 1-21 of the first 28-day cycle and on days 2-22 of 28-day cycles 2-6,NA
30068505,NCT01582776,436,obinutuzumab,3,1000,mg,1,"on days 8, 15, and 22 of the first cycle and on day 1 of cycles 2-6",fixed
30068505,NCT01582776,436,lenalidomide,4,25,mg,1,on days 1-21 of the first 28-day cycle and on days 2-22 of 28-day cycles 2-6,NA
30068505,NCT01582776,436,obinutuzumab,4,1000,mg,1,"on days 8, 15, and 22 of the first cycle and on day 1 of cycles 2-6",fixed
32758434,NCT02417285 ,437,avadomide,1,1,mg,1,daily on days 1–5 followed by 2 days off (5–7-day schedule) every week of each 28-day cycle,NA
32758434,NCT02417285 ,437,obinutuzumab,1,1000,mg,1,"on Days 2, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 though 8",fixed
32758434,NCT02417285 ,437,avadomide,2,2,mg,1,daily on days 1–5 followed by 2 days off (5–7-day schedule) every week of each 28-day cycle,NA
32758434,NCT02417285 ,437,obinutuzumab,2,1000,mg,1,"on Days 2, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 though 8",fixed
32758434,NCT02417285 ,437,avadomide,3,3,mg,1,daily on days 1–5 followed by 2 days off (5–7-day schedule) every week of each 28-day cycle,NA
32758434,NCT02417285 ,437,obinutuzumab,3,1000,mg,1,"on Days 2, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 though 8",fixed
32758434,NCT02417285 ,437,avadomide,4,4,mg,1,daily on days 1–5 followed by 2 days off (5–7-day schedule) every week of each 28-day cycle,NA
32758434,NCT02417285 ,437,obinutuzumab,4,1000,mg,1,"on Days 2, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 though 8",fixed
30563938,NCT01828034,438,binimetinib,1,30,mg,2,daily continuously,NA
30563938,NCT01828034,438,gemcitabine,1,800,mg/m2,1,on day 8 and 15 of a 21-day cycle,NA
30563938,NCT01828034,438,cisplatin,1,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
30563938,NCT01828034,438,cisplatin,1,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
30563938,NCT01828034,438,binimetinib,2,45,mg,2,daily continuously,NA
30563938,NCT01828034,438,gemcitabine,2,800,mg/m2,1,on day 8 and 15 of a 21-day cycle,NA
30563938,NCT01828034,438,cisplatin,2,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
30563938,NCT01828034,438,cisplatin,2,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
30563938,NCT01828034,438,binimetinib,3,45,mg,2,daily continuously,NA
30563938,NCT01828034,438,gemcitabine,3,1000,mg/m2,1,on day 8 and 15 of a 21-day cycle,NA
30563938,NCT01828034,438,cisplatin,3,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
30563938,NCT01828034,438,cisplatin,3,20,mg/m2,1,on day 8 and 15 of a 21-day cycle,fixed
33387490,NCT03214250 ,439,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,439,nab-paclitaxel,1,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,439,apx005m,1,0.1,mg/kg,1,on day 3 of each 28-day cycle,NA
33387490,NCT03214250 ,439,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,439,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,439,apx005m,2,0.3,mg/kg,1,on day 3 of each 28-day cycle,NA
33387490,NCT03214250 ,440,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,440,nab-paclitaxel,1,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,440,apx005m,1,0.1,mg/kg,1,on day 3 of each 28-day cycle,NA
33387490,NCT03214250 ,440,nivolumab,1,240,mg,1,on days 1 and 15 of each 28-day cycle,NA
33387490,NCT03214250 ,440,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,440,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
33387490,NCT03214250 ,440,apx005m,2,0.3,mg/kg,1,on day 3 of each 28-day cycle,NA
33387490,NCT03214250 ,440,nivolumab,2,240,mg,1,on days 1 and 15 of each 28-day cycle,NA
18317068,NA,441,cetuximab,1,100,mg/m2,1,weekly,NA
18317068,NA,441,gefitinib,1,250,mg,1,daily,fixed
18317068,NA,441,cetuximab,2,200,mg/m2,1,weekly,NA
18317068,NA,441,gefitinib,2,250,mg,1,daily,fixed
18317068,NA,441,cetuximab,3,250,mg/m2,1,weekly,NA
18317068,NA,441,gefitinib,3,250,mg,1,daily,fixed
17237473,NA,442,irinotecan,1,250,mg/m2,1,on day 1 of the 21-day cycle,NA
17237473,NA,442,gefitinib,1,250,mg,1,daily starting on day 1 of the first cycle,fixed
17237473,NA,442,irinotecan,-2,200,mg/m2,1,on day 1 of the 21-day cycle,NA
17237473,NA,442,gefitinib,-2,250,mg,1,daily starting on day 3 of the first cycle,fixed
17237473,NA,442,irinotecan,-1,225,mg/m2,1,on day 1 of the 21-day cycle,NA
17237473,NA,442,gefitinib,-1,250,mg,1,daily starting on day 3 of the first cycle,fixed
34953624,NCT02040064,443,gefitinib,1,250,mg,1,daily,NA
34953624,NCT02040064,443,tremelimumab,1,3,mg/kg,1,weekly every 4 weeks (Q4W) for 6 cycles and Q12W thereafter,NA
34953624,NCT02040064,443,gefitinib,2,250,mg,1,daily,NA
34953624,NCT02040064,443,tremelimumab,2,6,mg/kg,1,weekly every 4 weeks (Q4W) for 6 cycles and Q12W thereafter,NA
34953624,NCT02040064,443,gefitinib,3,250,mg,1,daily,NA
34953624,NCT02040064,443,tremelimumab,3,10,mg/kg,1,weekly every 4 weeks (Q4W) for 6 cycles and Q12W thereafter,NA
30488350,ACTRN12611000643976,444,gemcitabine,1,800,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,1,10,mg,1,weekly in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,gemcitabine,2,800,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,2,15,mg,1,weekly in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,gemcitabine,3,800,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,3,20,mg,1,weekly in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,gemcitabine,4,800,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,4,25,mg,1,weekly in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,gemcitabine,5,1000,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,5,20,mg,1,weekly in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,gemcitabine,6,1000,mg/m2,1,every 2 weeks in a 4-week cycle,NA
30488350,ACTRN12611000643976,444,temsirolimus,6,25,mg,1,weekly in a 4-week cycle,NA
33181832,NCT02558816,445,ibrutinib,1,560,mg,1,day 2 in each 28-day cycles for >=2 years,fixed
33181832,NCT02558816,445,obinutuzumab,1,1000,mg,1,"cycle 1 days 1, 8, and 15; cycle 1b-8 day 1; and every 2 months until cycle 23 (28 days per cycle)",fixed
33181832,NCT02558816,445,venetoclax,1,400,mg,1,daily from cycle 2,NA
33181832,NCT02558816,445,ibrutinib,2,560,mg,1,day 2 in each 28-day cycles for >=2 years,fixed
33181832,NCT02558816,445,obinutuzumab,2,1000,mg,1,"cycle 1 days 1, 8, and 15; cycle 1b-8 day 1; and every 2 months until cycle 23 (28 days per cycle))",fixed
33181832,NCT02558816,445,venetoclax,2,600,mg,1,daily from cycle 2,NA
33181832,NCT02558816,445,ibrutinib,3,560,mg,1,day 2 in each 28-day cycles for >=2 years,fixed
33181832,NCT02558816,445,obinutuzumab,3,1000,mg,1,"cycle 1 days 1, 8, and 15; cycle 1b-8 day 1; and every 2 months until cycle 23 (28 days per cycle))",fixed
33181832,NCT02558816,445,venetoclax,3,800,mg,1,daily from cycle 2,NA
31740568,NCT01473940,446,gemcitabine,1,750,mg/m2,1,weekly in weeks 1-7 and 9-11,NA
31740568,NCT01473940,446,ipilimumab,1,3,mg/kg,1,"weekly in weeks 1, 4, 7, and 10",NA
31740568,NCT01473940,446,gemcitabine,2,1000,mg/m2,1,weekly in weeks 1-7 and 9-11,NA
31740568,NCT01473940,446,ipilimumab,2,3,mg/kg,1,"weekly in weeks 1, 4, 7, and 10",NA
31740568,NCT01473940,446,gemcitabine,3,1000,mg/m2,1,weekly in weeks 1-7 and 9-11,NA
31740568,NCT01473940,446,ipilimumab,3,6,mg/kg,1,"weekly in weeks 1, 4, 7, and 10",NA
19879702,NA,447,gefitinib,0,250,mg,1,initiated on Day 1 and continued daily for 16 weeks,NA
19879702,NA,447,paclitaxel,0,36,mg/m2,1,initiated at Day 8 as a weekly 1-h intravenous infusion for six doses,NA
19879702,NA,447,radiation therapy,0,180,cGy,1,"to a maximum tumor dose of 6,600 to 7,600 cGy was initiated after the PAC dose on Day 8",NA
19879702,NA,447,gefitinib,1,250,mg,1,initiated on Day 1 and continued daily for 16 weeks,NA
19879702,NA,447,paclitaxel,1,45,mg/m2,1,initiated at Day 8 as a weekly 1-h intravenous infusion for six doses,NA
19879702,NA,447,radiation therapy,1,180,cGy,1,"to a maximum tumor dose of 6,600 to 7,600 cGy was initiated after the PAC dose on Day 8",NA
19879702,NA,447,gefitinib,2,250,mg,1,initiated on Day 1 and continued daily for 16 weeks,NA
19879702,NA,447,paclitaxel,2,56,mg/m2,1,initiated at Day 8 as a weekly 1-h intravenous infusion for six doses,NA
19879702,NA,447,radiation therapy,2,180,cGy,1,"to a maximum tumor dose of 6,600 to 7,600 cGy was initiated after the PAC dose on Day 8",NA
19879702,NA,447,gefitinib,3,500,mg,1,initiated on Day 1 and continued daily for 16 weeks,NA
19879702,NA,447,paclitaxel,3,45,mg/m2,1,initiated at Day 8 as a weekly 1-h intravenous infusion for six doses,NA
19879702,NA,447,radiation therapy,3,180,cGy,1,"to a maximum tumor dose of 6,600 to 7,600 cGy was initiated after the PAC dose on Day 8",NA
19879702,NA,447,gefitinib,4,500,mg,1,initiated on Day 1 and continued daily for 16 weeks,NA
19879702,NA,447,paclitaxel,4,56,mg/m2,1,initiated at Day 8 as a weekly 1-h intravenous infusion for six doses,NA
19879702,NA,447,radiation therapy,4,180,cGy,1,"to a maximum tumor dose of 6,600 to 7,600 cGy was initiated after the PAC dose on Day 8",NA
32334034,NCT01554410,450,gemcitabine,1,50,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,1,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,1,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,1,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,2,75,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,2,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,2,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,2,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,3,100,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,3,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,3,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,3,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,4,125,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,4,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,4,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,4,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,1.5,50,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,1.5,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,1.5,40,mg/m2,1,Weekly infusion preceding (CG) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,1.5,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",Extended Field cohort
32334034,NCT01554410,450,gemcitabine,4.5,125,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,4.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,4.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,4.5,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,3.5,100,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,3.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,3.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,3.5,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
32334034,NCT01554410,450,gemcitabine,2.5,75,mg/m2,1,Weekly infusion x 5 weeks,NA
32334034,NCT01554410,450,cisplatin,2.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,cisplatin,2.5,40,mg/m2,1,Weekly infusion following (GC) gemcitabine x 5 weeks,fixed
32334034,NCT01554410,450,image guided intensity modulated radiation therapy,2.5,1.8,Gy,1,"45 Gy in 25 daily fractions, 5 fractions per week",pelvic field cohort
16467100,NA,451,gefitinib,1,500,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,451,sirolimus,1,15,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,1,15,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,1,5,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,451,sirolimus,1,5,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,451,gefitinib,2,500,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,451,sirolimus,2,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,2,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,2,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,451,sirolimus,2,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,451,gefitinib,3,750,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,451,sirolimus,3,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,3,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,451,sirolimus,3,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,451,sirolimus,3,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,gefitinib,1,1000,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,452,sirolimus,1,15,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,1,15,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,1,5,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,sirolimus,1,5,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,cyp3a-inducing antiepileptic drugs,1,NA,NA,NA,NA,NA
16467100,NA,452,gefitinib,2,1000,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,452,sirolimus,2,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,2,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,2,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,sirolimus,2,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,cyp3a-inducing antiepileptic drugs,2,NA,NA,NA,NA,NA
16467100,NA,452,gefitinib,3,1500,mg,1,continuous daily dosing schedule of 28-day cycles,NA
16467100,NA,452,sirolimus,3,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,3,30,mg,1,loading dose on the first day of cycle 1,NA
16467100,NA,452,sirolimus,3,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,sirolimus,3,10,mg,1,continuous daily maintenance dose from day 2 of cycle 1,NA
16467100,NA,452,cyp3a-inducing antiepileptic drugs,3,NA,NA,NA,NA,NA
31297636,NCT02732938,453,pf-04136309,1,500,mg,2,daily in 28-day cycles,NA
31297636,NCT02732938,453,nab-paclitaxel,1,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31297636,NCT02732938,453,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31297636,NCT02732938,453,pf-04136309,2,750,mg,2,daily in 28-day cycles,NA
31297636,NCT02732938,453,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
31297636,NCT02732938,453,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
30862645,NCT01685892,454,venetoclax,1,100,mg,1,daily introduced after obinutuzumab,schedule A
30862645,NCT01685892,454,obinutuzumab,1,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule A
30862645,NCT01685892,454,venetoclax,1.5,100,mg,1,daily prior to obinutuzumab,schedule B
30862645,NCT01685892,454,obinutuzumab,1.5,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule B
30862645,NCT01685892,454,venetoclax,2,200,mg,1,daily introduced after obinutuzumab,schedule A
30862645,NCT01685892,454,obinutuzumab,2,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule A
30862645,NCT01685892,454,venetoclax,2.5,200,mg,1,daily prior to obinutuzumab,schedule B
30862645,NCT01685892,454,obinutuzumab,2.5,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule B
30862645,NCT01685892,454,venetoclax,3,400,mg,1,daily introduced after obinutuzumab,schedule A
30862645,NCT01685892,454,obinutuzumab,3,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule A
30862645,NCT01685892,454,venetoclax,3.5,400,mg,1,daily prior to obinutuzumab,schedule B
30862645,NCT01685892,454,obinutuzumab,3.5,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule B
30862645,NCT01685892,454,venetoclax,4,600,mg,1,daily introduced after obinutuzumab,schedule A
30862645,NCT01685892,454,obinutuzumab,4,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule A
30862645,NCT01685892,454,venetoclax,4.5,600,mg,1,daily prior to obinutuzumab,schedule B
30862645,NCT01685892,454,obinutuzumab,4.5,100/900/1000,mg,1,"100 milligrams (mg) on Day 1 of Cycle 1, 900 mg on Day 2 of Cycle 1, and 1000 mg on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6  in 28-day cycles",schedule B
32973176,NCT03307148,455,atra,1,15,mg/m2/d,2,on days 1-15 of each 28-day cycle,NA
32973176,NCT03307148,455,gemcitabine,1,800,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,atra,2,800,mg/m2/d,2,on D1-15 of each 28 day cycle,NA
32973176,NCT03307148,455,gemcitabine,2,100,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,nab-paclitaxel,2,30,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,atra,3,800,mg/m2/d,2,on D1-15 of each 28 day cycle,NA
32973176,NCT03307148,455,gemcitabine,3,100,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,nab-paclitaxel,3,45,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,atra,4,1000,mg/m2/d,2,on D1-15 of each 28 day cycle,NA
32973176,NCT03307148,455,gemcitabine,4,100,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,nab-paclitaxel,4,45,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,atra,5,1000,mg/m2/d,2,on D1-15 of each 28 day cycle,NA
32973176,NCT03307148,455,gemcitabine,5,125,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
32973176,NCT03307148,455,nab-paclitaxel,5,45,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
12796031,NA,456,gefitinib,1,100,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,2,150,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,3,225,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,4,300,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,5,400,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,6,525,mg/day,1,"on 14 consecutive days, every 28 days",NA
12796031,NA,456,gefitinib,7,700,mg/day,1,"on 14 consecutive days, every 28 days",NA
28955007,NCT02151721,457,gefitinib,1,250,mg,1,on days 1-14 in 28 day cycles,fixed
28955007,NCT02151721,457,vorinostat,1,200,mg,1,on days 1-7 in 28 day cycles,NA
28955007,NCT02151721,457,gefitinib,2,250,mg,1,on days 1-14 in 28 day cycles,fixed
28955007,NCT02151721,457,vorinostat,2,300,mg,1,on days 1-7 in 28 day cycles,NA
28955007,NCT02151721,457,gefitinib,3,250,mg,1,on days 1-14 in 28 day cycles,fixed
28955007,NCT02151721,457,vorinostat,3,400,mg,1,on days 1-7 in 28 day cycles,NA
31782583,NCT02151721,458,vorinostat,1,200,mg,1,on days 1-7 in a cycle of 14 days,NA
31782583,NCT02151721,458,gefitinib,1,250,mg,1,daily in a cycle of 14 days,fixed
31782583,NCT02151721,458,vorinostat,1,300,mg,1,on days 1-7 in a cycle of 14 days,NA
31782583,NCT02151721,458,vorinostat,1,400,mg,1,on days 1-7 in a cycle of 14 days,NA
31910346,NA,459,90y-dota-m5a,1,10,mCi/m2,1,"on day 1. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
31910346,NA,459,90y-dota-m5a,2,12,mCi/m2,1,"on day 1. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
31910346,NA,460,90y-dota-m5a,1,12,mCi/m2,1,"on day 1. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
31910346,NA,460,gemcitabine,1,150,mg/m2,1,"on days 1 and 3. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
31910346,NA,460,90y-dota-m5a,2,14,mCi/m2,1,"on day 1. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
31910346,NA,460,gemcitabine,2,150,mg/m2,1,"on days 1 and 3. If no DLTs were observed and toxicities returned to grade 1 or less, a second cycle of 90Y-DOTA-M5A was delivered 6–10 weeks later",NA
25552401,NCT01027676,462,gefitinib,1,250,mg,1,on days 1–28 of each 28 days cycle,fixed
25552401,NCT01027676,462,vorinostat,1,200,mg,1,on days 1–7 and days 15–21 of each 28 days cycle,NA
25552401,NCT01027676,462,gefitinib,2,250,mg,1,on days 1–28 of each 28 days cycle,fixed
25552401,NCT01027676,462,vorinostat,2,300,mg,1,on days 1–7 and days 15–21 of each 28 days cycle,NA
25552401,NCT01027676,462,gefitinib,3,250,mg,1,on days 1–28 of each 28 days cycle,fixed
25552401,NCT01027676,462,vorinostat,3,400,mg,1,on days 1–7 and days 15–21 of each 28 days cycle,NA
20142724,NCT00113529,463,sunitinib,1,37.5,mg,1,daily for 4 weeks followed by 2 weeks off treatment,NA
20142724,NCT00113529,463,gefitinib,1,250,mg,1,daily,fixed
20142724,NCT00113529,463,sunitinib,2,50,mg,1,daily for 4 weeks followed by 2 weeks off treatment,NA
20142724,NCT00113529,463,gefitinib,2,250,mg,1,daily,fixed
17694310,NA,464,geftinib,-1,250,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,-1,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,-1,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,1,500,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,1,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,1,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,2,750,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,2,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,2,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,3,1000,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,3,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,3,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,4,1250,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,4,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,4,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,5,1500,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,5,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,5,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,6,2000,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,6,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,6,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,geftinib,7,2500,mg/day,1,"daily in 35 days constituting cycle 1, and 28-treatment days constituting subsequent treatment cycles",NA
17694310,NA,464,temozolomide,7,150,mg/day,1,5 days every 28 days,NA
17694310,NA,464,temozolomide,7,150,mg/day,1,5 days every 28 days,NA
23182702,NA,465,gefitinib,1,250,mg,1,q.d.,NA
23182702,NA,465,radiation therapy,1,60,Gy,NA,in 30 fractions of 2 Gy each,NA
23182702,NA,465,gefitinib,2,500,mg,1,q.d.,NA
23182702,NA,465,radiation therapy,2,60,Gy,NA,in 30 fractions of 2 Gy each,NA
23182702,NA,465,gefitinib,3,750,mg,1,q.d.,only patients on EIAEDs
23182702,NA,465,radiation therapy,3,60,Gy,NA,in 30 fractions of 2 Gy each,only patients on EIAEDs
34837745,NCT01964287,466,nab-paclitaxel,1,100,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,gemcitabine,1,800,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,oxaliplatin,1,70,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,oxaliplatin,1,70,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,irinotecan,1,150,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,fluorouracil,1,bolus 400; continuous 2400,mg/m2,1,bolus injection and then continuous 46-h infusion at day 29 and 43 in 8-week cycles,fixed
34837745,NCT01964287,466,nab-paclitaxel,2,100,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,gemcitabine,2,800,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,oxaliplatin,2,85,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,oxaliplatin,2,85,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,irinotecan,2,180,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,fluorouracil,2,bolus 400; continuous 2400,mg/m2,1,bolus injection and then continuous 46-h infusion at day 29 and 43 in 8-week cycles,fixed
34837745,NCT01964287,466,nab-paclitaxel,2.5,125,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,gemcitabine,2.5,1000,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,oxaliplatin,2.5,70,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,oxaliplatin,2.5,70,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,irinotecan,2.5,150,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,fluorouracil,2.5,bolus 400; continuous 2400,mg/m2,1,bolus injection and then continuous 46-h infusion at day 29 and 43 in 8-week cycles,fixed
34837745,NCT01964287,466,nab-paclitaxel,3,125,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,gemcitabine,3,1000,mg/m2,1,"at day 1, 8 and 15 in 8-week cycles",NA
34837745,NCT01964287,466,oxaliplatin,3,85,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,oxaliplatin,3,85,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,irinotecan,3,180,mg/m2,1,at day 29 and 43 in 8-week cycles,NA
34837745,NCT01964287,466,fluorouracil,3,bolus 400; continuous 2400,mg/m2,1,bolus injection and then continuous 46-h infusion at day 29 and 43 in 8-week cycles,fixed
19687340,NA,467,irinotecan,1,15,mg/m2,1,IV daily for 5 days of 2 consecutive weeks,NA
19687340,NA,467,gefitinib,1,150,mg/m2,1,daily for 21 consecutive days ofeach course,NA
19687340,NA,467,irinotecan,2,15,mg/m2,1,IV daily for 5 days of 2 consecutive weeks,NA
19687340,NA,467,gefitinib,2,112.5,mg/m2,1,daily for 21 consecutive days ofeach course,NA
19687340,NA,467,irinotecan,3,15,mg/m2,1,IV daily for 5 days of 2 consecutive weeks,NA
19687340,NA,467,gefitinib,3,112.5,mg/m2,1,daily for 12 consecutive days ofeach course,NA
19687340,NA,467,irinotecan,4,20,mg/m2,1,IV daily for 5 days of 2 consecutive weeks,NA
19687340,NA,467,gefitinib,4,112.5,mg/m2,1,daily for 12 consecutive days ofeach course,NA
19687340,NA,467,irinotecan,5,20,mg/m2,1,IV daily for 5 days of 2 consecutive weeks,NA
19687340,NA,467,gefitinib,5,112.5,mg/m2,1,daily for 12 consecutive days ofeach course,with cefixime
33121235,NCT01671904,468,venetoclax,1,100,mg,1,once daily,NA
33121235,NCT01671904,468,rituximab,1,375/500,mg/m2,1,375 mg/m^2 on Day 1 of Cycle 1 and 500 mg/m^2 administered on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,468,bendamustine,1,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,468,venetoclax,2,200,mg,1,once daily,NA
33121235,NCT01671904,468,rituximab,2,375/500,mg/m2,1,375 mg/m^2 on Day 1 of Cycle 1 and 500 mg/m^2 administered on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,468,bendamustine,2,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,468,venetoclax,3,400,mg,1,once daily,NA
33121235,NCT01671904,468,rituximab,3,375/500,mg/m2,1,375 mg/m^2 on Day 1 of Cycle 1 and 500 mg/m^2 administered on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,468,bendamustine,3,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,venetoclax,1,100,mg,1,once daily,NA
33121235,NCT01671904,469,obinutuzumab,1,100/900/1000,mg,1,100 mg on Day 1 of Cycle 1; 900 mg administered on Day 2 of Cycle 1; and 1000 mg administered on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,bendamustine,1,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,venetoclax,2,200,mg,1,once daily,NA
33121235,NCT01671904,469,obinutuzumab,2,100/900/1000,mg,1,100 mg on Day 1 of Cycle 1; 900 mg administered on Day 2 of Cycle 1; and 1000 mg administered on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,bendamustine,2,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,venetoclax,3,400,mg,1,once daily,NA
33121235,NCT01671904,469,obinutuzumab,3,100/900/1000,mg,1,100 mg on Day 1 of Cycle 1; 900 mg administered on Day 2 of Cycle 1; and 1000 mg administered on Days 8 and 15 of Cycle 1 and on Day 1 of Cycles 2-6 in six 28-day cycles,NA
33121235,NCT01671904,469,bendamustine,3,90 or 70,mg/m2,1,on Days 2-3 of Cycle 1 and Days 1-2 of Cycles 2-6 in six 28-day cycles,NA
26289594,NA,470,cp-4126,1,30,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,2,60,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,3,120,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,4,240,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,5,480,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,6,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,7,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,8,1250,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,9,1400,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
26289594,NA,470,cp-4126,10,1600,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
28832976,NA,471,adi-peg 20,1,18,mg/m2,1,weekly,NA
28832976,NA,471,nab-paclitaxel,1,125,mg/m2,1,weekly for 3 of 4weeks,fixed
28832976,NA,471,gemcitabine,1,1000,mg/m2,1,weekly for 3 of 4weeks,fixed
28832976,NA,471,adi-peg 20,2,36,mg/m2,1,weekly,NA
28832976,NA,471,nab-paclitaxel,2,125,mg/m2,1,weekly for 3 of 4weeks,fixed
28832976,NA,471,gemcitabine,2,1000,mg/m2,1,weekly for 3 of 4weeks,fixed
26912134,NCT01242605,472,selumetinib,1,75,mg,2,daily,NA
26912134,NCT01242605,472,cisplatin,1,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,cisplatin,1,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,selumetinib,2,50,mg,2,daily,NA
26912134,NCT01242605,472,cisplatin,2,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,cisplatin,2,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,selumetinib,3,75,mg,1,daily,NA
26912134,NCT01242605,472,cisplatin,3,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,cisplatin,3,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,selumetinib,4,50,mg,1,daily,NA
26912134,NCT01242605,472,cisplatin,4,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,cisplatin,4,25,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
26912134,NCT01242605,472,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle for up to 8 cycles,fixed
23583440,NA,473,trametinib,1,1,mg,1,daily,NA
23583440,NA,473,gemcitabine,1,1000,mg/m2,1,"on Days 1, 8 and 15, of every 28-day cycle",fixed
23583440,NA,473,trametinib,2,2,mg,1,daily,NA
23583440,NA,473,gemcitabine,2,1000,mg/m2,1,"on Days 1, 8 and 15, of every 28-day cycle",fixed
23583440,NA,473,trametinib,3,2.5,mg,1,daily,NA
23583440,NA,473,gemcitabine,3,1000,mg/m2,1,"on Days 1, 8 and 15, of every 28-day cycle",fixed
24916770,NCT00887757,474,navitoclax,1,150,mg,1,on days 1–3 and 8–10 in 21-day cycles,NA
24916770,NCT00887757,474,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24916770,NCT00887757,474,navitoclax,2,200,mg,1,on days 1–3 and 8–10 in 21-day cycles,NA
24916770,NCT00887757,474,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24916770,NCT00887757,474,navitoclax,3,250,mg,1,on days 1–3 and 8–10 in 21-day cycles,NA
24916770,NCT00887757,474,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24916770,NCT00887757,474,navitoclax,4,325,mg,1,on days 1–3 and 8–10 in 21-day cycles,NA
24916770,NCT00887757,474,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24916770,NCT00887757,474,navitoclax,5,425,mg,1,on days 1–3 and 8–10 in 21-day cycles,NA
24916770,NCT00887757,474,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24916770,NCT00887757,474,navitoclax,6,325,mg,1,"on days 1–3, 8–10, and 15–17 in 28-day cycles",NA
24916770,NCT00887757,474,gemcitabine,6,1000,mg/m2,1,"on days 1, 8 and 15 in 28-day cycles",NA
24737778,NCT00874042,475,tivantinib,0,120,mg,2,daily continuously,NA
24737778,NCT00874042,475,gemcitabine,0,1000,mg/m2,1,"Cycle 1-weekly; cycle 2+ —day 1, 8 and 15 in 4-week cycles",NA
24737778,NCT00874042,475,tivantinib,1,240,mg,2,daily continuously,NA
24737778,NCT00874042,475,gemcitabine,1,1000,mg/m2,1,"Cycle 1-weekly; cycle 2+ —day 1, 8 and 15 in 4-week cycles",NA
24737778,NCT00874042,475,tivantinib,2,240,mg,2,daily for 2 weeks followed by 1 week off,NA
24737778,NCT00874042,475,gemcitabine,2,1000,mg/m2,1,"on day 8, day 15 and day 22 in 4-week cycles",NA
24737778,NCT00874042,475,tivantinib,3,360,mg,2,daily for 2 weeks followed by 1 week off,NA
24737778,NCT00874042,475,gemcitabine,3,1000,mg/m2,1,"on day 8, day 15 and day 22 in 4-week cycles",NA
24737778,NCT00874042,475,tivantinib,4,360,mg,2,daily for 3 weeks continuously followed by 1 week off,NA
24737778,NCT00874042,475,gemcitabine,4,1000,mg/m2,1,"on day 8, day 15 and day 22 in 4-week cycles",NA
24737778,NCT00874042,475,tivantinib,5,360,mg,2,daily continuously,NA
24737778,NCT00874042,475,gemcitabine,5,1000,mg/m2,1,"on day 7, day 14 and day 21 in 4-week cycles",NA
27234064, EudraCT No. 2010-019214-25,476,axp107-11,1,200,mg,2,daily,NA
27234064, EudraCT No. 2010-019214-25,476,gemcitabine,1,1000,mg/m2/weel,1,"the first seven of eight weeks and thereafter for a maximum of four x four-week treatment cycles (on days 1, 8, and 1).",NA
27234064, EudraCT No. 2010-019214-25,476,axp107-11,2,400,mg,2,daily,NA
27234064, EudraCT No. 2010-019214-25,476,gemcitabine,2,1000,mg/m2/weel,1,"the first seven of eight weeks and thereafter for a maximum of four x four-week treatment cycles (on days 1, 8, and 1).",NA
27234064, EudraCT No. 2010-019214-25,476,axp107-11,3,600,mg,2,daily,NA
27234064, EudraCT No. 2010-019214-25,476,gemcitabine,3,1000,mg/m2/weel,1,"the first seven of eight weeks and thereafter for a maximum of four x four-week treatment cycles (on days 1, 8, and 1).",NA
27234064, EudraCT No. 2010-019214-25,476,axp107-11,4,800,mg,2,daily,NA
27234064, EudraCT No. 2010-019214-25,476,gemcitabine,4,1000,mg/m2/weel,1,"the first seven of eight weeks and thereafter for a maximum of four x four-week treatment cycles (on days 1, 8, and 1).",NA
29362902,NCT02207465,477,nab-paclitaxel,1,75,mg/m2,1,weekly,NA
29362902,NCT02207465,477,external beam radiotherapy,1,52.5,Gy,NA,in 25 fractions,NA
29362902,NCT02207465,477,nab-paclitaxel,2,100,mg/m2,1,weekly,NA
29362902,NCT02207465,477,external beam radiotherapy,2,52.5,Gy,NA,in 25 fractions,NA
29362902,NCT02207465,477,nab-paclitaxel,3,125,mg/m2,1,weekly,NA
29362902,NCT02207465,477,external beam radiotherapy,3,52.5,Gy,NA,in 25 fractions,NA
24907635,NCT00556023,478,tremelimumab,1,6,mg/kg,1,on day 1 of each 84-day cycle,NA
24907635,NCT00556023,478,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycles",fixed
24907635,NCT00556023,478,tremelimumab,2,10,mg/kg,1,on day 1 of each 84-day cycle,NA
24907635,NCT00556023,478,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycles",fixed
24907635,NCT00556023,478,tremelimumab,3,15,mg/kg,1,on day 1 of each 84-day cycle,NA
24907635,NCT00556023,478,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycles",fixed
25837499,NCT01547260,479,lenalidomide,-2,5,mg,1,once daily for 21 days of a 28 day cycle,NA
25837499,NCT01547260,479,gemcitabine,-2,500,mg/m2,1,"on days 1, 8 and 15 every 28 day",fixed
25837499,NCT01547260,479,lenalidomide,-1,10,mg,1,once daily for 21 days of a 28 day cycle,NA
25837499,NCT01547260,479,gemcitabine,-1,750,mg/m2,1,"on days 1, 8 and 15 every 28 day",fixed
25837499,NCT01547260,479,lenalidomide,1,15,mg,1,once daily for 21 days of a 28 day cycle,NA
25837499,NCT01547260,479,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 every 28 day",fixed
25837499,NCT01547260,479,lenalidomide,2,20,mg,1,once daily for 21 days of a 28 day cycle,NA
25837499,NCT01547260,479,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 every 28 day",fixed
25837499,NCT01547260,479,lenalidomide,3,25,mg,1,once daily for 21 days of a 28 day cycle,NA
25837499,NCT01547260,479,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 every 28 day",fixed
30022224,NCT00078962,480,gemcitabine,1,400,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,1,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,1,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gemcitabine,2,600,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,2,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,2,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gemcitabine,3,800,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,3,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,3,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,4,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,4,100,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gemcitabine,5,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,5,140,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,5,140,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gemcitabine,6,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
30022224,NCT00078962,480,gti-2040,6,185,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
30022224,NCT00078962,480,gti-2040,6,185,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
23539344,NA,481,msc1992371a,1,10,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,2,15,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,3,21,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,4,28,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,5,37,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,6,49,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 1
23539344,NA,481,gemcitabine,6,1000,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 1
23539344,NA,481,msc1992371a,1.5,10,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 2
23539344,NA,481,gemcitabine,1.5,1000,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 2
23539344,NA,481,msc1992371a,2.5,15,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 2
23539344,NA,481,gemcitabine,2.5,1000,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 2
23539344,NA,481,msc1992371a,3.5,21,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 2
23539344,NA,481,gemcitabine,3.5,1000,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 2
23539344,NA,481,msc1992371a,4.5,28,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 2
23539344,NA,481,gemcitabine,4.5,1000,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 2
23539344,NA,481,msc1992371a,5.5,37,mg/m2,1,on days 1 and 8 in 21-day cycles,Schedule 2
23539344,NA,481,gemcitabine,5.5,1000,mg/m2,1,on days 2 and 9 in 21-day cycles,Schedule 2
23983255,NA,482,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
23983255,NA,482,"cp-870,893",1,0.1,mg/kg,1,on day three of each 28-day cycle,NA
23983255,NA,482,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",fixed
23983255,NA,482,"cp-870,893",2,0.2,mg/kg,1,on day three of each 28-day cycle,NA
22864469,NA,483,gemcitabine,1,1000,mg/m2,1,every week for 7 of 8 weeks,fixed
22864469,NA,483,imp321,1,0,mg,1,on days 2 and 16 in 4-week cycles,NA
22864469,NA,483,gemcitabine,2,1000,mg/m2,1,every week for 3 out of 4 weeks,fixed
22864469,NA,483,imp321,2,0.5,mg,1,on days 2 and 16 in 4-week cycles,NA
22864469,NA,483,gemcitabine,3,1000,mg/m2,1,every week for 3 out of 4 weeks,fixed
22864469,NA,483,imp321,3,2,mg,1,on days 2 and 16 in 4-week cycles,NA
29748012,NA,484,nintedanib,1,150,mg,2,"daily from Day 2 of each cycle, with no intake on the days of chemotherapy (Days 1 and 8)",NA
29748012,NA,484,cisplatin,1,75,mg/m2,1,on Day 1 of each 21-day cycle,NA
29748012,NA,484,cisplatin,1,75,mg/m2,1,on Day 1 of each 21-day cycle,NA
29748012,NA,484,gemcitabine,1,1250,mg/m2,1,on Days 1 and 8 of each 21-day cycle,NA
29748012,NA,484,nintedanib,2,200,mg,2,"daily from Day 2 of each cycle, with no intake on the days of chemotherapy (Days 1 and 8)",NA
29748012,NA,484,cisplatin,2,75,mg/m2,1,on Day 1 of each 21-day cycle,NA
29748012,NA,484,cisplatin,2,75,mg/m2,1,on Day 1 of each 21-day cycle,NA
29748012,NA,484,gemcitabine,2,1250,mg/m2,1,on Days 1 and 8 of each 21-day cycle,NA
22847785,NA,485,triapine,-2,75,mg,1,days 1 and 8 of a 21-day cycle,NA
22847785,NA,485,gemcitabine,-2,1000,mg/m2,1,days 1 and 8 of a 21-day cycle,fixed
22847785,NA,485,triapine,-1,90,mg,1,days 1 and 8 of a 21-day cycle,NA
22847785,NA,485,gemcitabine,-1,1000,mg/m2,1,days 1 and 8 of a 21-day cycle,fixed
22847785,NA,485,triapine,1,120,mg,1,days 1 and 8 of a 21-day cycle,NA
22847785,NA,485,gemcitabine,1,1000,mg/m2,1,days 1 and 8 of a 21-day cycle,fixed
22847785,NA,485,triapine,2,160,mg,1,days 1 and 8 of a 21-day cycle,NA
22847785,NA,485,gemcitabine,2,1000,mg/m2,1,days 1 and 8 of a 21-day cycle,fixed
22847785,NA,485,triapine,1.5,75,mg,1,days 1 and 15 of a 28-day cycle,NA
22847785,NA,485,gemcitabine,1.5,1000,mg/m2,1,days 1 and 15 of a 28-day cycle,fixed
22847785,NA,485,triapine,2.5,90,mg,1,days 1 and 15 of a 28-day cycle,NA
22847785,NA,485,gemcitabine,2.5,1000,mg/m2,1,days 1 and 15 of a 28-day cycle,fixed
22847785,NA,485,triapine,3.5,120,mg,1,days 1 and 15 of a 28-day cycle,NA
22847785,NA,485,gemcitabine,3.5,1000,mg/m2,1,days 1 and 15 of a 28-day cycle,fixed
29438372,NCT01098344,486,mk-0752,1,1200,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,1,800,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,2,1200,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,2.5,1500,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,2.5,800,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,3,1500,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,3.5,1800,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,3.5,800,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,4,1800,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,4,1000,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
29438372,NCT01098344,486,mk-0752,4.5,2100,mg/kg,1,on day 22 (28 day cycle),NA
29438372,NCT01098344,486,gemcitabine,4.5,800,mg/m2,1,"on days 1, 8 and 15 (28 day cycle)",NA
28748343,EudraCT 2009-016080-11,487,gemcitabine,1,140,mg/m2,1,"weekly for 6 weeks, starting 24 h before the first day of radiotherapy",NA
28748343,EudraCT 2009-016080-11,487,radiotherapy,1,1.8,Gy,1,54 Gy in 30 fractions in 6 weeks,fixed
28748343,EudraCT 2009-016080-11,487,gemcitabine,2,175,mg/m2,1,"weekly for 6 weeks, starting 24 h before the first day of radiotherapy",NA
28748343,EudraCT 2009-016080-11,487,radiotherapy,2,1.8,Gy,1,54 Gy in 30 fractions in 6 weeks,fixed
28748343,EudraCT 2009-016080-11,487,gemcitabine,3,200,mg/m2,1,"weekly for 6 weeks, starting 24 h before the first day of radiotherapy",NA
28748343,EudraCT 2009-016080-11,487,radiotherapy,3,1.8,Gy,1,54 Gy in 30 fractions in 6 weeks,fixed
22543215,NA,488,gemcitabine,1,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,1,45,Gy,NA,in 25 fractions over 5 weeks,NA
22543215,NA,488,gemcitabine,2,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,2,50,Gy,1,in 25 fractions over 5 weeks,NA
22543215,NA,488,gemcitabine,3,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,3,52.5,Gy,NA,in 25 fractions over 5 weeks,NA
22543215,NA,488,gemcitabine,4,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,4,55,Gy,NA,in 25 fractions over 5 weeks,NA
22543215,NA,488,gemcitabine,5,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,5,57.5,Gy,NA,in 25 fractions over 5 weeks,NA
22543215,NA,488,gemcitabine,6,1000,mg/m2,1,"day -22, day -15, day 1, day 8, day 22, day 29; One cycle of run-in chemotherapy was given before IMRT, and two cycles of FDR-G were given concurrently with IMRT (days 1, 8, 22, and 29)",NA
22543215,NA,488,imrt,6,60,Gy,NA,in 25 fractions over 5 weeks,NA
30082474,NCT02079636,489,abemaciclib,1,150,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,489,pemetrexed,1,500,mg/m2,1,Day 1 in 21-day cycles,fixed
30082474,NCT02079636,489,abemaciclib,2,200,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,489,pemetrexed,2,500,mg/m2,1,Day 1 in 21-day cycles,fixed
30082474,NCT02079636,490,abemaciclib,1,150,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,490,gemcitabine,1,1250,mg/m2,1,Day 1 and 8 in 21-day cycles,fixed
30082474,NCT02079636,490,abemaciclib,2,200,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,490,gemcitabine,2,1250,mg/m2,1,Day 1 and 8 in 21-day cycles,fixed
30082474,NCT02079636,491,abemaciclib,1,150,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,491,ramucirumab,1,10,mg/m2,1,Day 1 in 21-day cycles,NA
30082474,NCT02079636,491,abemaciclib,2,200,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,491,ramucirumab,2,10,mg/m2,1,Day 1 in 21-day cycles,NA
30082474,NCT02079636,491,abemaciclib,3,150,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,491,ramucirumab,3,8,mg/m2,1,Day 1 and 8 in 21-day cycles,NA
30082474,NCT02079636,491,abemaciclib,4,150,mg,2,on days 1 through 21 of a 21-day cycle,NA
30082474,NCT02079636,491,ramucirumab,4,10,mg/m2,1,Day 1 and 8 in 21-day cycles,NA
30206366,NCT01621854,492,nuc-1031,1,500,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,2,625,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,3,675,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,4,725,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,5,750,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,6,825,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,7,900,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,8,1000,mg/m2,1,"days 1, 8 and 15 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,9,375,mg/m2,2,"days 1, 5, 8, 12, 15 and 19 over a 28-day cycle",NA
30206366,NCT01621854,492,nuc-1031,10,825,mg/m2,2,"days 1, 5, 8, 12, 15 and 19 over a 28-day cycle",NA
25591040,NCT01426633,493,trabectedin,1,0.9,mg/m2,1,on day 1 in 21-day cycles,NA
25591040,NCT01426633,493,gemcitabine,1,700,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
25591040,NCT01426633,493,trabectedin,-1,0.7,mg/m2,1,on day 1 in 21-day cycles,NA
25591040,NCT01426633,493,gemcitabine,-1,700,mg/m2,1,on days 1 and 8 in 21-day cycles,NA
24368064,NCT00556621,494,gemcitabine,1,15,mg/m2,1,"on days 2, 5 every week",NA
24368064,NCT00556621,494,cisplatin,1,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,cisplatin,1,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,radiation therapy,1,1.8,Gy,1,daily 5 days a week over 7 weeks to total 63 Gy,fixed
24368064,NCT00556621,494,gemcitabine,2,20,mg/m2,1,"on days 2, 5 every week",NA
24368064,NCT00556621,494,cisplatin,2,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,cisplatin,2,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,radiation therapy,2,1.8,Gy,1,daily 5 days a week over 7 weeks to total 63 Gy,fixed
24368064,NCT00556621,494,gemcitabine,3,25,mg/m2,1,"on days 2, 5 every week",NA
24368064,NCT00556621,494,cisplatin,3,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,cisplatin,3,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,radiation therapy,3,1.8,Gy,1,daily 5 days a week over 7 weeks to total 63 Gy,fixed
24368064,NCT00556621,494,gemcitabine,4,30,mg/m2,1,"on days 2, 5 every week",NA
24368064,NCT00556621,494,cisplatin,4,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,cisplatin,4,20,mg/m2,1,from day 2 to day 5 every 21 days,fixed
24368064,NCT00556621,494,radiation therapy,4,1.8,Gy,1,daily 5 days a week over 7 weeks to total 63 Gy,fixed
24936582,NA,495,radiation,1,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,1,20,mg/m2,1,twice-weekly,NA
24936582,NA,495,radiation,2,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,2,27,mg/m2,1,twice-weekly,NA
24936582,NA,495,radiation,3,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,3,30,mg/m2,1,twice-weekly,NA
24936582,NA,495,radiation,4,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,4,33,mg/m2,1,twice-weekly,NA
24936582,NA,495,radiation,5,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,5,50,mg/m2,1,twice-weekly,NA
24936582,NA,495,radiation,6,1.85,Gy,1,5 fractions/week to a total dose of 55.5 Gy,NA
24936582,NA,495,gemcitabine,6,40,mg/m2,1,twice-weekly,NA
28224231,NA,496,nc-6004,1,60,mg/m2,1,daily for 21 days in 21-day cycles,NA
28224231,NA,496,gemcitabine,1,1000,mg/m2,1,"on day 1 and day 8 of each cycle, except for the first treatment cycle",fixed
28224231,NA,496,nc-6004,2,90,mg/m2,1,daily for 21 days in 21-day cycles,NA
28224231,NA,496,gemcitabine,2,1000,mg/m2,1,"on day 1 and day 8 of each cycle, except for the first treatment cycle",fixed
26177983,NCT02046304,497,gemcitabine,1,400,mg/m2,1,"on days 1, 8, 22, 29, 43, and 50",NA
26177983,NCT02046304,497,radiation,1,50,Gy,NA,in 25 fractions over 5 weeks,NA
26177983,NCT02046304,497,gemcitabine,2,500,mg/m2,1,"on days 1, 8, 22, 29, 43, and 50",NA
26177983,NCT02046304,497,radiation,2,50,Gy,NA,in 25 fractions over 5 weeks,NA
26177983,NCT02046304,497,gemcitabine,3,600,mg/m2,1,"on days 1, 8, 22, 29, 43, and 50",NA
26177983,NCT02046304,497,radiation,3,50,Gy,NA,in 25 fractions over 5 weeks,NA
26177983,NCT02046304,497,gemcitabine,4,700,mg/m2,1,"on days 1, 8, 22, 29, 43, and 50",NA
26177983,NCT02046304,497,radiation,4,50,Gy,NA,in 25 fractions over 5 weeks,NA
30105668,NCT02101021,498,momelotinib,1,100,mg,1,daily,NA
30105668,NCT02101021,498,gemcitabine,1,1000,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,nab-paclitaxel,1,125,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,momelotinib,2,150,mg,1,daily,NA
30105668,NCT02101021,498,gemcitabine,2,1000,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,nab-paclitaxel,2,125,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,momelotinib,3,200,mg,1,daily,NA
30105668,NCT02101021,498,gemcitabine,3,1000,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,nab-paclitaxel,3,125,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,momelotinib,4,150,mg,2,daily,NA
30105668,NCT02101021,498,gemcitabine,4,1000,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,nab-paclitaxel,4,125,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,momelotinib,5,200,mg,2,daily,NA
30105668,NCT02101021,498,gemcitabine,5,1000,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
30105668,NCT02101021,498,nab-paclitaxel,5,125,mg/m2,1,"on Days 1, 8, and 15 of each 28-day treatment cycle",fixed
29338080,NCT01585805,499,veliparib,0,20,mg,2,daily on days 1 to 12 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,0,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,0,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,veliparib,1,40,mg,2,daily on days 1 to 12 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,1,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,1,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,veliparib,2,80,mg,2,daily on days 1 to 12 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,2,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,2,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,veliparib,2.5,80,mg,2,daily on days 1 to 21 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,2.5,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,2.5,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,veliparib,3,140,mg,2,daily on days 1 to 21 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,3,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,3,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,veliparib,4,200,mg,2,daily on days 1 to 21 of each 21-day cycle,NA
29338080,NCT01585805,499,gemcitabine,4,600,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
29338080,NCT01585805,499,cisplatinand,4,25,mg/m2,1,on the 3rd and 10th days of each 21-day cycle,fixed
27873130,NCT01970553,500,pm01183,1,2.5,mg,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,gemcitabine,1,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,pm01183,2,3,mg,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,gemcitabine,2,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,pm01183,3,3.5,mg,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,gemcitabine,3,800,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,pm01183,4,3.5,mg,1,on Days 1 and 8 every 3 weeks,NA
27873130,NCT01970553,500,gemcitabine,4,1000,mg/m2,1,on Days 1 and 8 every 3 weeks,NA
26056353,NCT01175733,501,panitumumab,1,1,mg/kg,1,days 3-5 of the first week; days 1-5 of the 5 following weeks,NA
26056353,NCT01175733,501,gemcitabine,1,300,mg/m2,1,weekly (day 1) in the first 6 weeks,NA
26056353,NCT01175733,501,radiotherapy,1,1.8,Gy,1,"for 28 days (total dose of 50.4 Gy) between days 1 and 38, on days 3 to 5 of the first week and on day 1 to 5 in the five consecutive weeks",NA
26056353,NCT01175733,501,panitumumab,2,1.5,mg/kg,1,days 3-5 of the first week; days 1-5 of the 5 following weeks,NA
26056353,NCT01175733,501,gemcitabine,2,300,mg/m2,1,weekly (day 1) in the first 6 weeks,NA
26056353,NCT01175733,501,radiotherapy,2,1.8,Gy,1,"for 28 days (total dose of 50.4 Gy) between days 1 and 38, on days 3 to 5 of the first week and on day 1 to 5 in the five consecutive weeks",NA
26056353,NCT01175733,501,panitumumab,3,2,mg/kg,1,days 3-5 of the first week; days 1-5 of the 5 following weeks,NA
26056353,NCT01175733,501,gemcitabine,3,300,mg/m2,1,weekly (day 1) in the first 6 weeks,NA
26056353,NCT01175733,501,radiotherapy,3,1.8,Gy,1,"for 28 days (total dose of 50.4 Gy) between days 1 and 38, on days 3 to 5 of the first week and on day 1 to 5 in the five consecutive weeks",NA
26377590,NA,502,ly2334737,1,40,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,2,50,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,3,60,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,4,70,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,5,80,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,6,90,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,7,100,mg,1,"every other day for 21 days, followed by 7 drug-free days",NA
26377590,NA,502,ly2334737,1.5,40,mg,1,QD for 7 days followed by 7 drug-free days,NA
26377590,NA,502,ly2334737,2.5,50,mg,1,QD for 7 days followed by 7 drug-free days,NA
26377590,NA,502,ly2334737,3.5,60,mg,1,QD for 7 days followed by 7 drug-free days,NA
26377590,NA,502,ly2334737,4.5,70,mg,1,QD for 7 days followed by 7 drug-free days,NA
26377590,NA,502,ly2334737,5.5,80,mg,1,QD for 7 days followed by 7 drug-free days,NA
26377590,NA,502,ly2334737,6.5,90,mg,1,QD for 7 days followed by 7 drug-free days,NA
29348486,NCT01460537,503,copanlisib,1,0.6,mg/kg,1,"on days 1, 8 and 15 of a 28-day treatment cycle",NA
29348486,NCT01460537,503,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day treatment cycle",NA
29348486,NCT01460537,503,copanlisib,2,0.8,mg/kg,1,"on days 1, 8 and 15 of a 28-day treatment cycle",NA
29348486,NCT01460537,503,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day treatment cycle",NA
25003665,NCT01684449,504,sirolimus,1,2,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,sirolimus,1,2,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,gemcitabine,1,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25003665,NCT01684449,504,sirolimus,2,2,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,sirolimus,2,2,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25003665,NCT01684449,504,sirolimus,2.5,5,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,sirolimus,2.5,5,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,gemcitabine,2.5,800,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
25003665,NCT01684449,504,sirolimus,3,5,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,sirolimus,3,5,mg,1,daily starting on day 2 of cycle 1 until progression or intolerance,NA
25003665,NCT01684449,504,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
24614947,NCT01297998,505,gemcitabine,1,1000,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,cisplatin,1,25,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,cisplatin,1,25,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,gemcitabine,0,800,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,cisplatin,0,25,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,cisplatin,0,25,mg/m2,1,"on day 1 and 8, every 3 weeks",NA
24614947,NCT01297998,505,gemcitabine,-1,1000,mg/m2,1,"on day 1, every 2 weeks",NA
24614947,NCT01297998,505,cisplatin,-1,25,mg/m2,1,"on day 1, every 2 weeks",NA
24614947,NCT01297998,505,cisplatin,-1,25,mg/m2,1,"on day 1, every 2 weeks",NA
24614947,NCT01297998,505,gemcitabine,-2,800,mg/m2,1,"on day 1, every 2 weeks",NA
24614947,NCT01297998,505,cisplatin,-2,25,mg/m2,1,"on day 1, every 2 weeks",NA
24614947,NCT01297998,505,cisplatin,-2,25,mg/m2,1,"on day 1, every 2 weeks",NA
29502139,UMIN000012254,506,gemcitabine,0,400,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,nab-paclitaxel,0,75,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,radiation,0,1.8,Gy,1,28 fractions up to 50.4 Gy,NA
29502139,UMIN000012254,506,gemcitabine,1,600,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,nab-paclitaxel,1,75,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,radiation,1,1.8,Gy,1,28 fractions up to 50.4 Gy,NA
29502139,UMIN000012254,506,gemcitabine,2,600,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,nab-paclitaxel,2,100,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,radiation,2,1.8,Gy,1,28 fractions up to 50.4 Gy,NA
29502139,UMIN000012254,506,gemcitabine,3,800,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,nab-paclitaxel,3,100,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,radiation,3,1.8,Gy,1,28 fractions up to 50.4 Gy,NA
29502139,UMIN000012254,506,gemcitabine,4,800,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,nab-paclitaxel,4,125,mg/m2,1,"on day 1 repeated weekly for 3 weeks, followed by 1 week of rest",NA
29502139,UMIN000012254,506,radiation,4,1.8,Gy,1,28 fractions up to 50.4 Gy,NA
27815358,NCT01359696,507,gdc-0425,1,60,mg,1,"daily for 3 consecutive days starting on day -7 during cycle 0; Beginning with cycle 1, daily on days 2 to 4 and 9 to 11 of 21-day cycles",NA
27815358,NCT01359696,507,gemcitabine,1,750,mg/m2,1,on days 1 and 8 of 21-day cycles beginning with cycle 1,NA
27815358,NCT01359696,507,gdc-0425,2,60,mg,1,"daily for 3 consecutive days starting on day -7 during cycle 0; Beginning with cycle 1, daily on days 2 to 4 and 9 to 11 of 21-day cycles",NA
27815358,NCT01359696,507,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of 21-day cycles beginning with cycle 1,NA
27815358,NCT01359696,507,gdc-0425,3,60,mg,1,"single dose on day -7 during cycle 0; Beginning with cycle 1, daily on days 2 to 4 and 9 to 11 of 21-day cycles",NA
27815358,NCT01359696,507,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of 21-day cycles beginning with cycle 1,NA
27815358,NCT01359696,507,gdc-0425,4,80,mg,1,"single dose on day -7 during cycle 0; Beginning with cycle 1, daily on days 2 to 4 and 9 to 11 of 21-day cycles",NA
27815358,NCT01359696,507,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of 21-day cycles beginning with cycle 1,NA
23616084,NA,508,ly2334737,1,20,mg,1,"once daily for 14 days, followed by a 7-day drug-free period",NA
23616084,NA,508,ly2334737,2,30,mg,1,"once daily for 14 days, followed by a 7-day drug-free period",NA
23616084,NA,508,ly2334737,3,40,mg,1,"once daily for 14 days, followed by a 7-day drug-free period",NA
29788155,NCT01564251,509,gdc-0575,1,15,mg,1,"daily for three consecutive days starting on days 1, 8, and 15 of a 21-day cycle",NA
29788155,NCT01564251,509,gdc-0575,2,30,mg,1,"daily for three consecutive days starting on days 1, 8, and 15 of a 21-day cycle",NA
29788155,NCT01564251,509,gdc-0575,3,60,mg,1,"daily for three consecutive days starting on days 1, 8, and 15 of a 21-day cycle",NA
29788155,NCT01564251,509,gdc-0575,4,90,mg,1,"daily for three consecutive days starting on days 1, 8, and 15 of a 21-day cycle",NA
29788155,NCT01564251,510,gdc-0575,1,15,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,2,20,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,3,30,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,4,45,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,5,60,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,6,45,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,6,500,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,7,60,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,7,500,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,8,80,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,8,500,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
29788155,NCT01564251,510,gdc-0575,9,105,mg,1,on days 2 and 9 of a 21-day cycle,NA
29788155,NCT01564251,510,gemcitabine,9,500,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
28770300,NCT01154426,511,veliparib,1,10,mg,2,on days 1 through 21 of a 28-day cycle with a 1-week rest,NA
28770300,NCT01154426,511,gemcitabine,1,750,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
28770300,NCT01154426,511,veliparib,-1,10,mg,2,on days 1 through 21 of a 28-day cycle with a 1-week rest,NA
28770300,NCT01154426,511,gemcitabine,-1,500,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
28770300,NCT01154426,511,veliparib,1.5,20,mg,2,days 1–14 on a 21-day schedule,NA
28770300,NCT01154426,511,gemcitabine,1.5,500,mg/m2,1,on days 1 and 8 (21-day cycle),NA
28770300,NCT01154426,511,veliparib,2,20,mg,2,days 1–14 on a 21-day schedule,NA
28770300,NCT01154426,511,gemcitabine,2,750,mg/m2,1,on days 1 and 8 (21-day cycle),NA
28770300,NCT01154426,511,veliparib,3,40,mg,2,days 1–14 on a 21-day schedule,NA
28770300,NCT01154426,511,gemcitabine,3,750,mg/m2,1,on days 1 and 8 (21-day cycle),NA
27685612,UMIN000005787,512,gbs-01,1,3,g,1,daily,NA
27685612,UMIN000005787,512,gbs-01,2,7.5,g,1,daily,NA
27685612,UMIN000005787,512,gbs-01,3,12,g,1,daily,NA
22515232,UMIN000002152,513,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
22515232,UMIN000002152,513,candesartan,1,4,mg,1,day 1 to day 28 every 4 weeks,NA
22515232,UMIN000002152,513,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
22515232,UMIN000002152,513,candesartan,2,8,mg,1,day 1 to day 28 every 4 weeks,NA
22515232,UMIN000002152,513,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
22515232,UMIN000002152,513,candesartan,3,16,mg,1,day 1 to day 28 every 4 weeks,NA
22515232,UMIN000002152,513,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
22515232,UMIN000002152,513,candesartan,4,32,mg,1,day 1 to day 28 every 4 weeks,NA
23483298,NA,514,nab-paclitaxel,1,80,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
23483298,NA,514,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
23483298,NA,514,nab-paclitaxel,2,100,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
23483298,NA,514,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
23483298,NA,514,nab-paclitaxel,3,120,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
23483298,NA,514,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 and repeated every 21 days,NA
29238851,NCT00372437,515,gemcitabine,1,1000,mg/m2,1,on Day 1 of three consecutive weeks in 4-week treatment cycles,NA
29238851,NCT00372437,515,mocetinostat,1,50,mg,1,"Days 2, 4 and 6 of each week",NA
29238851,NCT00372437,515,gemcitabine,2,1000,mg/m2,1,on Day 1 of three consecutive weeks in 4-week treatment cycles,NA
29238851,NCT00372437,515,mocetinostat,2,75,mg,1,"Days 2, 4 and 6 of each week",NA
29238851,NCT00372437,515,gemcitabine,3,1000,mg/m2,1,on Day 1 of three consecutive weeks in 4-week treatment cycles,NA
29238851,NCT00372437,515,mocetinostat,3,90,mg,1,"Days 2, 4 and 6 of each week",NA
29238851,NCT00372437,515,gemcitabine,4,1000,mg/m2,1,on Day 1 of three consecutive weeks in 4-week treatment cycles,NA
29238851,NCT00372437,515,mocetinostat,4,110,mg,1,"Days 2, 4 and 6 of each week",NA
29756206,NCT01016483,516,gemcitabine,1,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,1,15,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,2,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,2,30,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,3,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,3,45,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,4,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,4,68,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,5,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,5,90,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,6,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,6,120,mg,1,5 days on and 2 days off,NA
29756206,NCT01016483,516,gemcitabine,7,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,7,60,mg,2,ontinu-ously for 28 days,NA
29756206,NCT01016483,516,gemcitabine,8,1000,mg/m2,1,"on Days 1,8 and 15 of subsequent 28-day cycles",NA
29756206,NCT01016483,516,pimasertib,8,75,mg,2,ontinu-ously for 28 days,NA
29030354,NCT02043288,517,nc-6004,1,60,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,1,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,2,75,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,2,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,3,90,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,3,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,4,105,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,4,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,5,120,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,5,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,6,135,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,6,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,7,150,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,7,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,8,165,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,8,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
29030354,NCT02043288,517,nc-6004,9,180,mg/m2,1,on day 1 every 3 weeks,NA
29030354,NCT02043288,517,gemcitabine,9,1250,mg/m2,1,on days 1 and 8 every 3 weeks,NA
26468947,NA,518,lapatinib,1,750,mg,1,daily,NA
26468947,NA,518,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
26468947,NA,518,cisplatin,1,70,mg/m2,1,on day 2 every 28 days,NA
26468947,NA,518,cisplatin,1,70,mg/m2,1,on day 2 every 28 days,NA
26468947,NA,518,lapatinib,2,1000,mg,1,daily,NA
26468947,NA,518,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
26468947,NA,518,cisplatin,2,70,mg/m2,1,on day 2 every 28 days,NA
26468947,NA,518,cisplatin,2,70,mg/m2,1,on day 2 every 28 days,NA
26468947,NA,518,lapatinib,3,1250,mg,1,daily,NA
26468947,NA,518,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
26468947,NA,518,cisplatin,3,70,mg/m2,1,on day 2 every 28 days,NA
26468947,NA,518,cisplatin,3,70,mg/m2,1,on day 2 every 28 days,NA
29158367,NCT01621243,519,necuparanib,1,0.5,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,1,0,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,1,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,2,1,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,2,0,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,2,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,3,1,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,3,125,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,3,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,4,2,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,4,125,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,4,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,5,4,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,5,125,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,5,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,6,6,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,6,125,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,6,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
29158367,NCT01621243,519,necuparanib,7,5,mg/kg,1,Daily,NA
29158367,NCT01621243,519,nab-paclitaxel,7,125,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",NA
29158367,NCT01621243,519,gemcitabine,7,1000,mg/m2,1,"Days 1, 8, and 15 of a 28-day cycle",fixed
28750271,NCT02018874,520,ly2780301,1,400,mg,1,daily,NA
28750271,NCT02018874,520,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-d cycle",NA
28750271,NCT02018874,520,ly2780301,1.5,500,mg,1,daily,NA
28750271,NCT02018874,520,gemcitabine,1.5,750,mg/m2,1,"on days 1, 8 and 15 of a 28-d cycle",NA
28750271,NCT02018874,520,ly2780301,2,500,mg,1,daily,NA
28750271,NCT02018874,520,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-d cycle",NA
23511559,NCT00615446,521,sunitinib,1,37.5,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,1,750,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,2,50,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,2,750,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,3,50,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,3,850,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,3.5,37.5,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,3.5,850,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,4,50,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,4.5,37.5,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,4.5,1000,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,-1,37.5,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,-1,600,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,521,sunitinib,-2,25,mg,1,repeated 6-week cycles consisting of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2),NA
23511559,NCT00615446,521,gemcitabine,-2,600,mg/m2,1,"on days 1, 8, 22, and 29",NA
23511559,NCT00615446,522,sunitinib,-2,25,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,-2,600,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,-1,37.5,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,-1,600,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,1,37.5,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,1,750,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,2,37.5,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,2,850,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,3,37.5,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,3,1000,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,4,50,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,4,1000,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,5,37.5,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,5,1250,mg/m2,1,on days 1 and 8,NA
23511559,NCT00615446,522,sunitinib,6,50,mg,1,3-week cycles consisting of 2 weeks on treatment followed by 1-week off (Schedule 2/1).,NA
23511559,NCT00615446,522,gemcitabine,6,1250,mg/m2,1,on days 1 and 8,NA
19415279,NA,523,paclitaxel,1,100,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,1,800,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,1,50,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,1,50,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,paclitaxel,2,100,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,2,800,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,2,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,2,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,paclitaxel,3,100,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,3,1000,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,3,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,3,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,paclitaxel,4,110,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,4,1000,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,4,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,4,60,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,paclitaxel,5,110,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,5,1000,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,5,70,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,5,70,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,paclitaxel,6,110,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,gemcitabine,6,1150,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,6,70,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
19415279,NA,523,oxaliplatin,6,70,mg/m2,1,on days 1 and 15 in cycles of every 4 weeks,NA
17641541,NA,524,gemcitabine,1,1250,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,1,300,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,2,1250,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,2,350,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,3,1500,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,3,350,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,4,1500,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,4,400,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,5,1750,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,5,400,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,6,1750,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,6,450,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,gemcitabine,7,2000,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
17641541,NA,524,pemetrexed,7,450,mg/m2,1,on days 1 and 15 in cycles of 4 weeks,NA
16328413,NA,525,gemcitabine,1,750,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,1,40,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,1,40,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,2,50,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,gemcitabine,3,1250,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,3,60,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,3,60,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,gemcitabine,4,1250,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,4,70,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,4,70,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,gemcitabine,5,1500,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,5,80,mg/m2,1,on days 1 and 8 every 21 days,NA
16328413,NA,525,oxaliplatin,5,80,mg/m2,1,on days 1 and 8 every 21 days,NA
17932893,NA,526,gemcitabine,1,800,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,1,50,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,2,800,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,2,75,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,3,1000,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,3,75,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,4,1000,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,4,100,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,5,1200,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,5,100,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,6,1200,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,6,125,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,gemcitabine,7,1400,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
17932893,NA,526,irinotecan,7,125,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
19556122,NA,527,gemcitabine,1,75,mg/m2,1,weekly for 3 weeks followed by 1 week rest,NA
19556122,NA,527,gemcitabine,2,135,mg/m2,1,weekly for 3 weeks followed by 1 week rest,NA
19556122,NA,527,gemcitabine,3,180,mg/m2,1,weekly for 3 weeks followed by 1 week rest,NA
19556122,NA,527,gemcitabine,4,240,mg/m2,1,weekly for 3 weeks followed by 1 week rest,NA
22371451,NCT00678132,528,olaparib,1,100,mg,2,on days 1 to 4 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,1,60,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,1,60,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,gemcitabine,1,500,mg/m2,1,on days 3 and 10 in 21-day cycles,NA
22371451,NCT00678132,528,olaparib,-1,100,mg,1,on days 1 to 4 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,-1,50,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,-1,50,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,gemcitabine,-1,400,mg/m2,1,on days 3 and 10 in 21-day cycles,NA
22371451,NCT00678132,528,olaparib,0.5,100,mg,1,on days 1 to 4 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,0.5,50,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,0.5,50,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,gemcitabine,0.5,400,mg/m2,1,on days 3 and 10 in 21-day cycles,NA
22371451,NCT00678132,528,olaparib,1.5,100,mg,2,on day 1 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,1.5,60,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,1.5,60,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,gemcitabine,1.5,100,mg/m2,1,on days 3 and 10 in 21-day cycles,NA
22371451,NCT00678132,528,olaparib,2,100,mg,2,on day 1 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,2,75,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,cisplatin,2,75,mg/m2,1,on day 3 in 21-day cycles,NA
22371451,NCT00678132,528,gemcitabine,2,100,mg/m2,1,on days 3 and 10 in 21-day cycles,NA
18058098,NA,529,lonafarnib,-1,50,mg/m2,2,on days 2–28 cycle 1 and days 1–28 subsequent cycles,"heavily pre-treated
patients"
18058098,NA,529,gemcitabine,-1,750,mg/m2,1,"on days 1, 8, 15 q 28 days","heavily pre-treated
patients"
18058098,NA,529,cisplatin,-1,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,-1,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,1,75,mg/m2,2,on days 2–28 cycle 1 and days 1–28 subsequent cycles,"heavily pre-treated
patients"
18058098,NA,529,gemcitabine,1,750,mg/m2,1,"on days 1, 8, 15 q 28 days","heavily pre-treated
patients"
18058098,NA,529,cisplatin,1,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,1,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,2,75,mg/m2,2,on days 2–28 cycle 1 and days 1–28 subsequent cycles,"heavily pre-treated
patients"
18058098,NA,529,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, 15 q 28 days","heavily pre-treated
patients"
18058098,NA,529,cisplatin,2,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,2,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,3,100,mg/m2,2,on days 2–28 cycle 1 and days 1–28 subsequent cycles,"heavily pre-treated
patients"
18058098,NA,529,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, 15 q 28 days","heavily pre-treated
patients"
18058098,NA,529,cisplatin,3,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,3,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,4,75,mg/m2,2,days 8–28 of cycle 1 and days 1–28 of subsequent 28-day cycles,less heavily pre-treated
18058098,NA,529,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, 15 q 28 days",less heavily pre-treated
18058098,NA,529,cisplatin,4,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,4,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,5,75,mg/m2,2,on days 8–21 of cycle 1 and days 1–21 to of subsequent 21-day cycles,less heavily pre-treated
18058098,NA,529,gemcitabine,5,750,mg/m2,1,on days 1 and 8 q 21 days,less heavily pre-treated
18058098,NA,529,cisplatin,5,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,5,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,lonafarnib,6,100,mg/m2,2,on days 8–21 of cycle 1 and days 1–21 to of subsequent 21-day cycles,less heavily pre-treated
18058098,NA,529,gemcitabine,6,1000,mg/m2,1,on days 1 and 8 q 21 days,less heavily pre-treated
18058098,NA,529,cisplatin,6,75,mg/m2,1,on day 1 of each cycle,fixed
18058098,NA,529,cisplatin,6,75,mg/m2,1,on day 1 of each cycle,fixed
17345085,NA,530,irinotecan,1,70,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,1,75,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17345085,NA,530,irinotecan,2,90,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,2,75,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17345085,NA,530,irinotecan,3,110,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,3,75,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17345085,NA,530,irinotecan,4,110,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,4,100,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17345085,NA,530,irinotecan,5,110,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,5,125,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17345085,NA,530,irinotecan,6,110,mg/m2,1,"24-h IV on D 2, 16 of each 4-week cycle",NA
17345085,NA,530,gemcitabine,6,150,mg/m2,1,24-h IV infusion on days 1 and 15 of each 4-week cycle,NA
17688925,NA,531,cisplatin,1,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,cisplatin,1,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,gemcitabine,1,50,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,external radiation therapy,1,180,cGy,1,25 fractions in 5 weeks and 3 days up to 45 Gy,fixed
17688925,NA,531,high-dose rate brachytherapy,1,600,cGy,1,"5 fractions for a total dose of 30 Gy, begin on week four, with at least one implant per week with no external radiation therapy given on the day of the insertion",fixed
17688925,NA,531,cisplatin,2,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,cisplatin,2,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,gemcitabine,2,100,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,external radiation therapy,2,180,cGy,1,25 fractions in 5 weeks and 3 days up to 45 Gy,fixed
17688925,NA,531,high-dose rate brachytherapy,2,600,cGy,1,"5 fractions for a total dose of 30 Gy, begin on week four, with at least one implant per week with no external radiation therapy given on the day of the insertion",fixed
17688925,NA,531,cisplatin,3,30,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,cisplatin,3,30,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,gemcitabine,3,75,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of externalradiation therapy",NA
17688925,NA,531,external radiation therapy,3,180,cGy,1,25 fractions in 5 weeks and 3 days up to 45 Gy,fixed
17688925,NA,531,high-dose rate brachytherapy,3,600,cGy,1,"5 fractions for a total dose of 30 Gy, begin on week four, with at least one implant per week with no external radiation therapy given on the day of the insertion",fixed
18305938,NA,532,gemcitabine,1,40,mg/m2,1,twice weekly concurrent with RT,NA
18305938,NA,532,radiation,1,3,Gy,1,"10 fractions, 5 fractions per week up to 30 Gy",NA
18305938,NA,532,gemcitabine,2,50,mg/m2,1,twice weekly concurrent with RT,NA
18305938,NA,532,radiation,2,3,Gy,1,"10 fractions, 5 fractions per week up to 30 Gy",NA
18305938,NA,532,gemcitabine,3,65,mg/m2,1,twice weekly concurrent with RT,NA
18305938,NA,532,radiation,3,3,Gy,1,"10 fractions, 5 fractions per week up to 30 Gy",NA
19855966,NA,533,imexon,1,200,mg/m2,1,on days 1–5 and 15–19 every 28 days,regimen A
19855966,NA,533,gemcitabine,1,800,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen A
19855966,NA,533,imexon,2,280,mg/m2,1,on days 1–5 and 15–19 every 28 days,regimen A
19855966,NA,533,gemcitabine,2,800,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen A
19855966,NA,533,imexon,3,200,mg/m2,1,on days 1–5 and 15–19 every 28 days,regimen A
19855966,NA,533,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen A
19855966,NA,533,imexon,4,280,mg/m2,1,on days 1–5 and 15–19 every 28 days,regimen A
19855966,NA,533,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen A
19855966,NA,533,imexon,5,390,mg/m2,1,on days 1–5 and 15–19 every 28 days,regimen A
19855966,NA,533,gemcitabine,5,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen A
19855966,NA,533,imexon,6,280,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,6,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,7,335,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,7,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,8,540,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,8,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,9,750,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,9,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,10,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,10,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,11,1300,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,11,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,12,1150,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,12,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,13,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,13,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,imexon,14,875,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
19855966,NA,533,gemcitabine,14,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",regimen B
17051371,NA,534,oxaliplatin,1,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,oxaliplatin,1,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,gemcitabine,1,700,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
17051371,NA,534,oxaliplatin,2,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,oxaliplatin,2,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,gemcitabine,2,800,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
17051371,NA,534,oxaliplatin,3,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,oxaliplatin,3,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,gemcitabine,3,1000,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
17051371,NA,534,oxaliplatin,4,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,oxaliplatin,4,130,mg/m2,1,on day 1 of a 21-day cycle,fixed
17051371,NA,534,gemcitabine,4,1200,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
21106728,NA,535,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
21106728,NA,535,reovirus type 3 dearing,1,3 x 10^9,TCID50,1,on days 1 to 5 of each cycle,NA
21106728,NA,535,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
21106728,NA,535,reovirus type 3 dearing,2,1 X 10^9,TCID50,1,on day 1 of each cycle,NA
21106728,NA,535,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
21106728,NA,535,reovirus type 3 dearing,3,3 X 10^9,TCID50,1,on day 1 of each cycle,NA
21106728,NA,535,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
21106728,NA,535,reovirus type 3 dearing,4,1 X 10^10,TCID50,1,on day 1 of each cycle,NA
21106728,NA,535,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
21106728,NA,535,reovirus type 3 dearing,5,3 X 10^10,TCID50,1,on day 1 of each cycle,NA
18217204,NA,536,cep-701,1,20,mg,2,daily during all 28 days of each cycle,NA
18217204,NA,536,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 of the 28-day cycle",fixed
18217204,NA,536,cep-701,2,40,mg,2,daily during all 28 days of each cycle,NA
18217204,NA,536,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of the 28-day cycle",fixed
18829514,NA,537,gemcitabine,1,1500,mg/m2,1,On day 1 of each 14-day cycle,fixed
18829514,NA,537,pemetrexed,1,300,mg/m2,1,On day 1 of each 14-day cycle,NA
18829514,NA,537,vitamin b12,1,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,vitamin b12,1,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,gemcitabine,2,1500,mg/m2,1,On day 1 of each 14-day cycle,fixed
18829514,NA,537,pemetrexed,2,400,mg/m2,1,On day 1 of each 14-day cycle,NA
18829514,NA,537,vitamin b12,2,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,vitamin b12,2,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,gemcitabine,3,1500,mg/m2,1,On day 1 of each 14-day cycle,fixed
18829514,NA,537,pemetrexed,3,500,mg/m2,1,On day 1 of each 14-day cycle,NA
18829514,NA,537,vitamin b12,3,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,vitamin b12,3,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,gemcitabine,4,1500,mg/m2,1,On day 1 of each 14-day cycle,fixed
18829514,NA,537,pemetrexed,4,600,mg/m2,1,On day 1 of each 14-day cycle,NA
18829514,NA,537,vitamin b12,4,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
18829514,NA,537,vitamin b12,4,1000,ug,1,1 to 2 weeks before first dose of pemetrexed and then approximately every 9 weeks while on study treatment and until 3 weeks after discontinuation of study treatment,fixed
21051221,NCT00540579,538,pomalidomide,-1,1,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,-1,750,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21051221,NCT00540579,538,pomalidomide,1,2,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21051221,NCT00540579,538,pomalidomide,2,3,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21051221,NCT00540579,538,pomalidomide,3,5,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21051221,NCT00540579,538,pomalidomide,4,7,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,4,1000,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21051221,NCT00540579,538,pomalidomide,5,10,mg,1,on days 1-21 of a 28 day cycle,NA
21051221,NCT00540579,538,gemcitabine,5,1000,mg/m2,1,"on days 1, 8 and 15 of a 28 day cycle",NA
21170669,NCT00265876,539,saracatinib,1,100,mg,1,daily every 4 weeks,NA
21170669,NCT00265876,539,gemcitabine,1,1000,mg/m2,1,weekly for 3 weeks followed by one-week break,fixed
21170669,NCT00265876,539,saracatinib,2,150,mg,1,daily every 4 weeks,NA
21170669,NCT00265876,539,gemcitabine,2,1000,mg/m2,1,weekly for 3 weeks followed by one-week break,fixed
21170669,NCT00265876,539,saracatinib,3,175,mg,1,daily every 4 weeks,NA
21170669,NCT00265876,539,gemcitabine,3,1000,mg/m2,1,weekly for 3 weeks followed by one-week break,fixed
20589760,NA,540,gemcitabine,1,150,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,1,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,1,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,1,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,2,225,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,2,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,2,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,2,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,3,300,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,3,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,3,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,3,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,4,350,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,4,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,4,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,4,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,5,400,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,5,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,5,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,5,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,6,450,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,6,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,6,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,6,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,7,500,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,7,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,7,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,7,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,8,550,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,8,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,8,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,8,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,9,625,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,9,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,9,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,9,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,gemcitabine,10,700,mg/m2,1,weekly on Fridays after the radiation dose for that day over 30 minutes for 6 weeks during radiotherapy,NA
20589760,NA,540,radiation,10,63,Gy,NA,5x1.8 Gy/wk with 6 MeV and 18 MeV energy photons,fixed
20589760,NA,540,cisplatin,10,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
20589760,NA,540,cisplatin,10,20,mg/m2,1,Day 1 to 3 in Weeks 1 and 5,fixed
18608594,NA,541,cisplatin,1,40,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,cisplatin,1,40,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,gemcitabine,1,600,mg/m2,1,"on day 1 within fever-range whole body thermal therapy (FR-WB-TT), and day 10 of 28-day cycles within  fever-range whole body thermal therapy (FR-WB-TT)",fixed
18608594,NA,541,interferon-a,1,1 x 10^6,IU,1,"beginning day 1, and continued for the duration of the protocol",fixed
18608594,NA,541,cisplatin,2,50,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,cisplatin,2,50,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,gemcitabine,2,600,mg/m2,1,"on day 1 within fever-range whole body thermal therapy (FR-WB-TT), and day 10 of 28-day cycles within  fever-range whole body thermal therapy (FR-WB-TT)",fixed
18608594,NA,541,interferon-a,2,1 x 10^6,IU,1,"beginning day 1, and continued for the duration of the protocol",fixed
18608594,NA,541,cisplatin,3,60,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,cisplatin,3,60,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,gemcitabine,3,600,mg/m2,1,"on day 1 within fever-range whole body thermal therapy (FR-WB-TT), and day 10 of 28-day cycles within  fever-range whole body thermal therapy (FR-WB-TT)",fixed
18608594,NA,541,interferon-a,3,1 x 10^6,IU,1,"beginning day 1, and continued for the duration of the protocol",fixed
18608594,NA,541,cisplatin,4,70,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,cisplatin,4,70,mg/m2,1,"on day 1 of 28-day cycles, approximately 36 hours prior to heat induction",NA
18608594,NA,541,gemcitabine,4,600,mg/m2,1,"on day 1 within fever-range whole body thermal therapy (FR-WB-TT), and day 10 of 28-day cycles within  fever-range whole body thermal therapy (FR-WB-TT)",fixed
18608594,NA,541,interferon-a,4,1 x 10^6,IU,1,"beginning day 1, and continued for the duration of the protocol",fixed
17987263,NA,542,gemcitabine,-1,175,mg/m2,1,weekly for 6 weeks,NA
17987263,NA,542,radiotherapy,-1,2,Gy,1,"5 days per week (Monday through Friday), over a period of 6 weeks, for a total dose of 60 Gys",fixed
17987263,NA,542,gemcitabine,1,200,mg/m2,1,weekly for 6 weeks,NA
17987263,NA,542,radiotherapy,1,2,Gy,1,"5 days per week (Monday through Friday), over a period of 6 weeks, for a total dose of 60 Gys",fixed
17987263,NA,542,gemcitabine,2,225,mg/m2,1,weekly for 6 weeks,NA
17987263,NA,542,radiotherapy,2,2,Gy,1,"5 days per week (Monday through Friday), over a period of 6 weeks, for a total dose of 60 Gys",fixed
17987263,NA,542,gemcitabine,3,250,mg/m2,1,weekly for 6 weeks,NA
17987263,NA,542,radiotherapy,3,2,Gy,1,"5 days per week (Monday through Friday), over a period of 6 weeks, for a total dose of 60 Gys",fixed
17987263,NA,542,gemcitabine,4,275,mg/m2,1,weekly for 6 weeks,NA
17987263,NA,542,radiotherapy,4,2,Gy,1,"5 days per week (Monday through Friday), over a period of 6 weeks, for a total dose of 60 Gys",fixed
16673059,NA,543,gemcitabine,1,1200,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
16673059,NA,543,gemcitabine,1,300,mg/m2,1,"every 2 weeks at days 43, 57, and 71",NA
16673059,NA,543,radiotherapy,1,66,Gy,NA,in 2.0-Gy fractions over 5 weeks starting on day 43 (14 days after induction chemotherapy),NA
16673059,NA,543,vinorelbine,1,30,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
16673059,NA,543,gemcitabine,2,1200,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
16673059,NA,543,gemcitabine,2,400,mg/m2,1,"every 2 weeks at days 43, 57, and 71",NA
16673059,NA,543,radiotherapy,2,66,Gy,NA,in 2.0-Gy fractions over 5 weeks starting on day 43 (14 days after induction chemotherapy),NA
16673059,NA,543,vinorelbine,2,30,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
16673059,NA,543,gemcitabine,3,1200,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
16673059,NA,543,gemcitabine,3,500,mg/m2,1,"every 2 weeks at days 43, 57, and 71",NA
16673059,NA,543,radiotherapy,3,66,Gy,NA,in 2.0-Gy fractions over 5 weeks starting on day 43 (14 days after induction chemotherapy),NA
16673059,NA,543,vinorelbine,3,30,mg/m2,1,"on day 1, 8 (first cycle) and on day 22, 29 (second cycle)",NA
21969517,NA,544,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
21969517,NA,544,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
21969517,NA,544,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
21969517,NA,544,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
21969517,NA,544,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
21969517,NA,544,nab-paclitaxel,3,150,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
19023677,NA,546,gemcitabine,0,600,mg/m2,1,on days 1 and 15 of an every-4-weeks,NA
19023677,NA,546,pemetrexed,0,500,mg/m2,1,on days 1 and 15 of an every-4-weeks,fixed
19023677,NA,546,gemcitabine,1,800,mg/m2,1,on days 1 and 15 of an every-4-weeks,NA
19023677,NA,546,pemetrexed,1,500,mg/m2,1,on days 1 and 15 of an every-4-weeks,fixed
19023677,NA,546,gemcitabine,2,1000,mg/m2,1,on days 1 and 15 of an every-4-weeks,NA
19023677,NA,546,pemetrexed,2,500,mg/m2,1,on days 1 and 15 of an every-4-weeks,fixed
19023677,NA,546,gemcitabine,3,1250,mg/m2,1,on days 1 and 15 of an every-4-weeks,NA
19023677,NA,546,pemetrexed,3,500,mg/m2,1,on days 1 and 15 of an every-4-weeks,fixed
19023677,NA,546,gemcitabine,4,1500,mg/m2,1,on days 1 and 15 of an every-4-weeks,NA
19023677,NA,546,pemetrexed,4,500,mg/m2,1,on days 1 and 15 of an every-4-weeks,fixed
18823054,NA,547,lipoplatin,1,100,mg/m2,1,on  Days  1  and  8 every 3 weeks,NA
18823054,NA,547,gemcitabine,1,1000,mg/m2,1,on  Days  1  and  8 every 3 weeks,fixed
18823054,NA,547,lipoplatin,2,110,mg/m2,1,on  Days  1  and  8 every 3 weeks,NA
18823054,NA,547,gemcitabine,2,1000,mg/m2,1,on  Days  1  and  8 every 3 weeks,fixed
18823054,NA,547,lipoplatin,3,120,mg/m2,1,on  Days  1  and  8 every 3 weeks,NA
18823054,NA,547,gemcitabine,3,1000,mg/m2,1,on  Days  1  and  8 every 3 weeks,fixed
18823054,NA,547,lipoplatin,4,130,mg/m2,1,on  Days  1  and  8 every 3 weeks,NA
18823054,NA,547,gemcitabine,4,1000,mg/m2,1,on  Days  1  and  8 every 3 weeks,fixed
19117344,NA,548,paclitaxel,1,175,mg/m2,1,on Day 1 in 3-week cycles,fixed
19117344,NA,548,cyclophosphamide,1,50,mg/m2,1,on Days 1-7 in 3-week cycles,NA
19117344,NA,548,paclitaxel,2,175,mg/m2,1,on Day 1 in 3-week cycles,fixed
19117344,NA,548,cyclophosphamide,2,100,mg/m2,1,on Days 1-7 in 3-week cycles,NA
19117344,NA,548,paclitaxel,3,175,mg/m2,1,on Day 1 in 3-week cycles,fixed
19117344,NA,548,cyclophosphamide,3,150,mg/m2,1,on Days 1-7 in 3-week cycles,NA
20044630,NA,549,gemcitabine,-1,500,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,irinotecan,-1,50,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,gemcitabine,1,700,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,irinotecan,1,50,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,gemcitabine,2,900,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,irinotecan,2,50,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,gemcitabine,3,900,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20044630,NA,549,irinotecan,3,75,mg/m2,1,"days 1, 8, 15 a four week (28-day) cycle",NA
20978761,NA,550,pemetrexed,1,300,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,1,900,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,2,500,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,2,900,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,3,500,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,3,1200,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,4,600,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,4,1200,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,5,700,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,5,1200,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,6,800,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,6,1200,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,pemetrexed,7,800,mg/m2,1,on Day 1 of each 14-day cycle,NA
20978761,NA,550,gemcitabine,7,1500,mg/m2,1,on Day 1 of each 14-day cycle,NA
21921646,NA,551,vandetanib,1,100,mg,1,daily,NA
21921646,NA,551,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 and 15 per 28-day cycle",fixed
21921646,NA,551,vandetanib,2,300,mg,1,daily,NA
21921646,NA,551,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 and 15 per 28-day cycle",fixed
20082116,NA,552,17-aag,1,154,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,gemcitabine,1,750,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,1,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,1,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,17-aag,2,154,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,gemcitabine,2,1000,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,2,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,2,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,17-aag,3,231,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,gemcitabine,3,750,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,3,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,3,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,17-aag,4,300,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,gemcitabine,4,750,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,4,20,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,552,cisplatin,4,20,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,553,17-aag,1,154,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,553,gemcitabine,1,750,NA,1,on days 2 and 9 on 21-day cycles,NA
20082116,NA,553,17-aag,2,231,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,553,gemcitabine,2,750,NA,1,on days 2 and 9 on 21-day cycles,NA
20082116,NA,554,17-aag,1,154,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,554,cisplatin,1,30,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,554,cisplatin,1,30,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,554,17-aag,2,154,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,554,cisplatin,2,40,NA,1,on days 1 and 8 on 21-day cycles,NA
20082116,NA,554,cisplatin,2,40,NA,1,on days 1 and 8 on 21-day cycles,NA
18236006,NA,555,gemcitabine,-1,800,mg/m2,1,on days 1 and 15 in a 28-day cycle,NA
18236006,NA,555,cisplatin,-1,50,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,cisplatin,-1,50,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,pemetrexed,-1,400,mg/m2,1,on day 15 in a 28-day cycle,NA
18236006,NA,555,gemcitabine,0,800,mg/m2,1,on days 1 and 15 in a 28-day cycle,NA
18236006,NA,555,cisplatin,0,60,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,cisplatin,0,60,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,pemetrexed,0,400,mg/m2,1,on day 15 in a 28-day cycle,NA
18236006,NA,555,gemcitabine,1,800,mg/m2,1,on days 1 and 15 in a 28-day cycle,NA
18236006,NA,555,cisplatin,1,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,cisplatin,1,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,pemetrexed,1,400,mg/m2,1,on day 15 in a 28-day cycle,NA
18236006,NA,555,gemcitabine,2,1000,mg/m2,1,on days 1 and 15 in a 28-day cycle,NA
18236006,NA,555,cisplatin,2,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,cisplatin,2,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,pemetrexed,2,400,mg/m2,1,on day 15 in a 28-day cycle,NA
18236006,NA,555,gemcitabine,3,1000,mg/m2,1,on days 1 and 15 in a 28-day cycle,NA
18236006,NA,555,cisplatin,3,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,cisplatin,3,70,mg/m2,1,on day 1 in a 28-day cycle,NA
18236006,NA,555,pemetrexed,3,500,mg/m2,1,on day 15 in a 28-day cycle,NA
17925553,NA,556,gemcitabine,-1,1000,mg/m2,1,"administered as a 30-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,-1,25,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,-1,25,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,-1,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,1,1000,mg/m2,1,"administered as a 30-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,1,40,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,1,40,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,1,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,2,1000,mg/m2,1,"administered as a 30-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,2,55,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,2,55,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,2,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,3,1000,mg/m2,1,"administered as a 30-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,3,70,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,3,70,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,3,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,4,1000,mg/m2,1,"administered as a 30-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,4,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,4,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,4,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,5,1000,mg/m2,1,"administered as a 65-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,5,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,5,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,5,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
17925553,NA,556,gemcitabine,6,1000,mg/m2,1,"administered as a 100-minute infusion on days 1, 8, and 15 at 28-day intervals",fixed
17925553,NA,556,oxaliplatin,6,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,oxaliplatin,6,85,mg/m2,1,days 1 and 15 at 28-day intervals,NA
17925553,NA,556,radiation therapy,6,1.8,Gy,1,"five times weekly, beginning on day 1 of the first cycle up to 27 Gy",fixed
19556811,NA,557,gemcitabine,-3,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-3,200,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,-2,600,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-2,200,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,-1,700,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-1,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,0,800,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,0,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,-2.5,"385 on day 1, 208 on day 8, 385 on day 15",mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-2.5,600,mg/m2,1,on day 1 every 4 weeks,NA
19556811,NA,557,gemcitabine,-1.5,"480 on day 1, 160 on day 8, 480 on day 15",mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-1.5,600,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,-0.5,"600 on day 1, 400 on day 8, 600 on day 15",mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,-0.5,600,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,1,"720 on day 1, 480 on day 8, 720 on day 15",mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,cyclophosphamide,1,600,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,0.5,"650 on day 1, 500 on day 8",mg/m2,1,on days 1 and 8 every 4 weeks,NA
19556811,NA,557,cyclophosphamide,0.5,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,1.5,"800 on day 1, 600 on day 8",mg/m2,1,on days 1 and 8 every 4 weeks,NA
19556811,NA,557,cyclophosphamide,1.5,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
19556811,NA,557,gemcitabine,2,"1000 on day 1, 750 on day 8",mg/m2,1,on days 1 and 8 every 4 weeks,NA
19556811,NA,557,cyclophosphamide,2,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
20332663,NA,558,gemcitabine,1,400,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
20332663,NA,558,radiotherapy,1,2,Gy,1,"40 Gy in 20 fractions, days 1–5, 8–12, 15–19, 22–26",NA
20332663,NA,558,gemcitabine,2,600,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
20332663,NA,558,radiotherapy,2,2,Gy,1,"40 Gy in 20 fractions, days 1–5, 8–12, 15–19, 22–26",NA
20332663,NA,558,gemcitabine,3,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
20332663,NA,558,radiotherapy,3,2,Gy,1,"40 Gy in 20 fractions, days 1–5, 8–12, 15–19, 22–26",NA
18449006,NA,559,nab-paclitaxe,1,260,mg/m2,1,on day 1 every 21 days,NA
18449006,NA,559,gemcitabine,1,1000,mg/m2,1,"on days 1, 8 every 21 days",fixed
18449006,NA,559,nab-paclitaxe,2,300,mg/m2,1,on day 1 every 21 days,NA
18449006,NA,559,gemcitabine,2,1000,mg/m2,1,"on days 1, 8 every 21 days",fixed
18449006,NA,559,nab-paclitaxe,3,340,mg/m2,1,on day 1 every 21 days,NA
18449006,NA,559,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 every 21 days",fixed
20349264,NA,560,oblimersen,1,5,mg/kg,1,on days 1–5 every two weeks,NA
20349264,NA,560,gemcitabine,1,1000,mg/m2,1,"on day 5, every two weeks",NA
20349264,NA,560,oblimersen,2,7,mg/kg,1,on days 1–5 every two weeks,NA
20349264,NA,560,gemcitabine,2,1000,mg/m2,1,"on day 5, every two weeks",NA
20349264,NA,560,oblimersen,3,7,mg/kg,1,on days 1–5 every two weeks,NA
20349264,NA,560,gemcitabine,3,1200,mg/m2,1,"on day 5, every two weeks",NA
20349264,NA,560,oblimersen,4,7,mg/kg,1,on days 1–5 every two weeks,NA
20349264,NA,560,gemcitabine,4,1500,mg/m2,1,"on day 5, every two weeks",NA
19194117,NA,561,topotecan,1,0.75,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,1,0.75,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,2,1,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,2,1,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,3,1.25,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,3,1.25,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,4,1.5,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,topotecan,4,1.5,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
19194117,NA,561,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
18379785,NA,562,trabectedin,1,0.3,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
18379785,NA,562,gemcitabine,1,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
18379785,NA,562,trabectedin,2,0.4,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
18379785,NA,562,gemcitabine,2,800,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
18379785,NA,562,trabectedin,3,0.4,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
18379785,NA,562,gemcitabine,3,1000,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
16566993,NA,563,cisplatin,1,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,cisplatin,1,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,gemcitabine,1,600,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
16566993,NA,563,cisplatin,2,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,cisplatin,2,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,gemcitabine,2,700,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
16566993,NA,563,cisplatin,3,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,cisplatin,3,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,gemcitabine,3,800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
16566993,NA,563,cisplatin,4,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,cisplatin,4,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,gemcitabine,4,900,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
16566993,NA,563,cisplatin,5,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,cisplatin,5,50,mg/m2,1,on day 1 of a 28-day cycle,fixed
16566993,NA,563,gemcitabine,5,1000,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
20153912,NA,564,ts-1,1,30,mg/m2,2,on days 1–4 every 4 weeks,NA
20153912,NA,564,gemcitabine,1,800,mg/m2,1,on days 8 and 15 every 4 weeks,NA
20153912,NA,564,ts-1,2,30,mg/m2,2,on days 1–4 every 4 weeks,NA
20153912,NA,564,gemcitabine,2,1000,mg/m2,1,on days 8 and 15 every 4 weeks,NA
20153912,NA,564,ts-1,3,40,mg/m2,2,on days 1–4 every 4 weeks,NA
20153912,NA,564,gemcitabine,3,1000,mg/m2,1,on days 8 and 15 every 4 weeks,NA
20197102,NA,565,gemcitabine,1,1250,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,vinorelbine,1,30,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,bcnu,1,10,mg/kg,1,on day -6,NA
20197102,NA,565,etoposide,1,60,mg/m2,1,on day -4,NA
20197102,NA,565,cy,1,100,mg/kg,1,on day -2,NA
20197102,NA,565,gemcitabine,2,1500,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,vinorelbine,2,30,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,bcnu,2,10,mg/kg,1,on day -6,NA
20197102,NA,565,etoposide,2,60,mg/m2,1,on day -4,NA
20197102,NA,565,cy,2,100,mg/kg,1,on day -2,NA
20197102,NA,565,gemcitabine,3,1800,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,vinorelbine,3,30,mg/m2,1,on days -13 and -8,NA
20197102,NA,565,bcnu,3,10,mg/kg,1,on day -6,NA
20197102,NA,565,etoposide,3,60,mg/m2,1,on day -4,NA
20197102,NA,565,cy,3,100,mg/kg,1,on day -2,NA
20188433,NA,566,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,1,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,1,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,sunitinib,1,37.5,mg/m2,1,on days 1–14 of a 21-day cycle,Schedule 2/1
20188433,NA,566,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,2,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,2,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,sunitinib,2,37.5,mg/m2,1,on days 1–14 of a 21-day cycle,Schedule 2/1
20188433,NA,566,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,3,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,3,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,sunitinib,3,37.5,mg/m2,1,on days 1–14 of a 21-day cycle,Schedule 2/1
20188433,NA,566,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,4,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,cisplatin,4,80,mg/m2,1,on day 1 of a 21-day cycle,Schedule 2/1
20188433,NA,566,sunitinib,4,37.5,mg/m2,1,on days 1–14 of a 21-day cycle,Schedule 2/1
20188433,NA,566,gemcitabine,5,1250,mg/m2,1,on days 1 and 8 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,5,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,5,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,sunitinib,5,25,mg/m2,1,started on day 1 and dosed dailythereafter,CDD schedule
20188433,NA,566,gemcitabine,6,1250,mg/m2,1,on days 1 and 8 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,6,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,6,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,sunitinib,6,37.5,mg/m2,1,started on day 1 and dosed dailythereafter,CDD schedule
20188433,NA,566,gemcitabine,7,1250,mg/m2,1,on days 1 and 8 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,7,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,cisplatin,7,80,mg/m2,1,on day 1 of a 21-day cycle,CDD schedule
20188433,NA,566,sunitinib,7,50,mg/m2,1,started on day 1 and dosed dailythereafter,CDD schedule
16337995,NA,567,gemcitabine,1,100,mg/m2,1,given concomitantly with weekly cisplatin for six cycles,NA
16337995,NA,567,cisplatin,1,40,mg/m2,1,weekly for six cycles,fixed
16337995,NA,567,cisplatin,1,40,mg/m2,1,weekly for six cycles,fixed
16337995,NA,567,pelvic radiation,1,4500-5000,cGy,NA,in 25 daily fractions over 5 weeks brachytherapy to take point A to >=8500 cGy,fixed
16337995,NA,567,gemcitabine,0,50,mg/m2,1,given concomitantly with weekly cisplatin for six cycles,NA
16337995,NA,567,cisplatin,0,40,mg/m2,1,weekly for six cycles,fixed
16337995,NA,567,cisplatin,0,40,mg/m2,1,weekly for six cycles,fixed
16337995,NA,567,pelvic radiation,0,4500-5000,cGy,NA,in 25 daily fractions over 5 weeks brachytherapy to take point A to >=8500 cGy,fixed
21570216,NA,568,gemcitabine,1,10,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,1,20,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,1,20,mg/m2,1,weekly,NA
21570216,NA,568,radiation therapy,1,2,Gy,1,for 5 consecutive days per week over a period of 6 to 7 weeks to a total dose of 70 Gy,NA
21570216,NA,568,gemcitabine,2,10,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,2,30,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,2,30,mg/m2,1,weekly,NA
21570216,NA,568,radiation therapy,2,2,Gy,1,for 5 consecutive days per week over a period of 6 to 7 weeks to a total dose of 70 Gy,NA
21570216,NA,568,gemcitabine,3,20,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,3,30,mg/m2,1,weekly,NA
21570216,NA,568,cisplatin,3,30,mg/m2,1,weekly,NA
21570216,NA,568,radiation therapy,3,2,Gy,1,for 5 consecutive days per week over a period of 6 to 7 weeks to a total dose of 70 Gy,NA
17439736,NA,569,gemcitabine,1,400,mg/m2,1,"concurrently with WBRT on days 1, 8 and 15",NA
17439736,NA,569,whole-brain radiotherapy,1,3750,cGy,NA,total 15 fractions in 3 weeks,NA
17439736,NA,569,gemcitabine,2,500,mg/m2,1,"concurrently with WBRT on days 1, 8 and 15",NA
17439736,NA,569,whole-brain radiotherapy,2,3750,cGy,NA,total 15 fractions in 3 weeks,NA
17439736,NA,569,gemcitabine,3,600,mg/m2,1,"concurrently with WBRT on days 1, 8 and 15",NA
17439736,NA,569,whole-brain radiotherapy,3,3750,cGy,NA,total 15 fractions in 3 weeks,NA
17439736,NA,569,gemcitabine,4,700,mg/m2,1,"concurrently with WBRT on days 1, 8 and 15",NA
17439736,NA,569,whole-brain radiotherapy,4,3750,cGy,NA,total 15 fractions in 3 weeks,NA
10690391,NA,570,gemcitabine,1,800,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,1,20,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,gemcitabine,2,800,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,2,25,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,gemcitabine,3,1000,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,3,25,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,gemcitabine,4,1000,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,4,30,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,gemcitabine,5,1250,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,5,30,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,gemcitabine,6,1500,mg/m2,1,day 1 and 8 every 3 weeks,NA
10690391,NA,570,vinorelbine,6,30,mg/m2,1,day 1 and 8 every 3 weeks,NA
25052698,NA,571,idarubicin,1,12,mg/m2,1,on day 1 every 3 weeks,NA
25052698,NA,571,methotrexate,1,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,methotrexate,1,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,vindesine,1,3,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,prednisolone,1,60,mg/m2,1,on days 1–5 every 3 weeks,fixed
25052698,NA,571,idarubicin,2,14,mg/m2,1,on day 1 every 3 weeks,NA
25052698,NA,571,methotrexate,2,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,methotrexate,2,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,vindesine,2,3,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,prednisolone,2,60,mg/m2,1,on days 1–5 every 3 weeks,fixed
25052698,NA,571,idarubicin,3,16,mg/m2,1,on day 1 every 3 weeks,NA
25052698,NA,571,methotrexate,3,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,methotrexate,3,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,vindesine,3,3,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,prednisolone,3,60,mg/m2,1,on days 1–5 every 3 weeks,fixed
25052698,NA,571,idarubicin,4,18,mg/m2,1,on day 1 every 3 weeks,NA
25052698,NA,571,methotrexate,4,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,methotrexate,4,3000,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,vindesine,4,3,mg/m2,1,on day 1 every 3 weeks,fixed
25052698,NA,571,prednisolone,4,60,mg/m2,1,on days 1–5 every 3 weeks,fixed
28869617,NCT00477815,572,90y zevalin,1,10,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,1,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,1,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,1,100,mg/m2,1,days − 2 and − 1,NA
28869617,NCT00477815,572,90y zevalin,2,12,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,2,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,2,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,2,100,mg/m2,1,days − 2 and − 1,NA
28869617,NCT00477815,572,90y zevalin,3,14,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,3,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,3,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,3,100,mg/m2,1,days − 2 and − 1,NA
28869617,NCT00477815,572,90y zevalin,4,16,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,4,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,4,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,4,100,mg/m2,1,days − 2 and − 1,NA
28869617,NCT00477815,572,90y zevalin,5,18,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,5,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,5,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,5,100,mg/m2,1,days − 2 and − 1,NA
28869617,NCT00477815,572,90y zevalin,6,20,Gy,1,on day -14,The dose of Zevalin will be based on the calculated radiation to the liver
28869617,NCT00477815,572,111in-zevalin,6,5,mCi,1,on day − 22,NA
28869617,NCT00477815,572,rituximab,6,250,mg/m2,1,"on day − 22, -14",NA
28869617,NCT00477815,572,melphalan,6,100,mg/m2,1,days − 2 and − 1,NA
22149206,NA,573,clofarabine,-1.5,20,mg/m2,1,on days 1 – 5,NA
22149206,NA,573,gemtuzumab ozogamicin,-1.5,3,mg/m2,1,on day 1,NA
22149206,NA,573,clofarabine,-1,10,mg/m2,1,on days 1 – 5,NA
22149206,NA,573,gemtuzumab ozogamicin,-1,3,mg/m2,1,"on days 1, 4,, 7",NA
22149206,NA,573,clofarabine,1,20,mg/m2,1,on days 1 – 5,NA
22149206,NA,573,gemtuzumab ozogamicin,1,3,mg/m2,1,"on days 1, 4,, 7",NA
22149206,NA,573,clofarabine,2,30,mg/m2,1,on days 1 – 5,NA
22149206,NA,573,gemtuzumab ozogamicin,2,3,mg/m2,1,"on days 1, 4,, 7",NA
22149206,NA,573,clofarabine,3,40,mg/m2,1,on days 1 – 5,NA
22149206,NA,573,gemtuzumab ozogamicin,3,3,mg/m2,1,"on days 1, 4,, 7",NA
16847470,NA,574,semisynthetic homoharringtonine,1,0.5,mg/m2/d,2,9 consecutive days,NA
16847470,NA,574,semisynthetic homoharringtonine,2,1,mg/m2/d,2,9 consecutive days,NA
16847470,NA,574,semisynthetic homoharringtonine,3,3,mg/m2/d,2,9 consecutive days,NA
16847470,NA,574,semisynthetic homoharringtonine,4,5,mg/m2/d,2,9 consecutive days,NA
16847470,NA,574,semisynthetic homoharringtonine,5,6,mg/m2/d,2,9 consecutive days,NA
8695365,NA,575,gemcitabine,1,10,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,2,20,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,3,40,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,4,80,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,5,120,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,6,180,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
8695365,NA,575,gemcitabine,7,210,mg/m2,1,"24 h infusion on days 0, 7 and 14 every 28 days",NA
10426665,NA,576,gemcitabine,1,800,mg/m2,1,every week for 3 weeks followed by 1 week of rest,NA
10426665,NA,576,leucovorin,1,25,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,5-fu,1,600,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,gemcitabine,2,1000,mg/m2,1,every week for 3 weeks followed by 1 week of rest,NA
10426665,NA,576,leucovorin,2,25,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,5-fu,2,600,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,gemcitabine,3,1250,mg/m2,1,every week for 3 weeks followed by 1 week of rest,NA
10426665,NA,576,leucovorin,3,25,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,5-fu,3,600,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,gemcitabine,4,1500,mg/m2,1,every week for 3 weeks followed by 1 week of rest,NA
10426665,NA,576,leucovorin,4,25,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
10426665,NA,576,5-fu,4,600,mg/m2,1,every week for 3 weeks followed by 1 week of rest,fixed
32777116,NCT01132586,577,lenalidomide,-1,25,mg,1,on days 1-21 of each 21-day course,NA
32777116,NCT01132586,577,cytarabine,-1,1000,mg/m2,1,on days 5-8 of each 21-day course,NA
32777116,NCT01132586,577,idarubicin,-1,8,mg/m2,1,on days 5-7 of each 21-day course,NA
32777116,NCT01132586,577,lenalidomide,1,25,mg,1,on days 1-21 of each 21-day course,NA
32777116,NCT01132586,577,cytarabine,1,1500,mg/m2,1,on days 5-8 of each 21-day course,NA
32777116,NCT01132586,577,idarubicin,1,12,mg/m2,1,on days 5-7 of each 21-day course,NA
32777116,NCT01132586,577,lenalidomide,2,30,mg,1,on days 1-21 of each 21-day course,NA
32777116,NCT01132586,577,cytarabine,2,1500,mg/m2,1,on days 5-8 of each 21-day course,NA
32777116,NCT01132586,577,idarubicin,2,12,mg/m2,1,on days 5-7 of each 21-day course,NA
10683085,NA,578,gemcitabine,1,800,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
10683085,NA,578,5-fu,1,200,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
10683085,NA,578,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
10683085,NA,578,5-fu,2,200,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
10683085,NA,578,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
10683085,NA,578,5-fu,3,300,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
10683085,NA,578,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
10683085,NA,578,5-fu,4,400,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
10683085,NA,578,gemcitabine,5,1000,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
10683085,NA,578,5-fu,5,525,mg/m2,1,14-day continuous intravenous infusion every 28 days,NA
33914097,NCT03661515,579,selinexor,1,60,mg,1,"on days 5, 12, and 19",NA
33914097,NCT03661515,579,fludarabine,1,30,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,idarubicin,1,10,mg/m2,1,on days 1 to 3,fixed
33914097,NCT03661515,579,cytarabine,1,2000,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,g-csf,1,300,mcg/m2,1,days −1 to 5,fixed
33914097,NCT03661515,579,g-csf,1,300,mcg/m2,1,days −1 to 5,fixed
33914097,NCT03661515,579,selinexor,2,80,mg,1,"on days 5, 12, and 19",NA
33914097,NCT03661515,579,fludarabine,2,30,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,idarubicin,2,10,mg/m2,1,on days 1 to 3,fixed
33914097,NCT03661515,579,cytarabine,2,2000,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,g-csf,2,300,mcg/m2,1,days −1 to 5,fixed
33914097,NCT03661515,579,g-csf,2,300,mcg/m2,1,days −1 to 5,fixed
33914097,NCT03661515,579,selinexor,3,100,mg,1,"on days 5, 12, and 19",NA
33914097,NCT03661515,579,fludarabine,3,30,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,idarubicin,3,10,mg/m2,1,on days 1 to 3,fixed
33914097,NCT03661515,579,cytarabine,3,2000,mg/m2,1,on days 1 to 4,fixed
33914097,NCT03661515,579,g-csf,3,300,mcg/m2,1,days −1 to 5,fixed
33914097,NCT03661515,579,g-csf,3,300,mcg/m2,1,days −1 to 5,fixed
9547676,NA,580,gemcitabine,1,1200,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
9547676,NA,580,gemcitabine,2,1500,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
9547676,NA,580,gemcitabine,3,1800,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
9436939,NA,581,idarubicin,1,5,mg/m2,1,on day 1 every 21 days,NA
9436939,NA,581,dexamethasone,1,20,mg,1,on days 2-5 and 11-14 every 21 days,NA
9436939,NA,581,i-dexa,1,1.5 x 10^5,U/day,1,3 times weekly,NA
9436939,NA,581,idarubicin,2,7.5,mg/m2,1,on day 1 every 21 days,NA
9436939,NA,581,dexamethasone,2,20,mg,1,on days 2-5 and 11-14 every 21 days,NA
9436939,NA,581,i-dexa,2,1.5 x 10^5,U/day,1,3 times weekly,NA
27342239,NCT01040559,582,idarubicin,-1,5,mg,1,single dose,NA
27342239,NCT01040559,582,idarubicin,1,10,mg,1,single dose,NA
27342239,NCT01040559,582,idarubicin,2,15,mg,1,single dose,NA
27342239,NCT01040559,582,idarubicin,3,20,mg,1,single dose,NA
27342239,NCT01040559,582,idarubicin,4,25,mg,1,single dose,NA
17158228,NA,583,pravastatin,1,40,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,1,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,1,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,2,80,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,2,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,2,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,3,160,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,3,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,3,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,4,320,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,4,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,4,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,5,480,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,5,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,5,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,6,640,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,6,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,6,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,7,880,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,7,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,7,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,8,1080,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,8,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,8,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,9,1280,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,9,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,9,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,10,1480,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,10,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,10,1500,mg/m2,1,continuous infusion on days 4-7,NA
17158228,NA,583,pravastatin,11,1680,mg,1,days 1-8,NA
17158228,NA,583,idarubicin,11,12,mg/m2,1,days 4-6,NA
17158228,NA,583,cytarabine,11,1500,mg/m2,1,continuous infusion on days 4-7,NA
10561293,NA,584,paclitaxel,1,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10561293,NA,584,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,1,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,1,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,paclitaxel,2,75,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10561293,NA,584,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,2,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,2,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,paclitaxel,3,100,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10561293,NA,584,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,3,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,3,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,paclitaxel,4,125,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10561293,NA,584,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,4,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,4,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,paclitaxel,5,150,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10561293,NA,584,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,5,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
10561293,NA,584,cisplatin,5,50,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
9818075,NA,585,gemcitabine,1,1200,mg/m2,1,weekly for three weeks every four weeks,NA
9818075,NA,585,gemcitabine,2,1500,mg/m2,1,weekly for three weeks every four weeks,NA
9818075,NA,585,gemcitabine,3,1800,mg/m2,1,weekly for three weeks every four weeks,NA
9818075,NA,585,gemcitabine,4,2250,mg/m2,1,weekly for three weeks every four weeks,NA
9818075,NA,585,gemcitabine,5,2800,mg/m2,1,weekly for three weeks every four weeks,NA
18756533,NA,586,clofarabine,1,22.5,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,idarubicin,1,12,mg/m2,1,Days 1 to 3 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,clofarabine,2,15,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,idarubicin,2,8,mg/m2,1,Days 1 to 3 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,clofarabine,3,18,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,idarubicin,3,10,mg/m2,1,Days 1 to 3 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,clofarabine,4,22.5,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,idarubicin,4,10,mg/m2,1,Days 1 to 3 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,clofarabine,5,30,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,586,idarubicin,5,10,mg/m2,1,Days 1 to 3 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,clofarabine,1,22.5,mg/m2,1,Days 2 to 6 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,idarubicin,1,8,mg/m2,1,Days 1 to 3every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,cytarabine,1,1000,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,clofarabine,2,15,mg/m2,1,Days 2 to 6 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,idarubicin,2,6,mg/m2,1,Days 1 to 3every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,cytarabine,2,750,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,clofarabine,3,22.5,mg/m2,1,Days 2 to 6 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,idarubicin,3,6,mg/m2,1,Days 1 to 3every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,cytarabine,3,750,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,clofarabine,4,30,mg/m2,1,Days 2 to 6 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,idarubicin,4,6,mg/m2,1,Days 1 to 3every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
18756533,NA,587,cytarabine,4,750,mg/m2,1,Days 1 to 5 every 4 to6 weeks as indicated by leukemia recurrence and he-matopoietic recovery,NA
24682421,NCT00838240,588,clofarabine,0,10,mg/m2,1,"an 1-h infusion on days 2, 4, 6, 8, and 10",NA
24682421,NCT00838240,588,cytosine arabinoside,0,100,mg/m2,1,on days 1–10,NA
24682421,NCT00838240,588,idarubicin,0,10,mg/m2,1,"on days 1, 3, and 5",NA
24682421,NCT00838240,588,clofarabine,1,15,mg/m2,1,"an 1-h infusion on days 2, 4, 6, 8, and 10",NA
24682421,NCT00838240,588,cytosine arabinoside,1,100,mg/m2,1,on days 1–10,NA
24682421,NCT00838240,588,idarubicin,1,10,mg/m2,1,"on days 1, 3, and 5",NA
24682421,NCT00838240,588,clofarabine,2,10,mg/m2,1,"a push injection on days 2, 4, 6, 8, and 10",NA
24682421,NCT00838240,588,cytosine arabinoside,2,100,mg/m2,1,on days 1–10,NA
24682421,NCT00838240,588,idarubicin,2,10,mg/m2,1,"on days 1, 3, and 5",NA
24682421,NCT00838240,588,clofarabine,3,15,mg/m2,1,"a push injection on days 2, 4, 6, 8, and 10",NA
24682421,NCT00838240,588,cytosine arabinoside,3,100,mg/m2,1,on days 1–10,NA
24682421,NCT00838240,588,idarubicin,3,10,mg/m2,1,"on days 1, 3, and 5",NA
20485286,NA,589,sunitinib,1,12.5,mg,1,daily,NA
20485286,NA,589,ifosfamide,1,9000,mg/m2,1,3-day continuous intravenous infusion (CIV) at 3-weekly intervals,NA
20485286,NA,589,sunitinib,2,25,mg,1,daily,NA
20485286,NA,589,ifosfamide,2,9000,mg/m2,1,3-day continuous intravenous infusion (CIV) at 3-weekly intervals,NA
20485286,NA,589,sunitinib,3,37.5,mg,1,daily,NA
20485286,NA,589,ifosfamide,3,9000,mg/m2,1,3-day continuous intravenous infusion (CIV) at 3-weekly intervals,NA
20485286,NA,589,sunitinib,4,12.5,mg,1,daily,NA
20485286,NA,589,ifosfamide,4,6000,mg/m2,1,5-day continuous intravenous infusion (CIV) at 3-weekly intervals,NA
11013279,NA,590,radiation therapy,-2,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,-2,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,-2,50,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,-1,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,-1,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,-1,75,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,1,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,1,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,1,100,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,2,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,2,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,2,200,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,3,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,3,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,3,300,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,4,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,4,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,4,400,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,5,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,5,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,5,600,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,6,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,6,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,6,800,mg/m2,1,weekly for 7 weeks,NA
11013279,NA,590,radiation therapy,7,59.4,Gy,NA,in 33 fractions in 45 days,fixed
11013279,NA,590,5-fu,7,200,mg/m2,1,beginning within 48 hours of the start ofradiation therapy and continuing until the last day,fixed
11013279,NA,590,gemcitabine,7,1000,mg/m2,1,weekly for 7 weeks,NA
11094306,NA,591,paclitaxel,1,40,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
11094306,NA,591,gemcitabine,1,800,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
11094306,NA,591,paclitaxel,2,40,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
11094306,NA,591,gemcitabine,2,1000,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
11094306,NA,591,paclitaxel,3,50,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
11094306,NA,591,gemcitabine,3,1000,mg/m2,1,on days 8 and 15 of a 28-day cycle,NA
24738629,NCT01040559,592,idarubicin,0,5,mg,1,1 unique course in a solution of 2ml DC Bead (300 µm-500µm),NA
24738629,NCT01040559,592,idarubicin,1,10,mg,1,1 unique course in a solution of 2ml DC Bead (300 µm-500µm),NA
24738629,NCT01040559,592,idarubicin,2,15,mg,1,1 unique course in a solution of 2ml DC Bead (300 µm-500µm),NA
24738629,NCT01040559,592,idarubicin,3,20,mg,1,1 unique course in a solution of 2ml DC Bead (300 µm-500µm),NA
24738629,NCT01040559,592,idarubicin,4,25,mg,1,1 unique course in a solution of 2ml DC Bead (300 µm-500µm),NA
10673977,NA,593,ifosfamide,1,1500,mg/m2,1,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,vinorelbine,1,25,mg/m2,1,on days 3 and 8 every three weeks,fixed
10673977,NA,593,gemcitabine,1,500,mg/m2,1,on days 3 and 8 every three weeks,NA
10673977,NA,593,mesna,1,300,mg/m2,3,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,ifosfamide,2,1500,mg/m2,1,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,vinorelbine,2,25,mg/m2,1,on days 3 and 8 every three weeks,fixed
10673977,NA,593,gemcitabine,2,800,mg/m2,1,on days 3 and 8 every three weeks,NA
10673977,NA,593,mesna,2,300,mg/m2,3,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,ifosfamide,3,1500,mg/m2,1,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,vinorelbine,3,25,mg/m2,1,on days 3 and 8 every three weeks,fixed
10673977,NA,593,gemcitabine,3,1000,mg/m2,1,on days 3 and 8 every three weeks,NA
10673977,NA,593,mesna,3,300,mg/m2,3,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,ifosfamide,4,1500,mg/m2,1,"on days 1, 2 and 3 every three weeks",fixed
10673977,NA,593,vinorelbine,4,25,mg/m2,1,on days 3 and 8 every three weeks,fixed
10673977,NA,593,gemcitabine,4,1200,mg/m2,1,on days 3 and 8 every three weeks,NA
10673977,NA,593,mesna,4,300,mg/m2,3,"on days 1, 2 and 3 every three weeks",fixed
11099327,NA,594,vesnarinone,1,30,mg,1,daily,NA
11099327,NA,594,gemcitabine,1,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
11099327,NA,594,vesnarinone,2,60,mg,1,daily,NA
11099327,NA,594,gemcitabine,2,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
11099327,NA,594,vesnarinone,3,90,mg,1,daily,NA
11099327,NA,594,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
11099327,NA,594,vesnarinone,4,120,mg,1,daily,NA
11099327,NA,594,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
11099327,NA,594,vesnarinone,5,150,mg,1,daily,NA
11099327,NA,594,gemcitabine,5,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
11099327,NA,594,vesnarinone,6,180,mg,1,daily,NA
11099327,NA,594,gemcitabine,6,1000,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",fixed
10997809,NA,595,gemcitabine,1,800,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,1,60,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,2,800,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,2,80,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,3,1000,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,3,80,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,4,1000,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,4,100,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,5,1500,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,5,100,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,6,1750,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,6,100,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,gemcitabine,7,2000,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
10997809,NA,595,paclitaxel,7,100,mg/m2,1,"on days 1, 8, 15 every 4 weeks",NA
11032598,NA,596,folinic acid,1,100,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,fluorouracil,1,450,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,gemcitabine,1,300,mg/m2,1,weekly for 6 weeks q 8 weeks,NA
11032598,NA,596,folinic acid,2,100,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,fluorouracil,2,450,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,gemcitabine,2,450,mg/m2,1,weekly for 6 weeks q 8 weeks,NA
11032598,NA,596,folinic acid,3,100,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,fluorouracil,3,450,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,gemcitabine,3,600,mg/m2,1,weekly for 6 weeks q 8 weeks,NA
11032598,NA,596,folinic acid,4,100,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,fluorouracil,4,450,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,gemcitabine,4,750,mg/m2,1,weekly for 6 weeks q 8 weeks,NA
11032598,NA,596,folinic acid,5,100,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,fluorouracil,5,450,mg/m2,1,weekly for 6 weeks q 8 weeks,fixed
11032598,NA,596,gemcitabine,5,900,mg/m2,1,weekly for 6 weeks q 8 weeks,NA
11005695,NA,597,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,1,90,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,1,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,2,120,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,2,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,3,150,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,3,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,4,180,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,4,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,5,210,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,5,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,6,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,6,240,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,6,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
11005695,NA,597,gemcitabine,7,1000,mg/m2,1,on days 1 and 8 of a 21-day cycle,fixed
11005695,NA,597,paclitaxel,7,370,mg/m2,1,on day 1 of a 21-day cycle,NA
11005695,NA,597,colony-stimulating factors,7,300,ug,1,"on days 5-6, 15-18 of a 21-day cycle",fixed
8622085,NA,598,gemcitabine,1,1000,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,1,25,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,1,25,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,2,1000,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,2,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,2,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,3,1250,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,3,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,3,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,4,1500,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,4,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,4,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,5,1750,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,5,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,5,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,6,2000,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,6,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,6,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,gemcitabine,7,2250,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,7,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
8622085,NA,598,cisplatin,7,30,mg/m2,1,weekly for 3 week every 4 weeks,NA
21519855,NA,599,ave9633,1,15,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,2,30,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,3,50,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,4,75,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,5,105,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,6,200,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,7,260,mg/m2,1,on day 1 of a 21-day cycle,Day 1 infusion schedule
21519855,NA,599,ave9633,8,30,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,9,50,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,10,75,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,11,105,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,12,130,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,13,150,mg/m2,1,on day 1 and day 8 of a 28-day cycle,Day1/Day8 infusion schedule
21519855,NA,599,ave9633,14,30,mg/m2,1,"on day 1, day 4 and day 7 of a 28-day cycle",Day1/Day4/Day7 infusion schedule
21519855,NA,599,ave9633,15,60,mg/m2,1,"on day 1, day 4 and day 7 of a 28-day cycle",Day1/Day4/Day7 infusion schedule
21519855,NA,599,ave9633,16,90,mg/m2,1,"on day 1, day 4 and day 7 of a 28-day cycle",Day1/Day4/Day7 infusion schedule
9400947,NA,600,gemcitabine,1,40,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,2,80,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,3,160,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,4,320,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,5,640,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,6,960,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,7,1200,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,8,1500,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,9,1875,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,10,2345,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,11,2930,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,12,3650,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,13,4560,mg/m2,1,once every 2 weeks.,NA
9400947,NA,600,gemcitabine,14,5700,mg/m2,1,once every 2 weeks.,NA
26750985,NCT01518556,601,idarubicin,1,12,mg/m2,1,three days in the induction therapy,NA
26750985,NCT01518556,601,cytarabine,1,100,mg/m2,1,continuous infusion for seven days in the induction therapy,fixed
26750985,NCT01518556,601,idarubicin,2,15,mg/m2,1,three days in the induction therapy,NA
26750985,NCT01518556,601,cytarabine,2,100,mg/m2,1,continuous infusion for seven days in the induction therapy,fixed
26750985,NCT01518556,601,idarubicin,3,18,mg/m2,1,three days in the induction therapy,NA
26750985,NCT01518556,601,cytarabine,3,100,mg/m2,1,continuous infusion for seven days in the induction therapy,fixed
10955861,NA,602,paclitaxel,1,150,mg/m2,1,on day 1 of a 21-day cycle,fixed
10955861,NA,602,gemcitabine,1,800,mg/m2,1,on day 8 of the 21-day cycle,NA
10955861,NA,602,paclitaxel,2,150,mg/m2,1,on day 1 of a 21-day cycle,fixed
10955861,NA,602,gemcitabine,2,900,mg/m2,1,on day 8 of the 21-day cycle,NA
10955861,NA,602,paclitaxel,3,150,mg/m2,1,on day 1 of a 21-day cycle,fixed
10955861,NA,602,gemcitabine,3,1000,mg/m2,1,on day 8 of the 21-day cycle,NA
22404399,NA,603,gemcitabine,1,1000,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,1,25,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,1,25,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,gemcitabine,2,1000,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,2,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,2,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,gemcitabine,3,1250,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,3,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,3,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,gemcitabine,4,1500,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,4,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,4,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,gemcitabine,5,1750,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,5,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
22404399,NA,603,cisplatin,5,30,mg/m2,1,"weekly x 3 with a l-week break,",NA
21585619, UMIN000001141 and UMIN000001142,604,idarubicin,1,10,mg/m2,1,days 1–3,NA
21585619, UMIN000001141 and UMIN000001142,604,cytarabine,1,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,604,gemtuzumab ozogamicin,1,3,mg/m2,1,on day 4,NA
21585619, UMIN000001141 and UMIN000001142,604,idarubicin,2,12,mg/m2,1,days 1–3,NA
21585619, UMIN000001141 and UMIN000001142,604,cytarabine,2,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,604,gemtuzumab ozogamicin,2,3,mg/m2,1,on day 4,NA
21585619, UMIN000001141 and UMIN000001142,604,idarubicin,3,12,mg/m2,1,days 1–3,NA
21585619, UMIN000001141 and UMIN000001142,604,cytarabine,3,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,604,gemtuzumab ozogamicin,3,5,mg/m2,1,on day 4,NA
21585619, UMIN000001141 and UMIN000001142,605,daunorubicin,1,50,mg/m2,1,days 1–3,NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,1,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,605,gemtuzumab ozogamicin,1,3,mg/m2,1,on day 4,NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,2,50,mg/m2,1,days 1–4,NA
21585619, UMIN000001141 and UMIN000001142,605,gemtuzumab ozogamicin,2,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,2,3,mg/m2,1,on day 5,NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,3,50,mg/m2,1,days 1–5,NA
21585619, UMIN000001141 and UMIN000001142,605,gemtuzumab ozogamicin,3,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,3,3,mg/m2,1,on day 6,NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,4,50,mg/m2,1,days 1–5,NA
21585619, UMIN000001141 and UMIN000001142,605,gemtuzumab ozogamicin,4,100,mg/m2,1,continuous  intravenous  infusion  (c.i.v.)  for  seven  consecutivedays (days 1–7),NA
21585619, UMIN000001141 and UMIN000001142,605,cytarabine,4,5,mg/m2,1,on day 6,NA
9739439,NA,606,paclitaxel,1,75,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,1,1500,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,2,75,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,2,2000,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,3,100,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,3,2000,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,4,100,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,4,2500,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,5,125,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,5,2500,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,5.5,175,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,5.5,2500,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,6,125,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,6,3000,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,7,150,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,7,3000,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,8,150,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,8,3500,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,paclitaxel,9,175,mg/m2,1,on day 1 of each two-week cycle,NA
9739439,NA,606,gemcitabine,9,3500,mg/m2,1,on day 1 of each two-week cycle,NA
23801301,NA,607,sorafenib,1,200,mg,2,started on day 2,NA
23801301,NA,607,ifosfamide,1,2000,mg/m2,1,3 consecutive days,NA
23801301,NA,607,mesna,1,400,mg/m2,3,"at 0, 4 and 8 h after ifosfamide",NA
23801301,NA,607,sorafenib,2,400,mg,2,started on day 2,NA
23801301,NA,607,ifosfamide,2,2000,mg/m2,1,3 consecutive days,NA
23801301,NA,607,mesna,2,400,mg/m2,3,"at 0, 4 and 8 h after ifosfamide",NA
23801301,NA,607,sorafenib,3,400,mg,2,started on day 2,NA
23801301,NA,607,ifosfamide,3,2500,mg/m2,1,3 consecutive days,NA
23801301,NA,607,mesna,3,500,mg/m2,3,"at 0, 4 and 8 h after ifosfamide",NA
23801301,NA,607,sorafenib,4,400,mg,2,started on day 2,NA
23801301,NA,607,ifosfamide,4,3000,mg/m2,1,3 consecutive days,NA
23801301,NA,607,mesna,4,600,mg/m2,3,"at 0, 4 and 8 h after ifosfamide",NA
11869937,NA,608,idarubicin,1,12.5,mg/m2,1,on days 3 and 10,NA
11869937,NA,608,cyclosporin a,1,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,cyclosporin a,1,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,granulocyte colony-stimulating factor,1,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,granulocyte colony-stimulating factor,1,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,cytarabine,1,3000,mg/m2,2,"on days 1, 2 and 8, 9",fixed
11869937,NA,608,idarubicin,2,15,mg/m2,1,on days 3 and 10,NA
11869937,NA,608,cyclosporin a,2,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,cyclosporin a,2,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,granulocyte colony-stimulating factor,2,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,granulocyte colony-stimulating factor,2,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,cytarabine,2,3000,mg/m2,2,"on days 1, 2 and 8, 9",fixed
11869937,NA,608,idarubicin,3,17.5,mg/m2,1,on days 3 and 10,NA
11869937,NA,608,cyclosporin a,3,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,cyclosporin a,3,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,granulocyte colony-stimulating factor,3,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,granulocyte colony-stimulating factor,3,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,cytarabine,3,3000,mg/m2,2,"on days 1, 2 and 8, 9",fixed
11869937,NA,608,idarubicin,4,20,mg/m2,1,on days 3 and 10,NA
11869937,NA,608,cyclosporin a,4,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,cyclosporin a,4,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,started 4 hours before IDR and lasted 12 hours,fixed
11869937,NA,608,granulocyte colony-stimulating factor,4,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,granulocyte colony-stimulating factor,4,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,608,cytarabine,4,3000,mg/m2,2,"on days 1, 2 and 8, 9",fixed
10080603,NA,609,gemcitabine,1,700,mg/m2,1,weekly for 3 consecutive weeks every 4 weeks,NA
10080603,NA,609,5-fu,1,200,mg/m2/d,1,continuously 5 days per week for 3 weeks every 28 days,NA
10080603,NA,609,gemcitabine,2,800,mg/m2,1,weekly for 3 consecutive weeks every 4 weeks,NA
10080603,NA,609,5-fu,2,200,mg/m2/d,1,continuously 5 days per week for 3 weeks every 28 days,NA
10080603,NA,609,gemcitabine,3,900,mg/m2,1,weekly for 3 consecutive weeks every 4 weeks,NA
10080603,NA,609,5-fu,3,200,mg/m2/d,1,continuously 5 days per week for 3 weeks every 28 days,NA
10080603,NA,609,gemcitabine,4,1000,mg/m2,1,weekly for 3 consecutive weeks every 4 weeks,NA
10080603,NA,609,5-fu,4,200,mg/m2/d,1,continuously 5 days per week for 3 weeks every 28 days,NA
10080603,NA,609,gemcitabine,5,1100,mg/m2,1,weekly for 3 consecutive weeks every 4 weeks,NA
10080603,NA,609,5-fu,5,200,mg/m2/d,1,continuously 5 days per week for 3 weeks every 28 days,NA
11137206,NA,610,paclitaxel,1,90,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,1,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
11137206,NA,610,paclitaxel,2,120,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,2,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
11137206,NA,610,paclitaxel,3,150,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,3,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
11137206,NA,610,paclitaxel,4,180,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
11137206,NA,610,paclitaxel,5,210,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,5,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
11137206,NA,610,paclitaxel,6,240,mg/m2,1,on day 1 of the 21-day cycle,NA
11137206,NA,610,gemcitabine,6,1000,mg/m2,1,on days 1 and 8 of the 21-day cycle,fixed
17154172,NA,611,homoharringtonine,0,2,mg/m2,2,"in the initial course, continuous infusion over 24 hours on Day 1",NA
17154172,NA,611,homoharringtonine,0,0.5,mg/m2,2,then s.c. daily for 13 days every month. Subsequent courses consisted of 14 days of s.c. HHT twice daily every month,NA
17154172,NA,611,homoharringtonine,1,2,mg/m2,2,"in the initial course, continuous infusion over 24 hours on Day 1",NA
17154172,NA,611,homoharringtonine,1,1,mg/m2,2,then s.c. daily for 13 days every month. Subsequent courses consisted of 14 days of s.c. HHT twice daily every month,NA
17154172,NA,611,homoharringtonine,2,2,mg/m2,2,"in the initial course, continuous infusion over 24 hours on Day 1",NA
17154172,NA,611,homoharringtonine,2,1.25,mg/m2,2,then s.c. daily for 13 days every month. Subsequent courses consisted of 14 days of s.c. HHT twice daily every month,NA
30378121,EudraCT 2010-021719-18,612,clofarabine,1,20,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,cytarabine,1,750,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,idarubicin,1,7.5,mg/m2,1,days 1+3,NA
30378121,EudraCT 2010-021719-18,612,clofarabine,2,25,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,cytarabine,2,750,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,idarubicin,2,7.5,mg/m2,1,days 1+3,NA
30378121,EudraCT 2010-021719-18,612,clofarabine,3,30,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,cytarabine,3,750,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,idarubicin,3,7.5,mg/m2,1,days 1+3,NA
30378121,EudraCT 2010-021719-18,612,clofarabine,4,35,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,cytarabine,4,750,mg/m2,1,days  1–5,NA
30378121,EudraCT 2010-021719-18,612,idarubicin,4,7.5,mg/m2,1,days 1+3,NA
12942571,NA,613,budr,1,1500,mg/m2/d,1,initiated within 3–3.5 weeks of the beginning of IDHAP; i.v. CI over 48 hours to begin on the Friday or Saturdayprior to WBRT and was repeated each weekend duringWBRT,NA
12942571,NA,613,methotrexate,1,3500,mg/m2,1,between Day 10 and Day 14after IDHAP,fixed
12942571,NA,613,methotrexate,1,3500,mg/m2,1,between Day 10 and Day 14after IDHAP,fixed
12942571,NA,613,idarubicin,1,1.5,mg/m2/d,1,4 days i.v. continuous infusion (i.v.CI) over 96 hours,fixed
12942571,NA,613,dexamethasone,1,40,mg,1,daily on Days 1–5,fixed
12942571,NA,613,cytosine arabinoside,1,2000,mg/m2,1,on Day 5,fixed
12942571,NA,613,cisplatin,1,25,mg/m2/d,1,4 days i.v.CI over 96 hours,fixed
12942571,NA,613,cisplatin,1,25,mg/m2/d,1,4 days i.v.CI over 96 hours,fixed
12942571,NA,613,wbrt,1,1.5,Gy,1,initiated within 3–3.5weeks of the beginning of IDHAP; 5 days a week up to a total dose of 45 Gy over 3 weeks,fixed
12942571,NA,613,budr,2,1800,mg/m2/d,1,initiated within 3–3.5 weeks of the beginning of IDHAP; i.v. CI over 48 hours to begin on the Friday or Saturdayprior to WBRT and was repeated each weekend duringWBRT,NA
12942571,NA,613,methotrexate,2,3500,mg/m2,1,between Day 10 and Day 14after IDHAP,fixed
12942571,NA,613,methotrexate,2,3500,mg/m2,1,between Day 10 and Day 14after IDHAP,fixed
12942571,NA,613,idarubicin,2,1.5,mg/m2/d,1,4 days i.v. continuous infusion (i.v.CI) over 96 hours,fixed
12942571,NA,613,dexamethasone,2,40,mg,1,daily on Days 1–5,fixed
12942571,NA,613,cytosine arabinoside,2,2000,mg/m2,1,on Day 5,fixed
12942571,NA,613,cisplatin,2,25,mg/m2/d,1,4 days i.v.CI over 96 hours,fixed
12942571,NA,613,cisplatin,2,25,mg/m2/d,1,4 days i.v.CI over 96 hours,fixed
12942571,NA,613,wbrt,2,1.5,Gy,1,initiated within 3–3.5weeks of the beginning of IDHAP; 5 days a week up to a total dose of 45 Gy over 3 weeks,fixed
9220290,NA,614,gemcitabine,0,300,mg/m2,1,"0.5 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,1,300,mg/m2,1,"1 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,2,300,mg/m2,1,"2 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,3,300,mg/m2,1,"3 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,4,300,mg/m2,1,"4.5 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,5,300,mg/m2,1,"6 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,6,874,mg/m2,1,"0.5 h infusion on days 1, 8 and 15 at 4-week intervals",NA
9220290,NA,614,gemcitabine,7,874,mg/m2,1,"1 h infusion on days 1, 8 and 15 at 4-week intervals",NA
10885899,NA,615,gemcitabine,1,200,mg/m2,1,"on days 1, 8 and 15 every 4 weeks as a 6 h i.v. infusion",NA
10885899,NA,615,gemcitabine,2,250,mg/m2,1,"on days 1, 8 and 15 every 4 weeks as a 6 h i.v. infusion",NA
10885899,NA,615,gemcitabine,3,300,mg/m2,1,"on days 1, 8 and 15 every 4 weeks as a 6 h i.v. infusion",NA
12637470,NA,616,troxacitabine,-1,4,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,616,topotecan,-1,0.75,mg/m2,1,continuous IV infusion on days 1 to 5,NA
12637470,NA,616,topotecan,-1,0.75,mg/m2,1,continuous IV infusion on days 1 to 5,NA
12637470,NA,617,troxacitabine,-1,4,NA,NA,daily for 5 consecutive days,NA
12637470,NA,617,idarubicin,-1,9,mg/m2,1,on days 1 to 3,NA
12637470,NA,618,troxacitabine,-1,4,NA,NA,daily for 5 consecutive days,NA
12637470,NA,618,ara-c,-1,0.75,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,ara-c,-1,0.75,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,616,troxacitabine,0,5,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,616,topotecan,0,1,mg/m2,1,continuous IV infusion on days 1 to 5,NA
12637470,NA,616,topotecan,0,1,mg/m2,1,continuous IV infusion on days 1 to 5,NA
12637470,NA,617,troxacitabine,0,5,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,617,idarubicin,0,12,mg/m2,1,on days 1 to 3,NA
12637470,NA,618,troxacitabine,0,5,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,618,ara-c,0,1,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,ara-c,0,1,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,troxacitabine,1,5,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,618,ara-c,1,1.25,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,ara-c,1,1.25,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,troxacitabine,2,6,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,618,ara-c,2,1,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,ara-c,2,1,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,618,troxacitabine,3,6,mg/m2,1,daily for 5 consecutive days,NA
12637470,NA,616,ara-c,3,1.25,mg/m2/d,1,on days 1 to 5,NA
12637470,NA,616,ara-c,3,1.25,mg/m2/d,1,on days 1 to 5,NA
11150903,NA,619,topotecan,1,0.7,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,topotecan,1,0.7,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,gemcitabine,1,200,mg/m2,1,"on days 1, 3 every 28 days",NA
11150903,NA,619,topotecan,2,0.8,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,topotecan,2,0.8,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,gemcitabine,2,400,mg/m2,1,"on days 1, 3 every 28 days",NA
11150903,NA,619,topotecan,3,0.9,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,topotecan,3,0.9,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,gemcitabine,3,600,mg/m2,1,"on days 1, 3 every 28 days",NA
11150903,NA,619,topotecan,4,0.9,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,topotecan,4,0.9,mg/m2,1,on days 1–5 every 28 days,NA
11150903,NA,619,gemcitabine,4,800,mg/m2,1,"on days 1, 3 every 28 days",NA
7860227,NA,620,gemcitabine,1,300,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,2,400,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,3,530,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,4,700,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,5,875,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,6,1095,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
7860227,NA,620,gemcitabine,7,1370,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
27677906,NCT00392691,621,y90‐it,1,0.4,mCi/kg,1,"on days -25, -18",fixed
27677906,NCT00392691,621,melphalan,1,100,mg/m2,1,on day -1,NA
27677906,NCT00392691,621,vinorelbine,1,35,mg/m2,1,on day -36,fixed
27677906,NCT00392691,621,y90‐it,2,0.4,mCi/kg,1,"on days -25, -18",fixed
27677906,NCT00392691,621,melphalan,2,140,mg/m2,1,on day -1,NA
27677906,NCT00392691,621,vinorelbine,2,35,mg/m2,1,on day -36,fixed
27677906,NCT00392691,621,y90‐it,3,0.4,mCi/kg,1,"on days -25, -18",fixed
27677906,NCT00392691,621,melphalan,3,170,mg/m2,1,on day -1,NA
27677906,NCT00392691,621,vinorelbine,3,35,mg/m2,1,on day -36,fixed
27677906,NCT00392691,621,y90‐it,4,0.4,mCi/kg,1,"on days -25, -18",fixed
27677906,NCT00392691,621,melphalan,4,200,mg/m2,1,on day -1,NA
27677906,NCT00392691,621,vinorelbine,4,35,mg/m2,1,on day -36,fixed
29610115,NCT02200848,622,rituximab,-2,375,mg/m2,1,on day 1 of cycles 1 to 6. Each cycle was 28 days,fixed
29610115,NCT02200848,622,ibrutinib,-2,280,mg,1,daily starting from day 1 and continuing untilprogression or intolerance. Each cycle was 28 days,NA
29610115,NCT02200848,622,lenalidomide,-2,2.5,mg,1,on days 1 to 21 of cycles 1 to 12. Each cycle was 28 days,NA
29610115,NCT02200848,622,rituximab,-1,375,mg/m2,1,on day 1 of cycles 1 to 6. Each cycle was 28 days,fixed
29610115,NCT02200848,622,ibrutinib,-1,420,mg,1,daily starting from day 1 and continuing untilprogression or intolerance. Each cycle was 28 days,NA
29610115,NCT02200848,622,lenalidomide,-1,2.5,mg,1,on days 1 to 21 of cycles 1 to 12. Each cycle was 28 days,NA
29610115,NCT02200848,622,rituximab,1,375,mg/m2,1,on day 1 of cycles 1 to 6. Each cycle was 28 days,fixed
29610115,NCT02200848,622,ibrutinib,1,420,mg,1,daily starting from day 1 and continuing untilprogression or intolerance. Each cycle was 28 days,NA
29610115,NCT02200848,622,lenalidomide,1,5,mg,1,on days 1 to 21 of cycles 1 to 12. Each cycle was 28 days,NA
29610115,NCT02200848,622,rituximab,2,375,mg/m2,1,on day 1 of cycles 1 to 6. Each cycle was 28 days,fixed
29610115,NCT02200848,622,ibrutinib,2,420,mg,1,daily starting from day 1 and continuing untilprogression or intolerance. Each cycle was 28 days,NA
29610115,NCT02200848,622,lenalidomide,2,10,mg,1,on days 1 to 21 of cycles 1 to 12. Each cycle was 28 days,NA
29610115,NCT02200848,622,rituximab,3,375,mg/m2,1,on day 1 of cycles 1 to 6. Each cycle was 28 days,fixed
29610115,NCT02200848,622,ibrutinib,3,420,mg,1,daily starting from day 1 and continuing untilprogression or intolerance. Each cycle was 28 days,NA
29610115,NCT02200848,622,lenalidomide,3,15,mg,1,on days 1 to 21 of cycles 1 to 12. Each cycle was 28 days,NA
33828254,NCT03332498,623,ibrutinib,1,420,mg,1,daily,NA
33828254,NCT03332498,623,pembrolizumab,1,200,mg,1,every 3 weeks,NA
33828254,NCT03332498,623,ibrutinib,2,560,mg,1,daily,NA
33828254,NCT03332498,623,pembrolizumab,2,200,mg,1,every 3 weeks,NA
31230047,NCT02401048,624,ibrutinib,1,560,mg,1,daily,NA
31230047,NCT02401048,624,durvalumab,1,10,mg/kg,1,every 2 weeks of each 28-day cycle,NA
31230047,NCT02401048,624,ibrutinib,-1,420,mg,1,daily,NA
31230047,NCT02401048,624,durvalumab,-1,10,mg/kg,1,every 2 weeks of each 28-day cycle,NA
31230047,NCT02401048,624,ibrutinib,-2,560,mg,1,daily,NA
31230047,NCT02401048,624,durvalumab,-2,3,mg/kg,1,every 2 weeks of each 28-day cycle,NA
31230047,NCT02401048,624,ibrutinib,-3,420,mg,1,daily,NA
31230047,NCT02401048,624,durvalumab,-3,3,mg/kg,1,every 2 weeks of each 28-day cycle,NA
17505827,NA,625,sunitinib,1,50,mg,1,daily for 14 days followed by a 7-day off period,NA
21469980,NA,626,imatinib,1,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,1,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,1,250,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,2,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,2,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,2,500,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,3,600,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,3,600,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,3,250,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,4,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,4,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,4,750,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,4.5,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,4.5,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,4.5,250 qam/500 qpm,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,5,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,5,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,5,500 qam/500 qpm,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,6,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,imatinib,6,400,mg,1,daily in the morning for a full 28-day treatment cycle,NA
21469980,NA,626,vatalanib,6,500 qam/750 qpm,mg,1,daily in the morning for a full 28-day treatment cycle,NA
24093213,NA,627,temozolomide,-2,75,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,-2,75,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,-2,1.5,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,-1,100,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,-1,100,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,-1,1.5,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,-0.5,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,-0.5,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,-0.5,1.5,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,1,100,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,1,100,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,1,3,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,2,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,2,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,2,3,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,3,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,3,125,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,3,4.5,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,4,150,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,4,150,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,4,4.5,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
24093213,NA,627,temozolomide,5,150,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,temozolomide,5,150,mg/m2,1,on days 1–7 and then on days 15–21 in 28 day cycles,NA
24093213,NA,627,peg-interferon alpha-2b,5,6,mg/kg,1,"on days 1, 8, 15, and 22 in 28 day cycles",NA
30101387,NCT02257541,628,imatinib,1,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,1,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,bgj398,1,100,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,2,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,2,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,bgj398,2,75,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,-1,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,-1,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,bgj398,-1,50,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,-2,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,imatinib,-2,400,mg,1,"daily 3 weeks on, 1 week off",NA
30101387,NCT02257541,628,bgj398,-2,25,mg,1,"daily 3 weeks on, 1 week off",NA
33683501,NA,629,bi 836826,1,100,mg,1,"in Cycle 1 as a 10 mg dose on Day 1, on Days 2 and 8 at 50% of the assigned dose on each day, and on Day 15 at 100% of the assigned dose. In Cycles 2–4, BI 836826 was administered at the assigned dose on Days 1 and 15 of each cycle. In Cycles 5–12, BI836826 was administered at the assigned dose on Day 1 only. BI 836826 was administered in 4-week cycles",NA
33683501,NA,629,ibrutinib,1,420,mg,1,daily,fixed
33683501,NA,629,bi 836826,2,200,mg,NA,"in Cycle 1 as a 10 mg dose on Day 1, on Days 2 and 8 at 50% of the assigned dose on each day, and on Day 15 at 100% of the assigned dose. In Cycles 2–4, BI 836826 was administered at the assigned dose on Days 1 and 15 of each cycle. In Cycles 5–12, BI836826 was administered at the assigned dose on Day 1 only. BI 836826 was administered in 4-week cycles",NA
33683501,NA,629,ibrutinib,2,420,mg,1,daily,fixed
7540421,NA,630,ifosfamide,1,9000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,1,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,2,10000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,2,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,3,11000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,3,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,4,12000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,4,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,5,13000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,5,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,6,14000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,6,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,7,15000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,7,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
7540421,NA,630,ifosfamide,8,16000,mg/m2,1,"days 1 to 4 by continuous infusion, in 3-weekcourses",NA
7540421,NA,630,mesna,8,NA,mg/m2,1,"5 consecutive days, in 3-weekcourses",NA
23045577,NCT00849654,631,ibrutinib,1,1.25,mg/kg,1,"on a 28 days on, 7 days off, schedule (35-day cycle)",NA
23045577,NCT00849654,631,ibrutinib,2,2.5,mg/kg,1,"on a 28 days on, 7 days off, schedule (35-day cycle)",NA
23045577,NCT00849654,631,ibrutinib,3,5,mg/kg,1,"on a 28 days on, 7 days off, schedule (35-day cycle)",NA
23045577,NCT00849654,631,ibrutinib,4,8.3,mg/kg,1,"on a 28 days on, 7 days off, schedule (35-day cycle)",NA
23045577,NCT00849654,631,ibrutinib,4.5,8.3,mg/kg,1,daily,NA
23045577,NCT00849654,631,ibrutinib,5,12.5,mg/kg,1,"on a 28 days on, 7 days off, schedule (35-day cycle)",NA
23045577,NCT00849654,631,ibrutinib,5.5,560,mg,1,daily,NA
25336693,NCT00878423,632,at13387,1,10,mg/m2,1,"on Days 1, 4, 8, 11, 15 and 18 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,2,20,mg/m2,1,"on Days 1, 4, 8, 11, 15 and 18 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,3,40,mg/m2,1,"on Days 1, 4, 8, 11, 15 and 18 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,4,80,mg/m2,1,"on Days 1, 4, 8, 11, 15 and 18 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,5,120,mg/m2,1,"on Days 1, 4, 8, 11, 15 and 18 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,1.5,150,mg/m2,1,"on Days 1, 8 and 15 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,2.5,180,mg/m2,1,"on Days 1, 8 and 15 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,3.5,220,mg/m2,1,"on Days 1, 8 and 15 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,4.5,260,mg/m2,1,"on Days 1, 8 and 15 of a twenty-eight day cycle",NA
25336693,NCT00878423,632,at13387,5.5,310,mg/m2,1,"on Days 1, 8 and 15 of a twenty-eight day cycle",NA
23403628,NA,633,osi-930,1,50-400,mg,1,daily every 3 weeks,NA
23403628,NA,633,osi-930,2,800,mg,1,daily every 3 weeks,NA
23403628,NA,633,osi-930,3,1200,mg,1,daily every 3 weeks,NA
23403628,NA,633,osi-930,4,1600,mg,1,daily every 3 weeks,NA
23403628,NA,633,osi-930,5,400,mg,2,daily every 3 weeks,NA
23403628,NA,633,osi-930,6,500,mg,2,daily every 3 weeks,NA
23403628,NA,633,osi-930,7,600,mg,2,daily every 3 weeks,NA
31331917,NA,634,ibrutinib,-1,560,mg,1,daily (QD) beginning Cycle 1 Day 1 throughout each 28-day treatment cycle,fixed
31331917,NA,634,lenalidomide,-1,10,mg,1,on Days 1-21 of each 28-day cycle,NA
31331917,NA,634,rituximab,-1,375,mg/m2,1,on Day 1 of each 28-day cycle for 6 cycles,NA
31331917,NA,634,ibrutinib,1,560,mg,1,daily (QD) beginning Cycle 1 Day 1 throughout each 28-day treatment cycle,fixed
31331917,NA,634,lenalidomide,1,15,mg,1,on Days 1-21 of each 28-day cycle,NA
31331917,NA,634,rituximab,1,375,mg/m2,1,on Day 1 of each 28-day cycle for 6 cycles,NA
31331917,NA,634,ibrutinib,1.5,560,mg,1,daily (QD) beginning Cycle 1 Day 1 throughout each 28-day treatment cycle,fixed
31331917,NA,634,lenalidomide,1.5,15,mg,1,on Days 1-21 of each 28-day cycle,Protocol Amendment to DLT Criteria
31331917,NA,634,rituximab,1.5,375,mg/m2,1,on Day 1 of each 28-day cycle for 6 cycles,NA
31331917,NA,634,ibrutinib,2,560,mg,1,daily (QD) beginning Cycle 1 Day 1 throughout each 28-day treatment cycle,fixed
31331917,NA,634,lenalidomide,2,20,mg,1,on Days 1-21 of each 28-day cycle,Protocol Amendment to DLT Criteria
31331917,NA,634,rituximab,2,375,mg/m2,1,on Day 1 of each 28-day cycle for 6 cycles,NA
31331917,NA,634,ibrutinib,3,560,mg,1,daily (QD) beginning Cycle 1 Day 1 throughout each 28-day treatment cycle,fixed
31331917,NA,634,lenalidomide,3,25,mg,1,on Days 1-21 of each 28-day cycle,Protocol Amendment to DLT Criteria
31331917,NA,634,rituximab,3,375,mg/m2,1,on Day 1 of each 28-day cycle for 6 cycles,NA
7625371,NA,635,ifosfamide,1,1200,mg/m2,1,continuous infusion for 5 days every 35 days,NA
7625371,NA,635,cisplatin,1,120,mg/m2,1,single 20-minute infusion every 35 days,NA
7625371,NA,635,cisplatin,1,120,mg/m2,1,single 20-minute infusion every 35 days,NA
7625371,NA,635,ifosfamide,-1,1000,mg/m2,1,continuous infusion for 4 days every 35 days,NA
7625371,NA,635,cisplatin,-1,30,mg/m2,1,daily for 4 days every 35 days,NA
7625371,NA,635,cisplatin,-1,30,mg/m2,1,daily for 4 days every 35 days,NA
8740798,NA,636,ifosfamide,1,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,1,135,mg/m2,1,24-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,1,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,1,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,1,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,ifosfamide,2,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,2,170,mg/m2,1,24-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,2,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,2,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,2,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,ifosfamide,3,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,3,200,mg/m2,1,24-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,3,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,3,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,3,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,ifosfamide,4,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,4,250,mg/m2,1,24-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,4,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,4,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,4,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,ifosfamide,5,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,5,300,mg/m2,1,24-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,5,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,5,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,5,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,ifosfamide,6,1600,mg/m2,1,on days 1-3 in 21-day cycles,fixed
8740798,NA,636,paclitaxel,6,250,mg/m2,1,1-hour continuous infusion on day 1 in 21-day cycles,NA
8740798,NA,636,mesna,6,400,mg/m2,1,"with ifosfamide, then Q4H x 2 dose in 21-day cycles",fixed
8740798,NA,636,g-csf,6,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
8740798,NA,636,g-csf,6,5,ug/kg,1,"on days 4 through 10, or until the absolute neutrophil count exceeded 4000/ul in 21-day cycles",fixed
32147671,NCT01468688,637,buparlisib,1,40,mg,1,daily,NA
32147671,NCT01468688,637,imatinib,1,400,mg,1,daily,fixed
32147671,NCT01468688,637,imatinib,1,400,mg,1,daily,fixed
32147671,NCT01468688,637,buparlisib,2,50,mg,1,daily,NA
32147671,NCT01468688,637,imatinib,2,400,mg,1,daily,fixed
32147671,NCT01468688,637,imatinib,2,400,mg,1,daily,fixed
32147671,NCT01468688,637,buparlisib,3,70,mg,1,daily,NA
32147671,NCT01468688,637,imatinib,3,400,mg,1,daily,fixed
32147671,NCT01468688,637,imatinib,3,400,mg,1,daily,fixed
32147671,NCT01468688,637,buparlisib,4,80,mg,1,daily,NA
32147671,NCT01468688,637,imatinib,4,400,mg,1,daily,fixed
32147671,NCT01468688,637,imatinib,4,400,mg,1,daily,fixed
32147671,NCT01468688,637,buparlisib,5,100,mg,1,daily,NA
32147671,NCT01468688,637,imatinib,5,400,mg,1,daily,fixed
32147671,NCT01468688,637,imatinib,5,400,mg,1,daily,fixed
9635927,NA,638,paclitaxel,1,135,mg/m2,1,"on day 1, q day 22",NA
9635927,NA,638,ifosfamide,1,1500,mg/m2,1,"on days 2-5, q day 22",NA
9635927,NA,638,paclitaxel,2,135,mg/m2,1,"on day 1, q day 22",NA
9635927,NA,638,ifosfamide,2,2000,mg/m2,1,"on days 2-5, q day 22",NA
9635927,NA,638,paclitaxel,3,175,mg/m2,1,"on day 1, q day 22",NA
9635927,NA,638,ifosfamide,3,2000,mg/m2,1,"on days 2-5, q day 22",NA
21263099,NA,639,dasatinib,1,50,mg/m2,2,daily for 28 days,NA
21263099,NA,639,dasatinib,2,65,mg/m2,2,daily for 28 days,NA
21263099,NA,639,dasatinib,3,85,mg/m2,2,daily for 28 days,NA
21263099,NA,639,dasatinib,4,110,mg/m2,2,daily for 28 days,NA
12228203,NA,640,pegylated ifna-2b,1,0.75,ug/kg,1,once weekly for 4 weeks,NA
12228203,NA,640,pegylated ifna-2b,2,1.5,ug/kg,1,once weekly for 4 weeks,NA
12228203,NA,640,pegylated ifna-2b,3,3,ug/kg,1,once weekly for 4 weeks,NA
12228203,NA,640,pegylated ifna-2b,4,4.5,ug/kg,1,once weekly for 4 weeks,NA
12228203,NA,640,pegylated ifna-2b,5,6,ug/kg,1,once weekly for 4 weeks,NA
12228203,NA,640,pegylated ifna-2b,6,7.5,ug/kg,1,once weekly for 4 weeks,NA
19541476,NA,641,masitinib,1,40,mg,1,daily,NA
19541476,NA,641,masitinib,2,100,mg,1,daily,NA
19541476,NA,641,masitinib,3,150,mg,1,daily,NA
19541476,NA,641,masitinib,4,250,mg,1,daily,NA
19541476,NA,641,masitinib,5,500,mg,1,daily,NA
19541476,NA,641,masitinib,6,1000,mg,1,daily,NA
19541476,NA,641,masitinib,7,800,mg,2,daily,NA
19541476,NA,641,masitinib,8,12-Jun,mg/kg,2,daily,within weight-adjusted dose groups
19541476,NA,641,masitinib,9,>12,mg/kg,2,daily,within weight-adjusted dose groups
20310049,NA,642,inno-406,1,30,mg,1,daily,NA
20310049,NA,642,inno-406,2,60,mg,1,daily,NA
20310049,NA,642,inno-406,3,120,mg,1,daily,NA
20310049,NA,642,inno-406,4,240,mg,1,daily,NA
20310049,NA,642,inno-406,5,480,mg,1,daily,NA
20310049,NA,642,inno-406,6,120,mg,2,daily,NA
20310049,NA,642,inno-406,7,240,mg,2,daily,NA
20310049,NA,642,inno-406,8,480,mg,2,daily,NA
11535501,NA,643,peg ifn-a-2b,1,0.75,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,2,1.5,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,3,3,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,4,4.5,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,5,6,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,6,7.5,ug/kg,1,weekly,NA
11535501,NA,643,peg ifn-a-2b,7,9,ug/kg,1,weekly,NA
11355147,NA,644,pegylated ifna-2b,1,750,mg/kg,1,once weekly,NA
11355147,NA,644,pegylated ifna-2b,2,1500,mg/kg,1,once weekly,NA
11355147,NA,644,pegylated ifna-2b,3,3000,mg/kg,1,once weekly,NA
11355147,NA,644,pegylated ifna-2b,4,4500,mg/kg,1,once weekly,NA
11355147,NA,644,pegylated ifna-2b,5,6000,mg/kg,1,once weekly,NA
11355147,NA,644,pegylated ifna-2b,6,7500,mg/kg,1,once weekly,NA
18235116,NA,645,imatinib,1,400,mg,1,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,1,400,mg,1,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,2,600,mg,1,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,2,600,mg,1,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,3,400,mg,2,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,3,400,mg,2,daily in 28-day cycles,Group A; Group B; Group C; Group D
18235116,NA,645,imatinib,-1,200,mg,1,daily in 28-day cycles,Group C; Group D
18235116,NA,645,imatinib,-1,200,mg,1,daily in 28-day cycles,Group C; Group D
18235116,NA,645,imatinib,-2,100,mg,1,daily in 28-day cycles,Group D
18235116,NA,645,imatinib,-2,100,mg,1,daily in 28-day cycles,Group D
11355147,NA,646,interleukin-2,1,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,interleukin-2,1,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,rhuifna-2a,1,5.0 x 10^6,IU/m2/d,1,three times weekly (TIW) for 4 weeks,NA
11355147,NA,646,5-fu,1,0,mg/m2,1,on days 1-5 (Monday-Friday) during week 1,NA
11355147,NA,646,interleukin-2,2,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,interleukin-2,2,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,rhuifna-2a,2,5.0 x 10^6,IU/m2/d,1,three times weekly (TIW) for 4 weeks,NA
11355147,NA,646,5-fu,2,250,mg/m2,1,on days 1-5 (Monday-Friday) during week 1,NA
11355147,NA,646,interleukin-2,3,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,interleukin-2,3,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,rhuifna-2a,3,5.0 x 10^6,IU/m2/d,1,three times weekly (TIW) for 4 weeks,NA
11355147,NA,646,5-fu,3,300,mg/m2,1,on days 1-5 (Monday-Friday) during week 1,NA
11355147,NA,646,interleukin-2,4,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,interleukin-2,4,5.0 x 10^6,IU/m2/d,1,on days 1-5 (Monday-Fri- day) for 4 weeks,NA
11355147,NA,646,rhuifna-2a,4,5.0 x 10^6,IU/m2/d,1,three times weekly (TIW) for 4 weeks,NA
11355147,NA,646,5-fu,4,375,mg/m2,1,on days 1-5 (Monday-Friday) during week 1,NA
15150579,NA,647,topotecan,1,0.4,mg/m2,1,5 days every 21 days,NA
15150579,NA,647,topotecan,1,0.4,mg/m2,1,5 days every 21 days,NA
15150579,NA,647,ifosfamide,1,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,2,0.6,mg/m2,1,5 days every 21 days,NA
15150579,NA,647,topotecan,2,0.6,mg/m2,1,5 days every 21 days,NA
15150579,NA,647,ifosfamide,2,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,3,0.6,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,topotecan,3,0.6,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,ifosfamide,3,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,4,0.8,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,topotecan,4,0.8,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,ifosfamide,4,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,5,1,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,topotecan,5,1,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,ifosfamide,5,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,6,1.2,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,topotecan,6,1.2,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,ifosfamide,6,1200,mg/m2,1,3 days every 21 days,fixed
15150579,NA,647,topotecan,7,1.4,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,topotecan,7,1.4,mg/m2,1,3 days every 21 days,NA
15150579,NA,647,ifosfamide,7,1200,mg/m2,1,3 days every 21 days,fixed
28428884,NCT01738139,648,imatinib mesylate,1,400,mg,1,daily,NA
28428884,NCT01738139,648,ipilimumab,1,1,mg/kg,1,on day 1 of each 21-day cycle for upto 4 cycles,NA
28428884,NCT01738139,648,imatinib mesylate,2,400,mg,2,daily,NA
28428884,NCT01738139,648,ipilimumab,2,1,mg/kg,1,on day 1 of each 21-day cycle for upto 4 cycles,NA
28428884,NCT01738139,648,imatinib mesylate,3,400,mg,1,daily,NA
28428884,NCT01738139,648,ipilimumab,3,3,mg/kg,1,on day 1 of each 21-day cycle for upto 4 cycles,NA
28428884,NCT01738139,648,imatinib mesylate,4,400,mg,2,daily,NA
28428884,NCT01738139,648,ipilimumab,4,3,mg/kg,1,on day 1 of each 21-day cycle for upto 4 cycles,NA
16144928,NA,649,peg-ifn,1,270,ug,1,once weekly for 48 weeks,NA
16144928,NA,649,peg-ifn,2,360,ug,1,once weekly for 48 weeks,NA
16144928,NA,649,peg-ifn,3,450,ug,1,once weekly for 48 weeks,NA
16144928,NA,649,peg-ifn,4,540,ug,1,once weekly for 48 weeks,NA
16144928,NA,649,peg-ifn,5,630,ug,1,once weekly for 48 weeks,NA
16144928,NA,650,peg-ifn,1,450,ug,1,once weekly for 48 weeks,NA
16144928,NA,650,cytarabine,1,10,mg,1,daily,NA
16144928,NA,650,peg-ifn,2,540,ug,1,once weekly for 48 weeks,NA
16144928,NA,650,cytarabine,2,10,mg,1,daily,NA
16144928,NA,650,peg-ifn,3,540,ug,1,once weekly for 48 weeks,NA
16144928,NA,650,cytarabine,3,20,mg,1,10 days/mo,NA
9457812,NA,651,ifn-a,1,12 x 10^6,units/m2,1,"days 1-3, every week of a 7-week cycle",after completing radiation
9457812,NA,651,bcnu,1,150,mg/m2,1,day 3 every 7 weeks,after completing radiation
9457812,NA,651,radiation therapy to brain,1,1.8,Gy,1,5 fractions per week for a total dose of 64.8 Gy,NA
9457812,NA,651,ifn-a,2,12 x 10^6,units/m2,1,"days 1-3, every other week of a 7-week cycle",after completing radiation
9457812,NA,651,bcnu,2,150,mg/m2,1,day 3 every 7 weeks,after completing radiation
9457812,NA,651,radiation therapy to brain,2,1.8,Gy,1,5 fractions per week for a total dose of 64.8 Gy,NA
19248046,NA,652,vatalanib,1,500,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,1,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,1,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,hydroxyurea,1,500,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,vatalanib,2,750,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,2,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,2,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,hydroxyurea,2,500,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,vatalanib,3,1000,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,3,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,imatinib,3,400,mg,1,daily,stratum A: patients not on EIAED
19248046,NA,652,hydroxyurea,3,500,mg,2,daily,stratum A: patients not on EIAED
19248046,NA,652,vatalanib,1.5,750,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,1.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,1.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,hydroxyurea,1.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,vatalanib,2.5,1000,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,2.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,2.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,hydroxyurea,2.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,vatalanib,3.5,1250,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,3.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,imatinib,3.5,500,mg,2,daily,stratum B: patients on EIAED
19248046,NA,652,hydroxyurea,3.5,500,mg,2,daily,stratum B: patients on EIAED
22805325,NCT 00424385,653,sorafenib,-2,200,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,-2,200,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,-2,200,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,-1,200,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,-1,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,-1,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,0,400,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,0,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,0,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,1,400,mg,2,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,1,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,1,300,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,2,400,mg,2,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,2,400,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,2,400,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,3,400,mg,2,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,3,600,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,3,600,mg,1,daily in 4-week cycles,NA
22805325,NCT 00424385,653,sorafenib,4,400,mg,2,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,4,400,mg,2,daily in 4-week cycles,NA
22805325,NCT 00424385,653,imatinib,4,400,mg,2,daily in 4-week cycles,NA
10410530,NA,654,irinotecan,1,30,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,1,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,1,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,1,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,2,40,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,2,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,2,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,2,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,3,50,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,3,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,3,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,3,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,4,60,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,4,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,4,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,4,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,5,70,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,5,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,5,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,5,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,6,80,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,6,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,6,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,6,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
10410530,NA,654,irinotecan,7,90,mg/m2,1,"on days 1,8 and 15 every 4 weeks",NA
10410530,NA,654,ifosfamide,7,1500,mg/m2,1,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,mesna,7,400,mg,3,on days 1 through 3 every 4 weeks,fixed
10410530,NA,654,granisetron,7,3,mg/m2,1,"on days 1 through 3, 8 and 15 every 4 weeks",fixed
18284451,NA,655,nedaplatin,1,65,mg/m2,1,initiated on the first day of radiation therapy; on day 1 every 4 weeks,NA
18284451,NA,655,ifosfamide,1,1000,mg/m2,1,initiated on the first day of radiation therapy; on days 1-5 every 4 weeks,fixed
18284451,NA,655,radiation therapy,1,NA,NA,NA,NA,fixed
18284451,NA,655,nedaplatin,2,70,mg/m2,1,initiated on the first day of radiation therapy; on day 1 every 4 weeks,NA
18284451,NA,655,ifosfamide,2,1000,mg/m2,1,initiated on the first day of radiation therapy; on days 1-5 every 4 weeks,fixed
18284451,NA,655,radiation therapy,2,NA,NA,NA,NA,fixed
18284451,NA,655,nedaplatin,3,75,mg/m2,1,initiated on the first day of radiation therapy; on day 1 every 4 weeks,NA
18284451,NA,655,ifosfamide,3,1000,mg/m2,1,initiated on the first day of radiation therapy; on days 1-5 every 4 weeks,fixed
18284451,NA,655,radiation therapy,3,NA,NA,NA,NA,fixed
18284451,NA,655,nedaplatin,4,80,mg/m2,1,initiated on the first day of radiation therapy; on day 1 every 4 weeks,NA
18284451,NA,655,ifosfamide,4,1000,mg/m2,1,initiated on the first day of radiation therapy; on days 1-5 every 4 weeks,fixed
18284451,NA,655,radiation therapy,4,NA,NA,NA,NA,fixed
10343194,NA,656,irinotecan,1,40,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
10343194,NA,656,cisplatin,1,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,cisplatin,1,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,ifosfamide,1,1500,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,rhg-csf,1,50,ug/m2,1,on days 5–18 except on the day of irinotecan treatment every 4 weeks,fixed
10343194,NA,656,irinotecan,2,50,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
10343194,NA,656,cisplatin,2,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,cisplatin,2,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,ifosfamide,2,1500,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,rhg-csf,2,50,ug/m2,1,on days 5–18 except on the day of irinotecan treatment every 4 weeks,fixed
10343194,NA,656,irinotecan,3,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
10343194,NA,656,cisplatin,3,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,cisplatin,3,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,ifosfamide,3,1500,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,rhg-csf,3,50,ug/m2,1,on days 5–18 except on the day of irinotecan treatment every 4 weeks,fixed
10343194,NA,656,irinotecan,4,70,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
10343194,NA,656,cisplatin,4,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,cisplatin,4,20,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,ifosfamide,4,1500,mg/m2,1,on days 1–4 every 4 weeks,fixed
10343194,NA,656,rhg-csf,4,50,ug/m2,1,on days 5–18 except on the day of irinotecan treatment every 4 weeks,fixed
18989889,NA,657,paclitaxel,1,250,mg/m2,1,6-hr continuous infusion on day 1 every 21–28 days,NA
18989889,NA,657,ifosfamide,1,2000,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,mesna,1,400,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,g-csf,1,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,g-csf,1,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,paclitaxel,2,325,mg/m2,1,6-hr continuous infusion on day 1 every 21–28 days,NA
18989889,NA,657,ifosfamide,2,2000,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,mesna,2,400,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,g-csf,2,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,g-csf,2,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,paclitaxel,3,425,mg/m2,1,6-hr continuous infusion on day 1 every 21–28 days,NA
18989889,NA,657,ifosfamide,3,2000,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,mesna,3,400,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,g-csf,3,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,g-csf,3,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,paclitaxel,4,550,mg/m2,1,6-hr continuous infusion on day 1 every 21–28 days,NA
18989889,NA,657,ifosfamide,4,2000,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,mesna,4,400,mg/m2,1,on days 1-3 every 21–28 days,NA
18989889,NA,657,g-csf,4,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
18989889,NA,657,g-csf,4,5,ug/kg,1,"daily beginning 24 hr after the final dose of ifosfamide and continued until the absolute neutrophil count was >5,000/ul on one measurement or >1,500/ul on two consecutive daily measurements",NA
24434430,EudraCT number: 2009-011417-24,658,panobinostat,1,20,mg,1,a three-times-per-week (MWF schedule) for 3 out of 4 weeks,NA
24434430,EudraCT number: 2009-011417-24,658,imatinib,1,400,mg,1,daily,NA
24434430,EudraCT number: 2009-011417-24,658,imatinib,1,400,mg,1,daily,NA
24434430,EudraCT number: 2009-011417-24,658,panobinostat,2,30,mg,1,a three-times-per-week (MWF schedule) for 3 out of 4 weeks,NA
24434430,EudraCT number: 2009-011417-24,658,imatinib,2,400,mg,1,daily,NA
24434430,EudraCT number: 2009-011417-24,658,imatinib,2,400,mg,1,daily,NA
31471313,NCT02164240,659,sunitinib,1,37.5,mg,1,3 continuous days in 28-day cycles,NA
31471313,NCT02164240,659,regorafenib,1,120,mg,1,4 continuous days in 28-day cycles,NA
31471313,NCT02164240,659,sunitinib,2,37.5,mg,1,3 continuous days in 28-day cycles,NA
31471313,NCT02164240,659,regorafenib,2,160,mg,1,4 continuous days in 28-day cycles,NA
9060524,NA,660,ifosfamide,1,2000,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,1,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,1,15,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,1,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,1,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,2,1600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,2,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,2,15,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,2,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,2,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,3,1600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,3,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,3,20,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,3,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,3,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,4,1600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,4,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,4,25,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,4,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,4,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,5,1600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,5,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,5,30,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,5,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,5,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,6,1600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,mesna,6,400,mg/m2,3,"on days 1, 2, and 3 every 21 days",fixed
9060524,NA,660,vinorelbine,6,35,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
9060524,NA,660,g-csf,6,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,6,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,ifosfamide,7,1600,mg/m2,1,"on days 1, 2, and 3 every 14 days",NA
9060524,NA,660,mesna,7,400,mg/m2,3,"on days 1, 2, and 3 every 14 days",fixed
9060524,NA,660,vinorelbine,7,25,mg/m2,1,"on days 1, 2, and 3 every 14 days",NA
9060524,NA,660,g-csf,7,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9060524,NA,660,g-csf,7,5,ug/kg,1,"on days 5 to 11 or until the absolute neutrophil count (ANC) was greater than 4,000/uL",fixed
9363862,NA,661,atra,1,60,mg/m2/d,3,"days 2, 3, and 4 repeated weekly for 4 weeks",NA
9363862,NA,661,ifn-a2a,1,3 x 10^6,IU/m2/d,1,days I to 5 repeated weekly for 4 weeks,fixed
9363862,NA,661,atra,2,90,mg/m2/d,3,"days 2, 3, and 4 repeated weekly for 4 weeks",NA
9363862,NA,661,ifn-a2a,2,3 x 10^6,IU/m2/d,1,days I to 5 repeated weekly for 4 weeks,fixed
9363862,NA,661,atra,3,120,mg/m2/d,3,"days 2, 3, and 4 repeated weekly for 4 weeks",NA
9363862,NA,661,ifn-a2a,3,3 x 10^6,IU/m2/d,1,days I to 5 repeated weekly for 4 weeks,fixed
11032596,NA,662,glufosfamide,1,800,mg/m2,1,every 3 weeks,NA
11032596,NA,662,glufosfamide,2,1600,mg/m2,1,every 3 weeks,NA
11032596,NA,662,glufosfamide,3,3200,mg/m2,1,every 3 weeks,NA
11032596,NA,662,glufosfamide,4,6000,mg/m2,1,every 3 weeks,NA
11032596,NA,662,glufosfamide,5,4500,mg/m2,1,every 3 weeks,NA
24492162,NA,663,imatinib,-2,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,-2,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,-2,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,-2,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,-2,350,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,imatinib,-1,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,-1,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,-1,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,-1,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,-1,400,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,imatinib,0,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,0,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,0,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,0,60,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,0,500,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,imatinib,1,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,1,300,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,1,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,1,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,1,500,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,imatinib,2,400,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,2,400,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,2,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,2,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,2,500,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,imatinib,3,600,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,imatinib,3,600,mg,1,daily in every 4-week cycle,NA
24492162,NA,663,cisplatin,3,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,cisplatin,3,75,mg/m2,1,every 28 days (+- 4 days),NA
24492162,NA,663,pemetrexed,3,500,mg/m2,1,every 28 days (+- 4 days),NA
17293590,NA,664,imatinib,1,200,mg/m2,2,"daily in each 28-day cycle, beginning withthe start of irradiation",NA
17293590,NA,664,imatinib,1,200,mg/m2,2,"daily in each 28-day cycle, beginning withthe start of irradiation",NA
17293590,NA,664,irradiation,1,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,664,imatinib,-1,150,mg/m2,2,daily in each 28-day cycle during RT,NA
17293590,NA,664,imatinib,-1,150,mg/m2,2,daily in each 28-day cycle during RT,NA
17293590,NA,664,irradiation,-1,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,664,imatinib,2,265,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,664,imatinib,2,265,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,664,irradiation,2,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,664,imatinib,3,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,664,imatinib,3,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,664,irradiation,3,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,665,imatinib,1,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,imatinib,1,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,irradiation,1,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,665,imatinib,2,465,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,imatinib,2,465,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,irradiation,2,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,665,imatinib,3,620,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,imatinib,3,620,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,irradiation,3,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,665,imatinib,4,800,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,imatinib,4,800,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,665,irradiation,4,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,666,imatinib,1,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,imatinib,1,350,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,irradiation,1,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,666,eiacds,1,NA,NA,NA,NA,NA
17293590,NA,666,imatinib,2,465,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,imatinib,2,465,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,irradiation,2,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,666,eiacds,2,NA,NA,NA,NA,NA
17293590,NA,666,imatinib,3,620,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,imatinib,3,620,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,irradiation,3,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,666,eiacds,3,NA,NA,NA,NA,NA
17293590,NA,666,imatinib,4,800,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,imatinib,4,800,mg/m2,2,"daily in each 28-day cycle, inititated after RT",NA
17293590,NA,666,irradiation,4,180,cGy,1,"five days per week, to a total dose of 5580 cGy",NA
17293590,NA,666,eiacds,4,NA,NA,NA,NA,NA
17909807,NA,667,peg-interferon,1,1.5,ug/kg,1,weekly in 6-week cycles,NA
17909807,NA,667,ril-2,1,10,MIU/m2,1,in weeks 1 and 4 given TIW in 6-week cycles,NA
17909807,NA,667,ril-2,1,5,MIU/m2,1,"during weeks 2, 3, 5, 6 given TIW in 6-week cyles",fixed
17909807,NA,667,peg-interferon,2,1.5,ug/kg,1,weekly in 6-week cycles,NA
17909807,NA,667,ril-2,2,15,MIU/m2,1,in weeks 1 and 4 given TIW in 6-week cycles,NA
17909807,NA,667,ril-2,2,5,MIU/m2,1,"during weeks 2, 3, 5, 6 given TIW in 6-week cyles",fixed
17909807,NA,667,peg-interferon,3,3,ug/kg,1,weekly in 6-week cycles,NA
17909807,NA,667,ril-2,3,15,MIU/m2,1,in weeks 1 and 4 given TIW in 6-week cycles,NA
17909807,NA,667,ril-2,3,5,MIU/m2,1,"during weeks 2, 3, 5, 6 given TIW in 6-week cyles",fixed
17909807,NA,667,peg-interferon,4,3,ug/kg,1,weekly in 6-week cycles,NA
17909807,NA,667,ril-2,4,20,MIU/m2,1,in weeks 1 and 4 given TIW in 6-week cycles,NA
17909807,NA,667,ril-2,4,5,MIU/m2,1,"during weeks 2, 3, 5, 6 given TIW in 6-week cyles",fixed
17909807,NA,667,peg-interferon,5,4.5,ug/kg,1,weekly in 6-week cycles,NA
17909807,NA,667,ril-2,5,20,MIU/m2,1,in weeks 1 and 4 given TIW in 6-week cycles,NA
17909807,NA,667,ril-2,5,5,MIU/m2,1,"during weeks 2, 3, 5, 6 given TIW in 6-week cyles",fixed
21242495,NCT00253474,668,pegylated interferon-α-2b,1,3,ug/kg,1,weekly,NA
21242495,NCT00253474,668,pegylated interferon-α-2b,2,4.5,ug/kg,1,weekly,NA
21242495,NCT00253474,668,pegylated interferon-α-2b,0,1,ug/kg,1,weekly,NA
10755315,NA,669,ifosfamide,1,1500,mg/m2,1,on days 1-4 every 4 weeks,fixed
10755315,NA,669,irinotecan,1,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",fixed
10755315,NA,669,cisplatin,1,60,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,cisplatin,1,60,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,rhg-csf,1,1,ug/kg,1,on days 5-18 every 4 weeks except on the day of irinotecan treatment,fixed
10755315,NA,669,ifosfamide,2,1500,mg/m2,1,on days 1-4 every 4 weeks,fixed
10755315,NA,669,irinotecan,2,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",fixed
10755315,NA,669,cisplatin,2,70,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,cisplatin,2,70,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,rhg-csf,2,1,ug/kg,1,on days 5-18 every 4 weeks except on the day of irinotecan treatment,fixed
10755315,NA,669,ifosfamide,3,1500,mg/m2,1,on days 1-4 every 4 weeks,fixed
10755315,NA,669,irinotecan,3,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",fixed
10755315,NA,669,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,NA
10755315,NA,669,rhg-csf,3,1,ug/kg,1,on days 5-18 every 4 weeks except on the day of irinotecan treatment,fixed
18359865,NA,670,imatinib,1,400,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,1,400,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,1,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,1,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,2,600,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,2,600,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,2,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,2,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,3,800,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,3,800,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,3,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,3,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,4,1000,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,4,1000,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,4,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,4,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,5,1200,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,imatinib,5,1200,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,5,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,670,temozolomide,5,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,1,400,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,1,400,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,1,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,1,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,eiaeds,1,NA,NA,NA,NA,NA
18359865,NA,671,imatinib,2,600,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,2,600,mg,1,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,2,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,2,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,eiaeds,2,NA,NA,NA,NA,NA
18359865,NA,671,imatinib,3,800,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,3,800,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,3,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,3,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,eiaeds,3,NA,NA,NA,NA,NA
18359865,NA,671,imatinib,4,1000,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,4,1000,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,4,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,4,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,eiaeds,4,NA,NA,NA,NA,NA
18359865,NA,671,imatinib,5,1200,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,imatinib,5,1200,mg/day,2,on days 1–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,5,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,temozolomide,5,200,mg/m2,1,on days 4–8 of each 4-week cycle,NA
18359865,NA,671,eiaeds,5,NA,NA,NA,NA,NA
17322542,NA,672,diflomotecan,1,0.005,mg/m2,1,on days 1–5 every 3 weeks,NA
17322542,NA,672,diflomotecan,2,0.1,mg/m2,1,on days 1–5 every 3 weeks,NA
17322542,NA,672,diflomotecan,3,0.125,mg/m2,1,on days 1–5 every 3 weeks,NA
17322542,NA,672,diflomotecan,4,0.15,mg/m2,1,on days 1–5 every 3 weeks,NA
18927314,NA,673,irinotecan,1,85,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,17aag,1,220,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,irinotecan,2,100,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,17aag,2,220,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,irinotecan,3,100,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,17aag,3,300,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,irinotecan,4,100,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
18927314,NA,673,17aag,4,375,mg/m2,1,once weekly for two consecutive weeks in a 21-d cycle,NA
16328416,NA,674,irinotecan,1,30,mg/m2,1,5 days every 3 weeks,NA
16328416,NA,674,irinotecan,2,40,mg/m2,1,5 days every 3 weeks,NA
16328416,NA,674,irinotecan,3,50,mg/m2,1,5 days every 3 weeks,NA
16328416,NA,674,irinotecan,4,60,mg/m2,1,5 days every 3 weeks,NA
16489079,NA,675,irinotecan,1,125,mg/m2,1,once weekly x 4 every 6 weeks,NA
16489079,NA,675,selenomethionine,1,2200,ug,1,daily starting 1 week before the first dose of irinotecan,fixed
16489079,NA,675,irinotecan,2,160,mg/m2,1,once weekly x 4 every 6 weeks,NA
16489079,NA,675,selenomethionine,2,2200,ug,1,daily starting 1 week before the first dose of irinotecan,fixed
15196737,NA,676,irinotecan,1,40,mg/m2,1,"on days 1 and 8 every 3 weeks. In the first cycle, irinotecan was initially administered and followed by paclitaxel infusion, while the sequence of drug administration was reversed in the second cycle",NA
15196737,NA,676,paclitaxel,1,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15196737,NA,676,irinotecan,2,40,mg/m2,1,"on days 1 and 8 every 3 weeks. In the first cycle, irinotecan was initially administered and followed by paclitaxel infusion, while the sequence of drug administration was reversed in the second cycle",NA
15196737,NA,676,paclitaxel,2,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15196737,NA,676,irinotecan,3,50,mg/m2,1,"on days 1 and 8 every 3 weeks. In the first cycle, irinotecan was initially administered and followed by paclitaxel infusion, while the sequence of drug administration was reversed in the second cycle",NA
15196737,NA,676,paclitaxel,3,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15196737,NA,676,irinotecan,4,50,mg/m2,1,"on days 1 and 8 every 3 weeks. In the first cycle, irinotecan was initially administered and followed by paclitaxel infusion, while the sequence of drug administration was reversed in the second cycle",NA
15196737,NA,676,paclitaxel,4,60,mg/m2,1,on days 1 and 8 every 3 weeks,NA
15196737,NA,676,irinotecan,5,60,mg/m2,1,"on days 1 and 8 every 3 weeks. In the first cycle, irinotecan was initially administered and followed by paclitaxel infusion, while the sequence of drug administration was reversed in the second cycle",NA
15196737,NA,676,paclitaxel,5,60,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16449240,NA,677,semaxanib,1,85,mg/m2,1,twice weekly for 6 weeks of each 6-week cycle,NA
16449240,NA,677,irinotecan,1,125,mg/m2,1,weekly for 4 weeks of each 6-week cycle,fixed
16449240,NA,677,semaxanib,2,110,mg/m2,1,twice weekly for 6 weeks of each 6-week cycle,NA
16449240,NA,677,irinotecan,2,125,mg/m2,1,weekly for 4 weeks of each 6-week cycle,fixed
16449240,NA,677,semaxanib,3,145,mg/m2,1,twice weekly for 6 weeks of each 6-week cycle,NA
16449240,NA,677,irinotecan,3,125,mg/m2,1,weekly for 4 weeks of each 6-week cycle,fixed
15768380,NA,678,irinotecan,1,125,mg/m2,1,weekly for 4 weeks in 6-week cycles,NA
15768380,NA,678,irinotecan,2,160,mg/m2,1,weekly for 4 weeks in 6-week cycles,NA
15768380,NA,678,irinotecan,3,200,mg/m2,1,weekly for 4 weeks in 6-week cycles,NA
14551303,NA,679,irinotecan,1,200,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,2,240,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,3,300,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,4,350,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,5,420,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,6,500,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,7,600,mg/m2,1,a 120-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,7.5,600,mg/m2,1,a 60-minute infusion every 3 weeks,NA
14551303,NA,679,irinotecan,8,720,mg/m2,1,a 120-minute infusion every 3 weeks,NA
16821636,NA,680,irinotecan,-2,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16821636,NA,680,amrubicin,-2,30,mg/m2,1,3 consecutive days every 3 weeks,NA
16821636,NA,680,irinotecan,-1,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16821636,NA,680,amrubicin,-1,30,mg/m2,1,3 consecutive days every 3 weeks,NA
16821636,NA,680,irinotecan,1,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16821636,NA,680,amrubicin,1,40,mg/m2,1,3 consecutive days every 3 weeks,NA
17146732,NA,681,irinotecan,1,300,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,1,100,mg,2,daily,NA
17146732,NA,681,irinotecan,2,300,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,2,200,mg,2,daily,NA
17146732,NA,681,irinotecan,3,300,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,3,300,mg,2,daily,NA
17146732,NA,681,irinotecan,4,250,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,4,300,mg,2,daily,NA
17146732,NA,681,irinotecan,5,250,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,5,400,mg,2,daily,NA
17146732,NA,681,irinotecan,6,250,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,6,500,mg,2,daily,NA
17146732,NA,681,irinotecan,7,250,mg/m2,1,every 21-days,NA
17146732,NA,681,ly293111,7,600,mg,2,daily,NA
12377659,NA,682,irinotecan,1,75,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,1,250,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,1,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,2,100,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,2,250,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,2,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,3,125,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,3,250,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,3,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,4,150,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,4,300,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,4,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,5,175,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,5,300,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,5,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,6,175,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,6,350,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,6,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,7,200,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,7,350,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,7,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,8,225,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,8,350,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,8,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,9,250,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,9,350,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,9,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,10,250,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,10,400,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,10,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,11,275,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,11,400,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,11,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
12377659,NA,682,irinotecan,12,300,mg/m2,1,on day 1 of each 21-day cycle,NA
12377659,NA,682,5-fluorouracil,12,400,mg/m2,1,on days 2–5 of each 21-day cycle,NA
12377659,NA,682,leucovorin,12,20,mg/m2,1,on days 2–5 of each 21-day cycle,fixed
20039040,NA,683,lomeguatrib,1,10,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,1,350,mg/m2,1,on day 4 of a 21-day cycle,NA
20039040,NA,683,lomeguatrib,2,10,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,2,250,mg/m2,1,on day 4 of a 21-day cycle,NA
20039040,NA,683,lomeguatrib,3,20,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,3,250,mg/m2,1,on day 4 of a 21-day cycle,NA
20039040,NA,683,lomeguatrib,4,40,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,4,250,mg/m2,1,on day 4 of a 21-day cycle,NA
20039040,NA,683,lomeguatrib,5,80,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,5,250,mg/m2,1,on day 4 of a 21-day cycle,NA
20039040,NA,683,lomeguatrib,6,80,mg,1,on days 1–5 of a 21-day cycle,NA
20039040,NA,683,irinotecan,6,300,mg/m2,1,on day 4 of a 21-day cycle,NA
12881390,NA,684,irinotecan,1,200,mg/m2,1,on day 1 of each 21-day cycle,NA
12881390,NA,684,uracil/tegafur,1,250,mg/m2,1,on days 1 to 14 of each 21-day cycle,NA
12881390,NA,684,leucovorin,1,90,mg,1,on days 1 to 14 of each 21-day cycle,NA
12881390,NA,684,irinotecan,2,250,mg/m2,1,on day 1 of each 21-day cycle,NA
12881390,NA,684,uracil/tegafur,2,250,mg/m2,1,on days 1 to 14 of each 21-day cycle,NA
12881390,NA,684,leucovorin,2,90,mg,1,on days 1 to 14 of each 21-day cycle,NA
12881390,NA,684,irinotecan,3,300,mg/m2,1,on day 1 of each 21-day cycle,NA
12881390,NA,684,uracil/tegafur,3,250,mg/m2,1,on days 1 to 14 of each 21-day cycle,NA
12881390,NA,684,leucovorin,3,90,mg,1,on days 1 to 14 of each 21-day cycle,NA
12598357,NA,685,oxaliplatin,1,60,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,1,60,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,1,90,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,1,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,1,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,2,60,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,2,60,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,2,120,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,2,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,2,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,3,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,3,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,3,120,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,3,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,3,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,4,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,4,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,4,150,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,4,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,4,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,5,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,5,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,5,180,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,5,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,5,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,6,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,6,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,6,200,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,6,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,6,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
12598357,NA,685,oxaliplatin,7,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,oxaliplatin,7,85,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,irinotecan,7,220,mg/m2,1,on day 1 of the 14-day cycle,NA
12598357,NA,685,leucovorin,7,200,mg/m2,1,"on day 1 and day 2 of the 14-day cycle,",fixed
12598357,NA,685,5-fluorouracil,7,400/600,mg/m2,1,"400 mg/m2 in a 10-min i.v. bolus, followed by 600 mg/m2 in a continuous 22-h infusion; on day 1 and day 2 of the 14-day cycle",fixed
16446328,NA,686,irinotecan,1,15,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,686,irinotecan,2,25,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,686,irinotecan,3,35,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,686,irinotecan,4,45,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,686,irinotecan,5,40,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,687,irinotecan,1,45,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,687,cefixime,1,8,mg/kg,1,beginning 5 days before irinotecan and continuing throughout the course,fixed
16446328,NA,687,irinotecan,2,60,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,687,cefixime,2,8,mg/kg,1,beginning 5 days before irinotecan and continuing throughout the course,fixed
16446328,NA,687,irinotecan,3,75,mg/m2,1,daily for 5 days for 2 consecutive weeks (repeated every 21 days),NA
16446328,NA,687,cefixime,3,8,mg/kg,1,beginning 5 days before irinotecan and continuing throughout the course,fixed
11839656,NA,688,irinotecan,1,15,mg/m2,1,5 days every 3 weeks by continuous HAI,NA
11839656,NA,688,irinotecan,2,20,mg/m2,1,5 days every 3 weeks by continuous HAI,NA
11839656,NA,688,irinotecan,3,25,mg/m2,1,5 days every 3 weeks by continuous HAI,NA
15138360,NA,689,paclitaxel,1,80,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,1,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,2,90,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,2,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,3,100,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,3,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,4,120,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,4,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,5,140,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,5,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,6,160,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,6,60,mg/m2,1,on day 1 every 2 weeks,fixed
15138360,NA,689,paclitaxel,7,180,mg/m2,1,on day 1 every 2 weeks,NA
15138360,NA,689,irinotecan,7,60,mg/m2,1,on day 1 every 2 weeks,fixed
18179842,RCTN75771514,690,irinotecan,1,340,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,1,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,1,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,irinotecan,1,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),NA
18179842,RCTN75771514,690,cisplatin,1,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,cisplatin,1,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,concurrent thoracic radiotherapy,1,1.8,Gy,1,"five fractions per weeks started at day 1 of cycle 2, and continued for 5 consecutive weeks",fixed
18179842,RCTN75771514,690,irinotecan,2,340,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,2,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,2,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,irinotecan,2,120,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),NA
18179842,RCTN75771514,690,cisplatin,2,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,cisplatin,2,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,concurrent thoracic radiotherapy,2,1.8,Gy,1,"five fractions per weeks started at day 1 of cycle 2, and continued for 5 consecutive weeks",fixed
18179842,RCTN75771514,690,irinotecan,3,340,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,3,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,cisplatin,3,135,mg,1,on day 1 every three weeks in cycles 1 and 4 (without TRT),fixed
18179842,RCTN75771514,690,irinotecan,3,140,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),NA
18179842,RCTN75771514,690,cisplatin,3,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,cisplatin,3,100,mg,1,on day 1 every three weeks in cycles 2 and 3 (with TRT),fixed
18179842,RCTN75771514,690,concurrent thoracic radiotherapy,3,1.8,Gy,1,"five fractions per weeks started at day 1 of cycle 2, and continued for 5 consecutive weeks",fixed
12187070,NA,691,irinotecan,-1,200,mg/m2,1,every 21 days,NA
12187070,NA,691,raltitrexed,-1,3,mg/m2,1,1 h after irinotecan every 21 days,fixed
12187070,NA,691,irinotecan,1,250,mg/m2,1,every 21 days,NA
12187070,NA,691,raltitrexed,1,3,mg/m2,1,1 h after irinotecan every 21 days,fixed
12187070,NA,691,irinotecan,2,300,mg/m2,1,every 21 days,NA
12187070,NA,691,raltitrexed,2,3,mg/m2,1,1 h after irinotecan every 21 days,fixed
12187070,NA,691,irinotecan,3,350,mg/m2,1,every 21 days,NA
12187070,NA,691,raltitrexed,3,3,mg/m2,1,1 h after irinotecan every 21 days,fixed
20176476,NA,692,irinotecan,1,200,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,2,240,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,3,300,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,4,350,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,5,420,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,6,500,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,7,600,mg/m2,1,a 3-week schedule,NA
20176476,NA,692,irinotecan,8,720,mg/m2,1,a 3-week schedule,NA
12453855,NA,693,oxaliplatin,1,85,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,1,85,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,irinotecan,1,150,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,2,85,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,2,85,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,irinotecan,2,175,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,3,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,3,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,irinotecan,3,175,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,4,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,oxaliplatin,4,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,693,irinotecan,4,200,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,oxaliplatin,1,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,oxaliplatin,1,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,irinotecan,1,175,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,leucovorin,1,250,mg/m2,1,"on day 2, every 2 weeks",fixed
12453855,NA,694,5-fluorouracil,1,650,mg/m2,1,"on day 2, every 2 weeks",NA
12453855,NA,694,oxaliplatin,2,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,oxaliplatin,2,110,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,irinotecan,2,175,mg/m2,1,"on day 1, every 2 weeks",NA
12453855,NA,694,leucovorin,2,250,mg/m2,1,"on day 2, every 2 weeks",fixed
12453855,NA,694,5-fluorouracil,2,800,mg/m2,1,"on day 2, every 2 weeks",NA
19402172,NA,695,temozolomide,1,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,1,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,1,60,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 1: EIAED
19402172,NA,695,o6-benzylguanine,1,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,2,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,2,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,2,90,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 1: EIAED
19402172,NA,695,o6-benzylguanine,2,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,3,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,3,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,3,120,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 1: EIAED
19402172,NA,695,o6-benzylguanine,3,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,4,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,4,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,4,150,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 1: EIAED
19402172,NA,695,o6-benzylguanine,4,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,1.5,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,1.5,355,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,1.5,40,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,1.5,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,2.5,267,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,2.5,267,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,2.5,40,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,2.5,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,3.5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,3.5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,3.5,40,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,3.5,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,4.5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,4.5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,4.5,60,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,4.5,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,5,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,5,80,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,5,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19402172,NA,695,temozolomide,6,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,temozolomide,6,200,mg/m2,1,on Day 1 of a 21-day treatment,fixed
19402172,NA,695,irinotecan,6,100,mg/m2,1,on Day 1 of a 21-day treatment,Stratum 2: not receivingEIAED
19402172,NA,695,o6-benzylguanine,6,120/30,mg/m2,1,"on Day 1 of a 21-day treatment, a 1-hour bolus infusion at a dose of 120 mg/m2 followed immediately by a 48-hour continuous infusion at a dose of 30mg/m2/day",fixed
19770383,NA,696,cetuximab,1,75,mg/m2,1,weekly,Pediatric group (A) & Adolescent group (B)
19770383,NA,696,irinotecan,1,20,mg/m2,1,5 consecutive days in weeks 1 and 2 every 21 days,Pediatric group (A) & Adolescent group (B)
19770383,NA,696,cetuximab,2,150,mg/m2,1,weekly,Pediatric group (A) & Adolescent group (B)
19770383,NA,696,irinotecan,2,20,mg/m2,1,5 consecutive days in weeks 1 and 2 every 21 days,Pediatric group (A) & Adolescent group (B)
19770383,NA,696,cetuximab,3,150,mg/m2,1,weekly,Pediatric group (A)
19770383,NA,696,irinotecan,3,16,mg/m2,1,5 consecutive days in weeks 1 and 2 every 21 days,Pediatric group (A)
19770383,NA,696,cetuximab,4,250,mg/m2,1,weekly,Pediatric group (A)
19770383,NA,696,irinotecan,4,16,mg/m2,1,5 consecutive days in weeks 1 and 2 every 21 days,Pediatric group (A)
19770383,NA,696,cetuximab,4.5,250,mg/m2,1,weekly,Adolescent group (B)
19770383,NA,696,irinotecan,4.5,20,mg/m2,1,5 consecutive days in weeks 1 and 2 every 21 days,Adolescent group (B)
15083177,NA,697,irinotecan,1,<300,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,1,200,mg,2,continuously,NA
15083177,NA,697,irinotecan,2,300,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,2,200,mg,2,continuously,NA
15083177,NA,697,irinotecan,3,350,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,3,200,mg,2,continuously,NA
15083177,NA,697,irinotecan,1.5,350,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,1.5,200,mg,2,"on days 1 – 14, and repeated every 21 days",NA
15083177,NA,697,irinotecan,2.5,350,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,2.5,300,mg,2,"on days 1 – 14, and repeated every 21 days",NA
15083177,NA,697,irinotecan,3.5,350,mg/m2,1,every 3 weeks starting on day 1,NA
15083177,NA,697,r115777,3.5,400,mg,2,"on days 1 – 14, and repeated every 21 days",NA
12357298,NA,698,irinotecan,1,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,1,1,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,2,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,2,1.5,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,3,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,3,2,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,4,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,4,2.5,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,5,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,5,3,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,6,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,6,3.5,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,7,125,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,7,3,mg/m2,1,on day 1 of each 21-day cycle,NA
12357298,NA,698,irinotecan,8,75,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,8,3,mg/m2,1,on day 2 of each 21-day cycle,NA
12357298,NA,698,irinotecan,9,100,mg/m2,1,on days 1 and 8 of each 21-day cycle,NA
12357298,NA,698,raltitrexed,9,3,mg/m2,1,on day 2 of each 21-day cycle,NA
12204669,NA,699,paclitaxel,1,120,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,1,40,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
12204669,NA,699,paclitaxel,2,120,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,2,50,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
12204669,NA,699,paclitaxel,3,150,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,3,50,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
12204669,NA,699,paclitaxel,4,180,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,4,50,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
12204669,NA,699,paclitaxel,5,210,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,5,50,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
12204669,NA,699,paclitaxel,6,180,mg/m2,1,on day 1 in a 4-week cycle,NA
12204669,NA,699,irinotecan,6,60,mg/m2,1,"on days 1, 8 and 15, in a 4-week cycle",NA
14760509,NA,700,irinotecan,1,100,mg/m2,1,"on days 1, 8, 15, and 22 of each 42-day cycle",NA
14760509,NA,700,r115777,1,100,mg,2,daily for 28 days of each 42-day cycle,NA
14760509,NA,700,irinotecan,2,100,mg/m2,1,"on days 1, 8, 15, and 22 of each 42-day cycle",NA
14760509,NA,700,r115777,2,200,mg,2,daily for 28 days of each 42-day cycle,NA
12963697,NA,701,irinotecan,-2,75,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,leucovorin,-2,20,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,fluorouracil,-2,320,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,oxaliplatin,-2,50,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,oxaliplatin,-2,50,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,irinotecan,-1,75,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,leucovorin,-1,20,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,fluorouracil,-1,320,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,oxaliplatin,-1,70,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,oxaliplatin,-1,70,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,irinotecan,1,100,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,leucovorin,1,20,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,fluorouracil,1,425,mg/m2,1,"on days 1, 8, 15, and 22 every 6 weeks",weekly schedule
12963697,NA,701,oxaliplatin,1,70,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,oxaliplatin,1,70,mg/m2,1,on days 1 and 15 every 6 weeks,weekly schedule
12963697,NA,701,irinotecan,-2.5,175,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,leucovorin,-2.5,20,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,fluorouracil,-2.5,240,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,-2.5,85,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,-2.5,85,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,irinotecan,-1.5,225,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,leucovorin,-1.5,20,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,fluorouracil,-1.5,240,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,-1.5,85,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,-1.5,85,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,irinotecan,1.5,250,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,leucovorin,1.5,20,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,fluorouracil,1.5,240,mg/m2,1,on days 2-5 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,1.5,110,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
12963697,NA,701,oxaliplatin,1.5,110,mg/m2,1,on day 1 every 3 weeks,3-weekly schedule
17429623,NA,702,ucn-01,1,50,mg/m2,1,on day 1 of a 21-day cycle,Doses of UCN-01 for subsequent cycles were half the starting dose
17429623,NA,702,irinotecan,1,60,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
17429623,NA,702,ucn-01,2,70,mg/m2,1,on day 1 of a 21-day cycle,Doses of UCN-01 for subsequent cycles were half the starting dose
17429623,NA,702,irinotecan,2,60,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
17429623,NA,702,ucn-01,3,90,mg/m2,1,on day 1 of a 21-day cycle,Doses of UCN-01 for subsequent cycles were half the starting dose
17429623,NA,702,irinotecan,3,60,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
17429623,NA,702,ucn-01,4,70,mg/m2,1,on day 1 of a 21-day cycle,Doses of UCN-01 for subsequent cycles were half the starting dose
17429623,NA,702,irinotecan,4,90,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
16832665,NA,703,irinotecan,1,60,mg/m2,1,on days 1 and 8 of each 3-week cycle,fixed
16832665,NA,703,amrubicin,1,25,mg/m2,1,on days 1 to 3 of each 3-week cycle,NA
16832665,NA,703,irinotecan,2,60,mg/m2,1,on days 1 and 8 of each 3-week cycle,fixed
16832665,NA,703,amrubicin,2,30,mg/m2,1,on days 1 to 3 of each 3-week cycle,NA
12912940,NA,704,irinotecan,1,125,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,1,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,2,144,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,2,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,3,189,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,3,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,4,238,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,4,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,5,267,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,5,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,6,296,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,6,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,7,344,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,7,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,8,411,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,8,NA,NA,NA,NA,NA
12912940,NA,704,irinotecan,9,444,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,704,eias,9,NA,NA,NA,NA,NA
12912940,NA,705,irinotecan,1,125,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,705,irinotecan,2,112,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12912940,NA,705,irinotecan,3,117,mg/m2,1,weekly as a 90-min i.v. infusion for four consecutive weeks followed by a 2-week break period,NA
12576438,NA,706,irinotecan,1,40,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",heavily pretreated & less heavily pretreated
12576438,NA,706,cisplatin,1,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",heavily pretreated & less heavily pretreated
12576438,NA,706,cisplatin,1,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",heavily pretreated & less heavily pretreated
12576438,NA,706,irinotecan,2,50,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,706,cisplatin,2,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,706,cisplatin,2,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,706,irinotecan,3,65,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,706,cisplatin,3,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,706,cisplatin,3,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,707,irinotecan,1,65,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,707,cisplatin,1,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,707,cisplatin,1,30,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,707,amifostine,1,825,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
12576438,NA,707,amifostine,1,825,mg/m2,1,"weekly for four consecutive weeks, every 6 weeks",less heavily pretreated
15746053,NA,708,irinotecan,1,70,mg/m2,1,daily for 5 consecutive days and repeated every 3 weeks,NA
15746053,NA,708,irinotecan,2,80,mg/m2,1,daily for 5 consecutive days and repeated every 3 weeks,NA
15592838,NA,709,irinotecan,1,7.5,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,2,10,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,3,12.5,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,4,15,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,5,17.5,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,6,20,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,7,22.5,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,8,30,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,9,35,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
15592838,NA,709,irinotecan,10,40,mg/m2,1,daily for 14 consecutive days followed by 1 week of rest,NA
20213078,NA,710,irinotecan,1,50,mg/m2,1,on day 1  every 3 weeks,NA
20213078,NA,710,irinotecan,2,100,mg/m2,1,on day 1  every 3 weeks,NA
20213078,NA,710,irinotecan,3,150,mg/m2,1,on day 1  every 3 weeks,NA
20213078,NA,710,irinotecan,4,200,mg/m2,1,on day 1  every 3 weeks,NA
20213078,NA,710,irinotecan,5,250,mg/m2,1,on day 1  every 3 weeks,NA
16080470,NA,711,amrubicin,1,35,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,1,60,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,amrubicin,2,35,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,2,80,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,amrubicin,3,40,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,3,80,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,amrubicin,4,40,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,4,100,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,amrubicin,5,45,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,5,100,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,amrubicin,6,50,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
16080470,NA,711,irinotecan,6,100,mg/m2,1,"on days 1 and 8, every 3 weeks",NA
12376204,NA,712,irinotecan,1,40,mg/m2,1,"days 1, 8 and 15 every 28 days for 4 cycles",NA
12376204,NA,712,cisplatin,1,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,cisplatin,1,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,split-course radiotherapy,1,2,Gy,1,"5 days/week with 2 Gy/day from day 2 ofeach chemotherapy cycle, with 20 Gy administered for the first to the third cycles (a total of 60 Gy)",fixed
12376204,NA,712,irinotecan,2,50,mg/m2,1,"days 1, 8 and 15 every 28 days for 4 cycles",NA
12376204,NA,712,cisplatin,2,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,cisplatin,2,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,split-course radiotherapy,2,2,Gy,1,"5 days/week with 2 Gy/day from day 2 ofeach chemotherapy cycle, with 20 Gy administered for the first to the third cycles (a total of 60 Gy)",fixed
12376204,NA,712,irinotecan,3,60,mg/m2,1,"days 1, 8 and 15 every 28 days for 4 cycles",NA
12376204,NA,712,cisplatin,3,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,cisplatin,3,60,mg/m2,1,day 1 every 28 days for 4 cycles,fixed
12376204,NA,712,split-course radiotherapy,3,2,Gy,1,"5 days/week with 2 Gy/day from day 2 ofeach chemotherapy cycle, with 20 Gy administered for the first to the third cycles (a total of 60 Gy)",fixed
20028383,NA,713,irinotecan,1,70,mg/m2,1,"on days1, 15, 29, 43, 57 and 71",Patients with the 6⁄6 or 6⁄7 genotype
20028383,NA,713,doxifluridine,1,5776,mg/m2,2,on five consecutive days followed by a 2-day washout during the 12-week treatment period,fixed
20028383,NA,713,irinotecan,2,100,mg/m2,1,"on days1, 15, 29, 43, 57 and 71",Patients with the 6⁄6 or 6⁄7 genotype
20028383,NA,713,doxifluridine,2,5776,mg/m2,2,on five consecutive days followed by a 2-day washout during the 12-week treatment period,fixed
20028383,NA,713,irinotecan,3,120,mg/m2,1,"on days1, 15, 29, 43, 57 and 71",Patients with the 6⁄6 genotype
20028383,NA,713,doxifluridine,3,5776,mg/m2,2,on five consecutive days followed by a 2-day washout during the 12-week treatment period,fixed
20028383,NA,713,irinotecan,4,150,mg/m2,1,"on days1, 15, 29, 43, 57 and 71",Patients with the 6⁄6 genotype
20028383,NA,713,doxifluridine,4,5776,mg/m2,2,on five consecutive days followed by a 2-day washout during the 12-week treatment period,fixed
16001174,NA,714,irinotecan,-3,9,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-3,60+-10,ng*h/ml,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-3,60+-10,ng*h/ml,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,-2,9,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-2,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-2,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,-1,12,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-1,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,-1,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,1,16,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,1,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,1,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,2,20,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,2,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,2,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,3,24,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,3,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,3,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,irinotecan,4,29,mg/m2,1,"followed by topotecan over 30 min daily for 5 days for two consecutive weeks, Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,4,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
16001174,NA,714,topotecan,4,2.5,mg/m2,1,"daily for five consecutive days, followed by a 2-day rest, and an additional five consecutive day course [(qd x 5) x 2], Treatment courses were repeated at 28-day intervals",NA
17717667,NA,715,vinorelbine,1,15,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17717667,NA,715,irinotecan,1,40,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
17717667,NA,715,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17717667,NA,715,irinotecan,2,40,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
17717667,NA,715,vinorelbine,3,20,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17717667,NA,715,irinotecan,3,50,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
17717667,NA,715,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 4 weeks,NA
17717667,NA,715,irinotecan,4,50,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
17717667,NA,715,vinorelbine,4.5,20,mg/m2,1,on days 1 and 8 every 4 weeks,Modified level 4
17717667,NA,715,irinotecan,4.5,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",Modified level 4
12885811,NA,716,irinotecan,1,65,mg/m2,1,weekly for four treatments during weeks 1 to 5,fixed
12885811,NA,716,cisplatin,1,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,cisplatin,1,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,irinotecan,1,40,mg/m2,1,"on days 1, 8, 22, and 29 of radiotherapy",NA
12885811,NA,716,radiotherapy,1,1.8,Gy,1,weeks 8 to 13 in daily fractions to a dose of 50.4 Gy,fixed
12885811,NA,716,irinotecan,2,65,mg/m2,1,weekly for four treatments during weeks 1 to 5,fixed
12885811,NA,716,cisplatin,2,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,cisplatin,2,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,irinotecan,2,50,mg/m2,1,"on days 1, 8, 22, and 29 of radiotherapy",NA
12885811,NA,716,radiotherapy,2,1.8,Gy,1,weeks 8 to 13 in daily fractions to a dose of 50.4 Gy,fixed
12885811,NA,716,irinotecan,3,65,mg/m2,1,weekly for four treatments during weeks 1 to 5,fixed
12885811,NA,716,cisplatin,3,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,cisplatin,3,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,irinotecan,3,65,mg/m2,1,"on days 1, 8, 22, and 29 of radiotherapy",NA
12885811,NA,716,radiotherapy,3,1.8,Gy,1,weeks 8 to 13 in daily fractions to a dose of 50.4 Gy,fixed
12885811,NA,716,irinotecan,4,65,mg/m2,1,weekly for four treatments during weeks 1 to 5,fixed
12885811,NA,716,cisplatin,4,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,cisplatin,4,30,mg/m2,1,"weekly for four treatments during weeks 1 to 5, then on days 1, 8, 22, and 29 of radiotherapy",fixed
12885811,NA,716,irinotecan,4,80,mg/m2,1,"on days 1, 8, 22, and 29 of radiotherapy",NA
12885811,NA,716,radiotherapy,4,1.8,Gy,1,weeks 8 to 13 in daily fractions to a dose of 50.4 Gy,fixed
16088964,NA,717,irinotecan,1,40,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,1,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,1,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,2,60,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,2,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,2,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,3,80,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,3,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,3,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,4,100,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,4,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,4,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,5,125,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,5,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,5,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,6,150,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum A & B
16088964,NA,717,temozolomide,6,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,6,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,7,175,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,7,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,7,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,8,200,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,8,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,8,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,9,225,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,9,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,9,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,10,275,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,10,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,10,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,11,325,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,11,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,11,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,irinotecan,12,375,mg/m2,1,"during Weeks 1, 2, 4, and 5 of each6-week treatment cycle",Stratum B
16088964,NA,717,temozolomide,12,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
16088964,NA,717,temozolomide,12,200,mg/m2,1,"on Days 1–5 during Weeks 1, 2, 4, and 5 of each 6-week cycle",fixed
19171709,NA,718,irinotecan,1,30,mg/m2,1,on days 1 through 5 and 8 through 12 of each 3-week course,NA
19171709,NA,718,temozolomide,1,100,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,temozolomide,1,100,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,cefixime,1,8,mg/kg,1,started 5 days before chemotherapy and continued daily,fixed
19171709,NA,718,irinotecan,1.5,30,mg/m2,1,on days 1 through 5 and 8 through 12 of each 3-week course,NA
19171709,NA,718,temozolomide,1.5,75,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,temozolomide,1.5,75,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,cefixime,1.5,8,mg/kg,1,started 5 days before chemotherapy and continued daily,fixed
19171709,NA,718,irinotecan,2,60,mg/m2,1,on days 1 through 5 and 8 through 12 of each 3-week course,NA
19171709,NA,718,temozolomide,2,75,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,temozolomide,2,75,mg/m2,1,on days 1 through 5 of each 3-week course and given at least 1 hour before irinotecan,NA
19171709,NA,718,cefixime,2,8,mg/kg,1,started 5 days before chemotherapy and continued daily,fixed
14871959,NA,719,irinotecan,1,10,mg/m2,1,daily for 5 days for 2 consecutive weeks of each 28-day cycles,NA
14871959,NA,719,temozolomide,1,100,mg/m2,1,daily for the first 5 days of each 28-day cycle,NA
14871959,NA,719,temozolomide,1,100,mg/m2,1,daily for the first 5 days of each 28-day cycle,NA
14871959,NA,719,irinotecan,2,15,mg/m2,1,daily for 5 days for 2 consecutive weeks of each 28-day cycles,NA
14871959,NA,719,temozolomide,2,100,mg/m2,1,daily for the first 5 days of each 28-day cycle,NA
14871959,NA,719,temozolomide,2,100,mg/m2,1,daily for the first 5 days of each 28-day cycle,NA
20049936,NA,720,irinotecan,1,35,mg/m2,1,on days 1–5 and 8–12 in 21-day courses,Schedule A
20049936,NA,720,temozolomide,1,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule A
20049936,NA,720,temozolomide,1,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule A
20049936,NA,720,vincristine,1,1.5,mg/m2,2,on days 1 and 8 in 21-day courses,Schedule A
20049936,NA,720,irinotecan,2,50,mg/m2,1,on days 1–5 and 8–12 in 21-day courses,Schedule A
20049936,NA,720,temozolomide,2,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule A
20049936,NA,720,temozolomide,2,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule A
20049936,NA,720,vincristine,2,1.5,mg/m2,2,on days 1 and 8 in 21-day courses,Schedule A
20049936,NA,720,irinotecan,3,70,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,3,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,3,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,vincristine,3,1.5,mg/m2,1,on days 1 and 8 in 21-day courses,Schedule B
20049936,NA,720,irinotecan,4,90,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,4,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,4,100,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,vincristine,4,1.5,mg/m2,1,on day 1 in 21-day courses,Schedule B
20049936,NA,720,irinotecan,5,90,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,5,125,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,5,125,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,vincristine,6,1.5,mg/m2,1,on day 1 in 21-day courses,Schedule B
20049936,NA,720,irinotecan,6,90,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,6,150,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,temozolomide,6,150,mg/m2,1,on days 1–5 in 21-day courses,Schedule B
20049936,NA,720,vincristine,5,1.5,mg/m2,1,on day 1 in 21-day courses,Schedule B
18956138,NA,721,paclitaxel,1,40,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",NA
18956138,NA,721,cisplatin,1,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,cisplatin,1,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,irinotecan,1,50,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,paclitaxel,2,50,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",NA
18956138,NA,721,cisplatin,2,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,cisplatin,2,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,irinotecan,2,50,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,paclitaxel,3,65,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",NA
18956138,NA,721,cisplatin,3,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,cisplatin,3,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,irinotecan,3,50,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,paclitaxel,4,80,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",NA
18956138,NA,721,cisplatin,4,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,cisplatin,4,30,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
18956138,NA,721,irinotecan,4,50,mg/m2,1,"once a week, in 6-week cycles (4 weeks on, 2 weeks off)",fixed
11843251,NA,722,irinotecan,1,100,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,mitomycin-c,1,5,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,irinotecan,2,125,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,mitomycin-c,2,5,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,irinotecan,3,150,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,mitomycin-c,3,5,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,irinotecan,4,150,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,mitomycin-c,4,7,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,irinotecan,5,150,mg/m2,1,On day I and day 15 every two weeks,NA
11843251,NA,722,mitomycin-c,5,10,mg/m2,1,On day I and day 15 every two weeks,NA
12750839,NA,723,irinotecan,1,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,1,50,mg/m2,1,on day 1  every 3 weeks,NA
12750839,NA,723,irinotecan,2,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,2,60,mg/m2,1,on day 1  every 3 weeks,NA
12750839,NA,723,irinotecan,3,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,3,70,mg/m2,1,on day 1  every 3 weeks,NA
12750839,NA,723,irinotecan,4,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,4,80,mg/m2,1,on day 1  every 3 weeks,NA
12750839,NA,723,irinotecan,5,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,5,90,mg/m2,1,on day 1  every 3 weeks,NA
12750839,NA,723,irinotecan,6,60,mg/m2,1,on days 1 and 8  every 3 weeks,fixed
12750839,NA,723,nedaplatin,6,100,mg/m2,1,on day 1  every 3 weeks,NA
12947066,NA,724,floxuridine,1,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,NA
12947066,NA,724,dexamethasone,1,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,1,60,mg/m2,1,"on days 1, 8 and 15 of a 4-week cycle",NA
12947066,NA,724,floxuridine,2,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,NA
12947066,NA,724,dexamethasone,2,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,2,80,mg/m2,1,"on days 1, 8 and 15 of a 4-week cycle",NA
12947066,NA,724,floxuridine,3,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,NA
12947066,NA,724,dexamethasone,3,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,3,100,mg/m2,1,"on days 1, 8 and 15 of a 4-week cycle",NA
12947066,NA,724,floxuridine,4,0.14,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,NA
12947066,NA,724,dexamethasone,4,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,4,100,mg/m2,1,"on days 1, 8 and 15 of a 4-week cycle",NA
12947066,NA,724,floxuridine,5,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,dexamethasone,5,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,5,150,mg/m2,1,every other week of a 4-week cycle,NA
12947066,NA,724,floxuridine,6,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,dexamethasone,6,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,6,200,mg/m2,1,every other week of a 4-week cycle,NA
12947066,NA,724,floxuridine,7,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,dexamethasone,7,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,7,225,mg/m2,1,every other week of a 4-week cycle,NA
12947066,NA,724,floxuridine,8,0.12,mg/kg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,dexamethasone,8,1,mg × pump volume ÷ by pump flow rate,1,started on day 1 for 14 days of each 4-week cycle,fixed
12947066,NA,724,irinotecan,8,250,mg/m2,1,every other week of a 4-week cycle,NA
20127092,NA,725,irinotecan,1,150,mg/m2,1,on day 1 of a 21-day cycle,NA
20127092,NA,725,3-ap,1,85,mg/m2,1,on days 1–3 of a 21-day cycle,NA
20127092,NA,725,irinotecan,2,150,mg/m2,1,on day 1 of a 21-day cycle,NA
20127092,NA,725,3-ap,2,60,mg/m2,1,on days 1–3 of a 21-day cycle,NA
20127092,NA,725,irinotecan,3,200,mg/m2,1,on day 1 of a 21-day cycle,NA
20127092,NA,725,3-ap,3,60,mg/m2,1,on days 1–3 of a 21-day cycle,NA
20127092,NA,725,irinotecan,4,250,mg/m2,1,on day 1 of a 21-day cycle,NA
20127092,NA,725,3-ap,4,60,mg/m2,1,on days 1–3 of a 21-day cycle,NA
20127092,NA,725,irinotecan,-1,100,mg/m2,1,on day 1 of a 21-day cycle,NA
20127092,NA,725,3-ap,-1,60,mg/m2,1,on days 1–3 of a 21-day cycle,NA
24252402,NCT00963547,726,trastuzumab,1,6-Aug,mg/kg,1,8 mg/kg on day 1 followed by 6 mg/kg every 3 weeks,NA
24252402,NCT00963547,726,mk-2206,1,45,mg,1,every other day (QOD),NA
24252402,NCT00963547,726,trastuzumab,2,6-Aug,mg/kg,1,8 mg/kg on day 1 followed by 6 mg/kg every 3 weeks,NA
24252402,NCT00963547,726,mk-2206,2,60,mg,1,every other day (QOD),NA
24252402,NCT00963547,726,trastuzumab,3,6-Aug,mg/kg,1,8 mg/kg on day 1 followed by 6 mg/kg every 3 weeks,NA
24252402,NCT00963547,726,mk-2206,3,135,mg,1,once weekly (QW),NA
24252402,NCT00963547,726,trastuzumab,4,6-Aug,mg/kg,1,8 mg/kg on day 1 followed by 6 mg/kg every 3 weeks,NA
24252402,NCT00963547,726,mk-2206,4,200,mg,1,once weekly (QW),NA
25641763,NA,727,lapatinib,1,750,mg,1,daily in 3-week cycles,NA
25641763,NA,727,cetuximab,1,400/250,mg/m2,1,400 mg/m2 on day 1 and 250 mg/m2 weekly thereafter,NA
25641763,NA,727,lapatinib,2,1000,mg,1,daily in 3-week cycles,NA
25641763,NA,727,cetuximab,2,400/250,mg/m2,1,400 mg/m2 on day 1 and 250 mg/m2 weekly thereafter,NA
25641763,NA,727,lapatinib,3,1250,mg,1,daily in 3-week cycles,NA
25641763,NA,727,cetuximab,3,400/250,mg/m2,1,400 mg/m2 on day 1 and 250 mg/m2 weekly thereafter,NA
26210681,NA,728,pazopanib,1,200,mg,1,every other day starting on day 1 with cycles repeated every 28 days,NA
26210681,NA,728,lapatinib,1,500,mg,1,daily,NA
26210681,NA,728,pazopanib,2,400,mg,1,every other day starting on day 1 with cycles repeated every 28 days,NA
26210681,NA,728,lapatinib,2,750,mg,1,daily,NA
11205914,NA,729,irinotecan,1,30,mg/m2,1,"daily for 5 days, every 21 days",NA
11205914,NA,729,irinotecan,2,39,mg/m2,1,"daily for 5 days, every 21 days",NA
11205914,NA,729,irinotecan,3,50,mg/m2,1,"daily for 5 days, every 21 days",NA
11205914,NA,729,irinotecan,4,65,mg/m2,1,"daily for 5 days, every 21 days",NA
24197661,NA,730,trastuzumab,1,2-Apr,mg/m2,1,"Four weeks after starting protocol therapy, 4 mg/kg loading dose then 2 mg/kg IV onceweekly",NA
24197661,NA,730,lapatinib,1,750,mg,2,On day 1,loading dose
24197661,NA,730,lapatinib,1,1000,mg,1,starting on day 2,NA
24197661,NA,730,whole brain radiotherapy,1,2.5,Gy,1,began between 1 and 8 days after the first dose of lapatinib and was delivered for a total of 15 fractions over 3 weeks,NA
24197661,NA,730,trastuzumab,2,2-Apr,mg/m2,1,"Four weeks after starting protocol therapy, 4 mg/kg loading dose then 2 mg/kg IV onceweekly",NA
24197661,NA,730,lapatinib,2,750,mg,2,On day 1,loading dose
24197661,NA,730,lapatinib,2,1250,mg,1,starting on day 2,NA
24197661,NA,730,whole brain radiotherapy,2,2.5,Gy,1,began between 1 and 8 days after the first dose of lapatinib and was delivered for a total of 15 fractions over 3 weeks,NA
24197661,NA,730,trastuzumab,3,2-Apr,mg/m2,1,"Four weeks after starting protocol therapy, 4 mg/kg loading dose then 2 mg/kg IV onceweekly",NA
24197661,NA,730,lapatinib,3,750,mg,2,On day 1,loading dose
24197661,NA,730,lapatinib,3,1500,mg,1,starting on day 2,NA
24197661,NA,730,whole brain radiotherapy,3,2.5,Gy,1,began between 1 and 8 days after the first dose of lapatinib and was delivered for a total of 15 fractions over 3 weeks,NA
23292205,ACTRN12611000418976,731,temozolomide,1,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,temozolomide,1,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,lapatinib,1,1000,mg,1,daily continuously,NA
23292205,ACTRN12611000418976,731,temozolomide,2,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,temozolomide,2,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,lapatinib,2,1250,mg,1,daily continuously,NA
23292205,ACTRN12611000418976,731,temozolomide,3,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,temozolomide,3,200,mg/m2,1,d1–d5 every 28 days,fixed
23292205,ACTRN12611000418976,731,lapatinib,3,1500,mg,1,daily continuously,NA
12440223,NA,732,depsipeptide,1,1,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,1,1,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,2,2,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,2,2,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,3,3.25,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,3,3.25,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,4,5,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,4,5,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,5,7.5,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,5,7.5,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,6,10,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,6,10,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,6.5,10,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,6.5,10,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,7,13.3,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,7,13.3,mg/m2,1,weekly x 3 with one week rest,NA
12440223,NA,732,depsipeptide,7.5,13.3,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,7.5,13.3,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,8,17.7,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,8,17.7,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,9,23.5,mg/m2,1,weekly x 3 with one week rest,after amendment
12440223,NA,732,depsipeptide,9,23.5,mg/m2,1,weekly x 3 with one week rest,after amendment
29315394,NCT00912275,733,vinorelbine,0,30,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
29315394,NCT00912275,733,lapatinib,0,1000,mg,1,daily/21-day cycle,NA
29315394,NCT00912275,733,vinorelbine,1,40,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
29315394,NCT00912275,733,lapatinib,1,1000,mg,1,daily/21-day cycle,NA
29315394,NCT00912275,733,vinorelbine,2,50,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
29315394,NCT00912275,733,lapatinib,2,1000,mg,1,daily/21-day cycle,NA
29315394,NCT00912275,733,vinorelbine,3,60,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
29315394,NCT00912275,733,lapatinib,3,1000,mg,1,daily/21-day cycle,NA
29315394,NCT00912275,733,vinorelbine,4,60,mg/m2,1,on Days 1 and 8 of a 21-day cycle,NA
29315394,NCT00912275,733,lapatinib,4,1250,mg,1,daily/21-day cycle,NA
31097774, NCT01434303,734,entinostat,1,5,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,1,1250,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,1,0,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,2,8,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,2,1250,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,2,0,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,3,10,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,3,1250,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,3,0,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,4,12,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,4,1250,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,4,0,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,5,15,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,5,1250,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,5,0,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,6,12,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,6,1000,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,6,8 mg/m2 initial loading dose with subsequent doses of 6 mg/m2,mg/kg,1,every 3 weeks,NA
31097774, NCT01434303,734,entinostat,7,15,mg,1,on days 1 and 15 with 28 days as one cycle,NA
31097774, NCT01434303,734,lapatinib,7,1000,mg,1,daily with 28 days as one cycle,NA
31097774, NCT01434303,734,trastuzumab,7,8 mg/m2 initial loading dose with subsequent doses of 6 mg/m2,mg/kg,1,every 3 weeks,NA
28464908,NA,735,foretinib,1,30,mg,1,daily in 4-week cycles,NA
28464908,NA,735,lapatinib,1,750,mg,1,daily in 4-week cycles,NA
28464908,NA,735,foretinib,2,30,mg,1,daily in 4-week cycles,NA
28464908,NA,735,lapatinib,2,1000,mg,1,daily in 4-week cycles,NA
28464908,NA,735,foretinib,3,45,mg,1,daily in 4-week cycles,NA
28464908,NA,735,lapatinib,3,1000,mg,1,daily in 4-week cycles,NA
28464908,NA,735,foretinib,4,45,mg,1,daily in 4-week cycles,NA
28464908,NA,735,lapatinib,4,1250,mg,1,daily in 4-week cycles,NA
23632474,NCT00445458,736,neratinib,1,160,mg,1,daily,NA
23632474,NCT00445458,736,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
23632474,NCT00445458,736,neratinib,2,240,mg,1,daily,NA
23632474,NCT00445458,736,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 of each 28-day cycle",NA
10509152,NA,737,irinotecan,1,150,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,1,600,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,1,250,mg/m2,1,on day 2 every two weeks,fixed
10509152,NA,737,irinotecan,2,150,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,2,750,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,2,250,mg/m2,1,on day 2 every two weeks,fixed
10509152,NA,737,irinotecan,3,175,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,3,750,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,3,250,mg/m2,1,on day 2 every two weeks,fixed
10509152,NA,737,irinotecan,4,175,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,4,950,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,4,250,mg/m2,1,on day 2 every two weeks,fixed
10509152,NA,737,irinotecan,5,210,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,5,950,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,5,250,mg/m2,1,on day 2 every two weeks,fixed
10509152,NA,737,irinotecan,6,200,mg/m2,1,on day 1 every two weeks,NA
10509152,NA,737,5-fluorouracil,6,850,mg/m2,1,on day 2 every two weeks,NA
10509152,NA,737,levo-folinic acid,6,250,mg/m2,1,on day 2 every two weeks,fixed
10561220,NA,738,irinotecan,1,20,mg/m2/d,1,(qd x 5) x 2 every 21 days,NA
10561220,NA,738,irinotecan,2,24,mg/m2/d,1,(qd x 5) x 2 every 21 days,NA
10561220,NA,738,irinotecan,3,29,mg/m2/d,1,(qd x 5) x 2 every 21 days,NA
24097864,NA,739,pertuzumab,1,840,mg,1,"every 3 weeks, Cycle 1, 840 mg; 420 mg all subsequent cycles.",NA
24097864,NA,739,trastuzumab emtansine,1,3,mg/kg,1,every 3 weeks,NA
24097864,NA,739,pertuzumab,2,840,mg,1,"every 3 weeks, Cycle 1, 840 mg; 420 mg all subsequent cycles.",NA
24097864,NA,739,trastuzumab emtansine,2,3.6,mg/kg,1,every 3 weeks,NA
24097864,NA,739,pertuzumab,-1,840,mg,1,"every 3 weeks, Cycle 1, 840 mg; 420 mg all subsequent cycles.",NA
24097864,NA,739,trastuzumab emtansine,-1,2.4,mg/kg,1,every 3 weeks,NA
10963644,NA,740,dx-8951f,1,0.1,mg/m2,1,daily for 5 days every 3 weeks,NA
10963644,NA,740,dx-8951f,2,0.2,mg/m2,1,daily for 5 days every 3 weeks,NA
10963644,NA,740,dx-8951f,3,0.4,mg/m2,1,daily for 5 days every 3 weeks,NA
10963644,NA,740,dx-8951f,4,0.6,mg/m2,1,daily for 5 days every 3 weeks,NA
10963644,NA,740,dx-8951f,5,0.5,mg/m2,1,daily for 5 days every 3 weeks,NA
10963644,NA,740,dx-8951f,6,0.3,mg/m2,1,daily for 5 days every 3 weeks,NA
9619758,NA,741,irinotecan,1,60,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",fixed
9619758,NA,741,cisplatin,1,27,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
9619758,NA,741,cisplatin,1,27,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
9619758,NA,741,irinotecan,2,60,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",fixed
9619758,NA,741,cisplatin,2,33,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
9619758,NA,741,cisplatin,2,33,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
9619758,NA,741,irinotecan,3,60,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",fixed
9619758,NA,741,cisplatin,3,40,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
9619758,NA,741,cisplatin,3,40,mg/m2,1,"on days 1, 8 and 15 over 4 weeks",NA
11241238,NA,742,irinotecan,1,175,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,1,900,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,1,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11241238,NA,742,irinotecan,2,175,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,2,700,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,2,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11241238,NA,742,irinotecan,3,225,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,3,700,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,3,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11241238,NA,742,irinotecan,4,275,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,4,700,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,4,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11241238,NA,742,irinotecan,5,325,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,5,700,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,5,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11241238,NA,742,irinotecan,6,250,mg/m2,1,on Day 1 every 3 weeks,NA
11241238,NA,742,5-fluorouracil,6,700,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,NA
11241238,NA,742,folinic acid,6,150,mg/m2,1,peak delivery rate at 04:00 for 5 days every 3 weeks,fixed
11244327,NA,743,irinotecan,1,150,mg/m2,1,on days 1 and 8 in a monthly cycle,NA
11244327,NA,743,mitomycin c,1,8,mg/m2,1,on day 1 in a monthly cycle,NA
11244327,NA,743,irinotecan,2,175,mg/m2,1,on days 1 and 8 in a monthly cycle,NA
11244327,NA,743,mitomycin c,2,8,mg/m2,1,on day 1 in a monthly cycle,NA
11244327,NA,743,irinotecan,3,175,mg/m2,1,on days 1 and 8 in a monthly cycle,NA
11244327,NA,743,mitomycin c,3,10,mg/m2,1,on day 1 in a monthly cycle,NA
11244327,NA,743,irinotecan,4,200,mg/m2,1,on days 1 and 8 in a monthly cycle,NA
11244327,NA,743,mitomycin c,4,10,mg/m2,1,on day 1 in a monthly cycle,NA
31471376,NCT01998035,744,5-azacytidine,1,100,mg,1,days 1-14 every 21 days,NA
31471376,NCT01998035,744,romidepsin,1,10,mg/m2,1,days 8 and 15 every 21 days,NA
31471376,NCT01998035,744,5-azacytidine,2,200,mg,1,days 1-14 every 21 days,NA
31471376,NCT01998035,744,romidepsin,2,10,mg/m2,1,days 8 and 15 every 21 days,NA
31471376,NCT01998035,744,5-azacytidine,3,200,mg,1,days 1-14 every 28 days,NA
31471376,NCT01998035,744,romidepsin,3,10,mg/m2,1,days 8 and 15 every 28 days,NA
31471376,NCT01998035,744,5-azacytidine,4,300,mg,1,days 1-14 every 28 days,NA
31471376,NCT01998035,744,romidepsin,4,10,mg/m2,1,days 8 and 15 every 28 days,NA
31471376,NCT01998035,744,5-azacytidine,5,300,mg,1,days 1-14 every 28 days,NA
31471376,NCT01998035,744,romidepsin,5,14,mg/m2,1,days 8 and 15 every 28 days,NA
31471376,NCT01998035,744,5-azacytidine,6,300,mg,1,days 1-14 every 35 days,NA
31471376,NCT01998035,744,romidepsin,6,14,mg/m2,1,"days 8, 15 and 22 every 35 days",NA
31471376,NCT01998035,744,5-azacytidine,7,200,mg,1,days 1-21 every 21 days,NA
31471376,NCT01998035,744,romidepsin,7,10,mg/m2,1,"days 8, 15 and 22 every 35 days",NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,1,100,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,2,200,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,3,400,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,4,800,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,5,1200,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
25434923,EudraCT Number: 2009-017817-3,745,s-222611,6,1600,mg,1,a single dose on Day 1 with continuous daily dosing from Day 8 in 28-day cycles,NA
7786821,NA,746,irinotecan,1,33,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,2,50,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,3,66,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,4,75,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,5,85,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,6,90,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,7,100,mg/m2,1,daily for three consecutive days every three weeks,NA
7786821,NA,746,irinotecan,8,115,mg/m2,1,daily for three consecutive days every three weeks,NA
32816943,NCT01638533,747,romidepsin,1,14,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Normal function
(cohort A) & Mild dysfunction (cohort B)"
32816943,NCT01638533,747,romidepsin,-1,10,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",Mild dysfunction (cohort B)
32816943,NCT01638533,747,romidepsin,-1,5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Moderate dysfunction
(cohort C)"
32816943,NCT01638533,747,romidepsin,1,7,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Moderate dysfunction
(cohort C)"
32816943,NCT01638533,747,romidepsin,2,10,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Moderate dysfunction
(cohort C)"
32816943,NCT01638533,747,romidepsin,3,14,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Moderate dysfunction
(cohort C)"
32816943,NCT01638533,747,romidepsin,-1,3.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Severe dysfunction
(cohort D)"
32816943,NCT01638533,747,romidepsin,1,5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Severe dysfunction
(cohort D)"
32816943,NCT01638533,747,romidepsin,2,7,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Severe dysfunction
(cohort D)"
32816943,NCT01638533,747,romidepsin,3,10,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Severe dysfunction
(cohort D)"
32816943,NCT01638533,747,romidepsin,4,14,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle","Severe dysfunction
(cohort D)"
10080615,NA,748,irinotecan,1,20,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients 65 or older & in patients younger than 65 years of age
10080615,NA,748,irinotecan,2,40,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients 65 or older & in patients younger than 65 years of age
10080615,NA,748,irinotecan,3,50,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients 65 or older
10080615,NA,748,irinotecan,4,66,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients 65 or older & in patients younger than 65 years of age
10080615,NA,748,irinotecan,5,80,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients younger than 65 years of age
10080615,NA,748,irinotecan,6,100,mg/m2,1,Daily for 5 Days Every 3 Weeks,in patients 65 or older & in patients younger than 65 years of age
8229134,NA,749,irinotecan,1,50,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8229134,NA,749,irinotecan,2,80,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8229134,NA,749,irinotecan,3,100,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8229134,NA,749,irinotecan,4,125,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8229134,NA,749,irinotecan,5,150,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8229134,NA,749,irinotecan,6,180,mg/m2,1,every week for 4 consecutive weeks followed by a 2-week rest period.,NA
8918493,NA,750,irinotecan,1,100,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,1,210,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,1,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,2,100,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,2,265,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,2,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,3,100,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,3,340,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,3,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,4,100,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,4,425,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,4,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,5,100,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,5,500,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,5,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,6,125,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,6,500,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,6,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
8918493,NA,750,irinotecan,7,150,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,fluorouracil,7,500,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,NA
8918493,NA,750,leucovorin,7,20,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment with all three drugs for 4 consecutive weeks followed by a 2-week break.,fixed
9850031,NA,751,cisplatin,1,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,cisplatin,1,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,irinotecan,1,50,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,NA
9850031,NA,751,cisplatin,2,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,cisplatin,2,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,irinotecan,2,65,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,NA
9850031,NA,751,cisplatin,3,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,cisplatin,3,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,irinotecan,3,85,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,NA
9850031,NA,751,cisplatin,4,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,cisplatin,4,30,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,fixed
9850031,NA,751,irinotecan,4,50,mg/m2,1,administered in repeated 6-week cycles that consisted of weekly treatment for 4 weeks followed by a 2-week rest,NA
11474256,NA,752,irinotecan,1,50,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,1,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,1,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,1.5,50,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,1.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,1.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,2,75,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,2,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,2,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,2.5,75,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,2.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,2.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,3,100,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,3,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,3,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,3.5,100,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,3.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,3.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,4,125,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,4,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,4,1,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,irinotecan,4.5,125,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,4.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
11474256,NA,752,topotecan,4.5,1.5,mg/m2,1,on a weekly schedule for 4 weeks followed by a week off and cycles were repeated at day 35,NA
24711549,NCT00544804,753,lapatinib,1,1750,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,2,2250,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,3,3000,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,4,4000,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,5,5250,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,6,7000,mg,2,on days 1 through 5 of repeating 14-day cycles,NA
24711549,NCT00544804,753,lapatinib,7,3000,mg,2,on days 1 through 5 of repeating 14-day cycles,"Protocol amendment, adaptive design"
24711549,NCT00544804,753,lapatinib,8,3000,mg,2,on days 1 through 5 of repeating 14-day cycles,"Protocol amendment, adaptive design with ketoconazole"
24711549,NCT00544804,753,lapatinib,9,3000,mg,4,on days 1 through 5 of repeating 14-day cycles,"Protocol amendment, adaptive design with ketoconazole"
24711549,NCT00544804,753,lapatinib,10,3000,mg,2,on days 1 through 5 of repeating 14-day cycles,"Protocol amendment, adaptive design with ketoconazole"
10873073,NA,754,irinotecan,1,240,mg/m2,1,every 3 weeks,NA
10873073,NA,754,irinotecan,2,290,mg/m2,1,every 3 weeks,NA
10873073,NA,754,irinotecan,3,320,mg/m2,1,every 3 weeks,NA
10873073,NA,754,irinotecan,4,340,mg/m2,1,every 3 weeks,NA
10071283,NA,755,irinotecan,1,80,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,1,500,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,1,1800,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,2,80,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,2,500,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,2,2000,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,3,80,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,3,500,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,3,2300,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,4,80,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,4,500,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,4,2600,mg/m2,1,"once a week for 4 consecutive weeks,   followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,5,80,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,5,500,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,5,2300,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,6,80,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,6,500,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,6,2600,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,irinotecan,7,100,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,leucovorin,7,500,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
10071283,NA,755,fluorouracil,7,2600,mg/m2,1,"once a week for 6 consecutive weeks, followed by a 1-week rest period (onecycle",NA
27026198,NA,756,lapatinib,1,1000,mg,1,daily,NA
27026198,NA,756,mk-2206,1,30,mg,1,"every other day in 28-day cycles except cycle 1 (35 days, including an initial 8 days of MK-2206) alone",NA
27026198,NA,756,lapatinib,2,1500,mg,1,daily,NA
27026198,NA,756,mk-2206,2,30,mg,1,"every other day in 28-day cycles except cycle 1 (35 days, including an initial 8 days of MK-2206) alone",NA
27026198,NA,756,lapatinib,3,1500,mg,1,daily,NA
27026198,NA,756,mk-2206,3,45,mg,1,"every other day in 28-day cycles except cycle 1 (35 days, including an initial 8 days of MK-2206) alone",NA
27026198,NA,756,lapatinib,4,1500,mg,1,daily,NA
27026198,NA,756,mk-2206,4,60,mg,1,"every other day in 28-day cycles except cycle 1 (35 days, including an initial 8 days of MK-2206) alone",NA
11352961,NA,757,irinotecan,1,60,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,1,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,1,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,irinotecan,2,80,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,2,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,2,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,irinotecan,3,100,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,3,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,fudr,3,0.12,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Cryosurgery arm & Noncryosurgery arm
11352961,NA,757,irinotecan,4,100,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Noncryosurgery arm
11352961,NA,757,fudr,4,0.14,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11352961,NA,757,fudr,4,0.14,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11352961,NA,757,irinotecan,5,100,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Noncryosurgery arm
11352961,NA,757,fudr,5,0.16,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11352961,NA,757,fudr,5,0.16,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11352961,NA,757,irinotecan,6,125,mg/m2,1,once a week for 3 weeks followed by a 1-week rest,Noncryosurgery arm
11352961,NA,757,fudr,6,0.14,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11352961,NA,757,fudr,6,0.14,mg/kg/d,1,"administered continuously over the first 2 weeks of every cycle, followed by 2 weeks of rest",Noncryosurgery arm
11435065,NA,758,irinotecan,1,40,mg/m2,1,"days 1, 8 and 15 repeated with a 28-day interval",NA
11435065,NA,758,cisplatin,1,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,cisplatin,1,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,thoracic radiation,1,2,Gy,1,"started on day 2 of each chemotherapy cycle, with 24 Gy and 36 Gy administered for the first and second cycle, respectively",fixed
11435065,NA,758,irinotecan,2,50,mg/m2,1,"days 1, 8 and 15 repeated with a 28-day interval",NA
11435065,NA,758,cisplatin,2,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,cisplatin,2,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,thoracic radiation,2,2,Gy,1,"started on day 2 of each chemotherapy cycle, with 24 Gy and 36 Gy administered for the first and second cycle, respectively",fixed
11435065,NA,758,irinotecan,3,60,mg/m2,1,"days 1, 8 and 15 repeated with a 28-day interval",NA
11435065,NA,758,cisplatin,3,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,cisplatin,3,60,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,thoracic radiation,3,2,Gy,1,"started on day 2 of each chemotherapy cycle, with 24 Gy and 36 Gy administered for the first and second cycle, respectively",fixed
11435065,NA,758,irinotecan,4,60,mg/m2,1,"days 1, 8 and 15 repeated with a 28-day interval",NA
11435065,NA,758,cisplatin,4,70,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,cisplatin,4,70,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,thoracic radiation,4,2,Gy,1,"started on day 2 of each chemotherapy cycle, with 24 Gy and 36 Gy administered for the first and second cycle, respectively",fixed
11435065,NA,758,irinotecan,5,60,mg/m2,1,"days 1, 8 and 15 repeated with a 28-day interval",NA
11435065,NA,758,cisplatin,5,80,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,cisplatin,5,80,mg/m2,1,day 1 repeated with a 28-day interval,NA
11435065,NA,758,thoracic radiation,5,2,Gy,1,"started on day 2 of each chemotherapy cycle, with 24 Gy and 36 Gy administered for the first and second cycle, respectively",fixed
10901362,NA,759,irinotecan,1,175,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,1,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,2,200,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,2,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,3,250,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,3,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,4,300,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,4,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,5,350,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,5,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,6,350,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,6,3,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,irinotecan,7,400,mg/m2,1,on day 1 repeated at 21-day intervals,NA
10901362,NA,759,raltitrexed,7,2.6,mg/m2,1,on day 1 repeated at 21-day intervals,NA
27902470,NCT01931943,760,qlnc120,1,450,mg,1,daily,NA
27902470,NCT01931943,760,qlnc120,2,750,mg,1,daily,NA
27902470,NCT01931943,760,qlnc120,3,1000,mg,1,daily,NA
27902470,NCT01931943,760,qlnc120,4,1250,mg,1,daily,NA
8382970,NA,761,topotecan,1,3.5,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,1,3.5,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,2,5.25,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,2,5.25,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,3,7.9,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,3,7.9,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,4,10,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,4,10,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,5,11.8,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,5,11.8,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,6,18,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
8382970,NA,761,topotecan,6,18,mg/m2,1,administeredas a continuous infusion over 5 days every 3 to 4 weeks,NA
24013582,NCT00614978,762,temozolomide,1,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,temozolomide,1,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,lapatinib,1,1000,mg,1,daily,NA
24013582,NCT00614978,762,temozolomide,2,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,temozolomide,2,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,lapatinib,2,1250,mg,1,daily,NA
24013582,NCT00614978,762,temozolomide,3,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,temozolomide,3,100,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,lapatinib,3,1500,mg,1,daily,NA
24013582,NCT00614978,762,temozolomide,4,150,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,temozolomide,4,150,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,lapatinib,4,1500,mg,1,daily,NA
24013582,NCT00614978,762,temozolomide,5,200,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,temozolomide,5,200,mg/m2,1,days 1–5 of every 28 days,NA
24013582,NCT00614978,762,lapatinib,5,1500,mg,1,daily,NA
11895901,NA,763,depsipeptide,1,1,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,1,1,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,2,1.7,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,2,1.7,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,3,2.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,3,2.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,4,3.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,4,3.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,5,6.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,5,6.5,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,6,9.1,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,6,9.1,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,7,12.7,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,7,12.7,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,8,17.8,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,8,17.8,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,9,24.9,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11895901,NA,763,depsipeptide,9,24.9,mg/m2,1,on day 1 and day 5 of a 21-day cycle,NA
11720832,NA,764,irinotecan,1,80,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,1,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,1,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,irinotecan,2,100,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,2,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,2,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,irinotecan,3,110,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,3,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,3,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,irinotecan,4,120,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,4,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,4,250,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,irinotecan,5,100,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,5,300,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,5,300,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,irinotecan,6,110,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
11720832,NA,764,uft,6,300,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
11720832,NA,764,uft,6,300,mg/m2/d,2 or 3,on days 1–21 every 4 weeks,NA
9060529,NA,765,irinotecan,1,60,mg/m2,1,on days 1 and 15 every 4 weeks,NA
9060529,NA,765,cisplatin,1,80,mg/m2,1,on day 1 every 4 weeks,NA
9060529,NA,765,cisplatin,1,80,mg/m2,1,on day 1 every 4 weeks,NA
9060529,NA,765,irinotecan,2,70,mg/m2,1,on days 1 and 15 every 4 weeks,NA
9060529,NA,765,cisplatin,2,80,mg/m2,1,on day 1 every 4 weeks,NA
9060529,NA,765,cisplatin,2,80,mg/m2,1,on day 1 every 4 weeks,NA
9060529,NA,765,irinotecan,3,80,mg/m2,1,on days 1 and 15 every 4 weeks,NA
9060529,NA,765,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,NA
9060529,NA,765,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,NA
28950146,NCT01589861,766,buparlisib,1,40,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,lapatinib,1,750,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,buparlisib,2,60,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,lapatinib,2,750,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,buparlisib,3,80,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,lapatinib,3,750,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,buparlisib,4,80,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,lapatinib,4,1000,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,buparlisib,5,80,mg,1,starting on day one and continuously during 28-day cycles,NA
28950146,NCT01589861,766,lapatinib,5,1250,mg,1,starting on day one and continuously during 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,-2,2.5,mg,1,"every other day in week 1, every day in week 2 and all subsequent weeks in 28-day cycles",NA
25082342,NCT00466895,767,lenalidomide,-1,2.5,mg,1,every other day in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,1,2.5,mg,1,everyday in week 1 in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,1,5,mg,1,everyday in week 2 and all subsequent weeks in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,2,2.5,mg,1,everyday in week 1 in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,2,5,mg,1,everyday in week 2 in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,2,7.5,mg,1,everyday in week 3 and all subsequent weeks in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,3,2.5,mg,1,everyday in week 1 in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,3,5,mg,1,everyday in week 2 in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,3,10,mg,1,everyday in week 3 and all subsequent weeks in 28-day cycles,NA
25082342,NCT00466895,767,lenalidomide,4,2.5,mg,1,everyday in week 1 in 28-day cycles,cohort A only
25082342,NCT00466895,767,lenalidomide,4,7.5,mg,1,everyday in week 2 in 28-day cycles,cohort A only
25082342,NCT00466895,767,lenalidomide,4,12.5,mg,1,everyday in week 3 and all subsequent weeks in 28-day cycles,cohort A only
25082342,NCT00466895,767,lenalidomide,5,2.5,mg,1,everyday in week 1 in 28-day cycles,cohort A only
25082342,NCT00466895,767,lenalidomide,5,7.5,mg,1,everyday in week 2 in 28-day cycles,cohort A only
25082342,NCT00466895,767,lenalidomide,5,15,mg,1,everyday in week 3 and all subsequent weeks in 28-day cycles,cohort A only
22426640,NCT01092091,768,peg-rharg1,1,500,U/KG,1,weekly for at least 8 weeks,NA
22426640,NCT01092091,768,peg-rharg1,2,1000,U/KG,1,weekly for at least 8 weeks,NA
22426640,NCT01092091,768,peg-rharg1,3,1600,U/KG,1,weekly for at least 8 weeks,NA
22426640,NCT01092091,768,peg-rharg1,4,2500,U/KG,1,weekly for at least 8 weeks,NA
34735674,NCT02089633,769,peg‑bct‑100,1,2.7,mg/kg,1,weekly in 21-day cycles,fixed
34735674,NCT02089633,769,capecitabine,1,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,capecitabine,1,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,oxaliplatin,1,85,mg/m2,1,on day one of a 21-day cycle,NA
34735674,NCT02089633,769,oxaliplatin,1,85,mg/m2,1,on day one of a 21-day cycle,NA
34735674,NCT02089633,769,peg‑bct‑100,2,2.7,mg/kg,1,weekly in 21-day cycles,fixed
34735674,NCT02089633,769,capecitabine,2,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,capecitabine,2,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,oxaliplatin,2,100,mg/m2,1,on day one of a 21-day cycle,NA
34735674,NCT02089633,769,oxaliplatin,2,100,mg/m2,1,on day one of a 21-day cycle,NA
34735674,NCT02089633,769,peg‑bct‑100,3,2.7,mg/kg,1,weekly in 21-day cycles,fixed
34735674,NCT02089633,769,capecitabine,3,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,capecitabine,3,1000,mg/m2,2,on days 1-14 of a 21-day cycle,fixed
34735674,NCT02089633,769,oxaliplatin,3,130,mg/m2,1,on day one of a 21-day cycle,NA
34735674,NCT02089633,769,oxaliplatin,3,130,mg/m2,1,on day one of a 21-day cycle,NA
28483761,NCT01749969,770,isatuximab,1,3,mg/kg,1,on Days 1 and 15 of every 28-day cycle,Q2W cohorts
28483761,NCT01749969,770,lenalidomide,1,25,mg,1,on Days 1 to 21 in 28-day cycles,fixed
28483761,NCT01749969,770,dexamethasone,1,40,mg,1,"on Days 1, 8, 15, 22 in 28-day cycles",fixed
28483761,NCT01749969,770,isatuximab,2,5,mg/kg,1,on Days 1 and 15 of every 28-day cycle,Q2W cohorts
28483761,NCT01749969,770,lenalidomide,2,25,mg,1,on Days 1 to 21 in 28-day cycles,fixed
28483761,NCT01749969,770,dexamethasone,2,40,mg,1,"on Days 1, 8, 15, 22 in 28-day cycles",fixed
28483761,NCT01749969,770,isatuximab,3,10,mg/kg,1,on Days 1 and 15 of every 28-day cycle,Q2W cohorts
28483761,NCT01749969,770,lenalidomide,3,25,mg,1,on Days 1 to 21 in 28-day cycles,fixed
28483761,NCT01749969,770,dexamethasone,3,40,mg,1,"on Days 1, 8, 15, 22 in 28-day cycles",fixed
28483761,NCT01749969,770,isatuximab,4,10,mg/kg,1,"on Days 1, 8, 15, and 22 of first cycle and Days 1 and 15 of every subsequent cycle",QW/Q2W cohorts
28483761,NCT01749969,770,lenalidomide,4,25,mg,1,on Days 1 to 21 in 28-day cycles,fixed
28483761,NCT01749969,770,dexamethasone,4,40,mg,1,"on Days 1, 8, 15, 22 in 28-day cycles",fixed
28483761,NCT01749969,770,isatuximab,5,20,mg/kg,1,"on Days 1, 8, 15, and 22 of first cycle and Days 1 and 15 of every subsequent cycle",QW/Q2W cohorts
28483761,NCT01749969,770,lenalidomide,5,25,mg,1,on Days 1 to 21 in 28-day cycles,fixed
28483761,NCT01749969,770,dexamethasone,5,40,mg,1,"on Days 1, 8, 15, 22 in 28-day cycles",fixed
28853315,NCT01368757,771,lenalidomide,1,5,mg,1,daily every 28 days,NA
28853315,NCT01368757,771,lenalidomide,2,10,mg,1,daily every 28 days,NA
28853315,NCT01368757,771,lenalidomide,3,15,mg,1,daily every 28 days,NA
33040274,NCT01222754,772,lenalidomide,-1,10,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,-1,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
33040274,NCT01222754,772,lenalidomide,0,15,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,0,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
33040274,NCT01222754,772,lenalidomide,1,32,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,1,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
33040274,NCT01222754,772,lenalidomide,2,52,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,2,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
33040274,NCT01222754,772,lenalidomide,3,88,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,3,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
33040274,NCT01222754,772,lenalidomide,4,116,mg/m2,1,"every day, beginning with the frst fraction of radiation therapy and continuing through the last fraction of radiation therapy",NA
33040274,NCT01222754,772,radiation therapy,4,180,cGy,1,"daily, 5 days/week to a prescription dose of 54–59 Gy",fixed
24914044,NCT00975806,773,lenalidomide,1,10,mg,1,on a continuous once-daily schedule for each 21-day cycle,NA
24914044,NCT00975806,773,sunitinib,1,37.5,mg,1,on a continuous once-daily schedule for each 21-day cycle,NA
24914044,NCT00975806,773,lenalidomide,2,10,mg,1,on a continuous once-daily schedule for each 21-day cycle,NA
24914044,NCT00975806,773,sunitinib,2,37.5,mg,1,on days 1–14 for each 21-day cycle,NA
24914044,NCT00975806,773,lenalidomide,3,15,mg,1,on a continuous once-daily schedule for each 21-day cycle,NA
24914044,NCT00975806,773,sunitinib,3,37.5,mg,1,on days 1–14 for each 21-day cycle,NA
19499221,NA,774,lapatinib,1,1000,mg,2,daily in 4-week cycles,Patients receiving EIAEDs
19499221,NA,774,lapatinib,-1,750,mg,2,daily in 4-week cycles,Patients not on EIAEDs
19499221,NA,774,lapatinib,2,1500,mg,2,daily in 4-week cycles,Patients receiving EIAEDs
28622959,NCT01460940,775,panobinostat,-4,5,mg,1,"on days 1, 3, and 5 of weeks 1 and 3  every 28 days",NA
28622959,NCT01460940,775,lenalidomide,-4,5,mg,1,on days 1 to 21 every 28 days,NA
28622959,NCT01460940,775,panobinostat,-3,5,mg,1,"on days 1, 3, and 5 of weeks 1 and 3  every 28 days",NA
28622959,NCT01460940,775,lenalidomide,-3,10,mg,1,on days 1 to 21 every 28 days,NA
28622959,NCT01460940,775,panobinostat,-2,10,mg,1,"on days 1, 3, and 5 of weeks 1 and 3  every 28 days",NA
28622959,NCT01460940,775,lenalidomide,-2,15,mg,1,on days 1 to 21 every 28 days,NA
28622959,NCT01460940,775,panobinostat,-1,15,mg,1,"on days 1, 3, and 5 of weeks 1 and 3 every 28 days",NA
28622959,NCT01460940,775,lenalidomide,-1,20,mg,1,on days 1 to 21 every 28 days,NA
28622959,NCT01460940,775,panobinostat,1,15,mg,1,"on days 1, 3, and 5 of weeks 1-4 every 28 days",NA
28622959,NCT01460940,775,lenalidomide,1,25,mg,1,on days 1 to 21 every 28 days,NA
28622959,NCT01460940,775,panobinostat,2,20,mg,1,"on days 1, 3, and 5 of weeks 1-4 every 28 days",NA
28622959,NCT01460940,775,lenalidomide,2,25,mg,1,on days 1 to 21 every 28 days,NA
27126994,NCT01791478,776,letrozole,1,2.5,mg,1,daily on a 28-day cycle,NA
27126994,NCT01791478,776,alpelisib,1,300,mg,1,daily on a 28-day cycle,NA
27126994,NCT01791478,776,letrozole,2,2.5,mg,1,daily on a 28-day cycle,NA
27126994,NCT01791478,776,alpelisib,2,350,mg,1,daily on a 28-day cycle,NA
21556801,NA,777,lenalidomide,1,5,mg,1,days 1–14 of a 21-day cycle,NA
21556801,NA,777,topotecan,1,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,topotecan,1,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,lenalidomide,2,10,mg,1,days 1–14 of a 21-day cycle,NA
21556801,NA,777,topotecan,2,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,topotecan,2,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,lenalidomide,3,15,mg,1,days 1–14 of a 21-day cycle,NA
21556801,NA,777,topotecan,3,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,topotecan,3,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,lenalidomide,4,20,mg,1,days 1–14 of a 21-day cycle,NA
21556801,NA,777,topotecan,4,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,topotecan,4,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,lenalidomide,5,25,mg,1,days 1–14 of a 21-day cycle,NA
21556801,NA,777,topotecan,5,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
21556801,NA,777,topotecan,5,1.25,mg/m2,1,days 1–5 of a 21-day cycle,fixed
12569301,NA,778,oxaliplatin,1,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,1,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,1,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,1,600,mg/m2,1,every 2 weeks,NA
12569301,NA,778,oxaliplatin,2,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,2,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,2,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,2,700,mg/m2,1,every 2 weeks,NA
12569301,NA,778,oxaliplatin,3,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,3,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,3,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,3,800,mg/m2,1,every 2 weeks,NA
12569301,NA,778,oxaliplatin,4,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,4,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,4,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,4,900,mg/m2,1,every 2 weeks,NA
12569301,NA,778,oxaliplatin,5,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,5,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,5,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,5,1000,mg/m2,1,every 2 weeks,NA
12569301,NA,778,oxaliplatin,6,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,oxaliplatin,6,85,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,5-fluorouracil,6,20,mg/m2,1,every 2 weeks,fixed
12569301,NA,778,leucovorin,6,1100,mg/m2,1,every 2 weeks,NA
26384354,NCT01464034,779,carfilzomib,-3,20,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,-3,2,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,-3,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,-2,27,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,-2,2,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,-2,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,-1,27,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,-1,3,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,-1,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,1,27,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,1,4,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,1,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,2,36,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,2,4,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,2,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,3,45,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,3,4,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,3,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
26384354,NCT01464034,779,carfilzomib,4,56,mg/m2,1,"on Days 1,2,8,9,15, and 16 every 28 days. The first 2 doses of carfilzomib in cycle 1 were to be administered at 20 mg/m2",NA
26384354,NCT01464034,779,pomalidomide,4,4,mg,1,"on Days 1-21, every 28 Days",NA
26384354,NCT01464034,779,dexamethasone,4,40,mg,1,"on Days 1, 8, 15, and 22, every 28 days.",fixed
22451423,NCT01042704,780,bendamustine,1,75,mg/m2,1,on day 1 and day 2 of each 28-day cycle,NA
22451423,NCT01042704,780,lenalidomide,1,5,mg,1,daily on days 1 to 21 of each 28-day cycle,NA
22451423,NCT01042704,780,dexamethasone,1,40,mg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
22451423,NCT01042704,780,bendamustine,2,75,mg/m2,1,on day 1 and day 2 of each 28-day cycle,NA
22451423,NCT01042704,780,lenalidomide,2,10,mg,1,daily on days 1 to 21 of each 28-day cycle,NA
22451423,NCT01042704,780,dexamethasone,2,40,mg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
22451423,NCT01042704,780,bendamustine,3,100,mg/m2,1,on day 1 and day 2 of each 28-day cycle,NA
22451423,NCT01042704,780,lenalidomide,3,10,mg,1,daily on days 1 to 21 of each 28-day cycle,NA
22451423,NCT01042704,780,dexamethasone,3,40,mg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
20956622,NA,781,lenalidomide,1,25,mg,1,daily on days 1 through 21 of 28-day cycles,NA
20956622,NA,781,lenalidomide,2,35,mg,1,daily on days 1 through 21 of 28-day cycles,NA
20956622,NA,781,lenalidomide,3,50,mg,1,daily on days 1 through 21 of 28-day cycles,NA
20956622,NA,781,lenalidomide,4,75,mg,1,daily on days 1 through 21 of 28-day cycles,NA
15060739,NA,782,mdam,0,80,mg/m2,1,five consecutive days repeated every 21 days,NA
15060739,NA,782,mdam,1,160,mg/m2,1,five consecutive days repeated every 21 days,NA
15060739,NA,782,mdam,2,240,mg/m2,1,five consecutive days repeated every 21 days,NA
15060739,NA,782,mdam,3,300,mg/m2,1,five consecutive days repeated every 21 days,NA
15060739,NA,782,mdam,4,270,mg/m2,1,five consecutive days repeated every 21 days,NA
12384400,NA,783,cc-5013,1,5,mg,1,daily in 28-day cycles,NA
12384400,NA,783,cc-5013,2,10,mg,1,daily in 28-day cycles,NA
12384400,NA,783,cc-5013,3,25,mg,1,daily in 28-day cycles,NA
12384400,NA,783,cc-5013,4,50,mg,1,daily in 28-day cycles,NA
25617965,NCT01093183,784,lenalidomide,1,10,mg,1,on days 1–21 followed by 7 days of rest (28 day cycle),NA
25617965,NCT01093183,784,cyclophosphamide,1,50,mg,1,daily on days 1–28 of a 28 day cycle,fixed
25617965,NCT01093183,784,lenalidomide,2,15,mg,1,on days 1–21 followed by 7 days of rest (28 day cycle),NA
25617965,NCT01093183,784,cyclophosphamide,2,50,mg,1,daily on days 1–28 of a 28 day cycle,fixed
25617965,NCT01093183,784,lenalidomide,3,20,mg,1,on days 1–21 followed by 7 days of rest (28 day cycle),NA
25617965,NCT01093183,784,cyclophosphamide,3,50,mg,1,daily on days 1–28 of a 28 day cycle,fixed
25617965,NCT01093183,784,lenalidomide,4,25,mg,1,on days 1–21 followed by 7 days of rest (28 day cycle),NA
25617965,NCT01093183,784,cyclophosphamide,4,50,mg,1,daily on days 1–28 of a 28 day cycle,fixed
20724537,NCT00621400,785,lenalidomide,1,5,mg,1,on days 1-21 in a 28-day cycle,NA
20724537,NCT00621400,785,melphalan,1,0.18,mg/kg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,dexamethasone,1,40,mg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,lenalidomide,2,10,mg,1,on days 1-21 in a 28-day cycle,NA
20724537,NCT00621400,785,melphalan,2,0.18,mg/kg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,dexamethasone,2,40,mg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,lenalidomide,3,15,mg,1,on days 1-21 in a 28-day cycle,NA
20724537,NCT00621400,785,melphalan,3,0.18,mg/kg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,dexamethasone,3,40,mg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,lenalidomide,4,20,mg,1,on days 1-21 in a 28-day cycle,NA
20724537,NCT00621400,785,melphalan,4,0.18,mg/kg,1,from day 1- 4 in each 28-day cycle,fixed
20724537,NCT00621400,785,dexamethasone,4,40,mg,1,from day 1- 4 in each 28-day cycle,fixed
26284823,NCT02302469,786,lenalidomide,1,15,mg,1,daily on days 1-21 of a 28 day cycle,NA
26284823,NCT02302469,786,lenalidomide,2,20,mg,1,daily on days 1-21 of a 28 day cycle,NA
27354719,NCT00963534,787,lenalidomide,1,5,mg,1,"days 1-14 of six 28-day cycles, followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks). In cycles 7 to 13, the dose of LEN was 25 mg",NA
27354719,NCT00963534,787,bendamustine,1,90,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,1,375,mg/m2,1,day 1 of 628-day cycles,NA
27354719,NCT00963534,787,lenalidomide,2,10,mg,1,"days 1-14 of six 28-day cycles, followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks). In cycles 7 to 13, the dose of LEN was 25 mg",NA
27354719,NCT00963534,787,bendamustine,2,90,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,2,375,mg/m2,1,day 1 of 628-day cycles,NA
27354719,NCT00963534,787,lenalidomide,3,15,mg,1,"days 1-14 of six 28-day cycles, followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks). In cycles 7 to 13, the dose of LEN was 25 mg",NA
27354719,NCT00963534,787,bendamustine,3,90,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,3,375,mg/m2,1,day 1 of 628-day cycles,NA
27354719,NCT00963534,787,lenalidomide,4,10,mg,1,"days 1-14  in cycles 2 through 6, and omitted in cycle 1 (28-day), followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks)",NA
27354719,NCT00963534,787,bendamustine,4,90,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,4,375,mg/m2,1,day 1 of 628-day cycles,NA
27354719,NCT00963534,787,lenalidomide,5,10,mg,1,"days 1-14  in cycles 2 through 6, and omitted in cycle 1 (28-day), followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks)",NA
27354719,NCT00963534,787,bendamustine,5,70,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,5,375,mg/m2,1,day 1 of 628-day cycles,NA
27354719,NCT00963534,787,lenalidomide,6,5,mg,1,"days 1-14  in cycles 2 through 6, and omitted in cycle 1 (28-day), followed by a maintenance phase with singleagent LEN (by mouth, days 1-21), cycle duration 28 days, up to a maximum of 7 cycles (total duration 52 weeks)",NA
27354719,NCT00963534,787,bendamustine,6,70,mg/m2,1,days 1-2 of 628-day cycles,NA
27354719,NCT00963534,787,rituximab,6,375,mg/m2,1,day 1 of 628-day cycles,NA
23692564,NA,788,bendamustine,1,60,mg/m2,1,on days 1 and 2 of a 28-day cycle,NA
23692564,NA,788,lenalidomide,1,10,mg,1,during 21 consecutive days of a 28-day cycle,NA
23692564,NA,788,prednisolone,1,100,mg,1,on days 1–4 of a 28-day cycle,fixed
23692564,NA,788,bendamustine,2,60,mg/m2,1,on days 1 and 2 of a 28-day cycle,NA
23692564,NA,788,lenalidomide,2,15,mg,1,during 21 consecutive days of a 28-day cycle,NA
23692564,NA,788,prednisolone,2,100,mg,1,on days 1–4 of a 28-day cycle,NA
23692564,NA,788,bendamustine,3,60,mg/m2,1,on days 1 and 2 of a 28-day cycle,NA
23692564,NA,788,lenalidomide,3,20,mg,1,during 21 consecutive days of a 28-day cycle,NA
23692564,NA,788,prednisolone,3,100,mg,1,on days 1–4 of a 28-day cycle,NA
23692564,NA,788,bendamustine,4,60,mg/m2,1,on days 1 and 2 of a 28-day cycle,NA
23692564,NA,788,lenalidomide,4,25,mg,1,during 21 consecutive days of a 28-day cycle,NA
23692564,NA,788,prednisolone,4,100,mg,1,on days 1–4 of a 28-day cycle,NA
23692564,NA,788,bendamustine,5,75,mg/m2,1,on days 1 and 2 of a 28-day cycle,NA
23692564,NA,788,lenalidomide,5,25,mg,1,during 21 consecutive days of a 28-day cycle,NA
23692564,NA,788,prednisolone,5,100,mg,1,on days 1–4 of a 28-day cycle,NA
31126332,NCT02619162,789,letrozole,1,2.5,mg,1,for 28 consecutive days (Days 1-28) in 4-week cycles,fixed
31126332,NCT02619162,789,nintedanib,1,150,mg,2,for 28 consecutive days (Days 1-28) in 4-week cycles,NA
31126332,NCT02619162,789,letrozole,2,2.5,mg,1,for 28 consecutive days (Days 1-28) in 4-week cycles,fixed
31126332,NCT02619162,789,nintedanib,2,200,mg,2,for 28 consecutive days (Days 1-28) in 4-week cycles,NA
22640031,NCT00415064,790,perifosine,1,50,mg,1,daily,NA
22640031,NCT00415064,790,lenalidomide,1,15,mg,1,daily for days 1 to 21 of each 28 day cycle,NA
22640031,NCT00415064,790,dexamethasone,1,20,mg,1,"on days 1-4, 9-12 and 17-20 for the first 4 cycles, and on days 1-4 of subsequent cycles",NA
22640031,NCT00415064,790,perifosine,2,50,mg,1,daily,NA
22640031,NCT00415064,790,lenalidomide,2,25,mg,1,daily for days 1 to 21 of each 28 day cycle,NA
22640031,NCT00415064,790,dexamethasone,2,20,mg,1,"on days 1-4, 9-12 and 17-20 for the first 4 cycles, and on days 1-4 of subsequent cycles",NA
22640031,NCT00415064,790,perifosine,3,100,mg,1,daily,NA
22640031,NCT00415064,790,lenalidomide,3,15,mg,1,daily for days 1 to 21 of each 28 day cycle,NA
22640031,NCT00415064,790,dexamethasone,3,40,mg,1,once weeklyfor the first four cycles and 20 mg per week for subsequent cycle,NA
22640031,NCT00415064,790,perifosine,4,100,mg,1,daily,NA
22640031,NCT00415064,790,lenalidomide,4,25,mg,1,daily for days 1 to 21 of each 28 day cycle,NA
22640031,NCT00415064,790,dexamethasone,4,40,mg,1,nce weeklyfor the first four cycles and 20 mg per week for subsequent cycle,NA
31074316,NCT01400685,791,lenalidomide,1,2.5,mg,1,"on D8–21 of C1, then days 1–21 of cycles 2–6",NA
31074316,NCT01400685,791,bendamustine,1,90,mg/m2,1,on days 1 and 2 of each 28-day cycle,NA
31074316,NCT01400685,791,rituximab,1,375/500,mg/m2,1,"on day 1 of cycle 1 at a dose of 375 mg/m2, and on day 1 of cycles 2–6 at a dose of 500 mg/m2",NA
31074316,NCT01400685,791,lenalidomide,2,2.5,mg,1,on D8–21 of C1,NA
31074316,NCT01400685,791,lenalidomide,2,5,mg,1,on days 1–21 of cycles 2–6,NA
31074316,NCT01400685,791,bendamustine,2,90,mg/m2,1,on days 1 and 2 of each 28-day cycle,NA
31074316,NCT01400685,791,rituximab,2,375/500,mg/m2,1,"on day 1 of cycle 1 at a dose of 375 mg/m2, and on day 1 of cycles 2–6 at a dose of 500 mg/m2",NA
31074316,NCT01400685,791,lenalidomide,3,5,mg,1,on D8–21 of C1,NA
31074316,NCT01400685,791,lenalidomide,3,10,mg,1,on days 1–21 of cycles 2–6,NA
31074316,NCT01400685,791,bendamustine,3,90,mg/m2,1,on days 1 and 2 of each 28-day cycle,NA
31074316,NCT01400685,791,rituximab,3,375/500,mg/m2,1,"on day 1 of cycle 1 at a dose of 375 mg/m2, and on day 1 of cycles 2–6 at a dose of 500 mg/m2",NA
33674736,NCT01665183,792,adi-peg20,1,18,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,1,20,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,1,20,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,adi-peg20,2,18,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,2,25,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,2,25,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,adi-peg20,3,18,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,3,30,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,3,30,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,adi-peg20,4,18,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,4,35,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,4,35,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,adi-peg20,5,36,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,5,30,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,5,30,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,adi-peg20,5.5,36,mg/m2,1,QW Weeks 1 - 4 every 28 days,NA
33674736,NCT01665183,792,cisplatin,5.5,35,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
33674736,NCT01665183,792,cisplatin,5.5,35,mg/m2,1,QW Weeks 1 - 3 every 28 days,NA
27531679,NCT01615029,793,daratumumab,1,2,mg/kg,1,"once per week for cycles 1 and 2, once every 2 weeks for cycles 3through 6, and once every 4 weeks thereafter until disease progression or unacceptable toxicity",NA
27531679,NCT01615029,793,lenalidomide,1,25,mg/m2,1,on days 1 to 21 of each 28-day cycle,fixed
27531679,NCT01615029,793,dexamethasone,1,40,mg,1,once weekly at 20 mg pre– and post–daratumumab infusion,fixed
27531679,NCT01615029,793,daratumumab,2,4,mg/kg,1,"once per week for cycles 1 and 2, once every 2 weeks for cycles 3through 6, and once every 4 weeks thereafter until disease progression or unacceptable toxicity",NA
27531679,NCT01615029,793,lenalidomide,2,25,mg/m2,1,on days 1 to 21 of each 28-day cycle,fixed
27531679,NCT01615029,793,dexamethasone,2,40,mg,1,once weekly at 20 mg pre– and post–daratumumab infusion,fixed
27531679,NCT01615029,793,daratumumab,3,8,mg/kg,1,"once per week for cycles 1 and 2, once every 2 weeks for cycles 3through 6, and once every 4 weeks thereafter until disease progression or unacceptable toxicity",NA
27531679,NCT01615029,793,lenalidomide,3,25,mg/m2,1,on days 1 to 21 of each 28-day cycle,fixed
27531679,NCT01615029,793,dexamethasone,3,40,mg,1,once weekly at 20 mg pre– and post–daratumumab infusion,fixed
27531679,NCT01615029,793,daratumumab,4,16,mg/kg,1,"once per week for cycles 1 and 2, once every 2 weeks for cycles 3through 6, and once every 4 weeks thereafter until disease progression or unacceptable toxicity",NA
27531679,NCT01615029,793,lenalidomide,4,25,mg/m2,1,on days 1 to 21 of each 28-day cycle,fixed
27531679,NCT01615029,793,dexamethasone,4,40,mg,1,once weekly at 20 mg pre– and post–daratumumab infusion,fixed
12853359,NA,794,5-fluorouracil,1,1000,mg/m2,1,weekly in 4-week cycles,NA
12853359,NA,794,leucovorin,1,500,mg/m2,1,weekly in 4-week cycles,fixed
12853359,NA,794,5-fluorouracil,2,1800,mg/m2,1,weekly in 4-week cycles,NA
12853359,NA,794,leucovorin,2,500,mg/m2,1,weekly in 4-week cycles,fixed
12853359,NA,794,5-fluorouracil,3,2600,mg/m2,1,weekly in 4-week cycles,NA
12853359,NA,794,leucovorin,3,500,mg/m2,1,weekly in 4-week cycles,fixed
12796032,NA,795,5-fu,1,2600,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,leucovorin,1,200,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,cci-779,1,15,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,NA
12796032,NA,795,5-fu,2,2600,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,leucovorin,2,200,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,cci-779,2,25,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,NA
12796032,NA,795,5-fu,3,2600,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,leucovorin,3,200,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,cci-779,3,45,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,NA
12796032,NA,795,5-fu,4,2600,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,leucovorin,4,200,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,fixed
12796032,NA,795,cci-779,4,75,mg/m2,1,beginning at day 8. One cycle consisted of six weekly administrations followed by 1 week of rest,NA
11948111,NA,796,isis 3521,1,1,mg/kg,1,a continuous 21-day infusion repeated every 28 days,NA
11948111,NA,796,5-fluorouracil,1,425,mg/m2,1,days 0–4 repeated every 28 days,fixed
11948111,NA,796,leucovorin,1,20,mg/m2,1,days 0–4 repeated every 28 days,fixed
11948111,NA,796,isis 3521,2,1.5,mg/kg,1,a continuous 21-day infusion repeated every 28 days,NA
11948111,NA,796,5-fluorouracil,2,425,mg/m2,1,days 0–4 repeated every 28 days,fixed
11948111,NA,796,leucovorin,2,20,mg/m2,1,days 0–4 repeated every 28 days,fixed
11948111,NA,796,isis 3521,3,2,mg/kg,1,a continuous 21-day infusion repeated every 28 days,NA
11948111,NA,796,5-fluorouracil,3,425,mg/m2,1,days 0–4 repeated every 28 days,fixed
11948111,NA,796,leucovorin,3,20,mg/m2,1,days 0–4 repeated every 28 days,fixed
29237802,NCT01750983,797,ipilimumab,1,1.5,mg/kg,1,on Day 1 of each 28 day cycle,NA
29237802,NCT01750983,797,lenalidomide,1,10,mg,1,on Days 1-21 of each 28 day cycle,NA
29237802,NCT01750983,797,ipilimumab,2,1.5,mg/kg,1,on Day 1 of each 28 day cycle,NA
29237802,NCT01750983,797,lenalidomide,2,15,mg,1,on Days 1-21 of each 28 day cycle,NA
29237802,NCT01750983,797,ipilimumab,3,3,mg/kg,1,on Day 1 of each 28 day cycle,NA
29237802,NCT01750983,797,lenalidomide,3,15,mg,1,on Days 1-21 of each 28 day cycle,NA
29237802,NCT01750983,797,ipilimumab,4,3,mg/kg,1,on Day 1 of each 28 day cycle,NA
29237802,NCT01750983,797,lenalidomide,4,20,mg,1,on Days 1-21 of each 28 day cycle,NA
29237802,NCT01750983,797,ipilimumab,5,3,mg/kg,1,on Day 1 of each 28 day cycle,NA
29237802,NCT01750983,797,lenalidomide,5,25,mg,1,on Days 1-21 of each 28 day cycle,NA
20859231,NA,798,dacarbazine,1,600,mg/m2,1,every 3 weeks,NA
20859231,NA,798,lenalidomide,1,25,mg,1,14 consecutive days followed by a 7-day rest (21-day cycle),fixed
20859231,NA,798,dacarbazine,2,800,mg/m2,1,every 3 weeks,NA
20859231,NA,798,lenalidomide,2,25,mg,1,14 consecutive days followed by a 7-day rest (21-day cycle),fixed
20859231,NA,798,dacarbazine,3,1000,mg/m2,1,every 3 weeks,NA
20859231,NA,798,lenalidomide,3,25,mg,1,14 consecutive days followed by a 7-day rest (21-day cycle),fixed
11432626,NA,799,oxaliplatin,1,60,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,oxaliplatin,1,60,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,leucovorin,1,500,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
11432626,NA,799,5-fluorouracil,1,2600,mg/m2,1,"48-h infusion once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
11432626,NA,799,oxaliplatin,2,65,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,oxaliplatin,2,65,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,leucovorin,2,500,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
11432626,NA,799,5-fluorouracil,2,2600,mg/m2,1,"48-h infusion once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
11432626,NA,799,oxaliplatin,3,70,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,oxaliplatin,3,70,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",NA
11432626,NA,799,leucovorin,3,500,mg/m2,1,"once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
11432626,NA,799,5-fluorouracil,3,2600,mg/m2,1,"48-h infusion once a week for four consecutive weeks.  One treatment cycle consisted of four weeks, followed by a one-week rest period",fixed
22240778,NA,800,lapatinib,1,750,mg,1,daily and continuous,NA
22240778,NA,800,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22240778,NA,800,lapatinib,2,1000,mg,1,daily and continuous,NA
22240778,NA,800,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22240778,NA,800,lapatinib,3,1000,mg,1,daily and continuous,NA
22240778,NA,800,vinorelbine,3,22.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22240778,NA,800,lapatinib,4,1000,mg,1,daily and continuous,NA
22240778,NA,800,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
22240778,NA,800,lapatinib,3.5,1250,mg,1,daily and continuous,NA
22240778,NA,800,vinorelbine,3.5,22.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
21307147,NA,801,ngr-htnf,1,0.2,ug/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,1,0.2,ug/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,1,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,1,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,2,0.4,ug/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,2,0.4,ug/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,2,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,2,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,3,0.8,ug/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,3,0.8,ug/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,3,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,3,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,4,1.6,ug/m2,1,once every three weeks,NA
21307147,NA,801,ngr-htnf,4,1.6,ug/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,4,80,mg/m2,1,once every three weeks,NA
21307147,NA,801,cisplatin,4,80,mg/m2,1,once every three weeks,NA
12439334,NA,802,leucovorin,1,90,mg,1,5 days per week simultaneously to a 5-week course of irradiation,fixed
12439334,NA,802,uft,1,250,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,uft,1,250,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,pelvic radiation,1,1.8,Gy,1,daily fractions up to a total dose of 50.4 Gy followed by a boost of 5.4 or 9.0 Gy,fixed
12439334,NA,802,leucovorin,2,90,mg,1,5 days per week simultaneously to a 5-week course of irradiation,fixed
12439334,NA,802,uft,2,300,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,uft,2,300,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,pelvic radiation,2,1.8,Gy,1,daily fractions up to a total dose of 50.4 Gy followed by a boost of 5.4 or 9.0 Gy,fixed
12439334,NA,802,leucovorin,3,90,mg,1,5 days per week simultaneously to a 5-week course of irradiation,fixed
12439334,NA,802,uft,3,350,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,uft,3,350,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,pelvic radiation,3,1.8,Gy,1,daily fractions up to a total dose of 50.4 Gy followed by a boost of 5.4 or 9.0 Gy,fixed
12439334,NA,802,leucovorin,4,90,mg,1,5 days per week simultaneously to a 5-week course of irradiation,fixed
12439334,NA,802,uft,4,400,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,uft,4,400,mg/m2/d,3,5 days per week simultaneously to a 5-week course of irradiation,NA
12439334,NA,802,pelvic radiation,4,1.8,Gy,1,daily fractions up to a total dose of 50.4 Gy followed by a boost of 5.4 or 9.0 Gy,fixed
29427149,NA,803,dasatinib,-1,55,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,-1,40,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,-1,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,-1,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,0,55,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,0,55,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,0,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,0,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,0.5,65,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,0.5,40,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,0.5,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,0.5,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,1,65,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,1,55,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,1,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,1,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,2,65,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,2,70,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,2,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,2,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,2.5,85,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,2.5,55,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,2.5,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,2.5,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,dasatinib,3,85,mg/m2,2,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,lenalidomide,3,70,mg/m2,1,"given for 21 days, followed by 7 days’ rest",NA
29427149,NA,803,temozolomide,3,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
29427149,NA,803,temozolomide,3,75,mg/m2,1,"given for 21 days, followed by 7 days’ rest",fixed
20713864,NA,804,lapatinib,1,300,mg,2,daily in each 28-day course,patients not receiving steroids & patients receiving steriods
20713864,NA,804,lapatinib,2,400,mg,2,daily in each 28-day course,patients not receiving steroids & patients receiving steriods
20713864,NA,804,lapatinib,3,520,mg,2,daily in each 28-day course,patients not receiving steroids & patients receiving steriods
20713864,NA,804,lapatinib,4,700,mg,2,daily in each 28-day course,patients not receiving steroids & patients receiving steriods
20713864,NA,804,lapatinib,5,900,mg,2,daily in each 28-day course,patients not receiving steroids & patients receiving steriods
20713864,NA,804,lapatinib,6,1150,mg,2,daily in each 28-day course,patients not receiving steroids
21825263,NA,805,cci-779,-1,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
21825263,NA,805,lenalidomide,-1,15,mg,1,on days 1 to 21 of a 28-day cycle,NA
21825263,NA,805,cci-779,1,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
21825263,NA,805,lenalidomide,1,20,mg,1,on days 1 to 21 of a 28-day cycle,NA
21825263,NA,805,cci-779,2,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
21825263,NA,805,lenalidomide,2,25,mg,1,on days 1 to 21 of a 28-day cycle,NA
21825263,NA,805,cci-779,3,20,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
21825263,NA,805,lenalidomide,3,25,mg,1,on days 1 to 21 of a 28-day cycle,NA
21149652,NA,806,lenalidomide,1,15,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,2,20,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,3,25,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,4,32,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,5,40,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,6,52,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,7,68,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,8,88,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,9,101,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
21149652,NA,806,lenalidomide,10,116,mg/m2,1,daily for 21 days followed by a 7-day rest,NA
25666183,NA,807,valproic acid,1,40,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,valproic acid,1,40,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,lenalidomide,1,15,mg,1,daily for 28 days,NA
25666183,NA,807,valproic acid,2,30,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,valproic acid,2,30,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,lenalidomide,2,15,mg,1,daily for 28 days,NA
25666183,NA,807,valproic acid,3,20,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,valproic acid,3,20,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,lenalidomide,3,20,mg,1,daily for 28 days,NA
25666183,NA,807,valproic acid,4,20,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,valproic acid,4,20,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,lenalidomide,4,25,mg,1,daily for 28 days,NA
25666183,NA,807,valproic acid,5,30,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,valproic acid,5,30,mg/kg,1,"daily on a 7-day-on, 7-day-off schedule",NA
25666183,NA,807,lenalidomide,5,25,mg,1,daily for 28 days,NA
33075165,NCT02509039 ,808,avadomide aic,1,2,mg,1,on a 5 continuous days out of 7 days per week intermittent dosing schedule in 28-day cycles,NA
33075165,NCT02509039 ,808,avadomide aic,2,3,mg,1,on a 5 continuous days out of 7 days per week intermittent dosing schedule in 28-day cycles,NA
33075165,NCT02509039 ,808,avadomide aic,3,4,mg,1,on a 5 continuous days out of 7 days per week intermittent dosing schedule in 28-day cycles,NA
33075165,NCT02509039 ,808,avadomide f6,4,3,mg,1,on a 5 continuous days out of 7 days per week intermittent dosing schedule in 28-day cycles,NA
34955443,NCT01578954,809,lenalidomide,1,25,mg,1,daily for a 28-day cycle,NA
34955443,NCT01578954,809,lenalidomide,2,35,mg,1,daily for a 28-day cycle,NA
34955443,NCT01578954,809,lenalidomide,3,50,mg,1,daily for a 28-day cycle,NA
23592273,NA,810,rituximab,-1,375,mg/m2,1,on day 1 on a 28-day treatment cycle,fixed
23592273,NA,810,bendamustine,-1,70,mg/m2,1,on days 1 and 2 on a 28-day treatment cycle,NA
23592273,NA,810,lenalidomide,-1,5,mg,1,daily for 21 days on a 28-day treatment cycle,NA
23592273,NA,810,rituximab,1,375,mg/m2,1,on day 1 on a 28-day treatment cycle,fixed
23592273,NA,810,bendamustine,1,70,mg/m2,1,on days 1 and 2 on a 28-day treatment cycle,NA
23592273,NA,810,lenalidomide,1,10,mg,1,daily for 21 days on a 28-day treatment cycle,NA
23592273,NA,810,rituximab,2,375,mg/m2,1,on day 1 on a 28-day treatment cycle,fixed
23592273,NA,810,bendamustine,2,70,mg/m2,1,on days 1 and 2 on a 28-day treatment cycle,NA
23592273,NA,810,lenalidomide,2,15,mg,1,daily for 21 days on a 28-day treatment cycle,NA
23592273,NA,810,rituximab,3,375,mg/m2,1,on day 1 on a 28-day treatment cycle,fixed
23592273,NA,810,bendamustine,3,70,mg/m2,1,on days 1 and 2 on a 28-day treatment cycle,NA
23592273,NA,810,lenalidomide,3,20,mg,1,daily for 21 days on a 28-day treatment cycle,NA
23592273,NA,810,rituximab,4,375,mg/m2,1,on day 1 on a 28-day treatment cycle,fixed
23592273,NA,810,bendamustine,4,90,mg/m2,1,on days 1 and 2 on a 28-day treatment cycle,NA
23592273,NA,810,lenalidomide,4,20,mg,1,daily for 21 days on a 28-day treatment cycle,NA
22967996,NCT00706030,811,neratinib,1,160,mg,1,daily,NA
22967996,NCT00706030,811,vinorelbine,1,25,mg/m2,1,on day 1 and day 8 of 21 day cycle,NA
22967996,NCT00706030,811,neratinib,2,240,mg,1,daily,NA
22967996,NCT00706030,811,vinorelbine,2,25,mg/m2,1,on day 1 and day 8 of 21 day cycle,NA
21149673,NA,812,lenalidomide,1,5,mg/m2,1,daily for 21 days with a 1-week rest,Patients with myelodysplastic syndrome
21149673,NA,812,lenalidomide,2,15,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,3,20,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,4,25,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,5,30,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,6,40,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,7,55,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
21149673,NA,812,lenalidomide,8,70,mg/m2,1,daily for 21 days with a 1-week rest,in patients with solid tumors
20553268,NA,813,cyclophosphamide,1,300,mg,1,on days 1 and 8 of a 28 d cycle,NA
20553268,NA,813,lenalidomide,1,25,mg,1,days 1–21 of a 28 d cycle,NA
20553268,NA,813,dexamethasone,1,20,mg,1,days 1–4 and 8–11 of a 28 d cycle,NA
20553268,NA,813,cyclophosphamide,2,400,mg,1,on days 1 and 8 of a 28 d cycle,NA
20553268,NA,813,lenalidomide,2,25,mg,1,days 1–21 of a 28 d cycle,NA
20553268,NA,813,dexamethasone,2,20,mg,1,days 1–4 and 8–11 of a 28 d cycle,NA
20553268,NA,813,cyclophosphamide,3,500,mg,1,on days 1 and 8 of a 28 d cycle,NA
20553268,NA,813,lenalidomide,3,25,mg,1,days 1–21 of a 28 d cycle,NA
20553268,NA,813,dexamethasone,3,20,mg,1,days 1–4 and 8–11 of a 28 d cycle,NA
20553268,NA,813,cyclophosphamide,4,600,mg,1,on days 1 and 8 of a 28 d cycle,NA
20553268,NA,813,lenalidomide,4,25,mg,1,days 1–21 of a 28 d cycle,NA
20553268,NA,813,dexamethasone,4,20,mg,1,days 1–4 and 8–11 of a 28 d cycle,NA
20553268,NA,813,cyclophosphamide,5,700,mg,1,on days 1 and 8 of a 28 d cycle,NA
20553268,NA,813,lenalidomide,5,25,mg,1,days 1–21 of a 28 d cycle,NA
20553268,NA,813,dexamethasone,5,20,mg,1,days 1–4 and 8–11 of a 28 d cycle,NA
29938772,NCT01383928,814,ixazomib,1,3,mg,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
29938772,NCT01383928,814,lenalidomide,1,25,mg,1,on days 1–14 of a 21-day cycle,fixed
29938772,NCT01383928,814,dexamethasone,1,20,mg,1,"on days 1, 2,4, 5, 8, 9, 11 and 12 of a 21-day cycle",fixed
29938772,NCT01383928,814,ixazomib,2,3.7,mg,1,"on days 1, 4, 8 and 11 of a 21-day cycle",NA
29938772,NCT01383928,814,lenalidomide,2,25,mg,1,on days 1–14 of a 21-day cycle,fixed
29938772,NCT01383928,814,dexamethasone,2,20,mg,1,"on days 1, 2,4, 5, 8, 9, 11 and 12 of a 21-day cycle",fixed
9932161,NA,815,5-methyltetrahydrofolate,1,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,1,400,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,5-methyltetrahydrofolate,2,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,2,450,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,5-methyltetrahydrofolate,3,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,3,500,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,5-methyltetrahydrofolate,4,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,4,550,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,5-methyltetrahydrofolate,5,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,5,600,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,5-methyltetrahydrofolate,6,100,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
9932161,NA,815,fluorouracil,6,650,mg/m2,1,given either as i.v. bolus injection or as a two-hour infusion on days 1-5 every four weeks,NA
10656432,NA,816,melphalan,1,20,mg/m2,1,24-h continuous infusion every 3 weeks,NA
10656432,NA,816,melphalan,2,30,mg/m2,1,24-h continuous infusion every 3 weeks,NA
10656432,NA,816,melphalan,3,40,mg/m2,1,24-h continuous infusion every 3 weeks,NA
14970856,NA,817,bb-3644,1,5,mg,2,daily for 28 days or 84 days,NA
14970856,NA,817,bb-3644,2,10,mg,2,daily for 28 days or 84 days,NA
14970856,NA,817,bb-3644,3,20,mg,2,daily for 28 days or 84 days,NA
14970856,NA,817,bb-3644,4,30,mg,2,daily for 28 days or 84 days,NA
22892551,NCT00482846,818,melphalan,1,200,mg/m2,1,on day -2,NA
22892551,NCT00482846,818,palifermin,1,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,palifermin,1,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,melphalan,2,220,mg/m2,1,on day -2,NA
22892551,NCT00482846,818,palifermin,2,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,palifermin,2,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,melphalan,3,240,mg/m2,1,on day -2,NA
22892551,NCT00482846,818,palifermin,3,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,palifermin,3,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,melphalan,4,260,mg/m2,1,on day -2,NA
22892551,NCT00482846,818,palifermin,4,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,palifermin,4,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,melphalan,5,280,mg/m2,1,on day -2,NA
22892551,NCT00482846,818,palifermin,5,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22892551,NCT00482846,818,palifermin,5,60,mg/kg,1,on days -5 to -3 and 1-3,fixed
22549288,NA,819,sorafenib,1,400,mg/d,2,7 days prior to and 7 days following ILI-M,NA
22549288,NA,819,melphalan,1,7.5,mg/L,1,on day 0,NA
22549288,NA,819,sorafenib,2,600,mg/d,2,7 days prior to and 7 days following ILI-M,NA
22549288,NA,819,melphalan,2,7.5,mg/L,1,on day 0,NA
22549288,NA,819,sorafenib,3,800,mg/d,2,7 days prior to and 7 days following ILI-M,NA
22549288,NA,819,melphalan,3,7.5,mg/L,1,on day 0,NA
10863063,NA,820,uft,1,150,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,uft,1,150,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,leucovorin,1,90,mg/d,3,daily for 35 days concurrent with radiation,fixed
10863063,NA,820,radiotherapy,1,1.8,Gy,1,daily up to total 45 Gy,fixed
10863063,NA,820,uft,2,200,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,uft,2,200,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,leucovorin,2,90,mg/d,3,daily for 35 days concurrent with radiation,fixed
10863063,NA,820,radiotherapy,2,1.8,Gy,1,daily up to total 45 Gy,fixed
10863063,NA,820,uft,3,250,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,uft,3,250,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,leucovorin,3,90,mg/d,3,daily for 35 days concurrent with radiation,fixed
10863063,NA,820,radiotherapy,3,1.8,Gy,1,daily up to total 45 Gy,fixed
10863063,NA,820,uft,4,300,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,uft,4,300,mg/d,3,daily for 35 days concurrent with radiation,NA
10863063,NA,820,leucovorin,4,90,mg/d,3,daily for 35 days concurrent with radiation,fixed
10863063,NA,820,radiotherapy,4,1.8,Gy,1,daily up to total 45 Gy,fixed
19034580,NA,821,oxaliplatin,1,5,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,1,5,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,2,10,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,2,10,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,3,20,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,3,20,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,4,40,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,4,40,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,5,60,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,5,60,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,6,90,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,6,90,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,7,120,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,7,120,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,8,150,mg/m2,1,NA,NA
19034580,NA,821,oxaliplatin,8,150,mg/m2,1,NA,NA
9389936,NA,822,paclitaxel,1,150,mg/m2,1,every 3 weeks,NA
9389936,NA,822,5-fluorouracil,1,500,mg/m2,1,weekly,fixed
9389936,NA,822,paclitaxel,2,175,mg/m2,1,every 3 weeks,NA
9389936,NA,822,5-fluorouracil,2,500,mg/m2,1,weekly,fixed
9389936,NA,822,paclitaxel,3,200,mg/m2,1,every 3 weeks,NA
9389936,NA,822,5-fluorouracil,3,500,mg/m2,1,weekly,fixed
9389936,NA,822,paclitaxel,4,225,mg/m2,1,every 3 weeks,NA
9389936,NA,822,5-fluorouracil,4,500,mg/m2,1,weekly,fixed
9389916,NA,823,5-fluorouracil,1,600,mg/m2,1,"at the first course, escalated by 100 mg/m2 for each subsequent cohort. for 5 consecutive days every 3 weeks",NA
9389916,NA,823,1-folinic acid,1,150,mg/m2,1,for 5 consecutive days every 3 weeks,NA
9389916,NA,823,5-fluorouracil,2,700,mg/m2,1,"at the first course, escalated by 100 mg/m2 for each subsequent cohort. for 5 consecutive days every 3 weeks",NA
9389916,NA,823,1-folinic acid,2,150,mg/m2,1,for 5 consecutive days every 3 weeks,NA
9389916,NA,823,5-fluorouracil,3,800,mg/m2,1,"at the first course, escalated by 100 mg/m2 for each subsequent cohort. for 5 consecutive days every 3 weeks",NA
9389916,NA,823,1-folinic acid,3,150,mg/m2,1,for 5 consecutive days every 3 weeks,NA
9389916,NA,823,5-fluorouracil,4,900,mg/m2,1,"at the first course, escalated by 100 mg/m2 for each subsequent cohort. for 5 consecutive days every 3 weeks",NA
9389916,NA,823,1-folinic acid,4,150,mg/m2,1,for 5 consecutive days every 3 weeks,NA
9389916,NA,823,5-fluorouracil,5,1000,mg/m2,1,"at the first course, escalated by 100 mg/m2 for each subsequent cohort. for 5 consecutive days every 3 weeks",NA
9389916,NA,823,1-folinic acid,5,150,mg/m2,1,for 5 consecutive days every 3 weeks,NA
10590370,NA,825,melphalan,1,6,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,1,135,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,1,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,1,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,1,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,1,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,melphalan,2,10,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,2,135,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,2,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,2,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,2,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,2,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,melphalan,3,14,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,3,135,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,3,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,3,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,3,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,3,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,melphalan,4,10,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,4,150,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,4,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,4,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,4,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,4,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,melphalan,5,10,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,5,175,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,5,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,5,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,5,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,5,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,melphalan,6,10,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,paclitaxel,6,200,mg/m2,1,on Day 1 every 4 weeks,NA
10590370,NA,825,cisplatin,6,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,cisplatin,6,75,mg/m2,1,on Day 1 every 4 weeks,fixed
10590370,NA,825,g-csf,6,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
10590370,NA,825,g-csf,6,5,ug/kg,1,"starting approximately 24 hours after completion of the cisplatin infusion, 12–19 days every 4 weeks",fixed
18497327,NA,826,temozolomide,1,100,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,temozolomide,1,100,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,lomustine,1,90,mg/m2,1,on day 1 of each 4-week cycle,NA
18497327,NA,826,temozolomide,2,125,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,temozolomide,2,125,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,lomustine,2,90,mg/m2,1,on day 1 of each 4-week cycle,NA
18497327,NA,826,temozolomide,3,160,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,temozolomide,3,160,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,lomustine,3,90,mg/m2,1,on day 1 of each 4-week cycle,NA
18497327,NA,826,temozolomide,4,200,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,temozolomide,4,200,mg/m2,1,on days 1–5 of each 4-week cycle,NA
18497327,NA,826,lomustine,4,90,mg/m2,1,on day 1 of each 4-week cycle,NA
17146474,NA,827,lomustine,1,60,mg/m2,1,on day 5 every 56 days,NA
17146474,NA,827,temozolomide,1,100,mg/m2,1,days 1 – 5 every 28 days,NA
17146474,NA,827,temozolomide,1,100,mg/m2,1,days 1 – 5 every 28 days,NA
17146474,NA,827,lomustine,2,60,mg/m2,1,on day 5 every 56 days,NA
17146474,NA,827,temozolomide,2,150,mg/m2,1,days 1 – 5 every 28 days,NA
17146474,NA,827,temozolomide,2,150,mg/m2,1,days 1 – 5 every 28 days,NA
17146474,NA,827,lomustine,3,80,mg/m2,1,on day 5 every 56 days,NA
17146474,NA,827,temozolomide,3,150,mg/m2,1,days 1 – 5 every 28 days,NA
17146474,NA,827,temozolomide,3,150,mg/m2,1,days 1 – 5 every 28 days,NA
15256243,NA,828,mitomycin c,1,10,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
15256243,NA,828,melphalan,1,10,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
15256243,NA,828,mitomycin c,2,15,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
15256243,NA,828,melphalan,2,10,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
15256243,NA,828,mitomycin c,3,20,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
15256243,NA,828,melphalan,3,10,mg/m2,1,"underwent HAP, 6 weeks later underwent CAI",NA
10907951,NA,829,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,1,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,1,2,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,1,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,1,750,mg/m2,1,on day 2 every 2 weeks,NA
10907951,NA,829,cisplatin,2,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,2,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,2,2.5,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,2,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,2,750,mg/m2,1,on day 2 every 2 weeks,NA
10907951,NA,829,cisplatin,3,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,3,40,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,3,2.5,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,3,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,3,900,mg/m2,1,on day 2 every 2 weeks,NA
10907951,NA,829,cisplatin,4,50,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,4,50,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,4,2.5,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,4,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,4,900,mg/m2,1,on day 2 every 2 weeks,NA
10907951,NA,829,cisplatin,5,50,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,5,50,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,5,3,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,5,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,5,900,mg/m2,1,on day 2 every 2 weeks,NA
10907951,NA,829,cisplatin,6,60,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,cisplatin,6,60,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,raltitrexed,6,2.5,mg/m2,1,on day 1 every 2 weeks,NA
10907951,NA,829,levofolinic acid,6,250,mg/m2,1,on day 2 every 2 weeks,fixed
10907951,NA,829,5-fluorouracil,6,900,mg/m2,1,on day 2 every 2 weeks,NA
9554592,NA,830,5-fu,1,450,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,1,25,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,2,50,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,2,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,3,75,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,3,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,4,100,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,4,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,5,150,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,5,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,6,225,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,6,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
9554592,NA,830,5-fu,7,300,mg/m2,1,daily for 5 days  every 5 weeks,NA
9554592,NA,830,levamisole,7,450,mg/m2,3,daily for 5 days  every 5 weeks,NA
8418223,NA,831,levamisole,1,1,mg/kg,1,every other day for six doses,NA
8418223,NA,831,ifn-r,1,0.1,mg/m2,1,every other day,fixed
8418223,NA,831,levamisole,2,2.5,mg/kg,1,every other day for six doses,NA
8418223,NA,831,ifn-r,2,0.1,mg/m2,1,every other day,fixed
8418223,NA,831,levamisole,3,5,mg/kg,1,every other day for six doses,NA
8418223,NA,831,ifn-r,3,0.1,mg/m2,1,every other day,fixed
8418223,NA,831,levamisole,4,10,mg/kg,1,every other day for six doses,NA
8418223,NA,831,ifn-r,4,0.1,mg/m2,1,every other day,fixed
23090987,NCT00948389,832,dasatinib,1,100,mg,2,once daily (q.d.) escalated to b.i.d.in cycle 2,NA
23090987,NCT00948389,832,lomustine,1,110,mg/m2,1,every 6 weeks,NA
23090987,NCT00948389,832,dasatinib,1.5,100,mg,2,once daily (q.d.) escalated to b.i.d.in cycle 2,NA
23090987,NCT00948389,832,lomustine,1.5,90,mg/m2,1,every 6 weeks,NA
23090987,NCT00948389,832,dasatinib,2,100,mg,2,daily b.i.d,NA
23090987,NCT00948389,832,lomustine,2,90,mg/m2,1,every 6 weeks,NA
23090987,NCT00948389,832,dasatinib,3,150,mg,2,100 mg AM and 50 mg PM daily,NA
23090987,NCT00948389,832,lomustine,3,90,mg/m2,1,every 6 weeks,NA
23090987,NCT00948389,832,dasatinib,3.5,100,mg,1,daily,NA
23090987,NCT00948389,832,lomustine,3.5,90,mg/m2,1,every 6 weeks,NA
26553306,NA,833,melflufen,1,25,mg,1,on day 1 of a 21-day treatment cycle (Q3W) for up to a total of six cycles,NA
26553306,NA,833,melflufen,2,50,mg,1,on day 1 of a 21-day treatment cycle (Q3W) for up to a total of six cycles,NA
26553306,NA,833,melflufen,3,75,mg,1,on day 1 of a 21-day treatment cycle (Q3W) for up to a total of six cycles,NA
26553306,NA,833,melflufen,4,100,mg,1,on day 1 of a 21-day treatment cycle (Q3W) for up to a total of six cycles,NA
26553306,NA,833,melflufen,5,130,mg,1,on day 1 of a 21-day treatment cycle (Q3W) for up to a total of six cycles,NA
8622018,NA,834,azidothymidine,1,500,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,1,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,1,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,2,1000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,2,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,2,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,3,2000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,3,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,3,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,4,3000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,4,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,4,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,5,4000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,5,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,5,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,6,5000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,6,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,6,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,7,6000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,7,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,7,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,8,7000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,8,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,8,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,9,8000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,9,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,9,250,mg/m2,1,once a week of each 1-week cycle,fixed
8622018,NA,834,azidothymidine,10,10000,mg/m2,1,once a week of each 1-week cycle,NA
8622018,NA,834,fluorouracil,10,500,mg/m2,1,once a week in the middle of a 2-hour IV infusion of leucovorin,fixed
8622018,NA,834,leucovorin,10,250,mg/m2,1,once a week of each 1-week cycle,fixed
25125340,NA,835,oxaliplatin,1,50,mg,1,NA,NA
25125340,NA,835,oxaliplatin,1,50,mg,1,NA,NA
25125340,NA,835,melphalan,1,100,mg,1,NA,NA
25125340,NA,835,oxaliplatin,2,100,mg,1,NA,NA
25125340,NA,835,oxaliplatin,2,100,mg,1,NA,NA
25125340,NA,835,melphalan,2,100,mg,1,NA,NA
25125340,NA,835,oxaliplatin,3,150,mg,1,NA,NA
25125340,NA,835,oxaliplatin,3,150,mg,1,NA,NA
25125340,NA,835,melphalan,3,100,mg,1,NA,NA
9816300,NA,836,leucovorin,1,250,mg/m2,1,Two 14-day infusions were given during the course of radiotherapy,NA
9816300,NA,836,idurd,1,250,mg/m2,1,a 14-day course of continuous i.v. infusion of IdUrd prior to initiation of radiotherapy. Two additional 14-day infusions with LV were given during the course of radiotherapy,NA
9816300,NA,836,radiotherapy,1,1.8-2.0,Gy,1,5 days/week up to total 60 Gy in 6 weeks,NA
9816300,NA,836,leucovorin,2,400,mg/m2,1,Two 14-day infusions were given during the course of radiotherapy,NA
9816300,NA,836,idurd,2,250,mg/m2,1,a 14-day course of continuous i.v. infusion of IdUrd prior to initiation of radiotherapy. Two additional 14-day infusions with LV were given during the course of radiotherapy,NA
9816300,NA,836,radiotherapy,2,1.8-2.0,Gy,1,5 days/week up to total 60 Gy in 6 weeks,NA
9816300,NA,836,leucovorin,3,250,mg/m2,1,Two 14-day infusions were given during the course of radiotherapy,NA
9816300,NA,836,idurd,3,600,mg/m2,1,a 14-day course of continuous i.v. infusion of IdUrd prior to initiation of radiotherapy. Two additional 14-day infusions with LV were given during the course of radiotherapy,NA
9816300,NA,836,radiotherapy,3,1.8-2.0,Gy,1,5 days/week up to total 60 Gy in 6 weeks,NA
20478715,NA,837,melphalan,1,15,mg,1,NA,NA
20478715,NA,837,melphalan,2,30,mg,1,NA,NA
20478715,NA,837,melphalan,3,45,mg,1,NA,NA
20478715,NA,837,melphalan,4,60,mg,1,NA,NA
22453252,NCT00482846,838,melphalan,1,140,mg/m2,1,on Day -2,NA
22453252,NCT00482846,838,palifermin,1,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,palifermin,1,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,melphalan,2,160,mg/m2,1,on Day -2,NA
22453252,NCT00482846,838,palifermin,2,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,palifermin,2,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,melphalan,3,180,mg/m2,1,on Day -2,NA
22453252,NCT00482846,838,palifermin,3,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,palifermin,3,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,melphalan,4,200,mg/m2,1,on Day -2,NA
22453252,NCT00482846,838,palifermin,4,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
22453252,NCT00482846,838,palifermin,4,60,mg/kg/d,1,"on days -5, -4, and -3 and then repeated on day +1, +2, and +3 (peripheral blood stem cells infused on day 0)",NA
10442367,NA,839,paclitaxel,1,175,mg/m2,1,on day 1. Cycles were repeated on day 21,fixed
10442367,NA,839,uft,1,300,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,uft,1,300,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,calcium folinate,1,90,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,fixed
10442367,NA,839,paclitaxel,2,175,mg/m2,1,on day 1. Cycles were repeated on day 21,fixed
10442367,NA,839,uft,2,400,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,uft,2,400,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,calcium folinate,2,90,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,fixed
10442367,NA,839,paclitaxel,3,175,mg/m2,1,on day 1. Cycles were repeated on day 21,fixed
10442367,NA,839,uft,3,500,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,uft,3,500,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,calcium folinate,3,90,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,fixed
10442367,NA,839,paclitaxel,4,175,mg/m2,1,on day 1. Cycles were repeated on day 21,fixed
10442367,NA,839,uft,4,600,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,uft,4,600,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,NA
10442367,NA,839,calcium folinate,4,90,mg/d,3,started at day 1 and continued through day 14. Cycles were repeated on day 21,fixed
25784682,NCT01279694,840,carfilzomib,1,20,mg/m2,1,"on days 1, 2, 8, 9, 22, 23, 29, and 30 of a 42-day cycle",NA
25784682,NCT01279694,840,melphalan,1,9,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,prednisone,1,60,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,carfilzomib,2,27,mg/m2,1,"on days 1, 2, 8, 9, 22, 23, 29, and 30 of a 42-day cycle",NA
25784682,NCT01279694,840,melphalan,2,9,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,prednisone,2,60,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,carfilzomib,3,36,mg/m2,1,"on days 1, 2, 8, 9, 22, 23, 29, and 30 of a 42-day cycle",NA
25784682,NCT01279694,840,melphalan,3,9,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,prednisone,3,60,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,carfilzomib,4,45,mg/m2,1,"on days 1, 2, 8, 9, 22, 23, 29, and 30 of a 42-day cycle",NA
25784682,NCT01279694,840,melphalan,4,9,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
25784682,NCT01279694,840,prednisone,4,60,mg/m2,1,on days 1 to 4 of a 42-day cycle,NA
8004761,NA,841,floxuridine,1,500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,leucovorin,1,500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,floxuridine,2,1000,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,leucovorin,2,500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,floxuridine,3,1500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,leucovorin,3,500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,floxuridine,4,1650,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,leucovorin,4,500,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,floxuridine,5,1750,mg/m2,1,weekly for 6 weeks,NA
8004761,NA,841,leucovorin,5,500,mg/m2,1,weekly for 6 weeks,NA
11432616,NA,842,oxaliplatin,1,25,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,1,25,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,1,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,1,600,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,oxaliplatin,2,50,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,2,50,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,2,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,2,600,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,oxaliplatin,3,75,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,3,75,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,3,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,3,600,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,oxaliplatin,4,100,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,4,100,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,4,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,4,600,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,oxaliplatin,5,125,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,5,125,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,5,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,5,600,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,oxaliplatin,6,150,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,oxaliplatin,6,150,mg/m2,1,a four-hour infusion on days two and four every three weeks,NA
11432616,NA,842,folinic acid,6,200,mg/m2,1,for five consecutive days every three weeks,fixed
11432616,NA,842,5-fluorouracil,6,600,mg/m2,1,for five consecutive days every three weeks,fixed
12203099,NA,843,megestrol acetate,1,750(19),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,1,250(6),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,1,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,2,750(19),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,2,375(9),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,2,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,3,1000(25),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,3,500(13),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,3,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,4,1500(38),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,4,1000(25),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,4,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,5,3000(75),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,5,2000(50),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,5,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,6,4500(113),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,6,3000(75),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,6,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,7,6000(150),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,7,4000(100),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,7,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
12203099,NA,843,megestrol acetate,8,7500(188),mg(ml),1,a loading dose on day 1 every 4 weeks,NA
12203099,NA,843,megestrol acetate,8,5000(125),mg(ml),2,maintenance dosing begun 6 h after the loadingdose on day 1 and continued for 7 days thereafter every 4 weeks,NA
12203099,NA,843,vinblastine,8,1.5,mg/m2,1,a 5-day continuous i.v. infusion on days 2 to 6 every 4 weeks,fixed
10999043,NA,844,5-fluorouracil,1,600,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
10999043,NA,844,granulocyte-macrophage colonystimulating factor,1,250,mg/m2,1,"Daily beginning day -5 through day 43, resume day 51 for next 8-week cycle",fixed
10999043,NA,844,leucovorin,1,500,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
10999043,NA,844,5-fluorouracil,2,700,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
10999043,NA,844,granulocyte-macrophage colonystimulating factor,2,250,mg/m2,1,"Daily beginning day -5 through day 43, resume day 51 for next 8-week cycle",fixed
10999043,NA,844,leucovorin,2,500,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
10999043,NA,844,5-fluorouracil,3,800,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
10999043,NA,844,granulocyte-macrophage colonystimulating factor,3,250,mg/m2,1,"Daily beginning day -5 through day 43, resume day 51 for next 8-week cycle",fixed
10999043,NA,844,leucovorin,3,500,mg/m2,1,weekly for six doses followed by a 2-week rest,NA
9552052,NA,845,aminopterin,1,2.5,mg/m2,2,every 12 hours for two doses weekly,NA
9552052,NA,845,leucovorin,1,0,mg/m2,2,NA,NA
9552052,NA,845,aminopterin,2,2,mg/m2,2,every 12 hours for two doses weekly,NA
9552052,NA,845,leucovorin,2,0,mg/m2,2,NA,NA
9552052,NA,845,aminopterin,3,2,mg/m2,2,every 12 hours for two doses weekly,NA
9552052,NA,845,leucovorin,3,5,mg/m2,2,every 12 hours for two doses beginning 24 hours after the last dose of AMT,NA
9552051,NA,846,eniluracil,1,0.74,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,1,20,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,2,3.7,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,2,10,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,3,3.7,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,3,20,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,4,3.7,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,4,25,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,5,3.7,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,5,30,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,6,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,6,25,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,7,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,7,30,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,846,eniluracil,8,50,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,846,fluorouracil,8,20,mg/m2,1,on days 2 through 6 every 28 days,oral
9552051,NA,847,eniluracil,1,3.7,mg/m2,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,1,10,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,847,leucovorin,1,50,mg,1,on days 2 through 6 every 28 days,fixed
9552051,NA,847,eniluracil,2,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,2,10,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,847,leucovorin,2,50,mg,1,on days 2 through 6 every 28 days,fixed
9552051,NA,847,eniluracil,3,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,3,15,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,847,leucovorin,3,50,mg,1,on days 2 through 6 every 28 days,fixed
9552051,NA,847,eniluracil,4,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,4,20,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,847,leucovorin,4,50,mg,1,on days 2 through 6 every 28 days,fixed
9552051,NA,847,eniluracil,5,10,mg,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,5,25,mg/m2,1,on days 2 through 6 every 28 days,i.v.
9552051,NA,847,leucovorin,5,50,mg,1,on days 2 through 6 every 28 days,fixed
9552051,NA,847,eniluracil,6,50,mg,1,on days 1-7 every 28 days,NA
9552051,NA,847,fluorouracil,6,15,mg/m2,1,on days 2 through 6 every 28 days,oral
9552051,NA,847,leucovorin,6,50,mg,1,on days 2 through 6 every 28 days,fixed
8269603,NA,848,5-fluorouracil,1,200,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,1,5,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,5-fluorouracil,2,200,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,2,10,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,5-fluorouracil,3,200,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,3,15,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,5-fluorouracil,4,200,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,4,20,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,5-fluorouracil,5,250,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,5,20,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,5-fluorouracil,6,300,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8269603,NA,848,leucovorin,6,20,mg/m2/d,1,a continuous circadian infusion over 14 days every 28 days,NA
8558227,NA,849,paclitaxel,1,135,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,1,600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,1,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,1,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,2,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,2,600,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,2,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,2,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,3,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,3,900,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,3,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,3,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,4,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,4,1200,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,4,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,4,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,5,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,5,1500,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,5,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,5,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,6,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,6,1800,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,6,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,6,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,7,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,7,2100,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,7,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,7,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,8,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,8,2400,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,8,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,8,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,9,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,9,2700,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,9,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,9,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,paclitaxel,10,160,mg/m2,1,72-hour continuous intravenous (IV) infusion on  days 1-3 every 21 days,NA
8558227,NA,849,cyclophosphamide,10,3300,mg/m2,1,"on days 1, 2, and 3 every 21 days",NA
8558227,NA,849,granulocyte colony-stimulating factor,10,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
8558227,NA,849,granulocyte colony-stimulating factor,10,5,ug/ml,1,"after the 72-hour paclitaxel infusion ended and continuing until the WBC count was >= 10,000/uL on two determinations after the expected nadir as recommended by the manufacturer",fixed
11032595,NA,850,uft,-2,150,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,-2,150,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,-2,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,-2,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
11032595,NA,850,uft,-1,200,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,-1,200,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,-1,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,-1,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
11032595,NA,850,uft,0,250,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,0,250,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,0,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,0,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
11032595,NA,850,uft,1,300,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,1,300,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,1,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,1,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
11032595,NA,850,uft,2,350,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,2,350,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,2,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,2,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
11032595,NA,850,uft,3,400,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,uft,3,400,mg/m2/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,leucovorin,3,90,mg/d,3,Mondays through Fridays for 5 consecutive weeks during radiation therapy,NA
11032595,NA,850,radiation therapy,3,1.8,Gy,1,"Mondays through Fridays for 5 consecutive weeks, totaling 45 Gy",NA
16146748,NA,851,temozolomide,1,75,mg/m2,1,days 1-21 in 28-day cycles,NA
16146748,NA,851,temozolomide,1,75,mg/m2,1,days 1-21 in 28-day cycles,NA
16146748,NA,851,lomustine,1,100,mg/m2,1,on day 1 every 28 days,fixed
16146748,NA,851,temozolomide,2,75,mg/m2,1,days 1-28 in 6-week cycles,NA
16146748,NA,851,temozolomide,2,75,mg/m2,1,days 1-28 in 6-week cycles,NA
16146748,NA,851,lomustine,2,100,mg/m2,1,on day 1 every 6-week,fixed
16146748,NA,851,temozolomide,3,100,mg/m2,1,days 1-28 in 6-week cycles,NA
16146748,NA,851,temozolomide,3,100,mg/m2,1,days 1-28 in 6-week cycles,NA
16146748,NA,851,lomustine,3,100,mg/m2,1,on day 1 every 6-week,fixed
9661893,NA,852,lododeoxyuridine,1,625,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,852,lododeoxyuridine,2,1250,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,852,lododeoxyuridine,3,2500,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,852,lododeoxyuridine,4,3750,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,852,lododeoxyuridine,5,4125,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,852,lododeoxyuridine,6,4538,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,853,lododeoxyuridine,1,2500,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,853,leucovorin,1,500,mg/m2,1,4.5 days every 3 weeks.,NA
9661893,NA,853,lododeoxyuridine,2,3125,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,853,leucovorin,2,500,mg/m2,1,4.5 days every 3 weeks.,NA
9661893,NA,853,lododeoxyuridine,3,3483,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,853,leucovorin,3,500,mg/m2,1,4.5 days every 3 weeks.,NA
9661893,NA,853,lododeoxyuridine,4,3750,mg/m2,1,daily for 4 days every 3 weeks.,NA
9661893,NA,853,leucovorin,4,500,mg/m2,1,4.5 days every 3 weeks.,NA
9626215,NA,854,marimastat,1,25,mg,2,daily,NA
9626215,NA,854,marimastat,2,50,mg,2,daily,NA
9626215,NA,854,marimastat,3,100,mg,2,daily,NA
9193347,NA,855,pn401,1,3300,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,1,600,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,2,6600,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,2,600,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,3,9900,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,3,600,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,4,6000,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,4,700,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,5,6000,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,5,800,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,6,3300,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,6,800,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,7,6600,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,7,800,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
9193347,NA,855,pn401,8,6000,mg,4,given every 6 hours for 10 doses,NA
9193347,NA,855,fluorouracil,8,1000,mg/m2,1,weekly for 6 weeks with a 2-week rest,NA
15084615,NA,856,tirapazamine,1,250,mg/m2,1,every 3 weeks,in heavily pretreated patients
15084615,NA,856,cyclophosphamide,1,1500,mg/m2,1,every 3 weeks,fixed
15084615,NA,856,tirapazamine,2,325,mg/m2,1,every 3 weeks,in heavily pretreated patients
15084615,NA,856,cyclophosphamide,2,1500,mg/m2,1,every 3 weeks,fixed
15084615,NA,856,tirapazamine,3,420,mg/m2,1,every 3 weeks,"in in heavily pretreated patients and less-heavily
pretreated patients (Stratum 2)"
15084615,NA,856,cyclophosphamide,3,1500,mg/m2,1,every 3 weeks,fixed
9720737,NA,857,melphalan,1,160,mg/m2,1,twice within 90 days,NA
9720737,NA,857,melphalan,2,180,mg/m2,1,twice within 90 days,NA
9720737,NA,857,melphalan,3,200,mg/m2,1,twice within 90 days,NA
9358936,NA,858,vinorelbine,1,25,mg/m2,1,on day 1  and 3 every three weeks,NA
9358936,NA,858,5-fluorouracil,1,350,mg/m2,1,"on day 1, 2 and 3 every three weeks",fixed
9358936,NA,858,folinic acid,1,100,mg/m2,1,every three weeks,fixed
9358936,NA,858,vinorelbine,2,30,mg/m2,1,on day 1  and 3 every three weeks,NA
9358936,NA,858,5-fluorouracil,2,350,mg/m2,1,"on day 1, 2 and 3 every three weeks",fixed
9358936,NA,858,folinic acid,2,100,mg/m2,1,every three weeks,fixed
9713314,NA,859,6-mercaptopurine,1,25,mg/m2/d,1,14-day infusion in 28-day cycles,NA
9713314,NA,859,6-mercaptopurine,2,30,mg/m2/d,1,14-day infusion in 28-day cycles,NA
9713314,NA,859,6-mercaptopurine,3,35,mg/m2/d,1,14-day infusion in 28-day cycles,NA
32400117,CTRI/2018/01/011542,860,mebendazole,0,100,mg,3,daily,NA
32400117,CTRI/2018/01/011542,860,temozolomide,0,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,temozolomide,0,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,radiation,0,50.4-54,Gy,1,in 28-30 fractions over 5.5-6 weeks,fixed
32400117,CTRI/2018/01/011542,860,mebendazole,1,200,mg,3,daily,NA
32400117,CTRI/2018/01/011542,860,temozolomide,1,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,temozolomide,1,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,radiation,1,50.4-54,Gy,1,in 28-30 fractions over 5.5-6 weeks,fixed
32400117,CTRI/2018/01/011542,860,mebendazole,2,400,mg,3,daily,NA
32400117,CTRI/2018/01/011542,860,temozolomide,2,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,temozolomide,2,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,radiation,2,50.4-54,Gy,1,in 28-30 fractions over 5.5-6 weeks,fixed
32400117,CTRI/2018/01/011542,860,mebendazole,3,800,mg,3,daily,NA
32400117,CTRI/2018/01/011542,860,temozolomide,3,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,temozolomide,3,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,radiation,3,50.4-54,Gy,1,in 28-30 fractions over 5.5-6 weeks,fixed
32400117,CTRI/2018/01/011542,860,mebendazole,4,1600,mg,3,daily,NA
32400117,CTRI/2018/01/011542,860,temozolomide,4,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,temozolomide,4,75,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,860,radiation,4,50.4-54,Gy,1,in 28-30 fractions over 5.5-6 weeks,fixed
32400117,CTRI/2018/01/011542,861,mebendazole,0,100,mg,3,daily,NA
32400117,CTRI/2018/01/011542,861,lomustine,0,110,mg/m2,1,on day 1 of a 42-day cycle,fixed
32400117,CTRI/2018/01/011542,861,mebendazole,1,200,mg,3,daily,NA
32400117,CTRI/2018/01/011542,861,lomustine,1,110,mg/m2,1,on day 1 of a 42-day cycle,fixed
32400117,CTRI/2018/01/011542,861,mebendazole,2,400,mg,3,daily,NA
32400117,CTRI/2018/01/011542,861,lomustine,2,110,mg/m2,1,on day 1 of a 42-day cycle,fixed
32400117,CTRI/2018/01/011542,861,mebendazole,3,800,mg,3,daily,NA
32400117,CTRI/2018/01/011542,861,lomustine,3,110,mg/m2,1,on day 1 of a 42-day cycle,fixed
32400117,CTRI/2018/01/011542,861,mebendazole,4,1600,mg,3,daily,NA
32400117,CTRI/2018/01/011542,861,lomustine,4,110,mg/m2,1,on day 1 of a 42-day cycle,fixed
32400117,CTRI/2018/01/011542,862,mebendazole,0,100,mg,3,daily,NA
32400117,CTRI/2018/01/011542,862,temozolomide,0,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,temozolomide,0,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,mebendazole,1,200,mg,3,daily,NA
32400117,CTRI/2018/01/011542,862,temozolomide,1,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,temozolomide,1,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,mebendazole,2,400,mg,3,daily,NA
32400117,CTRI/2018/01/011542,862,temozolomide,2,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,temozolomide,2,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,mebendazole,3,800,mg,3,daily,NA
32400117,CTRI/2018/01/011542,862,temozolomide,3,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,temozolomide,3,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,mebendazole,4,1600,mg,3,daily,NA
32400117,CTRI/2018/01/011542,862,temozolomide,4,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
32400117,CTRI/2018/01/011542,862,temozolomide,4,200,mg/m2,1,"from day 1 to day 5, in a 28-day cycle",fixed
7977165,NA,863,5-fluorouracil,1,450,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,1,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,1,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,5-fluorouracil,2,500,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,2,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,2,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,5-fluorouracil,3,550,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,3,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,3,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,5-fluorouracil,4,600,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,4,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,4,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,5-fluorouracil,5,650,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,5,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,5,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,5-fluorouracil,6,700,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,NA
7977165,NA,863,levofolinic acid,6,100,mg/m2,1,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
7977165,NA,863,hydroxyurea,6,1000,mg/m2/week,3,weekly for 6 consec­utive weeks followed by a 15-day rest period,fixed
12381899,NA,864,oxaliplatin,1,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,1,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,2,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,2,40,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,2,22,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,3,45,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,3,45,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,3,22,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,4,45,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,4,45,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,5,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,5,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,5,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,6,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,6,50,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,6,27,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,7,55,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,oxaliplatin,7,55,mg/m2,1,on days 1 and 8 every 3 weeks,NA
12381899,NA,864,vinorelbine,7,27,mg/m2,1,on days 1 and 8 every 3 weeks,NA
33021083,EudraCT2010-021525-13,865,modrapac001,1,2.5/2.5,mg,2,daily treatment with a morning dose of 2.5 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,1,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,1,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac001,2,5-May,mg,2,daily treatment with a morning dose of 5 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,2,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,2,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac001,3,7.5/7.5,mg,2,daily treatment with a morning dose of 7.5 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,3,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,3,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac001,4,10-Oct,mg,2,daily treatment with a morning dose of 10 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,4,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,4,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac001,5,15/15,mg,2,daily treatment with a morning dose of 15 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,5,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,5,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac001,6,20/20,mg,2,daily treatment with a morning dose of 20 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,6,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,6,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac005,7,20/20,mg,2,daily treatment with a morning dose of 20 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,7,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,7,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac005,8,30/20,mg,2,daily treatment with a morning dose of 30 mg followed by 20 mg evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,8,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,8,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,modrapac005,9,30/30,mg,2,daily treatment with a morning dose of 30 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,9,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
33021083,EudraCT2010-021525-13,865,ritonavir,9,100/100,mg,2,daily treatment with a morning dose of 100 mg followed by the same evening dose in treatment cycles of 21 days,NA
30077789,NA,866,nilotinib,-2,150,mg,1,qAM on days 1 to 56.,NA
30077789,NA,866,radiation,-2,1.8,Gy,1,"5 days per week, for a total of 28 fractions over a 6-week period to a dose of 50.4Gy",fixed
30077789,NA,866,nilotinib,-1,200,mg,1,qAM on days 1 to 56.,NA
30077789,NA,866,radiation,-1,1.8,Gy,1,"5 days per week, for a total of 28 fractions over a 6-week period to a dose of 50.4Gy",fixed
30077789,NA,866,nilotinib,1,200,mg,2,on days 1 to 56.,NA
30077789,NA,866,radiation,1,1.8,Gy,1,"5 days per week, for a total of 28 fractions over a 6-week period to a dose of 50.4Gy",fixed
30077789,NA,866,nilotinib,2,400 qAM/200qPM,mg,2,on days 1 to 56.,NA
30077789,NA,866,radiation,2,1.8,Gy,1,"5 days per week, for a total of 28 fractions over a 6-week period to a dose of 50.4Gy",fixed
30077789,NA,866,nilotinib,3,400,mg,2,on days 1 to 56.,NA
30077789,NA,866,radiation,3,1.8,Gy,1,"5 days per week, for a total of 28 fractions over a 6-week period to a dose of 50.4Gy",fixed
15539916,NA,867,bay59,1,15,mg/m2,1,every 3 weeks,NA
15539916,NA,867,bay59,2,30,mg/m2,1,every 3 weeks,NA
15539916,NA,867,bay59,3,50,mg/m2,1,every 3 weeks,NA
15539916,NA,867,bay59,4,75,mg/m2,1,every 3 weeks,NA
15539916,NA,867,bay59,5,90,mg/m2,1,every 3 weeks,NA
15539916,NA,867,bay59,6,100,mg/m2,1,every 3 weeks,NA
33039812,NCT03294252,868,oxaliplatin,1,90,mg/m2,1,two consecutives PIPAC sessions separated by 4-6 weeks,NA
33039812,NCT03294252,868,oxaliplatin,1,90,mg/m2,1,two consecutives PIPAC sessions separated by 4-6 weeks,NA
33039812,NCT03294252,868,5-fluorouracil,1,400,mg/m2,1,between 1 h and 24 h before PIPAC,fixed
33039812,NCT03294252,868,l-folinic acid,1,20,mg/m2,1,between 1 h and 24 h before PIPAC,fixed
33039812,NCT03294252,868,oxaliplatin,2,140,mg/m2,1,two consecutives PIPAC sessions separated by 4-6 weeks,NA
33039812,NCT03294252,868,oxaliplatin,2,140,mg/m2,1,two consecutives PIPAC sessions separated by 4-6 weeks,NA
33039812,NCT03294252,868,5-fluorouracil,2,400,mg/m2,1,between 1 h and 24 h before PIPAC,fixed
33039812,NCT03294252,868,l-folinic acid,2,20,mg/m2,1,between 1 h and 24 h before PIPAC,fixed
34518310,NCT02366949,869,bay 1217389,1,0.25,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",Oral solution
34518310,NCT02366949,869,paclitaxel,1,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,2,0.5,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",Oral solution
34518310,NCT02366949,869,paclitaxel,2,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,3,1,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",Oral solution
34518310,NCT02366949,869,paclitaxel,3,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,4,2,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",Oral solution
34518310,NCT02366949,869,paclitaxel,4,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,5,4,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",Oral solution
34518310,NCT02366949,869,paclitaxel,5,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,6,16,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,6,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,7,32,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,7,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,8,64,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,8,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,9,120,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,9,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,10,240,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,10,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
34518310,NCT02366949,869,bay 1217389,11,80,mg,2,"on D1, D2, D8, D9, D15 and D16 of a 28 day cycle",capsul formulation
34518310,NCT02366949,869,paclitaxel,11,90,mg/m2,1,"on D1, D8, and D15 of a 28 day cycle",fixed
29437791,NA,870,cpi-613,1,500,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,1,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,1,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,2,1000,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,2,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,2,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,3,1500,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,3,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,3,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,4,1750,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,4,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,4,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,5,2000,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,5,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,5,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,6,2250,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,6,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,6,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
29437791,NA,870,cpi-613,7,2500,mg/m2,1,"on days 1–5 of week 1, followed by 1 week of rest (14 days total)",NA
29437791,NA,870,cytarabine,7,3 gm/m2 for age <60 or 1.5 gm/m2 for age 60,gm/m2,2,"every 12 hours for 5 doses, starting on day 3 of week 1, followed by 1 week of rest (14 days total)",fixed
29437791,NA,870,mitoxantrone,7,6,mg/m2,1,"daily for 3 doses after the 1st, 3rd, and 5th doses of cytarabine",fixed
20445979,NA,871,osi-461,1,200,mg,2,"daily once on Cycle 1, Day 1 and twice daily from Day 2 onward",NA
20445979,NA,871,mitoxantrone,1,12,mg/m2,1,on Day 1 of every 21-day cycle,fixed
20445979,NA,871,osi-461,2,400,mg,2,"daily once on Cycle 1, Day 1 and twice daily from Day 2 onward",NA
20445979,NA,871,mitoxantrone,2,12,mg/m2,1,on Day 1 of every 21-day cycle,fixed
20445979,NA,871,osi-461,3,600,mg,2,"daily once on Cycle 1, Day 1 and twice daily from Day 2 onward",NA
20445979,NA,871,mitoxantrone,3,12,mg/m2,1,on Day 1 of every 21-day cycle,fixed
20445979,NA,871,osi-461,4,800,mg,2,"daily once on Cycle 1, Day 1 and twice daily from Day 2 onward",NA
20445979,NA,871,mitoxantrone,4,12,mg/m2,1,on Day 1 of every 21-day cycle,fixed
20445979,NA,871,osi-461,5,1000,mg,2,"daily once on Cycle 1, Day 1 and twice daily from Day 2 onward",NA
20445979,NA,871,mitoxantrone,5,12,mg/m2,1,on Day 1 of every 21-day cycle,fixed
19774342,NA,872,rebeccamycin analog,1,80,mg/m2,1,daily on days 1–5 every 21 days,NA
19774342,NA,872,oxaliplatin,1,90,mg/m2,1,on day 5 every 21 days,NA
19774342,NA,872,oxaliplatin,1,90,mg/m2,1,on day 5 every 21 days,NA
19774342,NA,872,rebeccamycin analog,2,80,mg/m2,1,daily on days 1–5 every 21 days,NA
19774342,NA,872,oxaliplatin,2,130,mg/m2,1,on day 5 every 21 days,NA
19774342,NA,872,oxaliplatin,2,130,mg/m2,1,on day 5 every 21 days,NA
19774342,NA,872,rebeccamycin analog,3,110,mg/m2,1,daily on days 1–5 every 21 days,NA
19774342,NA,872,oxaliplatin,3,130,mg/m2,1,on day 5 every 21 days,NA
19774342,NA,872,oxaliplatin,3,130,mg/m2,1,on day 5 every 21 days,NA
9849448,NA,873,paclitaxel,1,250,mg/m2,1,"3 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,1,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,1,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,2,300,mg/m2,1,"3 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,2,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,2,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,3,350,mg/m2,1,"3 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,3,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,3,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,4,350,mg/m2,1,"6 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,4,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,4,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,5,400,mg/m2,1,"3 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,5,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,5,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,6,400,mg/m2,1,"6 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,6,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,6,23.3,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,paclitaxel,7,450,mg/m2,1,"6 h i.v. infusion on day 4, after 48 h of rest, the ABSCs were re-infused and rhG-CSF was administered",NA
9849448,NA,873,cyclophosphamide,7,2000,mg/m2,1,on 3 consecutive days,NA
9849448,NA,873,mitoxantrone,7,23.3,mg/m2,1,on 3 consecutive days,NA
18493824,NA,874,oxaliplatin,1,200,mg/m2,1,NA,NA
18493824,NA,874,oxaliplatin,1,200,mg/m2,1,NA,NA
18493824,NA,874,oxaliplatin,2,250,mg/m2,1,NA,NA
18493824,NA,874,oxaliplatin,2,250,mg/m2,1,NA,NA
32816079,NA,875,temozolomide,1,50,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,temozolomide,1,50,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,radiotherapy,1,NA,Gy,NA,"5 days/week. Total 30 Gy to the whole brain plus leptomeninges to C2, including the third posterior of the orbital cavity (clinical target volume 2; CTV2), plus 6, 10, or 16 Gy to the primary site",NA
32816079,NA,875,temozolomide,2,60,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,temozolomide,2,60,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,radiotherapy,2,NA,Gy,NA,"5 days/week. Total 30 Gy to the whole brain plus leptomeninges to C2, including the third posterior of the orbital cavity (clinical target volume 2; CTV2), plus 6, 10, or 16 Gy to the primary site",NA
32816079,NA,875,temozolomide,3,75,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,temozolomide,3,75,mg/m2/d,1,"daily, 5 days/week during RT",NA
32816079,NA,875,radiotherapy,3,NA,Gy,NA,"5 days/week. Total 30 Gy to the whole brain plus leptomeninges to C2, including the third posterior of the orbital cavity (clinical target volume 2; CTV2), plus 6, 10, or 16 Gy to the primary site",NA
33602685,NCT2379247,876,alpelisib,1,250,mg,1,daily,NA
33602685,NCT2379247,876,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8, and 15 every 28 days",fixed
33602685,NCT2379247,876,alpelisib,2,300,mg,1,daily,NA
33602685,NCT2379247,876,nab-paclitaxel,2,100,mg/m2,1,"on days 1, 8, and 15 every 28 days",fixed
33602685,NCT2379247,876,alpelisib,3,350,mg,1,daily,NA
33602685,NCT2379247,876,nab-paclitaxel,3,100,mg/m2,1,"on days 1, 8, and 15 every 28 days",fixed
18394816,NA,877,mitomycin c,1,15,mg/m2,1,30 min before the sixth fraction of radiotherapy,fixed
18394816,NA,877,cisplatin,1,10,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,cisplatin,1,10,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,conventional radiotherapy,1,2,Gy,1,"75 Gy in 35 fractions, 5 fractions per week",fixed
18394816,NA,877,mitomycin c,2,15,mg/m2,1,30 min before the sixth fraction of radiotherapy,fixed
18394816,NA,877,cisplatin,2,12,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,cisplatin,2,12,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,conventional radiotherapy,2,2,Gy,1,"75 Gy in 35 fractions, 5 fractions per week",fixed
18394816,NA,877,mitomycin c,3,15,mg/m2,1,30 min before the sixth fraction of radiotherapy,fixed
18394816,NA,877,cisplatin,3,14,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,cisplatin,3,14,mg/m2,1,daily starting with the last 10 fractions of XRT,NA
18394816,NA,877,conventional radiotherapy,3,2,Gy,1,"75 Gy in 35 fractions, 5 fractions per week",fixed
32037195,NCT01952249,878,demcizumab,1,2.5,mg/kg,1,on days 1 and 15 for each of three 28-day cycles,NA
32037195,NCT01952249,878,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 for each of three 28-day cycles",NA
32037195,NCT01952249,878,demcizumab,2,3.5,mg/kg,1,on days 1 and 15 for each of three 28-day cycles,NA
32037195,NCT01952249,878,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 for each of three 28-day cycles",NA
32037195,NCT01952249,878,demcizumab,3,5,mg/kg,1,on days 1 and 15 for each of three 28-day cycles,NA
32037195,NCT01952249,878,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 for each of three 28-day cycles",NA
11281378,NA,879,mitoxantrone,1,20,mg/m2,1,every 4 weeks,NA
11281378,NA,879,cyclophosphamide,1,3000,mg/m2,1,every 4 weeks,NA
11281378,NA,879,mitoxantrone,2,20,mg/m2,1,every 4 weeks,NA
11281378,NA,879,cyclophosphamide,2,4000,mg/m2,1,every 4 weeks,NA
11281378,NA,879,mitoxantrone,3,25,mg/m2,1,every 4 weeks,NA
11281378,NA,879,cyclophosphamide,3,4000,mg/m2,1,every 4 weeks,NA
11281378,NA,879,mitoxantrone,4,30,mg/m2,1,every 4 weeks,NA
11281378,NA,879,cyclophosphamide,4,4000,mg/m2,1,every 4 weeks,NA
16619562,NA,880,lipoxal,1,100,mg/m2,1,once weekly for 8 consecutive weeks,NA
16619562,NA,880,lipoxal,2,150,mg/m2,1,once weekly for 8 consecutive weeks,NA
16619562,NA,880,lipoxal,3,200,mg/m2,1,once weekly for 8 consecutive weeks,NA
16619562,NA,880,lipoxal,4,250,mg/m2,1,once weekly for 8 consecutive weeks,NA
16619562,NA,880,lipoxal,5,300,mg/m2,1,once weekly for 8 consecutive weeks,NA
16619562,NA,880,lipoxal,6,350,mg/m2,1,once weekly for 8 consecutive weeks,NA
7544169,NA,881,mitoxantrone,1,3,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,vinorelbine,1,15,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,g-csf,1,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,g-csf,1,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,mitoxantrone,1,3,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,vinorelbine,1,15,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,mitoxantrone,1,3,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,vinorelbine,1,15,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,mitoxantrone,2,4,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,vinorelbine,2,20,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,g-csf,2,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,g-csf,2,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,mitoxantrone,2,4,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,vinorelbine,2,20,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,mitoxantrone,2,4,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,vinorelbine,2,20,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,mitoxantrone,3,5,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,vinorelbine,3,25,mg/m2,1,on d 1 every 3 weeks,schedule a
7544169,NA,881,g-csf,3,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,g-csf,3,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,mitoxantrone,3,5,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,vinorelbine,3,25,mg/m2,1,on d 1 and 8 every 3 weeks,schedule b
7544169,NA,881,mitoxantrone,3,5,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,vinorelbine,3,25,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,mitoxantrone,4,6,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,vinorelbine,4,30,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,g-csf,4,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,g-csf,4,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,mitoxantrone,5,7,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,vinorelbine,5,35,mg/m2,1,"in days 1, 8, and 15 every 3 weeks",schedule c
7544169,NA,881,g-csf,5,5,ug/kg,1,d 3-13 every 3 weeks,NA
7544169,NA,881,g-csf,5,5,ug/kg,1,d 3-13 every 3 weeks,NA
11283925,NCT01810718,882,oxaliplatin,1,85,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,oxaliplatin,1,85,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,raltitrexed,1,3,mg/m2,1,every 3 weeks for a total of eight courses,fixed
11283925,NCT01810718,882,oxaliplatin,2,100,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,oxaliplatin,2,100,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,raltitrexed,2,3,mg/m2,1,every 3 weeks for a total of eight courses,fixed
11283925,NCT01810718,882,oxaliplatin,3,120,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,oxaliplatin,3,120,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,raltitrexed,3,3,mg/m2,1,every 3 weeks for a total of eight courses,fixed
11283925,NCT01810718,882,oxaliplatin,4,130,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,oxaliplatin,4,130,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,raltitrexed,4,3,mg/m2,1,every 3 weeks for a total of eight courses,fixed
11283925,NCT01810718,882,oxaliplatin,5,140,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,oxaliplatin,5,140,mg/m2,1,every 3 weeks for a total of eight courses,NA
11283925,NCT01810718,882,raltitrexed,5,3,mg/m2,1,every 3 weeks for a total of eight courses,fixed
17681103,NA,883,pemetrexed,0,500,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,0,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,0,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,pemetrexed,1,600,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,1,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,1,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,pemetrexed,2,700,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,2,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,2,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,pemetrexed,3,800,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,3,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,3,120,mg/m2,1,every 3 weeks,NA
17681103,NA,883,pemetrexed,4,800,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,4,130,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,4,130,mg/m2,1,every 3 weeks,NA
17681103,NA,883,pemetrexed,5,900,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,5,130,mg/m2,1,every 3 weeks,NA
17681103,NA,883,oxaliplatin,5,130,mg/m2,1,every 3 weeks,NA
32520407,NCT00916630,884,pemetrexed,1,600,mg/m2,1,every 14 days,NA
32520407,NCT00916630,884,pemetrexed,2,900,mg/m2,1,every 14 days,NA
32520407,NCT00916630,884,pemetrexed,3,1200,mg/m2,1,every 14 days,NA
34256279,NCT01677559,885,alisertib,0,20,mg,1,on Days 1-3 of the first 3 weeks of each 4-week cycle,NA
34256279,NCT01677559,885,nab-paclitaxel,0,100,mg/m2,1,on Day 1 of the first 3 weeks of each 4-week cycle,fixed
34256279,NCT01677559,885,alisertib,1,30,mg,1,on Days 1-3 of the first 3 weeks of each 4-week cycle,NA
34256279,NCT01677559,885,nab-paclitaxel,1,100,mg/m2,1,on Day 1 of the first 3 weeks of each 4-week cycle,fixed
34256279,NCT01677559,885,alisertib,2,40,mg,1,on Days 1-3 of the first 3 weeks of each 4-week cycle,NA
34256279,NCT01677559,885,nab-paclitaxel,2,100,mg/m2,1,on Day 1 of the first 3 weeks of each 4-week cycle,fixed
34256279,NCT01677559,885,alisertib,3,50,mg,1,on Days 1-3 of the first 3 weeks of each 4-week cycle,NA
34256279,NCT01677559,885,nab-paclitaxel,3,100,mg/m2,1,on Day 1 of the first 3 weeks of each 4-week cycle,fixed
29720734,NCT02044796,886,cladribine,1,5,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,cytarabine,1,2000,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,filgrastim,1,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,filgrastim,1,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,mitoxantrone hydrochloride,1,12,mg/m2,1,on days 1-3,NA
29720734,NCT02044796,886,cladribine,2,5,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,cytarabine,2,2000,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,filgrastim,2,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,filgrastim,2,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,mitoxantrone hydrochloride,2,14,mg/m2,NA,on days 1-3,NA
29720734,NCT02044796,886,cladribine,3,5,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,cytarabine,3,2000,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,filgrastim,3,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,filgrastim,3,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,mitoxantrone hydrochloride,3,16,mg/m2,NA,on days 1-3,NA
29720734,NCT02044796,886,cladribine,4,5,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,cytarabine,4,2000,mg/m2,1,daily on days 1-5,fixed
29720734,NCT02044796,886,filgrastim,4,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,filgrastim,4,300 or 480,ug/day,1,daily on days 0-5,fixed
29720734,NCT02044796,886,mitoxantrone hydrochloride,4,18,mg/m2,NA,on days 1-3,NA
15205208,NA,887,pemetrexed,1,300,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,1,85,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,1,85,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,pemetrexed,2,400,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,2,85,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,2,85,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,pemetrexed,3,400,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,3,100,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,3,100,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,pemetrexed,4,500,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,4,100,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,4,100,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,pemetrexed,5,500,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,5,120,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,5,120,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,pemetrexed,6,500,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,6,130,mg/m2,1,on day 1 every 21 days,NA
15205208,NA,887,oxaliplatin,6,130,mg/m2,1,on day 1 every 21 days,NA
17308894,NA,888,ap5346,1,40,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,2,80,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,3,160,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,4,320,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,5,640,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,6,850,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17308894,NA,888,ap5346,7,1280,Pt/m2,1,"on days 1, 8, 15 of a 28-day cycle",NA
17538173,NA,889,oxaliplatin,0,oxaliplatin,mg/m2,1,every 2 weeks,NA
17538173,NA,889,oxaliplatin,0,oxaliplatin,mg/m2,1,every 2 weeks,NA
17538173,NA,889,oxaliplatin,1,100,mg/m2,1,at 3-week intervals,NA
17538173,NA,889,oxaliplatin,1,100,mg/m2,1,at 3-week intervals,NA
17538173,NA,889,oxaliplatin,2,130,mg/m2,1,at 3-week intervals,NA
17538173,NA,889,oxaliplatin,2,130,mg/m2,1,at 3-week intervals,NA
17538173,NA,889,oxaliplatin,3,160,mg/m2,1,at 3-week intervals,NA
17538173,NA,889,oxaliplatin,3,160,mg/m2,1,at 3-week intervals,NA
30889492,NCT02848443,890,trifluridine/tipiracil,1,25,mg/m2,2,"days 1e5, q14 days",NA
30889492,NCT02848443,890,oxaliplatin,1,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,oxaliplatin,1,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,trifluridine/tipiracil,2,30,mg/m2,2,"days 1e5, q14 days",NA
30889492,NCT02848443,890,oxaliplatin,2,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,oxaliplatin,2,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,trifluridine/tipiracil,3,35,mg/m2,2,"days 1e5, q14 days",NA
30889492,NCT02848443,890,oxaliplatin,3,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,oxaliplatin,3,85,mg/m2,1,"day 1, q14 days",fixed
30889492,NCT02848443,890,trifluridine/tipiracil,2.5,35,mg/m2,2,"days 1e5, q14 days",NA
30889492,NCT02848443,890,oxaliplatin,2.5,65,mg/m2,1,"day 1, q14 days",NA
30889492,NCT02848443,890,oxaliplatin,2.5,65,mg/m2,1,"day 1, q14 days",NA
34272090,NCT02788708,891,paclitaxel,-1,60,mg/m2,1,"day 1, 8, 15 on a 28-day cycle",NA
34272090,NCT02788708,891,lenvatinib,-1,8,mg,1,daily on a 28-day cycle,NA
34272090,NCT02788708,891,paclitaxel,1,80,mg/m2,1,"day 1, 8, 15 on a 28-day cycle",NA
34272090,NCT02788708,891,lenvatinib,1,8,mg,1,daily on a 28-day cycle,NA
34272090,NCT02788708,891,paclitaxel,2,80,mg/m2,1,"day 1, 8, 15 on a 28-day cycle",NA
34272090,NCT02788708,891,lenvatinib,2,12,mg,1,daily on a 28-day cycle,NA
34272090,NCT02788708,891,paclitaxel,3,80,mg/m2,1,"day 1, 8, 15 on a 28-day cycle",NA
34272090,NCT02788708,891,lenvatinib,3,16,mg,1,daily on a 28-day cycle,NA
34272090,NCT02788708,891,paclitaxel,4,80,mg/m2,1,"day 1, 8, 15 on a 28-day cycle",NA
34272090,NCT02788708,891,lenvatinib,4,20,mg,1,daily on a 28-day cycle,NA
15908652,NA,892,nelarabine,1,5,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",NA
15908652,NA,892,nelarabine,2,10,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",NA
15908652,NA,892,nelarabine,3,20,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",NA
15908652,NA,892,nelarabine,4,40,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",NA
15908652,NA,892,nelarabine,5,60,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",NA
15908652,NA,892,nelarabine,6,75,mg/kg,1,"daily for 5 consecutive days, every 21 to 28 days",pediatric only
15908652,NA,892,nelarabine,7,1000,mg/m2,1,"daily for 5 consecutive days, every 21 to 28 days",adult only
15908652,NA,892,nelarabine,8,1200,mg/m2,1,"daily for 5 consecutive days, every 21 to 28 days",NA
33975862,NCT02630199,893,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,1,40,mg,1,days 1 to 21 of every 28-day treatment cycle,"Solid tumors and
IO resistant melanoma"
33975862,NCT02630199,893,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,2,60,mg,1,days 1 to 21 of every 28-day treatment cycle,"Solid tumors and
IO resistant melanoma"
33975862,NCT02630199,893,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,3,80,mg,1,days 1 to 21 of every 28-day treatment cycle,"Solid tumors and
IO resistant melanoma"
33975862,NCT02630199,893,paclitaxel,4,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,4,160,mg,1,days 1 to 21 of every 28-day treatment cycle,"Solid tumors and
IO resistant melanoma"
33975862,NCT02630199,893,paclitaxel,5,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,5,240,mg,1,days 1 to 7 of every 28-day treatment cycle,IO-resistant melanoma only
33975862,NCT02630199,893,paclitaxel,5.5,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,5.5,160,mg,1,days 1 to 14 of every 28-day treatment cycle,IO-resistant melanoma only
33975862,NCT02630199,893,paclitaxel,6,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,6,160,mg,2,days 1 to 14 of every 28-day treatment cycle,IO-resistant melanoma only
33975862,NCT02630199,893,paclitaxel,7,80,mg/m2,1,"on days 1, 8, and 15 of every 28-day treatment cycle",fixed
33975862,NCT02630199,893,ceralasertib,7,240,mg,2,days 1 to 14 of every 28-day treatment cycle,IO-resistant melanoma only
31810960,UMIN 000010945,894,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8 and 15 of each 21-day cycle",NA
31810960,UMIN 000010945,894,cyclophosphamide,1,600,mg/m2,1,on day 1 of each 21-day cycle,NA
31810960,UMIN 000010945,894,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8 and 15 of each 21-day cycle",NA
31810960,UMIN 000010945,894,cyclophosphamide,2,600,mg/m2,1,on day 1 of each 21-day cycle,NA
31810960,UMIN 000010945,894,nab-paclitaxel,3,150,mg/m2,1,"on days 1, 8 and 15 of each 21-day cycle",NA
31810960,UMIN 000010945,894,cyclophosphamide,3,600,mg/m2,1,on day 1 of each 21-day cycle,NA
16142489,NA,895,mitomycin-c,1,2,mg/m2/d,1,on days 1–5 and 36–40,NA
16142489,NA,895,5-fu,1,600,mg/m2/d,1,on days 1–5 and 36–40,fixed
16142489,NA,895,irradiation,1,2,Gy,1,five times a week up to a total dose of 70 Gy,fixed
16142489,NA,895,mitomycin-c,2,2.6,mg/m2/d,1,on days 1–5 and 36–40,NA
16142489,NA,895,5-fu,2,600,mg/m2/d,1,on days 1–5 and 36–40,fixed
16142489,NA,895,irradiation,2,2,Gy,1,five times a week up to a total dose of 70 Gy,fixed
16142489,NA,895,mitomycin-c,3,3.2,mg/m2/d,1,on days 1–5 and 36–40,NA
16142489,NA,895,5-fu,3,600,mg/m2/d,1,on days 1–5 and 36–40,fixed
16142489,NA,895,irradiation,3,2,Gy,1,five times a week up to a total dose of 70 Gy,fixed
16142489,NA,895,mitomycin-c,4,4,mg/m2/d,1,on days 1–5 and 36–40,NA
16142489,NA,895,5-fu,4,600,mg/m2/d,1,on days 1–5 and 36–40,fixed
16142489,NA,895,irradiation,4,2,Gy,1,five times a week up to a total dose of 70 Gy,fixed
33585999,NCT02041429,896,ruxolitinib,1,10,mg,2,daily for 4 cycles,NA
33585999,NCT02041429,896,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
33585999,NCT02041429,896,ruxolitinib,2,15,mg,2,daily for 4 cycles,NA
33585999,NCT02041429,896,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
33585999,NCT02041429,896,ruxolitinib,3,20,mg,2,daily for 4 cycles,NA
33585999,NCT02041429,896,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
33585999,NCT02041429,896,ruxolitinib,4,25,mg,2,daily for 4 cycles,NA
33585999,NCT02041429,896,paclitaxel,4,80,mg/m2,1,"on days 1, 8, and 15 of a 21-day cycle",NA
31273010,NCT02316171,897,cva21,1,1 x 10^8,TCID50,1,"on day 1, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,897,cva21,2,3 x 10^8,TCID50,1,"on day 1, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,897,cva21,3,3 x 10^8,TCID50,1,"on days 1 and 2, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,898,cva21,1,1 x 10^8,TCID50,1,"on days 1 and 2, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,898,mitomycin c,1,10,mg,1,"on day 1, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,898,cva21,2,3 x 10^8,TCID50,1,"on days 1 and 2, a week before the patients underwent a TURBT",NA
31273010,NCT02316171,898,mitomycin c,2,10,mg,1,"on day 1, a week before the patients underwent a TURBT",NA
10213209,NA,899,mtx-hsa,1,20,mg/m2,1,once a week,NA
10213209,NA,899,mtx-hsa,2,40,mg/m2,1,once a week,NA
10213209,NA,899,mtx-hsa,3,50,mg/m2,1,once a week,NA
10213209,NA,899,mtx-hsa,4,60,mg/m2,1,once a week,NA
8157471,NA,900,mitoxantrone,1,12,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,1,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,1,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,mitoxantrone,2,21,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,2,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,2,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,mitoxantrone,3,28,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,3,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,3,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,mitoxantrone,4,32,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,4,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,4,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,mitoxantrone,5,37,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,5,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,5,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,mitoxantrone,6,48,mg/m2,1,on day 1 every 3 weeks,NA
8157471,NA,900,gm-csf,6,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
8157471,NA,900,gm-csf,6,5,ug/kg,1 or 2,on days 2 to 14 every 3 weeks,fixed
18463792,NA,901,pemetrexed,-1,300,mg/m2,1,on day 1 of a 14-day cycle,NA
18463792,NA,901,oxaliplatin,-1,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
18463792,NA,901,oxaliplatin,-1,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
18463792,NA,901,pemetrexed,1,400,mg/m2,1,on day 1 of a 14-day cycle,NA
18463792,NA,901,oxaliplatin,1,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
18463792,NA,901,oxaliplatin,1,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
18463792,NA,901,pemetrexed,2,500,mg/m2,1,on day 1 of a 14-day cycle,NA
18463792,NA,901,oxaliplatin,2,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
18463792,NA,901,oxaliplatin,2,85,mg/m2,1,on day 1 of a 14-day cycle,fixed
10829050,NA,902,raltitrexed,1,2,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,1,85,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,1,85,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,2,2.5,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,2,85,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,2,85,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,3,2.5,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,3,110,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,3,110,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,4,3,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,4,110,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,4,110,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,5,3,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,5,130,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,5,130,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,6,3.5,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,6,130,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,6,130,mg/m2,1,every 21 days,NA
10829050,NA,902,raltitrexed,7,3.75,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,7,130,mg/m2,1,every 21 days,NA
10829050,NA,902,oxaliplatin,7,130,mg/m2,1,every 21 days,NA
32918791,UMIN000012531,903,nab-paclitaxel,0,40,mg/m2,1,"on days 1, 8, and 15 of 3-week cycle",NA
32918791,UMIN000012531,903,cisplatin,0,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,cisplatin,0,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,thoracic radiotherapy,NA,NA,NA,NA,NA,NA
32918791,UMIN000012531,903,nab-paclitaxel,1,50,mg/m2,1,"on days 1, 8, and 15 of 3-week cycle",NA
32918791,UMIN000012531,903,cisplatin,1,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,cisplatin,1,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,thoracic radiotherapy,1,NA,NA,NA,NA,NA
32918791,UMIN000012531,903,nab-paclitaxel,2,60,mg/m2,1,"on days 1, 8, and 15 of 3-week cycle",NA
32918791,UMIN000012531,903,cisplatin,2,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,cisplatin,2,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,thoracic radiotherapy,2,NA,NA,NA,NA,NA
32918791,UMIN000012531,903,nab-paclitaxel,3,70,mg/m2,1,"on days 1, 8, and 15 of 3-week cycle",NA
32918791,UMIN000012531,903,cisplatin,3,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,cisplatin,3,75,mg/m2,1,on day 1 of 3-week cycle,fixed
32918791,UMIN000012531,903,thoracic radiotherapy,3,NA,NA,NA,NA,NA
11208839,NA,904,vinorelbine,1,22,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,1,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,vinorelbine,2,24,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,2,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,2,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,vinorelbine,3,26,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,3,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,3,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,vinorelbine,4,28,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,4,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,4,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,vinorelbine,5,30,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,5,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,5,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,vinorelbine,6,32,mg/m2,1,on days 1 and 8 every 3 weeks,NA
11208839,NA,904,oxaliplatin,6,130,mg/m2,1,on day 1 every 3 weeks,fixed
11208839,NA,904,oxaliplatin,6,130,mg/m2,1,on day 1 every 3 weeks,fixed
8656247,NA,905,125i-mab a33,1,50,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,2,100,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,3,150,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,4,200,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,5,250,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,6,300,mCi/m2,NA,single dose,NA
8656247,NA,905,125i-mab a33,7,350,mCi/m2,NA,single dose,NA
10506618,NA,906,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 4 weeks,NA
10506618,NA,906,mitomycin,1,4,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,mitomycin,1,4,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,cisplatin,1,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,cisplatin,1,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 4 weeks,NA
10506618,NA,906,mitomycin,2,6,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,mitomycin,2,6,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,cisplatin,2,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,cisplatin,2,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,vinorelbine,3,25,mg/m2,1,on days 1 and 8 every 4 weeks,NA
10506618,NA,906,mitomycin,3,6,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,mitomycin,3,6,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,cisplatin,3,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 4 weeks,NA
10506618,NA,906,mitomycin,4,8,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,mitomycin,4,8,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,cisplatin,4,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,cisplatin,4,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,vinorelbine,5,30,mg/m2,1,on days 1 and 8 every 4 weeks,NA
10506618,NA,906,mitomycin,5,8,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,mitomycin,5,8,mg/m2,1,on day 1 every 4 weeks,NA
10506618,NA,906,cisplatin,5,80,mg/m2,1,on day 1 every 4 weeks,fixed
10506618,NA,906,cisplatin,5,80,mg/m2,1,on day 1 every 4 weeks,fixed
32803633,NCT01973309,907,vantictumab,1,3.5,mg/kg,1,days 1 and 15 of every 28-day cycle,NA
32803633,NCT01973309,907,paclitaxel,1,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,2,7,mg/kg,NA,days 1 and 15 of every 28-day cycle,NA
32803633,NCT01973309,907,paclitaxel,2,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,3,14,mg/kg,NA,days 1 and 15 of every 28-day cycle,NA
32803633,NCT01973309,907,paclitaxel,3,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,4,3,mg/kg,NA,"days 1, 8 and 15 of every 28-day cycle",NA
32803633,NCT01973309,907,paclitaxel,4,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,5,5,mg/kg,NA,"days 1, 8 and 15 of every 28-day cycle",NA
32803633,NCT01973309,907,paclitaxel,5,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,6,8,mg/kg,NA,"days 1, 8 and 15 of every 28-day cycle",NA
32803633,NCT01973309,907,paclitaxel,6,90,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",fixed
32803633,NCT01973309,907,vantictumab,7,8,mg/kg,NA,day 1 of every 28-day cycle,NA
32803633,NCT01973309,907,paclitaxel,7,90,mg/m2,1,"Days 3, 10, and 17 of every 28-day cycle",fixed
34781168,NCT01980277,908,ly2780301,1,400,mg,2,daily,NA
34781168,NCT01980277,908,paclitaxel,1,70,mg/m2,1,"at days (D) 1, 8 and 15 every 21 days",NA
34781168,NCT01980277,908,ly2780301,2,400,mg,2,daily,NA
34781168,NCT01980277,908,paclitaxel,2,80,mg/m2,1,"at days (D) 1, 8 and 15 every 21 days",NA
34781168,NCT01980277,908,ly2780301,3,500,mg,2,daily,NA
34781168,NCT01980277,908,paclitaxel,3,80,mg/m2,1,"at days (D) 1, 8 and 15 every 21 days",NA
22781384,NCCCTS-09-387,909,methotrexate,1,24,mg/d,2,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,1,24,mg/d,2,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,2,40,mg/d,2,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,2,40,mg/d,2,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,3,60,mg/d,1,3 consecutive days of 14-day cycles,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,3,60,mg/d,1,3 consecutive days of 14-day cycles,ventriculolumbar perfusion therapy in the intraventricular bolus mode
22781384,NCCCTS-09-387,909,methotrexate,1.5,24,mg/d,1,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in  the continuous infusion mode
22781384,NCCCTS-09-387,909,methotrexate,1.5,24,mg/d,1,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in  the continuous infusion mode
22781384,NCCCTS-09-387,909,methotrexate,2.5,40,mg/d,1,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in  the continuous infusion mode
22781384,NCCCTS-09-387,909,methotrexate,2.5,40,mg/d,1,3 consecutive days of 14-day cycles at perfusion rate of 20 ml/hour,ventriculolumbar perfusion therapy in  the continuous infusion mode
22781384,NCCCTS-09-387,909,methotrexate,3.5,60,mg/d,1,3 consecutive days of 14-day cycles,ventriculolumbar perfusion therapy in  the continuous infusion mode
22781384,NCCCTS-09-387,909,methotrexate,3.5,60,mg/d,1,3 consecutive days of 14-day cycles,ventriculolumbar perfusion therapy in  the continuous infusion mode
25504632,NCT00866528,910,pazopanib,1,800,mg,1,daily,NA
25504632,NCT00866528,910,paclitaxel,1,135,mg/m2,1,on day 1 of each 3-week treatment cycle,NA
25504632,NCT00866528,910,pazopanib,2,800,mg,1,daily,NA
25504632,NCT00866528,910,paclitaxel,2,175,mg/m2,1,on day 1 of each 3-week treatment cycle,NA
25504632,NCT00866528,910,pazopanib,3,800,mg,1,daily,NA
25504632,NCT00866528,910,paclitaxel,3,150,mg/m2,1,on day 1 of each 3-week treatment cycle,NA
25504632,NCT00866528,910,pazopanib,4,175,mg,1,daily,NA
25504632,NCT00866528,910,paclitaxel,4,400,mg/m2,1,on day 1 of each 3-week treatment cycle,NA
20091169,NA,911,vatalanib,1,250,mg,1,daily,NA
20091169,NA,911,paclitaxel,1,75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
20091169,NA,911,vatalanib,2,500,mg,1,daily,NA
20091169,NA,911,paclitaxel,2,75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
20091169,NA,911,vatalanib,3,750,mg,1,daily,NA
20091169,NA,911,paclitaxel,3,75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
20091169,NA,911,vatalanib,4,1000,mg,1,daily,NA
20091169,NA,911,paclitaxel,4,85,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
20091169,NA,911,vatalanib,5,1250,mg,1,daily,NA
20091169,NA,911,paclitaxel,5,85,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
20091169,NA,911,vatalanib,6,1250,mg,1,daily,NA
20091169,NA,911,paclitaxel,6,100,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
22832803,NA,912,matuzumab,1,100,mg,1,"on days 1, 8 and 15 of a 3-week cycle",NA
22832803,NA,912,paclitaxel,1,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
22832803,NA,912,matuzumab,2,200,mg,1,"on days 1, 8 and 15 of a 3-week cycle",NA
22832803,NA,912,paclitaxel,2,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
22832803,NA,912,matuzumab,3,400,mg,1,"on days 1, 8 and 15 of a 3-week cycle",NA
22832803,NA,912,paclitaxel,3,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
22832803,NA,912,matuzumab,4,800,mg,1,"on days 1, 8 and 15 of a 3-week cycle",NA
22832803,NA,912,paclitaxel,4,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
22832803,NA,912,matuzumab,5,1200,mg,1,on day 1 of a 3-week cycle,NA
22832803,NA,912,paclitaxel,5,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
22832803,NA,912,matuzumab,6,1600,mg,1,on day 1 of a 3-week cycle,NA
22832803,NA,912,paclitaxel,6,175,mg/m2,1,on day 1 of the 3-week cycle,fixed
26433959,ChiECRCT2014025,913,paclitaxel,1,90,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,1,40,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,1,40,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,pelvic intensity-modulated radiotherapy,1,50-50.4,Gy,NA,in 25–28 fractions with two cycles of concurrent TP (paclitaxel and cisplatin),fixed
26433959,ChiECRCT2014025,913,paclitaxel,2,90,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,2,50,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,2,50,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,pelvic intensity-modulated radiotherapy,2,50-50.4,Gy,NA,in 25–28 fractions with two cycles of concurrent TP (paclitaxel and cisplatin),fixed
26433959,ChiECRCT2014025,913,paclitaxel,3,105,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,3,50,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,3,50,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,pelvic intensity-modulated radiotherapy,3,50-50.4,Gy,NA,in 25–28 fractions with two cycles of concurrent TP (paclitaxel and cisplatin),fixed
26433959,ChiECRCT2014025,913,paclitaxel,4,105,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,4,60,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,cisplatin,4,60,mg/m2,1,two cycles of TP on day 1 and day 29 of radiotherapy,NA
26433959,ChiECRCT2014025,913,pelvic intensity-modulated radiotherapy,4,50-50.4,Gy,NA,in 25–28 fractions with two cycles of concurrent TP (paclitaxel and cisplatin),fixed
28477227,NA,914,cilengitide,1,2000,mg,1,"days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,1,90,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,cilengitide,2,2000,mg,1,"days 1, 2, 8, 9, 15, 16 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,2,90,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,cilengitide,-1,2000,mg,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,-1,80,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,cilengitide,-2,2000,mg,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,-2,70,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,cilengitide,-3,2000,mg,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,-3,60,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,cilengitide,-4,1500,mg,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
28477227,NA,914,paclitaxel,-4,60,mg/m2,1,"Days 1, 8 and 15 of each 21-day treatment cycle",NA
25073954,UMIN000009046,915,nab-paclitaxel,1,180,mg/m2,1,on the first day of each 21-day treatment cycle,NA
25073954,UMIN000009046,915,cyclophosphamide,1,600,mg/m2,1,on the first day of each 21-day treatment cycle,NA
25073954,UMIN000009046,915,nab-paclitaxel,2,220,mg/m2,1,on the first day of each 21-day treatment cycle,NA
25073954,UMIN000009046,915,cyclophosphamide,3,600,mg/m2,1,on the first day of each 21-day treatment cycle,NA
25073954,UMIN000009046,915,nab-paclitaxel,4,260,mg/m2,1,on the first day of each 21-day treatment cycle,NA
25073954,UMIN000009046,915,cyclophosphamide,4,600,mg/m2,1,on the first day of each 21-day treatment cycle,NA
21406471,NA,916,paclitaxel,1,80,mg/m2,1,3 weeks of 4 (one cycle),fixed
21406471,NA,916,dasatinib,1,70,mg,1,daily,NA
21406471,NA,916,paclitaxel,2,80,mg/m2,1,3 weeks of 4 (one cycle),fixed
21406471,NA,916,dasatinib,2,100,mg,1,daily,NA
21406471,NA,916,paclitaxel,3,80,mg/m2,1,3 weeks of 4 (one cycle),fixed
21406471,NA,916,dasatinib,3,120,mg,1,daily,NA
21406471,NA,916,paclitaxel,4,80,mg/m2,1,3 weeks of 4 (one cycle),fixed
21406471,NA,916,dasatinib,4,150,mg,1,daily,NA
22695940,NA,917,dhp107,1,60,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,1,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,2,120,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,2,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,3,200,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,3,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,4,250,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,4,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,5,300,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,5,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,6,350,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,6,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,7,400,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,7,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,8,450,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,8,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,9,500,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,9,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,10,550,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,10,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
22695940,NA,917,dhp107,11,600,mg/m2,1,on day 1 in the first 3-week cycle,NA
22695940,NA,917,paclitaxel,11,175,mg/m2,1,on day 1 in the second and subsequent 3-week cycles,fixed
19738417,NA,918,paclitaxel,-1,135,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,-1,150,mg,1,every night at bedtime,NA
19738417,NA,918,paclitaxel,1,175,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,1,150,mg,1,every night at bedtime,NA
19738417,NA,918,paclitaxel,2,175,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,2,200,mg,1,every night at bedtime,NA
19738417,NA,918,paclitaxel,3,200,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,3,200,mg,1,every night at bedtime,NA
19738417,NA,918,paclitaxel,4,200,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,4,250,mg,1,every night at bedtime,NA
19738417,NA,918,paclitaxel,5,250,mg/m2,1,q3wk,NA
19738417,NA,918,carboxyamido-triazole,5,250,mg,1,every night at bedtime,NA
30623229,NCT00825201,919,nab-paclitaxel,1,35,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30623229,NCT00825201,919,nab-paclitaxel,2,70,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30623229,NCT00825201,919,nab-paclitaxel,3,90,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30623229,NCT00825201,919,nab-paclitaxel,4,112.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30623229,NCT00825201,919,nab-paclitaxel,5,140,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
30623229,NCT00825201,919,nab-paclitaxel,6,175,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
27998970,NCT01281852,920,paclitaxel,1,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,1,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,1,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,1,50,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,2,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,2,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,2,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,2,100,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,3,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,3,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,3,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,3,150,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,4,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,4,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,4,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,4,200,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,5,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,5,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,5,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,5,250,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,6,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,6,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,6,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,6,300,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,7,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,7,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,7,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,7,350,mg,2,on days 1–7 every 21 days,NA
27998970,NCT01281852,920,paclitaxel,8,175,mg/m2,1,on day 1 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,8,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,cisplatin,8,50,mg/m2,1,on day 2 every 21 days,fixed
27998970,NCT01281852,920,veliparib,8,400,mg,2,on days 1–7 every 21 days,NA
30876442, NCT02429622,921,imrt simultaneous integrated boost,1,2.17,Gy,1,"once daily 5 days a week for an average of 5.5 weeks, up to 60.76 Gy/28 f",NA
30876442, NCT02429622,921,paclitaxel,1,50,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,nedaplatin,1,25,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,imrt simultaneous integrated boost,2,2.21,Gy,1,"once daily 5 days a week for an average of 5.5 weeks, up to 61.88 Gy/28 f",NA
30876442, NCT02429622,921,paclitaxel,2,50,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,nedaplatin,2,25,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,imrt simultaneous integrated boost,3,2.29,Gy,1,"once daily 5 days a week for an average of 5.5 weeks, up to 64.12 Gy/28 f",NA
30876442, NCT02429622,921,paclitaxel,3,50,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,nedaplatin,3,25,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,imrt simultaneous integrated boost,-1,2.14,Gy,1,"once daily 5 days a week for an average of 5.5 weeks, up to 59.92 Gy/28 f",NA
30876442, NCT02429622,921,paclitaxel,-1,50,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
30876442, NCT02429622,921,nedaplatin,-1,25,mg/m2,1,weekly infusion concurrent with radiotherapy for at least 5 weeks,fixed
19010522,NA,922,paclitaxel,-1,20,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,-1,30,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,-1,30,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,extended field irradiation,-1,NA,NA,NA,NA,NA
19010522,NA,922,paclitaxel,1,30,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,1,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,1,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,extended field irradiation,1,NA,NA,NA,NA,NA
19010522,NA,922,paclitaxel,2,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,2,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,2,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,extended field irradiation,2,NA,NA,NA,NA,NA
19010522,NA,922,paclitaxel,3,50,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,3,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,3,40,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,extended field irradiation,3,NA,NA,NA,NA,NA
19010522,NA,922,paclitaxel,4,50,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,4,30,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,cisplatin,4,30,mg/m2,1,"on a weekly basis for five cycles, with the sixth cycle given concurrent with parametrial boost",NA
19010522,NA,922,extended field irradiation,4,NA,NA,NA,NA,NA
30945121,NA,923,poziotinib,1,8,mg,1,"once daily for 14 days, followed by 7 days of",NA
30945121,NA,923,paclitaxel,1,175,mg/m2,1,on day 1 every 3 weeks,NA
30945121,NA,923,trastuzumab,1,loading dose: 8; followed by 6,mg/kg,1,on day 1 every 3 weeks,NA
30945121,NA,923,poziotinib,2,12,mg,1,"once daily for 14 days, followed by 7 days of",NA
30945121,NA,923,paclitaxel,2,175,mg/m2,1,on day 1 every 3 weeks,NA
30945121,NA,923,trastuzumab,2,loading dose: 8; followed by 6,mg/kg,1,on day 1 every 3 weeks,NA
28196905, NCT02890511,924,dhp107,1,150,mg/m2,2,"on days 1, 8, and 15 every 4 weeks",NA
28196905, NCT02890511,924,dhp107,2,200,mg/m2,2,"on days 1, 8, and 15 every 4 weeks",NA
28196905, NCT02890511,924,dhp107,3,250,mg/m2,2,"on days 1, 8, and 15 every 4 weeks",NA
28196905, NCT02890511,924,dhp107,3.5,225,mg/m2,2,"on days 1, 8, and 15 every 4 weeks",NA
20877350,NA,925,paclitaxel,1,135,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,1,90,mg,1,daily,NA
20877350,NA,925,paclitaxel,2,175,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,2,90,mg,1,daily,NA
20877350,NA,925,paclitaxel,3,175,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,3,130,mg,1,daily,NA
20877350,NA,925,paclitaxel,4,175,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,4,180,mg,1,daily,NA
20877350,NA,925,paclitaxel,5,175,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,5,240,mg,1,daily,NA
20877350,NA,925,paclitaxel,6,200,mg/m2,1,every 21 days,NA
20877350,NA,925,tosedostat,6,240,mg,1,daily,NA
20877350,NA,925,paclitaxel,5.5,175,mg/m2,1,every 21 days,an amendment
20877350,NA,925,tosedostat,5.5,180,mg,1,daily from day 2 –17 of each cycle,an amendment
20877350,NA,925,paclitaxel,6.5,175,mg/m2,1,every 21 days,an amendment
20877350,NA,925,tosedostat,6.5,240,mg,1,daily from day 2 –17 of each cycle,an amendment
30635336,NCT01320592,926,palbociclib,1,50,mg,1,"on days 2, 3, 4, 5, 6; 9, 10, 11, 12, 13; and 16, 17, 18, 19, 20 of each 28-day cycle",NA
30635336,NCT01320592,926,paclitaxel,1,80,mg/m2,1,"on days 1, 8, 15, and 22 in 28-day cycles for the first 3 cycles; at the start of cycle 4, dosing was reduced to days 1, 8, and 15 every 28 days (3 weeks on/1 week off)",fixed
30635336,NCT01320592,926,palbociclib,2,75,mg,1,"on days 2, 3, 4, 5, 6; 9, 10, 11, 12, 13; and 16, 17, 18, 19, 20 of each 28-day cycle",NA
30635336,NCT01320592,926,paclitaxel,2,80,mg/m2,1,"on days 1, 8, 15, and 22 in 28-day cycles for the first 3 cycles; at the start of cycle 4, dosing was reduced to days 1, 8, and 15 every 28 days (3 weeks on/1 week off)",fixed
30635336,NCT01320592,926,palbociclib,3,100,mg,1,"on days 2, 3, 4, 5, 6; 9, 10, 11, 12, 13; and 16, 17, 18, 19, 20 of each 28-day cycle",NA
30635336,NCT01320592,926,paclitaxel,3,80,mg/m2,1,"on days 1, 8, 15, and 22 in 28-day cycles for the first 3 cycles; at the start of cycle 4, dosing was reduced to days 1, 8, and 15 every 28 days (3 weeks on/1 week off)",fixed
30635336,NCT01320592,926,palbociclib,4,125,mg,1,"on days 2, 3, 4, 5, 6; 9, 10, 11, 12, 13; and 16, 17, 18, 19, 20 of each 28-day cycle",NA
30635336,NCT01320592,926,paclitaxel,4,80,mg/m2,1,"on days 1, 8, 15, and 22 in 28-day cycles for the first 3 cycles; at the start of cycle 4, dosing was reduced to days 1, 8, and 15 every 28 days (3 weeks on/1 week off)",fixed
20530446,NA,927,lipoplatin,1,125,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,2,150,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,3,175,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,4,200,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,5,225,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,6,250,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,7,275,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,8,300,mg/m2,1,every 2 weeks,NA
20530446,NA,927,lipoplatin,9,350,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,1,100,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,1,100,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,2,150,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,2,100,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,3,150,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,3,135,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,4,200,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,4,135,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,5,200,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,5,175,mg/m2,1,every 2 weeks,NA
20530446,NA,928,lipoplatin,6,250,mg/m2,1,every 2 weeks,NA
20530446,NA,928,paclitaxel,6,175,mg/m2,1,every 2 weeks,NA
19386478,NA,929,paclitaxel,1,10,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,1,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,1,30,mg/m2,1,weekly,NA
19386478,NA,929,external beam radiation therapy to the pelvis,1,50,Gy,NA,in 25 fractions over 5 weeks,NA
19386478,NA,929,paclitaxel,2,20,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,2,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,2,30,mg/m2,1,weekly,NA
19386478,NA,929,external beam radiation therapy to the pelvis,2,50,Gy,NA,in 25 fractions over 5 weeks,NA
19386478,NA,929,paclitaxel,3,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,3,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,3,30,mg/m2,1,weekly,NA
19386478,NA,929,external beam radiation therapy to the pelvis,3,50,Gy,NA,in 25 fractions over 5 weeks,NA
19386478,NA,929,paclitaxel,4,40,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,4,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,4,30,mg/m2,1,weekly,NA
19386478,NA,929,external beam radiation therapy to the pelvis,4,50,Gy,NA,in 25 fractions over 5 weeks,NA
19386478,NA,929,paclitaxel,5,50,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,5,30,mg/m2,1,weekly,NA
19386478,NA,929,cisplatin,5,30,mg/m2,1,weekly,NA
19386478,NA,929,external beam radiation therapy to the pelvis,5,50,Gy,NA,in 25 fractions over 5 weeks,NA
18956139,NA,930,pemetrexed,1,400,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,paclitaxel,1,135,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,pemetrexed,2,400,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,paclitaxel,2,175,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,pemetrexed,3,500,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,paclitaxel,3,135,mg/m2,1,on day 1 in 21-day cycles,no vitamin supplemented
18956139,NA,930,pemetrexed,3.5,500,mg/m2,1,on day 1 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,3.5,135,mg/m2,1,on day 1 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,4,500,mg/m2,1,on day 1 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,4,175,mg/m2,1,on day 1 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,5,400,mg/m2,1,on day 1 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,5,40,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,6,400,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,6,30,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,7,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,7,30,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,8,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,8,40,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,9,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,9,50,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,10,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,10,60,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,11,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,11,75,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,12,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,12,90,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,13,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,13,100,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,pemetrexed,14,500,mg/m2,1,on day 8 in 21-day cycles,with vitamin supplemented
18956139,NA,930,paclitaxel,14,120,mg/m2,1,on days 1 and 8 in 21-day cycles,with vitamin supplemented
18794097,NA,931,lep-etu,1,135,mg/m2,1,q3w,NA
18794097,NA,931,lep-etu,2,175,mg/m2,1,q3w,NA
18794097,NA,931,lep-etu,3,225,mg/m2,1,q3w,NA
18794097,NA,931,lep-etu,4,275,mg/m2,1,q3w,NA
18794097,NA,931,lep-etu,5,325,mg/m2,1,q3w,NA
18794097,NA,931,lep-etu,6,375,mg/m2,1,q3w,NA
21853310,NA,932,nab-paclitaxel,1,80,mg/m2,1,once a week for three weekly doses repeated every 4 weeks,NA
21853310,NA,932,nab-paclitaxel,2,100,mg/m2,1,once a week for three weekly doses repeated every 4 weeks,NA
21853310,NA,932,nab-paclitaxel,3,125,mg/m2,1,once a week for three weekly doses repeated every 4 weeks,NA
21853310,NA,932,nab-paclitaxel,4,150,mg/m2,1,once a week for three weekly doses repeated every 4 weeks,NA
24658629,NA,933,pm paclitaxel,1,175,mg/m2,1,a 3-h infusion once every 3 weeks,NA
24658629,NA,933,pm paclitaxel,2,230,mg/m2,1,a 3-h infusion once every 3 weeks,NA
24658629,NA,933,pm paclitaxel,3,300,mg/m2,1,a 3-h infusion once every 3 weeks,NA
24658629,NA,933,pm paclitaxel,4,350,mg/m2,1,a 3-h infusion once every 3 weeks,NA
24658629,NA,933,pm paclitaxel,5,390,mg/m2,1,a 3-h infusion once every 3 weeks,NA
20406837,NA,934,paclitaxel,1,80,mg/m2,1,day 1 every 2 weeks,NA
20406837,NA,934,trabectedin,1,0.525,mg/m2,1,day 2 every 2 weeks,NA
20406837,NA,934,paclitaxel,2,80,mg/m2,1,day 1 every 2 weeks,NA
20406837,NA,934,trabectedin,2,0.58,mg/m2,1,day 2 every 2 weeks,NA
20406837,NA,934,paclitaxel,3,120,mg/m2,1,day 1 every 2 weeks,NA
20406837,NA,934,trabectedin,3,0.58,mg/m2,1,day 2 every 2 weeks,NA
20406837,NA,934,paclitaxel,4,120,mg/m2,1,day 1 every 2 weeks,NA
20406837,NA,934,trabectedin,4,0.65,mg/m2,1,day 2 every 2 weeks,NA
20406837,NA,934,paclitaxel,5,120,mg/m2,1,day 1 every 2 weeks,NA
20406837,NA,934,trabectedin,5,0.775,mg/m2,1,day 2 every 2 weeks,NA
20941597,NA,935,paclitaxel,0,150,mg/m2,1,on day 1 every 4 weeks,NA
20941597,NA,935,paclitaxel,1,175,mg/m2,1,on day 1 every 4 weeks,NA
20941597,NA,935,paclitaxel,2,200,mg/m2,1,on day 1 every 4 weeks,NA
20941597,NA,935,paclitaxel,3,225,mg/m2,1,on day 1 every 4 weeks,NA
20941597,NA,935,paclitaxel,4,250,mg/m2,1,on day 1 every 4 weeks,NA
20941597,NA,935,paclitaxel,5,275,mg/m2,1,on day 1 every 4 weeks,NA
28868573,NCT02667743,936,pm-paclitaxel,1,175,mg/m2,1,3 h on day 1 of each 21-day cycle,NA
28868573,NCT02667743,936,pm-paclitaxel,2,230,mg/m2,1,3 h on day 1 of each 21-day cycle,NA
28868573,NCT02667743,936,pm-paclitaxel,3,300,mg/m2,1,3 h on day 1 of each 21-day cycle,NA
28868573,NCT02667743,936,pm-paclitaxel,4,390,mg/m2,1,3 h on day 1 of each 21-day cycle,NA
28868573,NCT02667743,936,pm-paclitaxel,5,435,mg/m2,1,3 h on day 1 of each 21-day cycle,NA
26266640,NA,937,amrubicin,0,20,mg/m2,1,on days 1–3 every 4 weeks,NA
26266640,NA,937,paclitaxel,0,150,mg/m2,1,on day 1 every 4 weeks,fixed
26266640,NA,937,amrubicin,1,25,mg/m2,1,on days 1–3 every 4 weeks,NA
26266640,NA,937,paclitaxel,1,150,mg/m2,1,on day 1 every 4 weeks,fixed
26266640,NA,937,amrubicin,2,30,mg/m2,1,on days 1–3 every 4 weeks,NA
26266640,NA,937,paclitaxel,2,150,mg/m2,1,on day 1 every 4 weeks,fixed
26266640,NA,937,amrubicin,3,30,mg/m2,1,on days 1–3 every 4 weeks,NA
26266640,NA,937,paclitaxel,3,180,mg/m2,1,on day 1 every 4 weeks,NA
21820161,NA,938,paclitaxel,1,135,mg/m2,1,IV On day 1 of each 21-day cycle,NA
21820161,NA,938,paclitaxel,1,60,mg/m2,1,IP On day 8 of each 21-day cycle,NA
21820161,NA,938,cisplatin,1,75,mg/m2,1,IP On day 1 of each 21-day cycle,NA
21820161,NA,938,cisplatin,1,75,mg/m2,1,IP On day 1 of each 21-day cycle,NA
19633055,NA,939,genexol-pm,1,80,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,2,100,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,3,120,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,4,140,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,5,160,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,6,180,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
19633055,NA,939,genexol-pm,7,200,mg/m2,1,on a weekly basis for 3 weeks followed by a resting week,NA
29936064,NCT01962103,940,nab-paclitaxel,1,120,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
29936064,NCT01962103,940,nab-paclitaxel,2,150,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
29936064,NCT01962103,940,nab-paclitaxel,3,180,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
29936064,NCT01962103,940,nab-paclitaxel,4,210,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
29936064,NCT01962103,940,nab-paclitaxel,5,240,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
29936064,NCT01962103,940,nab-paclitaxel,6,270,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
21372602,NA,941,paclitaxel,1,100,mg/m2,1,IV on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,paclitaxel,1,20,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,cisplatin,1,30,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,cisplatin,1,30,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,paclitaxel,0,80,mg/m2,1,IV on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,paclitaxel,0,20,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,cisplatin,0,25,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
21372602,NA,941,cisplatin,0,25,mg/m2,1,IP on days 1 and 15 in 4-week cycles,NA
19509578,NA,942,cisplatin,-1,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,-1,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,-1,20,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,-1,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
19509578,NA,942,cisplatin,1,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,1,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,1,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,1,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
19509578,NA,942,cisplatin,2,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,2,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,2,40,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,2,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
19509578,NA,942,cisplatin,3,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,3,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,3,50,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,3,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
19509578,NA,942,cisplatin,4,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,4,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,4,60,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,4,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
19509578,NA,942,cisplatin,5,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,cisplatin,5,30,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,paclitaxel,5,70,mg/m2,1,once a week until termination of the radiation therapy,NA
19509578,NA,942,radiation therapy,5,NA,Gy,NA,Radiotherapy was administered with a combination of external irradiation and high-dose rate intracavitary radiation by aremote afterloading system (RALS) using iridium-192 sources,fixed
23349317,NA,943,grn1005,1,30,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,2,50,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,3,75,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,4,105,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,5,200,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,6,300,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,7,420,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,8,550,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,9,650,mg/m2,1,every 3 weeks,NA
23349317,NA,943,grn1005,10,700,mg/m2,1,every 3 weeks,NA
23053259,NA,944,lonafarnib,1,150,mg/d,2,"daily, started from cycle 2",NA
23053259,NA,944,paclitaxel,1,135,mg/m2,1,every 3 weeks,NA
23053259,NA,944,trastuzumab,1,4 mg/kg loading dose and 2 mg/kg thereafter,mg/kg,1,weekly,NA
23053259,NA,944,lonafarnib,2,150,mg/d,2,"daily, started from cycle 2",NA
23053259,NA,944,paclitaxel,2,175,mg/m2,1,every 3 weeks,NA
23053259,NA,944,trastuzumab,2,4 mg/kg loading dose and 2 mg/kg thereafter,mg/kg,1,weekly,NA
23053259,NA,944,lonafarnib,3,200,mg/d,2,"daily, started from cycle 2",NA
23053259,NA,944,paclitaxel,3,175,mg/m2,1,every 3 weeks,NA
23053259,NA,944,trastuzumab,3,4 mg/kg loading dose and 2 mg/kg thereafter,mg/kg,1,weekly,NA
23053259,NA,944,lonafarnib,4,250,mg/d,2,"daily, started from cycle 2",NA
23053259,NA,944,paclitaxel,4,175,mg/m2,1,every 3 weeks,NA
23053259,NA,944,trastuzumab,4,4 mg/kg loading dose and 2 mg/kg thereafter,mg/kg,1,weekly,NA
23053259,NA,944,lonafarnib,5,300,mg/d,2,"daily, started from cycle 2",NA
23053259,NA,944,paclitaxel,5,175,mg/m2,1,every 3 weeks,NA
23053259,NA,944,trastuzumab,5,4 mg/kg loading dose and 2 mg/kg thereafter,mg/kg,1,"‘1-week on, 1-week off, 1-week on’’ schedule",NA
27595901,"JapicCTI-101,233",945,nk105,1,50,mg/m2,1,"days 1, 8, and 15 every 4 weeks",NA
27595901,"JapicCTI-101,233",945,nk105,2,65,mg/m2,1,"days 1, 8, and 15 every 4 weeks",NA
27595901,"JapicCTI-101,233",945,nk105,3,80,mg/m2,1,"days 1, 8, and 15 every 4 weeks",NA
27595901,"JapicCTI-101,233",945,nk105,4,100,mg/m2,1,"days 1, 8, and 15 every 4 weeks",NA
27595901,"JapicCTI-101,233",945,nk105,5,120,mg/m2,1,"days 1, 8, and 15 every 4 weeks",NA
19034451,NA,946,paclitaxel poliglumex,1,20,mg/m2,1,weekly for a 6-week cycle,NA
19034451,NA,946,paclitaxel poliglumex,2,40,mg/m2,1,weekly for a 6-week cycle,NA
19034451,NA,946,paclitaxel poliglumex,3,60,mg/m2,1,weekly for a 6-week cycle,NA
19034451,NA,946,paclitaxel poliglumex,4,70,mg/m2,1,weekly for a 6-week cycle,NA
19034451,NA,946,paclitaxel poliglumex,5,80,mg/m2,1,weekly for a 6-week cycle,NA
24496920,NCT00736619,947,nab-paclitaxel,1,30,mg/m2,1,weekly,NA
24496920,NCT00736619,947,cetuximab,1,250,mg/m2,1,weekly,NA
24496920,NCT00736619,947,intensity-modulated radiation therapy,1,212,cGy,1,"one fraction per day (Monday through Friday) over 33 fractions, 212 cGy per fraction, to a total dose of 6996 cGy",NA
24496920,NCT00736619,947,nab-paclitaxel,2,45,mg/m2,1,weekly,NA
24496920,NCT00736619,947,cetuximab,2,250,mg/m2,1,weekly,NA
24496920,NCT00736619,947,intensity-modulated radiation therapy,2,212,cGy,1,"one fraction per day (Monday through Friday) over 33 fractions, 212 cGy per fraction, to a total dose of 6996 cGy",NA
24496920,NCT00736619,947,nab-paclitaxel,3,60,mg/m2,1,weekly,NA
24496920,NCT00736619,947,cetuximab,3,250,mg/m2,1,weekly,NA
24496920,NCT00736619,947,intensity-modulated radiation therapy,3,212,cGy,1,"one fraction per day (Monday through Friday) over 33 fractions, 212 cGy per fraction, to a total dose of 6996 cGy",NA
24496920,NCT00736619,947,nab-paclitaxel,4,80,mg/m2,1,weekly,NA
24496920,NCT00736619,947,cetuximab,4,250,mg/m2,1,weekly,NA
24496920,NCT00736619,947,intensity-modulated radiation therapy,4,212,cGy,1,"one fraction per day (Monday through Friday) over 33 fractions, 212 cGy per fraction, to a total dose of 6996 cGy",NA
22421191,NA,948,pemetrexed,1,60,mg/m2,1,day 1 every 21 days,NA
22421191,NA,948,cisplatin,1,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,cisplatin,1,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,paclitaxel,1,60,mg/m2,1,day 8 every 21 days,fixed
22421191,NA,948,pemetrexed,2,120,mg/m2,1,day 1 every 21 days,NA
22421191,NA,948,cisplatin,2,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,cisplatin,2,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,paclitaxel,2,60,mg/m2,1,day 8 every 21 days,fixed
22421191,NA,948,pemetrexed,3,500,mg/m2,1,day 1 every 21 days,NA
22421191,NA,948,cisplatin,3,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,cisplatin,3,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,paclitaxel,3,60,mg/m2,1,day 8 every 21 days,fixed
22421191,NA,948,pemetrexed,4,750,mg/m2,1,day 1 every 21 days,NA
22421191,NA,948,cisplatin,4,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,cisplatin,4,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,paclitaxel,4,60,mg/m2,1,day 8 every 21 days,fixed
22421191,NA,948,pemetrexed,5,1000,mg/m2,1,day 1 every 21 days,NA
22421191,NA,948,cisplatin,5,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,cisplatin,5,75,mg/m2,1,day 2 every 21 days,fixed
22421191,NA,948,paclitaxel,5,60,mg/m2,1,day 8 every 21 days,fixed
28317088,NCT01954355,949,sonidegib,1,400,mg,1,once daily (OD) continuously in 4-weekly cycles,NA
28317088,NCT01954355,949,paclitaxel,1,80,mg/m2,1,"on days 1, 8 and 15 in 4-weekly cycles",fixed
28317088,NCT01954355,949,sonidegib,2,800,mg,1,once daily (OD) continuously in 4-weekly cycles,NA
28317088,NCT01954355,949,paclitaxel,2,80,mg/m2,1,"on days 1, 8 and 15 in 4-weekly cycles",fixed
28317088,NCT01954355,949,sonidegib,3,600,mg,1,once daily (OD) continuously in 4-weekly cycles,NA
28317088,NCT01954355,949,paclitaxel,3,80,mg/m2,1,"on days 1, 8 and 15 in 4-weekly cycles",fixed
18962846,NA,950,paclitaxel,1,10,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,1,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,1,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,1,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,2,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,2,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,2,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,2,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,3,20,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,3,25,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,3,25,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,3,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,4,30,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,4,25,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,4,25,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,4,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,5,30,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,5,30,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,5,30,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,5,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,6,30,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,6,35,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,6,35,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,6,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,7,40,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,7,35,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,7,35,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,7,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
18962846,NA,950,paclitaxel,8,40,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,8,40,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,cisplatin,8,40,mg/m2,1,"weekly for 6 treatments on days 1, 8, 15, 22, 29 and 36.",NA
18962846,NA,950,whole abdominal radiation therapy,8,1.25/1.8,Gy,1,"each fraction, treating once per day, 5 days per week, total 25 Gy to the abdomen and 50.2 Gy to the pelvis, respectively",fixed
27411683,NCT01735409,951,cisplatin,1,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,cisplatin,1,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,nab-paclitaxel,1,260,mg/m2,1,on day 1 in 21-day treatment cycles,NA
27411683,NCT01735409,951,cisplatin,2,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,cisplatin,2,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,nab-paclitaxel,2,140,mg/m2,1,on days 1 and 8 in 21-day treatment cycles,NA
27411683,NCT01735409,951,cisplatin,3,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,cisplatin,3,75,mg/m2,1,on day 1 in 21-day treatment cycles,fixed
27411683,NCT01735409,951,nab-paclitaxel,3,100,mg/m2,1,"on days 1, 8 and 15 in 21-day treatment cycles",NA
25537644,NCT01042925,952,pilaralisib,1,200,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,952,trastuzumab,1,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,1,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,952,pilaralisib,2,300,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,952,trastuzumab,2,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,1,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,952,pilaralisib,3,400,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,952,trastuzumab,3,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,1,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,953,pilaralisib,1,200,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,953,trastuzumab,1,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,NA,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,953,paclitaxel,1,80,mg/m2,1,"on Day 1, 8 and 15 of 21-day cycles",fixed
25537644,NCT01042925,953,pilaralisib,2,300,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,953,trastuzumab,2,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,NA,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,953,paclitaxel,2,80,mg/m2,1,"on Day 1, 8 and 15 of 21-day cycles",fixed
25537644,NCT01042925,953,pilaralisib,3,400,mg,1,daily starting on Day 1 of 21-day cycles,NA
25537644,NCT01042925,953,trastuzumab,3,"8 mg/kg loading dose, followed by a 6 mg/kg in subsequent cycles",mg/kg,NA,on day 1 of 21-day cycles,fixed
25537644,NCT01042925,953,paclitaxel,3,80,mg/m2,1,"on Day 1, 8 and 15 of 21-day cycles",fixed
31792036,NCT02810418,954,lmb-100,-1,65,ug/kg,1,"30 minute infusion, on days 1, 3, and 5 of each 21-day treatment cycle",NA
31792036,NCT02810418,954,nab-paclitaxel,-1,125,mg/m2,1,on days 1 and 8 of each 21-day treatment cycle,NA
31792036,NCT02810418,954,lmb-100,1,100,ug/kg,1,"30 minute infusion, on days 1, 3, and 5 of each 21-day treatment cycle",NA
31792036,NCT02810418,954,nab-paclitaxel,1,125,mg/m2,1,on days 1 and 8 of each 21-day treatment cycle,NA
26112004,NCT01491217,955,hm30181ak,1,15,mg/d,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
26112004,NCT01491217,955,paclitaxel,1,90,mg/m2,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
26112004,NCT01491217,955,hm30181ak,2,15,mg/d,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
26112004,NCT01491217,955,paclitaxel,2,120,mg/m2,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
26112004,NCT01491217,955,hm30181ak,3,15,mg/d,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
26112004,NCT01491217,955,paclitaxel,3,150,mg/m2,1,"6 times per cycle (days 1, 2, 8, 9, 15, and 16) every 4 weeks",NA
24013936,NA,956,pemetrexed,1,500,mg/m2,1,on Day 1 of a 21 day treatment cycle,fixed
24013936,NA,956,nab-paclitaxel,1,180,mg/m2,1,on Day 1 of a 21 day treatment cycle,NA
24013936,NA,956,pemetrexed,2,500,mg/m2,1,on Day 1 of a 21 day treatment cycle,fixed
24013936,NA,956,nab-paclitaxel,2,220,mg/m2,1,on Day 1 of a 21 day treatment cycle,NA
24013936,NA,956,pemetrexed,3,500,mg/m2,1,on Day 1 of a 21 day treatment cycle,fixed
24013936,NA,956,nab-paclitaxel,3,260,mg/m2,1,on Day 1 of a 21 day treatment cycle,NA
29844129,NCT01649336,957,binimetinib,1,30,mg,2,on days 1 to 28 of every 28-day cycle,NA
29844129,NCT01649336,957,paclitaxel,1,80,mg/m2,1,weekly for 3 of 4 weeks,fixed
29844129,NCT01649336,957,binimetinib,2,45,mg,2,on days 1 to 28 of every 28-day cycle,NA
29844129,NCT01649336,957,paclitaxel,2,80,mg/m2,1,weekly for 3 of 4 weeks,fixed
29844129,NCT01649336,957,binimetinib,3,45,mg,2,"on days 1 to 5, days 8 to 12, and days 15 to 19 of every 28-day cycle",NA
29844129,NCT01649336,957,paclitaxel,3,80,mg/m2,1,weekly for 3 of 4 weeks,fixed
22203732,NA,958,grn1005,1,30,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,2,60,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,3,120,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,4,200,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,5,300,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,6,420,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,7,500,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,8,550,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,9,650,mg/m2,1,once in every 21 days,NA
22203732,NA,958,grn1005,10,700,mg/m2,1,once in every 21 days,NA
25103625,NA,959,dovitinib,1,200,mg,1,"on days 1-7, then starting from day 15 on a schedule of 5-days-on/2-days-off in 28-days cycles",NA
25103625,NA,959,paclitaxel,1,80,mg/m2,1,"on days 15, 22, 29 and 36 in 28-days cycles",NA
25103625,NA,959,dovitinib,1.5,200,mg,1,"on days 1-7, then starting from day 15 on a schedule of 5-days-on/2-days-off in 28-days cycles",NA
25103625,NA,959,paclitaxel,1.5,60,mg/m2,1,"on days 15, 22, 29 and 36 in 28-days cycles",NA
25103625,NA,959,dovitinib,2,300,mg,1,"on days 1-7, then starting from day 15 on a schedule of 5-days-on/2-days-off in 28-days cycles",NA
25103625,NA,959,paclitaxel,2,60,mg/m2,1,"on days 15, 22, 29 and 36 in 28-days cycles",NA
25688104,NCT01263145,960,paclitaxel,1,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",fixed
25688104,NCT01263145,960,mk-2206,1,90,mg,1,"on days 2, 9, and 16 every 21 days",NA
25688104,NCT01263145,960,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",fixed
25688104,NCT01263145,960,mk-2206,2,135,mg,1,"on days 2, 9, and 16 every 21 days",NA
25688104,NCT01263145,960,paclitaxel,3,80,mg/m2,1,"on days 1, 8, and 15 every 21 days",fixed
25688104,NCT01263145,960,mk-2206,3,200,mg,1,"on days 2, 9, and 16 every 21 days",NA
30016392,NCT02193633,961,vistusertib,1,25,mg,2,"Days 1-3 each week, in 7-week cycles",3 on/4 off schedule
30016392,NCT02193633,961,paclitaxel,1,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
30016392,NCT02193633,961,vistusertib,2,50,mg,2,"Days 1-3 each week, in 7-week cycles",3 on/4 off schedule
30016392,NCT02193633,961,paclitaxel,2,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
30016392,NCT02193633,961,vistusertib,3,75,mg,2,"Days 1-3 each week, in 7-week cycles",3 on/4 off schedule
30016392,NCT02193633,961,paclitaxel,3,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
30016392,NCT02193633,961,vistusertib,4,50,mg,2,"Days 1-2 each week, in 7-week cycles",2 on/5 off schedule
30016392,NCT02193633,961,paclitaxel,4,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
30016392,NCT02193633,961,vistusertib,5,75,mg,2,"Days 1-2 each week, in 7-week cycles",2 on/5 off schedule
30016392,NCT02193633,961,paclitaxel,5,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
30016392,NCT02193633,961,vistusertib,6,100,mg,2,"Days 1-2 each week, in 7-week cycles",2 on/5 off schedule
30016392,NCT02193633,961,paclitaxel,6,80,mg/m2,1,"on Day 1 each week, in 7-week cycles (6 weeks treatment followed by 1 week rest)",fixed
15865080,NA,962,paclitaxel,1,60,mg/m2,1,"on days 1, 8 and 15 on a 28-day cycle",NA
15865080,NA,962,doxifluridine,1,533,mg/m2,1,5 days per week on a 28-day cycle,fixed
15865080,NA,962,paclitaxel,2,70,mg/m2,1,"on days 1, 8 and 15 on a 28-day cycle",NA
15865080,NA,962,doxifluridine,2,533,mg/m2,1,5 days per week on a 28-day cycle,fixed
15865080,NA,962,paclitaxel,3,80,mg/m2,1,"on days 1, 8 and 15 on a 28-day cycle",NA
15865080,NA,962,doxifluridine,3,533,mg/m2,1,5 days per week on a 28-day cycle,fixed
15865080,NA,962,paclitaxel,4,90,mg/m2,1,"on days 1, 8 and 15 on a 28-day cycle",NA
15865080,NA,962,doxifluridine,4,533,mg/m2,1,5 days per week on a 28-day cycle,fixed
15865080,NA,962,paclitaxel,5,100,mg/m2,1,"on days 1, 8 and 15 on a 28-day cycle",NA
15865080,NA,962,doxifluridine,5,533,mg/m2,1,5 days per week on a 28-day cycle,fixed
11474274,NA,963,paclitaxel,1,70,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
11474274,NA,963,paclitaxel,2,80,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
11474274,NA,963,paclitaxel,3,90,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
11474274,NA,963,paclitaxel,4,100,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
11474274,NA,963,paclitaxel,5,110,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
11474274,NA,963,paclitaxel,5,120,mg/m2,1,weekly for 4 consecutive weeks every 6 weeks,NA
17668866,NA,964,paclitaxel,1,250,mg/m2,1,every 21 days over24 hr,schedule A
17668866,NA,964,paclitaxel,2,300,mg/m2,1,every 21 days over24 hr,schedule A
17668866,NA,964,paclitaxel,3,360,mg/m2,1,every 21 days over24 hr,schedule A
17668866,NA,964,paclitaxel,4,430,mg/m2,1,every 21 days over24 hr,schedule A
17668866,NA,964,paclitaxel,5,500,mg/m2,1,every 21 days over24 hr,schedule A
17668866,NA,964,paclitaxel,6,250,mg/m2,1,every 14 days,schedule A1
17668866,NA,964,paclitaxel,7,105,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
17668866,NA,964,paclitaxel,8,125,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
17668866,NA,964,paclitaxel,9,150,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
17668866,NA,964,paclitaxel,10,165,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
17668866,NA,964,paclitaxel,11,182,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
17668866,NA,964,paclitaxel,12,200,mg/m2,1,weekly for three consecutive weeks every 28 days,schedule B
11345652,NA,965,paclitaxel,1,60,mg/m2,2,"orally, daily during course 1 (3 weeks per week)",NA
11345652,NA,965,paclitaxel,NA,175,mg/m2,1,"i.v., 3-weekly during subsequent courses",fixed
11345652,NA,965,cyclosporin a,1,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,cyclosporin a,1,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,paclitaxel,2,90,mg/m2,2,"orally, daily during course 1 (3 weeks per week)",NA
11345652,NA,965,paclitaxel,2,175,mg/m2,1,"i.v., 3-weekly during subsequent courses",fixed
11345652,NA,965,cyclosporin a,2,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,cyclosporin a,2,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,paclitaxel,3,120,mg/m2,2,"orally, daily during course 1 (3 weeks per week)",NA
11345652,NA,965,paclitaxel,3,175,mg/m2,1,"i.v., 3-weekly during subsequent courses",fixed
11345652,NA,965,cyclosporin a,3,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,cyclosporin a,3,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,paclitaxel,4,160,mg/m2,2,"orally, daily during course 1 (3 weeks per week)",NA
11345652,NA,965,paclitaxel,4,175,mg/m2,1,"i.v., 3-weekly during subsequent courses",fixed
11345652,NA,965,cyclosporin a,4,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
11345652,NA,965,cyclosporin a,4,15,mg/kg,1,daily during course 1 (3 weeks per week),fixed
18682950,NA,966,paclitaxel poliglumex,1,175,mg/m2,1,On day 1 of each 21-day treatment cycle,NA
18682950,NA,966,cisplatin,1,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,cisplatin,1,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,paclitaxel poliglumex,2,210,mg/m2,1,On day 1 of each 21-day treatment cycle,NA
18682950,NA,966,cisplatin,2,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,cisplatin,2,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,paclitaxel poliglumex,3,225,mg/m2,1,On day 1 of each 21-day treatment cycle,NA
18682950,NA,966,cisplatin,3,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,cisplatin,3,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,paclitaxel poliglumex,4,250,mg/m2,1,On day 1 of each 21-day treatment cycle,NA
18682950,NA,966,cisplatin,4,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,cisplatin,4,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,paclitaxel poliglumex,5,270,mg/m2,1,On day 1 of each 21-day treatment cycle,NA
18682950,NA,966,cisplatin,5,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
18682950,NA,966,cisplatin,5,75,mg/m2,1,On day 1 of each 21-day treatment cycle,fixed
15297186,NA,967,adp53,1,3 x 10^10,vp,1,daily for 5 consecutive days every 3 weeks,NA
15297186,NA,967,adp53,1,3 x 10^11,vp,1,daily for 5 consecutive days every 3 weeks,NA
15297186,NA,967,adp53,1,1 x 10^12,vp,1,daily for 5 consecutive days every 3 weeks,NA
15297186,NA,967,adp53,1,3 x 10^12,vp,1,daily for 5 consecutive days every 3 weeks,NA
16533873,NA,968,matuzumab,1,100,mg/m2,1,On day 1 of the 3-week cycle,NA
16533873,NA,968,paclitaxel,1,175,mg/m2,1,On day 1 of the 3-week cycle,fixed
16533873,NA,968,matuzumab,2,200,mg/m2,1,On day 1 of the 3-week cycle,NA
16533873,NA,968,paclitaxel,2,175,mg/m2,1,On day 1 of the 3-week cycle,fixed
16533873,NA,968,matuzumab,3,400,mg/m2,1,On day 1 of the 3-week cycle,NA
16533873,NA,968,paclitaxel,3,175,mg/m2,1,On day 1 of the 3-week cycle,fixed
16533873,NA,968,matuzumab,4,800,mg/m2,1,On day 1 of the 3-week cycle,NA
16533873,NA,968,paclitaxel,4,175,mg/m2,1,On day 1 of the 3-week cycle,fixed
12827291,NA,969,zd0473,1,60,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,1,135,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,zd0473,2,90,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,2,135,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,zd0473,3,120,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,3,135,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,zd0473,4,120,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,4,150,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,zd0473,5,120,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,5,175,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,zd0473,6,150,mg/m2,1,on day 1 every 3 weeks,NA
12827291,NA,969,paclitaxel,6,175,mg/m2,1,on day 1 every 3 weeks,NA
16626792,NA,970,paclimer,1,60,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,2,120,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,3,240,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,4,480,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,5,900,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,6,1200,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,7,1500,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,8,1800,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,9,2100,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,10,2400,mg/m2,1,every 8 weeks for two cycles,NA
16626792,NA,970,paclimer,11,2700,mg/m2,1,every 8 weeks for two cycles,NA
12401907,NA,971,paclitaxel,1,60,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,1,8,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,1,0.8,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,paclitaxel,2,70,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,2,8,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,2,0.8,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,paclitaxel,3,70,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,3,10,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,3,1,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,paclitaxel,4,70,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,4,11.5,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,4,1.15,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,paclitaxel,5,80,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,5,10,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,5,1,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,paclitaxel,6,80,mg/m2,1,"on days 1, 8, 15, and 22 with cycles repeated every 35 days",NA
12401907,NA,971,eniluracil,6,11.5,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12401907,NA,971,5-fluorouracil,6,1.15,mg/m2,2,on days 1-28 with cycles repeated every 35 days,NA
12768320,NA,972,paclitaxel,1,70,mg/m2,1,on day 2 each week for 6 weeks out of an 8-week cycle,NA
12768320,NA,972,cra,1,1,mg/kg,1,on days 1 and 2 in an 8-week schedule,fixed
12768320,NA,972,ifn,1,6,MU/m2,1,on days 1 and 2 in an 8-week schedule,fixed
12768320,NA,972,paclitaxel,2,80,mg/m2,1,on day 2 each week for 6 weeks out of an 8-week cycle,NA
12768320,NA,972,cra,2,1,mg/kg,1,on days 1 and 2 in an 8-week schedule,fixed
12768320,NA,972,ifn,2,6,MU/m2,1,on days 1 and 2 in an 8-week schedule,fixed
14566475,NA,973,cisplatin,1,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,cisplatin,1,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,paclitaxel,1,20,mg/m2,1,twice weekly over the whole time of irradiation,NA
14566475,NA,973,irradiation,1,NA,Gy,NA,in daily doses of 2 Gy up to 30 Gy followed by 1.4 Gy twice daily up to 70.6 Gy to the primary tumor and involved nodes and 51 Gy to the clinically negative regional nodes,fixed
14566475,NA,973,cisplatin,2,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,cisplatin,2,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,paclitaxel,2,25,mg/m2,1,twice weekly over the whole time of irradiation,NA
14566475,NA,973,irradiation,2,NA,Gy,NA,in daily doses of 2 Gy up to 30 Gy followed by 1.4 Gy twice daily up to 70.6 Gy to the primary tumor and involved nodes and 51 Gy to the clinically negative regional nodes,fixed
14566475,NA,973,cisplatin,3,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,cisplatin,3,20,mg/m2,1,on days 1–5 and 29–33 as short infusion (infusion time about 30 min) immediately prior to the daily radiation fraction,fixed
14566475,NA,973,paclitaxel,3,30,mg/m2,1,twice weekly over the whole time of irradiation,NA
14566475,NA,973,irradiation,3,NA,Gy,NA,in daily doses of 2 Gy up to 30 Gy followed by 1.4 Gy twice daily up to 70.6 Gy to the primary tumor and involved nodes and 51 Gy to the clinically negative regional nodes,fixed
12140142,NA,974,cisplatin,1,50,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,cisplatin,1,50,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,paclitaxel,1,110,mg/m2,1,"on day 1 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,conventional thoracic irradiation,1,2,Gy,1,"daily for five times weekly to a total dose of 60 Gy, delivered in 6 weeks",fixed
12140142,NA,974,cisplatin,2,50,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,cisplatin,2,50,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,paclitaxel,2,135,mg/m2,1,"on day 1 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,conventional thoracic irradiation,2,2,Gy,1,"daily for five times weekly to a total dose of 60 Gy, delivered in 6 weeks",fixed
12140142,NA,974,cisplatin,3,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,cisplatin,3,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,paclitaxel,3,135,mg/m2,1,"on day 1 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,conventional thoracic irradiation,3,2,Gy,1,"daily for five times weekly to a total dose of 60 Gy, delivered in 6 weeks",fixed
12140142,NA,974,cisplatin,4,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,cisplatin,4,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,paclitaxel,4,170,mg/m2,1,"on day 1 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,conventional thoracic irradiation,4,2,Gy,1,"daily for five times weekly to a total dose of 60 Gy, delivered in 6 weeks",fixed
12140142,NA,974,cisplatin,5,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,cisplatin,5,75,mg/m2,1,"on day 2 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,paclitaxel,5,135 mg/m2 for the first two cycles and was 170 mg/m2 for the third and fourth cycles,mg/m2,1,"on day 1 in the first two cycles, given at 4-week intervals, and in the third and fourth cycles of chemotherapy were given at 3-week intervals",NA
12140142,NA,974,conventional thoracic irradiation,5,2,Gy,1,"daily for five times weekly to a total dose of 60 Gy, delivered in 6 weeks",fixed
11710824,NA,975,topotecan,1,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,topotecan,1,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,cisplatin,1,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43",NA
11710824,NA,975,cisplatin,1,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43",NA
11710824,NA,975,topotecan,2,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,topotecan,2,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,cisplatin,2,70,mg/m2,1,"on day 2, 9, 16, 30, 37, 44",NA
11710824,NA,975,cisplatin,2,70,mg/m2,1,"on day 2, 9, 16, 30, 37, 44",NA
11710824,NA,975,topotecan,3,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,topotecan,3,0.45,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,cisplatin,3,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43","CrEL administered with cisplatin at a
dose of 90 mg/m–2"
11710824,NA,975,cisplatin,3,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43","CrEL administered with cisplatin at a
dose of 90 mg/m–2"
11710824,NA,975,topotecan,3.5,0.6,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,topotecan,3.5,0.6,mg/m2,1,"day 1, 2, 8, 9, 15, 16, 29, 30, 36, 37, 43, 44",NA
11710824,NA,975,cisplatin,3.5,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43","CrEL administered with cisplatin at a
dose of 90 mg/m–2"
11710824,NA,975,cisplatin,3.5,70,mg/m2,1,"on day 1, 8, 15, 29, 36, 43","CrEL administered with cisplatin at a
dose of 90 mg/m–2"
15216957,NA,976,paclitaxel,1,30,mg/m2,1,During radiotherapy weekly paclitaxel was administered for 6 courses if feasible,NA
15216957,NA,976,irradiation,1,2,Gy,1,5 days per week up to a total dose of 66-70Gy,fixed
15216957,NA,976,paclitaxel,2,40,mg/m2,1,During radiotherapy weekly paclitaxel was administered for 6 courses if feasible,NA
15216957,NA,976,irradiation,2,2,Gy,1,5 days per week up to a total dose of 66-70Gy,fixed
15216957,NA,976,paclitaxel,3,50,mg/m2,1,During radiotherapy weekly paclitaxel was administered for 6 courses if feasible,NA
15216957,NA,976,irradiation,3,2,Gy,1,5 days per week up to a total dose of 66-70Gy,fixed
11603001,NA,977,ifn,1,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,1,0,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,1,45,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,2,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,2,0,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,2,40,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,3,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,3,25,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,3,32,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,4,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,4,50,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,4,32,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,5,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,5,75,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,5,32,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,6,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,6,100,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,6,32,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,7,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,7,100,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,7,36,mCi/m2,1,on day 1,NA
11603001,NA,977,ifn,8,3 x 10^6,U,1,"on days -5, -3, -1, and +2",fixed
11603001,NA,977,taxol,8,100,mg/m2,1,on day -2,NA
11603001,NA,977,177lu-cc49,8,40,mCi/m2,1,on day 1,NA
17021821,NA,978,vinorelbine,1,60,mg/m2,1,on days 1 and 8 every 3 weeks,NA
17021821,NA,978,paclitaxel,1,110,mg/m2,1,on day 1 every 3 weeks,NA
17021821,NA,978,vinorelbine,2,70,mg/m2,1,on days 1 and 8 or 15 every 3 weeks,NA
17021821,NA,978,paclitaxel,2,110,mg/m2,1,on days 1 and 8 every 3 weeks,NA
17021821,NA,978,vinorelbine,3,80,mg/m2,1,on day 1 every 3 weeks,NA
17021821,NA,978,paclitaxel,3,110,mg/m2,1,on days 1 and 8 or 15 every 3 weeks,NA
17021821,NA,978,vinorelbine,4,80,mg/m2,1,on days 1 and 8 every 3 weeks,NA
17021821,NA,978,paclitaxel,4,135,mg/m2,1,on day 1 every 3 weeks,NA
17021821,NA,978,vinorelbine,5,60,mg/m2,1,on days 1 and 8 or 15 every 3 weeks,NA
17021821,NA,978,paclitaxel,5,135,mg/m2,1,on days 1 and 8 every 3 weeks,NA
17021821,NA,978,vinorelbine,3.5,80,mg/m2,1,on days 1 and 15 every 3 weeks,NA
17021821,NA,978,paclitaxel,3.5,110,mg/m2,1,on day 1 every 3 weeks,NA
17021821,NA,978,vinorelbine,5.5,60,mg/m2,1,on days 1 and 15 every 3 weeks,NA
17021821,NA,978,paclitaxel,5.5,135,mg/m2,1,on day 1 every 3 weeks,NA
16891865,NA,979,paclitaxel poliglumex,1,40,mg/m2,1,"a 10-minute infusion before radiotherapy on days 1, 8, 15, 22, 29, 36",NA
16891865,NA,979,radiation,1,1.8,Gy,1,for a total of 28 days (5 days/wk),fixed
16891865,NA,979,paclitaxel poliglumex,2,50,mg/m2,1,"a 10-minute infusion before radiotherapy on days 1, 8, 15, 22, 29, 36",NA
16891865,NA,979,radiation,2,1.8,Gy,1,for a total of 28 days (5 days/wk),fixed
16891865,NA,979,paclitaxel poliglumex,3,60,mg/m2,1,"a 10-minute infusion before radiotherapy on days 1, 8, 15, 22, 29, 36",NA
16891865,NA,979,radiation,3,1.8,Gy,1,for a total of 28 days (5 days/wk),fixed
16891865,NA,979,paclitaxel poliglumex,4,70,mg/m2,1,"a 10-minute infusion before radiotherapy on days 1, 8, 15, 22, 29, 36",NA
16891865,NA,979,radiation,4,1.8,Gy,1,for a total of 28 days (5 days/wk),fixed
16891865,NA,979,paclitaxel poliglumex,5,80,mg/m2,1,"a 10-minute infusion before radiotherapy on days 1, 8, 15, 22, 29, 36",NA
16891865,NA,979,radiation,5,1.8,Gy,1,for a total of 28 days (5 days/wk),fixed
18414864,NA,980,dha-paclitaxel,1,100,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
18414864,NA,980,dha-paclitaxel,2,200,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
18414864,NA,980,dha-paclitaxel,3,300,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
18414864,NA,980,dha-paclitaxel,4,400,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
18414864,NA,980,dha-paclitaxel,5,500,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
18414864,NA,980,dha-paclitaxel,6,600,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
12006516,NA,981,abi-007,0,135,mg/m2,1,every 21 days,NA
12006516,NA,981,abi-007,1,200,mg/m2,1,every 21 days,NA
12006516,NA,981,abi-007,2,300,mg/m2,1,every 21 days,NA
12006516,NA,981,abi-007,3,375,mg/m2,1,every 21 days,NA
12231518,NA,982,bms-184476,1,7,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,2,14,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,3,28,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,4,40,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,5,50,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,6,60,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
12231518,NA,982,bms-184476,7,50,mg/m2,1,on days 1 and 8 of a 21-day cycle,protocol amendment
16258082,NA,983,abi-007,1,80,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Pretreatment not assigned patients
16258082,NA,983,abi-007,2,100,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Heavily and Lightly pretreated patients
16258082,NA,983,abi-007,3,125,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Heavily and Lightly pretreated patients
16258082,NA,983,abi-007,4,150,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Lightly pretreated patients
16258082,NA,983,abi-007,5,175,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Lightly pretreated patients
16258082,NA,983,abi-007,6,200,mg/m2,1,"weekly for 3 weeks, followed by 1 week of rest",Lightly pretreated patients
12460783,NA,984,ly355703,1,0.1,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,2,0.2,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,3,0.4,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,4,0.52,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,5,0.68,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,6,0.88,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,7,1.14,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,8,1.48,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,9,1.92,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,10,1.71,mg/m2,1,on day 1 every 3 weeks,NA
12460783,NA,984,ly355703,11,1,mg/m2,1,"d 1, 8, 15 q 4 wks",NA
12176795,NA,985,rpr 109881a,1,15,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,2,30,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,3,45,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,4,60,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,5,75,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,6,90,mg/m2,1,a 1-h infusion every 3 weeks,NA
12176795,NA,985,rpr 109881a,7,105,mg/m2,1,a 1-h infusion every 3 weeks,NA
16248762,NA,986,90y-mcc49,1,8,mCi/m2,1,on day 1,NA
16248762,NA,986,ifn,1,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,986,90y-mcc49,2,11,mCi/m2,1,on day 1,NA
16248762,NA,986,ifn,2,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,986,90y-mcc49,3,14,mCi/m2,1,on day 1,NA
16248762,NA,986,ifn,3,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,986,90y-mcc49,4,17,mCi/m2,1,on day 1,NA
16248762,NA,986,ifn,4,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,987,90y-mcc49,1,17,mCi/m2,1,on day 1,NA
16248762,NA,987,edta,1,25,mg/kg,2,infused over a 12-hour period for six doses (a total of 72 hours). Infusions started 30minutes  prior to the 90Y-mCC49 administration,NA
16248762,NA,987,ifn,1,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,987,90y-mcc49,2,17,mCi/m2,1,on day 1,NA
16248762,NA,987,dtpa,2,125,mg/m2,2,infused over a 12-hour period for six doses (a total of 72 hours). Infusions started 30minutes  prior to the 90Y-mCC49 administration,NA
16248762,NA,987,ifn,2,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,987,90y-mcc49,3,20,mCi/m2,1,on day 1,NA
16248762,NA,987,dtpa,3,125,mg/m2,2,infused over a 12-hour period for six doses (a total of 72 hours). Infusions started 30minutes  prior to the 90Y-mCC49 administration,NA
16248762,NA,987,ifn,3,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,988,90y-mcc49,1,14,mCi/m2,1,on day 1,NA
16248762,NA,988,paclitaxel,1,80,mg/m2,NA,"a 96-hour infusion, starting from day -2",NA
16248762,NA,988,ifn,1,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
16248762,NA,988,90y-mcc49,0,14,mCi/m2,1,on day 1,NA
16248762,NA,988,paclitaxel,0,60,mg/m2,NA,"a 96-hour infusion, starting from day -2",NA
16248762,NA,988,ifn,0,3 x 10^6,IU,1,"on days -5, -3, -1, and 2 (alternate days beginning 5 days prior to 90Y-mCC49 infusion)",NA
12110496,NA,989,paclitaxel,1,80,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",NA
12110496,NA,989,cisplatin,1,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,cisplatin,1,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,paclitaxel,2,90,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",NA
12110496,NA,989,cisplatin,2,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,cisplatin,2,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,paclitaxel,3,100,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",NA
12110496,NA,989,cisplatin,3,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,cisplatin,3,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,paclitaxel,4,110,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",NA
12110496,NA,989,cisplatin,4,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
12110496,NA,989,cisplatin,4,70,mg/m2,1,"on days 1, 8, 15, 29, 36 and 43",fixed
17452427,NA,990,paclitaxel,1,120,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,nedaplatin,1,80,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,thoracic radiation therapy,1,2,Gy,1,"once daily Monday through Friday for 6 weeks without interruption beginning on day 1 of the chemotherapy, up to total dose of 60 Gy/30 fractions",NA
17452427,NA,990,paclitaxel,2,135,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,nedaplatin,2,80,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,thoracic radiation therapy,2,2,Gy,1,"once daily Monday through Friday for 6 weeks without interruption beginning on day 1 of the chemotherapy, up to total dose of 60 Gy/30 fractions",NA
17452427,NA,990,paclitaxel,3,150,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,nedaplatin,3,80,mg/m2,1,on day 1 every 4 weeks for 3–4 cycles,NA
17452427,NA,990,thoracic radiation therapy,3,2,Gy,1,"once daily Monday through Friday for 6 weeks without interruption beginning on day 1 of the chemotherapy, up to total dose of 60 Gy/30 fractions",NA
17589845,NA,991,paclitaxel,0,60,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17589845,NA,991,nedaplatin,0,80,mg/m2,1,day 1 every 4 weeks,NA
17589845,NA,991,paclitaxel,1,70,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17589845,NA,991,nedaplatin,1,80,mg/m2,1,day 1 every 4 weeks,NA
17589845,NA,991,paclitaxel,2,80,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17589845,NA,991,nedaplatin,2,80,mg/m2,1,day 1 every 4 weeks,NA
17589845,NA,991,paclitaxel,3,90,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17589845,NA,991,nedaplatin,3,80,mg/m2,1,day 1 every 4 weeks,NA
17589845,NA,991,paclitaxel,4,90,mg/m2,1,"on days 1, 8, and 15 every 4 weeks",NA
17589845,NA,991,nedaplatin,4,100,mg/m2,1,day 1 every 4 weeks,NA
15711828,NA,992,ct-2103,1,235,mg/m2,1,every 3 weeks,NA
15711828,NA,992,ct-2103,2,270,mg/m2,1,every 3 weeks,NA
17519083,NA,993,paclitaxel,1,15,mg/m2,1,"twice weekly, 2 weeks in all",NA
17519083,NA,993,3d-conformal radiotherapy,1,2,Gy,1,"5 days a week for 6 weeks, up to 60 Gy in 30 fractions",NA
17519083,NA,993,paclitaxel,2,15,mg/m2,1,"twice weekly, 4 weeks in all",NA
17519083,NA,993,3d-conformal radiotherapy,2,2,Gy,1,"5 days a week for 6 weeks, up to 60 Gy in 30 fractions",NA
17519083,NA,993,paclitaxel,3,15,mg/m2,1,"twice weekly, 6 weeks in all",NA
17519083,NA,993,3d-conformal radiotherapy,3,2,Gy,1,"5 days a week for 6 weeks, up to 60 Gy in 30 fractions",NA
17519083,NA,993,paclitaxel,4,15,mg/m2,1,"three times a week, Monday, Wednesday and Friday for 4 weeks",NA
17519083,NA,993,3d-conformal radiotherapy,4,2,Gy,1,"5 days a week for 6 weeks, up to 60 Gy in 30 fractions",NA
17519083,NA,993,paclitaxel,5,15,mg/m2,1,"three times a week, Monday, Wednesday and Friday for 6 weeks",NA
17519083,NA,993,3d-conformal radiotherapy,5,2,Gy,1,"5 days a week for 6 weeks, up to 60 Gy in 30 fractions",NA
14701767,NA,994,paclitaxel,1,20,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,1,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,1,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",1,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
14701767,NA,994,paclitaxel,2,20,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,2,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,2,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",2,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
14701767,NA,994,paclitaxel,3,30,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,3,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,3,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",3,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
14701767,NA,994,paclitaxel,4,40,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,4,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,4,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",4,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
14701767,NA,994,paclitaxel,5,60,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,5,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,5,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",5,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
14701767,NA,994,paclitaxel,6,80,mg/m2,1,"a 96-hour IV infusion on days 1, 8, 15, 22, 29, and 36 of the radiation treatment",NA
14701767,NA,994,cisplatin,6,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,cisplatin,6,30,mg/m2,1,"days 1, 8, 15, 22, 29, and 36 of the radiation treatment",fixed
14701767,NA,994,"multifield, external-beam megavoltage radiation",6,1.8,Gy,1,five daily fractions  per week over a 6-week period to total 50.4 Gy,NA
16537186,NA,995,paclitaxel,1,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,1,12,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,1,12,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,hyperfractionated splitcourse radiotherapy,1,150,cGy,2,"RT-na ̈ıve patientsreceived 150 cGy x 5d Q 2wks x 4. Previously radiated patients received 150 cGy x 5, wk 1; then 120 cGy x 5d Q 2wk x 3.",fixed
16537186,NA,995,paclitaxel,2,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,2,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,2,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,hyperfractionated splitcourse radiotherapy,2,150,cGy,2,"RT-na ̈ıve patientsreceived 150 cGy x 5d Q 2wks x 4. Previously radiated patients received 150 cGy x 5, wk 1; then 120 cGy x 5d Q 2wk x 3",fixed
16537186,NA,995,paclitaxel,3,20,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,3,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,3,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,hyperfractionated splitcourse radiotherapy,3,150,cGy,2,"RT-na ̈ıve patientsreceived 150 cGy x 5d Q 2wks x 4. Previously radiated patients received 150 cGy x 5, wk 1; then 120 cGy x 5d Q 2wk x 3",fixed
16537186,NA,995,paclitaxel,3.5,20,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,addition of G-CSF during the off week (Days 6–12)
16537186,NA,995,cisplatin,3.5,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,cisplatin,3.5,15,mg/m2,1,daily for 5 consecutive days every 2 weeks for 4 cycles,NA
16537186,NA,995,hyperfractionated splitcourse radiotherapy,3.5,150,cGy,2,"RT-na ̈ıve patientsreceived 150 cGy x 5d Q 2wks x 4. Previously radiated patients received 150 cGy x 5, wk 1; then 120 cGy x 5d Q 2wk x 3",fixed
17091249,NA,996,mac-321,1,25,mg/m2,1,once every 21 days,NA
17091249,NA,996,mac-321,2,37,mg/m2,1,once every 21 days,NA
17091249,NA,996,mac-321,3,50,mg/m2,1,once every 21 days,NA
17091249,NA,996,mac-321,4,75,mg/m2,1,once every 21 days,NA
17091249,NA,996,mac-321,5,100,mg/m2,1,once every 21 days,NA
17091249,NA,996,mac-321,6,125,mg/m2,1,once every 21 days,NA
17510207,NA,997,paclitaxel,0,80,mg/m2,1,weekly in 21-day cylces,fixed
17510207,NA,997,bms-214662,0,80,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,1,80,mg/m2,1,weekly in 21-day cylces,fixed
17510207,NA,997,bms-214662,1,120,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,2,80,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",fixed
17510207,NA,997,bms-214662,2,160,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,3,80,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",fixed
17510207,NA,997,bms-214662,3,200,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,4,80,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",fixed
17510207,NA,997,bms-214662,4,225,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,5,80,mg/m2,1,weekly in 21-day cylces,fixed
17510207,NA,997,bms-214662,5,245,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, weekly in 21-day cylces",NA
17510207,NA,997,paclitaxel,3.5,80,mg/m2,1,weekly in 21-day cylces,fixed
17510207,NA,997,bms-214662,3.5,209,mg/m2,1,"administered, starting 30 min after completion of the paclitaxel, at a 24-h infusion weekly in 21-day cylces",NA
16551860,NA,998,bms-275183,1,5,mg,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,2,5,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,3,10,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,4,20,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,5,40,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,6,80,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,7,120,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,8,160,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,9,200,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,10,240,mg/m2,1,weekly of 4 weeks of treatment,NA
16551860,NA,998,bms-275183,11,320,mg/m2,1,weekly of 4 weeks of treatment,NA
16557435,NA,202,paclitaxel,1,100,mg/m2,1,every 2 weeks,NA
16557435,NA,202,cisplatin,1,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,cisplatin,1,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,paclitaxel,2,120,mg/m2,1,every 2 weeks,NA
16557435,NA,202,cisplatin,2,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,cisplatin,2,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,paclitaxel,3,140,mg/m2,1,every 2 weeks,NA
16557435,NA,202,cisplatin,3,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,cisplatin,3,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,paclitaxel,4,160,mg/m2,1,every 2 weeks,NA
16557435,NA,202,cisplatin,4,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,cisplatin,4,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,paclitaxel,5,180,mg/m2,1,every 2 weeks,NA
16557435,NA,202,cisplatin,5,30,mg/m2,1,every 2 weeks,fixed
16557435,NA,202,cisplatin,5,30,mg/m2,1,every 2 weeks,fixed
15026799,NA,203,paclitaxel,1,40,mg/m2,1,"on days 1, 8, and 15 in a 4-week cycle",NA
15026799,NA,203,cisplatin,1,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,cisplatin,1,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,paclitaxel,2,50,mg/m2,1,"on days 1, 8, and 15 in a 4-week cycle",NA
15026799,NA,203,cisplatin,2,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,cisplatin,2,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,paclitaxel,3,60,mg/m2,1,"on days 1, 8, and 15 in a 4-week cycle",NA
15026799,NA,203,cisplatin,3,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,cisplatin,3,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,paclitaxel,4,70,mg/m2,1,"on days 1, 8, and 15 in a 4-week cycle",NA
15026799,NA,203,cisplatin,4,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
15026799,NA,203,cisplatin,4,80,mg/m2,1,on day 1 in a 4-week cycle,fixed
18235124,NA,204,nab-paclitaxel,1,100,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18235124,NA,204,nab-paclitaxel,2,125,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18235124,NA,204,nab-paclitaxel,3,150,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
18235124,NA,204,nab-paclitaxel,4,175,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
15596915,NA,205,paclitaxel,1,20,mg/m2,1,every 7 days and 1 hour before radiation for 7 courses,NA
15596915,NA,205,conventional radiotherapy,1,2,Gy,1,for 5 days/wk up to total doses of 68–70 Gy over 7 weeks,NA
15596915,NA,205,paclitaxel,2,30,mg/m2,1,every 7 days and 1 hour before radiation for 7 courses,NA
15596915,NA,205,conventional radiotherapy,2,2,Gy,1,for 5 days/wk up to total doses of 68–70 Gy over 7 weeks,NA
15596915,NA,205,paclitaxel,3,40,mg/m2,1,every 7 days and 1 hour before radiation for 7 courses,NA
15596915,NA,205,conventional radiotherapy,3,2,Gy,1,for 5 days/wk up to total doses of 68–70 Gy over 7 weeks,NA
16889823,NA,206,paclitaxel,-1,20,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,-1,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,-1,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,-1,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,1,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,1,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,1,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,1,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,2,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,2,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,2,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,2,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,3,50,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,3,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,3,40,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,3,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,4,50,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,4,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,4,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,4,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,5,60,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,5,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,5,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,5,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
16889823,NA,206,paclitaxel,6,70,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,6,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,cisplatin,6,30,mg/m2,1,weekly for six cycles with external beam radiation therapy,NA
16889823,NA,206,whole pelvic irradiation,6,180,cGy,1,in 25 daily fractions of 180 cGy (total of 4500 cGy),fixed
15010068,NA,207,lep,1,90,mg/m2,1,once every week for 6 out of 8 weeks. A period of 8 weeks was defined as one cycle.,NA
15010068,NA,207,lep,2,120,mg/m2,1,once every week for 6 out of 8 weeks. A period of 8 weeks was defined as one cycle.,NA
15010068,NA,207,lep,3,150,mg/m2,1,once every week for 6 out of 8 weeks. A period of 8 weeks was defined as one cycle.,NA
33928486,NCT02613221,208,panitumumab,1,6,mg/kg,1,every 2 weeks (Q2W) in a 28-day cycle,NA
33928486,NCT02613221,208,trifuridine/tipiracil,1,35,mg/m2,2,days 1–5 and 8–12 in a 28-day cycle,NA
15127231,NA,209,topotecan,1,1.25,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,1,1.25,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,1,60,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,2,1.5,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,2,1.5,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,2,60,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,3,1.5,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,3,1.5,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,3,70,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,4,1.75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,4,1.75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,4,70,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,5,1.75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,5,1.75,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,5,80,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,6,2,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,topotecan,6,2,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15127231,NA,209,paclitaxel,6,80,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
15613553,NA,210,paclitaxel,1,30,mg/m2,1,once a week for 6 weeks,NA
15613553,NA,210,nedaplatin,1,20,mg/m2,1,once a week for 6 weeks,fixed
15613553,NA,210,thoracic rt,1,2,Gy,1,daily dose for 5 days per week,NA
15613553,NA,210,paclitaxel,2,35,mg/m2,1,once a week for 6 weeks,NA
15613553,NA,210,nedaplatin,2,20,mg/m2,1,once a week for 6 weeks,fixed
15613553,NA,210,thoracic rt,2,2,Gy,1,daily dose for 5 days per week,NA
15613553,NA,210,paclitaxel,3,40,mg/m2,1,once a week for 6 weeks,NA
15613553,NA,210,nedaplatin,3,20,mg/m2,1,once a week for 6 weeks,fixed
15613553,NA,210,thoracic rt,3,2,Gy,1,daily dose for 5 days per week,NA
31164456,NCT02352571,211,gc1118,1,0.3,mg/kg,1,"on days 1, 8, 15, and 22, followed by a 2-week rest",NA
31164456,NCT02352571,211,gc1118,2,1,mg/kg,1,"on days 1, 8, 15, and 22, followed by a 2-week rest",NA
31164456,NCT02352571,211,gc1118,3,3,mg/kg,1,"on days 1, 8, 15, and 22, followed by a 2-week rest",NA
31164456,NCT02352571,211,gc1118,4,4,mg/kg,1,"on days 1, 8, 15, and 22, followed by a 2-week rest",NA
31164456,NCT02352571,211,gc1118,5,5,mg/kg,1,"on days 1, 8, 15, and 22, followed by a 2-week rest",NA
23054206,NCT00692159,212,trc102,1,15,mg/m2,1,on days 1 to 4 of a 2-week cycle in cycle 1; on days 1 to 4 of 3-week cycles in cycle 2,NA
23054206,NCT00692159,212,pemetrexed,1,500,mg/m2,1,on day 1 of 3-week cycles in cycle 2,fixed
23054206,NCT00692159,212,trc102,2,30,mg/m2,1,on days 1 to 4 of a 2-week cycle in cycle 1; on days 1 to 4 of 3-week cycles in cycle 2,NA
23054206,NCT00692159,212,pemetrexed,2,500,mg/m2,1,on day 1 of 3-week cycles in cycle 2,fixed
23054206,NCT00692159,212,trc102,3,60,mg/m2,1,on days 1 to 4 of a 2-week cycle in cycle 1; on days 1 to 4 of 3-week cycles in cycle 2,NA
23054206,NCT00692159,212,pemetrexed,3,500,mg/m2,1,on day 1 of 3-week cycles in cycle 2,fixed
23054206,NCT00692159,212,trc102,4,100,mg/m2,1,on days 1 to 4 of a 2-week cycle in cycle 1; on days 1 to 4 of 3-week cycles in cycle 2,NA
23054206,NCT00692159,212,pemetrexed,4,500,mg/m2,1,on day 1 of 3-week cycles in cycle 2,fixed
26386124,ACTRN12609000294257,213,"cp-870,893",1,1,mg/kg,1,on day 8 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,pemetrexed,1,500,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,"cp-870,893",2,2,mg/kg,1,on day 8 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,pemetrexed,2,500,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,"cp-870,893",3,1.5,mg/kg,1,on day 8 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,NA
26386124,ACTRN12609000294257,213,pemetrexed,3,500,mg/m2,1,on day 1 of a 21-day cycle,NA
21989766,NCT00528619,214,sunitinib,1,37.5,mg,1,continuous daily,NA
21989766,NCT00528619,214,pemetrexed,1,300,mg/m2,1,once every 3 weeks (q3w),fixed
21989766,NCT00528619,214,sunitinib,2,37.5,mg,1,continuous daily,NA
21989766,NCT00528619,214,pemetrexed,2,400,mg/m2,1,once every 3 weeks (q3w),fixed
21989766,NCT00528619,214,sunitinib,5,50,mg,1,daily on 2 weeks on/1 week off treatment schedule,NA
21989766,NCT00528619,214,pemetrexed,5,500,mg/m2,1,once every 3 weeks (q3w),fixed
21989766,NCT00528619,214,sunitinib,3,37.5,mg,1,continuous daily,NA
21989766,NCT00528619,214,pemetrexed,3,500,mg/m2,1,once every 3 weeks (q3w),fixed
21989766,NCT00528619,214,sunitinib,4,50,mg,1,continuous daily,NA
21989766,NCT00528619,214,pemetrexed,4,500,mg/m2,1,once every 3 weeks (q3w),fixed
10501910,NA,215,ly231514,1,50,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,2,75,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,3,100,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,4,150,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,5,225,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,6,350,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,7,525,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,8,700,mg/m2,1,every 21 days,NA
10501910,NA,215,ly231514,9,900,mg/m2,1,every 21 days,NA
22658814,NA,216,bi 2536,1,100,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,1,500,mg/m2,1,on day 1 every 3 weeks,fixed
22658814,NA,216,bi 2536,2,150,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,2,500,mg/m2,1,on day 1 every 3 weeks,fixed
22658814,NA,216,bi 2536,3,200,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,3,500,mg/m2,1,on day 1 every 3 weeks,fixed
22658814,NA,216,bi 2536,4,250,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,4,500,mg/m2,1,on day 1 every 3 weeks,fixed
22658814,NA,216,bi 2536,5,300,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,5,500,mg/m2,1,on day 1 every 3 weeks,fixed
22658814,NA,216,bi 2536,6,325,mg,1,on day 1 every 3 weeks,NA
22658814,NA,216,pemetrexed,6,500,mg/m2,1,on day 1 every 3 weeks,fixed
27717315,ChiCTR-OPN-16008316,217,nedaplatin,1,60,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,NA
27717315,ChiCTR-OPN-16008316,217,pemetrexed,1,500,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,fixed
27717315,ChiCTR-OPN-16008316,217,thoracic intensity-modulated radiotherapy,1,2,Gy,1,delivered daily to a cumulative dose of 60–64 Gy,fixed
27717315,ChiCTR-OPN-16008316,217,nedaplatin,2,70,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,NA
27717315,ChiCTR-OPN-16008316,217,pemetrexed,2,500,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,fixed
27717315,ChiCTR-OPN-16008316,217,thoracic intensity-modulated radiotherapy,2,2,Gy,1,delivered daily to a cumulative dose of 60–64 Gy,fixed
27717315,ChiCTR-OPN-16008316,217,nedaplatin,3,80,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,NA
27717315,ChiCTR-OPN-16008316,217,pemetrexed,3,500,mg/m2,1,on day 1 for two concurrent cycles every 3 weeks,fixed
27717315,ChiCTR-OPN-16008316,217,thoracic intensity-modulated radiotherapy,3,2,Gy,1,delivered daily to a cumulative dose of 60–64 Gy,fixed
17145830,NA,218,pemetrexed,1,400,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,1,400,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,2,500,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,2,400,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,3,500,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,3,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,4,500,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,4,800,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,5,600,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,5,800,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,6,800,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,6,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,7,900,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,7,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,8,1000,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,8,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,9,1100,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,9,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,10,1300,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,10,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,11,1500,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,11,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,12,1800,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,12,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,13,2100,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,13,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
17145830,NA,218,pemetrexed,14,2400,mg/m2,1,on day 1 of a 21-day schedule,NA
17145830,NA,218,cyclophosphamide,14,600,mg/m2,1,on day 1 of a 21-day cycle beginning ~10 minutes after the completion of the pemetrexed infusion,NA
16940981,NA,219,pemetrexed,1,300,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,1,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,1,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,1,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,1,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,2,500,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,2,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,2,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,2,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,2,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,3,600,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,3,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,3,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,3,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,3,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,4,700,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,4,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,4,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,4,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,4,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,5,800,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,5,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,5,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,5,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,5,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,6,900,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,6,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,6,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,6,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,6,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,7,1000,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,7,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,7,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,7,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,7,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,8,1200,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,8,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,8,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,8,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,8,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,9,1450,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,9,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,9,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,9,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,9,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,pemetrexed,10,1750,mg/m2,1,on day 1 of a 21-day cycle,NA
16940981,NA,219,vitamin b12,10,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,vitamin b12,10,1000,ug,1,starting 1 week before day 1 of cycle 1 and repeated every 9 weeks until study discontinuation,fixed
16940981,NA,219,folate,10,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
16940981,NA,219,folate,10,500,ug,1,daily beginning 1 week before day 1 of cycle 1 until study discontinuation,fixed
20091088,NA,220,pemetrexed,1,900,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,1,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,1,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,1,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,1,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,pemetrexed,2,1200,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,2,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,2,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,2,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,2,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,pemetrexed,3,1500,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,3,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,3,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,3,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,3,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,pemetrexed,4,2000,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,4,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,4,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,4,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,4,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,pemetrexed,5,2700,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,5,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,5,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,5,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,5,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,pemetrexed,6,3600,mg/m2,1,every 3 to 4 weeks,NA
20091088,NA,220,folic acid,6,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,folic acid,6,350 to 600,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,6,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
20091088,NA,220,vitamin b12,6,1000,ug,1,daily administered ≥12 h prior to pemetrexed,fixed
34724131,NCT04012619,221,anlotinib,1,12,mg/m2,1,on days 1-14 of each 21-day cycle,NA
34724131,NCT04012619,221,pemetrexed,1,500,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34724131,NCT04012619,221,cisplatin or carboplatin,1,75 or 5,mg/m2 or AUC,1,on Day 1 of each 21-day cycle,fixed
34724131,NCT04012619,221,anlotinib,1,10,mg/m2,1,on days 1-14 of each 21-day cycle,NA
30382439,NA,222,pemetrexed disodium,1,500,mg/m2,1,"on day 1, of a 21-day cycle",fixed
30382439,NA,222,vatalanib,1,500,mg,2,daily continuously,NA
30382439,NA,222,pemetrexed disodium,2,500,mg/m2,1,"on day 1, of a 21-day cycle",fixed
30382439,NA,222,vatalanib,2,750,mg,2,daily continuously,NA
30382439,NA,222,pemetrexed disodium,3,500,mg/m2,1,"on day 1, of a 21-day cycle",fixed
30382439,NA,222,vatalanib,3,750/1000,mg,2,"750 mg po BID for days 1–7 of cycle 1 only, then 1000 mg po BID thereafter",NA
30382439,NA,222,pemetrexed disodium,4,500,mg/m2,1,"on day 1, of a 21-day cycle",fixed
30382439,NA,222,vatalanib,4,750/1000/1250,mg,2,"for days 1–7 of cycle 1 only, then 1000 mg po BID for days 8–14 of cycle 1 only, then 1250 mg po BID thereafter",NA
30382439,NA,222,pemetrexed disodium,-1,500,mg/m2,1,"on day 1, of a 21-day cycle",fixed
30382439,NA,222,vatalanib,-1,250,mg,2,daily continuously,NA
25920360,NCT01985295,223,pazopanib,1,400,mg,1,"daily for 6 weeks, initiated one week prior to RT on Day 1 of study and continued until the last fraction",NA
25920360,NCT01985295,223,radiotherapy,1,50,Gy,NA,in 25 fractions of 2 Gy started on Day 8,fixed
25920360,NCT01985295,223,pazopanib,2,600,mg,1,"daily for 6 weeks, initiated one week prior to RT on Day 1 of study and continued until the last fraction",NA
25920360,NCT01985295,223,radiotherapy,2,50,Gy,NA,in 25 fractions of 2 Gy started on Day 8,fixed
25920360,NCT01985295,223,pazopanib,3,800,mg,1,"daily for 6 weeks, initiated one week prior to RT on Day 1 of study and continued until the last fraction",NA
25920360,NCT01985295,223,radiotherapy,3,50,Gy,NA,in 25 fractions of 2 Gy started on Day 8,fixed
31186313,NCT01438554,224,pazopanib,1,400,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,trametinib,1,1,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,pazopanib,2,600,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,trametinib,2,1,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,pazopanib,3,800,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,trametinib,3,1,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,pazopanib,4,800,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,trametinib,4,1.5,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,pazopanib,5,800,mg,1,daily every day of a 28-day cycle,NA
31186313,NCT01438554,224,trametinib,5,2,mg,1,daily every day of a 28-day cycle,NA
15923057,NA,225,pemetrexed,1,300,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,1,15,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,2,400,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,2,15,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,3,400,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,3,23,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,4,500,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,4,23,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,5,500,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,5,30,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,6,600,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,6,30,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
15923057,NA,225,pemetrexed,7,700,mg/m2,1,on day 1 every 21 days,NA
15923057,NA,225,vinorelbine,7,300,mg/m2,1,on days 1 and 8 of a 21-day cycle,NA
31506897,NCT01591421,226,bkm120,-1,40,mg,1,daily,NA
31506897,NCT01591421,226,panitumumab,-1,6,mg/kg,1,day 1 and 15 each 28 day cycle,fixed
31506897,NCT01591421,226,bkm120,0.5,60,mg,1,daily 5 out of 7 days per week,NA
31506897,NCT01591421,226,panitumumab,0.5,6,mg/kg,1,day 1 and 15 each 28 day cycle,fixed
31506897,NCT01591421,226,bkm120,1,60,mg,1,daily,NA
31506897,NCT01591421,226,panitumumab,1,6,mg/kg,1,day 1 and 15 each 28 day cycle,fixed
31065954,NCT01868022,227,gsk3052230,1,10,mg/kg,1,"Day 1, Day 8, Day 15 in each 21-day cycle",NA
31065954,NCT01868022,227,pemetrexed,1,500,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,1,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,1,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,gsk3052230,2,15,mg/kg,1,"Day 1, Day 8, Day 15 in each 21-day cycle",NA
31065954,NCT01868022,227,pemetrexed,2,500,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,2,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,2,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,gsk3052230,3,20,mg/kg,1,"Day 1, Day 8, Day 15 in each 21-day cycle",NA
31065954,NCT01868022,227,pemetrexed,3,500,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,3,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
31065954,NCT01868022,227,carboplatin,3,75,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34740922,NCT02535325,228,methoxyamine,1,50,mg,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,NA
34740922,NCT02535325,228,pemetrexed,1,500,mg/m2,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,1,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,1,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,radiotherapy,1,2,Gy,1,"Cycle 1 includes 3 fractions in week 1 (W, Th & F) and Cycle 2 includes 4 fractions on week 1 (W, Th, F & Sat). The total radiation dose was selected to be 60 Gy, administered in 30 fractions",fixed
34740922,NCT02535325,228,methoxyamine,2,100,mg,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,NA
34740922,NCT02535325,228,pemetrexed,2,500,mg/m2,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,2,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,2,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,radiotherapy,2,2,Gy,1,"Cycle 1 includes 3 fractions in week 1 (W, Th & F) and Cycle 2 includes 4 fractions on week 1 (W, Th, F & Sat). The total radiation dose was selected to be 60 Gy, administered in 30 fractions",fixed
34740922,NCT02535325,228,methoxyamine,3,150,mg,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,NA
34740922,NCT02535325,228,pemetrexed,3,500,mg/m2,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,3,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,3,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,radiotherapy,3,2,Gy,1,"Cycle 1 includes 3 fractions in week 1 (W, Th & F) and Cycle 2 includes 4 fractions on week 1 (W, Th, F & Sat). The total radiation dose was selected to be 60 Gy, administered in 30 fractions",fixed
34740922,NCT02535325,228,methoxyamine,4,200,mg,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,NA
34740922,NCT02535325,228,pemetrexed,4,500,mg/m2,1,on day 1 of cycle 1 and again on day 1 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,4,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,cisplatin,4,75,mg/m2,1,on day 3 of cycle 1 and again on day 3 of cycle 2 at 3 weeks,fixed
34740922,NCT02535325,228,radiotherapy,4,2,Gy,1,"Cycle 1 includes 3 fractions in week 1 (W, Th & F) and Cycle 2 includes 4 fractions on week 1 (W, Th, F & Sat). The total radiation dose was selected to be 60 Gy, administered in 30 fractions",fixed
33933896,NCT02964689,229,binimetinib,1,30,mg,2,from day 1 to day 14 (day 3–14 in cycle 1) every 21 days (q3w),NA
33933896,NCT02964689,229,pemetrexed,1,500,mg/m2,1,on day 1 every 21 days (q3w),fixed
33933896,NCT02964689,229,cisplatin,1,75,mg/m2,1,on day 1 every 21 days (q3w),fixed
33933896,NCT02964689,229,cisplatin,1,75,mg/m2,1,on day 1 every 21 days (q3w),fixed
33933896,NCT02964689,229,binimetinib,2,45,mg,2,from day 1 to day 14 (day 3–14 in cycle 1) every 21 days (q3w),NA
33933896,NCT02964689,229,pemetrexed,2,500,mg/m2,1,on day 1 every 21 days (q3w),fixed
33933896,NCT02964689,229,cisplatin,2,75,mg/m2,1,on day 1 every 21 days (q3w),fixed
33933896,NCT02964689,229,cisplatin,2,75,mg/m2,1,on day 1 every 21 days (q3w),fixed
10506594,NA,230,ly231514,1,300,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,1,60,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,1,60,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,2,300,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,2,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,2,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,3,400,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,3,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,3,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,4,500,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,4,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,4,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,5,600,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,5,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,5,75,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,6,600,mg/m2,1,on day 1 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,6,100,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,cisplatin,6,100,mg/m2,1,on day 2 every 3 weeks,cohort 1
10506594,NA,230,ly231514,4.5,500,mg/m2,1,on day 1 every 3 weeks,cohort 2
10506594,NA,230,cisplatin,4.5,75,mg/m2,1,on day 2 every 3 weeks,cohort 2
10506594,NA,230,cisplatin,4.5,75,mg/m2,1,on day 2 every 3 weeks,cohort 2
10506594,NA,230,ly231514,5.5,600,mg/m2,1,on day 1 every 3 weeks,cohort 2
10506594,NA,230,cisplatin,5.5,75,mg/m2,1,on day 2 every 3 weeks,cohort 2
10506594,NA,230,cisplatin,5.5,75,mg/m2,1,on day 2 every 3 weeks,cohort 2
34180036,NCT01468922,231,pazopanib,1,400,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,tivantinib,1,120,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,pazopanib,2,600,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,tivantinib,2,120,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,pazopanib,3,600,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,tivantinib,3,240,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,pazopanib,4,800,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,tivantinib,4,240,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,pazopanib,5,800,mg,2,daily in  28-day courses,NA
34180036,NCT01468922,231,tivantinib,5,360,mg,2,daily in  28-day courses,NA
29081023,Eudract no. 2014–002415-41,232,pemetrexed,1,400,mg/m2,1,"on day 1, repeated every 21 days",NA
29081023,Eudract no. 2014–002415-41,232,vinflunine,1,280,mg/m2,1,"on day 1, repeated every 21 days",fixed
29081023,Eudract no. 2014–002415-41,232,pemetrexed,2,450,mg/m2,1,"on day 1, repeated every 21 days",NA
29081023,Eudract no. 2014–002415-41,232,vinflunine,2,280,mg/m2,1,"on day 1, repeated every 21 days",fixed
29081023,Eudract no. 2014–002415-41,232,pemetrexed,3,500,mg/m2,1,"on day 1, repeated every 21 days",NA
29081023,Eudract no. 2014–002415-41,232,vinflunine,3,280,mg/m2,1,"on day 1, repeated every 21 days",fixed
33203645,NCT01960023,233,cetuximab,1,400/250,mg/m2,1,a loading dose at 400 mg/m2 i.v. followed by weekly at 250 mg/m2,fixed
33203645,NCT01960023,233,neratinib,1,120,mg,1,daily of each 4-week cycle,NA
33203645,NCT01960023,233,cetuximab,2,400/250,mg/m2,1,a loading dose at 400 mg/m2 i.v. followed by weekly at 250 mg/m2,fixed
33203645,NCT01960023,233,neratinib,2,160,mg,1,daily of each 4-week cycle,NA
33203645,NCT01960023,233,cetuximab,3,400/250,mg/m2,1,a loading dose at 400 mg/m2 i.v. followed by weekly at 250 mg/m2,fixed
33203645,NCT01960023,233,neratinib,3,200,mg,1,daily of each 4-week cycle,NA
33203645,NCT01960023,233,cetuximab,4,400/250,mg/m2,1,a loading dose at 400 mg/m2 i.v. followed by weekly at 250 mg/m2,fixed
33203645,NCT01960023,233,neratinib,4,240,mg,1,daily of each 4-week cycle,NA
28528917,NCT01238770,234,pazopanib,1,400,mg,1,daily in 4-week cycles,NA
28528917,NCT01238770,234,cyclophosphamide,1,50,mg,1,daily in 4-week cycles,fixed
28528917,NCT01238770,234,pazopanib,2,600,mg,1,daily in 4-week cycles,NA
28528917,NCT01238770,234,cyclophosphamide,2,50,mg,1,daily in 4-week cycles,fixed
28528917,NCT01238770,234,pazopanib,3,800,mg,1,daily in 4-week cycles,NA
28528917,NCT01238770,234,cyclophosphamide,3,50,mg,1,daily in 4-week cycles,fixed
20096951,NA,235,pemetrexed,1,400,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,1,60,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,1,60,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,1,2,Gy,1,"66 Gy administered over 45 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,2,400,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,2,70,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,2,70,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,2,2,Gy,1,"66 Gy administered over 45 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,3,400,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,3,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,3,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,3,2,Gy,1,"66 Gy administered over 45 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,4,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,4,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,4,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,4,2,Gy,1,"66 Gy administered over 45 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,5,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,5,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,5,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,5,2.2,Gy,1,"66 Gy administered over 40 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,6,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,6,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,cisplatin,6,80,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,radiotherapy,6,2.4,Gy,1,"66 Gy administered over 37 days with daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study I (stage III NSCLC)
20096951,NA,235,pemetrexed,2.5,400,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,2.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,2.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,radiotherapy,2.5,2,Gy,1,"50 Gy administered in 25 daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,pemetrexed,3.5,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,3.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,3.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,radiotherapy,3.5,2,Gy,1,"50 Gy administered in 25 daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,pemetrexed,4.5,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,4.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,4.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,radiotherapy,4.5,2,Gy,1,"56 Gy administered in 28 daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,pemetrexed,5.5,500,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,5.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,cisplatin,5.5,75,mg/m2,1,"on day 1 of a 21-day cycle, in cycles 2 and 3",study II (LD-SCL)
20096951,NA,235,radiotherapy,5.5,2,Gy,1,"62 Gy administered in 31 daily fractions of 2 Gy, 5 days/week, during cycles 2 and 3",study II (LD-SCL)
19701110,NA,236,pemetrexed,1,500,mg/m2,1,day 1 of each 21 day cycle following cetuximab,NA
19701110,NA,236,cetuximab,1,400,mg/m2,1,day -7,fixed
19701110,NA,236,cetuximab,1,250,mg/m2,1,"day 1, 8, and 15 of each 21 day cylces",fixed
19701110,NA,236,pemetrexed,2,600,mg/m2,1,day 1 of each 21 day cycle following cetuximab,NA
19701110,NA,236,cetuximab,2,400,mg/m2,1,day -7,fixed
19701110,NA,236,cetuximab,2,250,mg/m2,1,"day 1, 8, and 15 of each 21 day cylces",fixed
19701110,NA,236,pemetrexed,3,750,mg/m2,1,day 1 of each 21 day cycle following cetuximab,NA
19701110,NA,236,cetuximab,3,400,mg/m2,1,day -7,fixed
19701110,NA,236,cetuximab,3,250,mg/m2,1,"day 1, 8, and 15 of each 21 day cylces",fixed
19701110,NA,236,pemetrexed,4,900,mg/m2,1,day 1 of each 21 day cycle following cetuximab,NA
19701110,NA,236,cetuximab,4,400,mg/m2,1,day -7,fixed
19701110,NA,236,cetuximab,4,250,mg/m2,1,"day 1, 8, and 15 of each 21 day cylces",fixed
24989332,NCT01445392,237,pemetrexed,1,500,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,ss1p,1,25,ug/kg,1,"on days 1, 3, and 5 of cycles 1and 2 only.",NA
24989332,NCT01445392,237,pemetrexed,2,500,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,ss1p,2,35,ug/kg,1,"on days 1, 3, and 5 of cycles 1and 2 only.",NA
24989332,NCT01445392,237,pemetrexed,3,500,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,ss1p,3,45,ug/kg,1,"on days 1, 3, and 5 of cycles 1and 2 only.",NA
24989332,NCT01445392,237,pemetrexed,4,500,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,4,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,cisplatin,4,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
24989332,NCT01445392,237,ss1p,4,55,ug/kg,1,"on days 1, 3, and 5 of cycles 1and 2 only.",NA
26291057,NCT00732420,238,pazopanib,0,400,mg,1,daily (QD) throughout the cycle,treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,0,4,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,0,4,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,pazopanib,1,400,mg,1,daily (QD) throughout the cycle,treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,1,6,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,1,6,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,pazopanib,2,800,mg,1,daily (QD) throughout the cycle,treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,2,6,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,2,6,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,pazopanib,3,800,mg,1,daily (QD) throughout the cycle,treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,3,8,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,3,8,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,pazopanib,4,800,mg,1,daily (QD) throughout the cycle,treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,4,10,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,topotecan,4,10,mg,1,"day 1, 8 and 15 in a 28-day cycle",treatment arm A (P2A)
26291057,NCT00732420,238,pazopanib,0,400,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,0,1.75,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,0,1.75,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,pazopanib,1,800,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,1,1.75,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,1,1.75,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,pazopanib,1.5,800,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,1.5,0,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,1.5,0,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,pazopanib,2,800,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,2,2.5,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,2,2.5,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,pazopanib,2.5,0,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,2.5,2.5,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,2.5,2.5,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,pazopanib,3,800,mg,1,daily (QD) throughout the cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,3,3,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
26291057,NCT00732420,238,topotecan,3,3,mg,1,on days 1–5 in a 21-day cycle,treatment arm B (P2B)
30496584,NA,239,thoracic radiotherapy,1,2,Gy,1,"started on Day 1, five times weekly, to a total of 60 Gy in 30 fractions over a 6-week period",fixed
30496584,NA,239,pemetrexed,1,400,mg/m2,1,"on Days 1, 22, 43, 64, 85 and 106",NA
30496584,NA,239,thoracic radiotherapy,0,2,Gy,1,"started on Day 1, five times weekly, to a total of 60 Gy in 30 fractions over a 6-week period",fixed
30496584,NA,239,pemetrexed,0,300,mg/m2,1,"on Days 1, 22, 43, 64, 85 and 106",NA
30496584,NA,239,thoracic radiotherapy,2,2,Gy,1,"started on Day 1, five times weekly, to a total of 60 Gy in 30 fractions over a 6-week period",fixed
30496584,NA,239,pemetrexed,2,500,mg/m2,1,"on Days 1, 22, 43, 64, 85 and 106",NA
21831954,NCT00370513,240,pazopanib,1,200,mg,1,daily (QD) on 21-day cycles,NA
21831954,NCT00370513,240,pazopanib,2,400,mg,1,daily (QD) on 21-day cycles,NA
21831954,NCT00370513,240,pazopanib,3,600,mg,1,daily (QD) on 21-day cycles,NA
21831954,NCT00370513,240,pazopanib,4,800,mg,1,daily (QD) on 21-day cycles,NA
20460487,NA,241,pemetrexed,1,500,mg/m2,1,on day 1 of the 21-day cycle,fixed
20460487,NA,241,bibf 1120,1,100,mg,2,on day 2 through day 21 of the 21-day cycle,NA
20460487,NA,241,pemetrexed,2,500,mg/m2,1,on day 1 of the 21-day cycle,fixed
20460487,NA,241,bibf 1120,2,150,mg,2,on day 2 through day 21 of the 21-day cycle,NA
20460487,NA,241,pemetrexed,3,500,mg/m2,1,on day 1 of the 21-day cycle,fixed
20460487,NA,241,bibf 1120,3,200,mg,2,on day 2 through day 21 of the 21-day cycle,NA
20460487,NA,241,pemetrexed,4,500,mg/m2,1,on day 1 of the 21-day cycle,fixed
20460487,NA,241,bibf 1120,4,250,mg,2,on day 2 through day 21 of the 21-day cycle,NA
23857966,NCT00929903,242,pazopanib,1,275,mg,1,daily in 28-day cycles,tablet
23857966,NCT00929903,242,pazopanib,2,350,mg,1,daily in 28-day cycles,tablet
23857966,NCT00929903,242,pazopanib,3,450,mg,1,daily in 28-day cycles,tablet
23857966,NCT00929903,242,pazopanib,4,600,mg,1,daily in 28-day cycles,tablet
23857966,NCT00929903,242,pazopanib,1,160,mg,1,daily in 28-day cycles,suspension
23857966,NCT00929903,242,pazopanib,2,225,mg,1,daily in 28-day cycles,suspension
26810581,NA,243,pemetrexed,1,300,mg/m2,1,"on weeks 1, 3, 5, prior to administration of CDDP",NA
26810581,NA,243,cisplatin,1,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,cisplatin,1,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,external beamradiation therapy,1,1.8,Gy,1,28 fractions at 1.8 Gy/day(five fractions per week) for a total of 50.4 Gy,fixed
26810581,NA,243,pemetrexed,2,500,mg/m2,1,"on weeks 1, 3, 5, prior to administration of CDDP",NA
26810581,NA,243,cisplatin,2,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,cisplatin,2,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,external beamradiation therapy,2,1.8,Gy,1,28 fractions at 1.8 Gy/day(five fractions per week) for a total of 50.4 Gy,fixed
26810581,NA,243,pemetrexed,3,750,mg/m2,1,"on weeks 1, 3, 5, prior to administration of CDDP",NA
26810581,NA,243,cisplatin,3,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,cisplatin,3,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,external beamradiation therapy,3,1.8,Gy,1,28 fractions at 1.8 Gy/day(five fractions per week) for a total of 50.4 Gy,fixed
26810581,NA,243,pemetrexed,4,1000,mg/m2,1,"on weeks 1, 3, 5, prior to administration of CDDP",NA
26810581,NA,243,cisplatin,4,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,cisplatin,4,20,mg/m2,1,weekly over 60–90 min for a total of five doses,fixed
26810581,NA,243,external beamradiation therapy,4,1.8,Gy,1,28 fractions at 1.8 Gy/day(five fractions per week) for a total of 50.4 Gy,fixed
21353323,NA,244,pemetrexed,0,500,mg/m2,1,"on day 1, every 21 days",fixed
21353323,NA,244,cisplatin,0,50,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,cisplatin,0,50,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,thoracic radiation,0,2,Gy,1,"at least 60 min after the chemotherapy infusion, 5 sessions per week, to a total dose of 66 Gy",fixed
21353323,NA,244,pemetrexed,1,500,mg/m2,1,"on day 1, every 21 days",fixed
21353323,NA,244,cisplatin,1,60,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,cisplatin,1,60,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,thoracic radiation,1,2,Gy,1,"at least 60 min after the chemotherapy infusion, 5 sessions per week, to a total dose of 66 Gy",fixed
21353323,NA,244,pemetrexed,2,500,mg/m2,1,"on day 1, every 21 days",fixed
21353323,NA,244,cisplatin,2,"75 (cycles 1,2), 60 (cycle 3)",mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,cisplatin,2,"75 (cycles 1,2), 60 (cycle 3)",mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,thoracic radiation,2,2,Gy,1,"at least 60 min after the chemotherapy infusion, 5 sessions per week, to a total dose of 66 Gy",fixed
21353323,NA,244,pemetrexed,3,500,mg/m2,1,"on day 1, every 21 days",fixed
21353323,NA,244,cisplatin,3,75,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,cisplatin,3,75,mg/m2,1,"on day 1, every 21 days",NA
21353323,NA,244,thoracic radiation,3,2,Gy,1,"at least 60 min after the chemotherapy infusion, 5 sessions per week, to a total dose of 66 Gy",fixed
21073623,NA,245,pemetrexed,1,500,mg/m2,1,on day 1 of a 21-day cycle,NA
21073623,NA,245,cisplatin,1,10,mg/m2,1,on days 1–5 and 22–26,NA
21073623,NA,245,cisplatin,1,10,mg/m2,1,on days 1–5 and 22–26,NA
21073623,NA,245,selective lymph node late course accelerated hyper-fractionated radiotherapy,1,59.6,Gy,NA,59.6 Gy/34 fractions in 5.4 weeks,NA
21073623,NA,245,pemetrexed,0,400,mg/m2,1,on day 1 of a 21-day cycle,NA
21073623,NA,245,cisplatin,0,10,mg/m2,1,on days 1–5 and 22–26,NA
21073623,NA,245,cisplatin,0,10,mg/m2,1,on days 1–5 and 22–26,NA
21073623,NA,245,selective lymph node late course accelerated hyper-fractionated radiotherapy,0,59.6,Gy,NA,59.6 Gy/34 fractions in 5.4 weeks,NA
26560486,NCT00979576,246,nintedanib,1,100,mg,2,on Day 1 in 21-day cycles,NA
26560486,NCT00979576,246,pemetrexed,1,500,mg/m2,1,on Days 2–21 in 21-day cycles,fixed
26560486,NCT00979576,246,nintedanib,2,150,mg,2,on Day 1 in 21-day cycles,NA
26560486,NCT00979576,246,pemetrexed,2,500,mg/m2,1,on Days 2–21 in 21-day cycles,fixed
26560486,NCT00979576,246,nintedanib,3,200,mg,2,on Day 1 in 21-day cycles,NA
26560486,NCT00979576,246,pemetrexed,3,500,mg/m2,1,on Days 2–21 in 21-day cycles,fixed
23653147,NA,247,pazopanib,1,800,mg,1,on days 1 to 21 of a 21-day cycle,"Group A Normal liver
function"
23653147,NA,247,pazopanib,1,400,mg,1,on days 1 to 21 of a 21-day cycle,"Group B Mild liver
dysfunction"
23653147,NA,247,pazopanib,2,800,mg,1,on days 1 to 21 of a 21-day cycle,"Group B Mild liver
dysfunction"
23653147,NA,247,pazopanib,1,200,mg,1,on days 1 to 21 of a 21-day cycle,Group C Moderate liver dysfunction
23653147,NA,247,pazopanib,2,400,mg,1,on days 1 to 21 of a 21-day cycle,Group C Moderate liver dysfunction
23653147,NA,247,pazopanib,3,800,mg,1,on days 1 to 21 of a 21-day cycle,Group C Moderate liver dysfunction
23653147,NA,247,pazopanib,1,100,mg,1,on days 1 to 21 of a 21-day cycle,"Group D Severe liver
dysfunction"
23653147,NA,247,pazopanib,2,200,mg,1,on days 1 to 21 of a 21-day cycle,"Group D Severe liver
dysfunction"
23653147,NA,247,pazopanib,3,400,mg,1,on days 1 to 21 of a 21-day cycle,"Group D Severe liver
dysfunction"
23653147,NA,247,pazopanib,4,800,mg,1,on days 1 to 21 of a 21-day cycle,"Group D Severe liver
dysfunction"
28238078,NCT01485042,248,pazopanib,1,800,mg,1,on days 1–28 of every 28-day cycle,fixed
28238078,NCT01485042,248,th-302,1,340,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",NA
28238078,NCT01485042,248,pazopanib,2,800,mg,1,on days 1–28 of every 28-day cycle,fixed
28238078,NCT01485042,248,th-302,2,480,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",NA
28238078,NCT01485042,248,pazopanib,3,800,mg,1,on days 1–28 of every 28-day cycle,fixed
28238078,NCT01485042,248,th-302,3,575,mg/m2,1,"on days 1, 8 and 15 of every 28-day cycle",NA
28771961,NA,249,pemetrexed,1,400,mg/m2,1,"on days 1, 22, 43, and 64",NA
28771961,NA,249,thoracic rt,1,60,Gy,NA,"once daily for 5 consecutive days of eachweek, total dose 60 Gy, commenced on day 1",fixed
28771961,NA,249,pemetrexed,2,500,mg/m2,1,"on days 1, 22, 43, and 64",NA
28771961,NA,249,thoracic rt,2,60,Gy,NA,"once daily for 5 consecutive days of eachweek, total dose 60 Gy, commenced on day 1",fixed
27213589,NA,250,pemetrexed,1,500,mg/m2,1,every 14 days,Cohort A
27213589,NA,250,sorafenib,1,200,mg,2,Continuous (D1–14) of each 14-day pemetrexed cycle,Cohort A
27213589,NA,250,pemetrexed,2,750,mg/m2,1,every 14 days,Cohort A
27213589,NA,250,sorafenib,2,"400 in AM, 200 in PM",mg,2,Continuous (D1–14) of each 14-day pemetrexed cycle,Cohort A
27213589,NA,250,pemetrexed,3,1000,mg/m2,1,every 14 days,Cohort A
27213589,NA,250,sorafenib,3,400,mg,2,Continuous (D1–14) of each 14-day pemetrexed cycle,Cohort A
27213589,NA,250,pemetrexed,6,500,mg/m2,1,every 14 days,Cohort B
27213589,NA,250,sorafenib,6,200,mg,2,Intermittent (D1–5) of each 14-day pemetrexed cycle,Cohort B
27213589,NA,250,pemetrexed,7,500,mg/m2,1,every 14 days,Cohort B
27213589,NA,250,sorafenib,7,400,mg,2,Intermittent (D1–5) of each 14-day pemetrexed cycle,Cohort B
27213589,NA,250,pemetrexed,8,750,mg/m2,1,every 14 days,Cohort B
27213589,NA,250,sorafenib,8,400,mg,2,Intermittent (D1–5) of each 14-day pemetrexed cycle,Cohort B
23698253,NCT01072890,251,temsirolimus,1,15,mg,1,"days 1, 8, 15, and 22 every 28 days",NA
23698253,NCT01072890,251,pazopanib,1,400,mg,1,on a daily basis starting day 1,NA
23698253,NCT01072890,251,temsirolimus,-2,10,mg,1,"days 1, 8, 15, and 22 every 28 days",NA
23698253,NCT01072890,251,pazopanib,-2,200,mg,1,on a daily basis starting day 1,NA
17442992,NA,252,pemetrexed,1,400,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,2,520,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,3,670,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,4,870,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,5,1130,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,6,1470,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,7,1910,mg/m2,1,every 21 days,NA
17442992,NA,252,pemetrexed,8,2480,mg/m2,1,every 21 days,NA
19830387,NA,253,pemetrexed,1,500,mg/m2,1,on day 1 of every 21 day cycle,NA
19830387,NA,253,vinflunine,1,280,mg/m2,1,on day 1 of every 21 day cycle,NA
19830387,NA,253,pemetrexed,2,500,mg/m2,1,on day 1 of every 21 day cycle,NA
19830387,NA,253,vinflunine,2,300,mg/m2,1,on day 1 of every 21 day cycle,NA
19830387,NA,253,pemetrexed,3,500,mg/m2,1,on day 1 of every 21 day cycle,NA
19830387,NA,253,vinflunine,3,320,mg/m2,1,on day 1 of every 21 day cycle,NA
23179337,NCT00619424,254,pazopanib,1,400,mg,1,daily,NA
23179337,NCT00619424,254,pemetrexed,1,400,mg/m2,1,on Day 1 of each 21-daycycle,NA
23179337,NCT00619424,254,pazopanib,2,400,mg,1,daily,NA
23179337,NCT00619424,254,pemetrexed,2,500,mg/m2,1,on Day 1 of each 21-daycycle,NA
23179337,NCT00619424,254,pazopanib,3,800,mg,1,daily,NA
23179337,NCT00619424,254,pemetrexed,3,500,mg/m2,1,on Day 1 of each 21-daycycle,NA
24919569,NCT00788957,255,panitumumab,1,6,mg/kg,1,once every 2 weeks (Q2W),NA
24919569,NCT00788957,255,rilotumumab,1,10,mg/m2,1,once every 2 weeks (Q2W),NA
24919569,NCT00788957,255,panitumumab,-1,6,mg/kg,1,once every 2 weeks (Q2W),NA
24919569,NCT00788957,255,rilotumumab,-1,5,mg/m2,1,once every 2 weeks (Q2W),NA
23108697,NCT00528619,256,sunitinib,1,37.5,mg,1,daily continuously,CDD schedule
23108697,NCT00528619,256,pemetrexed,1,400,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,cisplatin,1,75,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,cisplatin,1,75,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,sunitinib,2,37.5,mg,1,"daily 2 weeks on, 1 week off treatment",schedule 2/1
23108697,NCT00528619,256,pemetrexed,2,400,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,cisplatin,2,75,mg/m2,1,"daily 2 weeks on, 1 week off treatment",NA
23108697,NCT00528619,256,cisplatin,2,75,mg/m2,1,"daily 2 weeks on, 1 week off treatment",NA
23108697,NCT00528619,256,sunitinib,3,37.5,mg,1,once every 3 weeks (q3w),schedule 2/1
23108697,NCT00528619,256,pemetrexed,3,500,mg/m2,1,"daily 2 weeks on, 1 week off treatment",NA
23108697,NCT00528619,256,cisplatin,3,75,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,cisplatin,3,75,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,sunitinib,4,50,mg,1,"daily 2 weeks on, 1 week off treatment",schedule 2/1
23108697,NCT00528619,256,pemetrexed,4,500,mg/m2,1,once every 3 weeks (q3w),NA
23108697,NCT00528619,256,cisplatin,4,75,mg/m2,1,"daily 2 weeks on, 1 week off treatment",NA
23108697,NCT00528619,256,cisplatin,4,75,mg/m2,1,"daily 2 weeks on, 1 week off treatment",NA
33715996,NCT01642017,257,pazopanib,-1,200,mg,1,daily in 28-days cycles,NA
33715996,NCT01642017,257,pazopanib,1,400,mg,1,daily in 28-days cycles,NA
33715996,NCT01642017,257,pazopanib,1,600,mg,1,daily in 28-days cycles,NA
33715996,NCT01642017,257,pazopanib,1,800,mg,1,daily in 28-days cycles,NA
30958892,NCT01973868,258,regorafenib,3,120,mg,1,daily on Days 1-21 of each 28-day Cycle,NA
30958892,NCT01973868,258,cetuximab,3,250,mg/m2,1,weekly in a cycle of4 weeks,NA
30958892,NCT01973868,258,regorafenib,4,160,mg,1,daily on Days 1-21 of each 28-day Cycle,NA
30958892,NCT01973868,258,cetuximab,4,250,mg/m2,1,weekly in a cycle of4 weeks,NA
30958892,NCT01973868,258,regorafenib,1,60,mg,1,QD continuously,NA
30958892,NCT01973868,258,cetuximab,1,250,mg/m2,1,weekly in a cycle of4 weeks,NA
30958892,NCT01973868,258,regorafenib,2,100,mg,1,QD continuously,NA
30958892,NCT01973868,258,cetuximab,2,250,mg/m2,1,weekly in a cycle of4 weeks,NA
29438091,NCT00338494,259,clofarabine,1,10,mg/m2,1,3 consecutive weeks every 28 days,NA
29438091,NCT00338494,259,clofarabine,2,15,mg/m2,1,3 consecutive weeks every 28 days,NA
29438091,NCT00338494,259,clofarabine,3,20,mg/m2,1,3 consecutive weeks every 28 days,NA
29438091,NCT00338494,259,clofarabine,4,30,mg/m2,1,3 consecutive weeks every 28 days,NA
29438091,NCT00338494,259,clofarabine,5,40,mg/m2,1,3 consecutive weeks every 28 days,NA
22893631,NCT00347971,260,ril-21,1,30,ug/kg,1,once weekly for 4 weeks,NA
22893631,NCT00347971,260,rituximab,1,375,mg/m2,1,once weekly for 4 weeks,fixed
22893631,NCT00347971,260,ril-21,2,100,ug/kg,1,once weekly for 4 weeks,NA
22893631,NCT00347971,260,rituximab,2,375,mg/m2,1,once weekly for 4 weeks,fixed
22893631,NCT00347971,260,ril-21,3,150,ug/kg,1,once weekly for 4 weeks,NA
22893631,NCT00347971,260,rituximab,3,375,mg/m2,1,once weekly for 4 weeks,fixed
11332149,NA,261,raltitrexed,1,2,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,1,100,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,1,100,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,raltitrexed,2,2.5,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,2,80,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,2,80,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,raltitrexed,3,3,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,3,80,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,3,80,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,raltitrexed,4,3.5,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,4,80,mg/m2,1,on day one of each three-weekly cycle,NA
11332149,NA,261,cisplatin,4,80,mg/m2,1,on day one of each three-weekly cycle,NA
19894051,NA,262,ucn-01,1,17,mg/m2,1,continuous IV infusion (CIV) for 72 h on days 3–5 of the first cycle,NA
19894051,NA,262,ucn-01,1,"17 mg/m2 9 24 h, then 8.5 mg/m2 9 12 h",mg/m2,1,CIV over 36 h beginning on day 3 of the subsequent cycles,NA
19894051,NA,262,prednisone,1,60,mg/m2,1,days 1–5 every 28 days,fixed
19894051,NA,262,ucn-01,2,24,mg/m2,1,continuous IV infusion (CIV) for 72 h on days 3–5 of the first cycle,NA
19894051,NA,262,ucn-01,2,"24 mg/m2 9 24 h, then 12 mg/m2 9 12 h",mg/m2,1,CIV over 36 h beginning on day 3 of the subsequent cycles,NA
19894051,NA,262,prednisone,2,60,mg/m2,1,days 1–5 every 28 days,fixed
19894051,NA,262,ucn-01,3,34,mg/m2,1,continuous IV infusion (CIV) for 72 h on days 3–5 of the first cycle,NA
19894051,NA,262,ucn-01,3,"34 mg/m2 9 24 h, then 17 mg/m2 9 12 h",mg/m2,1,CIV over 36 h beginning on day 3 of the subsequent cycles,NA
19894051,NA,262,prednisone,3,60,mg/m2,1,days 1–5 every 28 days,fixed
28735378,NCT01610570,263,mithramycin,1,13,ug/kg,1,administered intravenously over 6  h once daily for 7  days for 28  day cycles,for the pediatric portion
28735378,NCT01610570,263,mithramycin,2,17.5,ug/kg,1,administered intravenously over 6  h once daily for 7  days for 28  day cycles,for adults
28735378,NCT01610570,263,mithramycin,3,25,ug/kg,1,administered intravenously over 6  h once daily for 7  days for 28  day cycles,for adults
23799873,NCT01653067,264,temsirolimus,1,25,mg,1,on day 1 and 8 every 3 weeks,NA
23799873,NCT01653067,264,rituximab,1,375,mg/m2,1,day 2 every 3 weeks,fixed
23799873,NCT01653067,264,dexamethasone,1,40,mg,1,day 3–6 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,1,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,1,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cytarabine,1,2000,mg/m2,2,day 4 every 3 weeks,fixed
23799873,NCT01653067,264,temsirolimus,2,50,mg,1,on day 1 and 8 every 3 weeks,NA
23799873,NCT01653067,264,rituximab,2,375,mg/m2,1,day 2 every 3 weeks,fixed
23799873,NCT01653067,264,dexamethasone,2,40,mg,1,day 3–6 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,2,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,2,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cytarabine,2,2000,mg/m2,2,day 4 every 3 weeks,fixed
23799873,NCT01653067,264,temsirolimus,3,75,mg,1,on day 1 and 8 every 3 weeks,NA
23799873,NCT01653067,264,rituximab,3,375,mg/m2,1,day 2 every 3 weeks,fixed
23799873,NCT01653067,264,dexamethasone,3,40,mg,1,day 3–6 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,3,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,3,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cytarabine,3,2000,mg/m2,2,day 4 every 3 weeks,fixed
23799873,NCT01653067,264,temsirolimus,4,100,mg,1,on day 1 and 8 every 3 weeks,NA
23799873,NCT01653067,264,rituximab,4,375,mg/m2,1,day 2 every 3 weeks,fixed
23799873,NCT01653067,264,dexamethasone,4,40,mg,1,day 3–6 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,4,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,4,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cytarabine,4,2000,mg/m2,2,day 4 every 3 weeks,fixed
23799873,NCT01653067,264,temsirolimus,-1,15,mg,1,on day 1 and 8 every 3 weeks,NA
23799873,NCT01653067,264,rituximab,-1,375,mg/m2,1,day 2 every 3 weeks,fixed
23799873,NCT01653067,264,dexamethasone,-1,40,mg,1,day 3–6 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,-1,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cisplatin,-1,100,mg/m2,1,day 3 every 3 weeks,fixed
23799873,NCT01653067,264,cytarabine,-1,2000,mg/m2,2,day 4 every 3 weeks,fixed
31420468,NCT02649686,265,durvalumab,-1,750,mg,1,on day 1 once every 3 weeks,NA
31420468,NCT02649686,265,trastuzumab,-1,6-Aug,mg/kg,1,on day 1 on a q3 weekly cycle. 8 mg/kg loading dose cycle 1 only and then at 6 mg/kg for subsequent cycles to a maximum of six cycles,fixed
31420468,NCT02649686,265,durvalumab,1,1125,mg,1,on day 1 once every 3 weeks,NA
31420468,NCT02649686,265,trastuzumab,1,6-Aug,mg/kg,1,on day 1 on a q3 weekly cycle. 8 mg/kg loading dose cycle 1 only and then at 6 mg/kg for subsequent cycles to a maximum of six cycles,fixed
28402581,NCT01369849,266,mk-2206,1,90,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
28402581,NCT01369849,266,bendamustine,1,70,mg/m2,1,on days 1-2 every 28 days,fixed
28402581,NCT01369849,266,rituximab,1,"cycle 1: 375 mg/m2, cycle 2–6: 500 mg/m2",mg/m2,1,on day 1 every 28 days,fixed
28402581,NCT01369849,266,mk-2206,2,135,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
28402581,NCT01369849,266,bendamustine,2,70,mg/m2,1,on days 1-2 every 28 days,fixed
28402581,NCT01369849,266,rituximab,2,"cycle 1: 375 mg/m2, cycle 2–6: 500 mg/m2",mg/m2,1,on day 1 every 28 days,fixed
28402581,NCT01369849,266,mk-2206,3,200,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
28402581,NCT01369849,266,bendamustine,3,70,mg/m2,1,on days 1-2 every 28 days,fixed
28402581,NCT01369849,266,rituximab,3,"cycle 1: 375 mg/m2, cycle 2–6: 500 mg/m2",mg/m2,1,on day 1 every 28 days,fixed
21425150,NCT00156013,267,clofarabine,1,4,mg/m2,1,daily for 5 consecutive days andrepeated every 28 days for a maximum of 6 cycles,NA
21425150,NCT00156013,267,clofarabine,2,6,mg/m2,1,daily for 5 consecutive days andrepeated every 28 days for a maximum of 6 cycles,NA
32144134,NCT01307267,268,utomilumab,1,0.06,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,1,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,2,0.12,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,2,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,3,0.18,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,3,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,4,0.24,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,4,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,5,0.3,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,5,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,6,0.6,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,6,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,7,1.2,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,7,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,8,2.4,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,8,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,9,5,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,9,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
32144134,NCT01307267,268,utomilumab,10,10,mg/kg,1,every 4 weeks,NA
32144134,NCT01307267,268,rituximab,10,375,mg/m2,1,"once weekly for 4 weeks per institutional standards, with the first and second doses given 8 days and 1 day prior to the initial utomilumab infusion, respectively.",fixed
11508814,NA,269,fotemustine,1,50,mg/m2,1,on days 5 and 12 in a 12-day induction cycle,NA
11508814,NA,269,procarbazine,1,100,mg,1,12 consecutive days in a 12-day induction cycle,fixed
11508814,NA,269,fotemustine,1,50,mg/m2,1,"After a 6-week rest period, a maximum of 4 maintenance cycles ( on day 4) was given every 4 weeks",NA
11508814,NA,269,procarbazine,1,300,mg,1,"After a 6-week rest period, a maximum of 4 maintenance cycles (4 days) was given every 4 weeks",fixed
11508814,NA,269,fotemustine,2,75,mg/m2,1,on days 5 and 12 in a 12-day induction cycle,NA
11508814,NA,269,procarbazine,2,100,mg,1,12 consecutive days in a 12-day induction cycle,fixed
11508814,NA,269,fotemustine,2,75,mg/m2,1,"After a 6-week rest period, a maximum of 4 maintenance cycles ( on day 4) was given every 4 weeks",NA
11508814,NA,269,procarbazine,2,300,mg,1,"After a 6-week rest period, a maximum of 4 maintenance cycles (4 days) was given every 4 weeks",fixed
11508814,NA,269,fotemustine,3,100,mg/m2,1,on days 5 and 12 in a 12-day induction cycle,NA
11508814,NA,269,procarbazine,3,100,mg,1,12 consecutive days in a 12-day induction cycle,fixed
11508814,NA,269,fotemustine,3,100,mg/m2,1,"After a 6-week rest period, a maximum of 4 maintenance cycles ( on day 4) was given every 4 weeks",NA
11508814,NA,269,procarbazine,3,300,mg,1,"After a 6-week rest period, a maximum of 4 maintenance cycles (4 days) was given every 4 weeks",fixed
11508814,NA,269,fotemustine,4,125,mg/m2,1,on days 5 and 12 in a 12-day induction cycle,NA
11508814,NA,269,procarbazine,4,100,mg,1,12 consecutive days in a 12-day induction cycle,fixed
11508814,NA,269,fotemustine,4,125,mg/m2,1,"After a 6-week rest period, a maximum of 4 maintenance cycles ( on day 4) was given every 4 weeks",NA
11508814,NA,269,procarbazine,4,300,mg,1,"After a 6-week rest period, a maximum of 4 maintenance cycles (4 days) was given every 4 weeks",fixed
7595747,NA,270,"ly231514,",1,10,mg/m2,1,"weekly for 4 weeks, every 42 days",NA
7595747,NA,270,"ly231514,",2,20,mg/m2,1,"weekly for 4 weeks, every 42 days",NA
7595747,NA,270,"ly231514,",3,30,mg/m2,1,"weekly for 4 weeks, every 42 days",NA
7595747,NA,270,"ly231514,",4,40,mg/m2,1,"weekly for 4 weeks, every 42 days",NA
23568716,NA,271,pertuzumab,1,420/210,mg,1,"received a loading dose of 420 mg IV on Cycle 1 Day 1, followed by a maintenance dose of 210 mg on Day 1 of each subsequent cycle",NA
23568716,NA,271,cetuximab,1,250,mg/m2,1,every 7 days in 21-day cycles,fixed
23568716,NA,271,pertuzumab,1.5,210,mg,1,on Day 1 of every 21-day cycle,NA
23568716,NA,271,cetuximab,1.5,250,mg/m2,1,every 7 days in 21-day cycles,fixed
23568716,NA,271,pertuzumab,-1,175,mg,1,on Day 1 of every 21-day cycle,NA
23568716,NA,271,cetuximab,-1,250,mg/m2,1,every 7 days in 21-day cycles,fixed
23568716,NA,271,pertuzumab,2,840/420,mg,1,"received a loading dose of 840 mg IV on Cycle 1 Day 1, followed by a maintenance dose of 420 mg on Day 1 of each subsequent cycle",NA
23568716,NA,271,cetuximab,2,250,mg/m2,1,every 7 days in 21-day cycles,fixed
34157616,NCT02085148,272,regorafenib,1,60,mg/m2,1,"daily for three weeks on/1 week off, in a 4-week cycle",NA
34157616,NCT02085148,272,regorafenib,2,72,mg/m2,1,"daily for three weeks on/1 week off, in a 4-week cycle",NA
34157616,NCT02085148,272,regorafenib,3,82,mg/m2,1,"daily for three weeks on/1 week off, in a 4-week cycle",NA
34157616,NCT02085148,272,regorafenib,4,93,mg/m2,1,"daily for three weeks on/1 week off, in a 4-week cycle",NA
32697348,NCT00943943,273,sorafenib,1,400,NA,2,daily continuously after G-CSF/Plerixafor injections,NA
32697348,NCT00943943,273,g-csf,1,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,g-csf,1,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,plerixafor,1,240,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,sorafenib,2,600,NA,2,daily continuously after G-CSF/Plerixafor injections,NA
32697348,NCT00943943,273,g-csf,2,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,g-csf,2,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,plerixafor,2,240,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,sorafenib,3,800,NA,2,daily continuously after G-CSF/Plerixafor injections,NA
32697348,NCT00943943,273,g-csf,3,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,g-csf,3,10,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
32697348,NCT00943943,273,plerixafor,3,240,ug/kg,1,every other day for seven doses starting on day one every 28 days,fixed
30262659,NCT01722305,274,pomalidomide,1,3,mg,1,"daily for 21 days every 28 days. After 2 cycles, POM was continued alone until disease progression, intolerance of side effects, orndecline by the patient to continue",NA
30262659,NCT01722305,274,dexamethasone,1,40,mg,1,every week,fixed
30262659,NCT01722305,274,pomalidomide,2,5,mg,1,"daily for 21 days every 28 days. After 2 cycles, POM was continued alone until disease progression, intolerance of side effects, orndecline by the patient to continue",NA
30262659,NCT01722305,274,dexamethasone,2,40,mg,1,every week,fixed
30262659,NCT01722305,274,pomalidomide,3,7,mg,1,"daily for 21 days every 28 days. After 2 cycles, POM was continued alone until disease progression, intolerance of side effects, orndecline by the patient to continue",NA
30262659,NCT01722305,274,dexamethasone,3,40,mg,1,every week,fixed
30262659,NCT01722305,274,pomalidomide,4,10,mg,1,"daily for 21 days every 28 days. After 2 cycles, POM was continued alone until disease progression, intolerance of side effects, orndecline by the patient to continue",NA
30262659,NCT01722305,274,dexamethasone,4,40,mg,1,every week,fixed
33025730,NCT03257631,275,pomalidomide,1,1.9,mg/m2,1,once daily for 21 consecutive days of a 28-day cycle,NA
33025730,NCT03257631,275,pomalidomide,2,2.6,mg/m2,1,once daily for 21 consecutive days of a 28-day cycle,NA
33025730,NCT03257631,275,pomalidomide,3,3.4,mg/m2,1,once daily for 21 consecutive days of a 28-day cycle,NA
34581757,NCT03255096,276,ro6870810,1,0.3,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,276,venetoclax,1,400,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,276,ro6870810,2,0.45,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,276,venetoclax,2,400,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,276,ro6870810,3,0.45,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,276,venetoclax,3,600,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,276,ro6870810,4,0.45,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,276,venetoclax,4,800,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,276,ro6870810,5,0.65,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,276,venetoclax,5,600,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,276,rituximab,5,375,mg/m2,1,weekly during the first 21-day cycle (C1) and on day 1 of each cycle thereafter.,fixed
34581757,NCT03255096,277,ro6870810,1,0.45,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,277,venetoclax,1,600,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,277,rituximab,1,375,mg/m2,1,weekly during the first 21-day cycle (C1) and on day 1 of each cycle thereafter.,fixed
34581757,NCT03255096,277,ro6870810,2,0.65,mg/kg,1,on Days 1-14 of 21-day cycles,NA
34581757,NCT03255096,277,venetoclax,2,600,mg,1,daily (QD) continuously for 21 days,NA
34581757,NCT03255096,277,rituximab,2,375,mg/m2,1,weekly during the first 21-day cycle (C1) and on day 1 of each cycle thereafter.,fixed
19261664,NA,278,pertuzumab,1,5,mg/kg,1,every 3 weeks,NA
19261664,NA,278,pertuzumab,2,10,mg/kg,1,every 3 weeks,NA
19261664,NA,278,pertuzumab,3,15,mg/kg,1,every 3 weeks,NA
19261664,NA,278,pertuzumab,4,20,mg/kg,1,every 3 weeks,NA
19261664,NA,278,pertuzumab,5,25,mg/kg,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,1,2.6,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,1,60,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,1,60,mg/m2,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,2,2.6,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,2,70,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,2,70,mg/m2,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,3,2.6,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,3,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,3,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,4,3,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,4,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,4,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,5,3.5,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,5,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,5,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,raltitrexed,6,4,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,6,80,mg/m2,1,every 3 weeks,NA
11955653,NA,279,cisplatin,6,80,mg/m2,1,every 3 weeks,NA
22753910,NCT00539682,280,sar3419,1,10,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,2,20,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,3,40,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,4,80,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,5,160,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,6,208,mg/m2,1,once every 21 days,NA
22753910,NCT00539682,280,sar3419,7,270,mg/m2,1,once every 21 days,NA
22921184,NA,281,sf1126,1,90,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,2,140,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,3,180,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,4,240,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,5,320,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,6,430,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,7,630,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,8,840,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
22921184,NA,281,sf1126,9,1110,mg/m2,1,"days 1 and 4, weekly in 28 day-cycles",NA
15249589,NA,282,cc-4047,1,1,mg,1,daily in 28-day cycles,NA
15249589,NA,282,cc-4047,2,2,mg,1,daily in 28-day cycles,NA
15249589,NA,282,cc-4047,3,5,mg,1,daily in 28-day cycles,NA
15249589,NA,282,cc-4047,4,10,mg,1,daily in 28-day cycles,NA
27154915,NCT01055496,283,inotuzumab ozogamicin,1,0.8,mg/m2,1,on day 2 of each 21-day cycle,NA
27154915,NCT01055496,283,rituximab,1,375,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,cyclophosphamide,1,375,mg/m2,1,on day 1 of each 21-day cycle,NA
27154915,NCT01055496,283,vincristine,1,1.4,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,prednisone,1,40,mg/m2,1,on days 1 to 5 of each 21-day cycle,NA
27154915,NCT01055496,283,inotuzumab ozogamicin,2,0.8,mg/m2,1,on day 2 of each 21-day cycle,NA
27154915,NCT01055496,283,rituximab,2,375,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,cyclophosphamide,2,550,mg/m2,1,on day 1 of each 21-day cycle,NA
27154915,NCT01055496,283,vincristine,2,1.4,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,prednisone,2,40,mg/m2,1,on days 1 to 5 of each 21-day cycle,NA
27154915,NCT01055496,283,inotuzumab ozogamicin,3,0.8,mg/m2,1,on day 2 of each 21-day cycle,NA
27154915,NCT01055496,283,rituximab,3,375,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,cyclophosphamide,3,750,mg/m2,1,on day 1 of each 21-day cycle,NA
27154915,NCT01055496,283,vincristine,3,1.4,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,prednisone,3,40,mg/m2,1,on days 1 to 5 of each 21-day cycle,NA
27154915,NCT01055496,283,inotuzumab ozogamicin,4,1.3,mg/m2,1,on day 2 of each 21-day cycle,NA
27154915,NCT01055496,283,rituximab,4,375,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,cyclophosphamide,4,750,mg/m2,1,on day 1 of each 21-day cycle,NA
27154915,NCT01055496,283,vincristine,4,1.4,mg/m2,1,on day 1 of each 21-day cycle,fixed
27154915,NCT01055496,283,prednisone,4,40,mg/m2,1,on days 1 to 5 of each 21-day cycle,NA
27601593,NCT01209130,284,pinatuzumab vedotin,1,0.1,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,2,0.25,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,3,0.5,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,4,1,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,5,1.8,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,6,2.4,mg/kg,1,every 21 days,NA
27601593,NCT01209130,284,pinatuzumab vedotin,7,3.2,mg/kg,1,every 21 days,NA
27601593,NCT01209130,285,pinatuzumab vedotin,1,1.8,mg/kg,1,every 21 days,NA
27601593,NCT01209130,285,rituximab,1,375,mg/m2,1,every 21 days,NA
27601593,NCT01209130,285,pinatuzumab vedotin,2,2.4,mg/kg,1,every 21 days,NA
27601593,NCT01209130,285,rituximab,2,375,mg/m2,1,every 21 days,NA
33451977,NCT02663518,286,tti-621,1,0.05,mg/kg,1,weekly for 3 weeks,NA
33451977,NCT02663518,286,tti-621,2,0.1,mg/kg,1,weekly for 3 weeks,NA
33451977,NCT02663518,286,tti-621,3,0.3,mg/kg,1,weekly for 3 weeks,NA
33451977,NCT02663518,286,tti-621,4,1,mg/kg,1,weekly for 3 weeks,NA
33451977,NCT02663518,286,tti-621,5,3,mg/kg,1,weekly for 3 weeks,NA
33451977,NCT02663518,286,tti-621,6,10,mg/kg,1,weekly for 3 weeks,NA
30082475,NCT01397825,287,alisertib,1,50,mg,2,on days 1 to 7 in 21-day cycles,NA
30082475,NCT01397825,287,rituximab,1,375,mg/m2,1,on day 1 in 21-day cycles,NA
30082475,NCT01397825,288,alisertib,1,30,mg,2,on days 1 to 7 in 21-day cycles,NA
30082475,NCT01397825,288,rituximab,1,375,mg/m2,1,on day 1 in 21-day cycles,fixed
30082475,NCT01397825,288,vincristine,1,1.4,mg/m2,1,on days 1 and 8 in 21-day cycles,fixed
30082475,NCT01397825,288,alisertib,2,40,mg,2,on days 1 to 7 in 21-day cycles,NA
30082475,NCT01397825,288,rituximab,2,375,mg/m2,1,on day 1 in 21-day cycles,fixed
30082475,NCT01397825,288,vincristine,2,1.4,mg/m2,1,on days 1 and 8 in 21-day cycles,fixed
30082475,NCT01397825,288,alisertib,3,50,mg,2,on days 1 to 7 in 21-day cycles,NA
30082475,NCT01397825,288,rituximab,3,375,mg/m2,1,on day 1 in 21-day cycles,fixed
30082475,NCT01397825,288,vincristine,3,1.4,mg/m2,1,on days 1 and 8 in 21-day cycles,fixed
22875080,NA,289,pomalidomide,1,5,mg,1,daily for 21 days followed by a 7 day rest for a 28 day cycle,Cohort A
22875080,NA,289,pomalidomide,2,10,mg,1,daily for 21 days followed by a 7 day rest for a 28 day cycle,Cohort A
22875080,NA,289,pomalidomide,2.5,7,mg,1,daily for 21 days followed by a 7 day rest for a 28 day cycle,Cohort A
22875080,NA,289,pomalidomide,1,3,mg,1,uninterrupted daily for 28 day cycles,Cohort B
22875080,NA,289,pomalidomide,2,5,mg,1,uninterrupted daily for 28 day cycles,Cohort B
22875080,NA,289,pomalidomide,2.5,4,mg,1,uninterrupted daily for 28 day cycles,Cohort B
25057177, NCT00787969,290,temsirolimus,1,15,mg,1,on day 1 every 28 days,NA
25057177, NCT00787969,290,rituximab,1,375,mg/m2,1,day 1 of a 28-day cycle,fixed
25057177, NCT00787969,290,cladribine,1,5,mg/m2,1,days 1–5 of a 28-day cycle,fixed
25057177, NCT00787969,290,pegfilgrastim or filgrastim,1,6; 300-480,mg; um,1,day 6 of a 28-day cycle; days 6–15 of a 28-day cycle,fixed
25057177, NCT00787969,290,temsirolimus,2,25,mg,1,on day 1 every 28 days,NA
25057177, NCT00787969,290,rituximab,2,375,mg/m2,1,day 1 of a 28-day cycle,fixed
25057177, NCT00787969,290,cladribine,2,5,mg/m2,1,days 1–5 of a 28-day cycle,fixed
25057177, NCT00787969,290,pegfilgrastim or filgrastim,2,6; 300-480,mg; um,1,day 6 of a 28-day cycle; days 6–15 of a 28-day cycle,fixed
25057177, NCT00787969,290,temsirolimus,3,25,mg,1,"on days 1, and 15 every 28 days",NA
25057177, NCT00787969,290,rituximab,3,375,mg/m2,1,day 1 of a 28-day cycle,fixed
25057177, NCT00787969,290,cladribine,3,5,mg/m2,1,days 1–5 of a 28-day cycle,fixed
25057177, NCT00787969,290,pegfilgrastim or filgrastim,3,6; 300-480,mg; um,1,day 6 of a 28-day cycle; days 6–15 of a 28-day cycle,fixed
25057177, NCT00787969,290,temsirolimus,4,25,mg,1,"on days 1, 8, and 15 every 28 days",NA
25057177, NCT00787969,290,rituximab,4,375,mg/m2,1,day 1 of a 28-day cycle,fixed
25057177, NCT00787969,290,cladribine,4,5,mg/m2,1,days 1–5 of a 28-day cycle,fixed
25057177, NCT00787969,290,pegfilgrastim or filgrastim,4,6; 300-480,mg; um,1,day 6 of a 28-day cycle; days 6–15 of a 28-day cycle,fixed
25057177, NCT00787969,290,temsirolimus,5,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
25057177, NCT00787969,290,rituximab,5,375,mg/m2,1,day 1 of a 28-day cycle,fixed
25057177, NCT00787969,290,cladribine,5,5,mg/m2,1,days 1–5 of a 28-day cycle,fixed
25057177, NCT00787969,290,pegfilgrastim or filgrastim,5,6; 300-480,mg; um,1,day 6 of a 28-day cycle; days 6–15 of a 28-day cycle,fixed
11432631,NA,291,raltitrexed,1,1,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,1,1050,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,2,1,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,2,2100,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,3,2,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,3,2100,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,4,2,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,4,4200,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,5,2,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,5,6300,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,6,2,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,6,8300,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,7,2,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,7,10400,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
11432631,NA,291,raltitrexed,8,2.5,mg/m2,1,every three weeks,NA
11432631,NA,291,idurd,8,10400,mg/m2,1,a 24-hour infusion after a raltitrexed 15-minute infusion every three weeks,NA
8622063,NA,292,zd1694,1,1.6,mg/m2,1,"every 3 weeks,",NA
8622063,NA,292,zd1694,2,2.6,mg/m2,1,"every 3 weeks,",NA
8622063,NA,292,zd1694,3,3,mg/m2,1,"every 3 weeks,",NA
8622063,NA,292,zd1694,4,3.5,mg/m2,1,"every 3 weeks,",NA
27293194,NCT01410513,293,voxtalisib,1,30,mg,2,daily continuously,NA
27293194,NCT01410513,293,rituximab,1,375,mg/m2,1,"on days 1, 8, 15 and 22 of a 28-d cycle for two cycles",fixed
27293194,NCT01410513,293,voxtalisib,2,50,mg,2,daily continuously,NA
27293194,NCT01410513,293,rituximab,2,375,mg/m2,1,"on days 1, 8, 15 and 22 of a 28-d cycle for two cycles",fixed
27293194,NCT01410513,294,voxtalisib,1,30,mg,2,daily continuously,patients with relapsed or refractory iNHL or MCL
27293194,NCT01410513,294,rituximab,1,375,mg/m2,1,on day 1 of each 28-d cycle for up to eightcycle,fixed
27293194,NCT01410513,294,bendamustine,1,90,mg/m2,1,on days 1 and 2 of each 28-d cycle for up to eight cycle,fixed
27293194,NCT01410513,294,voxtalisib,2,50,NA,2,daily continuously,NA
27293194,NCT01410513,294,rituximab,2,375,mg/m2,1,on day 1 of each 28-d cycle for up to eightcycle,NA
27293194,NCT01410513,294,bendamustine,2,70,mg/m2,1,on days 1 and 2 of each 28-d cycle for up to eight cycle,NA
27293194,NCT01410513,294,voxtalisib,1.5,30,mg,2,daily continuously,patients with relapsed or refractory CLL
27293194,NCT01410513,294,rituximab,1.5,375/500,mg/m2,1,375 mg/m2on day 1 of cycle 1 and 500 mg/m2on day 1 of cycles 2 to 6) for up to six cycles,fixed
27293194,NCT01410513,294,bendamustine,1.5,70,mg/m2,1,on days 1 and 2 of each 28-d cycle for up to eight cycle,fixed
27293194,NCT01410513,294,voxtalisib,2.5,50,mg,2,daily continuously,patients with relapsed or refractory CLL
27293194,NCT01410513,294,rituximab,2.5,375/500,mg/m2,1,375 mg/m2on day 1 of cycle 1 and 500 mg/m2on day 1 of cycles 2 to 6) for up to six cycles,fixed
27293194,NCT01410513,294,bendamustine,2.5,70,mg/m2,1,on days 1 and 2 of each 28-d cycle for up to eight cycle,fixed
19652067,NA,295,pralatrexate,1,135,mg/m2,1,day 1 and 15 every 28 days,NA
19652067,NA,295,pralatrexate,2,30,mg/m2,1,weekly for 3 weeks every 4 weeks,NA
19652067,NA,295,pralatrexate,3,30,mg/m2,1,weekly for 6 weeks every 7 weeks,NA
19652067,NA,295,pralatrexate,4,45,mg/m2,1,weekly for 6 weeks every 7 weeks,NA
27381904,NCT01570387,296,pomalidomide,1,2,mg,1,on days 1 to 28 of a 28-day cycle,NA
27381904,NCT01570387,296,dexamethasone,1,20,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",fixed
27381904,NCT01570387,296,pomalidomide,2,3,mg,1,on days 1 to 28 of a 28-day cycle,NA
27381904,NCT01570387,296,dexamethasone,2,20,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",fixed
27381904,NCT01570387,296,pomalidomide,3,4,mg,1,on days 1 to 21 every 28 days,NA
27381904,NCT01570387,296,dexamethasone,3,20,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",fixed
11597383,NA,298,raltitrexed,1,2,mg/m2,1,"on days 1, 19, and 38 during the radiation therapy",NA
11597383,NA,298,radiotherapy,1,1.8,Gy,1,"5 days per week, from Monday to Friday, up to 50.4 Gy",fixed
11597383,NA,298,raltitrexed,2,2.5,mg/m2,1,"on days 1, 19, and 38 during the radiation therapy",NA
11597383,NA,298,radiotherapy,2,1.8,Gy,1,"5 days per week, from Monday to Friday, up to 50.4 Gy",fixed
11597383,NA,298,raltitrexed,3,3,mg/m2,1,"on days 1, 19, and 38 during the radiation therapy",NA
11597383,NA,298,radiotherapy,3,1.8,Gy,1,"5 days per week, from Monday to Friday, up to 50.4 Gy",fixed
23572496,NA,299,177lu-dota-rituximab,1,740,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,1,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,2,925,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,2,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,3,1110,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,3,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,4,1295,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,4,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,5,1480,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,5,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,6,1665,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,6,250,mg/m2,1,on days 1 and 8,NA
23572496,NA,299,177lu-dota-rituximab,7,1850,MBq/m2,1,On day 8,NA
23572496,NA,299,rituximab,7,250,mg/m2,1,on days 1 and 8,NA
11038040,NA,300,raltitrexed,1,2,mg/m2,1,1 hour before radiotherapy on days 1 and 22 (3-week interval),NA
11038040,NA,300,radiotherapy,1,1.8,Gy,1,28 fractions at 1.8 Gy per fraction using 6-10 mV photons) 5 times per week for 5-6 weeks,fixed
11038040,NA,300,raltitrexed,2,2.6,mg/m2,1,1 hour before radiotherapy on days 1 and 22 (3-week interval),NA
11038040,NA,300,radiotherapy,2,1.8,Gy,1,28 fractions at 1.8 Gy per fraction using 6-10 mV photons) 5 times per week for 5-6 weeks,fixed
11038040,NA,300,raltitrexed,3,3,mg/m2,1,1 hour before radiotherapy on days 1 and 22 (3-week interval),NA
11038040,NA,300,radiotherapy,3,1.8,Gy,1,28 fractions at 1.8 Gy per fraction using 6-10 mV photons) 5 times per week for 5-6 weeks,fixed
10645208,NA,301,raltitrexed,1,0.5,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,1,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,2,1,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,2,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,3,1.5,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,3,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,4,2,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,4,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,5,2.5,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,5,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,6,3,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,6,900,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,7,3,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,7,1050,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,8,3,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,8,1200,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,9,3,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,9,1350,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,10,3.5,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,10,1200,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,11,4,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,11,1200,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,12,4.5,mg/m2,1,a 15-min infusionf ollowed 24 h later by bolus 5-FU every 3 weeks,NA
10645208,NA,301,5-fu,12,1200,mg/m2,1,bolus on a 3-weekly cycle,raltitrexed in combination with bolus 5-FU
10645208,NA,301,raltitrexed,13,2.6,mg/m2,1,on days 8 and 29 as a 15-min infusion followed 15 min later by the infusion of 5-FU,NA
10645208,NA,301,5-fu,13,1200,mg/m2,1,weekly for 5 weeks of a 6-week cycle as a 24-hinfusion,"raltitrexed in combination with
infusional 5-FU"
10645208,NA,301,raltitrexed,14,2.6,mg/m2,1,on days 8 and 29 as a 15-min infusion followed 15 min later by the infusion of 5-FU,NA
10645208,NA,301,5-fu,14,1600,mg/m2,1,weekly for 5 weeks of a 6-week cycle as a 24-hinfusion,"raltitrexed in combination with
infusional 5-FU"
10645208,NA,301,raltitrexed,15,2.6,mg/m2,1,on days 8 and 29 as a 15-min infusion followed 15 min later by the infusion of 5-FU,NA
10645208,NA,301,5-fu,15,2000,mg/m2,1,weekly for 5 weeks of a 6-week cycle as a 24-hinfusion,"raltitrexed in combination with
infusional 5-FU"
10645208,NA,301,raltitrexed,16,2.6,mg/m2,1,on days 8 and 29 as a 15-min infusion followed 15 min later by the infusion of 5-FU,NA
10645208,NA,301,5-fu,16,2400,mg/m2,1,weekly for 5 weeks of a 6-week cycle as a 24-hinfusion,"raltitrexed in combination with
infusional 5-FU"
10645208,NA,301,raltitrexed,17,3,mg/m2,1,on days 8 and 29 as a 15-min infusion followed 15 min later by the infusion of 5-FU,NA
10645208,NA,301,5-fu,17,2400,mg/m2,1,weekly for 5 weeks of a 6-week cycle as a 24-hinfusion,"raltitrexed in combination with
infusional 5-FU"
32343640,NCT03406871,302,regorafenib,1,80,mg,1,daily for 21 days on/7 days off in 4-week cycles,NA
32343640,NCT03406871,302,nivolumab,1,3,mg/kg,1,every 2 weeks in 4-week cycles,fixed
32343640,NCT03406871,302,regorafenib,2,120,mg,1,daily for 21 days on/7 days off in 4-week cycles,NA
32343640,NCT03406871,302,nivolumab,2,3,mg/kg,1,every 2 weeks in 4-week cycles,fixed
32343640,NCT03406871,302,regorafenib,3,160,mg,1,daily for 21 days on/7 days off in 4-week cycles,NA
32343640,NCT03406871,302,nivolumab,3,3,mg/kg,1,every 2 weeks in 4-week cycles,fixed
23295790,NCT00299494,303,rituximab,1,0.8,mg/m2,1,on day 1 every 4 weeks for up to eight cycles,NA
23295790,NCT00299494,303,inotuzumab ozogamicin,1,375,mg/m2,1,on day 2 every 4 weeks for up to eight cycles,fixed
23295790,NCT00299494,303,rituximab,2,1.3,mg/m2,1,on day 1 every 4 weeks for up to eight cycles,NA
23295790,NCT00299494,303,inotuzumab ozogamicin,2,375,mg/m2,1,on day 2 every 4 weeks for up to eight cycles,fixed
23295790,NCT00299494,303,rituximab,3,1.8,mg/m2,1,on day 1 every 4 weeks for up to eight cycles,NA
23295790,NCT00299494,303,inotuzumab ozogamicin,3,375,mg/m2,1,on day 2 every 4 weeks for up to eight cycles,fixed
28314788,NCT01326702,304,veliparib,1,50,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,1,70,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,2,50,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,2,90,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,3,100,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,3,90,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,4,150,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,4,90,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,5,200,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,5,90,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,6,300,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,6,90,mg/m2,1,on days 1-2 every 28 days,NA
28314788,NCT01326702,304,veliparib,7,400,mg,2,on days 1-7 every 28 days,NA
28314788,NCT01326702,304,bendamustine,7,90,mg/m2,1,on days 1-2 every 28 days,NA
12451472,NA,305,vinorelbine,1,22.5,mg/m2,1,on day 1 and on day 5 every 3 weeks,NA
12451472,NA,305,raltitrexed,1,2.5,mg/m2,1,on day 1 every 3 weeks,NA
12451472,NA,305,vinorelbine,2,22.5,mg/m2,1,on day 1 and on day 5 every 3 weeks,NA
12451472,NA,305,raltitrexed,2,3,mg/m2,1,on day 1 every 3 weeks,NA
12451472,NA,305,vinorelbine,3,25,mg/m2,1,on day 1 and on day 5 every 3 weeks,NA
12451472,NA,305,raltitrexed,3,3,mg/m2,1,on day 1 every 3 weeks,NA
12451472,NA,305,vinorelbine,4,27.5,mg/m2,1,on day 1 and on day 5 every 3 weeks,NA
12451472,NA,305,raltitrexed,4,3,mg/m2,1,on day 1 every 3 weeks,NA
12451472,NA,305,vinorelbine,5,30,mg/m2,1,on day 1 and on day 5 every 3 weeks,NA
12451472,NA,305,raltitrexed,5,3,mg/m2,1,on day 1 every 3 weeks,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),306,urelumab,1,8,mg,1,Q3W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),306,urelumab,2,8,mg,1,Q6W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),306,urelumab,3,0.3,mg/kg,1,Q3W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,urelumab,1,0.1,mg/m2,1,Q3W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,rituximab,1,375,mg/m2,1,QW (during the first 4 weeks of each 12-week cycle),NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,urelumab,2,8,mg,1,Q3W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,rituximab,2,375,mg/m2,1,QW (during the first 4 weeks of each 12-week cycle),NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,urelumab,3,0.3,mg/kg,1,Q3W,NA
32052473,NCT01471210 (CA186-011) & NCT01775631 (CA186-017),307,rituximab,3,375,mg/m2,1,QW (during the first 4 weeks of each 12-week cycle),NA
30060083,NCT01594229,308,venetoclax,1,50,mg,1,on days 1-3 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,1,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,1,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,2,100,mg,1,on days 1-3 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,2,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,2,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,3,100,mg,1,on days 1-7 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,3,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,3,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,4,200,mg,1,on days 1-7 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,4,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,4,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,5,400,mg,1,on days 1-7 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,5,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,5,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,6,200,mg,1,on days 1-7 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,6,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,6,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,7,400,mg,1,on days 1-28 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,7,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,7,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,8,600,mg,1,on days 1-28 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,8,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,8,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,9,800,mg,1,on days 1-28 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,9,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,9,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
30060083,NCT01594229,308,venetoclax,10,1200,mg,1,on days 1-28 of each 28 day cycle,NA
30060083,NCT01594229,308,rituximab,10,375,mg/m2,1,on day 1 of each 28 day cycle,fixed
30060083,NCT01594229,308,bendamustine,10,90,mg/m2,1,on days 2 and 3 of each 28 day cycle,fixed
29563636,NCT01004003,309,nintedanib,1,100,mg,2,daily,Group 1 & Group 2
29563636,NCT01004003,309,nintedanib,2,150,mg,2,daily,Group 1 & Group 2
29563636,NCT01004003,309,nintedanib,3,200,mg,2,daily,Group 1 & Group 2
29563636,NCT01004003,309,nintedanib,0,50,mg,2,daily,Group 2
25976292,NA,310,ruxolitinib,1,15,mg/m2,2,daily (BID) in 28-daycycles,patients with STs and patients with MPNs
25976292,NA,310,ruxolitinib,2,21,mg/m2,2,daily (BID) in 28-daycycles,patients with STs and patients with MPNs
25976292,NA,310,ruxolitinib,3,29,mg/m2,2,daily (BID) in 28-daycycles,patients with STs and patients with MPNs
25976292,NA,310,ruxolitinib,4,39,mg/m2,2,daily (BID) in 28-daycycles,patients with STs and patients with MPNs
25976292,NA,310,ruxolitinib,5,50,mg/m2,2,daily (BID) in 28-daycycles,patients with STs
25248753,NA,311,ganetespib,1,100,mg/m2,1,"on days 1, 8, and 15 of each 28 day cycle",NA
25248753,NA,311,ganetespib,2,150,mg/m2,1,"on days 1, 8, and 15 of each 28 day cycle",NA
25248753,NA,311,ganetespib,3,200,mg/m2,1,"on days 1, 8, and 15 of each 28 day cycle",NA
21045832,NA,312,sorafenib,0,200,mg,2,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,0,1,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,0,1,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sorafenib,1,200,mg,2,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,1,2,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,1,2,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sorafenib,2,400,mg,2,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,2,2,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,2,2,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sorafenib,3,400,mg,2,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,3,4,mg,1,daily of 28-day cycles,NA
21045832,NA,312,sirolimus,3,4,mg,1,daily of 28-day cycles,NA
22415798,NA,313,sorafenib,1,400,mg,2,days 1–21 of a 21-day cycle,fixed
22415798,NA,313,vorinostat,1,200,mg,1,daily days 1–14 of a 21-day cycle,NA
22415798,NA,313,sorafenib,2,400,mg,2,days 1–21 of a 21-day cycle,fixed
22415798,NA,313,vorinostat,2,300,mg,1,daily days 1–14 of a 21-day cycle,NA
22415798,NA,313,sorafenib,3,400,mg,2,days 1–21 of a 21-day cycle,fixed
22415798,NA,313,vorinostat,3,400,mg,1,daily days 1–14 of a 21-day cycle,NA
25371323,NA,314,sorafenib,1,200,mg,2,daily in 28-day cycle,NA
25371323,NA,314,entinostat,1,4,mg,1,once every 2 weeks in 28-day cycle,NA
25371323,NA,314,sorafenib,2,400,mg,2,daily in 28-day cycle,NA
25371323,NA,314,entinostat,2,4,mg,1,once every 2 weeks in 28-day cycle,NA
25371323,NA,314,sorafenib,3,400,mg,2,daily in 28-day cycle,NA
25371323,NA,314,entinostat,3,6,mg,1,once every 2 weeks in 28-day cycle,NA
25371323,NA,314,sorafenib,4,400,mg,2,daily in 28-day cycle,NA
25371323,NA,314,entinostat,4,10,mg,1,once every 2 weeks in 28-day cycle,NA
26644411,NCT00785226,315,refametinib,1,5,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,1,200,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,refametinib,2,5,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,2,400,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,refametinib,3,10,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,3,400,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,refametinib,4,30,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,4,400,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,refametinib,5,50,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,5,400,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,refametinib,2.5,10,mg,2,daily for 28 days,NA
26644411,NCT00785226,315,sorafenib,2.5,200,mg,2,daily for 28 days,NA
22962440,NA,316,sorafenib,1,150,mg/m2,2,for consecutive 28-day cycles,for children with solid tumors and children with leukemias
22962440,NA,316,sorafenib,-1,105,mg/m2,2,for consecutive 28-day cycles,for children with solid tumors
22962440,NA,316,sorafenib,0,130,mg/m2,2,for consecutive 28-day cycles,for children with solid tumors
22962440,NA,316,sorafenib,2,200,mg/m2,2,for consecutive 28-day cycles,for children with solid tumors and children with leukemias
22962440,NA,316,sorafenib,3,250,mg/m2,2,for consecutive 28-day cycles,for children with solid tumors
28488066,NCT01276210,317,sorafenib,1,400,mg,1,begun 5–7 days prior to SRS and continued for 14 days thereafter,NA
28488066,NCT01276210,317,stereotactic radiosurgery,1,NA,Gy,NA,NA,NA
28488066,NCT01276210,317,sorafenib,2,400,mg,2,begun 5–7 days prior to SRS and continued for 14 days thereafter,NA
28488066,NCT01276210,317,stereotactic radiosurgery,2,NA,Gy,NA,NA,NA
29520435,NCT01008566,318,cixutumumab,1,2,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
29520435,NCT01008566,318,sorafenib,1,400,mg,2,daily on days 1-28 every 28 days,fixed
29520435,NCT01008566,318,cixutumumab,2,4,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
29520435,NCT01008566,318,sorafenib,2,400,mg,2,daily on days 1-28 every 28 days,fixed
29520435,NCT01008566,318,cixutumumab,3,6,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
29520435,NCT01008566,318,sorafenib,3,400,mg,2,daily on days 1-28 every 28 days,fixed
34109515,NCT01724606  ,319,sorafenib,1,200,mg,1,daily at the start of WBRT for 21 days,NA
34109515,NCT01724606  ,319,whole brain radiotherapy,1,3,Gy,1,30 Gy in 10 fractions (1 fraction /day),fixed
34109515,NCT01724606  ,319,sorafenib,2,400,mg,1,daily at the start of WBRT for 21 days,NA
34109515,NCT01724606  ,319,whole brain radiotherapy,2,3,Gy,1,30 Gy in 10 fractions (1 fraction /day),fixed
34109515,NCT01724606  ,319,sorafenib,3,600,mg,1,daily at the start of WBRT for 21 days,NA
34109515,NCT01724606  ,319,whole brain radiotherapy,3,3,Gy,1,30 Gy in 10 fractions (1 fraction /day),fixed
23061485,NA,320,sorafenib,1,200,mg,2,on cycle days 2 – 28,NA
23061485,NA,320,cytarabine,1,10,mg,2,on cycle days 1 – 10,NA
23061485,NA,320,sorafenib,2,300,mg,2,on cycle days 2 – 28,NA
23061485,NA,320,cytarabine,2,10,mg,2,on cycle days 1 – 10,NA
23061485,NA,320,sorafenib,3,300,mg,2,on cycle days 2 – 28,NA
23061485,NA,320,cytarabine,3,20,mg,2,on cycle days 1 – 10,NA
23061485,NA,320,sorafenib,4,400,mg,2,on cycle days 2 – 28,NA
23061485,NA,320,cytarabine,4,20,mg,2,on cycle days 1 – 10,NA
25818407,NCT00783653,321,ara-c,1,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,ara-c,1,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,daunorubicin,1,60,mg/m2/d,1,on days 1–3,Induction therapy
25818407,NCT00783653,321,sunitinib,1,25,mg,1,continuously,maintenance therapy for 2 year
25818407,NCT00783653,321,ara-c,2,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,ara-c,2,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,daunorubicin,2,60,mg/m2/d,1,on days 1–3,Induction therapy
25818407,NCT00783653,321,sunitinib,2,50,mg,1,continuously,maintenance therapy for 2 year
25818407,NCT00783653,321,ara-c,-1,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,ara-c,-1,100,mg/m2/d,1,continuous intravenous infusion on days1–7,Induction therapy
25818407,NCT00783653,321,daunorubicin,-1,60,mg/m2/d,1,on days 1–3,Induction therapy
25818407,NCT00783653,321,sunitinib,-1,25,mg,1,days 1–7 of each che-motherapy cycle,maintenance therapy for 2 year
27681866,NCT01029418,322,sorafenib,0,400,mg,2,daily,fixed
27681866,NCT01029418,322,selumetinb,0,75,mg,1,daily,NA
27681866,NCT01029418,322,sorafenib,1,400,mg,2,daily,fixed
27681866,NCT01029418,322,selumetinb,1,50,mg,2,daily,NA
27681866,NCT01029418,322,sorafenib,1.5,400,mg,2,daily,fixed
27681866,NCT01029418,322,selumetinb,1.5,100,mg,1,daily,NA
30352941,NCT02024087,323,dalantercept,1,0.6,mg/kg,1,every 3 weeks,NA
30352941,NCT02024087,323,sorafenib,1,400,mg,1,daily,fixed
30352941,NCT02024087,323,dalantercept,2,0.4,mg/kg,1,every 3 weeks,NA
30352941,NCT02024087,323,sorafenib,2,400,mg,1,daily,fixed
20109071,NA,324,sorafenib,1,100,mg,2,28 days every 4 weeks,NA
20109071,NA,324,sorafenib,2,200,mg,2,28 days every 4 weeks,NA
20109071,NA,324,sorafenib,3,300,mg,2,28 days every 4 weeks,NA
20109071,NA,324,sorafenib,4,400,mg,2,28 days every 4 weeks,NA
20109071,NA,324,sorafenib,1.5,100,mg,2,"14 days of treatment, with a 14-day rest every 28 days",NA
20109071,NA,324,sorafenib,2.5,200,mg,2,"14 days of treatment, with a 14-day rest every 28 days",NA
20109071,NA,324,sorafenib,3.5,300,mg,2,"14 days of treatment, with a 14-day rest every 28 days",NA
20109071,NA,324,sorafenib,4.5,400,mg,2,"14 days of treatment, with a 14-day rest every 28 days",NA
26714427,NA,325,sorafenib,1,150,mg/m2,2,on days 1–28 of each 28-day cycle,NA
26714427,NA,325,topotecan,1,1,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26714427,NA,325,topotecan,1,1,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26714427,NA,325,sorafenib,2,150,mg/m2,2,on days 1–28 of each 28-day cycle,NA
26714427,NA,325,topotecan,2,1.4,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26714427,NA,325,topotecan,2,1.4,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26714427,NA,325,sorafenib,3,200,mg/m2,2,on days 1–28 of each 28-day cycle,NA
26714427,NA,325,topotecan,3,1.4,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26714427,NA,325,topotecan,3,1.4,mg/m2,1,on days 1–5 and 8–12 of each 28-day cycle,NA
26867886,NA,326,stereotactic body radiation therapy,-1,30-51,Gy,1,"6 fractions in total, 3 fractions per week) days 8-21",fixed
26867886,NA,326,sorafenib,-1,200,mg,1,days 1-84 (12 weeks),NA
26867886,NA,326,stereotactic body radiation therapy,1,30-51,Gy,1,"6 fractions in total, 3 fractions per week) days 8-21",fixed
26867886,NA,326,sorafenib,1,200,mg,2,days 1-84 (12 weeks),NA
26867886,NA,326,stereotactic body radiation therapy,2,30-51,Gy,1,"6 fractions in total, 3 fractions per week) days 8-21",fixed
26867886,NA,326,sorafenib,2,400 AM; 200 PM,mg,2,days 1-84 (12 weeks),NA
26867886,NA,326,stereotactic body radiation therapy,3,30-51,Gy,1,"6 fractions in total, 3 fractions per week) days 8-21",fixed
26867886,NA,326,sorafenib,3,400,mg,2,days 1-84 (12 weeks),NA
25294187,NA,327,tivantinib,1,360,mg,2,daily in 28-day cycles,NA
25294187,NA,327,sorafenib,1,200,mg,2,daily in 28-day cycles,NA
25294187,NA,327,tivantinib,2,360,mg,2,daily in 28-day cycles,NA
25294187,NA,327,sorafenib,2,400,mg,2,daily in 28-day cycles,NA
29313954,NCT00329719,328,temsirolimus,0,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
29313954,NCT00329719,328,sorafenib,0,200,mg,2,on days 1-28 every 28 days,NA
29313954,NCT00329719,328,temsirolimus,1,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
29313954,NCT00329719,328,sorafenib,1,400,mg,2,on days 1-28 every 28 days,NA
33824476,NCT02115373,329,tepotinib,1,300,mg,1,QD continuous 21-day cycles,NA
33824476,NCT02115373,329,tepotinib,2,500,mg,1,QD continuous 21-day cycles,NA
28465443,NCT01306058,330,trc105,1,3,mg/kg,1,every 2 weeks,NA
28465443,NCT01306058,330,sorafenib,1,400,mg,2,daily continuously in a 28 days cycle,fixed
28465443,NCT01306058,330,trc105,2,6,mg/kg,1,every 2 weeks,NA
28465443,NCT01306058,330,sorafenib,2,400,mg,2,daily continuously in a 28 days cycle,fixed
28465443,NCT01306058,330,trc105,3,10,mg/kg,1,every 2 weeks,NA
28465443,NCT01306058,330,sorafenib,3,400,mg,2,daily continuously in a 28 days cycle,fixed
28465443,NCT01306058,330,trc105,4,15,mg/kg,1,every 2 weeks,NA
28465443,NCT01306058,330,sorafenib,4,400,mg,2,daily continuously in a 28 days cycle,fixed
28668472,NA,331,sorafenib,1,200,mg,1,days 1–28,NA
28668472,NA,331,palliative radiation therapy,1,3,Gy,1,"30 Gy in 10 fractions, days 8–12 and 15–19",fixed
28668472,NA,331,sorafenib,2,200,mg,2,days 1–28,NA
28668472,NA,331,palliative radiation therapy,2,3,Gy,1,"30 Gy in 10 fractions, days 8–12 and 15–19",fixed
28668472,NA,331,sorafenib,3,400,mg,2,days 1–28,NA
28668472,NA,331,palliative radiation therapy,3,3,Gy,1,"30 Gy in 10 fractions, days 8–12 and 15–19",fixed
28668472,NA,331,sorafenib,4,400,mg,2,days 1–77,NA
28668472,NA,331,palliative radiation therapy,4,3,Gy,1,"30 Gy in 10 fractions, days 8–12 and 15–19",fixed
33649501,NCT01128998,332,sorafenib,1,400,mg/m2,2,"everyday, since Day 8 of Cycle 1",fixed
33649501,NCT01128998,332,s-1,1,30,mg,2,14 days every one cycle (21 days),NA
33649501,NCT01128998,332,sorafenib,2,400,mg/m2,2,"everyday, since Day 8 of Cycle 1",fixed
33649501,NCT01128998,332,s-1,2,35,mg,2,14 days every one cycle (21 days),NA
33649501,NCT01128998,332,sorafenib,3,400,mg/m2,2,"everyday, since Day 8 of Cycle 1",fixed
33649501,NCT01128998,332,s-1,3,40,mg,2,14 days every one cycle (21 days),NA
29898591,NCT01942083,333,opb-111077,1,50,mg,1,"daily in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,2,100,mg,1,"daily in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,3,150,mg,1,"daily in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,4,200,mg,1,"daily in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,5,250,mg,1,"daily in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,6,300,mg,1,"4-days on/3-days off  in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,7,500,mg,1,"4-days on/3-days off  in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
29898591,NCT01942083,333,opb-111077,8,600,mg,1,"4-days on/3-days off  in a 24-day initial treatment cycle (cycle 1), and 21-day subsequent treatment cycles (cycle 2 onwards)",NA
33785364,NCT02046291,334,romiplostim,1,4,ug/kg,1,6 weekly subcutaneous (SQ) injections beginning by day +42 post-UCBT with an end date by day +100,NA
33785364,NCT02046291,334,romiplostim,2,6,ug/kg,1,6 weekly subcutaneous (SQ) injections beginning by day +42 post-UCBT with an end date by day +100,NA
33785364,NCT02046291,334,romiplostim,3,8,ug/kg,1,6 weekly subcutaneous (SQ) injections beginning by day +42 post-UCBT with an end date by day +100,NA
33785364,NCT02046291,334,romiplostim,4,10,ug/kg,1,6 weekly subcutaneous (SQ) injections beginning by day +42 post-UCBT with an end date by day +100,NA
15870716,NA,335,bay 43-9006,1,50,mg,1,every 5 days for repeated cycles of 21 days,NA
15870716,NA,335,bay 43-9006,2,50,mg,1,every other day for repeated cycles of 21 days,NA
15870716,NA,335,bay 43-9006,3,100,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15870716,NA,335,bay 43-9006,4,200,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15870716,NA,335,bay 43-9006,5,300,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15870716,NA,335,bay 43-9006,6,400,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15870716,NA,335,bay 43-9006,7,600,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15870716,NA,335,bay 43-9006,8,800,mg,2,daily for repeated cycles of 21 days on/7 days off,NA
15073100,NA,336,rituximab,1,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,1,2,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,il-2,1,2,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,rituximab,2,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,2,4.5,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,il-2,2,4.5,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,rituximab,3,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,3,6,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,il-2,3,6,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,rituximab,4,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,4,7.5,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,il-2,4,7.5,MIU,1,"starting at week 2, daily for 4 consecutive weeks",NA
15073100,NA,336,rituximab,5,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,5,4.5,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,il-2,5,4.5,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,rituximab,6,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,6,10,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,il-2,6,10,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,rituximab,7,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,7,14,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,il-2,7,14,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,rituximab,8,375,mg/m2,1,"weekly, weeks 1–4",NA
15073100,NA,336,il-2,8,18,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
15073100,NA,336,il-2,8,18,MIU,1,"starting at week 2, thrice weekly for 4 consecutive weeks",NA
27103123,NA,337,sunitinib,1,50,mg,1,"C1: days 1–15, 2 weeks off; C2: daily × 4 weeks, 2 weeks off",NA
27103123,NA,337,sirolimus,1,4,mg,1,C1: not given; C2: 4 mg wkly,NA
27103123,NA,337,sirolimus,1,4,mg,1,C1: not given; C2: 4 mg wkly,NA
27103123,NA,337,sunitinib,2,50,mg,1,daily × 28 every 6 weeks,NA
27103123,NA,337,sirolimus,2,4,mg,1,weekly,NA
27103123,NA,337,sirolimus,2,4,mg,1,weekly,NA
27103123,NA,337,sunitinib,3,37.5,mg,1,daily × 28 every 6 weeks,NA
27103123,NA,337,sirolimus,3,4,mg,1,weekly,NA
27103123,NA,337,sirolimus,3,4,mg,1,weekly,NA
27103123,NA,337,sunitinib,4,37.5,mg,1,daily × 28 every 6 weeks,NA
27103123,NA,337,sirolimus,4,8,mg,1,weekly,NA
27103123,NA,337,sirolimus,4,8,mg,1,weekly,NA
28988377,NA,338,sorafenib,0,200,mg,2,daily,fixed
28988377,NA,338,tipifarnib,0,100,mg,2,d1–21 of 28-days,NA
28988377,NA,338,sorafenib,-1,200,mg,2,daily,fixed
28988377,NA,338,tipifarnib,-1,100,mg,1,d1–21 of 28-days,NA
31305287,NCT01075113,339,sorafenib,1,400,mg,2,daily,Cohort A
31305287,NCT01075113,339,vorinostat,1,200,mg,1,5 days of 7 each week,Cohort A
31305287,NCT01075113,339,sorafenib,2,400,mg,2,daily,Cohort A
31305287,NCT01075113,339,vorinostat,2,300,mg,1,5 days of 7 each week,Cohort A
31305287,NCT01075113,339,sorafenib,1,200,mg,2,daily,Cohort B
31305287,NCT01075113,339,vorinostat,1,200,mg,1,5 days of 7 each week,Cohort B
31305287,NCT01075113,339,sorafenib,2,200,mg,2,daily,Cohort B
31305287,NCT01075113,339,vorinostat,2,400,mg,1,5 days of 7 each week,Cohort B
24786603,NCT00884416,340,sorafenib,1,200,mg,1,starting on day 8 of RT,NA
24786603,NCT00884416,340,radiation therapy,1,2,Gy,1,30 daily fractions to a total dose of 60 Gy,fixed
24786603,NCT00884416,340,temozolomide,1,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
24786603,NCT00884416,340,temozolomide,1,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
24786603,NCT00884416,340,sorafenib,2,200,mg,2,starting on day 8 of RT,NA
24786603,NCT00884416,340,radiation therapy,2,2,Gy,1,30 daily fractions to a total dose of 60 Gy,fixed
24786603,NCT00884416,340,temozolomide,2,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
24786603,NCT00884416,340,temozolomide,2,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
24786603,NCT00884416,340,sorafenib,3,400,mg,2,starting on day 8 of RT,NA
24786603,NCT00884416,340,radiation therapy,3,2,Gy,1,30 daily fractions to a total dose of 60 Gy,fixed
24786603,NCT00884416,340,temozolomide,3,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
24786603,NCT00884416,340,temozolomide,3,75,mg/m2,1,"starting on the first day of RT, and administered daily for up to 42 days or until the end of RT",fixed
25711511,NCT01656265,341,tivantinib,1,120,mg,2,daily,capsule for CYP2C19 extensive metabolizers (EM)
25711511,NCT01656265,341,tivantinib,3,120,mg,2,daily,tablet for CYP2C19 extensive metabolizers (EM)
25711511,NCT01656265,341,tivantinib,2,240,mg,2,daily,capsule for CYP2C19 extensive metabolizers (EM)
25711511,NCT01656265,341,tivantinib,4,240,mg,2,daily,tablet for CYP2C19 extensive metabolizers (EM)
25711511,NCT01656265,341,tivantinib,1,120,mg,2,daily,capsule for CYP2C19 poor metabolizers (PM)
25711511,NCT01656265,341,tivantinib,3,120,mg,2,daily,tablet for CYP2C19 poor metabolizers (PM)
16006586,NA,342,bay 43-9006,1,50,mg,1,q4d,NA
16006586,NA,342,bay 43-9006,2,50,mg,1,qod,NA
16006586,NA,342,bay 43-9006,3,50,mg,1,qd,NA
16006586,NA,342,bay 43-9006,4,100,mg,1,qd,NA
16006586,NA,342,bay 43-9006,5,100,mg,2,bid,NA
16006586,NA,342,bay 43-9006,6,200,mg,2,bid,NA
16006586,NA,342,bay 43-9006,7,400,mg,2,bid,NA
16006586,NA,342,bay 43-9006,8,600,mg,2,bid,NA
22961690,NA,343,sorafenib,1,115,mg/m2,2,daily in each 28-day course,NA
22961690,NA,343,sorafenib,-1,80,mg/m2,2,daily in each 28-day course,NA
22961690,NA,343,sorafenib,2,150,mg/m2,2,daily in each 28-day course,NA
22961690,NA,343,sorafenib,3,200,mg/m2,2,daily in each 28-day course,NA
25239228,NCT01398501,344,sorafenib,1,200,mg,2,initiated between days 45 and 120 after HSCT and continued for 12 28-day cycle,NA
25239228,NCT01398501,344,sorafenib,2,400 AM; 200 PM,mg,2,initiated between days 45 and 120 after HSCT and continued for 12 28-day cycle,NA
25239228,NCT01398501,344,sorafenib,3,400,mg,2,initiated between days 45 and 120 after HSCT and continued for 12 28-day cycle,NA
24554062,NCT00805727,345,sorafenib,1,200,mg,2,initiated concomitant with RT on day 1 of study treatment,NA
24554062,NCT00805727,345,neoadjuvant conformal radiotherapy,1,50,Gy,NA,in 25 fractions of 200 cGy,fixed
24554062,NCT00805727,345,sorafenib,2,200 AM/400 PM,mg,2,initiated concomitant with RT on day 1 of study treatment,NA
24554062,NCT00805727,345,neoadjuvant conformal radiotherapy,2,50,Gy,NA,in 25 fractions of 200 cGy,fixed
28202227,NCT00892424,346,sorafenib,1,200,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,346,stereotactic radiotherapy,1,30-60,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",effective liver volume irradiated (Veff) < 80
28202227,NCT00892424,346,sorafenib,2,400 AM; 200 PM,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,346,stereotactic radiotherapy,2,30-60,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",effective liver volume irradiated (Veff) < 80
28202227,NCT00892424,346,sorafenib,3,400,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,346,stereotactic radiotherapy,3,30-60,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",effective liver volume irradiated (Veff) < 80
28202227,NCT00892424,347,sorafenib,1,200,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,347,whole liver radiotherapy,1,21.6,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",Veff > 80
28202227,NCT00892424,347,sorafenib,2,400 AM; 200 PM,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,347,whole liver radiotherapy,2,21.6,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",Veff > 80
28202227,NCT00892424,347,sorafenib,3,400,mg,2,"daily, administered for 4 weeks, starting 1 week prior to radiotherapy.",NA
28202227,NCT00892424,347,whole liver radiotherapy,3,21.6,Gy,NA,"in 6 fractions delivered on alternate days over 2 weeks, commencing on day 8 of sorafenib.",Veff > 80
21246251,NA,348,sorafenib,1,200,mg,2,daily in 28-day cycles,NA
21246251,NA,348,interferon-alpha,1,6,MIU,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21246251,NA,348,interferon-alpha,1,6,MIU,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21246251,NA,348,sorafenib,2,400,mg,2,daily in 28-day cycles,NA
21246251,NA,348,interferon-alpha,2,6,NA,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21246251,NA,348,interferon-alpha,2,6,NA,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21246251,NA,348,sorafenib,3,400,mg,2,daily in 28-day cycles,NA
21246251,NA,348,interferon-alpha,3,9,NA,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21246251,NA,348,interferon-alpha,3,9,NA,1,"from Day -14 to -1, then tiw with sorafenib in 28-day cycles",NA
21954442,NA,349,sorafenib,1,200,mg,2,on a continuous BID schedule,NA
21954442,NA,349,sorafenib,2,400,mg,2,on a continuous BID schedule,NA
21954442,NA,349,sorafenib,3,600,mg,2,on a continuous BID schedule,NA
21954442,NA,349,sorafenib,4,800,mg,2,on a continuous BID schedule,NA
21954442,NA,349,sorafenib,5,1000,mg,2,on a continuous BID schedule,NA
30478190, NCT01296581,350,vorolanib,1,20,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,2,40,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,3,80,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,4,160,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,5,300,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,6,400,mg,1,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,7,140,mg,2,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,8,200,mg,2,daily in a 28 day cycle,capsule
30478190, NCT01296581,350,vorolanib,1,50,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,2,100,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,3,150,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,4,200,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,5,300,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,6,400,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,7,600,mg,1,daily in a 28 day cycle,tablet
30478190, NCT01296581,350,vorolanib,8,800,mg,1,daily in a 28 day cycle,tablet
23099651,NA,351,sorafenib,1,200,mg,2,daily,NA
23099651,NA,351,temsirolimus,1,25,mg,1,once weekly,fixed
23099651,NA,351,sorafenib,0,400,mg,2,daily,NA
23099651,NA,351,temsirolimus,0,25,mg,1,once weekly,fixed
27992451, NCT00764972,352,sorafenib,1,200,mg,2,daily,NA
27992451, NCT00764972,352,vinorelbine,1,30,mg/m2,1,"days 1, 8 every 21",fixed
27992451, NCT00764972,352,sorafenib,2,400,mg,2,daily,NA
27992451, NCT00764972,352,vinorelbine,2,30,mg/m2,1,"days 1, 8 every 21",fixed
33646489,NA,353,sorafenib,0,200,mg,2,on days 1–28 of a 28-day cycle,fixed
33646489,NA,353,evofosfamide,0,240,mg/m2,1,"on days 8, 15, 22 of a 28-day cycle",NA
33646489,NA,353,sorafenib,1,200,mg,2,on days 1–28 of a 28-day cycle,fixed
33646489,NA,353,evofosfamide,1,480,mg/m2,1,"on days 8, 15, 22 of a 28-day cycle",NA
33646489,NA,353,sorafenib,1.5,200,mg,2,on days 1–28 of a 28-day cycle,fixed
33646489,NA,353,evofosfamide,1.5,340,mg/m2,1,"on days 8, 15, 22 of a 28-day cycle",NA
21594722,NA,354,pr-104,1,770,mg/m2,1,every 4 weeks,NA
21594722,NA,354,sorafenib,1,400,mg,2,daily and was commenced after the first dose of PR-104,fixed
21594722,NA,354,pr-104,2,550,mg/m2,1,every 4 weeks,NA
21594722,NA,354,sorafenib,2,400,mg,2,daily and was commenced after the first dose of PR-104,fixed
33972742,NCT01988493,355,tepotinib,1,300,mg,1,daily over a 21-day cycle,NA
33972742,NCT01988493,355,tepotinib,2,500,mg,1,daily over a 21-day cycle,NA
33972742,NCT01988493,355,tepotinib,3,1000,mg,1,daily over a 21-day cycle,NA
11304768,NA,356,rituximab,1,375,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,2,500,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,3,650,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,4,825,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,5,1000,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,6,1500,mg/m2,1,four weekly,NA
11304768,NA,356,rituximab,7,2250,mg/m2,1,four weekly,NA
32634234,NCT01787552,357,sonidegib,1,400,mg,1,daily,fixed
32634234,NCT01787552,357,ruxolitinib,1,10,mg,2,daily,NA
32634234,NCT01787552,357,sonidegib,2,400,mg,1,daily,fixed
32634234,NCT01787552,357,ruxolitinib,2,15,mg,2,daily,NA
32634234,NCT01787552,357,sonidegib,3,400,mg,1,daily,fixed
32634234,NCT01787552,357,ruxolitinib,3,20,mg,2,daily,NA
16061863,NA,358,bay 43-9006,1,100,mg,2,repeated 2-week cycles: 1-week on/1-week off treatment,NA
16061863,NA,358,bay 43-9006,2,200,mg,2,repeated 2-week cycles: 1-week on/1-week off treatment,NA
16061863,NA,358,bay 43-9006,3,400,mg,2,repeated 2-week cycles: 1-week on/1-week off treatment,NA
16061863,NA,358,bay 43-9006,4,600,mg,2,repeated 2-week cycles: 1-week on/1-week off treatment,NA
16061863,NA,358,bay 43-9006,5,800,mg,2,repeated 2-week cycles: 1-week on/1-week off treatment,NA
23519998,NA,359,temsirolimus,1,200,mg,1,weekly in 28-day cycles,NA
23519998,NA,359,sorafenib,1,15,mg,2,daily in 28-day cycles,NA
23519998,NA,359,temsirolimus,2,400,mg,1,weekly in 28-day cycles,NA
23519998,NA,359,sorafenib,2,15,mg,2,daily in 28-day cycles,NA
23519998,NA,359,temsirolimus,3,400,mg,1,weekly in 28-day cycles,NA
23519998,NA,359,sorafenib,3,25,mg,2,daily in 28-day cycles,NA
23519998,NA,359,temsirolimus,-1,200,mg,1,weekly in 28-day cycles,NA
23519998,NA,359,sorafenib,-1,10,mg,2,daily in 28-day cycles,NA
23519998,NA,359,temsirolimus,-2,200,mg,1,weekly in 28-day cycles,NA
23519998,NA,359,sorafenib,-2,20,mg,1,daily in 28-day cycles,NA
25145500,NA,360,temozolomide,1,200,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,1,200,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,2,400,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,2,400,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,3,800,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,3,800,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,4,1600,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,4,1600,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,5,3200,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,5,3200,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,6,3600,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
25145500,NA,360,temozolomide,6,3600,mg/m2,1,multiplied by 0.09 upper extremity or 0.18 lower extremity,NA
23554030,NCT01076530,361,vorinostat,1,230,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,1,150,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,1,150,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,vorinostat,2,300,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,2,150,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,2,150,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,vorinostat,3,300,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,3,200,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
23554030,NCT01076530,361,temozolomide,3,200,mg/m2,1,on Days 1–5 of each 28-day cycles,NA
28295182,NCT01403415,362,temsirolimus,1,10,mg/m2,1,"on days 1, 8, and 15 for a single 36-day cycle",NA
28295182,NCT01403415,362,dexamethasone,1,20,mg/m2,1,on days 1-5 and 15-19 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,1,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,1,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,mitoxantrone,1,10,mg/m2,1,days 1-2 for a single 36-day cycle,NA
28295182,NCT01403415,362,pegaspargase,1,1000,u/m2,1,on days 3 and 17 for a single 36-day cycle,NA
28295182,NCT01403415,362,vincristine,1,1.5,mg/m2,1,"on days 1, 8, 15, and 22 for a single 36-day cycle",NA
28295182,NCT01403415,362,temsirolimus,2,15,mg/m2,1,"on days 1, 8, and 15 for a single 36-day cycle",NA
28295182,NCT01403415,362,dexamethasone,2,20,mg/m2,1,on days 1-5 and 15-19 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,2,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,2,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,mitoxantrone,2,10,mg/m2,1,days 1-2 for a single 36-day cycle,NA
28295182,NCT01403415,362,pegaspargase,2,1000,u/m2,1,on days 3 and 17 for a single 36-day cycle,NA
28295182,NCT01403415,362,vincristine,2,1.5,mg/m2,1,"on days 1, 8, 15, and 22 for a single 36-day cycle",NA
28295182,NCT01403415,362,temsirolimus,3,15,mg/m2,1,"on days 1, 8, and 15 for a single 36-day cycle",NA
28295182,NCT01403415,362,dexamethasone,3,20,mg/m2,1,on days 1-5 and 15-19 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,3,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,3,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,mitoxantrone,3,10,mg/m2,1,days 1-2 for a single 36-day cycle,NA
28295182,NCT01403415,362,pegaspargase,3,1000,u/m2,1,on days 3 and 17 for a single 36-day cycle,NA
28295182,NCT01403415,362,vincristine,3,1.5,mg/m2,1,"on days 1, 8, 15, and 22 for a single 36-day cycle",NA
28295182,NCT01403415,362,temsirolimus,-1,7.5,mg/m2,1,"on days 1, and 8 for a single 36-day cycle",NA
28295182,NCT01403415,362,dexamethasone,-1,20,mg/m2,1,on days 1-5 and 15-19 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,-1,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,-1,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,mitoxantrone,-1,10,mg/m2,1,days 1-2 for a single 36-day cycle,NA
28295182,NCT01403415,362,pegaspargase,-1,1000,u/m2,1,on days 3 and 17 for a single 36-day cycle,NA
28295182,NCT01403415,362,vincristine,-1,1.5,mg/m2,1,"on days 1, 8, 15, and 22 for a single 36-day cycle",NA
28295182,NCT01403415,362,temsirolimus,0,7.5,mg/m2,1,"on days 1, 8, and 15 for a single 36-day cycle",NA
28295182,NCT01403415,362,dexamethasone,0,20,mg/m2,1,on days 1-5 and 15-19 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,0,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,methotrexate,0,1000,mg/m2,1,up to 72 hours prior to or on day 1 and on day 8 for a single 36-day cycle,NA
28295182,NCT01403415,362,mitoxantrone,0,10,mg/m2,1,days 1-2 for a single 36-day cycle,NA
28295182,NCT01403415,362,pegaspargase,0,1000,u/m2,1,on days 3 and 17 for a single 36-day cycle,NA
28295182,NCT01403415,362,vincristine,0,1.5,mg/m2,1,"on days 1, 8, 15, and 22 for a single 36-day cycle",NA
26235333,NA,363,tpi 287,1,90,mg/m2,1,"on days 1, 8, and 15 of a 28 day cycle",NA
26235333,NA,363,tpi 287,2,110,mg/m2,1,"on days 1, 8, and 15 of a 28 day cycle",NA
26235333,NA,363,tpi 287,3,125,mg/m2,1,"on days 1, 8, and 15 of a 28 day cycle",NA
26235333,NA,363,tpi 287,4,135,mg/m2,1,"on days 1, 8, and 15 of a 28 day cycle",NA
25467181,NA,365,cixutumumab,1,6,mg/kg,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,temsirolimus,1,15,mg/m2,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,cixutumumab,0,6,mg/kg,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,temsirolimus,0,10,mg/m2,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,cixutumumab,-1,4,mg/kg,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,temsirolimus,-1,8,mg/m2,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,cixutumumab,-0.5,6,mg/kg,1,once every 7 days in 28-day cycles,NA
25467181,NA,365,temsirolimus,-0.5,8,mg/m2,1,once every 7 days in 28-day cycles,NA
24194293,NA,366,nelfinavir,1,625,mg,2,daily starting 7–10 days prior to chemoradiotherapy continuing for the duration of chemoradiation for6 weeks,NA
24194293,NA,366,nelfinavir,1,625,mg,2,daily starting 7–10 days prior to chemoradiotherapy continuing for the duration of chemoradiation for6 weeks,NA
24194293,NA,366,temozolomide,1,75,mg/m2,1,daily starting on the first day of radiation and ending on the last day of radiation,NA
24194293,NA,366,temozolomide,1,75,mg/m2,1,daily starting on the first day of radiation and ending on the last day of radiation,NA
24194293,NA,366,radiotherapy,1,6000,cGy,NA,in 30 fractions in 6 weeks,NA
24194293,NA,366,nelfinavir,2,1250,mg,2,daily starting 7–10 days prior to chemoradiotherapy continuing for the duration of chemoradiation for6 weeks,NA
24194293,NA,366,nelfinavir,2,1250,mg,2,daily starting 7–10 days prior to chemoradiotherapy continuing for the duration of chemoradiation for6 weeks,NA
24194293,NA,366,temozolomide,2,75,mg/m2,1,daily starting on the first day of radiation and ending on the last day of radiation,NA
24194293,NA,366,temozolomide,2,75,mg/m2,1,daily starting on the first day of radiation and ending on the last day of radiation,NA
24194293,NA,366,radiotherapy,2,6000,cGy,NA,in 30 fractions in 6 weeks,NA
28004284,NA,367,tivantinib,-1,120,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,-1,15,mg,1,weekly every 28 days,NA
28004284,NA,367,tivantinib,1,120,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,1,20,mg,1,weekly every 28 days,NA
28004284,NA,367,tivantinib,2,240,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,2,20,mg,1,weekly every 28 days,NA
28004284,NA,367,tivantinib,3,360,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,3,20,mg,1,weekly every 28 days,NA
28004284,NA,367,tivantinib,4,360,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,4,25,mg,1,weekly every 28 days,NA
28004284,NA,367,tivantinib,5,480,mg,2,daily continuously,NA
28004284,NA,367,temsirolimus,5,25,mg,1,weekly every 28 days,NA
11302252,NA,368,bcnu,1,50,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,1,175,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,1,175,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,bcnu,2,75,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,2,275,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,2,275,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,bcnu,3,100,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,3,400,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,3,400,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,bcnu,4,150,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,4,550,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,4,550,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,bcnu,5,200,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,5,750,mg/m2,1,on day 1 of a 42-day cycle,NA
11302252,NA,368,temozolomide,5,750,mg/m2,1,on day 1 of a 42-day cycle,NA
26686201,NA,369,trebaninib,1,15,mg/kg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
26686201,NA,369,temsirolimus,1,25,mg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
26686201,NA,369,trebaninib,-1,15,mg/kg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
26686201,NA,369,temsirolimus,-1,20,mg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
26686201,NA,369,trebaninib,-2,10,mg/kg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
26686201,NA,369,temsirolimus,-2,20,mg,1,"on Day 1, 8, 15 and 22 of a 28-day cycle",NA
16134182,NA,370,temozolomide,1,100,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,1,100,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,2,140,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,2,140,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,3,180,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,3,180,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,4,220,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,4,220,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,5,250,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,5,250,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,6,300,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,6,300,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,7,360,mg,1,5 of every7 days continuously at 28-day intervals,NA
16134182,NA,370,temozolomide,7,360,mg,1,5 of every7 days continuously at 28-day intervals,NA
21735117,NA,371,sch 66336,1,75,mg,2,daily,stratum A
21735117,NA,371,temozolomide,1,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,temozolomide,1,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,sch 66336,2,100,mg,2,daily,stratum A
21735117,NA,371,temozolomide,2,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,temozolomide,2,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,sch 66336,3,150,mg,2,daily,stratum A
21735117,NA,371,temozolomide,3,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,temozolomide,3,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,sch 66336,4,200,mg,2,daily,stratum A
21735117,NA,371,temozolomide,4,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,temozolomide,4,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",stratum A
21735117,NA,371,sch 66336,1,125,mg,2,daily,Stratum B
21735117,NA,371,temozolomide,1,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,temozolomide,1,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,sch 66336,2,175,mg,2,daily,Stratum B
21735117,NA,371,temozolomide,2,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,temozolomide,2,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,sch 66336,3,250,mg,2,daily,Stratum B
21735117,NA,371,temozolomide,3,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,temozolomide,3,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,sch 66336,4,300,mg,2,daily,Stratum B
21735117,NA,371,temozolomide,4,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
21735117,NA,371,temozolomide,4,150/200,mg/m2,1,"150 mg/m2 daily for 5 days for the first 28-day cycle and escalated to 200 mg/m2 daily for 5 days every 28 days, during subsequent cycles if tolerated (no grade 3 or 4 toxicity).",Stratum B
23605083,NA,372,cixutumumab,1,3,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,1,25,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,2,5,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,2,25,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,3,6,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,3,25,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,-1,3,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,-1,20,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,-2,3,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,-2,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,-2A,4,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,-2A,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,cixutumumab,-2B,5,mg/kg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
23605083,NA,372,temsirolimus,-2B,15,mg,1,"on days 1, 8, 15, and 22 of a 28-day cycle",NA
20934264,NA,373,tipifarnib,1,200,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A
20934264,NA,373,conventional radiotherapy,1,2,Gy,1,to a planned total dose of 60 Gy,Group A
20934264,NA,373,tipifarnib,2,300,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A
20934264,NA,373,conventional radiotherapy,2,2,Gy,1,to a planned total dose of 60 Gy,Group A
20934264,NA,373,tipifarnib,3,400,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A
20934264,NA,373,conventional radiotherapy,3,2,Gy,1,to a planned total dose of 60 Gy,Group A
20934264,NA,373,tipifarnib,-1,100,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A
20934264,NA,373,conventional radiotherapy,-1,2,Gy,1,to a planned total dose of 60 Gy,Group A
20934264,NA,373,tipifarnib,-2,100,mg,1,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A
20934264,NA,373,conventional radiotherapy,-2,2,Gy,1,to a planned total dose of 60 Gy,Group A
20934264,NA,373,tipifarnib,-2,200,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group B
20934264,NA,373,conventional radiotherapy,-2,2,Gy,1,to a planned total dose of 60 Gy,Group B
20934264,NA,373,tipifarnib,-1,300,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group B
20934264,NA,373,conventional radiotherapy,-1,2,Gy,1,to a planned total dose of 60 Gy,Group B
20934264,NA,373,tipifarnib,1,400,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group B
20934264,NA,373,conventional radiotherapy,1,2,Gy,1,to a planned total dose of 60 Gy,Group B
20934264,NA,373,tipifarnib,2,500,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group B
20934264,NA,373,conventional radiotherapy,2,2,Gy,1,to a planned total dose of 60 Gy,Group B
20934264,NA,373,tipifarnib,3,600,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group B
20934264,NA,373,conventional radiotherapy,3,2,Gy,1,to a planned total dose of 60 Gy,Group B
20934264,NA,374,tipifarnib,-2,100,mg,1,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A + TMZ
20934264,NA,374,conventional radiotherapy,-2,2,Gy,1,to a planned total dose of 60 Gy,Group A + TMZ
20934264,NA,374,temozolomide,-2,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,temozolomide,-2,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,tipifarnib,-1,100,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A + TMZ
20934264,NA,374,conventional radiotherapy,-1,2,Gy,1,to a planned total dose of 60 Gy,Group A + TMZ
20934264,NA,374,temozolomide,-1,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,temozolomide,-1,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,tipifarnib,1,200,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A + TMZ
20934264,NA,374,conventional radiotherapy,1,2,Gy,1,to a planned total dose of 60 Gy,Group A + TMZ
20934264,NA,374,temozolomide,1,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,temozolomide,1,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,tipifarnib,2,300,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A + TMZ
20934264,NA,374,conventional radiotherapy,2,2,Gy,1,to a planned total dose of 60 Gy,Group A + TMZ
20934264,NA,374,temozolomide,2,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,temozolomide,2,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,tipifarnib,3,400,mg,2,daily for 21 days followed by 7 days off in repeating 28-day cycles. The first dose of tipifarnib was given 5 to 9 days before starting radiation or chemoradiation,Group A + TMZ
20934264,NA,374,conventional radiotherapy,3,2,Gy,1,to a planned total dose of 60 Gy,Group A + TMZ
20934264,NA,374,temozolomide,3,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
20934264,NA,374,temozolomide,3,75,mg/m2,1,"daily starting the first day of radiotherapy, and stopped the night before the last fraction of radiotherapy",Group A + TMZ
24908656,NA,375,veliparib,1,20,mg/m2,2,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,1,180,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,1,180,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,veliparib,0,15,mg/m2,2,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,0,180,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,0,180,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,veliparib,-1,15,mg/m2,2,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,-1,150,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,-1,150,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,veliparib,1A,20,mg/m2,2,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,1A,135,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,1A,135,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,veliparib,2A,25,mg/m2,2,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,2A,135,mg/m2,1,on days 1–5 of each 28-day course,NA
24908656,NA,375,temozolomide,2A,135,mg/m2,1,on days 1–5 of each 28-day course,NA
23860641,NCT 01198184,377,ro4929097,1,10,mg,1,"For cycle 1 only (28 days), given starting at cycle 1 day 8, using the 3/4 schedule (i.e. 3-days on/4-days off);  From cycle 2 onwards, on days 1-3, 8-10, and 15-17 every 21 days",NA
23860641,NCT 01198184,377,temsirolimus,1,25,mg,1,"For cycle 1 (28 days) only, given on days 1, 8, 15 and 22; from cycle 2 onwards, on days 1, 8, and 15 every 21 days",NA
23860641,NCT 01198184,377,ro4929097,2,20,mg,1,"For cycle 1 only (28 days), given starting at cycle 1 day 8, using the 3/4 schedule (i.e. 3-days on/4-days off);  From cycle 2 onwards, on days 1-3, 8-10, and 15-17 every 21 days",NA
23860641,NCT 01198184,377,temsirolimus,2,25,mg,1,"For cycle 1 (28 days) only, given on days 1, 8, 15 and 22; from cycle 2 onwards, on days 1, 8, and 15 every 21 days",NA
23860641,NCT 01198184,377,ro4929097,3,20,mg,1,"For cycle 1 only (28 days), given starting at cycle 1 day 8, using the 3/4 schedule (i.e. 3-days on/4-days off);  From cycle 2 onwards, on days 1-3, 8-10, and 15-17 every 21 days",NA
23860641,NCT 01198184,377,temsirolimus,3,37.5,mg,1,"For cycle 1 (28 days) only, given on days 1, 8, 15 and 22; from cycle 2 onwards, on days 1, 8, and 15 every 21 days",NA
15014015,NA,378,bcnu,1,55,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,1,35,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,1,35,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,2,75,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,2,55,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,2,55,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,3,100,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,3,80,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,3,80,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,4,150,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,4,110,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,4,110,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,5,200,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,5,150,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,5,150,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,6,240,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq B->T
15014015,NA,378,temozolomide,6,180,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,temozolomide,6,180,mg/m2,1,on days 1-5 every 6 weeks,on Seq B->T
15014015,NA,378,bcnu,-1,37,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,-1,26,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,-1,26,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,bcnu,1,55,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,1,35,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,1,35,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,bcnu,2,75,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,2,55,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,2,55,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,bcnu,3,100,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,3,80,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,3,80,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,bcnu,4,150,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,4,110,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,4,110,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,bcnu,5,200,mg/m2,1,"on day 1, 2 h before, and on day 5, 2 h after TEM every 6 weeks",on Seq T->B
15014015,NA,378,temozolomide,5,150,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
15014015,NA,378,temozolomide,5,150,mg/m2,1,on days 1-5 every 6 weeks,on Seq T->B
20156802,NA,379,enzastaurin,1,250,mg,1,daily before the first dose of RT to the night before the last dose of RT,NA
20156802,NA,379,temozolomide,1,75,mg/m2,1,daily before the first dose of RT to the night before the last dose of RT,fixed
20156802,NA,379,temozolomide,1,75,mg/m2,1,daily before the first dose of RT to the night before the last dose of RT,fixed
20156802,NA,379,radiation therapy,1,1.8 –2.0,Gy,1,for 5 d/wk (1.8 –2.0 Gy X 30 fractions) for 6 weeks,fixed
20156802,NA,379,enzastaurin,2,500,mg,1,daily before the first dose of RT to the night before the last dose of RT,NA
20156802,NA,379,temozolomide,2,75,mg/m2,1,daily before the first dose of RT to the night before the last dose of RT,fixed
20156802,NA,379,temozolomide,2,75,mg/m2,1,daily before the first dose of RT to the night before the last dose of RT,fixed
20156802,NA,379,radiation therapy,2,1.8 –2.0,Gy,1,for 5 d/wk (1.8 –2.0 Gy X 30 fractions) for 6 weeks,fixed
24880570,NA,380,cep-9722,1,150,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,1,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,1,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,cep-9722,2,300,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,2,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,2,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,cep-9722,3,500,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,3,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,3,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,cep-9722,4,750,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,4,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,4,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,cep-9722,5,750,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,5,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,5,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,cep-9722,6,1000,mg,1,"on days 1–5 in cycle 1 (14 days), on days 1-5 in cycle 2 (28 days)",NA
24880570,NA,380,temozolomide,6,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
24880570,NA,380,temozolomide,6,150,mg/m2,1,on days 1-5 in cycle 2 (28 days),fixed
23633392,NA,381,lonafarnib,1,100,mg,2,days 8 through 14 and days 22 through 28 of each 28-day course of therapy,NA
23633392,NA,381,temozolomide,1,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
23633392,NA,381,temozolomide,1,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
23633392,NA,381,lonafarnib,2,150,mg,2,days 8 through 14 and days 22 through 28 of each 28-day course of therapy,NA
23633392,NA,381,temozolomide,2,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
23633392,NA,381,temozolomide,2,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
23633392,NA,381,lonafarnib,3,200,mg,2,days 8 through 14 and days 22 through 28 of each 28-day course of therapy,NA
23633392,NA,381,temozolomide,3,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
23633392,NA,381,temozolomide,3,150,mg/m2,1,days 1 through 7 and days 15 through 21 of each 28-day course of therapy,fixed
25832688,NA,382,temozolomide,1,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,temozolomide,1,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,motexafin gadolinium,1,3,mg/kg,1,"Starting on the first day of RT, MGd was given intravenously over 30 minutes on Monday through Friday during weeks 1 and 2 of RT plusTMZ (RT-TMZ) therapy, then 3 times weekly (Monday, Wednesday, and Friday) during weeks 3 through 6 for a total of 22 doses",NA
25832688,NA,382,radiation therapy,1,2,Gy,1,5 days weekly to a total dose of 60 Gy over 6 weeks,fixed
25832688,NA,382,temozolomide,2,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,temozolomide,2,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,motexafin gadolinium,2,4,mg/kg,1,"Starting on the first day of RT, MGd was given intravenously over 30 minutes on Monday through Friday during weeks 1 and 2 of RT plusTMZ (RT-TMZ) therapy, then 3 times weekly (Monday, Wednesday, and Friday) during weeks 3 through 6 for a total of 22 doses",NA
25832688,NA,382,radiation therapy,2,2,Gy,1,5 days weekly to a total dose of 60 Gy over 6 weeks,fixed
25832688,NA,382,temozolomide,3,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,temozolomide,3,75,mg/m2,1,"during RT for a maximum of 42 consecutive days, beginning the night before the first radiation treatment and ending the night before the last radiation treatment",fixed
25832688,NA,382,motexafin gadolinium,3,5,mg/kg,1,"Starting on the first day of RT, MGd was given intravenously over 30 minutes on Monday through Friday during weeks 1 and 2 of RT plusTMZ (RT-TMZ) therapy, then 3 times weekly (Monday, Wednesday, and Friday) during weeks 3 through 6 for a total of 22 doses",NA
25832688,NA,382,radiation therapy,3,2,Gy,1,5 days weekly to a total dose of 60 Gy over 6 weeks,fixed
26503473,NCT00121680,383,lenvatinib,1,20,mg,1,daily in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,1,100,mg/m2,1,days 1–5 in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,1,100,mg/m2,1,days 1–5 in 28-day cycles,NA
26503473,NCT00121680,383,lenvatinib,2,24,mg,1,daily in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,2,100,mg/m2,1,days 1–5 in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,2,100,mg/m2,1,days 1–5 in 28-day cycles,NA
26503473,NCT00121680,383,lenvatinib,3,24,mg,1,daily in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,3,150,mg/m2,1,days 1–5 in 28-day cycles,NA
26503473,NCT00121680,383,temozolomide,3,150,mg/m2,1,days 1–5 in 28-day cycles,NA
10561328,NA,384,temozolomide,1,100,mg/m2,1,daily for 5 consecutive days every 28 days,NA
10561328,NA,384,temozolomide,1,100,mg/m2,1,daily for 5 consecutive days every 28 days,NA
10561328,NA,384,temozolomide,2,150,mg/m2,1,daily for 5 consecutive days every 28 days,NA
10561328,NA,384,temozolomide,2,150,mg/m2,1,daily for 5 consecutive days every 28 days,NA
10561328,NA,384,temozolomide,3,200,mg/m2,1,daily for 5 consecutive days every 28 days,NA
10561328,NA,384,temozolomide,3,200,mg/m2,1,daily for 5 consecutive days every 28 days,NA
32293798,NCT01051557,385,temsirolimus,1,15,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,1,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,2,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,2,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,3,50,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,3,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,4,75,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,4,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,5,115,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,5,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,6,170,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,6,600 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
32293798,NCT01051557,385,temsirolimus,7,170,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
32293798,NCT01051557,385,perifosine,7,900 (day 1)/100 (starting day 2),mg,1,on days 1-28 every 28 days,NA
25374407,NA,386,temsirolimus,1,20,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
25374407,NA,386,vinorelbine,1,20,mg/m2,1,on days 1 and 15 every 28 days,NA
25374407,NA,386,temsirolimus,2,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
25374407,NA,386,vinorelbine,2,20,mg/m2,1,on days 1 and 15 every 28 days,NA
25374407,NA,386,temsirolimus,3,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
25374407,NA,386,vinorelbine,3,25,mg/m2,1,on days 1 and 15 every 28 days,NA
25374407,NA,386,temsirolimus,4,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
25374407,NA,386,vinorelbine,4,30,mg/m2,1,on days 1 and 15 every 28 days,NA
10576660,NA,387,temozolomide,1,500,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,1,500,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,2,750,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,2,750,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,3,1000,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,3,1000,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,4,1250,mg/m2,1,daily for 5 days every 28 days,NA
10576660,NA,387,temozolomide,4,1250,mg/m2,1,daily for 5 days every 28 days,NA
26285766,NA,388,iniparib,1,5.1,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,1,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,1,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,2,6.1,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,2,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,2,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,3,6.8,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,3,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,3,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,4,8,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,4,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,4,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,5,8.6,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,5,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,5,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,6,9.5,mg/kg,1,"on two consecutive days weekly (weeks 1–4 with mTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,6,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,temozolomide,6,150/200,mg/m2,1,150 mg/m2 in cycle 1 and 200 mg/m2 in cycles 2–6 on days 1–5 of each of six 4-week cycles,fixed mTMZ
26285766,NA,388,iniparib,1,5.1,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,1,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,1,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,iniparib,2,6.1,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,2,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,2,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,iniparib,3,6.8,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,3,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,3,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,iniparib,4,8,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,4,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,4,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,iniparib,5,8.6,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,5,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,5,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,iniparib,6,9.5,mg/kg,1,"on two consecutive days weekly (weeks 1–6 with cTMZ, beginning with day 1 of TMZ",NA
26285766,NA,388,temozolomide,6,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
26285766,NA,388,temozolomide,6,150/200,mg/m2,1,daily for 6 weeks of each of three 10-weekcycles,fixed cTMZ
24323026,NCT00838539,389,neratinib,1,160,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,1,15,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,2,120,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,2,25,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,3,120,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,3,50,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,4,120,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,4,75,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,5,160,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,5,15,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,6,160,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,6,25,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,7,160,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,7,50,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,8,160,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,8,75,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,9,200,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,9,15,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,10,200,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,10,25,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,11,200,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,11,50,mg,1,once-weekly on a 28-day cycle,NA
24323026,NCT00838539,389,neratinib,12,240,mg,1,daily on a 28-day cycle,NA
24323026,NCT00838539,389,temsirolimus,12,15,mg,1,once-weekly on a 28-day cycle,NA
16234526,NA,390,o6-benzylguanine,1,60,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,1,28,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,1,28,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,2,90,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,2,28,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,2,28,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,3,120,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,3,29,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,3,29,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,4,120,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,4,40,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,4,40,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,5,120,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,5,55,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,5,55,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,6,120,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,6,75,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,6,75,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,o6-benzylguanine,7,120,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,7,100,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
16234526,NA,390,temozolomide,7,100,mg/m2,1,"on a daily schedule for 5 consecutive days, every 28 days",NA
20511167,NA,391,temozolomide,1,200,mg,2,daily for 5 doses,NA
20511167,NA,391,temozolomide,1,200,mg,2,daily for 5 doses,NA
20511167,NA,391,laromustine,1,100,mg/m2,1,on day 3,NA
20511167,NA,391,temozolomide,2,300,mg,2,daily for 5 doses,NA
20511167,NA,391,temozolomide,2,300,mg,2,daily for 5 doses,NA
20511167,NA,391,laromustine,2,100,mg/m2,1,on day 3,NA
20511167,NA,391,temozolomide,3,300,mg,2,daily for 5 doses,NA
20511167,NA,391,temozolomide,3,300,mg,2,daily for 5 doses,NA
20511167,NA,391,laromustine,3,200,mg/m2,1,on day 3,NA
20511167,NA,391,temozolomide,4,300,mg,2,daily for 5 doses,NA
20511167,NA,391,temozolomide,4,300,mg,2,daily for 5 doses,NA
20511167,NA,391,laromustine,4,300,mg/m2,1,on day 3,NA
20511167,NA,391,temozolomide,5,300,mg,2,daily for 5 doses,NA
20511167,NA,391,temozolomide,5,300,mg,2,daily for 5 doses,NA
20511167,NA,391,laromustine,5,400,mg/m2,1,on day 3,NA
9738573,NA,392,temozolomide,1,100,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,1,100,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,2,150,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,2,150,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,3,180,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,3,180,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,4,215,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,4,215,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,5,245,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,5,245,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,6,260,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9738573,NA,392,temozolomide,6,260,mg/m2,1,"daily for 5 days, with subsequent courses administered every 21 to 28 days",NA
9744506,NA,393,temozolomide,1,500,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,1,500,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,2,600,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,2,600,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,3,800,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,3,800,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,4,1000,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,4,1000,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,5,1200,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
9744506,NA,393,temozolomide,5,1200,mg/m2,1,on 5 consecutive days per 28-day cycle,NA
28618305,NA,394,temsirolimus,1,15,mg,1,once weekly every 4 weeks,NA
28618305,NA,394,cetuximab,1,150,mg,1,"a single bolus of 400 mg/m2 on day -7, then once weekly every 4 weeks",NA
28618305,NA,394,temsirolimus,2,15,mg,1,once weekly every 4 weeks,NA
28618305,NA,394,cetuximab,2,200,mg,1,"a single bolus of 400 mg/m2 on day -7, then once weekly every 4 weeks",NA
28618305,NA,394,temsirolimus,3,20,mg,1,once weekly every 4 weeks,NA
28618305,NA,394,cetuximab,3,200,mg,1,"a single bolus of 400 mg/m2 on day -7, then once weekly every 4 weeks",NA
28618305,NA,394,temsirolimus,4,20,mg,1,once weekly every 4 weeks,NA
28618305,NA,394,cetuximab,4,250,mg,1,"a single bolus of 400 mg/m2 on day -7, then once weekly every 4 weeks",NA
28618305,NA,394,temsirolimus,5,25,mg,1,once weekly every 4 weeks,NA
28618305,NA,394,cetuximab,5,250,mg,1,"a single bolus of 400 mg/m2 on day -7, then once weekly every 4 weeks",NA
21881915,NA,395,ekb-569,-2,10,mg,1,days 1–28 using a 28-day cycle,Cohort A1
21881915,NA,395,temsirolimus,-2,15,mg,1,"days 1–7, 15–21 using a 28-day cycle",Cohort A1
21881915,NA,395,ekb-569,-1,20,mg,1,days 1–28 using a 28-day cycle,Cohort A1
21881915,NA,395,temsirolimus,-1,15,mg,1,"days 1–7, 15–21 using a 28-day cycle",Cohort A1
21881915,NA,395,ekb-569,0,25,mg,1,days 1–28 using a 28-day cycle,Cohort A1
21881915,NA,395,temsirolimus,0,20,mg,1,"days 1–7, 15–21 using a 28-day cycle",Cohort A1
21881915,NA,395,ekb-569,1,35,mg,1,days 1–28 using a 28-day cycle,Cohort A1
21881915,NA,395,temsirolimus,1,25,mg,1,"days 1–7, 15–21 using a 28-day cycle",Cohort A1
21881915,NA,395,ekb-569,0,10,mg,1,days 1–28 using a 28-day cycle,Cohort A2
21881915,NA,395,temsirolimus,0,30,mg,1,"days 1–3, 15–17 using a 28-day cycle",Cohort A2
21881915,NA,395,ekb-569,1,20,mg,1,days 1–28 using a 28-day cycle,Cohort A2
21881915,NA,395,temsirolimus,1,30,mg,1,"days 1–3, 15–17 using a 28-day cycle",Cohort A2
21881915,NA,395,ekb-569,2,25,mg,1,days 1–28 using a 28-day cycle,Cohort A2
21881915,NA,395,temsirolimus,2,30,mg,1,"days 1–3, 15–17 using a 28-day cycle",Cohort A2
21881915,NA,395,ekb-569,3,35,mg,1,days 1–28 using a 28-day cycle,Cohort A2
21881915,NA,395,temsirolimus,3,30,mg,1,"days 1–3, 15–17 using a 28-day cycle",Cohort A2
21881915,NA,395,ekb-569,4,45,mg,1,days 1–28 using a 28-day cycle,Cohort A2
21881915,NA,395,temsirolimus,4,30,mg,1,"days 1–3, 15–17 using a 28-day cycle",Cohort A2
30393943,NA,396,vinblastine,1,4,mg/m2,1,once weekly over a 6-week cycle,NA
30393943,NA,396,temsirolimus,1,15,mg/m2,1,once weekly over a 6-week cycle,NA
30393943,NA,396,vinblastine,-2,4,mg/m2,1,once weekly over a 6-week cycle,NA
30393943,NA,396,temsirolimus,-2,10,mg/m2,1,once weekly over a 6-week cycle,NA
22923449,NCT00268385,397,vorinostat,1,200,mg,2,on days 1–14 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,1,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,1,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,vorinostat,2,300,mg,2,on days 1–14 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,2,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,2,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,vorinostat,2.5,200,mg,3,on days 1–14 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,2.5,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,2.5,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,vorinostat,-1,300,mg,1,on days 1–14 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,-1,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,temozolomide,-1,150,mg/m2,1,on days 1–5 of every 28 days,Part 1A
22923449,NCT00268385,397,vorinostat,1,400,mg,1,on days 1–7 and 14–21 of every 28 days,Part 1B
22923449,NCT00268385,397,temozolomide,1,150,mg/m2,1,on days 1–5of every 28 days,Part 1B
22923449,NCT00268385,397,temozolomide,1,150,mg/m2,1,on days 1–5of every 28 days,Part 1B
22923449,NCT00268385,397,vorinostat,2,500,mg,1,on days 1–7 and 14–21 of every 28 days,Part 1B
22923449,NCT00268385,397,temozolomide,2,150,mg/m2,1,on days 1–5of every 28 days,Part 1B
22923449,NCT00268385,397,temozolomide,2,150,mg/m2,1,on days 1–5of every 28 days,Part 1B
22923449,NCT00268385,397,vorinostat,1,400,mg,1,on days 1–7 and 14–21 of every 28 days,Part 2
22923449,NCT00268385,397,temozolomide,1,150/200,mg/m2,1,150 mg/m2 on days 1–5 of first 28 day cycle and 200 mg/m2 on days 1–5 of subsequent 28-day cycle,Part 2
22923449,NCT00268385,397,temozolomide,1,150/200,mg/m2,1,150 mg/m2 on days 1–5 of first 28 day cycle and 200 mg/m2 on days 1–5 of subsequent 28-day cycle,Part 2
22923449,NCT00268385,397,vorinostat,2,500,mg,1,on days 1–7 and 14–21 of every 28 days,Part 2
22923449,NCT00268385,397,temozolomide,2,150/200,mg/m2,1,150 mg/m2 on days 1–5 of first 28 day cycle and 200 mg/m2 on days 1–5 of subsequent 28-day cycle,Part 2
22923449,NCT00268385,397,temozolomide,2,150/200,mg/m2,1,150 mg/m2 on days 1–5 of first 28 day cycle and 200 mg/m2 on days 1–5 of subsequent 28-day cycle,Part 2
21750201,NA,398,cixutumumab,1,3,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,temsirolimus,1,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,cixutumumab,2,5,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,temsirolimus,2,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,cixutumumab,3,6,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,temsirolimus,3,25,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,cixutumumab,4,6,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
21750201,NA,398,temsirolimus,4,37.5,mg,1,"on days 1, 8, 15, and 22 every 28 days",NA
24991839,NA,399,hydroxychloroquine,1,100,mg,2,daily in 28-day cycles,NA
24991839,NA,399,hydroxychloroquine,1,100,mg,2,daily in 28-day cycles,NA
24991839,NA,399,temozolomide,1,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,temozolomide,1,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,hydroxychloroquine,2,200,mg,2,daily in 28-day cycles,NA
24991839,NA,399,hydroxychloroquine,2,200,mg,2,daily in 28-day cycles,NA
24991839,NA,399,temozolomide,2,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,temozolomide,2,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,hydroxychloroquine,3,400,mg,2,daily in 28-day cycles,NA
24991839,NA,399,hydroxychloroquine,3,400,mg,2,daily in 28-day cycles,NA
24991839,NA,399,temozolomide,3,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,temozolomide,3,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,hydroxychloroquine,4,500,mg,2,daily in 28-day cycles,NA
24991839,NA,399,hydroxychloroquine,4,500,mg,2,daily in 28-day cycles,NA
24991839,NA,399,temozolomide,4,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,temozolomide,4,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,hydroxychloroquine,5,600,mg,2,daily in 28-day cycles,NA
24991839,NA,399,hydroxychloroquine,5,600,mg,2,daily in 28-day cycles,NA
24991839,NA,399,temozolomide,5,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
24991839,NA,399,temozolomide,5,150,mg/m2,1,daily from day 8 to day 16 in 28-day cycles,fixed
28194539,NCT01378377,400,pimasertib,1,45,mg,1,on Days 1 to 15 in a 21-day cycle,NA
28194539,NCT01378377,400,temsirolimus,1,12.5,mg,1,once weekly in a 21-day cycle,NA
28194539,NCT01378377,400,pimasertib,2,45,mg,1,on Days 1 to 15 in a 21-day cycle,NA
28194539,NCT01378377,400,temsirolimus,2,25,mg,1,once weekly in a 21-day cycle,NA
28194539,NCT01378377,400,pimasertib,3,75,mg,1,on Days 1 to 15 in a 21-day cycle,NA
28194539,NCT01378377,400,temsirolimus,3,25,mg,1,once weekly in a 21-day cycle,NA
18006772,NA,401,temozolomide,1,267,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,1,267,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,1,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
18006772,NA,401,temozolomide,2,355,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,2,355,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,2,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
18006772,NA,401,temozolomide,3,472,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,3,472,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,3,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
18006772,NA,401,temozolomide,4,628,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,4,628,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,4,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
18006772,NA,401,temozolomide,5,835,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,5,835,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,5,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
18006772,NA,401,temozolomide,6,1111,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,temozolomide,6,1111,mg/m2,1,at least 6 h after completion of O6-benzylguanine bolus. Treatment was repeated at least 4weeks apart,NA
18006772,NA,401,o6-benzylguanine,6,120/30,mg/m2/d,1,i.v. as a 1-h bolus of 120 mg/m2 followed by 48-h continuous infusion at 30 mg/m2/day. Treatment was repeated at least 4weeks apart,fixed
19289491,NA,402,temozolomide,1,25,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,temozolomide,1,25,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,o6-benzylguanine,1,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 1
19289491,NA,402,temozolomide,2,50,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,temozolomide,2,50,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,o6-benzylguanine,2,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 1
19289491,NA,402,temozolomide,3,75,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,temozolomide,3,75,mg/m2,1,on day 1 at 200 mg/m2 and a dose of25 mg/m2/day on days 2–5 of a 28-day treatment cycle,schedule 1
19289491,NA,402,o6-benzylguanine,3,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 1
19289491,NA,402,temozolomide,1,25,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,temozolomide,1,25,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,o6-benzylguanine,1,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 2
19289491,NA,402,temozolomide,2,50,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,temozolomide,2,50,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,o6-benzylguanine,2,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 2
19289491,NA,402,temozolomide,3,75,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,temozolomide,3,75,mg/m2,1,on days 1–5 of a 28-day treatment cycle,schedule 2
19289491,NA,402,o6-benzylguanine,3,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 2
19289491,NA,402,temozolomide,1,25,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,temozolomide,1,25,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,o6-benzylguanine,1,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 3
19289491,NA,402,temozolomide,2,50,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,temozolomide,2,50,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,o6-benzylguanine,2,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 3
19289491,NA,402,temozolomide,3,75,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,temozolomide,3,75,mg/m2,1,on days 1–5  of a 28-day treatment cycle with pegfilgrastim between days 7 and 14,schedule 3
19289491,NA,402,o6-benzylguanine,3,120/30,mg/m2,1,"on days 1–5 of a 28-day treatment cycle. One-hour 120 mg/m2 bolus on days 1, 3, 5,  A continuous infusion of 30 mg/m2/day was administered immediately following the initial bolus infusion on day 1 and continued until immediately prior to the last bolus infusion.",schedule 3
16192602,NA,403,temozolomide,1,100,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,1,100,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,1,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
16192602,NA,403,temozolomide,2,200,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,2,200,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,2,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
16192602,NA,403,temozolomide,3,267,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,3,267,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,3,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
16192602,NA,403,temozolomide,4,355,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,4,355,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,4,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
16192602,NA,403,temozolomide,5,472,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,5,472,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,5,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
16192602,NA,403,temozolomide,6,628,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,temozolomide,6,628,mg/m2,1,on day 1 every 28 days,NA
16192602,NA,403,o6-benzylguanine,6,120/30,mg/m2,1,"120 mg/m2 over 1 hour IV, followed in the next hour by temozolomide, using a single dose regimen (cycles repeated every 28 days), at an initial dose of 100 mg/m2, followed by a continuous infusion with O6-BG at 30 mg/m2/d for 48 hours.",fixed
20821342,NA,404,vatalanib,1,250,mg,1,"daily, 5 days prior to concomitant radiation and temozolomide and vatalanib was continued daily during chemoradiation",NA
20821342,NA,404,vatalanib,2,250,mg,2,"daily, 5 days prior to concomitant radiation and temozolomide and vatalanib was continued daily during chemoradiation",NA
20821342,NA,404,vatalanib,3,500,mg,2,"daily, 5 days prior to concomitant radiation and temozolomide and vatalanib was continued daily during chemoradiation",NA
20821342,NA,404,vatalanib,4,750,mg,2,"daily, 5 days prior to concomitant radiation and temozolomide and vatalanib was continued daily during chemoradiation",NA
20821342,NA,404,vatalanib,5,1000,mg,2,"daily, 5 days prior to concomitant radiation and temozolomide and vatalanib was continued daily during chemoradiation",NA
25962426,NCT00321594,405,temsirolimus,-2,10,mg,1,"weekly, every 3 weeks",NA
25962426,NCT00321594,405,temsirolimus,-1,15,mg,1,"weekly, every 3 weeks",NA
25962426,NCT00321594,405,temsirolimus,1,20,mg,1,"weekly, every 3 weeks",NA
25962426,NCT00321594,405,temsirolimus,2,25,mg,1,"weekly, every 3 weeks",NA
25962426,NCT00321594,405,temsirolimus,3,30,mg,1,"weekly, every 3 weeks",NA
23726267,NA,406,tivozanib,1,0.5,mg,1,"once daily for 3 weeks, followed by a 1-week break (4 weeks = 1 cycle)",NA
23726267,NA,406,temsirolimus,1,15,mg,1,"once weekly, starting on day 8 of cycle 1 for a minimum of 8 weeks (two cycles",NA
23726267,NA,406,tivozanib,2,1,mg,1,"once daily for 3 weeks, followed by a 1-week break (4 weeks = 1 cycle)",NA
23726267,NA,406,temsirolimus,2,15,mg,1,"once weekly, starting on day 8 of cycle 1 for a minimum of 8 weeks (two cycles",NA
23726267,NA,406,tivozanib,3,1.5,mg,1,"once daily for 3 weeks, followed by a 1-week break (4 weeks = 1 cycle)",NA
23726267,NA,406,temsirolimus,3,15,mg,1,"once weekly, starting on day 8 of cycle 1 for a minimum of 8 weeks (two cycles",NA
23726267,NA,406,tivozanib,4,1.5,mg,1,"once daily for 3 weeks, followed by a 1-week break (4 weeks = 1 cycle)",NA
23726267,NA,406,temsirolimus,4,25,mg,1,"once weekly, starting on day 8 of cycle 1 for a minimum of 8 weeks (two cycles",NA
16899365,NA,407,temozolomide,1,50,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,1,50,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,2,65,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,2,65,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,4,85,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,4,85,mg/m2,1,once daily in the morning for 6 weeks,Heavily pre-treated
16899365,NA,407,temozolomide,3,75,mg/m2,1,once daily in the morning for 6 weeks,Not heavily pre-treated
16899365,NA,407,temozolomide,3,75,mg/m2,1,once daily in the morning for 6 weeks,Not heavily pre-treated
16899365,NA,407,temozolomide,5,100,mg/m2,1,once daily in the morning for 6 weeks,Not heavily pre-treated
16899365,NA,407,temozolomide,5,100,mg/m2,1,once daily in the morning for 6 weeks,Not heavily pre-treated
16614943,NA,408,vinorelbine,1,15,mg/m2,1,on days 1 and 8 of 28-day cycles,NA
16614943,NA,408,temozolomide,1,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,temozolomide,1,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,vinorelbine,2,20,mg/m2,1,on days 1 and 8 of 28-day cycles,NA
16614943,NA,408,temozolomide,2,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,temozolomide,2,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,vinorelbine,3,25,mg/m2,1,on days 1 and 8 of 28-day cycles,NA
16614943,NA,408,temozolomide,3,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,temozolomide,3,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,vinorelbine,4,30,mg/m2,1,on days 1 and 8 of 28-day cycles,NA
16614943,NA,408,temozolomide,4,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
16614943,NA,408,temozolomide,4,150,mg/m2,1,on days 17 and 15-21 of 28-day cycles,fixed
11606103,NA,409,topotecan,1,1.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,1,1.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,2,2,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,2,2,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,3,2.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,3,2.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,4,3,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,4,3,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,5,3.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,5,3.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,6,4,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,6,4,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,7,4.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,7,4.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,8,5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,8,5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,9,5.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,9,5.5,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,10,6,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,10,6,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,11,>6,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
11606103,NA,409,topotecan,11,>6,mg/m2,1,"on Days 0, 7, and 14 every 21 days",NA
21063221,NA,410,nifurtimox,1,20,mg/kg/d,3,daily for 21 days,NA
21063221,NA,410,cyclophosphamide,1,250,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,1,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,1,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,nifurtimox,2,30,mg/kg/d,3,daily for 21 days,NA
21063221,NA,410,cyclophosphamide,2,250,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,2,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,2,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,nifurtimox,3,40,mg/kg/d,3,daily for 21 days,NA
21063221,NA,410,cyclophosphamide,3,250,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,3,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
21063221,NA,410,topotecan,3,0.75,mg/m2,1,"starting from cycle 2, daily on days 1 to 5 for a 21 day cycle",fixed
11742479,NA,411,topotecan,1,5,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,1,5,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,2,10,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,2,10,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,3,15,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,3,15,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,4,20,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,4,20,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,5,30,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
11742479,NA,411,topotecan,5,30,mg/m2,1,on day 1 every 3 weeks to a maximum of 8,NA
29138343,NCT01012817,412,veliparib,1,10,mg,1,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,1,2,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,1,2,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,2,20,mg,1,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,2,2,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,2,2,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,3,10,mg,1,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,3,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,3,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,4,20,mg,1,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,4,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,4,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,5,20,mg,1,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,5,4,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,5,4,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,6,30,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,6,4,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,6,4,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,7,30,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,7,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,7,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,8,50,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,8,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,8,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,9,100,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,9,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,9,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,10,150,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,10,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,10,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,11,200,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,11,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,11,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,12,300,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,12,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,12,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,veliparib,13,400,mg,2,"on days 1-3, 8-10, and 15-17 every 28 days",NA
29138343,NCT01012817,412,topotecan,13,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
29138343,NCT01012817,412,topotecan,13,3,mg/m2,1,"on days 2, 9, and 16 every 28 days",fixed
11721172,NA,413,topotecan,1,0.75,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,1,0.75,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,2,0.9,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,2,0.9,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,3,1,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,3,1,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,4,1.1,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,4,1.1,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,5,1.2,mg/m2,1,for 3 consecutive days every 2 weeks,NA
11721172,NA,413,topotecan,5,1.2,mg/m2,1,for 3 consecutive days every 2 weeks,NA
23604531,NA,414,topotecan,1,3,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,1,3,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,2,3.5,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,2,3.5,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,3,4,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,3,4,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,4,4.5,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
23604531,NA,414,topotecan,4,4.5,mg/m2,1,"on days 1, 8, and 15, every 28 days",NA
16208519,NA,415,topotecan,1,0.5,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,1,0.5,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,1,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,1,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,topotecan,2,0.65,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,2,0.65,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,2,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,2,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,topotecan,3,0.8,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,3,0.8,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,3,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,3,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,topotecan,4,1,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,4,1,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,4,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,4,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,topotecan,5,1.2,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,5,1.2,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,5,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,5,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,topotecan,6,1.4,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,topotecan,6,1.4,mg/m2,1,on days 1–3 every 3 weeks,NA
16208519,NA,415,cisplatin,6,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
16208519,NA,415,cisplatin,6,20,mg/m2,1,on days 1–3 every 3 weeks,fixed
22198338,NA,416,topotecan,1,0.5,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",fixed
22198338,NA,416,topotecan,1,0.5,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",fixed
22198338,NA,416,cisplatin,1,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",NA
22198338,NA,416,cisplatin,1,40,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",NA
22198338,NA,416,pelvic radiation therapy,1,45,Gy,NA,in 25 fractions of 180 cGy,fixed
22198338,NA,416,topotecan,2,0.5,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",fixed
22198338,NA,416,topotecan,2,0.5,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",fixed
22198338,NA,416,cisplatin,2,30,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",NA
22198338,NA,416,cisplatin,2,30,mg/m2,1,"on days 1, 8, 15, 22, 29 and 36 of external radiation therapy",NA
22198338,NA,416,pelvic radiation therapy,2,45,Gy,NA,in 25 fractions of 180 cGy,fixed
20165849,NA,417,obatoclax mesylate,1,14,mg/m2,1,on day 1 of an every 3-week cycle,NA
20165849,NA,417,topotecan,1,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,topotecan,1,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,obatoclax mesylate,2,14,mg/m2,1,on days 1 and 3 of an every 3-week cycle,NA
20165849,NA,417,topotecan,2,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,topotecan,2,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,obatoclax mesylate,3,20,mg/m2,1,on day 1 of an every 3-week cycle,NA
20165849,NA,417,topotecan,3,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,topotecan,3,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,obatoclax mesylate,4,20,mg/m2,1,on days 1 and 3 of an every 3-week cycle,NA
20165849,NA,417,topotecan,4,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
20165849,NA,417,topotecan,4,1.25,mg/m2,1,on days 1–5 of an every 3-week cycle,NA
12626128,NA,418,topotecan,1,0.3,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,topotecan,1,0.3,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,radiotherapy,1,1.8,Gy,1,"5 days a week, to a total of 59.4 Gy",fixed
12626128,NA,418,topotecan,2,0.4,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,topotecan,2,0.4,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,radiotherapy,2,1.8,Gy,1,"5 days a week, to a total of 59.4 Gy",fixed
12626128,NA,418,topotecan,3,0.5,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,topotecan,3,0.5,mg/m2,1,a 30-min i.v. infusion 30–60 min before each XRT treatment given daily for 33 days,NA
12626128,NA,418,radiotherapy,3,1.8,Gy,1,"5 days a week, to a total of 59.4 Gy",fixed
15013589,NA,419,thoracic radiotherapy,1,2,Gy,1,"5 days per week, to a total of 60 Gy",fixed
15013589,NA,419,topotecan,1,0.2,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,topotecan,1,0.2,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,thoracic radiotherapy,2,2,Gy,1,"5 days per week, to a total of 60 Gy",fixed
15013589,NA,419,topotecan,2,0.3,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,topotecan,2,0.3,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,thoracic radiotherapy,3,2,Gy,1,"5 days per week, to a total of 60 Gy",fixed
15013589,NA,419,topotecan,3,0.4,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,topotecan,3,0.4,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,thoracic radiotherapy,4,2,Gy,1,"5 days per week, to a total of 60 Gy",fixed
15013589,NA,419,topotecan,4,0.5,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
15013589,NA,419,topotecan,4,0.5,mg/m2,1,daily session of XRT to 60 Gy over 6 weeks,NA
11104627,NA,420,topotecan,1,2.5,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,1,2.5,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,2,3.75,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,2,3.75,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,3,4.25,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,3,4.25,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,4,4.75,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,4,4.75,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,5,5,mg/m2,1,days 1–3 q 21 days,NA
11104627,NA,420,topotecan,5,5,mg/m2,1,days 1–3 q 21 days,NA
19885837,NA,421,cladribine,1,8.9,mg/m2,1,for 5 consecutive days per course,Stratum 1
19885837,NA,421,topotecan,1,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,topotecan,1,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,cladribine,2,9.1,mg/m2,1,for 5 consecutive days per course,Stratum 1
19885837,NA,421,topotecan,2,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,topotecan,2,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,cladribine,3,14.6,mg/m2,1,for 5 consecutive days per course,Stratum 1
19885837,NA,421,topotecan,3,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,topotecan,3,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,cladribine,4,16.3,mg/m2,1,for 5 consecutive days per course,Stratum 1
19885837,NA,421,topotecan,4,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,topotecan,4,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,cladribine,5,19.5,mg/m2,1,for 5 consecutive days per course,Stratum 1
19885837,NA,421,topotecan,5,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,topotecan,5,4,mg/m2,1,for 5 consecutive days per course,fixed
19885837,NA,421,cladribine,1,9.1,mg/m2,1,for 5 consecutive days per course,Stratum 2
19885837,NA,421,cladribine,2,13.6,mg/m2,1,for 5 consecutive days per course,Stratum 2
19885837,NA,421,cladribine,3,16.3,mg/m2,1,for 5 consecutive days per course,Stratum 2
18752593,NA,422,bendamustine,1,60,mg/m2,1,"on days 1, 8 and 15 every 28 d",fixed
18752593,NA,422,prednisolone,1,100,mg,1,"on days 1, 8, 15 and 22 every 28 d",fixed
18752593,NA,422,thalidomide,1,50,mg,1,on days 1–28 every 28 d,NA
18752593,NA,422,bendamustine,2,60,mg/m2,1,"on days 1, 8 and 15 every 28 d",fixed
18752593,NA,422,prednisolone,2,100,mg,1,"on days 1, 8, 15 and 22 every 28 d",fixed
18752593,NA,422,thalidomide,2,100,mg,1,on days 1–28 every 28 d,NA
18752593,NA,422,bendamustine,3,60,mg/m2,1,"on days 1, 8 and 15 every 28 d",fixed
18752593,NA,422,prednisolone,3,100,mg,1,"on days 1, 8, 15 and 22 every 28 d",fixed
18752593,NA,422,thalidomide,3,200,mg,1,on days 1–28 every 28 d,NA
9849451,NA,423,topotecan,1,1.2,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,1,1.2,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,2,1.8,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,2,1.8,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,3,2.3,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,3,2.3,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,4,2.7,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,4,2.7,mg/m2,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,5,4,mg,1,daily for 5 days every 21 days,NA
9849451,NA,423,topotecan,5,4,mg,1,daily for 5 days every 21 days,NA
9607572,NA,424,topotecan,1,1,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,1,1,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,2,1.4,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,2,1.4,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,3,1.6,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,3,1.6,mg/m2,1,for 10 days every 3 weeks,o.d. schedule
9607572,NA,424,topotecan,1,0.5,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,1,0.5,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,2,0.6,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,2,0.6,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,3,0.7,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,3,0.7,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,4,0.8,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
9607572,NA,424,topotecan,4,0.8,mg/m2,2,for 10 days every 3 weeks,b.i.d schedule
25677219,NCT00483860,425,topotecan,1,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group A
25677219,NCT00483860,425,topotecan,1,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group A
25677219,NCT00483860,425,topotecan,1,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group B
25677219,NCT00483860,425,topotecan,1,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group B
25677219,NCT00483860,425,topotecan,1,1.9,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group C
25677219,NCT00483860,425,topotecan,1,1.9,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group C
25677219,NCT00483860,425,topotecan,2,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group C
25677219,NCT00483860,425,topotecan,2,2.3,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group C
25677219,NCT00483860,425,topotecan,1,1.2,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,1,1.2,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,2,1.5,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,2,1.5,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,3,1.8,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,3,1.8,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group D
25677219,NCT00483860,425,topotecan,1,0.6,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
25677219,NCT00483860,425,topotecan,1,0.6,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
25677219,NCT00483860,425,topotecan,2,0.8,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
25677219,NCT00483860,425,topotecan,2,0.8,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
25677219,NCT00483860,425,topotecan,3,1.2,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
25677219,NCT00483860,425,topotecan,3,1.2,mg/m2/d,1,on days 1 to 5 in a 21 day cycle,Group E
27793021,NCT01670175,426,sirolimus,1,3-7.9,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,sirolimus,1,3-7.9,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,cyclophosphamide,1,25,mg/m2,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,topotecan,1,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
27793021,NCT01670175,426,topotecan,1,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
27793021,NCT01670175,426,sirolimus,2,12-Aug,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,sirolimus,2,12-Aug,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,cyclophosphamide,2,25,mg/m2,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,topotecan,2,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
27793021,NCT01670175,426,topotecan,2,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
27793021,NCT01670175,426,sirolimus,3,12-Aug,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,sirolimus,3,12-Aug,ng/ml,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,cyclophosphamide,3,50,mg/m2,1,days 1-21 in a 28-day cycle,NA
27793021,NCT01670175,426,topotecan,3,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
27793021,NCT01670175,426,topotecan,3,0.8,mg/m2,1,days 1-14 in a 28-day cycle,fixed
7949242,NA,427,topotecan,1,0.17,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,1,0.17,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,2,0.34,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,2,0.34,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,3,0.68,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,3,0.68,mg/m2/d,1,a continuous infusion for 5 consecutive days every 21 days,5 day CI
7949242,NA,427,topotecan,1,0.68,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,1,0.68,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,2,0.85,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,2,0.85,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,3,1.05,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,3,1.05,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,4,1.3,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,4,1.3,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,3 day CI
7949242,NA,427,topotecan,5,1.6,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,NA
7949242,NA,427,topotecan,5,1.6,mg/m2/d,1,a continuous infusion for 3 consecutive days every 21 days,NA
16520988,NA,428,thalidomide,1,100,mg/d,2,daily,NA
16520988,NA,428,thalidomide,2,200,mg/d,2,daily,NA
16520988,NA,428,thalidomide,3,300,mg/d,2,daily,NA
16520988,NA,428,thalidomide,4,400,mg/d,2,daily,NA
16520988,NA,428,thalidomide,5,600,mg/d,2,daily,NA
16520988,NA,428,thalidomide,6,800,mg/d,2,daily,NA
16520988,NA,428,thalidomide,7,1000,mg/d,2,daily,NA
16520988,NA,428,thalidomide,8,1200,mg/d,2,daily,NA
11099328,NA,429,dx-8951f,1,4,mg/m2,1,a 30-minute intravenous infusion every 3 weeks,NA
11099328,NA,429,dx-8951f,2,5.33,mg/m2,1,a 30-minute intravenous infusion every 3 weeks,NA
11099328,NA,429,dx-8951f,3,7.1,mg/m2,1,a 30-minute intravenous infusion every 3 weeks,NA
8637048,NA,430,topotecan,1,0.5,mg/m2,1,for 5 days every 3 weeks,NA
8637048,NA,430,topotecan,1,0.5,mg/m2,1,for 5 days every 3 weeks,NA
8637048,NA,430,topotecan,2,1,mg/m2,1,for 5 days every 3 weeks,NA
8637048,NA,430,topotecan,2,1,mg/m2,1,for 5 days every 3 weeks,NA
8637048,NA,430,topotecan,3,1.5,mg/m2,1,for 5 days every 3 weeks,NA
8637048,NA,430,topotecan,3,1.5,mg/m2,1,for 5 days every 3 weeks,NA
9779705,NA,431,topotecan,1,0.4,mg/m2/d,1,administered as a CIVI for 21 days of a 28-day schedule,NA
9779705,NA,431,topotecan,1,0.4,mg/m2/d,1,administered as a CIVI for 21 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,1,12.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day schedule",NA
9779705,NA,431,cisplatin,1,12.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day schedule",NA
9779705,NA,431,topotecan,2,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,topotecan,2,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,2,35,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,cisplatin,2,35,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,topotecan,3,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,topotecan,3,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,3,50,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,cisplatin,3,50,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,topotecan,4,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,topotecan,4,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,4,75,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,cisplatin,4,75,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,topotecan,5,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,topotecan,5,0.4,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,5,100,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,cisplatin,5,100,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,topotecan,6,0.5,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,topotecan,6,0.5,mg/m2/d,1,administered as a CIVI for 14 days of a 28-day schedule,NA
9779705,NA,431,cisplatin,6,75,mg/m2,1,on day 1 of a 28-day schedule,NA
9779705,NA,431,cisplatin,6,75,mg/m2,1,on day 1 of a 28-day schedule,NA
8648378,NA,432,topotecan,1,1.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,1,1.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,1,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,1,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,topotecan,2,2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,2,2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,2,5,ug/kg,1,began on day 1,fixed
8648378,NA,432,g-csf,2,5,ug/kg,1,began on day 1,fixed
8648378,NA,432,topotecan,3,2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,3,2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,3,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,3,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,topotecan,4,2.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,4,2.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,4,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,4,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,topotecan,5,3,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,5,3,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,5,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,5,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,topotecan,6,3.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,6,3.5,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,6,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,6,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,topotecan,7,4.2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,topotecan,7,4.2,mg/m2/d,1,daily for 5 days every 3 weeks,NA
8648378,NA,432,g-csf,7,5,ug/kg,1,began on day 6,fixed
8648378,NA,432,g-csf,7,5,ug/kg,1,began on day 6,fixed
9060549,NA,433,topotecan,1,0.15,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,1,0.15,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,2,0.3,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,2,0.3,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,3,0.4,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,3,0.4,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,4,0.5,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,4,0.5,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,5,0.6,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
9060549,NA,433,topotecan,5,0.6,mg/m2,2,"daily for 21 days, with cycles repeated every 28 days",NA
7738619,NA,434,novobiocin,1,500,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,1,500,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,1,750,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,1,100,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,2,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,2,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,2,750,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,2,100,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,3,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,3,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,3,1250,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,3,150,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,4,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,4,1000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,4,1500,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,4,200,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,5,2000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,5,2000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,5,1500,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,5,200,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,6,3000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,6,3000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,6,1500,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,6,200,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,7,4000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,7,4000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,7,1500,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,7,200,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,novobiocin,8,5000,mg/d,2,daily for 7 days,NA
7738619,NA,434,novobiocin,8,5000,mg/d,2,daily for 7 days,NA
7738619,NA,434,clophosphamide,8,1500,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
7738619,NA,434,thiotepa,8,200,mg/m2,1,"daily for 4 days,  begun immediately after the fourth dose of novobiocin",NA
10071262,NA,435,paclitaxel,1,110,mg/m2,1,day 1 every 3 weeks,NA
10071262,NA,435,cisplatin,1,50,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,cisplatin,1,50,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,topotecan,1,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,topotecan,1,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,g-csf,1,0,ug/kg,1,starting on day 6,NA
10071262,NA,435,g-csf,1,0,ug/kg,1,starting on day 6,NA
10071262,NA,435,paclitaxel,2,110,mg/m2,1,day 1 every 3 weeks,NA
10071262,NA,435,cisplatin,2,50,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,cisplatin,2,50,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,topotecan,2,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,topotecan,2,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,g-csf,2,5,ug/kg,1,starting on day 6,NA
10071262,NA,435,g-csf,2,5,ug/kg,1,starting on day 6,NA
10071262,NA,435,paclitaxel,3,110,mg/m2,1,day 1 every 3 weeks,NA
10071262,NA,435,cisplatin,3,75,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,cisplatin,3,75,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,topotecan,3,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,topotecan,3,0.3,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,g-csf,3,5,ug/kg,1,starting on day 6,NA
10071262,NA,435,g-csf,3,5,ug/kg,1,starting on day 6,NA
10071262,NA,435,paclitaxel,4,110,mg/m2,1,day 1 every 3 weeks,NA
10071262,NA,435,cisplatin,4,75,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,cisplatin,4,75,mg/m2,1,day 2 every 3 weeks,NA
10071262,NA,435,topotecan,4,0.4,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,topotecan,4,0.4,mg/m2,1,days 2 to 6 every 3 weeks,NA
10071262,NA,435,g-csf,4,5,ug/kg,1,starting on day 6,NA
10071262,NA,435,g-csf,4,5,ug/kg,1,starting on day 6,NA
20630830,NA,436,topotecan,1,4,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
20630830,NA,436,topotecan,1,4,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
20630830,NA,436,topotecan,2,6,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
20630830,NA,436,topotecan,2,6,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
20630830,NA,436,topotecan,3,8,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
20630830,NA,436,topotecan,3,8,mg/m2,1,"on days 1, 8, and 15 every 28 days",NA
7602366,NA,437,topotecan,1,2.5,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,1,2.5,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,2,3.75,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,2,3.75,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,3,5.6,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,3,5.6,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,4,8.4,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,4,8.4,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,5,10.5,mg/m2,1,24-hour continuous infusion every 21 days,NA
7602366,NA,437,topotecan,5,10.5,mg/m2,1,24-hour continuous infusion every 21 days,NA
12506183,NA,438,topotecan,1,0.025-0.2,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
12506183,NA,438,topotecan,1,0.025-0.2,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
12506183,NA,438,topotecan,2,0.4,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
12506183,NA,438,topotecan,2,0.4,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
12506183,NA,438,topotecan,3,0.7,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
12506183,NA,438,topotecan,3,0.7,mg,1,twice weekly (every 3 to 4 days) for 4 weeks (eight doses),NA
18096059,NCT00287963,439,topotecan,1,2,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,topotecan,1,2,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
18096059,NCT00287963,439,topotecan,2,2.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,topotecan,2,2.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
18096059,NCT00287963,439,topotecan,3,3,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,topotecan,3,3,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,vinorelbine,3,20,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
18096059,NCT00287963,439,topotecan,4,3.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,topotecan,4,3.5,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,vinorelbine,4,20,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
18096059,NCT00287963,439,topotecan,5,4,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,topotecan,5,4,mg/m2,1,on days 1 and 8 every 3 weeks,NA
18096059,NCT00287963,439,vinorelbine,5,20,mg/m2,1,on days 1 and 8 every 3 weeks,fixed
12109520,NA,440,topotecan,1,5,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,1,5,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,2,10,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,2,10,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,3,15,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,3,15,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,4,20,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,4,20,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,5,22.5,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,5,22.5,mg/m2,1,Single-dose study,NA
12109520,NA,440,topotecan,1,0.5,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,1,0.5,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,2,0.75,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,2,0.75,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,3,1,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,3,1,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,4,1.2,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,4,1.2,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,5,1.5,mg/m2,1,5-Day repeat-dose study,NA
12109520,NA,440,topotecan,5,1.5,mg/m2,1,5-Day repeat-dose study,NA
16501591,NA,441,topotecan,1,4,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,1,4,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,2,5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,2,5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,3,5.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,3,5.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,4,6,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,4,6,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,5,6.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,5,6.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,6,7,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,6,7,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,7,7.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,7,7.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,8,8,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,8,8,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,9,8.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,9,8.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,10,9,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,10,9,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,11,9.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,11,9.5,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,12,10,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
16501591,NA,441,topotecan,12,10,mg/m2,1,"receive one cycle of therapy, from day 1 to 5, as a 30 min infusion",NA
14752800,NA,442,cyclophosphamide,1,50,mg/m2,1,for consecutive 10 days every 21 – 28 days,NA
14752800,NA,442,topotecan,1,0.8,mg/m2,1,for consecutive 10 days every 21 – 28 days,NA
14752800,NA,442,topotecan,1,0.8,mg/m2,1,for consecutive 10 days every 21 – 28 days,NA
14752800,NA,442,cyclophosphamide,2,50,mg/m2,1,for consecutive 14 days every 21 – 28 days,NA
14752800,NA,442,topotecan,2,0.8,mg/m2,1,for consecutive 14 days every 21 – 28 days,NA
14752800,NA,442,topotecan,2,0.8,mg/m2,1,for consecutive 14 days every 21 – 28 days,NA
14752800,NA,442,cyclophosphamide,3,50,mg/m2,1,for consecutive 17 days every 21 – 28 days,NA
14752800,NA,442,topotecan,3,0.8,mg/m2,1,for consecutive 17 days every 21 – 28 days,NA
14752800,NA,442,topotecan,3,0.8,mg/m2,1,for consecutive 17 days every 21 – 28 days,NA
14519630,NA,443,topotecan,1,0.6,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,1,0.6,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,2,0.8,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,2,0.8,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,3,1.1,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,3,1.1,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,4,1.4,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,4,1.4,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,5,1.9,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
14519630,NA,443,topotecan,5,1.9,mg/m2,1,"5 consecutive days on and 2 days off, for 3 weeks (15 doses/course) followed by 2–4 weeks of rest",NA
21795476,NCT00553189,444,veliparib,1,10,mg,2,days 1 to 7 of 21-day cycles,NA
21795476,NCT00553189,444,topotecan,1,1.2,mg/m2,1,"on day -8, on days 2 to 5 for cycle 1,  on days 1 to 5 for cycle 2 onwards  (21-day cycle)",NA
21795476,NCT00553189,444,topotecan,1,1.2,mg/m2,1,"on day -8, on days 2 to 5 for cycle 1,  on days 1 to 5 for cycle 2 onwards  (21-day cycle)",NA
21795476,NCT00553189,444,veliparib,-1,10,mg,2,days 1 to 7 of 21-day cycles,NA
21795476,NCT00553189,444,topotecan,-1,0.9,mg/m2,1,"on day -8, on days 2 to 5 for cycle 1,  on days 1 to 5 for cycle 2 onwards  (21-day cycle)",NA
21795476,NCT00553189,444,topotecan,-1,0.9,mg/m2,1,"on day -8, on days 2 to 5 for cycle 1,  on days 1 to 5 for cycle 2 onwards  (21-day cycle)",NA
21795476,NCT00553189,444,veliparib,-2,10,mg,2,"on days 2 to 5 in cycle 1, on days 1 to 5 in subsequent cycles (21-day cycles)",NA
21795476,NCT00553189,444,topotecan,-2,0.75,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21795476,NCT00553189,444,topotecan,-2,0.75,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21795476,NCT00553189,444,veliparib,-3,10,mg,2,"on days 2 to 5 in cycle 1, on days 1 to 5 in subsequent cycles (21-day cycles)",NA
21795476,NCT00553189,444,topotecan,-3,0.6,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21795476,NCT00553189,444,topotecan,-3,0.6,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21795476,NCT00553189,444,veliparib,1.5,10,mg,2,on day 1 only in each cycle (21-day cycles),NA
21795476,NCT00553189,444,topotecan,1.5,0.75,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21795476,NCT00553189,444,topotecan,1.5,0.75,mg/m2,1,on days 1 to 5 of 21-day cycles,NA
21690471,NA,445,temsirolimus,1,10,mg/m2,1,weekly for 3 weeks per course,NA
21690471,NA,445,temsirolimus,2,25,mg/m2,1,weekly for 3 weeks per course,NA
21690471,NA,445,temsirolimus,3,75,mg/m2,1,weekly for 3 weeks per course,NA
21690471,NA,445,temsirolimus,4,150,mg/m2,1,weekly for 3 weeks per course,NA
11925142,NA,446,topotecan,1,0.5,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,topotecan,1,0.5,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,external-beam radiotherapy,1,4500,cGy,NA,"delivered to the pelvis in 25 daily fractions of 180 cGy each, and to the paraaortics in 30 fractions of 150 cGy each",fixed
11925142,NA,446,topotecan,2,0.75,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,topotecan,2,0.75,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,external-beam radiotherapy,2,4500,cGy,NA,"delivered to the pelvis in 25 daily fractions of 180 cGy each, and to the paraaortics in 30 fractions of 150 cGy each",fixed
11925142,NA,446,topotecan,3,1,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,topotecan,3,1,mg/m2,1,on Days 1 to 5 and Days 22 to 26 of external-beam irradiation,NA
11925142,NA,446,external-beam radiotherapy,3,4500,cGy,NA,"delivered to the pelvis in 25 daily fractions of 180 cGy each, and to the paraaortics in 30 fractions of 150 cGy each",fixed
18202794,NA,447,topotecan,1,1,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,topotecan,1,1,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,external cranial irradiation,1,1.8,Gy,1,"59.4 Gy/33 fractions, 5 days a week in 6.6 weeks",fixed
18202794,NA,447,topotecan,2,1.25,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,topotecan,2,1.25,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,external cranial irradiation,2,1.8,Gy,1,"59.4 Gy/33 fractions, 5 days a week in 6.6 weeks",fixed
18202794,NA,447,topotecan,3,1.5,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,topotecan,3,1.5,mg/m2,1,"administered intravenously by 30-min infusion before radiotherapy on days D1, D8, D15, D22, D29, D36, D43 and D4, D11, D18, D25, D32, D39, D46 respectively",NA
18202794,NA,447,external cranial irradiation,3,1.8,Gy,1,"59.4 Gy/33 fractions, 5 days a week in 6.6 weeks",fixed
8888741,NA,448,topotecan,1,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,448,topotecan,1,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,448,topotecan,2,1.7,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,448,topotecan,2,1.7,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,topotecan,1,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,topotecan,1,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,g-csf,1,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,g-csf,1,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,topotecan,2,1.7,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,topotecan,2,1.7,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,g-csf,2,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,g-csf,2,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,topotecan,3,2,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,topotecan,3,2,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,g-csf,3,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,g-csf,3,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,topotecan,4,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,topotecan,4,1.4,mg/m2,1,for 5 consecutive days every 21 days,NA
8888741,NA,449,g-csf,4,5,ug/kg,1,begun on the sixth day of the treatment course,NA
8888741,NA,449,g-csf,4,5,ug/kg,1,begun on the sixth day of the treatment course,NA
11990712,NA,450,topotecan,1,0.75,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,topotecan,1,0.75,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,cisplatin,1,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,cisplatin,1,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,g-csf,1,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,g-csf,1,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,topotecan,2,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,topotecan,2,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,cisplatin,2,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,cisplatin,2,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,g-csf,2,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,g-csf,2,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,topotecan,3,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,topotecan,3,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,cisplatin,3,60,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,cisplatin,3,60,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,g-csf,3,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,g-csf,3,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,topotecan,4,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,topotecan,4,1,mg/m2,1,for 3 days of continuous infusion,Stratum II
11990712,NA,450,cisplatin,4,75,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,cisplatin,4,75,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum II
11990712,NA,450,g-csf,4,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,g-csf,4,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum II
11990712,NA,450,topotecan,1,0.6,mg/m2,1,for 3 days of continuous infusion,Stratum I
11990712,NA,450,topotecan,1,0.6,mg/m2,1,for 3 days of continuous infusion,Stratum I
11990712,NA,450,cisplatin,1,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum I
11990712,NA,450,cisplatin,1,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum I
11990712,NA,450,g-csf,1,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum I
11990712,NA,450,g-csf,1,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum I
11990712,NA,450,topotecan,2,0.75,mg/m2,1,for 3 days of continuous infusion,Stratum I
11990712,NA,450,topotecan,2,0.75,mg/m2,1,for 3 days of continuous infusion,Stratum I
11990712,NA,450,cisplatin,2,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum I
11990712,NA,450,cisplatin,2,45,mg/m2,1,"infused over the course of 6 hours, followed by a 72-hour continuous infusion of topotecan",Stratum I
11990712,NA,450,g-csf,2,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum I
11990712,NA,450,g-csf,2,5,ug/kg,1,starting 24 hours after chemotherapy,Stratum I
8120553,NA,451,topotecan,1,0.2,mg/m2/d,1,"a 7-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,1,0.2,mg/m2/d,1,"a 7-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,2,0.2,mg/m2/d,1,"a 10-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,2,0.2,mg/m2/d,1,"a 10-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,3,0.2,mg/m2/d,1,"a 14-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,3,0.2,mg/m2/d,1,"a 14-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,4,0.2,mg/m2/d,1,"a 17-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,4,0.2,mg/m2/d,1,"a 17-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,5,0.2,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,5,0.2,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,6,0.3,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,6,0.3,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,7,0.4,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,7,0.4,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,8,0.53,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,8,0.53,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,9,0.7,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
8120553,NA,451,topotecan,9,0.7,mg/m2/d,1,"a 21-day infusion schedule, repeated every 28 days",NA
16683075,NA,452,thalidomide,1,100,mg,1,daily for 8 weeks,NA
16683075,NA,452,il-2,1,4.5,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16683075,NA,452,il-2,1,4.5,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16683075,NA,452,thalidomide,2,9,mg,1,daily for 8 weeks,NA
16683075,NA,452,il-2,2,100,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16683075,NA,452,il-2,2,100,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16683075,NA,452,thalidomide,3,100,mg,1,daily for 8 weeks,NA
16683075,NA,452,il-2,3,13.5/9,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest. 13.5 MIU/m2 for week 1, and 9 MIU/m2for weeks 2-6",NA
16683075,NA,452,il-2,3,13.5/9,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest. 13.5 MIU/m2 for week 1, and 9 MIU/m2for weeks 2-6",NA
16683075,NA,452,thalidomide,4,200,mg,1,daily for 8 weeks,NA
16683075,NA,452,il-2,4,9,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16683075,NA,452,il-2,4,9,MIU/m2,1,"daily, Monday through Friday for six weeks followed by a two week rest",NA
16284058,NA,453,ucn-01,1,70,mg/m2,1,"On day 1 every 21 days, the UCN-01 dose was reduced by 50% for cycles 2 and beyond",NA
16284058,NA,453,topotecan,1,0.75,mg/m2,1,on days 1-5 every 21 days,NA
16284058,NA,453,topotecan,1,0.75,mg/m2,1,on days 1-5 every 21 days,NA
16284058,NA,453,ucn-01,2,70,mg/m2,1,"On day 1 every 21 days, the UCN-01 dose was reduced by 50% for cycles 2 and beyond",NA
16284058,NA,453,topotecan,2,1,mg/m2,1,on days 1-5 every 21 days,NA
16284058,NA,453,topotecan,2,1,mg/m2,1,on days 1-5 every 21 days,NA
16284058,NA,453,ucn-01,3,90,mg/m2,1,"On day 1 every 21 days, the UCN-01 dose was reduced by 50% for cycles 2 and beyond",NA
16284058,NA,453,topotecan,3,1,mg/m2,1,on days 1-5 every 21 days,NA
16284058,NA,453,topotecan,3,1,mg/m2,1,on days 1-5 every 21 days,NA
17848737,NA,454,topotecan,1,0.4,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,topotecan,1,0.4,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,whole brain radiation therapy,1,3,Gy,1,"daily, on weekdays, for a total of 30 Gy",fixed
17848737,NA,454,topotecan,2,0.5,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,topotecan,2,0.5,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,whole brain radiation therapy,2,3,Gy,1,"daily, on weekdays, for a total of 30 Gy",fixed
17848737,NA,454,topotecan,3,0.6,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,topotecan,3,0.6,mg/m2/d,1,a 30-min infusion within 60 min prior to radiation on each day of radiation therapy for a total of 10 doses,NA
17848737,NA,454,whole brain radiation therapy,3,3,Gy,1,"daily, on weekdays, for a total of 30 Gy",fixed
28283779,NA,455,me-344,1,10,mg/kg,1,"on days 1, 8, 15, and 22 every 28 days",NA
28283779,NA,455,topotecan,1,4,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
28283779,NA,455,topotecan,1,4,mg/m2,1,"on days 1, 8 and 15 every 28 days",NA
25683772,NCT01057225,456,carfilzomib,-1,15 for C1; 20 for C2 and beyond,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
25683772,NCT01057225,456,cyclophosphamid,-1,300,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
25683772,NCT01057225,456,thalidomide,-1,100,mg,1,on days 1–28 of a 28-day cycle,NA
25683772,NCT01057225,456,dexamethasone,-1,40,mg,1,"on days1, 8, 15 and 22 of a 28-day cycle",NA
25683772,NCT01057225,456,carfilzomib,0,20 for C1; 27 for C2 and beyond,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
25683772,NCT01057225,456,cyclophosphamid,0,300,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
25683772,NCT01057225,456,thalidomide,0,100,mg,1,on days 1–28 of a 28-day cycle,NA
25683772,NCT01057225,456,dexamethasone,0,40,mg,1,"on days1, 8, 15 and 22 of a 28-day cycle",NA
25683772,NCT01057225,456,carfilzomib,1,20 for C1; 36 for C2 and beyond,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
25683772,NCT01057225,456,cyclophosphamid,1,300,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
25683772,NCT01057225,456,thalidomide,1,100,mg,1,on days 1–28 of a 28-day cycle,NA
25683772,NCT01057225,456,dexamethasone,1,40,mg,1,"on days1, 8, 15 and 22 of a 28-day cycle",NA
25683772,NCT01057225,456,carfilzomib,2,20 for C1; 45 for C2 and beyond,mg/m2,1,"on days 1, 2, 8, 9, 15 and 16 of a 28-day cycle",NA
25683772,NCT01057225,456,cyclophosphamid,2,300,mg/m2,1,"on days 1, 8 and 15 of a 28-day cycle",NA
25683772,NCT01057225,456,thalidomide,2,100,mg,1,on days 1–28 of a 28-day cycle,NA
25683772,NCT01057225,456,dexamethasone,2,40,mg,1,"on days1, 8, 15 and 22 of a 28-day cycle",NA
11896112,NA,457,topotecan,1,2,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,1,2,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,2,2.4,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,2,2.4,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,3,3,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,3,3,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,4,3.6,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,4,3.6,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,5,4.3,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,5,4.3,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,6,5.2,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,6,5.2,mg/m2,1,daily for 5 days every 3 weeks,NA
11896112,NA,457,topotecan,7,2.4,mg/m2,1,daily for 7 days every 3 weeks,NA
11896112,NA,457,topotecan,7,2.4,mg/m2,1,daily for 7 days every 3 weeks,NA
11896112,NA,457,topotecan,8,2.4,mg/m2,1,daily for 9 days every 3 weeks,NA
11896112,NA,457,topotecan,8,2.4,mg/m2,1,daily for 9 days every 3 weeks,NA
11896112,NA,457,topotecan,9,2.4,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,9,2.4,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,10,2,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,10,2,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,11,1.6,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,11,1.6,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,12,1.4,mg/m2,1,daily for 12 days every 3 weeks,NA
11896112,NA,457,topotecan,12,1.4,mg/m2,1,daily for 12 days every 3 weeks,NA
21590367,NCT00516438,458,olaparib,1,50,mg,2,daily on days 1–21 every 21 days,NA
21590367,NCT00516438,458,topotecan,1,0.5,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,topotecan,1,0.5,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,olaparib,2,100,mg,2,daily on days 1–21 every 21 days,NA
21590367,NCT00516438,458,topotecan,2,0.5,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,topotecan,2,0.5,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,olaparib,3,100,mg,2,daily on days 1–21 every 21 days,NA
21590367,NCT00516438,458,topotecan,3,1,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,topotecan,3,1,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,olaparib,4,200,mg,2,daily on days 1–21 every 21 days,NA
21590367,NCT00516438,458,topotecan,4,1,mg/m2,1,on days 1–3 every 21 days,NA
21590367,NCT00516438,458,topotecan,4,1,mg/m2,1,on days 1–3 every 21 days,NA
8955652,NA,459,topotecan,1,0.75,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,topotecan,1,0.75,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,cisplatin,1,50,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
8955652,NA,459,cisplatin,1,50,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
8955652,NA,459,topotecan,2,1,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,topotecan,2,1,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,cisplatin,2,50,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
8955652,NA,459,cisplatin,2,50,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
8955652,NA,459,topotecan,3,0.75,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,topotecan,3,0.75,mg/m2/d,1,on days 1-5 every 3 weeks,NA
8955652,NA,459,cisplatin,3,75,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
8955652,NA,459,cisplatin,3,75,mg/m2,1,on either day I (immediately before TPT) or day 5 (immediately after TPT).every 3 weeks,NA
29051322,NA,460,px-866,1,6,mg,1,from days 1 through 28 on a 28-day cycle,NA
29051322,NA,460,vemurafenib,1,720,mg,2,"Cycle 1, day 8 and onward on a 28-day cycle",NA
29051322,NA,460,px-866,2,6,mg,1,from days 1 through 28 on a 28-day cycle,NA
29051322,NA,460,vemurafenib,2,960,mg,2,"Cycle 1, day 8 and onward on a 28-day cycle",NA
29051322,NA,460,px-866,3,8,mg,1,from days 1 through 28 on a 28-day cycle,NA
29051322,NA,460,vemurafenib,3,960,mg,2,"Cycle 1, day 8 and onward on a 28-day cycle",NA
29051322,NA,460,px-866,4,8,mg,1,from days 1 through 28 on a 28-day cycle,NA
29051322,NA,460,vemurafenib,4,720,mg,2,"Cycle 1, day 8 and onward on a 28-day cycle",NA
15701855,NA,461,ecteinascidin-743,1,1100,ug/m2,1,every 21 days,NA
15701855,NA,461,ecteinascidin-743,2,1300,ug/m2,1,every 21 days,NA
20809205,NA,462,nanovnb,1,2.2,mg/m2,1,once every 14 days,NA
20809205,NA,462,nanovnb,2,4.4,mg/m2,1,once every 14 days,NA
20809205,NA,462,nanovnb,3,7.3,mg/m2,1,once every 14 days,NA
20809205,NA,462,nanovnb,4,12.3,mg/m2,1,once every 14 days,NA
20809205,NA,462,nanovnb,5,18.5,mg/m2,1,once every 14 days,NA
20809205,NA,462,nanovnb,6,23,mg/m2,1,once every 14 days,NA
1330081,NA,463,topotecan,1,2.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,1,2.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,2,5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,2,5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,3,8.3,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,3,8.3,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,4,10.4,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,4,10.4,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,5,12.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,5,12.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,6,15,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,6,15,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,7,17.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,7,17.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,8,22.5,mg/m2,1,every 21 days,NA
1330081,NA,463,topotecan,8,22.5,mg/m2,1,every 21 days,NA
17409986,NA,464,vandetanib,1,100,mg,1,"Patients received a single dose, which was followed by a 7-day observation period (cycle 0). On day 8, patients started a once-daily ZD6474 dosing regimen at the same dose as they had received in cycle 0 for a total of 28days (cycle 1). Further 28-day treatment cycles were repeated at the same dose",NA
17409986,NA,464,vandetanib,2,200,mg,1,"Patients received a single dose, which was followed by a 7-day observation period (cycle 0). On day 8, patients started a once-daily ZD6474 dosing regimen at the same dose as they had received in cycle 0 for a total of 28days (cycle 1). Further 28-day treatment cycles were repeated at the same dose",NA
17409986,NA,464,vandetanib,3,300,mg,1,"Patients received a single dose, which was followed by a 7-day observation period (cycle 0). On day 8, patients started a once-daily ZD6474 dosing regimen at the same dose as they had received in cycle 0 for a total of 28days (cycle 1). Further 28-day treatment cycles were repeated at the same dose",NA
17409986,NA,464,vandetanib,4,400,mg,1,"Patients received a single dose, which was followed by a 7-day observation period (cycle 0). On day 8, patients started a once-daily ZD6474 dosing regimen at the same dose as they had received in cycle 0 for a total of 28days (cycle 1). Further 28-day treatment cycles were repeated at the same dose",NA
22781552,NA,465,alvespimycin,1,60,mg/m2,1,weekly therapy in 4-week cycles,NA
22781552,NA,465,trastuzumab,1,"loading dose 4 mg/kg; on subsequent weeks, 2 mg/kg",mg/kg,1,"4 mg/kg loading dose on cycle 1/week 1, then 2 mg/kg on subsequent weeks",fixed
22781552,NA,465,alvespimycin,2,80,mg/m2,1,weekly therapy in 4-week cycles,NA
22781552,NA,465,trastuzumab,2,"loading dose 4 mg/kg; on subsequent weeks, 2 mg/kg",mg/kg,1,"4 mg/kg loading dose on cycle 1/week 1, then 2 mg/kg on subsequent weeks",fixed
22781552,NA,465,alvespimycin,3,100,mg/m2,1,weekly therapy in 4-week cycles,NA
22781552,NA,465,trastuzumab,3,"loading dose 4 mg/kg; on subsequent weeks, 2 mg/kg",mg/kg,1,"4 mg/kg loading dose on cycle 1/week 1, then 2 mg/kg on subsequent weeks",fixed
33947692,NCT02167854,466,alpelisib,1,200,mg,1,daily,Arm A
33947692,NCT02167854,466,trastuzumab,1,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
33947692,NCT02167854,466,ljm716,1,10,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",NA
33947692,NCT02167854,466,alpelisib,2,200,mg,1,daily,Arm A
33947692,NCT02167854,466,trastuzumab,2,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
33947692,NCT02167854,466,ljm716,2,20,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",NA
33947692,NCT02167854,466,alpelisib,3,250,mg,1,daily,Arm A
33947692,NCT02167854,466,trastuzumab,3,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
33947692,NCT02167854,466,ljm716,3,20,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",NA
33947692,NCT02167854,466,alpelisib,4,300,mg,1,daily,Arm A
33947692,NCT02167854,466,trastuzumab,4,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
33947692,NCT02167854,466,ljm716,4,20,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",NA
33947692,NCT02167854,466,alpelisib,5,350,mg,1,daily,Arm A
33947692,NCT02167854,466,trastuzumab,5,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",fixed
33947692,NCT02167854,466,ljm716,5,20,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day cycle",NA
33947692,NCT02167854,466,alpelisib,1,200,mg,1,"on days 1–4, 8–11, 15–18, and 22–25 of each 28-day cycle",Arm B
33947692,NCT02167854,466,alpelisib,2,200,mg,1,"on days 1–4, 8–11, 15–18, and 22–25 of each 28-day cycle",Arm B
33947692,NCT02167854,466,alpelisib,3,250,mg,1,"on days 1–4, 8–11, 15–18, and 22–25 of each 28-day cycle",Arm B
33947692,NCT02167854,466,alpelisib,4,300,mg,1,"on days 1–4, 8–11, 15–18, and 22–25 of each 28-day cycle",Arm B
33947692,NCT02167854,466,alpelisib,5,350,mg,1,"on days 1–4, 8–11, 15–18, and 22–25 of each 28-day cycle",Arm B
23429330,NCT01220284,467,satraplatin,1,60,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,1,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,2,60,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,2,60,mg/m2,1,"on days 1, 8, 15 and 22 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,3,70,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,3,60,mg/m2,1,"on days 1, 8, 15 and 22 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,3.5,70,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,3.5,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,4,80,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,4,60,mg/m2,1,"on days 1, 8, 15 and 22 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,4.5,80,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,4.5,60,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
23429330,NCT01220284,467,satraplatin,5,80,mg/m2,1,on days 1 to 5 every 4 weeks,NA
23429330,NCT01220284,467,vinorelbine,5,80,mg/m2,1,"on days 1, 8 and 15 every 4 weeks",NA
22847981,NA,468,trabectedin,1,1.1,mg/m2,1,continuous infusion over 24 hoursevery 21 days,NA
22847981,NA,468,trabectedin,2,1.5,mg/m2,1,continuous infusion over 24 hoursevery 21 days,NA
22847981,NA,468,trabectedin,3,1.7,mg/m2,1,continuous infusion over 24 hoursevery 21 days,NA
28623430,NCT00258349,469,saha,1,200,mg,2,on days 1–14 per 21-day cycle,NA
28623430,NCT00258349,469,trastuzumab,1,6,mg/kg,1,on day 1 per 21-day cycle,fixed
28623430,NCT00258349,469,saha,-1,"100 AM, 200 PM",mg,2,on days 1–14 per 21-day cycle,NA
28623430,NCT00258349,469,trastuzumab,-1,6,mg/kg,1,on day 1 per 21-day cycle,fixed
28623430,NCT00258349,469,saha,-2,100,mg,2,on days 1–14 per 21-day cycle,NA
28623430,NCT00258349,469,trastuzumab,-2,6,mg/kg,1,on day 1 per 21-day cycle,fixed
23099652,NCT 00272350,470,vandetanib,1,300,mg,1,daily on a 28-day cycle,NA
23099652,NCT 00272350,470,vandetanib,2,400,mg,1,daily on a 28-day cycle,NA
23099652,NCT 00272350,470,vandetanib,3,500,mg,1,daily on a 28-day cycle,NA
27450049,NCT01248858,471,trametinib,1,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,1,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,2,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,2,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,3,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,3,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,4,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,4,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,5,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,5,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,6,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,6,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,7,2,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,7,0.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,8,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,8,2,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,9,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,9,1,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,10,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,10,0.5,mg,2,daily for 28 days,NA
27450049,NCT01248858,471,trametinib,11,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,11,0.5,mg,2,"4 days on, 10 days off in 28-day cycles",NA
27450049,NCT01248858,471,trametinib,12,1.5,mg,1,daily for 28 days,NA
27450049,NCT01248858,471,gsk2126458,12,0.75,mg,2,"4 days on, 10 days off in 28-day cycles",NA
25500057,NCT01155453,472,buparlisib,1,30,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,1,0.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,2,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,2,0.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,3,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,3,1,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,4,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,4,1.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,4.5,80,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,4.5,1,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,5,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,5,1,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,5.5,80,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,5.5,1.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,6,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,6,1.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,7,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,7,2,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,7.5,60,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,7.5,1.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,8,70,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,8,1.5,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,8.5,90,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,8.5,1,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,buparlisib,9,70,mg,1,daily in a 28-day cycle,NA
25500057,NCT01155453,472,trametinib,9,1.5,mg,1,daily in a 28-day cycle,NA
30992546,NCT01938443,473,gsk2256098,1,500,mg,2,daily,NA
30992546,NCT01938443,473,trametinib,1,1,mg,1,daily,NA
30992546,NCT01938443,473,gsk2256098,2,500,mg,2,daily,NA
30992546,NCT01938443,473,trametinib,2,0.5,mg,1,daily,NA
30992546,NCT01938443,473,gsk2256098,3,250,mg,2,daily,NA
30992546,NCT01938443,473,trametinib,3,0.5,mg,1,daily,NA
30992546,NCT01938443,473,gsk2256098,4,500,mg,2,daily,NA
30992546,NCT01938443,473,trametinib,4,0.25,mg,1,daily,NA
30992546,NCT01938443,473,gsk2256098,5,500,mg,2,daily,NA
30992546,NCT01938443,473,trametinib,5,0.375,mg,1,daily,NA
29350463,NCT01519323,474,vemurafenib,1,720,mg/d,2,daily,for participants (>=45 kg)
29350463,NCT01519323,474,vemurafenib,1,960,mg/d,2,daily,for participants weighing <45 kg
15905307,NA,475,zd6474,1,50,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
15905307,NA,475,zd6474,2,100,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
15905307,NA,475,zd6474,3,200,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
15905307,NA,475,zd6474,4,300,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
15905307,NA,475,zd6474,5,500,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
15905307,NA,475,zd6474,6,600,mg,1,"a single oral dose followed by a 7-day observation period, then received further daily treatment in 28-day cycles",NA
11984084,NA,476,ecteinascidin 743,1,50,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,2,100,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,3,200,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,4,330,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,5,440,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,6,585,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,7,800,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,8,1000,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,9,1100,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,10,1000,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,11,1300,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,12,1500,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,13,1650,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
11984084,NA,476,ecteinascidin 743,14,1800,ug/m2,1,a 1-h i.v. infusion every 3 weeks,NA
18048823,NA,477,trastuzumab,1,4; 2,mg/kg,1,"weekly followed by tanespimycin, 4 kg/mg on day 0 in week 1, then 2 mg/kg on subsequent weeks in 4-week cycles",fixed
18048823,NA,477,tanespimycin,1,225,mg/m2,1,weekly in 4-week cylces,NA
18048823,NA,477,trastuzumab,2,4; 2,mg/kg,1,"weekly followed by tanespimycin, 4 kg/mg on day 0 in week 1, then 2 mg/kg on subsequent weeks in 4-week cycles",fixed
18048823,NA,477,tanespimycin,2,300,mg/m2,1,weekly in 4-week cylces,NA
18048823,NA,477,trastuzumab,3,4; 2,mg/kg,1,"weekly followed by tanespimycin, 4 kg/mg on day 0 in week 1, then 2 mg/kg on subsequent weeks in 4-week cycles",fixed
18048823,NA,477,tanespimycin,3,375,mg/m2,1,weekly in 4-week cylces,NA
18048823,NA,477,trastuzumab,4,4; 2,mg/kg,1,"weekly followed by tanespimycin, 4 kg/mg on day 0 in week 1, then 2 mg/kg on subsequent weeks in 4-week cycles",fixed
18048823,NA,477,tanespimycin,4,450,mg/m2,1,weekly in 4-week cylces,NA
17325895,NA,478,radioimmunotherapy  with tositumomab and iodine 131 tositumomab,1,45,cGy,NA,a total body dose,NA
17325895,NA,478,radioimmunotherapy  with tositumomab and iodine 131 tositumomab,2,55,cGy,NA,a total body dose,NA
28119295,NCT01148849,479,margetuximab,1,0.1,mg/kg,1,weekly (QW) in 3-week cycles,NA
28119295,NCT01148849,479,margetuximab,2,0.3,mg/kg,1,weekly (QW) in 3-week cycles,NA
28119295,NCT01148849,479,margetuximab,3,1,mg/kg,1,weekly (QW) in 3-week cycles,NA
28119295,NCT01148849,479,margetuximab,4,3,mg/kg,1,weekly (QW) in 3-week cycles,NA
28119295,NCT01148849,479,margetuximab,5,6,mg/kg,1,weekly (QW) in 3-week cycles,NA
28119295,NCT01148849,479,margetuximab,6,10,mg/kg,1,Q3W,NA
28119295,NCT01148849,479,margetuximab,7,15,mg/kg,1,Q3W,NA
28119295,NCT01148849,479,margetuximab,8,18,mg/kg,1,Q3W,NA
24954229,NA,480,vinorelbine,1,60,mg/week,1,"20 mg on days 1, 3, and 5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,1,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,2,90,mg/week,NA,"30 mg on days 1, 3, and 5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,2,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,3,100,mg/week,NA,"40 mg D1; 30 mg D 3,5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,3,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,4,120,mg/week,NA,"40 mg on days 1, 3, and 5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,4,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,5,130,mg/week,NA,"50 mg D1; 40 mg D 3,5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,5,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,6,150,mg/week,NA,"50 mg on days 1, 3, and 5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,6,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,7,160,mg/week,NA,"60 mg D1; 50 mg D3,5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,7,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,480,vinorelbine,8,180,mg/week,NA,"60 mg on days 1, 3, and 5 every week for 6 weeks",NA
24954229,NA,480,thoracic radiotherapy,8,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,fixed
24954229,NA,481,vinorelbine,4.5,130,mg/week,NA,"50 mg D1; 40 mg D3,5 every week for 6 weeks",NA
24954229,NA,481,cisplatin,4.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,cisplatin,4.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,thoracic radiotherapy,4.5,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,NA
24954229,NA,481,vinorelbine,5.5,140,mg/week,NA,"50 mg D1,3; 40 mg D5 every week for 6 weeks",NA
24954229,NA,481,cisplatin,5.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,cisplatin,5.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,thoracic radiotherapy,5.5,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,NA
24954229,NA,481,vinorelbine,6.5,150,mg/week,NA,"50 mg D1,3,5 every week for 6 weeks",NA
24954229,NA,481,cisplatin,6.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,cisplatin,6.5,80,mg/m2,1,on day 1 every 3 weeks,NA
24954229,NA,481,thoracic radiotherapy,6.5,2,Gy,1,a total dose of 60 Gy being delivered in daily fractions of 2 Gy over 5 days per week during 6 consecutive weeks,NA
8439950,NA,482,topotecan,1,2,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,1,2,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,2,3,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,2,3,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,3,4,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,3,4,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,4,5.5,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,4,5.5,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,5,7.5,mg/m2,1,a 24-h continuous infusion every 21 days,NA
8439950,NA,482,topotecan,5,7.5,mg/m2,1,a 24-h continuous infusion every 21 days,NA
29882016,NCT00620594,483,bez235,1,10,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,2,25,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,3,50,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,4,100,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,5,200,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,6,300,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,7,400,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,8,700,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,9,1100,mg,1,"once daily, in continuous 28-day cycles",HGC capsule
29882016,NCT00620594,483,bez235,1,400,mg,1,"once daily, in continuous 28-day cycles",SDS capsule A
29882016,NCT00620594,483,bez235,2,800,mg,1,"once daily, in continuous 28-day cycles",SDS capsule A
29882016,NCT00620594,483,bez235,3,1000,mg,1,"once daily, in continuous 28-day cycles",SDS capsule A
29882016,NCT00620594,483,bez235,1,800,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,bez235,2,1000,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,bez235,3,1200,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,bez235,5,1400,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,bez235,6,1600,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,bez235,1,800,mg,1,"once daily, in continuous 28-day cycles",SDS capsule B
29882016,NCT00620594,483,trastuzumab,1,2,mg/kg,1,weekly,SDS capsule A
29882016,NCT00620594,483,bez235,2,600,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,trastuzumab,2,2,mg/kg,1,weekly,SDS sachet
29882016,NCT00620594,483,bez235,3,800,mg,1,"once daily, in continuous 28-day cycles",SDS sachet
29882016,NCT00620594,483,trastuzumab,3,2,mg/kg,1,weekly,SDS sachet
30087028,NCT02258607,485,momelotinib,-1,100,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,-1,0.5,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,1,100,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,1,1,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,2,200,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,2,1,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,2.5,100,mg,2,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,2.5,1,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,3,150,mg,2,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,3,1,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,4,150,mg,2,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,4,1.5,mg,1,daily in 28-day cycles,NA
30087028,NCT02258607,485,momelotinib,5,150,mg,2,daily in 28-day cycles,NA
30087028,NCT02258607,485,trametinib,5,2,mg,1,daily in 28-day cycles,NA
31253596,NCT02016729,486,amg 232,1,60,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,486,amg 232,2,90,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,486,amg 232,3,180,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,486,amg 232,4,240,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,486,amg 232,5,360,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,487,amg 232,1,60,mg,1,daily for 7 days every 2 weeks,NA
31253596,NCT02016729,487,trametinib,1,2,mg,1,daily,NA
27129177,NCT01271920,488,auy922,1,55,mg/m2,1,"on days 1, 8, 15, and 22 of each 28-day treatment cycle",NA
27129177,NCT01271920,488,trastuzumab,1,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day treatment cycle",fixed
27129177,NCT01271920,488,auy922,2,70,mg/m2,1,"on days 1, 8, 15, and 22 of each 28-day treatment cycle",NA
27129177,NCT01271920,488,trastuzumab,2,2,mg/kg,1,"on days 1, 8, 15, and 22 of each 28-day treatment cycle",fixed
11234874,NA,489,ecteinascidin 743,1,600,ug/m2,1,a 72-h continuous i.v. infusion every 21 days,NA
11234874,NA,489,ecteinascidin 743,2,900,ug/m2,1,a 72-h continuous i.v. infusion every 21 days,NA
11234874,NA,489,ecteinascidin 743,3,1050,ug/m2,1,a 72-h continuous i.v. infusion every 21 days,NA
11234874,NA,489,ecteinascidin 743,4,1200,ug/m2,1,a 72-h continuous i.v. infusion every 21 days,NA
11230466,NA,490,ecteinascidin-743,1,50,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,2,100,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,3,200,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,4,400,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,5,600,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,6,900,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,7,1200,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,8,1500,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
11230466,NA,490,ecteinascidin-743,9,1800,ug/m2,1,a 24-hour continuous infusion every 3 weeks,NA
22996801,NA,491,vinflunine,1,320,mg/m2,1,on day 1 every 3 weeks,Group 1 & Group 2
22996801,NA,491,vinflunine,2,250,mg/m2,1,on day 1 every 3 weeks,Group 2 & Group 3
22996801,NA,491,vinflunine,3,200,mg/m2,1,on day 1 every 3 weeks,Group 3
21660618,NA,492,trabectedin,1,1.1,mg/m2,1,every 3 weeks,Stratum I
21660618,NA,492,trabectedin,2,1.3,mg/m2,1,every 3 weeks,Stratum I
21660618,NA,492,trabectedin,1,0.9,mg/m2,1,every 3 weeks,Stratum II
21660618,NA,492,trabectedin,2,1.1,mg/m2,1,every 3 weeks,Stratum II
21660618,NA,492,trabectedin,3,1.3,mg/m2,1,every 3 weeks,Stratum II
21660618,NA,492,trabectedin,1,0.75,mg/m2,1,every 3 weeks,Stratum III
21660618,NA,492,trabectedin,2,0.9,mg/m2,1,every 3 weeks,Stratum III
19417019,NA,493,trabectedin,1,0.46,mg/m2,1,1-h infusion weekly for 3 wk every 4-wk schedule,the 1-hour schedule
19417019,NA,493,trabectedin,2,0.58,mg/m2,1,1-h infusion weekly for 3 wk every 4-wk schedule,the 1-hour schedule
19417019,NA,493,trabectedin,3,0.61,mg/m2,1,1-h infusion weekly for 3 wk every 4-wk schedule,the 1-hour schedule
19417019,NA,493,trabectedin,4,0.7,mg/m2,1,1-h infusion weekly for 3 wk every 4-wk schedule,the 1-hour schedule
19417019,NA,493,trabectedin,5,0.8,mg/m2,1,1-h infusion weekly for 3 wk every 4-wk schedule,the 1-hour schedule
19417019,NA,493,trabectedin,1,0.3,mg/m2,1,3-h infusion weekly for 3 wk every-4-wk schedule,the 3-hour schedule
19417019,NA,493,trabectedin,2,0.4,mg/m2,1,3-h infusion weekly for 3 wk every-4-wk schedule,the 3-hour schedule
19417019,NA,493,trabectedin,3,0.525,mg/m2,1,3-h infusion weekly for 3 wk every-4-wk schedule,the 3-hour schedule
19417019,NA,493,trabectedin,4,0.65,mg/m2,1,3-h infusion weekly for 3 wk every-4-wk schedule,the 3-hour schedule
19417019,NA,493,trabectedin,5,0.58,mg/m2,1,3-h infusion weekly for 3 wk every-4-wk schedule,the 3-hour schedule
12932661,NA,494,et-743,1,50,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,2,100,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,3,200,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,4,330,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,5,440,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,6,585,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,7,800,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,8,1100,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,9,1000,ug/m2,1,an infusion over 1 h every 21 days,NA
12932661,NA,494,et-743,10,1000,ug/m2,1,an infusion over 3 h every 21 days,NA
12932661,NA,494,et-743,11,1300,ug/m2,1,an infusion over 3 h every 21 days,NA
12932661,NA,494,et-743,12,1500,ug/m2,1,an infusion over 3 h every 21 days,NA
12932661,NA,494,et-743,13,1800,ug/m2,1,an infusion over 3 h every 21 days,NA
12932661,NA,494,et-743,14,1650,ug/m2,1,an infusion over 3 h every 21 days,NA
19419856,NA,495,trabectedin,1,300,ug/m2,1,on days 1 and 8 every 3 week,NA
19419856,NA,495,cisplatin,1,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,cisplatin,1,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,trabectedin,2,400,ug/m2,1,on days 1 and 8 every 3 week,NA
19419856,NA,495,cisplatin,2,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,cisplatin,2,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,trabectedin,3,500,ug/m2,1,on days 1 and 8 every 3 week,NA
19419856,NA,495,cisplatin,3,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,cisplatin,3,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,trabectedin,4,600,ug/m2,1,on days 1 and 8 every 3 week,NA
19419856,NA,495,cisplatin,4,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,cisplatin,4,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,trabectedin,5,700,ug/m2,1,on days 1 and 8 every 3 week,NA
19419856,NA,495,cisplatin,5,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
19419856,NA,495,cisplatin,5,40,mg/m2,1,on days 1 and 8 every 3 week,fixed
23299791,NA,496,vinflunine,1,20,mg,1,once a day from day 1 to day 42 (6 consecutive weeks) followed by a 2-week rest,NA
23299791,NA,496,vinflunine,2,40,mg,1,once a day from day 1 to day 42 (6 consecutive weeks) followed by a 2-week rest,NA
23299791,NA,496,vinflunine,3,60,mg,1,once a day from day 1 to day 42 (6 consecutive weeks) followed by a 2-week rest,NA
23299791,NA,496,vinflunine,4,75,mg,1,once a day from day 1 to day 42 (6 consecutive weeks) followed by a 2-week rest,NA
23299791,NA,496,vinflunine,5,95,mg,1,once a day from day 1 to day 42 (6 consecutive weeks) followed by a 2-week rest,NA
22382883,NA,497,vinflunine,1,150,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
22382883,NA,497,vinflunine,2,190,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
22382883,NA,497,vinflunine,3,230,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
22382883,NA,497,vinflunine,4,250,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
22382883,NA,497,vinflunine,5,270,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
22382883,NA,497,vinflunine,6,300,mg/d,2,"on days 1 and 2, on days 8 and 9 and on days 15 and 16 of each 3-week cycle",NA
29635147,NCT01373710 ,498,trastuzumab,1,30,mg,1,"once a week, over the course of at least 4 weeks",NA
29635147,NCT01373710 ,498,trastuzumab,2,60,mg,1,"once a week, over the course of at least 4 weeks",NA
29635147,NCT01373710 ,498,trastuzumab,3,100,mg,1,"once a week, over the course of at least 4 weeks",NA
29635147,NCT01373710 ,498,trastuzumab,4,150,mg,1,"once a week, over the course of at least 4 weeks",NA
25417902,NCT01476137,499,trametinib,1,1,mg,1,daily,NA
25417902,NCT01476137,499,afuresertib,1,50,mg,1,daily,NA
25417902,NCT01476137,499,trametinib,2,1.5,mg,1,daily,NA
25417902,NCT01476137,499,afuresertib,2,25,mg,1,daily,NA
25417902,NCT01476137,499,trametinib,3,1.5,mg,1,daily,NA
25417902,NCT01476137,499,afuresertib,3,50,mg,1,daily,NA
25417902,NCT01476137,499,trametinib,4,1.5,mg,1,on Days 1–10 of every 28 days,NA
25417902,NCT01476137,499,afuresertib,4,50,mg,1,on Days 1–10 of every 28 days,NA
20921456,NA,500,vandetanib,1,50,mg/m2,1,administered concurrently with radiotherapy for a maximum of 2 years,NA
20921456,NA,500,three-dimensional conformal radiotherapy,1,1.8,Gy,1,"once daily, 5 days per week, for a cumulative target dose of 54 Gy",fixed
20921456,NA,500,vandetanib,2,65,mg/m2,1,administered concurrently with radiotherapy for a maximum of 2 years,NA
20921456,NA,500,three-dimensional conformal radiotherapy,2,1.8,Gy,1,"once daily, 5 days per week, for a cumulative target dose of 54 Gy",fixed
20921456,NA,500,vandetanib,3,85,mg/m2,1,administered concurrently with radiotherapy for a maximum of 2 years,NA
20921456,NA,500,three-dimensional conformal radiotherapy,3,1.8,Gy,1,"once daily, 5 days per week, for a cumulative target dose of 54 Gy",fixed
20921456,NA,500,vandetanib,4,110,mg/m2,1,administered concurrently with radiotherapy for a maximum of 2 years,NA
20921456,NA,500,three-dimensional conformal radiotherapy,4,1.8,Gy,1,"once daily, 5 days per week, for a cumulative target dose of 54 Gy",fixed
20921456,NA,500,vandetanib,5,145,mg/m2,1,administered concurrently with radiotherapy for a maximum of 2 years,NA
20921456,NA,500,three-dimensional conformal radiotherapy,5,1.8,Gy,1,"once daily, 5 days per week, for a cumulative target dose of 54 Gy",fixed
25352401,NCT00450138,501,vandetanib,1,100,mg,1,once-daily vandetanib for 14 days followed by the treatment of vandetanib + RT for 6 weeks,regimen 1
25352401,NCT00450138,501,radiotherapy,1,2.2,Gy,1,5 days/week for 6 weeks,fixed
25352401,NCT00450138,501,vandetanib,2,200,mg,1,once-daily vandetanib for 14 days followed by the treatment of vandetanib + RT for 6 weeks,regimen 1
25352401,NCT00450138,501,radiotherapy,2,2.2,Gy,1,5  days/week for 6 weeks,fixed
25352401,NCT00450138,502,vandetanib,1,100,mg,1,once-daily vandetanib for 14 days followed by the treatment of vandetanib + RT + cisplatin for 7 weeks,regimen 2
25352401,NCT00450138,502,radiotherapy,1,2,Gy,1,5  days/week for 7 weeks,fixed
25352401,NCT00450138,502,cisplatin,1,30,mg/m2,1,weekly for 7 weeks,fixed
25352401,NCT00450138,502,cisplatin,1,30,mg/m2,1,weekly for 7 weeks,fixed
25352401,NCT00450138,502,vandetanib,2,200,mg,1,once-daily vandetanib for 14 days followed by the treatment of vandetanib + RT + cisplatin for 7 weeks,regimen 2
25352401,NCT00450138,502,radiotherapy,2,2,Gy,1,5 days/week for 7 weeks,fixed
25352401,NCT00450138,502,cisplatin,2,30,mg/m2,1,weekly for 7 weeks,fixed
25352401,NCT00450138,502,cisplatin,2,30,mg/m2,1,weekly for 7 weeks,fixed
26801247,NCT0110429,503,veliparib,1,20,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,1,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,1,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,2,30,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,2,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,2,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,3,40,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,3,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,3,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,3,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,4,60,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,4,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,4,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,4,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,5,80,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,5,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,5,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,5,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,6,120,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,6,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,6,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,6,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,7,160,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,7,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,7,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,7,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,8,200,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,8,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,8,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,8,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
26801247,NCT0110429,503,veliparib,9,300,mg,2,days 1 through 14 of each 21-day cycle,NA
26801247,NCT0110429,503,cisplatin,9,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,cisplatin,9,75,mg/m2,1,on day 1 of each 21-day cycle,fixed
26801247,NCT0110429,503,vinorelbine,9,25,mg/m2,1,on day 1 (before cisplatin) and on day 8 of each 21-day cycle,fixed
21373895,NA,504,vinorelbine,1,20,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 1 week (followed by a 1-week rest period—dose level A) in every 4-week cyles",NA
21373895,NA,504,vinorelbine,2,20,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 2 weeks (followed by a 1-week rest period—dose level B) in every 4-week cyles",NA
21373895,NA,504,vinorelbine,3,20,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 3 weeks (followed by a 1-week rest period—dose level C) in every 4-week cyles",NA
21373895,NA,504,vinorelbine,4,30,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 3 weeks (followed by a 1-week rest period—dose level D) in every 4-week cyles",NA
21373895,NA,504,vinorelbine,5,40,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 3 weeks (followed by a 1-week rest period—dose level E) in every 4-week cyles",NA
21373895,NA,504,vinorelbine,6,50,mg/m2,1,"thrice weekly (e.g., Monday, Wednesday, Friday; or Tuesday, Thursday, Saturday) for progressively increasing durations of therapy, for 3 weeks (followed by a 1-week rest period—dose level F) in every 4-week cyles",NA
23536435,NA,505,vandetanib,-1,50,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,-1,50,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,-1,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,0,65,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,0,50,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,0,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,1,65,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,1,65,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,1,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,2,85,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,2,65,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,2,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,2.5,65,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,2.5,85,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,2.5,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,3,85,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,3,85,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,3,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
23536435,NA,505,vandetanib,4,110,mg/m2,1,daily started on day 9 of therapy,NA
23536435,NA,505,dasatinib,4,85,mg/m2,2,daily started on the same day with radiotherapy,NA
23536435,NA,505,radiotherapy,4,1.8,Gy,1,"once daily, 5 days a week, for a cumulative dose of 54 Gy",fixed
33947696,NCT02202200,506,palbociclib,1,25,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,1,720/960,mg,2,"daily continuously, during the first two cycles, 720 mg BID  and 960 mg BID next in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,2,50,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,2,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,3,75,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,3,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,4,100,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,4,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,5,125,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,5,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,6,150,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,6,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,7,175,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,7,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
33947696,NCT02202200,506,palbociclib,8,200,mg,1,daily for 14 days followed by a 7-day break,NA
33947696,NCT02202200,506,vemurafenib,8,720/960,mg,2,"daily continuously, the first cycle was performed using vemurafenib 720 mg BID and 960 mg BID for the next cycle in the absence of grade 3/4 toxicity",fixed
24470511,NA,507,buparlisib,1,50,mg,1,starting on day 1 of a continuous 28-day cycle,NA
24470511,NA,507,trastuzumab,1,2,mg/kg,1,weekly starting on cycle 1 day 1,fixed
24470511,NA,507,buparlisib,2,100,mg,1,starting on day 1 of a continuous 28-day cycle,NA
24470511,NA,507,trastuzumab,2,2,mg/kg,1,weekly starting on cycle 1 day 1,fixed
22082325,NA,508,vorinostat,1,200,mg,1,once a day 7 days/21 (weekly schedule),NA
22082325,NA,508,vinorelbine,1,25,mg/m2,1,weekly,fixed
25503302,NCT00821080,509,vandetanib,1,100,mg,1,daily in 28-day cycles,NA
25503302,NCT00821080,509,sirolimus,1,2,mg,1,daily in 28-day cycles,NA
25503302,NCT00821080,509,sirolimus,1,2,mg,1,daily in 28-day cycles,NA
25503302,NCT00821080,509,vandetanib,2,200,mg,1,daily in 28-day cycles,NA
25503302,NCT00821080,509,sirolimus,2,2,mg,1,daily in 28-day cycles,NA
25503302,NCT00821080,509,sirolimus,2,2,mg,1,daily in 28-day cycles,NA
19184020,NA,510,vandetanib,1,100,mg,1,daily in 14-day treatment cycles,NA
19184020,NA,510,irinotecan,1,180,mg/m2,1,on day 1 in 14-day treatment cycles,fixed
19184020,NA,510,leucovorin,1,400,mg/m2,1,on day 1 in 14-day treatment cycles,fixed
19184020,NA,510,5-fu,1,400/2400,mg/m2,1,"on day 1 in 14-day treatment cycles, 400 mg/m2 i.v. bolus then 2,400 mg/m2 46–48-h i.v. infusion",fixed
19184020,NA,510,vandetanib,2,300,mg,1,daily in 14-day treatment cycles,NA
19184020,NA,510,irinotecan,2,180,mg/m2,1,on day 1 in 14-day treatment cycles,fixed
19184020,NA,510,leucovorin,2,400,mg/m2,1,on day 1 in 14-day treatment cycles,fixed
19184020,NA,510,5-fu,2,400/2400,mg/m2,1,"on day 1 in 14-day treatment cycles, 400 mg/m2 i.v. bolus then 2,400 mg/m2 46–48-h i.v. infusion",fixed
30569244,NCT01810016,511,vorinostat,-1a,100,mg,1,"three times weekly, MTW",NA
30569244,NCT01810016,511,cisplatin,-1a,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,cisplatin,-1a,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,intensity modulated radiation therapy,-1a,2,Gy,1,5 days a week to a maximum of 70.2Gy over a 7 week period,fixed
30569244,NCT01810016,511,vorinostat,-1,100,mg,1,"three times weekly, MWF",NA
30569244,NCT01810016,511,cisplatin,-1,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,cisplatin,-1,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,intensity modulated radiation therapy,-1,2,Gy,1,5 days a week to a maximum of 70.2Gy over a 7 week period,fixed
30569244,NCT01810016,511,vorinostat,1,200,mg,1,"three times weekly, MWF",NA
30569244,NCT01810016,511,cisplatin,1,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,cisplatin,1,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,intensity modulated radiation therapy,1,2,Gy,1,5 days a week to a maximum of 70.2Gy over a 7 week period,fixed
30569244,NCT01810016,511,vorinostat,2,300,mg,1,"three times weekly, MWF",NA
30569244,NCT01810016,511,cisplatin,2,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,cisplatin,2,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,intensity modulated radiation therapy,2,2,Gy,1,5 days a week to a maximum of 70.2Gy over a 7 week period,fixed
30569244,NCT01810016,511,vorinostat,3,400,mg,1,"three times weekly, MWF",NA
30569244,NCT01810016,511,cisplatin,3,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,cisplatin,3,100,mg/m2,1,"during weeks 1, 4 and 7 of radiation therapy",fixed
30569244,NCT01810016,511,intensity modulated radiation therapy,3,2,Gy,1,5 days a week to a maximum of 70.2Gy over a 7 week period,fixed
11745237,NA,512,vinblastine,1,1.2,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,1,1.25,mg/kg,2,"every 12 hours for 8 days, In cycle 2, started on Day 8. In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,2,1.2,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,2,2.5,mg/kg,2,"every 12 hours for 8 days, In cycle 2, started on Day 8. In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,valspodar,3,5/2.5,mg/kg,2,"every 12 hours for 8 days, In cycle 1, 5 mg/kg started on Day 8. In cycle 2, 2.5 mg/kg started on day 1",the liquid formulation
11745237,NA,512,vinblastine,3,1.2,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,3a,2.5,mg/kg,2,"every 12 hours for 8 days, In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,3a,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,3b,5,mg/kg,2,"every 12 hours for 8 days, In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,3b,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,vinblastine,4,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,4,8,mg/kg,2,"every 12 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,5,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,5,12.5,mg/kg,2,"every 12 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,6,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,6,15,mg/kg,2,"every 12 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,7a,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,7a,16.5/15,mg/kg,2,"every 12 hours for 8 days, In cycle 1, 16.5 mg/kg started on Day 8. In cycle 2, 15 mg/kg started on day 1",the liquid formulation
11745237,NA,512,vinblastine,7b,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,7b,12.5,mg/kg,2,"every 12 hours for 8 days, In cycle 2, started on day 1",the liquid formulation
11745237,NA,512,vinblastine,8a,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,8a,4,mg/kg,3,"every 8 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,9a,0.9,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,9a,4-May,mg/kg,3,"every 8 hours for 8 days, In cycle 1, 5 mg/kg started on Day 8. In cycle 2, 4 mg/kg started on day 1",the microemulsion
11745237,NA,512,vinblastine,8b,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,8b,4,mg/kg,3,"every 8 hours for 8 days, In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,9b,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,9b,5,mg/kg,3,"every 6 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,10,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,10,5,mg/kg,4,"every 6 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,11,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,11,4,mg/kg,4,"every 6 hours for 8 days, In cycle 1, started on Day 8. In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,11a,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,11a,3,mg/kg,4,"every 6 hours for 8 days, In cycle 2, started on day 1",the microemulsion
11745237,NA,512,vinblastine,11b,0.6,mg/m2/d,1,"a continuous intravenous infusion (CIV) for 5 days.  In the first cycle, started on Day 1. In cyle 2, started on day 3",NA
11745237,NA,512,valspodar,11b,2,mg/kg,4,"every 6 hours for 8 days, In cycle 2, started on day 1",the microemulsion
10811501,NA,513,rhizoxin,1,0.2,mg/m2,NA,i.v. over 12 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,2,0.4,mg/m2,NA,i.v. over 12 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,3,0.4,mg/m2,NA,i.v. over 24 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,4,0.8,mg/m2,NA,i.v. over 48 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,5a,0.6,mg/m2,NA,i.v. over 72 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,5b,1.2,mg/m2,NA,i.v. over 72 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,6,2.4,mg/m2,NA,i.v. over 72 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
10811501,NA,513,rhizoxin,7,1.6,mg/m2,NA,i.v. over 72 hours administered every 3 weeks until a maximum infusion duration of 72-hours was reached,NA
8194022,NA,514,floxuridine,1,0.05,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,vinblastine,1,0.35,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,floxuridine,2,0.1,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,vinblastine,2,0.7,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,floxuridine,3,0.175,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,vinblastine,3,0.8,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,floxuridine,4,0.225,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
8194022,NA,514,vinblastine,4,0.9,mg/kg/d,1,constant rate infusion for 14 days every 28 days,NA
23639470,JapicCTI-101264,515,ch5424802,1,20,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,2,40,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,3,80,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,4,160,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,5,240,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,6,300,mg,2,daily,Fasting
23639470,JapicCTI-101264,515,ch5424802,7,240,mg,2,daily,Non-fasting
23639470,JapicCTI-101264,515,ch5424802,8,300,mg,2,daily,Non-fasting
9157072,NA,516,vinorelbine,1,35,mg/m2,1,once every 21 days,NA
9157072,NA,516,vinorelbine,2,40,mg/m2,1,once every 21 days,NA
9157072,NA,516,vinorelbine,3,45,mg/m2,1,once every 21 days,NA
29221762,NCT01118676,517,cilengitide,0,12,mg/h,1,"continuous infusion starting at 2 weeks before chemoradiotherapy, throughout the whole course of chemoradiotherapy (6 weeks), and then at a dose of 2000 mg twice weekly combined with chemotherapy",NA
29221762,NCT01118676,517,radiotherapy,0,2,Gy,1,"once daily, 5 times weekly, up to total dose of  66 Gy",fixed
29221762,NCT01118676,517,cisplatin,0,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,cisplatin,0,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,vinorelbine,0,15,mg/m2,1,"on days 1, 8, 29, and 36 of radiotherapy, then followed by 2 additional cycles on 25 mg/m2 on days 1 and 8 every 3 weeks",fixed
29221762,NCT01118676,517,cilengitide,1,18,mg/h,1,"continuous infusion starting at 2 weeks before chemoradiotherapy, throughout the whole course of chemoradiotherapy (6 weeks), and then at a dose of 2000 mg twice weekly combined with chemotherapy",NA
29221762,NCT01118676,517,radiotherapy,1,2,Gy,1,"once daily, 5 times weekly, up to total dose of  66 Gy",fixed
29221762,NCT01118676,517,cisplatin,1,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,cisplatin,1,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,vinorelbine,1,15,mg/m2,1,"on days 1, 8, 29, and 36 of radiotherapy, then followed by 2 additional cycles on 25 mg/m2 on days 1 and 8 every 3 weeks",fixed
29221762,NCT01118676,517,cilengitide,2,27,mg/h,1,"continuous infusion starting at 2 weeks before chemoradiotherapy, throughout the whole course of chemoradiotherapy (6 weeks), and then at a dose of 2000 mg twice weekly combined with chemotherapy",NA
29221762,NCT01118676,517,radiotherapy,2,2,Gy,1,"once daily, 5 times weekly, up to total dose of  66 Gy",fixed
29221762,NCT01118676,517,cisplatin,2,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,cisplatin,2,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,vinorelbine,2,15,mg/m2,1,"on days 1, 8, 29, and 36 of radiotherapy, then followed by 2 additional cycles on 25 mg/m2 on days 1 and 8 every 3 weeks",fixed
29221762,NCT01118676,517,cilengitide,3,40,mg/h,1,"continuous infusion starting at 2 weeks before chemoradiotherapy, throughout the whole course of chemoradiotherapy (6 weeks), and then at a dose of 2000 mg twice weekly combined with chemotherapy",NA
29221762,NCT01118676,517,radiotherapy,3,2,Gy,1,"once daily, 5 times weekly, up to total dose of  66 Gy",fixed
29221762,NCT01118676,517,cisplatin,3,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,cisplatin,3,80,mg/m2,1,"on days 1 and 29 of radiotherapy, then followed by 2 additional cycles on day 1 every 3 weeks",fixed
29221762,NCT01118676,517,vinorelbine,3,15,mg/m2,1,"on days 1, 8, 29, and 36 of radiotherapy, then followed by 2 additional cycles on 25 mg/m2 on days 1 and 8 every 3 weeks",fixed
34301808,NCT03013491,518,pacmilimab,1,3,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,1,3,mg/kg,1,every 3 weeks for four cycles,NA
34301808,NCT03013491,518,pacmilimab,2,1,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,2,3,mg/kg,1,every 3 weeks for four cycles,NA
34301808,NCT03013491,518,pacmilimab,3,3,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,3,3,mg/kg,1,every 3 weeks for four cycles,NA
34301808,NCT03013491,518,pacmilimab,4,10,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,4,3,mg/kg,1,every 3 weeks for four cycles,NA
34301808,NCT03013491,518,pacmilimab,5,10,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,5,6,mg/kg,1,every 3 weeks for four cycles,NA
34301808,NCT03013491,518,pacmilimab,6,10,mg/kg,1,"every 3 weeks for four cycles, followed by pacmilimab administered every 2 weeks as monotherapy",NA
34301808,NCT03013491,518,ipilimumab,6,10,mg/kg,1,every 3 weeks for four cycles,NA
32819972,NCT01557114,519,ipilimumab,1,10,mg/kg,1,"at weeks 1, 4, 7 and 10 for a total of four doses, at 3-week intervals; for maintenance with ipilimumab 10 mg/kg every 12 weeks starting at week 24 until severe toxicity or disease progression",fixed
32819972,NCT01557114,519,radiotherapy,1,9,Gy,NA,"delivered  in three fractions on week 4 (on Monday, Tuesday and Friday), at the time of the second cycle of ipilimumab",NA
32819972,NCT01557114,519,ipilimumab,2,10,mg/kg,1,"at weeks 1, 4, 7 and 10 for a total of four doses, at 3-week intervals; for maintenance with ipilimumab 10 mg/kg every 12 weeks starting at week 24 until severe toxicity or disease progression",fixed
32819972,NCT01557114,519,radiotherapy,2,15,Gy,NA,"delivered  in three fractions on week 4 (on Monday, Tuesday and Friday), at the time of the second cycle of ipilimumab",NA
32819972,NCT01557114,519,ipilimumab,3,10,mg/kg,1,"at weeks 1, 4, 7 and 10 for a total of four doses, at 3-week intervals; for maintenance with ipilimumab 10 mg/kg every 12 weeks starting at week 24 until severe toxicity or disease progression",fixed
32819972,NCT01557114,519,radiotherapy,3,18,Gy,NA,"delivered  in three fractions on week 4 (on Monday, Tuesday and Friday), at the time of the second cycle of ipilimumab",NA
32819972,NCT01557114,519,ipilimumab,4,10,mg/kg,1,"at weeks 1, 4, 7 and 10 for a total of four doses, at 3-week intervals; for maintenance with ipilimumab 10 mg/kg every 12 weeks starting at week 24 until severe toxicity or disease progression",fixed
32819972,NCT01557114,519,radiotherapy,4,24,Gy,NA,"delivered  in three fractions on week 4 (on Monday, Tuesday and Friday), at the time of the second cycle of ipilimumab",NA
31778074,NCT00585195,520,crizotinib,1,50,mg,1,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
31778074,NCT00585195,520,crizotinib,2,100,mg,1,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
31778074,NCT00585195,520,crizotinib,3,200,mg,1,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
31778074,NCT00585195,520,crizotinib,4,200,mg,2,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
31778074,NCT00585195,520,crizotinib,5,300,mg,2,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
31778074,NCT00585195,520,crizotinib,6,250,mg,2,"in continuous 28-day cycles, with a single lead-in dose 7 days before the first dose at cycle 1 (day −7)",NA
29563138,NCT01625234,521,ensartinib,1,25,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,2,50,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,3,100,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,4,200,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,5,250,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,6,225,mg,1,daily without food evrey 28 days,NA
29563138,NCT01625234,521,ensartinib,7,200,mg,1,daily without food evrey 28 days,NA
22234637,NA,522,vorinostat,1,300,mg,2,"daily for 3 consecutive days followed by 4off-drug days, repeated 3 times for each cycle of treatment",NA
22234637,NA,522,vorinostat,2,400,mg,1,for 21 consecutive days,NA
28032129,NCT00939770,523,crizotinib,1,100,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
28032129,NCT00939770,523,crizotinib,2,130,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
28032129,NCT00939770,523,crizotinib,3,165,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
28032129,NCT00939770,523,crizotinib,4,215,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
28032129,NCT00939770,523,crizotinib,5,280,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
28032129,NCT00939770,523,crizotinib,6,365,mg/m2,2,"daily, continuously on days 1-28 every 28 days",NA
26966027,NCT01284192,524,asp3026,1,25,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,2,50,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,3,75,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,4,125,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,5,200,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,6,325,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,7,525,mg,1,daily in 28-day cycles,NA
26966027,NCT01284192,524,asp3026,8,800,mg,1,daily in 28-day cycles,NA
14597873,NA,525,daunoxome,1,40,mg/m2,1,day 1 every 3 weeks,NA
14597873,NA,525,vincristine,1,1.4,mg/m2,1,day 1 every 3 weeks,fixed
14597873,NA,525,dexamethasone,1,40,mg,1,days 1–4 and 9–12 every 3 weeks,fixed
14597873,NA,525,daunoxome,2,60,mg/m2,1,day 1 every 3 weeks,NA
14597873,NA,525,vincristine,2,1.4,mg/m2,1,day 1 every 3 weeks,fixed
14597873,NA,525,dexamethasone,2,40,mg,1,days 1–4 and 9–12 every 3 weeks,fixed
14597873,NA,525,daunoxome,3,80,mg/m2,1,day 1 every 3 weeks,NA
14597873,NA,525,vincristine,3,1.4,mg/m2,1,day 1 every 3 weeks,fixed
14597873,NA,525,dexamethasone,3,40,mg,1,days 1–4 and 9–12 every 3 weeks,fixed
14597873,NA,525,daunoxome,4,100,mg/m2,1,day 1 every 3 weeks,NA
14597873,NA,525,vincristine,4,1.4,mg/m2,1,day 1 every 3 weeks,fixed
14597873,NA,525,dexamethasone,4,40,mg,1,days 1–4 and 9–12 every 3 weeks,fixed
31898184,NA,526,vorinostat,1,300,mg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,fixed
31898184,NA,526,isotretinoin,1,0.25,mg/kg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,NA
31898184,NA,526,vorinostat,2,300,mg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,fixed
31898184,NA,526,isotretinoin,2,0.375,mg/kg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,NA
31898184,NA,526,vorinostat,3,300,mg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,fixed
31898184,NA,526,isotretinoin,3,0.5,mg/kg,2,daily for 3 consecutive days per week (Tuesday/Wednesday/Thursday) in 4-week cycles,NA
33148673,NCT02737475,527,bms-986178,1,20,mg,1,Q2W,NA
33148673,NCT02737475,527,bms-986178,2,40,mg,1,Q2W,NA
33148673,NCT02737475,527,bms-986178,3,80,mg,1,Q2W,NA
33148673,NCT02737475,527,bms-986178,4,160,mg,1,Q2W,NA
33148673,NCT02737475,527,bms-986178,5,320,mg,1,Q2W,NA
33148673,NCT02737475,528,bms-986178,1,20,mg,1,Q2W,NA
33148673,NCT02737475,528,nivolumab,1,240,mg,1,Q2W,NA
33148673,NCT02737475,528,bms-986178,2,40,mg,1,Q2W,NA
33148673,NCT02737475,528,nivolumab,2,240,mg,1,Q2W,NA
33148673,NCT02737475,528,bms-986178,3,80,mg,1,Q2W,NA
33148673,NCT02737475,528,nivolumab,3,240,mg,1,Q2W,NA
33148673,NCT02737475,528,bms-986178,4,160,mg,1,Q2W,NA
33148673,NCT02737475,528,nivolumab,4,240,mg,1,Q2W,NA
33148673,NCT02737475,528,bms-986178,5,320,mg,1,Q2W,NA
33148673,NCT02737475,528,nivolumab,5,240,mg,1,Q2W,NA
33148673,NCT02737475,529,bms-986178,1,20,mg,1,Q3W,NA
33148673,NCT02737475,529,ipilimumab,1,1,mg/kg,1,Q3W,NA
33148673,NCT02737475,529,bms-986178,2,40,mg,1,Q3W,NA
33148673,NCT02737475,529,ipilimumab,2,1,mg/kg,1,Q3W,NA
33148673,NCT02737475,529,bms-986178,3,80,mg,1,Q3W,NA
33148673,NCT02737475,529,ipilimumab,3,1,mg/kg,1,Q3W,NA
33148673,NCT02737475,529,bms-986178,4,160,mg,1,Q3W,NA
33148673,NCT02737475,529,ipilimumab,4,1,mg/kg,1,Q3W,NA
33148673,NCT02737475,529,bms-986178,5,320,mg,1,Q3W,NA
33148673,NCT02737475,529,ipilimumab,5,1,mg/kg,1,Q3W,NA
20606092,NA,530,vorinostat,1,180,mg/m2,1,daily in each 28-day course,Part A
20606092,NA,530,vorinostat,2,230,mg/m2,1,daily in each 28-day course,Part A
20606092,NA,530,vorinostat,3,300,mg/m2,1,daily in each 28-day course,Part A
20606092,NA,530,vorinostat,2,230,mg/m2,1,daily in each 28-day course,Part B
20606092,NA,530,vorinostat,2,230,mg/m2,1,daily in each 28-day course,Part D suspension
20606092,NA,531,vorinostat,1,180,mg/m2,1,daily in each 28-day course,Part C
20606092,NA,531,cis retinoic acid,1,80,mg/m2,1,daily for 14 days in each 28-day course,Part C
20606092,NA,531,vorinostat,2,180,mg/m2,1,4 times per week in each 28-day course,Part C
20606092,NA,531,cis retinoic acid,2,80,mg/m2,1,daily for 14 days in each 28-day course,Part C
22080430,NA,532,marizomib,1,0.15,mg/m2,1,"on days 1, 8 and 15 of 28 day cycles",NA
22080430,NA,532,vorinostat,1,300,mg,1,on days 1–16 of each 28-day cycle,fixed
22080430,NA,532,marizomib,2,0.3,mg/m2,1,"on days 1, 8 and 15 of 28 day cycles",NA
22080430,NA,532,vorinostat,2,300,mg,1,on days 1–16 of each 28-day cycle,fixed
22080430,NA,532,marizomib,3,0.6,mg/m2,1,"on days 1, 8 and 15 of 28 day cycles",NA
22080430,NA,532,vorinostat,3,300,mg,1,on days 1–16 of each 28-day cycle,fixed
22080430,NA,532,marizomib,4,0.7,mg/m2,1,"on days 1, 8 and 15 of 28 day cycles",NA
22080430,NA,532,vorinostat,4,300,mg,1,on days 1–16 of each 28-day cycle,fixed
19708032,NA,533,vincristine,1,1.5,mg/m2,1,weekly of each 4-week cycle,NA
19708032,NA,533,dexamethasone,1,40,mg,1,on Days 1 through 4 and on Days 11 through 14 of each 4-week cycle,fixed
19708032,NA,533,vincristine,2,1.825,mg/m2,1,weekly of each 4-week cycle,NA
19708032,NA,533,dexamethasone,2,40,mg,1,on Days 1 through 4 and on Days 11 through 14 of each 4-week cycle,fixed
19708032,NA,533,vincristine,3,2,mg/m2,1,weekly of each 4-week cycle,NA
19708032,NA,533,dexamethasone,3,40,mg,1,on Days 1 through 4 and on Days 11 through 14 of each 4-week cycle,fixed
19708032,NA,533,vincristine,4,2.25,mg/m2,1,weekly of each 4-week cycle,NA
19708032,NA,533,dexamethasone,4,40,mg,1,on Days 1 through 4 and on Days 11 through 14 of each 4-week cycle,fixed
19708032,NA,533,vincristine,5,2.5,mg/m2,1,weekly of each 4-week cycle,NA
19708032,NA,533,dexamethasone,5,40,mg,1,on Days 1 through 4 and on Days 11 through 14 of each 4-week cycle,fixed
31617432,NCT01567709,534,alisertib,1,30,mg,2,on days 1-7 every 21 days,schedule I
31617432,NCT01567709,534,vorinostat,1,400,mg,1,on days 1-14 every 21 days,schedule I
31617432,NCT01567709,534,alisertib,2,40,mg,2,on days 1-7 every 21 days,schedule I
31617432,NCT01567709,534,vorinostat,2,200,mg,2,on days 1-14 every 21 days,schedule I
31617432,NCT01567709,534,alisertib,1,30,mg,2,days 1-3 and 8-10 every 21 days,schedule II
31617432,NCT01567709,534,vorinostat,1,200,mg,2,on days 1-5 and 8-12 every 21 days,schedule II
31617432,NCT01567709,534,alisertib,-1,20,mg,2,days 1-3 and 8-10 every 21 days,schedule II
31617432,NCT01567709,534,vorinostat,-1,200,mg,2,on days 1-5 and 8-12 every 21 days,schedule II
17962510,NA,535,vorinostat,1,100,mg,3,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,2,150,mg,3,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,3,200,mg,3,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,4,250,mg,3,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,5,300,mg,3,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,6,300,mg,2,"daily for 14 consecutive days, followed by 7 days of rest",NA
17962510,NA,535,vorinostat,6a,200,mg,2,"daily for 14 consecutive days, followed by 7 days of rest",NA
29512900,NA,536,dasatinib,0,50,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,0,100,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,1,50,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,1,130,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,2,65,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,2,130,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,3a,65,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,3a,165,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,3b,85,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,3b,130,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,4,85,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,4,165,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,5,85,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,crizotinib,5,215,mg/m2,2,daily,Twice-daily regimen
29512900,NA,536,dasatinib,0,50,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,0,130,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,1,50,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,1,165,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,2a,50,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,2a,215,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,2b,65,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,2b,165,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,3,65,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,3,215,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,4a,65,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,4a,280,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,dasatinib,4b,85,mg/m2,1,daily,Once-daily regimen
29512900,NA,536,crizotinib,4b,280,mg/m2,1,daily,Once-daily regimen
14676117,NA,537,bryostatin,1,12.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,1,12.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,1,1,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,2,16.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,2,16.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,2,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,3,22,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,3,22,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,3,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,4,30,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,4,30,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,4,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,5,40,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,5,40,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,5,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,6,50,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,6,50,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,6,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
14676117,NA,537,bryostatin,7,62.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,bryostatin,7,62.5,ug/m2/d,1,a single 24-h i.v. infusion on day 1 of each 3-week cycle,NA
14676117,NA,537,vincristine,7,1.4,mg/m2,1,every 2 weeks for a minimum of onecycle,NA
22506596,NCT00771472,538,vorinostat,1,400,mg,1,daily,NA
11843245,NA,539,vinorelbine,1,60,mg/m2,1,once weekly,NA
11843245,NA,539,vinorelbine,2,80,mg/m2,1,once weekly,NA
11843245,NA,539,vinorelbine,3,100,mg/m2,1,once weekly,NA
27589687,NCT01087554,540,sirolimus,0,1,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,0,1,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,0,100,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,1,2,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,1,2,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,1,100,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,2,2,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,2,2,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,2,200,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,3,3,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,3,3,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,3,200,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,4,3,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,4,3,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,4,300,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,5,4,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,5,4,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,5,300,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,5A,5,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,5A,5,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,5A,300,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,6,4,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,sirolimus,6,4,mg,1,on Days 1 - 28,NA
27589687,NCT01087554,540,vorinostat,6,400,mg,1,on Days 1 - 28,NA
10080616,NA,541,vincristine,1,0.5,mg/m2,1,once every 3 weeks,NA
10080616,NA,541,vincristine,2,1,mg/m2,1,once every 3 weeks,NA
10080616,NA,541,vincristine,3,1.5,mg/m2,1,once every 3 weeks,NA
10080616,NA,541,vincristine,4,2,mg/m2,1,once every 3 weeks,NA
10080616,NA,541,vincristine,5,2.4,mg/m2,1,once every 3 weeks,NA
10080616,NA,541,vincristine,6,2.8,mg/m2,1,once every 3 weeks,NA
11165410,NA,542,paclitaxel,1,135,mg/m2,1,on day 1 every 21 days,NA
11165410,NA,542,vinorelbine,1,25,mg/m2,1,on days 1 and 5  every 21 days,NA
11165410,NA,542,paclitaxel,2,100,mg/m2,1,on day 1 every 21 days,NA
11165410,NA,542,vinorelbine,2,20,mg/m2,1,on days 1 and 5  every 21 days,NA
11165410,NA,542,paclitaxel,3,115,mg/m2,1,on day 1 every 21 days,NA
11165410,NA,542,vinorelbine,3,20,mg/m2,1,on days 1 and 5  every 21 days,NA
11165410,NA,542,paclitaxel,4,135,mg/m2,1,on day 1 every 21 days,NA
11165410,NA,542,vinorelbine,4,20,mg/m2,1,on days 1 and 5  every 21 days,NA
29047029,NCT01744652,543,crizotinib,1,250,mg,2,daily,Arm A
29047029,NCT01744652,543,dasatinib,1,50,mg,1,daily,Arm A
29047029,NCT01744652,543,crizotinib,2,250,mg,2,daily,Arm A
29047029,NCT01744652,543,dasatinib,2,70,mg,1,daily,Arm A
29047029,NCT01744652,543,crizotinib,1,250,mg,1,every other day,Arm B
29047029,NCT01744652,543,dasatinib,1,140,mg,1,daily,Arm B
29047029,NCT01744652,543,crizotinib,2,200,mg,1,daily,Arm B
29047029,NCT01744652,543,dasatinib,2,140,mg,1,daily,Arm B
26091915,NCT01169532,544,rapamycin,1,20,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,1,100,mg,2,on days 1-3 weekly every 21 days,NA
26091915,NCT01169532,544,rapamycin,2,20,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,2,200,mg,2,on days 1-3 weekly every 21 days,NA
26091915,NCT01169532,544,rapamycin,3,40,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,3,100,mg,2,on days 1-3 weekly every 21 days,NA
26091915,NCT01169532,544,rapamycin,-1,10,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,-1,100,mg,2,on days 1-3 weekly every 21 days,NA
26091915,NCT01169532,544,rapamycin,-2,20,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,-2,100,mg,1,on days 1-3 weekly every 21 days,NA
26091915,NCT01169532,544,rapamycin,-3,10,mg,1,days 1–5 weekly every 21 days,NA
26091915,NCT01169532,544,vorinostat,-3,100,mg,1,on days 1-3 weekly every 21 days,NA
11241232,NA,545,vinorelbine,0,36,mg/m2,1,every 21 days,NA
11241232,NA,545,paclitaxel,0,175,mg/m2,1,every 21 days,NA
11241232,NA,545,vinorelbine,-1,30,mg/m2,1,every 21 days,NA
11241232,NA,545,paclitaxel,-1,175,mg/m2,1,every 21 days,NA
11241232,NA,545,vinorelbine,-2,25,mg/m2,1,every 21 days,NA
11241232,NA,545,paclitaxel,-2,175,mg/m2,1,every 21 days,NA
11241232,NA,545,vinorelbine,-3,30,mg/m2,1,every 21 days,NA
11241232,NA,545,paclitaxel,-3,150,mg/m2,1,every 21 days,NA
11241232,NA,545,vinorelbine,-4,25,mg/m2,1,every 21 days,NA
11241232,NA,545,paclitaxel,-4,150,mg/m2,1,every 21 days,NA
11241232,NA,546,vinorelbine,-1,25,mg/m2,1,every 21 days,NA
11241232,NA,546,paclitaxel,-1,150,mg/m2,1,every 21 days,NA
11241232,NA,546,g-csf,-1,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",fixed
11241232,NA,546,g-csf,-1,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",fixed
11241232,NA,546,vinorelbine,0,30,mg/m2,1,every 21 days,NA
11241232,NA,546,paclitaxel,0,150,mg/m2,1,every 21 days,NA
11241232,NA,546,g-csf,0,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,g-csf,0,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,vinorelbine,1,36,mg/m2,1,every 21 days,NA
11241232,NA,546,paclitaxel,1,150,mg/m2,1,every 21 days,NA
11241232,NA,546,g-csf,1,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,g-csf,1,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,vinorelbine,2,42,mg/m2,1,every 21 days,NA
11241232,NA,546,paclitaxel,2,150,mg/m2,1,every 21 days,NA
11241232,NA,546,g-csf,2,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,g-csf,2,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,vinorelbine,3,46,mg/m2,1,every 21 days,NA
11241232,NA,546,paclitaxel,3,150,mg/m2,1,every 21 days,NA
11241232,NA,546,g-csf,3,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
11241232,NA,546,g-csf,3,5,ug/kg,1,"on Days 3 through 8 or until absolute granulocyte count >10,000",NA
9626216,NA,547,vinorelbine,1,20,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
9626216,NA,547,cisplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,cisplatin,1,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,thoracic radiation,1,2,Gy,1,"daily (Monday to Friday) for approximately 6 weeks, for a total dose of approximately 60 Gy",fixed
9626216,NA,547,vinorelbine,2,25,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
9626216,NA,547,cisplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,cisplatin,2,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,thoracic radiation,2,2,Gy,1,"daily (Monday to Friday) for approximately 6 weeks, for a total dose of approximately 60 Gy",fixed
9626216,NA,547,vinorelbine,3,20,mg/m2,1,on days 1 and 8 of each 3-week cycle,NA
9626216,NA,547,cisplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,cisplatin,3,100,mg/m2,1,on day 1 of each 3-week cycle,NA
9626216,NA,547,thoracic radiation,3,2,Gy,1,"daily (Monday to Friday) for approximately 6 weeks, for a total dose of approximately 60 Gy",fixed
9626216,NA,547,vinorelbine,4A,15,mg/m2,1,"on days 1, 8, 22, and 29",NA
9626216,NA,547,cisplatin,4A,80,mg/m2,1,on days 1 and 22 of RT,NA
9626216,NA,547,cisplatin,4A,80,mg/m2,1,on days 1 and 22 of RT,NA
9626216,NA,547,thoracic radiation,4A,2,Gy,1,"daily (Monday to Friday) for approximately 6 weeks, for a total dose of approximately 60 Gy",fixed
9626216,NA,547,vinorelbine,4B,15,mg/m2,1,on days 1 and 2 of each 3-week cycle,NA
9626216,NA,547,cisplatin,4B,80,mg/m2,1,on days 1 and 22 of RT,NA
9626216,NA,547,cisplatin,4B,80,mg/m2,1,on days 1 and 22 of RT,NA
9626216,NA,547,thoracic radiation,4B,2,Gy,1,"daily (Monday to Friday) for approximately 6 weeks, for a total dose of approximately 60 Gy",fixed
25695691,NCT01019850,548,vorinostat,1,180,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,1,8,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,2,180,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,2,12,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,3,230,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,3,12,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,4,230,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,4,15,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,5,230,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,5,18,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,5a,180,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,5a,18,mCi/kg,1,On day 3,NA
25695691,NCT01019850,548,vorinostat,6,270,mg/m2,1,daily on days 1 to 14,NA
25695691,NCT01019850,548,131i-mibg,6,18,mCi/kg,1,On day 3,NA
29603591,NA,549,isotretinoin,1,80,mg/m2,2,daily on days 1–14 in each 28-day cycle,fixed
29603591,NA,549,vorinostat,1,180,mg/m2,1,on days 1–4 and days 8–11 in each 28-day cycle,NA
29603591,NA,549,isotretinoin,2,80,mg/m2,2,daily on days 1–14 in each 28-day cycle,fixed
29603591,NA,549,vorinostat,2,230,mg/m2,1,on days 1–4 and days 8–11 in each 28-day cycle,NA
29603591,NA,549,isotretinoin,3,80,mg/m2,2,daily on days 1–14 in each 28-day cycle,fixed
29603591,NA,549,vorinostat,3,300,mg/m2,1,on days 1–4 and days 8–11 in each 28-day cycle,NA
29603591,NA,549,isotretinoin,4,80,mg/m2,2,daily on days 1–14 in each 28-day cycle,fixed
29603591,NA,549,vorinostat,4,360,mg/m2,1,on days 1–4 and days 8–11 in each 28-day cycle,NA
29603591,NA,549,isotretinoin,5,80,mg/m2,2,daily on days 1–14 in each 28-day cycle,fixed
29603591,NA,549,vorinostat,5,430,mg/m2,1,on days 1–4 and days 8–11 in each 28-day cycle,NA
18297527,NCT00109109,550,vorinostat,1,200,mg,2,5 days/week/4-week cycle,NA
18297527,NCT00109109,550,vorinostat,2,250,mg,2,5 days/week/4-week cycle,NA
18297527,NCT00109109,550,vorinostat,3,300,mg,2,5 days/week/4-week cycle,NA
18297527,NCT00109109,550,vorinostat,4,200,mg,2,daily for 14 days/3-week cycle,NA
18297527,NCT00109109,550,vorinostat,5,300,mg,2,daily for 14 days/3-week cycle,NA
18297527,NCT00109109,550,vorinostat,6,400,mg,2,daily for 14 days/3-week cycle,NA
7747714,NA,551,cyclosporin a,1,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,1,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,1,6,mg/m2,1,on day 3 every 4 weeks,NA
7747714,NA,551,cyclosporin a,2,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,2,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,2,7,mg/m2,1,on day 3 every 4 weeks,NA
7747714,NA,551,cyclosporin a,3,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,3,14,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,3,8,mg/m2,1,on day 3 every 4 weeks,NA
7747714,NA,551,cyclosporin a,4,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,4,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,4,8,mg/m2,1,on day 3 every 4 weeks,NA
7747714,NA,551,cyclosporin a,5,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,5,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,5,9,mg/m2,1,on day 3 every 4 weeks,NA
7747714,NA,551,cyclosporin a,6,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,cyclosporin a,6,17,mg/kg/d,4,"a 5-mg/kg loading dose at 8 p.m. on day 0, and then given daily for 3 days in divided doses at 8 a.m., 12 p.m., 4 p.m., and 8 p.m. every 4 weeks",NA
7747714,NA,551,vinblastine,6,10,mg/m2,1,on day 3 every 4 weeks,NA
31409616,NCT02638090,552,pembrolizumab,1,200,mg,1,every 3 weeks,fixed
31409616,NCT02638090,552,vorinostat,1,200,mg,1,daily,NA
31409616,NCT02638090,552,pembrolizumab,2,200,mg,1,every 3 weeks,fixed
31409616,NCT02638090,552,vorinostat,2,400,mg,1,daily,NA
31823832,NCT01422499,553,vorinostat,-1,130,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,1,180,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,2,230,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,3,280,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,4,330,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,5,380,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,6,430,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,7,480,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,8,530,mg/m2/d,1,daily,NA
31823832,NCT01422499,553,vorinostat,9,580,mg/m2/d,1,daily,NA
7931480,NA,554,vinorelbine,1,5.5,mg/m2,NA,"an initial IV bolus of 8 mg/m 2 on day 1, by a 4-day CIV every 21 or 28 days",NA
7931480,NA,554,vinorelbine,2,7,mg/m2,NA,"an initial IV bolus of 8 mg/m 2 on day 1, by a 4-day CIV every 21 or 28 days",NA
7931480,NA,554,vinorelbine,3,8,mg/m2,NA,"an initial IV bolus of 8 mg/m 2 on day 1, by a 4-day CIV every 21 or 28 days",NA
7931480,NA,554,vinorelbine,4,9,mg/m2,NA,"an initial IV bolus of 8 mg/m 2 on day 1, by a 4-day CIV every 21 or 28 days",NA
7931480,NA,554,vinorelbine,5,10,mg/m2,NA,"an initial IV bolus of 8 mg/m 2 on day 1, by a 4-day CIV every 21 or 28 days",NA
34347089,NCT01189266,555,vorinostat,1,180,mg/m2,1,"started on the first day of radiation and given Monday through Friday for the duration of radiation treatment, and then continued at 230 mg/m2 daily for a maximum of twelve 28-day cycles",NA
34347089,NCT01189266,555,radiation,1,1.8,Gy,1,"Monday through Friday weekly, up to total of 54 Gy",fixed
34347089,NCT01189266,555,vorinostat,2,230,mg/m2,1,"started on the first day of radiation and given Monday through Friday for the duration of radiation treatment, and then continued at 230 mg/m2 daily for a maximum of twelve 28-day cycles",NA
34347089,NCT01189266,555,radiation,2,1.8,Gy,1,"Monday through Friday weekly, up to total of 54 Gy",fixed
19817748,NCT00127140,556,vorinostat,1,100,mg,2,daily for 14 consecutive days followed by a 1-week rest interval,NA
19817748,NCT00127140,556,vorinostat,2,200,mg,2,daily for 14 consecutive days followed by a 1-week rest interval,NA
34896762,NCT02521051,557,alectinib,1,600,mg,2,daily,NA
34896762,NCT02521051,557,bevacizumab,1,15,mg/kg,1,every 3 weeks,NA
32181989,NA,558,ct-707,1,300,mg,2,every 21 day,NA
32181989,NA,558,ct-707,2,450,mg,1,every 21 day,NA
32181989,NA,558,ct-707,3,600,mg,1,every 21 day,NA
10963843,NA,559,vinorelbine,1,4,mg/m2,1,"daily 5 days a week, for 6 weeks",NA
10963843,NA,559,thoracic radiotherapy,1,1.8/2,Gy,1,1.8 Gy for 5 days a week for 6 weeks and increased to 2.0 Gy during the sixth and last week with a totaldose of 55 Gy,fixed
10963843,NA,559,vinorelbine,2,5,mg/m2,1,"daily 5 days a week, for 6 weeks",NA
10963843,NA,559,thoracic radiotherapy,2,1.8/2,Gy,1,1.8 Gy for 5 days a week for 6 weeks and increased to 2.0 Gy during the sixth and last week with a totaldose of 55 Gy,fixed
26891067,NCT01222780,560,vincristine,1,1.75,mg/m2,1,"on days 1, 8, 15, and 22 ofa 28-day course",NA
26891067,NCT01222780,560,vincristine,2,2.25,mg/m2,1,"on days 1, 8, 15, and 22 ofa 28-day course",NA
28816142,NCT00946673,561,vorinostat,1,200,mg,1,for 14 days,NA
28816142,NCT00946673,561,stereotactic radiosurgery,1,NA,Gy,NA,on day 3 of vorinostat. diameter 0 to 1.0 cm: 24 Gy; 1.1 to 1.5 cm: 22 Gy; 1.6 to 2.0 cm: 20 Gy,NA
28816142,NCT00946673,561,vorinostat,2,300,mg,1,for 14 days,NA
28816142,NCT00946673,561,stereotactic radiosurgery,2,NA,Gy,NA,on day 3 of vorinostat. diameter 0 to 1.0 cm: 24 Gy; 1.1 to 1.5 cm: 22 Gy; 1.6 to 2.0 cm: 20 Gy,NA
28816142,NCT00946673,561,vorinostat,3,400,mg,1,for 14 days,NA
28816142,NCT00946673,561,stereotactic radiosurgery,3,NA,Gy,NA,on day 3 of vorinostat. diameter 0 to 1.0 cm: 24 Gy; 1.1 to 1.5 cm: 22 Gy; 1.6 to 2.0 cm: 20 Gy,NA
15736475,NA,562,leucovorin,1,500,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,5-fluorouracil,1,1500,mg/m2,NA,"a 22-hour c.i, on days 1 and 2 every two weeks",fixed
15736475,NA,562,cyclophosphamide,1,300,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,vinorelbine,1,20,mg/m2,1,day 1 every two weeks,NA
15736475,NA,562,leucovorin,2,500,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,5-fluorouracil,2,1500,mg/m2,NA,"a 22-hour c.i, on days 1 and 2 every two weeks",fixed
15736475,NA,562,cyclophosphamide,2,300,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,vinorelbine,2,25,mg/m2,1,day 1 every two weeks,NA
15736475,NA,562,leucovorin,3,500,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,5-fluorouracil,3,1500,mg/m2,NA,"a 22-hour c.i, on days 1 and 2 every two weeks",fixed
15736475,NA,562,cyclophosphamide,3,300,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,vinorelbine,3,22.5,mg/m2,1,day 1 every two weeks,NA
15736475,NA,562,leucovorin,4,500,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,5-fluorouracil,4,1500,mg/m2,NA,"a 22-hour c.i, on days 1 and 2 every two weeks",fixed
15736475,NA,562,cyclophosphamide,4,300,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,vinorelbine,4,22.5,mg/m2,1,day 1 every two weeks,#NAME?
15736475,NA,562,leucovorin,5,500,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,5-fluorouracil,5,1500,mg/m2,NA,"a 22-hour c.i, on days 1 and 2 every two weeks",fixed
15736475,NA,562,cyclophosphamide,5,300,mg/m2,1,day 1 every two weeks,fixed
15736475,NA,562,vinorelbine,5,25,mg/m2,1,day 1 every two weeks,#NAME?
20564083,NA,563,imexon,1,570,mg/m2,1,daily for 5 consecutive days every 3 week,NA
20564083,NA,563,dacarbazine,1,250,mg/m2,1,daily for 5 consecutive days every 3 week,fixed
20564083,NA,563,imexon,2,750,mg/m2,1,daily for 5 consecutive days every 3 week,NA
20564083,NA,563,dacarbazine,2,250,mg/m2,1,daily for 5 consecutive days every 3 week,fixed
20564083,NA,563,imexon,3,1000,mg/m2,1,daily for 5 consecutive days every 3 week,NA
20564083,NA,563,dacarbazine,3,250,mg/m2,1,daily for 5 consecutive days every 3 week,fixed
20564083,NA,563,imexon,4,1300,mg/m2,1,daily for 5 consecutive days every 3 week,NA
20564083,NA,563,dacarbazine,4,250,mg/m2,1,daily for 5 consecutive days every 3 week,fixed
23320927,NCT00132522,564,cyclophosphamide,1,300,mg/m2,1,on day 1 of each 21-day cycle,fixed
23320927,NCT00132522,564,huks-il2,1,0.5,mg/m2,1,"on days 2, 3, and 4 of each 21-day cycle",NA
23320927,NCT00132522,564,cyclophosphamide,2,300,mg/m2,1,on day 1 of each 21-day cycle,fixed
23320927,NCT00132522,564,huks-il2,2,1,mg/m2,1,"on days 2, 3, and 4 of each 21-day cycle",NA
23320927,NCT00132522,564,cyclophosphamide,3,300,mg/m2,1,on day 1 of each 21-day cycle,fixed
23320927,NCT00132522,564,huks-il2,3,2,mg/m2,1,"on days 2, 3, and 4 of each 21-day cycle",NA
23320927,NCT00132522,564,cyclophosphamide,4,300,mg/m2,1,on day 1 of each 21-day cycle,fixed
23320927,NCT00132522,564,huks-il2,4,3,mg/m2,1,"on days 2, 3, and 4 of each 21-day cycle",NA
23320927,NCT00132522,564,cyclophosphamide,5,300,mg/m2,1,on day 1 of each 21-day cycle,fixed
23320927,NCT00132522,564,huks-il2,5,4,mg/m2,1,"on days 2, 3, and 4 of each 21-day cycle",NA
31506385,NCT01677741,565,dabrafenib,1,3,mg/kg,NA,a single dose on Day 1 and twice daily from Day 2,NA
31506385,NCT01677741,565,dabrafenib,2,3.75,mg/kg,NA,a single dose on Day 1 and twice daily from Day 2,NA
31506385,NCT01677741,565,dabrafenib,3,4.5,mg/kg,NA,a single dose on Day 1 and twice daily from Day 2,NA
31506385,NCT01677741,565,dabrafenib,4,5.25,mg/kg,NA,a single dose on Day 1 and twice daily from Day 2,NA
22918078,NA,566,selectikine,1,0.075,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,2,0.15,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,3,0.225,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,4,0.3,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,5,0.45,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,6,0.6,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,566,selectikine,7,0.9,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,567,selectikine,1,0.45,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,567,cyclophosphamide,1,300,mg/m2,1,day 1 of each cycle,fixed
22918078,NA,567,selectikine,2,0.6,mg/kg,1,on days 1–3 of a 21-day cycle,NA
22918078,NA,567,cyclophosphamide,2,300,mg/m2,1,day 1 of each cycle,fixed
22307137,NCT00810966,568,veliparib,1,20,mg,1,daily for the first 7 days of the cycle,NA
22307137,NCT00810966,568,cyclophosphamide,1,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,2,30,mg,1,daily for the first 7 days of the cycle,NA
22307137,NCT00810966,568,cyclophosphamide,2,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,3,30,mg,1,daily for the first 14 days of the cycle,NA
22307137,NCT00810966,568,cyclophosphamide,3,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,4,40,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,cyclophosphamide,4,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,5,40,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,cyclophosphamide,5,100,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,6,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,cyclophosphamide,6,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,7,60,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,cyclophosphamide,7,50,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,veliparib,8,80,mg,1,daily throughout a 21-day cycle,NA
22307137,NCT00810966,568,cyclophosphamide,8,50,mg,1,daily throughout a 21-day cycle,NA
25728527,NCT01240538,569,reolysin,1,3 x 10-^8,TCID50/kg,1,"for 5 consecutive days, every 28 days",NA
25728527,NCT01240538,569,reolysin,2,5 x 10-^8,TCID50/kg,1,"for 5 consecutive days, every 28 days",NA
25728527,NCT01240538,570,reolysin,1,5 x 10-^8,TCID50/kg,1,"for 5 consecutive days, every 28 days",NA
25728527,NCT01240538,570,cyclophosphamide,1,50,mg/m2,1,daily for 21 consecutive days every 28 days,NA
8751547,NA,571,paclitaxel,1,135,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,1,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,1,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,1,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,1,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,1,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,paclitaxel,2,175,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,2,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,2,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,2,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,2,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,2,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,paclitaxel,3,200,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,3,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,3,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,3,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,3,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,3,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,paclitaxel,4,250,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,4,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,4,75,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,4,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,4,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,4,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,paclitaxel,5,250,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,5,100,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,5,100,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,5,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,5,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,5,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,paclitaxel,6,250,mg/m2,1,24-hr infusion from day 1 to day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,6,125,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cisplatin,6,125,mg/m2,1,day 2 on a 21-day cycle,NA
8751547,NA,571,cyclophosphamide,6,750,mg/m2,1,day 1 on a 21-day cycle,fixed
8751547,NA,571,g-csf,6,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
8751547,NA,571,g-csf,6,10,ug/kg,1,"administration continued 24 hr after the cisplatin infusion until the WBC was >=30,000/cm3 on a 21-day cycle",fixed
24991840,NCT00486603).,572,hydroxychloroquine,1,200,mg,1,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,hydroxychloroquine,1,200,mg,1,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,temozolomide,1,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,temozolomide,1,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,radiation therapy,1,60,Gy,NA,in 30 fractions during the first six weeks of treatment Monday-Friday,fixed
24991840,NCT00486603).,572,hydroxychloroquine,2,200,mg,2,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,hydroxychloroquine,2,200,mg,2,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,temozolomide,2,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,temozolomide,2,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,radiation therapy,2,60,Gy,NA,in 30 fractions during the first six weeks of treatment Monday-Friday,fixed
24991840,NCT00486603).,572,hydroxychloroquine,3,400  mg  in  the  morning  and  200  mg  in  the  evening,mg,NA,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,hydroxychloroquine,3,400  mg  in  the  morning  and  200  mg  in  the  evening,mg,NA,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,temozolomide,3,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,temozolomide,3,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,radiation therapy,3,60,Gy,NA,in 30 fractions during the first six weeks of treatment Monday-Friday,fixed
24991840,NCT00486603).,572,hydroxychloroquine,4,800,mg,2,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,hydroxychloroquine,4,800,mg,2,"daily on 1st day of RT and concomitant temozolomide for 6wks during RT. After 6 wks,  4 wkd of HCQ alone daily.",NA
24991840,NCT00486603).,572,temozolomide,4,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,temozolomide,4,75,mg/m2,1,daily for 6wks with RT+HCQ,fixed
24991840,NCT00486603).,572,radiation therapy,4,60,Gy,NA,in 30 fractions during the first six weeks of treatment Monday-Friday,fixed
11049969,NA,573,iodine-131–tositumomab,0,20,Gy,NA,NA,NA
11049969,NA,573,etoposide,0,60,mg/kg,1,NA,NA
11049969,NA,573,cyclophosphamide,0,100,mg/kg,1,NA,NA
11049969,NA,573,tositumomab,0,1.7,mg/kg,1,NA,fixed
11049969,NA,573,iodine-131–tositumomab,1,20,Gy,NA,NA,NA
11049969,NA,573,etoposide,1,60,mg/kg,1,NA,NA
11049969,NA,573,cyclophosphamide,1,100,mg/kg,1,NA,NA
11049969,NA,573,tositumomab,1,1.7,mg/kg,1,NA,fixed
11049969,NA,573,iodine-131–tositumomab,2,23,Gy,NA,NA,NA
11049969,NA,573,etoposide,2,60,mg/kg,1,NA,NA
11049969,NA,573,cyclophosphamide,2,100,mg/kg,1,NA,NA
11049969,NA,573,tositumomab,2,1.7,mg/kg,1,NA,fixed
11049969,NA,573,iodine-131–tositumomab,3,25,Gy,NA,NA,NA
11049969,NA,573,etoposide,3,60,mg/kg,1,NA,NA
11049969,NA,573,cyclophosphamide,3,100,mg/kg,1,NA,NA
11049969,NA,573,tositumomab,3,1.7,mg/kg,1,NA,fixed
11049969,NA,573,iodine-131–tositumomab,4,27,Gy,NA,NA,NA
11049969,NA,573,etoposide,4,60,mg/kg,1,NA,NA
11049969,NA,573,cyclophosphamide,4,100,mg/kg,1,NA,NA
11049969,NA,573,tositumomab,4,1.7,mg/kg,1,NA,fixed
25139740,NCT00741377,574,bhq880,1,3,mg/kg,1,Day 1 every 28 d,NA
25139740,NCT00741377,574,zoledronic acid,1,4,mg,1,Day 1 every 28 d,fixed
25139740,NCT00741377,574,bhq880,2,10,mg/kg,1,Day 1 every 28 d,NA
25139740,NCT00741377,574,zoledronic acid,2,4,mg,1,Day 1 every 28 d,fixed
25139740,NCT00741377,574,bhq880,3,20,mg/kg,1,Day 1 every 28 d,NA
25139740,NCT00741377,574,zoledronic acid,3,4,mg,1,Day 1 every 28 d,fixed
25139740,NCT00741377,574,bhq880,4,40,mg/kg,1,Day 1 every 28 d,NA
25139740,NCT00741377,574,zoledronic acid,4,4,mg,1,Day 1 every 28 d,fixed
32998961,NCT03303339,575,onvansertib,1,12,mg/m2,1,Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,575,low-dose cytarabine,1,20,mg/m2,1,daily on Day 1 through Day 10 every 28 days,fixed
32998961,NCT03303339,575,onvansertib,2,18,mg/m2,1,Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,575,low-dose cytarabine,2,20,mg/m2,1,daily on Day 1 through Day 10 every 28 days,fixed
32998961,NCT03303339,575,onvansertib,3,27,mg/m2,1,Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,575,low-dose cytarabine,3,20,mg/m2,1,daily on Day 1 through Day 10 every 28 days,fixed
32998961,NCT03303339,575,onvansertib,4,40,mg/m2,1,Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,575,low-dose cytarabine,4,20,mg/m2,1,daily on Day 1 through Day 10 every 28 days,fixed
32998961,NCT03303339,575,onvansertib,5,60,mg/m2,1,Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,575,low-dose cytarabine,5,20,mg/m2,1,daily on Day 1 through Day 10 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,1,12,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,1,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,2,18,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,2,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,3,27,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,3,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,4,40,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,4,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,5,60,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,5,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
32998961,NCT03303339,576,onvansertib,6,90,mg/m2,1,on Day 1 through Day 5 every 28 days,NA
32998961,NCT03303339,576,decitabine,6,20,mg/m2,1,on Day 1 through Day 5 every 28 days,fixed
7607931,NA,577,cyclophosphamide,2,60,mg/m2,1,on days -7 and -6,fixed
7607931,NA,577,total body irradiation,2,1.2,Gy,3,on days -4 to -1 for total 14.4 Gy,NA
7607931,NA,577,cyclophosphamide,1,60,mg/m2,1,on days -7 and -6,fixed
7607931,NA,577,total body irradiation,1,1.1,Gy,3,on days -4 to -1 for total 13.2Gy,NA
24682421,NCT 00838240,578,clofarabine,-2,5,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,-2,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,-2,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,-1,7.5,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,-1,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,-1,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,0,10,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,0,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,0,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,1,15,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,1,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,1,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,2,20,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,2,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,2,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,3,25,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,3,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,3,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,4,30,mg/m2,1,"1-h infusion on days 2, 4, 6, 8, and 10",Arm A
24682421,NCT 00838240,578,cytosine arabinoside,4,100,mg/m2,1,continuous infusion on days 1–10,fixed
24682421,NCT 00838240,578,idarubicin,4,10,mg/m2,1,"on days 1, 3, and 5",fixed
24682421,NCT 00838240,578,clofarabine,-2,5,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,-1,7.5,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,0,10,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,1,15,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,2,20,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,3,25,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
24682421,NCT 00838240,578,clofarabine,4,30,mg/m2,1,"push injection on days 2, 4, 6, 8, and 10",Arm B
23867058,NA,579,alvocidib,1,30,mg/m2,1,"30 mg/m2 IV (30 min), 30 mg/m2 IV (4 h)  C1D8; C2-6D1 and 8",NA
23867058,NA,579,rituximab,1,0,mg,1,NA,NA
23867058,NA,579,cyclophosphamide,1,0,mg/m2,1,NA,NA
23867058,NA,579,alvocidib,2,30/50,mg/m2,1,"30 mg/m2 IV (30 min), 50 mg/m2 IV (4 h)  C1D8; C2-6D1 and 8",NA
23867058,NA,579,rituximab,2,100,mg,1,C1D1,fixed
23867058,NA,579,rituximab,2,375,mg/m2,1,C1D2 and C2-6D1,fixed
23867058,NA,579,cyclophosphamide,2,300,mg/m2,1,C1-6D1-3,NA
23867058,NA,579,alvocidib,3,0,mg/m2,1,NA,NA
23867058,NA,579,rituximab,3,0,mg/m2,1,NA,NA
23867058,NA,579,cyclophosphamide,3,375,mg/m2,1,C1-6D1-3,NA
9213323,NA,580,docetaxel,1,NA,NA,NA,NA,dose levels not specified
9213323,NA,580,cyclophosphamide,1,NA,NA,NA,NA,NA
24958809,NCT00880321,581,dabrafenib,1,12,mg,1,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,2,35,mg,1,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,3,35,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,4,70,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,5,100,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,6,100,mg,3,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,7,150,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,8,200,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,9,300,mg,2,daily in 21-day treatment cycles,NA
24958809,NCT00880321,581,dabrafenib,10,75,mg,2,daily in 21-day treatment cycles,NA
31811016,NCT01677741,582,dabrafenib,1,3.75,mg/kg,2,"a single dose of 3 mg/kg dabrafenib on Day 1 and repeat dose will begin from Day 2, evenly divided in two daily doses in 28-day cycles",NA
31811016,NCT01677741,582,dabrafenib,2,4.5,mg/kg,2,"a single dose of 3 mg/kg dabrafenib on Day 1 and repeat dose will begin from Day 2, evenly divided in two daily doses in 28-day cycles",NA
31811016,NCT01677741,582,dabrafenib,3,5.25,mg/kg,2,"a single dose of 3 mg/kg dabrafenib on Day 1 and repeat dose will begin from Day 2, evenly divided in two daily doses in 28-day cycles",NA
31796520,NCT02383212,583,cemiplimab,1,1,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,583,cemiplimab,2,3,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,583,cemiplimab,3,10,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,584,cemiplimab,1,1,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,584,hypofractionated radiotherapy,1,6,Gy,1,"daily per fraction, for 5 fractions starting 1 week after the first dose of cemiplimab",NA
31796520,NCT02383212,584,cemiplimab,2,1,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,584,hypofractionated radiotherapy,2,9,Gy,1,"every other day per fraction, for 3 fractions , starting 1 week after the first dose of cemiplimab",NA
31796520,NCT02383212,585,cemiplimab,1,3,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,585,cyclophosphamide,1,200,mg/m2,1,1 day prior to each of the four doses of cemiplimab in cycle 1,NA
31796520,NCT02383212,586,cemiplimab,1,3 or MTD,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,586,hypofractionated radiotherapy,1,6,Gy,1,"daily per fraction, for 5 fractions starting 1 week after the first dose of cemiplimab",NA
31796520,NCT02383212,586,cyclophosphamide,1,200,mg/m2,1,1 day prior to each of the four doses of cemiplimab in cycle 1,NA
31796520,NCT02383212,586,cemiplimab,2,3 or MTD,mg/kg,1,every 2 weeks of each 8-week treatment cycle,NA
31796520,NCT02383212,586,hypofractionated radiotherapy,2,9,Gy,1,"every other day per fraction, for 5 fractions starting 1 week after the first dose of cemiplimab",NA
31796520,NCT02383212,586,cyclophosphamide,2,200,mg/m2,1,1 day prior to each of the four doses of cemiplimab in cycle 1,NA
32741971,NCT02597036,587,ly3127804,1,4,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,587,ly3127804,2,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,587,ly3127804,3,12,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,587,ly3127804,4,16,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,587,ly3127804,5,20,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,587,ly3127804,6,27,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort A
32741971,NCT02597036,588,ly3127804,1,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort B
32741971,NCT02597036,588,ramucirumab,1,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
32741971,NCT02597036,588,ly3127804,2,12,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort B
32741971,NCT02597036,588,ramucirumab,2,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
32741971,NCT02597036,588,ly3127804,3,16,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort B
32741971,NCT02597036,588,ramucirumab,3,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
32741971,NCT02597036,588,ly3127804,4,20,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort B
32741971,NCT02597036,588,ramucirumab,4,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
32741971,NCT02597036,588,ly3127804,5,27,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort B
32741971,NCT02597036,588,ramucirumab,5,8,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
32741971,NCT02597036,588,ly3127804,6,20,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,cohort C
32741971,NCT02597036,588,ramucirumab,6,12,mg/kg,1,every 2 weeks (Q2W) for 28 day cycle,fixed
8622060,NA,589,paclitaxel,1,135,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,1,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,1,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,1,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,2,200,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,2,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,2,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,2,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,3,250,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,3,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,3,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,3,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,4,325,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,4,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,4,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,4,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,5,425,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,5,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,5,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,5,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,6,525,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,6,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,6,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,6,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,7,626,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,7,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,7,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,7,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,8,725,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,8,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,8,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,8,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,9,825,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,9,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,9,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,9,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,paclitaxel,10,775,mg/m2,1,on day -7,NA
8622060,NA,589,cyclophosphamide,10,1875,mg/m2,1,on days -6 to -4,fixed
8622060,NA,589,cisplatin,10,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
8622060,NA,589,cisplatin,10,165,mg/m2,NA,a continuous infusion over 72 hours from days -6 to -4,fixed
21811257,NA,590,lomeguatrib,1,40,mg,1,on days 1 – 5 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,1,500,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,2,80,mg,1,on days 1 – 5 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,2,500,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,3,80,mg,1,on days 1 – 5 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,3,600,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,4,80,mg,1,on days 1 – 5 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,4,700,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,5,80,mg,1,on days 1 – 5 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,5,800,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,6,40,mg,2,on days 1 – 10 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,6,700,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,7,40,mg,2,on days 1 – 10 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,7,600,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,8,40,mg,2,on days 1 – 10 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,8,500,mg/m2,1,on day 2 of a 21-day cycle,NA
21811257,NA,590,lomeguatrib,9,40,mg,2,on days 1 – 10 of each 21-day cycle,NA
21811257,NA,590,dacarbazine,9,400,mg/m2,1,on day 2 of a 21-day cycle,NA
27649551,NCT02239900,591,ipilimumab,1,3,mg/kg,1,on Day 1 every 3 weeks for 4 doses,NA
27649551,NCT02239900,591,stereotactic ablative radiotherapy,1,50,Gy,NA,concurrent radiation in 4 fractions to a liver lesion on Days 1 - 4 of Cycle 1,NA
27649551,NCT02239900,591,ipilimumab,2,3,mg/kg,1,on Day 1 every 3 weeks for 4 doses,NA
27649551,NCT02239900,591,stereotactic ablative radiotherapy,2,50,Gy,NA,sequential radiation to 50 Gy in 4 fractions to a liver lesion on Days 29 - 33 of each 21 day cycle,NA
27649551,NCT02239900,591,ipilimumab,3,3,mg/kg,1,on Day 1 every 3 weeks for 4 doses,NA
27649551,NCT02239900,591,stereotactic ablative radiotherapy,3,50,Gy,NA,concurrent radiation to 50 Gy in 4 fractions to a lung lesion on Days 1 - 4 of Cycle 1,NA
27649551,NCT02239900,591,ipilimumab,4,3,mg/kg,1,on Day 1 every 3 weeks for 4 doses,NA
27649551,NCT02239900,591,stereotactic ablative radiotherapy,4,50,Gy,NA,sequential radiation to 50 Gy in 4 fractions to a lung lesion on Days 29 - 33 of each 21 day cycle,NA
27649551,NCT02239900,591,ipilimumab,5,3,mg/kg,1,on Day 1 every 3 weeks for 4 doses,NA
27649551,NCT02239900,591,stereotactic ablative radiotherapy,5,60,Gy,NA,sequential radiation to a liver or a lung lesion to 60 Gy in 10 fractions on Days 1 - 5 and Days 9 - 12 of Cycle 1,NA
26847165,NCT02340936,592,lenalidomide,1,5,mg,1,on days 1–14 of every 21-d cycle,NA
26847165,NCT02340936,592,rituximab,1,375,mg/m2,1,day 1 of every 21-d cycle,fixex
26847165,NCT02340936,592,etoposide,1,40,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,1,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,1,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cytarabine,1,2000,mg/m2,1,day  5 of every 21-d cycle,fixex
26847165,NCT02340936,592,methylprednisolone,1,500,mg,1,days 1–5 of every 21-d cycle,fixex
26847165,NCT02340936,592,lenalidomide,2,10,mg,1,on days 1–14 of every 21-d cycle,NA
26847165,NCT02340936,592,rituximab,2,375,mg/m2,1,day 1 of every 21-d cycle,fixex
26847165,NCT02340936,592,etoposide,2,40,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,2,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,2,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cytarabine,2,2000,mg/m2,1,day  5 of every 21-d cycle,fixex
26847165,NCT02340936,592,methylprednisolone,2,500,mg,1,days 1–5 of every 21-d cycle,fixex
26847165,NCT02340936,592,lenalidomide,3,15,mg,1,on days 1–14 of every 21-d cycle,NA
26847165,NCT02340936,592,rituximab,3,375,mg/m2,1,day 1 of every 21-d cycle,fixex
26847165,NCT02340936,592,etoposide,3,40,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,3,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,3,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cytarabine,3,2000,mg/m2,1,day  5 of every 21-d cycle,fixex
26847165,NCT02340936,592,methylprednisolone,3,500,mg,1,days 1–5 of every 21-d cycle,fixex
26847165,NCT02340936,592,lenalidomide,4,20,mg,1,on days 1–14 of every 21-d cycle,NA
26847165,NCT02340936,592,rituximab,4,375,mg/m2,1,day 1 of every 21-d cycle,fixex
26847165,NCT02340936,592,etoposide,4,40,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,4,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cisplatin,4,25,mg/m2,1,days 1–4 of every 21-d cycle,fixex
26847165,NCT02340936,592,cytarabine,4,2000,mg/m2,1,day  5 of every 21-d cycle,fixex
26847165,NCT02340936,592,methylprednisolone,4,500,mg,1,days 1–5 of every 21-d cycle,fixex
34428285,NCT02343536,593,azacitidine,1,100,mg,1,"7 days before cycle 1 and on days 8-21 of cycles 1-5, 21-day per cycle",NA
34428285,NCT02343536,593,rituximab,1,375,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,cyclophosphamide,1,750,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,doxorubicin,1,50,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,vincristine,1,1.4,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,prednisone,1,100,mg,1,Days 1-5 of each 21-day cycle,fixed
34428285,NCT02343536,593,azacitidine,2,250,mg,1,"7 days before cycle 1 and on days 8-21 of cycles 1-5, 21-day per cycle",NA
34428285,NCT02343536,593,rituximab,2,375,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,cyclophosphamide,2,750,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,doxorubicin,2,50,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,vincristine,2,1.4,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,prednisone,2,100,mg,1,Days 1-5 of each 21-day cycle,fixed
34428285,NCT02343536,593,azacitidine,3,200,mg,1,"7 days before cycle 1 and on days 8-21 of cycles 1-5, 21-day per cycle",NA
34428285,NCT02343536,593,rituximab,3,375,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,cyclophosphamide,3,750,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,doxorubicin,3,50,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,vincristine,3,1.4,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,prednisone,3,100,mg,1,Days 1-5 of each 21-day cycle,fixed
34428285,NCT02343536,593,azacitidine,4,300,mg,1,"7 days before cycle 1 and on days 8-21 of cycles 1-5, 21-day per cycle",NA
34428285,NCT02343536,593,rituximab,4,375,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,cyclophosphamide,4,750,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,doxorubicin,4,50,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,vincristine,4,1.4,mg/m2,1,on Day 1 of each 21-day cycle,fixed
34428285,NCT02343536,593,prednisone,4,100,mg,1,Days 1-5 of each 21-day cycle,fixed
11840607,NA,594,ifosfamide,1,1500,mg/m2,1,days 1-3 at three weeks interval,NA
11840607,NA,594,doxorubicin,1,45,mg/m2,1,at three weeks interval,fixed
11840607,NA,594,ifosfamide,2,1750,mg/m2,1,days 1-3 at three weeks interval,NA
11840607,NA,594,doxorubicin,2,45,mg/m2,1,at three weeks interval,fixed
11840607,NA,594,ifosfamide,3,2000,mg/m2,1,days 1-3 at three weeks interval,NA
11840607,NA,594,doxorubicin,3,45,mg/m2,1,at three weeks interval,fixed
11840607,NA,594,ifosfamide,4,2250,mg/m2,1,days 1-3 at three weeks interval,NA
11840607,NA,594,doxorubicin,4,45,mg/m2,1,at three weeks interval,fixed
11840607,NA,594,ifosfamide,5,2500,mg/m2,1,days 1-3 at three weeks interval,NA
11840607,NA,594,doxorubicin,5,45,mg/m2,1,at three weeks interval,fixed
30655615,ANZCTRN: 12613000924752,595,olaparib,-2,200,mg,2,daily continuously starting on day 1 of a 3 weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,cyclophosphamide,-2,50,mg,1,"days 1, 3 and 5 every week of a 3-weekly cycle",NA
30655615,ANZCTRN: 12613000924752,595,olaparib,-1,250,mg,2,daily continuously starting on day 1 of a 3 weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,cyclophosphamide,-1,50,mg,1,"days 1, 3 and 5 every week of a 3-weekly cycle",NA
30655615,ANZCTRN: 12613000924752,595,olaparib,1,300,mg,2,daily continuously starting on day 1 of a 3 weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,cyclophosphamide,1,50,mg,1,"days 1, 3 and 5 every week of a 3-weekly cycle",NA
30655615,ANZCTRN: 12613000924752,595,olaparib,2,300,mg,2,daily continuously starting on day 1 of a 3 weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,cyclophosphamide,2,50,mg,1,days 1–5 every week of a 3-weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,olaparib,3,300,mg,2,daily continuously starting on day 1 of a 3 weekly cycle,NA
30655615,ANZCTRN: 12613000924752,595,cyclophosphamide,3,50,mg,1,days 1–7 every week of a 3-weekly cycle,NA
33811482,NCT01246986,596,galunisertib,1,80,mg,2,from day 1 to 14 of a 28- day cycle,NA
33811482,NCT01246986,596,ramucirumab,1,8,mg/kg,1,on  days  1  and  15  of  every  cycle,NA
33811482,NCT01246986,596,galunisertib,2,150,mg,2,from day 1 to 14 of a 28- day cycle,NA
33811482,NCT01246986,596,ramucirumab,2,8,mg/kg,1,on  days  1  and  15  of  every  cycle,NA
24440659,NA,597,clofarabine,1,40,mg/m2,1,daily for 3 consecutive days starting on day 2,NA
24440659,NA,597,cyclophosphamide,1,200,mg/m2,2,every 12 hours for 6 doses on days 1 to 4,NA
24440659,NA,597,clofarabine,2,40,mg/m2,1,daily for 3 consecutive days starting on day 2,NA
24440659,NA,597,cyclophosphamide,2,300,mg/m2,2,every 12 hours for 6 doses on days 1 to 4,NA
21159616,NA,598,azixa,1,0.3,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,2,0.6,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,3,1,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,4,1.5,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,5,2.1,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,6,2.7,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,7,3.3,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,8,3.9,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
21159616,NA,598,azixa,9,4.5,mg/m2,1,once weekly for 3 consecutive weeks in a 28 -day cycle,NA
34433633,NCT00562640,599,wt1-sensitized t cells,1,5 x 10^6,/m2,1,once every 2 weeks for four doses,NA
34433633,NCT00562640,599,cyclophosphamide lymphodepletion,1,0,mg/m2,1,on day -2,NA
34433633,NCT00562640,599,wt1-sensitized t cells,2,2 x 10^7,/m2,1,once every 2 weeks for four doses,NA
34433633,NCT00562640,599,cyclophosphamide lymphodepletion,2,750,mg/m2,1,on day -2,NA
34433633,NCT00562640,599,wt1-sensitized t cells,3,5 x 10^7,/m2,1,once every 2 weeks for four doses,NA
34433633,NCT00562640,599,cyclophosphamide lymphodepletion,3,750,mg/m2,1,on day -2,NA
34433633,NCT00562640,599,wt1-sensitized t cells,4,1 x 10^8,/m2,1,once every 2 weeks for four doses,NA
34433633,NCT00562640,599,cyclophosphamide lymphodepletion,4,750,mg/m2,1,on day -2,NA
22887831,NCT00293410,600,clofarabine,1,20,mg/m2,1,"On days 1, 2, 3, 8, 9, and 10 of each 28-day cycles",NA
22887831,NCT00293410,600,cyclophosphamide,1,200/400,mg/m2,1,"200 mg/m2 on days 0 and 1, 400 mg/m2 on days 2, 3, 8, 9, and 10 of each 28-day cycles",NA
22887831,NCT00293410,600,clofarabine,2,30,mg/m2,1,"On days 1, 2, 3, 8, 9, and 10 of each 28-day cycles",NA
22887831,NCT00293410,600,cyclophosphamide,2,200/400,mg/m2,1,"200 mg/m2 on days 0 and 1, 400 mg/m2 on days 2, 3, 8, 9, and 10 of each 28-day cycles",NA
20048182,NA,601,ramucirumab,1,2,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,2,4,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,3,6,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,4,8,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,5,10,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,6,13,mg/kg,1,once weekly on 4-week cycles,NA
20048182,NA,601,ramucirumab,7,16,mg/kg,1,once weekly on 4-week cycles,NA
33046516,NCT02789345,602,osimertinib,0,80,mg,1,daily during each 14 day cycle,fixed
33046516,NCT02789345,602,ramucirumab,0,10,mg/kg,1,on day 1 every 2 weeks (Q2W),NA
33046516,NCT02789345,602,osimertinib,-1,80,mg,1,daily during each 14 day cycle,fixed
33046516,NCT02789345,602,ramucirumab,-1,8,mg/kg,1,on day 1 every 2 weeks (Q2W),NA
12114412,NA,603,bryostatin 1,1,12.5,ug/m2,1,a 24-h continuous infusion on day 1 (the first course) and day 11 (the second course),NA
12114412,NA,603,ara-c,1,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,ara-c,1,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,bryostatin 1,2,25,ug/m2,1,a 24-h continuous infusion on day 1 (the first course) and day 11 (the second course),NA
12114412,NA,603,ara-c,2,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,ara-c,2,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,bryostatin 1,3,37.5,ug/m2,1,a 24-h continuous infusion on day 1 (the first course) and day 11 (the second course),NA
12114412,NA,603,ara-c,3,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,ara-c,3,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,bryostatin 1,4,50,ug/m2,1,a 24-h continuous infusion on day 1 (the first course) and day 11 (the second course),NA
12114412,NA,603,ara-c,4,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,ara-c,4,1500,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,bryostatin 1,5,50,ug/m2,1,a 24-h continuous infusion on day 1 (the first course) and day 11 (the second course),NA
12114412,NA,603,ara-c,5,3000,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
12114412,NA,603,ara-c,5,3000,mg/m2,1,"i.v. over 3 h every 12 h x 4 on days 2 and 3 (the first course), 9 and 10 (the second course)",NA
25307519,NCT01048892,605,ntx-010,1,1 x 10^9,vp/kg,1,single dose,NA
25307519,NCT01048892,605,ntx-010,2,1 x 10^10,vp/kg,1,single dose,NA
25307519,NCT01048892,605,ntx-010,3,1 x 10^11,vp/kg,1,single dose,NA
25307519,NCT01048892,606,ntx-010,1,1 x 10^11,vp/kg,1,days 8 and 29,NA
25307519,NCT01048892,606,cyclophosphamide,1,25,mg/m2,1,orally on days 1-14,fixed
25307519,NCT01048892,606,cyclophosphamide,1,750,mg/m2,1,IV  on days 8 and 29,fixed
28439108,NCT00450814,607,mv-nis,1,10^6,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,607,mv-nis,2,10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,607,mv-nis,3,10^8,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,607,mv-nis,4,10^9,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,607,mv-nis,5,10^10,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,607,mv-nis,6,10^11,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,mv-nis,1,1 x 10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,cyclophosphamide,1,10,mg/kg,1,2 days prior to the MV-NIS,NA
28439108,NCT00450814,608,mv-nis,2,3 x 10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,cyclophosphamide,2,10,mg/kg,1,2 days prior to the MV-NIS,NA
28439108,NCT00450814,608,mv-nis,3,9 x 10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,cyclophosphamide,3,10,mg/kg,1,2 days prior to the MV-NIS,NA
28439108,NCT00450814,608,mv-nis,4,27 x 10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,cyclophosphamide,4,10,mg/kg,1,2 days prior to the MV-NIS,NA
28439108,NCT00450814,608,mv-nis,5,81 x 10^7,TCID50,1,single dose on day 1,NA
28439108,NCT00450814,608,cyclophosphamide,5,10,mg/kg,1,2 days prior to the MV-NIS,NA
11869937,NA,609,idarubicin,1,12.5,mg/m2,1,on days 3 and 10,NA
11869937,NA,609,cyclosporin a,1,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cyclosporin a,1,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cytosine arabinoside,1,3000,mg/m2,2,on days 1-2 and 8-9,fixed
11869937,NA,609,granulocyte colony-stimulating factor,1,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,granulocyte colony-stimulating factor,1,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,idarubicin,2,15,mg/m2,1,on days 3 and 10,NA
11869937,NA,609,cyclosporin a,2,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cyclosporin a,2,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cytosine arabinoside,2,3000,mg/m2,2,on days 1-2 and 8-9,fixed
11869937,NA,609,granulocyte colony-stimulating factor,2,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,granulocyte colony-stimulating factor,2,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,idarubicin,3,17.5,mg/m2,1,on days 3 and 10,NA
11869937,NA,609,cyclosporin a,3,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cyclosporin a,3,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cytosine arabinoside,3,3000,mg/m2,2,on days 1-2 and 8-9,fixed
11869937,NA,609,granulocyte colony-stimulating factor,3,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,granulocyte colony-stimulating factor,3,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,idarubicin,4,20,mg/m2,1,on days 3 and 10,NA
11869937,NA,609,cyclosporin a,4,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cyclosporin a,4,"6 mg/kg i.v. over 1 hour, followed by 7.5 mg/kg over the subsequent 11
hours",mg/kg,1,"on days 3 and 10, started 4 hours before IDR and lasted 12 hours",fixed
11869937,NA,609,cytosine arabinoside,4,3000,mg/m2,2,on days 1-2 and 8-9,fixed
11869937,NA,609,granulocyte colony-stimulating factor,4,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
11869937,NA,609,granulocyte colony-stimulating factor,4,5,ug/kg,1,from day 11 until the neutrophil count exceeded 1.5×109/L,fixed
10865980,NA,610,cda,1,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cda,1,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cyclophosphamide,1,200,mg/m2,1,"given immediately after the end of each CdA infusion, as a 1-h i.v. infusion, for 3 days, every 28 days",NA
10865980,NA,610,cda,2,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cda,2,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cyclophosphamide,2,300,mg/m2,1,"given immediately after the end of each CdA infusion, as a 1-h i.v. infusion, for 3 days, every 28 days",NA
10865980,NA,610,cda,3,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cda,3,5.6,mg/m2,1,"for 3 days, every 28 days",fixed
10865980,NA,610,cyclophosphamide,3,400,mg/m2,1,"given immediately after the end of each CdA infusion, as a 1-h i.v. infusion, for 3 days, every 28 days",NA
31895753,EudraCT: 2011-004200-38,611,ipilimumab,1,0.3,mg/kg,1,every 3 weeks for 4 cycles,NA
31895753,EudraCT: 2011-004200-38,611,ipilimumab,2,3,mg/kg,1,every 3 weeks for 4 cycles,NA
31895753,EudraCT: 2011-004200-38,611,ipilimumab,3,10,mg/kg,1,every 3 weeks for 4 cycles,NA
23954889,NCT01166113,612,pomalidomide,1,1.5,mg/m2,1,daily from days 1 to 28 for 6 28-day cycles,NA
23954889,NCT01166113,612,cyclophosphamide,1,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,prednisone,1,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,pomalidomide,2,1,mg/m2,1,daily from days 1 to 28 for 6 28-day cycles,NA
23954889,NCT01166113,612,cyclophosphamide,2,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,prednisone,2,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,pomalidomide,3,2,mg/m2,1,daily from days 1 to 28 for 6 28-day cycles,NA
23954889,NCT01166113,612,cyclophosphamide,3,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,prednisone,3,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,pomalidomide,4,2.5,mg/m2,1,daily from days 1 to 28 for 6 28-day cycles,NA
23954889,NCT01166113,612,cyclophosphamide,4,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
23954889,NCT01166113,612,prednisone,4,50,mg,1,"every other day on days 1 to 28, for 6 28-day cycles",fixed
33229456,NCT02791334,613,ly3300054,1,70,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,613,ly3300054,2,200,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,613,ly3300054,3,700,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,613,ly3300054,4,1000,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,613,ly3300054,5,1800,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,614,ly3300054,1,200,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,614,ramucirumab,1,8,mg/kg,1,on day 1 and day 15 of each 28-day cycle,NA
33229456,NCT02791334,614,ly3300054,2,700,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,614,ramucirumab,2,8,mg/kg,1,on day 1 and day 15 of each 28-day cycle,NA
33229456,NCT02791334,614,ly3300054,3,1400,mg,1,on day 1 and day 15 of a 21 day cycle,NA
33229456,NCT02791334,614,ramucirumab,3,8,mg/kg,1,on day 1 and day 8 ofeach 21-day cycle,NA
33229456,NCT02791334,615,ly3300054,1,200,mg,1,"Q2W, from day 15 of treatment cycle 1, then on days 1 and 15 of subsequent 28-day cycles",lead-in abemaciclib
33229456,NCT02791334,615,abemaciclib,1,150,mg,2,every 12 hours daily of a 28 day cycle,fixed
33229456,NCT02791334,615,ly3300054,-1,70,mg,1,"Q2W, from day 15 of treatment cycle 1, then on days 1 and 15 of subsequent 28-day cycles",lead-in abemaciclib
33229456,NCT02791334,615,abemaciclib,-1,150,mg,2,every 12 hours daily of a 28 day cycle,fixed
33229456,NCT02791334,615,ly3300054,1,70,mg,1,on day 1 and day 15 of a 28 day cycle,concurrent abemaciclib
33229456,NCT02791334,615,abemaciclib,1,150,mg,2,every 12 hours of a 28 day cycle,fixed
33229456,NCT02791334,615,ly3300054,2,200,mg,1,on day 1 and day 15 of a 28 day cycle,concurrent abemaciclib
33229456,NCT02791334,615,abemaciclib,2,150,mg,2,every 12 hours of a 28 day cycle,fixed
33229456,NCT02791334,615,ly3300054,3,700,mg,1,on day 1 and day 15 of a 28 day cycle,concurrent abemaciclib
33229456,NCT02791334,615,abemaciclib,3,150,mg,2,every 12 hours of a 28 day cycle,fixed
33229456,NCT02791334,616,ly3300054,1,200,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,616,merestinib,1,120,mg,1,once daily of a 28 day cycle,NA
33229456,NCT02791334,616,ly3300054,2,700,mg,1,on day 1 and day 15 of a 28 day cycle,NA
33229456,NCT02791334,616,merestinib,2,120,mg,1,once daily of a 28 day cycle,NA
28879519,NCT01582997,617,dabrafenib,1,75,mg,2,"A single dose was administered on Day −7, then continuous daily dosing schedule was started from Day 1 until Week 12",NA
28879519,NCT01582997,617,dabrafenib,2,100,mg,2,"A single dose was administered on Day −7, then continuous daily dosing schedule was started from Day 1 until Week 12",NA
28879519,NCT01582997,617,dabrafenib,3,150,mg,2,"A single dose was administered on Day −7, then continuous daily dosing schedule was started from Day 1 until Week 12",NA
27166393,NCT00566618,618,dasatinib,1,100,mg,1,daily on days 1–28 of the cycle,NA
27166393,NCT00566618,618,zoledronic acid,1,4,mg,1,on day 1 of a 28-day cycle,NA
16675578,NA,619,abt-751,1,200,mg,1,1 for 7 consecutive days every 3 weeks,NA
16675578,NA,619,abt-751,2,250,mg,1,1 for 7 consecutive days every 3 weeks,NA
16675578,NA,619,abt-751,3,300,mg,1,1 for 7 consecutive days every 3 weeks,NA
16675578,NA,619,abt-751,4,125,mg,2,1 for 7 consecutive days every 3 weeks,NA
16675578,NA,619,abt-751,5,150,mg,2,1 for 7 consecutive days every 3 weeks,NA
16675578,NA,619,abt-751,6,175,mg,2,1 for 7 consecutive days every 3 weeks,NA
26924128,NCT01365559,620,oprozomib,1,30,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,2,60,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,3,80,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,4,120,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,5,150,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,6,180,mg,1,on days 1–5 of 14-day cycles,QD treatment
26924128,NCT01365559,620,oprozomib,7,60/60,mg,2,given twice daily (4-6 h apart)on days 1–5 of 14-day cycles,split dose
26924128,NCT01365559,620,oprozomib,8,90/60,mg,2,given twice daily (4-6 h apart)on days 1–5 of 14-day cycles,split dose
26924128,NCT01365559,620,oprozomib,9,90/90,mg,2,given twice daily (4-6 h apart)on days 1–5 of 14-day cycles,split dose
26924128,NCT01365559,620,oprozomib,10,120/90,mg,2,given twice daily (4-6 h apart)on days 1–5 of 14-day cycles,split dose
24916771,NA,621,px-866,1,6,mg,1,once daily starting on cycle 1 day 1 in 21 day cycles,NA
24916771,NA,621,cetuximab,1,400/250,mg/m2,1,400 mg/m2 IV on cycle 1 day 1 and at 250 mg/m2 IV weekly thereafter in 21 day cycles,fixed
24916771,NA,621,px-866,2,8,mg,1,once daily starting on cycle 1 day 1 in 21 day cycles,NA
24916771,NA,621,cetuximab,2,400/250,mg/m2,1,400 mg/m2 IV on cycle 1 day 1 and at 250 mg/m2 IV weekly thereafter in 21 day cycles,fixed
33713742,NCT01674842,622,cisplatin,1,10,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,cisplatin,1,10,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,radiation,1,1.8-2,Gy,1,daily fractions to the breast up to total 50 to 50.4 Gy,In the BCT cohort
33713742,NCT01674842,622,cisplatin,1,10,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,1,10,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,radiation,1,1.8-2,Gy,1,once-daily fractions was administered to the chest wall to a total of 50 to 50.4 Gy,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,2,20,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,cisplatin,2,20,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,radiation,2,1.8-2,Gy,1,daily fractions to the breast up to total 50 to 50.4 Gy,In the BCT cohort
33713742,NCT01674842,622,cisplatin,2,20,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,2,20,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,radiation,2,1.8-2,Gy,1,once-daily fractions was administered to the chest wall to a total of 50 to 50.4 Gy,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,3,30,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,cisplatin,3,30,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,radiation,3,1.8-2,Gy,1,daily fractions to the breast up to total 50 to 50.4 Gy,In the BCT cohort
33713742,NCT01674842,622,cisplatin,3,30,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,3,30,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,radiation,3,1.8-2,Gy,1,once-daily fractions was administered to the chest wall to a total of 50 to 50.4 Gy,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,4,40,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,cisplatin,4,40,mg/m2,1,once weekly,In the BCT cohort
33713742,NCT01674842,622,radiation,4,1.8-2,Gy,1,daily fractions to the breast up to total 50 to 50.4 Gy,In the BCT cohort
33713742,NCT01674842,622,cisplatin,4,40,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,cisplatin,4,40,mg/m2,1,once weekly,In the mastectomy cohort
33713742,NCT01674842,622,radiation,4,1.8-2,Gy,1,once-daily fractions was administered to the chest wall to a total of 50 to 50.4 Gy,In the mastectomy cohort
33135391,NCT02429466,623,guadecitabine,1,30,mg/m2,1,"on days 1-5, for a 28-day cycle for up to six cycles",NA
33135391,NCT02429466,623,cisplatin,1,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33135391,NCT02429466,623,cisplatin,1,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33135391,NCT02429466,623,guadecitabine,2,45,mg/m2,1,"on days 1-5, for a 28-day cycle for up to six cycles",NA
33135391,NCT02429466,623,cisplatin,2,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33135391,NCT02429466,623,cisplatin,2,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33135391,NCT02429466,623,guadecitabine,3,60,mg/m2,1,"on days 1-5, for a 28-day cycle for up to six cycles",NA
33135391,NCT02429466,623,cisplatin,3,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33135391,NCT02429466,623,cisplatin,3,100,mg/m2,1,"on day 8, for a 28-day cycle for up to six cycles",fixed
33577866,NA,624,prexasertib,1,20,mg/m2,1,"once every 14 days (Days 02, 16, 30, and 44)",NA
33577866,NA,624,cisplatin,1,40,mg/m2,1,"weekly on Days 01, 08, 15, 22, 29, 36, and 43",fixed
33577866,NA,624,cisplatin,1,40,mg/m2,1,"weekly on Days 01, 08, 15, 22, 29, 36, and 43",fixed
33577866,NA,624,intensity-modulated radiation therapy,1,2,Gy,1,5 times per week for 7 weeks,NA
33577866,NA,625,prexasertib,1,20,mg/m2,1,"every 14 days (Days 08, 22, 36, and 50)",NA
33577866,NA,625,cetuximab,1,400/250,mg/m2,1,"weekly doses of 400 mg/m2 on Day 01, followed by 250 mg/m2 on Days 08, 15, 22, 29, 36, 43, and 50",fixed
33577866,NA,625,intensity-modulated radiation therapy,1,2,Gy,1,5 times per week for 7 weeks starting with Day 8,fixed
33577866,NA,625,prexasertib,2,30,mg/m2,1,"every 14 days (Days 08, 22, 36, and 50)",NA
33577866,NA,625,cetuximab,2,400/250,mg/m2,1,"weekly doses of 400 mg/m2 on Day 01, followed by 250 mg/m2 on Days 08, 15, 22, 29, 36, 43, and 50",fixed
33577866,NA,625,intensity-modulated radiation therapy,2,2,Gy,1,5 times per week for 7 weeks starting with Day 8,fixed
33577866,NA,625,prexasertib,3,40,mg/m2,1,"every 14 days (Days 08, 22, 36, and 50)",NA
33577866,NA,625,cetuximab,3,400/250,mg/m2,1,"weekly doses of 400 mg/m2 on Day 01, followed by 250 mg/m2 on Days 08, 15, 22, 29, 36, 43, and 50",fixed
33577866,NA,625,intensity-modulated radiation therapy,3,2,Gy,1,5 times per week for 7 weeks starting with Day 8,fixed
19169687,NA,626,cetuximab,1,100,mg/m2,1,"100 mg/m2 as an initial dose on day 1, and 100 mg/m2 as a repeated weekly dose on days 15, 22, 29, 36, 43, 50, then every 7 days",NA
19169687,NA,626,cetuximab,2,250,mg/m2,1,"250 mg/m2 as an initial dose on day 1, and 250 mg/m2 as a repeated weekly dose on days 15, 22, 29, 36, 43, 50, then every 7 days",NA
19169687,NA,626,cetuximab,3,400/250,mg/m2,1,"400 mg/m2 as an initial dose on day 1, and 250 mg/m2 as a repeated weekly dose on days 15, 22, 29, 36, 43, 50, then every 7 days",NA
19169687,NA,626,cetuximab,4,500/250,mg/m2,1,"500 mg/m2 as an initial dose on day 1, and 250 mg/m2 as a repeated weekly dose on days 15, 22, 29, 36, 43, 50, then every 7 days",NA
19169687,NA,626,cetuximab,5,400/250,mg/m2,1,"400 mg/m2 as an initial dose on day 1, and 250 mg/m2 as a repeated weekly dose on days 8, 15, 22, 29, 36, 43, 50, then every 7 days",NA
22761464,NCT00150462,627,carfilzomib,1,1.2,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,2,2.4,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,3,4,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,4,6,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,5,8.4,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,6,11,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,7,15,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,8,20,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
22761464,NCT00150462,627,carfilzomib,9,27,mg/m2,1,"on D1/2, D8/9, and D15/16 in each 28-day cycle",NA
17465237,NA,628,cisplatin,1,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,cisplatin,1,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,temozolomide,1,100,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,temozolomide,1,100,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,thalidomide,1,0,mg,1,daily every three weeks,NA
17465237,NA,628,cisplatin,2,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,cisplatin,2,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,temozolomide,2,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,temozolomide,2,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,thalidomide,2,0,mg,1,daily every three weeks,NA
17465237,NA,628,cisplatin,3,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,cisplatin,3,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,temozolomide,3,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,temozolomide,3,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,thalidomide,3,100,mg,1,daily every three weeks,NA
17465237,NA,628,cisplatin,4,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,cisplatin,4,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,temozolomide,4,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,temozolomide,4,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,thalidomide,4,150,mg,1,daily every three weeks,NA
17465237,NA,628,cisplatin,5,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,cisplatin,5,75,mg/m2,1,day 1 every three weeks,fixed
17465237,NA,628,temozolomide,5,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,temozolomide,5,150,mg/m2,1,days 1-5 every three weeks,NA
17465237,NA,628,thalidomide,5,200,mg,1,daily every three weeks,NA
22960004,NA,638,cetuximab,1,400/250,mg/m2,1,"400 mg/m2 on day 1, and then 250 mg/m2 on days 8, 15, 22, 29, and 36.",fixed
22960004,NA,638,cisplatin,1,30,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
22960004,NA,638,cisplatin,1,30,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
22960004,NA,638,radiotherapy,1,NA,NA,NA,a total of six weeks,NA
22960004,NA,638,cetuximab,2,400/250,mg/m2,1,"400 mg/m2 on day 1, and then 250 mg/m2 on days 8, 15, 22, 29, and 36.",fixed
22960004,NA,638,cisplatin,2,40,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
22960004,NA,638,cisplatin,2,40,mg/m2,1,"on days 1, 8, 15, 22, 29, and 36",NA
22960004,NA,638,radiotherapy,2,NA,NA,NA,a total of six weeks,NA
28363909,NCT01719380,640,encorafenib,1,100,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,640,cetuximab,1,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,640,encorafenib,2,200,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,640,cetuximab,2,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,640,encorafenib,3,400,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,640,cetuximab,3,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,640,encorafenib,4,450,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,640,cetuximab,4,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,641,encorafenib,1,200,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,641,cetuximab,1,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,641,alpelisib,1,100,mg,1,daily,NA
28363909,NCT01719380,641,encorafenib,2,200,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,641,cetuximab,2,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,641,alpelisib,2,200,mg,1,daily,NA
28363909,NCT01719380,641,encorafenib,3,300,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,641,cetuximab,3,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,641,alpelisib,3,200,mg,1,daily,NA
28363909,NCT01719380,641,encorafenib,4,200,mg,1,daily in 28-day cycles,NA
28363909,NCT01719380,641,cetuximab,4,400/250,mg/m2,1,a 400 mg/m2 loading dose (cycle 1 day 1) and 250 mg/m2 for subsequent weekly doses,fixed
28363909,NCT01719380,641,alpelisib,4,300,mg,1,daily,NA
31486207,NCT01816984,642,buparlisib,1,100,mg,1,on days -7 to 0,fixed
31486207,NCT01816984,642,cetuximab,1,500,mg/m2,1,on days 1 and 15 every 28 days,fixed
31486207,NCT01816984,642,buparlisib,2,100,mg,1,on days -7 to 0,fixed
31486207,NCT01816984,642,cetuximab,2,500,mg/m2,1,on days 1 and 15 every 28 days,fixed
33741296,NCT03502681,643,avelumab,0,10,mg/kg,1,on days 1 and 15 in every 28-d cycle,fixed
33741296,NCT03502681,643,eribulin mesylate,0,1.1,mg/m2,1,on days 1 and 15 in every 28-d cycle,NA
33741296,NCT03502681,643,avelumab,1,10,mg/kg,1,on days 1 and 15 in every 28-d cycle,fixed
33741296,NCT03502681,643,eribulin mesylate,1,1.4,mg/m2,1,on days 1 and 15 in every 28-d cycle,NA
31486872,NA,644,amrubicin,1,20,mg/m2,1,"on days 1, 2, and 3 every 4 weeks",NA
31486872,NA,644,cisplatin,1,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,cisplatin,1,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,thoracic radiotherapy,1,2,Gy,1,"once daily, started on day 2 of the frst cycle of chemotherapy (26 Gy/13 fractions [fr]) and day 30 (24 Gy/12 fr)",fixed
31486872,NA,644,amrubicin,2,25,mg/m2,1,"on days 1, 2, and 3 every 4 weeks",NA
31486872,NA,644,cisplatin,2,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,cisplatin,2,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,thoracic radiotherapy,2,2,Gy,1,"once daily, started on day 2 of the frst cycle of chemotherapy (26 Gy/13 fractions [fr]) and day 30 (24 Gy/12 fr)",fixed
31486872,NA,644,amrubicin,3,30,mg/m2,1,"on days 1, 2, and 3 every 4 weeks",NA
31486872,NA,644,cisplatin,3,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,cisplatin,3,60,mg/m2,1,on day 1 every 4 weeks,fixed
31486872,NA,644,thoracic radiotherapy,3,2,Gy,1,"once daily, started on day 2 of the frst cycle of chemotherapy (26 Gy/13 fractions [fr]) and day 30 (24 Gy/12 fr)",fixed
20148348,NA,645,cetuximab,0,400/250,mg/m2,1,an initial load of 400 mg/m2 intravenously (IV) followed by a weekly maintenance dose of 250 mg/m2,NA
20148348,NA,645,cetuximab,1,400/300,mg/m2,1,an initial load of 400 mg/m2 intravenously (IV) followed by a weekly maintenance dose of 300mg/m2,NA
20148348,NA,645,cetuximab,2,400/350,mg/m2,1,an initial load of 400 mg/m2 intravenously (IV) followed by a weekly maintenance dose of 350 mg/m2,NA
20148348,NA,645,cetuximab,3,400/400,mg/m2,1,an initial load of 400 mg/m2 intravenously (IV) followed by a weekly maintenance dose of 400 mg/m2,NA
30084837,NA,646,cetuximab,1,400/250,mg/m2,1,"a loading dose of cetuximab 400 mg/m2was administered beginning approximately 5–7 days before initiation of radiation, 250 mg/m2 was subsequently administered weekly for a least 6 additional doses",fixed
30084837,NA,646,radiation,1,69.3,Gy,NA,delivered in 33 fractions over 6.5 weeks,fixed
30084837,NA,646,olaparib,1,25,mg,2,"daily starting 5 days prior to their first cetuximab infusion (cycle 1, day -5)",NA
30084837,NA,646,cetuximab,2,400/250,mg/m2,1,"a loading dose of cetuximab 400 mg/m2was administered beginning approximately 5–7 days before initiation of radiation, 250 mg/m2 was subsequently administered weekly for a least 6 additional doses",fixed
30084837,NA,646,radiation,2,69.3,Gy,NA,delivered in 33 fractions over 6.5 weeks,fixed
30084837,NA,646,olaparib,2,50,mg,2,"daily starting 5 days prior to their first cetuximab infusion (cycle 1, day -5)",NA
30084837,NA,646,cetuximab,3,400/250,mg/m2,1,"a loading dose of cetuximab 400 mg/m2was administered beginning approximately 5–7 days before initiation of radiation, 250 mg/m2 was subsequently administered weekly for a least 6 additional doses",fixed
30084837,NA,646,radiation,3,69.3,Gy,NA,delivered in 33 fractions over 6.5 weeks,fixed
30084837,NA,646,olaparib,3,100,mg,2,"daily starting 5 days prior to their first cetuximab infusion (cycle 1, day -5)",NA
30084837,NA,646,cetuximab,4,400/250,mg/m2,1,"a loading dose of cetuximab 400 mg/m2was administered beginning approximately 5–7 days before initiation of radiation, 250 mg/m2 was subsequently administered weekly for a least 6 additional doses",fixed
30084837,NA,646,radiation,4,69.3,Gy,NA,delivered in 33 fractions over 6.5 weeks,fixed
30084837,NA,646,olaparib,4,200,mg,2,"daily starting 5 days prior to their first cetuximab infusion (cycle 1, day -5)",NA
17203757,NA,647,caelyx®,1,10,mg/L,NA,NA,NA
17203757,NA,647,caelyx®,2,12,mg/L,NA,NA,NA
17203757,NA,647,caelyx®,3,14,mg/L,NA,NA,NA
17203757,NA,647,caelyx®,4,16,mg/L,NA,NA,NA
17203757,NA,647,caelyx®,5,18,mg/L,NA,NA,NA
29567334,UMIN000010369,648,cisplatin,0,70,mg/m2,1,NA,NA
29567334,UMIN000010369,648,cisplatin,0,70,mg/m2,1,NA,NA
29567334,UMIN000010369,648,cisplatin,1,80,mg/m2,1,NA,NA
29567334,UMIN000010369,648,cisplatin,1,80,mg/m2,1,NA,NA
29567334,UMIN000010369,648,cisplatin,2,100,mg/m2,1,NA,NA
29567334,UMIN000010369,648,cisplatin,2,100,mg/m2,1,NA,NA
34040175,NCT02157792,649,berzosertib,1,18,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,1,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,2,36,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,2,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,3,60,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,3,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,4,72,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,4,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,5,90,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,5,500,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,6,140,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,6,500,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,7,210,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,7,500,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,8,210,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,8,750,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,9,210,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,9,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,649,berzosertib,10,210,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,649,gemcitabine,10,1000,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,650,berzosertib,1,90,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,650,gemcitabine,1,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,650,cisplatin,1,60,mg/m2,1,on days 1 Q3W,NA
34040175,NCT02157792,650,cisplatin,1,60,mg/m2,1,on days 1 Q3W,NA
34040175,NCT02157792,650,berzosertib,2,120,mg/m2,1,on days 2 and 9 Q3W,NA
34040175,NCT02157792,650,gemcitabine,2,875,mg/m2,1,on days 1 and 8 Q3W,NA
34040175,NCT02157792,650,cisplatin,2,60,mg/m2,1,on days 1 Q3W,NA
34040175,NCT02157792,650,cisplatin,2,60,mg/m2,1,on days 1 Q3W,NA
34668982,NA,651,carflzomib,1,20,mg/m2,1,"twice weekly on days 1, 2, 8, 9, 15, and 16, followed by 12 days of rest (28 day cycle) for up to 6 cycles",NA
34668982,NA,651,carflzomib,0,20/27,mg/m2,1,"twice weekly, 20 mg/m2 (cycle 1, days 1 and 2) and then 27 mg/m2 starting on day 8 andsubsequently",NA
34668982,NA,651,carflzomib,2,20/36,mg/m2,1,"twice weekly, 20 mg/m2 (cycle 1, days 1 and 2) and then 36 mg/m2 starting on day 8 andsubsequently",NA
34668982,NA,651,carflzomib,3,20/45,mg/m2,1,"twice weekly, 20 mg/m2 (cycle 1, days 1 and 2) and then 45 mg/m2 starting on day 8 andsubsequently",NA
12460785,NA,652,pnu-159548,1,1,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,2,2,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,3,4,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,4,6,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,5,9,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,6,12,mg/m2,1,every 21 days,i.v. over 10 min
12460785,NA,652,pnu-159548,7,14,mg/m2,1,every 21 days,i.v. over 10 min. Heavily pretreated patients.
12460785,NA,652,pnu-159548,8,14,mg/m2,1,every 21 days,i.v. over 10 min. Minimally pretreated/non-pretreated patients
12460785,NA,652,pnu-159548,9,14,mg/m2,1,every 21 days,Infusion duration 1 h
12460785,NA,652,pnu-159548,10,16,mg/m2,1,every 21 days,i.v. over 10 min
33262140,NCT01562210,654,olaparib,1,25,mg,2,daily start 2 days before RT and will continue for 2 days after the last RT fraction,NA
33262140,NCT01562210,654,cisplatin,1,6,mg/m2,1,daily 1–2 hours before radiotherapy,fixed
33262140,NCT01562210,654,cisplatin,1,6,mg/m2,1,daily 1–2 hours before radiotherapy,fixed
33262140,NCT01562210,654,radiation,1,66,Gy,NA,in 24 fractions from week 1 to 5 (5 days/week),fixed
33262140,NCT01562210,654,olaparib,2,25,mg,1,daily start 2 days before RT and will continue for 2 days after the last RT fraction,NA
33262140,NCT01562210,654,cisplatin,2,6,mg/m2,1,daily 1–2 hours before radiotherapy,fixed
33262140,NCT01562210,654,cisplatin,2,6,mg/m2,1,daily 1–2 hours before radiotherapy,fixed
33262140,NCT01562210,654,radiation,2,66,Gy,NA,in 24 fractions from week 1 to 5 (5 days/week),fixed
33262140,NCT01562210,655,olaparib,1,25,mg,2,daily start 2 days before RT and will continue for 2 days after the last RT fraction,NA
33262140,NCT01562210,655,scrt,1,66,Gy,NA,in 24 fractions from week 1 to 5 (5 days/week),fixed
33262140,NCT01562210,655,olaparib,2,25,mg,1,daily start 2 days before RT and will continue for 2 days after the last RT fraction,NA
33262140,NCT01562210,655,scrt,2,66,Gy,NA,in 24 fractions from week 1 to 5 (5 days/week),fixed
19789325,NA,656,dasatinib,1,35,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,2,50,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,3,70,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,4,90,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,5,120,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,6,160,mg,2,every 12 h for 5 consecutive days followed by 2 nontreatment days every week in 28-d treatment cycles,5D2 schedule
19789325,NA,656,dasatinib,7,70,mg,2,"continuously, twice-daily in 28-d treatment cycles",CDD schedule
19789325,NA,656,dasatinib,8,90,mg,2,"continuously, twice-daily in 28-d treatment cycles",CDD schedule
19789325,NA,656,dasatinib,9,100,mg,2,"continuously, twice-daily in 28-d treatment cycles",CDD schedule
19789325,NA,656,dasatinib,10,120,mg,2,"continuously, twice-daily in 28-d treatment cycles",CDD schedule
33607477,NCT01946867,657,nbtxr3,1,5,%,1,on day 1,NA
33607477,NCT01946867,657,imrt,1,2,Gy,1,"A total dose of 70 Gy was delivered as 35 fractions (2 Gy/fraction, five fractions/week for seven weeks), initiated on day 2",fixed
33607477,NCT01946867,657,nbtxr3,2,10,%,1,on day 1,NA
33607477,NCT01946867,657,imrt,2,2,Gy,1,"A total dose of 70 Gy was delivered as 35 fractions (2 Gy/fraction, five fractions/week for seven weeks), initiated on day 2",fixed
33607477,NCT01946867,657,nbtxr3,3,15,%,1,on day 1,NA
33607477,NCT01946867,657,imrt,3,2,Gy,1,"A total dose of 70 Gy was delivered as 35 fractions (2 Gy/fraction, five fractions/week for seven weeks), initiated on day 2",fixed
33607477,NCT01946867,657,nbtxr3,4,22,%,1,on day 1,NA
33607477,NCT01946867,657,imrt,4,2,Gy,1,"A total dose of 70 Gy was delivered as 35 fractions (2 Gy/fraction, five fractions/week for seven weeks), initiated on day 2",fixed
8402670,NA,658,cyclosporin a,1,5,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,1,5,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,doxorubicin,1,30,mg/m2,1,a single 10-min infusion 24 h after the initiation of CsA every 4 weeks,NA
8402670,NA,658,cyclosporin a,2,6,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,2,6,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,2,30,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,2,30,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,doxorubicin,3,6,mg/m2,1,a single 10-min infusion 24 h after the initiation of CsA every 4 weeks,NA
8402670,NA,658,cyclosporin a,3,40,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,3,40,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,4,6,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,cyclosporin a,4,6,ug/kg/min,NA,"a continuous infusion for 6 days, every 4 weeks",NA
8402670,NA,658,doxorubicin,4,45,mg/m2,1,a single 10-min infusion 24 h after the initiation of CsA every 4 weeks,NA
25225420,NCT00531284,659,carfilzomib,1,20/36,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle. in cycle one days 1 and 2 were 20 mg/m2, followed thereafter by dose escalation to 36 mg/m2",NA
25225420,NCT00531284,659,carfilzomib,2,20/45,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle. in cycle one days 1 and 2 were 20 mg/m2, followed thereafter by dose escalation to 45, mg/m2",NA
25225420,NCT00531284,659,carfilzomib,3,20/56,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle. in cycle one days 1 and 2 were 20 mg/m2, followed thereafter by dose escalation to 56 mg/m2",NA
25225420,NCT00531284,659,carfilzomib,4,20/70,mg/m2,1,"on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle. in cycle one days 1 and 2 were 20 mg/m2, followed thereafter by dose escalation to 70 mg/m2",NA
21781226,NCT00339144,660,dasatinib,1,100,mg,1,daily for 4-week cycles,NA
21781226,NCT00339144,660,dasatinib,2,150,mg,1,daily for 4-week cycles,NA
21781226,NCT00339144,660,dasatinib,3,200,mg,1,daily for 4-week cycles,NA
32464516,NCT02537223,661,alpelisib,1,200,mg,1,"once daily, starting on day 1, for 7 weeks",NA
32464516,NCT02537223,661,cisplatin,1,100,mg/m2,1,"every three weeks for a maximum of three doses on days 1, 22 and 43",fixed
32464516,NCT02537223,661,cisplatin,1,100,mg/m2,1,"every three weeks for a maximum of three doses on days 1, 22 and 43",fixed
32464516,NCT02537223,661,intensity modulated radiation therapy,1,2,Gy,1,"70 Gy in 35 fractions delivered once daily, starting on day 1, Monday to Friday over seven weeks",fixed
32464516,NCT02537223,661,alpelisib,2,250,mg,1,"once daily, starting on day 1, for 7 weeks",NA
32464516,NCT02537223,661,cisplatin,2,100,mg/m2,1,"every three weeks for a maximum of three doses on days 1, 22 and 43",fixed
32464516,NCT02537223,661,cisplatin,2,100,mg/m2,1,"every three weeks for a maximum of three doses on days 1, 22 and 43",fixed
32464516,NCT02537223,661,intensity modulated radiation therapy,2,2,Gy,1,"70 Gy in 35 fractions delivered once daily, starting on day 1, Monday to Friday over seven weeks",fixed
34322775,NCT02822482,662,copanlisib,1,45,mg,1,"on days 1, 8, and 15 of 28-day cycles",NA
34322775,NCT02822482,662,cetuximab,1,400/250,mg/m2,1,"400 mg/m2 loading dose followed by 250 mg/m2 on days 8, 15, and 22, and weekly thereafter",fixed
34322775,NCT02822482,662,copanlisib,-1,30,mg,1,"on days 1, 8, and 15 of 28-day cycles",NA
34322775,NCT02822482,662,cetuximab,-1,400/250,mg/m2,1,"400 mg/m2 loading dose followed by 250 mg/m2 on days 8, 15, and 22, and weekly thereafter",fixed
27289242,NA,663,dacomitinib,1,15,mg,NA,from day 1 to day 49,NA
27289242,NA,663,imrt,1,2,Gy,1,"70 Gy in 35 daily fractions, starting on day 1, Monday to Friday, over 7 weeks",fixed
27289242,NA,663,cisplatin,1,100,mg/m2,1,"every 3 weeks (days 1, 22 and 43)",fixed
27289242,NA,663,cisplatin,1,100,mg/m2,1,"every 3 weeks (days 1, 22 and 43)",fixed
27289242,NA,663,dacomitinib,1,30,mg,NA,from day 1 to day 49,NA
27289242,NA,663,dacomitinib,1,45,mg,NA,from day 1 to day 49,NA
32994295,NCT02022098,664,debio 1143,1,100,mg,1,"on days 1-14, 22-35 and 43-56",NA
32994295,NCT02022098,664,cisplatin,1,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,cisplatin,1,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,conventional fractionation radiotherapy,1,2,Gy,1,"daily for 5 days per week over 7 weeks, up to 70 Gy",fixed
32994295,NCT02022098,664,debio 1143,2,200,mg,1,"on days 1-14, 22-35 and 43-56",NA
32994295,NCT02022098,664,cisplatin,2,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,cisplatin,2,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,conventional fractionation radiotherapy,2,2,Gy,1,"daily for 5 days per week over 7 weeks, up to 70 Gy",fixed
32994295,NCT02022098,664,debio 1143,3,300,mg,1,"on days 1-14, 22-35 and 43-56",NA
32994295,NCT02022098,664,cisplatin,3,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,cisplatin,3,100,mg/m2,1,"every 3 weeks, on days 2, 23 and 44",fixed
32994295,NCT02022098,664,conventional fractionation radiotherapy,3,2,Gy,1,"daily for 5 days per week over 7 weeks, up to 70 Gy",fixed
33472913,ISRCTN 16332228,665,guadecitabine,1,20,mg/m2,1,on days 1–5 in 21-day cycles,NA
33472913,ISRCTN 16332228,665,cisplatin,1,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,cisplatin,1,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,gemcitabine,1,1000,mg/m2,1,on days 8 and 15 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,guadecitabine,3,30,mg/m2,1,on days 1–5 in 21-day cycles,with G-CSF
33472913,ISRCTN 16332228,665,cisplatin,3,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,cisplatin,3,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,gemcitabine,3,1000,mg/m2,1,on days 8 and 15 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,guadecitabine,2,20,mg/m2,1,on days 1–5 in 21-day cycles,with G-CSF
33472913,ISRCTN 16332228,665,cisplatin,2,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,cisplatin,2,70,mg/m2,1,on day 8 in 21-day cycles,fixed
33472913,ISRCTN 16332228,665,gemcitabine,2,1000,mg/m2,1,on days 8 and 15 in 21-day cycles,fixed
28679776,NCT01584284,666,gl-onc1,1,3 x 10^8,pfu,1,on day 3,NA
28679776,NCT01584284,666,cisplatin,1,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,cisplatin,1,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,intensity-modulated radiotherapy,1,70,Gy,NA,70 Gy to gross tumor in 33 to 35 fractions daily with 5 fractions per week,fixed
28679776,NCT01584284,666,gl-onc1,2,1 x 10^9,pfu,1,on day 3,NA
28679776,NCT01584284,666,cisplatin,2,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,cisplatin,2,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,intensity-modulated radiotherapy,2,70,Gy,NA,70 Gy to gross tumor in 33 to 35 fractions daily with 5 fractions per week,fixed
28679776,NCT01584284,666,gl-onc1,3,3 x 10^9,pfu,1,on day 3,NA
28679776,NCT01584284,666,cisplatin,3,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,cisplatin,3,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,intensity-modulated radiotherapy,3,70,Gy,NA,70 Gy to gross tumor in 33 to 35 fractions daily with 5 fractions per week,fixed
28679776,NCT01584284,666,gl-onc1,4,3 x 10^9,pfu,1,on days 3 and 8,NA
28679776,NCT01584284,666,cisplatin,4,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,cisplatin,4,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,intensity-modulated radiotherapy,4,70,Gy,NA,70 Gy to gross tumor in 33 to 35 fractions daily with 5 fractions per week,fixed
28679776,NCT01584284,666,gl-onc1,5,3 x 10^9,pfu,1,"days 3, 8, 15, and 22",NA
28679776,NCT01584284,666,cisplatin,5,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,cisplatin,5,100,mg/m2,1,"on days 1, 22, and 43",fixed
28679776,NCT01584284,666,intensity-modulated radiotherapy,5,70,Gy,NA,70 Gy to gross tumor in 33 to 35 fractions daily with 5 fractions per week,fixed
21765046,NA,667,ca4p,1,50,mg/m2,1,one dose in the first week,Patients with NSCLC
21765046,NA,667,radiotherapy,1,27,Gy,NA,27 Gy in 6 fractions treating twice weekly,Patients with NSCLC
21765046,NA,667,ca4p,2,50,mg/m2,1,once a week for 3 weeks,Patients with NSCLC
21765046,NA,667,radiotherapy,2,27,Gy,NA,27 Gy in 6 fractions treating twice weekly,Patients with NSCLC
21765046,NA,667,ca4p,3,50,mg/m2,1,one dose in the first week,patients with prostate adenocarcinoma
21765046,NA,667,radiotherapy,3,55,Gy,NA,in 20 fractions treating 5 days per week over 4 weeks,patients with prostate adenocarcinoma
21765046,NA,667,ca4p,4,50,mg/m2,1,once a week for 4 weeks,patients with prostate adenocarcinoma
21765046,NA,667,radiotherapy,4,55,Gy,NA,in 20 fractions treating 5 days per week over 4 weeks,patients with prostate adenocarcinoma
21765046,NA,667,ca4p,5,63,mg/m2,1,once a week for 4 weeks,patients with prostate adenocarcinoma
21765046,NA,667,radiotherapy,5,55,Gy,NA,in 20 fractions treating 5 days per week over 4 weeks,patients with prostate adenocarcinoma
21765046,NA,667,ca4p,6,50,mg/m2,1,twice a week for 3 weeks,Patients with NSCLC
21765046,NA,667,radiotherapy,6,27,Gy,NA,27 Gy in 6 fractions treating twice weekly,Patients with NSCLC
21765046,NA,667,ca4p,7,50,mg/m2,1,once weekly for 6 weeks,patients with SCCHN
21765046,NA,667,radiotherapy,7,66,Gy,NA,in 33 fractions treating daily over 6 weeks,patients with SCCHN
27810904,NCT01836029,668,cetuximab,1,250,mg/m2,1,"on days 1, 8, 15, and 22 of a 28-day cycle. The lead-in treatement cibsusted if one 400 mg/m2, following by 3 doses of 250 mg/m2 weekly in cycle 1.",fixed
27810904,NCT01836029,668,motolimod,1,2.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
27810904,NCT01836029,668,cetuximab,2,250,mg/m2,1,"on days 1, 8, 15, and 22 of a 28-day cycle. The lead-in treatement cibsusted if one 400 mg/m2, following by 3 doses of 250 mg/m2 weekly in cycle 1.",fixed
27810904,NCT01836029,668,motolimod,2,3,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
27810904,NCT01836029,668,cetuximab,3,250,mg/m2,1,"on days 1, 8, 15, and 22 of a 28-day cycle. The lead-in treatement cibsusted if one 400 mg/m2, following by 3 doses of 250 mg/m2 weekly in cycle 1.",fixed
27810904,NCT01836029,668,motolimod,3,3.5,mg/m2,1,"on days 1, 8, and 15 of a 28-day cycle",NA
15865068,NA,669,epirubicin,1,90,mg/m2,1,day 1  every 21 days,sequence A
15865068,NA,669,paclitaxel,1,175,mg/m2,1,day 2 every 21 days,sequence A
15865068,NA,669,epirubicin,2,90,mg/m2,1,day 1  every 21 days,sequence A
15865068,NA,669,paclitaxel,2,200,mg/m2,1,day 2 every 21 days,sequence A
15865068,NA,669,epirubicin,3,100,mg/m2,1,day 1  every 21 days,sequence A
15865068,NA,669,paclitaxel,3,200,mg/m2,1,day 2 every 21 days,sequence A
15865068,NA,669,epirubicin,4,100,mg/m2,1,day 1  every 21 days,sequence A
15865068,NA,669,paclitaxel,4,225,mg/m2,1,day 2 every 21 days,sequence A
15865068,NA,669,epirubicin,1,90,mg/m2,1,day 2 every 21 days,sequence B
15865068,NA,669,paclitaxel,1,175,mg/m2,1,day 1  every 21 days,sequence B
15865068,NA,669,epirubicin,2,90,mg/m2,1,day 2 every 21 days,sequence B
15865068,NA,669,paclitaxel,2,200,mg/m2,1,day 1  every 21 days,sequence B
15865068,NA,669,epirubicin,3,100,mg/m2,1,day 2 every 21 days,sequence B
15865068,NA,669,paclitaxel,3,200,mg/m2,1,day 1  every 21 days,sequence B
15865068,NA,669,epirubicin,4,100,mg/m2,1,day 2 every 21 days,sequence B
15865068,NA,669,paclitaxel,4,225,mg/m2,1,day 1  every 21 days,sequence B
16683074,NA,671,cisplatin,1,30,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,1,30,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,irofulven,1,0.3,mg/kg,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,2,30,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,2,30,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,irofulven,2,0.4,mg/kg,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,3,40,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,3,40,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,irofulven,3,0.4,mg/kg,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,4,40,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,cisplatin,4,40,mg/m2,1,on day 1 and 15 every 4 weeks,NA
16683074,NA,671,irofulven,4,0.5,mg/kg,1,on day 1 and 15 every 4 weeks,NA
17947485,NA,672,belotecan,1,0.4,mg/m2,1,on days 1 to 4 every 3 weeks,NA
17947485,NA,672,cisplatin,1,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,cisplatin,1,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,belotecan,2,0.45,mg/m2,1,on days 1 to 4 every 3 weeks,NA
17947485,NA,672,cisplatin,2,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,cisplatin,2,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,belotecan,3,0.5,mg/m2,1,on days 1 to 4 every 3 weeks,NA
17947485,NA,672,cisplatin,3,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,cisplatin,3,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,belotecan,4,0.55,mg/m2,1,on days 1 to 4 every 3 weeks,NA
17947485,NA,672,cisplatin,4,60,mg/m2,1,on day 1 every 3 weeks,fixed
17947485,NA,672,cisplatin,4,60,mg/m2,1,on day 1 every 3 weeks,fixed
21285987,NA,673,nc-6004,1,10,mg/m2,1,once every 3 weeks,NA
21285987,NA,673,nc-6004,2,20,mg/m2,1,once every 3 weeks,NA
21285987,NA,673,nc-6004,3,40,mg/m2,1,once every 3 weeks,NA
21285987,NA,673,nc-6004,4,60,mg/m2,1,once every 3 weeks,NA
21285987,NA,673,nc-6004,5,90,mg/m2,1,once every 3 weeks,NA
21285987,NA,673,nc-6004,6,120,mg/m2,1,once every 3 weeks,NA
21257722,NA,674,safingol,1,60,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,1,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,1,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,2,120,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,2,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,2,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,3,240,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,3,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,3,75,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,4,240,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,4,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,4,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,5,360,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,5,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,5,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,6,480,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,6,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,6,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,7,600,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,7,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,7,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,8,750,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,8,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,8,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,9,930,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,9,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,9,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,safingol,10,840,mg/m2,1,"given alone 1 week before the combination, then once every 3 weeks together with cisplatin",NA
21257722,NA,674,cisplatin,10,60,mg/m2,1,every 3 weeks,NA
21257722,NA,674,cisplatin,10,60,mg/m2,1,every 3 weeks,NA
16884375,NA,675,cisplatin,1,20,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,cisplatin,1,20,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,pelvic radiotherapy,1,NA,Gy,1,5 days per week,NA
16884375,NA,675,cisplatin,2,25,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,cisplatin,2,25,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,pelvic radiotherapy,2,NA,Gy,1,5 days per week,NA
16884375,NA,675,cisplatin,3,30,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,cisplatin,3,30,mg/m2,1,"weekly, for 6 weeks on the first day of every radiotherapy week, normally a Monday",NA
16884375,NA,675,pelvic radiotherapy,3,NA,Gy,1,5 days per week,NA
25573383,NA,676,cudc-101,1,225,mg/m2,1,"three times per week (Monday, Wednesday, Friday) for 1 week before the initiation of radiation and then as a part of combined modality treatment for weeks 1 to 7",NA
25573383,NA,676,cisplatin,1,100,mg/m2,1,"on days 2, 23, and 44",fixed
25573383,NA,676,cisplatin,1,100,mg/m2,1,"on days 2, 23, and 44",fixed
25573383,NA,676,external beam radiation,1,2,Gy,1,"once daily fractions for a total of 35 treatment days, 70 Gy",fixed
25573383,NA,676,cudc-101,2,275,mg/m2,1,"three times per week (Monday, Wednesday, Friday) for 1 week before the initiation of radiation and then as a part of combined modality treatment for weeks 1 to 7",NA
25573383,NA,676,cisplatin,2,100,mg/m2,1,"on days 2, 23, and 44",fixed
25573383,NA,676,cisplatin,2,100,mg/m2,1,"on days 2, 23, and 44",fixed
25573383,NA,676,external beam radiation,2,2,Gy,1,"once daily fractions for a total of 35 treatment days, 70 Gy",fixed
10589753,NA,677,paclitaxel,1,135,mg/m2,1,day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,cisplatin,1,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,cisplatin,1,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,etoposide,1,50,mg/m2,1,i.v. day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,etoposide,1,100,mg/m2,1,"p.o., days 2–3 every 21 days for a maximum of six cycles",NA
10589753,NA,677,paclitaxel,2,135,mg/m2,1,day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,cisplatin,2,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,cisplatin,2,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,etoposide,2,80,mg/m2,1,i.v. day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,etoposide,2,160,mg/m2,1,"p.o., days 2–3 every 21 days for a maximum of six cycles",NA
10589753,NA,677,paclitaxel,3,175,mg/m2,1,day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,cisplatin,3,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,cisplatin,3,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,etoposide,3,80,mg/m2,1,i.v. day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,etoposide,3,160,mg/m2,1,"p.o., days 2–3 every 21 days for a maximum of six cycles",NA
10589753,NA,677,paclitaxel,4,200,mg/m2,1,day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,cisplatin,4,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,cisplatin,4,80,mg/m2,1,day 1 every 21 days for a maximum of six cycles,fixed
10589753,NA,677,etoposide,4,80,mg/m2,1,i.v. day 1 every 21 days for a maximum of six cycles,NA
10589753,NA,677,etoposide,4,160,mg/m2,1,"p.o., days 2–3 every 21 days for a maximum of six cycles",NA
16619579,NA,678,paclitaxel,1,120,mg/m2,1,on day 1 of every 28-day cycle,NA
16619579,NA,678,cisplatin,1,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,cisplatin,1,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,s-1,1,70,mg/m2/d,1,14 consecutive days from day 1 of every 28-day cycle,fixed
16619579,NA,678,paclitaxel,2,140,mg/m2,1,on day 1 of every 28-day cycle,NA
16619579,NA,678,cisplatin,2,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,cisplatin,2,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,s-1,2,70,mg/m2/d,1,14 consecutive days from day 1 of every 28-day cycle,fixed
16619579,NA,678,paclitaxel,3,160,mg/m2,1,on day 1 of every 28-day cycle,NA
16619579,NA,678,cisplatin,3,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,cisplatin,3,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,s-1,3,70,mg/m2/d,1,14 consecutive days from day 1 of every 28-day cycle,fixed
16619579,NA,678,paclitaxel,4,180,mg/m2,1,on day 1 of every 28-day cycle,NA
16619579,NA,678,cisplatin,4,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,cisplatin,4,60,mg/m2,1,a 24-h infusion on day 14 of every 28-day cycle,fixed
16619579,NA,678,s-1,4,70,mg/m2/d,1,14 consecutive days from day 1 of every 28-day cycle,fixed
12796372,NA,679,topotecan,1,0.8,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,topotecan,1,0.8,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,paclitaxel,1,110,mg/m2,1,"d1 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,etoposide,1,120,mg/m2,1,"d1-3 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,1,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,1,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,thoracic radiotherapy,1,1.8,Gy,1,"25 daily fractions of 1.8 Gy for 5 weeks (total dose, 45 Gy), begun within 24 h of day 1, cycle 3, of chemotherapy",NA
12796372,NA,679,topotecan,2,1,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,topotecan,2,1,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,paclitaxel,2,135,mg/m2,1,"d1 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,etoposide,2,120,mg/m2,1,"d1-3 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,2,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,2,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,thoracic radiotherapy,2,1.8,Gy,1,"25 daily fractions of 1.8 Gy for 5 weeks (total dose, 45 Gy), begun within 24 h of day 1, cycle 3, of chemotherapy",NA
12796372,NA,679,topotecan,3,1.2,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,topotecan,3,1.2,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,paclitaxel,3,160,mg/m2,1,"d1 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,etoposide,3,120,mg/m2,1,"d1-3 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,3,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,3,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,thoracic radiotherapy,3,1.8,Gy,1,"25 daily fractions of 1.8 Gy for 5 weeks (total dose, 45 Gy), begun within 24 h of day 1, cycle 3, of chemotherapy",NA
12796372,NA,679,topotecan,4,1.4,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,topotecan,4,1.4,mg/m2,1,"d1–5 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,paclitaxel,4,175,mg/m2,1,"d1 every 21 days for cycles 1, 2, and 5",NA
12796372,NA,679,etoposide,4,120,mg/m2,1,"d1-3 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,4,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,cisplatin,4,60,mg/m2,1,"d1 every 21 days for cycles 3, 4, and 6",fixed
12796372,NA,679,thoracic radiotherapy,4,1.8,Gy,1,"25 daily fractions of 1.8 Gy for 5 weeks (total dose, 45 Gy), begun within 24 h of day 1, cycle 3, of chemotherapy",NA
21176985,NA,680,cisplatin,1,10,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,cisplatin,1,10,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,radiotherapy,1,2,Gy,1,"five fractions per week, up to 70 Gy in 35 fractions and seven weeks",fixed
21176985,NA,680,cisplatin,2,15,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,cisplatin,2,15,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,radiotherapy,2,2,Gy,1,"five fractions per week, up to 70 Gy in 35 fractions and seven weeks",fixed
21176985,NA,680,cisplatin,3,20,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,cisplatin,3,20,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,radiotherapy,3,2,Gy,1,"five fractions per week, up to 70 Gy in 35 fractions and seven weeks",fixed
21176985,NA,680,cisplatin,4,25,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,cisplatin,4,25,mg/m2/d,1,"daily over five consecutive days, once every other week for seven weeks",NA
21176985,NA,680,radiotherapy,4,2,Gy,1,"five fractions per week, up to 70 Gy in 35 fractions and seven weeks",fixed
11020576,NA,683,tirapazamine,1,190,mg/m2,1,"on Days 1, 15, and 29 of RT",NA
11020576,NA,683,tirapazamine,NA,160,mg/m2,1,"on Days 8, 10, 12 and 22, 24, 26 of RT",NA
11020576,NA,683,cisplatin,1,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,cisplatin,1,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,external-beam radiotherapy,1,4500,cGy,NA,in 25 daily fractions (Day 1–35),fixed
11020576,NA,683,tirapazamine,2,290,mg/m2,1,"on Days 1, 15, and 29 of RT",NA
11020576,NA,683,tirapazamine,2,220,mg/m2,1,"on Days 8, 10, 12 and 22, 24, 26 of RT",NA
11020576,NA,683,cisplatin,2,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,cisplatin,2,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,external-beam radiotherapy,2,4500,cGy,NA,in 25 daily fractions (Day 1–35),fixed
11020576,NA,683,tirapazamine,3,390,mg/m2,1,"on Days 1, 15, and 29 of RT",NA
11020576,NA,683,tirapazamine,3,220,mg/m2,1,"on Days 8, 10, 12 and 22, 24, 26 of RT",NA
11020576,NA,683,cisplatin,3,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,cisplatin,3,75,mg/m2,1,"on Days 1, 15, and 29 of RT",fixed
11020576,NA,683,external-beam radiotherapy,3,4500,cGy,NA,in 25 daily fractions (Day 1–35),fixed
27110950,UMIN000005585,684,proton beam therapy,1,66,Gy,NA,started on day 1 of the first cycle of chemotherapy and wasdelivered once daily for 5 days per week. The total dose of PBT was 66 Gy (RBE) in 33 fractions,NA
27110950,UMIN000005585,684,s-1,1,"80, 100, or 120",mg/d,2,"days 1–14, repeated as four cycles every 4 weeks. 40 mg(body surface area<1.25 m2), 50 mg (body surface area, 1.25–1.50 m2) and 60 mg (body surface area≥1.50 m2)",fixed
27110950,UMIN000005585,684,cisplatin,1,60,mg/m2,1,day 1 repeated as four cycles every 4 weeks,fixed
27110950,UMIN000005585,684,cisplatin,1,60,mg/m2,1,day 1 repeated as four cycles every 4 weeks,fixed
27110950,UMIN000005585,684,proton beam therapy,2,74,Gy,NA,started on day 1 of the first cycle of chemotherapy and wasdelivered once daily for 5 days per week. The total dose of PBT was 74Gy (RBE) in 37 fractions,NA
27110950,UMIN000005585,684,s-1,2,"80, 100, or 120",mg/d,2,"days 1–14, repeated as four cycles every 4 weeks. 40 mg(body surface area<1.25 m2), 50 mg (body surface area, 1.25–1.50 m2) and 60 mg (body surface area≥1.50 m2)",fixed
27110950,UMIN000005585,684,cisplatin,2,60,mg/m2,1,day 1 repeated as four cycles every 4 weeks,fixed
27110950,UMIN000005585,684,cisplatin,2,60,mg/m2,1,day 1 repeated as four cycles every 4 weeks,fixed
20801016,NA,685,liplaci,1,10,mg,1,every 3 weeks,NA
20801016,NA,685,liplaci,2,20,mg,1,every 3 weeks,NA
20801016,NA,685,liplaci,3,40,mg,1,every 3 weeks,NA
20801016,NA,685,liplaci,4,80,mg,1,every 3 weeks,NA
20801016,NA,685,liplaci,5,120,mg,1,every 3 weeks,NA
20855460,NA,686,farletuzumab,1,12.5,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,2,25,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,3,37.5,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,4,62.5,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,5,100,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,6,200,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
20855460,NA,686,farletuzumab,7,400,mg/m2,1,"on days 1, 8, 15, and 22 of a 5-week cycle",NA
16937305,NA,687,cisplatin,1,30,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,1,30,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,1,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,2,40,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,2,40,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,2,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,3,50,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,3,50,mg/m2,1,weekly for six courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,3,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,4,50,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,4,50,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,4,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,5,60,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,5,60,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,5,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,6,70,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,6,70,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,6,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,7,75,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,7,75,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,7,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,8,80,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,8,80,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,8,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,9,90,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,cisplatin,9,90,mg/m2,1,monthly for two courses,receive CDDP adjuvant therapy
16937305,NA,687,radiation,9,1.8,Gy,1,"on days 1 to 5 of each week, for a total of 28 fractions (total radiation dose, 50.4Gy)",fixed
16937305,NA,687,cisplatin,1,30,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,1,30,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,1,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,2,40,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,2,40,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,2,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,3,50,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,3,50,mg/m2,1,weekly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,3,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,4,50,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,4,50,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,4,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,5,60,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,5,60,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,5,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,6,70,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,6,70,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,6,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,7,75,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,7,75,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,7,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,8,80,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,8,80,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,8,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
16937305,NA,687,cisplatin,9,90,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,cisplatin,9,90,mg/m2,1,monthly for six courses,"receive CDDP primary
therapy"
16937305,NA,687,radiation,9,2,Gy,1,"at fractional doses of 2.0Gy per day on days 1 to 5, for a total of 15–17 fractions, with anadditional 20–30Gy with center split, and 5Gy at pointA-density, administered four times.",fixed
10427950,NA,688,ifn-a,1,6,Mio  IU,1,5 days every week,NA
10427950,NA,688,etretinate,1,4,mg/kg,1,"on 2 consecutive days in week 1, 3 consecutive days in week 3",NA
10427950,NA,688,ifn-a,2,6,Mio  IU,1,5 days every week,NA
10427950,NA,688,etretinate,2,4,mg/kg,1,on 3 consecutive days every other week,NA
10427950,NA,688,ifn-a,3,6,Mio  IU,1,5 days every week,NA
10427950,NA,688,etretinate,3,4,mg/kg,1,on 4 consecutive days every other week,NA
10427950,NA,688,ifn-a,4,6,Mio  IU,1,5 days every week,NA
10427950,NA,688,etretinate,4,4,mg/kg,1,on 5 consecutive days every other week,NA
16754599,NA,689,cisplatin,1,60,mg/m2,1,every 3 week,NA
16754599,NA,689,cisplatin,1,60,mg/m2,1,every 3 week,NA
16754599,NA,689,thiosulphate,1,12,mg/m2,1,every 3 week,fixed
16754599,NA,689,cisplatin,2,100,mg/m2,1,every 3 week,NA
16754599,NA,689,cisplatin,2,100,mg/m2,1,every 3 week,NA
16754599,NA,689,thiosulphate,2,12,mg/m2,1,every 3 week,fixed
16754599,NA,689,cisplatin,3,140,mg/m2,1,every 3 week,NA
16754599,NA,689,cisplatin,3,140,mg/m2,1,every 3 week,NA
16754599,NA,689,thiosulphate,3,12,mg/m2,1,every 3 week,fixed
16754599,NA,689,cisplatin,4,180,mg/m2,1,every 3 week,NA
16754599,NA,689,cisplatin,4,180,mg/m2,1,every 3 week,NA
16754599,NA,689,thiosulphate,4,12,mg/m2,1,every 3 week,fixed
16596187,NA,690,lipoplatin,1,25,mg/m2,1,on days 1 and 15 every 4 weeks,NA
16596187,NA,690,gemcitabine,1,1000,mg/m2,1,on days 1 and 15 every 4 weeks,fixed
16596187,NA,690,lipoplatin,2,50,mg/m2,1,on days 1 and 15 every 4 weeks,NA
16596187,NA,690,gemcitabine,2,1000,mg/m2,1,on days 1 and 15 every 4 weeks,fixed
16596187,NA,690,lipoplatin,3,75,mg/m2,1,on days 1 and 15 every 4 weeks,NA
16596187,NA,690,gemcitabine,3,1000,mg/m2,1,on days 1 and 15 every 4 weeks,fixed
16596187,NA,690,lipoplatin,4,100,mg/m2,1,on days 1 and 15 every 4 weeks,NA
16596187,NA,690,gemcitabine,4,1000,mg/m2,1,on days 1 and 15 every 4 weeks,fixed
16596187,NA,690,lipoplatin,5,125,mg/m2,1,on days 1 and 15 every 4 weeks,NA
16596187,NA,690,gemcitabine,5,1000,mg/m2,1,on days 1 and 15 every 4 weeks,fixed
18600301,NA,692,cisplatin,0,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,0,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,0,0.5,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,1,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,1,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,1,1,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,2,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,2,50,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,2,1.25,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,3,59,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,3,59,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,3,1.5,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,4,60,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,4,60,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,4,1.25,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,5,70,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,cisplatin,5,70,mg/m2,1,on Day 1 of each 4-week course,arm 1
18600301,NA,692,9-nitrocamptothecin,5,1.25,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 1
18600301,NA,692,cisplatin,10,20,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,10,20,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,10,1.5,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
18600301,NA,692,cisplatin,11,30,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,11,30,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,11,1.5,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
18600301,NA,692,cisplatin,12,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,12,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,12,1.5,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
18600301,NA,692,cisplatin,13,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,13,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,13,1.75,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
18600301,NA,692,cisplatin,14,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,14,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,14,2,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
18600301,NA,692,cisplatin,15,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,cisplatin,15,40,mg/m2,1,on Day 1 of each 4-week course,arm 2
18600301,NA,692,9-nitrocamptothecin,15,2.25,mg/m2,1,"5 consecutive days, every week, for 3 weeks of each 4-week course, starting on the evening of cisplatin administration",arm 2
28466360,UMIN000015595,693,sulfasalazine,1,6,g/d,4,daily 2 weeks on and 1 week off schedule,NA
28466360,UMIN000015595,693,cisplatin,1,60,mg/m2,1,every 3 weeks,fixed
28466360,UMIN000015595,693,cisplatin,1,60,mg/m2,1,every 3 weeks,fixed
28466360,UMIN000015595,693,sulfasalazine,2,8,g/d,4,daily 2 weeks on and 1 week off schedule,NA
28466360,UMIN000015595,693,cisplatin,2,60,mg/m2,1,every 3 weeks,fixed
28466360,UMIN000015595,693,cisplatin,2,60,mg/m2,1,every 3 weeks,fixed
20606530,NA,694,tirapazamine,1,290,mg/m2,1,on day 1 of weeks 1 to 5,NA
20606530,NA,694,cisplatin,1,40,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,cisplatin,1,40,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,external beam radiation,1,45-50.4,Gy,NA,"in 25 to 28 fractions, delivered daily, 5 fractions per week",fixed
20606530,NA,694,tirapazamine,-1,260,mg/m2,1,on day 1 of weeks 1 to 5,NA
20606530,NA,694,cisplatin,-1,30,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,cisplatin,-1,30,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,external beam radiation,-1,45-50.4,Gy,NA,"in 25 to 28 fractions, delivered daily, 5 fractions per week",fixed
20606530,NA,694,tirapazamine,-1A,260,mg/m2,1,on day 1 of weeks 1 to 5,NA
20606530,NA,694,cisplatin,-1A,35,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,cisplatin,-1A,35,mg/m2,1,on day 1 of weeks 1 to 6,NA
20606530,NA,694,external beam radiation,-1A,45-50.4,Gy,NA,"in 25 to 28 fractions, delivered daily, 5 fractions per week",fixed
20480279,NA,696,brostallicin,-1,4,mg/m2,1,on day 1 of a 21-day cycle,NA
20480279,NA,696,cisplatin,-1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,cisplatin,-1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,brostallicin,1,5,mg/m2,1,on day 1 of a 21-day cycle,NA
20480279,NA,696,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,cisplatin,1,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,brostallicin,2,7,mg/m2,1,on day 1 of a 21-day cycle,NA
20480279,NA,696,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,cisplatin,2,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,brostallicin,3,9,mg/m2,1,on day 1 of a 21-day cycle,NA
20480279,NA,696,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
20480279,NA,696,cisplatin,3,75,mg/m2,1,on day 1 of a 21-day cycle,fixed
26414837,NA,697,docetaxel,1,60,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,1,60,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,1,60,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,5-fluorouracil,1,600,mg/m2,1,on days 1–5 at 4-week intervals,NA
26414837,NA,697,docetaxel,2,60,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,2,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,2,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,5-fluorouracil,2,700,mg/m2,1,on days 1–5 at 4-week intervals,NA
26414837,NA,697,docetaxel,3,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,3,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,3,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,5-fluorouracil,3,700,mg/m2,1,on days 1–5 at 4-week intervals,NA
26414837,NA,697,docetaxel,4,70,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,4,80,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,cisplatin,4,80,mg/m2,1,on day 1 at 4-week intervals,NA
26414837,NA,697,5-fluorouracil,4,800,mg/m2,1,on days 1–5 at 4-week intervals,NA
21220472,NA,698,cbp501,1,0.9,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,2,1.8,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,3,3.6,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,4,7.2,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,5,9.6,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,6,12.7,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,7,16.9,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,698,cbp501,8,22.5,mg/m2,1,"days 1, 8, 15 every 28 days",NA
21220472,NA,699,cbp501,1,3.6,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,1,50,mg/m2,1,on day 1 of a 3-week cycle,NA
21220472,NA,699,cisplatin,1,50,mg/m2,1,on day 1 of a 3-week cycle,NA
21220472,NA,699,cbp501,2,3.6,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,2,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,2,75,mg/m2,1,NA,NA
21220472,NA,699,cbp501,3,7.2,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,3,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,3,75,mg/m2,1,NA,NA
21220472,NA,699,cbp501,4,10.8,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,4,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,4,75,mg/m2,1,NA,NA
21220472,NA,699,cbp501,5,16.2,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,5,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,5,75,mg/m2,1,NA,NA
21220472,NA,699,cbp501,6,25,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,6,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,6,75,mg/m2,1,NA,NA
21220472,NA,699,cbp501,7,36.4,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,7,75,mg/m2,1,NA,NA
21220472,NA,699,cisplatin,7,75,mg/m2,1,NA,NA
16418184,NA,700,amrubicin hydrochloride,1,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,NA
16418184,NA,700,cisplatin,1,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
16418184,NA,700,cisplatin,1,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
16418184,NA,700,amrubicin hydrochloride,2,25,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,NA
16418184,NA,700,cisplatin,2,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
16418184,NA,700,cisplatin,2,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
16418184,NA,700,amrubicin hydrochloride,3,30,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,NA
16418184,NA,700,cisplatin,3,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
16418184,NA,700,cisplatin,3,20,mg/m2,1,on days 1 through 3 of each 3 or 4-week cycle,fixed
12695856,NA,701,azidothymidine,1,400,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,1,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,1,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,2,800,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,2,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,2,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,3,1300,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,3,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,3,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,4,2000,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,4,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,4,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,5,2600,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,5,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,5,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,6,3458,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,6,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,6,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,7,4599,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,7,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,7,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,8,6166,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,8,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,8,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,9,8135,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,9,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,9,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,10,10820,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,10,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,10,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,11,14364,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,11,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,11,30,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,12,8135,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,12,45,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,12,45,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,azidothymidine,13,8135,mg/m2/d,1,a 72-h infusion on days 1–3 and 14–16 of a 28-day cycle,NA
12695856,NA,701,cisplatin,13,60,mg/m2,1,at hour 36 of each AZT infusion,NA
12695856,NA,701,cisplatin,13,60,mg/m2,1,at hour 36 of each AZT infusion,NA
26891913,NA,702,s-1,1,25,mg/m2,2,daily on Days1–14 and Days 22–35,NA
26891913,NA,702,cisplatin,1,80,mg/m2,1,on Days 1–3 and Days 22–24,NA
26891913,NA,702,cisplatin,1,80,mg/m2,1,on Days 1–3 and Days 22–24,NA
26891913,NA,702,lcaf rt,1,59.6,Gy,NA,"first phase: 40 Gy in 20 fractions; second phase: 19.6 Gy/1.4 Gy twice a dayin 14 fractions, 5 days per week, for 1.4 weeks",fixed
15589600,NA,703,cisplatin,1,6,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,1,6,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,1,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
15589600,NA,703,cisplatin,2,6.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,2,6.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,2,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
15589600,NA,703,cisplatin,3,7,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,3,7,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,3,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
15589600,NA,703,cisplatin,4,7.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,4,7.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,4,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
15589600,NA,703,cisplatin,5,8,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,5,8,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,5,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
15589600,NA,703,cisplatin,6,8.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,cisplatin,6,8.5,mg/m2,1,daily concurrently with RT,NA
15589600,NA,703,pelvic radiotherapy,6,2,Gy,1,"A total dose of 50 Gy was delivered in 25 daily fractions of 2.0 Gy, administered on 5 days a week (from Monday to Friday)",fixed
22994941,UMIN-CTR 000003541,704,miriplatin,1,80,mg,1,NA,fixed
22994941,UMIN-CTR 000003541,704,ddp-h,1,35,mg/m2,1,NA,NA
22994941,UMIN-CTR 000003541,704,miriplatin,2,80,mg,1,NA,fixed
22994941,UMIN-CTR 000003541,704,ddp-h,2,50,mg/m2,1,NA,NA
22994941,UMIN-CTR 000003541,704,miriplatin,3,80,mg,1,NA,fixed
22994941,UMIN-CTR 000003541,704,ddp-h,3,65,mg/m2,1,NA,NA
21868563,NA,705,s-1,0,80-120,mg/d,1,"every day on days 1-21, one cycle repeated after 6 weeks. less than 1.25 m2, 80 mg; 1.25-1.5 m2, 100 mg and greater than 1.5 m2, 120 mg",fixed
21868563,NA,705,cisplatin,0,15,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,cisplatin,0,15,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,radiation,0,2,Gy,1,"daily on days 1-5, 8-12, 15-19 and 22-26, one cycle repeated after 6 weeks",fixed
21868563,NA,705,s-1,1,80-120,mg/d,1,"every day on days 1-21, one cycle repeated after 6 weeks. less than 1.25 m2, 80 mg; 1.25-1.5 m2, 100 mg and greater than 1.5 m2, 120 mg",fixed
21868563,NA,705,cisplatin,1,20,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,cisplatin,1,20,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,radiation,1,2,Gy,1,"daily on days 1-5, 8-12, 15-19 and 22-26, one cycle repeated after 6 weeks",fixed
21868563,NA,705,s-1,2,80-120,mg/d,1,"every day on days 1-21, one cycle repeated after 6 weeks. less than 1.25 m2, 80 mg; 1.25-1.5 m2, 100 mg and greater than 1.5 m2, 120 mg",fixed
21868563,NA,705,cisplatin,2,25,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,cisplatin,2,25,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,radiation,2,2,Gy,1,"daily on days 1-5, 8-12, 15-19 and 22-26, one cycle repeated after 6 weeks",fixed
21868563,NA,705,s-1,3,80-120,mg/d,1,"every day on days 1-21, one cycle repeated after 6 weeks. less than 1.25 m2, 80 mg; 1.25-1.5 m2, 100 mg and greater than 1.5 m2, 120 mg",fixed
21868563,NA,705,cisplatin,3,30,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,cisplatin,3,30,mg/m2,1,"on days 1, 8 and 15, one cycle repeated after 6 weeks",NA
21868563,NA,705,radiation,3,2,Gy,1,"daily on days 1-5, 8-12, 15-19 and 22-26, one cycle repeated after 6 weeks",fixed
19443394,NA,706,s-1,1,65,mg/m2,1,for 21 consecutive days from day 1 every 35 days,NA
19443394,NA,706,cisplatin,1,60,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,cisplatin,1,60,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,s-1,2,65,mg/m2,1,for 21 consecutive days from day 1 every 35 days,NA
19443394,NA,706,cisplatin,2,70,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,cisplatin,2,70,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,s-1,3,80,mg/m2,1,for 21 consecutive days from day 1 every 35 days,NA
19443394,NA,706,cisplatin,3,60,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,cisplatin,3,60,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,s-1,4,80,mg/m2,1,for 21 consecutive days from day 1 every 35 days,NA
19443394,NA,706,cisplatin,4,70,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,cisplatin,4,70,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,s-1,5,80,mg/m2,1,for 21 consecutive days from day 1 every 35 days,NA
19443394,NA,706,cisplatin,5,80,mg/m2,1,on day 22 every 35 days,NA
19443394,NA,706,cisplatin,5,80,mg/m2,1,on day 22 every 35 days,NA
16077976,NA,707,vinorelbine,1,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,gemcitabine,1,600,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,vinorelbine,2,20,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,gemcitabine,2,800,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,vinorelbine,3,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,gemcitabine,3,800,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,vinorelbine,4,25,mg/m2,1,on days 1 and 8 every 3 weeks,NA
16077976,NA,707,gemcitabine,4,1000,mg/m2,1,on days 1 and 8 every 3 weeks,NA
10847466,NA,708,paclitaxel,1,40,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,1,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,1,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,pelvic radiotherapy,1,1.8,Gy,1,65 Gy with fractions of 1.8 Gy administered five days a week,fixed
10847466,NA,708,paclitaxel,2,45,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,2,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,2,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,pelvic radiotherapy,2,1.8,Gy,1,65 Gy with fractions of 1.8 Gy administered five days a week,fixed
10847466,NA,708,paclitaxel,3,50,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,3,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,3,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,pelvic radiotherapy,3,1.8,Gy,1,65 Gy with fractions of 1.8 Gy administered five days a week,fixed
10847466,NA,708,paclitaxel,4,55,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,4,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,cisplatin,4,30,mg/m2,1,"weekly for six weeks, starting on the first day of radiotherapy.",NA
10847466,NA,708,pelvic radiotherapy,4,1.8,Gy,1,65 Gy with fractions of 1.8 Gy administered five days a week,fixed
16575008,NA,709,cisplatin,1,50,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,1,50,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,1,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,2,100,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,2,100,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,2,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,3,150,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,3,150,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,3,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,4,175,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,4,175,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,4,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,5,200,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,5,200,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,5,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,6,225,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,6,225,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,6,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
16575008,NA,709,cisplatin,7,250,mg/m2,1,NA,NA
16575008,NA,709,cisplatin,7,250,mg/m2,1,NA,NA
16575008,NA,709,sodium thiosulfate,7,16,mg/m2,1,Immediately after the 1-hour cisplatin lavage,fixed
27878356,NCT00024323,710,triapine,-1b,84,mg/m2/d,1,Daily × 5 q 2 weeks schedule,Daily × 5 q 2 weeks schedule
27878356,NCT00024323,710,cisplatin,-1b,20,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,cisplatin,-1b,20,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,triapine,-1a,84,mg/m2/d,1,Daily × 5 q 2 weeks schedule,Daily × 5 q 2 weeks schedule
27878356,NCT00024323,710,cisplatin,-1a,25,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,cisplatin,-1a,25,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,triapine,1,96,mg/m2/d,1,Daily × 5 q 2 weeks schedule,Daily × 5 q 2 weeks schedule
27878356,NCT00024323,710,cisplatin,1,25,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,cisplatin,1,25,mg/m2,1,on day 3 every 2 weeks,NA
27878356,NCT00024323,710,triapine,2,96,mg/m2/d,1,Daily × 5 q 2 weeks schedule,Daily × 5 q 2 weeks schedule
27878356,NCT00024323,710,cisplatin,2,37.5,mg/m2,1,on day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,2,37.5,mg/m2,1,on day 3 every 3 weeks,NA
27878356,NCT00024323,710,triapine,-1,84,mg/m2/d,1,Daily × 5 q 3 weeks schedule,Daily × 5 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,-1,37.5,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,-1,37.5,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,triapine,1,96,mg/m2/d,1,Daily × 5 q 3 weeks schedule,Daily × 5 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,1,25,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,1,25,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,triapine,2,96,mg/m2/d,1,Daily × 5 q 3 weeks schedule,Daily × 5 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,2,37.5,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,2,37.5,mg/m2,NA,divided over day 3 and day 4 every 3 weeks,NA
27878356,NCT00024323,710,triapine,1,96,mg/m2/d,1,Daily × 4 q 3 weeks schedule,Daily × 4 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,1,50,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,1,50,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,triapine,2,96,mg/m2/d,1,Daily × 4 q 3 weeks schedule,Daily × 4 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,2,75,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,2,75,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,triapine,-1a,72,mg/m2/d,1,Daily × 4 q 3 weeks schedule,Daily × 4 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,-1a,75,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,-1a,75,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,triapine,-1b,72,mg/m2/d,1,Daily × 4 q 3 weeks schedule,Daily × 4 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,-1b,50,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,-1b,50,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,triapine,-2,48,mg/m2/d,1,Daily × 4 q 3 weeks schedule,Daily × 4 q 3 weeks schedule
27878356,NCT00024323,710,cisplatin,-2,40,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
27878356,NCT00024323,710,cisplatin,-2,40,mg/m2,NA,e divided over day 2 and day 3 every 3 weeks,NA
15653702,NA,711,cisplatin,1,60,mg/m2,1,on day 1  every 3 weeks for four to six courses.,fixed
15653702,NA,711,cisplatin,1,60,mg/m2,1,on day 1  every 3 weeks for four to six courses.,fixed
15653702,NA,711,amrubicin,1,40,mg/m2,1,on days 1–3  every 3 weeks for four to six courses.,NA
15653702,NA,711,cisplatin,2,60,mg/m2,1,on day 1  every 3 weeks for four to six courses.,fixed
15653702,NA,711,cisplatin,2,60,mg/m2,1,on day 1  every 3 weeks for four to six courses.,fixed
15653702,NA,711,amrubicin,2,45,mg/m2,1,on days 1–3  every 3 weeks for four to six courses.,NA
22922041,NA,712,cisplatin,1,35,mg/m2,1,NA,NA
22922041,NA,712,cisplatin,1,35,mg/m2,1,NA,NA
22922041,NA,712,cisplatin,2,50,mg/m2,1,NA,NA
22922041,NA,712,cisplatin,2,50,mg/m2,1,NA,NA
22922041,NA,712,cisplatin,3,65,mg/m2,1,NA,NA
22922041,NA,712,cisplatin,3,65,mg/m2,1,NA,NA
10561301,NA,713,cisplatin,1,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,cisplatin,1,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,5-fu,1,260,mg/m2,1,daily with each radiation dose during the last 2 weeks,NA
10561301,NA,713,radiation,1,2,Gy,1,"70 Gy delivered in 35 fractions in 7 weeks, 5 days per week",fixed
10561301,NA,713,cisplatin,2,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,cisplatin,2,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,5-fu,2,320,mg/m2,1,daily with each radiation dose during the last 2 weeks,NA
10561301,NA,713,radiation,2,2,Gy,1,"70 Gy delivered in 35 fractions in 7 weeks, 5 days per week",fixed
10561301,NA,713,cisplatin,3,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,cisplatin,3,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,5-fu,3,400,mg/m2,1,daily with each radiation dose during the last 2 weeks,NA
10561301,NA,713,radiation,3,2,Gy,1,"70 Gy delivered in 35 fractions in 7 weeks, 5 days per week",fixed
10561301,NA,713,cisplatin,4,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,cisplatin,4,10,mg/m2,1,daily with each radiation dose during the last 2 weeks,fixed
10561301,NA,713,5-fu,4,500,mg/m2,1,daily with each radiation dose during the last 2 weeks,NA
10561301,NA,713,radiation,4,2,Gy,1,"70 Gy delivered in 35 fractions in 7 weeks, 5 days per week",fixed
19723113,NA,714,ckd-602,1,0.3,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
19723113,NA,714,cisplatin,1,60,mg/m2,1,on day 5 every 3 weeks,NA
19723113,NA,714,cisplatin,1,60,mg/m2,1,on day 5 every 3 weeks,NA
19723113,NA,714,ckd-602,-1,0.25,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
19723113,NA,714,cisplatin,-1,60,mg/m2,1,on day 5 every 3 weeks,NA
19723113,NA,714,cisplatin,-1,60,mg/m2,1,on day 5 every 3 weeks,NA
19723113,NA,714,ckd-602,1,NA,mg/m2,1,daily for 5 consecutive days every 3 weeks,NA
23692812,NCT00359359,715,cisplatin,1,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,cisplatin,1,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,sagopilone,1,12,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
23692812,NCT00359359,715,cisplatin,2,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,cisplatin,2,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,sagopilone,2,16,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
23692812,NCT00359359,715,cisplatin,3,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,cisplatin,3,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,fixed
23692812,NCT00359359,715,sagopilone,3,19,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
23692812,NCT00359359,715,cisplatin,4,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
23692812,NCT00359359,715,cisplatin,4,75,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
23692812,NCT00359359,715,sagopilone,4,22,mg/m2,1,on day 1 every 3 weeks to a maximum of six cycles,NA
11821794,NA,716,cisplatin,1,70,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,1,70,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,2,80,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,2,80,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,3,100,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,3,100,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,4,120,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,4,120,mg/m2,1,in osmolarity 308 mOsm/L,isotonic intraperitoneal cisplatin
11821794,NA,716,cisplatin,5,70,mg/m2,1,dissolved in one-half normal sline solution and injected in osmolarity 180 mOsm/L,"hypotonic intraperitoneal
cisplatin"
11821794,NA,716,cisplatin,5,70,mg/m2,1,dissolved in one-half normal sline solution and injected in osmolarity 180 mOsm/L,"hypotonic intraperitoneal
cisplatin"
11821794,NA,716,cisplatin,6,70,mg/m2,1,dissolved in distilled water and injected in osmolarity 50 mOsm/L,"hypotonic intraperitoneal
cisplatin"
11821794,NA,716,cisplatin,6,70,mg/m2,1,dissolved in distilled water and injected in osmolarity 50 mOsm/L,"hypotonic intraperitoneal
cisplatin"
27503200,NCT01139970,717,veliparib,1A,20,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,1A,150,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,1A,150,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,1B,20,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,1B,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,1B,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,2,40,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,2,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,2,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,3,80,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,3,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,3,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,4,120,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,4,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,4,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,5,150,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,5,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,5,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,veliparib,6,200,mg,2,"on days 4 – 12 of cycle 1, days 1–8 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,6,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
27503200,NCT01139970,717,temozolomide,6,200,mg/m2,1,"on days 3–9 in cycle 1, days 1–5 in cycle ≥2, every 28–56 days",NA
9041168,NA,718,tamoxifen,1,80,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,1,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,1,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,tamoxifen,2,120,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,2,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,2,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,tamoxifen,3,160,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,3,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,3,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,tamoxifen,4,200,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,4,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,4,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,tamoxifen,5,240,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,5,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,5,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,tamoxifen,6,280,mg,1,"daily, beginning on Day 1",NA
9041168,NA,718,cisplatin,6,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
9041168,NA,718,cisplatin,6,80,mg/m2,1,"weekly, beginning on Day 2, for 3 weeks",fixed
27716819,NCT01488344,719,nintedanib,1,100,mg,2,daily for 28 days of a 28-day cycle,NA
27716819,NCT01488344,719,cytarabine,1,20,mg,2,days 1-10 of 28-day cycles,fixed
27716819,NCT01488344,719,nintedanib,2,150,mg,2,daily for 28 days of a 28-day cycle,NA
27716819,NCT01488344,719,cytarabine,2,20,mg,2,days 1-10 of 28-day cycles,fixed
27716819,NCT01488344,719,nintedanib,3,200,mg,2,daily for 28 days of a 28-day cycle,NA
27716819,NCT01488344,719,cytarabine,3,20,mg,2,days 1-10 of 28-day cycles,fixed
7911736,NA,720,cladribine,1,4,mg/m2/d,1,"daily for 5 days, with a cycle length of 28 days",NA
7911736,NA,720,cladribine,2,6,mg/m2/d,1,"daily for 5 days, with a cycle length of 28 days",NA
7911736,NA,720,cladribine,3,8,mg/m2/d,1,"daily for 5 days, with a cycle length of 28 days",NA
21174612,NA,721,ril-21,1,3,ug/kg,1,"TIW, starting from week 2",NA
21174612,NA,721,sunitinib,1,50,mg,1,OD at the  ‘ 4 weeks on/2 weeks off  ’  schedule,fixed
21174612,NA,721,ril-21,2,10,ug/kg,1,"TIW, starting from week 2",NA
21174612,NA,721,sunitinib,2,50,mg,1,OD at the  ‘ 4 weeks on/2 weeks off  ’  schedule,fixed
31707687,NCT02619864,722,vistusertib,1,100,mg,2,2 days on/5 days off weekly,NA
31707687,NCT02619864,722,temozolomide,1,150,mg/m2,1,daily for 5 days/28-days cycle,NA
31707687,NCT02619864,722,temozolomide,1,150,mg/m2,1,daily for 5 days/28-days cycle,NA
31707687,NCT02619864,722,vistusertib,2,125,mg,2,2 days on/5 days off weekly,NA
31707687,NCT02619864,722,temozolomide,2,150,mg/m2,1,daily for 5 days/28-days cycle,NA
31707687,NCT02619864,722,temozolomide,2,150,mg/m2,1,daily for 5 days/28-days cycle,NA
31707687,NCT02619864,722,vistusertib,3,125,mg,2,2 days on/5 days off weekly,NA
31707687,NCT02619864,722,temozolomide,3,150/200,mg/m2,1,"daily for 5 days/28-days cycle. 150 mg/m2 QD in cycle 2, then escalated to 200 mg/m2 QD in cycle 2",NA
31707687,NCT02619864,722,temozolomide,3,150/200,mg/m2,1,"daily for 5 days/28-days cycle. 150 mg/m2 QD in cycle 2, then escalated to 200 mg/m2 QD in cycle 2",NA
26966095,NCT01907165,723,temozolomide,1,150-200,mg/m2,1,Days 1-5 every 28 days,fixed
26966095,NCT01907165,723,temozolomide,1,150-200,mg/m2,1,Days 1-5 every 28 days,fixed
26966095,NCT01907165,723,disulfiram,1,500,mg,1,on days 1-28 every 28 days,NA
26966095,NCT01907165,723,temozolomide,2,150-200,mg/m2,1,Days 1-5 every 28 days,fixed
26966095,NCT01907165,723,temozolomide,2,150-200,mg/m2,1,Days 1-5 every 28 days,fixed
26966095,NCT01907165,723,disulfiram,2,1000,mg,1,on days 1-28 every 28 days,NA
21909644,NA,725,elacytarabine,1,75,mg/m2/d,2,D1-5 and D8-12 q4w,NA
21909644,NA,725,elacytarabine,2,100,mg/m2/d,2,D1-5 and D8-12 q4w,NA
21909644,NA,725,elacytarabine,3,125,mg/m2/d,2,D1-5 and D8-12 q4w,NA
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,tamoxifen,1,20,mg,1,daily in continuous 28-day cycles,fixed
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,venetoclax,1,200,mg,1,daily in continuous 28-day cycles,NA
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,tamoxifen,2,20,mg,1,daily in continuous 28-day cycles,fixed
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,venetoclax,2,400,mg,1,daily in continuous 28-day cycles,NA
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,tamoxifen,3,20,mg,1,daily in continuous 28-day cycles,fixed
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,venetoclax,3,600,mg,1,daily in continuous 28-day cycles,NA
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,tamoxifen,4,20,mg,1,daily in continuous 28-day cycles,fixed
30518523,ISRCTN (ISRCTN98335443) and ACTRN (ACTRN12615000702516),726,venetoclax,4,800,mg,1,daily in continuous 28-day cycles,NA
34787778,NCT00977431,727,afatinib,1,20,mg,1,"Day 1 to day 42, during the RT phase (i.e., days1–42), and then at 40 mg/day following RT (maintenance phase)",NA
34787778,NCT00977431,727,radiotherapy,1,2,Gy,1,on 5 days per week for 6 weeks (total dose of 60 Gy),NA
34787778,NCT00977431,727,afatinib,2,40,mg,1,"Day 1 to day 42, during the RT phase (i.e., days1–42), and then at 40 mg/day following RT (maintenance phase)",NA
34787778,NCT00977431,727,radiotherapy,2,2,Gy,1,on 5 days per week for 6 weeks (total dose of 60 Gy),NA
34787778,NCT00977431,728,afatinib,1,20,mg,1,"Day 1 to day 42, during the RT phase (i.e., days1–42), and then at 40 mg/day following RT (maintenance phase)",NA
34787778,NCT00977431,728,radiotherapy,1,2,Gy,1,on 5 days per week for 6 weeks (total dose of 60 Gy),NA
34787778,NCT00977431,728,temozolomide,1,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
34787778,NCT00977431,728,temozolomide,1,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
34787778,NCT00977431,728,afatinib,2,30,mg,1,"Day 1 to day 42, during the RT phase (i.e., days1–42), and then at 40 mg/day following RT (maintenance phase)",NA
34787778,NCT00977431,728,radiotherapy,2,2,Gy,1,on 5 days per week for 6 weeks (total dose of 60 Gy),NA
34787778,NCT00977431,728,temozolomide,2,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
34787778,NCT00977431,728,temozolomide,2,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
34787778,NCT00977431,728,afatinib,3,40,mg,1,"Day 1 to day 42, during the RT phase (i.e., days1–42), and then at 40 mg/day following RT (maintenance phase)",NA
34787778,NCT00977431,728,radiotherapy,3,2,Gy,1,on 5 days per week for 6 weeks (total dose of 60 Gy),NA
34787778,NCT00977431,728,temozolomide,3,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
34787778,NCT00977431,728,temozolomide,3,75,mg/m2,1,"daily Day 1 to day 42, during RT. 4 weeks after RT: given days 1 to 5 of 28 day cycles (150 mg/m2 in cycle 1, 200 mg/m2 in cycle 2 up to cycle 6)",NA
32866424,NCT02378532,729,chloroquine,1,200,mg,1,daily during the course of radiotherapy,NA
32866424,NCT02378532,729,temozolomide,1,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,temozolomide,1,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,radiotherapy,1,1.8,Gy,1,59.4 Gy in 33 fractions in 6.5 weeks,fixed
32866424,NCT02378532,729,chloroquine,2,300,mg,1,daily during the course of radiotherapy,NA
32866424,NCT02378532,729,temozolomide,2,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,temozolomide,2,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,radiotherapy,2,1.8,Gy,1,59.4 Gy in 33 fractions in 6.5 weeks,fixed
32866424,NCT02378532,729,chloroquine,3,400,mg,1,daily during the course of radiotherapy,NA
32866424,NCT02378532,729,temozolomide,3,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,temozolomide,3,75,mg/m2,1,"daily during the course of radiotherapy. After a 4 week break, patients will receive up to six cycles of adjuvant oral TMZ 150 - 200 mg/m² po qd for 5 days every 28 days. The starting dose is 150 mg/m² po qd. At the start of cycle 2 the dose will be escalated to 200mg/m2",fixed
32866424,NCT02378532,729,radiotherapy,3,1.8,Gy,1,59.4 Gy in 33 fractions in 6.5 weeks,fixed
32866424,NCT02378532,729,chloroquine,1,200,mg,1,"daily, starting one week before the course of chemoradiation until the end of radiotherapy",NA
32866424,NCT02378532,729,chloroquine,2,300,mg,1,"daily, starting one week before the course of chemoradiation until the end of radiotherapy",NA
32866424,NCT02378532,729,chloroquine,3,400,mg,1,"daily, starting one week before the course of chemoradiation until the end of radiotherapy",NA
14551141,NA,730,clofarabine,1,11.25,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
14551141,NA,730,clofarabine,2,15,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
14551141,NA,730,clofarabine,3,30,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
14551141,NA,730,clofarabine,4,40,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
14551141,NA,730,clofarabine,5,52,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
14551141,NA,730,clofarabine,6,70,mg/m2,1,daily for 5 days. Courses were repeated every 2 to 6 weeks,NA
11920222,NA,731,valspodar,1,2-Oct,mg/kg/24h,1,"10 mg/kg/24 h by continuous intravenous infusion [CIV] on days 1-4 with a 2-mg/kgloading dose on day 1, in each induction cycle",fixed
11920222,NA,731,daunorubicin,1,35,mg/m2,1,on days 1-3 in each induction cycle,NA
11920222,NA,731,cytarabine,1,200,mg/m2/d,1,on days 1-7 in each induction cycle,fixed
11920222,NA,731,valspodar,2,2-Oct,mg/kg/24h,1,"10 mg/kg/24 h by continuous intravenous infusion [CIV] on days 1-4 with a 2-mg/kgloading dose on day 1, in each induction cycle",fixed
11920222,NA,731,daunorubicin,2,45,mg/m2,1,on days 1-3 in each induction cycle,NA
11920222,NA,731,cytarabine,2,200,mg/m2/d,1,on days 1-7 in each induction cycle,fixed
28039367,NCT01800695,732,abt-414,1,0.5,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,1,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,1,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,1,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,2,0.7,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,2,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,2,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,2,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,3,1,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,3,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,3,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,3,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,4,2,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,4,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,4,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,4,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,5,2.3,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,5,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,5,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,5,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,6,2.4,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,6,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,6,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,6,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,7,2.6,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,7,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,7,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,7,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,8,3,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,8,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,8,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,8,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
28039367,NCT01800695,732,abt-414,9,3.2,mg/kg,1,"on day 1 of weeks 1, 3, and 5 during the RT and TMZ treatment phase",NA
28039367,NCT01800695,732,temozolomide,9,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,temozolomide,9,75,mg/m2,1,daily for 42 days,fixed
28039367,NCT01800695,732,radiation,9,2,Gy,1,60 Gy in 30 fractions over 42 days,fixed
29374809,NCT01907165,733,disulfiram,1,500,mg,1,"on days 1-28 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",NA
29374809,NCT01907165,733,temozolomide,1,150-200,mg/m2,1,"on days 1–5 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",fixed
29374809,NCT01907165,733,temozolomide,1,150-200,mg/m2,1,"on days 1–5 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",fixed
29374809,NCT01907165,733,disulfiram,2,1000,mg,1,"on days 1-28 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",NA
29374809,NCT01907165,733,temozolomide,2,150-200,mg/m2,1,"on days 1–5 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",fixed
29374809,NCT01907165,733,temozolomide,2,150-200,mg/m2,1,"on days 1–5 of every 28 day cycle, Beginning 4-6 weeks after completion of radiation therapy",fixed
21282541,NA,734,cpx-351,1,3,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,2,6,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,3,12,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,4,24,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,5,32,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,6,43,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,7,57,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,8,76,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,9,101,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
21282541,NA,734,cpx-351,10,134,unit/m2,1,"on days 1, 3, and 5 of each induction course",NA
18607882,NA,735,cp-4055,1,30,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,2,60,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,3,100,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,4,150,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,5,175,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,6,200,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,7,240,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 3 weeks,3 week schedule
18607882,NA,735,cp-4055,1,30,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,2,60,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,3,100,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,4,150,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,5,175,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,6,200,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,7,240,mg/m2/d,1,30 min infusion daily for 5 consecutive days every 4 weeks,4 week schedule
18607882,NA,735,cp-4055,8,240,mg/m2/d,1,2 h infusion daily for 5 consecutive days every 4 weeks,4 week schedule
32347934,NCT01390571,736,olaparib,1,100,mg,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,1,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,1,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,olaparib,2,100,mg,1,daily days 1– 5 per week for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,2,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,2,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,olaparib,3,150,mg,1,daily days 1– 5 per week for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,3,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,3,50,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,olaparib,4,150,mg,1,daily days 1– 5 per week for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,4,75,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,4,75,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,olaparib,5,150,mg,1,daily days 1–3 per week for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,5,75,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
32347934,NCT01390571,736,temozolomide,5,75,mg/m2,1,once daily continuously for 42 days of each 56-day cycle,NA
20922784,NCT00372853 ,737,tremelimumab,1,6,mg/kg,1,on Day 1 of every 90-day cycle,Arm 2
20922784,NCT00372853 ,737,sunitinib,1,50,mg,1,daily for 4 weeks on an every-6-week cycle,Arm 2
20922784,NCT00372853 ,737,tremelimumab,1,6,mg/kg,1,on Day 1 of every 90-day cycle,Arm 1
20922784,NCT00372853 ,737,sunitinib,1,37.5,mg,1,daily without any interruptions on an every-12-week cycle,Arm 1
20922784,NCT00372853 ,737,tremelimumab,2,10,mg/kg,1,on Day 1 of every 90-day cycle,Arm 1
20922784,NCT00372853 ,737,sunitinib,2,37.5,mg,1,daily without any interruptions on an every-12-week cycle,Arm 1
20922784,NCT00372853 ,737,tremelimumab,3,15,mg/kg,1,on Day 1 of every 90-day cycle,Arm 1
20922784,NCT00372853 ,737,sunitinib,3,37.5,mg,1,daily without any interruptions on an every-12-week cycle,Arm 1
30359477,NCT01430351,738,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,memantine,1,30,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,738,temozolomide,2,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,temozolomide,2,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,memantine,2,20,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,738,temozolomide,3,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,temozolomide,3,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,738,memantine,3,10,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,739,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,739,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,739,mefloquine,1,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,740,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,temozolomide,1,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,metformin,1,1000,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,740,temozolomide,2,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,temozolomide,2,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,metformin,2,850,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,740,temozolomide,3,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,temozolomide,3,150,mg/m2,1,daily on a week-on/week-off  schedule  (28-day  cycle),NA
30359477,NCT01430351,740,metformin,3,500,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,741,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,741,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,741,memantine,1,20,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,741,mefloquine,1,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,741,temozolomide,2,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,741,temozolomide,2,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,741,memantine,2,10,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,741,mefloquine,2,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,742,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,742,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,742,memantine,1,10,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,742,metformin,1,850,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,743,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,743,temozolomide,1,150-200,mg/m2,1,150 mg/m2 daily  on  a  week-on/week-off  schedule or 150-200 mg/m2 daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,743,mefloquine,1,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,743,metformin,1,850,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,744,temozolomide,1,150-200,mg/m2,1,daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,744,temozolomide,1,150-200,mg/m2,1,daily on days 1 through 5 of a 28-day cycle,NA
30359477,NCT01430351,744,memantine,1,10,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,744,mefloquine,1,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,744,metformin,1,850,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,744,memantine,2,10,mg,2,daily in 28-day cycles,NA
30359477,NCT01430351,744,mefloquine,2,250,mg,1,"on days 1-3 of week 1 and then days 2, 4, and 6 every other week",NA
30359477,NCT01430351,744,metformin,2,500,mg,2,daily in 28-day cycles,NA
19536893,NA,745,sunitinib,1,25,mg,1,daily in 6-weekcycles comprising 4 weeks of treatment followed by 2weeks without treatment,NA
19536893,NA,745,radiation,1,4,Gy,1,40 Gy in 10 fractions concurrently with the firstcycle of sunitinib during Day 8 to Day 19,NA
19536893,NA,745,sunitinib,2,37.5,mg,1,daily in 6-weekcycles comprising 4 weeks of treatment followed by 2weeks without treatment,NA
19536893,NA,745,radiation,2,4,Gy,1,40 Gy in 10 fractions concurrently with the firstcycle of sunitinib during Day 8 to Day 19,NA
19536893,NA,745,sunitinib,3,37.5,mg,1,daily in 6-weekcycles comprising 4 weeks of treatment followed by 2weeks without treatment,NA
19536893,NA,745,radiation,3,5,Gy,1,50 Gy in 10 fractions concurrently with the firstcycle of sunitinib during Day 8 to Day 19,NA
19536893,NA,745,sunitinib,4,50,mg,1,daily in 6-weekcycles comprising 4 weeks of treatment followed by 2weeks without treatment,NA
19536893,NA,745,radiation,4,5,Gy,1,50 Gy in 10 fractions concurrently with the firstcycle of sunitinib during Day 8 to Day 19,NA
19536893,NA,745,sunitinib,5,50,mg,1,daily in 6-weekcycles comprising 4 weeks of treatment followed by 2weeks without treatment,NA
19536893,NA,745,radiation,5,6,Gy,1,60 Gy in 10 fractionsconcurrently with the firstcycle of sunitinib during Day 8 to Day 19,NA
31724813,NCT02116777,746,talazoparib,1,400,ug/m2,1,on days 1-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,1,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,1,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,talazoparib,2,400,ug/m2,NA,Twice daily on day 1 followed by once daily on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,2,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,2,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,talazoparib,3,600,ug/m2,NA,Twice daily on day 1 followed by once daily on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,3,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,3,20,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,talazoparib,4,600,ug/m2,1,Twice daily on day 1 followed by once daily on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,4,30,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,4,30,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,talazoparib,5,600,ug/m2,NA,Twice daily on day 1 followed by once daily on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,5,40,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,5,40,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,talazoparib,6,600,ug/m2,1,Twice daily on day 1 followed by once daily on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,6,55,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
31724813,NCT02116777,746,temozolomide,6,55,mg/m2,1,on days 2-6 every 28 days for up to 24 courses,NA
21690570,NA,747,sunitinib,1,15,mg/m2,1,once daily for 28 days followed by a 14-day break between each cycle,Part B
21690570,NA,747,sunitinib,2,20,mg/m2,1,once daily for 28 days followed by a 14-day break between each cycle,Part B
21690570,NA,747,sunitinib,1,20,mg/m2,1,once daily for 28 days followed by a 14-day break between each cycle,Part A
21690570,NA,747,sunitinib,-1,15,mg/m2,1,once daily for 28 days followed by a 14-day break between each cycle,Part A
19933907,NA,748,sapacitabine,1,75,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,2,100,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,3,125,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,4,175,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,5,225,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,6,275,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,7,325,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,8,375,mg,2,7 consecutive days every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,9,375,mg,2,3 days for 2 weeks (days 1 through 3 and days 8 through 10) every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,10,425,mg,2,3 days for 2 weeks (days 1 through 3 and days 8 through 10) every 3 to 4 weeks,NA
19933907,NA,748,sapacitabine,11,475,mg,2,3 days for 2 weeks (days 1 through 3 and days 8 through 10) every 3 to 4 weeks,NA
12637486,NA,749,clofarabine,1,15,mg/m2,1,daily for 5 adys every 3 to 6 weeks,"in patients with solid
tumors and with acute leukemia"
12637486,NA,749,clofarabine,-3,2,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with solid tumors
12637486,NA,749,clofarabine,-1,7.5,mg/m2,1,daily for 5 adys every 3 to 6 weeks,"in patients with solid
tumors and with acute leukemia"
12637486,NA,749,clofarabine,0,11.25,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with acute leukemia
12637486,NA,749,clofarabine,2,22.5,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with acute leukemia
12637486,NA,749,clofarabine,3,30,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with acute leukemia
12637486,NA,749,clofarabine,4,40,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with acute leukemia
12637486,NA,749,clofarabine,5,55,mg/m2,1,daily for 5 adys every 3 to 6 weeks,in patients with acute leukemia
21353747,NA,750,temozolomide,1,50,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,temozolomide,1,50,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,radiotherapy,1,2,Gy,1,"once daily, 5 d/wk, to a total dose of 60 Gy",fixed
21353747,NA,750,temozolomide,2,75,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,temozolomide,2,75,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,radiotherapy,2,2,Gy,1,"once daily, 5 d/wk, to a total dose of 60 Gy",fixed
21353747,NA,750,temozolomide,3,100,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,temozolomide,3,100,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,radiotherapy,3,2,Gy,1,"once daily, 5 d/wk, to a total dose of 60 Gy",fixed
21353747,NA,750,temozolomide,4,125,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,temozolomide,4,125,mg/m2,2,during 6 weeks of concurrent RT,NA
21353747,NA,750,radiotherapy,4,2,Gy,1,"once daily, 5 d/wk, to a total dose of 60 Gy",fixed
11352969,NA,751,alitretinoin,1,70,mg/m2/d,1,daily every 4 weeks,NA
11352969,NA,751,tamoxifen,1,20,mg/d,1,daily starting from cycle 2,fixed
11352969,NA,751,alitretinoin,2,90,mg/m2/d,1,daily every 4 weeks,NA
11352969,NA,751,tamoxifen,2,20,mg/d,1,daily starting from cycle 2,fixed
11352969,NA,751,alitretinoin,-1,50,mg/m2/d,1,daily every 4 weeks,NA
11352969,NA,751,tamoxifen,-1,20,mg/d,1,daily starting from cycle 2,fixed
11352969,NA,751,alitretinoin,-2,37.5,mg/m2/d,1,daily every 4 weeks,NA
11352969,NA,751,tamoxifen,-2,20,mg/d,1,daily starting from cycle 2,fixed
31636097,NCT02403310,752,daunorubicin,1,60,mg/m2/d,1,on days 1 through 3,fixed
31636097,NCT02403310,752,cytarabine,1,100,mg/m2/d,1,a continuous intravenous infusion on days 1 through 7,fixed
31636097,NCT02403310,752,selinexor,1,60,mg,1,"during induction on days 1, 3, 8, 10, 15 and 17",NA
31636097,NCT02403310,752,daunorubicin,2,60,mg/m2/d,1,on days 1 through 3,fixed
31636097,NCT02403310,752,cytarabine,2,100,mg/m2/d,1,a continuous intravenous infusion on days 1 through 7,fixed
31636097,NCT02403310,752,selinexor,2,80,mg,1,"during induction on days 1, 3, 8, 10, 15 and 17",NA
31636097,NCT02403310,752,daunorubicin,-1,60,mg/m2/d,1,on days 1 through 3,fixed
31636097,NCT02403310,752,cytarabine,-1,100,mg/m2/d,1,a continuous intravenous infusion on days 1 through 7,fixed
31636097,NCT02403310,752,selinexor,-1,40,mg,1,"during induction on days 1, 3, 8, 10, 15 and 17",NA
23763917, NCT00926731,753,barasertib,1,800,mg,1,a 7-day continuous intravenous infusion from Day 1 to Day 7 of 28-day treatment cycles,NA
23763917, NCT00926731,753,cytosine arabinoside,1,20,mg,2,"from Day 1 to Day 10, of 28-day treatment cycles",fixed
23763917, NCT00926731,753,barasertib,2,1000,mg,1,a 7-day continuous intravenous infusion from Day 1 to Day 7 of 28-day treatment cycles,NA
23763917, NCT00926731,753,cytosine arabinoside,2,20,mg,2,"from Day 1 to Day 10, of 28-day treatment cycles",fixed
23763917, NCT00926731,753,barasertib,3,1200,mg,1,a 7-day continuous intravenous infusion from Day 1 to Day 7 of 28-day treatment cycles,NA
23763917, NCT00926731,753,cytosine arabinoside,3,20,mg,2,"from Day 1 to Day 10, of 28-day treatment cycles",fixed
24415560,NCT00727766,754,clofarabine,1,1,mg,1,"14 days of a 28 day cycle, for up to 5 cycles",NA
24415560,NCT00727766,754,clofarabine,2,1,mg,1,"21 days of a 28 day cycle, for up to 5 cycles",NA
24415560,NCT00727766,754,clofarabine,3,2,mg,1,"21 days of a 28 day cycle, for up to 5 cycles",NA
24415560,NCT00727766,754,clofarabine,4,3,mg,1,"21 days of a 28 day cycle, for up to 5 cycles",NA
24415560,NCT00727766,754,clofarabine,5,4,mg,1,"21 days of a 28 day cycle, for up to 5 cycles",NA
24415560,NCT00727766,754,clofarabine,6,6,mg,1,"21 days of a 28 day cycle, for up to 5 cycles",NA
25465491,NA,756,sunitinib,1,12.5,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,1,6,mg,1,weekly,NA
25465491,NA,756,sunitinib,2,25,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,2,12.5,mg,1,weekly,NA
25465491,NA,756,sunitinib,3,19,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,3,9,mg,1,weekly,NA
25465491,NA,756,sunitinib,7,25,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,7,6,mg,1,weekly,NA
25465491,NA,756,sunitinib,8,31,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,8,6,mg,1,weekly,NA
25465491,NA,756,sunitinib,9,37.5,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,9,6,mg,1,weekly,NA
25465491,NA,756,sunitinib,10,37.5,mg,1,"2 weeks of treatment, 1 week with no treatment",NA
25465491,NA,756,temsirolimus,10,8,mg,1,weekly,NA
29016887,NCT00731731,757,vorinostat,0,300,mg,1,"on days 1-5, 8-12, 15-19, 22-26, 29-33, and 36-40 (on days 1–5 weekly for 6 weeks beginning with the first dose of RT )",NA
29016887,NCT00731731,757,temozolomide,0,75,mg/m2,1,on days 1–42,fixed
29016887,NCT00731731,757,temozolomide,0,75,mg/m2,1,on days 1–42,fixed
29016887,NCT00731731,757,radiation,0,60,Gy,NA,NA,fixed
29016887,NCT00731731,757,vorinostat,1,400,mg,1,"on days 1-5, 8-12, 15-19, 22-26, 29-33, and 36-40 (on days 1–5 weekly for 6 weeks beginning with the first dose of RT )",NA
29016887,NCT00731731,757,temozolomide,1,75,mg/m2,1,on days 1–42,fixed
29016887,NCT00731731,757,temozolomide,1,75,mg/m2,1,on days 1–42,fixed
29016887,NCT00731731,757,radiation,1,60,Gy,NA,NA,fixed
29077941,NCT01800695,758,depatuxizumab mafodotin,1,0.5,mg/kg,1,on days 2 and 15 of cycle 1 and then on days 1and 15 of every subsequent 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,1,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,1,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,depatuxizumab mafodotin,2,1,mg/kg,1,on days 2 and 15 of cycle 1 and then on days 1and 15 of every subsequent 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,2,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,2,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,depatuxizumab mafodotin,3,2.25,mg/kg,1,on days 2 and 15 of cycle 1 and then on days 1and 15 of every subsequent 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,3,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,3,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,depatuxizumab mafodotin,4,1.5,mg/kg,1,on days 2 and 15 of cycle 1 and then on days 1and 15 of every subsequent 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,4,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,758,temozolomide,4,150,mg/m2,1,on days 1 through 5 of each 28-day cycle,NA
29077941,NCT01800695,759,depatuxizumab mafodotin,1,1.25,mg/kg,1,on days 1 and 15 of every 28-day cycle,NA
20858843,NA,760,cytarabine,1,200,mg/m2/d,1,continuous infusion for 5 days,fixed
20858843,NA,760,213bi-lintuzumab,1,18.5,MBq/kg,1,"Within 8 days after completion of cytarabine,  two to four injections of 213Bi-lintuzumab (518-1,262 MBq each) were given over 1 to 2 days.",NA
20858843,NA,760,cytarabine,2,200,mg/m2/d,1,continuous infusion for 5 days,fixed
20858843,NA,760,213bi-lintuzumab,2,27.75,MBq/kg,1,"Within 8 days after completion of cytarabine,  two to four injections of 213Bi-lintuzumab (518-1,262 MBq each) were given over 1 to 2 days.",NA
20858843,NA,760,cytarabine,3,200,mg/m2/d,1,continuous infusion for 5 days,fixed
20858843,NA,760,213bi-lintuzumab,3,37,MBq/kg,1,"Within 8 days after completion of cytarabine,  two to four injections of 213Bi-lintuzumab (518-1,262 MBq each) were given over 1 to 2 days.",NA
20858843,NA,760,cytarabine,4,200,mg/m2/d,1,continuous infusion for 5 days,fixed
20858843,NA,760,213bi-lintuzumab,4,46.25,MBq/kg,1,"Within 8 days after completion of cytarabine,  two to four injections of 213Bi-lintuzumab (518-1,262 MBq each) were given over 1 to 2 days.",NA
28371832,NCT01480050,761,mibefradil,1,25,mg,4,Days 1-7  per 28-day cycle,NA
28371832,NCT01480050,761,temozolomide,1,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,temozolomide,1,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,mibefradil,2,50,mg,4,Days 1-7  per 28-day cycle,NA
28371832,NCT01480050,761,temozolomide,2,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,temozolomide,2,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,mibefradil,3,75,mg,4,Days 1-7  per 28-day cycle,NA
28371832,NCT01480050,761,temozolomide,3,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,temozolomide,3,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,mibefradil,4,87.5,mg,4,Days 1-7  per 28-day cycle,NA
28371832,NCT01480050,761,temozolomide,4,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,temozolomide,4,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,mibefradil,5,100,mg,4,Days 1-7  per 28-day cycle,NA
28371832,NCT01480050,761,temozolomide,5,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
28371832,NCT01480050,761,temozolomide,5,150-200,mg/m2,1,Days 8-12  per 28-day cycle,fixed
30589027,NCT01465347,762,temozolomide,1,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,temozolomide,1,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,hypofractionated sib‑imrt,1,2.8,Gy,1,"56 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV1
30589027,NCT01465347,762,hypofractionated sib‑imrt,1,2.5,Gy,1,"50 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV2
30589027,NCT01465347,762,temozolomide,2,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,temozolomide,2,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,hypofractionated sib‑imrt,2,3.2,Gy,1,"56 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV1
30589027,NCT01465347,762,hypofractionated sib‑imrt,2,2.5,Gy,1,"50 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV2
30589027,NCT01465347,762,temozolomide,3,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,temozolomide,3,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,hypofractionated sib‑imrt,3,3.6,Gy,1,"56 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV1
30589027,NCT01465347,762,hypofractionated sib‑imrt,3,2.5,Gy,1,"50 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV2
30589027,NCT01465347,762,temozolomide,4,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,temozolomide,4,75,mg/m2,1,started on the 1st day until the end of the radiotherapy. at 150–200 mg/m2/day for 5 days every 28 days after the radiotheray,NA
30589027,NCT01465347,762,hypofractionated sib‑imrt,4,4,Gy,1,"56 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV1
30589027,NCT01465347,762,hypofractionated sib‑imrt,4,2.5,Gy,1,"50 Gy/20 fractions, one time/day and 5 days/week for 4 weeks",PTV2
16924496,NA,2,paclitaxel,1,80,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,1,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,1,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,fluorouracil,1,300,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,paclitaxel,2,80,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,2,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,2,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,fluorouracil,2,400,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,paclitaxel,3,80,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,3,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,3,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,fluorouracil,3,500,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,paclitaxel,4,80,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,4,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,cisplatin,4,25,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
16924496,NA,2,fluorouracil,4,600,mg/m2,1,"once per week for 3 weeks, every 4 weeks",NA
20041339,NA,3,s-1,1,80,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,3,s-1,2,90,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,3,s-1,3,100,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,4,s-1,1,80,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,5,s-1,1,70,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,5,s-1,2,80,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,6,s-1,1,50,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
20041339,NA,6,s-1,2,60,mg/m2/day,1,A 3 week treatment schedule consist- ing of 2 weeks of S-1 therapy and 1 week of no therapy,NA
19103671,NA,7,5-fluorouracil,-1,700,mg/m2/day,1,on Days 1–4 and 29–32,NA
19103671,NA,7,cisplatin,-1,70,mg/m2,1,Days 1 and 29,NA
19103671,NA,7,cisplatin,-1,70,mg/m2,1,Days 1 and 29,NA
19103671,NA,7,5-fluorouracil,1,800,mg/m2/day,1,on Days 1–4 and 29–32 ,NA
19103671,NA,7,cisplatin,1,75,mg/m2,1,Days 1 and 29,NA
19103671,NA,7,cisplatin,1,75,mg/m2,1,Days 1 and 29,NA
19103671,NA,7,5-fluorouracil,2,1000,mg/m2/day,1,on Days 1–4 and 29–32,NA
19103671,NA,7,cisplatin,2,75,mg/m2,1,Days 1 and 29,NA
19103671,NA,7,cisplatin,2,75,mg/m2,1,Days 1 and 29,NA
17262086,NA,9,irinotecan,1,6,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,1,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,1,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,2,8,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,2,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,2,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,3,10,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,3,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,3,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,4,12,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,4,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,4,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,5,14,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,5,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,5,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,6,16,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,6,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,6,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,7,18,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,7,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,7,20,mg m^-2,1,NA,NA
17262086,NA,9,irinotecan,8,20,mg m^-2,1,day 1-5 and 29-33,NA
17262086,NA,9,5-fluorouracil,8,350,mg m^-2,1,NA,NA
17262086,NA,9,leucovorin,8,20,mg m^-2,1,NA,NA
17053988,NA,10,celecoxib,1,200,mg,2,NA,NA
17053988,NA,10,5fu,1,1000,mg/m2/day,NA,"days 1–4, weeks 1 & 5",NA
17053988,NA,10,cisplatin,1,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,cisplatin,1,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,celecoxib,2,300,mg,2,NA,NA
17053988,NA,10,5fu,2,1000,mg/m2/day,NA,"days 1–4, weeks 1 & 5",NA
17053988,NA,10,cisplatin,2,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,cisplatin,2,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,celecoxib,3,400,mg,2,NA,NA
17053988,NA,10,5fu,3,1000,mg/m2/day,NA,"days 1–4, weeks 1 & 5",NA
17053988,NA,10,cisplatin,3,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,cisplatin,3,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,celecoxib,4,500,mg,2,NA,NA
17053988,NA,10,5fu,4,1000,mg/m2/day,NA,"days 1–4, weeks 1 & 5",NA
17053988,NA,10,cisplatin,4,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,cisplatin,4,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,celecoxib,5,600,mg,2,NA,NA
17053988,NA,10,5fu,5,1000,mg/m2/day,NA,"days 1–4, weeks 1 & 5",NA
17053988,NA,10,cisplatin,5,75,mg/m2,NA,days 1 & 29,NA
17053988,NA,10,cisplatin,5,75,mg/m2,NA,days 1 & 29,NA
17218488,NA,11,ptk/zk,1,500,NA,1, daily,NA
17218488,NA,11,ptk/zk,2,1000,NA,1,daily,NA
17218488,NA,11,ptk/zk,3,2000,NA,1,daily,NA
17218488,NA,11,ptk/zk,4,1500,NA,1,daily,NA
17218488,NA,11,ptk/zk,5,1250,NA,1,daily,NA
17218488,NA,11,oxaliplatin,1,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,1,NA,NA,NA,NA,NA
17218488,NA,11,5-fluorouracil,1,NA,NA,NA,NA,NA
17218488,NA,11,leucovorin,1,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,2,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,2,NA,NA,NA,NA,NA
17218488,NA,11,5-fluorouracil,2,NA,NA,NA,NA,NA
17218488,NA,11,leucovorin,2,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,3,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,3,NA,NA,NA,NA,NA
17218488,NA,11,5-fluorouracil,3,NA,NA,NA,NA,NA
17218488,NA,11,leucovorin,3,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,4,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,4,NA,NA,NA,NA,NA
17218488,NA,11,5-fluorouracil,4,NA,NA,NA,NA,NA
17218488,NA,11,leucovorin,4,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,5,NA,NA,NA,NA,NA
17218488,NA,11,oxaliplatin,5,NA,NA,NA,NA,NA
17218488,NA,11,5-fluorouracil,5,NA,NA,NA,NA,NA
17218488,NA,11,leucovorin,5,NA,NA,NA,NA,NA
17976948,NA,12,5-fluorouracil,-1,700,mg/m2 ,1,d1- d4,NA
17976948,NA,12,cisplatin,-1,50,mg/m2,1,d1,NA
17976948,NA,12,cisplatin,-1,50,mg/m2,1,d1,NA
17976948,NA,12,preoperative radiotherapy,-1,NA,NA,NA,NA,(28-30 daily 1.8-Gy fractions for a total of 50.4 or 54 Gy
17976948,NA,12,5-fluorouracil,0,835,mg/m2,1,d1- d4,NA
17976948,NA,12,cisplatin,0,50,mg/m2,1,d1,NA
17976948,NA,12,cisplatin,0,50,mg/m2,1,d1,NA
17976948,NA,12,preoperative radiotherapy,0,NA,NA,NA,NA,(28-30 daily 1.8-Gy fractions for a total of 50.4 or 54 Gy
17976948,NA,12,5-fluorouracil,1,NA,mg/m2,1,d1- d4,NA
17976948,NA,12,cisplatin,1,50,mg/m2,1,d1,NA
17976948,NA,12,cisplatin,1,50,mg/m2,1,d1,NA
17976948,NA,12,preoperative radiotherapy,1,NA,NA,NA,NA,(28-30 daily 1.8-Gy fractions for a total of 50.4 or 54 Gy
18682717,NA,13,irinotecan,1,180,mg m-2,1,day 1,NA
18682717,NA,13,oxaliplatin,1,100,mg m-2,1,day 15,NA
18682717,NA,13,oxaliplatin,1,100,mg m-2,1,day 15,NA
18682717,NA,13,uft,1,250,mg m-2,1,days 1 – 21 every 28 days,NA
18682717,NA,13,uft,1,250,mg m-2,1,days 1 – 21 every 28 days,NA
18682717,NA,13,leucovorin,1,90,mg,1,days 1 – 21 every 28 days,NA
19940007,NA,14,cetuximab,1,400/250,mg/m2,1,"infusion of cetuximab 400 mg/m2, followed by weekly doses of 250 mg/m2",NA
19940007,NA,14,irinotecan,1,180,mg/m2,1,NA,NA
19940007,NA,14,folinic acid,1,400,mg/m2,1,NA,NA
19940007,NA,14,5-fu,1,400,mg/m2,1,NA,NA
19940007,NA,14,cetuximab,2,400/400,mg/m2,NA,an initial cetuximab infusion of 400 mg/m2 followed by infusions of 400 mg/m2 every second week,NA
19940007,NA,14,irinotecan,2,180,mg/m2,1,NA,NA
19940007,NA,14,folinic acid,2,400,mg/m2,1,NA,NA
19940007,NA,14,5-fu,2,400,mg/m2,1,NA,NA
19940007,NA,14,cetuximab,3,400/500,mg/m2,NA,an initial cetuximab infusion of 400 mg/m2 followed by infusions of 500 mg/m2 every second week,NA
19940007,NA,14,irinotecan,3,180,mg/m2,1,NA,NA
19940007,NA,14,folinic acid,3,400,mg/m2,1,NA,NA
19940007,NA,14,5-fu,3,400,mg/m2,1,NA,NA
19940007,NA,14,cetuximab,4,400/600,mg/m2,NA,an initial cetuximab infusion of 400 mg/m2 followed by infusions of 600 mg/m2 every second week,NA
19940007,NA,14,irinotecan,4,180,mg/m2,1,NA,NA
19940007,NA,14,folinic acid,4,400,mg/m2,1,NA,NA
19940007,NA,14,5-fu,4,400,mg/m2,1,NA,NA
19940007,NA,14,cetuximab,5,400/700,mg/m2,NA,an initial cetuximab infusion of 400 mg/m2 followed by infusions of 700 mg/m2 every second week,NA
19940007,NA,14,irinotecan,5,180,mg/m2,1,NA,NA
19940007,NA,14,folinic acid,5,400,mg/m2,1,NA,NA
19940007,NA,14,5-fu,5,400,mg/m2,1,NA,NA
20038727,NA,15,irinotecan,1,215,mg/m2,1,administered as a 120-minute intravenous infusion every 2 weeks,*1/*1 and *1/*28
20038727,NA,15,fluorouracil,1,400/2400,mg/m2,1,"FU was administered as a 400-mg/m2 bolus right after the end of the irinotecan infusion, followed by 2,400 mg/m2 over a 46-hour continuous infusion",*1/*1 and *1/*28
20038727,NA,15,leucovorin,1,2400,mg/m2,1,plus 200 mg/m2 LV as a 120-minute intravenous infusion during irinotecan administration every 2 weeks.,*1/*1 and *1/*28
20038727,NA,15,irinotecan,2,260,mg/m2,1,administered as a 120-minute intravenous infusion every 2 weeks,*1/*1 and *1/*28
20038727,NA,15,fluorouracil,2,400/2400,mg/m2,1,"FU was administered as a 400-mg/m2 bolus right after the end of the irinotecan infusion, followed by 2,400 mg/m2 over a 46-hour continuous infusion",*1/*1 and *1/*28
20038727,NA,15,leucovorin,2,2400,mg/m2,1,plus 200 mg/m2 LV as a 120-minute intravenous infusion during irinotecan administration every 2 weeks.,*1/*1 and *1/*28
20038727,NA,15,irinotecan,3,310,mg/m2,1,administered as a 120-minute intravenous infusion every 2 weeks,*1/*1 and *1/*28
20038727,NA,15,fluorouracil,3,400/2400,mg/m2,1,"FU was administered as a 400-mg/m2 bolus right after the end of the irinotecan infusion, followed by 2,400 mg/m2 over a 46-hour continuous infusion",*1/*1 and *1/*28
20038727,NA,15,leucovorin,3,2400,mg/m2,1,plus 200 mg/m2 LV as a 120-minute intravenous infusion during irinotecan administration every 2 weeks.,*1/*1 and *1/*28
20038727,NA,15,irinotecan,4,370,mg/m2,1,administered as a 120-minute intravenous infusion every 2 weeks,*1/*1 and *1/*28
20038727,NA,15,fluorouracil,4,400/2400,mg/m2,1,"FU was administered as a 400-mg/m2 bolus right after the end of the irinotecan infusion, followed by 2,400 mg/m2 over a 46-hour continuous infusion",*1/*1 and *1/*28
20038727,NA,15,leucovorin,4,2400,mg/m2,1,plus 200 mg/m2 LV as a 120-minute intravenous infusion during irinotecan administration every 2 weeks.,*1/*1 and *1/*28
20038727,NA,15,irinotecan,5,420,mg/m2,1,administered as a 120-minute intravenous infusion every 2 weeks,*1/*1 only
20038727,NA,15,fluorouracil,5,400/2400,mg/m2,1,"FU was administered as a 400-mg/m2 bolus right after the end of the irinotecan infusion, followed by 2,400 mg/m2 over a 46-hour continuous infusion",*1/*1 only
20038727,NA,15,leucovorin,5,2400,mg/m2,1,plus 200 mg/m2 LV as a 120-minute intravenous infusion during irinotecan administration every 2 weeks.,*1/*1 only
17377918,NA,16,imatinib,1,300,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,imatinib,1,300,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,fluorouracil,1,2000,mg/m2,1,a 24hour infusion on Days 1 and 2,NA
17377918,NA,16,leucovorin,1,200,mg/m2,1,NA,NA
17377918,NA,16,imatinib,2,400,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,imatinib,2,400,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,fluorouracil,2,2000,mg/m2,1,a 24hour infusion on Days 1 and 2,NA
17377918,NA,16,leucovorin,2,200,mg/m2,1,NA,NA
17377918,NA,16,imatinib,3,500,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,imatinib,3,500,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,fluorouracil,3,2000,mg/m2,1,a 24hour infusion on Days 1 and 2,NA
17377918,NA,16,leucovorin,3,200,mg/m2,1,NA,NA
17377918,NA,16,imatinib,4,600,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,imatinib,4,600,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,fluorouracil,4,2000,mg/m2,1,a 24hour infusion on Days 1 and 2,NA
17377918,NA,16,leucovorin,4,200,mg/m2,1,NA,NA
17377918,NA,16,imatinib,5,700,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,imatinib,5,700,mg,1,a week-on/week-off schedule,NA
17377918,NA,16,fluorouracil,5,2000,mg/m2,1,a 24hour infusion on Days 1 and 2,NA
17377918,NA,16,leucovorin,5,200,mg/m2,1,NA,NA
18395356,NA,17,gefitinib,1,250,mg,1,NA,NA
18395356,NA,17,5-fluorouracil,1,225,mg/m2,1,"225 mg/m2 per day, 7 days per week",NA
18395356,NA,17,gefitinib,2,500,mg,1,NA,NA
18395356,NA,17,5-fluorouracil,2,225,mg/m2,1,"225 mg/m2 per day, 7 days per week",NA
18797462,NA,18,oxaliplatin,1,40,mg/m2,1,weekly,NA
18797462,NA,18,oxaliplatin,1,40,mg/m2,1,weekly,NA
18797462,NA,18,5-fluorouracil,1,225,mg/m2,1,NA,NA
18797462,NA,18,oxaliplatin,1,45,mg/m2,1,weekly,NA
18797462,NA,18,oxaliplatin,1,45,mg/m2,1,weekly,NA
18797462,NA,18,oxaliplatin,1,50,mg/m2,1,weekly,NA
18797462,NA,18,oxaliplatin,1,50,mg/m2,1,weekly,NA
19002384,NA,19,vandetanib,1,100,mg,1,once-daily,NA
19002384,NA,19,oxaliplatin,1,85,mg/m2,1,NA,NA
19002384,NA,19,oxaliplatin,1,85,mg/m2,1,NA,NA
19002384,NA,19,leucovorin,1,400,mg/m2,1,NA,NA
19002384,NA,19,5-fu,1,400,mg/m2,1,"5-FU 400 mg/mg2 intravenous bolus, then 5-FU 2,400 mg/m2 given as a 46-h infusion",NA
19002384,NA,19,vandetanib,2,300,mg,1,once-daily,NA
19002384,NA,19,oxaliplatin,2,85,mg/m2,1,NA,NA
19002384,NA,19,oxaliplatin,2,85,mg/m2,1,NA,NA
19002384,NA,19,leucovorin,2,300,mg/m2,1,once-daily,NA
19002384,NA,19,5-fu,2,400,mg/m2,1,"5-FU 400 mg/mg2 intravenous bolus, then 5-FU 2,400 mg/m2 given as a 46-h infusion",NA
16786333,NA,20,s-1,1,30,mg/m2/dose,2,twice-daily,NA
16786333,NA,20,s-1,2,35,mg/m2/dose,2,twice-daily,NA
16786333,NA,20,s-1,3,40,mg/m2/dose,2,twice-daily,NA
19194126,NA,21,irinotecan,1,100,mg/m2,NA,days 1–5,NA
19194126,NA,21,5-fu,1,500,mg/m2,NA,NA,NA
19194126,NA,21,uft,1,300,mg,NA,NA,NA
19194126,NA,21,uft,1,300,mg,NA,NA,NA
19194126,NA,21,irinotecan,1,100,mg/m2,NA,days 1–7,NA
19194126,NA,21,irinotecan,1,100,mg/m2,NA,days 1–10,NA
19194126,NA,21,irinotecan,1,125,mg/m2,NA,days 1–7,NA
19194126,NA,21,irinotecan,1,150,mg/m2,NA,days 1–7,NA
19299904,NA,22,paclitaxel,1,20,mg/m2,1,NA,intraperitoneally
19299904,NA,22,s-1,1,80,mg/m2/day,1,NA,NA
19299904,NA,22,paclitaxel,1,30,mg/m2,1,NA,intraperitoneally
19299904,NA,22,paclitaxel,1,40,mg/m2,1,NA,intraperitoneally
16704539,NA,23,gemcitabine,1,800,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,1,65,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,1,65,mg/m2,1,NA,NA
16704539,NA,23,fluorouracil,1,3000,mg/m2,1,48-h infusion,NA
16704539,NA,23,leucovorin,1,300,mg/m2,1,NA,NA
16704539,NA,23,gemcitabine,2,800,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,2,75,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,2,75,mg/m2,1,NA,NA
16704539,NA,23,fluorouracil,2,3000,mg/m2,1,48-h infusion,NA
16704539,NA,23,leucovorin,2,300,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,2,85,mg/m2,1,NA,NA
16704539,NA,23,oxaliplatin,2,85,mg/m2,1,NA,NA
19225923,NA,24,s-1,1,80,mg/m2,1,on days 1–14,NA
19225923,NA,24,irinotecan,1,50,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",NA
19225923,NA,24,s-1,2,80,mg/m2,1,on days 1–14,NA
19225923,NA,24,irinotecan,2,60,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",NA
19225923,NA,24,irinotecan,2,70,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",NA
19225923,NA,24,irinotecan,2,80,mg/m2,NA,"days 1, 8, and 15 of each 28-day cycle",NA
18929446,NA,25,s-1,0,50,mg/m2/day,2,twice daily for 14 days,NA
18929446,NA,25,cisplatin,0,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,cisplatin,0,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,s-1,1,60,mg/m2/day,2,twice daily for 14 days,NA
18929446,NA,25,cisplatin,1,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,cisplatin,1,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,s-1,2,70,mg/m2/day,2,twice daily for 14 days,NA
18929446,NA,25,cisplatin,2,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,cisplatin,2,40,mg/m2/day,NA,Days 1 and 8 of each cycle;,NA
18929446,NA,25,s-1,2,80,mg/m2/day,2,twice daily for 14 days,NA
18004083,NA,26,paclitaxel,-1,150,mg/m2,1,on day 1,NA
18004083,NA,26,uracil plus tegafur,-1,150,mg/m2,1,days 3–13,NA
18004083,NA,26,leucovorin,-1,90,mg/day,1,days 3–13,NA
18004083,NA,26,paclitaxel,0,150,mg/m2,1,on day 1,NA
18004083,NA,26,uracil plus tegafur,0,200,mg/m2,1,days 3–13,NA
18004083,NA,26,leucovorin,0,90,mg/day,1,days 3–13,NA
18004083,NA,26,paclitaxel,1,150,mg/m2,1,on day 1,NA
18004083,NA,26,uracil plus tegafur,1,250,mg/m2,1,days 3–13,NA
18004083,NA,26,leucovorin,1,90,mg/day,1,days 3–13,NA
18004083,NA,26,paclitaxel,2,150,mg/m2,1,on day 1,NA
18004083,NA,26,uracil plus tegafur,2,300,mg/m2,1,days 3–13,NA
18004083,NA,26,leucovorin,2,90,mg/day,1,days 3–13,NA
16821599,NA,27,s-1,1,NA,NA,2,"twice a day after breakfast and dinner, for 14 consecutive days, followed by a 2-week rest.","body surface area (BSA) less than 1.25 m2, 80 mg/day; BSA 1.25-1.5 m2, 100 mg/day; BSA 1.5 m2 or more, 120 mg/day."
16821599,NA,27,nedaplatin,1,80,mg/m2,1,administered intravenously over 1 h on day 8.,NA
16821599,NA,27,s-1,2,NA,NA,2,"twice a day after breakfast and dinner, for 14 consecutive days, followed by a 2-week rest.","body surface area (BSA) less than 1.25 m2, 80 mg/day; BSA 1.25-1.5 m2, 100 mg/day; BSA 1.5 m2 or more, 120 mg/day."
16821599,NA,27,nedaplatin,2,90,mg/m2,1,administered intravenously over 1 h on day 8.,NA
16821599,NA,27,nedaplatin,1,100,mg/m2,1,administered intravenously over 1 h on day 8.,NA
18323870,NA,29,cisplatin,1,37.5,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,1,37.5,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,5-fluorouracil,1,500,mg/m2,days 1-5,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,chemoradiotherapy,1,60,Gy,NA,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,2,45,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,2,45,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,5-fluorouracil,2,600,mg/m2,days 1-5,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,chemoradiotherapy,2,60,Gy,NA,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,3,52.5,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,3,52.5,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,5-fluorouracil,3,700,mg/m2,days 1-5,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,chemoradiotherapy,3,60,Gy,NA,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,4,60,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,4,60,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,5-fluorouracil,4,700,mg/m2,days 1-5,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,chemoradiotherapy,4,60,Gy,NA,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,5,60,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,cisplatin,5,60,mg/m2,day 1,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,5-fluorouracil,5,700,mg/m2,days 1-5,The regimen was repeated 4 times every 28 days.,NA
18323870,NA,29,chemoradiotherapy,5,50,Gy,NA,The regimen was repeated 4 times every 28 days.,NA
27628195,NA,30,oxaliplatin,1,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,oxaliplatin,1,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,irinotecan,1,120,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,s‑1,1,60,mg/m2,1,days 1–7,every 2 weeks
27628195,NA,30,oxaliplatin,2,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,oxaliplatin,2,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,irinotecan,2,120,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,s‑1,2,80,mg/m2,1,days 1–7,every 2 weeks
27628195,NA,30,oxaliplatin,3,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,oxaliplatin,3,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,irinotecan,3,120,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,s‑1,3,100,mg/m2,1,days 1–7,every 2 weeks
27628195,NA,30,oxaliplatin,4,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,oxaliplatin,4,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,irinotecan,4,150,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,s‑1,4,100,mg/m2,1,days 1–7,every 2 weeks
27628195,NA,30,oxaliplatin,5,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,oxaliplatin,5,85,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,irinotecan,5,180,mg/m2,1,day 1,every 2 weeks
27628195,NA,30,s‑1,5,100,mg/m2,1,days 1–7,every 2 weeks
17855009,NA,31,irinotecan,1,40,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,1,45,Gy,NA,NA,NA
17855009,NA,31,s-1,1,80,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
17855009,NA,31,irinotecan,2,60,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,2,45,Gy,NA,NA,NA
17855009,NA,31,s-1,2,80,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
17855009,NA,31,irinotecan,3,70,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,3,45,Gy,NA,NA,NA
17855009,NA,31,s-1,3,80,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
17855009,NA,31,irinotecan,4,80,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,4,45,Gy,NA,NA,NA
17855009,NA,31,s-1,4,80,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
17855009,NA,31,irinotecan,5,90,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,5,45,Gy,NA,NA,NA
17855009,NA,31,s-1,5,90,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
17855009,NA,31,irinotecan,6,40,mg/m2/day,1,"a 90-min continuous i.v. infusion on Days 1, 8, 22, and 29.",NA
17855009,NA,31,preoperative chemoradiotherapy,6,45,Gy,NA,NA,NA
17855009,NA,31,s-1,6,80,mg/m2/day,1,"on Days 1–5, 8–12, 22–26, and 29–33",NA
18510175,NA,32,s-1,1,60,mg/m2/day,2,twice daily for 14 days,NA
18510175,NA,32,gemcitabine,1,800,mg/m2/ day,NA,n days 1 and 15 of each cycle,NA
18510175,NA,32,s-1,2,60,mg/m2/day,2,twice daily for 14 days,NA
18510175,NA,32,gemcitabine,2,1000,mg/m2/ day,NA,n days 1 and 15 of each cycle,NA
18510175,NA,32,s-1,3,70,mg/m2/day,2,twice daily for 14 days,NA
18510175,NA,32,gemcitabine,3,1000,mg/m2/ day,NA,n days 1 and 15 of each cycle,NA
18510175,NA,32,s-1,4,80,mg/m2/day,2,twice daily for 14 days,NA
18510175,NA,32,gemcitabine,4,1000,mg/m2/ day,NA,n days 1 and 15 of each cycle,NA
27317556,NA,33,preoperative chemoradiotherapy,1,45,Gy,NA,NA,NA
27317556,NA,33,s-1,1,80,mg/m2/day,1,"on days 1–5, 8–12, 22–26, and 29–33",NA
27317556,NA,33,irinotecan,1,60,mg/m2,1,"days 1, 8, 22, and 29",NA
27317556,NA,33,preoperative chemoradiotherapy,2,45,Gy,NA,NA,NA
27317556,NA,33,s-1,2,80,mg/m2/day,1,"on days 1–5, 8–12, 22–26, and 29–33",NA
27317556,NA,33,irinotecan,2,80,mg/m2,1,"days 1, 8, 22, and 29",NA
27317556,NA,33,preoperative chemoradiotherapy,3,45,Gy,NA,NA,NA
27317556,NA,33,s-1,3,80,mg/m2/day,1,"on days 1–5, 8–12, 22–26, and 29–33",NA
27317556,NA,33,irinotecan,3,90,mg/m2,1,"days 1, 8, 22, and 29",NA
18841161,NA,34,oxaliplatin,1,50,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,oxaliplatin,1,50,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,5-fluorouracil,1,700,mg/m2,NA,"Bolus 5FU 300 mg/m2,Continuous infusion 400 mg/m2",NA
18841161,NA,34,folinic acid,1,200,mg/m2,NA,infusion over 2 h,NA
18841161,NA,34,radiotherapy,1,50,Gy,NA,delivered 5 days a week,NA
18841161,NA,34,oxaliplatin,2,50,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,oxaliplatin,2,50,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,5-fluorouracil,2,1000,mg/m2,NA,"Bolus 5FU 400 mg/m2,Continuous infusion 600 mg/m2",NA
18841161,NA,34,folinic acid,2,200,mg/m2,NA,infusion over 2 h,NA
18841161,NA,34,radiotherapy,2,50,Gy,NA,delivered 5 days a week,NA
18841161,NA,34,oxaliplatin,3,75,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,oxaliplatin,3,75,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,5-fluorouracil,3,1000,mg/m2,NA,"Bolus 5FU 400 mg/m2,Continuous infusion 600 mg/m2",NA
18841161,NA,34,folinic acid,3,200,mg/m2,NA,infusion over 2 h,NA
18841161,NA,34,radiotherapy,3,50,Gy,NA,delivered 5 days a week,NA
18841161,NA,34,oxaliplatin,4,85,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,oxaliplatin,4,85,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,5-fluorouracil,4,1000,mg/m2,NA,"Bolus 5FU 400 mg/m2,Continuous infusion 600 mg/m2",NA
18841161,NA,34,folinic acid,4,200,mg/m2,NA,infusion over 2 h,NA
18841161,NA,34,radiotherapy,4,50,Gy,NA,delivered 5 days a week,NA
18841161,NA,34,oxaliplatin,5,100,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,oxaliplatin,5,100,mg m2,NA,a 2 h i.v. infusion,NA
18841161,NA,34,5-fluorouracil,5,1000,mg/m2,NA,"Bolus 5FU 400 mg/m2,Continuous infusion 600 mg/m2",NA
18841161,NA,34,folinic acid,5,200,mg/m2,NA,infusion over 2 h,NA
18841161,NA,34,radiotherapy,5,50,Gy,NA,delivered 5 days a week,NA
16638094,NA,35,gemcitabine,1,800,mg/m2,1,a 30-min infusion,NA
16638094,NA,35,5-fluorouracil,1,1600,mg/m2,1,a 24-h infusion,NA
16638094,NA,35,leucovorin,1,300,mg/m2,1,"at day 1, day 8 and day 15 every 28 days",NA
16638094,NA,35,gemcitabine,2,800,mg/m2,1,a 30-min infusion,NA
16638094,NA,35,5-fluorouracil,2,2000,mg/m2,1,a 24-h infusion,NA
16638094,NA,35,leucovorin,2,300,mg/m2,1,"at day 1, day 8 and day 15 every 28 days",NA
16638094,NA,35,gemcitabine,3,800,mg/m2,1,a 30-min infusion,NA
16638094,NA,35,5-fluorouracil,3,2600,mg/m2,1,a 24-h infusion,NA
16638094,NA,35,leucovorin,3,300,mg/m2,1,"at day 1, day 8 and day 15 every 28 days",NA
31765987,NA,36,s-1,1,20,mg/m2,1,NA,NA
31765987,NA,36,leucovorin,1,20,mg/m2,2,from days 1 to 7 in a 2-week cycle,NA
31765987,NA,36,oxaliplatin,1,85,mg/m2,1,on day 1,NA
31765987,NA,36,oxaliplatin,1,85,mg/m2,1,on day 1,NA
31765987,NA,36,gemcitabine,1,800,mg/m2,1,fixed-rate infusion (10 mg/m2/min),NA
31765987,NA,36,s-1,2,30,mg/m2,1,NA,NA
31765987,NA,36,leucovorin,2,20,mg/m2,2,from days 1 to 7 in a 2-week cycle,NA
31765987,NA,36,oxaliplatin,2,85,mg/m2,1,on day 1,NA
31765987,NA,36,oxaliplatin,2,85,mg/m2,1,on day 1,NA
31765987,NA,36,gemcitabine,2,800,mg/m2,1,fixed-rate infusion (10 mg/m2/min),NA
31765987,NA,36,s-1,3,35,mg/m2,1,NA,NA
31765987,NA,36,leucovorin,3,20,mg/m2,2,from days 1 to 7 in a 2-week cycle,NA
31765987,NA,36,oxaliplatin,3,85,mg/m2,1,on day 1,NA
31765987,NA,36,oxaliplatin,3,85,mg/m2,1,on day 1,NA
31765987,NA,36,gemcitabine,3,800,mg/m2,1,fixed-rate infusion (10 mg/m2/min),NA
31765987,NA,36,s-1,4,40,mg/m2,1,NA,NA
31765987,NA,36,leucovorin,4,20,mg/m2,2,from days 1 to 7 in a 2-week cycle,NA
31765987,NA,36,oxaliplatin,4,85,mg/m2,1,on day 1,NA
31765987,NA,36,oxaliplatin,4,85,mg/m2,1,on day 1,NA
31765987,NA,36,gemcitabine,4,800,mg/m2,1,fixed-rate infusion (10 mg/m2/min),NA
19551382,NA,37,s-1,1,70,mg/m2,2,from D1 to D14 of a 3-week cycle,NA
19551382,NA,37,oxaliplatin,1,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,oxaliplatin,1,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,s-1,2,80,mg/m2,2,from D1 to D14 of a 3-week cycle,NA
19551382,NA,37,oxaliplatin,2,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,oxaliplatin,2,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,s-1,3,90,mg/m2,2,from D1 to D14 of a 3-week cycle,NA
19551382,NA,37,oxaliplatin,3,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,oxaliplatin,3,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,s-1,4,100,mg/m2,2,from D1 to D14 of a 3-week cycle,NA
19551382,NA,37,oxaliplatin,4,130,mg/m2,1,day 1 (D1),NA
19551382,NA,37,oxaliplatin,4,130,mg/m2,1,day 1 (D1),NA
17579864,NA,38,s-1,1,60,mg/m2/day,2,on D1 to D14,NA
17579864,NA,38,cisplatin,1,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,cisplatin,1,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,s-1,2,70,mg/m2/day,2,on D1 to D14,NA
17579864,NA,38,cisplatin,2,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,cisplatin,2,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,s-1,3,80,mg/m2/day,2,on D1 to D14,NA
17579864,NA,38,cisplatin,3,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,cisplatin,3,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,s-1,4,90,mg/m2/day,2,on D1 to D14,NA
17579864,NA,38,cisplatin,4,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,cisplatin,4,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,s-1,5,100,mg/m2/day,2,on D1 to D14,NA
17579864,NA,38,cisplatin,5,60,mg/m2,1,on day 1 (D1),NA
17579864,NA,38,cisplatin,5,60,mg/m2,1,on day 1 (D1),NA
29971467,NCT02102022,39,adi-peg 20,1,18,mg/m2,1,a weekly intramuscular injection,NA
29971467,NCT02102022,39,oxaliplatin,1,85,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,oxaliplatin,1,85,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,leucovorin,1,400,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,5-fluorouracil,1,1600,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,adi-peg 20,2,36,mg/m2,1,a weekly intramuscular injection,NA
29971467,NCT02102022,39,oxaliplatin,2,85,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,oxaliplatin,2,85,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,leucovorin,2,400,mg/m2,1,intravenous (IV) biweekly,NA
29971467,NCT02102022,39,5-fluorouracil,2,1600,mg/m2,1,intravenous (IV) biweekly,NA
18176087,NA,40,s-1,1,80,mg/m2,2,on days 1–14,NA
18176087,NA,40,paclitaxel,1,50,mg/m2,1,"on days 1, 8, and 15",NA
18176087,NA,40,s-1,2,80,mg/m2,2,on days 1–14,NA
18176087,NA,40,paclitaxel,2,60,mg/m2,1,"on days 1, 8, and 15",NA
17720738,NA,41,cpt-11,1,80,mg/m2,1,intravenously over 90 min,NA
17720738,NA,41,cpt-11,2,100,mg/m2,1,intravenously over 90 min,NA
17720738,NA,41,cpt-11,3,125,mg/m2,1,intravenously over 90 min,NA
17720738,NA,41,cpt-11,4,150,mg/m2,1,intravenously over 90 min,NA
28293715,UMIN000016630,42,gemcitabine,1,800,mg/m2,1,day 1,NA
28293715,UMIN000016630,42,nab-paclitaxel,1,100,mg/m2,1,day 1,NA
28293715,UMIN000016630,42,s-1,1,60-100,mg,2,days 1–7,"A daily dose of S-1 in both levels was defined based on the patient’s body surface area as follows: <1.25  m2, 60  mg; 1.25–1.5  m2, 80  mg; >1.5  m2, 100 mg. S-1 dose was fixed in both levels and administered orally twice a day on days 1–7."
28293715,UMIN000016630,42,gemcitabine,2,1000,mg/m2,1,day 1,NA
28293715,UMIN000016630,42,nab-paclitaxel,2,125,mg/m2,1,day 1,NA
28293715,UMIN000016630,42,s-1,2,60-100,mg,2,days 1–7,"A daily dose of S-1 in both levels was defined based on the patient’s body surface area as follows: <1.25  m2, 60  mg; 1.25–1.5  m2, 80  mg; >1.5  m2, 100 mg. S-1 dose was fixed in both levels and administered orally twice a day on days 1–7."
16684860,NA,43,oxaliplatin,1,86,mg/m2,1,intravenously over 2 h on days 1 and 15,NA
16684860,NA,43,oxaliplatin,1,86,mg/m2,1,intravenously over 2 h on days 1 and 15,NA
16684860,NA,43,fluorouracil,1,400,mg/m2,1,"an intravenous bolus on days 1, 8, and 15",Weekly Bolus
16684860,NA,43,leucovorin,1,250,mg/m2,1,intravenously over 2 h,NA
16684860,NA,43,oxaliplatin,2,86,mg/m2,1,intravenously over 2 h on days 1 and 15,NA
16684860,NA,43,oxaliplatin,2,86,mg/m2,1,intravenously over 2 h on days 1 and 15,NA
16684860,NA,43,fluorouracil,2,500,mg/m2,1,"an intravenous bolus on days 1, 8, and 15",NA
16684860,NA,43,leucovorin,2,250,mg/m2,1,intravenously over 2 h,NA
16636336,NA,44,oxaliplatin,1,30,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,oxaliplatin,1,30,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,fluorouracil,1,200,mg/m2,1,administered by an infusion pump over a period of 24 hours each day of each treatment week,NA
16636336,NA,44,radiation,1,50.4,Gy,1,RT dose was 1.8 Gy/fraction to a total dose of 50.4 Gy.,NA
16636336,NA,44,oxaliplatin,2,40,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,oxaliplatin,2,40,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,fluorouracil,2,200,mg/m2,1,administered by an infusion pump over a period of 24 hours each day of each treatment week,NA
16636336,NA,44,radiation,2,50.4,Gy,1,RT dose was 1.8 Gy/fraction to a total dose of 50.4 Gy.,NA
16636336,NA,44,oxaliplatin,3,50,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,oxaliplatin,3,50,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,fluorouracil,3,200,mg/m2,1,administered by an infusion pump over a period of 24 hours each day of each treatment week,NA
16636336,NA,44,radiation,3,50.4,Gy,1,RT dose was 1.8 Gy/fraction to a total dose of 50.4 Gy.,NA
16636336,NA,44,oxaliplatin,4,70,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,oxaliplatin,4,70,mg/m2,1,on day 1 of each 7-day treatment cycle as a 1-hour infusion.,NA
16636336,NA,44,fluorouracil,4,200,mg/m2,1,administered by an infusion pump over a period of 24 hours each day of each treatment week,NA
16636336,NA,44,radiation,4,50.4,Gy,1,RT dose was 1.8 Gy/fraction to a total dose of 50.4 Gy.,NA
17133268,NA,45,s-1,1,80,mg/m2,2,days 1 to 14 of a 28-day cycle,NA
17133268,NA,45,paclitaxel,1,40,mg/m2,1,"intravenously on days 1, 8, and 15, starting with a dose of 40 mg m2 day1.",NA
17133268,NA,45,s-1,2,80,mg/m2,2,days 1 to 14 of a 28-day cycle,NA
17133268,NA,45,paclitaxel,2,50,mg/m2,1,"intravenously on days 1, 8, and 15, starting with a dose of 40 mg m2 day1.",NA
17133268,NA,45,s-1,3,80,mg/m2,2,days 1 to 14 of a 28-day cycle,NA
17133268,NA,45,paclitaxel,3,60,mg/m2,1,"intravenously on days 1, 8, and 15, starting with a dose of 40 mg m2 day1.",NA
17133268,NA,45,s-1,4,80,mg/m2,2,days 1 to 14 of a 28-day cycle,NA
17133268,NA,45,paclitaxel,4,70,mg/m2,1,"intravenously on days 1, 8, and 15, starting with a dose of 40 mg m2 day1.",NA
19934112,NA,46,s-1,1,40,mg/m2,2,administered orally at 40 mg/m2 twice daily for 14 consecutive days,NA
19934112,NA,46,cisplatin,1,60,mg/m2,1,infused on day 8,NA
19934112,NA,46,cisplatin,1,60,mg/m2,1,infused on day 8,NA
19934112,NA,46,s-1,2,40,mg/m2,2,administered orally at 40 mg/m2 twice daily for 14 consecutive days,NA
19934112,NA,46,cisplatin,2,70,mg/m2,1,infused on day 8,NA
19934112,NA,46,cisplatin,2,70,mg/m2,1,infused on day 8,NA
18379784,NA,47,s-1,1,80,mg/m2,2,on days 1–21 every 35-day cycle (rest on days 2235),NA
18379784,NA,47,paclitaxel,1,40,mg/m2,1,"on days 1, 8 and 15",NA
18379784,NA,47,s-1,2,80,mg/m2,2,on days 1–21 every 35-day cycle (rest on days 2235),NA
18379784,NA,47,paclitaxel,2,50,mg/m2,1,"on days 1, 8 and 15",NA
18379784,NA,47,s-1,3,80,mg/m2,2,on days 1–21 every 35-day cycle (rest on days 2235),NA
18379784,NA,47,paclitaxel,3,60,mg/m2,1,"on days 1, 8 and 15",NA
18379784,NA,47,s-1,4,80,mg/m2,2,on days 1–21 every 35-day cycle (rest on days 2235),NA
18379784,NA,47,paclitaxel,4,70,mg/m2,1,"on days 1, 8 and 15",NA
17437021,NA,48,s-1,1,60,mg/m2,2,days 1 – 7 and 15 – 21,NA
17437021,NA,48,radiotherapy,1,1.25,Gy,2,totalling 50 Gy per 40 fractions for 4 weeks,NA
17437021,NA,48,s-1,2,60,mg/m2,2,1 – 14 day,NA
17437021,NA,48,radiotherapy,2,1.25,Gy,2,totalling 50 Gy per 40 fractions for 4 weeks,NA
17437021,NA,48,s-1,3a,60,mg/m2,2,1 – 21 day,NA
17437021,NA,48,radiotherapy,3a,1.25,Gy,2,totalling 50 Gy per 40 fractions for 4 weeks,NA
17437021,NA,48,s-1,3b,80,mg/m2,2,1 – 21 day,NA
17437021,NA,48,radiotherapy,3b,1.25,Gy,2,totalling 50 Gy per 40 fractions for 4 weeks,NA
17437021,NA,48,s-1,4,80,mg/m2,2,1 – 28 day,NA
17437021,NA,48,radiotherapy,4,1.25,Gy,2,totalling 50 Gy per 40 fractions for 4 weeks,NA
20694727,NA,49,ucn-01,1,50,mg/m2,1,a 3-h continuous intravenous infusion on days 2 and 23 every 42 days,NA
20694727,NA,49,irinotecan,1,75,mg/m2,1,"a 90-min intravenous infusion on days 1, 8, 15, and 22",NA
20694727,NA,49,ucn-01,2,70,mg/m2,1,a 3-h continuous intravenous infusion on days 2 and 23 every 42 days,NA
20694727,NA,49,irinotecan,2,75,mg/m2,1,"a 90-min intravenous infusion on days 1, 8, 15, and 22",NA
20694727,NA,49,ucn-01,3,70,mg/m2,1,a 3-h continuous intravenous infusion on days 2 and 23 every 42 days,NA
20694727,NA,49,irinotecan,3,100,mg/m2,1,"a 90-min intravenous infusion on days 1, 8, 15, and 22",NA
20694727,NA,49,ucn-01,4,70,mg/m2,1,a 3-h continuous intravenous infusion on days 2 and 23 every 42 days,NA
20694727,NA,49,irinotecan,4,125,mg/m2,1,"a 90-min intravenous infusion on days 1, 8, 15, and 22",NA
20694727,NA,49,ucn-01,5,90,mg/m2,1,a 3-h continuous intravenous infusion on days 2 and 23 every 42 days,NA
20694727,NA,49,irinotecan,5,125,mg/m2,1,"a 90-min intravenous infusion on days 1, 8, 15, and 22",NA
28233053,NA,50,irinotecan,-1,60,mg/m2,1,every 3 weeks,NA
28233053,NA,50,irinotecan,0,120,mg/m2,1,every 3 weeks,NA
28233053,NA,50,irinotecan,1,180,mg/m2,1,every 3 weeks,NA
28233053,NA,50,irinotecan,2,240,mg/m2,1,every 3 weeks,NA
28233053,NA,51,irinotecan,-1,30,mg/m2,1,every 3 weeks,NA
28233053,NA,51,irinotecan,0,60,mg/m2,1,every 3 weeks,NA
28233053,NA,51,irinotecan,1,90,mg/m2,1,every 3 weeks,NA
28233053,NA,51,irinotecan,2,120,mg/m2,1,every 3 weeks,NA
28233053,NA,51,irinotecan,3,150,mg/m2,1,every 3 weeks,NA
27061418,NA,52,nk012,1,9,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,2,12,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,3,16,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,4,21,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,5,28,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,6,37,mg/m2,1,a 30-min infusion every 21,NA
27061418,NA,52,nk012,7,28,mg/m2,1,every 28 days,NA
8217238,NA,54,interferon alpha-2a,1,3,IU/m2/d,1,"on days 1 to 5 of the first week of chemotherapy and on days 1, 3, 5 of each subsequent week, on a 28-day cycle.",NA
8217238,NA,54,5-fluorouracil,1,370,mg/m2,1,on days 1 to 5,NA
8217238,NA,54,leucovorin,1,200,mg/m2,1,on days 1 to 5,NA
8217238,NA,54,interferon alpha-2a,2,4,IU/m2/d,1,"on days 1 to 5 of the first week of chemotherapy and on days 1, 3, 5 of each subsequent week, on a 28-day cycle.",NA
8217238,NA,54,5-fluorouracil,2,370,mg/m2,1,on days 1 to 5,NA
8217238,NA,54,leucovorin,2,200,mg/m2,1,on days 1 to 5,NA
8217238,NA,54,interferon alpha-2a,3,4,IU/m2/d,1,"on days 1 to 5 of the first week of chemotherapy and on days 1, 3, 5 of each subsequent week, on a 28-day cycle.",NA
8217238,NA,54,5-fluorouracil,3,370,mg/m2,1,on days 1 to 5,NA
8217238,NA,54,leucovorin,3,200,mg/m2,1,on days 1 to 5,NA
7882458,NA,55,interferon alpha-2b,1,3*10^6,U/m2,1,on days 1-5 and then three times weekly,NA
7882458,NA,55,5-fluorouracil,1,750,mg/m2,1,days 1-5,NA
7882458,NA,55,cisplatin,1,75,mg/m2,1,day 1,NA
7882458,NA,55,cisplatin,1,75,mg/m2,1,day 1,NA
7882458,NA,55,interferon alpha-2b,-1,2*10^6,U/m2,1,on days 1-5 and then three times weekly,NA
7882458,NA,55,5-fluorouracil,-1,750,mg/m2,1,days 1-5,NA
7882458,NA,55,cisplatin,-1,75,mg/m2,1,day 1,NA
7882458,NA,55,cisplatin,-1,75,mg/m2,1,day 1,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,1,50,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,1,50,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,ftd/tpi,1,35,mg/m2,2,on days 1–5and15–19 every 4 weeks,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,2,65,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,2,65,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,ftd/tpi,2,35,mg/m2,2,on days 1–5and15–19 every 4 weeks,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,3,85,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,oxaliplatin,3,85,mg/m2,1,on days 1 and 15,NA
30838483,"UMIN-CTR, ID: 000015764",56,ftd/tpi,3,35,mg/m2,2,on days 1–5and15–19 every 4 weeks,NA
25860347,NCT01136031,57,paclitaxel,1,100,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,irinotecan,1,100,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,paclitaxel,2,100,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,irinotecan,2,120,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,paclitaxel,3,135,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,irinotecan,3,120,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,paclitaxel,4,135,mg/m2,1,D1 every 3 weekly,NA
25860347,NCT01136031,57,irinotecan,4,160,mg/m2,1,D1 every 3 weekly,NA
33611805,NA,58,irinotecan,0,20,mg/m2,1,for 5 days at weeks 1 and 2 every 3 weeks (d × 5 × 2),NA
33611805,NA,58,vincristine,0,1.4,mg/m2,1,on days 1 and 8,NA
33611805,NA,58,anlotinib,0,NA,NA,1,on days 1–14 within a 21-day cycle.,NA
33611805,NA,58,irinotecan,1,15,mg/m2,1,for 5 days at weeks 1 and 2 every 3 weeks (d × 5 × 2),NA
33611805,NA,58,vincristine,1,1.4,mg/m2,1,on days 1 and 8,NA
33611805,NA,58,anlotinib,1,NA,NA,1,on days 1–14 within a 21-day cycle.,NA
33611805,NA,59,irinotecan,0,20,mg/m2,1,for 5 days at weeks 1 and 2 every 3 weeks (d × 5 × 2),NA
33611805,NA,59,vincristine,0,1.4,mg/m2,1,on days 1 and 8,NA
33611805,NA,59,anlotinib,0,NA,NA,1,on days 1–14 within a 21-day cycle.,NA
8426214,NA,60,cisplatin,1,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,cisplatin,1,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,fluorouracil,1,800,mg/m2,1,a 5-day continuous intravenous infusion,NA
8426214,NA,60,leucovorin,1,100,mg,1,every 4 hours,NA
8426214,NA,60,interferon alfa-2b,1,0.5,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,interferon alfa-2b,1,0.5,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,cisplatin,2,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,cisplatin,2,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,fluorouracil,2,640,mg/m2,1,a 5-day continuous intravenous infusion,NA
8426214,NA,60,leucovorin,2,100,mg,1,every 4 hours,NA
8426214,NA,60,interferon alfa-2b,2,0.5,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,interferon alfa-2b,2,0.5,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,cisplatin,3,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,cisplatin,3,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,fluorouracil,3,640,mg/m2,1,a 5-day continuous intravenous infusion,NA
8426214,NA,60,leucovorin,3,100,mg,1,every 4 hours,NA
8426214,NA,60,interferon alfa-2b,3,1,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,interferon alfa-2b,3,1,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,cisplatin,4,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,cisplatin,4,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,fluorouracil,4,640,mg/m2,1,a 5-day continuous intravenous infusion,NA
8426214,NA,60,leucovorin,4,100,mg,1,every 4 hours,NA
8426214,NA,60,interferon alfa-2b,4,2,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,interferon alfa-2b,4,2,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,cisplatin,5,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,cisplatin,5,100,mg/m2,1,"administered in 1,000 mL of 5% dextrose in normal saline intravenously over 6 hours with 18.5 g mannitol,",NA
8426214,NA,60,fluorouracil,5,640,mg/m2,1,a 5-day continuous intravenous infusion,NA
8426214,NA,60,leucovorin,5,100,mg,1,every 4 hours,NA
8426214,NA,60,interferon alfa-2b,5,4,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
8426214,NA,60,interferon alfa-2b,5,4,IU/m2/d,1,administered subcutaneously 2 hours before the start ofcisplatin and repeated every 24 hours for a total of six doses.,NA
21424369,NA,61,irinotecan,1,100,mg/m2,NA,NA,NA
21424369,NA,61,mitomycin c,1,0.7,mg/kg,NA,NA,NA
21424369,NA,61,irinotecan,2,150,mg/m2,NA,NA,NA
21424369,NA,61,mitomycin c,2,0.7,mg/kg,NA,NA,NA
21509928,NCT00143533,62,irinotecan,1,20,mg/m2,1,administered intravenously on Days 1–5 and Days 8–12 of a 21-day cycle,NA
21509928,NCT00143533,62,cefpodoxime,1,10,mg/kg,1,ontinuous oral cefpodoxime starting 2 days prior to irinotecan,NA
21509928,NCT00143533,62,irinotecan,2,30,mg/m2,1,administered intravenously on Days 1–5 and Days 8–12 of a 21-day cycle,NA
21509928,NCT00143533,62,cefpodoxime,2,10,mg/kg,1,ontinuous oral cefpodoxime starting 2 days prior to irinotecan,NA
21509928,NCT00143533,62,irinotecan,3,45,mg/m2,1,administered intravenously on Days 1–5 and Days 8–12 of a 21-day cycle,NA
21509928,NCT00143533,62,cefpodoxime,3,10,mg/kg,1,ontinuous oral cefpodoxime starting 2 days prior to irinotecan,NA
21509928,NCT00143533,62,irinotecan,4,40,mg/m2,1,administered intravenously on Days 1–5 and Days 8–12 of a 21-day cycle,NA
21509928,NCT00143533,62,cefpodoxime,4,10,mg/kg,1,ontinuous oral cefpodoxime starting 2 days prior to irinotecan,NA
24958824,NA,63,irinotecan,1,500,mg,1,every 3 weeks,*28/*28 genotype
24958824,NA,63,irinotecan,2,400,mg,1,every 3 weeks,*28/*28 genotype
24958824,NA,64,irinotecan,1,850,mg,1,every 3 weeks,*1/*28
24958824,NA,64,irinotecan,2,700,mg,1,every 3 weeks,*1/*28
24958824,NA,65,irinotecan,1,700,mg,1,every 3 weeks,*1/*1 genotype
24958824,NA,65,irinotecan,2,850,mg,1,every 3 weeks,*1/*1 genotype
24958824,NA,65,irinotecan,3,1000,mg,1,every 3 weeks,*1/*1 genotype
7917927,NA,66,5-fluorouracil,1,400,mg/m2,NA,NA,NA
7917927,NA,66,interferon,1,1.5,mu,NA,given subcutaneously (s.c.) on alternate evenings throughout the study period.,NA
7917927,NA,66,leucovorin,1,200,mg/m2,NA,NA,NA
7917927,NA,66,5-fluorouracil,2,400,mg/m2,NA,NA,NA
7917927,NA,66,interferon,2,3,mu,NA,given subcutaneously (s.c.) on alternate evenings throughout the study period.,NA
7917927,NA,66,leucovorin,2,200,mg/m2,NA,NA,NA
7917927,NA,66,5-fluorouracil,3,400,mg/m2,NA,NA,NA
7917927,NA,66,interferon,3,4.5,mu,NA,given subcutaneously (s.c.) on alternate evenings throughout the study period.,NA
7917927,NA,66,leucovorin,3,200,mg/m2,NA,NA,NA
7917927,NA,66,5-fluorouracil,4,400,mg/m2,NA,NA,NA
7917927,NA,66,interferon,4,6,mu,NA,given subcutaneously (s.c.) on alternate evenings throughout the study period.,NA
7917927,NA,66,leucovorin,4,200,mg/m2,NA,NA,NA
7917927,NA,66,5-fluorouracil,5,400,mg/m2,NA,NA,NA
7917927,NA,66,interferon,5,9,mu,NA,given subcutaneously (s.c.) on alternate evenings throughout the study period.,NA
7917927,NA,66,leucovorin,5,200,mg/m2,NA,NA,NA
20405511,NA,67,vincristine,1,1.5,mg/m2,1,on days 1 and 8,NA
20405511,NA,67,irinotecan,1,15,mg/m2,1,over 1 hr on days 1–5 and 8–12,NA
20405511,NA,67,temozolomide,1,100,mg/m2,1,day 1 for 5 consecutive days,NA
20405511,NA,67,temozolomide,1,100,mg/m2,1,day 1 for 5 consecutive days,NA
20405511,NA,67,cefpodoxime,1,10,mg/kg,2,NA,NA
20405511,NA,67,vincristine,2,1.5,mg/m2,1,on days 1 and 8,NA
20405511,NA,67,irinotecan,2,20,mg/m2,1,over 1 hr on days 1–5 and 8–12,NA
20405511,NA,67,temozolomide,2,100,mg/m2,1,day 1 for 5 consecutive days,NA
20405511,NA,67,temozolomide,2,100,mg/m2,1,day 1 for 5 consecutive days,NA
20405511,NA,67,cefpodoxime,2,10,mg/kg,2,NA,NA
33289920,NCT02044120,68,niraparib,A1,300,mg,1,D1-28,NA
33289920,NCT02044120,68,temozolomide,A1,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,temozolomide,A1,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,niraparib,B1,300,mg,1,D1-7,NA
33289920,NCT02044120,68,temozolomide,B1,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,temozolomide,B1,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,niraparib,B4,200,mg,1,D1-7,NA
33289920,NCT02044120,68,temozolomide,B4,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,temozolomide,B4,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,niraparib,B5,200,mg,1,D1-14,NA
33289920,NCT02044120,68,temozolomide,B5,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,temozolomide,B5,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,niraparib,C1,200,mg,1,D1-7,NA
33289920,NCT02044120,68,temozolomide,C1,30,mg/m2,1,days 2-6,NA
33289920,NCT02044120,68,temozolomide,C1,30,mg/m2,1,days 2-6,NA
33289920,NCT02044120,69,niraparib,-1,100,mg,1,D1-7,NA
33289920,NCT02044120,69,irinotecan,-1,20,mg/m2,1,days 2-6,NA
33289920,NCT02044120,69,niraparib,1,100,mg,1,D1-7,NA
33289920,NCT02044120,69,irinotecan,1,25,mg/m2,1,days 2-6,NA
22674635,NCT00520637,70,ezn-2208,1,1.25,mg/m2,NA,NA,NA
22674635,NCT00520637,70,ezn-2208,2,2.5,mg/m2,NA,NA,NA
22674635,NCT00520637,70,ezn-2208,3,5,mg/m2,NA,NA,NA
22674635,NCT00520637,70,ezn-2208,4,10,mg/m2,NA,NA,NA
22674635,NCT00520637,70,ezn-2208,5,16.5,mg/m2,NA,NA,NA
22674635,NCT00520637,70,ezn-2208,6,25,mg/m2,NA,NA,NA
30406838,NA,71,irinotecan,1,20,mg/m2,1,once-daily oral irinotecan for 14 days followed by 1 week rest,NA
30406838,NA,71,irinotecan,2,30,mg/m2,1,once-daily oral irinotecan for 14 days followed by 1 week rest,NA
30406838,NA,71,irinotecan,3,25,mg/m2,1,once-daily oral irinotecan for 14 days followed by 1 week rest,NA
30406838,NA,71,irinotecan,4,16,mg/m2,1,once-daily oral irinotecan for 14 days followed by 1 week rest,NA
27920527,NA,72,dts-108,1,3,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,2,6,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,3,12,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,4,24,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,5,32,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,6,42,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,7,56,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,8,75,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,9,100,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,10,133,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,11,177,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,12,236,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,13,313,mg/m2,1,(1–2 hours) every 2 weeks,NA
27920527,NA,72,dts-108,14,416,mg/m2,1,(1–2 hours) every 2 weeks,NA
23921573,NCT00925015,73,mk‑0646,1,10,mg/kg,1,weekly starting on Day 22,NA
23921573,NCT00925015,73,cetuximab,1,400,mg/m2,1,"infused over 120 min as a loading dose on Day 1 of Cycle 1. On the following weeks, cetuximab at a dose of 250 mg/m2 was infused over 60 min once weekly as a maintenance dose",NA
23921573,NCT00925015,73,irinotecan,1,150,mg/m2,1,infused over 90 min every other week,NA
23921573,NCT00925015,73,mk‑0646,2,15,mg/kg,1,"on Day 8, followed by 7.5 mg/kg every 2 weeks",NA
23921573,NCT00925015,73,cetuximab,2,400,mg/m2,1,"infused over 120 min as a loading dose on Day 1 of Cycle 1. On the following weeks, cetuximab at a dose of 250 mg/m2 was infused over 60 min once weekly as a maintenance dose",NA
23921573,NCT00925015,73,irinotecan,2,250,mg/m2,1,infused over 90 min according to the dosage and regimen that the patient had most recently received prior to enrollment in this study,NA
23921573,NCT00925015,73,mk‑0646,3,10,mg/kg,1,on Day 1 and weekly starting on Day 22,NA
23921573,NCT00925015,73,cetuximab,3,400,mg/m2,1,"infused over 120 min as a loading dose on Day 8 of Cycle 1. On following weeks, cetuximab at a dose of 250 mg/m2 was infused over 60 min once weekly as a maintenance dose",NA
23921573,NCT00925015,73,irinotecan,3,150,mg/m2,1,infused every other week over 90 min at a dose of 150 mg/m2 starting on Day 8 of Cycle 1,NA
26429709,NCT01009073,74,navitoclax,1,150,mg,1,NA,NA
26429709,NCT01009073,74,irinotecan,1,180,mg/m2,NA,once-every-3-week regimen,NA
26429709,NCT01009073,74,navitoclax,2,150,mg,1,NA,NA
26429709,NCT01009073,74,irinotecan,2,250,mg/m2,NA,once-every-3-week regimen,NA
26429709,NCT01009073,74,navitoclax,3,150,mg,1,NA,NA
26429709,NCT01009073,74,irinotecan,3,350,mg/m2,NA,once-every-3-week regimen,NA
26429709,NCT01009073,75,navitoclax,1,150,mg,1,NA,NA
26429709,NCT01009073,75,irinotecan,1,75,mg/m2,NA,once-weekly regimen,NA
26429709,NCT01009073,75,navitoclax,2,150,mg,1,NA,NA
26429709,NCT01009073,75,irinotecan,2,100,mg/m2,NA,once-weekly regimen,NA
30859690,C000000314,76,irinotecan,0,40,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30859690,C000000314,76,irinotecan,1,45,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30859690,C000000314,76,irinotecan,2,40,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30859690,C000000314,76,irinotecan,3,45,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30859690,C000000314,76,irinotecan,4,40,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30859690,C000000314,76,irinotecan,5,45,mg/m2,NA,"days 1, 2, 3 and 8, 9, 10 in up to eight, 21 day cycles",NA
30167847,18606,77,irinotecan,1,150,mg/m2,NA,"on day 1,repeated every 2 weeks.",NA
30167847,18606,77,ramucirumab,1,8,mg/kg,NA,NA,NA
30167847,18606,77,irinotecan,0,120,mg/m2,NA,"on day 1,repeated every 2 weeks.",NA
30167847,18606,77,ramucirumab,0,8,mg/kg,NA,NA,NA
30167847,18606,77,irinotecan,-1,90,mg/m2,NA,"on day 1,repeated every 2 weeks.",NA
30167847,18606,77,ramucirumab,-1,8,mg/kg,NA,NA,NA
30042150,NCT02188264,78,selumetinib,1,50,mg,2,twice daily,NA
30042150,NCT02188264,78,cyclosporin a,1,2,mg/kg,2,twice daily on a 28-day cycle,NA
30042150,NCT02188264,78,cyclosporin a,1,2,mg/kg,2,twice daily on a 28-day cycle,NA
30042150,NCT02188264,78,selumetinib,2,75,mg,2,twice daily,NA
30042150,NCT02188264,78,cyclosporin a,2,2,mg/kg,2,twice daily on a 28-day cycle,NA
30042150,NCT02188264,78,cyclosporin a,2,2,mg/kg,2,twice daily on a 28-day cycle,NA
34031756,NCT04088604,79,liposomal irinotecan,1,30,mg/m2,1,administered intravenously every 2 weeks,NA
34031756,NCT04088604,79,liposomal irinotecan,2,60,mg/m2,1,administered intravenously every 2 weeks,NA
34031756,NCT04088604,79,liposomal irinotecan,3,90,mg/m2,1,administered intravenously every 2 weeks,NA
34031756,NCT04088604,79,liposomal irinotecan,4,120,mg/m2,1,administered intravenously every 2 weeks,NA
22415148,NA,80,irinotecan,1,60,mg/m2,NA,a 90-min intravenous infusion on days 1 and 8,NA
22415148,NA,80,amrubicin,1,30,mg/m2,NA,on days 1–3,NA
22415148,NA,80,prophylactic rhg-csf,1,50,ug/m2,NA,from day 4 to day 21,NA
22415148,NA,80,irinotecan,2,60,mg/m2,NA,on days 1 and 8,NA
22415148,NA,80,amrubicin,2,35,mg/m2,NA,on days 1–3,NA
22415148,NA,80,prophylactic rhg-csf,2,50,ug/m2,NA,from day 4 to day 21,NA
22415148,NA,80,irinotecan,3,60,mg/m2,NA,on days 1 and 8,NA
22415148,NA,80,amrubicin,3,40,mg/m2,NA,on days 1–3,NA
22415148,NA,80,prophylactic rhg-csf,3,50,ug/m2,NA,from day 4 to day 21,NA
33993383,NCT01923337,81,alisertib,1,20,mg,2,twice per day on days 1–3 and 8–10,NA
33993383,NCT01923337,81,irinotecan,1,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
33993383,NCT01923337,81,alisertib,1B,NA,mg,2,twice per day on days 1–3 and 8–10,"20 AM, 30 PM"
33993383,NCT01923337,81,irinotecan,1B,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
33993383,NCT01923337,81,alisertib,2,30,mg,2,twice per day on days 1–3 and 8–10,NA
33993383,NCT01923337,81,irinotecan,2,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
33993383,NCT01923337,81,alisertib,3,40,mg,2,twice per day on days 1–3 and 8–10,NA
33993383,NCT01923337,81,irinotecan,3,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
33993383,NCT01923337,81,alisertib,4,50,mg,2,twice per day on days 1–3 and 8–10,NA
33993383,NCT01923337,81,irinotecan,4,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
33993383,NCT01923337,81,alisertib,5,60,mg,2,twice per day on days 1–3 and 8–10,NA
33993383,NCT01923337,81,irinotecan,5,100,mg/m2,1,on day 1 and 8 of a 21-day cycle,NA
34383370,NCT01518413,82,sorafenib,0,105,mg/m2,2,NA,NA
34383370,NCT01518413,82,irinotecan,0,70,mg/m2,1,once daily days 1-5,NA
34383370,NCT01518413,82,sorafenib,1,150,mg/m2,2,NA,NA
34383370,NCT01518413,82,irinotecan,1,70,mg/m2,1,once daily days 1-5,NA
34383370,NCT01518413,82,sorafenib,2,200,mg/m2,2,NA,NA
34383370,NCT01518413,82,irinotecan,2,70,mg/m2,1,once daily days 1-5,NA
34383370,NCT01518413,82,irinotecan,2,9,mg/m2,1,once daily days 1-5,NA
24249672,NA,83,temsirolimus,1,15,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,1,50,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,1,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,2,20,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,2,50,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,2,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,3,25,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,3,50,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,3,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,3b,25,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,3b,50,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,3b,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,5,35,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,5,50,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,5,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,6,35,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,6,65,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,6,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,7,35,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,7,90,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,7,100,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,8,35,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,8,90,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,8,125,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,9,35,mg/m2,1,on days 1 and 8 of 21-day cycles,NA
24249672,NA,83,irinotecan,9,90,mg/m2,1,days 1-5,NA
24249672,NA,83,temsirolimus,9,150,mg/m2,1,days 1-5,NA
24691674,NCT00838578,84,krn330,1,1,mg/kg,1,"q2w, administered by intravenous (IV) infusion in 0.9 % saline over 60 min using an infusion pump with a low-protein-binding 0.22-μm in-line filter.",NA
24691674,NCT00838578,84,irinotecan,1,180,mg/m2,NA,administered as a 90min IV infusion 1–2 h after the completion of KRN330 infusion.,NA
24691674,NCT00838578,84,krn330,2,0.5,mg/kg,NA,"q2w, administered by intravenous (IV) infusion in 0.9 % saline over 60 min using an infusion pump with a low-protein-binding 0.22-μm in-line filter.",NA
24691674,NCT00838578,84,irinotecan,2,180,mg/m2,NA,NA,NA
24691674,NCT00838578,84,krn330,2,0.5,mg/kg,NA,"qw, administered by intravenous (IV) infusion in 0.9 % saline over 60 min using an infusion pump with a low-protein-binding 0.22-μm in-line filter.",NA
31857431,NA,86,adavosertib,1,50,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,irinotecan,1,70,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,adavosertib,2,65,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,irinotecan,2,70,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,adavosertib,3,65,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,irinotecan,3,90,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,adavosertib,4,85,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,irinotecan,4,90,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,adavosertib,5,110,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
31857431,NA,86,irinotecan,5,90,mg/m2/day,NA,days 1–5 of a 21-day cycle,NA
22615057,NCT00134069,87,irinotecan,1,120,mg/m2,NA,NA,NA
22615057,NCT00134069,87,sorafenib,1,200,mg,QD,NA,NA
22615057,NCT00134069,87,cetuximab,1,400/250,mg/m2,400 LD/ 250MD,NA,NA
22615057,NCT00134069,87,irinotecan,-1,120,mg/m2,NA,NA,NA
22615057,NCT00134069,87,sorafenib,-1,200,mg,QOD,NA,NA
22615057,NCT00134069,87,cetuximab,-1,400,mg/m2,400 LD/ 250MD,NA,NA
22615057,NCT00134069,87,irinotecan,1A,100,mg/m2,NA,NA,NA
22615057,NCT00134069,87,sorafenib,1A,200,mg,QD,NA,NA
22615057,NCT00134069,87,cetuximab,1A,400,mg/m2,400 LD/ 250MD,NA,NA
22615057,NCT00134069,87,irinotecan,2,100,mg/m2,NA,NA,NA
22615057,NCT00134069,87,sorafenib,2,200,mg,bid,NA,NA
22615057,NCT00134069,87,cetuximab,2,400,mg/m2,400 LD/ 250MD,NA,NA
22615057,NCT00134069,87,irinotecan,3,100,mg/m2,NA,NA,NA
22615057,NCT00134069,87,sorafenib,3,40,mg,bid,NA,NA
22615057,NCT00134069,87,cetuximab,3,400,mg/m2,400 LD/ 250MD,NA,NA
26842236,NCT00576654,88,veliparib,1,10,mg,2,NA,NA
26842236,NCT00576654,88,irinotecan,1,100,mg/m2,1,on days 1 and 8 of a 21-day cycle.,NA
26842236,NCT00576654,88,veliparib,2,20,mg,2,NA,NA
26842236,NCT00576654,88,irinotecan,2,100,mg/m2,1,on days 1 and 8 of a 21-day cycle.,NA
26842236,NCT00576654,88,veliparib,3,40,mg,2,NA,NA
26842236,NCT00576654,88,irinotecan,3,100,mg/m2,1,on days 1 and 8 of a 21-day cycle.,NA
26842236,NCT00576654,88,veliparib,4,50,mg,2,NA,NA
26842236,NCT00576654,88,irinotecan,4,100,mg/m2,1,on days 1 and 8 of a 21-day cycle.,NA
22701615,NCT00436072,89,cetuximab,1,400/250,mg/m2,NA,400 mg/m2 loading dose followed by weekly 250 mg/m2 doses,NA
22701615,NCT00436072,89,vandetanib,1,100,mg,NA,NA,NA
22701615,NCT00436072,89,cetuximab,2,400/250,mg/m2,NA,400 mg/m2 loading dose followed by weekly 250 mg/m2 doses,NA
22701615,NCT00436072,89,irinotecan,2,180,NA,NA,NA,NA
22701615,NCT00436072,89,vandetanib,2,100,mg,NA,NA,NA
22701615,NCT00436072,89,cetuximab,3,400/250,mg/m2,NA,400 mg/m2 loading dose followed by weekly 250 mg/m2 doses,NA
22701615,NCT00436072,89,irinotecan,3,NA,NA,NA,NA,NA
22701615,NCT00436072,89,vandetanib,3,200,mg,NA,NA,NA
22701615,NCT00436072,89,cetuximab,4,400/250,mg/m2,NA,400 mg/m2 loading dose followed by weekly 250 mg/m2 doses,NA
22701615,NCT00436072,89,irinotecan,4,NA,NA,NA,NA,NA
22701615,NCT00436072,89,vandetanib,4,300,mg,NA,NA,NA
25577133,NA,90,nanoliposomal irinotecan,1,60,mg/m2,NA,NA,NA
25577133,NA,90,nanoliposomal irinotecan,1,120,mg/m2,NA,NA,NA
25577133,NA,90,nanoliposomal irinotecan,1,180,mg/m2,NA,NA,NA
20943763,NA,91,nk012,1,2,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,2,4,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,3,8,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,4,12,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,5,16,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,6,20,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,7,24,mg/m2,NA,every 3 weeks,NA
20943763,NA,91,nk012,8,28,mg/m2,NA,every 3 weeks,NA
32537847,NCT02745769,92,ramucirumab,1,8,mg/kg,NA,on days 1 and 15,NA
32537847,NCT02745769,92,merestinib,1,80,mg,QD,28-day cycle,NA
8708712,NA,93,interleukin-2,1,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,interleukin-2,1,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,ifna-2a,1,1.5,mU/m 2,1,daily for a 4-week cycle,None (course 1) 1.5 (course 2)
8708712,NA,93,interleukin-2,2,3,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,interleukin-2,2,3,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,ifna-2a,2,1.5,mU/m 2,1,daily for a 4-week cycle,None (course 1) 1.5 (course 2)
8708712,NA,93,interleukin-2,3,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,interleukin-2,3,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,ifna-2a,3,1.5,mU/m 2,1,daily for a 4-week cycle,NA
8708712,NA,93,interleukin-2,4,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,interleukin-2,4,1.5,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,ifna-2a,4,3,mU/m 2,1,daily for a 4-week cycle,NA
8708712,NA,93,interleukin-2,5,3,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,interleukin-2,5,3,(mU)/m 2,1,Monday through Friday,NA
8708712,NA,93,ifna-2a,5,1.5,mU/m 2,1,daily for a 4-week cycle,NA
8708712,NA,93,interleukin-2,6,3,(mU)/m 2,TIW,Monday through Friday,NA
8708712,NA,93,interleukin-2,6,3,(mU)/m 2,TIW,Monday through Friday,NA
8708712,NA,93,ifna-2a,6,2.5,mU/m 2,TIW,daily for a 4-week cycle,NA
26884555,NA,94,alisertib,1,45,mg/m2,1,on days 1 to 7,NA
26884555,NA,94,irinotecan,1,50,mg/m2,NA,NA,NA
26884555,NA,94,temozolomide,1,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,temozolomide,1,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,alisertib,1B,45,mg/m2,1,on days 1 to 7,NA
26884555,NA,94,irinotecan,1B,50,mg/m2,NA,NA,NA
26884555,NA,94,temozolomide,1B,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,temozolomide,1B,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,alisertib,2B,60,mg/m2,1,on days 1 to 7,NA
26884555,NA,94,irinotecan,2B,50,mg/m2,NA,NA,NA
26884555,NA,94,temozolomide,2B,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,temozolomide,2B,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,alisertib,3B,80,mg/m2,1,on days 1 to 7,NA
26884555,NA,94,irinotecan,3B,50,mg/m2,NA,NA,NA
26884555,NA,94,temozolomide,3B,100,mg/m2,NA,days 1 to 5,NA
26884555,NA,94,temozolomide,3B,100,mg/m2,NA,days 1 to 5,NA
23170896,NA,95,tp300,1,1,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,2,2,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,3,4,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,4,6,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,5,8,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,6,10,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
23170896,NA,95,tp300,7,12,mg/m2,NA,a 1-hour i.v. infusion 3-weekly,NA
22421195,NA,96,irinotecan,1,20,mg/m2,NA,days 0 to 4 and 7 to 11,NA
22421195,NA,96,vincristine,1,1.5,mg/m2,NA,days 0 and 7,NA
22421195,NA,96,mibg,1,8,mCi/kg,NA,on day 1,NA
22421195,NA,96,irinotecan,2,20,mg/m2,NA,days 0 to 4 and 7 to 11,NA
22421195,NA,96,vincristine,2,1.5,mg/m2,NA,days 0 and 7,NA
22421195,NA,96,mibg,2,12,mCi/kg,NA,on day 1,NA
22421195,NA,96,irinotecan,3,20,mg/m2,NA,days 0 to 4 and 7 to 11,NA
22421195,NA,96,vincristine,3,1.5,mg/m2,NA,days 0 and 7,NA
22421195,NA,96,mibg,3,15,mCi/kg,NA,on day 1,NA
22421195,NA,96,irinotecan,4,20,mg/m2,NA,days 0 to 4 and 7 to 11,NA
22421195,NA,96,vincristine,4,1.5,mg/m2,NA,days 0 and 7,NA
22421195,NA,96,mibg,4,18,mCi/kg,NA,on day 1,NA
34559360,NCT02124148,97,prexasertib,A1,20,mg/m2,NA,D1-Q3W,"20  mg/m2 (Cohort 1), 40  mg/m2 (Cohort 2), 70  mg/m2 (Cohort 3), 55  mg/m2 (Cohort 4), 45  mg/m2 (Cohort 5)"
34559360,NCT02124148,97,cisplatin,A1,75,mg/m2,NA,D1-Q3W,NA
34559360,NCT02124148,97,cisplatin,A1,75,mg/m2,NA,D1-Q3W,NA
34559360,NCT02124148,97,prexasertib,A2,40,mg/m2,NA,D1-Q3W,G-CSF 24 h after prexasertib dose
34559360,NCT02124148,97,cisplatin,A2,75,mg/m2,NA,D1-Q3W,"prexasertib escalation doses: 40  mg/m2 (Cohort 1), 50  mg/m2 (Cohort 2), 60  mg/m2 (Cohort 3), 70  mg/m2 (Cohort 4), 90  mg/m2 (Cohort 5), 105 mg/m2 (Cohort 6)"
34559360,NCT02124148,97,cisplatin,A2,75,mg/m2,NA,D1-Q3W,"prexasertib escalation doses: 40  mg/m2 (Cohort 1), 50  mg/m2 (Cohort 2), 60  mg/m2 (Cohort 3), 70  mg/m2 (Cohort 4), 90  mg/m2 (Cohort 5), 105 mg/m2 (Cohort 6)"
34559360,NCT02124148,97,prexasertib,A3,40,mg/m2,NA,D2-Q3W,", prexasertib escalation doses: 40 mg/m2 (Cohort 1), 60 mg/m2 (Cohort 2), 80 mg/m2 (Cohort 3), 90 mg/m2 (Cohort 4)"
34559360,NCT02124148,97,cisplatin,A3,75,mg/m2,NA,D1-Q3W,"expansion arm (n = 6), treated with prexasertib 80 mg/m2"
34559360,NCT02124148,97,cisplatin,A3,75,mg/m2,NA,D1-Q3W,"expansion arm (n = 6), treated with prexasertib 80 mg/m2"
34559360,NCT02124148,97,prexasertib,A3expansion,80,mg/m2,NA,D2-Q3W,NA
34559360,NCT02124148,97,cisplatin,A3expansion,75,mg/m2,NA,D1-Q3W,NA
34559360,NCT02124148,97,cisplatin,A3expansion,75,mg/m2,NA,D1-Q3W,NA
34559360,NCT02124148,98,prexasertib,B1,40,mg/m2,NA,Q2W,"prexasertib escalation doses: 40 mg/m2 (Cohort 1), 70 mg/m2 (Cohort 2), 60 mg/m2 (Cohort 3)"
34559360,NCT02124148,98,cetuximab,B1,400,mg/m2,NA,QW,NA
34559360,NCT02124148,98,prexasertib,B2,60,mg/m2,NA,Q2W,G-CSF 24 h after prexasertib dose
34559360,NCT02124148,98,cetuximab,B2,400,mg/m2,NA,QW,cetuximab administered per the approved label (400 mg/m2 loading dose followed by 250 mg/m2 weekly)
34559360,NCT02124148,98,prexasertib,B3,60,mg/m2,NA,D1-Q2W,"prexasertib escalation doses: 60 mg/m2 (Cohort 1), 50 mg/m2 (Cohort 2), 60 mg/m2 (Cohort 3), 70 mg/m2 (Cohort 4)"
34559360,NCT02124148,98,cetuximab,B3,500,mg/m2,NA,D1-Q2W,NA
34559360,NCT02124148,99,prexasertib,C1,40,mg/m2,NA,Q3W,split dose 20 mg/m2 on D1 and D2
34559360,NCT02124148,99,pemetrexed,C1,500,mg/m2,NA,D1-Q3W,NA
34559360,NCT02124148,100,prexasertib,D1,40,mg/m2,NA,NA,NA
34559360,NCT02124148,100,5-fluorouracil,D1,400,mg/m2,NA,D1/ D2,"400 mg/m2 bolus following leucovorin, then 240"
34559360,NCT02124148,100,leucovorin,D1,400,mg/m2,NA,D1-Q2W,NA
27871319,NCT02884128,101,pep02,1,60,mg/m2,NA,a 90-min intravenous infusion on day 1,dose expressed as the irinotecan hydrochloride trihydrate salt
27871319,NCT02884128,101,5-fluorouracil,1,"2,000",mg/m2,NA,24 h infusion,NA
27871319,NCT02884128,101,leucovorin,1,200,mg/m2,NA,"on days 1 and 8, every 3 weeks.",NA
27871319,NCT02884128,101,pep02,2,80,mg/m2,NA,a 90-min intravenous infusion on day 1,dose expressed as the irinotecan hydrochloride trihydrate salt
27871319,NCT02884128,101,5-fluorouracil,2,"2,000",mg/m2,NA,24 h infusion,NA
27871319,NCT02884128,101,leucovorin,2,200,mg/m2,NA,"on days 1 and 8, every 3 weeks.",NA
27871319,NCT02884128,101,pep02,3,100,mg/m2,NA,a 90-min intravenous infusion on day 1,dose expressed as the irinotecan hydrochloride trihydrate salt
27871319,NCT02884128,101,5-fluorouracil,3,"2,000",mg/m2,NA,24 h infusion,NA
27871319,NCT02884128,101,leucovorin,3,200,mg/m2,NA,"on days 1 and 8, every 3 weeks.",NA
27871319,NCT02884128,101,pep02,4,120,mg/m2,NA,a 90-min intravenous infusion on day 1,dose expressed as the irinotecan hydrochloride trihydrate salt
27871319,NCT02884128,101,5-fluorouracil,4,"2,000",mg/m2,NA,24 h infusion,NA
27871319,NCT02884128,101,leucovorin,4,200,mg/m2,NA,"on days 1 and 8, every 3 weeks.",NA
28573606,UMIN000004313,102,sorafenib,1,800,mg,daily,NA,NA
28573606,UMIN000004313,102,5-fluorouracil,1,250,mg/m2,NA,NA,NA
28573606,UMIN000004313,102,sorafenib,2,800,mg,daily,NA,NA
28573606,UMIN000004313,102,5-fluorouracil,2,350,mg/m2,NA,NA,NA
28573606,UMIN000004313,102,sorafenib,3,800,mg,daily,NA,NA
28573606,UMIN000004313,102,5-fluorouracil,3,450,mg/m2,NA,NA,NA
27189323,NA,103,s-1,1,80,mg/m2,2,for 14 days,NA
27189323,NA,103,nab-paclitaxel,1,180,mg/m2,NA,on day 1,NA
27189323,NA,103,s-1,2,80,mg/m2,2,for 14 days,NA
27189323,NA,103,nab-paclitaxel,2,220,mg/m2,NA,on day 1,NA
27189323,NA,103,nab-paclitaxel,1,260,mg/m2,NA,on day 1,NA
27189323,NA,104,s-1,1,80,mg/m2,2,for 14 days,NA
27189323,NA,104,nab-paclitaxel,1,180,mg/m2,NA,on day  8,NA
27189323,NA,104,s-1,2,80,mg/m2,2,for 14 days,NA
27189323,NA,104,nab-paclitaxel,2,220,mg/m2,NA,on day  8,NA
27189323,NA,104,nab-paclitaxel,1,260,mg/m2,NA,on day  8,NA
26490655,NCT01571024,105,mfolfox6,1,NA,NA,NA,NA,"oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, 5-FU bolus 400 mg/m2 and 5-FU infusion 2400 mg/m2 over 46 h"
26490655,NCT01571024,105,bkm120,1,40,mg,NA,NA,NA
26490655,NCT01571024,105,mfolfox6,2,NA,NA,NA,NA,"oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, 5-FU bolus 400 mg/m2 and 5-FU infusion 2400 mg/m2 over 46 h"
26490655,NCT01571024,105,bkm120,2,60,mg,NA,NA,NA
26490655,NCT01571024,105,mfolfox6,3,NA,NA,NA,NA,"oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, 5-FU bolus 400 mg/m2 and 5-FU infusion 2400 mg/m2 over 46 h"
26490655,NCT01571024,105,bkm120,3,80,mg,NA,NA,NA
34050586,UMIN000017002,106,oxaliplatin,0,85,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,oxaliplatin,0,85,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,irinotecan,0,100,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,s-1,0,80,mg/m2,2,"on days 1–14, followed by 14 days of rest (one cycle)",NA
34050586,UMIN000017002,106,oxaliplatin,-1,65,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,oxaliplatin,-1,65,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,irinotecan,-1,100,mg/m2,NA,on days 1 and 15,NA
34050586,UMIN000017002,106,s-1,-1,80,mg/m2,2,"on days 1–14, followed by 14 days of rest (one cycle)",NA
26220846,NA,107,fdrgem,1,300,mg/m2,NA,"days 1, 8, 22, and 29",NA
26220846,NA,107,s‑1,1,60,mg/m2,NA,"on days 1–14, 22–35",NA
26220846,NA,107,radiation,1,50,Gy,NA,NA,NA
26220846,NA,107,fdrgem,2,400,mg/m2,NA,"days 1, 8, 22, and 29",NA
26220846,NA,107,s‑1,2,60,mg/m2,NA,"on days 1–14, 22–35",NA
26220846,NA,107,radiation,2,50,Gy,NA,NA,NA
26220846,NA,107,fdrgem,3,500,mg/m2,NA,"days 1, 8, 22, and 29",NA
26220846,NA,107,s‑1,3,60,mg/m2,NA,"on days 1–14, 22–35",NA
26220846,NA,107,radiation,3,50,Gy,NA,NA,NA
32669374,NCT01489865,108,veliparib,1,40,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,1,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,1,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,1,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,veliparib,2,60,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,2,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,2,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,2,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,veliparib,3,80,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,3,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,3,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,3,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,veliparib,4,100,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,4,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,4,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,4,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,veliparib,5,150,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,5,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,5,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,oxaliplatin,5,400,mg/m2,NA,day 1,NA
32669374,NCT01489865,108,veliparib,6,200,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,6,400,mg/m2,NA,NA,NA
32669374,NCT01489865,108,oxaliplatin,6,400,mg/m2,NA,NA,NA
32669374,NCT01489865,108,oxaliplatin,6,400,mg/m2,NA,NA,NA
32669374,NCT01489865,108,veliparib,7,250,mg,2,days 1–7 of each 14-day cycle,NA
32669374,NCT01489865,108,5-fluorouracil,7,400,mg/m2,NA,NA,NA
32669374,NCT01489865,108,oxaliplatin,7,400,mg/m2,NA,NA,NA
32669374,NCT01489865,108,oxaliplatin,7,400,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,cetuximab,1,400,mg/m2,NA,weekly,400 mg/m2 at week 1 and subsequently 250 mg/m2
33386556,UMIN000015620,109,irinotecan,1,100,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,1,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,1,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,l-leucovorin,1,200,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,5-fluorouracil,1,2400,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,cetuximab,2,400,mg/m2,NA,weekly,400 mg/m2 at week 1 and subsequently 250 mg/m2
33386556,UMIN000015620,109,irinotecan,2,120,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,2,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,2,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,l-leucovorin,2,200,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,5-fluorouracil,2,2400,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,cetuximab,3,400,mg/m2,NA,weekly,400 mg/m2 at week 1 and subsequently 250 mg/m2
33386556,UMIN000015620,109,irinotecan,3,150,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,3,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,oxaliplatin,3,85,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,l-leucovorin,3,200,mg/m2,NA,NA,NA
33386556,UMIN000015620,109,5-fluorouracil,3,2400,mg/m2,NA,NA,NA
29691300,NA,110,andecaliximab,1,200,mg,NA,every 2 weeks (q2w),NA
29691300,NA,110,andecaliximab,2,600,mg,NA,every 2 weeks (q2w),NA
29691300,NA,110,andecaliximab,3,1800,mg,NA,every 2 weeks (q2w),NA
29691300,NA,111,andecaliximab,1,800,mg,NA,on days 1 and 15 of each 28-day cycle,NA
29691300,NA,111,5-fluorouracil,1,400,mg/m2,NA,days 1 and 15 of each 28-day cycle,"5-fluorouracil bolus (400 mg/m2), followed by a 46-hour infusion of 5-fluorouracil (2,400 mg/m2)."
29691300,NA,111,leucovorin,1,200,mg/m2,NA,days 1 and 15 of each 28-day cycle,NA
29691300,NA,111,oxaliplatin,1,85,mg/m2,NA,days 1 and 15 of each 28-day cycle,NA
29691300,NA,111,oxaliplatin,1,85,mg/m2,NA,days 1 and 15 of each 28-day cycle,NA
31185328,NA,112,panitumumab,0,3,mg/kg,NA,NA,NA
31185328,NA,112,5-fu,0,600,mg/m2/day,NA,NA,NA
31185328,NA,112,panitumumab,1,3,mg/kg,NA,NA,NA
31185328,NA,112,5-fu,1,400,mg/m2/day,NA,NA,NA
31558477,NA,113,5-fluorouracil,1,2400,mg/m2,over 46 hours,every 14 days,NA
31558477,NA,113,leucovorin,1,400,mg/m2,NA,every 14 days,NA
31558477,NA,113,nab-paclitaxel,1,125,mg/m2,NA,every 14 days,NA
31558477,NA,113,irinotecan,1,180,mg/m2,NA,every 14 days,NA
31558477,NA,113,irinotecan,1,135,mg/m2,NA,every 14 days,NA
31558477,NA,113,irinotecan,1,90,mg/m2,NA,every 14 days,NA
33985455,ChiCTR1900027833,114,gemcitabine,1,1000,mg/m2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,nabpaclitaxel,1,125,mg/m 2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,s-1,1,40,mg,NA,NA,NA
33985455,ChiCTR1900027833,114,gemcitabine,2,1000,mg/m2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,nabpaclitaxel,2,125,mg/m 2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,s-1,2,60,mg,NA,NA,NA
33985455,ChiCTR1900027833,114,gemcitabine,3,1000,mg/m2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,nabpaclitaxel,3,125,mg/m 2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,s-1,3,80,mg,NA,NA,NA
33985455,ChiCTR1900027833,114,gemcitabine,4,1000,mg/m2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,nabpaclitaxel,4,125,mg/m 2,"day1, 8",NA,NA
33985455,ChiCTR1900027833,114,s-1,4,100,mg,NA,NA,NA
28489753,UMIN000005808,115,oxaliplatin,0,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,oxaliplatin,0,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,irinotecan,0,100,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,leucovorin,0,400,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,5-fluorouracil,0,400,mg/m2,NA,400 mg/m2 5-fluorouracil (5-FU) as a bolus on day 1 and 2400 mg/m2 5-FU as a 46-hour continuous infusion biweekly.,NA
28489753,UMIN000005808,115,oxaliplatin,1,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,oxaliplatin,1,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,irinotecan,1,125,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,leucovorin,1,400,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,5-fluorouracil,1,400,mg/m2,NA,400 mg/m2 5-fluorouracil (5-FU) as a bolus on day 1 and 2400 mg/m2 5-FU as a 46-hour continuous infusion biweekly.,NA
28489753,UMIN000005808,115,oxaliplatin,2,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,oxaliplatin,2,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,irinotecan,2,150,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,leucovorin,2,400,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,5-fluorouracil,2,400,mg/m2,NA,400 mg/m2 5-fluorouracil (5-FU) as a bolus on day 1 and 2400 mg/m2 5-FU as a 46-hour continuous infusion biweekly.,NA
28489753,UMIN000005808,115,oxaliplatin,3,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,oxaliplatin,3,85,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,irinotecan,3,180,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,leucovorin,3,400,mg/m2,NA,NA,NA
28489753,UMIN000005808,115,5-fluorouracil,3,400,mg/m2,NA,400 mg/m2 5-fluorouracil (5-FU) as a bolus on day 1 and 2400 mg/m2 5-FU as a 46-hour continuous infusion biweekly.,NA
30511200,NA,116,tas-114,1,5,mg/m2,2,NA,NA
30511200,NA,116,s-1,1,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,2,10,mg/m2,2,NA,NA
30511200,NA,116,s-1,2,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,3,20,mg/m2,2,NA,NA
30511200,NA,116,s-1,3,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,4,40,mg/m2,2,NA,NA
30511200,NA,116,s-1,4,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,5,60,mg/m2,2,NA,NA
30511200,NA,116,s-1,5,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,6,90,mg/m2,2,NA,NA
30511200,NA,116,s-1,6,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,7,120,mg/m2,2,NA,NA
30511200,NA,116,s-1,7,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,8,160,mg/m2,2,NA,NA
30511200,NA,116,s-1,8,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,9,200,mg/m2,2,NA,NA
30511200,NA,116,s-1,9,30,mg/m2,2,NA,NA
30511200,NA,116,tas-114,10,240,mg/m2,2,NA,NA
30511200,NA,116,s-1,10,30,mg/m2,2,NA,NA
33957442,NA,117,irinotecan,1,70,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,1,60,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,1,60,mg/m2,NA,NA,NA
33957442,NA,117,5-fluorouracil,1,2400,mg/m2,NA,NA,NA
33957442,NA,117,leucovorin,1,400,mg/m2,NA,NA,NA
33957442,NA,117,irinotecan,2,50,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,2,60,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,2,60,mg/m2,NA,NA,NA
33957442,NA,117,5-fluorouracil,2,2400,mg/m2,NA,NA,NA
33957442,NA,117,leucovorin,2,400,mg/m2,NA,NA,NA
33957442,NA,117,irinotecan,3,50,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,3,85,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,3,85,mg/m2,NA,NA,NA
33957442,NA,117,5-fluorouracil,3,2400,mg/m2,NA,NA,NA
33957442,NA,117,leucovorin,3,400,mg/m2,NA,NA,NA
33957442,NA,117,irinotecan,4,55,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,4,70,mg/m2,NA,NA,NA
33957442,NA,117,oxaliplatin,4,70,mg/m2,NA,NA,NA
33957442,NA,117,5-fluorouracil,4,2400,mg/m2,NA,NA,NA
33957442,NA,117,leucovorin,4,400,mg/m2,NA,NA,NA
27979915,NCT01172964,118,cd-nscs,1,1X10^7,NA,NA,NA,NA
27979915,NCT01172964,118,5-fc,1,75,mg/kg,NA,every 6 hours for 7 days.,NA
27979915,NCT01172964,118,cd-nscs,2,1X10^7,NA,NA,NA,NA
27979915,NCT01172964,118,5-fc,2,150,mg/kg,NA,every 6 hours for 7 days.,NA
27979915,NCT01172964,118,cd-nscs,3,5X10^7,NA,NA,NA,NA
27979915,NCT01172964,118,5-fc,3,150,mg/kg,NA,every 6 hours for 7 days.,NA
28058527,NA,119,oxaliplatin,1,50,mg/m2,NA,NA,NA
28058527,NA,119,oxaliplatin,1,50,mg/m2,NA,NA,NA
28058527,NA,119,5-fluorouracil,1,200,mg/m2,NA,NA,200 mg/m2 bolus and 2400 mg/m2/46-h continuous infusion
28058527,NA,119,l-leucovorin,1,200,mg/m2,NA,NA,NA
28058527,NA,119,oxaliplatin,2,100,mg/m2,NA,NA,NA
28058527,NA,119,oxaliplatin,2,100,mg/m2,NA,NA,NA
28058527,NA,119,5-fluorouracil,2,200,mg/m2,NA,NA,200 mg/m2 bolus and 2400 mg/m2/46-h continuous infusion
28058527,NA,119,l-leucovorin,2,200,mg/m2,NA,NA,NA
32877909,NA,120,nab-paclitaxel,1,50,mg/m2,NA,on days 1 and 8,NA
32877909,NA,120,s-1,1,80,mg/m2,NA,for 2 weeks,NA
32877909,NA,120,oxaliplatin,1,100,mg/m2,NA,on day 1,NA
32877909,NA,120,oxaliplatin,1,100,mg/m2,NA,on day 1,NA
32877909,NA,120,nab-paclitaxel,2,80,mg/m2,NA,on days 1 and 8,NA
32877909,NA,120,s-1,2,80,mg/m2,NA,for 2 weeks,NA
32877909,NA,120,oxaliplatin,2,100,mg/m2,NA,on day 1,NA
32877909,NA,120,oxaliplatin,2,100,mg/m2,NA,on day 1,NA
27155613,UMIN000006396,121,s-1,1,80,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,1,100,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,1,100,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,s-1,2,80,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,2,130,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,2,130,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,s-1,0,65,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,0,100,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27155613,UMIN000006396,121,oxaliplatin,0,100,mg/m2,NA,day 1 to day 14 of a 3-week cycle,NA
27745984,NCT00188266,122,cisplatin,1,0,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,1,0,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,5-fluorouracil,1,200,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,2,20,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,2,20,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,5-fluorouracil,2,200,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,3,30,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,3,30,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,5-fluorouracil,3,200,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,4,40,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,4,40,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,5-fluorouracil,4,200,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,5,40,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,cisplatin,5,40,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
27745984,NCT00188266,122,5-fluorouracil,5,200,mg/m2,NA,"during weeks 1, 3, 5, and 7,",NA
32642753,UMIN000012135,123,s-1,1,40,mg/m2,2,from days 1 to 14 and 22 to 35.,NA
32642753,UMIN000012135,123,carbon-ion radiotherapy,1,70.4,Gy,NA,5 days a week,NA
32642753,UMIN000012135,123,s-1,2,60,mg/m2,2,from days 1 to 14 and 22 to 35.,NA
32642753,UMIN000012135,123,carbon-ion radiotherapy,2,70.4,Gy,NA,5 days a week,NA
32642753,UMIN000012135,123,s-1,3,80,mg/m2,2,from days 1 to 14 and 22 to 35.,NA
32642753,UMIN000012135,123,carbon-ion radiotherapy,3,70.4,Gy,NA,5 days a week,NA
30191522,NCT02319018,124,alisertib,1,10,mg,2,twice daily (Days 1–3),NA
30191522,NCT02319018,124,leucovorin,1,400,mg/m2,NA,NA,NA
30191522,NCT02319018,124,oxaliplatin,1,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,oxaliplatin,1,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,5-fu,1,2400,mg/m2,NA,Days2–4 in 14-day cycles,NA
30191522,NCT02319018,124,alisertib,2,20,mg,2,twice daily (Days 1–3),NA
30191522,NCT02319018,124,leucovorin,2,400,mg/m2,NA,NA,NA
30191522,NCT02319018,124,oxaliplatin,2,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,oxaliplatin,2,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,5-fu,2,2400,mg/m2,NA,Days2–4 in 14-day cycles,NA
30191522,NCT02319018,124,alisertib,3,30,mg,2,twice daily (Days 1–3),NA
30191522,NCT02319018,124,leucovorin,3,400,mg/m2,NA,NA,NA
30191522,NCT02319018,124,oxaliplatin,3,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,oxaliplatin,3,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,5-fu,3,2400,mg/m2,NA,Days2–4 in 14-day cycles,NA
30191522,NCT02319018,124,alisertib,4,40,mg,2,twice daily (Days 1–3),NA
30191522,NCT02319018,124,leucovorin,4,400,mg/m2,NA,NA,NA
30191522,NCT02319018,124,oxaliplatin,4,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,oxaliplatin,4,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,5-fu,4,2400,mg/m2,NA,Days2–4 in 14-day cycles,NA
30191522,NCT02319018,124,alisertib,5,50,mg,2,twice daily (Days 1–3),NA
30191522,NCT02319018,124,leucovorin,5,400,mg/m2,NA,NA,NA
30191522,NCT02319018,124,oxaliplatin,5,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,oxaliplatin,5,85,mg/m2,NA,on Day 2,NA
30191522,NCT02319018,124,5-fu,5,2400,mg/m2,NA,Days2–4 in 14-day cycles,NA
26597443,NCT01621217.,125,cetuximab,-1,400,mg/m2,NA,NA,250mg/m2 weekily
26597443,NCT01621217.,125,5-fluorouracil,-1,800,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,mitomycin c,-1,6,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,cetuximab,0,400,mg/m2,NA,NA,250mg/m2 weekily
26597443,NCT01621217.,125,5-fluorouracil,0,800,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,mitomycin c,0,8,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,cetuximab,1,400,mg/m2,NA,NA,250mg/m2 weekily
26597443,NCT01621217.,125,5-fluorouracil,1,1000,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,mitomycin c,1,8,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,cetuximab,2,400,mg/m2,NA,NA,250mg/m2 weekily
26597443,NCT01621217.,125,5-fluorouracil,2,1000,mg/m2,NA,NA,NA
26597443,NCT01621217.,125,mitomycin c,2,10,mg/m2,NA,NA,NA
25989270,NA,126,pimasertib,1,45,mg,NA,a 5-day on/2-day off schedule continuously during the cycle,NA
25989270,NA,126,folfiri,1,NA,NA,NA,days 1 and 15 of each cycle.,"irinotecan (180 mg m - 2) and FA (l-leucovorin/FA 200 mg m - 2 or DL-leucovorin 400 mg m - 2, 90-min infusion), followed by 5-FU (400 mg m 2 2 bolus then 2400 mg m -2 46-h infusion)."
25989270,NA,126,pimasertib,2,60,mg,NA,a 5-day on/2-day off schedule continuously during the cycle,NA
25989270,NA,126,folfiri,2,NA,NA,NA,days 1 and 15 of each cycle.,"irinotecan (180 mg m - 2) and FA (l-leucovorin/FA 200 mg m - 2 or DL-leucovorin 400 mg m - 2, 90-min infusion), followed by 5-FU (400 mg m 2 2 bolus then 2400 mg m -2 46-h infusion)."
26025485,NA,127,s-1,1,40,mg/m2,2,from day 1 to 5 per week,NA
26025485,NA,127,postoperative radiotherapy,1,NA,NA,NA,NA,NA
26025485,NA,127,s-1,2,50,mg/m2,2,from day 1 to 5 per week,NA
26025485,NA,127,postoperative radiotherapy,2,NA,NA,NA,NA,NA
26025485,NA,127,s-1,3,60,mg/m2,2,from day 1 to 5 per week,NA
26025485,NA,127,postoperative radiotherapy,3,NA,NA,NA,NA,NA
26025485,NA,127,s-1,4,70,mg/m2,2,from day 1 to 5 per week,NA
26025485,NA,127,postoperative radiotherapy,4,NA,NA,NA,NA,NA
26025485,NA,127,s-1,5,80,mg/m2,2,from day 1 to 5 per week,NA
26025485,NA,127,postoperative radiotherapy,5,NA,NA,NA,NA,NA
26861740,NCT01376453,128,5-fu,1,225,mg/m2/24 h,NA,NA,NA
26861740,NCT01376453,128,sorafenib,1,200,mg,1,qd,NA
26861740,NCT01376453,128,radiation,1,50.4,Gy,NA,day 1–5,NA
26861740,NCT01376453,128,5-fu,2,225,mg/m2/24 h,NA,NA,NA
26861740,NCT01376453,128,sorafenib,2,200,mg,2,NA,NA
26861740,NCT01376453,128,radiation,2,50.4,Gy,NA,day 1–5,NA
29995287,"apicCTI-152,864",129,resminostat,1,200,mg,qd,on Days 1 to 14.,NA
29995287,"apicCTI-152,864",129,resminostat,2,200,mg,qd,on Days 1 to 14.,NA
29995287,"apicCTI-152,864",129,s-1,2,80-120,mg,bid,on Days 1 to 14.,NA
29995287,"apicCTI-152,864",129,resminostat,3,200,mg,qd,on Days 1 to 5 and Days 8 to 12: 5 days on/2 days off,NA
29995287,"apicCTI-152,864",129,s-1,3,80-120,mg,bid,on Days 1 to 14.,NA
30121935,NA,130,s-1,1,80,mg/m2,2,days 1–14 every 3 weeks,NA
30121935,NA,130,paclitaxel,1,60,mg/m2,NA,on day 1 and 8,NA
30121935,NA,130,s-1,2,80,mg/m2,2,days 1–14 every 3 weeks,NA
30121935,NA,130,paclitaxel,2,70,mg/m2,NA,on day 1 and 8,NA
30121935,NA,130,s-1,3,80,mg/m2,2,days 1–14 every 3 weeks,NA
30121935,NA,130,paclitaxel,3,80,mg/m2,NA,on day 1 and 8,NA
30121935,NA,130,paclitaxel,1,90,mg/m2,NA,on day 1 and 8,NA
26163340,JapicCTI-132099,131,tas-102,0,40,mg/m2,2,"for 5 days a week with 2 days rest for 2 weeks, followed by a 14-day rest",NA
26163340,JapicCTI-132099,131,irinotecan,0,150,mg/m2,NA,on Days 1 and 15 of a 28-day schedule,NA
26163340,JapicCTI-132099,131,tas-102,1,50,mg/m2,2,"for 5 days a week with 2 days rest for 2 weeks, followed by a 14-day rest",NA
26163340,JapicCTI-132099,131,irinotecan,1,150,mg/m2,NA,on Days 1 and 15 of a 28-day schedule,NA
26163340,JapicCTI-132099,131,tas-102,2,60,mg/m2,2,"for 5 days a week with 2 days rest for 2 weeks, followed by a 14-day rest",NA
26163340,JapicCTI-132099,131,irinotecan,2,150,mg/m2,NA,on Days 1 and 15 of a 28-day schedule,NA
26163340,JapicCTI-132099,131,tas-102,3,70,mg/m2,2,"for 5 days a week with 2 days rest for 2 weeks, followed by a 14-day rest",NA
26163340,JapicCTI-132099,131,irinotecan,3,150,mg/m2,NA,on Days 1 and 15 of a 28-day schedule,NA
8120556,NA,132,fludarabine,0,20,mg/m2,NA,for 2 consecutive days,NA
8120556,NA,132,mitoxantrone,0,8,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,0,20,mg,NA,for 5 consecutive days,NA
8120556,NA,132,fludarabine,1,25,mg/m2,NA,for 2 consecutive days,NA
8120556,NA,132,mitoxantrone,1,8,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,1,20,mg,NA,for 5 consecutive days,NA
8120556,NA,132,fludarabine,2,20,mg/m2,NA,for 3 consecutive days,NA
8120556,NA,132,mitoxantrone,2,8,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,2,20,mg,NA,for 5 consecutive days,NA
8120556,NA,132,fludarabine,3,20,mg/m2,NA,for 3 consecutive days,NA
8120556,NA,132,mitoxantrone,3,10,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,3,20,mg,NA,for 5 consecutive days,NA
8120556,NA,132,fludarabine,4,25,mg/m2,NA,for 3 consecutive days,NA
8120556,NA,132,mitoxantrone,4,10,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,4,20,mg,NA,for 5 consecutive days,NA
8120556,NA,132,fludarabine,5,25,mg/m2,NA,for 3 consecutive days,NA
8120556,NA,132,mitoxantrone,5,12,mg/m2,NA,NA,NA
8120556,NA,132,dexamethasone,5,20,mg,NA,for 5 consecutive days,NA
27919976,UMIN 000016377,133,nab-paclitaxel,0,180,mg/m2,NA,on day 1,NA
27919976,UMIN 000016377,133,s-1,0,65,mg/m2,NA,"on days 1-14,",NA
27919976,UMIN 000016377,133,nab-paclitaxel,1,220,mg/m2,NA,on day 1,NA
27919976,UMIN 000016377,133,s-1,1,65,mg/m2,NA,"on days 1-14,",NA
27919976,UMIN 000016377,133,nab-paclitaxel,2,260,mg/m2,NA,on day 1,NA
27919976,UMIN 000016377,133,s-1,2,65,mg/m2,NA,"on days 1-14,",NA
27919976,UMIN 000016377,133,nab-paclitaxel,3,260,mg/m2,NA,on day 1,NA
27919976,UMIN 000016377,133,s-1,3,80,mg/m2,NA,"on days 1-14,",NA
26019463,NA,134,gemcitabine,-1,800,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,-1,20,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,-1,20,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,s-1,-1,60,mg/m2,2,"days 1 to 7 and days 15 to 21, every 4 wk.",NA
26019463,NA,134,gemcitabine,0,800,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,0,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,0,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,s-1,0,60,mg/m2,2,"days 1 to 7 and days 15 to 21, every 4 wk.",NA
26019463,NA,134,gemcitabine,1,1000,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,1,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,1,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,s-1,1,60,mg/m2,2,"days 1 to 7 and days 15 to 21, every 4 wk.",NA
26019463,NA,134,gemcitabine,2,1000,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,2,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,cisplatin,2,25,mg/m2,NA,days 1 and 15,NA
26019463,NA,134,s-1,2,80,mg/m2,2,"days 1 to 7 and days 15 to 21, every 4 wk.",NA
26275531,NA,135,pasireotide,1,40,mg,NA,28 days,NA
26275531,NA,135,folfiri,1,NA,NA,NA,on days 1 and 15 of of 28day cycle,"onsisting of irinotecan 180 mg/m2 IVover 90 min, leucovorin 400 mg/m2 IVover 2 h, 5-fluorouracil 400 mg/m2 bolus followed by 5-fluorouracil 2400 mg/m2 over 46 h"
26275531,NA,135,pasireotide,2,60,mg,NA,28 days,NA
26275531,NA,135,folfiri,2,NA,NA,NA,on days 1 and 15 of of 28day cycle,"onsisting of irinotecan 180 mg/m2 IVover 90 min, leucovorin 400 mg/m2 IVover 2 h, 5-fluorouracil 400 mg/m2 bolus followed by 5-fluorouracil 2400 mg/m2 over 46 h"
26275531,NA,135,pasireotide,3,80,mg,NA,28 days,NA
26275531,NA,135,folfiri,3,NA,NA,NA,on days 1 and 15 of of 28day cycle,"onsisting of irinotecan 180 mg/m2 IVover 90 min, leucovorin 400 mg/m2 IVover 2 h, 5-fluorouracil 400 mg/m2 bolus followed by 5-fluorouracil 2400 mg/m2 over 46 h"
26275531,NA,135,pasireotide,4,100,mg,NA,28 days,NA
26275531,NA,135,folfiri,4,NA,NA,NA,on days 1 and 15 of of 28day cycle,"onsisting of irinotecan 180 mg/m2 IVover 90 min, leucovorin 400 mg/m2 IVover 2 h, 5-fluorouracil 400 mg/m2 bolus followed by 5-fluorouracil 2400 mg/m2 over 46 h"
26275531,NA,135,pasireotide,5,120,mg,NA,28 days,NA
26275531,NA,135,folfiri,5,NA,NA,NA,on days 1 and 15 of of 28day cycle,"onsisting of irinotecan 180 mg/m2 IVover 90 min, leucovorin 400 mg/m2 IVover 2 h, 5-fluorouracil 400 mg/m2 bolus followed by 5-fluorouracil 2400 mg/m2 over 46 h"
32253228,NA,136,trametinib,-1,0.5,mg,NA,a 5-day lead-in period daily Monday–Friday starting at day –7,NA
32253228,NA,136,5-fu,-1,200,mg/m2,NA,NA,NA
32253228,NA,136,trametinib,1,0.5,mg,NA,a 5-day lead-in period daily Monday–Friday starting at day –7,NA
32253228,NA,136,5-fu,1,225,mg/m2,NA,NA,NA
32253228,NA,136,trametinib,2,1,mg,NA,a 5-day lead-in period daily Monday–Friday starting at day –7,NA
32253228,NA,136,5-fu,2,225,mg/m2,NA,NA,NA
32253228,NA,136,trametinib,2a,1.5,mg,NA,a 5-day lead-in period daily Monday–Friday starting at day –7,NA
32253228,NA,136,5-fu,2a,225,mg/m2,NA,NA,NA
32253228,NA,136,trametinib,3,2,mg,NA,a 5-day lead-in period daily Monday–Friday starting at day –7,NA
32253228,NA,136,5-fu,3,225,mg/m2,NA,NA,NA
26117830,JapicCTI-090973,137,s-1,0,"60, 80, 100",mg,NA,days 1–28 of a 42-day,NA
26117830,JapicCTI-090973,137,sorafenib,0,400,mg,NA,days 1–42,NA
26117830,JapicCTI-090973,137,s-1,1a,"80,100,120",mg,NA,days 1–28 of a 42-day,NA
26117830,JapicCTI-090973,137,sorafenib,1a,400,mg,NA,NA,NA
26117830,JapicCTI-090973,137,s-1,1b,"60,80,100",mg,NA,days 1–28 of a 42-day,NA
26117830,JapicCTI-090973,137,sorafenib,1b,800,mg,NA,NA,NA
26117830,JapicCTI-090973,137,s-1,2,"80, 100 or 120",mg,NA,days 1–28 of a 42-day,NA
26117830,JapicCTI-090973,137,sorafenib,2,800,mg,NA,NA,NA
32977220,NCT02504333,138,nab-paclitaxel,1,125,mg/m2,NA,NA,NA
32977220,NCT02504333,138,gemcitabine,1,1000,mg/m2,NA,"on days 1, 8 and 15",NA
32977220,NCT02504333,138,folfox,1,NA,NA,NA,on day 28,"oxaliplatin [85 mg/ m2], 5-FU bolus [400mg/m2], 5-FU infusion [2400mg/m2])"
32977220,NCT02504333,138,nab-paclitaxel,2,125,mg/m2,NA,NA,NA
32977220,NCT02504333,138,gemcitabine,2,1000,mg/m2,NA,"on days 1, 8 and 15",NA
32977220,NCT02504333,138,folfox,2,NA,NA,NA,on day 28,"oxaliplatin [75mg/ m2], 5-FU bolus [300 mg/m2], 5-FU infusion [2000mg/m2])"
32977220,NCT02504333,138,nab-paclitaxel,3,100,mg/m2,NA,NA,NA
32977220,NCT02504333,138,gemcitabine,3,800,mg/m2,NA,"on days 1, 8 and 15",NA
32977220,NCT02504333,138,folfox,3,NA,NA,NA,on day 28,"oxaliplatin [75 mg/ m2], 5-FU bolus [300 mg/m2], 5-FU infusion [2000 mg/m2])"
32977220,NCT02504333,138,nab-paclitaxel,4,100,mg/m2,NA,NA,NA
32977220,NCT02504333,138,gemcitabine,4,800,mg/m2,NA,"on days 1, 8 and 15",NA
32977220,NCT02504333,138,folfox,4,NA,NA,NA,on day 28,"oxaliplatin [65 mg/ m2], 5-FU bolus [200 mg/m2], 5-FU infusion [1600 mg/m2])"
32710148,UMIN000023277,139,ramucirumab,0,150,mg/ m2,NA,NA,NA
32710148,UMIN000023277,139,folfoxiri,0,NA,NA,NA,NA,fluorouracil 2400 mg/m2
32710148,UMIN000023277,139,ramucirumab,1,165,mg/ m2,NA,NA,NA
32710148,UMIN000023277,139,folfoxiri,1,NA,NA,NA,NA,"165 mg/m2 of irinotecan, 85 mg/m2 of oxaliplatin, 200 mg/m2 of l-leucovorin, and 3200 mg/m2 of fluorouracil."
32694153,NA,140,ipafricept,1,3.5,mg/kg,Q2W,"days 1, 15",NA
32694153,NA,140,gemcitabine,1,125,mg/m2,NA,NA,NA
32694153,NA,140,nab-paclitaxel,1,"1,000",mg/m2,NA,NA,NA
32694153,NA,140,ipafricept,2,3,mg/kg,Q4W,"days 1, 15",NA
32694153,NA,140,gemcitabine,2,125,mg/m2,NA,NA,NA
32694153,NA,140,nab-paclitaxel,2,"1,000",mg/m2,NA,NA,NA
32694153,NA,140,ipafricept,3,5,mg/kg,Q4W,"days 1, 15",NA
32694153,NA,140,gemcitabine,3,125,mg/m2,NA,NA,NA
32694153,NA,140,nab-paclitaxel,3,"1,000",mg/m2,NA,NA,NA
32694153,NA,140,ipafricept,4,5,mg/kg,Q4W,"days 1, 15",NA
32694153,NA,140,gemcitabine,4,125,mg/m2,NA,NA,NA
32694153,NA,140,nab-paclitaxel,4,"1,000",mg/m2,NA,NA,NA